rp_entity_id,category,relevance,ess,rpna_date_utc
03D5F9,legal-issues-defendant,100,22,1/1/2019
147C38,unit-acquisition-completed-acquiree,100,67,1/1/2019
147C38,unit-acquisition-acquiree,100,76,1/1/2019
147C38,unit-acquisition-completed-acquiree,100,67,1/1/2019
152E1D,legal-issues-defendant,100,22,1/1/2019
1FE3CB,acquisition-completed-acquirer,100,49,1/1/2019
251988,asset-sale,100,62,1/1/2019
251988,asset-sale,100,62,1/1/2019
2CB4C9,unit-acquisition-completed-acquirer,100,49,1/1/2019
2CB4C9,unit-acquisition-acquirer,100,49,1/1/2019
3D9999,legal-issues-defendant,100,22,1/1/2019
4.00E+163,legal-issues-defendant,100,22,1/1/2019
43A74A,business-contract,100,69,1/1/2019
86A1B9,business-contract,100,69,1/1/2019
AE7D16,legal-issues-defendant,100,22,1/1/2019
B8EF97,legal-issues-defendant,100,22,1/1/2019
FAE021,award,100,58,1/1/2019
FF6644,legal-issues-defendant,100,22,1/1/2019
48590,executive-appointment,100,54,1/2/2019
05AF14,unit-acquisition-acquiree,100,76,1/2/2019
081AB9,buybacks,100,74,1/2/2019
081AB9,conference-call,100,50,1/2/2019
95294,legal-issues-defendant,100,22,1/2/2019
0B400D,acquisition-completed-acquirer,100,49,1/2/2019
0B7375,conference-participant,100,50,1/2/2019
0C466B,executive-appointment,100,54,1/2/2019
0E439E,earnings,100,50,1/2/2019
0E499E,conference-participant,100,50,1/2/2019
0F0693,conference-participant,100,50,1/2/2019
106394,acquisition-completed-acquirer,100,49,1/2/2019
10C19B,dividend-up,100,81,1/2/2019
1220D2,conference-participant,100,50,1/2/2019
12E454,earnings,100,50,1/2/2019
147C38,executive-appointment,100,54,1/2/2019
14833D,legal-issues-defendant,100,22,1/2/2019
18D9FA,fundraising,100,64,1/2/2019
1A2D9F,earnings,100,50,1/2/2019
1EBF8D,conference-participant,100,50,1/2/2019
1FC422,conference-participant,100,50,1/2/2019
2082EA,executive-appointment,100,54,1/2/2019
219B21,executive-appointment,100,54,1/2/2019
221AD7,earnings,100,50,1/2/2019
228D42,partnership,100,61,1/2/2019
2920D5,acquisition-completed-acquiree,100,76,1/2/2019
2920D5,conference-participant,100,50,1/2/2019
2AA6A8,conference-participant,100,50,1/2/2019
2B0AF4,conference-call,100,50,1/2/2019
2C19A4,dividend,100,50,1/2/2019
2C681C,conference-participant,100,50,1/2/2019
2C681C,conference-participant,100,50,1/2/2019
2EB88B,unit-acquisition-completed-acquirer,100,49,1/2/2019
30DFD3,conference-call,100,50,1/2/2019
31553A,earnings,100,50,1/2/2019
31F25C,merger-completed,100,66,1/2/2019
328250,merger-completed,100,66,1/2/2019
32F943,conference-participant,100,50,1/2/2019
339F20,merger-completed,100,66,1/2/2019
341759,conference-participant,100,50,1/2/2019
367E1C,conference-participant,100,50,1/2/2019
36E479,executive-appointment,100,54,1/2/2019
370C50,acquisition-completed-acquirer,100,49,1/2/2019
37727A,executive-appointment,100,54,1/2/2019
382EAE,acquisition-completed-acquirer,100,49,1/2/2019
385DD4,legal-issues-defendant,100,22,1/2/2019
385DD4,legal-issues-defendant,100,22,1/2/2019
3A94DF,acquisition-completed-acquirer,100,49,1/2/2019
3AF7FD,conference-call,100,50,1/2/2019
3C11C4,executive-appointment,100,54,1/2/2019
3C7F5F,partnership,100,61,1/2/2019
3C7F5F,earnings,100,50,1/2/2019
3D9999,legal-issues-defendant,100,22,1/2/2019
3DDE54,conference-participant,100,50,1/2/2019
408089,earnings,100,50,1/2/2019
40F7DE,acquisition-acquirer,100,49,1/2/2019
40F7DE,legal-issues-defendant,100,22,1/2/2019
40F7DE,legal-issues-defendant,100,22,1/2/2019
41B53E,dividend,100,50,1/2/2019
42EFC7,conference-participant,100,50,1/2/2019
44ED36,acquisition-acquirer,100,49,1/2/2019
44ED36,acquisition-acquirer,100,49,1/2/2019
4649D5,executive-appointment,100,54,1/2/2019
46CF27,earnings,100,50,1/2/2019
50070E,conference-organizer,100,57,1/2/2019
5403F8,executive-resignation,100,44,1/2/2019
545272,award,100,58,1/2/2019
55438C,legal-issues-defendant,100,22,1/2/2019
57CAAB,conference-participant,100,50,1/2/2019
59B229,earnings,100,50,1/2/2019
59C539,conference-call,100,50,1/2/2019
59DB8C,conference-participant,100,50,1/2/2019
5D0337,joint-venture,100,62,1/2/2019
5EC388,earnings,100,50,1/2/2019
5F3D91,conference-participant,100,50,1/2/2019
5F9CE3,conference-participant,100,50,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
619882,conference-organizer,100,57,1/2/2019
620381,conference-participant,100,50,1/2/2019
63F892,earnings,100,50,1/2/2019
665618,dividend-up,100,60,1/2/2019
68BA15,conference-call,100,50,1/2/2019
6925EB,conference-participant,100,50,1/2/2019
6B494E,facility-open,100,65,1/2/2019
6BC6F9,conference-participant,100,50,1/2/2019
6-Dec-05,business-contract,100,69,1/2/2019
6E1E61,earnings,100,50,1/2/2019
6E8864,conference-participant,100,50,1/2/2019
701531,conference-participant,100,50,1/2/2019
723548,dividend,100,50,1/2/2019
72CB93,award,100,58,1/2/2019
7.45E+28,conference-participant,100,50,1/2/2019
747219,conference-participant,100,50,1/2/2019
763DBE,conference-participant,100,50,1/2/2019
765913,earnings,100,50,1/2/2019
791EC1,unit-acquisition-acquirer,100,49,1/2/2019
810FAD,conference-call,100,50,1/2/2019
8303CD,executive-appointment,100,54,1/2/2019
83B1C8,conference-participant,100,50,1/2/2019
85AD00,conference-call,100,50,1/2/2019
862941,conference-participant,100,50,1/2/2019
8665BA,conference-participant,100,50,1/2/2019
8AB85C,conference-participant,100,50,1/2/2019
8E93A4,acquisition-completed-acquirer,100,49,1/2/2019
91E5EE,acquisition-completed-acquirer,100,49,1/2/2019
925759,conference-participant,100,50,1/2/2019
92D3A0,conference-call,100,50,1/2/2019
94983E,conference-participant,100,50,1/2/2019
95DC1F,unit-acquisition-acquiree,100,76,1/2/2019
9.62E+76,earnings,100,50,1/2/2019
9.74E+08,conference-participant,100,50,1/2/2019
977A1E,executive-appointment,100,54,1/2/2019
979451,legal-issues-defendant,100,22,1/2/2019
979451,legal-issues-defendant,100,22,1/2/2019
9978F1,conference-participant,100,50,1/2/2019
9ABD30,executive-appointment,100,54,1/2/2019
9C009A,executive-appointment,100,54,1/2/2019
9D5FA4,conference-participant,100,50,1/2/2019
9F37C5,dividend,100,50,1/2/2019
A3F598,acquisition-completed-acquiree,100,76,1/2/2019
A48593,conference-participant,100,50,1/2/2019
A4B899,unit-acquisition-acquirer,100,49,1/2/2019
A5151E,executive-resignation,100,44,1/2/2019
A5151E,executive-resignation,100,44,1/2/2019
A5195E,conference-participant,100,50,1/2/2019
A5195E,clinical-trials-start,100,64,1/2/2019
A5A4F5,acquisition-acquirer,100,49,1/2/2019
A5B913,earnings,100,50,1/2/2019
A63387,acquisition-acquirer,100,49,1/2/2019
A6828A,dividend,100,50,1/2/2019
A72FD9,executive-appointment,100,54,1/2/2019
A868C9,conference-participant,100,50,1/2/2019
A8CBDA,conference-call,100,50,1/2/2019
AA3AB8,conference-participant,100,50,1/2/2019
AB4A7E,product-release,100,64,1/2/2019
AB4A7E,partnership,100,61,1/2/2019
AEF2C3,conference-participant,100,50,1/2/2019
AFF43F,earnings,100,50,1/2/2019
B04426,conference-participant,100,50,1/2/2019
B076A1,acquisition-completed-acquirer,100,49,1/2/2019
B1B10C,unit-acquisition-acquirer,100,49,1/2/2019
B290A2,conference-participant,100,50,1/2/2019
B2DAF6,conference-participant,100,50,1/2/2019
B642E8,asset-sale,100,62,1/2/2019
B7FA9B,conference-participant,100,50,1/2/2019
B80AD1,conference-participant,100,50,1/2/2019
B83D67,conference-participant,100,50,1/2/2019
B8F71F,executive-appointment,100,54,1/2/2019
BA218A,conference-call,100,50,1/2/2019
BB88B6,earnings,100,50,1/2/2019
BCC55F,conference-participant,100,50,1/2/2019
BCE9DA,acquisition-completed-acquirer,100,49,1/2/2019
BCE9DA,acquisition-completed-acquirer,100,49,1/2/2019
BDE867,acquisition-completed-acquirer,100,49,1/2/2019
BE5935,conference-participant,100,50,1/2/2019
C07E05,executive-appointment,100,54,1/2/2019
C22BE8,acquisition-completed-acquirer,100,49,1/2/2019
C4F9C6,patient-enrollment-start,100,58,1/2/2019
C584BE,credit-extension-recipient,100,69,1/2/2019
C598D7,conference-call,100,50,1/2/2019
C5D2AE,earnings,100,50,1/2/2019
C7AE14,dividend,100,50,1/2/2019
C941DC,conference-participant,100,50,1/2/2019
C9E107,earnings,100,50,1/2/2019
CBDB4D,executive-appointment,100,54,1/2/2019
CE4FD9,acquisition-acquirer,100,49,1/2/2019
CE4FD9,acquisition-acquirer,100,49,1/2/2019
CF3FF9,conference-participant,100,50,1/2/2019
D0DE27,conference-participant,100,50,1/2/2019
D437C3,earnings,100,50,1/2/2019
D5AF19,earnings,100,50,1/2/2019
D6EAA3,acquisition-completed-acquirer,100,49,1/2/2019
D76AEF,executive-appointment,100,54,1/2/2019
D76AEF,acquisition-completed-acquirer,100,49,1/2/2019
DEF058,earnings,100,50,1/2/2019
DF1F7A,conference-call,100,50,1/2/2019
E10D31,legal-issues-defendant,100,22,1/2/2019
E124EB,conference-participant,100,50,1/2/2019
E20392,conference-participant,100,50,1/2/2019
E3E68E,legal-issues-defendant,100,22,1/2/2019
E87676,acquisition-acquirer,100,49,1/2/2019
EB61C4,unit-acquisition-acquirer,100,49,1/2/2019
EC8116,dividend,100,50,1/2/2019
ECD263,executive-appointment,100,54,1/2/2019
ED2A5E,conference-participant,100,50,1/2/2019
EF5BED,executive-resignation,100,44,1/2/2019
EF77A3,legal-issues-defendant,100,22,1/2/2019
F0B335,conference-participant,100,50,1/2/2019
F15E41,legal-issues-defendant,100,22,1/2/2019
F47871,conference-participant,100,50,1/2/2019
F4E992,earnings,100,50,1/2/2019
F5D059,dividend,100,50,1/2/2019
F6E248,conference-participant,100,50,1/2/2019
FB7724,conference-participant,100,50,1/2/2019
FDC7E6,buybacks,100,74,1/2/2019
FDC7E6,conference-call,100,50,1/2/2019
FDD3FC,conference-participant,100,50,1/2/2019
FE7A63,acquisition-completed-acquirer,100,49,1/2/2019
FF227B,conference-participant,100,50,1/2/2019
00326D,earnings,100,50,1/3/2019
9397,earnings,100,50,1/3/2019
01478A,earnings-guidance,100,50,1/3/2019
03542C,unit-acquisition-acquirer,100,49,1/3/2019
03D5F9,legal-issues-defendant,100,22,1/3/2019
03FAA6,conference-participant,100,50,1/3/2019
04EB2F,conference-participant,100,50,1/3/2019
078D52,dividend,100,50,1/3/2019
0A9D0A,legal-issues-defendant,100,22,1/3/2019
0CC62B,conference-call,100,50,1/3/2019
0F91FC,acquisition-completed-acquirer,100,49,1/3/2019
0F91FC,acquisition-completed-acquirer,100,49,1/3/2019
105D00,conference-call,100,50,1/3/2019
1080C0,conference-participant,100,50,1/3/2019
152AB9,conference-participant,100,50,1/3/2019
152FA5,conference-participant,100,50,1/3/2019
16C7F0,conference-call,100,50,1/3/2019
184988,conference-participant,100,50,1/3/2019
1AC649,executive-appointment,100,54,1/3/2019
1BC12C,executive-appointment,100,54,1/3/2019
1C2593,conference-participant,100,50,1/3/2019
1CD09C,conference-participant,100,50,1/3/2019
1CD4B5,conference-participant,100,50,1/3/2019
1DB6A6,asset-sale,100,62,1/3/2019
1E1125,conference-organizer,100,57,1/3/2019
1EBF8D,partnership,100,61,1/3/2019
1EBF8D,partnership,100,61,1/3/2019
1EBF8D,business-contract,100,69,1/3/2019
1F716B,business-contract,100,69,1/3/2019
221AD7,legal-issues-defendant,100,22,1/3/2019
22C58E,earnings,100,50,1/3/2019
250BEE,conference-call,100,50,1/3/2019
25A6CC,executive-appointment,100,54,1/3/2019
267718,clinical-trials-start,100,64,1/3/2019
267718,clinical-trials-start,100,64,1/3/2019
29A4CC,conference-call,100,50,1/3/2019
2CC71C,clinical-trials-start,100,64,1/3/2019
2D643C,conference-call,100,50,1/3/2019
2D76CE,earnings,100,50,1/3/2019
2D76CE,earnings,100,50,1/3/2019
2F7474,conference-call,100,50,1/3/2019
32DCB3,patent-awarded,100,72,1/3/2019
35557B,business-contract,100,69,1/3/2019
38C46F,dividend,100,50,1/3/2019
3E15F6,trading-halt,100,43,1/3/2019
3FACA7,partnership,100,61,1/3/2019
3FACA7,earnings,100,50,1/3/2019
4.00E+163,legal-issues-defendant,100,22,1/3/2019
4.00E+163,legal-issues-defendant,100,22,1/3/2019
416C55,award,100,58,1/3/2019
41785E,earnings,100,50,1/3/2019
434F38,earnings,100,50,1/3/2019
43A74A,conference-participant,100,50,1/3/2019
47752F,executive-resignation,100,44,1/3/2019
4A2457,business-contract,100,69,1/3/2019
4A6F00,business-contract,100,69,1/3/2019
4A6F00,investment-investor,100,55,1/3/2019
4B3555,earnings,100,50,1/3/2019
4B49CF,earnings,100,50,1/3/2019
4B49CF,earnings,100,50,1/3/2019
4E913D,partnership,100,61,1/3/2019
4EC4C1,conference-call,100,50,1/3/2019
514067,legal-issues-defendant,100,22,1/3/2019
550D01,executive-appointment,100,54,1/3/2019
56B7C1,dividend,100,50,1/3/2019
57CAAB,partnership,100,61,1/3/2019
58CA9A,product-release,100,64,1/3/2019
58CA9A,conference-organizer,100,57,1/3/2019
5968F9,conference-participant,100,50,1/3/2019
5DD486,conference-call,100,50,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-call,100,50,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
619882,conference-organizer,100,57,1/3/2019
636BBF,merger-completed,100,66,1/3/2019
665440,executive-appointment,100,54,1/3/2019
665D7D,conference-call,100,50,1/3/2019
665D7D,partnership,100,61,1/3/2019
67303E,conference-participant,100,50,1/3/2019
67303E,legal-issues-defendant,100,22,1/3/2019
67529E,conference-call,100,50,1/3/2019
6810DE,partnership,100,61,1/3/2019
69CE71,business-contract,100,69,1/3/2019
69CE71,dividend,100,50,1/3/2019
69E8E1,conference-call,100,50,1/3/2019
69E8E1,conference-call,100,50,1/3/2019
69E8E1,conference-call,100,50,1/3/2019
6CC55E,executive-appointment,100,54,1/3/2019
6-Dec-05,executive-appointment,100,54,1/3/2019
6.00E+19,business-contract,100,69,1/3/2019
701531,executive-appointment,100,54,1/3/2019
70FCEF,executive-appointment,100,54,1/3/2019
7255D2,conference-call,100,50,1/3/2019
762A3E,acquisition-completed-acquirer,100,49,1/3/2019
762A3E,acquisition-completed-acquirer,100,49,1/3/2019
76F067,settlement,100,56,1/3/2019
76F067,settlement,100,56,1/3/2019
76F067,conference-participant,100,50,1/3/2019
775439,earnings,100,50,1/3/2019
791EC1,unit-acquisition-acquirer,100,49,1/3/2019
7A3633,executive-appointment,100,54,1/3/2019
7A975D,earnings,100,50,1/3/2019
7A975D,earnings,100,50,1/3/2019
7AB859,partnership,100,61,1/3/2019
7AB859,partnership,100,61,1/3/2019
7AB859,partnership,100,61,1/3/2019
7B0BA6,business-contract,100,69,1/3/2019
7B8CB5,partnership,100,61,1/3/2019
7C4F43,conference-participant,100,50,1/3/2019
7E2DE6,earnings,100,50,1/3/2019
7FEEE1,conference-participant,100,50,1/3/2019
805CD8,conference-participant,100,50,1/3/2019
81EAD4,conference-participant,100,50,1/3/2019
8665BA,conference-call,100,50,1/3/2019
8EF425,earnings,100,50,1/3/2019
902670,conference-call,100,50,1/3/2019
92D757,conference-participant,100,50,1/3/2019
93965C,executive-appointment,100,54,1/3/2019
93965C,partnership,100,61,1/3/2019
94637C,earnings-per-share-guidance,100,50,1/3/2019
94637C,earnings-per-share-guidance,100,50,1/3/2019
94637C,acquisition-acquirer,100,49,1/3/2019
94637C,acquisition-acquirer,100,49,1/3/2019
94637C,acquisition-acquirer,100,49,1/3/2019
9.74E+08,partnership,100,61,1/3/2019
97FE80,conference-participant,100,50,1/3/2019
9D56F2,conference-call,100,50,1/3/2019
9D5FA4,executive-resignation,100,44,1/3/2019
9F6B1A,business-contract,100,69,1/3/2019
9F6B1A,business-contract,100,69,1/3/2019
9F6B1A,business-contract,100,69,1/3/2019
A26C26,conference-participant,100,50,1/3/2019
A3AAA5,executive-appointment,100,54,1/3/2019
A5A4F5,acquisition-acquirer,100,49,1/3/2019
A5DD24,conference-participant,100,50,1/3/2019
A6828A,partnership,100,61,1/3/2019
A75D43,conference-call,100,50,1/3/2019
AB4A7E,conference-participant,100,50,1/3/2019
AD375D,partnership,100,61,1/3/2019
B04426,patient-enrollment-complete,100,64,1/3/2019
B05118,partnership,100,61,1/3/2019
B08954,earnings,100,50,1/3/2019
B5766D,conference-call,100,50,1/3/2019
B604DF,earnings-guidance,100,50,1/3/2019
B604DF,acquisition-completed-acquirer,100,49,1/3/2019
B8A51F,executive-appointment,100,54,1/3/2019
B8EF97,legal-issues-defendant,100,22,1/3/2019
BB0787,campaign-ad-release,100,59,1/3/2019
BB0787,campaign-ad-release,100,59,1/3/2019
BB5142,earnings,100,50,1/3/2019
BDEC1E,conference-participant,100,50,1/3/2019
BE14CF,conference-call,100,50,1/3/2019
BEB756,conference-call,100,50,1/3/2019
C32A39,earnings-guidance,100,50,1/3/2019
C3F99F,conference-participant,100,50,1/3/2019
C564E4,conference-participant,100,50,1/3/2019
C598D7,executive-appointment,100,54,1/3/2019
C659EB,executive-appointment,100,54,1/3/2019
C941DC,partnership,100,61,1/3/2019
C98CDB,conference-participant,100,50,1/3/2019
CAD7D9,earnings,100,50,1/3/2019
CB89EA,conference-participant,100,50,1/3/2019
CC339B,earnings,100,50,1/3/2019
CC35BE,acquisition-completed-acquirer,100,49,1/3/2019
CC6F6E,conference-participant,100,50,1/3/2019
CFF97C,product-release,100,64,1/3/2019
D1173F,conference-call,100,50,1/3/2019
D21D8A,conference-call,100,50,1/3/2019
D48275,buybacks,100,74,1/3/2019
D4AC65,partnership,100,61,1/3/2019
D54E62,conference-call,100,50,1/3/2019
D78CCD,conference-call,100,50,1/3/2019
D8442A,legal-issues-defendant,100,22,1/3/2019
D8442A,legal-issues-defendant,100,22,1/3/2019
D8442A,legal-issues-defendant,100,22,1/3/2019
D8760C,conference-call,100,50,1/3/2019
DB7014,executive-appointment,100,54,1/3/2019
DB88A1,executive-appointment,100,54,1/3/2019
DC2F77,earnings,100,50,1/3/2019
DD0099,earnings,100,50,1/3/2019
E09E2B,legal-issues-defendant,100,22,1/3/2019
E09E2B,legal-issues-defendant,100,22,1/3/2019
E28D9C,conference-participant,100,50,1/3/2019
E5752F,conference-participant,100,50,1/3/2019
E71AE6,partnership,100,61,1/3/2019
E829E8,executive-appointment,100,54,1/3/2019
EB7FBF,dividend,100,50,1/3/2019
ED5171,earnings,100,50,1/3/2019
EEA6B3,unit-acquisition-completed-acquirer,100,49,1/3/2019
EF77A3,legal-issues-defendant,100,22,1/3/2019
F209B4,merger,100,66,1/3/2019
F294DD,earnings,100,50,1/3/2019
F30508,conference-participant,100,50,1/3/2019
F3EDB4,executive-appointment,100,54,1/3/2019
F4CDA3,unit-acquisition-acquirer,100,49,1/3/2019
F4D241,conference-participant,100,50,1/3/2019
F7935D,business-contract,100,69,1/3/2019
FA918D,executive-resignation,100,44,1/3/2019
FC01C0,conference-participant,100,50,1/3/2019
FC4550,dividend,100,50,1/3/2019
FD2565,conference-participant,100,50,1/3/2019
FDD3FC,clinical-trials-start,100,64,1/3/2019
FF4BA4,earnings,100,50,1/3/2019
FF6644,facility-upgrade,100,65,1/3/2019
01D03F,business-contract,100,69,1/4/2019
31025,earnings,100,50,1/4/2019
03D5F9,legal-issues-defendant,100,22,1/4/2019
48590,earnings,100,50,1/4/2019
09062E,conference-participant,100,50,1/4/2019
95294,legal-issues-defendant,100,22,1/4/2019
0A9D0A,legal-issues-defendant,100,22,1/4/2019
0C2A0D,conference-participant,100,50,1/4/2019
0F04E5,conference-participant,100,50,1/4/2019
14833D,legal-issues-defendant,100,22,1/4/2019
152E1D,legal-issues-defendant,100,22,1/4/2019
188394,conference-call,100,50,1/4/2019
1921DD,partnership,100,61,1/4/2019
1D5C51,conference-participant,100,50,1/4/2019
2082EA,clinical-trials-positive,100,87,1/4/2019
221AD7,legal-issues-defendant,100,22,1/4/2019
2667B6,earnings,100,50,1/4/2019
272704,acquisition-acquirer,100,49,1/4/2019
272704,acquisition-acquirer,100,49,1/4/2019
28DCA8,earnings-guidance,100,50,1/4/2019
2A1009,executive-resignation,100,44,1/4/2019
338544,conference-call,100,50,1/4/2019
33AD83,conference-participant,100,50,1/4/2019
37020C,dividend,100,50,1/4/2019
3E15F6,trading-resumed,100,58,1/4/2019
3EE65E,product-release,100,64,1/4/2019
4.00E+163,conference-call,100,50,1/4/2019
4.00E+163,legal-issues-defendant,100,22,1/4/2019
40F7DE,conference-call,100,50,1/4/2019
40F7DE,legal-issues-defendant,100,22,1/4/2019
42DC93,earnings,100,50,1/4/2019
442587,business-contract,100,69,1/4/2019
4A6F00,partnership,100,61,1/4/2019
4D8313,conference-call,100,50,1/4/2019
510EA1,conference-participant,100,50,1/4/2019
52BF94,conference-call,100,50,1/4/2019
5675EB,earnings,100,50,1/4/2019
57CAAB,fast-track-designation,100,81,1/4/2019
57CAAB,partnership,100,61,1/4/2019
57DDB9,conference-participant,100,50,1/4/2019
5BC2F4,earnings,100,50,1/4/2019
5CC29D,earnings,100,50,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
619882,conference-organizer,100,57,1/4/2019
627186,earnings,100,50,1/4/2019
66A667,dividend,100,50,1/4/2019
66A667,dividend,100,50,1/4/2019
6B6375,conference-participant,100,50,1/4/2019
70FCEF,executive-appointment,100,54,1/4/2019
719477,conference-call,100,50,1/4/2019
71B0CF,executive-appointment,100,54,1/4/2019
7B1E50,donation,100,54,1/4/2019
82B57E,conference-participant,100,50,1/4/2019
834152,executive-appointment,100,54,1/4/2019
877C0C,executive-appointment,100,54,1/4/2019
8D5145,earnings,100,50,1/4/2019
8E0E32,earnings,100,50,1/4/2019
8E4250,conference-call,100,50,1/4/2019
9196A2,conference-call,100,50,1/4/2019
940C3D,earnings,100,50,1/4/2019
958938,conference-participant,100,50,1/4/2019
95F59E,executive-appointment,100,54,1/4/2019
96A6CD,conference-participant,100,50,1/4/2019
9B730A,conference-participant,100,50,1/4/2019
9CE4C7,earnings,100,50,1/4/2019
9D3360,earnings,100,50,1/4/2019
9E5C2C,conference-call,100,50,1/4/2019
A01664,earnings,100,50,1/4/2019
A1E3B3,conference-participant,100,50,1/4/2019
A5195E,executive-appointment,100,54,1/4/2019
A5A4F5,acquisition-acquirer,100,49,1/4/2019
A871B0,conference-participant,100,50,1/4/2019
AB4A7E,partnership,100,61,1/4/2019
ADF092,earnings,100,50,1/4/2019
AFF7B4,conference-call,100,50,1/4/2019
B446B8,earnings,100,50,1/4/2019
B4528F,conference-participant,100,50,1/4/2019
B4703C,conference-call,100,50,1/4/2019
B54A74,conference-participant,100,50,1/4/2019
B762D3,earnings,100,50,1/4/2019
B83BCE,conference-participant,100,50,1/4/2019
B8EF97,legal-issues-defendant,100,22,1/4/2019
C062D4,conference-call,100,50,1/4/2019
C230FE,executive-appointment,100,54,1/4/2019
C27E19,earnings,100,50,1/4/2019
C356AC,acquisition-completed-acquirer,100,49,1/4/2019
C564E4,clinical-trials-positive,100,87,1/4/2019
C5C137,reorganization-approval,100,74,1/4/2019
C81E00,conference-call,100,50,1/4/2019
C81E00,conference-call,100,50,1/4/2019
C8923A,executive-appointment,100,54,1/4/2019
C97B2D,conference-call,100,50,1/4/2019
CA212F,earnings,100,50,1/4/2019
CD06A2,earnings,100,50,1/4/2019
CEDFD5,partnership,100,61,1/4/2019
CEDFD5,partnership,100,61,1/4/2019
CF6A5A,earnings,100,50,1/4/2019
D0909F,earnings-guidance,100,50,1/4/2019
D78BF1,earnings,100,50,1/4/2019
DAFED3,conference-call,100,50,1/4/2019
DB5CA5,dividend,100,50,1/4/2019
DB7FA7,conference-call,100,50,1/4/2019
DBCA3F,acquisition-completed-acquirer,100,49,1/4/2019
DF5F14,merger,100,66,1/4/2019
E09E2B,legal-issues-defendant,100,22,1/4/2019
E259C7,unit-acquisition-completed-acquirer,100,49,1/4/2019
E30B34,award,100,58,1/4/2019
E30B34,conference-participant,100,50,1/4/2019
E30B34,conference-participant,100,50,1/4/2019
E40FB6,acquisition-completed-acquirer,100,49,1/4/2019
E829E8,conference-call,100,50,1/4/2019
EEA6B3,partnership,100,61,1/4/2019
EF77A3,legal-issues-defendant,100,22,1/4/2019
F0B335,business-contract,100,69,1/4/2019
F0B335,business-contract,100,69,1/4/2019
F5D059,earnings,100,50,1/4/2019
F5D059,earnings,100,50,1/4/2019
F5D059,earnings,100,50,1/4/2019
F5D059,earnings,100,50,1/4/2019
F5D059,earnings,100,50,1/4/2019
F6FF0D,conference-call,100,50,1/4/2019
F80389,earnings-guidance,100,50,1/4/2019
FACF19,conference-participant,100,50,1/4/2019
FC9A88,earnings,100,50,1/4/2019
FEC475,conference-call,100,50,1/4/2019
FF227B,business-contract,100,69,1/4/2019
14833D,legal-issues-defendant,100,22,1/5/2019
152E1D,legal-issues-defendant,100,22,1/5/2019
385DD4,legal-issues-defendant,100,22,1/5/2019
4.00E+163,legal-issues-defendant,100,22,1/5/2019
550D01,conference-call,100,50,1/5/2019
94637C,conference-participant,100,50,1/5/2019
B8EF97,legal-issues-defendant,100,22,1/5/2019
619882,conference-organizer,100,57,1/6/2019
B83D67,executive-appointment,100,54,1/6/2019
D2B9E5,facility-open,100,65,1/6/2019
F6E248,partnership,100,61,1/6/2019
00067A,earnings,100,50,1/7/2019
0157B1,partnership,100,61,1/7/2019
0157B1,partnership,100,61,1/7/2019
0157B1,partnership,100,61,1/7/2019
0157B1,product-release,100,64,1/7/2019
03B8CF,partnership,100,61,1/7/2019
03CF95,partnership,100,61,1/7/2019
03D5F9,legal-issues-defendant,100,22,1/7/2019
05D148,clinical-trials,100,56,1/7/2019
061A3B,earnings,100,50,1/7/2019
95294,acquisition-acquirer,100,49,1/7/2019
95294,acquisition-acquirer,100,49,1/7/2019
95294,acquisition-acquirer,100,49,1/7/2019
95294,acquisition-acquirer,100,49,1/7/2019
099A02,executive-appointment,100,54,1/7/2019
0A9D0A,legal-issues-defendant,100,22,1/7/2019
0B4D10,public-offering,100,43,1/7/2019
0BC853,conference-call,100,50,1/7/2019
0C6293,executive-appointment,100,54,1/7/2019
10100E,revenues,100,50,1/7/2019
11074E,revenues,100,50,1/7/2019
11A49E,patient-enrollment-complete,100,64,1/7/2019
1220D2,executive-appointment,100,54,1/7/2019
147C38,partnership,100,61,1/7/2019
147C38,partnership,100,61,1/7/2019
14833D,legal-issues-defendant,100,22,1/7/2019
152E1D,legal-issues-defendant,100,22,1/7/2019
154272,executive-appointment,100,54,1/7/2019
15789A,credit-extension-recipient,100,69,1/7/2019
16FC89,earnings,100,50,1/7/2019
17EDA5,partnership,100,61,1/7/2019
17EDA5,partnership,100,61,1/7/2019
17EDA5,product-release,100,64,1/7/2019
19CAC7,earnings-guidance,100,50,1/7/2019
1AB808,revenue-guidance-up,100,77,1/7/2019
1F352C,earnings,100,50,1/7/2019
1F9D90,earnings,100,50,1/7/2019
1FAF22,clinical-trials-start,100,64,1/7/2019
206852,conference-call,100,50,1/7/2019
21022F,conference-participant,100,50,1/7/2019
228D42,partnership,100,61,1/7/2019
228D42,business-contract,100,69,1/7/2019
232053,conference-participant,100,50,1/7/2019
25A6CC,conference-participant,100,50,1/7/2019
267718,partnership,100,61,1/7/2019
26DC29,debt-extension-recipient,100,73,1/7/2019
2A1009,earnings,100,50,1/7/2019
2B5483,partnership,100,61,1/7/2019
2B8179,executive-appointment,100,54,1/7/2019
2BF36E,legal-issues-defendant,100,22,1/7/2019
2C3348,executive-appointment,100,54,1/7/2019
2C35B5,executive-appointment,100,54,1/7/2019
2F7A7E,conference-call,100,50,1/7/2019
3.14E+47,earnings,100,50,1/7/2019
315EB0,investment-investor,100,55,1/7/2019
326EDD,conference-call,100,50,1/7/2019
3390DE,conference-call,100,50,1/7/2019
33AD83,partnership,100,61,1/7/2019
3461CF,award,100,58,1/7/2019
34B411,earnings,100,50,1/7/2019
34B97A,conference-call,100,50,1/7/2019
36C09B,conference-participant,100,50,1/7/2019
370C50,conference-call,100,50,1/7/2019
385DD4,executive-appointment,100,54,1/7/2019
385DD4,legal-issues-defendant,100,22,1/7/2019
39BFF6,conference-call,100,50,1/7/2019
39FB23,acquisition-acquirer,100,49,1/7/2019
3B2311,executive-appointment,100,54,1/7/2019
3BCF24,earnings,100,50,1/7/2019
3EE65E,product-release,100,64,1/7/2019
3F1C69,patient-enrollment-complete,100,64,1/7/2019
408380,conference-participant,100,50,1/7/2019
4.00E+163,legal-issues-defendant,100,22,1/7/2019
416C55,executive-appointment,100,54,1/7/2019
41A93D,conference-participant,100,50,1/7/2019
434F38,acquisition-completed-acquirer,100,49,1/7/2019
44A4FC,investment-investor,100,55,1/7/2019
458D2C,earnings-guidance,100,50,1/7/2019
45BC35,revenues,100,50,1/7/2019
467F2C,conference-participant,100,50,1/7/2019
4A5C8D,partnership,100,61,1/7/2019
4A5C8D,conference-call,100,50,1/7/2019
4BBA23,revenues,100,50,1/7/2019
4C6C63,partnership,100,61,1/7/2019
4D8124,earnings,100,50,1/7/2019
50070E,business-contract,100,69,1/7/2019
514067,executive-appointment,100,54,1/7/2019
52015A,dividend,100,50,1/7/2019
53F491,earnings,100,50,1/7/2019
5.43E+08,conference-participant,100,50,1/7/2019
546A9C,partnership,100,61,1/7/2019
5.47E+28,business-contract,100,69,1/7/2019
5.47E+28,business-contract,100,69,1/7/2019
55438C,legal-issues-defendant,100,22,1/7/2019
56765E,executive-resignation,100,44,1/7/2019
589803,partnership,100,61,1/7/2019
589803,partnership,100,61,1/7/2019
589803,partnership,100,61,1/7/2019
5A0FF1,conference-participant,100,50,1/7/2019
5B6C11,earnings,100,50,1/7/2019
5BE42C,conference-call,100,50,1/7/2019
5C7601,business-contract,100,69,1/7/2019
5E6959,conference-call,100,50,1/7/2019
5F9CE3,earnings,100,50,1/7/2019
5FE4B6,conference-participant,100,50,1/7/2019
60DD84,executive-appointment,100,54,1/7/2019
6.18E+08,conference-participant,100,50,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,conference-organizer,100,57,1/7/2019
619882,product-release,100,64,1/7/2019
619882,conference-organizer,100,57,1/7/2019
67303E,partnership,100,61,1/7/2019
67529E,executive-appointment,100,54,1/7/2019
69C99E,clinical-trials-complete,100,56,1/7/2019
69C99E,clinical-trials-complete,100,56,1/7/2019
69C99E,fundraising,100,64,1/7/2019
6B0784,conference-call,100,50,1/7/2019
6D3F35,product-release,100,64,1/7/2019
6.00E+19,executive-appointment,100,54,1/7/2019
6E8864,revenues,100,50,1/7/2019
6FCEF9,conference-participant,100,50,1/7/2019
71553E,revenues,100,50,1/7/2019
72FCA3,product-release,100,64,1/7/2019
72FCA3,product-release,100,64,1/7/2019
72FCA3,product-release,100,64,1/7/2019
72FCA3,partnership,100,61,1/7/2019
741937,executive-appointment,100,54,1/7/2019
762A3E,executive-appointment,100,54,1/7/2019
77B8E9,patent-awarded,100,72,1/7/2019
790C34,partnership,100,61,1/7/2019
7A10FF,earnings,100,50,1/7/2019
7CD98F,earnings-guidance,100,50,1/7/2019
7F0372,executive-appointment,100,54,1/7/2019
7F2922,conference-participant,100,50,1/7/2019
7F3665,conference-participant,100,50,1/7/2019
7F3669,conference-participant,100,50,1/7/2019
7F3A5F,partnership,100,61,1/7/2019
7F3A5F,partnership,100,61,1/7/2019
7F3A5F,partnership,100,61,1/7/2019
8.10E+32,dividend,100,50,1/7/2019
81222C,earnings,100,50,1/7/2019
838ADD,acquisition-completed-acquirer,100,49,1/7/2019
83A065,executive-appointment,100,54,1/7/2019
862941,earnings-guidance,100,50,1/7/2019
895D56,acquisition-completed-acquirer,100,49,1/7/2019
8A8E41,partnership,100,61,1/7/2019
8A8E41,product-release,100,64,1/7/2019
8C1238,reorganization,100,53,1/7/2019
8DAAB9,earnings,100,50,1/7/2019
8DCBBB,conference-call,100,50,1/7/2019
911AB8,earnings,100,50,1/7/2019
91E5EE,revenue-guidance,100,50,1/7/2019
92D757,product-release,100,64,1/7/2019
92D757,executive-appointment,100,54,1/7/2019
9.36E+10,business-contract,100,69,1/7/2019
9.39E+69,executive-appointment,100,54,1/7/2019
93AD2E,earnings,100,50,1/7/2019
93D207,partnership,100,61,1/7/2019
93D207,earnings,100,50,1/7/2019
94637C,partnership,100,61,1/7/2019
949D62,revenues,100,50,1/7/2019
9592FB,revenues,100,50,1/7/2019
95DC1F,partnership,100,61,1/7/2019
9.74E+08,partnership,100,61,1/7/2019
9.86E+03,conference-participant,100,50,1/7/2019
990AD0,conference-organizer,100,57,1/7/2019
9978F1,partnership,100,61,1/7/2019
9ABD30,fundraising,100,64,1/7/2019
9AF3DC,conference-call,100,50,1/7/2019
9C5174,executive-appointment,100,54,1/7/2019
9E5C2C,conference-participant,100,50,1/7/2019
A02FB1,conference-call,100,50,1/7/2019
A1EAC8,executive-appointment,100,54,1/7/2019
A247F5,patent-awarded,100,72,1/7/2019
A3800A,conference-participant,100,50,1/7/2019
A3AAA5,dividend,100,50,1/7/2019
A5A4F5,acquisition-acquirer,100,49,1/7/2019
A6213D,conference-participant,100,50,1/7/2019
A6ABE9,earnings-guidance,100,50,1/7/2019
AADE0B,acquisition-acquirer,100,49,1/7/2019
AADE0B,acquisition-acquirer,100,49,1/7/2019
ABBAD1,earnings,100,50,1/7/2019
AC3584,executive-appointment,100,54,1/7/2019
AE7D16,legal-issues-defendant,100,22,1/7/2019
AED61E,revenues,100,50,1/7/2019
AEFC90,clinical-trials-start,100,64,1/7/2019
B13B68,conference-participant,100,50,1/7/2019
B1A85D,business-contract,100,69,1/7/2019
B1B10C,conference-call,100,50,1/7/2019
B2206F,earnings,100,50,1/7/2019
B2E6B5,conference-call,100,50,1/7/2019
B48FC9,earnings,100,50,1/7/2019
B7202A,earnings-guidance,100,50,1/7/2019
B7FA9B,conference-participant,100,50,1/7/2019
B8DD94,conference-call,100,50,1/7/2019
B8EF97,legal-issues-defendant,100,22,1/7/2019
BBF349,business-contract,100,69,1/7/2019
BBF349,product-release,100,64,1/7/2019
BDD12C,award,100,58,1/7/2019
BDE867,conference-participant,100,50,1/7/2019
BE379D,clinical-trials-positive,100,87,1/7/2019
BE5935,earnings,100,50,1/7/2019
C0BA36,conference-participant,100,50,1/7/2019
C5C0E9,conference-participant,100,50,1/7/2019
C659EB,conference-call,100,50,1/7/2019
C951A2,earnings,100,50,1/7/2019
C9732E,clinical-trials-positive,100,87,1/7/2019
CAC8D0,conference-participant,100,50,1/7/2019
CAD7D9,conference-participant,100,50,1/7/2019
CBDB4D,clinical-trials,100,56,1/7/2019
CC35BE,executive-appointment,100,54,1/7/2019
CD2DA4,dividend,100,50,1/7/2019
CD4DA8,executive-appointment,100,54,1/7/2019
CDC817,conference-participant,100,50,1/7/2019
CE96E7,conference-call,100,50,1/7/2019
D501DC,dividend,100,50,1/7/2019
D6489C,earnings-up,100,68,1/7/2019
D65A13,revenue-up,100,73,1/7/2019
D6853F,conference-call,100,50,1/7/2019
D854F3,product-release,100,64,1/7/2019
D8F347,executive-appointment,100,54,1/7/2019
DAFED3,conference-participant,100,50,1/7/2019
DC5299,conference-call,100,50,1/7/2019
DCD97F,conference-call,100,50,1/7/2019
DF11D9,conference-call,100,50,1/7/2019
DF18E6,earnings-guidance,100,50,1/7/2019
E05026,executive-resignation,100,44,1/7/2019
E09E2B,product-release,100,64,1/7/2019
E09E2B,product-release,100,64,1/7/2019
E10D31,legal-issues-defendant,100,22,1/7/2019
E12A6E,earnings,100,50,1/7/2019
E2F130,dividend,100,50,1/7/2019
E30A8F,earnings,100,50,1/7/2019
E3E68E,legal-issues-defendant,100,22,1/7/2019
E592F0,conference-participant,100,50,1/7/2019
E67C2C,conference-participant,100,50,1/7/2019
E70531,drilling,100,68,1/7/2019
E8A49A,earnings,100,50,1/7/2019
E8B315,earnings,100,50,1/7/2019
E9E6FD,conference-call,100,50,1/7/2019
EB7FBF,earnings,100,50,1/7/2019
ECDEB2,earnings,100,50,1/7/2019
ECDEB2,merger,100,66,1/7/2019
ED2A5E,executive-appointment,100,54,1/7/2019
EEA734,clinical-trials,100,56,1/7/2019
EF1AD9,conference-call,100,50,1/7/2019
EFD406,conference-participant,100,50,1/7/2019
F0B335,business-contract,100,69,1/7/2019
F1529C,executive-appointment,100,54,1/7/2019
F1529C,executive-appointment,100,54,1/7/2019
F30508,acquisition-acquirer,100,49,1/7/2019
F30508,acquisition-acquirer,100,49,1/7/2019
F30508,acquisition-acquirer,100,49,1/7/2019
F30508,acquisition-acquirer,100,49,1/7/2019
F4E882,business-contract,100,69,1/7/2019
F6DE54,unit-acquisition-acquirer,100,49,1/7/2019
FD0CA4,conference-call,100,50,1/7/2019
FDF799,earnings,100,50,1/7/2019
FF5413,revenue-volume,100,50,1/7/2019
FF6644,earnings,100,50,1/7/2019
0358AF,conference-participant,100,50,1/8/2019
036C6F,conference-call,100,50,1/8/2019
51332,conference-call,100,50,1/8/2019
07EC43,earnings-guidance,100,50,1/8/2019
95294,legal-issues-defendant,100,22,1/8/2019
95294,legal-issues-defendant,100,22,1/8/2019
95294,legal-issues-defendant,100,22,1/8/2019
95294,legal-issues-defendant,100,22,1/8/2019
0B4D10,public-offering,100,43,1/8/2019
0BF528,conference-participant,100,50,1/8/2019
135B09,conference-call,100,50,1/8/2019
14BA06,earnings,100,50,1/8/2019
152E1D,legal-issues-defendant,100,22,1/8/2019
15789A,executive-appointment,100,54,1/8/2019
15901B,executive-appointment,100,54,1/8/2019
165B3A,executive-appointment,100,54,1/8/2019
168A5D,executive-appointment,100,54,1/8/2019
17EDA5,product-release,100,64,1/8/2019
17EDA5,product-release,100,64,1/8/2019
1866B2,conference-participant,100,50,1/8/2019
1921DD,partnership,100,61,1/8/2019
1BC12C,conference-call,100,50,1/8/2019
1CDD1C,facility-open,100,65,1/8/2019
1DDEDA,executive-appointment,100,54,1/8/2019
1FE7F0,executive-appointment,100,54,1/8/2019
20BEEA,conference-call,100,50,1/8/2019
251988,business-contract,100,69,1/8/2019
27A791,revenues,100,50,1/8/2019
28B730,executive-appointment,100,54,1/8/2019
2.90E+62,business-contract,100,69,1/8/2019
2E61CC,dividend,100,50,1/8/2019
31DB20,dividend,100,50,1/8/2019
33AD83,product-release,100,64,1/8/2019
33AD83,product-release,100,64,1/8/2019
35557B,executive-appointment,100,54,1/8/2019
37727A,earnings,100,50,1/8/2019
39FB23,earnings,100,50,1/8/2019
3A113F,earnings,100,50,1/8/2019
3A113F,business-contract,100,69,1/8/2019
3D9999,earnings,100,50,1/8/2019
40F7DE,earnings,100,50,1/8/2019
44209A,earnings,100,50,1/8/2019
442587,business-contract,100,69,1/8/2019
4591D3,conference-call,100,50,1/8/2019
47FCF2,executive-appointment,100,54,1/8/2019
4A6F00,partnership,100,61,1/8/2019
4C7DB5,earnings,100,50,1/8/2019
4F9926,product-release,100,64,1/8/2019
4F9926,product-release,100,64,1/8/2019
4F9926,product-release,100,64,1/8/2019
52FB2F,executive-appointment,100,54,1/8/2019
5BE42C,executive-appointment,100,54,1/8/2019
5F2FF7,earnings,100,50,1/8/2019
601785,earnings,100,50,1/8/2019
619882,conference-organizer,100,57,1/8/2019
619882,conference-organizer,100,57,1/8/2019
61A586,conference-participant,100,50,1/8/2019
62CDDE,conference-participant,100,50,1/8/2019
64E615,conference-participant,100,50,1/8/2019
66A667,award,100,58,1/8/2019
6ACFBF,executive-appointment,100,54,1/8/2019
6B0E45,conference-call,100,50,1/8/2019
6B494E,dividend,100,50,1/8/2019
6BF593,earnings,100,50,1/8/2019
70FCEF,executive-appointment,100,54,1/8/2019
713810,partnership,100,61,1/8/2019
728737,earnings,100,50,1/8/2019
73C9E2,conference-call,100,50,1/8/2019
7.44E+09,conference-call,100,50,1/8/2019
756BB4,conference-participant,100,50,1/8/2019
77B8E9,clinical-trials-start,100,64,1/8/2019
7A975D,dividend,100,50,1/8/2019
7AF5B8,clinical-trials-start,100,64,1/8/2019
7B0BA6,earnings,100,50,1/8/2019
7B9AFA,conference-participant,100,50,1/8/2019
7BC92D,executive-appointment,100,54,1/8/2019
7D7716,earnings,100,50,1/8/2019
7F3A5F,partnership,100,61,1/8/2019
8.10E+32,executive-appointment,100,54,1/8/2019
8.22E+27,conference-call,100,50,1/8/2019
8303CD,executive-appointment,100,54,1/8/2019
8377DB,partnership,100,61,1/8/2019
83A065,public-offering,100,43,1/8/2019
84A6B9,earnings,100,50,1/8/2019
87486A,conference-call,100,50,1/8/2019
88350F,reorganization,100,53,1/8/2019
89F693,executive-appointment,100,54,1/8/2019
89F693,executive-appointment,100,54,1/8/2019
8A8E41,partnership,100,61,1/8/2019
8A8E41,partnership,100,61,1/8/2019
8AC65D,conference-call,100,50,1/8/2019
8D4486,product-release,100,64,1/8/2019
8D4486,product-release,100,64,1/8/2019
8D4486,partnership,100,61,1/8/2019
8D4486,patent-awarded,100,72,1/8/2019
8D4486,patent-awarded,100,72,1/8/2019
8D4486,patent-awarded,100,72,1/8/2019
8D4486,product-release,100,64,1/8/2019
8D4486,business-contract,100,69,1/8/2019
8E0E32,dividend,100,50,1/8/2019
8E8E6E,executive-appointment,100,54,1/8/2019
8E93A4,earnings,100,50,1/8/2019
92B047,conference-call,100,50,1/8/2019
9.36E+10,business-contract,100,69,1/8/2019
93965C,partnership,100,61,1/8/2019
93F143,partnership,100,61,1/8/2019
9.65E+09,conference-participant,100,50,1/8/2019
965360,earnings,100,50,1/8/2019
979451,legal-issues-defendant,100,22,1/8/2019
9.82E+06,conference-participant,100,50,1/8/2019
9.82E+06,executive-appointment,100,54,1/8/2019
990AD0,dividend,100,50,1/8/2019
9A2760,conference-participant,100,50,1/8/2019
9C5BA5,business-contract,100,69,1/8/2019
9CA4C6,conference-call,100,50,1/8/2019
9D65C1,conference-participant,100,50,1/8/2019
9D65C1,earnings,100,50,1/8/2019
9EBAFA,dividend-up,100,81,1/8/2019
A16DEA,earnings,100,50,1/8/2019
A204A7,conference-participant,100,50,1/8/2019
A28C54,government-contract,100,69,1/8/2019
A4F67C,earnings,100,50,1/8/2019
A5A4F5,acquisition-acquirer,100,49,1/8/2019
A666C8,executive-appointment,100,54,1/8/2019
A6828A,partnership,100,61,1/8/2019
A6FC89,conference-participant,100,50,1/8/2019
A74F6F,conference-call,100,50,1/8/2019
A790A5,executive-appointment,100,54,1/8/2019
A8AC4C,conference-participant,100,50,1/8/2019
A99576,earnings,100,50,1/8/2019
AAEE21,partnership,100,61,1/8/2019
AB7F05,partnership,100,61,1/8/2019
AC642C,earnings-guidance,100,50,1/8/2019
AC642C,earnings-guidance,100,50,1/8/2019
AC642C,earnings-guidance,100,50,1/8/2019
ADF092,stake-acquirer,100,48,1/8/2019
AEBB80,conference-participant,100,50,1/8/2019
AFD1CA,executive-appointment,100,54,1/8/2019
AFDF2E,earnings,100,50,1/8/2019
AFDF2E,earnings,100,50,1/8/2019
B09B1F,conference-participant,100,50,1/8/2019
B2256A,conference-call,100,50,1/8/2019
B2DAF6,earnings,100,50,1/8/2019
B4C673,facility-open,100,65,1/8/2019
B5BA39,executive-appointment,100,54,1/8/2019
B83BCE,earnings,100,50,1/8/2019
B9CD50,conference-participant,100,50,1/8/2019
BB0787,product-release,100,64,1/8/2019
BB0787,product-release,100,64,1/8/2019
BB07E4,note-sale,100,52,1/8/2019
BBAE2A,conference-call,100,50,1/8/2019
BD15E8,conference-call,100,50,1/8/2019
BD9668,conference-call,100,50,1/8/2019
BFE02C,earnings,100,50,1/8/2019
C15DB3,acquisition-completed-acquirer,100,49,1/8/2019
C16A8F,conference-call,100,50,1/8/2019
C3BAE7,conference-participant,100,50,1/8/2019
C41C25,earnings,100,50,1/8/2019
C4452A,business-contract,100,69,1/8/2019
C83B88,product-release,100,64,1/8/2019
C85A72,index-listing,100,76,1/8/2019
C8A059,conference-participant,100,50,1/8/2019
C97B2D,revenues,100,50,1/8/2019
CBA33B,acquisition-acquirer,100,49,1/8/2019
CC339B,product-release,100,64,1/8/2019
CE4FD9,conference-participant,100,50,1/8/2019
CFF15D,partnership,100,61,1/8/2019
D06996,acquisition-acquirer,100,49,1/8/2019
D9E036,conference-participant,100,50,1/8/2019
DAFED3,partnership,100,61,1/8/2019
DAFED3,partnership,100,61,1/8/2019
DB5CA5,facility-open,100,65,1/8/2019
DB5CA5,earnings,100,50,1/8/2019
DC0998,product-release,100,64,1/8/2019
DF01B1,partnership,100,61,1/8/2019
DF532D,conference-call,100,50,1/8/2019
E1BD05,conference-participant,100,50,1/8/2019
E2CB7B,executive-appointment,100,54,1/8/2019
E2CB7B,conference-participant,100,50,1/8/2019
E2F130,earnings,100,50,1/8/2019
E3E68E,legal-issues-defendant,100,22,1/8/2019
E754F0,conference-participant,100,50,1/8/2019
E866D2,revenue-volume,100,50,1/8/2019
E8E899,partnership,100,61,1/8/2019
E8E899,partnership,100,61,1/8/2019
E9FF33,executive-appointment,100,54,1/8/2019
EA62FC,asset-sale,100,62,1/8/2019
EAA0A7,acquisition-completed-acquirer,100,49,1/8/2019
EAA0A7,acquisition-completed-acquirer,100,49,1/8/2019
EB5E78,earnings,100,50,1/8/2019
EBD89A,government-contract,100,69,1/8/2019
EEBCEF,earnings,100,50,1/8/2019
F15E41,legal-issues-defendant,100,22,1/8/2019
F1CD47,earnings,100,50,1/8/2019
F40EE2,partnership,100,61,1/8/2019
F5349B,joint-venture,100,62,1/8/2019
F5349B,joint-venture,100,62,1/8/2019
F5349B,joint-venture,100,62,1/8/2019
F5349B,joint-venture,100,62,1/8/2019
F5C78B,earnings,100,50,1/8/2019
F5D410,conference-call,100,50,1/8/2019
F6E248,regulatory-product-approval-granted,100,81,1/8/2019
FAEABE,market-entry,100,57,1/8/2019
FD2565,partnership,100,61,1/8/2019
FD4588,conference-participant,100,50,1/8/2019
001F1B,revenues,100,50,1/9/2019
001F1B,operating-earnings,100,50,1/9/2019
00E601,earnings,100,50,1/9/2019
48781,executive-appointment,100,54,1/9/2019
95294,legal-issues-defendant,100,22,1/9/2019
0A9D0A,legal-issues-defendant,100,22,1/9/2019
0A9D0A,legal-issues-defendant,100,22,1/9/2019
0B57D7,conference-call,100,50,1/9/2019
0F04E5,partnership,100,61,1/9/2019
0F04E5,partnership,100,61,1/9/2019
0F04E5,partnership,100,61,1/9/2019
0F04E5,partnership,100,61,1/9/2019
0F04E5,partnership,100,61,1/9/2019
1220D2,earnings,100,50,1/9/2019
156A99,buybacks,100,74,1/9/2019
168A5D,acquisition-acquiree,100,76,1/9/2019
1748B3,conference-call,100,50,1/9/2019
17EDA5,partnership,100,61,1/9/2019
1AD9CC,revenues,100,50,1/9/2019
1B9535,partnership,100,61,1/9/2019
1D1B07,earnings,100,50,1/9/2019
1D1B07,earnings,100,50,1/9/2019
1D1B07,earnings,100,50,1/9/2019
1D1B07,earnings,100,50,1/9/2019
1D943E,conference-participant,100,50,1/9/2019
1E1125,executive-appointment,100,54,1/9/2019
21DED4,conference-call,100,50,1/9/2019
228D42,partnership,100,61,1/9/2019
228D42,partnership,100,61,1/9/2019
228D42,partnership,100,61,1/9/2019
22C58E,product-release,100,64,1/9/2019
2.45E+15,earnings,100,50,1/9/2019
275300,conference-call,100,50,1/9/2019
2B8179,clinical-trials-start,100,64,1/9/2019
2CA60F,partnership,100,61,1/9/2019
2EB88B,buybacks,100,74,1/9/2019
31666F,dividend,100,50,1/9/2019
31AA84,conference-participant,100,50,1/9/2019
339F20,executive-resignation,100,44,1/9/2019
3461CF,credit-rating-upgrade-rater,20,50,1/9/2019
384CD3,earnings,100,50,1/9/2019
3A113F,executive-appointment,100,54,1/9/2019
3CBA2A,conference-call,100,50,1/9/2019
3DE4D1,conference-call,100,50,1/9/2019
3F4497,conference-call,100,50,1/9/2019
458D2C,product-release,100,64,1/9/2019
4A6F00,partnership,100,61,1/9/2019
4A6F00,partnership,100,61,1/9/2019
4A6F00,partnership,100,61,1/9/2019
4EC4C1,earnings,100,50,1/9/2019
4EC4C1,earnings,100,50,1/9/2019
4EC4C1,earnings,100,50,1/9/2019
4EC4C1,earnings,100,50,1/9/2019
510EA6,executive-appointment,100,54,1/9/2019
546A9C,earnings,100,50,1/9/2019
5546DA,conference-call,100,50,1/9/2019
55CD6F,executive-resignation,100,44,1/9/2019
5704AC,executive-resignation,100,44,1/9/2019
57356F,conference-call,100,50,1/9/2019
5B6C11,product-release,100,64,1/9/2019
5D1956,earnings,100,50,1/9/2019
60DD84,conference-call,100,50,1/9/2019
60EA12,earnings,100,50,1/9/2019
6.18E+08,earnings,100,50,1/9/2019
61BCA7,earnings,100,50,1/9/2019
639BD6,earnings-guidance,100,50,1/9/2019
66A667,earnings,100,50,1/9/2019
6D3B7B,business-contract-terminated,100,31,1/9/2019
6F39FC,note-sale,100,52,1/9/2019
70FCEF,executive-appointment,100,54,1/9/2019
72FCA3,earnings,100,50,1/9/2019
7.40E+289,earnings,100,50,1/9/2019
7.40E+289,earnings,100,50,1/9/2019
7.40E+289,earnings,100,50,1/9/2019
7.40E+289,earnings,100,50,1/9/2019
75F665,dividend,100,50,1/9/2019
769F40,executive-appointment,100,54,1/9/2019
773A17,conference-participant,100,50,1/9/2019
787D14,product-release,100,64,1/9/2019
79340A,earnings,100,50,1/9/2019
7AB859,conference-call,100,50,1/9/2019
7AF5B8,partnership,100,61,1/9/2019
7B492C,executive-appointment,100,54,1/9/2019
7C75FD,conference-call,100,50,1/9/2019
7D85A9,executive-appointment,100,54,1/9/2019
7DD584,conference-participant,100,50,1/9/2019
7FD8B9,conference-participant,100,50,1/9/2019
82B57E,business-contract,100,69,1/9/2019
83A065,public-offering,100,43,1/9/2019
86478F,earnings,100,50,1/9/2019
8B2C4A,conference-call,100,50,1/9/2019
8B6E7E,product-release,100,64,1/9/2019
91C82E,earnings-per-share-positive,100,69,1/9/2019
91C82E,earnings-per-share-positive,100,69,1/9/2019
91C82E,earnings-per-share-positive,100,69,1/9/2019
91C82E,earnings-per-share-positive,100,69,1/9/2019
91C82E,earnings-per-share-positive,100,69,1/9/2019
91E5EE,partnership,100,61,1/9/2019
93633B,conference-call,100,50,1/9/2019
980C14,conference-call,100,50,1/9/2019
98CEBB,product-release,100,64,1/9/2019
990AD0,merger-completed,100,66,1/9/2019
990AD0,merger-completed,100,66,1/9/2019
990AD0,merger-completed,100,66,1/9/2019
990AD0,merger-completed,100,66,1/9/2019
990AD0,earnings,100,50,1/9/2019
99ACAD,earnings,100,50,1/9/2019
9B71A7,earnings,100,50,1/9/2019
9B71A7,earnings,100,50,1/9/2019
9BB35A,conference-call,100,50,1/9/2019
9E98F2,earnings,100,50,1/9/2019
9EED50,conference-call,100,50,1/9/2019
A433A5,acquisition-completed-acquirer,100,49,1/9/2019
A4386C,credit-rating-upgrade,100,77,1/9/2019
A5A4F5,acquisition-acquirer,100,49,1/9/2019
A666C8,conference-participant,100,50,1/9/2019
A666C8,conference-participant,100,50,1/9/2019
A746F6,conference-call,100,50,1/9/2019
B1FC3B,business-contract,100,69,1/9/2019
B54A74,earnings,100,50,1/9/2019
B7EB38,earnings,100,50,1/9/2019
B83BCE,partnership,100,61,1/9/2019
B8EF97,revenues,100,50,1/9/2019
B96637,conference-participant,100,50,1/9/2019
BAD655,patient-enrollment-start,100,58,1/9/2019
BB0787,product-release,100,64,1/9/2019
BDE867,business-contract,100,69,1/9/2019
BFAEB4,partnership,100,61,1/9/2019
BFCACF,conference-call,100,50,1/9/2019
C0BA36,conference-participant,100,50,1/9/2019
C3EE99,earnings,100,50,1/9/2019
C66B44,conference-call,100,50,1/9/2019
C6C702,conference-call,100,50,1/9/2019
C83B88,business-contract,100,69,1/9/2019
C941DC,conference-participant,100,50,1/9/2019
CA3CB9,conference-call,100,50,1/9/2019
CE5664,conference-participant,100,50,1/9/2019
D06755,earnings,100,50,1/9/2019
D08D2C,conference-call,100,50,1/9/2019
D0DFE5,executive-appointment,100,54,1/9/2019
D17F7E,earnings,100,50,1/9/2019
D2B9E5,earnings,100,50,1/9/2019
D2C0B6,conference-participant,100,50,1/9/2019
D58A11,earnings,100,50,1/9/2019
D7A953,earnings,100,50,1/9/2019
D7AC6E,earnings,100,50,1/9/2019
DB5CA5,investment-investor,100,55,1/9/2019
DBFB51,settlement,100,56,1/9/2019
DDCB34,conference-participant,100,50,1/9/2019
E21871,executive-appointment,100,54,1/9/2019
E959F3,earnings,100,50,1/9/2019
EBD89A,business-contract,100,69,1/9/2019
ED0402,business-contract,100,69,1/9/2019
ED9576,earnings,100,50,1/9/2019
F0B2B5,executive-appointment,100,54,1/9/2019
F15E41,legal-issues-defendant,100,22,1/9/2019
F4E992,earnings,100,50,1/9/2019
F50BAB,earnings,100,50,1/9/2019
F7902B,business-contract,100,69,1/9/2019
F7ADEB,revenue-above-expectations,100,86,1/9/2019
FC1B7B,conference-call,100,50,1/9/2019
FC4550,conference-call,100,50,1/9/2019
FD9526,conference-call,100,50,1/9/2019
00326E,conference-call,100,50,1/10/2019
13528,executive-appointment,100,54,1/10/2019
0157B1,partnership,100,61,1/10/2019
036C6F,revenue-up,100,56,1/10/2019
48590,partnership,100,61,1/10/2019
71860,earnings,100,50,1/10/2019
07CA6A,conference-call,100,50,1/10/2019
07CA6A,conference-call,100,50,1/10/2019
083F72,conference-call,100,50,1/10/2019
95294,legal-issues-defendant,100,22,1/10/2019
0A9D0A,legal-issues-defendant,100,22,1/10/2019
0E3436,partnership,100,61,1/10/2019
0E3436,partnership,100,61,1/10/2019
0E3436,executive-appointment,100,54,1/10/2019
0E3436,executive-appointment,100,54,1/10/2019
0F0440,revenues,100,50,1/10/2019
119CB6,conference-call,100,50,1/10/2019
1272B3,conference-participant,100,50,1/10/2019
13C3E0,earnings,100,50,1/10/2019
147C38,award,100,58,1/10/2019
1BDB2A,merger-regulatory-approval,100,81,1/10/2019
1DEBBE,executive-appointment,100,54,1/10/2019
1E9A6D,earnings,100,50,1/10/2019
1FE3CB,conference-call,100,50,1/10/2019
21153F,award,100,58,1/10/2019
22C58E,executive-resignation,100,44,1/10/2019
24CB56,dividend,100,50,1/10/2019
24D81E,executive-appointment,100,54,1/10/2019
270305,merger,100,66,1/10/2019
2B9DBB,conference-call,100,50,1/10/2019
2BF36E,legal-issues-defendant,100,22,1/10/2019
2F960F,fundraising,100,64,1/10/2019
309922,conference-call,100,50,1/10/2019
342218,conference-call,100,50,1/10/2019
353DBB,earnings,100,50,1/10/2019
385DD4,legal-issues-defendant,100,22,1/10/2019
39D9DA,earnings,100,50,1/10/2019
3A3447,product-release,100,64,1/10/2019
458D2C,revenue-volume,100,50,1/10/2019
4885C8,earnings,100,50,1/10/2019
4.91E+58,conference-call,100,50,1/10/2019
494EB9,earnings,100,50,1/10/2019
4D971D,earnings,100,50,1/10/2019
504FE2,conference-call,100,50,1/10/2019
507AE7,name-change,100,49,1/10/2019
514067,legal-issues-defendant,100,22,1/10/2019
514067,legal-issues-defendant,100,22,1/10/2019
51527B,conference-call,100,50,1/10/2019
55438C,legal-issues-defendant,100,22,1/10/2019
567F3D,conference-call,100,50,1/10/2019
583A75,revenue-volume,100,50,1/10/2019
589846,conference-participant,100,50,1/10/2019
58CA9A,conference-organizer,100,57,1/10/2019
5B97B2,earnings,100,50,1/10/2019
5C2A47,conference-call,100,50,1/10/2019
5EAA43,asset-sale,100,62,1/10/2019
5EAA43,business-contract,100,69,1/10/2019
641F17,merger-completed,100,66,1/10/2019
64E615,executive-appointment,100,54,1/10/2019
66749D,earnings,100,50,1/10/2019
6830FE,product-release,100,64,1/10/2019
6B67BD,clinical-trials-filed,100,60,1/10/2019
6E705B,product-release,100,64,1/10/2019
6E705B,facility-open,100,65,1/10/2019
728737,dividend,100,50,1/10/2019
72CB93,conference-call,100,50,1/10/2019
7448A3,earnings,100,50,1/10/2019
76CEFB,earnings,100,50,1/10/2019
773A17,earnings,100,50,1/10/2019
7740DE,same-store-sales,100,50,1/10/2019
7823A3,earnings,100,50,1/10/2019
7B9212,revenues,100,50,1/10/2019
8.10E+32,conference-call,100,50,1/10/2019
837C04,conference-call,100,50,1/10/2019
8614A2,acquisition-acquirer,100,49,1/10/2019
8802B4,conference-call,100,50,1/10/2019
89F693,earnings,100,50,1/10/2019
8A8E41,partnership,100,61,1/10/2019
8BE916,earnings,100,50,1/10/2019
901327,product-release,100,64,1/10/2019
91C82E,dividend,100,50,1/10/2019
91C82E,buybacks,100,74,1/10/2019
922F0C,earnings,100,50,1/10/2019
954004,executive-appointment,100,54,1/10/2019
9.74E+08,earnings,100,50,1/10/2019
977A1E,conference-call,100,50,1/10/2019
980C14,dividend,100,50,1/10/2019
9.82E+06,buybacks,100,74,1/10/2019
9CA432,conference-call,100,50,1/10/2019
9F5997,conference-call,100,50,1/10/2019
A1A317,conference-call,100,50,1/10/2019
A5A4F5,acquisition-acquirer,100,49,1/10/2019
A6828A,executive-appointment,100,54,1/10/2019
A9ED24,executive-appointment,100,54,1/10/2019
AA5C8E,earnings,100,50,1/10/2019
B0FE08,conference-call,100,50,1/10/2019
B1FC3B,business-contract,100,69,1/10/2019
B5734D,earnings,100,50,1/10/2019
B6843B,credit-extension-recipient,100,69,1/10/2019
B9CD50,executive-appointment,100,54,1/10/2019
BB5271,conference-call,100,50,1/10/2019
BBBB41,conference-call,100,50,1/10/2019
BD682F,dividend,100,50,1/10/2019
C0F70B,earnings,100,50,1/10/2019
C230FE,earnings,100,50,1/10/2019
C45CE7,conference-participant,100,50,1/10/2019
C4706C,dividend,100,50,1/10/2019
C4C77F,dividend,100,50,1/10/2019
C5C137,earnings,100,50,1/10/2019
C6C702,conference-participant,100,50,1/10/2019
C7863D,conference-call,100,50,1/10/2019
C7AE14,conference-call,100,50,1/10/2019
CC6FF5,earnings,100,50,1/10/2019
CD4DA8,earnings,100,50,1/10/2019
CE5664,campaign-ad-release,100,59,1/10/2019
CE5664,earnings,100,50,1/10/2019
D08D2C,dividend,100,50,1/10/2019
D09938,conference-call,100,50,1/10/2019
D17C1B,earnings,100,50,1/10/2019
D33270,facility-open,100,65,1/10/2019
D64C6D,partnership,100,61,1/10/2019
D65A13,conference-call,100,50,1/10/2019
DA199F,earnings,100,50,1/10/2019
DA199F,earnings,100,50,1/10/2019
DA199F,earnings,100,50,1/10/2019
DA199F,earnings,100,50,1/10/2019
DA199F,earnings,100,50,1/10/2019
DA199F,earnings,100,50,1/10/2019
DA199F,earnings,100,50,1/10/2019
DA199F,dividend,100,50,1/10/2019
DB23C8,conference-participant,100,50,1/10/2019
DB23C8,conference-participant,100,50,1/10/2019
DBCA3F,executive-appointment,100,54,1/10/2019
DF46C5,earnings,100,50,1/10/2019
DF6FDD,earnings,100,50,1/10/2019
E12A6E,dividend,100,50,1/10/2019
E20BFE,revenue-up,100,69,1/10/2019
EAEBF3,note-sale,100,52,1/10/2019
EB61C4,executive-appointment,100,54,1/10/2019
EB61C4,executive-appointment,100,54,1/10/2019
EB6965,dividend,100,50,1/10/2019
F11638,board-meeting,100,51,1/10/2019
F179ED,executive-appointment,100,54,1/10/2019
F4E992,conference-participant,100,50,1/10/2019
F5349B,business-contract,100,69,1/10/2019
F5349B,business-contract,100,69,1/10/2019
F5349B,business-contract,100,69,1/10/2019
F5349B,business-contract,100,69,1/10/2019
F6DCE4,revenues,100,50,1/10/2019
F6DCE4,dividend,100,50,1/10/2019
F6FA6A,business-contract,100,69,1/10/2019
F72E4B,business-contract,100,69,1/10/2019
F7ADEB,conference-participant,100,50,1/10/2019
F88A04,earnings,100,50,1/10/2019
FCA54E,conference-participant,100,50,1/10/2019
FE89E0,business-contract,100,69,1/10/2019
FE89E0,conference-call,100,50,1/10/2019
FEBFE1,orphan-drug-designation,100,76,1/10/2019
FEBFE1,orphan-drug-designation,100,76,1/10/2019
FF5413,earnings,100,50,1/10/2019
0358AF,earnings,100,50,1/11/2019
95294,legal-issues-defendant,100,22,1/11/2019
0A9D0A,legal-issues-defendant,100,22,1/11/2019
0BC17A,earnings,100,50,1/11/2019
147C38,donation,100,54,1/11/2019
1CD09C,business-contract,100,69,1/11/2019
1D1B07,executive-appointment,100,54,1/11/2019
1D1B07,executive-appointment,100,54,1/11/2019
1DE526,conference-call,100,50,1/11/2019
20BEEA,earnings,100,50,1/11/2019
238302,conference-call,100,50,1/11/2019
2.89E+11,dividend,100,50,1/11/2019
2950FF,earnings,100,50,1/11/2019
2950FF,earnings,100,50,1/11/2019
2B7A40,acquisition-acquirer,100,49,1/11/2019
2B7A40,unit-acquisition-acquirer,100,49,1/11/2019
2B7A40,unit-acquisition-acquirer,100,49,1/11/2019
2CB4C9,earnings,100,50,1/11/2019
2D485F,earnings,100,50,1/11/2019
2DB344,earnings,100,50,1/11/2019
2EBA55,capital-increase,100,43,1/11/2019
2EBA55,capital-increase,100,43,1/11/2019
2EBA55,dividend,100,50,1/11/2019
2F6782,reorganization-costs,100,47,1/11/2019
328250,conference-call,100,50,1/11/2019
32CB22,conference-call,100,50,1/11/2019
34B97A,executive-appointment,100,54,1/11/2019
3B318A,executive-appointment,100,54,1/11/2019
40F7DE,legal-issues-defendant,100,22,1/11/2019
420168,earnings,100,50,1/11/2019
468DD4,partnership,100,61,1/11/2019
4B3DC9,conference-call,100,50,1/11/2019
514067,legal-issues-defendant,100,22,1/11/2019
514067,legal-issues-defendant,100,22,1/11/2019
514067,legal-issues-defendant,100,22,1/11/2019
51B442,earnings,100,50,1/11/2019
520632,partnership,100,61,1/11/2019
525A1C,earnings,100,50,1/11/2019
5BE42C,unit-acquisition-acquiree,100,76,1/11/2019
693ECD,clinical-trials,100,56,1/11/2019
698FF9,earnings-guidance,100,50,1/11/2019
6C4D2F,conference-call,100,50,1/11/2019
6CDFC6,conference-call,100,50,1/11/2019
6D0CAB,dividend,100,50,1/11/2019
79167B,acquisition-completed-acquirer,100,49,1/11/2019
7E62B5,earnings-guidance,100,50,1/11/2019
86A1B9,earnings,100,50,1/11/2019
896771,acquisition-completed-acquirer,100,49,1/11/2019
896771,stock-splits,100,49,1/11/2019
8E8E6E,executive-appointment,100,54,1/11/2019
900356,earnings-guidance,100,50,1/11/2019
92D757,executive-appointment,100,54,1/11/2019
93965C,conference-participant,100,50,1/11/2019
93F143,earnings,100,50,1/11/2019
945DE6,dividend,100,50,1/11/2019
965360,merger-regulatory-approval,100,81,1/11/2019
986AF6,conference-call,100,50,1/11/2019
9C8664,conference-call,100,50,1/11/2019
9F03CF,conference-call,100,50,1/11/2019
A41450,dividend,100,50,1/11/2019
A5628C,executive-appointment,100,54,1/11/2019
A5A4F5,acquisition-acquirer,100,49,1/11/2019
B13B68,partnership,100,61,1/11/2019
B1DF3C,earnings,100,50,1/11/2019
BFD0A7,conference-participant,100,50,1/11/2019
C5E100,conference-participant,100,50,1/11/2019
C66A8C,revenues,100,50,1/11/2019
CDE118,earnings,100,50,1/11/2019
D17C1B,revenue-volume,100,50,1/11/2019
D1C26F,conference-participant,100,50,1/11/2019
D57D99,conference-participant,100,50,1/11/2019
D82EF3,conference-call,100,50,1/11/2019
DB5CA5,award,100,58,1/11/2019
DCD97F,executive-appointment,100,54,1/11/2019
E10D31,legal-issues-defendant,100,22,1/11/2019
E35610,legal-issues-defendant,100,22,1/11/2019
E35610,legal-issues-defendant,100,22,1/11/2019
E35610,legal-issues-defendant,100,22,1/11/2019
E592F0,earnings,100,50,1/11/2019
EB36DE,business-contract,100,69,1/11/2019
EB6965,conference-call,100,50,1/11/2019
ECD263,legal-issues-defendant,100,22,1/11/2019
ED3CA8,earnings,100,50,1/11/2019
EE74E1,earnings,100,50,1/11/2019
F02D0A,earnings,100,50,1/11/2019
F179ED,earnings,100,50,1/11/2019
F46EC9,earnings,100,50,1/11/2019
F7902B,earnings,100,50,1/11/2019
FC1B7B,conference-call,100,50,1/11/2019
10943B,conference-call,100,50,1/12/2019
3C7F5F,business-contract,100,69,1/12/2019
E35610,legal-issues-defendant,100,22,1/12/2019
E35610,legal-issues-defendant,100,22,1/12/2019
F0B2B5,legal-issues-defendant,100,22,1/12/2019
F0B2B5,legal-issues-defendant,100,22,1/13/2019
F0B2B5,legal-issues-defendant,100,22,1/13/2019
0142B5,conference-call,100,50,1/14/2019
03B431,buybacks,100,74,1/14/2019
03CF95,executive-appointment,100,54,1/14/2019
048B70,conference-call,100,50,1/14/2019
0624BE,earnings-guidance-meet-expectations,100,59,1/14/2019
09DE1F,executive-appointment,100,54,1/14/2019
0A59F8,partnership,100,61,1/14/2019
0A6824,public-offering,100,43,1/14/2019
0A9D0A,executive-appointment,100,54,1/14/2019
0C355F,revenue-guidance-up,100,83,1/14/2019
0C8D82,executive-appointment,100,54,1/14/2019
0CBC4D,earnings,100,50,1/14/2019
0D26E0,dividend,100,50,1/14/2019
0ED415,conference-call,100,50,1/14/2019
0FDE97,conference-call,100,50,1/14/2019
108FDA,executive-appointment,100,54,1/14/2019
1272B3,executive-appointment,100,54,1/14/2019
12DE76,partnership,100,61,1/14/2019
1BDB2A,conference-call,100,50,1/14/2019
1D5C51,partnership,100,61,1/14/2019
1DF15D,conference-call,100,50,1/14/2019
1EBF8D,business-contract,100,69,1/14/2019
1EBF8D,business-contract,100,69,1/14/2019
1F08A6,conference-call,100,50,1/14/2019
21022F,revenues,100,50,1/14/2019
21D903,executive-appointment,100,54,1/14/2019
250BEE,dividend,100,50,1/14/2019
263216,conference-participant,100,50,1/14/2019
29B702,earnings,100,50,1/14/2019
2B49F4,executive-appointment,100,54,1/14/2019
2B9DBB,executive-appointment,100,54,1/14/2019
2C7505,public-offering,100,43,1/14/2019
2F5256,executive-appointment,100,54,1/14/2019
3159AA,facility-open,100,65,1/14/2019
315EB0,market-entry,100,57,1/14/2019
3.88E+02,dividend,100,50,1/14/2019
389CFB,earnings,100,50,1/14/2019
4.03E+05,earnings-guidance,100,50,1/14/2019
44A4FC,earnings,100,50,1/14/2019
45ABCC,product-release,100,64,1/14/2019
45ABCC,product-release,100,64,1/14/2019
467F2C,earnings,100,50,1/14/2019
4885C8,conference-call,100,50,1/14/2019
49A344,earnings,100,50,1/14/2019
4AC91D,partnership,100,61,1/14/2019
4D8124,product-release,100,64,1/14/2019
51D876,earnings,100,50,1/14/2019
5225A4,conference-call,100,50,1/14/2019
532D47,earnings-guidance,100,50,1/14/2019
553949,partnership,100,61,1/14/2019
564F3E,earnings,100,50,1/14/2019
58B46F,conference-call,100,50,1/14/2019
58CA9A,earnings,100,50,1/14/2019
5A0FF1,earnings,100,50,1/14/2019
5A64D5,conference-call,100,50,1/14/2019
5C2A47,facility-open,100,65,1/14/2019
5CEE02,executive-firing,100,36,1/14/2019
605F40,earnings-guidance,100,50,1/14/2019
610D47,conference-call,100,50,1/14/2019
616E3B,conference-call,100,50,1/14/2019
619882,conference-organizer,100,57,1/14/2019
62B1C6,dividend,100,50,1/14/2019
68E3E0,dividend,100,50,1/14/2019
6D3B7B,executive-appointment,100,54,1/14/2019
6D6B40,earnings,100,50,1/14/2019
6F3936,partnership,100,61,1/14/2019
6FCEF9,earnings-guidance-up,100,83,1/14/2019
6FCEF9,earnings-guidance-up,100,83,1/14/2019
7239BB,executive-appointment,100,54,1/14/2019
731675,partnership,100,61,1/14/2019
767F86,earnings,100,50,1/14/2019
76B926,acquisition-completed-acquirer,100,49,1/14/2019
76CEFB,debt-restructuring,100,59,1/14/2019
771985,earnings,100,50,1/14/2019
7AB859,partnership,100,61,1/14/2019
7D5384,executive-appointment,100,54,1/14/2019
7F3669,earnings,100,50,1/14/2019
7F9E16,executive-appointment,100,54,1/14/2019
85CDC9,regulatory-product-approval-granted,100,81,1/14/2019
85DA04,unit-acquisition-acquirer,100,49,1/14/2019
863350,earnings-guidance,100,50,1/14/2019
8B6E7E,conference-call,100,50,1/14/2019
8E4F9A,conference-participant,100,50,1/14/2019
8E9CD8,earnings,100,50,1/14/2019
9.54E+32,executive-appointment,100,54,1/14/2019
95C392,earnings,100,50,1/14/2019
97693A,earnings-guidance,100,50,1/14/2019
990AD0,conference-organizer,100,57,1/14/2019
990AD0,conference-organizer,100,57,1/14/2019
990AD0,conference-organizer,100,57,1/14/2019
9A02C4,campaign-ad-release,100,59,1/14/2019
9A602D,conference-call,100,50,1/14/2019
9CE4C7,executive-appointment,100,54,1/14/2019
9D30A8,conference-participant,100,50,1/14/2019
9F37C5,public-offering,100,43,1/14/2019
A26C26,earnings-up,100,68,1/14/2019
A4B899,unit-acquisition-acquirer,100,49,1/14/2019
A5628C,executive-appointment,100,54,1/14/2019
A5A4F5,acquisition-acquirer,100,49,1/14/2019
A6213D,conference-call,100,50,1/14/2019
A75D43,conference-participant,100,50,1/14/2019
A868C9,partnership,100,61,1/14/2019
AA3AB8,revenue-up,100,56,1/14/2019
AAC8B6,executive-appointment,100,54,1/14/2019
AAC8B6,executive-appointment,100,54,1/14/2019
AADE0B,conference-call,100,50,1/14/2019
AC3584,partnership,100,61,1/14/2019
AD1ACF,executive-appointment,100,54,1/14/2019
AD9F1D,earnings,100,50,1/14/2019
AE3113,earnings,100,50,1/14/2019
AE7D16,legal-issues-defendant,100,22,1/14/2019
AFF7B4,dividend,100,50,1/14/2019
B09B1F,facility-close,100,47,1/14/2019
B09B1F,executive-appointment,100,54,1/14/2019
B4703C,executive-appointment,100,54,1/14/2019
B4B281,revenues,100,50,1/14/2019
B642E8,partnership,100,61,1/14/2019
B642E8,partnership,100,61,1/14/2019
B7BDA3,earnings,100,50,1/14/2019
B9CD50,executive-appointment,100,54,1/14/2019
B9CD50,public-offering,100,43,1/14/2019
BDF85E,earnings-guidance-up,100,83,1/14/2019
C0200F,earnings,100,50,1/14/2019
C41C25,buybacks,100,74,1/14/2019
C9D866,conference-call,100,50,1/14/2019
CBA33B,product-release,100,64,1/14/2019
CBFFDD,executive-appointment,100,54,1/14/2019
CBFFDD,executive-appointment,100,54,1/14/2019
CDC817,earnings,100,50,1/14/2019
CDE51C,earnings,100,50,1/14/2019
CF6A5A,earnings,100,50,1/14/2019
CFF15D,dividend,100,50,1/14/2019
D1C0B9,earnings,100,50,1/14/2019
D1C26F,partnership,100,61,1/14/2019
D3F64D,earnings-guidance,100,50,1/14/2019
D6489C,partnership,100,61,1/14/2019
D76AEF,conference-participant,100,50,1/14/2019
D78CCD,executive-appointment,100,54,1/14/2019
DC6EF3,executive-appointment,100,54,1/14/2019
DD682D,earnings,100,50,1/14/2019
DD7A96,conference-call,100,50,1/14/2019
E10D31,legal-issues-defendant,100,22,1/14/2019
E12A6E,dividend,100,50,1/14/2019
E35610,legal-issues-defendant,100,22,1/14/2019
E829E8,executive-appointment,100,54,1/14/2019
EB36DE,business-contract,100,69,1/14/2019
EB43F4,revenues,100,50,1/14/2019
ECA300,same-store-sales,100,50,1/14/2019
ECA300,same-store-sales,100,50,1/14/2019
EE967B,earnings,100,50,1/14/2019
EF5914,acquisition-completed-acquirer,100,49,1/14/2019
EF5BED,executive-appointment,100,54,1/14/2019
F0B2B5,legal-issues-defendant,100,22,1/14/2019
F0B2B5,legal-issues-defendant,100,22,1/14/2019
F30508,business-contract,100,69,1/14/2019
F40EE2,product-release,100,64,1/14/2019
F57F6F,executive-appointment,100,54,1/14/2019
F8084B,conference-call,100,50,1/14/2019
F85CC0,earnings,100,50,1/14/2019
F93C8A,dividend,100,50,1/14/2019
F9CAF8,earnings-guidance,100,50,1/14/2019
FAB97A,conference-call,100,50,1/14/2019
FF4343,conference-call,100,50,1/14/2019
00067A,business-contract,100,69,1/15/2019
00067A,executive-appointment,100,54,1/15/2019
0157B1,partnership,100,61,1/15/2019
01D03F,product-release,100,64,1/15/2019
01D03F,product-release,100,64,1/15/2019
03596A,earnings,100,50,1/15/2019
03B431,conference-call,100,50,1/15/2019
03FAA6,business-contract,100,69,1/15/2019
03FB17,earnings,100,50,1/15/2019
71860,partnership,100,61,1/15/2019
07C69F,conference-call,100,50,1/15/2019
95294,partnership,100,61,1/15/2019
0A6824,note-sale,100,52,1/15/2019
0A77DB,partnership,100,61,1/15/2019
0BC29E,executive-appointment,100,54,1/15/2019
0C2A0D,earnings,100,50,1/15/2019
0C4131,merger,100,66,1/15/2019
0F0440,donation,100,54,1/15/2019
14833D,legal-issues-defendant,100,22,1/15/2019
149301,public-offering,100,43,1/15/2019
15789A,conference-participant,100,50,1/15/2019
188394,executive-appointment,100,54,1/15/2019
1A6A94,dividend,100,50,1/15/2019
1E83DE,legal-issues-defendant,100,22,1/15/2019
1F19C8,fundraising,100,64,1/15/2019
1F716B,conference-call,100,50,1/15/2019
202E5A,reorganization,100,53,1/15/2019
205AD5,earnings,100,50,1/15/2019
205AD5,earnings,100,50,1/15/2019
205AD5,earnings,100,50,1/15/2019
205AD5,earnings,100,50,1/15/2019
214051,earnings,100,50,1/15/2019
222BF9,conference-call,100,50,1/15/2019
2B7A40,earnings,100,50,1/15/2019
2BA977,partnership,100,61,1/15/2019
2BA977,partnership,100,61,1/15/2019
2C7505,public-offering,100,43,1/15/2019
2CC71C,executive-appointment,100,54,1/15/2019
2DA92D,conference-call,100,50,1/15/2019
2F1299,conference-call,100,50,1/15/2019
3.14E+47,earnings,100,50,1/15/2019
3159AA,facility-open,100,65,1/15/2019
315EB0,conference-call,100,50,1/15/2019
3461CF,executive-appointment,100,54,1/15/2019
34A959,conference-participant,100,50,1/15/2019
35F4B5,earnings,100,50,1/15/2019
367E1C,conference-call,100,50,1/15/2019
37020C,earnings-guidance,100,50,1/15/2019
370C50,unit-acquisition-acquirer,100,49,1/15/2019
383ADA,acquisition-acquirer,100,49,1/15/2019
387541,dividend-up,100,59,1/15/2019
3A4BDB,executive-appointment,100,54,1/15/2019
3B20AB,dividend,100,50,1/15/2019
3E15F6,conference-call,100,50,1/15/2019
416C55,earnings,100,50,1/15/2019
41A93D,conference-participant,100,50,1/15/2019
43A74A,business-contract,100,69,1/15/2019
44ED36,earnings,100,50,1/15/2019
48F795,earnings,100,50,1/15/2019
4A6F00,partnership,100,61,1/15/2019
4B5054,conference-call,100,50,1/15/2019
4FCC78,dividend,100,50,1/15/2019
514067,legal-issues-defendant,100,22,1/15/2019
514067,legal-issues-defendant,100,22,1/15/2019
514067,legal-issues-defendant,100,22,1/15/2019
514067,legal-issues-defendant,100,22,1/15/2019
514067,legal-issues-defendant,100,22,1/15/2019
524CE4,conference-call,100,50,1/15/2019
546A27,business-contract,100,69,1/15/2019
546A27,business-contract,100,69,1/15/2019
546A27,business-contract,100,69,1/15/2019
546A27,business-contract,100,69,1/15/2019
54DF47,unit-acquisition-acquirer,100,49,1/15/2019
57A854,executive-appointment,100,54,1/15/2019
583A75,conference-call,100,50,1/15/2019
58CA9A,dividend,100,50,1/15/2019
5B35C7,earnings-positive,100,69,1/15/2019
5B35C7,earnings-up,100,68,1/15/2019
5B35C7,earnings-up,100,68,1/15/2019
5F1B7B,earnings,100,50,1/15/2019
6137BF,settlement,100,56,1/15/2019
619882,earnings,100,50,1/15/2019
619882,dividend,100,50,1/15/2019
66E04A,earnings,100,50,1/15/2019
66ECFD,dividend,100,50,1/15/2019
68B03F,business-contract,100,69,1/15/2019
6BC6F9,executive-appointment,100,54,1/15/2019
6D0CAB,operating-earnings,100,50,1/15/2019
6D3B7B,executive-appointment,100,54,1/15/2019
6.00E+19,business-contract,100,69,1/15/2019
6E705B,earnings,100,50,1/15/2019
6E705B,earnings,100,50,1/15/2019
6E705B,earnings,100,50,1/15/2019
6E705B,earnings,100,50,1/15/2019
6E705B,earnings,100,50,1/15/2019
6E705B,earnings,100,50,1/15/2019
6F5DD2,exchange-compliance,100,76,1/15/2019
70FCEF,executive-appointment,100,54,1/15/2019
722D55,earnings,100,50,1/15/2019
741937,earnings,100,50,1/15/2019
762A3E,conference-organizer,100,57,1/15/2019
789ADD,earnings,100,50,1/15/2019
793C11,executive-appointment,100,54,1/15/2019
793C11,executive-appointment,100,54,1/15/2019
7ADE57,partnership,100,61,1/15/2019
7B6EB1,executive-appointment,100,54,1/15/2019
7D5384,conference-call,100,50,1/15/2019
7DC1C4,earnings-guidance,100,50,1/15/2019
7F9984,earnings,100,50,1/15/2019
82C202,earnings,100,50,1/15/2019
855DF7,dividend,100,50,1/15/2019
859281,earnings,100,50,1/15/2019
8802B4,dividend-up,100,81,1/15/2019
8802B4,earnings-guidance,100,50,1/15/2019
8802B4,earnings-guidance,100,50,1/15/2019
88923D,earnings,100,50,1/15/2019
88923D,earnings,100,50,1/15/2019
8DDA23,dividend,100,50,1/15/2019
92D757,executive-resignation,100,44,1/15/2019
95C575,buybacks,100,74,1/15/2019
965360,acquisition-regulatory-approval-acquirer,100,54,1/15/2019
967D92,conference-call,100,50,1/15/2019
979451,legal-issues-defendant,100,22,1/15/2019
9810C0,conference-call,100,50,1/15/2019
9BF177,partnership,100,61,1/15/2019
9D30A8,earnings,100,50,1/15/2019
9E0811,earnings,100,50,1/15/2019
9E298A,conference-call,100,50,1/15/2019
9E575E,public-offering,100,43,1/15/2019
9F37C5,public-offering,100,43,1/15/2019
A247F5,partnership,100,61,1/15/2019
A43906,conference-call,100,50,1/15/2019
A4A612,earnings,100,50,1/15/2019
A5A4F5,acquisition-acquirer,100,49,1/15/2019
A6213D,partnership,100,61,1/15/2019
A666C8,dividend,100,50,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A746F6,earnings-per-share-positive,100,69,1/15/2019
A75D43,executive-resignation,100,44,1/15/2019
A80FE0,conference-call,100,50,1/15/2019
AD1ACF,partnership,100,61,1/15/2019
AD3008,earnings-per-share-guidance,100,50,1/15/2019
B09B1F,partnership,100,61,1/15/2019
B1FC3B,award,100,58,1/15/2019
B2D492,earnings,100,50,1/15/2019
B4C673,partnership,100,61,1/15/2019
B560AF,executive-resignation,100,44,1/15/2019
B614F8,stock-gain,100,63,1/15/2019
B642E8,index-listing,100,76,1/15/2019
B96DF5,earnings,100,50,1/15/2019
B96DF5,earnings,100,50,1/15/2019
B96DF5,earnings,100,50,1/15/2019
BBF349,earnings,100,50,1/15/2019
BD8517,earnings,100,50,1/15/2019
C0030A,earnings,100,50,1/15/2019
C32A39,dividend,100,50,1/15/2019
C356AC,facility-open,100,65,1/15/2019
C3BAE7,acquisition-completed-acquirer,100,49,1/15/2019
C50B26,unit-acquisition-completed-acquirer,100,49,1/15/2019
C5C0E9,earnings,100,50,1/15/2019
C5E100,award,100,58,1/15/2019
C7859D,earnings-up,100,68,1/15/2019
C7859D,earnings-up,100,68,1/15/2019
C7859D,earnings-up,100,68,1/15/2019
C7859D,earnings-up,100,68,1/15/2019
C7859D,earnings-up,100,68,1/15/2019
C7859D,earnings-up,100,68,1/15/2019
C97B2D,settlement,100,56,1/15/2019
CB6A9C,product-release,100,64,1/15/2019
CBFFDD,legal-issues-defendant,100,22,1/15/2019
CBFFDD,legal-issues-defendant,100,22,1/15/2019
CBFFDD,legal-issues-defendant,100,22,1/15/2019
CBFFDD,legal-issues-defendant,100,22,1/15/2019
CBFFDD,legal-issues-defendant,100,22,1/15/2019
CEC5B9,conference-call,100,50,1/15/2019
D1AE3B,dividend,100,50,1/15/2019
D1C26F,executive-appointment,100,54,1/15/2019
D3FA2C,conference-call,100,50,1/15/2019
D6144F,conference-participant,100,50,1/15/2019
D88EF3,note-sale,100,52,1/15/2019
DB06B0,earnings,100,50,1/15/2019
E074A0,earnings,100,50,1/15/2019
E10D31,legal-issues-defendant,100,22,1/15/2019
E35610,legal-issues-defendant,100,22,1/15/2019
E35610,legal-issues-defendant,100,22,1/15/2019
E3E68E,conference-call,100,50,1/15/2019
E68733,product-release,100,64,1/15/2019
E6BC2C,conference-call,100,50,1/15/2019
E6D89E,earnings,100,50,1/15/2019
E6E012,earnings,100,50,1/15/2019
E6E012,earnings,100,50,1/15/2019
E8846E,earnings-positive,100,69,1/15/2019
EA62FC,conference-call,100,50,1/15/2019
EB61C4,conference-call,100,50,1/15/2019
EBD89A,business-contract,100,69,1/15/2019
ED3CA8,public-offering,100,43,1/15/2019
EDF5CA,earnings,100,50,1/15/2019
EDF5CA,earnings,100,50,1/15/2019
EDF5CA,earnings,100,50,1/15/2019
EDF5CA,earnings,100,50,1/15/2019
EDF5CA,earnings,100,50,1/15/2019
EDF5CA,earnings,100,50,1/15/2019
EDF5CA,earnings,100,50,1/15/2019
EDF5CA,dividend,100,50,1/15/2019
EE6F1C,earnings,100,50,1/15/2019
EEA6B3,earnings,100,50,1/15/2019
EEA734,executive-appointment,100,54,1/15/2019
F15E41,legal-verdict-disfavored,100,22,1/15/2019
F8BA6C,conference-call,100,50,1/15/2019
FA044A,conference-call,100,50,1/15/2019
FA36A4,dividend,100,50,1/15/2019
FACF19,partnership,100,61,1/15/2019
FACF19,partnership,100,61,1/15/2019
FACF19,partnership,100,61,1/15/2019
FAEABE,earnings-per-share-positive,100,69,1/15/2019
FAEABE,earnings,100,50,1/15/2019
FAEABE,earnings,100,50,1/15/2019
FB728F,dividend,100,50,1/15/2019
FD9A97,revenue-guidance,100,50,1/15/2019
FDF28E,earnings,100,50,1/15/2019
FE7A63,earnings,100,50,1/15/2019
FE7A63,earnings,100,50,1/15/2019
FE7A63,earnings,100,50,1/15/2019
FE7A63,earnings,100,50,1/15/2019
FE7A63,earnings,100,50,1/15/2019
FE7A63,earnings,100,50,1/15/2019
FE7A63,earnings,100,50,1/15/2019
FE7A63,earnings,100,50,1/15/2019
FF6644,conference-participant,100,50,1/15/2019
003B70,dividend-up,100,81,1/16/2019
48590,legal-issues-defendant,100,22,1/16/2019
04996E,executive-appointment,100,54,1/16/2019
04EB2F,earnings,100,50,1/16/2019
09F623,dividend-up,100,81,1/16/2019
0BC29E,executive-appointment,100,54,1/16/2019
0BC853,unit-acquisition-acquirer,100,49,1/16/2019
0C6293,facility-open,100,65,1/16/2019
1065BC,unit-acquisition-acquirer,100,49,1/16/2019
10C19B,executive-appointment,100,54,1/16/2019
1272B3,acquisition-completed-acquirer,100,49,1/16/2019
1348C9,conference-call,100,50,1/16/2019
16F4D8,earnings,100,50,1/16/2019
190B91,business-combination,100,54,1/16/2019
190B91,business-combination,100,54,1/16/2019
190B91,business-combination,100,54,1/16/2019
1CDD1C,earnings-guidance,100,50,1/16/2019
1DEBBE,executive-appointment,100,54,1/16/2019
1F19C8,conference-call,100,50,1/16/2019
1F3CFB,executive-appointment,100,54,1/16/2019
228D42,product-release,100,64,1/16/2019
24C48B,conference-call,100,50,1/16/2019
25102A,product-release,100,64,1/16/2019
25102A,product-release,100,64,1/16/2019
26F31D,earnings,100,50,1/16/2019
2720AB,conference-call,100,50,1/16/2019
27B191,conference-call,100,50,1/16/2019
2D2D43,earnings,100,50,1/16/2019
31A7CC,earnings-up,100,68,1/16/2019
31AA84,executive-appointment,100,54,1/16/2019
3.30E+34,earnings-up,100,68,1/16/2019
3.30E+34,earnings-up,100,68,1/16/2019
3.30E+34,earnings-up,100,68,1/16/2019
3461CF,credit-rating-upgrade-rater,20,50,1/16/2019
34A959,executive-appointment,100,54,1/16/2019
3.50E+27,earnings,100,50,1/16/2019
366A08,dividend,100,50,1/16/2019
3696BF,conference-call,100,50,1/16/2019
3A3447,product-recall,100,29,1/16/2019
3BE00F,earnings,100,50,1/16/2019
3DCECC,conference-call,100,50,1/16/2019
43A74A,business-contract,100,69,1/16/2019
4AC91D,dividend,100,50,1/16/2019
4B3676,earnings,100,50,1/16/2019
4B49CF,earnings,100,50,1/16/2019
4B49CF,earnings,100,50,1/16/2019
50070E,credit-extension-provider,100,57,1/16/2019
50070E,credit-extension-provider,100,57,1/16/2019
514067,legal-issues-defendant,100,22,1/16/2019
53E575,conference-call,100,50,1/16/2019
545272,conference-call,100,50,1/16/2019
55438C,investment-investor,100,55,1/16/2019
589F5A,dividend,100,50,1/16/2019
58B46F,merger,100,66,1/16/2019
58B46F,merger,100,66,1/16/2019
58B46F,merger,100,66,1/16/2019
5E9934,conference-call,100,50,1/16/2019
5FDBD0,conference-call,100,50,1/16/2019
609208,executive-appointment,100,54,1/16/2019
6166D1,earnings,100,50,1/16/2019
61B81B,earnings-positive,100,69,1/16/2019
61B81B,earnings-positive,100,69,1/16/2019
61B81B,earnings-positive,100,69,1/16/2019
61B81B,earnings-positive,100,69,1/16/2019
61B81B,earnings-positive,100,69,1/16/2019
61B81B,earnings-positive,100,69,1/16/2019
61B81B,earnings-positive,100,69,1/16/2019
622DBE,conference-call,100,50,1/16/2019
66A667,award,100,58,1/16/2019
66A667,award,100,58,1/16/2019
69345C,earnings,100,50,1/16/2019
6B236C,executive-appointment,100,54,1/16/2019
6D3F35,conference-call,100,50,1/16/2019
7448A3,dividend,100,50,1/16/2019
746373,conference-call,100,50,1/16/2019
762B8D,dividend,100,50,1/16/2019
790C34,earnings,100,50,1/16/2019
7999F3,earnings,100,50,1/16/2019
7AB859,business-contract,100,69,1/16/2019
7AB859,partnership,100,61,1/16/2019
7F3669,unit-acquisition-acquirer,100,49,1/16/2019
7F3A5F,earnings,100,50,1/16/2019
80D744,conference-call,100,50,1/16/2019
8.10E+32,executive-appointment,100,54,1/16/2019
8275FE,earnings,100,50,1/16/2019
82E58A,earnings-guidance,100,50,1/16/2019
83598E,ownership-decrease-owner,100,46,1/16/2019
83598E,ownership-decrease-owner,100,46,1/16/2019
83598E,ownership-decrease-owner,100,46,1/16/2019
83598E,ownership-decrease-owner,100,46,1/16/2019
838ADD,earnings,100,50,1/16/2019
850779,earnings-per-share-positive,100,69,1/16/2019
850779,earnings-per-share,100,50,1/16/2019
850779,earnings-per-share,100,50,1/16/2019
850779,earnings-per-share,100,50,1/16/2019
85DE00,conference-call,100,50,1/16/2019
860AB6,dividend-up,100,81,1/16/2019
860AB6,dividend,100,50,1/16/2019
8AB85C,clinical-trials,100,56,1/16/2019
8B3B0E,conference-call,100,50,1/16/2019
8CF6DD,earnings,100,50,1/16/2019
8D4486,partnership,100,61,1/16/2019
8D4486,partnership,100,61,1/16/2019
8E82A6,earnings,100,50,1/16/2019
8E8E6E,earnings,100,50,1/16/2019
8FE7A5,earnings,100,50,1/16/2019
915E7B,earnings-guidance,100,50,1/16/2019
91C82E,executive-appointment,100,54,1/16/2019
92D3A0,dividend,100,50,1/16/2019
94C0B5,conference-call,100,50,1/16/2019
99028D,conference-call,100,50,1/16/2019
990AD0,earnings,100,50,1/16/2019
9978F1,public-offering,100,43,1/16/2019
9A602D,acquisition-completed-acquirer,100,49,1/16/2019
9B5968,dividend,100,50,1/16/2019
9B5968,dividend,100,50,1/16/2019
9B5968,executive-appointment,100,54,1/16/2019
9CF9B1,earnings,100,50,1/16/2019
9D4EC7,acquisition-completed-acquirer,100,49,1/16/2019
9D4EC7,unit-acquisition-acquirer,100,49,1/16/2019
9E5C2C,note-sale,100,52,1/16/2019
9F6B1A,earnings,100,50,1/16/2019
9FA83B,partnership,100,61,1/16/2019
A2CAF7,earnings,100,50,1/16/2019
A3F598,conference-call,100,50,1/16/2019
A5A4F5,acquisition-acquirer,100,49,1/16/2019
A6213D,partnership,100,61,1/16/2019
A94718,conference-call,100,50,1/16/2019
A9ED24,dividend-up,100,81,1/16/2019
AA5C8E,dividend,100,50,1/16/2019
AA5C8E,dividend,100,50,1/16/2019
AA5C8E,dividend,100,50,1/16/2019
AA5C8E,dividend,100,50,1/16/2019
AA5C8E,dividend,100,50,1/16/2019
AA5C8E,dividend,100,50,1/16/2019
AABEA0,dividend,100,50,1/16/2019
B4703C,dividend,100,50,1/16/2019
B6082A,conference-call,100,50,1/16/2019
B72BE9,conference-call,100,50,1/16/2019
B8DD94,executive-appointment,100,54,1/16/2019
B9CD50,public-offering,100,43,1/16/2019
BA218A,earnings-up,100,68,1/16/2019
BA218A,earnings-up,100,68,1/16/2019
BA218A,earnings-up,100,68,1/16/2019
BA218A,earnings-up,100,68,1/16/2019
BA218A,earnings-up,100,68,1/16/2019
BA218A,earnings-up,100,68,1/16/2019
BB0587,conference-call,100,50,1/16/2019
BC4876,dividend,100,50,1/16/2019
BD15E8,acquisition-completed-acquirer,100,49,1/16/2019
C4A241,facility-open,100,65,1/16/2019
CB7AB2,earnings,100,50,1/16/2019
CBFFDD,legal-issues-defendant,100,22,1/16/2019
CD2A4D,executive-appointment,100,54,1/16/2019
CFF15D,executive-appointment,100,54,1/16/2019
CFF97C,conference-call,100,50,1/16/2019
D1CFC8,note-sale,100,52,1/16/2019
D33D8C,earnings-positive,100,69,1/16/2019
D33D8C,earnings-positive,100,69,1/16/2019
D33D8C,earnings-positive,100,69,1/16/2019
D33D8C,earnings-positive,100,69,1/16/2019
D33D8C,earnings-positive,100,69,1/16/2019
D33D8C,earnings-positive,100,69,1/16/2019
D42DBA,asset-sale,100,62,1/16/2019
D5AF19,earnings,100,50,1/16/2019
D63B0F,conference-participant,100,50,1/16/2019
D8760C,executive-resignation,100,44,1/16/2019
D8C09D,earnings-guidance,100,50,1/16/2019
D93A25,earnings,100,50,1/16/2019
DBCA3F,revenue-guidance-down,100,19,1/16/2019
E05DC8,executive-appointment,100,54,1/16/2019
E09997,facility-close,100,47,1/16/2019
E1E36F,earnings,100,50,1/16/2019
E26FC3,earnings,100,50,1/16/2019
E3E68E,legal-issues-defendant,100,22,1/16/2019
E4CE73,business-contract,100,69,1/16/2019
E8B315,acquisition-acquirer,100,49,1/16/2019
EF5BED,dividend,100,50,1/16/2019
EF5BED,earnings-positive,100,69,1/16/2019
EF5BED,earnings,100,50,1/16/2019
EF5BED,earnings,100,50,1/16/2019
EF5BED,earnings,100,50,1/16/2019
EF5BED,earnings,100,50,1/16/2019
EF5BED,earnings,100,50,1/16/2019
F15E41,legal-issues-defendant,100,22,1/16/2019
F32F88,conference-call,100,50,1/16/2019
F3EDB4,dividend,100,50,1/16/2019
F72E4B,acquisition-acquirer,100,49,1/16/2019
F748C7,product-release,100,64,1/16/2019
F88147,executive-resignation,100,44,1/16/2019
FACCF6,earnings,100,50,1/16/2019
FAE021,executive-appointment,100,54,1/16/2019
FAEABE,dividend-up,100,61,1/16/2019
FC9869,earnings-guidance-up,100,83,1/16/2019
00698D,dividend,100,50,1/17/2019
0157B1,conference-call,100,50,1/17/2019
01D03F,regulatory-product-approval-granted,100,81,1/17/2019
01D03F,regulatory-product-approval-granted,100,81,1/17/2019
03B8CF,partnership,100,61,1/17/2019
03CF95,executive-appointment,100,54,1/17/2019
099A02,dividend-guidance,100,50,1/17/2019
0A6824,note-sale,100,52,1/17/2019
0BB9E5,earnings,100,50,1/17/2019
105D00,earnings,100,50,1/17/2019
10C19B,earnings,100,50,1/17/2019
125212,partnership,100,61,1/17/2019
147C38,dividend,100,50,1/17/2019
14833D,legal-issues-defendant,100,22,1/17/2019
1490F3,earnings-guidance,100,50,1/17/2019
152E1D,conference-call,100,50,1/17/2019
1.79E+10,conference-call,100,50,1/17/2019
19C105,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
1A3E1B,earnings,100,50,1/17/2019
20D00A,earnings,100,50,1/17/2019
219B21,earnings,100,50,1/17/2019
221783,earnings,100,50,1/17/2019
239106,conference-call,100,50,1/17/2019
24CB56,earnings-positive,100,69,1/17/2019
24CB56,earnings,100,50,1/17/2019
24CB56,earnings,100,50,1/17/2019
24CB56,earnings,100,50,1/17/2019
24CB56,earnings,100,50,1/17/2019
24CB56,earnings,100,50,1/17/2019
24CB56,earnings,100,50,1/17/2019
24CB56,earnings,100,50,1/17/2019
24CB56,earnings,100,50,1/17/2019
24CB56,earnings,100,50,1/17/2019
284289,conference-call,100,50,1/17/2019
2A17B1,conference-call,100,50,1/17/2019
2A9C0A,conference-call,100,50,1/17/2019
2B5483,earnings,100,50,1/17/2019
2BA977,investment-investor,100,55,1/17/2019
2BA977,investment-investor,100,55,1/17/2019
2BA977,investment-investor,100,55,1/17/2019
2BA977,conference-call,100,50,1/17/2019
2F7474,acquisition-acquirer,100,49,1/17/2019
314D88,earnings,100,50,1/17/2019
31666F,earnings,100,50,1/17/2019
31666F,earnings,100,50,1/17/2019
326EDD,dividend,100,50,1/17/2019
343996,dividend-up,100,81,1/17/2019
343996,dividend,100,50,1/17/2019
34B97A,public-offering,100,43,1/17/2019
366A08,conference-call,100,50,1/17/2019
370C50,executive-appointment,100,54,1/17/2019
370C50,executive-appointment,100,54,1/17/2019
385DD4,legal-issues-defendant,100,22,1/17/2019
39BFF6,dividend,100,50,1/17/2019
39FB23,earnings,100,50,1/17/2019
39FB23,earnings-guidance,100,50,1/17/2019
39FB23,dividend,100,50,1/17/2019
3A4BDB,dividend,100,50,1/17/2019
3C8A04,earnings,100,50,1/17/2019
3DC887,earnings,100,50,1/17/2019
3ED92D,conference-call,100,50,1/17/2019
3FBC9B,earnings,100,50,1/17/2019
414FFF,partnership,100,61,1/17/2019
416291,dividend,100,50,1/17/2019
423279,earnings-per-share-positive,100,69,1/17/2019
449A26,earnings-positive,100,69,1/17/2019
449A26,dividend,100,50,1/17/2019
4A3438,product-release,100,64,1/17/2019
4C37C5,earnings-per-share-positive,100,69,1/17/2019
4C37C5,earnings,100,50,1/17/2019
4C37C5,earnings,100,50,1/17/2019
4D203E,earnings,100,50,1/17/2019
4EEB00,conference-participant,100,50,1/17/2019
50D1EC,executive-appointment,100,54,1/17/2019
513A86,earnings,100,50,1/17/2019
514067,legal-issues-defendant,100,22,1/17/2019
5225A4,earnings,100,50,1/17/2019
53A226,earnings,100,50,1/17/2019
5480A7,earnings-up,100,68,1/17/2019
5480A7,earnings-up,100,68,1/17/2019
5480A7,earnings-up,100,68,1/17/2019
5480A7,earnings-up,100,68,1/17/2019
55438C,legal-issues-defendant,100,22,1/17/2019
556F08,public-offering,100,43,1/17/2019
586BD7,conference-call,100,50,1/17/2019
5876DC,dividend,100,50,1/17/2019
5A9F54,executive-appointment,100,54,1/17/2019
5AF08A,earnings,100,50,1/17/2019
5B3415,conference-call,100,50,1/17/2019
5BC2F4,dividend,100,50,1/17/2019
5D63F1,earnings,100,50,1/17/2019
5EAA43,conference-call,100,50,1/17/2019
6137BF,conference-call,100,50,1/17/2019
622037,earnings,100,50,1/17/2019
6830FE,product-release,100,64,1/17/2019
68AB62,conference-call,100,50,1/17/2019
68BA15,dividend,100,50,1/17/2019
6D3B7B,earnings,100,50,1/17/2019
6D3B7B,earnings,100,50,1/17/2019
6F0A63,earnings-guidance,100,50,1/17/2019
713810,product-release,100,64,1/17/2019
73BCBA,conference-call,100,50,1/17/2019
7.45E+28,executive-appointment,100,54,1/17/2019
789A7D,conference-call,100,50,1/17/2019
79167B,conference-call,100,50,1/17/2019
791EC1,unit-acquisition-acquirer,100,49,1/17/2019
7999F3,note-sale,100,52,1/17/2019
7A3633,product-release,100,64,1/17/2019
7A5D58,dividend-up,100,81,1/17/2019
7B6C88,conference-call,100,50,1/17/2019
7BAAE7,dividend-up,100,81,1/17/2019
7BAAE7,earnings,100,50,1/17/2019
82C202,legal-issues-defendant,100,22,1/17/2019
838ADD,dividend,100,50,1/17/2019
845655,conference-call,100,50,1/17/2019
845655,conference-call,100,50,1/17/2019
863350,executive-appointment,100,54,1/17/2019
885758,earnings,100,50,1/17/2019
89FBB1,dividend-up,100,57,1/17/2019
8D4486,partnership,100,61,1/17/2019
8D4486,partnership,100,61,1/17/2019
8D4486,partnership,100,61,1/17/2019
8D4486,partnership,100,61,1/17/2019
8D9993,conference-call,100,50,1/17/2019
8E0E32,conference-organizer,100,57,1/17/2019
92D3A0,earnings,100,50,1/17/2019
93633B,earnings,100,50,1/17/2019
9368BE,conference-call,100,50,1/17/2019
949625,conference-call,100,50,1/17/2019
95DC1F,unit-acquisition-acquiree,100,76,1/17/2019
979451,legal-issues-defendant,100,22,1/17/2019
97AAF6,dividend,100,50,1/17/2019
9978F1,public-offering,100,43,1/17/2019
9B5968,executive-appointment,100,54,1/17/2019
9E575E,public-offering,100,43,1/17/2019
9E5C2C,conference-participant,100,50,1/17/2019
A1EAC8,conference-call,100,50,1/17/2019
A29A46,earnings-guidance-up,100,83,1/17/2019
A5628C,earnings,100,50,1/17/2019
A5628C,earnings,100,50,1/17/2019
A5A4F5,acquisition-acquirer,100,49,1/17/2019
A6828A,acquisition-completed-acquirer,100,49,1/17/2019
A7CCF0,conference-call,100,50,1/17/2019
A8CBDA,dividend,100,50,1/17/2019
AA847A,conference-call,100,50,1/17/2019
AD23DE,partnership,100,61,1/17/2019
AD375D,market-entry,100,57,1/17/2019
ADF1B0,product-release,100,64,1/17/2019
B13B68,earnings-guidance,100,50,1/17/2019
B1B10C,executive-appointment,100,54,1/17/2019
BAAA60,conference-call,100,50,1/17/2019
BDCC11,earnings,100,50,1/17/2019
BDEF34,acquisition-acquiree,100,76,1/17/2019
C0BA36,conference-call,100,50,1/17/2019
C50B26,conference-organizer,100,57,1/17/2019
C98CDB,earnings,100,50,1/17/2019
C9B932,earnings,100,50,1/17/2019
C9E107,dividend,100,50,1/17/2019
CBFFDD,legal-issues-defendant,100,22,1/17/2019
CF6A5A,executive-appointment,100,54,1/17/2019
CFD4B6,partnership,100,61,1/17/2019
CFF15D,earnings-guidance,100,50,1/17/2019
D11C1C,executive-appointment,100,54,1/17/2019
D13F1C,executive-appointment,100,54,1/17/2019
D1AE3B,earnings,100,50,1/17/2019
D296C6,executive-appointment,100,54,1/17/2019
D3CEDF,conference-call,100,50,1/17/2019
D6489C,reorganization-unit,100,53,1/17/2019
DA0CB8,dividend,100,50,1/17/2019
DC0998,conference-call,100,50,1/17/2019
DD0F15,executive-appointment,100,54,1/17/2019
E114F4,conference-call,100,50,1/17/2019
E21871,earnings,100,50,1/17/2019
E30B34,earnings-guidance,100,50,1/17/2019
E30B34,earnings-guidance,100,50,1/17/2019
E35610,legal-issues-defendant,100,22,1/17/2019
E35610,legal-issues-defendant,100,22,1/17/2019
E35610,legal-issues-defendant,100,22,1/17/2019
E68733,patient-enrollment-start,100,58,1/17/2019
E8B315,earnings-positive,100,69,1/17/2019
EAEBF3,dividend,100,50,1/17/2019
EB2F14,earnings,100,50,1/17/2019
ECD263,earnings,100,50,1/17/2019
ED79D9,executive-appointment,100,54,1/17/2019
ED9576,earnings,100,50,1/17/2019
EF77A3,dividend-up,100,61,1/17/2019
F0B2B5,legal-issues-defendant,100,22,1/17/2019
F0B2B5,legal-issues-defendant,100,22,1/17/2019
F15E41,legal-issues-defendant,100,22,1/17/2019
F15E41,legal-issues-defendant,100,22,1/17/2019
F3EDB4,business-contract,100,69,1/17/2019
F509E2,conference-call,100,50,1/17/2019
F8BDCE,earnings,100,50,1/17/2019
F8BDCE,earnings,100,50,1/17/2019
F8BDCE,earnings,100,50,1/17/2019
FA918D,earnings-guidance,100,50,1/17/2019
FD4BBE,earnings,100,50,1/17/2019
06EF42,conference-call,100,50,1/18/2019
083F72,dividend,100,50,1/18/2019
95294,earnings,100,50,1/18/2019
0A0D9E,conference-call,100,50,1/18/2019
0A7650,earnings,100,50,1/18/2019
0C4131,conference-call,100,50,1/18/2019
0F65C9,dividend,100,50,1/18/2019
16F4D8,business-contract,100,69,1/18/2019
16FC89,dividend,100,50,1/18/2019
1A6A94,dividend,100,50,1/18/2019
1DA44F,conference-call,100,50,1/18/2019
21F9CA,executive-appointment,100,54,1/18/2019
25102A,executive-appointment,100,54,1/18/2019
28AF37,earnings,100,50,1/18/2019
2BF36E,legal-issues-defendant,100,22,1/18/2019
2E902B,conference-call,100,50,1/18/2019
2F98A5,dividend,100,50,1/18/2019
2FEA66,dividend,100,50,1/18/2019
33E8C7,earnings,100,50,1/18/2019
355B19,dividend,100,50,1/18/2019
3A3447,facility-open,100,65,1/18/2019
3C11C4,earnings,100,50,1/18/2019
3D9999,earnings,100,50,1/18/2019
435ACE,conference-call,100,50,1/18/2019
442587,business-contract,100,69,1/18/2019
4595EF,conference-call,100,50,1/18/2019
49BBBC,legal-issues-defendant,100,22,1/18/2019
514067,legal-issues-defendant,100,22,1/18/2019
55438C,product-release,100,64,1/18/2019
556F08,public-offering,100,43,1/18/2019
562853,earnings,100,50,1/18/2019
57DDB9,executive-appointment,100,54,1/18/2019
589803,earnings,100,50,1/18/2019
5BC2F4,earnings-per-share-positive,100,69,1/18/2019
5BC2F4,earnings-per-share,100,50,1/18/2019
5BC2F4,earnings-per-share,100,50,1/18/2019
5BC2F4,earnings-per-share,100,50,1/18/2019
5BC2F4,earnings-per-share,100,50,1/18/2019
5BC2F4,earnings-per-share,100,50,1/18/2019
5D0337,earnings,100,50,1/18/2019
5D87DF,earnings,100,50,1/18/2019
5F2FF7,partnership,100,61,1/18/2019
647143,dividend,100,50,1/18/2019
665D7D,clinical-trials,100,56,1/18/2019
665D7D,clinical-trials,100,56,1/18/2019
66CB62,dividend,100,50,1/18/2019
69CE71,business-contract,100,69,1/18/2019
6E705B,executive-appointment,100,54,1/18/2019
6F6559,dividend,100,50,1/18/2019
6F6559,dividend,100,50,1/18/2019
6F92A9,product-release,100,64,1/18/2019
713810,business-contract,100,69,1/18/2019
73C521,earnings,100,50,1/18/2019
73C521,earnings,100,50,1/18/2019
73C521,earnings,100,50,1/18/2019
73C521,earnings,100,50,1/18/2019
73C521,earnings,100,50,1/18/2019
73C521,earnings,100,50,1/18/2019
769F40,executive-appointment,100,54,1/18/2019
7A5097,conference-call,100,50,1/18/2019
7A51FE,conference-call,100,50,1/18/2019
7AC86E,investment-investor,100,55,1/18/2019
848C0B,settlement,100,56,1/18/2019
855DF7,dividend,100,50,1/18/2019
859281,conference-participant,100,50,1/18/2019
85AD00,conference-call,100,50,1/18/2019
8E8E6E,executive-appointment,100,54,1/18/2019
911ACB,earnings,100,50,1/18/2019
9196A2,partnership,100,61,1/18/2019
93965C,earnings,100,50,1/18/2019
97B027,dividend,100,50,1/18/2019
97FE80,acquisition-completed-acquirer,100,49,1/18/2019
9D2790,earnings,100,50,1/18/2019
9F5997,business-contract,100,69,1/18/2019
A1EAC8,unit-acquisition-acquirer,100,49,1/18/2019
A29DBD,conference-call,100,50,1/18/2019
A2CA3F,conference-call,100,50,1/18/2019
A350C1,conference-call,100,50,1/18/2019
A5A4F5,acquisition-acquirer,100,49,1/18/2019
AFDF2E,dividend,100,50,1/18/2019
B09B1F,executive-appointment,100,54,1/18/2019
B0B969,conference-call,100,50,1/18/2019
B9764A,earnings,100,50,1/18/2019
BDD12C,executive-appointment,100,54,1/18/2019
BEB756,dividend,100,50,1/18/2019
BFE02C,earnings-positive,100,69,1/18/2019
CBBFBF,earnings,100,50,1/18/2019
CBFFDD,legal-issues-defendant,100,22,1/18/2019
CD06A2,earnings,100,50,1/18/2019
D42DBA,revenues,100,50,1/18/2019
D42DBA,revenues,100,50,1/18/2019
D501DC,conference-call,100,50,1/18/2019
D78CCD,earnings,100,50,1/18/2019
D78CCD,earnings,100,50,1/18/2019
D78CCD,earnings,100,50,1/18/2019
D78CCD,earnings,100,50,1/18/2019
D78CCD,earnings,100,50,1/18/2019
D78CCD,earnings,100,50,1/18/2019
D78CCD,earnings,100,50,1/18/2019
DD682D,dividend,100,50,1/18/2019
E3E68E,legal-issues-defendant,100,22,1/18/2019
E8D221,dividend,100,50,1/18/2019
E96E0B,executive-appointment,100,54,1/18/2019
EBD89A,conference-call,100,50,1/18/2019
F0B2B5,legal-issues-defendant,100,22,1/18/2019
F15E41,legal-issues-defendant,100,22,1/18/2019
F24FF0,conference-call,100,50,1/18/2019
F5C78B,dividend,100,50,1/18/2019
F82D37,earnings-up,100,68,1/18/2019
F8BA6C,clinical-trials-positive,100,87,1/18/2019
FA36A4,dividend,100,50,1/18/2019
FB728F,dividend,100,50,1/18/2019
FD6926,acquisition-completed-acquirer,100,49,1/18/2019
48590,legal-issues-defendant,100,22,1/19/2019
099A02,earnings,100,50,1/19/2019
099A02,earnings,100,50,1/19/2019
DD3BB1,earnings,100,50,1/19/2019
0A9D0A,legal-issues-defendant,100,22,1/21/2019
2C7505,partnership,100,61,1/21/2019
2EB04E,partnership,100,61,1/21/2019
387375,conference-call,100,50,1/21/2019
40F7DE,legal-issues-defendant,100,22,1/21/2019
49BBBC,legal-issues-defendant,100,22,1/21/2019
49BBBC,legal-issues-defendant,100,22,1/21/2019
514067,legal-issues-defendant,100,22,1/21/2019
5487B1,conference-call,100,50,1/21/2019
57CAAB,regulatory-product-approval-granted,100,81,1/21/2019
5A0FF1,partnership,100,61,1/21/2019
5EC388,earnings,100,50,1/21/2019
67303E,legal-issues-defendant,100,22,1/21/2019
69FDFC,product-release,100,64,1/21/2019
6B5379,earnings,100,50,1/21/2019
6DD6BA,acquisition-completed-acquirer,100,49,1/21/2019
77B8E9,patent-awarded,100,72,1/21/2019
78F9ED,conference-call,100,50,1/21/2019
797C20,conference-call,100,50,1/21/2019
7DC1C4,earnings,100,50,1/21/2019
8.10E+32,executive-appointment,100,54,1/21/2019
82FD6D,conference-call,100,50,1/21/2019
901327,earnings,100,50,1/21/2019
A5A4F5,acquisition-acquirer,100,49,1/21/2019
BB58FF,conference-organizer,100,57,1/21/2019
D54E62,stake-acquiree,100,62,1/21/2019
D54E62,stake-acquiree,100,62,1/21/2019
D854DD,conference-call,100,50,1/21/2019
DD9E41,earnings,100,50,1/21/2019
F04E05,dividend-up,100,70,1/21/2019
F15E41,acquisition-completed-acquirer,100,49,1/21/2019
F15E41,acquisition-completed-acquirer,100,49,1/21/2019
F30508,conference-call,100,50,1/21/2019
FAE021,earnings,100,50,1/21/2019
FEC475,executive-appointment,100,54,1/21/2019
00326E,bankruptcy-unit,100,10,1/22/2019
00D6B5,conference-call,100,50,1/22/2019
13528,partnership,100,61,1/22/2019
018C11,conference-call,100,50,1/22/2019
20751,orphan-drug-designation,100,76,1/22/2019
02870F,partnership,100,61,1/22/2019
034B61,product-release,100,64,1/22/2019
03FAA6,earnings,100,50,1/22/2019
03FB17,dividend,100,50,1/22/2019
48590,legal-issues-defendant,100,22,1/22/2019
55018,earnings-positive,100,69,1/22/2019
05D148,public-offering,100,43,1/22/2019
06A456,executive-resignation,100,44,1/22/2019
75172,conference-call,100,50,1/22/2019
95294,legal-issues-defendant,100,22,1/22/2019
09F623,conference-call,100,50,1/22/2019
0BC29E,earnings,100,50,1/22/2019
0BF528,executive-appointment,100,54,1/22/2019
0CC01F,earnings,100,50,1/22/2019
0CE7F6,partnership,100,61,1/22/2019
1065BC,conference-call,100,50,1/22/2019
1220D2,product-release,100,64,1/22/2019
14833D,legal-issues-defendant,100,22,1/22/2019
159AE4,dividend,100,50,1/22/2019
159AE4,dividend,100,50,1/22/2019
16B183,award,100,58,1/22/2019
1748B3,earnings,100,50,1/22/2019
1748B3,earnings,100,50,1/22/2019
1748B3,earnings,100,50,1/22/2019
1748B3,earnings,100,50,1/22/2019
1748B3,earnings,100,50,1/22/2019
1748B3,earnings,100,50,1/22/2019
1782D5,conference-call,100,50,1/22/2019
1B16C1,earnings,100,50,1/22/2019
1D943E,earnings,100,50,1/22/2019
1D9E55,earnings,100,50,1/22/2019
1E1125,conference-organizer,100,57,1/22/2019
1E5786,buybacks,100,74,1/22/2019
1EBF8D,conference-call,100,50,1/22/2019
200D8B,unit-acquisition-acquirer,100,49,1/22/2019
20BEEA,conference-call,100,50,1/22/2019
21F9CA,earnings,100,50,1/22/2019
225CA2,conference-call,100,50,1/22/2019
238302,dividend,100,50,1/22/2019
25DD05,earnings,100,50,1/22/2019
267718,partnership,100,61,1/22/2019
26D8ED,conference-call,100,50,1/22/2019
272704,earnings-up,100,68,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
272704,earnings,100,50,1/22/2019
282C18,earnings,100,50,1/22/2019
28AF37,award,100,58,1/22/2019
2AA6A8,executive-appointment,100,54,1/22/2019
2ABF77,conference-call,100,50,1/22/2019
2AE625,conference-call,100,50,1/22/2019
2B49F4,earnings,100,50,1/22/2019
2B49F4,earnings,100,50,1/22/2019
2B49F4,earnings,100,50,1/22/2019
2B49F4,earnings,100,50,1/22/2019
2CBB58,conference-call,100,50,1/22/2019
2D643C,executive-appointment,100,54,1/22/2019
2E1322,earnings,100,50,1/22/2019
332F87,earnings-per-share-up,100,76,1/22/2019
366A08,capex,100,50,1/22/2019
366A08,capex,100,50,1/22/2019
373B06,earnings,100,50,1/22/2019
3798B9,earnings,100,50,1/22/2019
385DD4,legal-issues-defendant,100,22,1/22/2019
3A3447,facility-open,100,65,1/22/2019
3A3447,earnings,100,50,1/22/2019
3BCF24,buybacks,100,74,1/22/2019
3CCC90,dividend-up,100,81,1/22/2019
3CCC90,executive-appointment,100,54,1/22/2019
3D9999,dividend,100,50,1/22/2019
4135F7,conference-call,100,50,1/22/2019
41785E,earnings,100,50,1/22/2019
43A060,partnership,100,61,1/22/2019
43A74A,note-sale,100,52,1/22/2019
43A74A,note-sale,100,52,1/22/2019
442587,business-contract,100,69,1/22/2019
450ECB,partnership,100,61,1/22/2019
450ECB,executive-appointment,100,54,1/22/2019
4591D3,revenues,100,50,1/22/2019
467F2C,conference-call,100,50,1/22/2019
46A16E,conference-call,100,50,1/22/2019
485445,earnings,100,50,1/22/2019
490D4B,conference-call,100,50,1/22/2019
49914B,earnings,100,50,1/22/2019
49BBBC,legal-issues-defendant,100,22,1/22/2019
4AE584,unit-acquisition-acquirer,100,49,1/22/2019
4D371E,earnings,100,50,1/22/2019
4EE167,public-offering,100,43,1/22/2019
514067,executive-appointment,100,54,1/22/2019
51F541,executive-resignation,100,44,1/22/2019
543900,award,100,58,1/22/2019
545272,dividend,100,50,1/22/2019
55438C,legal-issues-defendant,100,22,1/22/2019
57CAAB,earnings,100,50,1/22/2019
586BD7,legal-issues-defendant,100,22,1/22/2019
586FFD,conference-call,100,50,1/22/2019
5D63F1,product-release,100,64,1/22/2019
5F9CE3,award,100,58,1/22/2019
616E3B,award,100,58,1/22/2019
6.18E+08,earnings,100,50,1/22/2019
619882,partnership,100,61,1/22/2019
61A586,executive-appointment,100,54,1/22/2019
61B81B,acquisition-acquiree,100,76,1/22/2019
641F17,conference-participant,100,50,1/22/2019
647143,earnings,100,50,1/22/2019
647143,earnings,100,50,1/22/2019
647143,earnings,100,50,1/22/2019
647143,earnings,100,50,1/22/2019
64854A,conference-call,100,50,1/22/2019
65D0AA,clinical-trials,100,56,1/22/2019
67B923,conference-call,100,50,1/22/2019
693ECD,patent-awarded,100,72,1/22/2019
69CE71,award,100,58,1/22/2019
6A961B,conference-call,100,50,1/22/2019
6BD606,executive-appointment,100,54,1/22/2019
6BD606,executive-appointment,100,54,1/22/2019
6C4D2F,earnings-up,100,68,1/22/2019
6C4D2F,earnings-up,100,68,1/22/2019
6C4D2F,earnings-up,100,68,1/22/2019
6C4D2F,earnings-up,100,68,1/22/2019
6C4D2F,earnings-up,100,68,1/22/2019
6C4D2F,earnings-up,100,68,1/22/2019
6C4D2F,earnings-up,100,68,1/22/2019
6C4D2F,earnings-up,100,68,1/22/2019
6CC55E,clinical-trials-start,100,64,1/22/2019
6D4636,award,100,58,1/22/2019
6D4636,conference-call,100,50,1/22/2019
7032D0,earnings,100,50,1/22/2019
70CA28,conference-call,100,50,1/22/2019
70FCEF,executive-appointment,100,54,1/22/2019
71E2EF,conference-call,100,50,1/22/2019
747219,earnings,100,50,1/22/2019
75F665,earnings,100,50,1/22/2019
75F665,dividend,100,50,1/22/2019
762B8D,earnings,100,50,1/22/2019
7A2A49,conference-call,100,50,1/22/2019
7AB859,merger,100,66,1/22/2019
7AB859,merger,100,66,1/22/2019
7AB859,merger,100,66,1/22/2019
7B4B91,conference-call,100,50,1/22/2019
7B6EB1,earnings,100,50,1/22/2019
7E3F8F,award,100,58,1/22/2019
8.10E+205,earnings-guidance,100,50,1/22/2019
82E58A,dividend,100,50,1/22/2019
8303CD,conference-call,100,50,1/22/2019
8377DB,earnings,100,50,1/22/2019
8377DB,earnings,100,50,1/22/2019
8377DB,earnings,100,50,1/22/2019
8377DB,earnings,100,50,1/22/2019
8377DB,earnings,100,50,1/22/2019
84920B,earnings,100,50,1/22/2019
85AD00,acquisition-acquirer,100,49,1/22/2019
85DA04,earnings,100,50,1/22/2019
877C0C,executive-appointment,100,54,1/22/2019
877C0C,executive-appointment,100,54,1/22/2019
88350F,conference-call,100,50,1/22/2019
8876D6,partnership,100,61,1/22/2019
8C5519,earnings,100,50,1/22/2019
8CF6DD,dividend,100,50,1/22/2019
8D4486,business-contract,100,69,1/22/2019
8D4486,earnings,100,50,1/22/2019
8D4AE6,earnings,100,50,1/22/2019
8D9993,dividend,100,50,1/22/2019
8DAAB9,dividend,100,50,1/22/2019
8DBBE6,conference-call,100,50,1/22/2019
8DE56F,earnings,100,50,1/22/2019
8DE56F,earnings,100,50,1/22/2019
8F6995,earnings-guidance,100,50,1/22/2019
8F8F2F,unit-acquisition-acquirer,100,49,1/22/2019
9196A2,executive-appointment,100,54,1/22/2019
92D6A5,dividend,100,50,1/22/2019
934029,conference-call,100,50,1/22/2019
93C130,earnings,100,50,1/22/2019
93C130,earnings,100,50,1/22/2019
93C130,earnings,100,50,1/22/2019
93C130,dividend,100,50,1/22/2019
94C0B5,dividend,100,50,1/22/2019
958938,executive-appointment,100,54,1/22/2019
965360,earnings,100,50,1/22/2019
968B00,earnings,100,50,1/22/2019
96F126,earnings,100,50,1/22/2019
979451,legal-issues-defendant,100,22,1/22/2019
979451,earnings,100,50,1/22/2019
98CAED,earnings,100,50,1/22/2019
9978F1,public-offering,100,43,1/22/2019
9BB35A,conference-call,100,50,1/22/2019
9CA4C6,dividend-up,100,81,1/22/2019
9D4EC7,conference-call,100,50,1/22/2019
9D6A24,award,100,58,1/22/2019
9E575E,public-offering,100,43,1/22/2019
9F5997,business-contract,100,69,1/22/2019
9F6B1A,award,100,58,1/22/2019
9FF5F1,earnings,100,50,1/22/2019
A23747,unit-acquisition-acquirer,100,49,1/22/2019
A23747,earnings,100,50,1/22/2019
A2CA3F,earnings,100,50,1/22/2019
A403CF,earnings,100,50,1/22/2019
A4386C,earnings,100,50,1/22/2019
A4D173,award,100,58,1/22/2019
A4D173,award,100,58,1/22/2019
A4D173,conference-call,100,50,1/22/2019
A4D173,conference-call,100,50,1/22/2019
A5628C,executive-appointment,100,54,1/22/2019
A5A4F5,acquisition-acquirer,100,49,1/22/2019
A60354,legal-issues-plaintiff,100,44,1/22/2019
A63387,conference-call,100,50,1/22/2019
A65325,earnings-positive,100,69,1/22/2019
A65325,earnings,100,50,1/22/2019
A65325,earnings,100,50,1/22/2019
A65325,earnings,100,50,1/22/2019
A65325,earnings,100,50,1/22/2019
A65325,earnings,100,50,1/22/2019
A65325,earnings,100,50,1/22/2019
A65325,earnings,100,50,1/22/2019
A6828A,earnings,100,50,1/22/2019
A87CD6,earnings,100,50,1/22/2019
AA5C8E,business-contract,100,69,1/22/2019
AC775C,conference-call,100,50,1/22/2019
AFDF2E,revenues,100,50,1/22/2019
AFF43F,earnings,100,50,1/22/2019
AFF43F,dividend,100,50,1/22/2019
B01111,legal-verdict-disfavored,100,22,1/22/2019
B0FE08,executive-appointment,100,54,1/22/2019
B1FC3B,conference-participant,100,50,1/22/2019
B2DAF6,earnings,100,50,1/22/2019
B2DAF6,earnings,100,50,1/22/2019
B642E8,award,100,58,1/22/2019
B8F71F,executive-appointment,100,54,1/22/2019
B98EFA,partnership,100,61,1/22/2019
B9CD50,earnings,100,50,1/22/2019
BD9668,earnings,100,50,1/22/2019
BDD12C,earnings,100,50,1/22/2019
BE7BA4,public-offering,100,43,1/22/2019
C037A8,conference-call,100,50,1/22/2019
C06EB6,clinical-trials-start,100,64,1/22/2019
C06EB6,clinical-trials-start,100,64,1/22/2019
C188F8,business-contract,100,69,1/22/2019
C32A39,earnings,100,50,1/22/2019
C4A241,conference-call,100,50,1/22/2019
C4C77F,merger-completed,100,66,1/22/2019
C4F9C6,executive-appointment,100,54,1/22/2019
C65004,earnings,100,50,1/22/2019
C83B88,partnership,100,61,1/22/2019
C99CC8,conference-call,100,50,1/22/2019
C9B932,award,100,58,1/22/2019
C9E107,executive-resignation,100,44,1/22/2019
CAB222,public-offering,100,43,1/22/2019
CBA33B,dividend,100,50,1/22/2019
CBA33B,executive-appointment,100,54,1/22/2019
CBFFDD,legal-issues-defendant,100,22,1/22/2019
CC35BE,executive-appointment,100,54,1/22/2019
CD051C,earnings,100,50,1/22/2019
CDAF5B,conference-call,100,50,1/22/2019
CDE118,executive-appointment,100,54,1/22/2019
CE1002,earnings,100,50,1/22/2019
CE1002,earnings,100,50,1/22/2019
CE1002,earnings,100,50,1/22/2019
CE1002,earnings,100,50,1/22/2019
CE1002,earnings,100,50,1/22/2019
CE4FD9,award,100,58,1/22/2019
CFE5BE,earnings-up,100,68,1/22/2019
CFE5BE,earnings-up,100,68,1/22/2019
CFE5BE,earnings-up,100,68,1/22/2019
CFE5BE,earnings-up,100,68,1/22/2019
CFE5BE,earnings-up,100,68,1/22/2019
CFE5BE,earnings-up,100,68,1/22/2019
CFE5BE,earnings-up,100,68,1/22/2019
CFE5BE,earnings-up,100,68,1/22/2019
CFF97C,credit-rating-upgrade-rater,20,50,1/22/2019
CFF97C,credit-rating-upgrade-rater,20,50,1/22/2019
D1173F,earnings,100,50,1/22/2019
D1C26F,executive-appointment,100,54,1/22/2019
D64EDF,note-sale,100,52,1/22/2019
D8760C,earnings-positive,100,69,1/22/2019
D8760C,earnings,100,50,1/22/2019
D8760C,earnings,100,50,1/22/2019
D8760C,earnings,100,50,1/22/2019
D8760C,earnings,100,50,1/22/2019
D8760C,earnings,100,50,1/22/2019
D8DA3D,conference-call,100,50,1/22/2019
D9164D,earnings,100,50,1/22/2019
D9B1C9,award,100,58,1/22/2019
D9B1C9,dividend,100,50,1/22/2019
DB5CA5,award,100,58,1/22/2019
DDB002,executive-appointment,100,54,1/22/2019
DF532D,earnings,100,50,1/22/2019
DF532D,earnings,100,50,1/22/2019
E0207A,earnings,100,50,1/22/2019
E1BD05,earnings,100,50,1/22/2019
E35610,legal-issues-defendant,100,22,1/22/2019
E3656D,conference-call,100,50,1/22/2019
E3E68E,award,100,58,1/22/2019
E49AA3,earnings,100,50,1/22/2019
E5752F,earnings,100,50,1/22/2019
E610CD,earnings,100,50,1/22/2019
E6A53A,business-contract,100,69,1/22/2019
E6A53A,business-contract,100,69,1/22/2019
E6A53A,business-contract,100,69,1/22/2019
E6A53A,business-contract,100,69,1/22/2019
E87676,dividend-up,100,81,1/22/2019
EA62FC,dividend,100,50,1/22/2019
EBD89A,business-contract,100,69,1/22/2019
ECDEB2,earnings-up,100,68,1/22/2019
ED79D9,conference-call,100,50,1/22/2019
EEA734,executive-appointment,100,54,1/22/2019
F0027C,patient-enrollment-complete,100,64,1/22/2019
F0B2B5,legal-issues-defendant,100,22,1/22/2019
F15E41,legal-issues-defendant,100,22,1/22/2019
F179ED,executive-appointment,100,54,1/22/2019
F1CD47,earnings,100,50,1/22/2019
F3816D,public-offering,100,43,1/22/2019
F39E1E,partnership,100,61,1/22/2019
F57F6F,earnings,100,50,1/22/2019
F5C78B,earnings,100,50,1/22/2019
F6E248,earnings,100,50,1/22/2019
F80FF9,conference-call,100,50,1/22/2019
F8BA6C,legal-issues-defendant,100,22,1/22/2019
F95726,earnings,100,50,1/22/2019
FA35C6,earnings,100,50,1/22/2019
FD0CA4,earnings,100,50,1/22/2019
FF5413,acquisition-completed-acquiree,100,76,1/22/2019
00FC70,conference-call,100,50,1/23/2019
0142B5,dividend,100,50,1/23/2019
03596A,business-contract,100,69,1/23/2019
03F5A4,earnings-positive,100,69,1/23/2019
48590,legal-issues-defendant,100,22,1/23/2019
0624BE,executive-appointment,100,54,1/23/2019
71860,earnings,100,50,1/23/2019
081AB9,earnings,100,50,1/23/2019
081AB9,dividend,100,50,1/23/2019
099C88,business-contract,100,69,1/23/2019
0B57D7,earnings,100,50,1/23/2019
0B57D7,buybacks,100,74,1/23/2019
0B9E6F,earnings,100,50,1/23/2019
0B9E6F,earnings,100,50,1/23/2019
0C136E,earnings,100,50,1/23/2019
0CADBC,dividend,100,50,1/23/2019
0E6027,earnings-positive,100,69,1/23/2019
0F91FC,conference-call,100,50,1/23/2019
106394,executive-appointment,100,54,1/23/2019
10673F,earnings-up,100,68,1/23/2019
10673F,earnings-up,100,68,1/23/2019
10AE08,earnings,100,50,1/23/2019
129DC8,conference-call,100,50,1/23/2019
12E454,business-contract,100,69,1/23/2019
15789A,earnings,100,50,1/23/2019
165B3A,earnings-positive,100,69,1/23/2019
165B3A,earnings-positive,100,69,1/23/2019
165B3A,earnings-positive,100,69,1/23/2019
165B3A,earnings-positive,100,69,1/23/2019
1A9DE1,earnings-up,100,68,1/23/2019
1A9DE1,earnings-up,100,68,1/23/2019
1A9DE1,earnings-up,100,68,1/23/2019
1BC12C,executive-appointment,100,54,1/23/2019
1E5786,dividend-up,100,59,1/23/2019
1E8A99,earnings,100,50,1/23/2019
1E9A6D,dividend,100,50,1/23/2019
1F9D90,earnings,100,50,1/23/2019
1FA8F7,earnings-up,100,83,1/23/2019
2.45E+15,earnings,100,50,1/23/2019
2667B6,earnings,100,50,1/23/2019
2667B6,earnings,100,50,1/23/2019
2667B6,earnings,100,50,1/23/2019
2667B6,earnings,100,50,1/23/2019
2667B6,earnings,100,50,1/23/2019
275300,earnings,100,50,1/23/2019
2BF36E,partnership,100,61,1/23/2019
2BF36E,legal-issues-defendant,100,22,1/23/2019
2D643C,dividend-up,100,58,1/23/2019
2D643C,executive-appointment,100,54,1/23/2019
2DB344,earnings,100,50,1/23/2019
2E61CC,earnings,100,50,1/23/2019
2EBA55,conference-call,100,50,1/23/2019
31803E,executive-appointment,100,54,1/23/2019
32CB22,earnings,100,50,1/23/2019
33AD83,product-release,100,64,1/23/2019
3461CF,credit-rating-upgrade-rater,20,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
34B411,earnings,100,50,1/23/2019
3.73E+87,revenue-up,100,69,1/23/2019
3.73E+87,revenue-up,100,69,1/23/2019
3.73E+87,revenue-up,100,69,1/23/2019
39BFF6,earnings,100,50,1/23/2019
39BFF6,earnings,100,50,1/23/2019
39BFF6,earnings,100,50,1/23/2019
3C3B6B,earnings,100,50,1/23/2019
3CCC90,earnings,100,50,1/23/2019
3D9999,earnings-positive,100,69,1/23/2019
3D9999,partnership,100,61,1/23/2019
3DE4D1,earnings,100,50,1/23/2019
3DE4D1,earnings,100,50,1/23/2019
3DE4D1,earnings,100,50,1/23/2019
3DE4D1,earnings,100,50,1/23/2019
3DE4D1,earnings,100,50,1/23/2019
415188,conference-call,100,50,1/23/2019
41B0E2,earnings,100,50,1/23/2019
41EC04,executive-appointment,100,54,1/23/2019
42AABD,conference-call,100,50,1/23/2019
4.91E+58,executive-appointment,100,54,1/23/2019
49BBBC,legal-issues-defendant,100,22,1/23/2019
4AC91D,executive-appointment,100,54,1/23/2019
4B3555,earnings,100,50,1/23/2019
4B3555,earnings,100,50,1/23/2019
4B3555,earnings,100,50,1/23/2019
4B3555,earnings,100,50,1/23/2019
4B3555,earnings,100,50,1/23/2019
4B3555,earnings,100,50,1/23/2019
4B3555,earnings,100,50,1/23/2019
4B3555,earnings,100,50,1/23/2019
4B3555,earnings,100,50,1/23/2019
4C37C5,dividend,100,50,1/23/2019
4D971D,dividend,100,50,1/23/2019
4D971D,earnings,100,50,1/23/2019
4D971D,earnings,100,50,1/23/2019
4D971D,earnings,100,50,1/23/2019
4D971D,earnings,100,50,1/23/2019
4D971D,earnings,100,50,1/23/2019
4D971D,earnings,100,50,1/23/2019
4E7C1F,earnings,100,50,1/23/2019
4E7C1F,earnings,100,50,1/23/2019
4E7C1F,earnings,100,50,1/23/2019
4F9487,earnings,100,50,1/23/2019
4F9487,earnings,100,50,1/23/2019
4F9487,earnings,100,50,1/23/2019
4F9487,earnings,100,50,1/23/2019
4F9487,earnings,100,50,1/23/2019
4F9487,earnings,100,50,1/23/2019
4F9487,earnings,100,50,1/23/2019
4F9487,earnings,100,50,1/23/2019
4F9926,partnership,100,61,1/23/2019
514067,legal-issues-defendant,100,22,1/23/2019
51888A,dividend,100,50,1/23/2019
520632,earnings,100,50,1/23/2019
520632,earnings,100,50,1/23/2019
520632,earnings,100,50,1/23/2019
520632,earnings,100,50,1/23/2019
520632,earnings,100,50,1/23/2019
520632,earnings,100,50,1/23/2019
53E575,earnings,100,50,1/23/2019
53F491,earnings-per-share-negative,100,33,1/23/2019
53F491,earnings-negative,100,33,1/23/2019
53F491,earnings-negative,100,33,1/23/2019
53F491,earnings-negative,100,33,1/23/2019
53F491,earnings-negative,100,33,1/23/2019
556F08,public-offering,100,43,1/23/2019
5675EB,dividend,100,50,1/23/2019
5675EB,acquisition-acquirer,100,49,1/23/2019
5675EB,earnings,100,50,1/23/2019
56AFF4,operating-earnings,100,50,1/23/2019
57634F,earnings,100,50,1/23/2019
57CAAB,executive-appointment,100,54,1/23/2019
58C2D4,partnership,100,61,1/23/2019
58C2D4,partnership,100,61,1/23/2019
5B97B2,earnings,100,50,1/23/2019
5BE42C,dividend-up,100,81,1/23/2019
5BFE94,dividend,100,50,1/23/2019
5F6D73,earnings,100,50,1/23/2019
5F6D73,earnings,100,50,1/23/2019
5F6D73,earnings,100,50,1/23/2019
5F6D73,earnings,100,50,1/23/2019
5F6D73,earnings,100,50,1/23/2019
5FF95F,earnings,100,50,1/23/2019
62B20A,conference-call,100,50,1/23/2019
64E346,acquisition-completed-acquirer,100,49,1/23/2019
6634D9,earnings,100,50,1/23/2019
665440,executive-appointment,100,54,1/23/2019
694749,product-release,100,64,1/23/2019
6B5379,executive-appointment,100,54,1/23/2019
6BC6F9,earnings,100,50,1/23/2019
6C987C,earnings-positive,100,69,1/23/2019
6D3F35,legal-issues-defendant,100,22,1/23/2019
6D3F35,legal-issues-defendant,100,22,1/23/2019
70FCEF,executive-appointment,100,54,1/23/2019
70FCEF,executive-appointment,100,54,1/23/2019
713810,partnership,100,61,1/23/2019
726DDF,unit-acquisition-acquirer,100,49,1/23/2019
775439,dividend,100,50,1/23/2019
7.83E+79,earnings-up,100,68,1/23/2019
7.83E+79,earnings-up,100,68,1/23/2019
7.83E+79,earnings-up,100,68,1/23/2019
7.83E+79,earnings-up,100,68,1/23/2019
7.83E+79,earnings-up,100,68,1/23/2019
80C400,product-release,100,64,1/23/2019
80D744,dividend,100,50,1/23/2019
830BDB,conference-call,100,50,1/23/2019
834152,executive-appointment,100,54,1/23/2019
835C86,dividend,100,50,1/23/2019
84A6B9,earnings,100,50,1/23/2019
84A6B9,earnings,100,50,1/23/2019
84A6B9,earnings,100,50,1/23/2019
84A6B9,earnings,100,50,1/23/2019
84A6B9,earnings,100,50,1/23/2019
84A6B9,earnings,100,50,1/23/2019
84A6B9,earnings,100,50,1/23/2019
85AD00,earnings,100,50,1/23/2019
860AB6,earnings,100,50,1/23/2019
8.79E+06,executive-appointment,100,54,1/23/2019
8D4486,earnings,100,50,1/23/2019
8D4486,business-contract,100,69,1/23/2019
8E8E6E,award,100,58,1/23/2019
8FF2EF,earnings,100,50,1/23/2019
90D6A5,earnings-guidance,100,50,1/23/2019
911CA9,clinical-trials-positive,100,87,1/23/2019
938D89,ipo,100,71,1/23/2019
93AD2E,facility-close,100,47,1/23/2019
93F143,earnings,100,50,1/23/2019
942165,dividend,100,50,1/23/2019
954A47,earnings-positive,100,69,1/23/2019
9.62E+76,earnings,100,50,1/23/2019
9.92E+94,earnings,100,50,1/23/2019
9981C6,earnings,100,50,1/23/2019
99DC8D,conference-call,100,50,1/23/2019
9CE4C7,earnings,100,50,1/23/2019
9D30A8,earnings,100,50,1/23/2019
9D3360,executive-resignation,100,44,1/23/2019
9FA83B,conference-call,100,50,1/23/2019
A247F5,earnings,100,50,1/23/2019
A3F598,merger-failed,100,21,1/23/2019
A3F598,merger-failed,100,21,1/23/2019
A3F598,merger-failed,100,21,1/23/2019
A5A4F5,acquisition-acquirer,100,49,1/23/2019
A6213D,earnings,100,50,1/23/2019
A7102F,acquisition-acquirer,100,49,1/23/2019
A806FA,earnings-guidance,100,50,1/23/2019
A9ED24,conference-call,100,50,1/23/2019
AABEA0,earnings-up,100,72,1/23/2019
AE4125,executive-appointment,100,54,1/23/2019
AED6CF,dividend,100,50,1/23/2019
AFD1CA,conference-participant,100,50,1/23/2019
AFD7DD,conference-call,100,50,1/23/2019
B37FB4,product-release,100,64,1/23/2019
B604DF,earnings,100,50,1/23/2019
B604DF,dividend,100,50,1/23/2019
B83D67,clinical-trials-start,100,64,1/23/2019
B8DD94,operating-earnings,100,50,1/23/2019
BB02FB,unit-acquisition-acquiree,100,76,1/23/2019
BE7BA4,public-offering,100,43,1/23/2019
BFCACF,earnings,100,50,1/23/2019
C0BA36,product-release,100,64,1/23/2019
C3DE7D,executive-appointment,100,54,1/23/2019
C3F99F,business-contract,100,69,1/23/2019
C41C25,earnings,100,50,1/23/2019
C72B8F,conference-call,100,50,1/23/2019
C83B88,earnings,100,50,1/23/2019
C83B88,dividend-up,100,60,1/23/2019
C99CC8,executive-appointment,100,54,1/23/2019
C9B932,earnings,100,50,1/23/2019
C9F39B,earnings,100,50,1/23/2019
C9F39B,earnings,100,50,1/23/2019
C9F39B,earnings,100,50,1/23/2019
C9F39B,earnings,100,50,1/23/2019
C9F39B,earnings,100,50,1/23/2019
C9F39B,earnings,100,50,1/23/2019
C9F39B,earnings,100,50,1/23/2019
CA99D7,conference-call,100,50,1/23/2019
CAB222,public-offering,100,43,1/23/2019
CBA33B,earnings,100,50,1/23/2019
CBBFBF,dividend,100,50,1/23/2019
CBFFDD,legal-issues-defendant,100,22,1/23/2019
CDAA0E,earnings,100,50,1/23/2019
D139BC,conference-call,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D21D8A,earnings,100,50,1/23/2019
D33D8C,award,100,58,1/23/2019
D393DF,acquisition-acquirer,100,49,1/23/2019
D393DF,earnings,100,50,1/23/2019
D393DF,earnings,100,50,1/23/2019
D437C3,executive-resignation,100,44,1/23/2019
D437C3,earnings,100,50,1/23/2019
D518D8,conference-call,100,50,1/23/2019
D58A11,earnings,100,50,1/23/2019
D58A11,earnings,100,50,1/23/2019
D58A11,earnings,100,50,1/23/2019
D63B0F,conference-call,100,50,1/23/2019
D6853F,award,100,58,1/23/2019
D7918D,dividend,100,50,1/23/2019
D7918D,conference-call,100,50,1/23/2019
D7A953,earnings,100,50,1/23/2019
D854F3,partnership,100,61,1/23/2019
DBFB51,buybacks,100,74,1/23/2019
DF01B1,conference-call,100,50,1/23/2019
E07573,dividend,100,50,1/23/2019
E11C41,conference-call,100,50,1/23/2019
E393B0,earnings-up,100,68,1/23/2019
E393B0,earnings-up,100,68,1/23/2019
E393B0,earnings-up,100,68,1/23/2019
E393B0,earnings-up,100,68,1/23/2019
E393B0,earnings-up,100,68,1/23/2019
E393B0,earnings-up,100,68,1/23/2019
E3E68E,legal-issues-defendant,100,22,1/23/2019
E4158B,earnings,100,50,1/23/2019
E68C3D,earnings,100,50,1/23/2019
E8A49A,facility-upgrade,100,65,1/23/2019
E90C84,conference-call,100,50,1/23/2019
E9FF33,earnings,100,50,1/23/2019
EBD89A,business-contract,100,69,1/23/2019
F0B2B5,legal-issues-defendant,100,22,1/23/2019
F0B877,conference-call,100,50,1/23/2019
F11638,donation,100,54,1/23/2019
F1CD47,note-sale,100,52,1/23/2019
F209B4,reverse-stock-splits,100,51,1/23/2019
F209B4,reverse-stock-splits,100,51,1/23/2019
F24FF0,earnings,100,50,1/23/2019
F294DD,earnings,100,50,1/23/2019
F2E253,executive-appointment,100,54,1/23/2019
F3816D,public-offering,100,43,1/23/2019
F3FCC3,conference-call,100,50,1/23/2019
F50BAB,dividend,100,50,1/23/2019
FA36A4,conference-call,100,50,1/23/2019
FACF19,settlement,100,56,1/23/2019
FC4550,earnings,100,50,1/23/2019
FC9A88,earnings-up,100,68,1/23/2019
FC9A88,earnings-up,100,68,1/23/2019
FC9A88,earnings-up,100,68,1/23/2019
FC9A88,earnings-up,100,68,1/23/2019
FC9A88,earnings-up,100,68,1/23/2019
FC9A88,earnings-up,100,68,1/23/2019
FD39EB,dividend,100,50,1/23/2019
FDC7E6,dividend-up,100,70,1/23/2019
FDC7E6,earnings,100,50,1/23/2019
FEBFE1,stake-acquirer,100,48,1/23/2019
FEE4B0,dividend-up,100,81,1/23/2019
003B70,earnings,100,50,1/24/2019
003B70,dividend,100,50,1/24/2019
03B431,conference-call,100,50,1/24/2019
43862,conference-call,100,50,1/24/2019
48590,legal-issues-defendant,100,22,1/24/2019
48590,legal-issues-defendant,100,22,1/24/2019
48590,legal-issues-defendant,100,22,1/24/2019
51332,dividend,100,50,1/24/2019
0560D8,dividend,100,50,1/24/2019
58828,operating-earnings,100,50,1/24/2019
68396,dividend,100,50,1/24/2019
07C907,earnings,100,50,1/24/2019
0A1D77,earnings,100,50,1/24/2019
0AB700,earnings,100,50,1/24/2019
0AB700,earnings,100,50,1/24/2019
0B2071,dividend,100,50,1/24/2019
0C4131,earnings-positive,100,69,1/24/2019
0C4131,earnings-positive,100,69,1/24/2019
0C4131,earnings-positive,100,69,1/24/2019
0C4131,earnings-positive,100,69,1/24/2019
0C4131,earnings-positive,100,69,1/24/2019
0C8D82,conference-call,100,50,1/24/2019
0DC050,earnings,100,50,1/24/2019
12E454,business-contract,100,69,1/24/2019
1490F3,business-contract,100,69,1/24/2019
16B183,fundraising,100,64,1/24/2019
16B183,conference-call,100,50,1/24/2019
182B8C,conference-call,100,50,1/24/2019
18EC17,earnings,100,50,1/24/2019
1B637E,dividend,100,50,1/24/2019
1B9535,conference-call,100,50,1/24/2019
2031CE,earnings-up,100,68,1/24/2019
2031CE,earnings-up,100,68,1/24/2019
2031CE,earnings-up,100,68,1/24/2019
2031CE,earnings-up,100,68,1/24/2019
2031CE,earnings-up,100,68,1/24/2019
20DC4E,earnings,100,50,1/24/2019
25529C,earnings,100,50,1/24/2019
26CC63,dividend,100,50,1/24/2019
272472,earnings,100,50,1/24/2019
272704,dividend,100,50,1/24/2019
29B702,earnings,100,50,1/24/2019
2A1009,executive-appointment,100,54,1/24/2019
2A9C0A,earnings-positive,100,69,1/24/2019
2A9C0A,earnings,100,50,1/24/2019
2A9C0A,earnings,100,50,1/24/2019
2A9C0A,earnings,100,50,1/24/2019
2A9C0A,earnings,100,50,1/24/2019
2A9C0A,earnings,100,50,1/24/2019
2B9DBB,earnings,100,50,1/24/2019
2D643C,earnings,100,50,1/24/2019
2DA92D,earnings,100,50,1/24/2019
2DC88B,earnings,100,50,1/24/2019
2E0496,partnership,100,61,1/24/2019
2E0496,partnership,100,61,1/24/2019
2F7474,earnings,100,50,1/24/2019
3159AA,conference-call,100,50,1/24/2019
31643A,facility-open,100,65,1/24/2019
328250,earnings,100,50,1/24/2019
3CBA2A,earnings,100,50,1/24/2019
3CBA2A,earnings,100,50,1/24/2019
3CBA2A,earnings,100,50,1/24/2019
3CBA2A,earnings,100,50,1/24/2019
3CBA2A,earnings,100,50,1/24/2019
434F38,earnings,100,50,1/24/2019
453282,earnings-per-share-positive,100,69,1/24/2019
453282,earnings,100,50,1/24/2019
45ABCC,facility-open,100,65,1/24/2019
46CF27,earnings,100,50,1/24/2019
487B7A,earnings-up,100,68,1/24/2019
487B7A,earnings-up,100,68,1/24/2019
487B7A,earnings-up,100,68,1/24/2019
487B7A,earnings-up,100,68,1/24/2019
487B7A,earnings-up,100,68,1/24/2019
487B7A,earnings-up,100,68,1/24/2019
49BBBC,legal-issues-defendant,100,22,1/24/2019
49BBBC,legal-issues-defendant,100,22,1/24/2019
4A6F00,partnership,100,61,1/24/2019
4A6F00,partnership,100,61,1/24/2019
4B49CF,dividend,100,50,1/24/2019
4BBA23,operating-earnings,100,50,1/24/2019
4BD6DB,earnings,100,50,1/24/2019
4E5784,partnership,100,61,1/24/2019
4EE167,public-offering,100,43,1/24/2019
4EEE7E,earnings,100,50,1/24/2019
50070E,conference-call,100,50,1/24/2019
514067,legal-issues-defendant,100,22,1/24/2019
519FE0,earnings,100,50,1/24/2019
52015A,award,100,58,1/24/2019
55438C,legal-issues-defendant,100,22,1/24/2019
5A64D5,dividend,100,50,1/24/2019
5D1329,executive-appointment,100,54,1/24/2019
5D1956,earnings,100,50,1/24/2019
5D63F1,business-contract,100,69,1/24/2019
5F1B7B,conference-participant,100,50,1/24/2019
61B81B,partnership,100,61,1/24/2019
622037,dividend,100,50,1/24/2019
6284B5,conference-call,100,50,1/24/2019
636931,earnings,100,50,1/24/2019
641F17,dividend-up,100,62,1/24/2019
6474BA,earnings,100,50,1/24/2019
6474BA,earnings-up,100,68,1/24/2019
6474BA,earnings-up,100,68,1/24/2019
6474BA,earnings-up,100,68,1/24/2019
6474BA,earnings-up,100,68,1/24/2019
6474BA,earnings-up,100,68,1/24/2019
6474BA,earnings-up,100,68,1/24/2019
6474BA,earnings-up,100,68,1/24/2019
6474BA,earnings-up,100,68,1/24/2019
6474BA,earnings,100,50,1/24/2019
6474BA,earnings,100,50,1/24/2019
6810DE,business-contract,100,69,1/24/2019
68B03F,earnings,100,50,1/24/2019
69CE71,business-contract,100,69,1/24/2019
6B494E,conference-call,100,50,1/24/2019
6B5379,dividend,100,50,1/24/2019
6CC55E,earnings,100,50,1/24/2019
6CDFC6,earnings,100,50,1/24/2019
6D2BF6,partnership,100,61,1/24/2019
6E705B,product-release,100,64,1/24/2019
6E8864,regulatory-product-approval-granted,100,81,1/24/2019
6EB9DA,earnings,100,50,1/24/2019
6EB9DA,earnings,100,50,1/24/2019
6EB9DA,earnings,100,50,1/24/2019
73A71F,earnings,100,50,1/24/2019
73C9E2,earnings,100,50,1/24/2019
7520CC,earnings,100,50,1/24/2019
752A70,earnings,100,50,1/24/2019
76CEFB,earnings,100,50,1/24/2019
76F067,earnings,100,50,1/24/2019
773A17,revenue-up,100,65,1/24/2019
773A17,revenue-up,100,69,1/24/2019
773A17,revenue-up,100,69,1/24/2019
78A1BB,earnings,100,50,1/24/2019
791D59,earnings,100,50,1/24/2019
7A5D58,earnings,100,50,1/24/2019
7AC86E,earnings-guidance,100,50,1/24/2019
7ADE57,partnership,100,61,1/24/2019
7B1156,earnings-guidance,100,50,1/24/2019
7B8CB5,business-contract,100,69,1/24/2019
7C62A3,conference-call,100,50,1/24/2019
7C75FD,dividend,100,50,1/24/2019
7D5384,earnings,100,50,1/24/2019
7D5384,earnings,100,50,1/24/2019
7D5384,earnings,100,50,1/24/2019
7D5384,earnings,100,50,1/24/2019
7D5384,earnings,100,50,1/24/2019
7D97DE,conference-call,100,50,1/24/2019
80C400,executive-appointment,100,54,1/24/2019
8.22E+27,earnings,100,50,1/24/2019
83598E,earnings,100,50,1/24/2019
83598E,dividend,100,50,1/24/2019
837C04,earnings,100,50,1/24/2019
837C04,dividend,100,50,1/24/2019
859281,dividend,100,50,1/24/2019
860AB6,conference-call,100,50,1/24/2019
86478F,earnings,100,50,1/24/2019
877C0C,earnings,100,50,1/24/2019
87B81A,earnings,100,50,1/24/2019
8817D5,earnings-up,100,68,1/24/2019
8BE916,earnings,100,50,1/24/2019
8BE916,earnings-up,100,68,1/24/2019
8BE916,earnings-up,100,68,1/24/2019
8BE916,earnings-up,100,68,1/24/2019
8BE916,earnings-up,100,68,1/24/2019
8BE916,earnings-up,100,68,1/24/2019
8BE916,earnings-up,100,68,1/24/2019
8C1238,conference-call,100,50,1/24/2019
8D4486,partnership,100,61,1/24/2019
8D5145,earnings,100,50,1/24/2019
8DAAB9,earnings,100,50,1/24/2019
8DBE73,conference-call,100,50,1/24/2019
8F3231,earnings,100,50,1/24/2019
907ED2,earnings,100,50,1/24/2019
907ED2,earnings,100,50,1/24/2019
907ED2,earnings,100,50,1/24/2019
907ED2,earnings,100,50,1/24/2019
907ED2,earnings,100,50,1/24/2019
907ED2,earnings,100,50,1/24/2019
907ED2,earnings,100,50,1/24/2019
907ED2,earnings,100,50,1/24/2019
91E5EE,business-contract,100,69,1/24/2019
91E5EE,business-contract,100,69,1/24/2019
91E5EE,business-contract,100,69,1/24/2019
92D6A5,earnings,100,50,1/24/2019
940C3D,dividend,100,50,1/24/2019
94637C,conference-call,100,50,1/24/2019
94637C,earnings,100,50,1/24/2019
95DC1F,executive-appointment,100,54,1/24/2019
95DC1F,executive-appointment,100,54,1/24/2019
965360,dividend,100,50,1/24/2019
96F126,dividend,100,50,1/24/2019
971F7B,earnings,100,50,1/24/2019
989E2F,earnings,100,50,1/24/2019
989E2F,earnings,100,50,1/24/2019
989E2F,earnings,100,50,1/24/2019
9CDA4F,conference-participant,100,50,1/24/2019
9D56F2,earnings-up,100,68,1/24/2019
9D56F2,earnings-up,100,68,1/24/2019
9D56F2,earnings-up,100,68,1/24/2019
9D56F2,earnings-up,100,68,1/24/2019
9D56F2,earnings-up,100,68,1/24/2019
9E298A,dividend,100,50,1/24/2019
9E98F2,earnings,100,50,1/24/2019
9E98F2,earnings,100,50,1/24/2019
9E98F2,earnings,100,50,1/24/2019
A5A4F5,acquisition-acquirer,100,49,1/24/2019
A60354,conference-call,100,50,1/24/2019
A6828A,executive-appointment,100,54,1/24/2019
A868C9,conference-call,100,50,1/24/2019
A8CBDA,earnings-positive,100,69,1/24/2019
AA247D,earnings,100,50,1/24/2019
AC1952,buybacks,100,74,1/24/2019
AC1952,earnings,100,50,1/24/2019
AD1ACF,product-release,100,64,1/24/2019
B0998E,earnings,100,50,1/24/2019
B2206F,award,100,58,1/24/2019
B37FB4,partnership,100,61,1/24/2019
B4C673,partnership,100,61,1/24/2019
B5766D,earnings-per-share-positive,100,69,1/24/2019
B5766D,earnings,100,50,1/24/2019
B5766D,earnings,100,50,1/24/2019
B5766D,earnings,100,50,1/24/2019
B5766D,earnings,100,50,1/24/2019
B5766D,earnings,100,50,1/24/2019
B619CB,earnings-positive,100,69,1/24/2019
B6CD92,earnings,100,50,1/24/2019
B840EF,conference-call,100,50,1/24/2019
B8EF97,dividend,100,50,1/24/2019
BB5271,acquisition-completed-acquirer,100,49,1/24/2019
BC3AD2,earnings,100,50,1/24/2019
BC3AD2,earnings,100,50,1/24/2019
BC3AD2,earnings,100,50,1/24/2019
BC3AD2,earnings,100,50,1/24/2019
BC3AD2,earnings,100,50,1/24/2019
BC3AD2,earnings,100,50,1/24/2019
BC3AD2,earnings,100,50,1/24/2019
BC3AD2,earnings,100,50,1/24/2019
BC5680,earnings,100,50,1/24/2019
BDF2BD,conference-call,100,50,1/24/2019
BEB756,earnings,100,50,1/24/2019
C0200F,award,100,58,1/24/2019
C062D4,dividend,100,50,1/24/2019
C1CBA4,earnings-positive,100,69,1/24/2019
C2F597,earnings,100,50,1/24/2019
C3BAE7,earnings,100,50,1/24/2019
C4706C,conference-call,100,50,1/24/2019
C4A912,conference-call,100,50,1/24/2019
C54140,earnings,100,50,1/24/2019
C598D7,dividend,100,50,1/24/2019
C9881C,executive-appointment,100,54,1/24/2019
C9E107,earnings,100,50,1/24/2019
CB6A9C,product-release,100,64,1/24/2019
CBFFDD,legal-issues-defendant,100,22,1/24/2019
CBFFDD,legal-issues-defendant,100,22,1/24/2019
CDEDFE,earnings,100,50,1/24/2019
CDFCC9,partnership,100,61,1/24/2019
CE2791,conference-call,100,50,1/24/2019
CE96E7,earnings,100,50,1/24/2019
CE96E7,earnings,100,50,1/24/2019
CE96E7,earnings,100,50,1/24/2019
CF6A5A,earnings,100,50,1/24/2019
CFE5BE,dividend,100,50,1/24/2019
D0DFE5,earnings,100,50,1/24/2019
D17C1B,earnings,100,50,1/24/2019
D17C1B,earnings,100,50,1/24/2019
D17C1B,earnings,100,50,1/24/2019
D17C1B,earnings,100,50,1/24/2019
D1C26F,conference-participant,100,50,1/24/2019
D4463B,earnings,100,50,1/24/2019
D8760C,dividend,100,50,1/24/2019
D8F347,earnings,100,50,1/24/2019
D9B1C9,earnings,100,50,1/24/2019
D9B1C9,earnings,100,50,1/24/2019
D9B1C9,earnings,100,50,1/24/2019
DA48E4,dividend-up,100,81,1/24/2019
DAFED3,executive-appointment,100,54,1/24/2019
DBCA3F,earnings,100,50,1/24/2019
DC0D18,earnings,100,50,1/24/2019
DD1BA1,earnings,100,50,1/24/2019
DE4924,conference-call,100,50,1/24/2019
DF6FDD,earnings,100,50,1/24/2019
E0339F,earnings,100,50,1/24/2019
E0339F,earnings,100,50,1/24/2019
E0339F,earnings,100,50,1/24/2019
E0339F,earnings,100,50,1/24/2019
E0339F,earnings,100,50,1/24/2019
E2CFD2,partnership,100,61,1/24/2019
E35610,earnings-guidance,100,50,1/24/2019
E35610,legal-issues-defendant,100,22,1/24/2019
E67C2C,earnings,100,50,1/24/2019
E68733,acquisition-acquirer,100,49,1/24/2019
E6A53A,earnings,100,50,1/24/2019
E71AE6,public-offering,100,43,1/24/2019
E8846E,campaign-ad-release,100,59,1/24/2019
E8E899,product-release,100,64,1/24/2019
E94704,conference-call,100,50,1/24/2019
EA4E68,earnings,100,50,1/24/2019
EA4E68,earnings,100,50,1/24/2019
EA4E68,earnings,100,50,1/24/2019
EA79C7,clinical-trials,100,56,1/24/2019
EB36DE,earnings,100,50,1/24/2019
EBD89A,earnings,100,50,1/24/2019
ED8676,earnings-positive,100,69,1/24/2019
ED8676,earnings-up,100,68,1/24/2019
ED8676,earnings-up,100,68,1/24/2019
ED8676,earnings-up,100,68,1/24/2019
ED8676,earnings-up,100,68,1/24/2019
ED8676,earnings-up,100,68,1/24/2019
ED8676,earnings-up,100,68,1/24/2019
ED8676,earnings-up,100,68,1/24/2019
ED8676,earnings-up,100,68,1/24/2019
ED8676,dividend-up,100,59,1/24/2019
EDF5CA,buybacks,100,74,1/24/2019
EEA6B3,product-release,100,64,1/24/2019
F0027C,clinical-trials-start,100,64,1/24/2019
F3EDB4,partnership,100,61,1/24/2019
F4E882,conference-call,100,50,1/24/2019
F4F46F,conference-call,100,50,1/24/2019
F6E248,business-contract,100,69,1/24/2019
F88A04,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FF4343,earnings,100,50,1/24/2019
FFE543,partnership,100,61,1/24/2019
48590,legal-issues-defendant,100,22,1/25/2019
05D148,public-offering,100,43,1/25/2019
95294,unit-acquisition-acquirer,100,49,1/25/2019
98977,earnings,100,50,1/25/2019
0A748B,earnings,100,50,1/25/2019
108FDA,earnings,100,50,1/25/2019
139303,conference-call,100,50,1/25/2019
152E1D,legal-issues-defendant,100,22,1/25/2019
156A99,earnings,100,50,1/25/2019
168A5D,donation,100,54,1/25/2019
1921DD,business-contract,100,69,1/25/2019
19C105,earnings,100,50,1/25/2019
19C105,earnings,100,50,1/25/2019
19C105,earnings,100,50,1/25/2019
19C105,dividend,100,50,1/25/2019
1E68B3,executive-appointment,100,54,1/25/2019
1EC3E8,earnings,100,50,1/25/2019
225CA2,award,100,58,1/25/2019
272472,dividend-up,100,81,1/25/2019
3E39A5,dividend,100,50,1/25/2019
423279,dividend,100,50,1/25/2019
435ACE,dividend,100,50,1/25/2019
45444E,conference-call,100,50,1/25/2019
460C93,earnings,100,50,1/25/2019
49BBBC,legal-issues-defendant,100,22,1/25/2019
4DD09F,business-contract,100,69,1/25/2019
553949,conference-call,100,50,1/25/2019
55438C,legal-issues-defendant,100,22,1/25/2019
556A57,dividend,100,50,1/25/2019
556A57,earnings,100,50,1/25/2019
56277A,regulatory-product-approval-granted,100,81,1/25/2019
587EDF,earnings,100,50,1/25/2019
594402,business-contract,100,69,1/25/2019
5B6C11,product-release,100,64,1/25/2019
5FE4B6,earnings,100,50,1/25/2019
636639,acquisition-completed-acquirer,100,49,1/25/2019
6.52E+64,legal-issues-defendant,100,22,1/25/2019
665D7D,earnings,100,50,1/25/2019
665D7D,earnings,100,50,1/25/2019
665D7D,earnings,100,50,1/25/2019
665D7D,earnings,100,50,1/25/2019
665D7D,earnings,100,50,1/25/2019
66667F,facility-open,100,65,1/25/2019
693ECD,conference-participant,100,50,1/25/2019
6ABCB8,earnings,100,50,1/25/2019
6B236C,conference-call,100,50,1/25/2019
6B236C,dividend,100,50,1/25/2019
6CDFC6,earnings,100,50,1/25/2019
6E705B,donation,100,54,1/25/2019
70FCEF,executive-appointment,100,54,1/25/2019
72F0FC,dividend,100,50,1/25/2019
72F0FC,earnings,100,50,1/25/2019
72FCA3,dividend,100,50,1/25/2019
762A3E,dividend,100,50,1/25/2019
76B926,executive-appointment,100,54,1/25/2019
76D79A,earnings-guidance,100,50,1/25/2019
7B4B91,earnings,100,50,1/25/2019
7BC92D,award,100,58,1/25/2019
7DD8CC,dividend,100,50,1/25/2019
7F0372,credit-extension-recipient,100,69,1/25/2019
862941,executive-appointment,100,54,1/25/2019
868808,executive-appointment,100,54,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
8B2C4A,earnings,100,50,1/25/2019
902255,earnings,100,50,1/25/2019
945DE6,business-contract,100,69,1/25/2019
95A92E,executive-appointment,100,54,1/25/2019
95DC1F,dividend,100,50,1/25/2019
95DE39,earnings,100,50,1/25/2019
95DE39,operating-earnings,100,50,1/25/2019
95DE39,operating-earnings,100,50,1/25/2019
95DE39,operating-earnings,100,50,1/25/2019
977A1E,dividend,100,50,1/25/2019
977A1E,executive-appointment,100,54,1/25/2019
997348,earnings,100,50,1/25/2019
997348,earnings,100,50,1/25/2019
9ABD30,patent-filing,100,64,1/25/2019
9C5174,earnings,100,50,1/25/2019
9CA619,executive-appointment,100,54,1/25/2019
9EED50,earnings-up,100,68,1/25/2019
A15C71,earnings,100,50,1/25/2019
A23747,executive-appointment,100,54,1/25/2019
A5A4F5,acquisition-acquirer,100,49,1/25/2019
A63387,facility-upgrade,100,65,1/25/2019
AA98ED,conference-call,100,50,1/25/2019
AD3C93,earnings,100,50,1/25/2019
AFEC35,earnings,100,50,1/25/2019
B2AA0A,earnings-guidance,100,50,1/25/2019
B4C673,dividend-up,100,67,1/25/2019
B76C82,executive-appointment,100,54,1/25/2019
B76C82,executive-appointment,100,54,1/25/2019
BB02FB,conference-call,100,50,1/25/2019
BBBB41,dividend,100,50,1/25/2019
BD8517,award,100,58,1/25/2019
C16A8F,dividend,100,50,1/25/2019
C1CBA4,dividend-up,100,84,1/25/2019
C29715,earnings,100,50,1/25/2019
C4A432,conference-call,100,50,1/25/2019
C66B44,settlement,100,56,1/25/2019
CAC8D0,reverse-stock-splits,100,51,1/25/2019
CBFFDD,legal-issues-defendant,100,22,1/25/2019
CC176E,earnings,100,50,1/25/2019
CDAB24,earnings,100,50,1/25/2019
CE5C6E,business-contract,100,69,1/25/2019
CFF97C,credit-rating-upgrade-rater,20,50,1/25/2019
D04D9F,earnings,100,50,1/25/2019
D7F569,dividend,100,50,1/25/2019
D854F3,earnings,100,50,1/25/2019
DA48E4,earnings-up,100,68,1/25/2019
DA48E4,earnings,100,50,1/25/2019
DA48E4,earnings,100,50,1/25/2019
DA48E4,earnings,100,50,1/25/2019
DA48E4,earnings,100,50,1/25/2019
DAFED3,earnings,100,50,1/25/2019
DE5611,dividend,100,50,1/25/2019
E00373,earnings,100,50,1/25/2019
E71AE6,public-offering,100,43,1/25/2019
E8B315,acquisition-acquirer,100,49,1/25/2019
EB6965,earnings,100,50,1/25/2019
EB6965,earnings,100,50,1/25/2019
EB6965,earnings,100,50,1/25/2019
EB6965,earnings,100,50,1/25/2019
EB6965,earnings,100,50,1/25/2019
EB6965,earnings,100,50,1/25/2019
EB6965,earnings,100,50,1/25/2019
EBC84C,earnings,100,50,1/25/2019
F2526D,earnings,100,50,1/25/2019
F31B13,earnings-up,100,68,1/25/2019
F3FCC3,dividend,100,50,1/25/2019
F793FA,executive-appointment,100,54,1/25/2019
FACF19,dividend,100,50,1/25/2019
FD0CA4,dividend-up,100,81,1/25/2019
FD4BBE,government-contract,100,69,1/25/2019
49BBBC,legal-issues-defendant,100,22,1/26/2019
A6828A,patent-infringement-defendant,100,26,1/26/2019
A6828A,patent-infringement-defendant,100,26,1/26/2019
AE7D16,earnings,100,50,1/26/2019
CBFFDD,legal-issues-defendant,100,22,1/26/2019
7AB859,legal-issues-defendant,100,22,1/27/2019
070B45,acquisition-acquirer,100,49,1/28/2019
95294,legal-issues-defendant,100,22,1/28/2019
095A04,partnership,100,61,1/28/2019
0A6824,dividend,100,50,1/28/2019
0A9D0A,legal-issues-defendant,100,22,1/28/2019
0BC29E,executive-appointment,100,54,1/28/2019
0C6861,conference-call,100,50,1/28/2019
0DE3D5,conference-call,100,50,1/28/2019
0FABBD,executive-appointment,100,54,1/28/2019
1151F4,award,100,58,1/28/2019
14833D,legal-issues-defendant,100,22,1/28/2019
149301,conference-call,100,50,1/28/2019
157D9F,conference-call,100,50,1/28/2019
16C544,dividend,100,50,1/28/2019
1E68B3,earnings,100,50,1/28/2019
1F43A1,dividend,100,50,1/28/2019
1FE3CB,dividend,100,50,1/28/2019
1FE3CB,buybacks,100,74,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
206852,earnings,100,50,1/28/2019
20BEEA,award,100,58,1/28/2019
20DC4E,dividend,100,50,1/28/2019
2158DF,earnings,100,50,1/28/2019
29A4CC,earnings,100,50,1/28/2019
29A4CC,earnings,100,50,1/28/2019
29A4CC,earnings,100,50,1/28/2019
29A4CC,earnings,100,50,1/28/2019
29A4CC,earnings,100,50,1/28/2019
29A4CC,earnings,100,50,1/28/2019
29A4CC,earnings,100,50,1/28/2019
2D2D43,dividend-up,100,81,1/28/2019
2EB88B,earnings,100,50,1/28/2019
30E01D,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
31F25C,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
370C50,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
38FB49,earnings,100,50,1/28/2019
3A4BDB,earnings-up,100,68,1/28/2019
3A4BDB,earnings-up,100,68,1/28/2019
3A4BDB,earnings-up,100,68,1/28/2019
3A4BDB,earnings-up,100,68,1/28/2019
3A4BDB,earnings-up,100,68,1/28/2019
3AF7FD,conference-participant,100,50,1/28/2019
3B37F7,earnings,100,50,1/28/2019
3CCC90,executive-appointment,100,54,1/28/2019
4649D5,unit-acquisition-acquiree,100,76,1/28/2019
4806CE,donation,100,54,1/28/2019
494EB9,earnings,100,50,1/28/2019
49BBBC,legal-issues-defendant,100,22,1/28/2019
49BBBC,legal-issues-defendant,100,22,1/28/2019
4B3DC9,merger,100,66,1/28/2019
4B3DC9,earnings-positive,100,69,1/28/2019
4B6EF9,earnings,100,50,1/28/2019
4B6EF9,dividend,100,50,1/28/2019
4C7DB5,executive-appointment,100,54,1/28/2019
4D72C8,conference-call,100,50,1/28/2019
4D8313,revenue-up,100,69,1/28/2019
4D8313,revenue-up,100,69,1/28/2019
4D8313,revenue-up,100,69,1/28/2019
4D8313,revenue-up,100,69,1/28/2019
4DD09F,conference-participant,100,50,1/28/2019
4EE167,public-offering,100,43,1/28/2019
4FB770,conference-call,100,50,1/28/2019
51527B,earnings,100,50,1/28/2019
51527B,earnings,100,50,1/28/2019
51527B,earnings,100,50,1/28/2019
51527B,earnings,100,50,1/28/2019
51527B,earnings,100,50,1/28/2019
51B442,earnings,100,50,1/28/2019
548AC0,conference-call,100,50,1/28/2019
583223,product-release,100,64,1/28/2019
5876DC,credit-extension-recipient,100,69,1/28/2019
59DB8C,earnings,100,50,1/28/2019
5A9A82,executive-appointment,100,54,1/28/2019
5BE42C,earnings-up,100,68,1/28/2019
62EFEE,earnings,100,50,1/28/2019
65CF8E,dividend,100,50,1/28/2019
65CF8E,earnings,100,50,1/28/2019
665440,executive-appointment,100,54,1/28/2019
665D7D,regulatory-product-approval-granted,100,81,1/28/2019
6844D2,executive-appointment,100,54,1/28/2019
69CE71,business-contract,100,69,1/28/2019
6A171E,executive-appointment,100,54,1/28/2019
6CB7F9,conference-call,100,50,1/28/2019
6CD55A,earnings,100,50,1/28/2019
6D4636,earnings,100,50,1/28/2019
6D4636,earnings,100,50,1/28/2019
6D4636,executive-resignation,100,44,1/28/2019
6DD6BA,business-contract,100,69,1/28/2019
6F3936,executive-appointment,100,54,1/28/2019
72C2CE,conference-call,100,50,1/28/2019
75F665,earnings,100,50,1/28/2019
762A3E,conference-organizer,100,57,1/28/2019
767F86,earnings,100,50,1/28/2019
76D79A,dividend,100,50,1/28/2019
782B46,earnings,100,50,1/28/2019
7B492C,conference-call,100,50,1/28/2019
7F3669,earnings,100,50,1/28/2019
850779,dividend,100,50,1/28/2019
859281,earnings,100,50,1/28/2019
859281,earnings,100,50,1/28/2019
859281,earnings,100,50,1/28/2019
859281,earnings,100,50,1/28/2019
859281,earnings,100,50,1/28/2019
859281,earnings,100,50,1/28/2019
8665BA,business-contract,100,69,1/28/2019
880C0C,conference-call,100,50,1/28/2019
8A8E41,earnings,100,50,1/28/2019
8C1238,earnings,100,50,1/28/2019
8C1238,earnings,100,50,1/28/2019
8C1238,earnings,100,50,1/28/2019
8C1238,earnings,100,50,1/28/2019
8C1238,earnings,100,50,1/28/2019
8C5519,dividend,100,50,1/28/2019
8E93A4,earnings,100,50,1/28/2019
9548BB,earnings,100,50,1/28/2019
977A1E,merger-completed,100,66,1/28/2019
979451,legal-issues-defendant,100,22,1/28/2019
986AF6,conference-call,100,50,1/28/2019
9C5174,executive-appointment,100,54,1/28/2019
9C5BA5,conference-call,100,50,1/28/2019
9C8BC3,conference-call,100,50,1/28/2019
9D5D35,earnings,100,50,1/28/2019
9DDE1B,dividend,100,50,1/28/2019
9E91C6,settlement,100,56,1/28/2019
9F18FA,earnings,100,50,1/28/2019
9F18FA,earnings,100,50,1/28/2019
9F37C5,dividend,100,50,1/28/2019
9F62D1,earnings,100,50,1/28/2019
9F62D1,earnings,100,50,1/28/2019
9F62D1,earnings,100,50,1/28/2019
9FD2D9,note-sale,100,52,1/28/2019
A1A317,earnings,100,50,1/28/2019
A1A317,earnings,100,50,1/28/2019
A1A317,earnings,100,50,1/28/2019
A1A317,earnings,100,50,1/28/2019
A3800A,earnings,100,50,1/28/2019
A3AAA5,conference-call,100,50,1/28/2019
A3AAA5,dividend,100,50,1/28/2019
A3AAA5,public-offering,100,43,1/28/2019
A58224,conference-call,100,50,1/28/2019
A5A4F5,acquisition-acquirer,100,49,1/28/2019
A79F7D,conference-call,100,50,1/28/2019
A99576,earnings,100,50,1/28/2019
AADE0B,unit-acquisition-acquirer,100,49,1/28/2019
AAEE21,conference-call,100,50,1/28/2019
AB7726,conference-participant,100,50,1/28/2019
AB7726,earnings,100,50,1/28/2019
AC7C4F,award,100,58,1/28/2019
AECCA9,note-sale,100,52,1/28/2019
B2DAF6,joint-venture,100,62,1/28/2019
B2F431,earnings,100,50,1/28/2019
B4C673,executive-appointment,100,54,1/28/2019
B72BE9,revenues,100,50,1/28/2019
B72BE9,revenues,100,50,1/28/2019
B72BE9,revenues,100,50,1/28/2019
B803B1,conference-call,100,50,1/28/2019
BC948D,conference-call,100,50,1/28/2019
BDD12C,earnings,100,50,1/28/2019
BE7BA4,public-offering,100,43,1/28/2019
C22BE8,product-release,100,64,1/28/2019
C50B26,award,100,58,1/28/2019
C598D7,revenue-up,100,57,1/28/2019
C598D7,revenues,100,50,1/28/2019
C598D7,revenues,100,50,1/28/2019
C598D7,revenues,100,50,1/28/2019
C941DC,earnings,100,50,1/28/2019
CBFFDD,legal-issues-defendant,100,22,1/28/2019
CC8F6E,earnings,100,50,1/28/2019
CF9054,earnings,100,50,1/28/2019
D0DFE5,earnings,100,50,1/28/2019
D15833,dividend,100,50,1/28/2019
D1C26F,earnings,100,50,1/28/2019
D1CFC8,award,100,58,1/28/2019
D29B44,earnings,100,50,1/28/2019
D501DC,earnings,100,50,1/28/2019
D8760C,executive-appointment,100,54,1/28/2019
DAC66A,earnings,100,50,1/28/2019
DF46C5,dividend,100,50,1/28/2019
DF46C5,earnings,100,50,1/28/2019
DF46C5,earnings,100,50,1/28/2019
DF46C5,earnings,100,50,1/28/2019
DF46C5,earnings,100,50,1/28/2019
DFADDB,clinical-trials,100,56,1/28/2019
E09E2B,earnings-guidance,100,50,1/28/2019
E09E2B,earnings-guidance,100,50,1/28/2019
E09E2B,legal-issues-defendant,100,22,1/28/2019
E10D31,conference-call,100,50,1/28/2019
E2F130,partnership,100,61,1/28/2019
E2F130,partnership,100,61,1/28/2019
E68733,campaign-ad-release,100,59,1/28/2019
E70531,earnings,100,50,1/28/2019
E99180,earnings,100,50,1/28/2019
EB7D6C,partnership,100,61,1/28/2019
ECDEB2,earnings,100,50,1/28/2019
ECDEB2,earnings,100,50,1/28/2019
ECDEB2,earnings,100,50,1/28/2019
ECDEB2,earnings,100,50,1/28/2019
ECDEB2,earnings,100,50,1/28/2019
ECDEB2,earnings,100,50,1/28/2019
EE74E1,business-contract,100,69,1/28/2019
F15E41,legal-issues-defendant,100,22,1/28/2019
F30508,partnership,100,61,1/28/2019
F31B13,public-offering,100,43,1/28/2019
F39E1E,earnings,100,50,1/28/2019
F5349B,earnings,100,50,1/28/2019
F6A945,earnings,100,50,1/28/2019
F793FA,earnings,100,50,1/28/2019
F7FCA4,dividend,100,50,1/28/2019
FA40E2,executive-appointment,100,54,1/28/2019
FC1B7B,conference-participant,100,50,1/28/2019
00067A,executive-appointment,100,54,1/29/2019
00326E,earnings,100,50,1/29/2019
9397,executive-appointment,100,54,1/29/2019
03B8CF,earnings,100,50,1/29/2019
03B8CF,earnings,100,50,1/29/2019
03B8CF,earnings,100,50,1/29/2019
03B8CF,earnings,100,50,1/29/2019
03B8CF,earnings,100,50,1/29/2019
03B8CF,earnings,100,50,1/29/2019
48590,legal-issues-defendant,100,22,1/29/2019
0E439E,earnings,100,50,1/29/2019
0E439E,earnings,100,50,1/29/2019
0E439E,earnings,100,50,1/29/2019
0E439E,earnings,100,50,1/29/2019
0F0440,partnership,100,61,1/29/2019
102727,earnings,100,50,1/29/2019
10AE08,earnings,100,50,1/29/2019
1216D1,earnings-up,100,68,1/29/2019
1216D1,earnings-up,100,68,1/29/2019
1216D1,earnings-up,100,68,1/29/2019
1216D1,earnings-up,100,68,1/29/2019
1216D1,earnings-up,100,68,1/29/2019
1216D1,earnings-up,100,68,1/29/2019
1216D1,earnings-up,100,68,1/29/2019
152FA5,executive-appointment,100,54,1/29/2019
1A3E1B,dividend,100,50,1/29/2019
1BC12C,business-contract,100,69,1/29/2019
1BDB2A,earnings,100,50,1/29/2019
1D9E55,market-entry,100,57,1/29/2019
1DDEDA,conference-call,100,50,1/29/2019
1DE526,earnings,100,50,1/29/2019
1E1125,conference-organizer,100,57,1/29/2019
1E9A6D,earnings,100,50,1/29/2019
1EBF8D,dividend,100,50,1/29/2019
1EBF8D,executive-appointment,100,54,1/29/2019
1FAF22,conference-participant,100,50,1/29/2019
1FAF22,conference-participant,100,50,1/29/2019
20D00A,executive-resignation,100,44,1/29/2019
21268E,conference-call,100,50,1/29/2019
214051,earnings-up,100,68,1/29/2019
221AD7,earnings-up,100,68,1/29/2019
222BF9,earnings,100,50,1/29/2019
228D42,partnership,100,61,1/29/2019
22C58E,earnings,100,50,1/29/2019
251988,partnership,100,61,1/29/2019
267718,earnings,100,50,1/29/2019
26CC63,conference-participant,100,50,1/29/2019
275300,note-sale,100,52,1/29/2019
275300,note-sale,100,52,1/29/2019
28DCF3,earnings-up,100,91,1/29/2019
2BF36E,legal-issues-defendant,100,22,1/29/2019
2E0496,earnings,100,50,1/29/2019
2EC172,executive-appointment,100,54,1/29/2019
2EC172,conference-call,100,50,1/29/2019
2F5256,earnings,100,50,1/29/2019
32F24A,earnings,100,50,1/29/2019
34A959,partnership,100,61,1/29/2019
34A959,business-contract,100,69,1/29/2019
34B97A,earnings,100,50,1/29/2019
34B97A,earnings,100,50,1/29/2019
34B97A,earnings,100,50,1/29/2019
34B97A,earnings,100,50,1/29/2019
34B97A,earnings,100,50,1/29/2019
3.50E+27,earnings,100,50,1/29/2019
385DD4,legal-issues-defendant,100,22,1/29/2019
3.88E+02,earnings,100,50,1/29/2019
3A94DF,earnings,100,50,1/29/2019
3BCF24,earnings,100,50,1/29/2019
3C3B6B,partnership,100,61,1/29/2019
3CCC90,executive-appointment,100,54,1/29/2019
416C55,earnings,100,50,1/29/2019
41EC04,conference-call,100,50,1/29/2019
420168,unit-acquisition-acquirer,100,49,1/29/2019
420168,earnings,100,50,1/29/2019
447FC6,conference-call,100,50,1/29/2019
449217,earnings,100,50,1/29/2019
449217,earnings,100,50,1/29/2019
449217,earnings,100,50,1/29/2019
449217,earnings,100,50,1/29/2019
449217,earnings,100,50,1/29/2019
449217,earnings,100,50,1/29/2019
4649D5,unit-acquisition-acquiree,100,76,1/29/2019
479930,earnings,100,50,1/29/2019
49BBBC,legal-issues-defendant,100,22,1/29/2019
49BBBC,legal-issues-defendant,100,22,1/29/2019
4A6F00,partnership,100,61,1/29/2019
4BEB48,earnings,100,50,1/29/2019
4C1FA1,acquisition-completed-acquirer,100,49,1/29/2019
4C6C63,business-contract,100,69,1/29/2019
4C6C63,dividend,100,50,1/29/2019
4C6C63,dividend,100,50,1/29/2019
50070E,conference-organizer,100,57,1/29/2019
507AE7,earnings,100,50,1/29/2019
5088A5,earnings,100,50,1/29/2019
5.47E+28,clinical-trials-start,100,64,1/29/2019
54A646,earnings-up,100,68,1/29/2019
54A646,earnings-up,100,68,1/29/2019
54A646,earnings-up,100,68,1/29/2019
54A646,earnings-up,100,68,1/29/2019
54F271,earnings,100,50,1/29/2019
56277A,conference-participant,100,50,1/29/2019
567F3D,dividend,100,50,1/29/2019
56B7C1,earnings,100,50,1/29/2019
583A75,earnings,100,50,1/29/2019
586BD7,legal-issues-defendant,100,22,1/29/2019
586BD7,legal-issues-defendant,100,22,1/29/2019
586BD7,legal-issues-defendant,100,22,1/29/2019
589846,earnings-up,100,68,1/29/2019
59A832,conference-call,100,50,1/29/2019
59B229,earnings,100,50,1/29/2019
59C539,dividend,100,50,1/29/2019
5B15E1,earnings,100,50,1/29/2019
5D63F1,award,100,58,1/29/2019
5DA8B3,earnings,100,50,1/29/2019
5E9934,earnings,100,50,1/29/2019
5EAA43,acquisition-acquiree,100,76,1/29/2019
5EF130,conference-call,100,50,1/29/2019
636639,revenue-up,100,56,1/29/2019
636639,revenue-up,100,69,1/29/2019
636639,revenue-up,100,69,1/29/2019
636639,revenue-up,100,69,1/29/2019
636639,revenue-up,100,69,1/29/2019
6.52E+64,reorganization,100,53,1/29/2019
68B03F,executive-appointment,100,54,1/29/2019
68E3E0,executive-resignation,100,44,1/29/2019
69345C,earnings,100,50,1/29/2019
69494C,conference-call,100,50,1/29/2019
6D156D,earnings,100,50,1/29/2019
724F84,earnings,100,50,1/29/2019
72EF75,earnings,100,50,1/29/2019
732449,earnings,100,50,1/29/2019
735388,earnings,100,50,1/29/2019
73A213,earnings,100,50,1/29/2019
742AAB,conference-call,100,50,1/29/2019
765913,earnings,100,50,1/29/2019
76CEFB,public-offering,100,43,1/29/2019
76F067,earnings,100,50,1/29/2019
782B46,dividend,100,50,1/29/2019
7B0BA6,partnership,100,61,1/29/2019
7CBC40,product-release,100,64,1/29/2019
7D35D8,earnings-guidance,100,50,1/29/2019
7D5FD6,earnings,100,50,1/29/2019
7E0EB0,index-listing,100,76,1/29/2019
7F3669,partnership,100,61,1/29/2019
859D62,dividend,100,50,1/29/2019
85CDC9,earnings,100,50,1/29/2019
88193E,conference-call,100,50,1/29/2019
89F693,product-release,100,64,1/29/2019
8A8E41,earnings,100,50,1/29/2019
8AB37F,partnership,100,61,1/29/2019
8D4486,dividend,100,50,1/29/2019
8D4486,dividend,100,50,1/29/2019
8E8E6E,business-contract,100,69,1/29/2019
90B678,dividend,100,50,1/29/2019
93D207,partnership,100,61,1/29/2019
93D207,product-release,100,64,1/29/2019
94983E,product-release,100,64,1/29/2019
95C575,earnings,100,50,1/29/2019
95DC1F,executive-appointment,100,54,1/29/2019
95F59E,executive-appointment,100,54,1/29/2019
96F126,earnings,100,50,1/29/2019
96F126,business-contract,100,69,1/29/2019
972356,earnings,100,50,1/29/2019
986AF6,earnings,100,50,1/29/2019
986AF6,earnings,100,50,1/29/2019
986AF6,earnings,100,50,1/29/2019
98CEBB,earnings,100,50,1/29/2019
9BB35A,conference-participant,100,50,1/29/2019
9CE4C7,conference-participant,100,50,1/29/2019
9DDE1B,public-offering,100,43,1/29/2019
A29DBD,executive-appointment,100,54,1/29/2019
A3AAA5,public-offering,100,43,1/29/2019
A48593,conference-call,100,50,1/29/2019
A4D173,earnings,100,50,1/29/2019
A4D173,earnings,100,50,1/29/2019
A5A4F5,acquisition-acquirer,100,49,1/29/2019
A631A3,partnership,100,61,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AE4EEB,earnings,100,50,1/29/2019
AF210D,earnings,100,50,1/29/2019
B05118,earnings,100,50,1/29/2019
B1B10C,earnings,100,50,1/29/2019
B2206F,earnings,100,50,1/29/2019
B4703C,revenue-up,100,69,1/29/2019
B48FC9,earnings,100,50,1/29/2019
B5766D,dividend,100,50,1/29/2019
B6082A,earnings,100,50,1/29/2019
B7BBFF,conference-call,100,50,1/29/2019
B8F71F,earnings,100,50,1/29/2019
B934BF,conference-call,100,50,1/29/2019
BC3AD2,earnings,100,50,1/29/2019
BC3AD2,earnings,100,50,1/29/2019
BDEF34,earnings,100,50,1/29/2019
BE14CF,trading-halt,100,43,1/29/2019
BE379D,earnings,100,50,1/29/2019
BF79F5,business-contract,100,69,1/29/2019
BFEA04,conference-call,100,50,1/29/2019
C4F567,revenue-up,100,69,1/29/2019
C4F567,earnings,100,50,1/29/2019
C4F567,earnings,100,50,1/29/2019
C4F567,earnings,100,50,1/29/2019
C659EB,earnings,100,50,1/29/2019
C66B44,earnings,100,50,1/29/2019
C72B8F,conference-organizer,100,57,1/29/2019
C72B8F,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C81E00,earnings,100,50,1/29/2019
C9732E,clinical-trials-positive,100,87,1/29/2019
C9C62A,earnings,100,50,1/29/2019
CBCC6A,executive-appointment,100,54,1/29/2019
CBFFDD,legal-issues-defendant,100,22,1/29/2019
CD06A2,executive-appointment,100,54,1/29/2019
CEC08B,unit-acquisition-acquirer,100,49,1/29/2019
D5B13D,business-contract,100,69,1/29/2019
D70365,conference-call,100,50,1/29/2019
D77F7E,merger,100,66,1/29/2019
D8442A,earnings,100,50,1/29/2019
D8442A,earnings,100,50,1/29/2019
D8442A,earnings,100,50,1/29/2019
D854DD,earnings,100,50,1/29/2019
D9CAF0,earnings,100,50,1/29/2019
DA90E1,earnings,100,50,1/29/2019
DB396B,conference-call,100,50,1/29/2019
DB7FA7,earnings-positive,100,69,1/29/2019
DB7FA7,earnings,100,50,1/29/2019
DB7FA7,earnings,100,50,1/29/2019
DB7FA7,earnings,100,50,1/29/2019
DB7FA7,earnings,100,50,1/29/2019
DB7FA7,earnings,100,50,1/29/2019
DB7FA7,earnings,100,50,1/29/2019
DB7FA7,earnings,100,50,1/29/2019
DC486E,earnings,100,50,1/29/2019
DEF058,earnings-up,100,71,1/29/2019
E0207A,executive-appointment,100,54,1/29/2019
E09E2B,legal-issues-defendant,100,22,1/29/2019
E11C41,executive-appointment,100,54,1/29/2019
E124EB,earnings,100,50,1/29/2019
E15736,conference-call,100,50,1/29/2019
E15736,conference-call,100,50,1/29/2019
E1BD05,revenue-up,100,79,1/29/2019
E1BD05,revenue-up,100,79,1/29/2019
E28D9C,executive-appointment,100,54,1/29/2019
E35610,legal-issues-defendant,100,22,1/29/2019
E3E68E,legal-issues-defendant,100,22,1/29/2019
E4CE73,product-release,100,64,1/29/2019
E6D89E,earnings,100,50,1/29/2019
E6D89E,earnings,100,50,1/29/2019
E6D89E,earnings,100,50,1/29/2019
E6D89E,earnings,100,50,1/29/2019
E70531,facility-upgrade,100,65,1/29/2019
E8A49A,earnings,100,50,1/29/2019
E8B21D,earnings-up,100,68,1/29/2019
E8B21D,earnings,100,50,1/29/2019
E8B21D,earnings,100,50,1/29/2019
E8B21D,earnings,100,50,1/29/2019
E8B21D,earnings,100,50,1/29/2019
E8B21D,earnings,100,50,1/29/2019
E9E6FD,earnings,100,50,1/29/2019
EC99D0,earnings,100,50,1/29/2019
EC99D0,dividend-up,100,81,1/29/2019
ED2EFD,dividend,100,50,1/29/2019
ED9576,earnings,100,50,1/29/2019
EE1E44,earnings-up,100,68,1/29/2019
EE1E44,earnings-up,100,68,1/29/2019
EE1E44,earnings-up,100,68,1/29/2019
EE1E44,earnings-up,100,68,1/29/2019
EE1E44,earnings-up,100,68,1/29/2019
EE1E44,earnings-up,100,68,1/29/2019
EE6F1C,earnings-up,100,68,1/29/2019
EE6F1C,earnings,100,50,1/29/2019
EE6F1C,earnings,100,50,1/29/2019
F04E05,earnings,100,50,1/29/2019
F0A9DE,earnings,100,50,1/29/2019
F0B2B5,legal-issues-defendant,100,22,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F294DD,earnings,100,50,1/29/2019
F2E253,facility-open,100,65,1/29/2019
F30508,clinical-trials,100,56,1/29/2019
F40EE2,earnings,100,50,1/29/2019
F43A11,index-listing,100,76,1/29/2019
F57F6F,business-contract,100,69,1/29/2019
F5A214,earnings,100,50,1/29/2019
F5A214,earnings,100,50,1/29/2019
F5A214,earnings,100,50,1/29/2019
F5A214,earnings,100,50,1/29/2019
F8BA6C,legal-issues-defendant,100,22,1/29/2019
F8BA6C,legal-issues-defendant,100,22,1/29/2019
F8BA6C,legal-issues-defendant,100,22,1/29/2019
F9CAF8,earnings,100,50,1/29/2019
F9CAF8,earnings,100,50,1/29/2019
F9CAF8,earnings,100,50,1/29/2019
FADF1A,conference-call,100,50,1/29/2019
FD4588,earnings,100,50,1/29/2019
FD9A97,dividend,100,50,1/29/2019
03CF95,earnings,100,50,1/30/2019
48590,legal-issues-defendant,100,22,1/30/2019
55018,partnership,100,61,1/30/2019
58828,earnings-per-share-up,100,79,1/30/2019
06EF42,partnership,100,61,1/30/2019
09062E,conference-call,100,50,1/30/2019
0986B5,earnings,100,50,1/30/2019
0A748B,acquisition-acquirer,100,49,1/30/2019
0B2071,earnings-up,100,68,1/30/2019
0B2071,earnings,100,50,1/30/2019
0B4D10,earnings,100,50,1/30/2019
0BD970,executive-appointment,100,54,1/30/2019
1096C6,partnership,100,61,1/30/2019
1096C6,partnership,100,61,1/30/2019
11074E,earnings,100,50,1/30/2019
126F95,earnings,100,50,1/30/2019
126F95,earnings,100,50,1/30/2019
126F95,earnings,100,50,1/30/2019
126F95,earnings,100,50,1/30/2019
12DE76,conference-call,100,50,1/30/2019
12E454,earnings,100,50,1/30/2019
1748F6,legal-issues-plaintiff,100,44,1/30/2019
197019,dividend-up,100,81,1/30/2019
1A2D9F,earnings,100,50,1/30/2019
1B4F31,earnings,100,50,1/30/2019
1CF3A8,conference-call,100,50,1/30/2019
1DA44F,dividend-up,100,81,1/30/2019
1E1125,conference-organizer,100,57,1/30/2019
1E1125,conference-organizer,100,57,1/30/2019
1E1125,conference-organizer,100,57,1/30/2019
1E1125,conference-organizer,100,57,1/30/2019
1E9A6D,conference-participant,100,50,1/30/2019
1F9258,business-contract,100,69,1/30/2019
2093B1,earnings,100,50,1/30/2019
2093B1,earnings,100,50,1/30/2019
2093B1,earnings,100,50,1/30/2019
221783,conference-participant,100,50,1/30/2019
25102A,acquisition-interest-acquirer,100,46,1/30/2019
25102A,acquisition-interest-acquirer,100,46,1/30/2019
25102A,acquisition-interest-acquirer,100,46,1/30/2019
25102A,earnings,100,50,1/30/2019
25102A,dividend,100,50,1/30/2019
251988,earnings,100,50,1/30/2019
251988,earnings,100,50,1/30/2019
251988,earnings,100,50,1/30/2019
251988,earnings,100,50,1/30/2019
251988,earnings,100,50,1/30/2019
251988,earnings,100,50,1/30/2019
251988,earnings,100,50,1/30/2019
251988,partnership,100,61,1/30/2019
2571FA,conference-participant,100,50,1/30/2019
25AB8E,conference-call,100,50,1/30/2019
25DD05,dividend,100,50,1/30/2019
264EB3,earnings,100,50,1/30/2019
264EB3,earnings,100,50,1/30/2019
267718,earnings,100,50,1/30/2019
270305,earnings,100,50,1/30/2019
270305,earnings,100,50,1/30/2019
270305,earnings,100,50,1/30/2019
270305,earnings,100,50,1/30/2019
270305,dividend,100,50,1/30/2019
2720AB,earnings,100,50,1/30/2019
27BFA1,earnings,100,50,1/30/2019
2B0AF4,earnings,100,50,1/30/2019
2BBE62,earnings,100,50,1/30/2019
2F1299,dividend,100,50,1/30/2019
2F94A5,earnings,100,50,1/30/2019
31553A,earnings,100,50,1/30/2019
3224CC,earnings,100,50,1/30/2019
34E9F9,conference-call,100,50,1/30/2019
3696BF,earnings-positive,100,69,1/30/2019
3696BF,earnings,100,50,1/30/2019
3696BF,earnings,100,50,1/30/2019
3696BF,earnings,100,50,1/30/2019
3696BF,earnings,100,50,1/30/2019
3696BF,earnings,100,50,1/30/2019
3696BF,earnings,100,50,1/30/2019
37020C,earnings,100,50,1/30/2019
37020C,earnings,100,50,1/30/2019
37020C,earnings,100,50,1/30/2019
37020C,earnings,100,50,1/30/2019
37020C,earnings,100,50,1/30/2019
37020C,earnings,100,50,1/30/2019
371B0A,conference-call,100,50,1/30/2019
3A3447,dividend,100,50,1/30/2019
3B20AB,earnings,100,50,1/30/2019
3C3B6B,executive-appointment,100,54,1/30/2019
3C7F5F,partnership,100,61,1/30/2019
4017AD,earnings,100,50,1/30/2019
450ECB,earnings,100,50,1/30/2019
46017C,conference-call,100,50,1/30/2019
460C93,conference-participant,100,50,1/30/2019
47752F,earnings,100,50,1/30/2019
4885C8,dividend,100,50,1/30/2019
49BBBC,legal-issues-defendant,100,22,1/30/2019
4C6C63,earnings,100,50,1/30/2019
4C6C63,debt-extension-recipient,100,73,1/30/2019
4E2D94,earnings,100,50,1/30/2019
4E2D94,dividend,100,50,1/30/2019
4FCC78,conference-call,100,50,1/30/2019
50070E,conference-organizer,100,57,1/30/2019
50070E,conference-organizer,100,57,1/30/2019
50070E,legal-issues-defendant,100,22,1/30/2019
514067,legal-issues-defendant,100,22,1/30/2019
525A1C,earnings,100,50,1/30/2019
525A1C,earnings,100,50,1/30/2019
525A1C,earnings,100,50,1/30/2019
525A1C,earnings,100,50,1/30/2019
525A1C,earnings,100,50,1/30/2019
525A1C,earnings,100,50,1/30/2019
54A646,buybacks,100,74,1/30/2019
54A646,dividend,100,50,1/30/2019
55438C,earnings-up,100,68,1/30/2019
55438C,earnings-up,100,68,1/30/2019
55438C,earnings-up,100,68,1/30/2019
55438C,earnings-up,100,68,1/30/2019
55438C,earnings-up,100,68,1/30/2019
5704AC,earnings,100,50,1/30/2019
57634F,earnings,100,50,1/30/2019
57B174,conference-call,100,50,1/30/2019
57DDB9,merger,100,66,1/30/2019
57DDB9,merger,100,66,1/30/2019
57F3DA,earnings,100,50,1/30/2019
586BD7,legal-issues-defendant,100,22,1/30/2019
587EDF,earnings,100,50,1/30/2019
589F5A,earnings,100,50,1/30/2019
5B6C11,earnings,100,50,1/30/2019
5EF130,earnings,100,50,1/30/2019
5EF130,earnings,100,50,1/30/2019
5EF130,earnings,100,50,1/30/2019
60DD84,revenues,100,50,1/30/2019
60DD84,revenues,100,50,1/30/2019
60DD84,revenues,100,50,1/30/2019
61B81B,acquisition-acquiree,100,76,1/30/2019
63E8D5,earnings,100,50,1/30/2019
63F892,partnership,100,61,1/30/2019
64854A,earnings,100,50,1/30/2019
662682,earnings,100,50,1/30/2019
662682,dividend,100,50,1/30/2019
66ECFD,earnings,100,50,1/30/2019
673C9A,conference-call,100,50,1/30/2019
67529E,earnings-positive,100,69,1/30/2019
67529E,earnings-positive,100,69,1/30/2019
67529E,earnings-positive,100,69,1/30/2019
67529E,earnings-positive,100,69,1/30/2019
67529E,earnings-positive,100,69,1/30/2019
67529E,earnings-positive,100,69,1/30/2019
67529E,earnings-positive,100,69,1/30/2019
67529E,earnings-positive,100,69,1/30/2019
69C99E,clinical-trials-start,100,64,1/30/2019
6ACFBF,earnings,100,50,1/30/2019
6D1ADF,conference-call,100,50,1/30/2019
6EB9DA,dividend,100,50,1/30/2019
6ED519,conference-call,100,50,1/30/2019
6F3FA8,conference-call,100,50,1/30/2019
722DE3,earnings-up,100,68,1/30/2019
722DE3,earnings,100,50,1/30/2019
728737,earnings,100,50,1/30/2019
731675,conference-call,100,50,1/30/2019
7.44E+09,dividend,100,50,1/30/2019
75768D,executive-appointment,100,54,1/30/2019
762A3E,conference-organizer,100,57,1/30/2019
76CEFB,public-offering,100,43,1/30/2019
7A10FF,earnings,100,50,1/30/2019
7A3633,earnings,100,50,1/30/2019
7AB859,earnings,100,50,1/30/2019
7B6C88,earnings,100,50,1/30/2019
7D7716,earnings,100,50,1/30/2019
7E3F8F,earnings,100,50,1/30/2019
7E62B5,earnings,100,50,1/30/2019
81222C,earnings,100,50,1/30/2019
824CCA,earnings,100,50,1/30/2019
83598E,earnings,100,50,1/30/2019
84AB66,earnings-positive,100,69,1/30/2019
855DF7,conference-call,100,50,1/30/2019
8665BA,earnings,100,50,1/30/2019
86BAC7,earnings,100,50,1/30/2019
86BAC7,earnings,100,50,1/30/2019
890FF4,conference-call,100,50,1/30/2019
8B3B0E,partnership,100,61,1/30/2019
8BAA15,earnings,100,50,1/30/2019
8DCBBB,earnings,100,50,1/30/2019
8DE74B,dividend,100,50,1/30/2019
8E93A4,dividend,100,50,1/30/2019
8EF425,earnings,100,50,1/30/2019
8EF425,earnings,100,50,1/30/2019
8EF425,earnings,100,50,1/30/2019
8EF425,earnings,100,50,1/30/2019
8EF425,earnings,100,50,1/30/2019
8EF425,earnings,100,50,1/30/2019
8FE7A5,earnings,100,50,1/30/2019
902670,executive-appointment,100,54,1/30/2019
902670,dividend,100,50,1/30/2019
93D207,earnings,100,50,1/30/2019
943239,earnings,100,50,1/30/2019
94563D,partnership,100,61,1/30/2019
9.54E+32,earnings,100,50,1/30/2019
965360,earnings,100,50,1/30/2019
97AAF6,product-release,100,64,1/30/2019
97AAF6,earnings,100,50,1/30/2019
986AF6,capex-up,100,65,1/30/2019
990AD0,dividend,100,50,1/30/2019
9.92E+94,earnings,100,50,1/30/2019
9.92E+94,earnings,100,50,1/30/2019
9.92E+94,earnings,100,50,1/30/2019
9A02C4,earnings,100,50,1/30/2019
9A02C4,dividend,100,50,1/30/2019
9C8664,earnings,100,50,1/30/2019
9C8664,earnings,100,50,1/30/2019
9C8664,earnings,100,50,1/30/2019
9C8664,earnings,100,50,1/30/2019
9C8664,earnings,100,50,1/30/2019
9C8664,earnings,100,50,1/30/2019
9DDE1B,public-offering,100,43,1/30/2019
9E91C6,earnings,100,50,1/30/2019
9F18FA,note-sale,100,52,1/30/2019
9F18FA,note-sale,100,52,1/30/2019
A0F146,conference-call,100,50,1/30/2019
A15C71,facility-open,100,65,1/30/2019
A247F5,earnings-per-share-positive,100,69,1/30/2019
A247F5,earnings-per-share-positive,100,69,1/30/2019
A247F5,earnings-per-share-positive,100,69,1/30/2019
A429A5,earnings,100,50,1/30/2019
A495F7,product-release,100,64,1/30/2019
A5A4F5,acquisition-acquirer,100,49,1/30/2019
A65325,dividend,100,50,1/30/2019
A6ABE9,earnings,100,50,1/30/2019
A70BF5,earnings,100,50,1/30/2019
A70BF5,earnings,100,50,1/30/2019
A70BF5,earnings,100,50,1/30/2019
A70BF5,earnings,100,50,1/30/2019
A70BF5,earnings,100,50,1/30/2019
A70BF5,earnings,100,50,1/30/2019
A70BF5,earnings,100,50,1/30/2019
A8CBDA,conference-participant,100,50,1/30/2019
AADE0B,dividend-up,100,81,1/30/2019
AB7F05,earnings,100,50,1/30/2019
AC3584,facility-open,100,65,1/30/2019
AC7C4F,acquisition-acquirer,100,49,1/30/2019
AECCA9,note-sale,100,52,1/30/2019
AFF7B4,partnership,100,61,1/30/2019
B08954,earnings,100,50,1/30/2019
B0FE08,dividend,100,50,1/30/2019
B96637,conference-call,100,50,1/30/2019
BB88B6,earnings,100,50,1/30/2019
BB88B6,earnings,100,50,1/30/2019
BB88B6,earnings,100,50,1/30/2019
BB88B6,earnings,100,50,1/30/2019
BB88B6,earnings,100,50,1/30/2019
BB88B6,earnings,100,50,1/30/2019
BB88B6,earnings,100,50,1/30/2019
BBAE2A,dividend-up,100,61,1/30/2019
BD8517,earnings,100,50,1/30/2019
BE14CF,trading-resumed,100,58,1/30/2019
BE7BA4,conference-call,100,50,1/30/2019
BE86A1,earnings-up,100,68,1/30/2019
C1114B,conference-call,100,50,1/30/2019
C188F8,earnings,100,50,1/30/2019
C66A8C,earnings,100,50,1/30/2019
C7AE14,earnings,100,50,1/30/2019
C951A2,earnings,100,50,1/30/2019
C951A2,earnings,100,50,1/30/2019
C951A2,earnings,100,50,1/30/2019
C951A2,earnings,100,50,1/30/2019
C951A2,earnings,100,50,1/30/2019
C98CDB,partnership,100,61,1/30/2019
C99CC8,partnership,100,61,1/30/2019
CB9E13,conference-call,100,50,1/30/2019
CC339B,earnings,100,50,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CD4DA8,earnings-up,100,68,1/30/2019
CE1002,business-contract,100,69,1/30/2019
CEC5B9,product-release,100,64,1/30/2019
CFF15D,earnings,100,50,1/30/2019
CFF15D,earnings,100,50,1/30/2019
CFF97C,dividend-up,100,64,1/30/2019
D06755,earnings,100,50,1/30/2019
D1AE3B,executive-appointment,100,54,1/30/2019
D1C26F,executive-appointment,100,54,1/30/2019
D33D8C,buybacks,100,74,1/30/2019
D437C3,executive-appointment,100,54,1/30/2019
D48275,earnings,100,50,1/30/2019
D54E62,dividend-up,100,81,1/30/2019
D5A350,earnings,100,50,1/30/2019
D8DBA3,operating-earnings,100,50,1/30/2019
DBCA3F,partnership,100,61,1/30/2019
DC2F77,dividend,100,50,1/30/2019
DCD97F,earnings,100,50,1/30/2019
DCD97F,business-contract,100,69,1/30/2019
DCD97F,business-contract,100,69,1/30/2019
DD3BB1,earnings,100,50,1/30/2019
DDC415,earnings,100,50,1/30/2019
DF11D9,earnings,100,50,1/30/2019
DF11D9,earnings,100,50,1/30/2019
DF11D9,earnings,100,50,1/30/2019
DF11D9,earnings,100,50,1/30/2019
DF11D9,earnings,100,50,1/30/2019
DF11D9,earnings,100,50,1/30/2019
DF11D9,earnings,100,50,1/30/2019
E10D31,executive-appointment,100,54,1/30/2019
E5752F,partnership,100,61,1/30/2019
E5F0A8,earnings-positive,100,69,1/30/2019
E5F0A8,earnings,100,50,1/30/2019
E5F0A8,earnings,100,50,1/30/2019
E5F0A8,earnings,100,50,1/30/2019
E5F0A8,earnings,100,50,1/30/2019
E70531,dividend,100,50,1/30/2019
E71AE6,public-offering,100,43,1/30/2019
E829E8,earnings-per-share-positive,100,69,1/30/2019
E829E8,earnings-per-share-positive,100,69,1/30/2019
E829E8,earnings-per-share-positive,100,69,1/30/2019
E829E8,earnings-per-share-positive,100,69,1/30/2019
E866D2,dividend,100,50,1/30/2019
E8846E,conference-participant,100,50,1/30/2019
E90C84,conference-call,100,50,1/30/2019
E96E0B,conference-call,100,50,1/30/2019
EB6965,campaign-ad-release,100,59,1/30/2019
EE74E1,executive-resignation,100,44,1/30/2019
EE74E1,earnings-per-share,100,50,1/30/2019
EE74E1,earnings-per-share,100,50,1/30/2019
EE74E1,earnings-per-share,100,50,1/30/2019
EEA6B3,acquisition-completed-acquirer,100,49,1/30/2019
EEEA9F,earnings,100,50,1/30/2019
EF45B6,earnings,100,50,1/30/2019
EFD406,conference-call,100,50,1/30/2019
F0B2B5,conference-call,100,50,1/30/2019
F2E253,dividend,100,50,1/30/2019
F31B13,dividend-up,100,72,1/30/2019
F3FCC3,revenues,100,50,1/30/2019
F3FCC3,earnings,100,50,1/30/2019
F3FCC3,earnings,100,50,1/30/2019
F3FCC3,earnings,100,50,1/30/2019
F4F46F,conference-participant,100,50,1/30/2019
F50BAB,earnings,100,50,1/30/2019
F51DB0,conference-call,100,50,1/30/2019
F5349B,executive-appointment,100,54,1/30/2019
F7902B,earnings,100,50,1/30/2019
F7902B,earnings,100,50,1/30/2019
F8084B,earnings-per-share-positive,100,69,1/30/2019
F8084B,earnings,100,50,1/30/2019
F8084B,earnings,100,50,1/30/2019
F8084B,earnings,100,50,1/30/2019
FA918D,executive-appointment,100,54,1/30/2019
FACCF6,executive-appointment,100,54,1/30/2019
FD4E8D,revenue-up,100,69,1/30/2019
FD4E8D,earnings,100,50,1/30/2019
FD4E8D,earnings,100,50,1/30/2019
FD9A97,earnings,100,50,1/30/2019
FE89E0,dividend,100,50,1/30/2019
FEC475,executive-appointment,100,54,1/30/2019
001F1B,executive-appointment,100,54,1/31/2019
9397,earnings,100,50,1/31/2019
13528,executive-appointment,100,54,1/31/2019
0142B5,earnings-per-share-positive,100,69,1/31/2019
01478A,earnings,100,50,1/31/2019
0157B1,revenue-up,100,70,1/31/2019
0157B1,revenue-up,100,70,1/31/2019
0157B1,revenue-up,100,70,1/31/2019
0157B1,revenue-up,100,70,1/31/2019
0157B1,revenue-up,100,70,1/31/2019
0157B1,revenue-up,100,70,1/31/2019
0157B1,revenue-up,100,70,1/31/2019
03B8CF,business-contract,100,69,1/31/2019
48590,legal-issues-defendant,100,22,1/31/2019
48590,legal-issues-defendant,100,22,1/31/2019
054B55,trading-delisting,100,36,1/31/2019
55018,dividend,100,50,1/31/2019
070B45,earnings,100,50,1/31/2019
07CA6A,earnings,100,50,1/31/2019
07CA6A,earnings,100,50,1/31/2019
07EC43,award,100,58,1/31/2019
0BC17A,dividend-up,100,71,1/31/2019
0BC17A,earnings,100,50,1/31/2019
0BC853,earnings,100,50,1/31/2019
0BF528,conference-call,100,50,1/31/2019
0CE204,earnings,100,50,1/31/2019
0D26E0,earnings-positive,100,69,1/31/2019
0D26E0,earnings-up,100,68,1/31/2019
0D26E0,earnings-up,100,68,1/31/2019
0D26E0,earnings-up,100,68,1/31/2019
0D26E0,earnings-up,100,68,1/31/2019
0ED415,earnings,100,50,1/31/2019
0F0440,donation,100,54,1/31/2019
105D00,dividend,100,50,1/31/2019
108BD2,earnings-positive,100,69,1/31/2019
108BD2,earnings,100,50,1/31/2019
108BD2,earnings,100,50,1/31/2019
108BD2,earnings,100,50,1/31/2019
108BD2,earnings,100,50,1/31/2019
1151F4,earnings,100,50,1/31/2019
1151F4,earnings,100,50,1/31/2019
1151F4,earnings,100,50,1/31/2019
1151F4,earnings,100,50,1/31/2019
1151F4,earnings,100,50,1/31/2019
1151F4,earnings,100,50,1/31/2019
1151F4,earnings,100,50,1/31/2019
1201B5,earnings,100,50,1/31/2019
159AE4,earnings,100,50,1/31/2019
17EDA5,executive-appointment,100,54,1/31/2019
182B8C,earnings,100,50,1/31/2019
188394,earnings-guidance-up,100,83,1/31/2019
19C105,conference-participant,100,50,1/31/2019
1A6A94,conference-call,100,50,1/31/2019
1DB6A6,earnings,100,50,1/31/2019
1DB6A6,earnings,100,50,1/31/2019
1DB6A6,earnings,100,50,1/31/2019
1DB6A6,earnings,100,50,1/31/2019
1DB6A6,earnings,100,50,1/31/2019
1DB6A6,earnings,100,50,1/31/2019
1E1125,conference-organizer,100,57,1/31/2019
1E1125,conference-organizer,100,57,1/31/2019
1FAF22,earnings,100,50,1/31/2019
219B21,earnings,100,50,1/31/2019
219B21,earnings,100,50,1/31/2019
219B21,earnings,100,50,1/31/2019
219B21,earnings,100,50,1/31/2019
219B21,earnings,100,50,1/31/2019
219B21,earnings,100,50,1/31/2019
221445,dividend,100,50,1/31/2019
228D42,partnership,100,61,1/31/2019
23207A,conference-call,100,50,1/31/2019
238302,public-offering,100,43,1/31/2019
24C48B,acquisition-acquirer,100,49,1/31/2019
25D3CE,partnership,100,61,1/31/2019
270305,earnings-up,100,68,1/31/2019
27BFA1,dividend,100,50,1/31/2019
28B730,acquisition-completed-acquirer,100,49,1/31/2019
28DCA8,earnings,100,50,1/31/2019
28DCF3,earnings,100,50,1/31/2019
2A17B1,earnings,100,50,1/31/2019
2A17B1,earnings,100,50,1/31/2019
2A17B1,earnings,100,50,1/31/2019
2A17B1,earnings,100,50,1/31/2019
2BA977,earnings,100,50,1/31/2019
2F24A5,partnership,100,61,1/31/2019
2F6782,conference-call,100,50,1/31/2019
306623,conference-call,100,50,1/31/2019
30AB63,index-listing,100,76,1/31/2019
31A7CC,dividend,100,50,1/31/2019
33FD66,earnings,100,50,1/31/2019
366A08,conference-call,100,50,1/31/2019
36E479,earnings,100,50,1/31/2019
3A113F,conference-call,100,50,1/31/2019
3B37F7,conference-organizer,100,57,1/31/2019
3C3B6B,partnership,100,61,1/31/2019
3C7F5F,dividend,100,50,1/31/2019
3ED92D,earnings,100,50,1/31/2019
3ED92D,earnings,100,50,1/31/2019
3ED92D,earnings,100,50,1/31/2019
3ED92D,earnings,100,50,1/31/2019
3ED92D,earnings,100,50,1/31/2019
3ED92D,earnings,100,50,1/31/2019
3ED92D,earnings,100,50,1/31/2019
3ED92D,earnings,100,50,1/31/2019
3F6A9C,conference-call,100,50,1/31/2019
408089,earnings,100,50,1/31/2019
40F7DE,revenue-up,100,69,1/31/2019
41785E,conference-participant,100,50,1/31/2019
41D61C,earnings,100,50,1/31/2019
422A82,earnings,100,50,1/31/2019
422A82,earnings,100,50,1/31/2019
422A82,earnings,100,50,1/31/2019
43A74A,earnings,100,50,1/31/2019
44209A,executive-appointment,100,54,1/31/2019
448215,earnings,100,50,1/31/2019
451D61,conference-call,100,50,1/31/2019
4595EF,earnings,100,50,1/31/2019
45ABCC,earnings,100,50,1/31/2019
47FCF2,earnings,100,50,1/31/2019
485445,conference-participant,100,50,1/31/2019
4885C8,earnings,100,50,1/31/2019
49A344,executive-appointment,100,54,1/31/2019
49BBBC,legal-issues-defendant,100,22,1/31/2019
49F4D0,earnings,100,50,1/31/2019
4A3438,conference-call,100,50,1/31/2019
4A5C8D,earnings,100,50,1/31/2019
4A5C8D,earnings,100,50,1/31/2019
4D7BD8,earnings,100,50,1/31/2019
4E5784,earnings,100,50,1/31/2019
504FE2,conference-participant,100,50,1/31/2019
507AE7,dividend,100,50,1/31/2019
52015A,conference-call,100,50,1/31/2019
53A226,earnings,100,50,1/31/2019
56765E,earnings,100,50,1/31/2019
57EF50,dividend,100,50,1/31/2019
586FFD,revenues,100,50,1/31/2019
586FFD,revenues,100,50,1/31/2019
59C539,earnings,100,50,1/31/2019
5A64D5,earnings,100,50,1/31/2019
5D16CF,conference-call,100,50,1/31/2019
5F3D91,legal-issues-defendant,100,22,1/31/2019
6137BF,earnings,100,50,1/31/2019
641F17,earnings,100,50,1/31/2019
69494C,earnings,100,50,1/31/2019
6B494E,revenues,100,50,1/31/2019
6B5379,earnings,100,50,1/31/2019
6B5379,earnings,100,50,1/31/2019
6B5379,earnings,100,50,1/31/2019
6CF43C,earnings,100,50,1/31/2019
6DDA15,earnings,100,50,1/31/2019
6F92A9,earnings,100,50,1/31/2019
732449,executive-appointment,100,54,1/31/2019
735388,dividend,100,50,1/31/2019
762A3E,conference-organizer,100,57,1/31/2019
7AC86E,dividend,100,50,1/31/2019
7B0BA6,dividend-up,100,59,1/31/2019
7CBC40,earnings,100,50,1/31/2019
7D85A9,earnings,100,50,1/31/2019
7DC1C4,earnings,100,50,1/31/2019
7DD584,earnings,100,50,1/31/2019
7E3F8F,product-release,100,64,1/31/2019
8377DB,acquisition-completed-acquirer,100,49,1/31/2019
858942,earnings,100,50,1/31/2019
86BAC7,dividend,100,50,1/31/2019
89F693,earnings,100,50,1/31/2019
89F693,earnings,100,50,1/31/2019
89F693,executive-appointment,100,54,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8B1F37,earnings,100,50,1/31/2019
8D4486,conference-organizer,100,57,1/31/2019
8D9993,earnings-up,100,57,1/31/2019
8D9993,earnings-up,100,57,1/31/2019
8D9993,earnings-up,100,57,1/31/2019
8D9993,earnings-up,100,57,1/31/2019
8DE56F,earnings,100,50,1/31/2019
8DE56F,earnings,100,50,1/31/2019
8DE74B,conference-call,100,50,1/31/2019
8E0E32,earnings,100,50,1/31/2019
8F3231,unit-acquisition-acquirer,100,49,1/31/2019
9087B9,dividend,100,50,1/31/2019
9196A2,conference-organizer,100,57,1/31/2019
922F0C,earnings-per-share-up,100,68,1/31/2019
949625,earnings,100,50,1/31/2019
965360,executive-appointment,100,54,1/31/2019
979451,earnings,100,50,1/31/2019
98CEBB,business-contract,100,69,1/31/2019
990AD0,conference-organizer,100,57,1/31/2019
9.97E+09,earnings,100,50,1/31/2019
9.97E+09,acquisition-acquirer,100,49,1/31/2019
9B5968,earnings,100,50,1/31/2019
9B5968,earnings,100,50,1/31/2019
9D6A24,earnings,100,50,1/31/2019
9D6A24,earnings,100,50,1/31/2019
9E298A,earnings,100,50,1/31/2019
9E298A,earnings,100,50,1/31/2019
9E298A,earnings,100,50,1/31/2019
9E3224,earnings,100,50,1/31/2019
9F03CF,earnings,100,50,1/31/2019
9F03CF,dividend,100,50,1/31/2019
9F5CBB,dividend,100,50,1/31/2019
A01664,conference-participant,100,50,1/31/2019
A02FB1,earnings,100,50,1/31/2019
A1EAC8,business-contract,100,69,1/31/2019
A3AAA5,dividend,100,50,1/31/2019
A41450,earnings,100,50,1/31/2019
A4386C,dividend,100,50,1/31/2019
A5A4F5,acquisition-acquirer,100,49,1/31/2019
A5E715,earnings-per-share-up,100,75,1/31/2019
A5E715,earnings,100,50,1/31/2019
A5E715,earnings,100,50,1/31/2019
A5E715,earnings,100,50,1/31/2019
A5E715,earnings,100,50,1/31/2019
A5E715,earnings,100,50,1/31/2019
A5E715,earnings,100,50,1/31/2019
A63387,product-release,100,64,1/31/2019
A6828A,partnership,100,61,1/31/2019
A6828A,business-contract,100,69,1/31/2019
A6828A,partnership,100,61,1/31/2019
A6828A,settlement,100,56,1/31/2019
A6828A,settlement,100,56,1/31/2019
A75D43,earnings,100,50,1/31/2019
A7F0A5,conference-call,100,50,1/31/2019
A806FA,dividend,100,50,1/31/2019
A8B137,dividend-up,100,81,1/31/2019
AADE0B,earnings,100,50,1/31/2019
ABBAD1,earnings,100,50,1/31/2019
AD3C93,earnings,100,50,1/31/2019
ADF1B0,executive-appointment,100,54,1/31/2019
AECCA9,conference-call,100,50,1/31/2019
AFF7B4,conference-participant,100,50,1/31/2019
B0B969,earnings,100,50,1/31/2019
B290A2,executive-appointment,100,54,1/31/2019
B290A2,executive-appointment,100,54,1/31/2019
B381D8,earnings,100,50,1/31/2019
B614F8,public-offering,100,43,1/31/2019
BB07E4,dividend,100,50,1/31/2019
BCC55F,conference-call,100,50,1/31/2019
BDD12C,award,100,58,1/31/2019
BF5959,public-offering,100,43,1/31/2019
BF79F5,conference-call,100,50,1/31/2019
C0200F,earnings,100,50,1/31/2019
C062D4,earnings,100,50,1/31/2019
C062D4,earnings,100,50,1/31/2019
C062D4,earnings,100,50,1/31/2019
C062D4,earnings,100,50,1/31/2019
C062D4,earnings,100,50,1/31/2019
C062D4,earnings,100,50,1/31/2019
C062D4,earnings,100,50,1/31/2019
C0BA36,earnings,100,50,1/31/2019
C0BA36,earnings,100,50,1/31/2019
C0BA36,earnings,100,50,1/31/2019
C0BA36,earnings,100,50,1/31/2019
C2609A,dividend,100,50,1/31/2019
C356AC,unit-acquisition-acquiree,100,76,1/31/2019
C5D2AE,earnings,100,50,1/31/2019
C5F463,merger-completed,100,66,1/31/2019
C5F463,merger-completed,100,66,1/31/2019
C5F463,merger-completed,100,66,1/31/2019
C8A248,earnings,100,50,1/31/2019
C97B2D,product-release,100,64,1/31/2019
CA1620,conference-call,100,50,1/31/2019
CAB222,product-release,100,64,1/31/2019
CBFFDD,legal-issues-defendant,100,22,1/31/2019
CCBBAD,earnings,100,50,1/31/2019
CEC5B9,earnings,100,50,1/31/2019
CEC5B9,earnings,100,50,1/31/2019
D1C0B9,revenue-up,100,69,1/31/2019
D1C0B9,revenue-up,100,69,1/31/2019
D1C0B9,revenue-up,100,69,1/31/2019
D1C0B9,revenue-up,100,69,1/31/2019
D3FA2C,dividend,100,50,1/31/2019
D4070C,earnings,100,50,1/31/2019
D56D6D,earnings,100,50,1/31/2019
D5AF19,conference-participant,100,50,1/31/2019
D6489C,conference-organizer,100,57,1/31/2019
D6534D,conference-call,100,50,1/31/2019
D65A13,revenue-up,100,73,1/31/2019
D65A13,revenue-up,100,69,1/31/2019
D721C6,earnings,100,50,1/31/2019
D78CCD,executive-appointment,100,54,1/31/2019
D88EF3,earnings,100,50,1/31/2019
D88EF3,earnings,100,50,1/31/2019
D88EF3,earnings,100,50,1/31/2019
D88EF3,earnings,100,50,1/31/2019
D88EF3,earnings,100,50,1/31/2019
D88EF3,earnings,100,50,1/31/2019
D88EF3,earnings,100,50,1/31/2019
D93A25,executive-appointment,100,54,1/31/2019
DBB28E,executive-appointment,100,54,1/31/2019
DC2F77,earnings,100,50,1/31/2019
DC5299,operating-earnings,100,50,1/31/2019
DD0F15,executive-appointment,100,54,1/31/2019
DE4924,dividend,100,50,1/31/2019
DE4924,earnings,100,50,1/31/2019
DF42A0,conference-call,100,50,1/31/2019
E114F4,earnings,100,50,1/31/2019
E114F4,earnings,100,50,1/31/2019
E114F4,earnings,100,50,1/31/2019
E114F4,earnings,100,50,1/31/2019
E4CE73,conference-call,100,50,1/31/2019
E6A53A,dividend,100,50,1/31/2019
E8E899,partnership,100,61,1/31/2019
E959F3,dividend,100,50,1/31/2019
EC70EC,earnings,100,50,1/31/2019
ED0402,earnings,100,50,1/31/2019
ED0D7C,conference-call,100,50,1/31/2019
ED7F13,earnings,100,50,1/31/2019
ED9576,dividend,100,50,1/31/2019
EF5BED,ownership-increase-owner,100,56,1/31/2019
F0A9DE,buybacks,100,74,1/31/2019
F11638,earnings,100,50,1/31/2019
F15E41,legal-issues-defendant,100,22,1/31/2019
F46EC9,revenue-up,100,69,1/31/2019
F46EC9,revenue-up,100,69,1/31/2019
F46EC9,revenue-up,100,69,1/31/2019
F46EC9,revenue-up,100,69,1/31/2019
F46EC9,revenue-up,100,69,1/31/2019
F46EC9,revenue-up,100,69,1/31/2019
F46EC9,revenue-up,100,69,1/31/2019
F58C23,conference-organizer,100,57,1/31/2019
F8BA6C,legal-issues-defendant,100,22,1/31/2019
F8BA6C,legal-issues-defendant,100,22,1/31/2019
F8BA6C,legal-issues-defendant,100,22,1/31/2019
FA918D,earnings,100,50,1/31/2019
FA918D,earnings,100,50,1/31/2019
FBDA0F,earnings,100,50,1/31/2019
FC1B7B,earnings,100,50,1/31/2019
FC1F9D,earnings-up,100,68,1/31/2019
FD4BBE,earnings,100,50,1/31/2019
FE7A63,note-sale,100,52,1/31/2019
FE89E0,earnings,100,50,1/31/2019
FEE4B0,earnings,100,50,1/31/2019
FEE4B0,earnings,100,50,1/31/2019
FEE4B0,earnings,100,50,1/31/2019
FEE4B0,earnings,100,50,1/31/2019
FEE4B0,earnings,100,50,1/31/2019
FF5413,earnings-positive,100,69,1/31/2019
FF5413,earnings-positive,100,69,1/31/2019
FF5413,business-contract,100,69,1/31/2019
FFE543,earnings,100,50,1/31/2019
02870F,conference-call,100,50,2/1/2019
03B8CF,unit-acquisition-acquirer,100,49,2/1/2019
07CA6A,product-release,100,64,2/1/2019
07CA6A,product-release,100,64,2/1/2019
0C2A0D,earnings,100,50,2/1/2019
0CCCB7,conference-call,100,50,2/1/2019
0E5223,conference-call,100,50,2/1/2019
0F04E5,earnings,100,50,2/1/2019
0FDE97,earnings,100,50,2/1/2019
0FDE97,earnings,100,50,2/1/2019
0FDE97,earnings,100,50,2/1/2019
0FDE97,earnings,100,50,2/1/2019
0FDE97,earnings,100,50,2/1/2019
0FDE97,earnings,100,50,2/1/2019
0FDE97,earnings,100,50,2/1/2019
129DC8,asset-sale,100,62,2/1/2019
139303,earnings,100,50,2/1/2019
139303,earnings,100,50,2/1/2019
14391F,note-sale,100,52,2/1/2019
1921DD,unit-acquisition-completed-acquiree,100,67,2/1/2019
1921DD,legal-issues-defendant,100,22,2/1/2019
1A5D5D,credit-extension-recipient,100,69,2/1/2019
1BDB2A,acquisition-completed-acquirer,100,49,2/1/2019
1E1125,conference-organizer,100,57,2/1/2019
1E1125,conference-organizer,100,57,2/1/2019
1E1125,conference-organizer,100,57,2/1/2019
1EBF8D,earnings,100,50,2/1/2019
20BEEA,stake-acquirer,100,48,2/1/2019
22C58E,conference-participant,100,50,2/1/2019
24CB56,earnings,100,50,2/1/2019
28DCF3,operating-earnings,100,50,2/1/2019
2BF36E,conference-call,100,50,2/1/2019
2C3348,regulatory-product-approval-granted,100,81,2/1/2019
31AA84,award,100,58,2/1/2019
353DBB,earnings,100,50,2/1/2019
353DBB,earnings,100,50,2/1/2019
353DBB,earnings,100,50,2/1/2019
4.03E+05,unit-acquisition-completed-acquirer,100,49,2/1/2019
41A93D,earnings,100,50,2/1/2019
49BBBC,legal-issues-defendant,100,22,2/1/2019
49BBBC,legal-issues-defendant,100,22,2/1/2019
4C6C63,acquisition-completed-acquirer,100,49,2/1/2019
4D371E,dividend,100,50,2/1/2019
4F9926,partnership,100,61,2/1/2019
50070E,conference-organizer,100,57,2/1/2019
507AE7,executive-appointment,100,54,2/1/2019
51E682,dividend-up,100,81,2/1/2019
545272,executive-appointment,100,54,2/1/2019
553949,earnings,100,50,2/1/2019
56277A,earnings,100,50,2/1/2019
562853,earnings,100,50,2/1/2019
57356F,conference-participant,100,50,2/1/2019
57DDB9,conference-call,100,50,2/1/2019
583223,acquisition-completed-acquiree,100,76,2/1/2019
583223,acquisition-completed-acquiree,100,76,2/1/2019
583223,acquisition-completed-acquiree,100,76,2/1/2019
58B46F,merger-completed,100,66,2/1/2019
58CA9A,executive-appointment,100,54,2/1/2019
58CA9A,executive-appointment,100,54,2/1/2019
5B7739,conference-call,100,50,2/1/2019
5BFE94,conference-call,100,50,2/1/2019
5C8D61,earnings,100,50,2/1/2019
5E6959,executive-appointment,100,54,2/1/2019
5E6959,earnings-up,100,68,2/1/2019
66CB62,acquisition-completed-acquirer,100,49,2/1/2019
68E6E9,acquisition-completed-acquirer,100,49,2/1/2019
6A6BDC,dividend,100,50,2/1/2019
6B236C,dividend-up,100,68,2/1/2019
6D3B7B,dividend,100,50,2/1/2019
6D3B7B,executive-appointment,100,54,2/1/2019
6E7060,dividend,100,50,2/1/2019
6ED519,dividend,100,50,2/1/2019
6F39FC,conference-call,100,50,2/1/2019
7032D0,earnings,100,50,2/1/2019
70FCEF,partnership,100,61,2/1/2019
719B43,acquisition-acquirer,100,49,2/1/2019
726DDF,conference-call,100,50,2/1/2019
726EEA,earnings,100,50,2/1/2019
72EF75,dividend,100,50,2/1/2019
72EF75,buybacks,100,74,2/1/2019
73529F,conference-call,100,50,2/1/2019
743C70,earnings,100,50,2/1/2019
743C70,earnings,100,50,2/1/2019
762A3E,conference-organizer,100,57,2/1/2019
763724,facility-open,100,65,2/1/2019
76BD96,dividend,100,50,2/1/2019
790C34,earnings,100,50,2/1/2019
8195B7,ipo,100,71,2/1/2019
81F4BE,unit-acquisition-acquirer,100,49,2/1/2019
835C86,earnings,100,50,2/1/2019
85AD00,acquisition-completed-acquiree,100,76,2/1/2019
86A1B9,earnings-positive,100,69,2/1/2019
86A1B9,earnings-positive,100,69,2/1/2019
86A1B9,earnings-positive,100,69,2/1/2019
86A1B9,earnings-positive,100,69,2/1/2019
86A1B9,earnings-positive,100,69,2/1/2019
893904,regulatory-product-approval-granted,100,81,2/1/2019
893904,regulatory-product-approval-granted,100,81,2/1/2019
8AC740,conference-call,100,50,2/1/2019
8B4A45,facility-open,100,65,2/1/2019
8BFAA4,executive-appointment,100,54,2/1/2019
8D4486,partnership,100,61,2/1/2019
900356,earnings-up,100,68,2/1/2019
902255,dividend,100,50,2/1/2019
9043FE,acquisition-completed-acquirer,100,49,2/1/2019
9043FE,acquisition-completed-acquirer,100,49,2/1/2019
911ACB,acquisition-completed-acquirer,100,49,2/1/2019
92D9C9,conference-call,100,50,2/1/2019
93AD2E,executive-appointment,100,54,2/1/2019
94563D,earnings,100,50,2/1/2019
958938,conference-call,100,50,2/1/2019
95F59E,earnings,100,50,2/1/2019
965360,unit-acquisition-completed-acquirer,100,49,2/1/2019
966DBE,earnings,100,50,2/1/2019
971F7B,unit-acquisition-acquirer,100,49,2/1/2019
977A1E,earnings,100,50,2/1/2019
9D30A8,conference-participant,100,50,2/1/2019
9D6A24,dividend,100,50,2/1/2019
9F18FA,note-sale,100,52,2/1/2019
9F18FA,note-sale,100,52,2/1/2019
9FA83B,executive-appointment,100,54,2/1/2019
A21649,conference-call,100,50,2/1/2019
A2CA3F,dividend,100,50,2/1/2019
A4BCDE,earnings,100,50,2/1/2019
A5A4F5,acquisition-acquirer,100,49,2/1/2019
A666C8,earnings,100,50,2/1/2019
AA3AB8,dividend,100,50,2/1/2019
AD3008,earnings,100,50,2/1/2019
AE7D16,credit-extension-recipient,100,69,2/1/2019
AECCA9,acquisition-regulatory-approval-acquirer,100,54,2/1/2019
B5BA39,earnings,100,50,2/1/2019
B7EB38,earnings,100,50,2/1/2019
BDE867,operating-earnings,100,50,2/1/2019
BFE02C,conference-participant,100,50,2/1/2019
C15DB3,executive-appointment,100,54,2/1/2019
C6C702,award,100,58,2/1/2019
C6C702,award,100,58,2/1/2019
C74887,executive-appointment,100,54,2/1/2019
C97B2D,hirings,100,65,2/1/2019
CA3CB9,earnings,100,50,2/1/2019
CB22CD,acquisition-completed-acquirer,100,49,2/1/2019
CB22CD,acquisition-completed-acquirer,100,49,2/1/2019
CB22CD,acquisition-completed-acquirer,100,49,2/1/2019
CBBFBF,earnings,100,50,2/1/2019
CBBFBF,earnings,100,50,2/1/2019
CBBFBF,earnings,100,50,2/1/2019
CBBFBF,earnings,100,50,2/1/2019
CBBFBF,earnings,100,50,2/1/2019
CBCC6A,earnings,100,50,2/1/2019
CBCC6A,earnings,100,50,2/1/2019
CBDB4D,business-contract,100,69,2/1/2019
D2E553,acquisition-completed-acquirer,100,49,2/1/2019
D54E62,earnings-positive,100,69,2/1/2019
D54E62,earnings-positive,100,69,2/1/2019
D54E62,earnings-positive,100,69,2/1/2019
D54E62,earnings-positive,100,69,2/1/2019
D598E7,earnings,100,50,2/1/2019
DDB002,legal-issues-defendant,100,22,2/1/2019
DDB002,legal-issues-defendant,100,22,2/1/2019
DDB002,legal-issues-defendant,100,22,2/1/2019
DDB002,legal-issues-defendant,100,22,2/1/2019
E259C7,dividend,100,50,2/1/2019
E35610,legal-issues-defendant,100,22,2/1/2019
E35610,campaign-ad-release,100,59,2/1/2019
E3E68E,legal-issues-defendant,100,22,2/1/2019
E5752F,unit-acquisition-completed-acquiree,100,67,2/1/2019
E5752F,acquisition-completed-acquiree,100,76,2/1/2019
E5752F,acquisition-completed-acquiree,100,76,2/1/2019
E6E012,dividend,100,50,2/1/2019
E6E012,dividend,100,50,2/1/2019
E70531,earnings,100,50,2/1/2019
E70531,earnings,100,50,2/1/2019
E70531,earnings,100,50,2/1/2019
E70531,earnings,100,50,2/1/2019
E70531,earnings,100,50,2/1/2019
ECDEB2,earnings,100,50,2/1/2019
ECDEB2,earnings,100,50,2/1/2019
ED9C04,acquisition-acquirer,100,49,2/1/2019
EEBCEF,dividend,100,50,2/1/2019
EF7163,conference-call,100,50,2/1/2019
F00285,acquisition-completed-acquirer,100,49,2/1/2019
F179ED,acquisition-completed-acquirer,100,49,2/1/2019
F1C04C,dividend,100,50,2/1/2019
F82D37,dividend,100,50,2/1/2019
F8BA6C,legal-issues-defendant,100,22,2/1/2019
FB728F,conference-call,100,50,2/1/2019
FF4BA4,earnings,100,50,2/1/2019
DDB002,legal-issues-defendant,100,22,2/2/2019
003B70,executive-appointment,100,54,2/4/2019
036C6F,earnings,100,50,2/4/2019
03B8CF,legal-issues-defendant,100,22,2/4/2019
03D5F9,unit-acquisition-acquirer,100,49,2/4/2019
04EB2F,unit-acquisition-acquirer,100,49,2/4/2019
71860,conference-participant,100,50,2/4/2019
078D52,revenues,100,50,2/4/2019
078D52,revenues,100,50,2/4/2019
07EC43,conference-participant,100,50,2/4/2019
95294,legal-issues-defendant,100,22,2/4/2019
099C88,conference-participant,100,50,2/4/2019
099C88,business-contract,100,69,2/4/2019
0CBC4D,executive-appointment,100,54,2/4/2019
0F2BC9,conference-call,100,50,2/4/2019
138DDE,public-offering,100,43,2/4/2019
1834C0,unit-acquisition-acquirer,100,49,2/4/2019
1921DD,legal-issues-defendant,100,22,2/4/2019
1921DD,legal-issues-defendant,100,22,2/4/2019
1921DD,merger,100,66,2/4/2019
1D943E,earnings,100,50,2/4/2019
1DDEDA,earnings,100,50,2/4/2019
1E1125,conference-organizer,100,57,2/4/2019
1E1125,conference-organizer,100,57,2/4/2019
1E1125,conference-organizer,100,57,2/4/2019
1EBF8D,regulatory-product-review-positive,100,73,2/4/2019
202E5A,conference-participant,100,50,2/4/2019
2262BD,earnings,100,50,2/4/2019
228D42,partnership,100,61,2/4/2019
250BEE,earnings,100,50,2/4/2019
250BEE,earnings,100,50,2/4/2019
250BEE,earnings,100,50,2/4/2019
250BEE,earnings,100,50,2/4/2019
250BEE,earnings,100,50,2/4/2019
25102A,public-offering,100,43,2/4/2019
25102A,public-offering,100,43,2/4/2019
2571FA,earnings,100,50,2/4/2019
2667B6,dividend,100,50,2/4/2019
2BF36E,legal-issues-defendant,100,22,2/4/2019
2C3348,note-sale,100,52,2/4/2019
2CA60F,earnings,100,50,2/4/2019
2CBB58,revenues,100,50,2/4/2019
2CBB58,revenues,100,50,2/4/2019
2CBB58,revenues,100,50,2/4/2019
2CBB58,revenues,100,50,2/4/2019
2D485F,dividend,100,50,2/4/2019
2EB88B,executive-appointment,100,54,2/4/2019
2F9304,earnings,100,50,2/4/2019
2FEA66,operating-earnings,100,50,2/4/2019
30E01D,executive-appointment,100,54,2/4/2019
31DB20,earnings,100,50,2/4/2019
326EDD,earnings,100,50,2/4/2019
34A959,executive-appointment,100,54,2/4/2019
34E9F9,dividend,100,50,2/4/2019
36E479,conference-participant,100,50,2/4/2019
373B06,earnings,100,50,2/4/2019
38C46F,dividend,100,50,2/4/2019
39BFF6,unit-acquisition-acquiree,100,76,2/4/2019
3D9999,executive-appointment,100,54,2/4/2019
3DB18B,earnings,100,50,2/4/2019
416291,credit-extension-recipient,100,69,2/4/2019
422A82,executive-appointment,100,54,2/4/2019
447FC6,earnings,100,50,2/4/2019
447FC6,earnings,100,50,2/4/2019
45BC35,earnings-guidance,100,50,2/4/2019
4806CE,business-contract,100,69,2/4/2019
492117,product-release,100,64,2/4/2019
49BBBC,note-sale,100,52,2/4/2019
4A2457,product-release,100,64,2/4/2019
4AE584,unit-acquisition-acquirer,100,49,2/4/2019
4C3FE9,patient-enrollment-complete,100,64,2/4/2019
4D371E,conference-participant,100,50,2/4/2019
4F9926,partnership,100,61,2/4/2019
50070E,conference-organizer,100,57,2/4/2019
50070E,conference-organizer,100,57,2/4/2019
50070E,conference-organizer,100,57,2/4/2019
514067,legal-issues-defendant,100,22,2/4/2019
5403F8,earnings,100,50,2/4/2019
5.47E+28,regulatory-product-approval-granted,100,81,2/4/2019
56632F,dividend,100,50,2/4/2019
56EA2B,revenue-up,100,68,2/4/2019
587EDF,debt-reduction,100,74,2/4/2019
5A423F,earnings,100,50,2/4/2019
6.18E+08,earnings,100,50,2/4/2019
6.18E+08,earnings,100,50,2/4/2019
6.18E+08,earnings,100,50,2/4/2019
6.18E+08,earnings,100,50,2/4/2019
62B1C6,earnings,100,50,2/4/2019
633043,earnings,100,50,2/4/2019
64E615,conference-call,100,50,2/4/2019
693ECD,conference-participant,100,50,2/4/2019
6D0CAB,earnings,100,50,2/4/2019
6DD6BA,conference-call,100,50,2/4/2019
6F3936,partnership,100,61,2/4/2019
719477,earnings,100,50,2/4/2019
731675,executive-appointment,100,54,2/4/2019
73A213,earnings,100,50,2/4/2019
73A213,earnings,100,50,2/4/2019
73A213,earnings,100,50,2/4/2019
762A3E,conference-organizer,100,57,2/4/2019
762A3E,conference-organizer,100,57,2/4/2019
766047,earnings,100,50,2/4/2019
7DA412,earnings,100,50,2/4/2019
7F2922,earnings,100,50,2/4/2019
80C400,dividend-up,100,81,2/4/2019
85DA04,business-contract,100,69,2/4/2019
8665BA,partnership,100,61,2/4/2019
868808,operating-earnings,100,50,2/4/2019
893904,conference-call,100,50,2/4/2019
89B2E7,executive-appointment,100,54,2/4/2019
89E771,earnings,100,50,2/4/2019
89F693,executive-appointment,100,54,2/4/2019
89F693,executive-appointment,100,54,2/4/2019
8B6E7E,earnings,100,50,2/4/2019
8BFAA4,dividend,100,50,2/4/2019
8D4486,partnership,100,61,2/4/2019
8DCF18,partnership,100,61,2/4/2019
8DCF18,partnership,100,61,2/4/2019
8DCF18,partnership,100,61,2/4/2019
8F6995,earnings,100,50,2/4/2019
9043FE,earnings,100,50,2/4/2019
9043FE,earnings,100,50,2/4/2019
911AB8,executive-appointment,100,54,2/4/2019
91E5EE,earnings,100,50,2/4/2019
92D757,dividend-up,100,81,2/4/2019
93965C,earnings,100,50,2/4/2019
94563D,award,100,58,2/4/2019
945DE6,merger,100,66,2/4/2019
971F7B,sponsorship,100,57,2/4/2019
979451,legal-issues-defendant,100,22,2/4/2019
990AD0,conference-organizer,100,57,2/4/2019
9981C6,earnings,100,50,2/4/2019
9A602D,spin-off,100,58,2/4/2019
9A602D,spin-off,100,58,2/4/2019
9A602D,spin-off,100,58,2/4/2019
9A602D,conference-call,100,50,2/4/2019
9B5968,executive-appointment,100,54,2/4/2019
9D2790,earnings,100,50,2/4/2019
9D2790,earnings,100,50,2/4/2019
9D2790,earnings,100,50,2/4/2019
9D2790,earnings,100,50,2/4/2019
9D2790,earnings,100,50,2/4/2019
9D2790,earnings,100,50,2/4/2019
9D4EC7,earnings,100,50,2/4/2019
9D56F2,partnership,100,61,2/4/2019
9EA947,conference-call,100,50,2/4/2019
9EED50,acquisition-completed-acquirer,100,49,2/4/2019
9F71E5,conference-participant,100,50,2/4/2019
9FA83B,executive-appointment,100,54,2/4/2019
9FD2D9,earnings-guidance,100,50,2/4/2019
A01664,executive-appointment,100,54,2/4/2019
A02FB1,executive-appointment,100,54,2/4/2019
A52B6B,earnings,100,50,2/4/2019
A5628C,executive-appointment,100,54,2/4/2019
A5A4F5,acquisition-acquirer,100,49,2/4/2019
A63387,executive-appointment,100,54,2/4/2019
A6FC89,conference-call,100,50,2/4/2019
A753BB,earnings,100,50,2/4/2019
AA1EAA,earnings,100,50,2/4/2019
ACC7D3,conference-participant,100,50,2/4/2019
ACDF88,legal-issues-defendant,100,22,2/4/2019
AD3C93,executive-appointment,100,54,2/4/2019
B0FE08,executive-appointment,100,54,2/4/2019
B48D6A,conference-participant,100,50,2/4/2019
B614F8,public-offering,100,43,2/4/2019
B6843B,executive-appointment,100,54,2/4/2019
B8F71F,executive-appointment,100,54,2/4/2019
BB58FF,earnings,100,50,2/4/2019
C0F70B,conference-participant,100,50,2/4/2019
C11C46,earnings,100,50,2/4/2019
C16A8F,earnings,100,50,2/4/2019
C16A8F,earnings,100,50,2/4/2019
C16A8F,earnings,100,50,2/4/2019
C16A8F,earnings,100,50,2/4/2019
C230FE,earnings-up,100,68,2/4/2019
C230FE,earnings,100,50,2/4/2019
C2DD02,public-offering,100,43,2/4/2019
C564E4,executive-appointment,100,54,2/4/2019
C7AE14,conference-participant,100,50,2/4/2019
D25249,conference-call,100,50,2/4/2019
D33270,hirings,100,65,2/4/2019
D3FD6D,executive-appointment,100,54,2/4/2019
D63B0F,unit-acquisition-acquirer,100,49,2/4/2019
D77F7E,earnings,100,50,2/4/2019
D8ECA1,business-contract,100,69,2/4/2019
DA90E1,unit-acquisition-acquirer,100,49,2/4/2019
DA91AE,earnings,100,50,2/4/2019
DCD97F,business-contract,100,69,2/4/2019
DD3BB1,merger,100,66,2/4/2019
DD9E41,earnings,100,50,2/4/2019
DDB002,legal-issues-defendant,100,22,2/4/2019
DDB002,legal-issues-defendant,100,22,2/4/2019
E074A0,earnings,100,50,2/4/2019
E13782,business-contract,100,69,2/4/2019
E3E68E,legal-issues-defendant,100,22,2/4/2019
E802CE,conference-call,100,50,2/4/2019
E8846E,investment-investor,100,55,2/4/2019
EA62FC,earnings,100,50,2/4/2019
EAEBF3,earnings,100,50,2/4/2019
EBD89A,conference-participant,100,50,2/4/2019
F02D0A,executive-appointment,100,54,2/4/2019
F15E41,legal-issues-defendant,100,22,2/4/2019
F2E253,executive-appointment,100,54,2/4/2019
F3016C,earnings,100,50,2/4/2019
F30508,clinical-trials,100,56,2/4/2019
F30508,clinical-trials,100,56,2/4/2019
F4CDA3,conference-call,100,50,2/4/2019
F6E248,earnings,100,50,2/4/2019
F6E248,dividend-up,100,61,2/4/2019
F6FA6A,conference-call,100,50,2/4/2019
F721A7,earnings,100,50,2/4/2019
F721A7,earnings,100,50,2/4/2019
F85CC0,conference-participant,100,50,2/4/2019
F88A04,partnership,100,61,2/4/2019
F8BA6C,legal-issues-defendant,100,22,2/4/2019
F90EE5,executive-appointment,100,54,2/4/2019
FC80E6,acquisition-completed-acquirer,100,49,2/4/2019
FF6644,partnership,100,61,2/4/2019
9397,conference-participant,100,50,2/5/2019
0157B1,partnership,100,61,2/5/2019
01D03F,government-contract,100,69,2/5/2019
02FC1A,executive-resignation,100,44,2/5/2019
31025,revenue-up,100,69,2/5/2019
03596A,earnings,100,50,2/5/2019
03B8CF,dividend-up,100,56,2/5/2019
03FB17,earnings,100,50,2/5/2019
48590,legal-issues-defendant,100,22,2/5/2019
06A456,executive-appointment,100,54,2/5/2019
06A456,earnings,100,50,2/5/2019
099A92,conference-call,100,50,2/5/2019
0A6824,earnings,100,50,2/5/2019
0A7650,conference-call,100,50,2/5/2019
0A9D0A,legal-issues-defendant,100,22,2/5/2019
0B13E8,supply-increase,100,74,2/5/2019
0C355F,headquarters-change,100,50,2/5/2019
0F65C9,conference-call,100,50,2/5/2019
0FC848,executive-appointment,100,54,2/5/2019
135B09,earnings-guidance,100,50,2/5/2019
135B09,earnings,100,50,2/5/2019
135B09,earnings,100,50,2/5/2019
135B09,earnings,100,50,2/5/2019
135B09,earnings,100,50,2/5/2019
138DDE,public-offering,100,43,2/5/2019
147C38,earnings,100,50,2/5/2019
1490F3,earnings,100,50,2/5/2019
14ED2B,dividend,100,50,2/5/2019
17EDA5,partnership,100,61,2/5/2019
18D9FA,executive-appointment,100,54,2/5/2019
1921DD,legal-issues-defendant,100,22,2/5/2019
19CAC7,earnings,100,50,2/5/2019
1BC12C,dividend,100,50,2/5/2019
1DB6A6,dividend,100,50,2/5/2019
1DDEDA,legal-issues-defendant,100,22,2/5/2019
1DDEDA,legal-issues-defendant,100,22,2/5/2019
1E1125,conference-organizer,100,57,2/5/2019
1E1125,conference-organizer,100,57,2/5/2019
1E1125,conference-organizer,100,57,2/5/2019
1E1125,conference-organizer,100,57,2/5/2019
1E1125,conference-organizer,100,57,2/5/2019
1E1125,conference-organizer,100,57,2/5/2019
1E1125,conference-organizer,100,57,2/5/2019
1EA923,earnings,100,50,2/5/2019
1EA923,earnings,100,50,2/5/2019
1EA923,earnings,100,50,2/5/2019
1F08A6,dividend,100,50,2/5/2019
1FAF22,partnership,100,61,2/5/2019
21F9CA,revenues,100,50,2/5/2019
238302,earnings,100,50,2/5/2019
25102A,conference-participant,100,50,2/5/2019
251988,merger,100,66,2/5/2019
26F31D,product-release,100,64,2/5/2019
284289,earnings,100,50,2/5/2019
28AF37,executive-resignation,100,44,2/5/2019
28B730,earnings,100,50,2/5/2019
2950FF,earnings,100,50,2/5/2019
2950FF,earnings,100,50,2/5/2019
2B7A40,earnings-per-share-positive,100,69,2/5/2019
2B7A40,earnings-positive,100,69,2/5/2019
2B7A40,earnings-positive,100,69,2/5/2019
2B7A40,earnings-positive,100,69,2/5/2019
2B7A40,earnings-positive,100,69,2/5/2019
2C19A4,conference-call,100,50,2/5/2019
2D76CE,executive-appointment,100,54,2/5/2019
2DC88B,conference-participant,100,50,2/5/2019
2F1299,earnings,100,50,2/5/2019
2F1299,earnings,100,50,2/5/2019
2F1299,earnings,100,50,2/5/2019
2F1299,earnings,100,50,2/5/2019
2F1299,earnings,100,50,2/5/2019
2F1299,earnings,100,50,2/5/2019
2F24A5,earnings,100,50,2/5/2019
30CBF9,partnership,100,61,2/5/2019
31803E,earnings,100,50,2/5/2019
339F20,executive-resignation,100,44,2/5/2019
33E8C7,earnings,100,50,2/5/2019
343996,earnings,100,50,2/5/2019
3461CF,product-release,100,64,2/5/2019
35AE32,earnings,100,50,2/5/2019
35F4B5,earnings-up,100,68,2/5/2019
367E1C,earnings,100,50,2/5/2019
372037,executive-appointment,100,54,2/5/2019
387541,conference-call,100,50,2/5/2019
396D7C,executive-appointment,100,54,2/5/2019
3BE00F,earnings,100,50,2/5/2019
3C7F5F,executive-appointment,100,54,2/5/2019
3D9999,legal-issues-defendant,100,22,2/5/2019
4.03E+05,earnings-guidance-up,100,83,2/5/2019
4.03E+05,earnings,100,50,2/5/2019
4.03E+05,earnings,100,50,2/5/2019
4.03E+05,dividend,100,50,2/5/2019
4.00E+163,earnings,100,50,2/5/2019
40F7DE,conference-call,100,50,2/5/2019
435ACE,earnings,100,50,2/5/2019
43E8F5,conference-call,100,50,2/5/2019
442769,business-contract,100,69,2/5/2019
442769,conference-call,100,50,2/5/2019
444CC8,product-release,100,64,2/5/2019
44A4FC,earnings,100,50,2/5/2019
453282,dividend,100,50,2/5/2019
49BBBC,note-sale,100,52,2/5/2019
49BBBC,legal-issues-defendant,100,22,2/5/2019
4A6F00,partnership,100,61,2/5/2019
4A6F00,partnership,100,61,2/5/2019
50070E,conference-organizer,100,57,2/5/2019
50070E,conference-call,100,50,2/5/2019
50070E,conference-organizer,100,57,2/5/2019
514067,legal-issues-defendant,100,22,2/5/2019
51888A,earnings-per-share-positive,100,69,2/5/2019
51888A,earnings,100,50,2/5/2019
51888A,earnings,100,50,2/5/2019
51B442,earnings,100,50,2/5/2019
5340D0,earnings,100,50,2/5/2019
54F1D2,earnings,100,50,2/5/2019
54F1D2,earnings,100,50,2/5/2019
54F1D2,earnings,100,50,2/5/2019
54F1D2,earnings,100,50,2/5/2019
54F1D2,earnings,100,50,2/5/2019
55438C,partnership,100,61,2/5/2019
55C9B5,executive-appointment,100,54,2/5/2019
55C9B5,dividend,100,50,2/5/2019
57CAAB,earnings,100,50,2/5/2019
57CAAB,earnings,100,50,2/5/2019
57CAAB,earnings,100,50,2/5/2019
57CAAB,earnings,100,50,2/5/2019
57CAAB,earnings,100,50,2/5/2019
57CAAB,earnings,100,50,2/5/2019
5DD48B,earnings,100,50,2/5/2019
5E6959,unit-acquisition-acquiree,100,76,2/5/2019
5F1B7B,earnings,100,50,2/5/2019
5F3E74,award,100,58,2/5/2019
5FE4B6,earnings,100,50,2/5/2019
601785,dividend,100,50,2/5/2019
61A586,earnings,100,50,2/5/2019
61E975,dividend,100,50,2/5/2019
62B1C6,earnings,100,50,2/5/2019
62B20A,earnings,100,50,2/5/2019
62EFEE,unit-acquisition-acquirer,100,49,2/5/2019
62EFEE,earnings-up,100,68,2/5/2019
62EFEE,earnings,100,50,2/5/2019
665618,conference-call,100,50,2/5/2019
66667F,facility-open,100,65,2/5/2019
67B923,earnings,100,50,2/5/2019
69345C,conference-participant,100,50,2/5/2019
6BDA0C,dividend,100,50,2/5/2019
6D3F35,earnings,100,50,2/5/2019
6.00E+19,earnings,100,50,2/5/2019
6F6559,award,100,58,2/5/2019
71B0CF,public-offering,100,43,2/5/2019
722D55,earnings,100,50,2/5/2019
7262F2,earnings,100,50,2/5/2019
73529F,earnings-guidance,100,50,2/5/2019
73529F,earnings-guidance,100,50,2/5/2019
742AAB,earnings,100,50,2/5/2019
789ADD,earnings,100,50,2/5/2019
789ADD,earnings,100,50,2/5/2019
789ADD,earnings,100,50,2/5/2019
789ADD,earnings,100,50,2/5/2019
79340A,earnings,100,50,2/5/2019
797C20,dividend-up,100,81,2/5/2019
7A2A49,earnings,100,50,2/5/2019
7D85A9,dividend,100,50,2/5/2019
7F9984,earnings,100,50,2/5/2019
7F9984,earnings,100,50,2/5/2019
8.10E+205,earnings,100,50,2/5/2019
82FD6D,earnings,100,50,2/5/2019
835C86,earnings,100,50,2/5/2019
835C86,earnings,100,50,2/5/2019
858942,executive-appointment,100,54,2/5/2019
85DE00,dividend,100,50,2/5/2019
85DE00,earnings,100,50,2/5/2019
8665BA,partnership,100,61,2/5/2019
885758,business-contract,100,69,2/5/2019
885758,earnings,100,50,2/5/2019
89F693,conference-participant,100,50,2/5/2019
8AC65D,executive-appointment,100,54,2/5/2019
8AC65D,earnings,100,50,2/5/2019
8C311A,earnings,100,50,2/5/2019
8D4486,partnership,100,61,2/5/2019
8D4486,business-contract,100,69,2/5/2019
8D4AE6,dividend,100,50,2/5/2019
8D5145,dividend-up,100,81,2/5/2019
8F6995,dividend,100,50,2/5/2019
8F8F2F,conference-call,100,50,2/5/2019
905356,conference-call,100,50,2/5/2019
922F0C,dividend,100,50,2/5/2019
92D757,executive-appointment,100,54,2/5/2019
931AE7,public-offering,100,43,2/5/2019
968966,earnings,100,50,2/5/2019
9.74E+08,earnings,100,50,2/5/2019
97644E,executive-resignation,100,44,2/5/2019
990AD0,conference-organizer,100,57,2/5/2019
99DC8D,dividend,100,50,2/5/2019
99DC8D,earnings,100,50,2/5/2019
9CA619,dividend,100,50,2/5/2019
9D307D,partnership,100,61,2/5/2019
9D30A8,unit-acquisition-acquirer,100,49,2/5/2019
9E0811,earnings,100,50,2/5/2019
9F18FA,earnings,100,50,2/5/2019
9F18FA,earnings,100,50,2/5/2019
9FA83B,conference-participant,100,50,2/5/2019
A1E3B3,earnings,100,50,2/5/2019
A4B899,earnings,100,50,2/5/2019
A5A4F5,acquisition-acquirer,100,49,2/5/2019
A5E715,executive-appointment,100,54,2/5/2019
A5E715,executive-death,100,31,2/5/2019
A6828A,conference-participant,100,50,2/5/2019
A8FDE8,earnings-revision,100,29,2/5/2019
ACD9A4,earnings,100,50,2/5/2019
AD3C93,executive-appointment,100,54,2/5/2019
AE4125,conference-call,100,50,2/5/2019
AFF7B4,earnings,100,50,2/5/2019
AFF7B4,earnings,100,50,2/5/2019
AFF7B4,earnings,100,50,2/5/2019
AFF7B4,earnings,100,50,2/5/2019
B0FE08,earnings,100,50,2/5/2019
B0FE08,earnings,100,50,2/5/2019
B0FE08,earnings,100,50,2/5/2019
B0FE08,earnings,100,50,2/5/2019
B290A2,orphan-drug-designation,100,76,2/5/2019
B2E6B5,dividend,100,50,2/5/2019
B2E6B5,earnings,100,50,2/5/2019
B2E6B5,earnings,100,50,2/5/2019
B303A6,dividend,100,50,2/5/2019
B54A74,earnings,100,50,2/5/2019
B66928,dividend,100,50,2/5/2019
B7BBFF,earnings,100,50,2/5/2019
B83BCE,earnings,100,50,2/5/2019
B8F71F,conference-participant,100,50,2/5/2019
B9764A,earnings,100,50,2/5/2019
BB5142,earnings-up,100,68,2/5/2019
BB5142,earnings,100,50,2/5/2019
BB5142,earnings,100,50,2/5/2019
BBBB41,earnings,100,50,2/5/2019
BBBB41,earnings,100,50,2/5/2019
BBBB41,earnings,100,50,2/5/2019
BBBB41,earnings,100,50,2/5/2019
BBBB41,earnings,100,50,2/5/2019
BBBB41,earnings,100,50,2/5/2019
BD9668,merger,100,66,2/5/2019
C2609A,earnings,100,50,2/5/2019
C5C0E9,earnings,100,50,2/5/2019
C5D2AE,conference-participant,100,50,2/5/2019
C659EB,conference-participant,100,50,2/5/2019
C8A248,award,100,58,2/5/2019
C9C62A,earnings,100,50,2/5/2019
CB89EA,executive-appointment,100,54,2/5/2019
CBFFDD,legal-issues-defendant,100,22,2/5/2019
CC0C78,product-release,100,64,2/5/2019
CC0C78,product-release,100,64,2/5/2019
CC8F6E,earnings,100,50,2/5/2019
CD4DA8,conference-participant,100,50,2/5/2019
CDD75E,conference-participant,100,50,2/5/2019
CDE118,earnings,100,50,2/5/2019
CDFCC9,dividend,100,50,2/5/2019
CDFCC9,earnings,100,50,2/5/2019
CDFCC9,earnings,100,50,2/5/2019
CDFCC9,earnings,100,50,2/5/2019
CDFCC9,earnings,100,50,2/5/2019
CDFCC9,earnings,100,50,2/5/2019
CE1002,executive-appointment,100,54,2/5/2019
CE5664,earnings,100,50,2/5/2019
CE5664,earnings,100,50,2/5/2019
CE5664,earnings,100,50,2/5/2019
CFF97C,credit-rating-upgrade-rater,20,50,2/5/2019
D0909F,conference-participant,100,50,2/5/2019
D0DFE5,executive-appointment,100,54,2/5/2019
D1C26F,partnership,100,61,2/5/2019
D57D99,earnings,100,50,2/5/2019
D60BB2,partnership,100,61,2/5/2019
D60BB2,earnings,100,50,2/5/2019
D6489C,product-release,100,64,2/5/2019
D69D42,earnings,100,50,2/5/2019
D7918D,earnings,100,50,2/5/2019
D8442A,executive-appointment,100,54,2/5/2019
DA9443,conference-participant,100,50,2/5/2019
DB06B0,earnings,100,50,2/5/2019
DB06B0,earnings,100,50,2/5/2019
DB06B0,earnings,100,50,2/5/2019
DB06B0,earnings,100,50,2/5/2019
DB06B0,earnings,100,50,2/5/2019
DC1405,earnings,100,50,2/5/2019
DDB002,legal-issues-defendant,100,22,2/5/2019
E09997,dividend,100,50,2/5/2019
E09E2B,legal-issues-defendant,100,22,2/5/2019
E15736,earnings,100,50,2/5/2019
E1BD05,partnership,100,61,2/5/2019
E1C16B,executive-appointment,100,54,2/5/2019
E1E093,partnership,100,61,2/5/2019
E1E093,partnership,100,61,2/5/2019
E1E093,partnership,100,61,2/5/2019
E22FDE,business-contract,100,69,2/5/2019
E35610,legal-issues-defendant,100,22,2/5/2019
E592F0,earnings,100,50,2/5/2019
E592F0,earnings,100,50,2/5/2019
E68C3D,executive-appointment,100,54,2/5/2019
E6A53A,earnings,100,50,2/5/2019
E6E012,earnings,100,50,2/5/2019
E6E012,earnings,100,50,2/5/2019
E829E8,earnings,100,50,2/5/2019
E87676,conference-call,100,50,2/5/2019
E90C84,earnings,100,50,2/5/2019
E90C84,conference-participant,100,50,2/5/2019
EAA0A7,earnings,100,50,2/5/2019
EB36DE,earnings,100,50,2/5/2019
EB5E78,buybacks,100,74,2/5/2019
EB5E78,earnings,100,50,2/5/2019
EB5E78,earnings,100,50,2/5/2019
EB5E78,earnings,100,50,2/5/2019
EB5E78,earnings,100,50,2/5/2019
ECF709,executive-appointment,100,54,2/5/2019
EF25A5,partnership,100,61,2/5/2019
EF5BED,executive-resignation,100,44,2/5/2019
F0B2B5,legal-issues-defendant,100,22,2/5/2019
F0B2B5,earnings,100,50,2/5/2019
F0B2B5,earnings,100,50,2/5/2019
F0B2B5,earnings,100,50,2/5/2019
F0B2B5,earnings,100,50,2/5/2019
F0B2B5,earnings,100,50,2/5/2019
F0B2B5,earnings,100,50,2/5/2019
F15E41,joint-venture,100,62,2/5/2019
F15E41,joint-venture,100,62,2/5/2019
F15E41,joint-venture,100,62,2/5/2019
F294DD,dividend-up,100,81,2/5/2019
F30508,clinical-trials,100,56,2/5/2019
F509E2,earnings,100,50,2/5/2019
F57F6F,earnings,100,50,2/5/2019
F5D410,earnings-guidance-up,100,83,2/5/2019
F5D410,earnings,100,50,2/5/2019
F5D410,earnings,100,50,2/5/2019
F5D410,earnings,100,50,2/5/2019
F5D410,earnings,100,50,2/5/2019
F72E4B,conference-participant,100,50,2/5/2019
F80FF9,earnings,100,50,2/5/2019
F85CC0,earnings,100,50,2/5/2019
F8BA6C,legal-issues-defendant,100,22,2/5/2019
F8DE55,earnings,100,50,2/5/2019
F9CAF8,dividend,100,50,2/5/2019
FB7724,earnings,100,50,2/5/2019
FC4550,dividend,100,50,2/5/2019
FEE4B0,partnership,100,61,2/5/2019
00067A,earnings,100,50,2/6/2019
0157B1,partnership,100,61,2/6/2019
03B431,earnings,100,50,2/6/2019
048B70,earnings,100,50,2/6/2019
048B70,earnings,100,50,2/6/2019
048B70,earnings,100,50,2/6/2019
04996E,earnings,100,50,2/6/2019
0560D8,conference-participant,100,50,2/6/2019
07EC43,earnings,100,50,2/6/2019
07EC43,executive-appointment,100,54,2/6/2019
0BD4E8,dividend,100,50,2/6/2019
0CBC4D,revenues,100,50,2/6/2019
0CBC4D,earnings,100,50,2/6/2019
0CE7F6,earnings,100,50,2/6/2019
0EC508,earnings,100,50,2/6/2019
1065BC,dividend,100,50,2/6/2019
1279ED,conference-call,100,50,2/6/2019
131443,earnings,100,50,2/6/2019
1.79E+10,conference-call,100,50,2/6/2019
1921DD,legal-issues-defendant,100,22,2/6/2019
19BF16,earnings,100,50,2/6/2019
1AD9CC,revenues,100,50,2/6/2019
1DDEDA,legal-issues-defendant,100,22,2/6/2019
1DDEDA,legal-issues-defendant,100,22,2/6/2019
1DDEDA,legal-issues-defendant,100,22,2/6/2019
1DF15D,facility-open,100,65,2/6/2019
1E1125,conference-organizer,100,57,2/6/2019
1E1125,conference-organizer,100,57,2/6/2019
1E7785,conference-participant,100,50,2/6/2019
1F19C8,revenues,100,50,2/6/2019
1F19C8,revenues,100,50,2/6/2019
1F19C8,revenues,100,50,2/6/2019
1F19C8,revenues,100,50,2/6/2019
1F19C8,revenues,100,50,2/6/2019
1F19C8,revenues,100,50,2/6/2019
1F716B,business-contract,100,69,2/6/2019
1F9D90,partnership,100,61,2/6/2019
1F9D90,partnership,100,61,2/6/2019
1F9D90,partnership,100,61,2/6/2019
1FA886,partnership,100,61,2/6/2019
1FA886,business-contract,100,69,2/6/2019
1FA886,business-contract,100,69,2/6/2019
1FAF22,conference-participant,100,50,2/6/2019
200D8B,earnings,100,50,2/6/2019
222BF9,dividend,100,50,2/6/2019
227F04,earnings,100,50,2/6/2019
228D42,partnership,100,61,2/6/2019
24C48B,dividend,100,50,2/6/2019
263216,earnings,100,50,2/6/2019
263216,earnings,100,50,2/6/2019
263216,earnings,100,50,2/6/2019
263216,earnings,100,50,2/6/2019
263216,earnings,100,50,2/6/2019
263216,earnings,100,50,2/6/2019
2667B6,conference-participant,100,50,2/6/2019
26D8ED,earnings,100,50,2/6/2019
26E3BA,conference-participant,100,50,2/6/2019
26F31D,earnings,100,50,2/6/2019
27A791,conference-call,100,50,2/6/2019
27B191,earnings,100,50,2/6/2019
27B191,earnings,100,50,2/6/2019
27B191,earnings,100,50,2/6/2019
27B191,earnings,100,50,2/6/2019
27B191,dividend,100,50,2/6/2019
2A6DBE,earnings,100,50,2/6/2019
2AA6A8,executive-appointment,100,54,2/6/2019
2ABF77,earnings,100,50,2/6/2019
2ABF77,earnings,100,50,2/6/2019
2BA977,conference-call,100,50,2/6/2019
2BAE5F,dividend-up,100,56,2/6/2019
2BC05E,dividend,100,50,2/6/2019
2CA60F,partnership,100,61,2/6/2019
2CA60F,partnership,100,61,2/6/2019
315EB0,partnership,100,61,2/6/2019
31643A,earnings,100,50,2/6/2019
31AA84,earnings,100,50,2/6/2019
33AD83,product-recall,100,29,2/6/2019
3461CF,award,100,58,2/6/2019
34A959,executive-appointment,100,54,2/6/2019
370C50,dividend,100,50,2/6/2019
384CD3,dividend,100,50,2/6/2019
3A3447,earnings,100,50,2/6/2019
3A3447,earnings,100,50,2/6/2019
3A3447,earnings,100,50,2/6/2019
3A3447,earnings,100,50,2/6/2019
3A6D90,executive-resignation,100,44,2/6/2019
3AF7FD,earnings,100,50,2/6/2019
3AF7FD,dividend,100,50,2/6/2019
3F4668,earnings,100,50,2/6/2019
3FACA7,dividend,100,50,2/6/2019
416C55,dividend,100,50,2/6/2019
41785E,dividend,100,50,2/6/2019
425BDC,conference-call,100,50,2/6/2019
442587,earnings,100,50,2/6/2019
442587,earnings,100,50,2/6/2019
444CC8,revenue-up,100,69,2/6/2019
453282,buybacks,100,74,2/6/2019
492117,earnings,100,50,2/6/2019
4AC91D,partnership,100,61,2/6/2019
4EEB00,conference-participant,100,50,2/6/2019
514067,legal-issues-defendant,100,22,2/6/2019
51E682,earnings,100,50,2/6/2019
545272,earnings,100,50,2/6/2019
54F271,revenues,100,50,2/6/2019
55ACCB,earnings,100,50,2/6/2019
56AFF4,dividend,100,50,2/6/2019
583A75,revenue-volume,100,50,2/6/2019
589803,earnings,100,50,2/6/2019
58CA9A,partnership,100,61,2/6/2019
5C7601,earnings,100,50,2/6/2019
5D02B7,earnings,100,50,2/6/2019
5DD486,dividend-up,100,57,2/6/2019
5F60CE,earnings,100,50,2/6/2019
605F40,earnings,100,50,2/6/2019
622DBE,earnings,100,50,2/6/2019
639BD6,revenues,100,50,2/6/2019
639BD6,revenues,100,50,2/6/2019
639BD6,revenues,100,50,2/6/2019
63F892,earnings,100,50,2/6/2019
64FF65,conference-call,100,50,2/6/2019
66749D,dividend,100,50,2/6/2019
68E3E0,conference-call,100,50,2/6/2019
698FF9,earnings,100,50,2/6/2019
6A961B,earnings,100,50,2/6/2019
6BD606,dividend,100,50,2/6/2019
6BD606,dividend,100,50,2/6/2019
6E1E61,earnings,100,50,2/6/2019
705636,dividend,100,50,2/6/2019
7273FF,earnings,100,50,2/6/2019
728737,conference-participant,100,50,2/6/2019
729368,earnings,100,50,2/6/2019
72FCA3,note-sale,100,52,2/6/2019
72FCA3,note-sale,100,52,2/6/2019
762A3E,conference-organizer,100,57,2/6/2019
76BD96,conference-call,100,50,2/6/2019
7ADE57,executive-appointment,100,54,2/6/2019
7B6EB1,conference-participant,100,50,2/6/2019
7B9AFA,earnings,100,50,2/6/2019
7D35D8,revenue-up,100,69,2/6/2019
7D35D8,earnings,100,50,2/6/2019
7D35D8,earnings,100,50,2/6/2019
7D5FD6,dividend,100,50,2/6/2019
7E1D5D,earnings,100,50,2/6/2019
7FDE1C,conference-call,100,50,2/6/2019
8.10E+32,partnership,100,61,2/6/2019
8.10E+32,earnings,100,50,2/6/2019
810FAD,earnings-up,100,68,2/6/2019
810FAD,earnings-up,100,68,2/6/2019
810FAD,earnings-up,100,68,2/6/2019
810FAD,earnings-up,100,68,2/6/2019
810FAD,earnings-up,100,68,2/6/2019
810FAD,earnings-up,100,68,2/6/2019
810FAD,dividend-up,100,56,2/6/2019
82E58A,earnings,100,50,2/6/2019
838ADD,earnings,100,50,2/6/2019
84920B,earnings-positive,100,69,2/6/2019
8B4A45,facility-open,100,65,2/6/2019
8B9B3B,regulatory-product-application,100,69,2/6/2019
8D4486,product-release,100,64,2/6/2019
8D4AE6,earnings,100,50,2/6/2019
8D4AE6,earnings,100,50,2/6/2019
8E10BF,conference-participant,100,50,2/6/2019
8EEA28,dividend,100,50,2/6/2019
92B047,earnings,100,50,2/6/2019
934029,conference-participant,100,50,2/6/2019
9.39E+69,clinical-trials,100,56,2/6/2019
949625,dividend,100,50,2/6/2019
9673BD,conference-call,100,50,2/6/2019
96A6CD,executive-appointment,100,54,2/6/2019
9810C0,earnings,100,50,2/6/2019
9.86E+03,earnings,100,50,2/6/2019
99028D,earnings,100,50,2/6/2019
990AD0,product-release,100,64,2/6/2019
990AD0,conference-organizer,100,57,2/6/2019
990AD0,conference-organizer,100,57,2/6/2019
990AD0,conference-organizer,100,57,2/6/2019
990AD0,conference-organizer,100,57,2/6/2019
9BB35A,earnings,100,50,2/6/2019
9BF177,partnership,100,61,2/6/2019
9D56F2,conference-participant,100,50,2/6/2019
9D5D35,facility-open,100,65,2/6/2019
9D5D35,facility-open,100,65,2/6/2019
9D5D35,facility-open,100,65,2/6/2019
9FA83B,earnings,100,50,2/6/2019
A01664,earnings,100,50,2/6/2019
A072C4,business-contract,100,69,2/6/2019
A1EAC8,dividend,100,50,2/6/2019
A26C26,joint-venture,100,62,2/6/2019
A4A612,earnings,100,50,2/6/2019
A5A4F5,acquisition-acquirer,100,49,2/6/2019
A631A3,partnership,100,61,2/6/2019
A63387,earnings,100,50,2/6/2019
A63820,earnings-up,100,68,2/6/2019
A7102F,conference-call,100,50,2/6/2019
A7F0A5,dividend,100,50,2/6/2019
A868C9,revenues,100,50,2/6/2019
A868C9,revenues,100,50,2/6/2019
A868C9,revenues,100,50,2/6/2019
A8B137,executive-appointment,100,54,2/6/2019
AA847A,earnings,100,50,2/6/2019
AB4A7E,reorganization,100,53,2/6/2019
AD3C93,conference-participant,100,50,2/6/2019
AED61E,revenues,100,50,2/6/2019
AED61E,revenues,100,50,2/6/2019
AEF2C3,conference-call,100,50,2/6/2019
B0D41A,regulatory-product-approval-granted,100,81,2/6/2019
B2E6B5,executive-resignation,100,44,2/6/2019
B3CB74,conference-organizer,100,57,2/6/2019
B3ED62,conference-call,100,50,2/6/2019
B48D6A,conference-participant,100,50,2/6/2019
B4C673,conference-call,100,50,2/6/2019
B72BE9,dividend,100,50,2/6/2019
B8EF97,revenues,100,50,2/6/2019
BAAA60,earnings,100,50,2/6/2019
BD682F,earnings,100,50,2/6/2019
C06EB6,earnings,100,50,2/6/2019
C15F8F,earnings,100,50,2/6/2019
C188F8,revenue-up,100,69,2/6/2019
C188F8,revenue-up,100,69,2/6/2019
C188F8,revenue-up,100,69,2/6/2019
C188F8,revenue-up,100,69,2/6/2019
C230FE,credit-extension-recipient,100,69,2/6/2019
C3BCD5,dividend,100,50,2/6/2019
C3EE99,conference-call,100,50,2/6/2019
C425AE,earnings,100,50,2/6/2019
C50B26,earnings,100,50,2/6/2019
C62AA4,conference-call,100,50,2/6/2019
C65004,revenue-up,100,71,2/6/2019
C65004,revenue-up,100,69,2/6/2019
C97B2D,earnings,100,50,2/6/2019
C9E04B,conference-call,100,50,2/6/2019
CA1620,business-contract,100,69,2/6/2019
CA99D7,earnings,100,50,2/6/2019
CB6A9C,conference-call,100,50,2/6/2019
CB9E13,earnings,100,50,2/6/2019
CC35BE,earnings,100,50,2/6/2019
CCB623,revenues,100,50,2/6/2019
CDAB24,earnings,100,50,2/6/2019
CF351E,earnings,100,50,2/6/2019
D06996,conference-call,100,50,2/6/2019
D17F7E,earnings,100,50,2/6/2019
D17F7E,earnings,100,50,2/6/2019
D17F7E,earnings,100,50,2/6/2019
D17F7E,earnings,100,50,2/6/2019
D17F7E,earnings,100,50,2/6/2019
D17F7E,earnings,100,50,2/6/2019
D17F7E,earnings,100,50,2/6/2019
D29B44,earnings,100,50,2/6/2019
D2C0B6,earnings,100,50,2/6/2019
D4AC65,earnings-up,100,68,2/6/2019
D4AC65,earnings-up,100,68,2/6/2019
D4AC65,earnings-up,100,68,2/6/2019
D4AC65,earnings-up,100,68,2/6/2019
D4AC65,earnings-up,100,68,2/6/2019
D4AC65,earnings-up,100,68,2/6/2019
D5A350,dividend,100,50,2/6/2019
D64EDF,earnings,100,50,2/6/2019
D76AEF,conference-call,100,50,2/6/2019
D76AEF,executive-appointment,100,54,2/6/2019
D78BF1,earnings,100,50,2/6/2019
DC437D,earnings,100,50,2/6/2019
DCD97F,business-contract,100,69,2/6/2019
DDB002,legal-issues-defendant,100,22,2/6/2019
DF42A0,business-contract,100,69,2/6/2019
DF532D,partnership,100,61,2/6/2019
E19A99,earnings,100,50,2/6/2019
E1C16B,conference-participant,100,50,2/6/2019
E1E36F,earnings,100,50,2/6/2019
E1E36F,earnings,100,50,2/6/2019
E1E36F,earnings,100,50,2/6/2019
E1E36F,earnings,100,50,2/6/2019
E1E36F,earnings,100,50,2/6/2019
E1E36F,earnings,100,50,2/6/2019
E1E36F,earnings,100,50,2/6/2019
E20392,earnings,100,50,2/6/2019
E259C7,revenue-up,100,69,2/6/2019
E259C7,revenue-up,100,69,2/6/2019
E259C7,revenue-up,100,69,2/6/2019
E259C7,revenue-up,100,69,2/6/2019
E259C7,revenue-up,100,69,2/6/2019
E26FC3,dividend-up,100,81,2/6/2019
E30A8F,executive-appointment,100,54,2/6/2019
E30A8F,earnings,100,50,2/6/2019
E30A8F,earnings,100,50,2/6/2019
E30A8F,earnings,100,50,2/6/2019
E30A8F,earnings,100,50,2/6/2019
E30A8F,earnings,100,50,2/6/2019
E6D89E,executive-appointment,100,54,2/6/2019
E6EDED,earnings,100,50,2/6/2019
E829E8,executive-appointment,100,54,2/6/2019
E82A2D,dividend,100,50,2/6/2019
E8846E,executive-appointment,100,54,2/6/2019
E8A49A,partnership,100,61,2/6/2019
EBC84C,facility-open,100,65,2/6/2019
EC1AF3,conference-call,100,50,2/6/2019
EC4E82,acquisition-completed-acquirer,100,49,2/6/2019
ED2A5E,conference-call,100,50,2/6/2019
EDD234,conference-call,100,50,2/6/2019
F1529C,conference-participant,100,50,2/6/2019
F1EB39,conference-participant,100,50,2/6/2019
F30508,earnings-positive,100,69,2/6/2019
F30508,earnings,100,50,2/6/2019
F30508,earnings,100,50,2/6/2019
F30508,earnings,100,50,2/6/2019
F30508,earnings,100,50,2/6/2019
F30508,earnings,100,50,2/6/2019
F30508,earnings,100,50,2/6/2019
F31B13,public-offering,100,43,2/6/2019
F32F88,dividend,100,50,2/6/2019
F40EE2,dividend-up,100,81,2/6/2019
F4CDA3,earnings,100,50,2/6/2019
F4E882,executive-appointment,100,54,2/6/2019
F6FA6A,dividend,100,50,2/6/2019
F769E9,conference-call,100,50,2/6/2019
F8BA6C,legal-issues-defendant,100,22,2/6/2019
FA35C6,earnings,100,50,2/6/2019
FC1F9D,dividend,100,50,2/6/2019
FD4BBE,conference-participant,100,50,2/6/2019
FDC7E6,trading-halt,100,43,2/6/2019
FDF799,conference-participant,100,50,2/6/2019
FE7A63,award,100,58,2/6/2019
FEC475,earnings,100,50,2/6/2019
FEC475,earnings,100,50,2/6/2019
FEC475,earnings,100,50,2/6/2019
FEC475,earnings,100,50,2/6/2019
FEC475,earnings,100,50,2/6/2019
FEC475,earnings,100,50,2/6/2019
FF5413,dividend-up,100,81,2/6/2019
00067A,business-contract,100,69,2/7/2019
00067A,business-contract,100,69,2/7/2019
001F1B,revenues,100,50,2/7/2019
9397,product-release,100,64,2/7/2019
13528,partnership,100,61,2/7/2019
0157B1,partnership,100,61,2/7/2019
0358AF,revenue-up,100,69,2/7/2019
0560D8,executive-appointment,100,54,2/7/2019
0560D8,earnings,100,50,2/7/2019
61366,earnings,100,50,2/7/2019
75172,earnings,100,50,2/7/2019
083F72,earnings,100,50,2/7/2019
0B13E8,conference-call,100,50,2/7/2019
0BB9E5,investment-investor,100,55,2/7/2019
0C2A0D,product-release,100,64,2/7/2019
0CC62B,conference-participant,100,50,2/7/2019
0DC050,earnings,100,50,2/7/2019
102F04,earnings,100,50,2/7/2019
108A2B,conference-call,100,50,2/7/2019
10943B,earnings,100,50,2/7/2019
119CB6,revenue-up,100,65,2/7/2019
119CB6,revenues,100,50,2/7/2019
119CB6,revenues,100,50,2/7/2019
1201B5,revenue-up,100,85,2/7/2019
12DE76,acquisition-completed-acquirer,100,49,2/7/2019
1348C9,partnership,100,61,2/7/2019
152B9E,earnings-guidance,100,50,2/7/2019
152E1D,legal-issues-defendant,100,22,2/7/2019
157D9F,earnings,100,50,2/7/2019
182BE7,conference-call,100,50,2/7/2019
1834C0,earnings-guidance,100,50,2/7/2019
184866,earnings,100,50,2/7/2019
190B91,earnings,100,50,2/7/2019
1A3E1B,business-combination,100,54,2/7/2019
1A3E1B,business-combination,100,54,2/7/2019
1A3E1B,business-combination,100,54,2/7/2019
1A3E1B,business-combination,100,54,2/7/2019
1A3E1B,acquisition-interest-acquirer,100,46,2/7/2019
1AB808,earnings,100,50,2/7/2019
1BDB2A,conference-participant,100,50,2/7/2019
1C599A,earnings,100,50,2/7/2019
1D5C51,conference-call,100,50,2/7/2019
1DA44F,earnings-up,100,68,2/7/2019
1DA44F,earnings-up,100,68,2/7/2019
1DA44F,earnings-up,100,68,2/7/2019
1DA44F,earnings-up,100,68,2/7/2019
1DA44F,earnings-up,100,68,2/7/2019
1DDEDA,executive-appointment,100,54,2/7/2019
1DE526,conference-participant,100,50,2/7/2019
1DEBBE,facility-open,100,65,2/7/2019
1E1125,conference-organizer,100,57,2/7/2019
1E1125,conference-organizer,100,57,2/7/2019
1F464F,earnings,100,50,2/7/2019
202E5A,earnings,100,50,2/7/2019
21D903,earnings,100,50,2/7/2019
225CA2,business-contract,100,69,2/7/2019
23207A,earnings-per-share-positive,100,69,2/7/2019
23207A,earnings-per-share-positive,100,69,2/7/2019
23207A,earnings-per-share-positive,100,69,2/7/2019
239106,earnings-per-share-positive,100,69,2/7/2019
239106,earnings-per-share-positive,100,69,2/7/2019
239106,earnings-per-share-positive,100,69,2/7/2019
2491BC,earnings,100,50,2/7/2019
24C48B,earnings,100,50,2/7/2019
251988,executive-appointment,100,54,2/7/2019
28DCA8,conference-participant,100,50,2/7/2019
2.90E+62,dividend-up,100,81,2/7/2019
2.90E+62,earnings,100,50,2/7/2019
2A1009,earnings,100,50,2/7/2019
2B5483,earnings,100,50,2/7/2019
2C7505,earnings,100,50,2/7/2019
2D2D43,earnings,100,50,2/7/2019
2DC88B,earnings,100,50,2/7/2019
2E89AE,earnings,100,50,2/7/2019
2EB88B,revenue-up,100,69,2/7/2019
2EC172,earnings,100,50,2/7/2019
2FDEE3,stake-acquiree,100,62,2/7/2019
306623,dividend,100,50,2/7/2019
314D88,earnings,100,50,2/7/2019
3159AA,earnings,100,50,2/7/2019
32C8CD,earnings,100,50,2/7/2019
3390DE,earnings,100,50,2/7/2019
3461CF,campaign-ad-release,100,59,2/7/2019
34A959,earnings,100,50,2/7/2019
3587B4,earnings,100,50,2/7/2019
3587B4,earnings,100,50,2/7/2019
3587B4,earnings,100,50,2/7/2019
3587B4,earnings,100,50,2/7/2019
36E479,earnings,100,50,2/7/2019
39692D,earnings,100,50,2/7/2019
3BA1BF,conference-participant,100,50,2/7/2019
3C11C4,earnings,100,50,2/7/2019
3E70FC,earnings,100,50,2/7/2019
3E70FC,executive-appointment,100,54,2/7/2019
3F4497,earnings,100,50,2/7/2019
3F6A9C,earnings,100,50,2/7/2019
3F6A9C,earnings,100,50,2/7/2019
3F6A9C,earnings,100,50,2/7/2019
3F6A9C,earnings,100,50,2/7/2019
3F6A9C,earnings,100,50,2/7/2019
3F6A9C,earnings,100,50,2/7/2019
3F868D,earnings-guidance,100,50,2/7/2019
3FBC9B,operating-earnings,100,50,2/7/2019
401072,conference-participant,100,50,2/7/2019
429BFB,conference-call,100,50,2/7/2019
42AABD,product-release,100,64,2/7/2019
43A74A,partnership,100,61,2/7/2019
44209A,earnings,100,50,2/7/2019
4455C4,conference-call,100,50,2/7/2019
47752F,dividend,100,50,2/7/2019
479930,award,100,58,2/7/2019
4806CE,earnings-guidance,100,50,2/7/2019
49F4D0,earnings,100,50,2/7/2019
4A7C1F,revenue-guidance,100,50,2/7/2019
4AE584,unit-acquisition-acquirer,100,49,2/7/2019
4B7006,earnings,100,50,2/7/2019
4BDCA7,conference-participant,100,50,2/7/2019
4C1FA1,earnings,100,50,2/7/2019
4CDA2B,ipo-pricing,100,50,2/7/2019
4EE167,earnings,100,50,2/7/2019
4EEB00,executive-appointment,100,54,2/7/2019
4EEE7E,earnings,100,50,2/7/2019
51F541,conference-call,100,50,2/7/2019
52FB2F,earnings,100,50,2/7/2019
548AC0,earnings,100,50,2/7/2019
54A713,earnings,100,50,2/7/2019
562853,dividend,100,50,2/7/2019
567F3D,earnings,100,50,2/7/2019
567F3D,earnings,100,50,2/7/2019
567F3D,earnings,100,50,2/7/2019
567F3D,earnings,100,50,2/7/2019
567F3D,earnings,100,50,2/7/2019
56FB7C,dividend-up,100,81,2/7/2019
57356F,earnings,100,50,2/7/2019
57356F,earnings,100,50,2/7/2019
57356F,earnings,100,50,2/7/2019
57356F,earnings,100,50,2/7/2019
59872F,conference-call,100,50,2/7/2019
59DB8C,executive-appointment,100,54,2/7/2019
59DB8C,earnings,100,50,2/7/2019
5D0337,earnings,100,50,2/7/2019
5EAA43,earnings,100,50,2/7/2019
5F2FF7,dividend,100,50,2/7/2019
61E975,conference-call,100,50,2/7/2019
620381,conference-participant,100,50,2/7/2019
6284B5,dividend,100,50,2/7/2019
651C85,conference-participant,100,50,2/7/2019
66749D,earnings,100,50,2/7/2019
66749D,earnings,100,50,2/7/2019
66749D,earnings,100,50,2/7/2019
66749D,earnings,100,50,2/7/2019
66749D,earnings,100,50,2/7/2019
67B052,earnings,100,50,2/7/2019
68BA15,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
69E8E1,earnings,100,50,2/7/2019
6A171E,earnings,100,50,2/7/2019
6B0784,earnings,100,50,2/7/2019
6CF43C,earnings,100,50,2/7/2019
6F5DD2,conference-participant,100,50,2/7/2019
6F92A9,earnings,100,50,2/7/2019
717DB4,earnings,100,50,2/7/2019
719477,conference-call,100,50,2/7/2019
7262F2,executive-appointment,100,54,2/7/2019
72CB93,earnings,100,50,2/7/2019
73C521,dividend,100,50,2/7/2019
73C521,executive-resignation,100,44,2/7/2019
7.44E+09,earnings,100,50,2/7/2019
762A3E,conference-call,100,50,2/7/2019
7740DE,same-store-sales-up,100,52,2/7/2019
791D59,revenues,100,50,2/7/2019
791D59,revenues,100,50,2/7/2019
791D59,revenues,100,50,2/7/2019
791D59,revenues,100,50,2/7/2019
791D59,revenues,100,50,2/7/2019
791D59,revenues,100,50,2/7/2019
791D59,revenues,100,50,2/7/2019
793C11,earnings,100,50,2/7/2019
793C11,earnings,100,50,2/7/2019
793C11,earnings,100,50,2/7/2019
793C11,earnings,100,50,2/7/2019
793C11,earnings,100,50,2/7/2019
7A10FF,dividend,100,50,2/7/2019
7AC86E,earnings,100,50,2/7/2019
7AC86E,earnings,100,50,2/7/2019
7AC86E,earnings,100,50,2/7/2019
7B1156,earnings,100,50,2/7/2019
7B492C,earnings,100,50,2/7/2019
7B9212,revenues,100,50,2/7/2019
7C62A3,earnings,100,50,2/7/2019
7CD98F,earnings,100,50,2/7/2019
7DD584,revenue-up,100,82,2/7/2019
7DD584,revenue-up,100,82,2/7/2019
7DD584,revenue-up,100,82,2/7/2019
803FED,dividend,100,50,2/7/2019
82C202,earnings,100,50,2/7/2019
834152,executive-appointment,100,54,2/7/2019
85CDC9,conference-participant,100,50,2/7/2019
8614A2,earnings,100,50,2/7/2019
87B81A,revenue-up,100,69,2/7/2019
87B81A,earnings,100,50,2/7/2019
87B81A,earnings,100,50,2/7/2019
87B81A,earnings,100,50,2/7/2019
87B81A,earnings,100,50,2/7/2019
87B81A,buybacks,100,74,2/7/2019
896771,product-release,100,64,2/7/2019
89B2E7,earnings,100,50,2/7/2019
8A8E41,partnership,100,61,2/7/2019
8DCF18,conference-call,100,50,2/7/2019
92B73F,partnership,100,61,2/7/2019
92D757,earnings,100,50,2/7/2019
934029,earnings,100,50,2/7/2019
938D89,ipo-pricing,100,50,2/7/2019
94563D,earnings,100,50,2/7/2019
94563D,earnings,100,50,2/7/2019
94563D,earnings,100,50,2/7/2019
94563D,earnings,100,50,2/7/2019
94563D,earnings,100,50,2/7/2019
94563D,earnings,100,50,2/7/2019
9548BB,earnings-per-share-positive,100,69,2/7/2019
957A07,earnings,100,50,2/7/2019
958938,clinical-trials,100,56,2/7/2019
958938,clinical-trials,100,56,2/7/2019
9.62E+76,dividend,100,50,2/7/2019
96B4FF,conference-participant,100,50,2/7/2019
9.74E+08,partnership,100,61,2/7/2019
98D33E,dividend,100,50,2/7/2019
990AD0,conference-organizer,100,57,2/7/2019
990AD0,conference-organizer,100,57,2/7/2019
990AD0,conference-organizer,100,57,2/7/2019
990AD0,buybacks,100,74,2/7/2019
9.97E+09,earnings,100,50,2/7/2019
9978F1,conference-participant,100,50,2/7/2019
9AF3DC,earnings,100,50,2/7/2019
9B0C9C,earnings,100,50,2/7/2019
9B0C9C,earnings,100,50,2/7/2019
9B0C9C,earnings,100,50,2/7/2019
9CF9B1,earnings,100,50,2/7/2019
9D5D35,earnings,100,50,2/7/2019
9DDE1B,earnings,100,50,2/7/2019
9EBAFA,conference-call,100,50,2/7/2019
9F5CBB,conference-call,100,50,2/7/2019
9F6B1A,earnings,100,50,2/7/2019
9F71E5,dividend-up,100,65,2/7/2019
A16DEA,earnings,100,50,2/7/2019
A398B9,earnings,100,50,2/7/2019
A3AAA5,earnings,100,50,2/7/2019
A403CF,earnings,100,50,2/7/2019
A403CF,dividend,100,50,2/7/2019
A47F2E,earnings,100,50,2/7/2019
A495F7,earnings,100,50,2/7/2019
A4CD53,earnings,100,50,2/7/2019
A5B913,earnings,100,50,2/7/2019
A60354,earnings,100,50,2/7/2019
A70BF5,conference-participant,100,50,2/7/2019
A79F7D,public-offering,100,43,2/7/2019
A7CCF0,earnings-up,100,68,2/7/2019
A7CCF0,earnings,100,50,2/7/2019
A7CCF0,earnings,100,50,2/7/2019
A806FA,earnings,100,50,2/7/2019
A806FA,earnings,100,50,2/7/2019
A806FA,earnings,100,50,2/7/2019
A806FA,earnings,100,50,2/7/2019
ABBAD1,conference-participant,100,50,2/7/2019
AD1ACF,unit-acquisition-acquirer,100,49,2/7/2019
AD1ACF,earnings-up,100,68,2/7/2019
AD1ACF,earnings,100,50,2/7/2019
AD1ACF,earnings,100,50,2/7/2019
AD1ACF,earnings,100,50,2/7/2019
AD1ACF,earnings,100,50,2/7/2019
AD1ACF,dividend,100,50,2/7/2019
AEFC90,earnings,100,50,2/7/2019
B0998E,earnings,100,50,2/7/2019
B0D41A,conference-participant,100,50,2/7/2019
B1DF3C,earnings,100,50,2/7/2019
B642E8,asset-sale,100,62,2/7/2019
B66928,business-contract,100,69,2/7/2019
B8F5C8,legal-issues-defendant,100,22,2/7/2019
BB0787,earnings,100,50,2/7/2019
BBF349,earnings,100,50,2/7/2019
BBF349,earnings,100,50,2/7/2019
BBF349,earnings,100,50,2/7/2019
BC5680,earnings-up,100,68,2/7/2019
BC5680,earnings,100,50,2/7/2019
BC5680,earnings,100,50,2/7/2019
BD9668,dividend,100,50,2/7/2019
BE14CF,earnings,100,50,2/7/2019
BE379D,conference-call,100,50,2/7/2019
C037A8,earnings,100,50,2/7/2019
C2609A,conference-participant,100,50,2/7/2019
C2F597,earnings,100,50,2/7/2019
C38440,earnings,100,50,2/7/2019
C3DE7D,earnings,100,50,2/7/2019
C4706C,earnings,100,50,2/7/2019
C4A241,earnings,100,50,2/7/2019
C5E100,business-contract,100,69,2/7/2019
C659EB,dividend,100,50,2/7/2019
C72B8F,executive-appointment,100,54,2/7/2019
C8257F,conference-call,100,50,2/7/2019
C98CDB,earnings,100,50,2/7/2019
CA1620,earnings,100,50,2/7/2019
CB22CD,conference-call,100,50,2/7/2019
CE5C6E,clinical-trials-start,100,64,2/7/2019
CED4D0,earnings,100,50,2/7/2019
CFF97C,earnings,100,50,2/7/2019
D04D9F,earnings,100,50,2/7/2019
D04D9F,earnings,100,50,2/7/2019
D04D9F,earnings,100,50,2/7/2019
D04D9F,earnings,100,50,2/7/2019
D11C1C,conference-call,100,50,2/7/2019
D29F43,conference-call,100,50,2/7/2019
D3F64D,earnings,100,50,2/7/2019
D3FD6D,conference-call,100,50,2/7/2019
D5938F,earnings,100,50,2/7/2019
D64EDF,business-contract,100,69,2/7/2019
D64EDF,business-contract,100,69,2/7/2019
D6853F,dividend,100,50,2/7/2019
D8DA3D,earnings,100,50,2/7/2019
D8F347,dividend-up,100,60,2/7/2019
D96202,earnings,100,50,2/7/2019
DA0A9E,executive-appointment,100,54,2/7/2019
DAFED3,buybacks,100,74,2/7/2019
DBB28E,conference-call,100,50,2/7/2019
DC437D,dividend,100,50,2/7/2019
DCD97F,award,100,58,2/7/2019
DCD97F,award,100,58,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DD1BA1,earnings,100,50,2/7/2019
DDB002,legal-issues-defendant,100,22,2/7/2019
DDCB34,conference-call,100,50,2/7/2019
DE5611,conference-call,100,50,2/7/2019
DF204B,conference-call,100,50,2/7/2019
DF42A0,dividend,100,50,2/7/2019
DF42A0,earnings,100,50,2/7/2019
DF42A0,earnings,100,50,2/7/2019
DF42A0,earnings,100,50,2/7/2019
DF42A0,earnings,100,50,2/7/2019
E05DC8,earnings,100,50,2/7/2019
E074A0,dividend,100,50,2/7/2019
E0D3BA,earnings,100,50,2/7/2019
E20BFE,revenues,100,50,2/7/2019
E28D9C,conference-call,100,50,2/7/2019
E2CFD2,conference-call,100,50,2/7/2019
E49AA3,earnings,100,50,2/7/2019
E5752F,earnings,100,50,2/7/2019
E5752F,earnings,100,50,2/7/2019
E5752F,earnings,100,50,2/7/2019
E5752F,earnings,100,50,2/7/2019
E5752F,earnings,100,50,2/7/2019
E94704,earnings,100,50,2/7/2019
EF1AD9,dividend,100,50,2/7/2019
EF1AD9,earnings,100,50,2/7/2019
EF1AD9,earnings,100,50,2/7/2019
EF1AD9,earnings,100,50,2/7/2019
F30508,earnings-positive,100,69,2/7/2019
F44EA2,earnings,100,50,2/7/2019
F4E882,earnings,100,50,2/7/2019
F4E882,earnings,100,50,2/7/2019
F4E882,earnings,100,50,2/7/2019
F4E882,earnings,100,50,2/7/2019
F4E882,earnings,100,50,2/7/2019
F4E882,earnings,100,50,2/7/2019
F4F46F,earnings,100,50,2/7/2019
F58C23,earnings,100,50,2/7/2019
F58C23,earnings,100,50,2/7/2019
F5D410,stock-splits,100,49,2/7/2019
F6FA6A,executive-appointment,100,54,2/7/2019
F82D37,executive-appointment,100,54,2/7/2019
FAB97A,earnings,100,50,2/7/2019
FC1A6E,earnings,100,50,2/7/2019
FC1F9D,executive-appointment,100,54,2/7/2019
FC1F9D,executive-appointment,100,54,2/7/2019
FC80E6,conference-call,100,50,2/7/2019
FD6926,conference-call,100,50,2/7/2019
FF6644,dividend,100,50,2/7/2019
FFE543,revenue-up,100,69,2/7/2019
FFE543,revenue-up,100,69,2/7/2019
FFE543,revenue-up,100,69,2/7/2019
FFE543,revenue-up,100,69,2/7/2019
0B9E6F,partnership,100,61,2/8/2019
0BD4E8,conference-call,100,50,2/8/2019
1065BC,earnings,100,50,2/8/2019
1096C6,earnings,100,50,2/8/2019
152E1D,legal-issues-defendant,100,22,2/8/2019
15901B,executive-appointment,100,54,2/8/2019
16B183,dividend,100,50,2/8/2019
1921DD,fraud-defendant,100,20,2/8/2019
19CAC7,dividend,100,50,2/8/2019
1D1B07,conference-participant,100,50,2/8/2019
1D1B07,conference-participant,100,50,2/8/2019
1DDEDA,legal-issues-defendant,100,22,2/8/2019
1E1125,conference-organizer,100,57,2/8/2019
1E1125,conference-organizer,100,57,2/8/2019
1F43A1,earnings,100,50,2/8/2019
2667B6,executive-appointment,100,54,2/8/2019
2BAE5F,partnership,100,61,2/8/2019
2DDB22,earnings-guidance,100,50,2/8/2019
2E6514,earnings,100,50,2/8/2019
2E6514,earnings,100,50,2/8/2019
2E6514,earnings,100,50,2/8/2019
2E6514,earnings,100,50,2/8/2019
2F960F,conference-call,100,50,2/8/2019
34B97A,business-contract,100,69,2/8/2019
3FACA7,earnings-positive,100,69,2/8/2019
3FACA7,earnings,100,50,2/8/2019
3FACA7,earnings,100,50,2/8/2019
3FACA7,earnings,100,50,2/8/2019
458D2C,revenue-volume,100,50,2/8/2019
4C7DB5,earnings,100,50,2/8/2019
50070E,conference-organizer,100,57,2/8/2019
50070E,conference-organizer,100,57,2/8/2019
54512F,award,100,58,2/8/2019
57B174,dividend-up,100,81,2/8/2019
586BD7,legal-issues-defendant,100,22,2/8/2019
5968F9,earnings,100,50,2/8/2019
5DD486,executive-appointment,100,54,2/8/2019
622DBE,note-sale,100,52,2/8/2019
622DBE,note-sale,100,52,2/8/2019
657097,unit-acquisition-acquirer,100,49,2/8/2019
69CE71,conference-call,100,50,2/8/2019
6B0784,executive-appointment,100,54,2/8/2019
6F0096,conference-call,100,50,2/8/2019
741937,dividend,100,50,2/8/2019
76B926,conference-call,100,50,2/8/2019
7823A3,conference-participant,100,50,2/8/2019
789A7D,dividend,100,50,2/8/2019
7999F3,earnings,100,50,2/8/2019
7A10FF,conference-participant,100,50,2/8/2019
7BAAE7,dividend,100,50,2/8/2019
7DD8CC,conference-call,100,50,2/8/2019
82F088,earnings,100,50,2/8/2019
883D82,earnings,100,50,2/8/2019
895D56,note-sale,100,52,2/8/2019
8A8E41,executive-appointment,100,54,2/8/2019
91C82E,facility-open,100,65,2/8/2019
91E5EE,dividend,100,50,2/8/2019
949625,conference-participant,100,50,2/8/2019
968B00,executive-appointment,100,54,2/8/2019
980C14,dividend,100,50,2/8/2019
A16DEA,conference-participant,100,50,2/8/2019
A3F598,earnings,100,50,2/8/2019
A3F598,earnings,100,50,2/8/2019
A3F598,earnings,100,50,2/8/2019
A3F598,earnings,100,50,2/8/2019
A5A4F5,acquisition-acquirer,100,49,2/8/2019
A63820,facility-open,100,65,2/8/2019
A666C8,earnings,100,50,2/8/2019
A7102F,spin-off,100,58,2/8/2019
A7102F,spin-off,100,58,2/8/2019
A79F7D,public-offering,100,43,2/8/2019
AA98ED,earnings,100,50,2/8/2019
AA98ED,earnings,100,50,2/8/2019
AA98ED,earnings,100,50,2/8/2019
AA98ED,earnings,100,50,2/8/2019
AA98ED,earnings,100,50,2/8/2019
AA98ED,earnings,100,50,2/8/2019
AD9F1D,dividend,100,50,2/8/2019
B076A1,conference-call,100,50,2/8/2019
B303A6,earnings,100,50,2/8/2019
B4528F,earnings,100,50,2/8/2019
B4528F,earnings,100,50,2/8/2019
B4528F,earnings,100,50,2/8/2019
B8A51F,conference-participant,100,50,2/8/2019
C037A8,partnership,100,61,2/8/2019
C66B44,product-release,100,64,2/8/2019
CED4D0,executive-resignation,100,44,2/8/2019
D13F1C,conference-participant,100,50,2/8/2019
D20C8F,earnings,100,50,2/8/2019
D29B44,conference-participant,100,50,2/8/2019
D77F7E,earnings,100,50,2/8/2019
D7F569,earnings,100,50,2/8/2019
DA9443,clinical-trials,100,56,2/8/2019
DAFED3,conference-participant,100,50,2/8/2019
DDB002,legal-issues-defendant,100,22,2/8/2019
DDB002,legal-issues-defendant,100,22,2/8/2019
DF16DE,ipo-pricing,100,50,2/8/2019
DF16DE,ipo-pricing,100,50,2/8/2019
DF16DE,ipo-pricing,100,50,2/8/2019
DF6FDD,dividend,100,50,2/8/2019
E00373,earnings,100,50,2/8/2019
E15736,dividend,100,50,2/8/2019
E16133,earnings,100,50,2/8/2019
E1C16B,dividend-up,100,59,2/8/2019
E3E68E,legal-issues-defendant,100,22,2/8/2019
E68733,earnings,100,50,2/8/2019
E74B55,conference-call,100,50,2/8/2019
EB61C4,conference-participant,100,50,2/8/2019
EEA734,trading-resumed,100,58,2/8/2019
F02D0A,unit-acquisition-acquiree,100,76,2/8/2019
F02D0A,unit-acquisition-acquiree,100,76,2/8/2019
F1529C,earnings-up,100,68,2/8/2019
F1529C,earnings,100,50,2/8/2019
F1529C,earnings,100,50,2/8/2019
F1529C,earnings,100,50,2/8/2019
F1529C,earnings,100,50,2/8/2019
F1529C,earnings-up,100,68,2/8/2019
F1529C,earnings,100,50,2/8/2019
F1529C,earnings,100,50,2/8/2019
F1529C,earnings,100,50,2/8/2019
F1529C,earnings,100,50,2/8/2019
F1529C,earnings,100,50,2/8/2019
F179ED,conference-participant,100,50,2/8/2019
F18844,dividend,100,50,2/8/2019
F18844,earnings,100,50,2/8/2019
F31B13,public-offering,100,43,2/8/2019
F6A987,earnings,100,50,2/8/2019
F93C8A,conference-call,100,50,2/8/2019
FACCF6,conference-participant,100,50,2/8/2019
FC80E6,dividend,100,50,2/8/2019
FD39EB,earnings,100,50,2/8/2019
FF4BA4,dividend,100,50,2/8/2019
FF5413,revenue-volume,100,50,2/8/2019
FF6644,conference-participant,100,50,2/8/2019
95294,legal-issues-defendant,100,22,2/9/2019
1E1125,conference-organizer,100,57,2/9/2019
46A16E,conference-participant,100,50,2/9/2019
E35610,legal-issues-defendant,100,22,2/9/2019
E3E68E,legal-issues-defendant,100,22,2/9/2019
02870F,earnings-up,100,68,2/11/2019
036C6F,earnings,100,50,2/11/2019
036C6F,earnings,100,50,2/11/2019
036C6F,earnings,100,50,2/11/2019
03FAA6,partnership,100,61,2/11/2019
0490C6,acquisition-acquirer,100,49,2/11/2019
06A456,merger,100,66,2/11/2019
07EC43,partnership,100,61,2/11/2019
98977,legal-issues-defendant,100,22,2/11/2019
0A0D9E,conference-participant,100,50,2/11/2019
0A7650,earnings-up,100,68,2/11/2019
0A7650,earnings-up,100,68,2/11/2019
0A7650,earnings-up,100,68,2/11/2019
0A7650,earnings-up,100,68,2/11/2019
0A7650,earnings-up,100,68,2/11/2019
0BC29E,award,100,58,2/11/2019
12731D,conference-call,100,50,2/11/2019
138DDE,earnings,100,50,2/11/2019
157CC1,business-contract,100,69,2/11/2019
184988,clinical-trials-start,100,64,2/11/2019
188394,earnings,100,50,2/11/2019
1AE482,earnings,100,50,2/11/2019
1AF7E2,earnings,100,50,2/11/2019
1BC12C,executive-appointment,100,54,2/11/2019
1D3A00,conference-call,100,50,2/11/2019
1E1125,conference-organizer,100,57,2/11/2019
1F716B,earnings,100,50,2/11/2019
1FA886,supply-increase,100,74,2/11/2019
1FE7F0,earnings,100,50,2/11/2019
221AD7,executive-appointment,100,54,2/11/2019
2262BD,earnings,100,50,2/11/2019
249674,conference-call,100,50,2/11/2019
24A89A,executive-appointment,100,54,2/11/2019
24CB56,conference-participant,100,50,2/11/2019
26008A,conference-call,100,50,2/11/2019
279916,business-contract,100,69,2/11/2019
27C10F,acquisition-completed-acquirer,100,49,2/11/2019
27C10F,acquisition-completed-acquirer,100,49,2/11/2019
27C10F,acquisition-completed-acquirer,100,49,2/11/2019
27C10F,acquisition-completed-acquirer,100,49,2/11/2019
2CA60F,partnership,100,61,2/11/2019
2FF046,earnings,100,50,2/11/2019
2FF046,earnings,100,50,2/11/2019
2FF046,earnings,100,50,2/11/2019
306623,earnings,100,50,2/11/2019
30AB63,earnings,100,50,2/11/2019
30DE64,public-offering,100,43,2/11/2019
37E18B,conference-call,100,50,2/11/2019
382EAE,conference-call,100,50,2/11/2019
385DD4,product-release,100,64,2/11/2019
3BB616,conference-call,100,50,2/11/2019
3CCC90,business-contract,100,69,2/11/2019
3DED49,conference-call,100,50,2/11/2019
40F7DE,earnings,100,50,2/11/2019
448BF3,patient-enrollment-complete,100,64,2/11/2019
44ED36,earnings,100,50,2/11/2019
490D4B,earnings,100,50,2/11/2019
494EB9,dividend,100,50,2/11/2019
49F4D0,public-offering,100,43,2/11/2019
4A2457,business-contract,100,69,2/11/2019
4A6F00,partnership,100,61,2/11/2019
4A6F00,partnership,100,61,2/11/2019
4AC91D,earnings,100,50,2/11/2019
4AE584,unit-acquisition-acquirer,100,49,2/11/2019
4B3676,partnership,100,61,2/11/2019
4DD09F,earnings,100,50,2/11/2019
50070E,conference-organizer,100,57,2/11/2019
50070E,conference-organizer,100,57,2/11/2019
50070E,conference-organizer,100,57,2/11/2019
50070E,conference-organizer,100,57,2/11/2019
504FE2,business-contract,100,69,2/11/2019
54F271,executive-appointment,100,54,2/11/2019
5B3415,earnings,100,50,2/11/2019
5C8D61,earnings,100,50,2/11/2019
5C8D61,earnings,100,50,2/11/2019
5C8D61,earnings,100,50,2/11/2019
5CEE02,earnings,100,50,2/11/2019
5CEE02,earnings,100,50,2/11/2019
5CEE02,earnings,100,50,2/11/2019
5F9CE3,unit-acquisition-acquirer,100,49,2/11/2019
5FF95F,unit-acquisition-acquirer,100,49,2/11/2019
629F0F,earnings,100,50,2/11/2019
62CDDE,conference-call,100,50,2/11/2019
649CBD,conference-call,100,50,2/11/2019
66667F,conference-participant,100,50,2/11/2019
67303E,executive-appointment,100,54,2/11/2019
6830FE,executive-appointment,100,54,2/11/2019
6830FE,executive-appointment,100,54,2/11/2019
69FDFC,earnings,100,50,2/11/2019
69FDFC,executive-appointment,100,54,2/11/2019
6A01DF,earnings,100,50,2/11/2019
6D3F35,legal-issues-defendant,100,22,2/11/2019
6D6B40,earnings,100,50,2/11/2019
6-Dec-05,conference-participant,100,50,2/11/2019
704B78,business-contract,100,69,2/11/2019
704B78,business-contract,100,69,2/11/2019
73F70F,conference-call,100,50,2/11/2019
762B8D,earnings,100,50,2/11/2019
76959C,executive-appointment,100,54,2/11/2019
76BD96,executive-appointment,100,54,2/11/2019
7A51FE,earnings,100,50,2/11/2019
7C790D,conference-call,100,50,2/11/2019
7F0372,earnings,100,50,2/11/2019
7F3669,conference-participant,100,50,2/11/2019
834152,executive-appointment,100,54,2/11/2019
8377DB,product-release,100,64,2/11/2019
85DA04,earnings,100,50,2/11/2019
85DA04,earnings,100,50,2/11/2019
85DA04,earnings,100,50,2/11/2019
85DA04,earnings,100,50,2/11/2019
860AB6,earnings,100,50,2/11/2019
86AA9C,conference-call,100,50,2/11/2019
88923D,award,100,58,2/11/2019
895D56,earnings,100,50,2/11/2019
8AC740,earnings,100,50,2/11/2019
8BAA15,acquisition-interest-acquirer,100,46,2/11/2019
8C6C1B,facility-open,100,65,2/11/2019
900356,partnership,100,61,2/11/2019
900356,partnership,100,61,2/11/2019
9196A2,acquisition-acquirer,100,49,2/11/2019
9196A2,business-contract,100,69,2/11/2019
9196A2,conference-organizer,100,57,2/11/2019
9196A2,conference-organizer,100,57,2/11/2019
9196A2,conference-organizer,100,57,2/11/2019
92D757,earnings,100,50,2/11/2019
940C3D,merger,100,66,2/11/2019
94637C,regulatory-product-approval-granted,100,81,2/11/2019
9470CC,earnings,100,50,2/11/2019
94983E,earnings,100,50,2/11/2019
9.54E+32,product-release,100,64,2/11/2019
968B00,earnings-positive,100,69,2/11/2019
968B00,earnings-positive,100,69,2/11/2019
97FE80,earnings,100,50,2/11/2019
9CA619,donation,100,54,2/11/2019
9D6A24,debt-extension-recipient,100,73,2/11/2019
9E98F2,conference-participant,100,50,2/11/2019
9F5997,executive-appointment,100,54,2/11/2019
A1EAC8,government-contract,100,69,2/11/2019
A5A4F5,acquisition-acquirer,100,49,2/11/2019
AA09AD,partnership,100,61,2/11/2019
AA5C8E,conference-participant,100,50,2/11/2019
AA5C8E,conference-participant,100,50,2/11/2019
AAEE21,earnings,100,50,2/11/2019
AB4A7E,earnings,100,50,2/11/2019
AD6141,earnings,100,50,2/11/2019
AE7D16,earnings,100,50,2/11/2019
AECCA9,acquisition-completed-acquirer,100,49,2/11/2019
B1A85D,earnings,100,50,2/11/2019
B1FC3B,business-contract,100,69,2/11/2019
B290A2,fast-track-designation,100,81,2/11/2019
B7EB38,conference-participant,100,50,2/11/2019
B9764A,partnership,100,61,2/11/2019
BB02FB,executive-appointment,100,54,2/11/2019
BB0587,earnings,100,50,2/11/2019
BB127B,conference-participant,100,50,2/11/2019
BB127B,conference-call,100,50,2/11/2019
BB127B,product-release,100,64,2/11/2019
BB127B,product-release,100,64,2/11/2019
BB58FF,conference-participant,100,50,2/11/2019
BB88B6,conference-participant,100,50,2/11/2019
BC4876,earnings,100,50,2/11/2019
C0F70B,earnings,100,50,2/11/2019
C356AC,earnings,100,50,2/11/2019
C584BE,business-contract,100,69,2/11/2019
C659EB,executive-appointment,100,54,2/11/2019
C72B8F,executive-appointment,100,54,2/11/2019
C8257F,dividend-up,100,58,2/11/2019
C83B88,conference-participant,100,50,2/11/2019
C9732E,clinical-trials-positive,100,87,2/11/2019
C9732E,clinical-trials-positive,100,87,2/11/2019
CD4DA8,executive-appointment,100,54,2/11/2019
CDAF5B,dividend,100,50,2/11/2019
CDFCC9,conference-participant,100,50,2/11/2019
D60BB2,dividend-up,100,81,2/11/2019
D9E036,business-contract,100,69,2/11/2019
DA91AE,dividend,100,50,2/11/2019
DCD97F,conference-participant,100,50,2/11/2019
E22FDE,executive-appointment,100,54,2/11/2019
E3656D,earnings,100,50,2/11/2019
E8846E,donation,100,54,2/11/2019
E9C7C0,earnings,100,50,2/11/2019
E9C7C0,earnings,100,50,2/11/2019
E9C7C0,earnings,100,50,2/11/2019
E9C7C0,earnings,100,50,2/11/2019
E9C7C0,earnings,100,50,2/11/2019
E9C7C0,earnings,100,50,2/11/2019
E9C7C0,earnings,100,50,2/11/2019
E9C7C0,earnings,100,50,2/11/2019
EAA0A7,conference-participant,100,50,2/11/2019
EB61C4,executive-appointment,100,54,2/11/2019
ECF709,earnings,100,50,2/11/2019
EE967B,earnings,100,50,2/11/2019
EF25A5,product-release,100,64,2/11/2019
F11638,product-release,100,64,2/11/2019
F1C04C,executive-appointment,100,54,2/11/2019
F1CD47,acquisition-completed-acquirer,100,49,2/11/2019
F48947,earnings,100,50,2/11/2019
F6DA75,earnings,100,50,2/11/2019
F6FF0D,earnings,100,50,2/11/2019
F769E9,earnings,100,50,2/11/2019
F8BA6C,earnings,100,50,2/11/2019
FC9A88,executive-appointment,100,54,2/11/2019
FD0CA4,conference-participant,100,50,2/11/2019
FD9526,dividend,100,50,2/11/2019
FE1A1D,product-release,100,64,2/11/2019
FE1A1D,product-release,100,64,2/11/2019
00698D,conference-call,100,50,2/12/2019
48590,earnings,100,50,2/12/2019
48590,legal-issues-defendant,100,22,2/12/2019
06A456,merger,100,66,2/12/2019
71860,partnership,100,61,2/12/2019
95294,legal-issues-defendant,100,22,2/12/2019
0968A5,conference-call,100,50,2/12/2019
98977,legal-issues-defendant,100,22,2/12/2019
98977,legal-issues-defendant,100,22,2/12/2019
0C355F,conference-call,100,50,2/12/2019
0FABBD,conference-call,100,50,2/12/2019
1096C6,conference-participant,100,50,2/12/2019
12DE76,partnership,100,61,2/12/2019
131443,dividend,100,50,2/12/2019
149301,dividend,100,50,2/12/2019
16C544,earnings,100,50,2/12/2019
16C7F0,executive-resignation,100,44,2/12/2019
182B8C,partnership,100,61,2/12/2019
1A3E1B,conference-call,100,50,2/12/2019
1A5957,earnings,100,50,2/12/2019
1BDB2A,dividend,100,50,2/12/2019
1E4FB9,earnings,100,50,2/12/2019
228D42,partnership,100,61,2/12/2019
241AF7,conference-call,100,50,2/12/2019
2491BC,executive-appointment,100,54,2/12/2019
25A6CC,earnings,100,50,2/12/2019
25AB8E,earnings,100,50,2/12/2019
26DC29,conference-call,100,50,2/12/2019
29CEBF,conference-call,100,50,2/12/2019
2A1009,executive-appointment,100,54,2/12/2019
2E61CC,executive-appointment,100,54,2/12/2019
326EDD,dividend,100,50,2/12/2019
339F20,earnings,100,50,2/12/2019
343996,earnings-up,100,68,2/12/2019
343996,earnings-up,100,68,2/12/2019
37727A,earnings,100,50,2/12/2019
38FB49,dividend,100,50,2/12/2019
3A3948,earnings,100,50,2/12/2019
3B318A,conference-call,100,50,2/12/2019
3B37F7,executive-appointment,100,54,2/12/2019
3B50FE,conference-call,100,50,2/12/2019
3BC360,earnings,100,50,2/12/2019
3C8A04,dividend,100,50,2/12/2019
3E149C,business-contract,100,69,2/12/2019
4.03E+05,partnership,100,61,2/12/2019
41EC04,earnings,100,50,2/12/2019
427F32,conference-call,100,50,2/12/2019
442769,conference-participant,100,50,2/12/2019
45ABCC,product-release,100,64,2/12/2019
45ABCC,product-release,100,64,2/12/2019
467F2C,earnings,100,50,2/12/2019
479930,earnings,100,50,2/12/2019
4.91E+58,earnings-up,100,68,2/12/2019
4.91E+58,earnings,100,50,2/12/2019
4.91E+58,earnings,100,50,2/12/2019
4.91E+58,earnings,100,50,2/12/2019
4.91E+58,earnings,100,50,2/12/2019
4.91E+58,earnings,100,50,2/12/2019
4.91E+58,earnings,100,50,2/12/2019
4.91E+58,earnings,100,50,2/12/2019
49F4D0,public-offering,100,43,2/12/2019
4C7DB5,executive-appointment,100,54,2/12/2019
4F9926,executive-appointment,100,54,2/12/2019
4F9926,executive-appointment,100,54,2/12/2019
513A86,earnings,100,50,2/12/2019
513A86,executive-resignation,100,44,2/12/2019
514067,legal-issues-defendant,100,22,2/12/2019
514067,legal-issues-defendant,100,22,2/12/2019
53E575,partnership,100,61,2/12/2019
5.43E+08,public-offering,100,43,2/12/2019
5480A7,dividend,100,50,2/12/2019
56632F,conference-call,100,50,2/12/2019
57DDB9,partnership,100,61,2/12/2019
59A832,earnings,100,50,2/12/2019
5B6C11,dividend,100,50,2/12/2019
5B6C11,dividend,100,50,2/12/2019
5C2A47,conference-call,100,50,2/12/2019
5CCDAD,earnings,100,50,2/12/2019
6137BF,acquisition-acquirer,100,49,2/12/2019
616E3B,acquisition-completed-acquiree,100,76,2/12/2019
616E3B,acquisition-completed-acquiree,100,76,2/12/2019
619882,conference-organizer,100,57,2/12/2019
61BCA7,earnings,100,50,2/12/2019
6.52E+64,earnings-guidance,100,50,2/12/2019
673C9A,earnings,100,50,2/12/2019
69FDFC,product-release,100,64,2/12/2019
6ABCB8,earnings,100,50,2/12/2019
6D156D,earnings,100,50,2/12/2019
6DC1D7,conference-call,100,50,2/12/2019
6E8864,earnings,100,50,2/12/2019
701531,earnings,100,50,2/12/2019
713810,conference-call,100,50,2/12/2019
717DB4,dividend,100,50,2/12/2019
728737,dividend,100,50,2/12/2019
72C2CE,earnings,100,50,2/12/2019
7734AC,dividend,100,50,2/12/2019
78F9ED,earnings,100,50,2/12/2019
78F9ED,legal-issues-defendant,100,22,2/12/2019
78F9ED,legal-issues-defendant,100,22,2/12/2019
78F9ED,legal-issues-defendant,100,22,2/12/2019
7ADE57,business-contract,100,69,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7B0BA6,earnings,100,50,2/12/2019
7F9BE2,dividend,100,50,2/12/2019
80C400,conference-call,100,50,2/12/2019
8303CD,earnings,100,50,2/12/2019
85AD00,partnership,100,61,2/12/2019
85CDC9,clinical-trials-start,100,64,2/12/2019
85CDC9,earnings,100,50,2/12/2019
85DA04,legal-issues-defendant,100,22,2/12/2019
881190,conference-call,100,50,2/12/2019
895D56,note-sale,100,52,2/12/2019
8A8E41,product-release,100,64,2/12/2019
8BE916,note-sale,100,52,2/12/2019
8C6C1B,facility-open,100,65,2/12/2019
8D4486,partnership,100,61,2/12/2019
8E9CD8,earnings-up,100,68,2/12/2019
8E9CD8,earnings,100,50,2/12/2019
8E9CD8,earnings,100,50,2/12/2019
8E9CD8,earnings,100,50,2/12/2019
8E9CD8,earnings,100,50,2/12/2019
8EEA28,earnings,100,50,2/12/2019
8FCA78,earnings,100,50,2/12/2019
8FCA78,earnings,100,50,2/12/2019
8FCA78,earnings,100,50,2/12/2019
8FCA78,earnings,100,50,2/12/2019
8FCA78,earnings,100,50,2/12/2019
900356,buybacks,100,74,2/12/2019
902255,earnings,100,50,2/12/2019
9087B9,earnings,100,50,2/12/2019
915E7B,earnings,100,50,2/12/2019
9196A2,conference-organizer,100,57,2/12/2019
92D9C9,earnings,100,50,2/12/2019
9.31E+77,conference-call,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
9.36E+10,earnings,100,50,2/12/2019
938D89,ipo-completed,100,76,2/12/2019
945DE6,executive-resignation,100,44,2/12/2019
95C575,dividend,100,50,2/12/2019
9.65E+09,earnings,100,50,2/12/2019
9673BD,buybacks,100,74,2/12/2019
968B00,dividend,100,50,2/12/2019
97AF94,earnings,100,50,2/12/2019
990AD0,conference-organizer,100,57,2/12/2019
9934AD,conference-call,100,50,2/12/2019
9CA432,conference-participant,100,50,2/12/2019
9CA432,conference-participant,100,50,2/12/2019
9CDA4F,earnings,100,50,2/12/2019
9D5FA4,earnings,100,50,2/12/2019
9E575E,earnings,100,50,2/12/2019
9F62D1,dividend,100,50,2/12/2019
9FF5F1,earnings,100,50,2/12/2019
A1EAC8,conference-call,100,50,2/12/2019
A23747,earnings,100,50,2/12/2019
A41450,earnings,100,50,2/12/2019
A4D173,dividend,100,50,2/12/2019
A4D173,dividend,100,50,2/12/2019
A4F67C,earnings,100,50,2/12/2019
A58224,conference-call,100,50,2/12/2019
A5A4F5,acquisition-acquirer,100,49,2/12/2019
A790A5,conference-call,100,50,2/12/2019
A79F7D,public-offering,100,43,2/12/2019
A868C9,conference-participant,100,50,2/12/2019
A94718,earnings,100,50,2/12/2019
AC7C4F,business-contract,100,69,2/12/2019
ACDF88,conference-call,100,50,2/12/2019
AEBB80,earnings,100,50,2/12/2019
AFD1CA,earnings,100,50,2/12/2019
B01111,earnings,100,50,2/12/2019
B08C51,credit-extension-recipient,100,69,2/12/2019
B2206F,note-sale,100,52,2/12/2019
B3CB74,conference-organizer,100,57,2/12/2019
B642E8,unit-acquisition-acquiree,100,76,2/12/2019
B642E8,asset-sale,100,62,2/12/2019
B642E8,unit-acquisition-acquiree,100,76,2/12/2019
B7FA9B,conference-call,100,50,2/12/2019
B803B1,conference-call,100,50,2/12/2019
B9764A,conference-participant,100,50,2/12/2019
BB5271,joint-venture,100,62,2/12/2019
BB5271,earnings,100,50,2/12/2019
BCC13E,earnings,100,50,2/12/2019
BCC55F,conference-participant,100,50,2/12/2019
C03C8B,dividend,100,50,2/12/2019
C07E05,earnings,100,50,2/12/2019
C15F8F,conference-participant,100,50,2/12/2019
C32A39,note-sale,100,52,2/12/2019
C3BAE7,earnings,100,50,2/12/2019
C48574,earnings,100,50,2/12/2019
C564E4,conference-call,100,50,2/12/2019
C5C137,partnership,100,61,2/12/2019
C5C137,executive-appointment,100,54,2/12/2019
C81E00,conference-participant,100,50,2/12/2019
C81E00,conference-participant,100,50,2/12/2019
C8257F,earnings,100,50,2/12/2019
C83B88,business-contract,100,69,2/12/2019
C99CC8,earnings,100,50,2/12/2019
C99CC8,earnings,100,50,2/12/2019
C99CC8,earnings,100,50,2/12/2019
C99CC8,earnings,100,50,2/12/2019
C99CC8,earnings,100,50,2/12/2019
C9E4EC,earnings,100,50,2/12/2019
CA212F,earnings,100,50,2/12/2019
CD2DA4,conference-participant,100,50,2/12/2019
CDE51C,product-release,100,64,2/12/2019
CDE51C,partnership,100,61,2/12/2019
CDE51C,unit-acquisition-acquirer,100,49,2/12/2019
CDE51C,earnings,100,50,2/12/2019
CE1002,dividend,100,50,2/12/2019
CE4FD9,earnings,100,50,2/12/2019
CE4FD9,earnings,100,50,2/12/2019
CE4FD9,earnings,100,50,2/12/2019
CE4FD9,earnings,100,50,2/12/2019
CE4FD9,earnings,100,50,2/12/2019
CE8251,business-contract,100,69,2/12/2019
CFF15D,product-release,100,64,2/12/2019
D0DFE5,executive-appointment,100,54,2/12/2019
D11C1C,market-entry,100,57,2/12/2019
D139BC,earnings,100,50,2/12/2019
D17C1B,revenue-volume,100,50,2/12/2019
D17C1B,partnership,100,61,2/12/2019
D1C26F,earnings-up,100,68,2/12/2019
D1C26F,earnings-up,100,68,2/12/2019
D1C26F,earnings-up,100,68,2/12/2019
D1C26F,earnings-up,100,68,2/12/2019
D33270,business-contract,100,69,2/12/2019
D45285,conference-call,100,50,2/12/2019
D56D6D,award,100,58,2/12/2019
D56D6D,dividend,100,50,2/12/2019
D6534D,earnings,100,50,2/12/2019
D9B1C9,unit-acquisition-acquirer,100,49,2/12/2019
D9B1C9,unit-acquisition-acquirer,100,49,2/12/2019
DA0CB8,earnings,100,50,2/12/2019
DB06B0,partnership,100,61,2/12/2019
DB5CA5,dividend,100,50,2/12/2019
DBFB51,conference-call,100,50,2/12/2019
DCD97F,business-contract,100,69,2/12/2019
DD682D,earnings,100,50,2/12/2019
DD7A96,facility-open,100,65,2/12/2019
DDB002,legal-issues-defendant,100,22,2/12/2019
DF5F14,executive-resignation,100,44,2/12/2019
E06265,dividend,100,50,2/12/2019
E124EB,facility-open,100,65,2/12/2019
E35610,legal-issues-defendant,100,22,2/12/2019
E4CE73,product-release,100,64,2/12/2019
E829E8,dividend,100,50,2/12/2019
E8A49A,executive-appointment,100,54,2/12/2019
E93A40,earnings,100,50,2/12/2019
EB43F4,executive-appointment,100,54,2/12/2019
EB61C4,partnership,100,61,2/12/2019
EB61C4,partnership,100,61,2/12/2019
ED0D7C,dividend,100,50,2/12/2019
F179ED,earnings,100,50,2/12/2019
F1EB39,product-release,100,64,2/12/2019
F48947,conference-participant,100,50,2/12/2019
F4D241,earnings,100,50,2/12/2019
F721A7,earnings,100,50,2/12/2019
F721A7,earnings,100,50,2/12/2019
F90EE5,earnings,100,50,2/12/2019
F93C8A,dividend,100,50,2/12/2019
FA044A,earnings,100,50,2/12/2019
FA044A,earnings,100,50,2/12/2019
FA044A,earnings,100,50,2/12/2019
FA044A,earnings,100,50,2/12/2019
FC1B7B,dividend,100,50,2/12/2019
FD2565,earnings,100,50,2/12/2019
FD4588,award,100,58,2/12/2019
FDF28E,earnings,100,50,2/12/2019
003B70,executive-appointment,100,54,2/13/2019
00E601,dividend,100,50,2/13/2019
13528,dividend,100,50,2/13/2019
04EB2F,earnings,100,50,2/13/2019
053EFF,dividend,100,50,2/13/2019
07C69F,earnings,100,50,2/13/2019
98977,legal-issues-defendant,100,22,2/13/2019
98977,earnings,100,50,2/13/2019
0A9D0A,settlement,100,56,2/13/2019
0B4D10,earnings,100,50,2/13/2019
0B57D7,dividend,100,50,2/13/2019
0BC29E,earnings,100,50,2/13/2019
0BC29E,earnings,100,50,2/13/2019
0BC29E,earnings,100,50,2/13/2019
0BC29E,earnings,100,50,2/13/2019
0BC29E,earnings,100,50,2/13/2019
0BC29E,earnings,100,50,2/13/2019
0BC29E,earnings,100,50,2/13/2019
0C28D1,business-contract,100,69,2/13/2019
0C2A0D,dividend-guidance,100,50,2/13/2019
0F91FC,earnings,100,50,2/13/2019
12DE76,earnings,100,50,2/13/2019
12DE76,earnings,100,50,2/13/2019
12DE76,earnings,100,50,2/13/2019
12DE76,earnings,100,50,2/13/2019
12DE76,earnings,100,50,2/13/2019
12DE76,earnings,100,50,2/13/2019
1348C9,dividend,100,50,2/13/2019
149301,earnings,100,50,2/13/2019
16C7F0,executive-resignation,100,44,2/13/2019
16F4D8,earnings,100,50,2/13/2019
1921DD,legal-issues-defendant,100,22,2/13/2019
1A2D9F,executive-appointment,100,54,2/13/2019
1CD09C,conference-call,100,50,2/13/2019
1CF3A8,earnings,100,50,2/13/2019
1D9E55,earnings,100,50,2/13/2019
1D9E55,earnings-up,100,68,2/13/2019
1D9E55,earnings-up,100,68,2/13/2019
1D9E55,earnings-up,100,68,2/13/2019
1D9E55,earnings-up,100,68,2/13/2019
1D9E55,earnings-up,100,68,2/13/2019
1D9E55,earnings-up,100,68,2/13/2019
1DEBBE,earnings,100,50,2/13/2019
1E04A5,earnings,100,50,2/13/2019
1E68B3,business-contract,100,69,2/13/2019
1FA886,executive-appointment,100,54,2/13/2019
1FAF22,conference-participant,100,50,2/13/2019
205AD5,executive-appointment,100,54,2/13/2019
20D00A,earnings,100,50,2/13/2019
21022F,earnings,100,50,2/13/2019
221783,partnership,100,61,2/13/2019
227F04,conference-participant,100,50,2/13/2019
228D42,partnership,100,61,2/13/2019
228D42,partnership,100,61,2/13/2019
228D42,partnership,100,61,2/13/2019
253B2F,conference-call,100,50,2/13/2019
25DD05,earnings,100,50,2/13/2019
275300,conference-participant,100,50,2/13/2019
28F905,executive-appointment,100,54,2/13/2019
2920D5,dividend-up,100,81,2/13/2019
2920D5,earnings,100,50,2/13/2019
297DA8,conference-call,100,50,2/13/2019
2D643C,conference-participant,100,50,2/13/2019
2F6782,dividend-up,100,81,2/13/2019
2F6782,earnings,100,50,2/13/2019
2F94A5,executive-resignation,100,44,2/13/2019
30CBF9,product-release,100,64,2/13/2019
30DFD3,earnings,100,50,2/13/2019
315EB0,earnings,100,50,2/13/2019
315EB0,dividend,100,50,2/13/2019
31DB20,earnings,100,50,2/13/2019
3224CC,acquisition-acquirer,100,49,2/13/2019
339F20,earnings,100,50,2/13/2019
3461CF,credit-rating-upgrade-rater,20,50,2/13/2019
3461CF,credit-rating-outlook-stable-rater,20,50,2/13/2019
3461CF,credit-rating-set-rater,20,50,2/13/2019
3461CF,credit-rating-upgrade-rater,20,50,2/13/2019
3461CF,analyst-ratings-change-positive-rater,20,50,2/13/2019
3461CF,executive-appointment,100,54,2/13/2019
35F4B5,dividend,100,50,2/13/2019
366A08,settlement,100,56,2/13/2019
366A08,board-meeting,100,51,2/13/2019
36A1CB,conference-call,100,50,2/13/2019
370C50,unit-acquisition-completed-acquirer,100,49,2/13/2019
371C01,conference-call,100,50,2/13/2019
372037,conference-call,100,50,2/13/2019
3798B9,earnings,100,50,2/13/2019
3BA1BF,conference-call,100,50,2/13/2019
3C3B6B,revenue-up,100,69,2/13/2019
3C3B6B,earnings,100,50,2/13/2019
3C3B6B,earnings,100,50,2/13/2019
3DCECC,earnings,100,50,2/13/2019
408089,dividend,100,50,2/13/2019
40B903,earnings,100,50,2/13/2019
416C55,conference-participant,100,50,2/13/2019
423279,conference-participant,100,50,2/13/2019
42AABD,earnings,100,50,2/13/2019
4455C4,earnings,100,50,2/13/2019
4455C4,earnings,100,50,2/13/2019
4455C4,earnings,100,50,2/13/2019
4455C4,earnings,100,50,2/13/2019
44A4FC,executive-appointment,100,54,2/13/2019
4649D5,earnings,100,50,2/13/2019
468DD4,earnings,100,50,2/13/2019
47FCF2,earnings,100,50,2/13/2019
485445,earnings,100,50,2/13/2019
49BBBC,legal-issues-defendant,100,22,2/13/2019
49BBBC,product-release,100,64,2/13/2019
4E5784,conference-participant,100,50,2/13/2019
4EE14A,earnings,100,50,2/13/2019
4EE14A,earnings,100,50,2/13/2019
4F9926,legal-issues-defendant,100,22,2/13/2019
532D47,earnings,100,50,2/13/2019
5.43E+08,public-offering,100,43,2/13/2019
55438C,joint-venture,100,62,2/13/2019
556F08,conference-participant,100,50,2/13/2019
55C9B5,executive-resignation,100,44,2/13/2019
564F3E,earnings,100,50,2/13/2019
567F3D,executive-appointment,100,54,2/13/2019
57F3DA,earnings,100,50,2/13/2019
58CA9A,conference-organizer,100,57,2/13/2019
59A832,dividend,100,50,2/13/2019
5A9F54,revenue-up,100,69,2/13/2019
5A9F54,revenue-up,100,69,2/13/2019
5A9F54,revenue-up,100,69,2/13/2019
5A9F54,revenue-up,100,69,2/13/2019
5A9F54,revenue-up,100,69,2/13/2019
5AF08A,earnings,100,50,2/13/2019
5AF08A,unit-acquisition-acquirer,100,49,2/13/2019
5B226B,acquisition-acquirer,100,49,2/13/2019
5C2A47,earnings,100,50,2/13/2019
5E6959,conference-participant,100,50,2/13/2019
60EA12,dividend-up,100,81,2/13/2019
60EA12,earnings,100,50,2/13/2019
6166D1,partnership,100,61,2/13/2019
619882,business-contract,100,69,2/13/2019
61E975,earnings-positive,100,69,2/13/2019
61E975,earnings,100,50,2/13/2019
61E975,earnings,100,50,2/13/2019
61E975,earnings,100,50,2/13/2019
61E975,earnings,100,50,2/13/2019
61E975,earnings,100,50,2/13/2019
61E975,earnings,100,50,2/13/2019
636BBF,executive-appointment,100,54,2/13/2019
6559D8,conference-participant,100,50,2/13/2019
66E04A,earnings,100,50,2/13/2019
68E6E9,dividend,100,50,2/13/2019
69FDFC,partnership,100,61,2/13/2019
6B494E,earnings,100,50,2/13/2019
6BDA0C,conference-call,100,50,2/13/2019
6CB7F9,earnings,100,50,2/13/2019
6E7060,conference-call,100,50,2/13/2019
6F0A63,earnings,100,50,2/13/2019
6F22E7,conference-call,100,50,2/13/2019
6F3FA8,earnings,100,50,2/13/2019
6F3FA8,earnings,100,50,2/13/2019
6F3FA8,earnings,100,50,2/13/2019
6F3FA8,earnings,100,50,2/13/2019
6F3FA8,earnings,100,50,2/13/2019
6F3FA8,earnings,100,50,2/13/2019
70FCEF,executive-appointment,100,54,2/13/2019
719477,dividend,100,50,2/13/2019
71E2EF,settlement,100,56,2/13/2019
722D55,conference-participant,100,50,2/13/2019
7239BB,facility-open,100,65,2/13/2019
73A71F,dividend,100,50,2/13/2019
73BCBA,unit-acquisition-acquirer,100,49,2/13/2019
73BCBA,earnings,100,50,2/13/2019
73BCBA,earnings,100,50,2/13/2019
73BCBA,earnings,100,50,2/13/2019
73BCBA,earnings,100,50,2/13/2019
73F70F,dividend,100,50,2/13/2019
769F40,business-contract,100,69,2/13/2019
78F9ED,legal-issues-defendant,100,22,2/13/2019
790D0D,earnings,100,50,2/13/2019
7C75FD,earnings,100,50,2/13/2019
7F9BE2,earnings,100,50,2/13/2019
7FDE1C,earnings,100,50,2/13/2019
824CCA,buybacks,100,74,2/13/2019
824CCA,earnings,100,50,2/13/2019
8303CD,conference-participant,100,50,2/13/2019
83A065,conference-call,100,50,2/13/2019
86A1B9,stock-gain,100,63,2/13/2019
881190,dividend,100,50,2/13/2019
8A0368,conference-call,100,50,2/13/2019
8AB37F,conference-call,100,50,2/13/2019
8B4A45,facility-open,100,65,2/13/2019
8C6C1B,facility-open,100,65,2/13/2019
8D4486,business-contract,100,69,2/13/2019
8DBE73,revenues,100,50,2/13/2019
8E8E6E,earnings,100,50,2/13/2019
8FCA78,dividend,100,50,2/13/2019
8FF2EF,earnings,100,50,2/13/2019
901327,dividend,100,50,2/13/2019
9196A2,conference-organizer,100,57,2/13/2019
9196A2,conference-organizer,100,57,2/13/2019
9196A2,conference-organizer,100,57,2/13/2019
9196A2,conference-organizer,100,57,2/13/2019
934CC3,earnings,100,50,2/13/2019
9.36E+10,earnings,100,50,2/13/2019
9.36E+10,earnings,100,50,2/13/2019
943239,earnings,100,50,2/13/2019
97644E,earnings,100,50,2/13/2019
990AD0,conference-organizer,100,57,2/13/2019
990AD0,conference-organizer,100,57,2/13/2019
9B4066,unit-acquisition-acquirer,100,49,2/13/2019
9BB35A,dividend-up,100,53,2/13/2019
9BB35A,earnings-per-share-positive,100,69,2/13/2019
9BB35A,earnings-per-share,100,50,2/13/2019
9BB35A,earnings-per-share,100,50,2/13/2019
9BB35A,earnings-per-share,100,50,2/13/2019
9F18FA,note-sale,100,52,2/13/2019
9F18FA,note-sale,100,52,2/13/2019
9F37C5,conference-call,100,50,2/13/2019
9FD2D9,earnings,100,50,2/13/2019
9FD2D9,earnings,100,50,2/13/2019
9FD2D9,earnings,100,50,2/13/2019
A29A46,earnings,100,50,2/13/2019
A398F8,earnings,100,50,2/13/2019
A4386C,earnings,100,50,2/13/2019
A43906,dividend,100,50,2/13/2019
A5151E,earnings,100,50,2/13/2019
A5A4F5,acquisition-acquirer,100,49,2/13/2019
A5E715,executive-resignation,100,44,2/13/2019
A63387,business-contract,100,69,2/13/2019
A6FC89,partnership,100,61,2/13/2019
A7102F,conference-participant,100,50,2/13/2019
A87CD6,earnings,100,50,2/13/2019
A87CD6,dividend,100,50,2/13/2019
AA09AD,earnings,100,50,2/13/2019
AB7F05,earnings-up,100,68,2/13/2019
ACC7D3,earnings,100,50,2/13/2019
ACDF88,award,100,58,2/13/2019
AD22F2,executive-appointment,100,54,2/13/2019
AD3008,earnings,100,50,2/13/2019
ADF1B0,conference-call,100,50,2/13/2019
AE79CD,earnings,100,50,2/13/2019
B076A1,earnings,100,50,2/13/2019
B13B68,acquisition-completed-acquirer,100,49,2/13/2019
B13B68,earnings,100,50,2/13/2019
B1FC3B,business-contract,100,69,2/13/2019
B33E77,note-sale,100,52,2/13/2019
B48FC9,conference-participant,100,50,2/13/2019
B4B281,conference-call,100,50,2/13/2019
B5DE80,earnings,100,50,2/13/2019
B642E8,earnings,100,50,2/13/2019
B66928,earnings,100,50,2/13/2019
B7202A,conference-call,100,50,2/13/2019
B9764A,product-release,100,64,2/13/2019
BCE9DA,earnings,100,50,2/13/2019
BCE9DA,earnings,100,50,2/13/2019
BD682F,dividend,100,50,2/13/2019
BE14CF,executive-resignation,100,44,2/13/2019
C06EB6,earnings,100,50,2/13/2019
C06EB6,earnings,100,50,2/13/2019
C06EB6,earnings,100,50,2/13/2019
C1114B,earnings,100,50,2/13/2019
C1114B,earnings,100,50,2/13/2019
C1114B,earnings,100,50,2/13/2019
C1114B,earnings,100,50,2/13/2019
C27E19,earnings,100,50,2/13/2019
C4A912,earnings,100,50,2/13/2019
C4F567,executive-appointment,100,54,2/13/2019
C659EB,conference-participant,100,50,2/13/2019
C8923A,earnings,100,50,2/13/2019
C9E04B,earnings,100,50,2/13/2019
CC0C78,earnings,100,50,2/13/2019
CC8F6E,conference-participant,100,50,2/13/2019
CD2A4D,earnings,100,50,2/13/2019
CDAA0E,earnings,100,50,2/13/2019
CF6A5A,earnings,100,50,2/13/2019
D08D2C,earnings,100,50,2/13/2019
D08D2C,earnings,100,50,2/13/2019
D11C1C,earnings,100,50,2/13/2019
D1C26F,conference-participant,100,50,2/13/2019
D2B9E5,earnings,100,50,2/13/2019
D2B9E5,earnings,100,50,2/13/2019
D2B9E5,earnings,100,50,2/13/2019
D2B9E5,earnings,100,50,2/13/2019
D2E553,executive-appointment,100,54,2/13/2019
D56E4C,acquisition-completed-acquirer,100,49,2/13/2019
D8760C,buybacks,100,74,2/13/2019
DA48E4,conference-participant,100,50,2/13/2019
DB7014,operating-earnings,100,50,2/13/2019
DC6AA0,earnings,100,50,2/13/2019
DF18E6,conference-participant,100,50,2/13/2019
E124EB,conference-participant,100,50,2/13/2019
E12A6E,earnings,100,50,2/13/2019
E21871,business-contract,100,69,2/13/2019
E21871,earnings,100,50,2/13/2019
E2F66E,earnings-guidance,100,50,2/13/2019
E30B34,earnings,100,50,2/13/2019
E30B34,earnings,100,50,2/13/2019
E8846E,executive-appointment,100,54,2/13/2019
EA62FC,conference-participant,100,50,2/13/2019
EAA0A7,executive-appointment,100,54,2/13/2019
EAEBF3,business-contract,100,69,2/13/2019
EBD89A,business-contract,100,69,2/13/2019
ED2A5E,conference-participant,100,50,2/13/2019
EE74E1,business-contract,100,69,2/13/2019
EEA734,product-release,100,64,2/13/2019
EF25A5,earnings,100,50,2/13/2019
EFD406,earnings,100,50,2/13/2019
EFD406,earnings,100,50,2/13/2019
EFD406,earnings,100,50,2/13/2019
EFD406,earnings,100,50,2/13/2019
EFD406,earnings,100,50,2/13/2019
EFD406,earnings,100,50,2/13/2019
EFD406,earnings,100,50,2/13/2019
F1529C,dividend,100,50,2/13/2019
F1C04C,conference-call,100,50,2/13/2019
F2E253,partnership,100,61,2/13/2019
F39E1E,executive-appointment,100,54,2/13/2019
F702CA,dividend,100,50,2/13/2019
F702CA,executive-resignation,100,44,2/13/2019
F93C8A,executive-resignation,100,44,2/13/2019
F93C8A,executive-appointment,100,54,2/13/2019
FC9869,executive-resignation,100,44,2/13/2019
FD9526,earnings,100,50,2/13/2019
FFAB4A,earnings,100,50,2/13/2019
03B8CF,legal-issues-defendant,100,22,2/14/2019
04EB2F,earnings,100,50,2/14/2019
070B45,earnings,100,50,2/14/2019
07CA6A,dividend,100,50,2/14/2019
07CA6A,dividend,100,50,2/14/2019
98977,legal-issues-defendant,100,22,2/14/2019
099C88,conference-call,100,50,2/14/2019
09DE1F,earnings,100,50,2/14/2019
0A0D9E,executive-appointment,100,54,2/14/2019
0A9D0A,dividend,100,50,2/14/2019
0C28D1,earnings-meet-expectations,100,59,2/14/2019
0C28D1,earnings,100,50,2/14/2019
0C28D1,earnings,100,50,2/14/2019
0C28D1,earnings,100,50,2/14/2019
0C28D1,earnings,100,50,2/14/2019
0C28D1,earnings,100,50,2/14/2019
0C8D82,earnings,100,50,2/14/2019
106394,earnings,100,50,2/14/2019
135B09,dividend,100,50,2/14/2019
14391F,earnings,100,50,2/14/2019
1.79E+10,dividend,100,50,2/14/2019
1.79E+10,earnings,100,50,2/14/2019
197612,earnings-up,100,83,2/14/2019
1AC649,conference-participant,100,50,2/14/2019
1F08A6,earnings,100,50,2/14/2019
1FA886,business-contract,100,69,2/14/2019
1FA886,earnings-up,100,68,2/14/2019
1FA886,dividend,100,50,2/14/2019
1FA886,earnings-per-share-positive,100,69,2/14/2019
1FA886,revenues,100,50,2/14/2019
1FA886,ebit-positive,100,69,2/14/2019
1FA886,earnings-up,100,68,2/14/2019
2096DE,earnings,100,50,2/14/2019
20BEEA,dividend-up,100,81,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
21153F,earnings,100,50,2/14/2019
221445,conference-call,100,50,2/14/2019
227D48,earnings,100,50,2/14/2019
228D42,business-contract,100,69,2/14/2019
284289,dividend,100,50,2/14/2019
2920D5,conference-participant,100,50,2/14/2019
295F9F,executive-appointment,100,54,2/14/2019
2E1322,earnings,100,50,2/14/2019
2EBA55,earnings,100,50,2/14/2019
2F98A5,partnership,100,61,2/14/2019
301493,conference-call,100,50,2/14/2019
30DE64,public-offering,100,43,2/14/2019
32CB22,conference-participant,100,50,2/14/2019
32DCB3,ipo-completed,100,76,2/14/2019
33AD83,conference-call,100,50,2/14/2019
3461CF,credit-rating-outlook-positive-rater,20,50,2/14/2019
3461CF,executive-appointment,100,54,2/14/2019
3471C0,conference-call,100,50,2/14/2019
349DA4,earnings,100,50,2/14/2019
34B97A,conference-participant,100,50,2/14/2019
34E9F9,earnings,100,50,2/14/2019
35557B,executive-appointment,100,54,2/14/2019
35AE32,earnings,100,50,2/14/2019
366A08,earnings,100,50,2/14/2019
37426C,conference-call,100,50,2/14/2019
3798B9,conference-participant,100,50,2/14/2019
383ADA,dividend-up,100,81,2/14/2019
389CFB,conference-call,100,50,2/14/2019
396D7C,earnings,100,50,2/14/2019
3A3447,facility-open,100,65,2/14/2019
3BA1BF,conference-call,100,50,2/14/2019
3C7F5F,business-contract,100,69,2/14/2019
3C7F5F,earnings,100,50,2/14/2019
3DC887,earnings,100,50,2/14/2019
3DDE54,earnings,100,50,2/14/2019
3DDE54,earnings,100,50,2/14/2019
3DDE54,earnings,100,50,2/14/2019
3DDE54,earnings,100,50,2/14/2019
3DDE54,earnings,100,50,2/14/2019
3DDE54,earnings,100,50,2/14/2019
3DDE54,earnings,100,50,2/14/2019
4.03E+05,campaign-ad-release,100,59,2/14/2019
41A93D,earnings,100,50,2/14/2019
44DDBD,conference-call,100,50,2/14/2019
451D61,earnings,100,50,2/14/2019
45ABCC,conference-participant,100,50,2/14/2019
45ABCC,revenue-up,100,73,2/14/2019
45ABCC,revenue-up,100,73,2/14/2019
45ABCC,revenue-up,100,73,2/14/2019
4A2457,conference-call,100,50,2/14/2019
4B5054,dividend,100,50,2/14/2019
4C350A,earnings,100,50,2/14/2019
4C5CC9,conference-call,100,50,2/14/2019
4C6C63,buybacks,100,74,2/14/2019
4E3D15,board-meeting,100,51,2/14/2019
4E4E75,conference-call,100,50,2/14/2019
4FB770,dividend,100,50,2/14/2019
504FE2,conference-participant,100,50,2/14/2019
514067,earnings,100,50,2/14/2019
52BF94,earnings,100,50,2/14/2019
54F271,executive-appointment,100,54,2/14/2019
567F3D,conference-participant,100,50,2/14/2019
56EFC7,earnings,100,50,2/14/2019
5704AC,executive-appointment,100,54,2/14/2019
57B174,earnings,100,50,2/14/2019
57B174,earnings,100,50,2/14/2019
57B174,earnings,100,50,2/14/2019
57B174,earnings,100,50,2/14/2019
57B174,earnings,100,50,2/14/2019
58B46F,conference-call,100,50,2/14/2019
58CA9A,conference-organizer,100,57,2/14/2019
59872F,executive-appointment,100,54,2/14/2019
5A9A82,earnings,100,50,2/14/2019
5A9A82,earnings,100,50,2/14/2019
5A9A82,earnings,100,50,2/14/2019
5A9A82,earnings,100,50,2/14/2019
5B226B,dividend,100,50,2/14/2019
5D16CF,earnings,100,50,2/14/2019
5DD486,earnings,100,50,2/14/2019
5DE5A5,earnings-up,100,68,2/14/2019
5DE5A5,earnings-up,100,68,2/14/2019
5DE5A5,earnings-up,100,68,2/14/2019
5E6959,partnership,100,61,2/14/2019
5F9CE3,earnings,100,50,2/14/2019
616E3B,earnings,100,50,2/14/2019
622DBE,partnership,100,61,2/14/2019
6284B5,earnings,100,50,2/14/2019
657097,index-listing,100,76,2/14/2019
665618,earnings-up,100,68,2/14/2019
665618,earnings-up,100,68,2/14/2019
665618,earnings-up,100,68,2/14/2019
66667F,revenue-up,100,88,2/14/2019
67B052,earnings,100,50,2/14/2019
6844D2,executive-appointment,100,54,2/14/2019
694749,earnings,100,50,2/14/2019
6B236C,earnings,100,50,2/14/2019
6BD606,conference-call,100,50,2/14/2019
6BD606,conference-call,100,50,2/14/2019
6CC55E,earnings,100,50,2/14/2019
6D3F35,legal-issues-defendant,100,22,2/14/2019
6F39FC,dividend,100,50,2/14/2019
6F5DD2,earnings,100,50,2/14/2019
701531,conference-participant,100,50,2/14/2019
709AED,dividend,100,50,2/14/2019
709AED,earnings-up,100,68,2/14/2019
709AED,earnings,100,50,2/14/2019
709AED,earnings,100,50,2/14/2019
709AED,earnings,100,50,2/14/2019
70FCEF,product-resumed,100,52,2/14/2019
71B0CF,executive-appointment,100,54,2/14/2019
73A71F,earnings,100,50,2/14/2019
73C521,executive-appointment,100,54,2/14/2019
75F982,product-release,100,64,2/14/2019
75F982,acquisition-acquirer,100,49,2/14/2019
762A3E,conference-organizer,100,57,2/14/2019
762A3E,earnings,100,50,2/14/2019
76B926,dividend,100,50,2/14/2019
76D79A,executive-appointment,100,54,2/14/2019
7710F3,conference-call,100,50,2/14/2019
7823A3,executive-appointment,100,54,2/14/2019
789A7D,earnings,100,50,2/14/2019
789A7D,earnings,100,50,2/14/2019
789A7D,earnings,100,50,2/14/2019
789A7D,earnings,100,50,2/14/2019
78F9ED,legal-issues-defendant,100,22,2/14/2019
791EC1,conference-call,100,50,2/14/2019
7A0EC4,conference-call,100,50,2/14/2019
7CBC40,earnings,100,50,2/14/2019
7E3F8F,earnings,100,50,2/14/2019
80C400,earnings,100,50,2/14/2019
80D744,earnings,100,50,2/14/2019
8195B7,ipo-pricing,100,50,2/14/2019
845533,earnings,100,50,2/14/2019
862941,earnings,100,50,2/14/2019
86BAC7,unit-acquisition-acquiree,100,76,2/14/2019
88923D,earnings,100,50,2/14/2019
88923D,earnings,100,50,2/14/2019
88923D,earnings,100,50,2/14/2019
88923D,earnings,100,50,2/14/2019
88923D,earnings,100,50,2/14/2019
88923D,earnings,100,50,2/14/2019
896771,conference-call,100,50,2/14/2019
89F693,product-release,100,64,2/14/2019
8A8E41,facility-close,100,47,2/14/2019
8A8E41,award,100,58,2/14/2019
8AC65D,conference-participant,100,50,2/14/2019
8B3B0E,earnings,100,50,2/14/2019
8BE916,dividend,100,50,2/14/2019
8C6C1B,facility-open,100,65,2/14/2019
8D4486,partnership,100,61,2/14/2019
8D4486,partnership,100,61,2/14/2019
8DBBE6,earnings,100,50,2/14/2019
8DE74B,earnings,100,50,2/14/2019
8E4250,earnings,100,50,2/14/2019
9043FE,earnings,100,50,2/14/2019
9043FE,earnings,100,50,2/14/2019
9196A2,conference-organizer,100,57,2/14/2019
93AD2E,earnings,100,50,2/14/2019
943239,earnings,100,50,2/14/2019
94756D,earnings,100,50,2/14/2019
95C392,earnings,100,50,2/14/2019
9.65E+07,conference-call,100,50,2/14/2019
96B4FF,earnings,100,50,2/14/2019
96B4FF,earnings,100,50,2/14/2019
971F7B,earnings,100,50,2/14/2019
977A1E,executive-appointment,100,54,2/14/2019
990AD0,conference-organizer,100,57,2/14/2019
9.92E+94,fundraising,100,64,2/14/2019
9.97E+09,dividend,100,50,2/14/2019
9ABD30,earnings,100,50,2/14/2019
9C25FF,earnings-guidance,100,50,2/14/2019
9DDE1B,earnings,100,50,2/14/2019
9E4A5F,earnings,100,50,2/14/2019
9E98F2,product-release,100,64,2/14/2019
9F048E,earnings,100,50,2/14/2019
9F37C5,dividend,100,50,2/14/2019
9F37C5,earnings,100,50,2/14/2019
A16DEA,partnership,100,61,2/14/2019
A1BB98,earnings,100,50,2/14/2019
A1EAC8,earnings,100,50,2/14/2019
A4BCDE,earnings,100,50,2/14/2019
A52B6B,conference-participant,100,50,2/14/2019
A5A4F5,acquisition-acquirer,100,49,2/14/2019
A631A3,earnings,100,50,2/14/2019
A6828A,clinical-trials,100,56,2/14/2019
A6828A,conference-participant,100,50,2/14/2019
A70BF5,partnership,100,61,2/14/2019
A7F0A5,earnings,100,50,2/14/2019
AAC8B6,conference-call,100,50,2/14/2019
AAC8B6,conference-call,100,50,2/14/2019
ACC7D3,conference-participant,100,50,2/14/2019
AD6141,dividend,100,50,2/14/2019
AD9F1D,revenue-up,100,65,2/14/2019
AD9F1D,revenue-up,100,69,2/14/2019
AD9F1D,revenue-up,100,69,2/14/2019
AD9F1D,revenue-up,100,69,2/14/2019
AD9F1D,revenue-up,100,69,2/14/2019
AD9F1D,revenue-up,100,69,2/14/2019
AD9F1D,revenue-up,100,69,2/14/2019
AD9F1D,revenue-up,100,69,2/14/2019
AED6CF,conference-call,100,50,2/14/2019
B09B1F,conference-call,100,50,2/14/2019
B1A85D,conference-call,100,50,2/14/2019
B2206F,note-sale,100,52,2/14/2019
B33E77,note-sale,100,52,2/14/2019
B54A74,revenue-down,100,30,2/14/2019
BB02FB,earnings-per-share-positive,100,69,2/14/2019
BB02FB,earnings-per-share,100,50,2/14/2019
BB02FB,earnings-per-share,100,50,2/14/2019
BB02FB,earnings-per-share,100,50,2/14/2019
BB02FB,earnings-per-share,100,50,2/14/2019
BB02FB,earnings-per-share,100,50,2/14/2019
BB0587,dividend,100,50,2/14/2019
BF5959,private-placement,100,56,2/14/2019
BF79F5,earnings,100,50,2/14/2019
BFE02C,executive-appointment,100,54,2/14/2019
C0030A,earnings,100,50,2/14/2019
C03C8B,earnings,100,50,2/14/2019
C1114B,dividend,100,50,2/14/2019
C4FBDC,earnings,100,50,2/14/2019
C584BE,earnings,100,50,2/14/2019
C66A8C,executive-appointment,100,54,2/14/2019
C66A8C,earnings,100,50,2/14/2019
C7859D,executive-appointment,100,54,2/14/2019
C8A248,dividend,100,50,2/14/2019
C8A248,dividend,100,50,2/14/2019
C8A248,dividend,100,50,2/14/2019
C97B2D,conference-participant,100,50,2/14/2019
CAB222,conference-call,100,50,2/14/2019
CC0C78,conference-participant,100,50,2/14/2019
CE5664,dividend,100,50,2/14/2019
CE96E7,dividend,100,50,2/14/2019
CFD4B6,conference-call,100,50,2/14/2019
D03C7A,dividend,100,50,2/14/2019
D0DE27,earnings,100,50,2/14/2019
D17C1B,product-release,100,64,2/14/2019
D29B44,executive-appointment,100,54,2/14/2019
D4070C,dividend,100,50,2/14/2019
D518D8,earnings,100,50,2/14/2019
D518D8,earnings,100,50,2/14/2019
D518D8,earnings,100,50,2/14/2019
D518D8,earnings,100,50,2/14/2019
D54E62,business-contract,100,69,2/14/2019
D57D99,product-release,100,64,2/14/2019
D6489C,executive-appointment,100,54,2/14/2019
D64C6D,partnership,100,61,2/14/2019
D64C6D,dividend,100,50,2/14/2019
D75910,conference-call,100,50,2/14/2019
D854DD,dividend,100,50,2/14/2019
D8DA3D,dividend,100,50,2/14/2019
D9164D,dividend,100,50,2/14/2019
D9164D,earnings,100,50,2/14/2019
DA0A9E,dividend,100,50,2/14/2019
DB2E4E,business-contract,100,69,2/14/2019
DB5CA5,earnings,100,50,2/14/2019
DB9829,earnings,100,50,2/14/2019
DC0D18,earnings,100,50,2/14/2019
DC1405,conference-participant,100,50,2/14/2019
DDB002,legal-issues-defendant,100,22,2/14/2019
DDC415,earnings,100,50,2/14/2019
DF16DE,ipo-completed,100,76,2/14/2019
DF16DE,ipo-completed,100,76,2/14/2019
DF16DE,ipo-completed,100,76,2/14/2019
DF16DE,ipo-completed,100,76,2/14/2019
DF1F7A,earnings,100,50,2/14/2019
E0207A,earnings,100,50,2/14/2019
E09E2B,legal-issues-defendant,100,22,2/14/2019
E09E2B,earnings,100,50,2/14/2019
E09E2B,earnings,100,50,2/14/2019
E09E2B,earnings,100,50,2/14/2019
E261E9,partnership,100,61,2/14/2019
E3E68E,facility-close,100,47,2/14/2019
E3E68E,earnings,100,50,2/14/2019
E49AA3,dividend,100,50,2/14/2019
E68733,partnership,100,61,2/14/2019
E94704,dividend,100,50,2/14/2019
EB61C4,earnings,100,50,2/14/2019
ED0402,business-contract,100,69,2/14/2019
EEA6B3,earnings,100,50,2/14/2019
F02D0A,earnings-per-share-positive,100,69,2/14/2019
F02D0A,earnings-positive,100,69,2/14/2019
F0EEFB,conference-call,100,50,2/14/2019
F1CD47,conference-participant,100,50,2/14/2019
F209B4,earnings,100,50,2/14/2019
F209B4,earnings,100,50,2/14/2019
F294DD,dividend,100,50,2/14/2019
F702CA,earnings,100,50,2/14/2019
F7935D,earnings,100,50,2/14/2019
F8BA6C,legal-issues-defendant,100,22,2/14/2019
F9AA02,hirings,100,65,2/14/2019
FDF799,earnings,100,50,2/14/2019
FF4343,earnings-per-share-guidance,100,50,2/14/2019
13528,earnings,100,50,2/15/2019
036C6F,dividend,100,50,2/15/2019
0624BE,earnings,100,50,2/15/2019
07EC43,regulatory-investigation,100,22,2/15/2019
07EC43,regulatory-investigation,100,22,2/15/2019
84625,dividend,100,50,2/15/2019
0A7650,earnings,100,50,2/15/2019
0B4D10,dividend,100,50,2/15/2019
0BF198,conference-call,100,50,2/15/2019
12A3A3,dividend,100,50,2/15/2019
1921DD,dividend,100,50,2/15/2019
1D1B07,partnership,100,61,2/15/2019
1F19C8,credit-extension-provider,100,57,2/15/2019
21268E,conference-participant,100,50,2/15/2019
27C10F,earnings,100,50,2/15/2019
2.89E+11,dividend,100,50,2/15/2019
2B9DBB,dividend,100,50,2/15/2019
2BF36E,legal-issues-defendant,100,22,2/15/2019
2CB4C9,dividend,100,50,2/15/2019
2CC60C,executive-appointment,100,54,2/15/2019
2E89AE,patent-filing,100,64,2/15/2019
301493,unit-acquisition-acquirer,100,49,2/15/2019
319BE2,conference-call,100,50,2/15/2019
3224CC,executive-appointment,100,54,2/15/2019
3461CF,earnings,100,50,2/15/2019
3461CF,dividend,100,50,2/15/2019
353DBB,dividend,100,50,2/15/2019
385DD4,dividend,100,50,2/15/2019
416291,dividend,100,50,2/15/2019
416291,conference-call,100,50,2/15/2019
453282,acquisition-regulatory-approval-acquirer,100,54,2/15/2019
49BBBC,legal-issues-defendant,100,22,2/15/2019
49CC59,conference-call,100,50,2/15/2019
49F4D0,dividend,100,50,2/15/2019
4B5054,earnings,100,50,2/15/2019
4D8313,dividend,100,50,2/15/2019
504FE2,dividend,100,50,2/15/2019
53A226,dividend,100,50,2/15/2019
54DF47,earnings-guidance,100,50,2/15/2019
58C2D4,earnings,100,50,2/15/2019
5BFE94,earnings,100,50,2/15/2019
619882,dividend,100,50,2/15/2019
636639,dividend,100,50,2/15/2019
64E615,earnings,100,50,2/15/2019
6844D2,dividend,100,50,2/15/2019
69CE71,conference-participant,100,50,2/15/2019
6E8349,earnings,100,50,2/15/2019
704B78,earnings,100,50,2/15/2019
741937,revenue-up,100,69,2/15/2019
741937,earnings,100,50,2/15/2019
741937,earnings,100,50,2/15/2019
762A3E,award,100,58,2/15/2019
762A3E,award,100,58,2/15/2019
767F86,executive-appointment,100,54,2/15/2019
76BD96,earnings,100,50,2/15/2019
76BECC,conference-call,100,50,2/15/2019
78F9ED,dividend,100,50,2/15/2019
78F9ED,legal-issues-defendant,100,22,2/15/2019
78F9ED,legal-issues-defendant,100,22,2/15/2019
78F9ED,legal-issues-defendant,100,22,2/15/2019
78F9ED,legal-issues-defendant,100,22,2/15/2019
7AF5B8,clinical-trials-start,100,64,2/15/2019
80D744,trading-resumed,100,58,2/15/2019
8.10E+32,dividend,100,50,2/15/2019
81EAD4,conference-call,100,50,2/15/2019
88611B,dividend,100,50,2/15/2019
8C6C1B,facility-open,100,65,2/15/2019
8C6C1B,facility-open,100,65,2/15/2019
8FF2EF,dividend,100,50,2/15/2019
9196A2,conference-organizer,100,57,2/15/2019
9196A2,conference-organizer,100,57,2/15/2019
9.36E+10,executive-appointment,100,54,2/15/2019
94983E,dividend,100,50,2/15/2019
A21649,dividend,100,50,2/15/2019
A4B899,dividend,100,50,2/15/2019
A5A4F5,acquisition-acquirer,100,49,2/15/2019
A6213D,award,100,58,2/15/2019
A9ED24,dividend,100,50,2/15/2019
ABEE43,earnings-up,100,68,2/15/2019
B1B10C,executive-appointment,100,54,2/15/2019
B3CB74,conference-organizer,100,57,2/15/2019
BFEA04,earnings,100,50,2/15/2019
C15F8F,executive-appointment,100,54,2/15/2019
C3BCD5,earnings,100,50,2/15/2019
C3BCD5,conference-participant,100,50,2/15/2019
C3CF29,earnings,100,50,2/15/2019
C8257F,executive-appointment,100,54,2/15/2019
C8257F,award,100,58,2/15/2019
CA14CC,dividend,100,50,2/15/2019
CA99D7,dividend,100,50,2/15/2019
CD2A4D,conference-participant,100,50,2/15/2019
CE96E7,executive-appointment,100,54,2/15/2019
CF9054,earnings,100,50,2/15/2019
D17C1B,partnership,100,61,2/15/2019
D25249,dividend,100,50,2/15/2019
D296C6,dividend,100,50,2/15/2019
D296C6,earnings,100,50,2/15/2019
D57D99,dividend,100,50,2/15/2019
DB23C8,earnings,100,50,2/15/2019
DBEF02,earnings,100,50,2/15/2019
E09E2B,legal-issues-defendant,100,22,2/15/2019
E5D914,conference-call,100,50,2/15/2019
E61888,earnings,100,50,2/15/2019
E8846E,dividend,100,50,2/15/2019
EEA6B3,executive-appointment,100,54,2/15/2019
F05B1B,patent-awarded,100,72,2/15/2019
F30508,acquisition-completed-acquirer,100,49,2/15/2019
F4E882,partnership,100,61,2/15/2019
F4F46F,conference-participant,100,50,2/15/2019
F6DE54,dividend,100,50,2/15/2019
F8BA6C,legal-issues-defendant,100,22,2/15/2019
FAE021,dividend-up,100,81,2/15/2019
FC1B7B,conference-participant,100,50,2/15/2019
FC4550,dividend,100,50,2/15/2019
FF4343,dividend,100,50,2/15/2019
78F9ED,legal-issues-defendant,100,22,2/16/2019
0C466B,acquisition-acquirer,100,49,2/18/2019
0CC62B,earnings,100,50,2/18/2019
14A113,patent-infringement-defendant,100,26,2/18/2019
152E1D,conference-participant,100,50,2/18/2019
168A5D,facility-open,100,65,2/18/2019
1921DD,dividend,100,50,2/18/2019
1921DD,dividend,100,50,2/18/2019
221AD7,product-release,100,64,2/18/2019
221AD7,product-release,100,64,2/18/2019
2BF36E,legal-issues-defendant,100,22,2/18/2019
3461CF,credit-rating-upgrade-rater,20,50,2/18/2019
44A4FC,award,100,58,2/18/2019
56632F,conference-call,100,50,2/18/2019
64854A,executive-appointment,100,54,2/18/2019
6DD6BA,earnings,100,50,2/18/2019
72DF04,acquisition-completed-acquirer,100,49,2/18/2019
797C20,earnings-per-share-up,100,63,2/18/2019
817ED9,earnings,100,50,2/18/2019
9004C4,conference-call,100,50,2/18/2019
A28C54,business-contract,100,69,2/18/2019
A5195E,earnings,100,50,2/18/2019
A52533,facility-open,100,65,2/18/2019
A5A4F5,acquisition-acquirer,100,49,2/18/2019
B48D6A,conference-participant,100,50,2/18/2019
B96637,conference-call,100,50,2/18/2019
BBBB41,conference-participant,100,50,2/18/2019
E09E2B,legal-issues-defendant,100,22,2/18/2019
E3E68E,product-release,100,64,2/18/2019
EB61C4,dividend,100,50,2/18/2019
ECF4F8,conference-call,100,50,2/18/2019
EEA734,conference-call,100,50,2/18/2019
F32F88,conference-participant,100,50,2/18/2019
00E601,operating-earnings,100,50,2/19/2019
0157B1,partnership,100,61,2/19/2019
018C11,conference-participant,100,50,2/19/2019
034B61,business-contract,100,69,2/19/2019
04996E,earnings,100,50,2/19/2019
070B45,conference-participant,100,50,2/19/2019
09DE1F,business-contract,100,69,2/19/2019
0A0D9E,product-release,100,64,2/19/2019
126F95,dividend,100,50,2/19/2019
12731D,conference-call,100,50,2/19/2019
1348C9,earnings,100,50,2/19/2019
14BA06,earnings,100,50,2/19/2019
152E1D,earnings,100,50,2/19/2019
157CC1,unit-acquisition-acquiree,100,76,2/19/2019
182B8C,product-release,100,64,2/19/2019
1866B2,conference-call,100,50,2/19/2019
197612,dividend,100,50,2/19/2019
19BF16,earnings,100,50,2/19/2019
19BF16,earnings,100,50,2/19/2019
19BF16,earnings,100,50,2/19/2019
19BF16,earnings,100,50,2/19/2019
1A5D5D,earnings,100,50,2/19/2019
1B4F31,earnings-up,100,68,2/19/2019
1B4F31,earnings,100,50,2/19/2019
1B4F31,earnings,100,50,2/19/2019
1B4F31,earnings,100,50,2/19/2019
1B4F31,earnings,100,50,2/19/2019
1B4F31,earnings,100,50,2/19/2019
1CDD1C,earnings,100,50,2/19/2019
1EBF8D,regulatory-product-approval-granted,100,81,2/19/2019
1EBF8D,regulatory-product-approval-granted,100,81,2/19/2019
1EBF8D,regulatory-product-approval-granted,100,81,2/19/2019
1EBF8D,regulatory-product-approval-granted,100,81,2/19/2019
1FAF22,dividend,100,50,2/19/2019
1FC422,earnings,100,50,2/19/2019
2082EA,earnings,100,50,2/19/2019
223216,revenue-up,100,64,2/19/2019
239106,note-sale,100,52,2/19/2019
239106,note-sale,100,52,2/19/2019
24CB56,conference-organizer,100,57,2/19/2019
267718,regulatory-product-approval-granted,100,81,2/19/2019
267718,regulatory-product-approval-granted,100,81,2/19/2019
267718,partnership,100,61,2/19/2019
270B78,earnings,100,50,2/19/2019
28B730,earnings,100,50,2/19/2019
2AA6A8,business-contract,100,69,2/19/2019
2AA6A8,business-contract,100,69,2/19/2019
2B49F4,executive-appointment,100,54,2/19/2019
2CC60C,conference-call,100,50,2/19/2019
2D485F,earnings,100,50,2/19/2019
2D485F,earnings,100,50,2/19/2019
2D485F,earnings,100,50,2/19/2019
2E0496,earnings,100,50,2/19/2019
2E0496,dividend,100,50,2/19/2019
2E902B,conference-participant,100,50,2/19/2019
2F9304,executive-appointment,100,54,2/19/2019
31803E,earnings,100,50,2/19/2019
31AA84,conference-participant,100,50,2/19/2019
3224CC,earnings,100,50,2/19/2019
32DCB3,ipo-completed,100,76,2/19/2019
3461CF,conference-participant,100,50,2/19/2019
37E18B,earnings,100,50,2/19/2019
37E18B,earnings,100,50,2/19/2019
37E18B,earnings,100,50,2/19/2019
39FB23,investment-investor,100,55,2/19/2019
39FB23,investment-investor,100,55,2/19/2019
3A3447,facility-open,100,65,2/19/2019
3ACF46,business-contract,100,69,2/19/2019
3B2311,earnings,100,50,2/19/2019
3C6CCC,earnings,100,50,2/19/2019
3D7971,dividend,100,50,2/19/2019
3E15F6,dividend,100,50,2/19/2019
3FACA7,partnership,100,61,2/19/2019
401072,earnings,100,50,2/19/2019
416C55,joint-venture,100,62,2/19/2019
43E8F5,earnings,100,50,2/19/2019
44740A,conference-call,100,50,2/19/2019
46A16E,earnings,100,50,2/19/2019
4.60E+06,conference-participant,100,50,2/19/2019
479930,conference-participant,100,50,2/19/2019
4BDCA7,conference-call,100,50,2/19/2019
4C5CC9,dividend,100,50,2/19/2019
4C5CC9,executive-appointment,100,54,2/19/2019
504FE2,partnership,100,61,2/19/2019
5088A5,earnings,100,50,2/19/2019
514067,conference-participant,100,50,2/19/2019
53E575,conference-participant,100,50,2/19/2019
53EF9E,earnings,100,50,2/19/2019
53EF9E,earnings,100,50,2/19/2019
53F491,conference-participant,100,50,2/19/2019
5.43E+08,conference-call,100,50,2/19/2019
55438C,business-contract,100,69,2/19/2019
556F08,earnings,100,50,2/19/2019
567F3D,note-sale,100,52,2/19/2019
56EA2B,credit-rating-upgrade,100,77,2/19/2019
56EFC7,award,100,58,2/19/2019
58CA9A,conference-organizer,100,57,2/19/2019
5A64D5,executive-appointment,100,54,2/19/2019
5AA3B1,business-combination,100,54,2/19/2019
5C7601,product-release,100,64,2/19/2019
5D02B7,conference-call,100,50,2/19/2019
5F60CE,earnings,100,50,2/19/2019
5F9CE3,executive-appointment,100,54,2/19/2019
609208,executive-appointment,100,54,2/19/2019
616E3B,dividend,100,50,2/19/2019
665440,partnership,100,61,2/19/2019
665D7D,product-release,100,64,2/19/2019
66749D,conference-participant,100,50,2/19/2019
68586A,facility-open,100,65,2/19/2019
6B0E45,dividend,100,50,2/19/2019
6BF593,acquisition-acquirer,100,49,2/19/2019
6BF593,earnings,100,50,2/19/2019
6BF593,earnings,100,50,2/19/2019
6CC55E,conference-participant,100,50,2/19/2019
6D9B53,executive-appointment,100,54,2/19/2019
6E8864,partnership,100,61,2/19/2019
704B78,executive-appointment,100,54,2/19/2019
713810,same-store-sales-up,100,54,2/19/2019
713810,dividend-up,100,81,2/19/2019
71553E,conference-participant,100,50,2/19/2019
72DF04,conference-participant,100,50,2/19/2019
762A3E,conference-organizer,100,57,2/19/2019
767F86,conference-participant,100,50,2/19/2019
78F9ED,legal-issues-defendant,100,22,2/19/2019
78F9ED,legal-issues-defendant,100,22,2/19/2019
78F9ED,legal-issues-defendant,100,22,2/19/2019
791D59,conference-participant,100,50,2/19/2019
7999F3,note-sale,100,52,2/19/2019
7999F3,note-sale,100,52,2/19/2019
7B1E50,earnings,100,50,2/19/2019
7B1E50,earnings,100,50,2/19/2019
7B9AFA,earnings,100,50,2/19/2019
7D5FD6,conference-participant,100,50,2/19/2019
7E0EB0,conference-call,100,50,2/19/2019
7F3A5F,executive-appointment,100,54,2/19/2019
7F9E16,conference-call,100,50,2/19/2019
805CD8,earnings,100,50,2/19/2019
82B57E,executive-appointment,100,54,2/19/2019
82B57E,dividend,100,50,2/19/2019
82B57E,earnings,100,50,2/19/2019
83066C,conference-call,100,50,2/19/2019
862941,conference-participant,100,50,2/19/2019
87486A,conference-participant,100,50,2/19/2019
8AB85C,clinical-trials-start,100,64,2/19/2019
8AC65D,product-release,100,64,2/19/2019
8C311A,product-release,100,64,2/19/2019
8C6C1B,facility-open,100,65,2/19/2019
8C6C1B,conference-call,100,50,2/19/2019
905356,earnings-per-share-positive,100,69,2/19/2019
905356,earnings,100,50,2/19/2019
905356,earnings,100,50,2/19/2019
9196A2,conference-organizer,100,57,2/19/2019
9196A2,conference-organizer,100,57,2/19/2019
92B625,conference-call,100,50,2/19/2019
92D9C9,public-offering,100,43,2/19/2019
943239,executive-appointment,100,54,2/19/2019
94C0B5,earnings,100,50,2/19/2019
986AF6,dividend,100,50,2/19/2019
990AD0,conference-organizer,100,57,2/19/2019
9978F1,executive-appointment,100,54,2/19/2019
9A602D,earnings-per-share-positive,100,69,2/19/2019
9A602D,earnings-per-share-positive,100,69,2/19/2019
9A602D,earnings-per-share-positive,100,69,2/19/2019
9A602D,earnings-per-share-positive,100,69,2/19/2019
9A602D,earnings-per-share-positive,100,69,2/19/2019
9A602D,earnings-per-share-positive,100,69,2/19/2019
9A602D,earnings-per-share-positive,100,69,2/19/2019
9AF3DC,executive-appointment,100,54,2/19/2019
9B5968,acquisition-acquiree,100,76,2/19/2019
9C5174,conference-participant,100,50,2/19/2019
9CDA4F,business-contract,100,69,2/19/2019
9EA947,executive-appointment,100,54,2/19/2019
9EBAFA,conference-call,100,50,2/19/2019
9F37C5,public-offering,100,43,2/19/2019
9F71E5,product-release,100,64,2/19/2019
A072C4,conference-call,100,50,2/19/2019
A247F5,conference-participant,100,50,2/19/2019
A26C26,earnings,100,50,2/19/2019
A29DBD,product-release,100,64,2/19/2019
A3800A,dividend,100,50,2/19/2019
A47A7D,earnings,100,50,2/19/2019
A48593,earnings,100,50,2/19/2019
A4B899,earnings-up,100,68,2/19/2019
A4B899,earnings,100,50,2/19/2019
A4B899,earnings,100,50,2/19/2019
A790A5,revenue-up,100,63,2/19/2019
A790A5,revenue-up,100,63,2/19/2019
A790A5,revenue-up,100,63,2/19/2019
A790A5,revenue-up,100,63,2/19/2019
A871B0,earnings,100,50,2/19/2019
A8AC4C,conference-call,100,50,2/19/2019
AAC8B6,dividend,100,50,2/19/2019
AAC8B6,dividend,100,50,2/19/2019
ACC7D3,conference-participant,100,50,2/19/2019
ACDF88,hirings,100,65,2/19/2019
ACDF88,conference-participant,100,50,2/19/2019
ACF0B4,executive-appointment,100,54,2/19/2019
AD23DE,conference-call,100,50,2/19/2019
ADF1B0,earnings,100,50,2/19/2019
AE7D16,legal-issues-defendant,100,22,2/19/2019
B05118,dividend,100,50,2/19/2019
B1DF3C,conference-participant,100,50,2/19/2019
B1FC3B,business-contract,100,69,2/19/2019
B1FC3B,conference-participant,100,50,2/19/2019
B381D8,earnings,100,50,2/19/2019
B3CB74,conference-organizer,100,57,2/19/2019
B3CB74,conference-organizer,100,57,2/19/2019
B3CB74,conference-organizer,100,57,2/19/2019
B3CB74,conference-organizer,100,57,2/19/2019
B3CB74,conference-organizer,100,57,2/19/2019
B3CB74,conference-organizer,100,57,2/19/2019
B446B8,earnings,100,50,2/19/2019
B446B8,earnings,100,50,2/19/2019
B446B8,earnings,100,50,2/19/2019
B446B8,earnings,100,50,2/19/2019
B54A74,conference-participant,100,50,2/19/2019
B8A51F,earnings,100,50,2/19/2019
B96637,operating-earnings,100,50,2/19/2019
B96637,earnings,100,50,2/19/2019
B9764A,conference-participant,100,50,2/19/2019
B9CD50,earnings,100,50,2/19/2019
BDD12C,dividend,100,50,2/19/2019
BE5935,earnings,100,50,2/19/2019
C15DB3,earnings,100,50,2/19/2019
C15DB3,revenues,100,50,2/19/2019
C3DE7D,product-release,100,64,2/19/2019
C45CE7,dividend,100,50,2/19/2019
C45CE7,earnings,100,50,2/19/2019
C4C77F,conference-call,100,50,2/19/2019
C564E4,earnings,100,50,2/19/2019
C584BE,earnings,100,50,2/19/2019
C584BE,earnings,100,50,2/19/2019
C584BE,earnings,100,50,2/19/2019
C584BE,earnings,100,50,2/19/2019
C62AA4,earnings,100,50,2/19/2019
C6C702,conference-participant,100,50,2/19/2019
C85A72,revenue-up,100,69,2/19/2019
C85A72,revenue-up,100,69,2/19/2019
C85A72,revenue-up,100,69,2/19/2019
C85A72,revenue-up,100,69,2/19/2019
C8A059,earnings,100,50,2/19/2019
C9732E,clinical-trials-positive,100,87,2/19/2019
C98CDB,product-release,100,64,2/19/2019
CAC8D0,partnership,100,61,2/19/2019
CB6A9C,executive-appointment,100,54,2/19/2019
CB7AB2,conference-participant,100,50,2/19/2019
CC6FF5,partnership,100,61,2/19/2019
CC6FF5,earnings,100,50,2/19/2019
CD4DA8,business-contract,100,69,2/19/2019
CDC817,conference-call,100,50,2/19/2019
CE4FD9,trading-halt,100,43,2/19/2019
CE4FD9,trading-resumed,100,58,2/19/2019
CF6A5A,executive-appointment,100,54,2/19/2019
CFF57D,conference-call,100,50,2/19/2019
CFF97C,credit-rating-upgrade-rater,20,50,2/19/2019
D09938,earnings,100,50,2/19/2019
D296C6,public-offering,100,43,2/19/2019
D29F43,earnings,100,50,2/19/2019
D3CEDF,earnings,100,50,2/19/2019
D57D99,earnings,100,50,2/19/2019
D63B0F,earnings,100,50,2/19/2019
D63B0F,earnings,100,50,2/19/2019
D63B0F,earnings,100,50,2/19/2019
D63B0F,dividend-up,100,81,2/19/2019
D63B0F,earnings,100,50,2/19/2019
DA199F,acquisition-interest-acquirer,100,46,2/19/2019
DB396B,earnings,100,50,2/19/2019
DB396B,dividend,100,50,2/19/2019
DBB28E,product-release,100,64,2/19/2019
DC0066,executive-appointment,100,54,2/19/2019
DC5299,public-offering,100,43,2/19/2019
DF01B1,earnings,100,50,2/19/2019
DF204B,conference-participant,100,50,2/19/2019
DF6FDD,executive-appointment,100,54,2/19/2019
E15736,earnings,100,50,2/19/2019
E1E093,patent-awarded,100,72,2/19/2019
E38906,earnings,100,50,2/19/2019
E3E68E,note-sale,100,52,2/19/2019
E3E68E,note-sale,100,52,2/19/2019
E4158B,dividend,100,50,2/19/2019
E4CE73,product-release,100,64,2/19/2019
E5D914,earnings,100,50,2/19/2019
E68733,earnings,100,50,2/19/2019
E68C3D,dividend-up,100,62,2/19/2019
E69BA5,dividend,100,50,2/19/2019
E84500,earnings,100,50,2/19/2019
E87676,revenue-up,100,69,2/19/2019
E87676,earnings,100,50,2/19/2019
E87676,earnings,100,50,2/19/2019
E93A40,executive-appointment,100,54,2/19/2019
E94704,buybacks,100,74,2/19/2019
EAEBF3,ownership-decrease-owner,100,46,2/19/2019
EB2F14,dividend,100,50,2/19/2019
EC1AF3,earnings,100,50,2/19/2019
ED9C04,partnership,100,61,2/19/2019
EE74E1,business-contract,100,69,2/19/2019
EEA734,conference-participant,100,50,2/19/2019
EEEA9F,earnings,100,50,2/19/2019
EEEA9F,earnings,100,50,2/19/2019
EEEA9F,earnings,100,50,2/19/2019
EEEA9F,earnings,100,50,2/19/2019
F05B1B,fast-track-designation,100,81,2/19/2019
F1EB39,earnings-guidance,100,50,2/19/2019
F2E253,conference-call,100,50,2/19/2019
F39E1E,earnings,100,50,2/19/2019
F4F46F,partnership,100,61,2/19/2019
F57F6F,executive-appointment,100,54,2/19/2019
F5C8AB,earnings-per-share-positive,100,69,2/19/2019
F5C8AB,earnings-per-share,100,50,2/19/2019
F5C8AB,earnings-per-share,100,50,2/19/2019
F5C8AB,earnings-per-share,100,50,2/19/2019
F6E248,regulatory-product-approval-granted,100,81,2/19/2019
F6E248,regulatory-product-approval-granted,100,81,2/19/2019
F7ADEB,conference-participant,100,50,2/19/2019
FD6926,conference-participant,100,50,2/19/2019
FF5413,joint-venture,100,62,2/19/2019
003B70,operating-earnings,100,50,2/20/2019
00FC70,dividend,100,50,2/20/2019
018C11,earnings,100,50,2/20/2019
02FC1A,conference-participant,100,50,2/20/2019
03D5F9,earnings,100,50,2/20/2019
061A3B,earnings-guidance,100,50,2/20/2019
68396,earnings,100,50,2/20/2019
0A0D9E,earnings,100,50,2/20/2019
0A59F8,partnership,100,61,2/20/2019
0B7375,conference-participant,100,50,2/20/2019
0BD4E8,earnings,100,50,2/20/2019
0BD4E8,earnings,100,50,2/20/2019
0BD4E8,earnings,100,50,2/20/2019
0BD4E8,earnings,100,50,2/20/2019
0BF198,conference-participant,100,50,2/20/2019
0C466B,revenues,100,50,2/20/2019
0C466B,revenues,100,50,2/20/2019
0CE204,earnings,100,50,2/20/2019
102F04,earnings,100,50,2/20/2019
10673F,dividend,100,50,2/20/2019
1080C0,conference-participant,100,50,2/20/2019
11074E,conference-participant,100,50,2/20/2019
1151F4,dividend-up,100,57,2/20/2019
12E454,partnership,100,61,2/20/2019
138DDE,earnings,100,50,2/20/2019
13D576,earnings,100,50,2/20/2019
143C52,conference-call,100,50,2/20/2019
147C38,earnings,100,50,2/20/2019
152B9E,earnings,100,50,2/20/2019
159739,earnings,100,50,2/20/2019
159739,earnings,100,50,2/20/2019
165B86,conference-call,100,50,2/20/2019
184866,clinical-trials-start,100,64,2/20/2019
197019,earnings,100,50,2/20/2019
1C2593,conference-call,100,50,2/20/2019
1CD708,earnings,100,50,2/20/2019
1D1B07,conference-participant,100,50,2/20/2019
1D1B07,conference-participant,100,50,2/20/2019
1D3A00,product-release,100,64,2/20/2019
1E83DE,earnings,100,50,2/20/2019
1F08A6,note-sale,100,52,2/20/2019
1F3CFB,earnings,100,50,2/20/2019
2031CE,dividend,100,50,2/20/2019
24CB56,conference-organizer,100,57,2/20/2019
26FA41,revenues,100,50,2/20/2019
275300,conference-participant,100,50,2/20/2019
2.90E+62,executive-appointment,100,54,2/20/2019
2A17B1,dividend-up,100,63,2/20/2019
2B49F4,conference-call,100,50,2/20/2019
2BAE5F,earnings,100,50,2/20/2019
2BAE5F,earnings,100,50,2/20/2019
2BAE5F,earnings,100,50,2/20/2019
30AB63,conference-participant,100,50,2/20/2019
31DB20,dividend,100,50,2/20/2019
385DD4,partnership,100,61,2/20/2019
387541,earnings,100,50,2/20/2019
3A1C46,earnings,100,50,2/20/2019
3A3447,facility-open,100,65,2/20/2019
3AF7FD,conference-participant,100,50,2/20/2019
3B8484,earnings,100,50,2/20/2019
3BB616,conference-call,100,50,2/20/2019
3C3B6B,conference-participant,100,50,2/20/2019
3C7F5F,note-sale,100,52,2/20/2019
3F868D,earnings,100,50,2/20/2019
4017AD,earnings,100,50,2/20/2019
422A82,unit-acquisition-acquirer,100,49,2/20/2019
434F38,settlement,100,56,2/20/2019
442769,earnings,100,50,2/20/2019
442769,earnings,100,50,2/20/2019
442769,earnings,100,50,2/20/2019
442769,earnings,100,50,2/20/2019
44A4FC,partnership,100,61,2/20/2019
44DDBD,earnings,100,50,2/20/2019
4591D3,executive-appointment,100,54,2/20/2019
47752F,earnings,100,50,2/20/2019
49A344,earnings,100,50,2/20/2019
49A344,earnings,100,50,2/20/2019
49A344,earnings,100,50,2/20/2019
49BBBC,earnings,100,50,2/20/2019
4C1FA1,earnings,100,50,2/20/2019
4C37C5,business-contract,100,69,2/20/2019
4C7DB5,dividend,100,50,2/20/2019
4D8124,dividend-up,100,55,2/20/2019
4EEB00,conference-participant,100,50,2/20/2019
4FB770,earnings,100,50,2/20/2019
50070E,investment-investor,100,55,2/20/2019
507AE7,acquisition-completed-acquirer,100,49,2/20/2019
50D1EC,conference-call,100,50,2/20/2019
520632,partnership,100,61,2/20/2019
525A1C,executive-appointment,100,54,2/20/2019
55438C,product-release,100,64,2/20/2019
55CD6F,earnings,100,50,2/20/2019
567F3D,note-sale,100,52,2/20/2019
594402,earnings,100,50,2/20/2019
596116,earnings,100,50,2/20/2019
59F0B0,earnings,100,50,2/20/2019
59F0B0,earnings,100,50,2/20/2019
59F0B0,earnings,100,50,2/20/2019
59F0B0,earnings,100,50,2/20/2019
59F0B0,earnings,100,50,2/20/2019
5D63F1,facility-open,100,65,2/20/2019
5D87DF,dividend,100,50,2/20/2019
5F3D91,conference-participant,100,50,2/20/2019
5F60CE,earnings-positive,100,69,2/20/2019
5F9CE3,partnership,100,61,2/20/2019
619882,conference-organizer,100,57,2/20/2019
61BCA7,executive-appointment,100,54,2/20/2019
676FFD,earnings,100,50,2/20/2019
68E6E9,earnings,100,50,2/20/2019
69CE71,earnings,100,50,2/20/2019
6A3C35,earnings,100,50,2/20/2019
6A3C35,earnings,100,50,2/20/2019
6A3C35,earnings,100,50,2/20/2019
6A3C35,earnings,100,50,2/20/2019
6A3C35,earnings,100,50,2/20/2019
6A3C35,earnings,100,50,2/20/2019
6D1ADF,earnings,100,50,2/20/2019
6DDA15,earnings,100,50,2/20/2019
6DDA15,earnings,100,50,2/20/2019
6DDA15,earnings,100,50,2/20/2019
6DDA15,earnings,100,50,2/20/2019
6DDA15,earnings,100,50,2/20/2019
6DDA15,earnings,100,50,2/20/2019
6DDA15,earnings,100,50,2/20/2019
6E705B,legal-issues-defendant,100,22,2/20/2019
6E7060,earnings,100,50,2/20/2019
6ED519,earnings,100,50,2/20/2019
6ED519,earnings,100,50,2/20/2019
6ED519,earnings,100,50,2/20/2019
6F0096,earnings,100,50,2/20/2019
6F0A63,dividend,100,50,2/20/2019
6F22E7,earnings,100,50,2/20/2019
6F39FC,earnings,100,50,2/20/2019
7255D2,award,100,58,2/20/2019
72609A,conference-call,100,50,2/20/2019
7273FF,earnings,100,50,2/20/2019
72CB93,conference-participant,100,50,2/20/2019
73F70F,earnings,100,50,2/20/2019
76D79A,earnings,100,50,2/20/2019
76E80F,conference-call,100,50,2/20/2019
771985,earnings,100,50,2/20/2019
78A1BB,dividend,100,50,2/20/2019
78F9ED,legal-issues-defendant,100,22,2/20/2019
78F9ED,legal-issues-defendant,100,22,2/20/2019
790C34,product-release,100,64,2/20/2019
7B6EB1,earnings,100,50,2/20/2019
7BC92D,executive-appointment,100,54,2/20/2019
7C75FD,earnings,100,50,2/20/2019
7C75FD,earnings,100,50,2/20/2019
7C75FD,earnings,100,50,2/20/2019
7C75FD,earnings,100,50,2/20/2019
7C75FD,earnings,100,50,2/20/2019
7C75FD,earnings,100,50,2/20/2019
7C75FD,earnings,100,50,2/20/2019
7D5384,executive-appointment,100,54,2/20/2019
7D5FD6,conference-participant,100,50,2/20/2019
7E1D5D,earnings,100,50,2/20/2019
7E1D5D,earnings,100,50,2/20/2019
7E1D5D,earnings,100,50,2/20/2019
7E1D5D,earnings,100,50,2/20/2019
7E1D5D,earnings,100,50,2/20/2019
7F3665,unit-acquisition-acquirer,100,49,2/20/2019
7FEEE1,conference-participant,100,50,2/20/2019
81222C,earnings,100,50,2/20/2019
81222C,executive-appointment,100,54,2/20/2019
818A2F,dividend-up,100,81,2/20/2019
81EAD4,product-release,100,64,2/20/2019
83B1C8,earnings,100,50,2/20/2019
859D62,earnings,100,50,2/20/2019
85DE00,conference-participant,100,50,2/20/2019
8802B4,earnings,100,50,2/20/2019
881190,conference-participant,100,50,2/20/2019
88193E,earnings,100,50,2/20/2019
88350F,partnership,100,61,2/20/2019
88611B,earnings,100,50,2/20/2019
89E771,earnings,100,50,2/20/2019
8A8E41,board-meeting,100,51,2/20/2019
8B4A45,earnings,100,50,2/20/2019
8B9B3B,conference-participant,100,50,2/20/2019
8C6C1B,facility-open,100,65,2/20/2019
8D4486,business-contract,100,69,2/20/2019
8DE56F,partnership,100,61,2/20/2019
8DE56F,partnership,100,61,2/20/2019
8E3F58,earnings,100,50,2/20/2019
8EDACA,conference-call,100,50,2/20/2019
901327,earnings,100,50,2/20/2019
901327,earnings,100,50,2/20/2019
901327,earnings,100,50,2/20/2019
901327,earnings,100,50,2/20/2019
901327,earnings,100,50,2/20/2019
90D6A5,dividend,100,50,2/20/2019
90D6A5,earnings,100,50,2/20/2019
911AB8,dividend,100,50,2/20/2019
9196A2,conference-organizer,100,57,2/20/2019
9196A2,conference-organizer,100,57,2/20/2019
9196A2,conference-organizer,100,57,2/20/2019
9196A2,conference-organizer,100,57,2/20/2019
91E5EE,business-contract,100,69,2/20/2019
92D9C9,public-offering,100,43,2/20/2019
958938,regulatory-product-approval-granted,100,81,2/20/2019
9592FB,conference-participant,100,50,2/20/2019
966ACE,conference-participant,100,50,2/20/2019
9673BD,earnings-up,100,68,2/20/2019
96BFF4,executive-appointment,100,54,2/20/2019
96F126,business-contract,100,69,2/20/2019
97B027,conference-call,100,50,2/20/2019
9A2760,earnings,100,50,2/20/2019
9B5968,partnership,100,61,2/20/2019
9B730A,conference-call,100,50,2/20/2019
9D65C1,earnings,100,50,2/20/2019
9F048E,acquisition-completed-acquirer,100,49,2/20/2019
9F37C5,public-offering,100,43,2/20/2019
A37D68,earnings,100,50,2/20/2019
A5A4F5,campaign-ad-release,100,59,2/20/2019
A7102F,earnings,100,50,2/20/2019
A7102F,earnings,100,50,2/20/2019
A7102F,earnings,100,50,2/20/2019
A7102F,earnings,100,50,2/20/2019
A7102F,earnings,100,50,2/20/2019
A75D43,partnership,100,61,2/20/2019
A871B0,executive-appointment,100,54,2/20/2019
AAEE21,note-sale,100,52,2/20/2019
ABEE43,earnings,100,50,2/20/2019
AC775C,earnings,100,50,2/20/2019
ACC7D3,conference-participant,100,50,2/20/2019
AD23DE,earnings,100,50,2/20/2019
AD23DE,earnings,100,50,2/20/2019
AD23DE,earnings,100,50,2/20/2019
AD23DE,earnings,100,50,2/20/2019
AD23DE,earnings,100,50,2/20/2019
AD23DE,earnings,100,50,2/20/2019
AD23DE,earnings,100,50,2/20/2019
AD23DE,earnings,100,50,2/20/2019
AD23DE,dividend,100,50,2/20/2019
AED61E,conference-participant,100,50,2/20/2019
AEF2C3,earnings,100,50,2/20/2019
B05118,product-release,100,64,2/20/2019
B0D41A,executive-appointment,100,54,2/20/2019
B1FC3B,fundraising,100,64,2/20/2019
B3CB74,conference-organizer,100,57,2/20/2019
B3CB74,conference-organizer,100,57,2/20/2019
B3CB74,conference-organizer,100,57,2/20/2019
B3CB74,conference-organizer,100,57,2/20/2019
B3CB74,conference-organizer,100,57,2/20/2019
B9CD50,conference-participant,100,50,2/20/2019
BAD655,earnings,100,50,2/20/2019
BDEC1E,conference-call,100,50,2/20/2019
C05839,earnings,100,50,2/20/2019
C0BA36,conference-participant,100,50,2/20/2019
C2E426,earnings,100,50,2/20/2019
C2F597,executive-appointment,100,54,2/20/2019
C32A39,dividend,100,50,2/20/2019
C4F9C6,earnings,100,50,2/20/2019
C8257F,executive-appointment,100,54,2/20/2019
C83B88,conference-participant,100,50,2/20/2019
C8A248,conference-participant,100,50,2/20/2019
C9D866,earnings,100,50,2/20/2019
C9E4EC,executive-appointment,100,54,2/20/2019
CB22CD,dividend-up,100,81,2/20/2019
CB7AB2,earnings,100,50,2/20/2019
CB88B3,earnings,100,50,2/20/2019
CC35BE,earnings,100,50,2/20/2019
CCBBAD,dividend-up,100,54,2/20/2019
CD4DA8,conference-organizer,100,57,2/20/2019
CDAF5B,operating-earnings,100,50,2/20/2019
CDE118,dividend,100,50,2/20/2019
CE5C6E,earnings,100,50,2/20/2019
CF3FF9,conference-participant,100,50,2/20/2019
CFF97C,conference-participant,100,50,2/20/2019
D139BC,conference-participant,100,50,2/20/2019
D1AE3B,dividend,100,50,2/20/2019
D27FAB,conference-call,100,50,2/20/2019
D296C6,public-offering,100,43,2/20/2019
D29F43,dividend,100,50,2/20/2019
D3CEDF,partnership,100,61,2/20/2019
D4AC65,partnership,100,61,2/20/2019
D56D6D,earnings,100,50,2/20/2019
D76AEF,earnings,100,50,2/20/2019
D8DBA3,dividend-up,100,81,2/20/2019
D9FC89,earnings,100,50,2/20/2019
DB7EC3,earnings,100,50,2/20/2019
DB7FA7,partnership,100,61,2/20/2019
DB7FA7,partnership,100,61,2/20/2019
DD7A96,earnings,100,50,2/20/2019
DDB002,legal-issues-defendant,100,22,2/20/2019
DF16DE,conference-participant,100,50,2/20/2019
DF6FDD,conference-participant,100,50,2/20/2019
E05026,acquisition-completed-acquirer,100,49,2/20/2019
E07573,earnings-guidance,100,50,2/20/2019
E1E36F,conference-participant,100,50,2/20/2019
E21871,dividend,100,50,2/20/2019
E610CD,earnings,100,50,2/20/2019
E68733,campaign-ad-release,100,59,2/20/2019
E68C3D,earnings,100,50,2/20/2019
E82A2D,conference-call,100,50,2/20/2019
EAEBF3,earnings,100,50,2/20/2019
EB5E78,partnership,100,61,2/20/2019
EBC84C,earnings,100,50,2/20/2019
EBC84C,earnings,100,50,2/20/2019
EBC84C,earnings,100,50,2/20/2019
EBC84C,earnings,100,50,2/20/2019
EBC84C,earnings,100,50,2/20/2019
EBC84C,earnings,100,50,2/20/2019
EBC84C,earnings,100,50,2/20/2019
EC99D0,partnership,100,61,2/20/2019
ED2A5E,earnings,100,50,2/20/2019
ED79D9,earnings,100,50,2/20/2019
ED7F13,earnings,100,50,2/20/2019
F1529C,conference-participant,100,50,2/20/2019
F15E41,earnings,100,50,2/20/2019
F15E41,earnings,100,50,2/20/2019
F46EC9,conference-participant,100,50,2/20/2019
F50BAB,executive-appointment,100,54,2/20/2019
F7FCA4,earnings,100,50,2/20/2019
F83279,dividend,100,50,2/20/2019
F8C5D7,earnings,100,50,2/20/2019
F90EE5,dividend,100,50,2/20/2019
FA36A4,earnings,100,50,2/20/2019
FD6926,business-contract,100,69,2/20/2019
FF227B,conference-participant,100,50,2/20/2019
FFAB4A,dividend,100,50,2/20/2019
00FC70,earnings,100,50,2/21/2019
0157B1,facility-open,100,65,2/21/2019
03FAA6,earnings,100,50,2/21/2019
0560D8,earnings,100,50,2/21/2019
61366,earnings,100,50,2/21/2019
06A456,conference-call,100,50,2/21/2019
06C826,conference-call,100,50,2/21/2019
84625,earnings,100,50,2/21/2019
84625,earnings,100,50,2/21/2019
099A92,earnings,100,50,2/21/2019
09F623,executive-appointment,100,54,2/21/2019
0BA8CE,earnings,100,50,2/21/2019
0C136E,earnings,100,50,2/21/2019
0CE204,partnership,100,61,2/21/2019
0E499E,earnings,100,50,2/21/2019
0F04E5,earnings,100,50,2/21/2019
0F04E5,earnings,100,50,2/21/2019
0F04E5,earnings,100,50,2/21/2019
0F04E5,earnings,100,50,2/21/2019
10100E,earnings,100,50,2/21/2019
1096C6,earnings,100,50,2/21/2019
1272B3,earnings,100,50,2/21/2019
12731D,earnings,100,50,2/21/2019
129DC8,earnings,100,50,2/21/2019
157CC1,conference-participant,100,50,2/21/2019
184866,clinical-trials-start,100,64,2/21/2019
184866,clinical-trials-start,100,64,2/21/2019
184866,earnings,100,50,2/21/2019
184988,executive-appointment,100,54,2/21/2019
184988,conference-participant,100,50,2/21/2019
1921DD,executive-appointment,100,54,2/21/2019
1A5957,earnings,100,50,2/21/2019
1AB808,earnings,100,50,2/21/2019
1AF7E2,earnings-up,100,68,2/21/2019
1AF7E2,earnings,100,50,2/21/2019
1AF7E2,earnings,100,50,2/21/2019
1AF7E2,earnings,100,50,2/21/2019
1AF7E2,earnings,100,50,2/21/2019
1B637E,dividend,100,50,2/21/2019
1B9535,earnings,100,50,2/21/2019
1D5C51,earnings,100,50,2/21/2019
1E04A5,executive-appointment,100,54,2/21/2019
1E7785,conference-participant,100,50,2/21/2019
1EBF8D,acquisition-acquirer,100,49,2/21/2019
202E5A,clinical-trials-start,100,64,2/21/2019
2093B1,dividend-up,100,81,2/21/2019
225CA2,dividend,100,50,2/21/2019
228D42,partnership,100,61,2/21/2019
228D42,partnership,100,61,2/21/2019
239106,conference-participant,100,50,2/21/2019
2.45E+15,dividend,100,50,2/21/2019
24CB56,conference-organizer,100,57,2/21/2019
253B2F,earnings,100,50,2/21/2019
275300,dividend,100,50,2/21/2019
279916,earnings,100,50,2/21/2019
284289,buybacks,100,74,2/21/2019
2920D5,executive-resignation,100,44,2/21/2019
297DA8,earnings,100,50,2/21/2019
2A1009,earnings,100,50,2/21/2019
2A4131,earnings-positive,100,69,2/21/2019
2AA6A8,conference-call,100,50,2/21/2019
2B8179,conference-participant,100,50,2/21/2019
2C19A4,earnings,100,50,2/21/2019
2CA60F,partnership,100,61,2/21/2019
2CD1E0,asset-sale,100,62,2/21/2019
2DDB22,earnings,100,50,2/21/2019
2E36AD,conference-participant,100,50,2/21/2019
2E61CC,partnership,100,61,2/21/2019
2E89AE,earnings,100,50,2/21/2019
2F5256,dividend,100,50,2/21/2019
2FDEE3,earnings,100,50,2/21/2019
314D88,earnings,100,50,2/21/2019
314D88,acquisition-acquirer,100,49,2/21/2019
314D88,acquisition-acquirer,100,49,2/21/2019
319BE2,dividend-up,100,81,2/21/2019
319BE2,earnings,100,50,2/21/2019
3390DE,executive-resignation,100,44,2/21/2019
3.30E+34,executive-appointment,100,54,2/21/2019
3.30E+34,executive-appointment,100,54,2/21/2019
34B97A,executive-appointment,100,54,2/21/2019
3.50E+27,dividend,100,50,2/21/2019
371C01,earnings,100,50,2/21/2019
371C01,earnings,100,50,2/21/2019
387375,earnings,100,50,2/21/2019
3A113F,earnings,100,50,2/21/2019
3BB616,earnings,100,50,2/21/2019
3BE00F,dividend,100,50,2/21/2019
3DD5E2,earnings,100,50,2/21/2019
3DDE54,conference-participant,100,50,2/21/2019
3E15F6,earnings,100,50,2/21/2019
3E15F6,earnings,100,50,2/21/2019
3E15F6,earnings,100,50,2/21/2019
3E15F6,earnings,100,50,2/21/2019
3F4668,investment-investor,100,55,2/21/2019
414FFF,acquisition-acquirer,100,49,2/21/2019
415188,dividend-up,100,81,2/21/2019
415188,earnings,100,50,2/21/2019
41ED98,conference-call,100,50,2/21/2019
429BFB,earnings,100,50,2/21/2019
42EFC7,conference-participant,100,50,2/21/2019
448BF3,conference-participant,100,50,2/21/2019
44A4FC,executive-appointment,100,54,2/21/2019
451D61,conference-participant,100,50,2/21/2019
46017C,earnings,100,50,2/21/2019
48F795,earnings,100,50,2/21/2019
4C3FE9,clinical-trials-start,100,64,2/21/2019
4C5CC9,facility-upgrade,100,65,2/21/2019
4D72C8,earnings,100,50,2/21/2019
4D72C8,earnings,100,50,2/21/2019
4D8124,earnings,100,50,2/21/2019
4D8E5E,merger,100,66,2/21/2019
4D8E5E,merger,100,66,2/21/2019
4E5784,earnings,100,50,2/21/2019
4E6F5A,conference-participant,100,50,2/21/2019
4EE167,earnings,100,50,2/21/2019
504FE2,buybacks,100,74,2/21/2019
51888A,asset-sale,100,62,2/21/2019
51F541,dividend-up,100,81,2/21/2019
52015A,earnings,100,50,2/21/2019
524CE4,earnings,100,50,2/21/2019
532D47,partnership,100,61,2/21/2019
53A226,conference-participant,100,50,2/21/2019
543900,business-contract,100,69,2/21/2019
546A27,earnings,100,50,2/21/2019
5487B1,earnings,100,50,2/21/2019
5487B1,earnings,100,50,2/21/2019
5487B1,earnings,100,50,2/21/2019
5487B1,earnings,100,50,2/21/2019
5487B1,earnings,100,50,2/21/2019
5487B1,earnings,100,50,2/21/2019
54A713,dividend-up,100,55,2/21/2019
5704AC,earnings,100,50,2/21/2019
57A854,earnings,100,50,2/21/2019
57CAAB,executive-appointment,100,54,2/21/2019
5968F9,earnings,100,50,2/21/2019
5BC2F4,dividend,100,50,2/21/2019
5EAA43,dividend,100,50,2/21/2019
620381,clinical-trials,100,56,2/21/2019
633054,partnership,100,61,2/21/2019
633054,partnership,100,61,2/21/2019
633054,partnership,100,61,2/21/2019
641F17,conference-participant,100,50,2/21/2019
649CBD,earnings,100,50,2/21/2019
6634D9,earnings,100,50,2/21/2019
665D7D,business-contract,100,69,2/21/2019
665D7D,dividend,100,50,2/21/2019
67303E,earnings,100,50,2/21/2019
67A658,earnings,100,50,2/21/2019
6830FE,earnings,100,50,2/21/2019
68586A,conference-call,100,50,2/21/2019
693ECD,conference-participant,100,50,2/21/2019
6A171E,earnings,100,50,2/21/2019
6B0E45,earnings,100,50,2/21/2019
6BC6F9,earnings,100,50,2/21/2019
6D3F35,legal-issues-defendant,100,22,2/21/2019
6DC1D7,earnings,100,50,2/21/2019
6DC1D7,earnings,100,50,2/21/2019
6F3FA8,dividend,100,50,2/21/2019
713810,partnership,100,61,2/21/2019
717DB4,earnings,100,50,2/21/2019
71E2EF,earnings,100,50,2/21/2019
729368,earnings,100,50,2/21/2019
752A70,earnings,100,50,2/21/2019
763724,acquisition-acquirer,100,49,2/21/2019
763724,conference-call,100,50,2/21/2019
766047,dividend,100,50,2/21/2019
76B926,earnings,100,50,2/21/2019
771985,conference-participant,100,50,2/21/2019
78F9ED,legal-issues-defendant,100,22,2/21/2019
78F9ED,legal-issues-defendant,100,22,2/21/2019
791EC1,dividend,100,50,2/21/2019
79340A,conference-participant,100,50,2/21/2019
7AC86E,executive-appointment,100,54,2/21/2019
7B8CB5,dividend,100,50,2/21/2019
7C4168,earnings,100,50,2/21/2019
7E1D5D,partnership,100,61,2/21/2019
7E3F8F,executive-appointment,100,54,2/21/2019
7F2922,conference-participant,100,50,2/21/2019
7FD8B9,conference-call,100,50,2/21/2019
810FAD,partnership,100,61,2/21/2019
81A88D,earnings,100,50,2/21/2019
830BDB,earnings,100,50,2/21/2019
83A065,earnings,100,50,2/21/2019
83E0AC,conference-call,100,50,2/21/2019
85AD00,dividend,100,50,2/21/2019
86AA9C,earnings,100,50,2/21/2019
88193E,conference-participant,100,50,2/21/2019
8B9B3B,earnings,100,50,2/21/2019
8BAA15,earnings,100,50,2/21/2019
8C6C1B,facility-open,100,65,2/21/2019
8DCF18,earnings,100,50,2/21/2019
8E4F9A,conference-participant,100,50,2/21/2019
903AB4,earnings,100,50,2/21/2019
911AB8,earnings,100,50,2/21/2019
9196A2,conference-organizer,100,57,2/21/2019
9196A2,conference-organizer,100,57,2/21/2019
9196A2,conference-organizer,100,57,2/21/2019
9196A2,conference-organizer,100,57,2/21/2019
91E5EE,private-placement,100,56,2/21/2019
92D757,executive-appointment,100,54,2/21/2019
93965C,partnership,100,61,2/21/2019
947B0B,conference-call,100,50,2/21/2019
949D62,earnings,100,50,2/21/2019
958938,conference-call,100,50,2/21/2019
95C392,executive-appointment,100,54,2/21/2019
9.65E+07,earnings,100,50,2/21/2019
9.65E+07,earnings,100,50,2/21/2019
9.65E+07,earnings,100,50,2/21/2019
967D92,dividend,100,50,2/21/2019
97AAF6,earnings,100,50,2/21/2019
97AAF6,earnings,100,50,2/21/2019
97AAF6,earnings,100,50,2/21/2019
97AAF6,earnings,100,50,2/21/2019
9810C0,market-entry,100,57,2/21/2019
9.86E+03,earnings,100,50,2/21/2019
98CAED,dividend,100,50,2/21/2019
990AD0,conference-organizer,100,57,2/21/2019
990AD0,conference-organizer,100,57,2/21/2019
9BF177,earnings,100,50,2/21/2019
9D2790,dividend,100,50,2/21/2019
9D65C1,conference-participant,100,50,2/21/2019
9E5C2C,earnings,100,50,2/21/2019
9EA947,dividend,100,50,2/21/2019
9F5997,earnings,100,50,2/21/2019
A1BB98,earnings,100,50,2/21/2019
A1BB98,earnings,100,50,2/21/2019
A1BB98,earnings,100,50,2/21/2019
A1BB98,earnings,100,50,2/21/2019
A1BB98,earnings,100,50,2/21/2019
A1BB98,earnings,100,50,2/21/2019
A1BB98,earnings,100,50,2/21/2019
A21649,earnings,100,50,2/21/2019
A29DBD,partnership,100,61,2/21/2019
A29DBD,earnings,100,50,2/21/2019
A47A7D,product-release,100,64,2/21/2019
A47A7D,product-release,100,64,2/21/2019
A631A3,partnership,100,61,2/21/2019
A631A3,partnership,100,61,2/21/2019
A666C8,index-listing,100,76,2/21/2019
A6828A,partnership,100,61,2/21/2019
A72AB6,conference-call,100,50,2/21/2019
A94637,conference-call,100,50,2/21/2019
AA1EAA,earnings,100,50,2/21/2019
AA3AB8,earnings,100,50,2/21/2019
AB4A7E,earnings,100,50,2/21/2019
AFD1CA,earnings,100,50,2/21/2019
AFD7DD,earnings,100,50,2/21/2019
B05118,earnings,100,50,2/21/2019
B1A85D,earnings,100,50,2/21/2019
B1A85D,earnings,100,50,2/21/2019
B1A85D,earnings,100,50,2/21/2019
B1A85D,earnings,100,50,2/21/2019
B1A85D,earnings,100,50,2/21/2019
B1A85D,earnings,100,50,2/21/2019
B1A85D,earnings,100,50,2/21/2019
B37FB4,dividend,100,50,2/21/2019
B3CB74,conference-organizer,100,57,2/21/2019
B3CB74,conference-organizer,100,57,2/21/2019
B5734D,conference-call,100,50,2/21/2019
B83D67,conference-participant,100,50,2/21/2019
B840EF,earnings,100,50,2/21/2019
B85DCE,buybacks,100,74,2/21/2019
B8F71F,stock-splits,100,49,2/21/2019
B934BF,dividend,100,50,2/21/2019
BB0787,dividend,100,50,2/21/2019
BCC55F,revenue-up,100,71,2/21/2019
BCC55F,revenue-up,100,71,2/21/2019
BCC55F,revenue-up,100,71,2/21/2019
BCC55F,revenue-up,100,71,2/21/2019
BCC55F,revenue-up,100,71,2/21/2019
BD15E8,dividend,100,50,2/21/2019
BD682F,earnings,100,50,2/21/2019
BDEC1E,conference-participant,100,50,2/21/2019
BDF2BD,earnings,100,50,2/21/2019
BE14CF,dividend,100,50,2/21/2019
BE7BA4,earnings,100,50,2/21/2019
BF79F5,dividend,100,50,2/21/2019
C11C46,executive-appointment,100,54,2/21/2019
C15F8F,conference-participant,100,50,2/21/2019
C356AC,earnings,100,50,2/21/2019
C356AC,dividend,100,50,2/21/2019
C38440,earnings,100,50,2/21/2019
C3F99F,conference-call,100,50,2/21/2019
C45C1F,earnings,100,50,2/21/2019
C4A432,earnings,100,50,2/21/2019
C4A432,earnings,100,50,2/21/2019
C62AA4,dividend,100,50,2/21/2019
C6C702,earnings,100,50,2/21/2019
C7FC95,earnings,100,50,2/21/2019
C7FC95,earnings,100,50,2/21/2019
C97B2D,note-sale,100,52,2/21/2019
C9E4EC,earnings,100,50,2/21/2019
C9F39B,product-release,100,64,2/21/2019
CB22CD,revenue-up,100,69,2/21/2019
CB22CD,revenue-up,100,69,2/21/2019
CB22CD,revenue-up,100,69,2/21/2019
CB22CD,revenue-up,100,69,2/21/2019
CB89EA,earnings,100,50,2/21/2019
CB89EA,earnings,100,50,2/21/2019
CBFFDD,legal-issues-defendant,100,22,2/21/2019
CD4DA8,conference-organizer,100,57,2/21/2019
CE5C6E,conference-participant,100,50,2/21/2019
CF3FF9,earnings,100,50,2/21/2019
D03C7A,earnings,100,50,2/21/2019
D17F7E,executive-appointment,100,54,2/21/2019
D1AE3B,executive-appointment,100,54,2/21/2019
D2C0B6,earnings,100,50,2/21/2019
D4070C,partnership,100,61,2/21/2019
D48275,conference-call,100,50,2/21/2019
D48275,conference-call,100,50,2/21/2019
D518D8,dividend,100,50,2/21/2019
D58A11,conference-participant,100,50,2/21/2019
D5B13D,conference-participant,100,50,2/21/2019
D64C6D,conference-call,100,50,2/21/2019
D650A7,conference-call,100,50,2/21/2019
D6534D,dividend,100,50,2/21/2019
D6853F,earnings,100,50,2/21/2019
D6EAA3,dividend,100,50,2/21/2019
D8C09D,earnings,100,50,2/21/2019
DB7014,conference-participant,100,50,2/21/2019
DB9829,earnings-up,100,68,2/21/2019
DB9829,earnings,100,50,2/21/2019
DB9829,earnings,100,50,2/21/2019
DBB28E,earnings,100,50,2/21/2019
DBB28E,earnings,100,50,2/21/2019
DBB28E,earnings,100,50,2/21/2019
DBB28E,earnings,100,50,2/21/2019
DBB28E,earnings,100,50,2/21/2019
DBB28E,earnings,100,50,2/21/2019
DBB28E,earnings,100,50,2/21/2019
DBB28E,earnings,100,50,2/21/2019
E0207A,executive-appointment,100,54,2/21/2019
E05DC8,earnings,100,50,2/21/2019
E2CB7B,earnings,100,50,2/21/2019
E30B34,conference-participant,100,50,2/21/2019
E30B34,conference-participant,100,50,2/21/2019
E3656D,conference-participant,100,50,2/21/2019
E4CE73,earnings,100,50,2/21/2019
E5752F,conference-participant,100,50,2/21/2019
E74FED,earnings,100,50,2/21/2019
E8846E,donation,100,54,2/21/2019
E8846E,donation,100,54,2/21/2019
EB6965,executive-appointment,100,54,2/21/2019
EB7FBF,conference-call,100,50,2/21/2019
EBD89A,business-contract,100,69,2/21/2019
EBD89A,business-contract,100,69,2/21/2019
ED0D7C,earnings,100,50,2/21/2019
ED0D7C,earnings,100,50,2/21/2019
ED0D7C,earnings,100,50,2/21/2019
ED0D7C,earnings,100,50,2/21/2019
ED3CA8,earnings,100,50,2/21/2019
ED7F13,earnings,100,50,2/21/2019
ED9C04,earnings,100,50,2/21/2019
EEA6B3,dividend-up,100,81,2/21/2019
F0027C,earnings,100,50,2/21/2019
F11638,revenue-up,100,62,2/21/2019
F11638,revenue-up,100,69,2/21/2019
F11638,revenue-up,100,69,2/21/2019
F11638,revenue-up,100,69,2/21/2019
F11638,revenue-up,100,69,2/21/2019
F11638,revenue-up,100,69,2/21/2019
F1C04C,operating-earnings,100,50,2/21/2019
F47871,earnings,100,50,2/21/2019
F51DB0,earnings,100,50,2/21/2019
F66B58,conference-call,100,50,2/21/2019
F7ADEB,earnings,100,50,2/21/2019
F83279,earnings-guidance,100,50,2/21/2019
F83279,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F92DBC,earnings,100,50,2/21/2019
F93C8A,earnings,100,50,2/21/2019
F93C8A,earnings,100,50,2/21/2019
F93C8A,earnings,100,50,2/21/2019
F93C8A,earnings,100,50,2/21/2019
F93C8A,earnings,100,50,2/21/2019
FC80E6,earnings,100,50,2/21/2019
FD6926,earnings,100,50,2/21/2019
FD6926,dividend,100,50,2/21/2019
FDE409,earnings,100,50,2/21/2019
FDF1C0,dividend,100,50,2/21/2019
FEE4B0,conference-participant,100,50,2/21/2019
FFCD0E,conference-call,100,50,2/21/2019
02FC1A,earnings,100,50,2/22/2019
02FC1A,earnings,100,50,2/22/2019
04EB2F,executive-appointment,100,54,2/22/2019
070B45,acquisition-completed-acquirer,100,49,2/22/2019
95294,legal-issues-defendant,100,22,2/22/2019
0A7650,dividend,100,50,2/22/2019
0BA8CE,executive-appointment,100,54,2/22/2019
0BD4E8,government-contract,100,69,2/22/2019
0BF198,earnings,100,50,2/22/2019
0E2992,dividend,100,50,2/22/2019
138DDE,board-meeting,100,51,2/22/2019
139303,executive-appointment,100,54,2/22/2019
13D576,acquisition-completed-acquirer,100,49,2/22/2019
1490F3,dividend-up,100,81,2/22/2019
1834C0,dividend,100,50,2/22/2019
1F43A1,earnings,100,50,2/22/2019
1FE7F0,earnings,100,50,2/22/2019
21022F,product-release,100,64,2/22/2019
238302,conference-participant,100,50,2/22/2019
295F9F,conference-call,100,50,2/22/2019
2AE625,earnings,100,50,2/22/2019
2DA92D,dividend,100,50,2/22/2019
2DB344,dividend,100,50,2/22/2019
2EC172,acquisition-acquirer,100,49,2/22/2019
342218,earnings,100,50,2/22/2019
355B19,earnings,100,50,2/22/2019
36529A,conference-participant,100,50,2/22/2019
37B120,earnings,100,50,2/22/2019
387541,executive-appointment,100,54,2/22/2019
3A3447,facility-open,100,65,2/22/2019
3AF7FD,product-release,100,64,2/22/2019
41785E,executive-appointment,100,54,2/22/2019
45ABCC,revenues,100,50,2/22/2019
4C3FE9,conference-participant,100,50,2/22/2019
520632,dividend,100,50,2/22/2019
524CE4,conference-participant,100,50,2/22/2019
539F49,executive-appointment,100,54,2/22/2019
53EF9E,dividend,100,50,2/22/2019
5876DC,conference-call,100,50,2/22/2019
5B35C7,dividend,100,50,2/22/2019
5B35C7,earnings-up,100,68,2/22/2019
5B35C7,earnings-up,100,68,2/22/2019
5B3FA2,earnings,100,50,2/22/2019
619882,conference-organizer,100,57,2/22/2019
62B1C6,earnings,100,50,2/22/2019
62B1C6,earnings,100,50,2/22/2019
665D7D,partnership,100,61,2/22/2019
665D7D,partnership,100,61,2/22/2019
6E8864,conference-participant,100,50,2/22/2019
7032D0,dividend,100,50,2/22/2019
709AED,conference-participant,100,50,2/22/2019
726EEA,dividend-up,100,60,2/22/2019
726EEA,earnings,100,50,2/22/2019
726EEA,earnings,100,50,2/22/2019
726EEA,earnings,100,50,2/22/2019
726EEA,earnings,100,50,2/22/2019
726EEA,earnings,100,50,2/22/2019
726EEA,earnings,100,50,2/22/2019
726EEA,earnings,100,50,2/22/2019
73F7F9,conference-call,100,50,2/22/2019
7448A3,conference-participant,100,50,2/22/2019
756045,dividend,100,50,2/22/2019
75F665,dividend,100,50,2/22/2019
762A3E,conference-organizer,100,57,2/22/2019
78F9ED,legal-issues-defendant,100,22,2/22/2019
7ACD98,earnings-guidance,100,50,2/22/2019
7B9AFA,conference-participant,100,50,2/22/2019
7D5384,executive-resignation,100,44,2/22/2019
7F2922,earnings,100,50,2/22/2019
81EAD4,earnings,100,50,2/22/2019
81EAD4,earnings,100,50,2/22/2019
81EAD4,earnings,100,50,2/22/2019
81EAD4,earnings,100,50,2/22/2019
838ADD,conference-participant,100,50,2/22/2019
863350,facility-open,100,65,2/22/2019
88350F,executive-appointment,100,54,2/22/2019
88350F,earnings,100,50,2/22/2019
8AB85C,conference-participant,100,50,2/22/2019
8C6C1B,facility-open,100,65,2/22/2019
8C6C1B,facility-open,100,65,2/22/2019
90D6A5,merger-regulatory-approval,100,81,2/22/2019
9196A2,conference-organizer,100,57,2/22/2019
9196A2,conference-organizer,100,57,2/22/2019
9196A2,conference-organizer,100,57,2/22/2019
9196A2,conference-organizer,100,57,2/22/2019
9196A2,conference-organizer,100,57,2/22/2019
9196A2,conference-organizer,100,57,2/22/2019
9196A2,conference-organizer,100,57,2/22/2019
91E5EE,private-placement,100,56,2/22/2019
945DE6,earnings,100,50,2/22/2019
954A47,dividend,100,50,2/22/2019
95DC1F,conference-call,100,50,2/22/2019
95F59E,earnings,100,50,2/22/2019
96A6CD,clinical-trials,100,56,2/22/2019
971334,earnings,100,50,2/22/2019
971334,dividend,100,50,2/22/2019
9A602D,dividend,100,50,2/22/2019
9AF3DC,executive-appointment,100,54,2/22/2019
9AF3DC,dividend,100,50,2/22/2019
9CA432,executive-appointment,100,54,2/22/2019
A1E3B3,conference-participant,100,50,2/22/2019
A350C1,dividend,100,50,2/22/2019
A350C1,dividend,100,50,2/22/2019
A350C1,dividend,100,50,2/22/2019
A48593,conference-participant,100,50,2/22/2019
A4CD53,earnings,100,50,2/22/2019
A80FE0,conference-participant,100,50,2/22/2019
A80FE0,conference-participant,100,50,2/22/2019
AD23DE,executive-appointment,100,54,2/22/2019
B08C51,settlement,100,56,2/22/2019
B0D41A,conference-participant,100,50,2/22/2019
B3CB74,conference-organizer,100,57,2/22/2019
B3CB74,conference-organizer,100,57,2/22/2019
B3CB74,conference-organizer,100,57,2/22/2019
B3CB74,conference-organizer,100,57,2/22/2019
B840EF,regulatory-product-approval-granted,100,81,2/22/2019
BCE9DA,dividend,100,50,2/22/2019
BCE9DA,dividend,100,50,2/22/2019
BE7BA4,earnings,100,50,2/22/2019
BFE02C,conference-participant,100,50,2/22/2019
BFE02C,dividend,100,50,2/22/2019
C062D4,conference-participant,100,50,2/22/2019
C11C46,conference-participant,100,50,2/22/2019
C356AC,legal-issues-defendant,100,22,2/22/2019
C5C137,dividend,100,50,2/22/2019
C624A1,earnings,100,50,2/22/2019
C624A1,earnings,100,50,2/22/2019
CBDB4D,clinical-trials,100,56,2/22/2019
CC35BE,product-release,100,64,2/22/2019
CE4E6D,conference-call,100,50,2/22/2019
D13F1C,conference-call,100,50,2/22/2019
D56E4C,conference-call,100,50,2/22/2019
DA0A9E,earnings,100,50,2/22/2019
DDB002,conference-call,100,50,2/22/2019
DF204B,revenue-up,100,69,2/22/2019
DFADDB,conference-participant,100,50,2/22/2019
E1C16B,conference-participant,100,50,2/22/2019
E1E36F,dividend,100,50,2/22/2019
E35610,earnings,100,50,2/22/2019
EBC84C,dividend,100,50,2/22/2019
ED7F13,conference-participant,100,50,2/22/2019
EE6F1C,dividend,100,50,2/22/2019
EE967B,dividend,100,50,2/22/2019
EEA734,partnership,100,61,2/22/2019
EEA734,partnership,100,61,2/22/2019
EEB5F9,conference-participant,100,50,2/22/2019
EF45B6,dividend,100,50,2/22/2019
F11638,conference-participant,100,50,2/22/2019
F6FA6A,revenues,100,50,2/22/2019
F73DD1,dividend,100,50,2/22/2019
FA40E2,fraud-defendant,100,20,2/22/2019
FACF19,conference-participant,100,50,2/22/2019
002A99,earnings,100,50,2/23/2019
07EC43,conference-participant,100,50,2/23/2019
0919B1,earnings,100,50,2/23/2019
0BC853,executive-resignation,100,44,2/23/2019
0F65C9,earnings,100,50,2/23/2019
0F65C9,dividend,100,50,2/23/2019
14A113,patent-infringement-defendant,100,26,2/23/2019
157CC1,unit-acquisition-acquiree,100,76,2/23/2019
1D3A00,executive-appointment,100,54,2/23/2019
39BFF6,patent-infringement-defendant,100,26,2/23/2019
4A6F00,partnership,100,61,2/23/2019
504FE2,earnings,100,50,2/23/2019
51F541,earnings,100,50,2/23/2019
56632F,conference-call,100,50,2/23/2019
5C2A47,partnership,100,61,2/23/2019
5F9CE3,executive-appointment,100,54,2/23/2019
6D3F35,legal-issues-defendant,100,22,2/23/2019
6E705B,conference-participant,100,50,2/23/2019
6E8864,partnership,100,61,2/23/2019
767F86,conference-participant,100,50,2/23/2019
767F86,executive-appointment,100,54,2/23/2019
767F86,executive-appointment,100,54,2/23/2019
8C6C1B,facility-open,100,65,2/23/2019
9196A2,conference-organizer,100,57,2/23/2019
968103,earnings,100,50,2/23/2019
968103,earnings,100,50,2/23/2019
968103,earnings,100,50,2/23/2019
968103,earnings,100,50,2/23/2019
968103,earnings,100,50,2/23/2019
96F126,partnership,100,61,2/23/2019
9CA619,earnings-guidance-meet-expectations,100,59,2/23/2019
A52B6B,acquisition-interest-acquirer,100,46,2/23/2019
A63387,executive-appointment,100,54,2/23/2019
A63387,executive-appointment,100,54,2/23/2019
A63387,dividend,100,50,2/23/2019
ABEE43,dividend-up,100,84,2/23/2019
B1FC3B,product-release,100,64,2/23/2019
C356AC,legal-issues-defendant,100,22,2/23/2019
CC35BE,settlement,100,56,2/23/2019
CE1002,conference-participant,100,50,2/23/2019
D296C6,earnings,100,50,2/23/2019
DA48E4,business-contract,100,69,2/23/2019
DCD97F,product-release,100,64,2/23/2019
E69BA5,earnings,100,50,2/23/2019
F30508,clinical-trials,100,56,2/23/2019
F4E882,award,100,58,2/23/2019
F4E882,award,100,58,2/23/2019
F6DE54,earnings,100,50,2/23/2019
12DE76,partnership,100,61,2/24/2019
12DE76,partnership,100,61,2/24/2019
12DE76,partnership,100,61,2/24/2019
1E7785,earnings,100,50,2/24/2019
1E7785,earnings,100,50,2/24/2019
1E7785,earnings,100,50,2/24/2019
1E7785,earnings,100,50,2/24/2019
1E7785,earnings,100,50,2/24/2019
1E7785,earnings,100,50,2/24/2019
1E7785,earnings,100,50,2/24/2019
251988,legal-issues-defendant,100,22,2/24/2019
56632F,earnings,100,50,2/24/2019
8A8E41,product-release,100,64,2/24/2019
01D03F,merger,100,66,2/25/2019
01D03F,merger,100,66,2/25/2019
034B61,product-release,100,64,2/25/2019
0624BE,dividend,100,50,2/25/2019
84625,executive-appointment,100,54,2/25/2019
98977,legal-issues-defendant,100,22,2/25/2019
099C88,business-contract,100,69,2/25/2019
099C88,business-contract,100,69,2/25/2019
09DE1F,product-release,100,64,2/25/2019
0A9D0A,legal-issues-defendant,100,22,2/25/2019
0CC62B,conference-participant,100,50,2/25/2019
0E5223,earnings,100,50,2/25/2019
1096C6,product-release,100,64,2/25/2019
126F95,executive-appointment,100,54,2/25/2019
12E454,partnership,100,61,2/25/2019
131443,executive-appointment,100,54,2/25/2019
139303,acquisition-acquirer,100,49,2/25/2019
13A782,earnings,100,50,2/25/2019
152AB9,conference-call,100,50,2/25/2019
15789A,revenue-volume-up,100,57,2/25/2019
16FC89,earnings,100,50,2/25/2019
1748F6,regulatory-product-approval-granted,100,81,2/25/2019
1748F6,earnings,100,50,2/25/2019
1782D5,earnings,100,50,2/25/2019
17EDA5,partnership,100,61,2/25/2019
182BE7,product-recall,100,29,2/25/2019
190B91,executive-appointment,100,54,2/25/2019
1921DD,unit-acquisition-acquiree,100,76,2/25/2019
1921DD,unit-acquisition-acquiree,100,76,2/25/2019
1921DD,unit-acquisition-acquiree,100,76,2/25/2019
1921DD,merger,100,66,2/25/2019
1A3E1B,conference-participant,100,50,2/25/2019
1A5D5D,business-combination,100,54,2/25/2019
1B5FEA,conference-participant,100,50,2/25/2019
1B637E,earnings,100,50,2/25/2019
1DDEDA,executive-appointment,100,54,2/25/2019
2082EA,earnings,100,50,2/25/2019
21DED4,executive-appointment,100,54,2/25/2019
228D42,partnership,100,61,2/25/2019
228D42,partnership,100,61,2/25/2019
232053,earnings,100,50,2/25/2019
241AF7,earnings,100,50,2/25/2019
251988,partnership,100,61,2/25/2019
251988,partnership,100,61,2/25/2019
263216,acquisition-acquirer,100,49,2/25/2019
263216,acquisition-acquirer,100,49,2/25/2019
263216,acquisition-acquirer,100,49,2/25/2019
27A791,earnings,100,50,2/25/2019
28AF37,conference-participant,100,50,2/25/2019
28F905,conference-call,100,50,2/25/2019
295F9F,executive-appointment,100,54,2/25/2019
2CA60F,earnings,100,50,2/25/2019
2CA60F,partnership,100,61,2/25/2019
2E0496,partnership,100,61,2/25/2019
2E0496,partnership,100,61,2/25/2019
2F5256,conference-participant,100,50,2/25/2019
31803E,public-offering,100,43,2/25/2019
326EDD,conference-participant,100,50,2/25/2019
39FB23,partnership,100,61,2/25/2019
3B2311,earnings,100,50,2/25/2019
3C6CCC,conference-participant,100,50,2/25/2019
3D7971,earnings,100,50,2/25/2019
3D7971,earnings,100,50,2/25/2019
3D7971,earnings,100,50,2/25/2019
3D7971,earnings,100,50,2/25/2019
3D7971,earnings,100,50,2/25/2019
3D7971,earnings,100,50,2/25/2019
3D7971,earnings,100,50,2/25/2019
3DB18B,earnings,100,50,2/25/2019
3DE4D1,executive-resignation,100,44,2/25/2019
3F96D5,earnings,100,50,2/25/2019
3FACA7,conference-participant,100,50,2/25/2019
40F7DE,executive-resignation,100,44,2/25/2019
420168,conference-participant,100,50,2/25/2019
4290EF,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
43A74A,earnings,100,50,2/25/2019
44209A,product-release,100,64,2/25/2019
448BF3,earnings,100,50,2/25/2019
451D61,clinical-trials,100,56,2/25/2019
451D61,clinical-trials,100,56,2/25/2019
46017C,conference-participant,100,50,2/25/2019
460C93,executive-appointment,100,54,2/25/2019
46A16E,executive-appointment,100,54,2/25/2019
490D4B,executive-appointment,100,54,2/25/2019
49BBBC,product-release,100,64,2/25/2019
49BBBC,partnership,100,61,2/25/2019
4A2457,conference-participant,100,50,2/25/2019
4BDCA7,earnings,100,50,2/25/2019
4DD203,earnings,100,50,2/25/2019
4ECD1A,earnings,100,50,2/25/2019
510EA1,earnings,100,50,2/25/2019
520632,conference-participant,100,50,2/25/2019
539F49,conference-participant,100,50,2/25/2019
5403F8,partnership,100,61,2/25/2019
5403F8,earnings,100,50,2/25/2019
55C9B5,partnership,100,61,2/25/2019
55C9B5,partnership,100,61,2/25/2019
56B7C1,earnings,100,50,2/25/2019
5704AC,note-sale,100,52,2/25/2019
58CA9A,award,100,58,2/25/2019
58CA9A,conference-organizer,100,57,2/25/2019
58CA9A,conference-organizer,100,57,2/25/2019
58CA9A,conference-organizer,100,57,2/25/2019
58CA9A,conference-organizer,100,57,2/25/2019
5AF08A,executive-appointment,100,54,2/25/2019
5D63F1,dividend,100,50,2/25/2019
5FDBD0,earnings,100,50,2/25/2019
619882,conference-organizer,100,57,2/25/2019
620381,clinical-trials,100,56,2/25/2019
620381,clinical-trials,100,56,2/25/2019
636639,executive-resignation,100,44,2/25/2019
649CBD,conference-call,100,50,2/25/2019
64FF65,earnings,100,50,2/25/2019
6CB7F9,investment-investor,100,55,2/25/2019
6D3F35,legal-issues-defendant,100,22,2/25/2019
6E8349,earnings,100,50,2/25/2019
70FCEF,executive-appointment,100,54,2/25/2019
752A70,conference-participant,100,50,2/25/2019
762A3E,conference-organizer,100,57,2/25/2019
762A3E,conference-organizer,100,57,2/25/2019
762A3E,conference-organizer,100,57,2/25/2019
762A3E,conference-organizer,100,57,2/25/2019
769F40,earnings,100,50,2/25/2019
7712CB,earnings,100,50,2/25/2019
7712CB,dividend,100,50,2/25/2019
7712CB,dividend,100,50,2/25/2019
78F776,earnings,100,50,2/25/2019
78F9ED,legal-issues-defendant,100,22,2/25/2019
791EC1,earnings,100,50,2/25/2019
7B8CB5,earnings,100,50,2/25/2019
7DA412,partnership,100,61,2/25/2019
7E1D5D,partnership,100,61,2/25/2019
8665BA,product-release,100,64,2/25/2019
881190,earnings,100,50,2/25/2019
881190,earnings,100,50,2/25/2019
881190,earnings,100,50,2/25/2019
881190,earnings,100,50,2/25/2019
881190,earnings,100,50,2/25/2019
8B3B0E,conference-participant,100,50,2/25/2019
8B6E7E,award,100,58,2/25/2019
8BAA15,product-release,100,64,2/25/2019
8C6C1B,facility-open,100,65,2/25/2019
8EEA28,conference-participant,100,50,2/25/2019
8F8F2F,dividend,100,50,2/25/2019
8F8F2F,earnings,100,50,2/25/2019
8F8F2F,earnings,100,50,2/25/2019
8F8F2F,earnings,100,50,2/25/2019
901327,product-release,100,64,2/25/2019
902670,stake-acquiree,100,62,2/25/2019
902670,business-contract,100,69,2/25/2019
9087B9,unit-acquisition-acquirer,100,49,2/25/2019
9087B9,unit-acquisition-acquirer,100,49,2/25/2019
911AB8,conference-participant,100,50,2/25/2019
911AB8,acquisition-interest-acquiree,100,82,2/25/2019
9196A2,conference-organizer,100,57,2/25/2019
9196A2,conference-organizer,100,57,2/25/2019
9196A2,conference-organizer,100,57,2/25/2019
92005C,earnings,100,50,2/25/2019
9368BE,conference-call,100,50,2/25/2019
945DE6,merger-completed,100,66,2/25/2019
945DE6,merger-completed,100,66,2/25/2019
945DE6,earnings,100,50,2/25/2019
945DE6,earnings,100,50,2/25/2019
945DE6,earnings,100,50,2/25/2019
945DE6,merger,100,66,2/25/2019
94983E,conference-participant,100,50,2/25/2019
949D62,regulatory-product-approval-granted,100,81,2/25/2019
9592FB,earnings,100,50,2/25/2019
980C14,earnings,100,50,2/25/2019
990AD0,conference-organizer,100,57,2/25/2019
990AD0,product-release,100,64,2/25/2019
990AD0,conference-organizer,100,57,2/25/2019
990AD0,conference-organizer,100,57,2/25/2019
9A2760,executive-appointment,100,54,2/25/2019
9C5174,revenue-up,100,72,2/25/2019
9C5174,revenues,100,50,2/25/2019
9C5BA5,earnings,100,50,2/25/2019
9EA947,earnings-up,100,68,2/25/2019
9EA947,earnings-up,100,68,2/25/2019
9EA947,earnings-up,100,68,2/25/2019
9EA947,earnings-up,100,68,2/25/2019
9FD2D9,acquisition-completed-acquirer,100,49,2/25/2019
A072C4,executive-appointment,100,54,2/25/2019
A0F146,executive-resignation,100,44,2/25/2019
A1EAC8,unit-acquisition-acquirer,100,49,2/25/2019
A350C1,earnings,100,50,2/25/2019
A350C1,conference-call,100,50,2/25/2019
A350C1,public-offering,100,43,2/25/2019
A398F8,conference-participant,100,50,2/25/2019
A433A5,product-release,100,64,2/25/2019
A47F2E,earnings,100,50,2/25/2019
A4CD53,conference-participant,100,50,2/25/2019
A52533,earnings,100,50,2/25/2019
A631A3,partnership,100,61,2/25/2019
A63387,conference-participant,100,50,2/25/2019
A63387,executive-appointment,100,54,2/25/2019
A6828A,award,100,58,2/25/2019
A8FDE8,dividend,100,50,2/25/2019
A9ED24,earnings,100,50,2/25/2019
AA5C8E,executive-appointment,100,54,2/25/2019
ACD9A4,dividend,100,50,2/25/2019
AFF7B4,executive-appointment,100,54,2/25/2019
B381D8,earnings,100,50,2/25/2019
B3CB74,conference-organizer,100,57,2/25/2019
B3CB74,conference-organizer,100,57,2/25/2019
B3CB74,conference-organizer,100,57,2/25/2019
B3CB74,conference-organizer,100,57,2/25/2019
B3CB74,conference-organizer,100,57,2/25/2019
B5DE80,note-sale,100,52,2/25/2019
B7BDA3,business-contract,100,69,2/25/2019
B8F71F,conference-participant,100,50,2/25/2019
B934BF,earnings,100,50,2/25/2019
B98EFA,conference-participant,100,50,2/25/2019
BFD0A7,product-release,100,64,2/25/2019
BFD0A7,product-release,100,64,2/25/2019
C11C46,earnings,100,50,2/25/2019
C27E19,conference-participant,100,50,2/25/2019
C356AC,legal-issues-defendant,100,22,2/25/2019
C356AC,legal-issues-defendant,100,22,2/25/2019
C3CF29,earnings,100,50,2/25/2019
C3CF29,earnings,100,50,2/25/2019
C3CF29,earnings,100,50,2/25/2019
C3CF29,earnings,100,50,2/25/2019
C45CE7,earnings,100,50,2/25/2019
C4C77F,merger-completed,100,66,2/25/2019
C4C77F,executive-appointment,100,54,2/25/2019
C4FBDC,earnings,100,50,2/25/2019
C50B26,credit-extension-recipient,100,69,2/25/2019
C564E4,public-offering,100,43,2/25/2019
C65004,conference-participant,100,50,2/25/2019
C66A8C,partnership,100,61,2/25/2019
C7859D,executive-appointment,100,54,2/25/2019
C81E00,acquisition-acquirer,100,49,2/25/2019
C941DC,earnings,100,50,2/25/2019
C97B2D,public-offering,100,43,2/25/2019
C97B2D,note-sale,100,52,2/25/2019
C9A96E,conference-participant,100,50,2/25/2019
CB89EA,partnership,100,61,2/25/2019
CCB623,earnings,100,50,2/25/2019
CD4DA8,executive-appointment,100,54,2/25/2019
CDFCC9,conference-participant,100,50,2/25/2019
CE1002,conference-participant,100,50,2/25/2019
CE4E6D,executive-appointment,100,54,2/25/2019
CFF15D,product-release,100,64,2/25/2019
CFF15D,partnership,100,61,2/25/2019
CFF15D,partnership,100,61,2/25/2019
CFF97C,credit-rating-outlook-positive-rater,20,50,2/25/2019
D07B07,conference-participant,100,50,2/25/2019
D15833,conference-call,100,50,2/25/2019
D3FA2C,conference-call,100,50,2/25/2019
D4AC65,product-release,100,64,2/25/2019
D63B0F,conference-participant,100,50,2/25/2019
D70365,earnings,100,50,2/25/2019
D854F3,conference-participant,100,50,2/25/2019
DBB28E,product-release,100,64,2/25/2019
DBFB51,earnings,100,50,2/25/2019
DDEA6A,earnings,100,50,2/25/2019
DE20DF,dividend,100,50,2/25/2019
E114F4,executive-appointment,100,54,2/25/2019
E11C41,earnings,100,50,2/25/2019
E124EB,unit-acquisition-acquirer,100,49,2/25/2019
E124EB,unit-acquisition-acquirer,100,49,2/25/2019
E124EB,unit-acquisition-acquirer,100,49,2/25/2019
E124EB,unit-acquisition-acquirer,100,49,2/25/2019
E124EB,public-offering,100,43,2/25/2019
E2F130,conference-participant,100,50,2/25/2019
E67C2C,earnings,100,50,2/25/2019
E829E8,acquisition-completed-acquiree,100,76,2/25/2019
E93A40,earnings,100,50,2/25/2019
EB61C4,executive-appointment,100,54,2/25/2019
ED2A5E,conference-participant,100,50,2/25/2019
EE1E44,dividend,100,50,2/25/2019
EE967B,executive-appointment,100,54,2/25/2019
EF5BED,executive-resignation,100,44,2/25/2019
EF5BED,executive-resignation,100,44,2/25/2019
F02170,conference-participant,100,50,2/25/2019
F44EA2,earnings,100,50,2/25/2019
F47871,executive-appointment,100,54,2/25/2019
F48947,earnings,100,50,2/25/2019
F51DB0,public-offering,100,43,2/25/2019
F5D059,note-sale,100,52,2/25/2019
F7935D,conference-call,100,50,2/25/2019
F80389,facility-sale,100,52,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
F80389,earnings,100,50,2/25/2019
FA40E2,legal-issues-defendant,100,22,2/25/2019
FD554E,conference-call,100,50,2/25/2019
FEC475,business-contract,100,69,2/25/2019
FFAB4A,earnings,100,50,2/25/2019
00067A,partnership,100,61,2/26/2019
00698D,earnings,100,50,2/26/2019
00E601,conference-participant,100,50,2/26/2019
02FC1A,regulatory-product-approval-granted,100,81,2/26/2019
0358AF,board-meeting,100,51,2/26/2019
03FAA6,partnership,100,61,2/26/2019
48590,legal-issues-defendant,100,22,2/26/2019
053EFF,earnings,100,50,2/26/2019
07C907,dividend-up,100,81,2/26/2019
07CA6A,note-sale,100,52,2/26/2019
07CA6A,note-sale,100,52,2/26/2019
09062E,earnings,100,50,2/26/2019
0919B1,dividend,100,50,2/26/2019
0968A5,earnings,100,50,2/26/2019
0986B5,dividend,100,50,2/26/2019
98977,legal-issues-defendant,100,22,2/26/2019
98977,legal-issues-defendant,100,22,2/26/2019
099A92,conference-participant,100,50,2/26/2019
099C88,earnings,100,50,2/26/2019
0A9D0A,legal-issues-defendant,100,22,2/26/2019
0B400D,earnings,100,50,2/26/2019
0B400D,earnings,100,50,2/26/2019
0B400D,earnings,100,50,2/26/2019
0B9E6F,buybacks,100,74,2/26/2019
0BD4E8,award,100,58,2/26/2019
0C136E,dividend,100,50,2/26/2019
0CCCB7,dividend,100,50,2/26/2019
0CCCB7,earnings,100,50,2/26/2019
0CE7F6,partnership,100,61,2/26/2019
0F0440,award,100,58,2/26/2019
0FABBD,earnings,100,50,2/26/2019
0FC848,earnings,100,50,2/26/2019
1080C0,earnings,100,50,2/26/2019
108A2B,operating-earnings,100,50,2/26/2019
1220D2,earnings,100,50,2/26/2019
12A3A3,earnings-guidance,100,50,2/26/2019
1348C9,award,100,58,2/26/2019
147098,dividend,100,50,2/26/2019
147098,earnings,100,50,2/26/2019
14833D,conference-participant,100,50,2/26/2019
14BA33,earnings,100,50,2/26/2019
168A5D,campaign-ad-release,100,59,2/26/2019
17EDA5,partnership,100,61,2/26/2019
17EDA5,product-release,100,64,2/26/2019
1880C5,clinical-trials,100,56,2/26/2019
1A5957,legal-issues-defendant,100,22,2/26/2019
1CB9D3,conference-call,100,50,2/26/2019
1CD4B5,clinical-trials-positive,100,87,2/26/2019
1CF3A8,conference-participant,100,50,2/26/2019
202E5A,earnings,100,50,2/26/2019
2571FA,earnings,100,50,2/26/2019
25A6CC,earnings,100,50,2/26/2019
25A6CC,earnings,100,50,2/26/2019
25A6CC,earnings,100,50,2/26/2019
25A6CC,earnings,100,50,2/26/2019
25DD05,conference-participant,100,50,2/26/2019
26008A,earnings-up,100,68,2/26/2019
26008A,earnings-up,100,68,2/26/2019
26008A,earnings-up,100,68,2/26/2019
270B78,dividend,100,50,2/26/2019
2B0AF4,executive-appointment,100,54,2/26/2019
2C3348,earnings,100,50,2/26/2019
2CB4C9,award,100,58,2/26/2019
2F98A5,earnings,100,50,2/26/2019
30AB63,executive-appointment,100,54,2/26/2019
315EB0,public-offering,100,43,2/26/2019
31803E,public-offering,100,43,2/26/2019
32CB22,conference-participant,100,50,2/26/2019
32DCB3,patent-awarded,100,72,2/26/2019
34B97A,award,100,58,2/26/2019
36A1CB,earnings,100,50,2/26/2019
36A1CB,earnings,100,50,2/26/2019
36C09B,clinical-trials-start,100,64,2/26/2019
382EAE,executive-appointment,100,54,2/26/2019
384CD3,earnings,100,50,2/26/2019
3A3447,facility-open,100,65,2/26/2019
3A3948,earnings,100,50,2/26/2019
3A6D90,executive-appointment,100,54,2/26/2019
3B50FE,earnings,100,50,2/26/2019
3F4668,revenue-up,100,69,2/26/2019
3FACA7,earnings,100,50,2/26/2019
401072,earnings,100,50,2/26/2019
416C55,award,100,58,2/26/2019
45444E,earnings,100,50,2/26/2019
47752F,award,100,58,2/26/2019
4B6EF9,dividend,100,50,2/26/2019
4B6EF9,earnings,100,50,2/26/2019
4C350A,conference-call,100,50,2/26/2019
4DD09F,earnings-up,100,68,2/26/2019
4DD09F,earnings-up,100,68,2/26/2019
4DD09F,earnings-up,100,68,2/26/2019
4DD203,business-contract,100,69,2/26/2019
4F0A80,dividend,100,50,2/26/2019
4F783B,earnings,100,50,2/26/2019
4F783B,earnings,100,50,2/26/2019
4F783B,earnings,100,50,2/26/2019
4F783B,earnings,100,50,2/26/2019
4F783B,earnings,100,50,2/26/2019
50070E,executive-appointment,100,54,2/26/2019
50070E,partnership,100,61,2/26/2019
514067,earnings,100,50,2/26/2019
51D876,award,100,58,2/26/2019
543900,business-contract,100,69,2/26/2019
550D01,earnings,100,50,2/26/2019
55438C,executive-appointment,100,54,2/26/2019
55438C,partnership,100,61,2/26/2019
55438C,partnership,100,61,2/26/2019
567F3D,conference-participant,100,50,2/26/2019
56FB7C,earnings,100,50,2/26/2019
57EF50,conference-call,100,50,2/26/2019
58CA9A,conference-organizer,100,57,2/26/2019
58CA9A,conference-organizer,100,57,2/26/2019
58CA9A,conference-organizer,100,57,2/26/2019
596116,earnings,100,50,2/26/2019
5CCDAD,earnings,100,50,2/26/2019
5E6959,conference-participant,100,50,2/26/2019
5F3D91,legal-issues-defendant,100,22,2/26/2019
5F3D91,legal-issues-defendant,100,22,2/26/2019
5F3D91,executive-appointment,100,54,2/26/2019
60EA12,market-entry,100,57,2/26/2019
6166D1,partnership,100,61,2/26/2019
6166D1,award,100,58,2/26/2019
619882,conference-organizer,100,57,2/26/2019
619882,conference-organizer,100,57,2/26/2019
619882,investment-investor,100,55,2/26/2019
619882,conference-organizer,100,57,2/26/2019
619882,conference-organizer,100,57,2/26/2019
619882,conference-organizer,100,57,2/26/2019
61A586,earnings,100,50,2/26/2019
627186,conference-participant,100,50,2/26/2019
633054,partnership,100,61,2/26/2019
64636E,legal-issues-defendant,100,22,2/26/2019
657097,earnings,100,50,2/26/2019
66749D,award,100,58,2/26/2019
68E3E0,dividend,100,50,2/26/2019
68E3E0,earnings,100,50,2/26/2019
68E3E0,earnings,100,50,2/26/2019
68E3E0,earnings,100,50,2/26/2019
68E3E0,earnings,100,50,2/26/2019
68E3E0,earnings,100,50,2/26/2019
68E3E0,earnings,100,50,2/26/2019
69CE71,legal-issues-defendant,100,22,2/26/2019
6B6375,earnings,100,50,2/26/2019
6BD606,earnings,100,50,2/26/2019
6BD606,earnings,100,50,2/26/2019
6CD55A,dividend,100,50,2/26/2019
6CF43C,business-contract,100,69,2/26/2019
6.00E+19,earnings,100,50,2/26/2019
6.00E+19,business-contract,100,69,2/26/2019
6E8864,operating-earnings,100,50,2/26/2019
6E8864,operating-earnings,100,50,2/26/2019
6E8864,operating-earnings,100,50,2/26/2019
6EA292,earnings,100,50,2/26/2019
6F6559,award,100,58,2/26/2019
701531,earnings,100,50,2/26/2019
705636,earnings-up,100,68,2/26/2019
70FCEF,executive-appointment,100,54,2/26/2019
7262F2,earnings,100,50,2/26/2019
762A3E,conference-organizer,100,57,2/26/2019
766047,award,100,58,2/26/2019
78F9ED,legal-issues-defendant,100,22,2/26/2019
78F9ED,legal-issues-defendant,100,22,2/26/2019
790C34,award,100,58,2/26/2019
791D59,conference-participant,100,50,2/26/2019
7ADE57,conference-call,100,50,2/26/2019
7C4168,conference-participant,100,50,2/26/2019
7E0EB0,earnings,100,50,2/26/2019
7E0EB0,buybacks,100,74,2/26/2019
803FED,earnings,100,50,2/26/2019
805CD8,earnings,100,50,2/26/2019
817ED9,buybacks,100,74,2/26/2019
81EAD4,conference-participant,100,50,2/26/2019
82F088,earnings,100,50,2/26/2019
82F088,partnership,100,61,2/26/2019
8377DB,award,100,58,2/26/2019
8377DB,dividend,100,50,2/26/2019
83A065,public-offering,100,43,2/26/2019
85DE00,business-contract,100,69,2/26/2019
8665BA,dividend-up,100,81,2/26/2019
8AB37F,revenue-up,100,84,2/26/2019
8AB37F,earnings,100,50,2/26/2019
8C6C1B,facility-open,100,65,2/26/2019
8D4486,award,100,58,2/26/2019
8D4486,executive-appointment,100,54,2/26/2019
8E0E32,award,100,58,2/26/2019
8E4F9A,earnings,100,50,2/26/2019
8E82A6,dividend-up,100,81,2/26/2019
8EF425,note-sale,100,52,2/26/2019
903AB4,dividend,100,50,2/26/2019
911AB8,merger-regulatory-approval,100,81,2/26/2019
911AB8,merger-regulatory-approval,100,81,2/26/2019
911AB8,merger-regulatory-approval,100,81,2/26/2019
911AB8,merger-regulatory-approval,100,81,2/26/2019
9196A2,conference-organizer,100,57,2/26/2019
9.31E+77,earnings-up,100,68,2/26/2019
9470CC,earnings,100,50,2/26/2019
9470CC,public-offering,100,43,2/26/2019
9.65E+09,earnings,100,50,2/26/2019
967D92,earnings,100,50,2/26/2019
96A6CD,earnings,100,50,2/26/2019
97AF94,earnings,100,50,2/26/2019
9.86E+03,note-sale,100,52,2/26/2019
99ACAD,dividend,100,50,2/26/2019
99ACAD,earnings,100,50,2/26/2019
9A02C4,buybacks,100,74,2/26/2019
9AF3DC,award,100,58,2/26/2019
9CA432,earnings,100,50,2/26/2019
9E575E,earnings,100,50,2/26/2019
9E98F2,product-release,100,64,2/26/2019
9EBAFA,earnings,100,50,2/26/2019
9EF4CF,product-release,100,64,2/26/2019
A072C4,earnings,100,50,2/26/2019
A1E3B3,earnings,100,50,2/26/2019
A350C1,public-offering,100,43,2/26/2019
A38F30,earnings,100,50,2/26/2019
A43906,earnings,100,50,2/26/2019
A48593,executive-appointment,100,54,2/26/2019
A52B6B,earnings,100,50,2/26/2019
A5DD24,earnings,100,50,2/26/2019
A5E715,dividend-up,100,55,2/26/2019
A60354,dividend,100,50,2/26/2019
A7102F,award,100,58,2/26/2019
A753BB,dividend-guidance-up,100,83,2/26/2019
A790A5,dividend,100,50,2/26/2019
AADE0B,award,100,58,2/26/2019
AC3584,earnings,100,50,2/26/2019
ACDF88,earnings,100,50,2/26/2019
ACDF88,earnings,100,50,2/26/2019
ACF0B4,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
ADF092,earnings,100,50,2/26/2019
AE79CD,earnings,100,50,2/26/2019
AEBB80,earnings,100,50,2/26/2019
AECCA9,dividend,100,50,2/26/2019
AFEC35,earnings,100,50,2/26/2019
B2206F,product-release,100,64,2/26/2019
B290A2,earnings,100,50,2/26/2019
B3CB74,conference-organizer,100,57,2/26/2019
B3CB74,conference-organizer,100,57,2/26/2019
B3CB74,conference-organizer,100,57,2/26/2019
B3CB74,conference-organizer,100,57,2/26/2019
B3CB74,conference-organizer,100,57,2/26/2019
B3CB74,conference-organizer,100,57,2/26/2019
B3CB74,conference-organizer,100,57,2/26/2019
B5BA39,earnings,100,50,2/26/2019
B5BA39,earnings,100,50,2/26/2019
B5BA39,earnings,100,50,2/26/2019
B5BA39,earnings,100,50,2/26/2019
B5BA39,earnings,100,50,2/26/2019
B5BA39,earnings,100,50,2/26/2019
B5BA39,earnings,100,50,2/26/2019
B5BA39,award,100,58,2/26/2019
B5DE80,conference-participant,100,50,2/26/2019
B642E8,earnings-up,100,68,2/26/2019
B642E8,earnings-up,100,68,2/26/2019
B642E8,earnings-up,100,68,2/26/2019
B642E8,earnings-up,100,68,2/26/2019
B642E8,earnings-up,100,68,2/26/2019
B642E8,earnings-up,100,68,2/26/2019
B83D67,private-placement,100,56,2/26/2019
B85DCE,buybacks,100,74,2/26/2019
B9764A,award,100,58,2/26/2019
BB58FF,conference-participant,100,50,2/26/2019
BCC13E,earnings,100,50,2/26/2019
BD8517,award,100,58,2/26/2019
C07E05,earnings,100,50,2/26/2019
C356AC,legal-issues-defendant,100,22,2/26/2019
C3DE7D,partnership,100,61,2/26/2019
C3DE7D,executive-appointment,100,54,2/26/2019
C4A241,award,100,58,2/26/2019
C4F9C6,conference-participant,100,50,2/26/2019
C5C137,earnings,100,50,2/26/2019
C5E100,conference-call,100,50,2/26/2019
C66B44,partnership,100,61,2/26/2019
C7AE14,executive-appointment,100,54,2/26/2019
C83B88,partnership,100,61,2/26/2019
C83B88,partnership,100,61,2/26/2019
C8923A,earnings-up,100,68,2/26/2019
CA14CC,earnings,100,50,2/26/2019
CBFFDD,conference-participant,100,50,2/26/2019
CBFFDD,conference-participant,100,50,2/26/2019
CC176E,earnings,100,50,2/26/2019
CD4DA8,conference-organizer,100,57,2/26/2019
CE96E7,award,100,58,2/26/2019
D0DE27,dividend,100,50,2/26/2019
D20C8F,earnings,100,50,2/26/2019
D29F43,executive-appointment,100,54,2/26/2019
D33270,product-release,100,64,2/26/2019
D4070C,award,100,58,2/26/2019
D45285,earnings,100,50,2/26/2019
D48275,conference-participant,100,50,2/26/2019
D64EDF,dividend,100,50,2/26/2019
D6853F,business-contract,100,69,2/26/2019
D697DE,earnings,100,50,2/26/2019
D75910,earnings,100,50,2/26/2019
D75910,earnings,100,50,2/26/2019
D75910,earnings,100,50,2/26/2019
D75910,earnings,100,50,2/26/2019
D78CCD,award,100,58,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
D9C07E,earnings,100,50,2/26/2019
DB9829,conference-participant,100,50,2/26/2019
DC1405,earnings,100,50,2/26/2019
DC2F77,conference-participant,100,50,2/26/2019
DD7A96,conference-participant,100,50,2/26/2019
DF6FDD,award,100,58,2/26/2019
E06265,earnings,100,50,2/26/2019
E15736,public-offering,100,43,2/26/2019
E1C16B,award,100,58,2/26/2019
E21871,conference-participant,100,50,2/26/2019
E2F130,partnership,100,61,2/26/2019
E35610,legal-issues-defendant,100,22,2/26/2019
E4CE73,award,100,58,2/26/2019
E4CE73,product-release,100,64,2/26/2019
E69BA5,earnings,100,50,2/26/2019
E754F0,earnings,100,50,2/26/2019
E866D2,conference-participant,100,50,2/26/2019
E959F3,award,100,58,2/26/2019
E96E0B,earnings,100,50,2/26/2019
EB43F4,earnings,100,50,2/26/2019
EB61C4,award,100,58,2/26/2019
ECF709,same-store-sales-up,100,53,2/26/2019
ECF709,same-store-sales-up,100,62,2/26/2019
ECF709,same-store-sales-up,100,62,2/26/2019
ED0402,earnings-up,100,90,2/26/2019
ED0402,earnings-up,100,90,2/26/2019
ED0402,earnings-up,100,90,2/26/2019
ED0402,earnings-up,100,90,2/26/2019
ED0402,earnings-up,100,90,2/26/2019
ED3CA8,conference-participant,100,50,2/26/2019
EEA734,earnings,100,50,2/26/2019
EEBCEF,earnings,100,50,2/26/2019
F0B877,earnings,100,50,2/26/2019
F1CD47,dividend,100,50,2/26/2019
F2E253,earnings,100,50,2/26/2019
F2E253,earnings,100,50,2/26/2019
F2E253,earnings,100,50,2/26/2019
F2E253,earnings,100,50,2/26/2019
F2E253,earnings,100,50,2/26/2019
F2E253,earnings,100,50,2/26/2019
F2E253,earnings,100,50,2/26/2019
F3016C,earnings,100,50,2/26/2019
F3016C,earnings,100,50,2/26/2019
F3016C,earnings,100,50,2/26/2019
F3016C,earnings,100,50,2/26/2019
F3FCC3,conference-participant,100,50,2/26/2019
F51DB0,public-offering,100,43,2/26/2019
F6FF0D,index-listing,100,76,2/26/2019
F8BA6C,legal-issues-defendant,100,22,2/26/2019
FB7724,earnings,100,50,2/26/2019
FD2565,earnings,100,50,2/26/2019
FD4588,earnings,100,50,2/26/2019
FD6926,conference-participant,100,50,2/26/2019
FDF799,conference-participant,100,50,2/26/2019
00067A,partnership,100,61,2/27/2019
00067A,conference-participant,100,50,2/27/2019
002A99,earnings,100,50,2/27/2019
00D6B5,earnings,100,50,2/27/2019
0157B1,partnership,100,61,2/27/2019
01D03F,legal-issues-defendant,100,22,2/27/2019
20751,earnings,100,50,2/27/2019
0325B7,conference-call,100,50,2/27/2019
03B431,conference-participant,100,50,2/27/2019
04EB2F,product-release,100,64,2/27/2019
68396,earnings,100,50,2/27/2019
06C826,earnings,100,50,2/27/2019
06C826,earnings,100,50,2/27/2019
070B45,product-release,100,64,2/27/2019
09062E,conference-participant,100,50,2/27/2019
095A04,earnings,100,50,2/27/2019
98977,legal-issues-defendant,100,22,2/27/2019
98977,legal-issues-defendant,100,22,2/27/2019
0A9D0A,earnings,100,50,2/27/2019
0B13E8,earnings,100,50,2/27/2019
0C6293,conference-call,100,50,2/27/2019
0C6861,earnings,100,50,2/27/2019
0DE3D5,earnings,100,50,2/27/2019
0DE3D5,earnings,100,50,2/27/2019
0DE3D5,earnings,100,50,2/27/2019
0DE3D5,earnings,100,50,2/27/2019
0DE3D5,earnings,100,50,2/27/2019
0E439E,dividend-up,100,81,2/27/2019
1220D2,conference-participant,100,50,2/27/2019
1279ED,earnings,100,50,2/27/2019
14391F,earnings,100,50,2/27/2019
165B86,earnings-up,100,68,2/27/2019
165B86,earnings,100,50,2/27/2019
165B86,earnings,100,50,2/27/2019
165B86,earnings,100,50,2/27/2019
165B86,earnings,100,50,2/27/2019
16B183,earnings,100,50,2/27/2019
184988,earnings,100,50,2/27/2019
188394,dividend,100,50,2/27/2019
19CAC7,executive-appointment,100,54,2/27/2019
1A3E1B,conference-participant,100,50,2/27/2019
1AF7E2,executive-appointment,100,54,2/27/2019
1C599A,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1DEBBE,earnings,100,50,2/27/2019
1E04A5,earnings,100,50,2/27/2019
1E04A5,earnings,100,50,2/27/2019
1E04A5,earnings,100,50,2/27/2019
1E04A5,earnings,100,50,2/27/2019
1E4FB9,unit-acquisition-acquiree,100,76,2/27/2019
1E5786,conference-participant,100,50,2/27/2019
1F08A6,conference-participant,100,50,2/27/2019
21022F,earnings,100,50,2/27/2019
2158DF,earnings,100,50,2/27/2019
2158DF,earnings,100,50,2/27/2019
2158DF,earnings,100,50,2/27/2019
2158DF,earnings,100,50,2/27/2019
2158DF,earnings,100,50,2/27/2019
2262BD,executive-appointment,100,54,2/27/2019
227D48,earnings,100,50,2/27/2019
228D42,partnership,100,61,2/27/2019
228D42,partnership,100,61,2/27/2019
270B78,earnings,100,50,2/27/2019
2BBE62,earnings,100,50,2/27/2019
2BBE62,earnings,100,50,2/27/2019
2BBE62,earnings,100,50,2/27/2019
2C3348,earnings,100,50,2/27/2019
2C35B5,executive-appointment,100,54,2/27/2019
2D981A,earnings,100,50,2/27/2019
2DC88B,conference-participant,100,50,2/27/2019
2F7A7E,earnings,100,50,2/27/2019
301493,facility-open,100,65,2/27/2019
315EB0,credit-rating-upgrade,100,77,2/27/2019
31803E,public-offering,100,43,2/27/2019
3.20E+263,earnings,100,50,2/27/2019
32F943,acquisition-acquiree,100,76,2/27/2019
32F943,earnings,100,50,2/27/2019
34A959,revenues,100,50,2/27/2019
366C3B,partnership,100,61,2/27/2019
372037,dividend-up,100,81,2/27/2019
372037,earnings,100,50,2/27/2019
389CFB,product-release,100,64,2/27/2019
396D7C,earnings,100,50,2/27/2019
3A3447,facility-open,100,65,2/27/2019
3DCECC,conference-organizer,100,57,2/27/2019
40B903,earnings,100,50,2/27/2019
416C55,note-sale,100,52,2/27/2019
41C36B,earnings,100,50,2/27/2019
422CE3,executive-appointment,100,54,2/27/2019
422CE3,dividend,100,50,2/27/2019
425BDC,earnings,100,50,2/27/2019
431B74,dividend,100,50,2/27/2019
431B74,dividend,100,50,2/27/2019
448215,earnings,100,50,2/27/2019
45444E,earnings,100,50,2/27/2019
4649D5,earnings,100,50,2/27/2019
467F2C,conference-participant,100,50,2/27/2019
468DD4,earnings,100,50,2/27/2019
48F795,note-sale,100,52,2/27/2019
4.91E+58,award,100,58,2/27/2019
49BBBC,legal-issues-defendant,100,22,2/27/2019
4AC91D,earnings,100,50,2/27/2019
4AC91D,earnings,100,50,2/27/2019
4AC91D,earnings,100,50,2/27/2019
4AC91D,earnings,100,50,2/27/2019
4AC91D,earnings,100,50,2/27/2019
4AC91D,earnings,100,50,2/27/2019
4AC91D,earnings,100,50,2/27/2019
4F9926,product-release,100,64,2/27/2019
514067,legal-issues-defendant,100,22,2/27/2019
5340D0,public-offering,100,43,2/27/2019
543900,earnings,100,50,2/27/2019
543900,earnings,100,50,2/27/2019
543900,earnings,100,50,2/27/2019
543900,earnings,100,50,2/27/2019
543900,earnings,100,50,2/27/2019
543900,earnings,100,50,2/27/2019
543900,earnings,100,50,2/27/2019
543900,earnings,100,50,2/27/2019
543900,earnings,100,50,2/27/2019
5487B1,conference-participant,100,50,2/27/2019
55438C,business-contract,100,69,2/27/2019
55C289,dividend,100,50,2/27/2019
564F3E,dividend,100,50,2/27/2019
589846,conference-call,100,50,2/27/2019
58CA9A,conference-organizer,100,57,2/27/2019
58CA9A,conference-organizer,100,57,2/27/2019
58CA9A,conference-organizer,100,57,2/27/2019
58CA9A,conference-organizer,100,57,2/27/2019
594402,earnings,100,50,2/27/2019
5A0FF1,earnings,100,50,2/27/2019
5AAE17,conference-call,100,50,2/27/2019
5BC2F4,executive-appointment,100,54,2/27/2019
5D1329,earnings,100,50,2/27/2019
5D41E4,conference-call,100,50,2/27/2019
5E6959,conference-participant,100,50,2/27/2019
5E7E82,earnings-above-expectations,100,88,2/27/2019
5F2FF7,conference-participant,100,50,2/27/2019
5F3D91,legal-issues-defendant,100,22,2/27/2019
5F3D91,legal-issues-defendant,100,22,2/27/2019
5F3D91,legal-issues-defendant,100,22,2/27/2019
619882,conference-organizer,100,57,2/27/2019
619882,conference-organizer,100,57,2/27/2019
619882,conference-organizer,100,57,2/27/2019
619882,conference-organizer,100,57,2/27/2019
619882,conference-organizer,100,57,2/27/2019
619882,conference-organizer,100,57,2/27/2019
619882,conference-organizer,100,57,2/27/2019
61B81B,conference-participant,100,50,2/27/2019
6284B5,conference-participant,100,50,2/27/2019
649CBD,clinical-trials,100,56,2/27/2019
665618,conference-participant,100,50,2/27/2019
66CB62,earnings,100,50,2/27/2019
6844D2,partnership,100,61,2/27/2019
6BDA0C,earnings,100,50,2/27/2019
6D3F35,legal-issues-defendant,100,22,2/27/2019
6E705B,conference-participant,100,50,2/27/2019
6F30F9,earnings,100,50,2/27/2019
704B78,earnings,100,50,2/27/2019
713810,partnership,100,61,2/27/2019
723548,earnings,100,50,2/27/2019
72609A,earnings,100,50,2/27/2019
728737,public-offering,100,43,2/27/2019
72CB93,award,100,58,2/27/2019
7448A3,earnings,100,50,2/27/2019
7.45E+28,conference-participant,100,50,2/27/2019
746373,earnings,100,50,2/27/2019
746373,dividend-up,100,64,2/27/2019
756BB4,executive-appointment,100,54,2/27/2019
762A3E,conference-organizer,100,57,2/27/2019
762A3E,conference-organizer,100,57,2/27/2019
76BECC,earnings,100,50,2/27/2019
76E80F,revenues,100,50,2/27/2019
76E80F,revenues,100,50,2/27/2019
76E80F,revenues,100,50,2/27/2019
76E80F,revenues,100,50,2/27/2019
790C34,executive-appointment,100,54,2/27/2019
7A3633,earnings,100,50,2/27/2019
7C4F43,clinical-trials,100,56,2/27/2019
7CD98F,dividend-up,100,81,2/27/2019
7DA412,earnings,100,50,2/27/2019
7DD8CC,earnings,100,50,2/27/2019
7F3665,earnings,100,50,2/27/2019
83598E,acquisition-acquiree,100,76,2/27/2019
83598E,business-contract,100,69,2/27/2019
83A065,public-offering,100,43,2/27/2019
83E0AC,earnings,100,50,2/27/2019
855DF7,earnings,100,50,2/27/2019
86A1B9,dividend,100,50,2/27/2019
86F123,business-contract,100,69,2/27/2019
877734,conference-call,100,50,2/27/2019
8.79E+06,earnings,100,50,2/27/2019
880C0C,earnings,100,50,2/27/2019
893904,executive-appointment,100,54,2/27/2019
896771,earnings,100,50,2/27/2019
8A0368,earnings,100,50,2/27/2019
8B1E11,earnings,100,50,2/27/2019
8C6C1B,facility-open,100,65,2/27/2019
8D4486,executive-appointment,100,54,2/27/2019
8EDACA,earnings,100,50,2/27/2019
8FCA78,executive-appointment,100,54,2/27/2019
8FCA78,note-sale,100,52,2/27/2019
9087B9,earnings,100,50,2/27/2019
92005C,earnings,100,50,2/27/2019
925759,earnings-guidance,100,50,2/27/2019
925759,earnings-guidance,100,50,2/27/2019
925759,earnings-guidance,100,50,2/27/2019
98CEBB,earnings,100,50,2/27/2019
98CEBB,earnings,100,50,2/27/2019
990AD0,conference-organizer,100,57,2/27/2019
9B730A,earnings,100,50,2/27/2019
9CA619,conference-call,100,50,2/27/2019
9D4EC7,dividend,100,50,2/27/2019
9DDE1B,dividend,100,50,2/27/2019
9E98F2,partnership,100,61,2/27/2019
A15C71,earnings,100,50,2/27/2019
A29A46,earnings,100,50,2/27/2019
A398F8,earnings-positive,100,69,2/27/2019
A5DD24,conference-participant,100,50,2/27/2019
A7102F,conference-participant,100,50,2/27/2019
A790A5,conference-participant,100,50,2/27/2019
A806FA,conference-participant,100,50,2/27/2019
A80FE0,earnings,100,50,2/27/2019
AC7AAE,clinical-trials,100,56,2/27/2019
ACF0B4,earnings,100,50,2/27/2019
ACF0B4,acquisition-acquirer,100,49,2/27/2019
ACF0B4,business-contract,100,69,2/27/2019
AD3C93,conference-participant,100,50,2/27/2019
AE4EEB,conference-participant,100,50,2/27/2019
AECCA9,earnings,100,50,2/27/2019
AECCA9,earnings,100,50,2/27/2019
AECCA9,earnings,100,50,2/27/2019
AECCA9,earnings,100,50,2/27/2019
AECCA9,earnings,100,50,2/27/2019
AEF2C3,note-sale,100,52,2/27/2019
B01111,dividend-up,100,71,2/27/2019
B09B1F,earnings-up,100,68,2/27/2019
B09B1F,earnings-up,100,68,2/27/2019
B09B1F,earnings-up,100,68,2/27/2019
B09B1F,earnings-up,100,68,2/27/2019
B1B10C,dividend,100,50,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-call,100,50,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B3CB74,conference-organizer,100,57,2/27/2019
B4C673,partnership,100,61,2/27/2019
B53C12,earnings,100,50,2/27/2019
B560AF,earnings,100,50,2/27/2019
B560AF,earnings,100,50,2/27/2019
B560AF,earnings,100,50,2/27/2019
B66928,earnings,100,50,2/27/2019
B7202A,earnings,100,50,2/27/2019
B76C82,earnings,100,50,2/27/2019
B77F14,conference-call,100,50,2/27/2019
BAD655,conference-participant,100,50,2/27/2019
BC3AD2,dividend,100,50,2/27/2019
BDE867,dividend,100,50,2/27/2019
BDEC1E,earnings,100,50,2/27/2019
BFEA04,executive-appointment,100,54,2/27/2019
C01737,earnings,100,50,2/27/2019
C2E39B,partnership,100,61,2/27/2019
C356AC,legal-issues-defendant,100,22,2/27/2019
C356AC,legal-issues-defendant,100,22,2/27/2019
C407A0,earnings,100,50,2/27/2019
C564E4,public-offering,100,43,2/27/2019
C659EB,conference-participant,100,50,2/27/2019
C8257F,executive-appointment,100,54,2/27/2019
C97B2D,conference-participant,100,50,2/27/2019
C9E4EC,conference-participant,100,50,2/27/2019
CA212F,dividend,100,50,2/27/2019
CB6A9C,earnings,100,50,2/27/2019
CC0C78,earnings,100,50,2/27/2019
CD2A4D,earnings,100,50,2/27/2019
CDC817,conference-participant,100,50,2/27/2019
CE1002,note-sale,100,52,2/27/2019
CE4E6D,earnings-up,100,68,2/27/2019
CE4E6D,earnings-up,100,68,2/27/2019
CE4E6D,earnings-up,100,68,2/27/2019
CE4E6D,earnings-up,100,68,2/27/2019
CE4E6D,earnings-up,100,68,2/27/2019
CF351E,earnings,100,50,2/27/2019
CFF97C,credit-rating-upgrade-rater,20,50,2/27/2019
D09938,earnings,100,50,2/27/2019
D15833,dividend,100,50,2/27/2019
D17F7E,dividend,100,50,2/27/2019
D33270,product-release,100,64,2/27/2019
D3F64D,dividend,100,50,2/27/2019
D77F7E,acquisition-regulatory-approval-acquirer,100,54,2/27/2019
D81463,earnings,100,50,2/27/2019
D81463,earnings,100,50,2/27/2019
D81463,dividend-up,100,81,2/27/2019
D81463,dividend-up,100,81,2/27/2019
D96202,award,100,58,2/27/2019
D9FC89,conference-participant,100,50,2/27/2019
DB2E4E,earnings,100,50,2/27/2019
DC0998,executive-appointment,100,54,2/27/2019
DC486E,dividend-up,100,81,2/27/2019
DDEA6A,conference-participant,100,50,2/27/2019
E0207A,business-contract,100,69,2/27/2019
E0339F,dividend,100,50,2/27/2019
E07573,earnings,100,50,2/27/2019
E07573,earnings,100,50,2/27/2019
E07573,earnings,100,50,2/27/2019
E07573,earnings,100,50,2/27/2019
E124EB,public-offering,100,43,2/27/2019
E13782,earnings,100,50,2/27/2019
E15736,public-offering,100,43,2/27/2019
E19A99,earnings,100,50,2/27/2019
E1E093,acquisition-interest-acquirer,100,46,2/27/2019
E1E093,acquisition-interest-acquirer,100,46,2/27/2019
E20392,conference-participant,100,50,2/27/2019
E28D9C,earnings,100,50,2/27/2019
E41190,earnings,100,50,2/27/2019
E592F0,product-release,100,64,2/27/2019
E61888,earnings,100,50,2/27/2019
E6EDED,conference-participant,100,50,2/27/2019
E802CE,earnings,100,50,2/27/2019
E8846E,investment-investor,100,55,2/27/2019
E8A49A,executive-appointment,100,54,2/27/2019
ECA300,conference-call,100,50,2/27/2019
ECF4F8,earnings,100,50,2/27/2019
EE1E44,conference-participant,100,50,2/27/2019
EF25A5,award,100,58,2/27/2019
EF7163,earnings,100,50,2/27/2019
F02170,revenue-up,100,69,2/27/2019
F02170,revenue-up,100,69,2/27/2019
F02170,revenue-up,100,69,2/27/2019
F02170,revenue-up,100,69,2/27/2019
F02170,revenue-up,100,69,2/27/2019
F0A9DE,dividend-up,100,81,2/27/2019
F0EEFB,earnings,100,50,2/27/2019
F4E882,partnership,100,61,2/27/2019
F5349B,earnings,100,50,2/27/2019
F5349B,dividend,100,50,2/27/2019
F67165,conference-participant,100,50,2/27/2019
F72E4B,earnings,100,50,2/27/2019
F72E4B,earnings,100,50,2/27/2019
F72E4B,earnings,100,50,2/27/2019
F72E4B,earnings,100,50,2/27/2019
F72E4B,earnings,100,50,2/27/2019
FA40E2,legal-issues-defendant,100,22,2/27/2019
FE1A1D,earnings,100,50,2/27/2019
FE7A63,conference-participant,100,50,2/27/2019
FFE543,conference-participant,100,50,2/27/2019
01478A,dividend-up,100,81,2/28/2019
01D03F,regulatory-product-approval-granted,100,81,2/28/2019
02870F,dividend-up,100,81,2/28/2019
51332,credit-rating-affirmation,100,51,2/28/2019
07C69F,conference-participant,100,50,2/28/2019
98977,legal-issues-defendant,100,22,2/28/2019
099C88,business-contract,100,69,2/28/2019
0A59F8,partnership,100,61,2/28/2019
0C355F,earnings,100,50,2/28/2019
0C6861,conference-participant,100,50,2/28/2019
0E499E,revenue-up,100,69,2/28/2019
0E499E,earnings,100,50,2/28/2019
0E499E,earnings,100,50,2/28/2019
0FC848,facility-open,100,65,2/28/2019
10100E,conference-participant,100,50,2/28/2019
106394,conference-participant,100,50,2/28/2019
108A2B,conference-participant,100,50,2/28/2019
10AE08,private-placement,100,56,2/28/2019
11A49E,earnings,100,50,2/28/2019
15B10D,conference-call,100,50,2/28/2019
180DA0,earnings,100,50,2/28/2019
180DA0,earnings,100,50,2/28/2019
182BE7,earnings,100,50,2/28/2019
1834C0,earnings,100,50,2/28/2019
1A6A94,earnings,100,50,2/28/2019
1CB9D3,earnings,100,50,2/28/2019
1CB9D3,earnings,100,50,2/28/2019
1CB9D3,earnings,100,50,2/28/2019
1CB9D3,earnings,100,50,2/28/2019
1CD09C,earnings,100,50,2/28/2019
1D3A00,dividend,100,50,2/28/2019
1EC3E8,executive-appointment,100,54,2/28/2019
1F464F,earnings,100,50,2/28/2019
1F9258,business-contract,100,69,2/28/2019
1FCC00,conference-call,100,50,2/28/2019
2096DE,earnings,100,50,2/28/2019
221445,earnings,100,50,2/28/2019
228D42,partnership,100,61,2/28/2019
228D42,partnership,100,61,2/28/2019
249674,earnings,100,50,2/28/2019
249674,earnings,100,50,2/28/2019
249674,earnings,100,50,2/28/2019
249674,earnings,100,50,2/28/2019
25102A,conference-participant,100,50,2/28/2019
26CC63,earnings,100,50,2/28/2019
272704,conference-participant,100,50,2/28/2019
29A4CC,dividend-up,100,81,2/28/2019
29A4CC,executive-appointment,100,54,2/28/2019
2A1009,government-contract,100,69,2/28/2019
2AA6A8,earnings,100,50,2/28/2019
2BA977,dividend,100,50,2/28/2019
2BF36E,dividend,100,50,2/28/2019
2E0496,partnership,100,61,2/28/2019
2E2E6E,dividend,100,50,2/28/2019
2F9304,earnings,100,50,2/28/2019
301493,earnings,100,50,2/28/2019
30AB63,earnings-guidance,100,50,2/28/2019
315EB0,public-offering,100,43,2/28/2019
32F943,partnership,100,61,2/28/2019
33AD83,earnings,100,50,2/28/2019
3471C0,earnings,100,50,2/28/2019
36C09B,public-offering,100,43,2/28/2019
382EAE,executive-appointment,100,54,2/28/2019
385DD4,earnings,100,50,2/28/2019
389CFB,earnings,100,50,2/28/2019
3B8484,earnings-up,100,68,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3BA1BF,earnings,100,50,2/28/2019
3C3B6B,partnership,100,61,2/28/2019
3CCC90,executive-appointment,100,54,2/28/2019
3E39A5,earnings-guidance,100,50,2/28/2019
3E70FC,executive-appointment,100,54,2/28/2019
407878,earnings,100,50,2/28/2019
416291,earnings,100,50,2/28/2019
416C55,conference-participant,100,50,2/28/2019
416C55,note-sale,100,52,2/28/2019
41B53E,earnings,100,50,2/28/2019
41B53E,earnings,100,50,2/28/2019
41B53E,earnings,100,50,2/28/2019
41ED98,earnings,100,50,2/28/2019
422CE3,earnings,100,50,2/28/2019
427F32,earnings,100,50,2/28/2019
4290EF,dividend,100,50,2/28/2019
43A060,earnings,100,50,2/28/2019
442769,unit-acquisition-acquirer,100,49,2/28/2019
44740A,earnings,100,50,2/28/2019
44740A,earnings,100,50,2/28/2019
44740A,earnings,100,50,2/28/2019
4806CE,earnings,100,50,2/28/2019
4A2457,earnings,100,50,2/28/2019
4A3438,earnings,100,50,2/28/2019
4A6F00,partnership,100,61,2/28/2019
4A6F00,partnership,100,61,2/28/2019
4B7006,earnings,100,50,2/28/2019
4BEB48,earnings,100,50,2/28/2019
4E4E75,earnings,100,50,2/28/2019
4ECD1A,dividend,100,50,2/28/2019
4FB770,conference-participant,100,50,2/28/2019
50070E,earnings,100,50,2/28/2019
51E682,acquisition-completed-acquirer,100,49,2/28/2019
52FB2F,earnings,100,50,2/28/2019
5340D0,public-offering,100,43,2/28/2019
546A27,earnings,100,50,2/28/2019
55438C,business-contract,100,69,2/28/2019
55438C,executive-appointment,100,54,2/28/2019
55CD6F,dividend,100,50,2/28/2019
56765E,earnings,100,50,2/28/2019
56765E,earnings,100,50,2/28/2019
56765E,earnings,100,50,2/28/2019
56765E,earnings,100,50,2/28/2019
56765E,earnings,100,50,2/28/2019
56765E,earnings,100,50,2/28/2019
56765E,earnings,100,50,2/28/2019
583223,earnings,100,50,2/28/2019
58B46F,earnings-per-share-positive,100,69,2/28/2019
58B46F,earnings,100,50,2/28/2019
58B46F,earnings,100,50,2/28/2019
58B46F,earnings,100,50,2/28/2019
58B46F,earnings,100,50,2/28/2019
58CA9A,conference-organizer,100,57,2/28/2019
58CA9A,conference-organizer,100,57,2/28/2019
59872F,earnings,100,50,2/28/2019
59F0B0,conference-participant,100,50,2/28/2019
5A423F,earnings,100,50,2/28/2019
5B7739,earnings,100,50,2/28/2019
5C7601,dividend,100,50,2/28/2019
5DD486,conference-participant,100,50,2/28/2019
5DD48B,product-release,100,64,2/28/2019
5DE5A5,dividend,100,50,2/28/2019
5DE5A5,conference-participant,100,50,2/28/2019
5E7E82,dividend,100,50,2/28/2019
601785,conference-participant,100,50,2/28/2019
619882,conference-organizer,100,57,2/28/2019
619882,conference-organizer,100,57,2/28/2019
619882,conference-organizer,100,57,2/28/2019
619882,conference-organizer,100,57,2/28/2019
62CDDE,earnings,100,50,2/28/2019
639BD6,product-release,100,64,2/28/2019
649CBD,earnings,100,50,2/28/2019
64E346,earnings-up,100,68,2/28/2019
64E346,earnings-up,100,68,2/28/2019
64E346,earnings-up,100,68,2/28/2019
64E346,earnings-up,100,68,2/28/2019
64E346,earnings-up,100,68,2/28/2019
665D7D,conference-participant,100,50,2/28/2019
66E04A,buybacks,100,74,2/28/2019
6925EB,earnings,100,50,2/28/2019
694749,earnings,100,50,2/28/2019
6C987C,dividend,100,50,2/28/2019
6CF43C,executive-appointment,100,54,2/28/2019
6D3F35,partnership,100,61,2/28/2019
6E8349,note-sale,100,52,2/28/2019
70FCEF,earnings,100,50,2/28/2019
713810,conference-participant,100,50,2/28/2019
71B0CF,earnings,100,50,2/28/2019
7255D2,earnings,100,50,2/28/2019
73529F,earnings,100,50,2/28/2019
747219,conference-call,100,50,2/28/2019
762A3E,conference-organizer,100,57,2/28/2019
762A3E,conference-organizer,100,57,2/28/2019
762A3E,conference-organizer,100,57,2/28/2019
763724,earnings-up,100,68,2/28/2019
763724,earnings-up,100,68,2/28/2019
763724,earnings-up,100,68,2/28/2019
763DBE,earnings,100,50,2/28/2019
771985,drilling,100,68,2/28/2019
790D0D,dividend,100,50,2/28/2019
79167B,buybacks,100,74,2/28/2019
79167B,earnings,100,50,2/28/2019
7A51FE,executive-resignation,100,44,2/28/2019
7AF5B8,business-contract,100,69,2/28/2019
7B1E50,trading-delisting,100,36,2/28/2019
7B1E50,trading-halt,100,43,2/28/2019
7B4B91,dividend,100,50,2/28/2019
7C4F43,earnings,100,50,2/28/2019
7DA412,partnership,100,61,2/28/2019
7E3F8F,conference-participant,100,50,2/28/2019
7FC386,earnings,100,50,2/28/2019
817ED9,earnings,100,50,2/28/2019
8303CD,conference-participant,100,50,2/28/2019
8377DB,executive-appointment,100,54,2/28/2019
83B1C8,earnings,100,50,2/28/2019
83E0AC,conference-call,100,50,2/28/2019
845533,earnings,100,50,2/28/2019
858942,earnings,100,50,2/28/2019
862941,earnings,100,50,2/28/2019
868808,executive-appointment,100,54,2/28/2019
86F123,conference-call,100,50,2/28/2019
877C0C,earnings,100,50,2/28/2019
895D56,earnings,100,50,2/28/2019
8BFAA4,conference-call,100,50,2/28/2019
8C5519,conference-participant,100,50,2/28/2019
8C6C1B,facility-open,100,65,2/28/2019
8E3F58,earnings,100,50,2/28/2019
902670,executive-appointment,100,54,2/28/2019
903AB4,executive-appointment,100,54,2/28/2019
931AE7,conference-call,100,50,2/28/2019
942165,earnings,100,50,2/28/2019
944B2E,earnings,100,50,2/28/2019
94756D,earnings,100,50,2/28/2019
947B0B,earnings,100,50,2/28/2019
957A07,earnings,100,50,2/28/2019
958938,earnings,100,50,2/28/2019
9.65E+09,executive-appointment,100,54,2/28/2019
966DBE,earnings,100,50,2/28/2019
966DBE,earnings,100,50,2/28/2019
966DBE,earnings,100,50,2/28/2019
966DBE,earnings,100,50,2/28/2019
966DBE,earnings,100,50,2/28/2019
9.86E+03,note-sale,100,52,2/28/2019
9934AD,earnings,100,50,2/28/2019
9978F1,earnings,100,50,2/28/2019
9ABD30,earnings,100,50,2/28/2019
9BBFA5,conference-call,100,50,2/28/2019
9C009A,earnings,100,50,2/28/2019
9C25FF,earnings,100,50,2/28/2019
9CDA4F,earnings,100,50,2/28/2019
9D307D,conference-call,100,50,2/28/2019
9D5FA4,earnings,100,50,2/28/2019
9F048E,earnings,100,50,2/28/2019
9F5CBB,dividend,100,50,2/28/2019
A0F146,earnings,100,50,2/28/2019
A16DEA,acquisition-acquiree,100,76,2/28/2019
A16DEA,acquisition-acquiree,100,76,2/28/2019
A16DEA,acquisition-acquiree,100,76,2/28/2019
A16DEA,acquisition-acquiree,100,76,2/28/2019
A16DEA,acquisition-acquiree,100,76,2/28/2019
A16DEA,acquisition-acquiree,100,76,2/28/2019
A204A7,earnings,100,50,2/28/2019
A28675,earnings,100,50,2/28/2019
A398B9,earnings-up,100,68,2/28/2019
A398B9,earnings-up,100,68,2/28/2019
A398B9,earnings-up,100,68,2/28/2019
A398B9,earnings-up,100,68,2/28/2019
A5151E,earnings,100,50,2/28/2019
A5195E,conference-participant,100,50,2/28/2019
A631A3,earnings,100,50,2/28/2019
A666C8,executive-appointment,100,54,2/28/2019
A6828A,partnership,100,61,2/28/2019
A6828A,conference-participant,100,50,2/28/2019
A8B137,conference-participant,100,50,2/28/2019
AA247D,credit-extension-recipient,100,69,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AAC8B6,earnings,100,50,2/28/2019
AC7AAE,earnings,100,50,2/28/2019
AD23DE,business-contract,100,69,2/28/2019
AD6141,earnings,100,50,2/28/2019
AD6141,earnings,100,50,2/28/2019
AD6141,earnings,100,50,2/28/2019
AD6141,earnings,100,50,2/28/2019
AD6141,buybacks,100,74,2/28/2019
AE3113,earnings,100,50,2/28/2019
AEF2C3,note-sale,100,52,2/28/2019
B04426,earnings,100,50,2/28/2019
B0998E,executive-appointment,100,54,2/28/2019
B1FC3B,business-contract,100,69,2/28/2019
B1FC3B,acquisition-completed-acquirer,100,49,2/28/2019
B2256A,earnings,100,50,2/28/2019
B290A2,partnership,100,61,2/28/2019
B2AA0A,earnings,100,50,2/28/2019
B2D492,business-contract,100,69,2/28/2019
B2D492,earnings,100,50,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B3CB74,conference-organizer,100,57,2/28/2019
B5BA39,conference-participant,100,50,2/28/2019
B6082A,dividend,100,50,2/28/2019
B619CB,executive-appointment,100,54,2/28/2019
B73395,conference-call,100,50,2/28/2019
B803B1,earnings,100,50,2/28/2019
B98EFA,operating-earnings,100,50,2/28/2019
BAAA60,dividend,100,50,2/28/2019
BDEF34,dividend,100,50,2/28/2019
C27E19,dividend,100,50,2/28/2019
C3DE7D,earnings,100,50,2/28/2019
C3F99F,earnings,100,50,2/28/2019
C45C1F,earnings,100,50,2/28/2019
C4F9C6,earnings,100,50,2/28/2019
C54140,earnings,100,50,2/28/2019
C54140,earnings,100,50,2/28/2019
C54140,earnings,100,50,2/28/2019
C54140,earnings,100,50,2/28/2019
C54140,earnings,100,50,2/28/2019
C5F463,executive-appointment,100,54,2/28/2019
C83B88,executive-appointment,100,54,2/28/2019
C83B88,business-contract,100,69,2/28/2019
C8FAC7,earnings,100,50,2/28/2019
C8FAC7,earnings,100,50,2/28/2019
C8FAC7,dividend,100,50,2/28/2019
C9A96E,earnings,100,50,2/28/2019
C9D866,conference-participant,100,50,2/28/2019
C9E107,conference-participant,100,50,2/28/2019
C9E4EC,executive-appointment,100,54,2/28/2019
CAB222,earnings,100,50,2/28/2019
CB9E13,note-sale,100,52,2/28/2019
CB9E13,note-sale,100,52,2/28/2019
CBFFDD,trading-halt,100,43,2/28/2019
CBFFDD,earnings,100,50,2/28/2019
CBFFDD,earnings,100,50,2/28/2019
CBFFDD,earnings,100,50,2/28/2019
CBFFDD,earnings,100,50,2/28/2019
CBFFDD,earnings,100,50,2/28/2019
CD4DA8,conference-organizer,100,57,2/28/2019
CE2791,earnings,100,50,2/28/2019
CF3FF9,earnings,100,50,2/28/2019
CF7292,conference-call,100,50,2/28/2019
CFD4B6,earnings,100,50,2/28/2019
D06996,earnings,100,50,2/28/2019
D0DE27,facility-open,100,65,2/28/2019
D0DE27,earnings,100,50,2/28/2019
D1173F,executive-appointment,100,54,2/28/2019
D25249,earnings,100,50,2/28/2019
D3FA2C,earnings,100,50,2/28/2019
D56E4C,earnings,100,50,2/28/2019
D56E4C,earnings-guidance,100,50,2/28/2019
D56E4C,earnings-guidance,100,50,2/28/2019
D64EDF,earnings-above-expectations,100,88,2/28/2019
D64EDF,earnings,100,50,2/28/2019
D64EDF,earnings,100,50,2/28/2019
D64EDF,earnings,100,50,2/28/2019
D64EDF,earnings,100,50,2/28/2019
D76AEF,dividend-up,100,56,2/28/2019
DA0CB8,executive-appointment,100,54,2/28/2019
DA48E4,conference-participant,100,50,2/28/2019
DB5CA5,executive-appointment,100,54,2/28/2019
DC2B00,conference-call,100,50,2/28/2019
DC6AA0,dividend,100,50,2/28/2019
DD0F15,earnings,100,50,2/28/2019
DDCB34,dividend,100,50,2/28/2019
DDCB34,earnings,100,50,2/28/2019
DDEA6A,earnings,100,50,2/28/2019
DE20DF,earnings,100,50,2/28/2019
DF01B1,conference-participant,100,50,2/28/2019
DF18E6,conference-participant,100,50,2/28/2019
E10D31,dividend,100,50,2/28/2019
E10D31,earnings,100,50,2/28/2019
E16133,earnings,100,50,2/28/2019
E2CB7B,earnings,100,50,2/28/2019
E2CFD2,earnings-meet-expectations,100,59,2/28/2019
E2CFD2,earnings,100,50,2/28/2019
E2CFD2,earnings,100,50,2/28/2019
E2CFD2,earnings,100,50,2/28/2019
E2CFD2,earnings,100,50,2/28/2019
E2F66E,earnings,100,50,2/28/2019
E70531,resource-discovery,100,88,2/28/2019
E71AE6,legal-issues-defendant,100,22,2/28/2019
E74B55,earnings,100,50,2/28/2019
E866D2,partnership,100,61,2/28/2019
EAA0A7,earnings,100,50,2/28/2019
EC70EC,note-sale,100,52,2/28/2019
EC70EC,note-sale,100,52,2/28/2019
ED4560,earnings,100,50,2/28/2019
ED4560,acquisition-acquirer,100,49,2/28/2019
ED79D9,product-release,100,64,2/28/2019
EF1AD9,business-contract,100,69,2/28/2019
EF25A5,earnings,100,50,2/28/2019
EF25A5,earnings,100,50,2/28/2019
EF25A5,earnings,100,50,2/28/2019
EF25A5,earnings,100,50,2/28/2019
EF25A5,acquisition-acquirer,100,49,2/28/2019
EF25A5,acquisition-acquirer,100,49,2/28/2019
EF25A5,acquisition-acquirer,100,49,2/28/2019
EF25A5,acquisition-acquirer,100,49,2/28/2019
EF25A5,acquisition-acquirer,100,49,2/28/2019
EF25A5,acquisition-acquirer,100,49,2/28/2019
F0027C,earnings,100,50,2/28/2019
F00285,earnings,100,50,2/28/2019
F1529C,conference-participant,100,50,2/28/2019
F47871,earnings,100,50,2/28/2019
F4D241,earnings,100,50,2/28/2019
F5D410,earnings,100,50,2/28/2019
F6E1B5,earnings,100,50,2/28/2019
F73DD1,executive-resignation,100,44,2/28/2019
F90EE5,product-release,100,64,2/28/2019
F92DBC,partnership,100,61,2/28/2019
F9AA02,earnings,100,50,2/28/2019
FAAFA2,ipo-pricing,100,50,2/28/2019
FC1A6E,earnings,100,50,2/28/2019
FC1B7B,executive-appointment,100,54,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD39EB,earnings,100,50,2/28/2019
FD554E,earnings,100,50,2/28/2019
FEC475,conference-participant,100,50,2/28/2019
FF227B,public-offering,100,43,2/28/2019
FF6644,conference-participant,100,50,2/28/2019
08A40F,acquisition-completed-acquirer,100,49,3/1/2019
98977,legal-issues-defendant,100,22,3/1/2019
0A9D0A,legal-issues-defendant,100,22,3/1/2019
0C6293,executive-appointment,100,54,3/1/2019
0CE7F6,earnings,100,50,3/1/2019
0F65C9,conference-participant,100,50,3/1/2019
108A2B,conference-participant,100,50,3/1/2019
10C19B,conference-participant,100,50,3/1/2019
11074E,index-listing,100,76,3/1/2019
157D9F,acquisition-completed-acquirer,100,49,3/1/2019
16B882,earnings,100,50,3/1/2019
16F4D8,executive-appointment,100,54,3/1/2019
1782D5,dividend,100,50,3/1/2019
182BE7,conference-participant,100,50,3/1/2019
1834C0,conference-participant,100,50,3/1/2019
1A5957,legal-issues-defendant,100,22,3/1/2019
1A5957,legal-issues-defendant,100,22,3/1/2019
1A5957,legal-issues-defendant,100,22,3/1/2019
1E8A99,dividend,100,50,3/1/2019
20BEEA,acquisition-completed-acquirer,100,49,3/1/2019
228D42,partnership,100,61,3/1/2019
2720AB,executive-appointment,100,54,3/1/2019
2E902B,conference-participant,100,50,3/1/2019
36529A,conference-participant,100,50,3/1/2019
36A1CB,dividend,100,50,3/1/2019
37020C,dividend,100,50,3/1/2019
383ADA,earnings,100,50,3/1/2019
38FB49,conference-participant,100,50,3/1/2019
39FB23,acquisition-completed-acquirer,100,49,3/1/2019
3A3447,facility-open,100,65,3/1/2019
3A94DF,dividend,100,50,3/1/2019
3C11C4,conference-participant,100,50,3/1/2019
3C7F5F,partnership,100,61,3/1/2019
3DB18B,executive-resignation,100,44,3/1/2019
4.03E+05,facility-open,100,65,3/1/2019
408380,earnings,100,50,3/1/2019
4135F7,earnings,100,50,3/1/2019
431B74,executive-appointment,100,54,3/1/2019
431B74,executive-appointment,100,54,3/1/2019
4455C4,conference-participant,100,50,3/1/2019
45BC35,conference-participant,100,50,3/1/2019
48F795,note-sale,100,52,3/1/2019
49A344,acquisition-acquirer,100,49,3/1/2019
49CC59,earnings,100,50,3/1/2019
4A3438,conference-participant,100,50,3/1/2019
4A7C1F,conference-call,100,50,3/1/2019
4DAF5F,buybacks,100,74,3/1/2019
4DAF5F,buybacks,100,74,3/1/2019
4F9487,conference-participant,100,50,3/1/2019
514067,legal-issues-defendant,100,22,3/1/2019
52FB2F,conference-participant,100,50,3/1/2019
5.47E+28,conference-participant,100,50,3/1/2019
54DF47,dividend,100,50,3/1/2019
5675EB,acquisition-completed-acquirer,100,49,3/1/2019
58CA9A,conference-organizer,100,57,3/1/2019
58CA9A,conference-organizer,100,57,3/1/2019
58CA9A,conference-organizer,100,57,3/1/2019
58CA9A,conference-organizer,100,57,3/1/2019
58CA9A,conference-organizer,100,57,3/1/2019
5A9F54,executive-appointment,100,54,3/1/2019
5B226B,revenue-up,100,76,3/1/2019
5B226B,revenue-up,100,76,3/1/2019
5B226B,revenue-up,100,76,3/1/2019
5D02B7,dividend,100,50,3/1/2019
5F3D91,legal-issues-defendant,100,22,3/1/2019
5F3D91,legal-issues-defendant,100,22,3/1/2019
5F9CE3,dividend,100,50,3/1/2019
619882,executive-appointment,100,54,3/1/2019
619882,conference-organizer,100,57,3/1/2019
6284B5,conference-participant,100,50,3/1/2019
639BD6,acquisition-acquiree,100,76,3/1/2019
665D7D,conference-participant,100,50,3/1/2019
67A658,executive-appointment,100,54,3/1/2019
67A658,executive-appointment,100,54,3/1/2019
6B236C,conference-participant,100,50,3/1/2019
6D3F35,conference-participant,100,50,3/1/2019
6D3F35,legal-issues-defendant,100,22,3/1/2019
6E7060,executive-appointment,100,54,3/1/2019
726DDF,earnings,100,50,3/1/2019
7410C3,earnings,100,50,3/1/2019
75F665,merger-regulatory-approval,100,81,3/1/2019
762A3E,conference-organizer,100,57,3/1/2019
762A3E,conference-organizer,100,57,3/1/2019
762A3E,conference-organizer,100,57,3/1/2019
767F86,conference-participant,100,50,3/1/2019
76CEFB,buybacks,100,74,3/1/2019
7740DE,dividend,100,50,3/1/2019
7999F3,conference-participant,100,50,3/1/2019
7A10FF,conference-participant,100,50,3/1/2019
7AB859,conference-organizer,100,57,3/1/2019
804708,dividend,100,50,3/1/2019
8614A2,legal-issues-defendant,100,22,3/1/2019
862941,conference-participant,100,50,3/1/2019
89E771,dividend,100,50,3/1/2019
8A8E41,unit-acquisition-acquirer,100,49,3/1/2019
8C6C1B,facility-open,100,65,3/1/2019
8E10BF,conference-call,100,50,3/1/2019
8E4250,index-listing,100,76,3/1/2019
8EF425,dividend,100,50,3/1/2019
8EF425,conference-participant,100,50,3/1/2019
90D6A5,acquisition-completed-acquirer,100,49,3/1/2019
92D757,conference-participant,100,50,3/1/2019
93633B,conference-participant,100,50,3/1/2019
9470CC,public-offering,100,43,3/1/2019
947B0B,asset-sale,100,62,3/1/2019
95A92E,earnings,100,50,3/1/2019
990AD0,conference-organizer,100,57,3/1/2019
997348,dividend,100,50,3/1/2019
9981C6,dividend,100,50,3/1/2019
9E9147,executive-appointment,100,54,3/1/2019
A5151E,conference-participant,100,50,3/1/2019
A52533,facility-open,100,65,3/1/2019
A72FD9,business-contract,100,69,3/1/2019
A8FDE8,earnings,100,50,3/1/2019
A96867,dividend-up,100,61,3/1/2019
AC7C4F,acquisition-completed-acquirer,100,49,3/1/2019
AEFC90,conference-participant,100,50,3/1/2019
AFEC35,conference-participant,100,50,3/1/2019
B106FA,earnings,100,50,3/1/2019
B3CB74,conference-organizer,100,57,3/1/2019
B3CB74,conference-organizer,100,57,3/1/2019
B3CB74,conference-organizer,100,57,3/1/2019
B3CB74,conference-organizer,100,57,3/1/2019
B3CB74,conference-organizer,100,57,3/1/2019
B3CB74,conference-organizer,100,57,3/1/2019
B3CB74,conference-organizer,100,57,3/1/2019
B3CB74,conference-organizer,100,57,3/1/2019
B77F14,earnings,100,50,3/1/2019
B7FA9B,conference-participant,100,50,3/1/2019
BD15E8,executive-appointment,100,54,3/1/2019
BDE867,earnings,100,50,3/1/2019
BDE867,earnings,100,50,3/1/2019
BDE867,earnings,100,50,3/1/2019
BE86A1,dividend,100,50,3/1/2019
C356AC,legal-issues-defendant,100,22,3/1/2019
C659EB,acquisition-acquirer,100,49,3/1/2019
C7859D,dividend,100,50,3/1/2019
C83B88,partnership,100,61,3/1/2019
C83B88,executive-appointment,100,54,3/1/2019
CBBFBF,partnership,100,61,3/1/2019
CBCC6A,conference-organizer,100,57,3/1/2019
CBFFDD,trading-resumed,100,58,3/1/2019
CC0C78,conference-participant,100,50,3/1/2019
CD4DA8,conference-organizer,100,57,3/1/2019
CE4FD9,conference-participant,100,50,3/1/2019
CFF97C,credit-rating-outlook-revision-rater,20,50,3/1/2019
D6EAA3,earnings,100,50,3/1/2019
D6EAA3,earnings,100,50,3/1/2019
D6EAA3,earnings,100,50,3/1/2019
D6EAA3,earnings,100,50,3/1/2019
D6EAA3,earnings,100,50,3/1/2019
D77F7E,acquisition-completed-acquirer,100,49,3/1/2019
D77F7E,acquisition-completed-acquirer,100,49,3/1/2019
DA0CB8,conference-participant,100,50,3/1/2019
DA48E4,acquisition-completed-acquirer,100,49,3/1/2019
DD7A96,dividend,100,50,3/1/2019
DDB002,earnings,100,50,3/1/2019
DDB002,executive-appointment,100,54,3/1/2019
DDC415,executive-appointment,100,54,3/1/2019
DF1F7A,dividend,100,50,3/1/2019
DF1F7A,executive-appointment,100,54,3/1/2019
E124EB,public-offering,100,43,3/1/2019
E1E093,acquisition-bid-rejected-acquirer,100,46,3/1/2019
E38906,earnings,100,50,3/1/2019
E70531,executive-resignation,100,44,3/1/2019
E71AE6,legal-issues-defendant,100,22,3/1/2019
E8846E,donation,100,54,3/1/2019
E99180,acquisition-completed-acquirer,100,49,3/1/2019
EB43F4,earnings,100,50,3/1/2019
EC70EC,note-sale,100,52,3/1/2019
F0B2B5,legal-issues-defendant,100,22,3/1/2019
F6E1B5,conference-participant,100,50,3/1/2019
F85CC0,acquisition-acquirer,100,49,3/1/2019
FB728F,earnings,100,50,3/1/2019
FC4550,dividend,100,50,3/1/2019
FF227B,public-offering,100,43,3/1/2019
FF227B,conference-call,100,50,3/1/2019
154272,clinical-trials-positive,100,87,3/2/2019
1A5957,legal-issues-defendant,100,22,3/2/2019
1A5957,legal-issues-defendant,100,22,3/2/2019
1A5957,legal-issues-defendant,100,22,3/2/2019
251988,legal-issues-defendant,100,22,3/2/2019
514067,legal-issues-defendant,100,22,3/2/2019
B3CB74,conference-organizer,100,57,3/2/2019
E35610,legal-issues-defendant,100,22,3/2/2019
FA40E2,legal-issues-defendant,100,22,3/2/2019
0157B1,partnership,100,61,3/4/2019
20751,conference-participant,100,50,3/4/2019
0490C6,joint-venture,100,62,3/4/2019
98977,legal-issues-defendant,100,22,3/4/2019
0B7375,conference-call,100,50,3/4/2019
0C6861,conference-participant,100,50,3/4/2019
0DBB81,conference-participant,100,50,3/4/2019
0E64D4,executive-appointment,100,54,3/4/2019
11074E,conference-participant,100,50,3/4/2019
1490F3,public-offering,100,43,3/4/2019
1866B2,dividend,100,50,3/4/2019
1A5957,legal-issues-defendant,100,22,3/4/2019
1A5957,legal-issues-defendant,100,22,3/4/2019
1AB023,earnings,100,50,3/4/2019
1AB023,earnings,100,50,3/4/2019
1AB023,earnings,100,50,3/4/2019
1AC649,conference-participant,100,50,3/4/2019
1CF3A8,acquisition-completed-acquirer,100,49,3/4/2019
1EBF8D,regulatory-product-review-positive,100,73,3/4/2019
214051,facility-open,100,65,3/4/2019
232053,conference-participant,100,50,3/4/2019
251988,legal-issues-defendant,100,22,3/4/2019
26F99F,executive-appointment,100,54,3/4/2019
272704,conference-participant,100,50,3/4/2019
28DCF3,acquisition-completed-acquirer,100,49,3/4/2019
2BAE5F,partnership,100,61,3/4/2019
2C35B5,product-release,100,64,3/4/2019
2CC71C,conference-call,100,50,3/4/2019
2CD1E0,partnership,100,61,3/4/2019
32DCB3,regulatory-product-approval-granted,100,81,3/4/2019
33AD83,partnership,100,61,3/4/2019
34B97A,partnership,100,61,3/4/2019
34B97A,executive-appointment,100,54,3/4/2019
38C46F,dividend,100,50,3/4/2019
397A8F,earnings,100,50,3/4/2019
3BB616,dividend,100,50,3/4/2019
3C75D6,earnings,100,50,3/4/2019
3C75D6,earnings,100,50,3/4/2019
3C75D6,earnings,100,50,3/4/2019
41C528,conference-call,100,50,3/4/2019
42978B,dividend,100,50,3/4/2019
451D61,conference-participant,100,50,3/4/2019
4.60E+06,earnings,100,50,3/4/2019
4A2457,award,100,58,3/4/2019
4B7006,board-meeting,100,51,3/4/2019
4C3FE9,earnings,100,50,3/4/2019
4D8313,product-release,100,64,3/4/2019
4DAF5F,buybacks,100,74,3/4/2019
4DAF5F,buybacks,100,74,3/4/2019
510EA1,earnings,100,50,3/4/2019
514067,conference-participant,100,50,3/4/2019
514067,legal-issues-defendant,100,22,3/4/2019
52FB2F,acquisition-acquirer,100,49,3/4/2019
54512F,earnings,100,50,3/4/2019
56EA2B,dividend,100,50,3/4/2019
57634F,note-sale,100,52,3/4/2019
57EF50,revenues,100,50,3/4/2019
57EF50,revenues,100,50,3/4/2019
57EF50,revenues,100,50,3/4/2019
57EF50,revenues,100,50,3/4/2019
5876DC,earnings,100,50,3/4/2019
58CA9A,award,100,58,3/4/2019
594402,conference-participant,100,50,3/4/2019
5D0EAE,trading-halt,100,43,3/4/2019
5E1DF3,revenues,100,50,3/4/2019
5E1DF3,earnings,100,50,3/4/2019
5E1DF3,earnings,100,50,3/4/2019
5EC388,executive-appointment,100,54,3/4/2019
5F1B7B,partnership,100,61,3/4/2019
60DD84,conference-participant,100,50,3/4/2019
6166D1,conference-call,100,50,3/4/2019
619882,conference-organizer,100,57,3/4/2019
619882,conference-organizer,100,57,3/4/2019
64636E,earnings,100,50,3/4/2019
64636E,earnings,100,50,3/4/2019
651C85,private-placement,100,56,3/4/2019
67B052,conference-participant,100,50,3/4/2019
6925EB,conference-participant,100,50,3/4/2019
69C99E,clinical-trials-start,100,64,3/4/2019
6D2BF6,earnings,100,50,3/4/2019
6F0096,dividend,100,50,3/4/2019
73C9E2,conference-participant,100,50,3/4/2019
75768D,conference-call,100,50,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
762A3E,conference-organizer,100,57,3/4/2019
76D79A,dividend,100,50,3/4/2019
78A1BB,facility-open,100,65,3/4/2019
79167B,conference-participant,100,50,3/4/2019
7A2A49,conference-participant,100,50,3/4/2019
7A975D,award,100,58,3/4/2019
7A975D,award,100,58,3/4/2019
7ADE57,partnership,100,61,3/4/2019
7BEA98,conference-participant,100,50,3/4/2019
7C790D,earnings,100,50,3/4/2019
7DD8CC,ownership-decrease-held,100,49,3/4/2019
7E0EB0,executive-appointment,100,54,3/4/2019
817ED9,unit-acquisition-acquirer,100,49,3/4/2019
83066C,earnings,100,50,3/4/2019
83066C,earnings,100,50,3/4/2019
8377DB,earnings,100,50,3/4/2019
8377DB,conference-participant,100,50,3/4/2019
860AB6,ownership-decrease-owner,100,46,3/4/2019
8665BA,conference-participant,100,50,3/4/2019
8AB37F,conference-participant,100,50,3/4/2019
8AC740,dividend,100,50,3/4/2019
8C6C1B,facility-open,100,65,3/4/2019
8EEA28,earnings,100,50,3/4/2019
92005C,conference-participant,100,50,3/4/2019
9470CC,conference-participant,100,50,3/4/2019
9592FB,conference-participant,100,50,3/4/2019
95C392,public-offering,100,43,3/4/2019
9673BD,partnership,100,61,3/4/2019
96A6CD,conference-participant,100,50,3/4/2019
97B027,earnings-up,100,68,3/4/2019
97B027,earnings,100,50,3/4/2019
97B027,earnings,100,50,3/4/2019
97B027,earnings,100,50,3/4/2019
990AD0,partnership,100,61,3/4/2019
994468,dividend,100,50,3/4/2019
9FB4B7,conference-call,100,50,3/4/2019
A29DBD,product-release,100,64,3/4/2019
A5195E,earnings,100,50,3/4/2019
A58224,conference-participant,100,50,3/4/2019
A5A4F5,product-release,100,64,3/4/2019
A5A4F5,product-release,100,64,3/4/2019
A6828A,business-contract,100,69,3/4/2019
A7102F,acquisition-completed-acquirer,100,49,3/4/2019
A79F7D,clinical-trials,100,56,3/4/2019
A8CBDA,partnership,100,61,3/4/2019
A9ED24,conference-participant,100,50,3/4/2019
AA1EAA,conference-participant,100,50,3/4/2019
AADE0B,unit-acquisition-acquirer,100,49,3/4/2019
AADE0B,unit-acquisition-acquirer,100,49,3/4/2019
AADE0B,acquisition-acquirer,100,49,3/4/2019
AADE0B,acquisition-acquirer,100,49,3/4/2019
AADE0B,acquisition-acquirer,100,49,3/4/2019
ADFB3A,conference-participant,100,50,3/4/2019
B04426,conference-participant,100,50,3/4/2019
B08C51,earnings,100,50,3/4/2019
B13B68,conference-participant,100,50,3/4/2019
B1FC3B,earnings,100,50,3/4/2019
B290A2,conference-participant,100,50,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B3CB74,conference-organizer,100,57,3/4/2019
B48FC9,public-offering,100,43,3/4/2019
B66928,partnership,100,61,3/4/2019
B7EB38,executive-appointment,100,54,3/4/2019
B803B1,conference-participant,100,50,3/4/2019
B80AD1,earnings,100,50,3/4/2019
B83D67,conference-participant,100,50,3/4/2019
BB02FB,award,100,58,3/4/2019
BB127B,earnings-up,100,68,3/4/2019
BB5271,product-release,100,64,3/4/2019
BB88B6,executive-appointment,100,54,3/4/2019
BBC05B,earnings,100,50,3/4/2019
BC948D,conference-participant,100,50,3/4/2019
BCC13E,conference-participant,100,50,3/4/2019
C0BA36,partnership,100,61,3/4/2019
C11C46,executive-appointment,100,54,3/4/2019
C356AC,partnership,100,61,3/4/2019
C356AC,legal-issues-defendant,100,22,3/4/2019
C356AC,legal-issues-defendant,100,22,3/4/2019
C45C1F,conference-participant,100,50,3/4/2019
C45CE7,buybacks,100,74,3/4/2019
C4F9C6,conference-participant,100,50,3/4/2019
C584BE,credit-extension-recipient,100,69,3/4/2019
C624A1,clinical-trials-start,100,64,3/4/2019
C65004,executive-appointment,100,54,3/4/2019
C6C702,product-release,100,64,3/4/2019
C6C702,product-release,100,64,3/4/2019
C9C62A,executive-appointment,100,54,3/4/2019
CAB222,reorganization-unit,100,53,3/4/2019
CB89EA,conference-participant,100,50,3/4/2019
CBA33B,award,100,58,3/4/2019
CBB77B,earnings,100,50,3/4/2019
CDC217,conference-call,100,50,3/4/2019
CE4FD9,executive-appointment,100,54,3/4/2019
CEDFD5,acquisition-acquirer,100,49,3/4/2019
CEDFD5,acquisition-acquirer,100,49,3/4/2019
CEDFD5,acquisition-acquiree,100,76,3/4/2019
CEDFD5,acquisition-acquiree,100,76,3/4/2019
CF6A5A,product-release,100,64,3/4/2019
CF6A5A,product-release,100,64,3/4/2019
CFF15D,business-contract,100,69,3/4/2019
CFF15D,business-contract,100,69,3/4/2019
D3F64D,executive-resignation,100,44,3/4/2019
D42DBA,dividend,100,50,3/4/2019
D6EAA3,conference-participant,100,50,3/4/2019
DBCA3F,facility-open,100,65,3/4/2019
DBCA3F,facility-open,100,65,3/4/2019
DDB002,legal-issues-defendant,100,22,3/4/2019
DDEA6A,executive-appointment,100,54,3/4/2019
DEF058,acquisition-completed-acquirer,100,49,3/4/2019
DF204B,conference-participant,100,50,3/4/2019
DFADDB,earnings,100,50,3/4/2019
E0647D,earnings,100,50,3/4/2019
E0647D,earnings,100,50,3/4/2019
E09997,conference-call,100,50,3/4/2019
E1C16B,dividend,100,50,3/4/2019
E1E093,patent-awarded,100,72,3/4/2019
E259C7,conference-participant,100,50,3/4/2019
E2CFD2,partnership,100,61,3/4/2019
E67C2C,conference-participant,100,50,3/4/2019
E68733,note-sale,100,52,3/4/2019
E71AE6,executive-appointment,100,54,3/4/2019
E71AE6,legal-issues-defendant,100,22,3/4/2019
E866D2,conference-participant,100,50,3/4/2019
E8846E,donation,100,54,3/4/2019
E8C557,product-release,100,64,3/4/2019
E9E6FD,buybacks,100,74,3/4/2019
EA79C7,conference-participant,100,50,3/4/2019
EAA0A7,conference-participant,100,50,3/4/2019
EC99D0,acquisition-interest-acquirer,100,46,3/4/2019
EEB5F9,executive-appointment,100,54,3/4/2019
EF5BED,partnership,100,61,3/4/2019
F30508,product-release,100,64,3/4/2019
F30508,product-release,100,64,3/4/2019
F32F88,conference-participant,100,50,3/4/2019
F5D410,conference-participant,100,50,3/4/2019
F7902B,executive-appointment,100,54,3/4/2019
F88147,executive-appointment,100,54,3/4/2019
F9CAF8,executive-resignation,100,44,3/4/2019
FAAFA2,ipo-completed,100,76,3/4/2019
FFCD0E,earnings,100,50,3/4/2019
0325B7,earnings,100,50,3/5/2019
0490C6,earnings,100,50,3/5/2019
054E7E,earnings,100,50,3/5/2019
98977,legal-issues-defendant,100,22,3/5/2019
099C88,dividend,100,50,3/5/2019
09DE1F,product-release,100,64,3/5/2019
0BC853,unit-acquisition-completed-acquirer,100,49,3/5/2019
0CCCB7,executive-appointment,100,54,3/5/2019
0F0440,earnings,100,50,3/5/2019
0F0440,earnings,100,50,3/5/2019
0F0440,partnership,100,61,3/5/2019
0FABBD,legal-issues-defendant,100,22,3/5/2019
0FABBD,legal-issues-defendant,100,22,3/5/2019
1080C0,regulatory-product-approval-granted,100,81,3/5/2019
1080C0,earnings,100,50,3/5/2019
12DE76,product-release,100,64,3/5/2019
12E454,legal-issues-defendant,100,22,3/5/2019
14833D,earnings,100,50,3/5/2019
14833D,earnings,100,50,3/5/2019
14833D,earnings,100,50,3/5/2019
14833D,earnings,100,50,3/5/2019
152FA5,conference-participant,100,50,3/5/2019
1748F6,earnings,100,50,3/5/2019
1866B2,earnings,100,50,3/5/2019
190B91,conference-participant,100,50,3/5/2019
1A5957,legal-issues-defendant,100,22,3/5/2019
1CD09C,conference-participant,100,50,3/5/2019
1E5786,conference-participant,100,50,3/5/2019
1EBF8D,note-sale,100,52,3/5/2019
202E5A,conference-participant,100,50,3/5/2019
2082EA,conference-participant,100,50,3/5/2019
21268E,earnings,100,50,3/5/2019
221AD7,facility-close,100,47,3/5/2019
228D42,award,100,58,3/5/2019
250BEE,acquisition-completed-acquirer,100,49,3/5/2019
250BEE,acquisition-completed-acquirer,100,49,3/5/2019
250BEE,acquisition-completed-acquirer,100,49,3/5/2019
251988,legal-issues-defendant,100,22,3/5/2019
267718,note-sale,100,52,3/5/2019
27C10F,earnings,100,50,3/5/2019
29CEBF,earnings,100,50,3/5/2019
2B8179,earnings,100,50,3/5/2019
2B9DBB,executive-appointment,100,54,3/5/2019
2CC71C,conference-participant,100,50,3/5/2019
337024,earnings,100,50,3/5/2019
337024,earnings,100,50,3/5/2019
33FD66,facility-open,100,65,3/5/2019
349DA4,conference-participant,100,50,3/5/2019
34B411,acquisition-acquirer,100,49,3/5/2019
34B411,acquisition-acquirer,100,49,3/5/2019
367E1C,conference-participant,100,50,3/5/2019
370C50,supply-guidance-increase,100,74,3/5/2019
3798B9,public-offering,100,43,3/5/2019
396D7C,conference-participant,100,50,3/5/2019
3B37F7,earnings,100,50,3/5/2019
3B50FE,dividend,100,50,3/5/2019
3C11C4,conference-participant,100,50,3/5/2019
3C7F5F,conference-participant,100,50,3/5/2019
3D7971,product-release,100,64,3/5/2019
3DE4D1,executive-appointment,100,54,3/5/2019
3EE65E,earnings,100,50,3/5/2019
3F1C69,earnings,100,50,3/5/2019
401072,conference-participant,100,50,3/5/2019
40B903,product-release,100,64,3/5/2019
448BF3,earnings,100,50,3/5/2019
45BC35,note-sale,100,52,3/5/2019
47FCF2,product-release,100,64,3/5/2019
485445,dividend,100,50,3/5/2019
4.91E+58,executive-appointment,100,54,3/5/2019
4A2457,business-contract,100,69,3/5/2019
4A5C8D,partnership,100,61,3/5/2019
4A6F00,partnership,100,61,3/5/2019
4C3FE9,conference-participant,100,50,3/5/2019
4D229C,earnings,100,50,3/5/2019
4DAF5F,buybacks,100,74,3/5/2019
4DAF5F,buybacks,100,74,3/5/2019
4E3D15,operating-earnings,100,50,3/5/2019
507AE7,earnings-guidance,100,50,3/5/2019
50D1EC,earnings,100,50,3/5/2019
51E682,conference-participant,100,50,3/5/2019
55D0F3,earnings,100,50,3/5/2019
56EA2B,conference-call,100,50,3/5/2019
57634F,note-sale,100,52,3/5/2019
58C2D4,earnings,100,50,3/5/2019
59DB8C,conference-participant,100,50,3/5/2019
5B3FA2,product-release,100,64,3/5/2019
5EAA43,partnership,100,61,3/5/2019
5F1B7B,partnership,100,61,3/5/2019
5F3D91,legal-issues-defendant,100,22,3/5/2019
5F3E74,conference-participant,100,50,3/5/2019
619882,partnership,100,61,3/5/2019
61A586,public-offering,100,43,3/5/2019
61B81B,conference-call,100,50,3/5/2019
633043,earnings,100,50,3/5/2019
63F892,partnership,100,61,3/5/2019
665440,conference-call,100,50,3/5/2019
69C99E,earnings,100,50,3/5/2019
69CE71,conference-participant,100,50,3/5/2019
701531,conference-participant,100,50,3/5/2019
726DDF,unit-acquisition-acquirer,100,49,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
762A3E,conference-organizer,100,57,3/5/2019
763724,acquisition-completed-acquirer,100,49,3/5/2019
76959C,earnings,100,50,3/5/2019
7A10FF,product-release,100,64,3/5/2019
7ADE57,earnings,100,50,3/5/2019
7ADE57,earnings,100,50,3/5/2019
7ADE57,earnings,100,50,3/5/2019
7ADE57,earnings,100,50,3/5/2019
7ADE57,earnings,100,50,3/5/2019
7D85A9,donation,100,54,3/5/2019
7E3F8F,public-offering,100,43,3/5/2019
7FEEE1,conference-participant,100,50,3/5/2019
8.10E+32,dividend,100,50,3/5/2019
81EAD4,business-contract,100,69,3/5/2019
81EAD4,product-release,100,64,3/5/2019
826FD6,earnings,100,50,3/5/2019
82C202,asset-sale,100,62,3/5/2019
82C202,asset-sale,100,62,3/5/2019
83B1C8,conference-participant,100,50,3/5/2019
85DE00,conference-participant,100,50,3/5/2019
85DE00,award,100,58,3/5/2019
8614A2,legal-issues-defendant,100,22,3/5/2019
88193E,conference-participant,100,50,3/5/2019
895D56,acquisition-acquirer,100,49,3/5/2019
8C6C1B,facility-open,100,65,3/5/2019
8C6C1B,earnings,100,50,3/5/2019
9087B9,note-sale,100,52,3/5/2019
91E5EE,conference-participant,100,50,3/5/2019
934029,conference-participant,100,50,3/5/2019
9.39E+69,conference-participant,100,50,3/5/2019
94637C,conference-participant,100,50,3/5/2019
95C392,public-offering,100,43,3/5/2019
966ACE,conference-participant,100,50,3/5/2019
968966,partnership,100,61,3/5/2019
96A6CD,earnings,100,50,3/5/2019
990AD0,conference-organizer,100,57,3/5/2019
9978F1,conference-participant,100,50,3/5/2019
9D30A8,product-release,100,64,3/5/2019
9D30A8,product-release,100,64,3/5/2019
A05C43,earnings,100,50,3/5/2019
A26C26,joint-venture,100,62,3/5/2019
A26EF7,conference-participant,100,50,3/5/2019
A48593,public-offering,100,43,3/5/2019
A631A3,product-release,100,64,3/5/2019
A631A3,partnership,100,61,3/5/2019
A63820,earnings,100,50,3/5/2019
A6FB29,executive-appointment,100,54,3/5/2019
A70BF5,dividend,100,50,3/5/2019
A74F6F,earnings,100,50,3/5/2019
A868C9,business-contract,100,69,3/5/2019
A8AC4C,earnings,100,50,3/5/2019
A94637,buybacks,100,74,3/5/2019
ACC7D3,conference-participant,100,50,3/5/2019
ACDF88,hirings,100,65,3/5/2019
AFF43F,executive-appointment,100,54,3/5/2019
B076A1,dividend,100,50,3/5/2019
B0D41A,earnings,100,50,3/5/2019
B1A85D,note-sale,100,52,3/5/2019
B2256A,buybacks,100,74,3/5/2019
B33E77,earnings,100,50,3/5/2019
B3A166,dividend,100,50,3/5/2019
B4C673,campaign-ad-release,100,59,3/5/2019
B7FA9B,earnings,100,50,3/5/2019
B98EFA,market-entry,100,57,3/5/2019
BDA775,earnings,100,50,3/5/2019
BDEC1E,conference-participant,100,50,3/5/2019
C03C8B,executive-appointment,100,54,3/5/2019
C2DD02,dividend,100,50,3/5/2019
C8923A,executive-appointment,100,54,3/5/2019
C9F39B,executive-appointment,100,54,3/5/2019
CBDB4D,conference-call,100,50,3/5/2019
CD2DA4,earnings,100,50,3/5/2019
CD4DA8,conference-organizer,100,57,3/5/2019
CDAA0E,acquisition-acquirer,100,49,3/5/2019
CDAA0E,acquisition-acquirer,100,49,3/5/2019
CDC817,earnings,100,50,3/5/2019
CDFCC9,earnings-guidance-down,100,19,3/5/2019
CF3FF9,public-offering,100,43,3/5/2019
CFF57D,earnings,100,50,3/5/2019
CFF57D,earnings,100,50,3/5/2019
CFF57D,earnings,100,50,3/5/2019
CFF57D,earnings,100,50,3/5/2019
CFF57D,market-entry,100,57,3/5/2019
D17C1B,partnership,100,61,3/5/2019
D9164D,executive-appointment,100,54,3/5/2019
DC0998,award,100,58,3/5/2019
DC486E,acquisition-acquirer,100,49,3/5/2019
DD9E41,government-contract,100,69,3/5/2019
DF5F14,conference-call,100,50,3/5/2019
E09556,conference-call,100,50,3/5/2019
E09997,executive-appointment,100,54,3/5/2019
E20BFE,revenues,100,50,3/5/2019
E20BFE,revenues,100,50,3/5/2019
E20BFE,revenues,100,50,3/5/2019
E22FDE,earnings,100,50,3/5/2019
E70531,supply-guidance-increase,100,74,3/5/2019
E71AE6,legal-issues-defendant,100,22,3/5/2019
E7BF32,earnings,100,50,3/5/2019
E7BF32,earnings,100,50,3/5/2019
E8846E,donation,100,54,3/5/2019
E8846E,donation,100,54,3/5/2019
E8846E,donation,100,54,3/5/2019
E8C557,conference-participant,100,50,3/5/2019
EE04F0,conference-call,100,50,3/5/2019
F05B1B,bought-deal,100,43,3/5/2019
F0B2B5,legal-issues-defendant,100,22,3/5/2019
F1EB39,earnings,100,50,3/5/2019
F4CDA3,unit-acquisition-acquirer,100,49,3/5/2019
F569FD,conference-participant,100,50,3/5/2019
F66B58,earnings,100,50,3/5/2019
F6DCE4,earnings,100,50,3/5/2019
F6E248,conference-participant,100,50,3/5/2019
F6E248,executive-appointment,100,54,3/5/2019
F7ADEB,conference-participant,100,50,3/5/2019
F8DE55,legal-issues-defendant,100,22,3/5/2019
F8DE55,legal-issues-defendant,100,22,3/5/2019
FAB97A,executive-appointment,100,54,3/5/2019
FC4550,conference-participant,100,50,3/5/2019
FD554E,dividend,100,50,3/5/2019
FD554E,dividend,100,50,3/5/2019
FE7A63,dividend,100,50,3/5/2019
FF227B,public-offering,100,43,3/5/2019
FF5413,revenue-volume,100,50,3/5/2019
FF6644,facility-upgrade,100,65,3/5/2019
01D03F,regulatory-product-approval-granted,100,81,3/6/2019
01D03F,regulatory-product-approval-granted,100,81,3/6/2019
0358AF,dividend-up,100,81,3/6/2019
053EFF,earnings,100,50,3/6/2019
0624BE,earnings,100,50,3/6/2019
0AD2E3,earnings,100,50,3/6/2019
0AD2E3,earnings,100,50,3/6/2019
10AE08,executive-appointment,100,54,3/6/2019
11B8A4,buybacks,100,74,3/6/2019
1201B5,business-contract,100,69,3/6/2019
1201B5,business-contract,100,69,3/6/2019
1220D2,conference-participant,100,50,3/6/2019
1272B3,earnings,100,50,3/6/2019
143C52,earnings,100,50,3/6/2019
143C52,executive-appointment,100,54,3/6/2019
159739,dividend,100,50,3/6/2019
159739,dividend,100,50,3/6/2019
159AE4,conference-call,100,50,3/6/2019
196D18,conference-participant,100,50,3/6/2019
1C2593,earnings-up,100,68,3/6/2019
1D3A00,earnings,100,50,3/6/2019
1D3A00,executive-appointment,100,54,3/6/2019
1E83DE,earnings,100,50,3/6/2019
2003A5,earnings,100,50,3/6/2019
21245F,executive-appointment,100,54,3/6/2019
24FA23,earnings,100,50,3/6/2019
251988,product-release,100,64,3/6/2019
26F99F,conference-participant,100,50,3/6/2019
274B8A,conference-call,100,50,3/6/2019
279916,earnings,100,50,3/6/2019
295F9F,earnings,100,50,3/6/2019
2C7505,clinical-trials-positive,100,87,3/6/2019
2CC60C,revenue-up,100,69,3/6/2019
2CC60C,earnings,100,50,3/6/2019
2CC60C,earnings,100,50,3/6/2019
2CC60C,earnings,100,50,3/6/2019
2CC71C,earnings,100,50,3/6/2019
2F960F,earnings,100,50,3/6/2019
301493,product-release,100,64,3/6/2019
30DE64,earnings,100,50,3/6/2019
33AD83,note-sale,100,52,3/6/2019
36E479,conference-participant,100,50,3/6/2019
3B50FE,conference-participant,100,50,3/6/2019
3CCC90,partnership,100,61,3/6/2019
3D9999,acquisition-acquirer,100,49,3/6/2019
3ED92D,executive-appointment,100,54,3/6/2019
3F6A9C,award,100,58,3/6/2019
44A4FC,conference-participant,100,50,3/6/2019
458D2C,business-contract,100,69,3/6/2019
49BBBC,legal-issues-defendant,100,22,3/6/2019
4A2457,business-contract,100,69,3/6/2019
4A2457,partnership,100,61,3/6/2019
4C31F3,conference-call,100,50,3/6/2019
4CDA2B,conference-participant,100,50,3/6/2019
4D8313,product-release,100,64,3/6/2019
4DAF5F,buybacks,100,74,3/6/2019
4DAF5F,buybacks,100,74,3/6/2019
4E6F5A,earnings,100,50,3/6/2019
4F0A80,earnings,100,50,3/6/2019
5487B1,dividend,100,50,3/6/2019
556F08,earnings,100,50,3/6/2019
56EFC7,dividend,100,50,3/6/2019
5AAE17,earnings,100,50,3/6/2019
5C7601,conference-participant,100,50,3/6/2019
620381,conference-participant,100,50,3/6/2019
6830FE,earnings,100,50,3/6/2019
69345C,partnership,100,61,3/6/2019
69C99E,loan-recipient,100,59,3/6/2019
69CE71,dividend,100,50,3/6/2019
6C6D73,executive-appointment,100,54,3/6/2019
6E8864,conference-participant,100,50,3/6/2019
70FCEF,partnership,100,61,3/6/2019
71694D,merger-regulatory-approval,100,81,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
762A3E,conference-organizer,100,57,3/6/2019
763724,executive-resignation,100,44,3/6/2019
7ACD98,earnings,100,50,3/6/2019
7BC92D,earnings,100,50,3/6/2019
7BEA98,earnings,100,50,3/6/2019
7CD98F,conference-participant,100,50,3/6/2019
7E3F8F,public-offering,100,43,3/6/2019
7FC386,dividend,100,50,3/6/2019
805CD8,conference-participant,100,50,3/6/2019
830BDB,conference-participant,100,50,3/6/2019
859D62,earnings-positive,100,69,3/6/2019
859D62,earnings-positive,100,69,3/6/2019
859D62,earnings-positive,100,69,3/6/2019
859D62,earnings-positive,100,69,3/6/2019
859D62,earnings-positive,100,69,3/6/2019
859D62,earnings-positive,100,69,3/6/2019
877C0C,conference-participant,100,50,3/6/2019
890FF4,conference-participant,100,50,3/6/2019
895D56,executive-appointment,100,54,3/6/2019
8AB85C,conference-participant,100,50,3/6/2019
8C6C1B,facility-open,100,65,3/6/2019
8CF6DD,conference-participant,100,50,3/6/2019
90D6A5,note-sale,100,52,3/6/2019
92005C,earnings,100,50,3/6/2019
94637C,conference-participant,100,50,3/6/2019
9592FB,earnings,100,50,3/6/2019
966ACE,clinical-trials-start,100,64,3/6/2019
990AD0,conference-organizer,100,57,3/6/2019
990AD0,conference-organizer,100,57,3/6/2019
990AD0,conference-organizer,100,57,3/6/2019
9BB35A,unit-acquisition-acquirer,100,49,3/6/2019
9BF177,earnings,100,50,3/6/2019
9EA947,conference-participant,100,50,3/6/2019
A017F4,conference-participant,100,50,3/6/2019
A16DEA,conference-participant,100,50,3/6/2019
A21649,dividend,100,50,3/6/2019
A48593,public-offering,100,43,3/6/2019
A5DD24,conference-participant,100,50,3/6/2019
A6828A,regulatory-product-approval-granted,100,81,3/6/2019
A79F7D,conference-participant,100,50,3/6/2019
A871B0,earnings,100,50,3/6/2019
A94A7B,conference-participant,100,50,3/6/2019
AC642C,earnings,100,50,3/6/2019
AC642C,earnings,100,50,3/6/2019
AC7AAE,conference-participant,100,50,3/6/2019
AF93DE,conference-call,100,50,3/6/2019
AFF7B4,conference-participant,100,50,3/6/2019
B04426,earnings,100,50,3/6/2019
B1A85D,note-sale,100,52,3/6/2019
B1B10C,executive-appointment,100,54,3/6/2019
B1FC3B,earnings,100,50,3/6/2019
B1FC3B,dividend,100,50,3/6/2019
B290A2,public-offering,100,43,3/6/2019
B3A166,earnings,100,50,3/6/2019
B48FC9,public-offering,100,43,3/6/2019
B80AD1,conference-participant,100,50,3/6/2019
B98EFA,conference-participant,100,50,3/6/2019
BB0587,executive-appointment,100,54,3/6/2019
BB127B,award,100,58,3/6/2019
BB88B6,product-release,100,64,3/6/2019
BDCC11,product-release,100,64,3/6/2019
C01737,earnings,100,50,3/6/2019
C22BE8,conference-call,100,50,3/6/2019
C5E100,earnings,100,50,3/6/2019
C624A1,conference-participant,100,50,3/6/2019
C65004,conference-participant,100,50,3/6/2019
C93C44,earnings,100,50,3/6/2019
C9E107,conference-participant,100,50,3/6/2019
CBB77B,dividend,100,50,3/6/2019
CBCC6A,conference-organizer,100,57,3/6/2019
CE4E6D,executive-appointment,100,54,3/6/2019
CF3FF9,public-offering,100,43,3/6/2019
D0909F,dividend,100,50,3/6/2019
D1C26F,conference-participant,100,50,3/6/2019
D2E553,earnings,100,50,3/6/2019
D2E553,earnings,100,50,3/6/2019
D2E553,earnings,100,50,3/6/2019
D6489C,partnership,100,61,3/6/2019
D854F3,dividend-up,100,81,3/6/2019
DCD97F,dividend-up,100,81,3/6/2019
DCD97F,executive-appointment,100,54,3/6/2019
DDEA6A,conference-participant,100,50,3/6/2019
DE5611,earnings,100,50,3/6/2019
DF18E6,earnings,100,50,3/6/2019
E06265,earnings,100,50,3/6/2019
E13782,earnings,100,50,3/6/2019
E49AA3,product-release,100,64,3/6/2019
E8846E,donation,100,54,3/6/2019
E94704,conference-participant,100,50,3/6/2019
EC8116,earnings,100,50,3/6/2019
EDD234,earnings,100,50,3/6/2019
EEB5F9,conference-participant,100,50,3/6/2019
F3816D,conference-participant,100,50,3/6/2019
F4CDA3,unit-acquisition-acquirer,100,49,3/6/2019
F4E882,executive-appointment,100,54,3/6/2019
F509E2,executive-appointment,100,54,3/6/2019
F5349B,executive-appointment,100,54,3/6/2019
F569FD,clinical-trials-start,100,64,3/6/2019
F721A7,debt-extension-recipient,100,73,3/6/2019
F721A7,debt-extension-recipient,100,73,3/6/2019
F72E4B,earnings,100,50,3/6/2019
F8DE55,legal-issues-defendant,100,22,3/6/2019
FA40E2,earnings,100,50,3/6/2019
FC1736,earnings,100,50,3/6/2019
FD2565,conference-participant,100,50,3/6/2019
FDF799,earnings,100,50,3/6/2019
FDF799,earnings,100,50,3/6/2019
FF227B,conference-participant,100,50,3/6/2019
001F1B,revenues,100,50,3/7/2019
001F1B,revenues,100,50,3/7/2019
13528,executive-appointment,100,54,3/7/2019
0157B1,partnership,100,61,3/7/2019
01D03F,regulatory-product-application,100,69,3/7/2019
01D03F,regulatory-product-application,100,69,3/7/2019
20751,earnings,100,50,3/7/2019
20751,earnings,100,50,3/7/2019
03542C,earnings,100,50,3/7/2019
48590,legal-issues-defendant,100,22,3/7/2019
06CB5B,revenue-up,100,51,3/7/2019
07EC43,buybacks,100,74,3/7/2019
98977,conference-participant,100,50,3/7/2019
98977,legal-issues-defendant,100,22,3/7/2019
98977,legal-issues-defendant,100,22,3/7/2019
0A59F8,partnership,100,61,3/7/2019
0BF528,earnings,100,50,3/7/2019
0C2A0D,partnership,100,61,3/7/2019
0E5619,conference-call,100,50,3/7/2019
0F2BC9,earnings,100,50,3/7/2019
0FABBD,legal-issues-defendant,100,22,3/7/2019
0FABBD,legal-issues-defendant,100,22,3/7/2019
0FE3A6,earnings,100,50,3/7/2019
10100E,earnings,100,50,3/7/2019
129DC8,conference-participant,100,50,3/7/2019
154272,earnings,100,50,3/7/2019
16FC89,dividend,100,50,3/7/2019
182B8C,conference-participant,100,50,3/7/2019
184988,conference-participant,100,50,3/7/2019
1B16C1,earnings-guidance,100,50,3/7/2019
1C2593,public-offering,100,43,3/7/2019
1CD708,buybacks,100,74,3/7/2019
1D1B07,earnings,100,50,3/7/2019
1D1B07,earnings,100,50,3/7/2019
1F19C8,executive-appointment,100,54,3/7/2019
1F9258,earnings,100,50,3/7/2019
1FAF22,conference-call,100,50,3/7/2019
221AD7,business-contract,100,69,3/7/2019
227D48,dividend,100,50,3/7/2019
228D42,business-contract,100,69,3/7/2019
228D42,executive-appointment,100,54,3/7/2019
228D42,partnership,100,61,3/7/2019
25102A,business-contract-terminated,100,31,3/7/2019
251988,product-release,100,64,3/7/2019
3159AA,conference-organizer,100,57,3/7/2019
31643A,dividend,100,50,3/7/2019
31F25C,executive-appointment,100,54,3/7/2019
33AD83,note-sale,100,52,3/7/2019
35557B,earnings,100,50,3/7/2019
366A08,executive-appointment,100,54,3/7/2019
371B0A,earnings-up,100,68,3/7/2019
371B0A,earnings-up,100,68,3/7/2019
371B0A,earnings-up,100,68,3/7/2019
371B0A,earnings-up,100,68,3/7/2019
371B0A,earnings-up,100,68,3/7/2019
37B120,product-release,100,64,3/7/2019
37E18B,note-sale,100,52,3/7/2019
383ADA,earnings,100,50,3/7/2019
3ACF46,earnings,100,50,3/7/2019
3BC360,earnings,100,50,3/7/2019
3C7F5F,earnings,100,50,3/7/2019
3DD5E2,earnings,100,50,3/7/2019
4017AD,dividend,100,50,3/7/2019
41C528,earnings,100,50,3/7/2019
427F32,dividend,100,50,3/7/2019
43A74A,conference-participant,100,50,3/7/2019
44209A,award,100,58,3/7/2019
4.91E+58,executive-appointment,100,54,3/7/2019
4A6F00,partnership,100,61,3/7/2019
4C3FE9,earnings,100,50,3/7/2019
4C92B9,earnings,100,50,3/7/2019
4D229C,earnings,100,50,3/7/2019
4D371E,conference-participant,100,50,3/7/2019
4DAF5F,buybacks,100,74,3/7/2019
4DAF5F,buybacks,100,74,3/7/2019
4DD203,revenue-up,100,60,3/7/2019
4E6F5A,clinical-trials,100,56,3/7/2019
4E913D,partnership,100,61,3/7/2019
4FCC78,earnings,100,50,3/7/2019
4FCC78,earnings,100,50,3/7/2019
514067,legal-issues-defendant,100,22,3/7/2019
51D876,earnings-guidance,100,50,3/7/2019
52BF94,conference-call,100,50,3/7/2019
55438C,donation,100,54,3/7/2019
56277A,dividend,100,50,3/7/2019
56EFC7,earnings-guidance,100,50,3/7/2019
57634F,note-sale,100,52,3/7/2019
583A75,revenue-volume,100,50,3/7/2019
5B3FA2,earnings,100,50,3/7/2019
5C7601,conference-participant,100,50,3/7/2019
5F3D91,legal-issues-defendant,100,22,3/7/2019
5F9CE3,note-sale,100,52,3/7/2019
64E346,business-contract,100,69,3/7/2019
66ECFD,executive-appointment,100,54,3/7/2019
68586A,earnings,100,50,3/7/2019
68B03F,executive-appointment,100,54,3/7/2019
6BC6F9,partnership,100,61,3/7/2019
6C6D73,conference-participant,100,50,3/7/2019
6D3F35,legal-issues-defendant,100,22,3/7/2019
6F5DD2,business-contract,100,69,3/7/2019
70FCEF,earnings,100,50,3/7/2019
713810,conference-participant,100,50,3/7/2019
7255D2,earnings,100,50,3/7/2019
73F7F9,earnings,100,50,3/7/2019
7.45E+28,earnings,100,50,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
762A3E,conference-organizer,100,57,3/7/2019
76B926,headquarters-change,100,50,3/7/2019
76F067,conference-participant,100,50,3/7/2019
76F067,dividend,100,50,3/7/2019
7740DE,same-store-sales-down,100,40,3/7/2019
78F9ED,legal-issues-defendant,100,22,3/7/2019
7A10FF,investment-investor,100,55,3/7/2019
7AB859,business-contract,100,69,3/7/2019
7B9212,earnings,100,50,3/7/2019
7C4F43,earnings,100,50,3/7/2019
7FD8B9,earnings,100,50,3/7/2019
8377DB,merger-regulatory-approval,100,81,3/7/2019
85DA04,business-contract,100,69,3/7/2019
8614A2,legal-issues-defendant,100,22,3/7/2019
863350,earnings,100,50,3/7/2019
89FBB1,earnings,100,50,3/7/2019
8B1F37,dividend,100,50,3/7/2019
8B3B0E,dividend,100,50,3/7/2019
8B4A45,acquisition-acquirer,100,49,3/7/2019
8C6C1B,facility-open,100,65,3/7/2019
8D9993,conference-participant,100,50,3/7/2019
8E10BF,earnings,100,50,3/7/2019
8E4F9A,operating-earnings,100,50,3/7/2019
8E8E6E,business-contract,100,69,3/7/2019
925759,conference-participant,100,50,3/7/2019
931AE7,earnings,100,50,3/7/2019
93D207,partnership,100,61,3/7/2019
942633,dividend,100,50,3/7/2019
94563D,partnership,100,61,3/7/2019
94637C,earnings,100,50,3/7/2019
94637C,dividend,100,50,3/7/2019
949D62,earnings,100,50,3/7/2019
954004,conference-call,100,50,3/7/2019
95C392,executive-appointment,100,54,3/7/2019
95DE39,buybacks,100,74,3/7/2019
968966,partnership,100,61,3/7/2019
97FE80,earnings,100,50,3/7/2019
97FE80,earnings,100,50,3/7/2019
9810C0,dividend,100,50,3/7/2019
990AD0,conference-organizer,100,57,3/7/2019
9.92E+94,partnership,100,61,3/7/2019
9.92E+94,partnership,100,61,3/7/2019
9FB4B7,earnings,100,50,3/7/2019
A05C43,earnings,100,50,3/7/2019
A204A7,earnings,100,50,3/7/2019
A26EF7,earnings,100,50,3/7/2019
A28675,earnings,100,50,3/7/2019
A37D68,earnings,100,50,3/7/2019
A4BCDE,award,100,58,3/7/2019
A52533,earnings,100,50,3/7/2019
A63387,product-release,100,64,3/7/2019
A72AB6,earnings,100,50,3/7/2019
A8E72A,conference-participant,100,50,3/7/2019
AC3584,earnings-up,100,84,3/7/2019
AC3584,earnings-up,100,84,3/7/2019
AC3584,earnings-up,100,84,3/7/2019
AC7AAE,earnings,100,50,3/7/2019
ADFB3A,earnings,100,50,3/7/2019
AE4125,earnings,100,50,3/7/2019
B08C51,earnings,100,50,3/7/2019
B106FA,earnings,100,50,3/7/2019
B290A2,public-offering,100,43,3/7/2019
B3ED62,earnings,100,50,3/7/2019
B4C673,executive-appointment,100,54,3/7/2019
B5734D,earnings,100,50,3/7/2019
B66928,donation,100,54,3/7/2019
B83D67,conference-participant,100,50,3/7/2019
B8A51F,conference-participant,100,50,3/7/2019
B8EF97,earnings,100,50,3/7/2019
B98EFA,revenue-up,100,69,3/7/2019
BDCC11,earnings,100,50,3/7/2019
C01737,conference-participant,100,50,3/7/2019
C22BE8,dividend,100,50,3/7/2019
C356AC,legal-issues-defendant,100,22,3/7/2019
C4A241,facility-open,100,65,3/7/2019
C85A72,conference-participant,100,50,3/7/2019
C8A059,earnings,100,50,3/7/2019
CA1620,dividend,100,50,3/7/2019
CAC8D0,partnership,100,61,3/7/2019
CB89EA,partnership,100,61,3/7/2019
CB89EA,earnings,100,50,3/7/2019
CCB623,government-contract,100,69,3/7/2019
CCB623,earnings,100,50,3/7/2019
CDAF5B,dividend,100,50,3/7/2019
D064D5,earnings,100,50,3/7/2019
D6144F,conference-call,100,50,3/7/2019
D64EDF,product-release,100,64,3/7/2019
D697DE,conference-participant,100,50,3/7/2019
D8760C,conference-participant,100,50,3/7/2019
D9B1C9,executive-appointment,100,54,3/7/2019
DA9443,earnings,100,50,3/7/2019
DBCA3F,credit-extension-provider,100,57,3/7/2019
DC6AA0,earnings,100,50,3/7/2019
DD0F15,earnings,100,50,3/7/2019
DF16DE,earnings,100,50,3/7/2019
E28D9C,conference-participant,100,50,3/7/2019
E30B34,conference-participant,100,50,3/7/2019
E30B34,conference-participant,100,50,3/7/2019
E68733,note-sale,100,52,3/7/2019
E68E62,earnings,100,50,3/7/2019
E68E62,earnings,100,50,3/7/2019
E71AE6,earnings,100,50,3/7/2019
E8846E,donation,100,54,3/7/2019
E8C557,earnings,100,50,3/7/2019
EB2F14,merger-regulatory-approval,100,81,3/7/2019
EF5914,earnings,100,50,3/7/2019
EF7163,executive-appointment,100,54,3/7/2019
F3EDB4,earnings,100,50,3/7/2019
F4F46F,partnership,100,61,3/7/2019
F6E1B5,earnings,100,50,3/7/2019
F769E9,conference-participant,100,50,3/7/2019
F7FCA4,note-sale,100,52,3/7/2019
F7FCA4,note-sale,100,52,3/7/2019
F88147,earnings,100,50,3/7/2019
F8BA6C,legal-issues-defendant,100,22,3/7/2019
F8DE55,legal-issues-defendant,100,22,3/7/2019
F9AA02,earnings,100,50,3/7/2019
FA840E,ipo-pricing,100,50,3/7/2019
FAE021,facility-open,100,65,3/7/2019
FB7724,legal-issues-defendant,100,22,3/7/2019
FB7724,legal-issues-defendant,100,22,3/7/2019
FB7724,legal-issues-defendant,100,22,3/7/2019
FB7724,legal-issues-defendant,100,22,3/7/2019
FBD92D,earnings,100,50,3/7/2019
FDE409,revenues,100,50,3/7/2019
FE609F,conference-call,100,50,3/7/2019
01D03F,regulatory-product-approval-granted,100,81,3/8/2019
03B8CF,facility-open,100,65,3/8/2019
09062E,executive-appointment,100,54,3/8/2019
095A04,earnings,100,50,3/8/2019
0B73A7,earnings,100,50,3/8/2019
0B73A7,earnings,100,50,3/8/2019
0DBB81,earnings,100,50,3/8/2019
0FABBD,legal-issues-defendant,100,22,3/8/2019
159739,conference-call,100,50,3/8/2019
159739,conference-call,100,50,3/8/2019
16B882,earnings,100,50,3/8/2019
190B91,conference-participant,100,50,3/8/2019
19BF16,acquisition-completed-acquirer,100,49,3/8/2019
19BF16,acquisition-completed-acquirer,100,49,3/8/2019
1A5957,legal-issues-defendant,100,22,3/8/2019
1F08A6,dividend,100,50,3/8/2019
1FCC00,dividend,100,50,3/8/2019
1FCC00,revenues,100,50,3/8/2019
1FCC00,revenues,100,50,3/8/2019
1FCC00,revenues,100,50,3/8/2019
1FCC00,index-listing,100,76,3/8/2019
21022F,executive-appointment,100,54,3/8/2019
292A70,dividend,100,50,3/8/2019
2DDB22,conference-participant,100,50,3/8/2019
2EBA55,dividend,100,50,3/8/2019
36A1CB,conference-participant,100,50,3/8/2019
3B9886,conference-call,100,50,3/8/2019
448215,dividend,100,50,3/8/2019
49BBBC,legal-issues-defendant,100,22,3/8/2019
4B3DC9,conference-participant,100,50,3/8/2019
4BDCA7,business-contract,100,69,3/8/2019
4DAF5F,buybacks,100,74,3/8/2019
4DAF5F,buybacks,100,74,3/8/2019
5.43E+08,conference-participant,100,50,3/8/2019
54DF47,earnings,100,50,3/8/2019
589803,conference-call,100,50,3/8/2019
5E9934,conference-call,100,50,3/8/2019
67303E,conference-participant,100,50,3/8/2019
6810DE,earnings,100,50,3/8/2019
68BA15,conference-call,100,50,3/8/2019
69CE71,legal-issues-defendant,100,22,3/8/2019
6C4D2F,product-release,100,64,3/8/2019
6C6D73,conference-participant,100,50,3/8/2019
6DC1D7,dividend,100,50,3/8/2019
6F3936,conference-call,100,50,3/8/2019
756045,earnings,100,50,3/8/2019
762A3E,conference-organizer,100,57,3/8/2019
762A3E,conference-organizer,100,57,3/8/2019
762A3E,conference-organizer,100,57,3/8/2019
762A3E,conference-organizer,100,57,3/8/2019
76B926,executive-appointment,100,54,3/8/2019
787D14,dividend,100,50,3/8/2019
7A975D,earnings,100,50,3/8/2019
7ACBA4,earnings,100,50,3/8/2019
7B9AFA,conference-participant,100,50,3/8/2019
83066C,conference-participant,100,50,3/8/2019
838ADD,executive-appointment,100,54,3/8/2019
895D56,conference-participant,100,50,3/8/2019
896771,business-contract,100,69,3/8/2019
8A8E41,dividend,100,50,3/8/2019
8C6C1B,facility-open,100,65,3/8/2019
8E8E6E,executive-appointment,100,54,3/8/2019
93D207,conference-participant,100,50,3/8/2019
980C14,dividend,100,50,3/8/2019
990AD0,conference-organizer,100,57,3/8/2019
990AD0,dividend,100,50,3/8/2019
9A02C4,product-release,100,64,3/8/2019
9B5968,hirings,100,65,3/8/2019
A4BCDE,dividend-up,100,81,3/8/2019
ACC7D3,earnings,100,50,3/8/2019
AD22F2,conference-call,100,50,3/8/2019
B01215,conference-call,100,50,3/8/2019
B3ED62,executive-appointment,100,54,3/8/2019
B48D6A,earnings,100,50,3/8/2019
B48D6A,earnings,100,50,3/8/2019
B762D3,earnings,100,50,3/8/2019
B762D3,earnings,100,50,3/8/2019
BE5935,conference-participant,100,50,3/8/2019
BE7BA4,conference-participant,100,50,3/8/2019
BF79F5,facility-open,100,65,3/8/2019
C11C46,conference-participant,100,50,3/8/2019
C54140,earnings,100,50,3/8/2019
C58D71,earnings,100,50,3/8/2019
CC339B,dividend-up,100,81,3/8/2019
CC35BE,legal-issues-defendant,100,22,3/8/2019
D13F1C,revenue-up,100,89,3/8/2019
D13F1C,revenue-up,100,89,3/8/2019
D13F1C,revenue-up,100,89,3/8/2019
D13F1C,revenue-up,100,89,3/8/2019
D13F1C,revenue-up,100,89,3/8/2019
D33D8C,award,100,58,3/8/2019
D58A11,conference-participant,100,50,3/8/2019
D622D5,operating-earnings,100,50,3/8/2019
D8ECA1,earnings,100,50,3/8/2019
DA0CB8,dividend,100,50,3/8/2019
E124EB,dividend,100,50,3/8/2019
E68733,dividend,100,50,3/8/2019
E6EDED,dividend,100,50,3/8/2019
E84500,merger-completed,100,66,3/8/2019
E84500,asset-sale,100,62,3/8/2019
E8846E,donation,100,54,3/8/2019
E8846E,award,100,58,3/8/2019
E8846E,donation,100,54,3/8/2019
E8846E,donation,100,54,3/8/2019
ED2EFD,earnings,100,50,3/8/2019
EF1AD9,conference-participant,100,50,3/8/2019
F0B2B5,legal-issues-defendant,100,22,3/8/2019
F30508,conference-participant,100,50,3/8/2019
F3816D,earnings,100,50,3/8/2019
F4E882,legal-issues-defendant,100,22,3/8/2019
F7935D,clinical-trials,100,56,3/8/2019
F95726,merger-completed,100,66,3/8/2019
FB7724,legal-issues-defendant,100,22,3/8/2019
FCA54E,earnings,100,50,3/8/2019
FEBFE1,earnings,100,50,3/8/2019
FF227B,earnings,100,50,3/8/2019
03B8CF,facility-open,100,65,3/9/2019
0FABBD,legal-issues-defendant,100,22,3/9/2019
1A5957,legal-issues-defendant,100,22,3/9/2019
514067,legal-issues-defendant,100,22,3/9/2019
B2D799,legal-issues-defendant,100,22,3/9/2019
CBFFDD,legal-issues-defendant,100,22,3/9/2019
DDB002,legal-issues-defendant,100,22,3/9/2019
E35610,legal-issues-defendant,100,22,3/9/2019
FB7724,legal-issues-defendant,100,22,3/9/2019
13528,earnings,100,50,3/11/2019
03542C,dividend,100,50,3/11/2019
03542C,earnings,100,50,3/11/2019
03FAA6,partnership,100,61,3/11/2019
98977,legal-issues-defendant,100,22,3/11/2019
09F623,note-sale,100,52,3/11/2019
0B7375,earnings,100,50,3/11/2019
0FABBD,legal-issues-defendant,100,22,3/11/2019
1272B3,partnership,100,61,3/11/2019
12F98C,earnings,100,50,3/11/2019
12F98C,earnings,100,50,3/11/2019
168A5D,executive-appointment,100,54,3/11/2019
1880C5,conference-organizer,100,57,3/11/2019
1880C5,conference-organizer,100,57,3/11/2019
1A5957,buybacks,100,74,3/11/2019
1A5957,legal-issues-defendant,100,22,3/11/2019
1AB023,earnings,100,50,3/11/2019
1AB023,earnings,100,50,3/11/2019
1AB023,earnings,100,50,3/11/2019
1D9E55,conference-participant,100,50,3/11/2019
1DF15D,market-entry,100,57,3/11/2019
1E1125,executive-appointment,100,54,3/11/2019
221783,acquisition-acquirer,100,49,3/11/2019
232053,earnings,100,50,3/11/2019
250BEE,dividend,100,50,3/11/2019
292A70,earnings,100,50,3/11/2019
2ABF77,conference-participant,100,50,3/11/2019
2C681C,conference-call,100,50,3/11/2019
2C681C,conference-call,100,50,3/11/2019
2CC71C,partnership,100,61,3/11/2019
2D981A,conference-participant,100,50,3/11/2019
328250,buybacks,100,74,3/11/2019
36C09B,conference-participant,100,50,3/11/2019
371B0A,conference-participant,100,50,3/11/2019
37B120,conference-participant,100,50,3/11/2019
37B618,dividend,100,50,3/11/2019
3ACF46,acquisition-completed-acquirer,100,49,3/11/2019
3B318A,earnings,100,50,3/11/2019
3F6A9C,partnership,100,61,3/11/2019
4.03E+05,business-contract,100,69,3/11/2019
414FFF,conference-call,100,50,3/11/2019
448215,public-offering,100,43,3/11/2019
4A7C1F,earnings,100,50,3/11/2019
4A7C1F,earnings,100,50,3/11/2019
4A7C1F,earnings,100,50,3/11/2019
4A7C1F,earnings,100,50,3/11/2019
4C31F3,earnings,100,50,3/11/2019
4C37C5,dividend,100,50,3/11/2019
4D203E,executive-appointment,100,54,3/11/2019
4DAF5F,buybacks,100,74,3/11/2019
4DAF5F,buybacks,100,74,3/11/2019
4E7C1F,business-contract,100,69,3/11/2019
4E7C1F,business-contract,100,69,3/11/2019
4E7C1F,business-contract,100,69,3/11/2019
510EA1,executive-appointment,100,54,3/11/2019
553949,executive-appointment,100,54,3/11/2019
553949,executive-appointment,100,54,3/11/2019
56FB7C,executive-appointment,100,54,3/11/2019
586BD7,conference-participant,100,50,3/11/2019
586BD7,conference-call,100,50,3/11/2019
58CA9A,executive-appointment,100,54,3/11/2019
5B226B,acquisition-interest-acquirer,100,46,3/11/2019
5B226B,acquisition-interest-acquirer,100,46,3/11/2019
5DD486,executive-appointment,100,54,3/11/2019
619882,conference-organizer,100,57,3/11/2019
651C85,conference-participant,100,50,3/11/2019
651C85,conference-participant,100,50,3/11/2019
65D0AA,clinical-trials,100,56,3/11/2019
65D0AA,clinical-trials,100,56,3/11/2019
665440,earnings,100,50,3/11/2019
6844D2,executive-appointment,100,54,3/11/2019
68E6E9,earnings,100,50,3/11/2019
69CE71,legal-issues-defendant,100,22,3/11/2019
69FDFC,award,100,58,3/11/2019
6C4D2F,dividend,100,50,3/11/2019
6DDA15,conference-participant,100,50,3/11/2019
6F0A63,executive-appointment,100,54,3/11/2019
6F0A63,executive-appointment,100,54,3/11/2019
6F0A63,executive-appointment,100,54,3/11/2019
6F0A63,executive-appointment,100,54,3/11/2019
6F0A63,executive-appointment,100,54,3/11/2019
6F39FC,dividend,100,50,3/11/2019
70CA28,conference-participant,100,50,3/11/2019
70CA28,conference-participant,100,50,3/11/2019
70CA28,conference-participant,100,50,3/11/2019
70CA28,conference-participant,100,50,3/11/2019
756BB4,earnings,100,50,3/11/2019
762A3E,conference-organizer,100,57,3/11/2019
762A3E,conference-organizer,100,57,3/11/2019
762A3E,conference-organizer,100,57,3/11/2019
762A3E,conference-organizer,100,57,3/11/2019
76DD0C,regulatory-product-approval-granted,100,81,3/11/2019
78F776,conference-participant,100,50,3/11/2019
78F776,trading-delisting,100,36,3/11/2019
78F776,trading-delisting,100,36,3/11/2019
7ACBA4,acquisition-acquirer,100,49,3/11/2019
7B8CB5,executive-appointment,100,54,3/11/2019
7FEEE1,executive-appointment,100,54,3/11/2019
7FEEE1,executive-appointment,100,54,3/11/2019
818A2F,earnings,100,50,3/11/2019
862941,conference-participant,100,50,3/11/2019
863350,earnings,100,50,3/11/2019
86A1B9,business-contract,100,69,3/11/2019
8A0368,product-release,100,64,3/11/2019
8C6C1B,facility-open,100,65,3/11/2019
8D4486,partnership,100,61,3/11/2019
911AB8,joint-venture,100,62,3/11/2019
911AB8,joint-venture,100,62,3/11/2019
92D757,executive-appointment,100,54,3/11/2019
9546A5,earnings,100,50,3/11/2019
97644E,earnings,100,50,3/11/2019
98D33E,earnings,100,50,3/11/2019
990AD0,conference-organizer,100,57,3/11/2019
9A2760,earnings,100,50,3/11/2019
9A2760,earnings,100,50,3/11/2019
9A2760,earnings,100,50,3/11/2019
9A2760,earnings,100,50,3/11/2019
9B4066,unit-acquisition-acquirer,100,49,3/11/2019
9E0811,public-offering,100,43,3/11/2019
A433A5,conference-participant,100,50,3/11/2019
A48593,conference-participant,100,50,3/11/2019
A631A3,partnership,100,61,3/11/2019
ADF092,earnings,100,50,3/11/2019
AEFC90,clinical-trials-start,100,64,3/11/2019
B1A85D,business-contract,100,69,3/11/2019
B290A2,public-offering,100,43,3/11/2019
B2D799,legal-issues-defendant,100,22,3/11/2019
B2D799,legal-issues-defendant,100,22,3/11/2019
B5BA39,executive-appointment,100,54,3/11/2019
B80AD1,earnings,100,50,3/11/2019
BDF85E,dividend,100,50,3/11/2019
C188F8,business-contract,100,69,3/11/2019
C188F8,partnership,100,61,3/11/2019
C188F8,partnership,100,61,3/11/2019
C2DD02,conference-call,100,50,3/11/2019
C2E120,earnings,100,50,3/11/2019
C407A0,business-contract,100,69,3/11/2019
C48574,revenue-up,100,69,3/11/2019
C48574,revenue-up,100,69,3/11/2019
C48574,revenue-up,100,69,3/11/2019
C564E4,conference-participant,100,50,3/11/2019
C81E00,product-release,100,64,3/11/2019
C83B88,partnership,100,61,3/11/2019
C83B88,facility-open,100,65,3/11/2019
C8FAC7,partnership,100,61,3/11/2019
C9881C,conference-call,100,50,3/11/2019
CBB77B,earnings,100,50,3/11/2019
CBB77B,earnings,100,50,3/11/2019
CBCC6A,conference-organizer,100,57,3/11/2019
CBCC6A,conference-organizer,100,57,3/11/2019
CBDB4D,partnership,100,61,3/11/2019
CBDB4D,partnership,100,61,3/11/2019
CF3FF9,public-offering,100,43,3/11/2019
D6853F,executive-appointment,100,54,3/11/2019
D82EF3,executive-appointment,100,54,3/11/2019
D90441,earnings,100,50,3/11/2019
D9B1C9,executive-appointment,100,54,3/11/2019
E0647D,earnings,100,50,3/11/2019
E0647D,earnings,100,50,3/11/2019
E09556,earnings,100,50,3/11/2019
E09E2B,acquisition-acquirer,100,49,3/11/2019
E09E2B,acquisition-acquirer,100,49,3/11/2019
E71AE6,conference-participant,100,50,3/11/2019
EEA734,partnership,100,61,3/11/2019
EEA734,partnership,100,61,3/11/2019
F05B1B,bought-deal,100,43,3/11/2019
F0B2B5,legal-issues-defendant,100,22,3/11/2019
F3D2EB,dividend,100,50,3/11/2019
F46EC9,conference-participant,100,50,3/11/2019
F4E882,legal-issues-defendant,100,22,3/11/2019
F6A987,dividend,100,50,3/11/2019
F6E1B5,conference-participant,100,50,3/11/2019
F7935D,earnings,100,50,3/11/2019
F88147,conference-participant,100,50,3/11/2019
F8BA6C,conference-participant,100,50,3/11/2019
FA840E,ipo-completed,100,76,3/11/2019
FACF19,earnings-guidance,100,50,3/11/2019
FB7724,legal-issues-defendant,100,22,3/11/2019
FEC475,earnings,100,50,3/11/2019
13528,executive-appointment,100,54,3/12/2019
13528,executive-appointment,100,54,3/12/2019
03B8CF,legal-issues-defendant,100,22,3/12/2019
0919B1,earnings,100,50,3/12/2019
0A0D9E,partnership,100,61,3/12/2019
0A77DB,partnership,100,61,3/12/2019
0D03C8,earnings,100,50,3/12/2019
0E5223,note-sale,100,52,3/12/2019
0E5223,note-sale,100,52,3/12/2019
0E5619,earnings,100,50,3/12/2019
0EF1AF,conference-call,100,50,3/12/2019
12E454,executive-appointment,100,54,3/12/2019
15789A,award,100,58,3/12/2019
1AB023,conference-participant,100,50,3/12/2019
1AB023,conference-participant,100,50,3/12/2019
1AB023,conference-participant,100,50,3/12/2019
1E1125,executive-appointment,100,54,3/12/2019
1F3CFB,conference-participant,100,50,3/12/2019
1F9258,conference-participant,100,50,3/12/2019
1FC422,earnings,100,50,3/12/2019
20403D,earnings,100,50,3/12/2019
2082EA,regulatory-product-approval-granted,100,81,3/12/2019
2082EA,revenues,100,50,3/12/2019
225CA2,trading-halt,100,43,3/12/2019
225CA2,trading-resumed,100,58,3/12/2019
228D42,dividend,100,50,3/12/2019
228D42,partnership,100,61,3/12/2019
241AF7,executive-appointment,100,54,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,earnings,100,50,3/12/2019
251988,partnership,100,61,3/12/2019
251988,product-release,100,64,3/12/2019
25DD05,dividend,100,50,3/12/2019
25DD05,dividend,100,50,3/12/2019
263216,dividend,100,50,3/12/2019
2B8179,earnings,100,50,3/12/2019
2EBC0B,dividend,100,50,3/12/2019
32C8CD,earnings,100,50,3/12/2019
32DCB3,trading-listing,100,61,3/12/2019
32F24A,earnings,100,50,3/12/2019
36529A,earnings,100,50,3/12/2019
367E1C,clinical-trials-positive,100,87,3/12/2019
3.73E+87,product-release,100,64,3/12/2019
3A1C46,earnings,100,50,3/12/2019
3C6CCC,earnings,100,50,3/12/2019
3F1C69,earnings,100,50,3/12/2019
4.03E+05,partnership,100,61,3/12/2019
416C55,conference-participant,100,50,3/12/2019
450ECB,earnings,100,50,3/12/2019
458D2C,revenue-volume,100,50,3/12/2019
47FCF2,partnership,100,61,3/12/2019
4A6F00,partnership,100,61,3/12/2019
4AC91D,product-recall,100,29,3/12/2019
4DAF5F,buybacks,100,74,3/12/2019
4DAF5F,buybacks,100,74,3/12/2019
4E4E75,dividend,100,50,3/12/2019
5065B1,dividend,100,50,3/12/2019
53F491,earnings,100,50,3/12/2019
567F3D,conference-participant,100,50,3/12/2019
56EA2B,note-sale,100,52,3/12/2019
56EA2B,note-sale,100,52,3/12/2019
583223,executive-appointment,100,54,3/12/2019
589846,conference-participant,100,50,3/12/2019
58C2D4,conference-participant,100,50,3/12/2019
594402,conference-participant,100,50,3/12/2019
5B6C11,dividend,100,50,3/12/2019
5C8D61,note-sale,100,52,3/12/2019
619882,partnership,100,61,3/12/2019
627186,earnings,100,50,3/12/2019
62A48D,conference-participant,100,50,3/12/2019
651C85,earnings,100,50,3/12/2019
6559D8,earnings,100,50,3/12/2019
657097,dividend,100,50,3/12/2019
68AB62,earnings,100,50,3/12/2019
69CE71,legal-issues-defendant,100,22,3/12/2019
69E8E1,executive-appointment,100,54,3/12/2019
69E8E1,executive-appointment,100,54,3/12/2019
6D2BF6,earnings,100,50,3/12/2019
6FCEF9,earnings,100,50,3/12/2019
70FCEF,executive-appointment,100,54,3/12/2019
713810,partnership,100,61,3/12/2019
71553E,earnings,100,50,3/12/2019
717DB4,earnings,100,50,3/12/2019
728737,dividend,100,50,3/12/2019
728737,dividend,100,50,3/12/2019
7410C3,fraud-defendant,100,20,3/12/2019
7410C3,fraud-defendant,100,20,3/12/2019
7.49E+07,earnings,100,50,3/12/2019
7.49E+07,earnings,100,50,3/12/2019
762A3E,conference-organizer,100,57,3/12/2019
76F067,partnership,100,61,3/12/2019
773A17,conference-participant,100,50,3/12/2019
78F776,clinical-trials,100,56,3/12/2019
7AF5B8,earnings,100,50,3/12/2019
7AF5B8,earnings,100,50,3/12/2019
7C790D,conference-participant,100,50,3/12/2019
7DD584,conference-participant,100,50,3/12/2019
848C0B,earnings,100,50,3/12/2019
877734,earnings,100,50,3/12/2019
877C0C,product-release,100,64,3/12/2019
8C311A,partnership,100,61,3/12/2019
9004C4,earnings-up,100,68,3/12/2019
944B2E,earnings,100,50,3/12/2019
94637C,partnership,100,61,3/12/2019
94637C,partnership,100,61,3/12/2019
94C0B5,conference-call,100,50,3/12/2019
950CDB,dividend,100,50,3/12/2019
9548BB,executive-appointment,100,54,3/12/2019
958938,executive-appointment,100,54,3/12/2019
96F126,partnership,100,61,3/12/2019
97644E,note-sale,100,52,3/12/2019
97B027,conference-participant,100,50,3/12/2019
990AD0,conference-organizer,100,57,3/12/2019
990AD0,conference-organizer,100,57,3/12/2019
990AD0,conference-organizer,100,57,3/12/2019
9D56F2,conference-call,100,50,3/12/2019
9E0811,public-offering,100,43,3/12/2019
A017F4,earnings,100,50,3/12/2019
A26C26,earnings,100,50,3/12/2019
A3800A,conference-participant,100,50,3/12/2019
A38F30,index-listing,100,76,3/12/2019
A3AAA5,dividend,100,50,3/12/2019
A631A3,product-release,100,64,3/12/2019
A79D88,facility-open,100,65,3/12/2019
A80FE0,note-sale,100,52,3/12/2019
A8AC4C,conference-participant,100,50,3/12/2019
AF93DE,earnings,100,50,3/12/2019
B01111,earnings-per-share-positive,100,69,3/12/2019
B01111,earnings,100,50,3/12/2019
B01111,earnings,100,50,3/12/2019
B01111,earnings,100,50,3/12/2019
B13B68,business-contract,100,69,3/12/2019
B13B68,business-contract,100,69,3/12/2019
B2D799,legal-issues-defendant,100,22,3/12/2019
B33E77,executive-appointment,100,54,3/12/2019
B33E77,earnings,100,50,3/12/2019
B66928,conference-participant,100,50,3/12/2019
B85DCE,conference-participant,100,50,3/12/2019
BDCC11,legal-issues-defendant,100,22,3/12/2019
BFCACF,executive-appointment,100,54,3/12/2019
C037A8,executive-appointment,100,54,3/12/2019
C06EB6,conference-participant,100,50,3/12/2019
C54140,partnership,100,61,3/12/2019
C5D2AE,award,100,58,3/12/2019
C99CC8,award,100,58,3/12/2019
CB89EA,conference-participant,100,50,3/12/2019
CBDB4D,earnings,100,50,3/12/2019
CC3EC4,earnings,100,50,3/12/2019
CC6FF5,product-release,100,64,3/12/2019
CF3FF9,conference-participant,100,50,3/12/2019
CFD4B6,conference-participant,100,50,3/12/2019
CFF97C,credit-rating-upgrade-rater,20,50,3/12/2019
CFF97C,credit-rating-confirmation-rater,20,50,3/12/2019
D17C1B,revenue-volume,100,50,3/12/2019
D3DE34,earnings,100,50,3/12/2019
D75910,dividend,100,50,3/12/2019
DD0099,conference-participant,100,50,3/12/2019
DF46C5,executive-appointment,100,54,3/12/2019
DF5F14,earnings,100,50,3/12/2019
DF5F14,executive-appointment,100,54,3/12/2019
DF8855,business-contract,100,69,3/12/2019
E00373,note-sale,100,52,3/12/2019
E0207A,partnership,100,61,3/12/2019
E1BD05,conference-participant,100,50,3/12/2019
E22FDE,conference-participant,100,50,3/12/2019
E30A8F,award,100,58,3/12/2019
E38906,conference-participant,100,50,3/12/2019
E3E68E,product-release,100,64,3/12/2019
E49AA3,executive-appointment,100,54,3/12/2019
E68E62,clinical-trials-start,100,64,3/12/2019
E71AE6,earnings,100,50,3/12/2019
E71AE6,legal-issues-defendant,100,22,3/12/2019
E71AE6,legal-issues-defendant,100,22,3/12/2019
E7BF32,earnings,100,50,3/12/2019
E7BF32,earnings,100,50,3/12/2019
E82A2D,earnings,100,50,3/12/2019
E8C557,conference-participant,100,50,3/12/2019
EBC84C,conference-participant,100,50,3/12/2019
ED9576,settlement,100,56,3/12/2019
EE6F1C,earnings,100,50,3/12/2019
F0027C,conference-participant,100,50,3/12/2019
F4E882,legal-issues-defendant,100,22,3/12/2019
F6FA6A,conference-call,100,50,3/12/2019
FACF19,business-contract,100,69,3/12/2019
FCA54E,earnings,100,50,3/12/2019
FEBFE1,earnings,100,50,3/12/2019
00326D,dividend,100,50,3/13/2019
00326E,executive-appointment,100,54,3/13/2019
0142B5,executive-appointment,100,54,3/13/2019
48590,legal-issues-defendant,100,22,3/13/2019
06A456,earnings,100,50,3/13/2019
07C69F,buybacks,100,74,3/13/2019
0A77DB,earnings,100,50,3/13/2019
0C6293,earnings,100,50,3/13/2019
0C6293,earnings,100,50,3/13/2019
0C6293,earnings,100,50,3/13/2019
0CADBC,earnings,100,50,3/13/2019
0EF1AF,conference-participant,100,50,3/13/2019
0FABBD,partnership,100,61,3/13/2019
0FC848,earnings,100,50,3/13/2019
11A49E,conference-participant,100,50,3/13/2019
1272B3,conference-participant,100,50,3/13/2019
1.79E+10,conference-call,100,50,3/13/2019
17EDA5,award,100,58,3/13/2019
1921DD,partnership,100,61,3/13/2019
1A5957,legal-issues-defendant,100,22,3/13/2019
1B16C1,earnings,100,50,3/13/2019
1B5FEA,earnings,100,50,3/13/2019
21022F,executive-appointment,100,54,3/13/2019
21D903,earnings,100,50,3/13/2019
221783,earnings,100,50,3/13/2019
228D42,partnership,100,61,3/13/2019
24FA23,earnings,100,50,3/13/2019
26DC29,earnings,100,50,3/13/2019
282C18,dividend,100,50,3/13/2019
2B49F4,government-contract,100,69,3/13/2019
2CC60C,dividend,100,50,3/13/2019
2DC88B,legal-issues-defendant,100,22,3/13/2019
2E0496,partnership,100,61,3/13/2019
301493,product-release,100,64,3/13/2019
341759,earnings,100,50,3/13/2019
367434,merger-completed,100,66,3/13/2019
387375,legal-verdict-favored,100,78,3/13/2019
3ACF46,conference-participant,100,50,3/13/2019
3D6933,pretax-earnings-up,100,68,3/13/2019
3D6933,pretax-earnings-up,100,68,3/13/2019
3DDE54,earnings,100,50,3/13/2019
42EFC7,earnings,100,50,3/13/2019
449A26,conference-call,100,50,3/13/2019
485445,stake-acquirer,100,48,3/13/2019
4A6F00,partnership,100,61,3/13/2019
4B49CF,earnings,100,50,3/13/2019
4D8313,product-release,100,64,3/13/2019
4DAF5F,buybacks,100,74,3/13/2019
4DAF5F,buybacks,100,74,3/13/2019
4EE14A,earnings,100,50,3/13/2019
4EE14A,earnings,100,50,3/13/2019
4F9926,partnership,100,61,3/13/2019
507AE7,note-sale,100,52,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
52D936,earnings,100,50,3/13/2019
586BD7,earnings,100,50,3/13/2019
589846,earnings,100,50,3/13/2019
5CC29D,conference-call,100,50,3/13/2019
6.18E+08,conference-participant,100,50,3/13/2019
62A48D,conference-call,100,50,3/13/2019
636BBF,earnings,100,50,3/13/2019
657097,earnings,100,50,3/13/2019
6830FE,partnership,100,61,3/13/2019
69CE71,legal-issues-defendant,100,22,3/13/2019
6F6559,earnings,100,50,3/13/2019
70FCEF,executive-appointment,100,54,3/13/2019
71B0CF,conference-participant,100,50,3/13/2019
76959C,earnings,100,50,3/13/2019
769F40,earnings,100,50,3/13/2019
790C34,product-release,100,64,3/13/2019
7AB859,partnership,100,61,3/13/2019
7BEA98,earnings,100,50,3/13/2019
7DD584,public-offering,100,43,3/13/2019
834152,conference-participant,100,50,3/13/2019
86F123,earnings-positive,100,69,3/13/2019
8.79E+06,earnings,100,50,3/13/2019
880C0C,dividend,100,50,3/13/2019
8B8656,earnings,100,50,3/13/2019
8D0EEA,conference-participant,100,50,3/13/2019
8E10BF,conference-participant,100,50,3/13/2019
8FF2EF,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
8FF57A,earnings,100,50,3/13/2019
911AB8,legal-issues-defendant,100,22,3/13/2019
97693A,conference-call,100,50,3/13/2019
9B0C9C,conference-participant,100,50,3/13/2019
9B4066,facility-sale,100,52,3/13/2019
9CA4C6,partnership,100,61,3/13/2019
9CA4C6,partnership,100,61,3/13/2019
9CA4C6,partnership,100,61,3/13/2019
9D307D,conference-participant,100,50,3/13/2019
9F71E5,business-contract,100,69,3/13/2019
A350C1,executive-appointment,100,54,3/13/2019
A433A5,earnings,100,50,3/13/2019
A8B137,earnings-guidance,100,50,3/13/2019
AADE0B,unit-acquisition-acquirer,100,49,3/13/2019
AEBB80,dividend,100,50,3/13/2019
AEF2C3,conference-participant,100,50,3/13/2019
B2D799,legal-issues-defendant,100,22,3/13/2019
B3A166,earnings,100,50,3/13/2019
B73395,earnings,100,50,3/13/2019
B73395,earnings,100,50,3/13/2019
B73395,earnings,100,50,3/13/2019
B73395,earnings,100,50,3/13/2019
B73395,earnings,100,50,3/13/2019
B9CD50,product-release,100,64,3/13/2019
B9CD50,product-release,100,64,3/13/2019
BD682F,dividend,100,50,3/13/2019
BE645B,conference-participant,100,50,3/13/2019
BFD0A7,conference-call,100,50,3/13/2019
C2E39B,earnings,100,50,3/13/2019
C356AC,legal-issues-defendant,100,22,3/13/2019
C5E100,acquisition-acquirer,100,49,3/13/2019
C5E100,acquisition-acquirer,100,49,3/13/2019
C5E100,acquisition-acquirer,100,49,3/13/2019
C5E100,acquisition-acquirer,100,49,3/13/2019
C5E100,acquisition-acquirer,100,49,3/13/2019
C5E100,acquisition-acquirer,100,49,3/13/2019
C9881C,partnership,100,61,3/13/2019
CAD7D9,conference-call,100,50,3/13/2019
CC176E,product-release,100,64,3/13/2019
CC176E,executive-appointment,100,54,3/13/2019
CC6F6E,earnings,100,50,3/13/2019
D07B07,earnings,100,50,3/13/2019
D07B07,earnings,100,50,3/13/2019
D08D2C,conference-call,100,50,3/13/2019
D650A7,dividend,100,50,3/13/2019
D650A7,revenue-up,100,69,3/13/2019
D650A7,revenue-up,100,69,3/13/2019
D650A7,revenue-up,100,69,3/13/2019
D82EF3,executive-appointment,100,54,3/13/2019
D8DBA3,buybacks,100,74,3/13/2019
DC6AA0,equity-shelf-registration,100,43,3/13/2019
E2CFD2,partnership,100,61,3/13/2019
E49AA3,business-contract,100,69,3/13/2019
E71AE6,legal-issues-defendant,100,22,3/13/2019
E71AE6,legal-issues-defendant,100,22,3/13/2019
E71AE6,legal-issues-defendant,100,22,3/13/2019
E8B315,dividend-up,100,66,3/13/2019
E8D221,earnings,100,50,3/13/2019
EA79C7,earnings,100,50,3/13/2019
EF5BED,earnings,100,50,3/13/2019
F2E253,partnership,100,61,3/13/2019
FB7724,legal-issues-defendant,100,22,3/13/2019
FC9869,earnings,100,50,3/13/2019
FE609F,earnings,100,50,3/13/2019
01D03F,regulatory-product-approval-granted,100,81,3/14/2019
03B8CF,partnership,100,61,3/14/2019
0490C6,earnings-up,100,68,3/14/2019
0490C6,earnings,100,50,3/14/2019
0490C6,earnings,100,50,3/14/2019
0490C6,earnings,100,50,3/14/2019
06EF42,earnings,100,50,3/14/2019
95294,dividend,100,50,3/14/2019
09DE1F,earnings,100,50,3/14/2019
0B4D10,dividend,100,50,3/14/2019
0EF1AF,earnings,100,50,3/14/2019
106394,dividend,100,50,3/14/2019
108A2B,public-offering,100,43,3/14/2019
14391F,earnings,100,50,3/14/2019
14391F,earnings,100,50,3/14/2019
14391F,earnings,100,50,3/14/2019
14391F,earnings,100,50,3/14/2019
152AB9,conference-call,100,50,3/14/2019
15789A,revenues,100,50,3/14/2019
157CC1,regulatory-product-application,100,69,3/14/2019
15B10D,earnings,100,50,3/14/2019
15B10D,earnings,100,50,3/14/2019
17EDA5,dividend,100,50,3/14/2019
190BE6,earnings,100,50,3/14/2019
19BF16,executive-appointment,100,54,3/14/2019
1AD9CC,earnings,100,50,3/14/2019
1DF15D,executive-appointment,100,54,3/14/2019
1E7785,executive-appointment,100,54,3/14/2019
1E9A6D,executive-appointment,100,54,3/14/2019
1EBF8D,regulatory-product-approval-granted,100,81,3/14/2019
1EBF8D,regulatory-product-approval-granted,100,81,3/14/2019
1EBF8D,regulatory-product-approval-granted,100,81,3/14/2019
1EBF8D,regulatory-product-approval-granted,100,81,3/14/2019
1F43A1,dividend-up,100,81,3/14/2019
1FC422,executive-appointment,100,54,3/14/2019
221AD7,partnership,100,61,3/14/2019
221AD7,partnership,100,61,3/14/2019
25D3CE,conference-participant,100,50,3/14/2019
26CC63,earnings,100,50,3/14/2019
26CC63,earnings,100,50,3/14/2019
26CC63,earnings,100,50,3/14/2019
26CC63,earnings,100,50,3/14/2019
2C35B5,earnings,100,50,3/14/2019
2F960F,public-offering,100,43,3/14/2019
2FDEE3,dividend,100,50,3/14/2019
30DE64,clinical-trials-start,100,64,3/14/2019
31553A,earnings,100,50,3/14/2019
32CB22,conference-participant,100,50,3/14/2019
32DCB3,partnership,100,61,3/14/2019
371B0A,conference-participant,100,50,3/14/2019
372037,executive-appointment,100,54,3/14/2019
385DD4,partnership,100,61,3/14/2019
3CCC90,business-contract,100,69,3/14/2019
3DC887,product-release,100,64,3/14/2019
3E39A5,revenues,100,50,3/14/2019
40F7DE,conference-participant,100,50,3/14/2019
4.60E+06,acquisition-acquirer,100,49,3/14/2019
4.60E+06,earnings,100,50,3/14/2019
4A2457,conference-participant,100,50,3/14/2019
4DAF5F,buybacks,100,74,3/14/2019
4DAF5F,buybacks,100,74,3/14/2019
4E6F5A,executive-appointment,100,54,3/14/2019
507AE7,note-sale,100,52,3/14/2019
520632,regulatory-product-approval-granted,100,81,3/14/2019
5.47E+28,earnings,100,50,3/14/2019
54DF47,dividend,100,50,3/14/2019
55D0F3,earnings,100,50,3/14/2019
57A854,earnings-up,100,68,3/14/2019
57A854,earnings,100,50,3/14/2019
57A854,earnings,100,50,3/14/2019
58CA9A,earnings,100,50,3/14/2019
5BC2F4,partnership,100,61,3/14/2019
5D0EAE,trading-resumed,100,58,3/14/2019
5D41E4,earnings,100,50,3/14/2019
5F3D91,earnings,100,50,3/14/2019
5F3D91,earnings,100,50,3/14/2019
5F3D91,earnings,100,50,3/14/2019
62CDDE,conference-participant,100,50,3/14/2019
641F17,earnings,100,50,3/14/2019
673C9A,conference-participant,100,50,3/14/2019
6810DE,earnings,100,50,3/14/2019
693ECD,patient-enrollment-start,100,58,3/14/2019
69C99E,earnings,100,50,3/14/2019
6C6D73,private-placement,100,56,3/14/2019
6D4636,partnership,100,61,3/14/2019
6EA292,dividend,100,50,3/14/2019
6ED519,executive-appointment,100,54,3/14/2019
6F39FC,board-meeting,100,51,3/14/2019
71B0CF,earnings,100,50,3/14/2019
7239BB,conference-call,100,50,3/14/2019
72FCA3,earnings,100,50,3/14/2019
731675,market-share,100,50,3/14/2019
7710F3,earnings,100,50,3/14/2019
7712CB,note-sale,100,52,3/14/2019
7712CB,note-sale,100,52,3/14/2019
78F776,credit-extension-recipient,100,69,3/14/2019
7A0EC4,earnings,100,50,3/14/2019
7AB859,drilling,100,68,3/14/2019
7AB859,drilling,100,68,3/14/2019
7ACBA4,dividend,100,50,3/14/2019
7BC92D,earnings,100,50,3/14/2019
7CBC40,executive-appointment,100,54,3/14/2019
7DD584,public-offering,100,43,3/14/2019
7E1D5D,product-release,100,64,3/14/2019
7F3669,product-release,100,64,3/14/2019
7F9BE2,public-offering,100,43,3/14/2019
7FD8B9,conference-participant,100,50,3/14/2019
83E0AC,conference-participant,100,50,3/14/2019
8AB85C,earnings,100,50,3/14/2019
8AC740,board-meeting,100,51,3/14/2019
8B4A45,facility-upgrade,100,65,3/14/2019
8BFAA4,earnings,100,50,3/14/2019
8D0EEA,earnings,100,50,3/14/2019
911CA9,earnings,100,50,3/14/2019
911CA9,earnings,100,50,3/14/2019
91C82E,conference-call,100,50,3/14/2019
92D757,executive-appointment,100,54,3/14/2019
94983E,acquisition-acquirer,100,49,3/14/2019
95DC1F,dividend,100,50,3/14/2019
96F126,executive-appointment,100,54,3/14/2019
98A286,earnings,100,50,3/14/2019
990AD0,conference-organizer,100,57,3/14/2019
9D307D,earnings,100,50,3/14/2019
9E0811,public-offering,100,43,3/14/2019
9F18FA,acquisition-completed-acquirer,100,49,3/14/2019
9F18FA,acquisition-completed-acquirer,100,49,3/14/2019
A495F7,earnings,100,50,3/14/2019
A63387,acquisition-acquirer,100,49,3/14/2019
A63820,executive-appointment,100,54,3/14/2019
A87CD6,conference-participant,100,50,3/14/2019
AA3AB8,earnings,100,50,3/14/2019
AB4A7E,conference-participant,100,50,3/14/2019
ABBAD1,acquisition-completed-acquirer,100,49,3/14/2019
AC642C,earnings,100,50,3/14/2019
AC642C,earnings,100,50,3/14/2019
AD1ACF,partnership,100,61,3/14/2019
AE4EEB,dividend-up,100,81,3/14/2019
B01215,earnings,100,50,3/14/2019
B01215,earnings,100,50,3/14/2019
B2D799,legal-issues-defendant,100,22,3/14/2019
B381D8,legal-issues-defendant,100,22,3/14/2019
B48FC9,conference-participant,100,50,3/14/2019
B4F5F4,earnings,100,50,3/14/2019
B560AF,unit-acquisition-acquirer,100,49,3/14/2019
B8A51F,earnings,100,50,3/14/2019
BBC05B,settlement,100,56,3/14/2019
BD15E8,acquisition-regulatory-approval-acquirer,100,54,3/14/2019
BD44C9,earnings,100,50,3/14/2019
BFAEB4,conference-call,100,50,3/14/2019
C3BCD5,executive-appointment,100,54,3/14/2019
C5C0E9,buybacks,100,74,3/14/2019
C74887,earnings,100,50,3/14/2019
C81E00,acquisition-acquirer,100,49,3/14/2019
C8257F,executive-appointment,100,54,3/14/2019
C8257F,executive-appointment,100,54,3/14/2019
C9732E,earnings,100,50,3/14/2019
C9881C,revenue-up,100,69,3/14/2019
C9881C,revenue-up,100,69,3/14/2019
C9881C,revenue-up,100,69,3/14/2019
C9881C,revenue-up,100,69,3/14/2019
CAD7D9,conference-participant,100,50,3/14/2019
CBFFDD,legal-issues-defendant,100,22,3/14/2019
CD051C,earnings,100,50,3/14/2019
CD051C,earnings,100,50,3/14/2019
CD051C,earnings,100,50,3/14/2019
CD051C,earnings,100,50,3/14/2019
CD051C,earnings,100,50,3/14/2019
CD051C,earnings,100,50,3/14/2019
CDD75E,earnings,100,50,3/14/2019
CF6A5A,earnings,100,50,3/14/2019
CF7292,earnings,100,50,3/14/2019
D0DE27,conference-participant,100,50,3/14/2019
D5AF19,executive-appointment,100,54,3/14/2019
D6144F,earnings,100,50,3/14/2019
D697DE,earnings,100,50,3/14/2019
D78BF1,award,100,58,3/14/2019
D78CCD,executive-appointment,100,54,3/14/2019
DC0998,product-release,100,64,3/14/2019
DC2B00,same-store-sales-up,100,54,3/14/2019
DF16DE,earnings,100,50,3/14/2019
E00373,note-sale,100,52,3/14/2019
E0207A,note-sale,100,52,3/14/2019
E0207A,note-sale,100,52,3/14/2019
E1C16B,executive-appointment,100,54,3/14/2019
E1E093,partnership,100,61,3/14/2019
E1E093,partnership,100,61,3/14/2019
E1E093,partnership,100,61,3/14/2019
E5D914,product-release,100,64,3/14/2019
E5D914,product-release,100,64,3/14/2019
E754F0,earnings,100,50,3/14/2019
E866D2,legal-issues-defendant,100,22,3/14/2019
E8B315,note-sale,100,52,3/14/2019
E8C557,earnings,100,50,3/14/2019
EA4E68,dividend,100,50,3/14/2019
EA62FC,executive-appointment,100,54,3/14/2019
EB36DE,business-contract,100,69,3/14/2019
EB6965,dividend-up,100,81,3/14/2019
EC70EC,note-sale,100,52,3/14/2019
EC99D0,conference-call,100,50,3/14/2019
ECA300,earnings,100,50,3/14/2019
ECD263,earnings,100,50,3/14/2019
EE74E1,partnership,100,61,3/14/2019
EEA6B3,earnings,100,50,3/14/2019
EEB5F9,earnings,100,50,3/14/2019
EF5914,earnings,100,50,3/14/2019
F0EEFB,conference-participant,100,50,3/14/2019
F2E253,executive-appointment,100,54,3/14/2019
F5D059,conference-call,100,50,3/14/2019
F66B58,conference-participant,100,50,3/14/2019
F6DCE4,dividend,100,50,3/14/2019
F6FA6A,earnings,100,50,3/14/2019
F88147,earnings,100,50,3/14/2019
FACF19,executive-appointment,100,54,3/14/2019
FBD92D,acquisition-acquirer,100,49,3/14/2019
FBD92D,earnings-up,100,68,3/14/2019
FBD92D,earnings,100,50,3/14/2019
FBD92D,earnings,100,50,3/14/2019
FBD92D,earnings,100,50,3/14/2019
FC1F9D,facility-open,100,65,3/14/2019
FCA54E,conference-participant,100,50,3/14/2019
FD9A97,conference-participant,100,50,3/14/2019
FDD3FC,earnings,100,50,3/14/2019
01D03F,regulatory-product-approval-granted,100,81,3/15/2019
0C355F,conference-participant,100,50,3/15/2019
108A2B,public-offering,100,43,3/15/2019
136B26,acquisition-acquirer,100,49,3/15/2019
152AB9,merger,100,66,3/15/2019
152AB9,earnings,100,50,3/15/2019
152FA5,clinical-trials-start,100,64,3/15/2019
188394,conference-call,100,50,3/15/2019
1AF7E2,dividend,100,50,3/15/2019
1EBF8D,business-contract,100,69,3/15/2019
2DC88B,legal-issues-defendant,100,22,3/15/2019
2DC88B,legal-issues-defendant,100,22,3/15/2019
2E902B,dividend,100,50,3/15/2019
306623,conference-participant,100,50,3/15/2019
339F20,dividend,100,50,3/15/2019
3F4497,dividend,100,50,3/15/2019
442587,facility-open,100,65,3/15/2019
4DAF5F,buybacks,100,74,3/15/2019
4DAF5F,buybacks,100,74,3/15/2019
5675EB,dividend,100,50,3/15/2019
5704AC,dividend,100,50,3/15/2019
5B226B,business-contract,100,69,3/15/2019
5B226B,business-contract,100,69,3/15/2019
5B3FA2,conference-participant,100,50,3/15/2019
5F3D91,legal-issues-defendant,100,22,3/15/2019
60FE03,earnings,100,50,3/15/2019
60FE03,earnings,100,50,3/15/2019
619882,dividend,100,50,3/15/2019
6CF43C,dividend,100,50,3/15/2019
6D3B7B,dividend,100,50,3/15/2019
71694D,acquisition-completed-acquirer,100,49,3/15/2019
775439,earnings,100,50,3/15/2019
7B9212,earnings,100,50,3/15/2019
7F9BE2,public-offering,100,43,3/15/2019
826FD6,dividend,100,50,3/15/2019
893904,earnings,100,50,3/15/2019
913437,earnings,100,50,3/15/2019
9196A2,dividend,100,50,3/15/2019
986AF6,earnings-guidance,100,50,3/15/2019
990AD0,conference-organizer,100,57,3/15/2019
9BB35A,public-offering,100,43,3/15/2019
A3800A,partnership,100,61,3/15/2019
A3AAA5,dividend,100,50,3/15/2019
AA7FE0,conference-call,100,50,3/15/2019
AD375D,dividend,100,50,3/15/2019
AE4125,executive-appointment,100,54,3/15/2019
B2D799,legal-issues-defendant,100,22,3/15/2019
B381D8,legal-issues-defendant,100,22,3/15/2019
B4B281,earnings,100,50,3/15/2019
B762D3,dividend,100,50,3/15/2019
BAD9EA,earnings,100,50,3/15/2019
BBBB41,conference-participant,100,50,3/15/2019
BCC55F,executive-appointment,100,54,3/15/2019
BE14CF,joint-venture,100,62,3/15/2019
BE14CF,joint-venture,100,62,3/15/2019
C0030A,partnership,100,61,3/15/2019
C16A8F,executive-appointment,100,54,3/15/2019
C2DD02,dividend,100,50,3/15/2019
C356AC,fraud-defendant,100,20,3/15/2019
C407A0,shareholder-rights-plan,100,43,3/15/2019
C598D7,acquisition-acquirer,100,49,3/15/2019
C9F39B,dividend,100,50,3/15/2019
CBA33B,acquisition-acquiree,100,76,3/15/2019
CBCC6A,conference-organizer,100,57,3/15/2019
CFF15D,legal-verdict-favored,100,78,3/15/2019
CFF97C,credit-rating-downgrade,100,33,3/15/2019
D139BC,dividend,100,50,3/15/2019
D3FA2C,dividend,100,50,3/15/2019
D6144F,conference-participant,100,50,3/15/2019
D69D42,dividend,100,50,3/15/2019
D8442A,legal-verdict-disfavored,100,22,3/15/2019
D96202,conference-call,100,50,3/15/2019
DF01B1,business-contract,100,69,3/15/2019
E11C41,dividend,100,50,3/15/2019
E2CFD2,partnership,100,61,3/15/2019
E8846E,donation,100,54,3/15/2019
EC99D0,executive-appointment,100,54,3/15/2019
EF7163,dividend,100,50,3/15/2019
EFA7B2,merger,100,66,3/15/2019
EFA7B2,earnings,100,50,3/15/2019
F3816D,earnings,100,50,3/15/2019
F748C7,product-release,100,64,3/15/2019
F80389,dividend,100,50,3/15/2019
FA40E2,legal-issues-defendant,100,22,3/15/2019
FA40E2,legal-issues-defendant,100,22,3/15/2019
FACF19,merger,100,66,3/15/2019
49BBBC,legal-issues-defendant,100,22,3/16/2019
5F3D91,legal-issues-defendant,100,22,3/16/2019
78F9ED,legal-issues-defendant,100,22,3/16/2019
883D82,legal-issues-defendant,100,22,3/16/2019
92D230,earnings,100,50,3/16/2019
B381D8,legal-issues-defendant,100,22,3/16/2019
B381D8,legal-issues-defendant,100,22,3/16/2019
F8BA6C,legal-issues-defendant,100,22,3/16/2019
FB7724,legal-issues-defendant,100,22,3/16/2019
FB7724,legal-issues-defendant,100,22,3/17/2019
48590,legal-issues-defendant,100,22,3/18/2019
07CA6A,award,100,58,3/18/2019
08A40F,executive-appointment,100,54,3/18/2019
0CC01F,dividend,100,50,3/18/2019
0E64D4,executive-appointment,100,54,3/18/2019
0F0693,earnings,100,50,3/18/2019
10943B,acquisition-acquirer,100,49,3/18/2019
138DDE,dividend,100,50,3/18/2019
13A782,executive-appointment,100,54,3/18/2019
14BA33,conference-participant,100,50,3/18/2019
152E1D,executive-appointment,100,54,3/18/2019
168A5D,acquisition-completed-acquirer,100,49,3/18/2019
180DA0,executive-appointment,100,54,3/18/2019
1880C5,earnings,100,50,3/18/2019
18D9FA,earnings,100,50,3/18/2019
1CD4B5,earnings,100,50,3/18/2019
1CD4B5,earnings,100,50,3/18/2019
20403D,dividend,100,50,3/18/2019
2082EA,clinical-trials-start,100,64,3/18/2019
20BEEA,earnings-guidance,100,50,3/18/2019
228D42,partnership,100,61,3/18/2019
24A89A,earnings,100,50,3/18/2019
24A89A,earnings,100,50,3/18/2019
25D3CE,earnings,100,50,3/18/2019
27C10F,public-offering,100,43,3/18/2019
2ABF77,patient-enrollment-complete,100,64,3/18/2019
2C681C,earnings,100,50,3/18/2019
2C681C,earnings,100,50,3/18/2019
2DC88B,legal-issues-defendant,100,22,3/18/2019
2DC88B,legal-issues-defendant,100,22,3/18/2019
2EB04E,ipo,100,71,3/18/2019
2F1299,product-release,100,64,3/18/2019
32DCB3,conference-participant,100,50,3/18/2019
34B411,merger-regulatory-approval,100,81,3/18/2019
36E479,clinical-trials-start,100,64,3/18/2019
37B618,earnings,100,50,3/18/2019
3A3447,facility-open,100,65,3/18/2019
3B8484,acquisition-acquirer,100,49,3/18/2019
3BC360,public-offering,100,43,3/18/2019
3C8A04,conference-call,100,50,3/18/2019
3DD5E2,public-offering,100,43,3/18/2019
3F96D5,earnings,100,50,3/18/2019
407878,earnings-guidance,100,50,3/18/2019
407878,earnings-guidance,100,50,3/18/2019
408380,earnings,100,50,3/18/2019
416291,dividend,100,50,3/18/2019
41EC04,executive-appointment,100,54,3/18/2019
420168,dividend,100,50,3/18/2019
42978B,conference-call,100,50,3/18/2019
42EFC7,executive-appointment,100,54,3/18/2019
449447,revenue-up,100,79,3/18/2019
45ABCC,partnership,100,61,3/18/2019
45ABCC,partnership,100,61,3/18/2019
4AC91D,conference-organizer,100,57,3/18/2019
4D8124,partnership,100,61,3/18/2019
4D8124,partnership,100,61,3/18/2019
4DAF5F,buybacks,100,74,3/18/2019
4DAF5F,buybacks,100,74,3/18/2019
54512F,earnings,100,50,3/18/2019
545272,public-offering,100,43,3/18/2019
55438C,legal-issues-defendant,100,22,3/18/2019
55C289,executive-resignation,100,44,3/18/2019
5B6C11,executive-appointment,100,54,3/18/2019
5CEE02,executive-appointment,100,54,3/18/2019
5E6959,dividend,100,50,3/18/2019
5E9934,earnings,100,50,3/18/2019
662682,partnership,100,61,3/18/2019
66749D,award,100,58,3/18/2019
6830FE,public-offering,100,43,3/18/2019
68586A,unit-acquisition-acquirer,100,49,3/18/2019
69FDFC,executive-appointment,100,54,3/18/2019
6F0096,facility-close,100,47,3/18/2019
73BCBA,executive-appointment,100,54,3/18/2019
73C521,earnings,100,50,3/18/2019
7410C3,earnings,100,50,3/18/2019
747219,conference-call,100,50,3/18/2019
7520CC,index-listing,100,76,3/18/2019
762A3E,executive-appointment,100,54,3/18/2019
78F776,earnings,100,50,3/18/2019
78F9ED,legal-issues-defendant,100,22,3/18/2019
790C34,product-release,100,64,3/18/2019
7B0BA6,business-combination,100,54,3/18/2019
7B0BA6,business-combination,100,54,3/18/2019
7B0BA6,merger,100,66,3/18/2019
7E2DE6,earnings,100,50,3/18/2019
7F0372,executive-appointment,100,54,3/18/2019
8665BA,investment-investor,100,55,3/18/2019
893904,earnings,100,50,3/18/2019
896771,partnership,100,61,3/18/2019
8D9993,executive-appointment,100,54,3/18/2019
8FCA78,earnings-guidance,100,50,3/18/2019
90D6A5,dividend,100,50,3/18/2019
9196A2,conference-organizer,100,57,3/18/2019
92D230,earnings,100,50,3/18/2019
9.36E+10,credit-extension-provider,100,57,3/18/2019
93F143,partnership,100,61,3/18/2019
95C392,executive-appointment,100,54,3/18/2019
971334,executive-appointment,100,54,3/18/2019
97644E,note-sale,100,52,3/18/2019
9A602D,executive-resignation,100,44,3/18/2019
9ABD30,executive-appointment,100,54,3/18/2019
9EA947,product-release,100,64,3/18/2019
A28C54,executive-appointment,100,54,3/18/2019
A4D173,executive-appointment,100,54,3/18/2019
A4D173,executive-appointment,100,54,3/18/2019
A9ED24,dividend,100,50,3/18/2019
AA1EAA,dividend,100,50,3/18/2019
AD23DE,partnership,100,61,3/18/2019
AD6141,public-offering,100,43,3/18/2019
ADD9DC,earnings,100,50,3/18/2019
AE79CD,public-offering,100,43,3/18/2019
AED61E,earnings,100,50,3/18/2019
AEFC90,clinical-trials-filed,100,60,3/18/2019
B05000,earnings,100,50,3/18/2019
B381D8,executive-appointment,100,54,3/18/2019
B381D8,legal-issues-defendant,100,22,3/18/2019
B381D8,legal-issues-defendant,100,22,3/18/2019
B46E12,dividend-up,100,69,3/18/2019
BBBB41,partnership,100,61,3/18/2019
BBC05B,earnings,100,50,3/18/2019
BE645B,earnings,100,50,3/18/2019
BE645B,earnings,100,50,3/18/2019
BFD0A7,executive-appointment,100,54,3/18/2019
BFD0A7,earnings,100,50,3/18/2019
C0BA36,facility-open,100,65,3/18/2019
C2DD02,earnings,100,50,3/18/2019
C2E39B,earnings,100,50,3/18/2019
C38440,executive-appointment,100,54,3/18/2019
C83B88,conference-call,100,50,3/18/2019
C8A248,buybacks,100,74,3/18/2019
C98CDB,business-contract,100,69,3/18/2019
C98CDB,product-release,100,64,3/18/2019
CBCC6A,conference-organizer,100,57,3/18/2019
CBCC6A,conference-organizer,100,57,3/18/2019
CBFFDD,award,100,58,3/18/2019
CC0C78,executive-appointment,100,54,3/18/2019
CDC217,earnings,100,50,3/18/2019
CFF15D,business-contract,100,69,3/18/2019
D06755,product-release,100,64,3/18/2019
D17C1B,executive-appointment,100,54,3/18/2019
D296C6,dividend,100,50,3/18/2019
D57D99,product-release,100,64,3/18/2019
D78BF1,dividend,100,50,3/18/2019
D8ECA1,earnings,100,50,3/18/2019
D8ECA1,earnings,100,50,3/18/2019
D8ECA1,earnings,100,50,3/18/2019
D8ECA1,earnings,100,50,3/18/2019
DC6EF3,earnings,100,50,3/18/2019
DD682D,public-offering,100,43,3/18/2019
DDB002,conference-participant,100,50,3/18/2019
E0339F,earnings,100,50,3/18/2019
E09997,earnings,100,50,3/18/2019
E09E2B,partnership,100,61,3/18/2019
E114F4,award,100,58,3/18/2019
E22FDE,earnings,100,50,3/18/2019
E30B34,award,100,58,3/18/2019
E7BF32,conference-call,100,50,3/18/2019
E7BF32,conference-call,100,50,3/18/2019
EBD89A,business-contract,100,69,3/18/2019
F05B1B,earnings,100,50,3/18/2019
F0B335,clinical-trials,100,56,3/18/2019
F24FF0,earnings,100,50,3/18/2019
F4CDA3,dividend,100,50,3/18/2019
F57F6F,conference-organizer,100,57,3/18/2019
F6581D,earnings,100,50,3/18/2019
F73DD1,earnings,100,50,3/18/2019
F90EE5,executive-appointment,100,54,3/18/2019
FB7724,legal-issues-defendant,100,22,3/18/2019
FC1736,revenues,100,50,3/18/2019
FF6644,partnership,100,61,3/18/2019
0157B1,partnership,100,61,3/19/2019
01D03F,regulatory-product-approval-granted,100,81,3/19/2019
01D03F,regulatory-product-approval-granted,100,81,3/19/2019
01D03F,regulatory-product-approval-granted,100,81,3/19/2019
01D03F,regulatory-product-approval-granted,100,81,3/19/2019
03B8CF,legal-issues-defendant,100,22,3/19/2019
03D5F9,partnership,100,61,3/19/2019
03D5F9,partnership,100,61,3/19/2019
0B73A7,executive-resignation,100,44,3/19/2019
0B73A7,executive-resignation,100,44,3/19/2019
0BF528,acquisition-completed-acquirer,100,49,3/19/2019
0E3436,earnings,100,50,3/19/2019
0E3436,earnings,100,50,3/19/2019
0E5619,regulatory-product-approval-granted,100,81,3/19/2019
0F0440,donation,100,54,3/19/2019
108A2B,dividend,100,50,3/19/2019
152E1D,legal-issues-defendant,100,22,3/19/2019
16C544,award,100,58,3/19/2019
16F4D8,conference-participant,100,50,3/19/2019
1.79E+10,executive-appointment,100,54,3/19/2019
1A3E1B,executive-appointment,100,54,3/19/2019
1E7785,conference-participant,100,50,3/19/2019
1F08A6,executive-appointment,100,54,3/19/2019
1FAF22,partnership,100,61,3/19/2019
1FAF22,partnership,100,61,3/19/2019
225CA2,partnership,100,61,3/19/2019
228D42,award,100,58,3/19/2019
26F99F,earnings,100,50,3/19/2019
275300,dividend,100,50,3/19/2019
27C10F,public-offering,100,43,3/19/2019
2A1009,clinical-trials-start,100,64,3/19/2019
2A6DBE,clinical-trials-start,100,64,3/19/2019
2A6DBE,public-offering,100,43,3/19/2019
2DC88B,legal-issues-defendant,100,22,3/19/2019
2DC88B,legal-issues-defendant,100,22,3/19/2019
2E89AE,executive-appointment,100,54,3/19/2019
3.14E+47,dividend,100,50,3/19/2019
31803E,regulatory-product-approval-granted,100,81,3/19/2019
32DCB3,clinical-trials-complete,100,56,3/19/2019
3461CF,business-contract,100,69,3/19/2019
3461CF,business-contract,100,69,3/19/2019
35AE32,buybacks,100,74,3/19/2019
39FB23,executive-appointment,100,54,3/19/2019
3A3447,facility-open,100,65,3/19/2019
3BC360,public-offering,100,43,3/19/2019
3C11C4,conference-participant,100,50,3/19/2019
3D9999,legal-issues-defendant,100,22,3/19/2019
3DD5E2,public-offering,100,43,3/19/2019
42EFC7,clinical-trials-start,100,64,3/19/2019
453282,conference-call,100,50,3/19/2019
45BC35,executive-appointment,100,54,3/19/2019
4.91E+58,acquisition-acquirer,100,49,3/19/2019
4AC91D,partnership,100,61,3/19/2019
4AC91D,partnership,100,61,3/19/2019
4AC91D,product-release,100,64,3/19/2019
4AC91D,product-release,100,64,3/19/2019
4B3555,dividend,100,50,3/19/2019
4C37C5,conference-call,100,50,3/19/2019
4DAF5F,buybacks,100,74,3/19/2019
4DAF5F,buybacks,100,74,3/19/2019
504FE2,business-contract,100,69,3/19/2019
545272,public-offering,100,43,3/19/2019
545272,dividend,100,50,3/19/2019
5.47E+28,executive-appointment,100,54,3/19/2019
55C9B5,business-contract,100,69,3/19/2019
5B97B2,dividend-guidance,100,50,3/19/2019
6166D1,dividend,100,50,3/19/2019
619882,dividend,100,50,3/19/2019
620381,earnings,100,50,3/19/2019
62CDDE,conference-participant,100,50,3/19/2019
64E346,partnership,100,61,3/19/2019
6559D8,earnings,100,50,3/19/2019
665D7D,legal-issues-defendant,100,22,3/19/2019
66A667,earnings,100,50,3/19/2019
66A667,earnings,100,50,3/19/2019
6844D2,earnings,100,50,3/19/2019
6844D2,earnings,100,50,3/19/2019
6844D2,earnings,100,50,3/19/2019
69FDFC,business-contract,100,69,3/19/2019
69FDFC,business-contract,100,69,3/19/2019
6B236C,public-offering,100,43,3/19/2019
6BD606,acquisition-acquirer,100,49,3/19/2019
6BD606,acquisition-acquirer,100,49,3/19/2019
6ED519,dividend,100,50,3/19/2019
713810,revenue-up,100,72,3/19/2019
762A3E,conference-organizer,100,57,3/19/2019
76DD0C,earnings,100,50,3/19/2019
790C34,partnership,100,61,3/19/2019
7B1E50,dividend,100,50,3/19/2019
7D5FD6,facility-open,100,65,3/19/2019
7E1D5D,conference-call,100,50,3/19/2019
7F2922,partnership,100,61,3/19/2019
83A065,dividend,100,50,3/19/2019
8665BA,product-release,100,64,3/19/2019
8B8656,conference-participant,100,50,3/19/2019
8B9B3B,business-contract,100,69,3/19/2019
8C5519,partnership,100,61,3/19/2019
8C5519,earnings,100,50,3/19/2019
8DBBE6,executive-appointment,100,54,3/19/2019
92D230,legal-issues-defendant,100,22,3/19/2019
92D230,legal-issues-defendant,100,22,3/19/2019
9368BE,partnership,100,61,3/19/2019
957A07,executive-appointment,100,54,3/19/2019
966DBE,conference-participant,100,50,3/19/2019
968966,partnership,100,61,3/19/2019
971F7B,executive-appointment,100,54,3/19/2019
9B5968,executive-appointment,100,54,3/19/2019
9CDA4F,conference-participant,100,50,3/19/2019
9D30A8,business-contract,100,69,3/19/2019
9E9147,stake-acquirer,100,48,3/19/2019
9FA83B,acquisition-acquirer,100,49,3/19/2019
A16DEA,partnership,100,61,3/19/2019
A6828A,conference-call,100,50,3/19/2019
AA247D,facility-open,100,65,3/19/2019
ADF092,acquisition-acquirer,100,49,3/19/2019
AE3113,product-release,100,64,3/19/2019
B1A85D,note-sale,100,52,3/19/2019
B37FB4,earnings,100,50,3/19/2019
B381D8,legal-issues-defendant,100,22,3/19/2019
B381D8,legal-issues-defendant,100,22,3/19/2019
B381D8,legal-issues-defendant,100,22,3/19/2019
B5766D,conference-call,100,50,3/19/2019
B7FA9B,conference-participant,100,50,3/19/2019
BDF85E,earnings,100,50,3/19/2019
BE379D,executive-appointment,100,54,3/19/2019
BFEA04,partnership,100,61,3/19/2019
C05839,dividend,100,50,3/19/2019
C0BA36,product-release,100,64,3/19/2019
C3DE7D,product-release,100,64,3/19/2019
C407A0,executive-appointment,100,54,3/19/2019
C50B26,unit-acquisition-acquirer,100,49,3/19/2019
CBFFDD,legal-issues-defendant,100,22,3/19/2019
CFF15D,product-release,100,64,3/19/2019
D11C1C,dividend-up,100,60,3/19/2019
D1CFC8,earnings,100,50,3/19/2019
D598E7,award,100,58,3/19/2019
D7AC6E,executive-appointment,100,54,3/19/2019
D8442A,partnership,100,61,3/19/2019
DB9829,dividend,100,50,3/19/2019
DCD97F,business-contract,100,69,3/19/2019
DD1BA1,executive-appointment,100,54,3/19/2019
DD682D,public-offering,100,43,3/19/2019
E09E2B,partnership,100,61,3/19/2019
E09E2B,partnership,100,61,3/19/2019
E09E2B,partnership,100,61,3/19/2019
E09E2B,partnership,100,61,3/19/2019
E09E2B,product-release,100,64,3/19/2019
E124EB,conference-call,100,50,3/19/2019
E1E093,partnership,100,61,3/19/2019
E61888,dividend,100,50,3/19/2019
E8846E,donation,100,54,3/19/2019
ED7F13,dividend,100,50,3/19/2019
EF5BED,product-release,100,64,3/19/2019
F0B877,executive-appointment,100,54,3/19/2019
F3EDB4,earnings,100,50,3/19/2019
F3EDB4,earnings,100,50,3/19/2019
F43A11,conference-call,100,50,3/19/2019
F57F6F,conference-organizer,100,57,3/19/2019
FB7724,legal-issues-defendant,100,22,3/19/2019
FEC475,partnership,100,61,3/19/2019
FF6644,partnership,100,61,3/19/2019
05AF14,earnings,100,50,3/20/2019
05AF14,dividend,100,50,3/20/2019
0A0CF0,dividend,100,50,3/20/2019
0A9D0A,executive-appointment,100,54,3/20/2019
0AB700,dividend,100,50,3/20/2019
0BD970,earnings,100,50,3/20/2019
0FABBD,legal-issues-defendant,100,22,3/20/2019
1065BC,executive-resignation,100,44,3/20/2019
15901B,executive-appointment,100,54,3/20/2019
1EBF8D,partnership,100,61,3/20/2019
228D42,partnership,100,61,3/20/2019
238302,dividend,100,50,3/20/2019
267718,acquisition-completed-acquirer,100,49,3/20/2019
26DC29,product-release,100,64,3/20/2019
2A6DBE,public-offering,100,43,3/20/2019
2D981A,executive-appointment,100,54,3/20/2019
2F24A5,earnings,100,50,3/20/2019
30E01D,executive-appointment,100,54,3/20/2019
385DD4,executive-appointment,100,54,3/20/2019
40F7DE,legal-issues-defendant,100,22,3/20/2019
467F2C,conference-participant,100,50,3/20/2019
499C75,patient-enrollment-start,100,58,3/20/2019
49BBBC,earnings,100,50,3/20/2019
4D8313,product-release,100,64,3/20/2019
4DAF5F,buybacks,100,74,3/20/2019
4DAF5F,buybacks,100,74,3/20/2019
514067,legal-issues-defendant,100,22,3/20/2019
520632,conference-call,100,50,3/20/2019
53EF9E,conference-participant,100,50,3/20/2019
596116,conference-participant,100,50,3/20/2019
59F0B0,conference-call,100,50,3/20/2019
5B226B,legal-issues-defendant,100,22,3/20/2019
5BC2F4,executive-appointment,100,54,3/20/2019
5D41E4,conference-participant,100,50,3/20/2019
609208,earnings,100,50,3/20/2019
6284B5,partnership,100,61,3/20/2019
63E8D5,dividend-up,100,81,3/20/2019
66ECFD,earnings,100,50,3/20/2019
68586A,conference-participant,100,50,3/20/2019
69FDFC,product-release,100,64,3/20/2019
6B236C,public-offering,100,43,3/20/2019
6F3936,earnings,100,50,3/20/2019
6F3936,earnings,100,50,3/20/2019
6F3936,earnings,100,50,3/20/2019
6F3936,earnings,100,50,3/20/2019
6F3936,earnings,100,50,3/20/2019
6F3936,earnings,100,50,3/20/2019
6F3936,earnings,100,50,3/20/2019
6F6559,business-contract,100,69,3/20/2019
713810,partnership,100,61,3/20/2019
7255D2,public-offering,100,43,3/20/2019
747219,earnings,100,50,3/20/2019
747219,dividend,100,50,3/20/2019
762A3E,conference-organizer,100,57,3/20/2019
775439,dividend,100,50,3/20/2019
7A5097,earnings,100,50,3/20/2019
85AD00,dividend,100,50,3/20/2019
85AD00,conference-call,100,50,3/20/2019
896771,note-sale,100,52,3/20/2019
896771,note-sale,100,52,3/20/2019
8E4250,conference-call,100,50,3/20/2019
913437,earnings,100,50,3/20/2019
92D230,legal-issues-defendant,100,22,3/20/2019
9B5968,dividend,100,50,3/20/2019
9B5968,dividend,100,50,3/20/2019
9B5968,note-sale,100,52,3/20/2019
9CA619,earnings-up,100,68,3/20/2019
9CA619,earnings,100,50,3/20/2019
9CA619,earnings,100,50,3/20/2019
9CA619,earnings,100,50,3/20/2019
9CA619,earnings,100,50,3/20/2019
9CA619,earnings,100,50,3/20/2019
9CA619,earnings,100,50,3/20/2019
9CA619,earnings,100,50,3/20/2019
9D6A24,conference-call,100,50,3/20/2019
A350C1,business-contract,100,69,3/20/2019
A43906,conference-call,100,50,3/20/2019
A6213D,product-release,100,64,3/20/2019
AD22F2,executive-appointment,100,54,3/20/2019
AD6141,public-offering,100,43,3/20/2019
B1FC3B,business-contract,100,69,3/20/2019
B5766D,note-sale,100,52,3/20/2019
BAD655,public-offering,100,43,3/20/2019
BDE867,unit-acquisition-acquirer,100,49,3/20/2019
C22BE8,earnings,100,50,3/20/2019
C27E19,earnings,100,50,3/20/2019
C425AE,conference-participant,100,50,3/20/2019
CDAF5B,conference-call,100,50,3/20/2019
CDD75E,conference-participant,100,50,3/20/2019
D21D8A,dividend,100,50,3/20/2019
D854F3,conference-call,100,50,3/20/2019
DA0A9E,conference-call,100,50,3/20/2019
DB88A1,earnings,100,50,3/20/2019
DB9829,executive-appointment,100,54,3/20/2019
DC0998,product-release,100,64,3/20/2019
DDB002,legal-issues-defendant,100,22,3/20/2019
DF46C5,executive-appointment,100,54,3/20/2019
E1E093,facility-open,100,65,3/20/2019
E21871,conference-participant,100,50,3/20/2019
E959F3,earnings,100,50,3/20/2019
EB7FBF,dividend,100,50,3/20/2019
ECF709,buybacks,100,74,3/20/2019
ED79D9,dividend,100,50,3/20/2019
F3FCC3,stake-acquiree,100,62,3/20/2019
F509E2,executive-appointment,100,54,3/20/2019
F5349B,executive-appointment,100,54,3/20/2019
F748C7,dividend-up,100,62,3/20/2019
F7ADEB,regulatory-product-approval-granted,100,81,3/20/2019
F82D37,conference-call,100,50,3/20/2019
F85CC0,dividend,100,50,3/20/2019
FE7A63,executive-appointment,100,54,3/20/2019
00698D,credit-extension-recipient,100,69,3/21/2019
20751,executive-appointment,100,54,3/21/2019
034B61,product-release,100,64,3/21/2019
55018,conference-call,100,50,3/21/2019
98977,legal-issues-defendant,100,22,3/21/2019
0A0CF0,earnings,100,50,3/21/2019
0A77DB,earnings,100,50,3/21/2019
0B400D,trading-halt,100,43,3/21/2019
0C28D1,executive-appointment,100,54,3/21/2019
0E5223,conference-participant,100,50,3/21/2019
0FABBD,legal-issues-defendant,100,22,3/21/2019
0FABBD,legal-issues-defendant,100,22,3/21/2019
10AE08,executive-resignation,100,44,3/21/2019
152B9E,executive-appointment,100,54,3/21/2019
1A5957,legal-issues-defendant,100,22,3/21/2019
1AB023,conference-participant,100,50,3/21/2019
1AB023,conference-participant,100,50,3/21/2019
1AB023,conference-participant,100,50,3/21/2019
1AC649,earnings,100,50,3/21/2019
1DE526,conference-participant,100,50,3/21/2019
1FC422,executive-appointment,100,54,3/21/2019
205AD5,earnings,100,50,3/21/2019
2093B1,public-offering,100,43,3/21/2019
21153F,business-contract,100,69,3/21/2019
251988,partnership,100,61,3/21/2019
2DC88B,legal-issues-defendant,100,22,3/21/2019
2E6514,executive-appointment,100,54,3/21/2019
30E01D,note-sale,100,52,3/21/2019
3224CC,executive-appointment,100,54,3/21/2019
32F24A,executive-appointment,100,54,3/21/2019
39D9DA,conference-call,100,50,3/21/2019
3A3447,facility-open,100,65,3/21/2019
3D9999,earnings,100,50,3/21/2019
417BF9,conference-call,100,50,3/21/2019
4BBA23,trading-halt,100,43,3/21/2019
4BBA23,trading-resumed,100,58,3/21/2019
4DAF5F,buybacks,100,74,3/21/2019
4DAF5F,buybacks,100,74,3/21/2019
53A226,acquisition-acquirer,100,49,3/21/2019
53F491,dividend,100,50,3/21/2019
55438C,legal-issues-defendant,100,22,3/21/2019
5BC2F4,award,100,58,3/21/2019
5C7601,earnings,100,50,3/21/2019
5CC29D,dividend,100,50,3/21/2019
5DD486,conference-call,100,50,3/21/2019
5E1DF3,conference-participant,100,50,3/21/2019
5F3D91,legal-issues-defendant,100,22,3/21/2019
61BCA7,executive-appointment,100,54,3/21/2019
633043,dividend,100,50,3/21/2019
641F17,note-sale,100,52,3/21/2019
665D7D,donation,100,54,3/21/2019
6830FE,executive-appointment,100,54,3/21/2019
69CE71,legal-issues-defendant,100,22,3/21/2019
69CE71,legal-issues-defendant,100,22,3/21/2019
6D3F35,legal-issues-defendant,100,22,3/21/2019
6D3F35,legal-issues-defendant,100,22,3/21/2019
7262F2,executive-appointment,100,54,3/21/2019
73C521,earnings,100,50,3/21/2019
746373,conference-call,100,50,3/21/2019
75768D,earnings,100,50,3/21/2019
75768D,earnings,100,50,3/21/2019
75768D,earnings,100,50,3/21/2019
75768D,earnings,100,50,3/21/2019
75768D,earnings,100,50,3/21/2019
7712CB,note-sale,100,52,3/21/2019
7740DE,earnings,100,50,3/21/2019
7771D7,earnings,100,50,3/21/2019
79340A,executive-appointment,100,54,3/21/2019
7AC86E,partnership,100,61,3/21/2019
7ADE57,dividend,100,50,3/21/2019
7D5FD6,executive-appointment,100,54,3/21/2019
810FAD,conference-participant,100,50,3/21/2019
84AB66,dividend,100,50,3/21/2019
87486A,executive-appointment,100,54,3/21/2019
895D56,award,100,58,3/21/2019
8AB85C,earnings,100,50,3/21/2019
8D0EEA,conference-participant,100,50,3/21/2019
8EF425,dividend,100,50,3/21/2019
911AB8,acquisition-interest-acquirer,100,46,3/21/2019
911AB8,acquisition-interest-acquirer,100,46,3/21/2019
92D230,legal-issues-defendant,100,22,3/21/2019
92D6A5,buybacks,100,74,3/21/2019
954004,earnings,100,50,3/21/2019
9546A5,earnings,100,50,3/21/2019
972356,product-release,100,64,3/21/2019
97644E,note-sale,100,52,3/21/2019
9.82E+06,earnings,100,50,3/21/2019
98A286,earnings-per-share-positive,100,69,3/21/2019
9B5968,note-sale,100,52,3/21/2019
9BBFA5,earnings,100,50,3/21/2019
A6213D,executive-appointment,100,54,3/21/2019
A63387,product-release,100,64,3/21/2019
A6FB29,earnings,100,50,3/21/2019
A6FC89,earnings-up,100,68,3/21/2019
A6FC89,earnings,100,50,3/21/2019
A6FC89,earnings,100,50,3/21/2019
A6FC89,earnings,100,50,3/21/2019
A6FC89,earnings,100,50,3/21/2019
A70BF5,earnings,100,50,3/21/2019
A761FE,conference-call,100,50,3/21/2019
AD22F2,earnings,100,50,3/21/2019
AD9F1D,product-release,100,64,3/21/2019
ADD9DC,facility-open,100,65,3/21/2019
ADFB3A,executive-appointment,100,54,3/21/2019
B05000,executive-appointment,100,54,3/21/2019
B1FC3B,government-contract,100,69,3/21/2019
B381D8,legal-issues-defendant,100,22,3/21/2019
B381D8,legal-issues-defendant,100,22,3/21/2019
B5BA39,product-release,100,64,3/21/2019
B6082A,conference-call,100,50,3/21/2019
BAD655,public-offering,100,43,3/21/2019
BDE867,award,100,58,3/21/2019
BFAEB4,earnings,100,50,3/21/2019
C4A241,facility-open,100,65,3/21/2019
C659EB,executive-resignation,100,44,3/21/2019
C81E00,conference-call,100,50,3/21/2019
C81E00,conference-call,100,50,3/21/2019
C951A2,facility-open,100,65,3/21/2019
CAC8D0,reverse-stock-splits,100,51,3/21/2019
CB7AB2,award,100,58,3/21/2019
CBFFDD,executive-appointment,100,54,3/21/2019
CBFFDD,executive-appointment,100,54,3/21/2019
CEDFD5,clinical-trials-suspended,100,24,3/21/2019
D0DE27,conference-participant,100,50,3/21/2019
D11C1C,partnership,100,61,3/21/2019
D21D8A,dividend,100,50,3/21/2019
D2B9E5,award,100,58,3/21/2019
D2E553,dividend,100,50,3/21/2019
D4070C,product-release,100,64,3/21/2019
D42DBA,executive-appointment,100,54,3/21/2019
D56E4C,executive-appointment,100,54,3/21/2019
D5B13D,earnings,100,50,3/21/2019
D622D5,dividend,100,50,3/21/2019
D64C6D,earnings,100,50,3/21/2019
D7AC6E,conference-call,100,50,3/21/2019
DDCB34,conference-participant,100,50,3/21/2019
DF11D9,conference-call,100,50,3/21/2019
DF5F14,merger-regulatory-approval,100,81,3/21/2019
DF5F14,merger,100,66,3/21/2019
E2F130,conference-call,100,50,3/21/2019
E41190,merger-failed,100,21,3/21/2019
E41190,merger-failed,100,21,3/21/2019
E49AA3,conference-organizer,100,57,3/21/2019
E6EDED,conference-call,100,50,3/21/2019
E71AE6,legal-issues-defendant,100,22,3/21/2019
E9FF33,executive-appointment,100,54,3/21/2019
EB7FBF,earnings,100,50,3/21/2019
ECDEB2,dividend,100,50,3/21/2019
F6581D,earnings,100,50,3/21/2019
F7FCA4,note-sale,100,52,3/21/2019
F88147,executive-appointment,100,54,3/21/2019
FA40E2,earnings,100,50,3/21/2019
FA40E2,earnings,100,50,3/21/2019
FA40E2,earnings,100,50,3/21/2019
FA40E2,earnings,100,50,3/21/2019
FA40E2,earnings,100,50,3/21/2019
FA40E2,earnings,100,50,3/21/2019
FA40E2,earnings,100,50,3/21/2019
FA40E2,earnings,100,50,3/21/2019
FA40E2,legal-issues-defendant,100,22,3/21/2019
FAAFA2,clinical-trials-start,100,64,3/21/2019
FAE021,partnership,100,61,3/21/2019
FB7724,legal-issues-defendant,100,22,3/21/2019
FB7724,legal-issues-defendant,100,22,3/21/2019
06A456,acquisition-completed-acquirer,100,49,3/22/2019
09DE1F,award,100,58,3/22/2019
0B400D,trading-resumed,100,58,3/22/2019
0BD970,buybacks,100,74,3/22/2019
0CC62B,conference-participant,100,50,3/22/2019
14BA06,conference-participant,100,50,3/22/2019
168A5D,business-contract,100,69,3/22/2019
1BC12C,investment-investor,100,55,3/22/2019
228D42,award,100,58,3/22/2019
24D81E,facility-open,100,65,3/22/2019
251988,earnings,100,50,3/22/2019
253B2F,dividend,100,50,3/22/2019
2571FA,conference-participant,100,50,3/22/2019
28AF37,conference-participant,100,50,3/22/2019
3B9886,earnings,100,50,3/22/2019
3B9886,executive-appointment,100,54,3/22/2019
3BA1BF,conference-participant,100,50,3/22/2019
3DDE54,conference-participant,100,50,3/22/2019
408089,earnings,100,50,3/22/2019
4398A2,earnings,100,50,3/22/2019
4398A2,earnings,100,50,3/22/2019
49BBBC,legal-issues-defendant,100,22,3/22/2019
4BBA23,trading-halt,100,43,3/22/2019
4BBA23,trading-resumed,100,58,3/22/2019
4DAF5F,buybacks,100,74,3/22/2019
4DAF5F,buybacks,100,74,3/22/2019
56277A,conference-call,100,50,3/22/2019
586BD7,conference-call,100,50,3/22/2019
58CA9A,trading-delisting,100,36,3/22/2019
5F3D91,legal-issues-defendant,100,22,3/22/2019
616E3B,conference-call,100,50,3/22/2019
6474BA,earnings,100,50,3/22/2019
67303E,facility-open,100,65,3/22/2019
6D3F35,legal-issues-defendant,100,22,3/22/2019
6F30F9,dividend,100,50,3/22/2019
76BD96,note-sale,100,52,3/22/2019
76E80F,dividend,100,50,3/22/2019
7712CB,note-sale,100,52,3/22/2019
790C34,business-contract,100,69,3/22/2019
7E0EB0,conference-participant,100,50,3/22/2019
834152,executive-resignation,100,44,3/22/2019
8377DB,merger-completed,100,66,3/22/2019
863350,market-entry,100,57,3/22/2019
8817D5,conference-call,100,50,3/22/2019
8AB85C,clinical-trials,100,56,3/22/2019
8AC65D,hirings,100,65,3/22/2019
92B047,executive-appointment,100,54,3/22/2019
938D89,earnings,100,50,3/22/2019
97644E,dividend-guidance,100,50,3/22/2019
A8FDE8,conference-participant,100,50,3/22/2019
B05118,partnership,100,61,3/22/2019
DE4924,conference-participant,100,50,3/22/2019
E6BC2C,earnings,100,50,3/22/2019
E71AE6,legal-issues-defendant,100,22,3/22/2019
E829E8,auditor-appointment,100,50,3/22/2019
E8846E,earnings,100,50,3/22/2019
E90C84,dividend,100,50,3/22/2019
EC8116,public-offering,100,43,3/22/2019
F15E41,unit-acquisition-acquirer,100,49,3/22/2019
F15E41,unit-acquisition-acquirer,100,49,3/22/2019
F2E253,partnership,100,61,3/22/2019
F5349B,partnership,100,61,3/22/2019
F8BA6C,legal-issues-defendant,100,22,3/22/2019
F8DE55,legal-issues-defendant,100,22,3/22/2019
8DDA23,buybacks,100,74,3/23/2019
00E601,earnings,100,50,3/25/2019
02ACBD,conference-call,100,50,3/25/2019
0490C6,conference-participant,100,50,3/25/2019
054E7E,executive-appointment,100,54,3/25/2019
07C69F,conference-call,100,50,3/25/2019
0B6EED,earnings,100,50,3/25/2019
0B6EED,earnings,100,50,3/25/2019
0B6EED,earnings,100,50,3/25/2019
0B6EED,earnings,100,50,3/25/2019
0BC29E,executive-appointment,100,54,3/25/2019
0C136E,earnings,100,50,3/25/2019
0CC01F,earnings,100,50,3/25/2019
0E439E,earnings,100,50,3/25/2019
0F2BC9,unit-acquisition-acquirer,100,49,3/25/2019
125212,earnings,100,50,3/25/2019
125212,earnings,100,50,3/25/2019
157CC1,earnings,100,50,3/25/2019
15B10D,conference-participant,100,50,3/25/2019
1AC649,conference-participant,100,50,3/25/2019
1B5FEA,conference-participant,100,50,3/25/2019
228D42,product-release,100,64,3/25/2019
25102A,note-sale,100,52,3/25/2019
25102A,note-sale,100,52,3/25/2019
25102A,note-sale,100,52,3/25/2019
25102A,note-sale,100,52,3/25/2019
25102A,note-sale,100,52,3/25/2019
25102A,note-sale,100,52,3/25/2019
292A70,earnings,100,50,3/25/2019
297DA8,product-release,100,64,3/25/2019
2EB04E,partnership,100,61,3/25/2019
2F9304,executive-appointment,100,54,3/25/2019
31F25C,executive-appointment,100,54,3/25/2019
35B907,dividend,100,50,3/25/2019
371B0A,conference-participant,100,50,3/25/2019
385DD4,facility-open,100,65,3/25/2019
3A3447,facility-open,100,65,3/25/2019
3A4BDB,dividend,100,50,3/25/2019
3C11C4,earnings-guidance,100,50,3/25/2019
3DD5E2,public-offering,100,43,3/25/2019
3E149C,facility-open,100,65,3/25/2019
408089,partnership,100,61,3/25/2019
434F38,product-release,100,64,3/25/2019
43E8F5,executive-resignation,100,44,3/25/2019
46A16E,conference-participant,100,50,3/25/2019
49A344,earnings,100,50,3/25/2019
4B5054,conference-call,100,50,3/25/2019
4DAF5F,buybacks,100,74,3/25/2019
4DAF5F,buybacks,100,74,3/25/2019
4E7C1F,award,100,58,3/25/2019
4F9926,partnership,100,61,3/25/2019
510EA6,product-release,100,64,3/25/2019
57356F,conference-call,100,50,3/25/2019
58B46F,conference-call,100,50,3/25/2019
5D16CF,executive-appointment,100,54,3/25/2019
64E346,executive-appointment,100,54,3/25/2019
6D3F35,legal-issues-defendant,100,22,3/25/2019
713810,conference-participant,100,50,3/25/2019
713810,partnership,100,61,3/25/2019
723548,dividend,100,50,3/25/2019
7239BB,facility-open,100,65,3/25/2019
732A9B,clinical-trials-start,100,64,3/25/2019
76959C,note-sale,100,52,3/25/2019
76DD0C,executive-appointment,100,54,3/25/2019
7AF907,conference-participant,100,50,3/25/2019
7B0BA6,award,100,58,3/25/2019
7B8CB5,asset-sale,100,62,3/25/2019
7BC92D,executive-appointment,100,54,3/25/2019
7DD8CC,executive-appointment,100,54,3/25/2019
863350,facility-open,100,65,3/25/2019
8665BA,acquisition-acquirer,100,49,3/25/2019
8B9B3B,conference-participant,100,50,3/25/2019
8E10BF,clinical-trials-filed,100,60,3/25/2019
8FF57A,award,100,58,3/25/2019
911AB8,dividend,100,50,3/25/2019
911AB8,dividend,100,50,3/25/2019
925759,executive-appointment,100,54,3/25/2019
92D9C9,dividend,100,50,3/25/2019
9.39E+69,earnings,100,50,3/25/2019
96BFF4,earnings,100,50,3/25/2019
96F126,business-contract,100,69,3/25/2019
A790A5,executive-appointment,100,54,3/25/2019
A79F7D,earnings,100,50,3/25/2019
AADE0B,unit-acquisition-acquirer,100,49,3/25/2019
AC7C4F,award,100,58,3/25/2019
AD6141,public-offering,100,43,3/25/2019
AE79CD,public-offering,100,43,3/25/2019
AFD7DD,executive-appointment,100,54,3/25/2019
B1FC3B,government-contract,100,69,3/25/2019
B33E77,executive-appointment,100,54,3/25/2019
B5DE80,conference-call,100,50,3/25/2019
B8A51F,conference-participant,100,50,3/25/2019
B8F71F,earnings,100,50,3/25/2019
BDD12C,partnership,100,61,3/25/2019
BE14CF,board-meeting,100,51,3/25/2019
C4A432,dividend,100,50,3/25/2019
C4A432,executive-appointment,100,54,3/25/2019
C4C77F,merger-completed,100,66,3/25/2019
C584BE,executive-appointment,100,54,3/25/2019
C9A96E,executive-appointment,100,54,3/25/2019
CFD4B6,conference-participant,100,50,3/25/2019
D1AE3B,conference-call,100,50,3/25/2019
D8442A,product-release,100,64,3/25/2019
D8442A,product-release,100,64,3/25/2019
D8442A,product-release,100,64,3/25/2019
D90F43,acquisition-rumor-acquirer,100,56,3/25/2019
E22FDE,conference-participant,100,50,3/25/2019
E4CE73,executive-appointment,100,54,3/25/2019
EF5BED,business-contract,100,69,3/25/2019
F3D2EB,dividend,100,50,3/25/2019
F40EE2,facility-open,100,65,3/25/2019
F40EE2,facility-open,100,65,3/25/2019
F5D410,conference-organizer,100,57,3/25/2019
F88147,reverse-stock-splits,100,51,3/25/2019
F8DE55,legal-issues-defendant,100,22,3/25/2019
F93C8A,public-offering,100,43,3/25/2019
FD6926,partnership,100,61,3/25/2019
FE609F,conference-participant,100,50,3/25/2019
FEE4B0,credit-extension-recipient,100,69,3/25/2019
0157B1,revenue-up,100,91,3/26/2019
03542C,business-contract,100,69,3/26/2019
0A59F8,business-contract,100,69,3/26/2019
0A7650,dividend,100,50,3/26/2019
0F0440,donation,100,54,3/26/2019
1921DD,partnership,100,61,3/26/2019
19BF16,legal-issues-defendant,100,22,3/26/2019
1AC649,patent-awarded,100,72,3/26/2019
1E9A6D,executive-appointment,100,54,3/26/2019
228D42,partnership,100,61,3/26/2019
22C58E,conference-participant,100,50,3/26/2019
251988,product-release,100,64,3/26/2019
26F99F,earnings,100,50,3/26/2019
2B0AF4,conference-call,100,50,3/26/2019
2D643C,executive-appointment,100,54,3/26/2019
30CBF9,business-contract,100,69,3/26/2019
3.14E+47,product-release,100,64,3/26/2019
33FD66,earnings,100,50,3/26/2019
3A3447,facility-open,100,65,3/26/2019
3BCF24,dividend,100,50,3/26/2019
3CCC90,conference-call,100,50,3/26/2019
3F4497,conference-call,100,50,3/26/2019
49F4D0,dividend,100,50,3/26/2019
4A6F00,partnership,100,61,3/26/2019
4C3FE9,clinical-trials-start,100,64,3/26/2019
4CDA2B,earnings,100,50,3/26/2019
4DAF5F,buybacks,100,74,3/26/2019
4DAF5F,buybacks,100,74,3/26/2019
4F9926,partnership,100,61,3/26/2019
4F9926,partnership,100,61,3/26/2019
510EA6,earnings,100,50,3/26/2019
510EA6,earnings,100,50,3/26/2019
519FE0,merger-regulatory-approval,100,81,3/26/2019
525A1C,product-release,100,64,3/26/2019
5BC2F4,earnings,100,50,3/26/2019
5D0337,executive-appointment,100,54,3/26/2019
61BCA7,earnings,100,50,3/26/2019
65D0AA,clinical-trials,100,56,3/26/2019
69345C,business-contract,100,69,3/26/2019
693ECD,patent-awarded,100,72,3/26/2019
6B0E45,buybacks,100,74,3/26/2019
6F3FA8,conference-participant,100,50,3/26/2019
6FCEF9,earnings,100,50,3/26/2019
713810,conference-participant,100,50,3/26/2019
72FCA3,earnings,100,50,3/26/2019
72FCA3,earnings,100,50,3/26/2019
72FCA3,earnings,100,50,3/26/2019
72FCA3,earnings,100,50,3/26/2019
732A9B,earnings,100,50,3/26/2019
7.40E+289,dividend,100,50,3/26/2019
762A3E,conference-organizer,100,57,3/26/2019
762A3E,executive-appointment,100,54,3/26/2019
762A3E,executive-appointment,100,54,3/26/2019
762A3E,conference-organizer,100,57,3/26/2019
76F067,partnership,100,61,3/26/2019
7A5097,business-contract,100,69,3/26/2019
7ACFD4,executive-appointment,100,54,3/26/2019
7B9212,dividend,100,50,3/26/2019
7D5FD6,earnings,100,50,3/26/2019
7F3A5F,partnership,100,61,3/26/2019
7FDE1C,business-contract,100,69,3/26/2019
8195B7,partnership,100,61,3/26/2019
850779,earnings,100,50,3/26/2019
86478F,executive-appointment,100,54,3/26/2019
8D9993,dividend-up,100,81,3/26/2019
913437,partnership,100,61,3/26/2019
92D3A0,conference-call,100,50,3/26/2019
954004,facility-open,100,65,3/26/2019
967D92,index-listing,100,76,3/26/2019
968966,index-listing,100,76,3/26/2019
9A602D,conference-call,100,50,3/26/2019
9B5968,product-release,100,64,3/26/2019
9D56F2,earnings,100,50,3/26/2019
9D56F2,earnings,100,50,3/26/2019
9D56F2,earnings,100,50,3/26/2019
9D56F2,earnings,100,50,3/26/2019
9D56F2,earnings,100,50,3/26/2019
9E3224,dividend,100,50,3/26/2019
9EA947,note-sale,100,52,3/26/2019
A15C71,executive-appointment,100,54,3/26/2019
A1EAC8,business-contract,100,69,3/26/2019
A1EAC8,business-contract,100,69,3/26/2019
A4CD53,legal-issues-defendant,100,22,3/26/2019
A52533,executive-appointment,100,54,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A5A4F5,earnings,100,50,3/26/2019
A65325,award,100,58,3/26/2019
A72FD9,earnings,100,50,3/26/2019
A79D88,conference-participant,100,50,3/26/2019
AA98ED,conference-call,100,50,3/26/2019
AD6141,executive-appointment,100,54,3/26/2019
B48D6A,conference-participant,100,50,3/26/2019
BB88B6,partnership,100,61,3/26/2019
BD9668,conference-call,100,50,3/26/2019
C0BA36,merger,100,66,3/26/2019
C11C46,legal-issues-defendant,100,22,3/26/2019
C32A39,facility-open,100,65,3/26/2019
C7859D,conference-call,100,50,3/26/2019
C8A248,index-listing,100,76,3/26/2019
C9881C,partnership,100,61,3/26/2019
C9881C,partnership,100,61,3/26/2019
CBDB4D,patent-infringement-defendant,100,26,3/26/2019
CC176E,earnings,100,50,3/26/2019
CF351E,dividend,100,50,3/26/2019
CFF15D,partnership,100,61,3/26/2019
CFF97C,credit-rating-upgrade-rater,20,50,3/26/2019
D15833,dividend,100,50,3/26/2019
D1C26F,business-contract,100,69,3/26/2019
D90F43,acquisition-acquirer,100,49,3/26/2019
DB88A1,partnership,100,61,3/26/2019
DC486E,earnings,100,50,3/26/2019
E6D89E,partnership,100,61,3/26/2019
E8846E,donation,100,54,3/26/2019
E8846E,donation,100,54,3/26/2019
EAA0A7,executive-appointment,100,54,3/26/2019
EF5BED,executive-appointment,100,54,3/26/2019
F1529C,conference-call,100,50,3/26/2019
F43A11,earnings,100,50,3/26/2019
F569FD,earnings,100,50,3/26/2019
F6E248,regulatory-product-approval-granted,100,81,3/26/2019
F702CA,executive-appointment,100,54,3/26/2019
F8DE55,legal-issues-defendant,100,22,3/26/2019
FAE021,partnership,100,61,3/26/2019
FDF799,patent-infringement-plaintiff,100,47,3/26/2019
FE7A63,earnings,100,50,3/26/2019
0157B1,partnership,100,61,3/27/2019
0157B1,partnership,100,61,3/27/2019
0157B1,partnership,100,61,3/27/2019
03F5A4,dividend,100,50,3/27/2019
55018,partnership,100,61,3/27/2019
06C826,note-sale,100,52,3/27/2019
0BF198,executive-appointment,100,54,3/27/2019
0C6293,executive-appointment,100,54,3/27/2019
0E2992,conference-call,100,50,3/27/2019
125212,name-change,100,49,3/27/2019
16B183,partnership,100,61,3/27/2019
1A5957,legal-issues-defendant,100,22,3/27/2019
1A5957,legal-issues-defendant,100,22,3/27/2019
1B5FEA,earnings,100,50,3/27/2019
1B5FEA,earnings,100,50,3/27/2019
214051,facility-relocation,100,50,3/27/2019
225CA2,product-release,100,64,3/27/2019
251988,partnership,100,61,3/27/2019
2F7474,dividend,100,50,3/27/2019
32DCB3,regulatory-product-approval-granted,100,81,3/27/2019
3390DE,conference-call,100,50,3/27/2019
34B411,award,100,58,3/27/2019
39FB23,earnings,100,50,3/27/2019
3A3447,facility-open,100,65,3/27/2019
3DD5E2,campaign-ad-release,100,59,3/27/2019
401072,public-offering,100,43,3/27/2019
4135F7,conference-call,100,50,3/27/2019
414FFF,earnings,100,50,3/27/2019
4A6F00,partnership,100,61,3/27/2019
4AE584,earnings,100,50,3/27/2019
4B49CF,earnings,100,50,3/27/2019
4B49CF,earnings,100,50,3/27/2019
4B49CF,earnings,100,50,3/27/2019
4B49CF,earnings,100,50,3/27/2019
4C37C5,conference-call,100,50,3/27/2019
4DAF5F,buybacks,100,74,3/27/2019
4DAF5F,buybacks,100,74,3/27/2019
4F9487,dividend-up,100,58,3/27/2019
543900,dividend,100,50,3/27/2019
55438C,earnings,100,50,3/27/2019
55438C,conference-call,100,50,3/27/2019
5A9F54,partnership,100,61,3/27/2019
5F2FF7,earnings,100,50,3/27/2019
5F3D91,legal-issues-defendant,100,22,3/27/2019
62CDDE,executive-appointment,100,54,3/27/2019
67529E,executive-appointment,100,54,3/27/2019
6A3C35,dividend,100,50,3/27/2019
6F6559,earnings,100,50,3/27/2019
6F6559,earnings,100,50,3/27/2019
6F6559,earnings,100,50,3/27/2019
6F6559,earnings,100,50,3/27/2019
6F6559,earnings,100,50,3/27/2019
7.45E+28,clinical-trials,100,56,3/27/2019
756BB4,earnings,100,50,3/27/2019
75F665,conference-call,100,50,3/27/2019
762A3E,conference-organizer,100,57,3/27/2019
78F9ED,legal-issues-defendant,100,22,3/27/2019
790C34,acquisition-acquirer,100,49,3/27/2019
790C34,acquisition-acquirer,100,49,3/27/2019
7A3633,partnership,100,61,3/27/2019
7A975D,earnings,100,50,3/27/2019
7A975D,earnings,100,50,3/27/2019
7A975D,earnings,100,50,3/27/2019
7E1D5D,partnership,100,61,3/27/2019
819492,ipo-pricing,100,50,3/27/2019
82BB33,earnings,100,50,3/27/2019
8377DB,executive-appointment,100,54,3/27/2019
863350,earnings,100,50,3/27/2019
863350,executive-appointment,100,54,3/27/2019
8E8E6E,note-sale,100,52,3/27/2019
8E8E6E,note-sale,100,52,3/27/2019
911AB8,conference-call,100,50,3/27/2019
911ACB,dividend,100,50,3/27/2019
911ACB,dividend,100,50,3/27/2019
91C82E,earnings-per-share-positive,100,69,3/27/2019
91C82E,earnings-per-share-positive,100,69,3/27/2019
91C82E,earnings-per-share-positive,100,69,3/27/2019
9.31E+77,conference-call,100,50,3/27/2019
93AD2E,earnings,100,50,3/27/2019
97693A,earnings,100,50,3/27/2019
98CEBB,executive-appointment,100,54,3/27/2019
9CDA4F,executive-appointment,100,54,3/27/2019
9D56F2,dividend,100,50,3/27/2019
9E98F2,earnings,100,50,3/27/2019
9F37C5,dividend,100,50,3/27/2019
9FB4B7,patient-enrollment-start,100,58,3/27/2019
A247F5,partnership,100,61,3/27/2019
A26C26,dividend,100,50,3/27/2019
A4B899,stake-acquiree,100,62,3/27/2019
A5A4F5,acquisition-acquirer,100,49,3/27/2019
A5A4F5,business-contract,100,69,3/27/2019
A6828A,executive-appointment,100,54,3/27/2019
AB7726,executive-appointment,100,54,3/27/2019
AC1952,equity-shelf-registration,100,43,3/27/2019
AC7AAE,public-offering,100,43,3/27/2019
AD23DE,partnership,100,61,3/27/2019
AD9F1D,executive-appointment,100,54,3/27/2019
B33E77,conference-participant,100,50,3/27/2019
B33E77,conference-participant,100,50,3/27/2019
BDE867,executive-appointment,100,54,3/27/2019
C2E120,dividend,100,50,3/27/2019
C81E00,executive-appointment,100,54,3/27/2019
C81E00,executive-appointment,100,54,3/27/2019
C97B2D,conference-call,100,50,3/27/2019
C9D866,conference-call,100,50,3/27/2019
CAC8D0,earnings,100,50,3/27/2019
CC6F6E,earnings,100,50,3/27/2019
CC6F6E,earnings,100,50,3/27/2019
CC6F6E,earnings,100,50,3/27/2019
CC6F6E,earnings,100,50,3/27/2019
D4463B,dividend,100,50,3/27/2019
D6EAA3,conference-call,100,50,3/27/2019
D93A25,conference-call,100,50,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DB88A1,earnings-up,100,68,3/27/2019
DF11D9,executive-resignation,100,44,3/27/2019
E30A8F,award,100,58,3/27/2019
E99180,dividend,100,50,3/27/2019
ED0402,partnership,100,61,3/27/2019
F46EC9,executive-appointment,100,54,3/27/2019
F5D410,business-combination,100,54,3/27/2019
F5D410,business-combination,100,54,3/27/2019
F5D410,business-combination,100,54,3/27/2019
F5D410,business-combination,100,54,3/27/2019
F702CA,executive-appointment,100,54,3/27/2019
F8DE55,legal-issues-defendant,100,22,3/27/2019
F8DE55,legal-issues-defendant,100,22,3/27/2019
FB7724,legal-issues-defendant,100,22,3/27/2019
FC4550,conference-call,100,50,3/27/2019
00D6B5,executive-appointment,100,54,3/28/2019
02ACBD,earnings,100,50,3/28/2019
06C826,note-sale,100,52,3/28/2019
07EC43,award,100,58,3/28/2019
0B7375,executive-appointment,100,54,3/28/2019
0D03C8,earnings,100,50,3/28/2019
0F2BC9,business-contract,100,69,3/28/2019
119CB6,conference-call,100,50,3/28/2019
1490F3,conference-call,100,50,3/28/2019
17EDA5,partnership,100,61,3/28/2019
1A9DE1,dividend,100,50,3/28/2019
2093B1,public-offering,100,43,3/28/2019
221AD7,business-contract,100,69,3/28/2019
221AD7,settlement,100,56,3/28/2019
22C58E,partnership,100,61,3/28/2019
24FA23,conference-participant,100,50,3/28/2019
25102A,business-contract,100,69,3/28/2019
25A6CC,conference-participant,100,50,3/28/2019
28DCA8,executive-appointment,100,54,3/28/2019
28DCF3,buybacks,100,74,3/28/2019
2920D5,earnings,100,50,3/28/2019
2EB04E,ipo-pricing,100,50,3/28/2019
2F7474,conference-call,100,50,3/28/2019
3.14E+47,earnings,100,50,3/28/2019
3.20E+263,conference-participant,100,50,3/28/2019
37727A,dividend-up,100,81,3/28/2019
3DD5E2,partnership,100,61,3/28/2019
3DD5E2,partnership,100,61,3/28/2019
41EC04,partnership,100,61,3/28/2019
46A16E,conference-call,100,50,3/28/2019
4DAF5F,buybacks,100,74,3/28/2019
4DAF5F,buybacks,100,74,3/28/2019
524CE4,credit-rating-outlook-positive,100,72,3/28/2019
543900,executive-resignation,100,44,3/28/2019
550D01,partnership,100,61,3/28/2019
567F3D,conference-call,100,50,3/28/2019
56B7C1,executive-appointment,100,54,3/28/2019
59B229,earnings,100,50,3/28/2019
5BC2F4,earnings,100,50,3/28/2019
5FF95F,earnings,100,50,3/28/2019
601785,earnings,100,50,3/28/2019
60EA12,product-release,100,64,3/28/2019
62A48D,earnings,100,50,3/28/2019
62A48D,earnings,100,50,3/28/2019
62A48D,earnings,100,50,3/28/2019
651C85,conference-participant,100,50,3/28/2019
6559D8,executive-appointment,100,54,3/28/2019
66667F,joint-venture,100,62,3/28/2019
6D156D,legal-issues-defendant,100,22,3/28/2019
6D156D,legal-issues-defendant,100,22,3/28/2019
713810,board-meeting,100,51,3/28/2019
7239BB,earnings,100,50,3/28/2019
7255D2,campaign-ad-release,100,59,3/28/2019
72CB93,earnings,100,50,3/28/2019
73529F,conference-call,100,50,3/28/2019
742AAB,product-release,100,64,3/28/2019
7.45E+28,earnings,100,50,3/28/2019
7.45E+28,clinical-trials-positive,100,87,3/28/2019
76959C,note-sale,100,52,3/28/2019
76DD0C,earnings,100,50,3/28/2019
789ADD,unit-acquisition-acquirer,100,49,3/28/2019
7A0EC4,investment-investor,100,55,3/28/2019
7AB859,fundraising,100,64,3/28/2019
7FEEE1,earnings,100,50,3/28/2019
8.10E+32,supply-increase,100,74,3/28/2019
8195B7,clinical-trials,100,56,3/28/2019
85DE00,partnership,100,61,3/28/2019
85DE00,partnership,100,61,3/28/2019
868808,dividend,100,50,3/28/2019
88923D,award,100,58,3/28/2019
88923D,award,100,58,3/28/2019
8E4F9A,executive-appointment,100,54,3/28/2019
931AE7,conference-participant,100,50,3/28/2019
934029,conference-call,100,50,3/28/2019
93633B,dividend,100,50,3/28/2019
93633B,executive-appointment,100,54,3/28/2019
94756D,earnings,100,50,3/28/2019
949D62,campaign-ad-release,100,59,3/28/2019
968103,earnings,100,50,3/28/2019
97693A,buybacks,100,74,3/28/2019
990AD0,investment-investor,100,55,3/28/2019
A398B9,product-release,100,64,3/28/2019
A433A5,partnership,100,61,3/28/2019
A52B6B,acquisition-completed-acquirer,100,49,3/28/2019
A5628C,executive-appointment,100,54,3/28/2019
A5A4F5,acquisition-acquirer,100,49,3/28/2019
A6213D,conference-call,100,50,3/28/2019
A6828A,regulatory-product-application,100,69,3/28/2019
A6828A,clinical-trials-filed,100,60,3/28/2019
A6FB29,earnings-up,100,68,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A6FB29,earnings,100,50,3/28/2019
A70BF5,board-meeting,100,51,3/28/2019
A761FE,earnings,100,50,3/28/2019
A8E72A,earnings,100,50,3/28/2019
A9ED24,executive-appointment,100,54,3/28/2019
ABBAD1,credit-extension-recipient,100,69,3/28/2019
AC642C,conference-participant,100,50,3/28/2019
AC642C,conference-participant,100,50,3/28/2019
AD23DE,partnership,100,61,3/28/2019
AD23DE,partnership,100,61,3/28/2019
ADFB3A,executive-appointment,100,54,3/28/2019
B2D799,legal-issues-defendant,100,22,3/28/2019
B2D799,legal-issues-defendant,100,22,3/28/2019
BBAE2A,merger-completed,100,66,3/28/2019
BBAE2A,conference-call,100,50,3/28/2019
BCC55F,award,100,58,3/28/2019
C2E39B,executive-appointment,100,54,3/28/2019
C58D71,public-offering,100,43,3/28/2019
C9881C,partnership,100,61,3/28/2019
CC0C78,conference-participant,100,50,3/28/2019
CC6FF5,partnership,100,61,3/28/2019
CFF97C,credit-rating-outlook-positive-rater,20,50,3/28/2019
D0DFE5,facility-open,100,65,3/28/2019
D1173F,business-contract,100,69,3/28/2019
D33D8C,product-release,100,64,3/28/2019
D33D8C,product-release,100,64,3/28/2019
D6489C,business-contract,100,69,3/28/2019
D78BF1,earnings,100,50,3/28/2019
DA199F,earnings,100,50,3/28/2019
DA199F,dividend,100,50,3/28/2019
DB88A1,award,100,58,3/28/2019
DC0066,earnings,100,50,3/28/2019
DD0F15,executive-appointment,100,54,3/28/2019
DF204B,business-contract,100,69,3/28/2019
DF204B,partnership,100,61,3/28/2019
E1E093,stake-acquirer,100,48,3/28/2019
E49AA3,product-release,100,64,3/28/2019
E49AA3,product-release,100,64,3/28/2019
E8846E,executive-resignation,100,44,3/28/2019
E9C7C0,partnership,100,61,3/28/2019
EA79C7,clinical-trials,100,56,3/28/2019
EEA734,clinical-trials,100,56,3/28/2019
F2E253,executive-appointment,100,54,3/28/2019
F6FA6A,executive-appointment,100,54,3/28/2019
F748C7,partnership,100,61,3/28/2019
F7935D,executive-appointment,100,54,3/28/2019
F92DBC,partnership,100,61,3/28/2019
F92DBC,partnership,100,61,3/28/2019
FAB97A,product-release,100,64,3/28/2019
FC1B7B,partnership,100,61,3/28/2019
FC9A88,dividend,100,50,3/28/2019
FD2565,regulatory-product-approval-granted,100,81,3/28/2019
FD9526,business-contract,100,69,3/28/2019
FD9526,conference-call,100,50,3/28/2019
FE609F,business-contract,100,69,3/28/2019
FF4BA4,earnings,100,50,3/28/2019
FF6644,conference-call,100,50,3/28/2019
09DE1F,note-sale,100,52,3/29/2019
09DE1F,note-sale,100,52,3/29/2019
09F623,conference-participant,100,50,3/29/2019
10943B,conference-call,100,50,3/29/2019
10C19B,conference-call,100,50,3/29/2019
168A5D,partnership,100,61,3/29/2019
16F4D8,conference-call,100,50,3/29/2019
1F19C8,fundraising,100,64,3/29/2019
251988,dividend,100,50,3/29/2019
26E3BA,earnings,100,50,3/29/2019
2EB04E,strike,100,25,3/29/2019
39FB23,earnings-up,100,68,3/29/2019
401072,public-offering,100,43,3/29/2019
46A16E,conference-participant,100,50,3/29/2019
4DAF5F,buybacks,100,74,3/29/2019
4DAF5F,buybacks,100,74,3/29/2019
4DD203,executive-appointment,100,54,3/29/2019
4EC4C1,conference-call,100,50,3/29/2019
519FE0,acquisition-completed-acquiree,100,76,3/29/2019
5.47E+28,fast-track-designation,100,81,3/29/2019
55C9B5,conference-call,100,50,3/29/2019
5B226B,product-release,100,64,3/29/2019
5D41E4,partnership,100,61,3/29/2019
5E6959,conference-call,100,50,3/29/2019
60EA12,earnings,100,50,3/29/2019
6166D1,campaign-ad-release,100,59,3/29/2019
66A667,dividend,100,50,3/29/2019
66A667,dividend,100,50,3/29/2019
67303E,regulatory-product-review-positive,100,73,3/29/2019
765913,earnings,100,50,3/29/2019
791EC1,conference-call,100,50,3/29/2019
7F7C87,earnings,100,50,3/29/2019
8614A2,legal-issues-defendant,100,22,3/29/2019
8CF6DD,conference-call,100,50,3/29/2019
8E0E32,earnings,100,50,3/29/2019
92B047,conference-call,100,50,3/29/2019
934029,patient-enrollment-complete,100,64,3/29/2019
934CC3,stake-acquirer,100,48,3/29/2019
93633B,unit-acquisition-acquiree,100,76,3/29/2019
958938,clinical-trials,100,56,3/29/2019
9934AD,business-contract,100,69,3/29/2019
9934AD,business-contract,100,69,3/29/2019
9C25FF,executive-appointment,100,54,3/29/2019
9EA947,note-sale,100,52,3/29/2019
9F5CBB,dividend,100,50,3/29/2019
A3F598,investment-investor,100,55,3/29/2019
A65325,conference-call,100,50,3/29/2019
A80FE0,conference-call,100,50,3/29/2019
AA7FE0,earnings,100,50,3/29/2019
AFF43F,earnings,100,50,3/29/2019
B2D799,legal-issues-defendant,100,22,3/29/2019
B2D799,legal-issues-defendant,100,22,3/29/2019
B2D799,legal-issues-defendant,100,22,3/29/2019
B6CD92,dividend,100,50,3/29/2019
BF5959,conference-call,100,50,3/29/2019
C03C8B,conference-call,100,50,3/29/2019
C58D71,public-offering,100,43,3/29/2019
C598D7,conference-call,100,50,3/29/2019
C83B88,conference-call,100,50,3/29/2019
C9F39B,conference-call,100,50,3/29/2019
CF7292,partnership,100,61,3/29/2019
D42DBA,executive-appointment,100,54,3/29/2019
D42DBA,executive-appointment,100,54,3/29/2019
D77F7E,acquisition-completed-acquiree,100,76,3/29/2019
D88EF3,conference-call,100,50,3/29/2019
D90F43,strike,100,25,3/29/2019
DBB28E,partnership,100,61,3/29/2019
DBB28E,partnership,100,61,3/29/2019
DCD97F,executive-appointment,100,54,3/29/2019
DF5F14,merger-completed,100,66,3/29/2019
DF5F14,merger-completed,100,66,3/29/2019
E261E9,earnings,100,50,3/29/2019
E6BC2C,revenue-up,100,71,3/29/2019
E6D89E,patent-infringement-plaintiff,100,47,3/29/2019
E9FF33,earnings,100,50,3/29/2019
EAEA91,earnings,100,50,3/29/2019
EE967B,executive-appointment,100,54,3/29/2019
F30508,business-contract,100,69,3/29/2019
F7935D,executive-appointment,100,54,3/29/2019
F8DE55,legal-issues-defendant,100,22,3/29/2019
F8DE55,legal-issues-defendant,100,22,3/29/2019
FA40E2,legal-issues-defendant,100,22,3/29/2019
FC1B7B,award,100,58,3/29/2019
FC9A88,executive-appointment,100,54,3/29/2019
16C7F0,conference-call,100,50,3/30/2019
251988,legal-issues-defendant,100,22,3/30/2019
B2D799,legal-issues-defendant,100,22,3/30/2019
B2D799,legal-issues-defendant,100,22,3/31/2019
CC35BE,legal-issues-defendant,100,22,3/31/2019
01478A,executive-appointment,100,54,4/1/2019
20751,conference-participant,100,50,4/1/2019
04CCCD,dividend,100,50,4/1/2019
04EB2F,unit-acquisition-completed-acquirer,100,49,4/1/2019
081AB9,buybacks,100,74,4/1/2019
081AB9,conference-call,100,50,4/1/2019
095A04,clinical-trials,100,56,4/1/2019
099C88,business-contract,100,69,4/1/2019
0BC17A,conference-call,100,50,4/1/2019
0BC29E,executive-appointment,100,54,4/1/2019
0BF198,conference-participant,100,50,4/1/2019
0BF528,partnership,100,61,4/1/2019
0C6861,dividend,100,50,4/1/2019
0E439E,executive-appointment,100,54,4/1/2019
0FABBD,executive-appointment,100,54,4/1/2019
0FDE97,award,100,58,4/1/2019
10C19B,dividend-up,100,81,4/1/2019
12DE76,partnership,100,61,4/1/2019
12E454,earnings,100,50,4/1/2019
152FA5,earnings,100,50,4/1/2019
152FA5,earnings,100,50,4/1/2019
168A5D,partnership,100,61,4/1/2019
1.79E+10,executive-appointment,100,54,4/1/2019
184866,conference-participant,100,50,4/1/2019
184988,conference-participant,100,50,4/1/2019
1921DD,legal-issues-defendant,100,22,4/1/2019
1AC649,executive-appointment,100,54,4/1/2019
1CD09C,business-contract,100,69,4/1/2019
1EBF8D,acquisition-completed-acquirer,100,49,4/1/2019
1EC3E8,executive-appointment,100,54,4/1/2019
1F9D90,executive-resignation,100,44,4/1/2019
1FE7F0,conference-participant,100,50,4/1/2019
2082EA,executive-appointment,100,54,4/1/2019
21D903,earnings,100,50,4/1/2019
221AD7,earnings,100,50,4/1/2019
25102A,unit-acquisition-acquiree,100,76,4/1/2019
25102A,unit-acquisition-acquiree,100,76,4/1/2019
25102A,product-release,100,64,4/1/2019
25102A,conference-call,100,50,4/1/2019
251988,business-contract,100,69,4/1/2019
251988,legal-issues-defendant,100,22,4/1/2019
297DA8,product-release,100,64,4/1/2019
2B8179,conference-participant,100,50,4/1/2019
2C19A4,dividend,100,50,4/1/2019
2CBB58,acquisition-acquirer,100,49,4/1/2019
30CBF9,executive-appointment,100,54,4/1/2019
32DCB3,clinical-trials-start,100,64,4/1/2019
338544,conference-call,100,50,4/1/2019
34B411,merger-completed,100,66,4/1/2019
39BFF6,unit-acquisition-completed-acquiree,100,67,4/1/2019
3AF7FD,conference-call,100,50,4/1/2019
3B20AB,buybacks,100,74,4/1/2019
3C11C4,executive-appointment,100,54,4/1/2019
3DD5E2,partnership,100,61,4/1/2019
41B53E,dividend,100,50,4/1/2019
42DC93,earnings,100,50,4/1/2019
448BF3,fast-track-designation,100,81,4/1/2019
449A26,acquisition-completed-acquirer,100,49,4/1/2019
46CF27,earnings,100,50,4/1/2019
4806CE,credit-extension-recipient,100,69,4/1/2019
49A344,acquisition-completed-acquirer,100,49,4/1/2019
4AE584,revenues,100,50,4/1/2019
4AE584,revenues,100,50,4/1/2019
4AE584,revenues,100,50,4/1/2019
4AE584,revenues,100,50,4/1/2019
4BDCA7,conference-participant,100,50,4/1/2019
4C7DB5,earnings,100,50,4/1/2019
4CDA2B,clinical-trials-start,100,64,4/1/2019
4D371E,earnings,100,50,4/1/2019
4FCC78,dividend,100,50,4/1/2019
50070E,unit-acquisition-acquiree,100,76,4/1/2019
539F49,earnings,100,50,4/1/2019
567F3D,unit-acquisition-completed-acquirer,100,49,4/1/2019
56FB7C,credit-extension-recipient,100,69,4/1/2019
58B46F,executive-appointment,100,54,4/1/2019
59872F,legal-issues-defendant,100,22,4/1/2019
59C539,conference-call,100,50,4/1/2019
5A423F,conference-participant,100,50,4/1/2019
5D41E4,business-contract,100,69,4/1/2019
5EAA43,asset-sale,100,62,4/1/2019
5EC388,earnings,100,50,4/1/2019
622DBE,executive-appointment,100,54,4/1/2019
627186,regulatory-product-approval-granted,100,81,4/1/2019
627186,conference-participant,100,50,4/1/2019
62CDDE,executive-appointment,100,54,4/1/2019
639BD6,acquisition-completed-acquiree,100,76,4/1/2019
649CBD,clinical-trials,100,56,4/1/2019
665618,dividend,100,50,4/1/2019
66749D,acquisition-acquirer,100,49,4/1/2019
66E3C0,executive-appointment,100,54,4/1/2019
67529E,conference-call,100,50,4/1/2019
69FDFC,business-contract,100,69,4/1/2019
6B0E45,conference-call,100,50,4/1/2019
6BF593,conference-call,100,50,4/1/2019
6E1E61,conference-call,100,50,4/1/2019
713810,unit-acquisition-completed-acquiree,100,67,4/1/2019
71B0CF,conference-participant,100,50,4/1/2019
73BCBA,acquisition-completed-acquirer,100,49,4/1/2019
7.45E+28,public-offering,100,43,4/1/2019
77B8E9,clinical-trials,100,56,4/1/2019
7ACBA4,acquisition-acquirer,100,49,4/1/2019
7ACBA4,acquisition-acquirer,100,49,4/1/2019
7BEA98,clinical-trials-start,100,64,4/1/2019
80C400,unit-acquisition-acquirer,100,49,4/1/2019
80C400,unit-acquisition-acquirer,100,49,4/1/2019
810FAD,conference-call,100,50,4/1/2019
819492,ipo-completed,100,76,4/1/2019
8195B7,earnings,100,50,4/1/2019
834152,executive-appointment,100,54,4/1/2019
83598E,acquisition-completed-acquiree,100,76,4/1/2019
84A6B9,earnings,100,50,4/1/2019
8665BA,conference-call,100,50,4/1/2019
877C0C,business-contract,100,69,4/1/2019
88D80A,earnings,100,50,4/1/2019
8DCBBB,conference-call,100,50,4/1/2019
8E8E6E,business-contract,100,69,4/1/2019
902670,business-contract,100,69,4/1/2019
931AE7,clinical-trials,100,56,4/1/2019
957A07,earnings,100,50,4/1/2019
958938,conference-call,100,50,4/1/2019
9.62E+76,earnings,100,50,4/1/2019
96BFF4,earnings,100,50,4/1/2019
96BFF4,earnings,100,50,4/1/2019
96BFF4,earnings,100,50,4/1/2019
96F126,partnership,100,61,4/1/2019
9978F1,conference-participant,100,50,4/1/2019
9AF3DC,acquisition-acquiree,100,76,4/1/2019
9B4066,unit-acquisition-acquirer,100,49,4/1/2019
9B5968,acquisition-completed-acquirer,100,49,4/1/2019
9B5968,acquisition-completed-acquirer,100,49,4/1/2019
9CA432,conference-call,100,50,4/1/2019
9F03CF,conference-call,100,50,4/1/2019
9F37C5,dividend,100,50,4/1/2019
9F6B1A,earnings,100,50,4/1/2019
9FB4B7,conference-participant,100,50,4/1/2019
A1E3B3,executive-appointment,100,54,4/1/2019
A29DBD,executive-appointment,100,54,4/1/2019
A5151E,market-entry,100,57,4/1/2019
A5195E,conference-participant,100,50,4/1/2019
A5B913,earnings,100,50,4/1/2019
A6828A,unit-acquisition-completed-acquiree,100,67,4/1/2019
A6828A,acquisition-completed-acquirer,100,49,4/1/2019
A8CBDA,conference-call,100,50,4/1/2019
ABBAD1,conference-call,100,50,4/1/2019
AC7C4F,business-contract,100,69,4/1/2019
ACF0B4,acquisition-completed-acquirer,100,49,4/1/2019
B09B1F,unit-acquisition-acquiree,100,76,4/1/2019
B09B1F,unit-acquisition-acquiree,100,76,4/1/2019
B1A85D,partnership,100,61,4/1/2019
B33E77,patient-enrollment-complete,100,64,4/1/2019
B48D6A,conference-participant,100,50,4/1/2019
B604DF,conference-call,100,50,4/1/2019
B7202A,conference-participant,100,50,4/1/2019
B803B1,dividend,100,50,4/1/2019
B80AD1,conference-participant,100,50,4/1/2019
BE645B,business-contract,100,69,4/1/2019
BEA527,executive-appointment,100,54,4/1/2019
C1CBA4,buybacks,100,74,4/1/2019
C32A39,conference-call,100,50,4/1/2019
C4A432,partnership,100,61,4/1/2019
C5C137,executive-appointment,100,54,4/1/2019
C7AE14,dividend,100,50,4/1/2019
C8A248,spin-off,100,58,4/1/2019
C98CDB,executive-appointment,100,54,4/1/2019
CBFFDD,business-contract,100,69,4/1/2019
CBFFDD,business-contract,100,69,4/1/2019
CC0C78,award,100,58,4/1/2019
CF6A5A,earnings,100,50,4/1/2019
D1173F,conference-call,100,50,4/1/2019
D3F64D,earnings-guidance,100,50,4/1/2019
D4070C,acquisition-acquirer,100,49,4/1/2019
D42DBA,business-contract,100,69,4/1/2019
D721C6,note-sale,100,52,4/1/2019
DA91AE,executive-appointment,100,54,4/1/2019
DB88A1,executive-appointment,100,54,4/1/2019
DB88A1,partnership,100,61,4/1/2019
DB9829,acquisition-completed-acquirer,100,49,4/1/2019
DDB002,legal-issues-defendant,100,22,4/1/2019
DE5611,patent-awarded,100,72,4/1/2019
DEF058,earnings,100,50,4/1/2019
DF01B1,acquisition-completed-acquirer,100,49,4/1/2019
DF18E6,executive-appointment,100,54,4/1/2019
DF1F7A,conference-call,100,50,4/1/2019
E09E2B,executive-appointment,100,54,4/1/2019
E10D31,conference-call,100,50,4/1/2019
E12A6E,public-offering,100,43,4/1/2019
E2F130,dividend,100,50,4/1/2019
E5752F,business-contract,100,69,4/1/2019
E71AE6,legal-issues-defendant,100,22,4/1/2019
E74B55,supply-increase,100,74,4/1/2019
E74B55,supply-increase,100,74,4/1/2019
E8B315,acquisition-completed-acquirer,100,49,4/1/2019
EAEA91,dividend,100,50,4/1/2019
EB2F14,merger-completed,100,66,4/1/2019
EC8116,dividend,100,50,4/1/2019
EE74E1,earnings,100,50,4/1/2019
EEB5F9,clinical-trials,100,56,4/1/2019
EF77A3,earnings,100,50,4/1/2019
F6FF0D,conference-call,100,50,4/1/2019
F8BA6C,legal-issues-dismissed-defendant,100,79,4/1/2019
FA044A,conference-call,100,50,4/1/2019
FA40E2,legal-issues-defendant,100,22,4/1/2019
FDC7E6,conference-call,100,50,4/1/2019
FDC7E6,buybacks,100,74,4/1/2019
FE1A1D,executive-appointment,100,54,4/1/2019
FF227B,conference-participant,100,50,4/1/2019
0157B1,partnership,100,61,4/2/2019
0157B1,executive-appointment,100,54,4/2/2019
018C11,conference-call,100,50,4/2/2019
03D5F9,partnership,100,61,4/2/2019
48590,earnings,100,50,4/2/2019
0A9D0A,settlement,100,56,4/2/2019
0A9D0A,settlement,100,56,4/2/2019
0B7375,conference-participant,100,50,4/2/2019
0BF528,product-release,100,64,4/2/2019
0C2A0D,partnership,100,61,4/2/2019
0DBB81,conference-participant,100,50,4/2/2019
0DE3D5,conference-call,100,50,4/2/2019
0FABBD,legal-issues-defendant,100,22,4/2/2019
1151F4,conference-call,100,50,4/2/2019
1220D2,conference-participant,100,50,4/2/2019
13C3E0,product-release,100,64,4/2/2019
1748B3,executive-appointment,100,54,4/2/2019
17EDA5,partnership,100,61,4/2/2019
17EDA5,executive-appointment,100,54,4/2/2019
196D18,clinical-trials,100,56,4/2/2019
19CAC7,earnings-guidance,100,50,4/2/2019
1A2D9F,earnings,100,50,4/2/2019
1AB023,trading-listing,100,61,4/2/2019
1AB023,trading-listing,100,61,4/2/2019
1AB023,trading-listing,100,61,4/2/2019
1BC12C,conference-call,100,50,4/2/2019
1CD4B5,clinical-trials,100,56,4/2/2019
1CD4B5,clinical-trials,100,56,4/2/2019
1DDEDA,executive-appointment,100,54,4/2/2019
1DDEDA,executive-appointment,100,54,4/2/2019
1EBF8D,conference-call,100,50,4/2/2019
1EBF8D,acquisition-completed-acquirer,100,49,4/2/2019
1F716B,conference-call,100,50,4/2/2019
1FA886,partnership,100,61,4/2/2019
206852,conference-call,100,50,4/2/2019
251988,legal-issues-defendant,100,22,4/2/2019
251988,legal-issues-defendant,100,22,4/2/2019
2571FA,conference-call,100,50,4/2/2019
2667B6,earnings,100,50,4/2/2019
26E3BA,executive-appointment,100,54,4/2/2019
270305,merger-completed,100,66,4/2/2019
270B78,executive-appointment,100,54,4/2/2019
2720AB,acquisition-completed-acquirer,100,49,4/2/2019
27BFA1,conference-call,100,50,4/2/2019
284289,conference-participant,100,50,4/2/2019
28DCA8,earnings-guidance,100,50,4/2/2019
2CC71C,clinical-trials,100,56,4/2/2019
2DC88B,legal-issues-defendant,100,22,4/2/2019
30DFD3,unit-acquisition-acquiree,100,76,4/2/2019
31F25C,conference-call,100,50,4/2/2019
33AD83,executive-appointment,100,54,4/2/2019
3.30E+34,executive-appointment,100,54,4/2/2019
342218,conference-call,100,50,4/2/2019
34B411,earnings,100,50,4/2/2019
34B97A,conference-call,100,50,4/2/2019
367434,executive-appointment,100,54,4/2/2019
384CD3,earnings,100,50,4/2/2019
38C46F,dividend,100,50,4/2/2019
39BFF6,conference-call,100,50,4/2/2019
3B37F7,executive-appointment,100,54,4/2/2019
3CCC90,executive-appointment,100,54,4/2/2019
3E15F6,conference-call,100,50,4/2/2019
401072,public-offering,100,43,4/2/2019
40B903,dividend,100,50,4/2/2019
41785E,earnings,100,50,4/2/2019
43E8F5,partnership,100,61,4/2/2019
45ABCC,executive-appointment,100,54,4/2/2019
4.60E+06,acquisition-completed-acquirer,100,49,4/2/2019
485445,facility-open,100,65,4/2/2019
4BBA23,revenues,100,50,4/2/2019
4BDCA7,partnership,100,61,4/2/2019
4C37C5,partnership,100,61,4/2/2019
4C3FE9,clinical-trials,100,56,4/2/2019
51E682,conference-call,100,50,4/2/2019
524CE4,earnings,100,50,4/2/2019
5.43E+08,conference-participant,100,50,4/2/2019
55C9B5,partnership,100,61,4/2/2019
56B7C1,dividend,100,50,4/2/2019
57CAAB,executive-appointment,100,54,4/2/2019
586BD7,conference-participant,100,50,4/2/2019
58CA9A,facility-open,100,65,4/2/2019
59872F,legal-issues-defendant,100,22,4/2/2019
5A0FF1,earnings,100,50,4/2/2019
5B226B,legal-issues-defendant,100,22,4/2/2019
5CC29D,earnings,100,50,4/2/2019
5EAA43,supply-decrease,100,28,4/2/2019
5F2FF7,partnership,100,61,4/2/2019
5F3D91,conference-participant,100,50,4/2/2019
627186,earnings,100,50,4/2/2019
63F892,earnings,100,50,4/2/2019
64854A,conference-participant,100,50,4/2/2019
649CBD,clinical-trials,100,56,4/2/2019
649CBD,clinical-trials,100,56,4/2/2019
6830FE,business-contract,100,69,4/2/2019
68BA15,dividend,100,50,4/2/2019
69CE71,legal-issues-defendant,100,22,4/2/2019
6BC6F9,product-release,100,64,4/2/2019
6E8864,clinical-trials,100,56,4/2/2019
70CA28,product-release,100,64,4/2/2019
70FCEF,partnership,100,61,4/2/2019
723548,dividend,100,50,4/2/2019
7273FF,executive-resignation,100,44,4/2/2019
732A9B,executive-appointment,100,54,4/2/2019
73A71F,award,100,58,4/2/2019
747219,asset-sale,100,62,4/2/2019
763724,dividend,100,50,4/2/2019
76DD0C,clinical-trials,100,56,4/2/2019
787D14,earnings,100,50,4/2/2019
78F776,earnings,100,50,4/2/2019
78F9ED,legal-issues-defendant,100,22,4/2/2019
7A975D,dividend,100,50,4/2/2019
7ACD98,award,100,58,4/2/2019
7B0BA6,award,100,58,4/2/2019
7BEA98,conference-participant,100,50,4/2/2019
7C4F43,clinical-trials,100,56,4/2/2019
7C4F43,clinical-trials,100,56,4/2/2019
7DD8CC,executive-appointment,100,54,4/2/2019
7F9BE2,acquisition-completed-acquirer,100,49,4/2/2019
8.10E+32,unit-acquisition-completed-acquiree,100,67,4/2/2019
8.10E+32,conference-call,100,50,4/2/2019
810FAD,product-release,100,64,4/2/2019
830BDB,conference-call,100,50,4/2/2019
84A6B9,merger-regulatory-approval,100,81,4/2/2019
87486A,conference-call,100,50,4/2/2019
877C0C,executive-appointment,100,54,4/2/2019
8802B4,conference-call,100,50,4/2/2019
885758,legal-issues-defendant,100,22,4/2/2019
8B8656,partnership,100,61,4/2/2019
8C311A,partnership,100,61,4/2/2019
8D0EEA,executive-appointment,100,54,4/2/2019
8D5145,earnings,100,50,4/2/2019
901327,product-release,100,64,4/2/2019
901327,product-release,100,64,4/2/2019
92B625,conference-participant,100,50,4/2/2019
96F126,partnership,100,61,4/2/2019
9810C0,conference-call,100,50,4/2/2019
98CAED,earnings,100,50,4/2/2019
990AD0,conference-organizer,100,57,4/2/2019
99ACAD,product-release,100,64,4/2/2019
99ACAD,earnings,100,50,4/2/2019
9A02C4,business-contract,100,69,4/2/2019
9BB35A,conference-call,100,50,4/2/2019
9CA4C6,conference-call,100,50,4/2/2019
9D3360,conference-call,100,50,4/2/2019
9D5FA4,executive-appointment,100,54,4/2/2019
A16DEA,product-release,100,64,4/2/2019
A63387,product-release,100,64,4/2/2019
AD9F1D,conference-call,100,50,4/2/2019
AE79CD,conference-participant,100,50,4/2/2019
AFD1CA,facility-open,100,65,4/2/2019
AFEC35,earnings,100,50,4/2/2019
AFF7B4,conference-call,100,50,4/2/2019
B0FE08,unit-acquisition-acquirer,100,49,4/2/2019
B0FE08,acquisition-acquirer,100,49,4/2/2019
B0FE08,acquisition-acquirer,100,49,4/2/2019
B1DF3C,acquisition-acquirer,100,49,4/2/2019
B2D799,legal-issues-defendant,100,22,4/2/2019
B2D799,legal-issues-defendant,100,22,4/2/2019
B2DAF6,earnings,100,50,4/2/2019
B381D8,legal-issues-defendant,100,22,4/2/2019
B3ED62,conference-call,100,50,4/2/2019
B4703C,conference-call,100,50,4/2/2019
B4C673,business-contract,100,69,4/2/2019
B54A74,executive-appointment,100,54,4/2/2019
B614F8,earnings,100,50,4/2/2019
B7202A,executive-appointment,100,54,4/2/2019
B7EB38,earnings,100,50,4/2/2019
BDCC11,earnings,100,50,4/2/2019
BDF85E,same-store-sales-up,100,62,4/2/2019
BEB756,conference-call,100,50,4/2/2019
BF5959,revenue-up,100,69,4/2/2019
BFD0A7,executive-appointment,100,54,4/2/2019
C0200F,earnings,100,50,4/2/2019
C11C46,executive-appointment,100,54,4/2/2019
C16A8F,conference-call,100,50,4/2/2019
C5F463,business-contract,100,69,4/2/2019
C85A72,conference-participant,100,50,4/2/2019
C93C44,conference-participant,100,50,4/2/2019
C9E107,earnings,100,50,4/2/2019
CB7AB2,earnings,100,50,4/2/2019
CB88B3,earnings,100,50,4/2/2019
CC35BE,legal-issues-defendant,100,22,4/2/2019
CCB623,business-contract,100,69,4/2/2019
CD06A2,earnings,100,50,4/2/2019
CE8A7B,earnings,100,50,4/2/2019
CFF15D,executive-resignation,100,44,4/2/2019
D42DBA,earnings,100,50,4/2/2019
D501DC,conference-call,100,50,4/2/2019
D54E62,conference-call,100,50,4/2/2019
D5AF19,earnings,100,50,4/2/2019
D6489C,business-contract,100,69,4/2/2019
D6853F,conference-call,100,50,4/2/2019
DA9443,clinical-trials-start,100,64,4/2/2019
DC2B00,product-release,100,64,4/2/2019
DC2F77,earnings,100,50,4/2/2019
DC486E,business-contract,100,69,4/2/2019
DC5299,conference-call,100,50,4/2/2019
DD0F15,conference-participant,100,50,4/2/2019
DF532D,conference-call,100,50,4/2/2019
E12A6E,public-offering,100,43,4/2/2019
E22FDE,legal-issues-defendant,100,22,4/2/2019
E28D9C,joint-venture,100,62,4/2/2019
E2F130,partnership,100,61,4/2/2019
E30B34,executive-appointment,100,54,4/2/2019
E6BC2C,credit-extension-recipient,100,69,4/2/2019
E70531,investment-investor,100,55,4/2/2019
E71AE6,legal-issues-defendant,100,22,4/2/2019
EB61C4,conference-call,100,50,4/2/2019
ED79D9,product-release,100,64,4/2/2019
EDD234,reorganization-unit,100,53,4/2/2019
EDD234,reorganization,100,53,4/2/2019
EDF5CA,conference-call,100,50,4/2/2019
EEA734,conference-participant,100,50,4/2/2019
EF1AD9,conference-call,100,50,4/2/2019
EF5914,note-sale,100,52,4/2/2019
EF5BED,executive-resignation,100,44,4/2/2019
F0B335,conference-participant,100,50,4/2/2019
F0B877,conference-call,100,50,4/2/2019
F179ED,product-release,100,64,4/2/2019
F1CD47,earnings,100,50,4/2/2019
F1EB39,business-contract,100,69,4/2/2019
F3816D,conference-participant,100,50,4/2/2019
F4CDA3,unit-acquisition-acquirer,100,49,4/2/2019
F4E992,conference-call,100,50,4/2/2019
F6A392,earnings,100,50,4/2/2019
F6A392,earnings,100,50,4/2/2019
F702CA,executive-appointment,100,54,4/2/2019
F8DE55,legal-issues-defendant,100,22,4/2/2019
F90EE5,executive-appointment,100,54,4/2/2019
FA40E2,legal-issues-defendant,100,22,4/2/2019
FA40E2,legal-issues-defendant,100,22,4/2/2019
FACF19,earnings,100,50,4/2/2019
FB728F,reorganization-unit,100,53,4/2/2019
FD2565,clinical-trials,100,56,4/2/2019
FD4588,conference-call,100,50,4/2/2019
FEE4B0,earnings,100,50,4/2/2019
31025,earnings,100,50,4/3/2019
06C826,note-sale,100,52,4/3/2019
083F72,earnings,100,50,4/3/2019
0B57D7,conference-call,100,50,4/3/2019
0BF528,product-release,100,64,4/3/2019
0CADBC,dividend,100,50,4/3/2019
1348C9,conference-call,100,50,4/3/2019
135B09,conference-call,100,50,4/3/2019
1490F3,joint-venture,100,62,4/3/2019
190B91,partnership,100,61,4/3/2019
196D18,conference-participant,100,50,4/3/2019
197019,merger-regulatory-approval,100,81,4/3/2019
1AF7E2,revenue-guidance-up,100,83,4/3/2019
1D1B07,business-contract,100,69,4/3/2019
1F352C,earnings,100,50,4/3/2019
228D42,partnership,100,61,4/3/2019
251988,legal-issues-defendant,100,22,4/3/2019
251988,legal-issues-defendant,100,22,4/3/2019
275300,conference-call,100,50,4/3/2019
29A4CC,conference-call,100,50,4/3/2019
2AA6A8,partnership,100,61,4/3/2019
2AE625,conference-call,100,50,4/3/2019
2CA60F,product-release,100,64,4/3/2019
2D643C,conference-call,100,50,4/3/2019
2F5256,executive-appointment,100,54,4/3/2019
3159AA,facility-open,100,65,4/3/2019
3.30E+34,award,100,58,4/3/2019
349DA4,conference-participant,100,50,4/3/2019
34E9F9,dividend,100,50,4/3/2019
37727A,conference-call,100,50,4/3/2019
387375,partnership,100,61,4/3/2019
387375,partnership,100,61,4/3/2019
39FB23,product-price-raise,100,57,4/3/2019
3CCC90,executive-appointment,100,54,4/3/2019
4.03E+05,investment-investor,100,55,4/3/2019
415188,conference-call,100,50,4/3/2019
416C55,dividend,100,50,4/3/2019
4398A2,conference-participant,100,50,4/3/2019
43A060,legal-issues-defendant,100,22,4/3/2019
43A060,legal-issues-defendant,100,22,4/3/2019
444CC8,executive-appointment,100,54,4/3/2019
47752F,earnings,100,50,4/3/2019
479930,executive-appointment,100,54,4/3/2019
4885C8,earnings,100,50,4/3/2019
49A344,business-contract,100,69,4/3/2019
4A6F00,partnership,100,61,4/3/2019
4FCC78,conference-call,100,50,4/3/2019
51D876,earnings,100,50,4/3/2019
52015A,dividend,100,50,4/3/2019
550D01,conference-call,100,50,4/3/2019
57DDB9,business-contract,100,69,4/3/2019
5B226B,legal-issues-defendant,100,22,4/3/2019
5D1956,earnings,100,50,4/3/2019
5F3D91,legal-issues-defendant,100,22,4/3/2019
5F3D91,public-offering,100,43,4/3/2019
60FE03,conference-participant,100,50,4/3/2019
64E346,partnership,100,61,4/3/2019
6.52E+64,executive-appointment,100,54,4/3/2019
6.52E+64,executive-appointment,100,54,4/3/2019
6.52E+64,executive-appointment,100,54,4/3/2019
65CF8E,product-release,100,64,4/3/2019
665D7D,conference-call,100,50,4/3/2019
66A667,earnings,100,50,4/3/2019
66ECFD,dividend,100,50,4/3/2019
67B052,conference-participant,100,50,4/3/2019
6D156D,legal-issues-defendant,100,22,4/3/2019
6E7060,dividend,100,50,4/3/2019
719477,conference-call,100,50,4/3/2019
722DE3,acquisition-acquirer,100,49,4/3/2019
7.44E+09,conference-call,100,50,4/3/2019
752A70,earnings,100,50,4/3/2019
76DD0C,conference-participant,100,50,4/3/2019
76E80F,note-sale,100,52,4/3/2019
77B8E9,patent-awarded,100,72,4/3/2019
7A3633,earnings,100,50,4/3/2019
7AF907,conference-participant,100,50,4/3/2019
7FEEE1,conference-participant,100,50,4/3/2019
834152,conference-participant,100,50,4/3/2019
85DA04,executive-appointment,100,54,4/3/2019
86A1B9,product-release,100,64,4/3/2019
895D56,conference-participant,100,50,4/3/2019
8AC65D,conference-call,100,50,4/3/2019
8B1F37,executive-appointment,100,54,4/3/2019
8BE916,earnings,100,50,4/3/2019
8E10BF,conference-participant,100,50,4/3/2019
8E8E6E,executive-appointment,100,54,4/3/2019
9087B9,earnings,100,50,4/3/2019
9196A2,conference-call,100,50,4/3/2019
9368BE,conference-call,100,50,4/3/2019
949625,dividend,100,50,4/3/2019
94983E,acquisition-acquirer,100,49,4/3/2019
9507FF,ipo-pricing,100,50,4/3/2019
958938,public-offering,100,43,4/3/2019
990AD0,conference-organizer,100,57,4/3/2019
9CE4C7,earnings,100,50,4/3/2019
9CE4C7,executive-appointment,100,54,4/3/2019
9EED50,conference-call,100,50,4/3/2019
9F5997,business-contract,100,69,4/3/2019
9F6B1A,partnership,100,61,4/3/2019
9F6B1A,partnership,100,61,4/3/2019
A26EF7,conference-participant,100,50,4/3/2019
A8E2FE,executive-appointment,100,54,4/3/2019
AB7F05,earnings,100,50,4/3/2019
AD1ACF,partnership,100,61,4/3/2019
AE79CD,clinical-trials,100,56,4/3/2019
B04426,clinical-trials,100,56,4/3/2019
B2D799,legal-issues-defendant,100,22,4/3/2019
B840EF,earnings,100,50,4/3/2019
B96637,conference-call,100,50,4/3/2019
BA218A,conference-call,100,50,4/3/2019
BAAA60,conference-call,100,50,4/3/2019
BB0587,union-pact,100,61,4/3/2019
BB5271,partnership,100,61,4/3/2019
BB88B6,earnings,100,50,4/3/2019
BCC13E,conference-participant,100,50,4/3/2019
C037A8,conference-call,100,50,4/3/2019
C07E05,executive-resignation,100,44,4/3/2019
C3EE99,earnings,100,50,4/3/2019
C4F9C6,conference-participant,100,50,4/3/2019
C58D71,public-offering,100,43,4/3/2019
C5D2AE,earnings,100,50,4/3/2019
C5F463,partnership,100,61,4/3/2019
C5F463,partnership,100,61,4/3/2019
C659EB,conference-call,100,50,4/3/2019
C659EB,conference-call,100,50,4/3/2019
C74887,conference-participant,100,50,4/3/2019
C83B88,executive-appointment,100,54,4/3/2019
C8A248,reverse-stock-splits,100,51,4/3/2019
C8A248,reverse-stock-splits,100,51,4/3/2019
C941DC,earnings,100,50,4/3/2019
C951A2,earnings,100,50,4/3/2019
C9B932,business-contract,100,69,4/3/2019
CAD7D9,earnings,100,50,4/3/2019
CBFFDD,partnership,100,61,4/3/2019
CBFFDD,partnership,100,61,4/3/2019
CC35BE,legal-issues-defendant,100,22,4/3/2019
CDAA0E,acquisition-completed-acquirer,100,49,4/3/2019
CDAA0E,acquisition-completed-acquirer,100,49,4/3/2019
CDD75E,conference-participant,100,50,4/3/2019
CE5C6E,conference-participant,100,50,4/3/2019
D139BC,conference-call,100,50,4/3/2019
D33270,executive-appointment,100,54,4/3/2019
D437C3,earnings,100,50,4/3/2019
D77F7E,settlement,100,56,4/3/2019
D8760C,conference-call,100,50,4/3/2019
D8C09D,conference-call,100,50,4/3/2019
DA9443,conference-participant,100,50,4/3/2019
DB396B,conference-call,100,50,4/3/2019
DB7FA7,conference-call,100,50,4/3/2019
DF5F14,executive-appointment,100,54,4/3/2019
E12A6E,earnings,100,50,4/3/2019
E30B34,earnings-guidance,100,50,4/3/2019
E30B34,earnings-guidance,100,50,4/3/2019
E38906,conference-participant,100,50,4/3/2019
ECD263,executive-appointment,100,54,4/3/2019
ED5171,earnings,100,50,4/3/2019
EDF5CA,executive-appointment,100,54,4/3/2019
EF5BED,partnership,100,61,4/3/2019
F0B2B5,executive-appointment,100,54,4/3/2019
F5D059,dividend,100,50,4/3/2019
F80389,conference-call,100,50,4/3/2019
F8DE55,legal-issues-defendant,100,22,4/3/2019
FA36A4,conference-call,100,50,4/3/2019
FA840E,patient-enrollment-complete,100,64,4/3/2019
FC01C0,conference-participant,100,50,4/3/2019
FC4550,dividend,100,50,4/3/2019
FC9A88,conference-call,100,50,4/3/2019
FE609F,clinical-trials,100,56,4/3/2019
0157B1,partnership,100,61,4/4/2019
01D03F,clinical-trials,100,56,4/4/2019
03D5F9,product-release,100,64,4/4/2019
061A3B,earnings,100,50,4/4/2019
070B45,product-release,100,64,4/4/2019
07CA6A,executive-appointment,100,54,4/4/2019
07CA6A,executive-appointment,100,54,4/4/2019
07CA6A,conference-call,100,50,4/4/2019
07CA6A,conference-call,100,50,4/4/2019
98977,legal-issues-defendant,100,22,4/4/2019
0BC29E,earnings,100,50,4/4/2019
0BC853,earnings,100,50,4/4/2019
0C2A0D,partnership,100,61,4/4/2019
0CC62B,conference-call,100,50,4/4/2019
105D00,conference-call,100,50,4/4/2019
18D9FA,partnership,100,61,4/4/2019
1A5957,legal-issues-defendant,100,22,4/4/2019
1B9535,conference-call,100,50,4/4/2019
1D1B07,earnings,100,50,4/4/2019
1DEBBE,executive-appointment,100,54,4/4/2019
1F716B,partnership,100,61,4/4/2019
1F9D90,earnings,100,50,4/4/2019
1FAF22,conference-call,100,50,4/4/2019
21245F,product-release,100,64,4/4/2019
22C58E,earnings,100,50,4/4/2019
24A89A,fast-track-designation,100,81,4/4/2019
24A89A,fast-track-designation,100,81,4/4/2019
24FA23,clinical-trials,100,56,4/4/2019
251988,legal-issues-defendant,100,22,4/4/2019
272704,earnings,100,50,4/4/2019
284289,earnings-guidance,100,50,4/4/2019
29B702,executive-appointment,100,54,4/4/2019
2.90E+62,earnings,100,50,4/4/2019
2DC88B,legal-issues-defendant,100,22,4/4/2019
2F7474,acquisition-acquirer,100,49,4/4/2019
32CB22,conference-call,100,50,4/4/2019
32DCB3,patent-awarded,100,72,4/4/2019
353DBB,conference-call,100,50,4/4/2019
366A08,conference-call,100,50,4/4/2019
387375,earnings,100,50,4/4/2019
3B37F7,executive-appointment,100,54,4/4/2019
3DC887,earnings,100,50,4/4/2019
417BF9,earnings,100,50,4/4/2019
425BDC,conference-call,100,50,4/4/2019
43A74A,earnings,100,50,4/4/2019
4806CE,conference-call,100,50,4/4/2019
49914B,asset-sale,100,62,4/4/2019
49A344,award,100,58,4/4/2019
4A3438,conference-participant,100,50,4/4/2019
4A6F00,partnership,100,61,4/4/2019
4B3555,earnings,100,50,4/4/2019
4B49CF,dividend-up,100,81,4/4/2019
4D8313,conference-call,100,50,4/4/2019
4E7C1F,facility-open,100,65,4/4/2019
4E7C1F,facility-open,100,65,4/4/2019
50070E,earnings,100,50,4/4/2019
504FE2,conference-call,100,50,4/4/2019
51B442,index-listing,100,76,4/4/2019
59DB8C,partnership,100,61,4/4/2019
5A423F,earnings,100,50,4/4/2019
5AF08A,earnings,100,50,4/4/2019
5B226B,business-contract,100,69,4/4/2019
5EAA43,business-contract,100,69,4/4/2019
5F9CE3,earnings,100,50,4/4/2019
60DD84,conference-call,100,50,4/4/2019
61B81B,dividend,100,50,4/4/2019
6284B5,conference-call,100,50,4/4/2019
62B20A,conference-call,100,50,4/4/2019
665618,acquisition-completed-acquirer,100,49,4/4/2019
66667F,partnership,100,61,4/4/2019
68AB62,conference-call,100,50,4/4/2019
69E8E1,conference-call,100,50,4/4/2019
69E8E1,conference-call,100,50,4/4/2019
6E705B,award,100,58,4/4/2019
709AED,executive-resignation,100,44,4/4/2019
7.45E+28,public-offering,100,43,4/4/2019
747219,earnings,100,50,4/4/2019
762A3E,award,100,58,4/4/2019
762A3E,award,100,58,4/4/2019
76CEFB,earnings,100,50,4/4/2019
7771D7,earnings,100,50,4/4/2019
789ADD,earnings,100,50,4/4/2019
7CD98F,earnings-guidance,100,50,4/4/2019
7D7716,earnings,100,50,4/4/2019
7D97DE,conference-call,100,50,4/4/2019
7E2DE6,earnings,100,50,4/4/2019
804708,partnership,100,61,4/4/2019
838ADD,earnings,100,50,4/4/2019
83B1C8,clinical-trials,100,56,4/4/2019
873DB9,conference-call,100,50,4/4/2019
8876D6,partnership,100,61,4/4/2019
8876D6,partnership,100,61,4/4/2019
8876D6,partnership,100,61,4/4/2019
8A8E41,executive-appointment,100,54,4/4/2019
8AB85C,conference-participant,100,50,4/4/2019
8D4486,business-contract,100,69,4/4/2019
8DBBE6,conference-call,100,50,4/4/2019
8E82A6,earnings,100,50,4/4/2019
922F0C,earnings,100,50,4/4/2019
934029,conference-call,100,50,4/4/2019
93D207,earnings,100,50,4/4/2019
93F143,executive-appointment,100,54,4/4/2019
958938,public-offering,100,43,4/4/2019
967D92,conference-call,100,50,4/4/2019
97AAF6,partnership,100,61,4/4/2019
986AF6,conference-call,100,50,4/4/2019
9C5174,earnings,100,50,4/4/2019
9C8664,conference-call,100,50,4/4/2019
9E5C2C,conference-call,100,50,4/4/2019
A017F4,regulatory-product-approval-granted,100,81,4/4/2019
A017F4,clinical-trials,100,56,4/4/2019
A350C1,conference-call,100,50,4/4/2019
A398B9,earnings,100,50,4/4/2019
A4386C,earnings,100,50,4/4/2019
A6213D,revenue-up,100,54,4/4/2019
A746F6,conference-call,100,50,4/4/2019
A75D43,conference-call,100,50,4/4/2019
A868C9,partnership,100,61,4/4/2019
A87CD6,earnings,100,50,4/4/2019
A8CBDA,conference-call,100,50,4/4/2019
A99576,earnings-guidance,100,50,4/4/2019
A9ED24,conference-call,100,50,4/4/2019
ADD9DC,earnings,100,50,4/4/2019
B1B10C,conference-call,100,50,4/4/2019
B2256A,conference-call,100,50,4/4/2019
B2D799,legal-issues-defendant,100,22,4/4/2019
B446B8,earnings,100,50,4/4/2019
B560AF,business-contract,100,69,4/4/2019
B66928,earnings,100,50,4/4/2019
B7BBFF,dividend,100,50,4/4/2019
B8DD94,conference-call,100,50,4/4/2019
BB5271,conference-call,100,50,4/4/2019
BBF349,earnings,100,50,4/4/2019
BD8517,executive-appointment,100,54,4/4/2019
BE14CF,conference-call,100,50,4/4/2019
BF5959,market-entry,100,57,4/4/2019
C01737,conference-participant,100,50,4/4/2019
C4A241,index-listing,100,76,4/4/2019
C4C77F,product-release,100,64,4/4/2019
CB22CD,conference-call,100,50,4/4/2019
CB7AB2,award,100,58,4/4/2019
CE5664,earnings,100,50,4/4/2019
CE96E7,earnings,100,50,4/4/2019
D1173F,business-contract,100,69,4/4/2019
D1173F,executive-appointment,100,54,4/4/2019
D42DBA,partnership,100,61,4/4/2019
D90F43,partnership,100,61,4/4/2019
D90F43,partnership,100,61,4/4/2019
DB5CA5,partnership,100,61,4/4/2019
DB5CA5,earnings,100,50,4/4/2019
E22FDE,legal-issues-defendant,100,22,4/4/2019
E2F130,partnership,100,61,4/4/2019
E30A8F,earnings,100,50,4/4/2019
E35610,conference-call,100,50,4/4/2019
E94704,conference-call,100,50,4/4/2019
E959F3,earnings,100,50,4/4/2019
ED3CA8,conference-call,100,50,4/4/2019
ED9576,earnings,100,50,4/4/2019
EE6F1C,merger-regulatory-approval,100,81,4/4/2019
F02D0A,earnings,100,50,4/4/2019
F0EEFB,conference-participant,100,50,4/4/2019
F32F88,conference-call,100,50,4/4/2019
F4E882,earnings,100,50,4/4/2019
F5C78B,conference-call,100,50,4/4/2019
F5D059,earnings,100,50,4/4/2019
F5D059,earnings,100,50,4/4/2019
F5D059,earnings,100,50,4/4/2019
F5D059,earnings,100,50,4/4/2019
F5D059,earnings,100,50,4/4/2019
FA40E2,legal-issues-defendant,100,22,4/4/2019
FAB97A,earnings,100,50,4/4/2019
FD0CA4,conference-call,100,50,4/4/2019
FEC475,conference-call,100,50,4/4/2019
FF5413,earnings,100,50,4/4/2019
001F1B,revenues,100,50,4/5/2019
01D03F,clinical-trials,100,56,4/5/2019
0358AF,earnings,100,50,4/5/2019
04EB2F,board-meeting,100,51,4/5/2019
0A0D9E,conference-call,100,50,4/5/2019
0BC29E,executive-appointment,100,54,4/5/2019
0CE204,product-release,100,64,4/5/2019
147C38,earnings,100,50,4/5/2019
1748B3,conference-call,100,50,4/5/2019
1782D5,conference-call,100,50,4/5/2019
1A6A94,conference-call,100,50,4/5/2019
2B7A40,earnings,100,50,4/5/2019
2DB344,earnings,100,50,4/5/2019
2DC88B,legal-issues-defendant,100,22,4/5/2019
315EB0,conference-call,100,50,4/5/2019
3461CF,award,100,58,4/5/2019
34E9F9,conference-call,100,50,4/5/2019
36E479,conference-participant,100,50,4/5/2019
370C50,conference-call,100,50,4/5/2019
3B9886,executive-resignation,100,44,4/5/2019
43A060,legal-issues-defendant,100,22,4/5/2019
43A060,legal-issues-defendant,100,22,4/5/2019
4D8124,earnings,100,50,4/5/2019
4EC4C1,earnings,100,50,4/5/2019
4EC4C1,earnings,100,50,4/5/2019
4EC4C1,earnings,100,50,4/5/2019
4EC4C1,earnings,100,50,4/5/2019
564F3E,earnings,100,50,4/5/2019
5675EB,earnings,100,50,4/5/2019
5B6C11,earnings,100,50,4/5/2019
5C7601,executive-appointment,100,54,4/5/2019
639BD6,conference-call,100,50,4/5/2019
6D156D,legal-issues-defendant,100,22,4/5/2019
6D6B40,earnings,100,50,4/5/2019
6E705B,executive-appointment,100,54,4/5/2019
6F39FC,dividend,100,50,4/5/2019
7AB859,conference-call,100,50,4/5/2019
80D744,conference-call,100,50,4/5/2019
859281,earnings,100,50,4/5/2019
85CDC9,conference-participant,100,50,4/5/2019
88193E,award,100,58,4/5/2019
88350F,conference-call,100,50,4/5/2019
90D6A5,conference-call,100,50,4/5/2019
91C82E,facility-open,100,65,4/5/2019
92D757,executive-appointment,100,54,4/5/2019
9548BB,earnings,100,50,4/5/2019
977A1E,conference-call,100,50,4/5/2019
980C14,conference-call,100,50,4/5/2019
990AD0,dividend,100,50,4/5/2019
9ABD30,earnings,100,50,4/5/2019
9AF3DC,conference-call,100,50,4/5/2019
A072C4,executive-resignation,100,44,4/5/2019
A1EAC8,conference-call,100,50,4/5/2019
A41450,dividend,100,50,4/5/2019
A6213D,revenue-up,100,69,4/5/2019
AF210D,earnings,100,50,4/5/2019
AFDF2E,dividend,100,50,4/5/2019
B05118,product-release,100,64,4/5/2019
BB5142,conference-call,100,50,4/5/2019
BD15E8,conference-call,100,50,4/5/2019
C7863D,conference-call,100,50,4/5/2019
CC35BE,legal-issues-defendant,100,22,4/5/2019
CC6FF5,earnings,100,50,4/5/2019
CD06A2,award,100,58,4/5/2019
CFF97C,conference-call,100,50,4/5/2019
D0909F,earnings-guidance,100,50,4/5/2019
D3FA2C,conference-call,100,50,4/5/2019
D501DC,dividend,100,50,4/5/2019
E11C41,conference-call,100,50,4/5/2019
E3E68E,conference-call,100,50,4/5/2019
E829E8,conference-call,100,50,4/5/2019
E9E6FD,conference-call,100,50,4/5/2019
EBC84C,earnings,100,50,4/5/2019
EE6F1C,business-contract,100,69,4/5/2019
F294DD,earnings,100,50,4/5/2019
F6A945,earnings,100,50,4/5/2019
F6E248,regulatory-product-application,100,69,4/5/2019
F6E248,clinical-trials-filed,100,60,4/5/2019
F7902B,earnings,100,50,4/5/2019
FF5413,revenue-volume,100,50,4/5/2019
15B10D,partnership,100,61,4/6/2019
6F3936,product-release,100,64,4/6/2019
228D42,partnership,100,61,4/7/2019
4F9926,product-release,100,64,4/7/2019
4F9926,product-release,100,64,4/7/2019
4F9926,product-release,100,64,4/7/2019
BB5271,partnership,100,61,4/7/2019
DD9E41,product-release,100,64,4/7/2019
00067A,earnings,100,50,4/8/2019
01478A,conference-call,100,50,4/8/2019
0157B1,partnership,100,61,4/8/2019
0157B1,partnership,100,61,4/8/2019
048B70,conference-call,100,50,4/8/2019
05D148,business-contract,100,69,4/8/2019
06EE79,ipo,100,71,4/8/2019
078D52,dividend,100,50,4/8/2019
0919B1,conference-call,100,50,4/8/2019
0919B1,conference-call,100,50,4/8/2019
95294,business-contract,100,69,4/8/2019
0A7650,conference-call,100,50,4/8/2019
0CBC4D,earnings,100,50,4/8/2019
0F65C9,conference-call,100,50,4/8/2019
16FC89,earnings,100,50,4/8/2019
1AC649,executive-appointment,100,54,4/8/2019
1AC649,clinical-trials,100,56,4/8/2019
1BDB2A,conference-call,100,50,4/8/2019
1C599A,executive-appointment,100,54,4/8/2019
1DE526,conference-call,100,50,4/8/2019
1F08A6,conference-call,100,50,4/8/2019
1F08A6,conference-call,100,50,4/8/2019
1FE3CB,conference-call,100,50,4/8/2019
20BEEA,conference-call,100,50,4/8/2019
214051,executive-appointment,100,54,4/8/2019
228D42,partnership,100,61,4/8/2019
228D42,partnership,100,61,4/8/2019
250BEE,conference-call,100,50,4/8/2019
251988,partnership,100,61,4/8/2019
27C10F,executive-appointment,100,54,4/8/2019
295F9F,executive-appointment,100,54,4/8/2019
2C7505,partnership,100,61,4/8/2019
2C7505,partnership,100,61,4/8/2019
2D2D43,earnings,100,50,4/8/2019
2D485F,earnings,100,50,4/8/2019
2E902B,conference-call,100,50,4/8/2019
30DFD3,conference-call,100,50,4/8/2019
31643A,facility-open,100,65,4/8/2019
326EDD,conference-call,100,50,4/8/2019
367E1C,earnings,100,50,4/8/2019
371B0A,conference-call,100,50,4/8/2019
387541,conference-call,100,50,4/8/2019
39FB23,executive-appointment,100,54,4/8/2019
3AAEAE,executive-appointment,100,54,4/8/2019
3BB616,earnings,100,50,4/8/2019
3CCC90,executive-appointment,100,54,4/8/2019
3DD5E2,conference-call,100,50,4/8/2019
3DE4D1,conference-call,100,50,4/8/2019
4.00E+163,conference-call,100,50,4/8/2019
435ACE,conference-call,100,50,4/8/2019
45BC35,earnings-guidance,100,50,4/8/2019
467F2C,conference-call,100,50,4/8/2019
494EB9,earnings,100,50,4/8/2019
49A344,business-contract,100,69,4/8/2019
4A6F00,partnership,100,61,4/8/2019
4A6F00,acquisition-interest-acquiree,100,82,4/8/2019
5088A5,earnings,100,50,4/8/2019
52B567,ipo,100,71,4/8/2019
532D47,conference-call,100,50,4/8/2019
587D25,business-combination,100,54,4/8/2019
587D25,business-combination,100,54,4/8/2019
589803,partnership,100,61,4/8/2019
589803,partnership,100,61,4/8/2019
589803,earnings,100,50,4/8/2019
5BE42C,conference-call,100,50,4/8/2019
5C2A47,conference-call,100,50,4/8/2019
636931,conference-call,100,50,4/8/2019
63F892,partnership,100,61,4/8/2019
63F892,partnership,100,61,4/8/2019
6CB7F9,conference-call,100,50,4/8/2019
71E2EF,earnings,100,50,4/8/2019
7239BB,executive-appointment,100,54,4/8/2019
741937,earnings,100,50,4/8/2019
7.45E+28,public-offering,100,43,4/8/2019
773A17,executive-appointment,100,54,4/8/2019
7823A3,earnings,100,50,4/8/2019
79340A,earnings,100,50,4/8/2019
79340A,earnings,100,50,4/8/2019
7C790D,executive-appointment,100,54,4/8/2019
7DA412,award,100,58,4/8/2019
7F3669,earnings,100,50,4/8/2019
7F7C87,earnings-up,100,68,4/8/2019
81A88D,conference-call,100,50,4/8/2019
82B57E,executive-appointment,100,54,4/8/2019
8665BA,partnership,100,61,4/8/2019
8665BA,partnership,100,61,4/8/2019
877C0C,earnings,100,50,4/8/2019
881190,conference-call,100,50,4/8/2019
89FBB1,conference-call,100,50,4/8/2019
8A0368,product-release,100,64,4/8/2019
8B2C4A,conference-call,100,50,4/8/2019
8B9B3B,regulatory-product-approval-denied,100,21,4/8/2019
8BAA15,earnings,100,50,4/8/2019
8E9CD8,executive-appointment,100,54,4/8/2019
902670,conference-call,100,50,4/8/2019
915E7B,conference-call,100,50,4/8/2019
940C3D,partnership,100,61,4/8/2019
9507FF,ipo-completed,100,76,4/8/2019
958938,public-offering,100,43,4/8/2019
9C8BC3,conference-call,100,50,4/8/2019
9CE4C7,award,100,58,4/8/2019
9D65C1,earnings,100,50,4/8/2019
9F048E,earnings,100,50,4/8/2019
9F5997,business-contract,100,69,4/8/2019
A017F4,public-offering,100,43,4/8/2019
A247F5,partnership,100,61,4/8/2019
A26EF7,business-contract,100,69,4/8/2019
A47F2E,earnings,100,50,4/8/2019
A4A612,conference-call,100,50,4/8/2019
A6213D,dividend,100,50,4/8/2019
A63387,business-contract,100,69,4/8/2019
A6828A,executive-appointment,100,54,4/8/2019
A6828A,executive-appointment,100,54,4/8/2019
A6828A,business-contract,100,69,4/8/2019
A7CCF0,conference-call,100,50,4/8/2019
A94A7B,executive-appointment,100,54,4/8/2019
B05118,partnership,100,61,4/8/2019
B4703C,unit-acquisition-acquirer,100,49,4/8/2019
B4703C,dividend,100,50,4/8/2019
B83BCE,earnings,100,50,4/8/2019
B98EFA,conference-participant,100,50,4/8/2019
BB127B,partnership,100,61,4/8/2019
BBAE2A,acquisition-completed-acquirer,100,49,4/8/2019
BBAE2A,acquisition-completed-acquirer,100,49,4/8/2019
BBBB41,conference-call,100,50,4/8/2019
BF5959,executive-appointment,100,54,4/8/2019
C0F70B,earnings,100,50,4/8/2019
C4A241,conference-call,100,50,4/8/2019
C8A248,award,100,58,4/8/2019
C99CC8,partnership,100,61,4/8/2019
CD4DA8,conference-call,100,50,4/8/2019
CDE118,earnings,100,50,4/8/2019
D1173F,supply-guidance-unchanged,100,50,4/8/2019
D4AC65,product-release,100,64,4/8/2019
D518D8,conference-call,100,50,4/8/2019
D63B0F,conference-call,100,50,4/8/2019
D96202,facility-open,100,65,4/8/2019
E09E2B,partnership,100,61,4/8/2019
E22FDE,legal-issues-defendant,100,22,4/8/2019
E4CE73,product-release,100,64,4/8/2019
E5752F,executive-appointment,100,54,4/8/2019
E71AE6,executive-appointment,100,54,4/8/2019
E8A49A,earnings,100,50,4/8/2019
E8B315,earnings,100,50,4/8/2019
EBD89A,business-contract,100,69,4/8/2019
ED0402,earnings,100,50,4/8/2019
EDF5CA,executive-resignation,100,44,4/8/2019
EE6F1C,business-contract,100,69,4/8/2019
EE6F1C,business-contract,100,69,4/8/2019
EF5914,note-sale,100,52,4/8/2019
F5C78B,acquisition-completed-acquirer,100,49,4/8/2019
F5D410,partnership,100,61,4/8/2019
F5D410,partnership,100,61,4/8/2019
F85CC0,earnings,100,50,4/8/2019
FC1B7B,conference-call,100,50,4/8/2019
FD39EB,dividend,100,50,4/8/2019
FD39EB,earnings,100,50,4/8/2019
001F1B,operating-earnings,100,50,4/9/2019
00326E,product-release,100,64,4/9/2019
00326E,conference-call,100,50,4/9/2019
0157B1,product-release,100,64,4/9/2019
31025,partnership,100,61,4/9/2019
034B61,conference-participant,100,50,4/9/2019
036C6F,revenue-up,100,58,4/9/2019
03FAA6,earnings,100,50,4/9/2019
03FB17,earnings,100,50,4/9/2019
51332,earnings,100,50,4/9/2019
070B45,earnings,100,50,4/9/2019
71860,product-release,100,64,4/9/2019
099C88,business-contract,100,69,4/9/2019
09F623,conference-call,100,50,4/9/2019
0BF198,patent-awarded,100,72,4/9/2019
0BF198,patent-awarded,100,72,4/9/2019
0C6293,award,100,58,4/9/2019
0C6861,conference-call,100,50,4/9/2019
0C8D82,conference-call,100,50,4/9/2019
0E499E,acquisition-completed-acquirer,100,49,4/9/2019
0E499E,acquisition-completed-acquirer,100,49,4/9/2019
0EF1AF,executive-appointment,100,54,4/9/2019
0F0440,award,100,58,4/9/2019
0F04E5,earnings,100,50,4/9/2019
0F0693,business-contract,100,69,4/9/2019
0F0693,business-contract,100,69,4/9/2019
0FC848,executive-appointment,100,54,4/9/2019
129DC8,award,100,58,4/9/2019
12DE76,partnership,100,61,4/9/2019
15789A,award,100,58,4/9/2019
17EDA5,partnership,100,61,4/9/2019
1A2D9F,executive-appointment,100,54,4/9/2019
1A5957,executive-appointment,100,54,4/9/2019
1AB808,earnings,100,50,4/9/2019
1CDD1C,conference-call,100,50,4/9/2019
1DEBBE,executive-appointment,100,54,4/9/2019
1E04A5,product-release,100,64,4/9/2019
1E9A6D,earnings,100,50,4/9/2019
1F08A6,award,100,58,4/9/2019
21022F,earnings,100,50,4/9/2019
21245F,product-release,100,64,4/9/2019
221AD7,unit-acquisition-acquirer,100,49,4/9/2019
228D42,business-contract,100,69,4/9/2019
26F99F,public-offering,100,43,4/9/2019
2950FF,earnings,100,50,4/9/2019
2950FF,earnings,100,50,4/9/2019
2A6DBE,public-offering,100,43,4/9/2019
2B9DBB,conference-call,100,50,4/9/2019
2BF36E,conference-call,100,50,4/9/2019
2CB4C9,earnings,100,50,4/9/2019
2D76CE,revenues,100,50,4/9/2019
2DC88B,partnership,100,61,4/9/2019
2E0496,earnings,100,50,4/9/2019
2E61CC,dividend-up,100,81,4/9/2019
31643A,unit-acquisition-acquirer,100,49,4/9/2019
326EDD,award,100,58,4/9/2019
32DCB3,clinical-trials-complete,100,56,4/9/2019
33E8C7,earnings,100,50,4/9/2019
3A113F,conference-call,100,50,4/9/2019
3A3948,conference-call,100,50,4/9/2019
3BE00F,earnings,100,50,4/9/2019
3C3B6B,product-release,100,64,4/9/2019
3CCC90,business-contract,100,69,4/9/2019
3CCC90,executive-appointment,100,54,4/9/2019
44A4FC,earnings,100,50,4/9/2019
4591D3,conference-call,100,50,4/9/2019
490D4B,conference-call,100,50,4/9/2019
4.91E+58,award,100,58,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4A6F00,partnership,100,61,4/9/2019
4C6C63,earnings,100,50,4/9/2019
51D876,award,100,58,4/9/2019
525A1C,earnings,100,50,4/9/2019
55438C,legal-issues-defendant,100,22,4/9/2019
55438C,legal-issues-defendant,100,22,4/9/2019
583A75,conference-call,100,50,4/9/2019
589846,conference-organizer,100,57,4/9/2019
59872F,business-contract,100,69,4/9/2019
59872F,business-contract,100,69,4/9/2019
59B229,acquisition-acquirer,100,49,4/9/2019
59B229,acquisition-acquirer,100,49,4/9/2019
5B3415,conference-call,100,50,4/9/2019
5B35C7,earnings-up,100,68,4/9/2019
5B6C11,partnership,100,61,4/9/2019
5D63F1,earnings,100,50,4/9/2019
5EAA43,partnership,100,61,4/9/2019
6137BF,conference-call,100,50,4/9/2019
619882,conference-participant,100,50,4/9/2019
619882,conference-organizer,100,57,4/9/2019
6284B5,award,100,58,4/9/2019
6559D8,clinical-trials-start,100,64,4/9/2019
69CE71,partnership,100,61,4/9/2019
6B494E,dividend,100,50,4/9/2019
6BC6F9,executive-appointment,100,54,4/9/2019
6C4D2F,conference-call,100,50,4/9/2019
6.00E+19,business-contract,100,69,4/9/2019
72C2CE,conference-call,100,50,4/9/2019
76D79A,conference-call,100,50,4/9/2019
7B0BA6,earnings,100,50,4/9/2019
7B6EB1,earnings,100,50,4/9/2019
7B8CB5,executive-appointment,100,54,4/9/2019
7CBC40,campaign-ad-release,100,59,4/9/2019
7D5384,conference-call,100,50,4/9/2019
7DA412,earnings,100,50,4/9/2019
8.10E+32,award,100,58,4/9/2019
8295B8,ipo-pricing,100,50,4/9/2019
8303CD,conference-call,100,50,4/9/2019
85DE00,conference-call,100,50,4/9/2019
86478F,earnings,100,50,4/9/2019
880C0C,conference-call,100,50,4/9/2019
88923D,conference-call,100,50,4/9/2019
88923D,conference-call,100,50,4/9/2019
89B2E7,dividend,100,50,4/9/2019
8E93A4,conference-call,100,50,4/9/2019
8F8F2F,conference-call,100,50,4/9/2019
8FE7A5,earnings,100,50,4/9/2019
901327,partnership,100,61,4/9/2019
934CC3,award,100,58,4/9/2019
93633B,conference-call,100,50,4/9/2019
95C392,conference-call,100,50,4/9/2019
95DC1F,executive-appointment,100,54,4/9/2019
95F59E,earnings,100,50,4/9/2019
965360,earnings,100,50,4/9/2019
968966,partnership,100,61,4/9/2019
968B00,earnings,100,50,4/9/2019
96BFF4,asset-sale,100,62,4/9/2019
96F126,product-release,100,64,4/9/2019
9.74E+08,business-contract,100,69,4/9/2019
9.74E+08,business-contract,100,69,4/9/2019
9.74E+08,business-contract,100,69,4/9/2019
9.74E+08,business-contract,100,69,4/9/2019
990AD0,workforce-salary-increase,100,44,4/9/2019
990AD0,earnings,100,50,4/9/2019
9B71A7,conference-call,100,50,4/9/2019
9E575E,executive-appointment,100,54,4/9/2019
9EBAFA,dividend-up,100,81,4/9/2019
A017F4,public-offering,100,43,4/9/2019
A02FB1,conference-call,100,50,4/9/2019
A15C71,conference-call,100,50,4/9/2019
A58224,conference-call,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A5A4F5,earnings,100,50,4/9/2019
A63387,award,100,58,4/9/2019
A666C8,dividend,100,50,4/9/2019
A6828A,partnership,100,61,4/9/2019
A871B0,executive-appointment,100,54,4/9/2019
AA847A,conference-call,100,50,4/9/2019
AADE0B,acquisition-completed-acquirer,100,49,4/9/2019
AD23DE,partnership,100,61,4/9/2019
B05118,earnings,100,50,4/9/2019
B0FE08,conference-call,100,50,4/9/2019
B1DF3C,earnings,100,50,4/9/2019
B2D492,earnings,100,50,4/9/2019
B803B1,conference-call,100,50,4/9/2019
B934BF,conference-call,100,50,4/9/2019
BC948D,conference-call,100,50,4/9/2019
BCC55F,board-meeting,100,51,4/9/2019
C2E120,earnings,100,50,4/9/2019
CDE51C,earnings,100,50,4/9/2019
D17C1B,earnings,100,50,4/9/2019
D2B9E5,earnings,100,50,4/9/2019
D4070C,award,100,58,4/9/2019
D6144F,note-sale,100,52,4/9/2019
D6489C,award,100,58,4/9/2019
D70365,conference-call,100,50,4/9/2019
D7AC6E,earnings,100,50,4/9/2019
D9164D,earnings,100,50,4/9/2019
DBB28E,business-contract,100,69,4/9/2019
DBB28E,business-contract,100,69,4/9/2019
DBB28E,partnership,100,61,4/9/2019
DC0998,conference-call,100,50,4/9/2019
DC0998,product-release,100,64,4/9/2019
DC0D18,earnings,100,50,4/9/2019
DC1405,earnings,100,50,4/9/2019
DCD97F,conference-call,100,50,4/9/2019
DD0099,earnings,100,50,4/9/2019
DD682D,earnings,100,50,4/9/2019
DF01B1,conference-call,100,50,4/9/2019
E0D3BA,earnings,100,50,4/9/2019
E12A6E,dividend,100,50,4/9/2019
E2F130,earnings,100,50,4/9/2019
E4CE73,partnership,100,61,4/9/2019
E5D914,executive-appointment,100,54,4/9/2019
E6D89E,earnings,100,50,4/9/2019
E6E012,earnings,100,50,4/9/2019
E6E012,earnings,100,50,4/9/2019
E72599,ipo,100,71,4/9/2019
E87676,conference-call,100,50,4/9/2019
E8846E,acquisition-acquiree,100,76,4/9/2019
E8846E,acquisition-acquiree,100,76,4/9/2019
E8B315,conference-call,100,50,4/9/2019
EE967B,earnings,100,50,4/9/2019
F40EE2,award,100,58,4/9/2019
F4E992,revenue-up,100,69,4/9/2019
F4E992,earnings,100,50,4/9/2019
F50BAB,conference-call,100,50,4/9/2019
F6E248,product-release,100,64,4/9/2019
FDF28E,earnings,100,50,4/9/2019
FE609F,business-contract,100,69,4/9/2019
FE89E0,conference-call,100,50,4/9/2019
FEC475,executive-appointment,100,54,4/9/2019
FF4343,conference-call,100,50,4/9/2019
003B70,operating-earnings,100,50,4/10/2019
00D6B5,settlement,100,56,4/10/2019
00D6B5,acquisition-completed-acquirer,100,49,4/10/2019
07EC43,award,100,58,4/10/2019
099A92,conference-call,100,50,4/10/2019
0BA2EF,earnings,100,50,4/10/2019
0C6293,award,100,58,4/10/2019
0C6293,award,100,58,4/10/2019
0F0440,partnership,100,61,4/10/2019
0FDE97,conference-call,100,50,4/10/2019
11074E,conference-call,100,50,4/10/2019
12DE76,partnership,100,61,4/10/2019
14BA06,earnings,100,50,4/10/2019
16B183,conference-call,100,50,4/10/2019
1921DD,business-contract,100,69,4/10/2019
1B4F31,earnings,100,50,4/10/2019
1DA44F,conference-call,100,50,4/10/2019
1F19C8,conference-call,100,50,4/10/2019
21DED4,conference-call,100,50,4/10/2019
221445,dividend,100,50,4/10/2019
2.45E+15,earnings,100,50,4/10/2019
25A6CC,earnings,100,50,4/10/2019
29A4CC,business-contract,100,69,4/10/2019
29B702,earnings,100,50,4/10/2019
29CEBF,conference-call,100,50,4/10/2019
2A17B1,conference-call,100,50,4/10/2019
2D2D43,award,100,58,4/10/2019
2EB04E,earnings,100,50,4/10/2019
309922,conference-call,100,50,4/10/2019
31666F,dividend,100,50,4/10/2019
371C01,conference-call,100,50,4/10/2019
3A3447,facility-open,100,65,4/10/2019
3A3948,partnership,100,61,4/10/2019
3A3948,partnership,100,61,4/10/2019
3A3948,partnership,100,61,4/10/2019
3BCF24,earnings,100,50,4/10/2019
3CBA2A,conference-call,100,50,4/10/2019
3EE65E,product-release,100,64,4/10/2019
3F868D,conference-call,100,50,4/10/2019
416C55,earnings,100,50,4/10/2019
44209A,earnings,100,50,4/10/2019
450ECB,earnings,100,50,4/10/2019
4A5C8D,conference-call,100,50,4/10/2019
4A6F00,award,100,58,4/10/2019
4A6F00,partnership,100,61,4/10/2019
4A6F00,partnership,100,61,4/10/2019
4A6F00,partnership,100,61,4/10/2019
4A6F00,partnership,100,61,4/10/2019
4A6F00,partnership,100,61,4/10/2019
4A6F00,partnership,100,61,4/10/2019
4A6F00,product-release,100,64,4/10/2019
4B3DC9,conference-call,100,50,4/10/2019
4B6EF9,earnings,100,50,4/10/2019
4BBA23,conference-call,100,50,4/10/2019
4D971D,conference-call,100,50,4/10/2019
50D1EC,executive-appointment,100,54,4/10/2019
51527B,conference-call,100,50,4/10/2019
51888A,buybacks,100,74,4/10/2019
5487B1,conference-call,100,50,4/10/2019
55438C,legal-issues-defendant,100,22,4/10/2019
55438C,legal-issues-defendant,100,22,4/10/2019
55438C,legal-issues-defendant,100,22,4/10/2019
55438C,legal-issues-defendant,100,22,4/10/2019
57A854,acquisition-acquirer,100,49,4/10/2019
57A854,unit-acquisition-acquirer,100,49,4/10/2019
57A854,public-offering,100,43,4/10/2019
5B97B2,earnings,100,50,4/10/2019
5D0337,earnings,100,50,4/10/2019
5F2FF7,earnings-positive,100,69,4/10/2019
662682,conference-call,100,50,4/10/2019
66749D,earnings,100,50,4/10/2019
66ECFD,product-release,100,64,4/10/2019
6E705B,award,100,58,4/10/2019
6ED519,conference-call,100,50,4/10/2019
713810,campaign-ad-release,100,59,4/10/2019
7255D2,partnership,100,61,4/10/2019
728737,dividend,100,50,4/10/2019
73BCBA,conference-call,100,50,4/10/2019
73C9E2,conference-call,100,50,4/10/2019
7.40E+289,earnings,100,50,4/10/2019
7.40E+289,earnings,100,50,4/10/2019
7.40E+289,earnings,100,50,4/10/2019
7.40E+289,earnings,100,50,4/10/2019
75F982,revenue-up,100,66,4/10/2019
767F86,earnings,100,50,4/10/2019
767F86,dividend,100,50,4/10/2019
767F86,dividend,100,50,4/10/2019
76B926,business-contract,100,69,4/10/2019
78F9ED,conference-call,100,50,4/10/2019
791D59,earnings,100,50,4/10/2019
7A5097,dividend,100,50,4/10/2019
7AB859,partnership,100,61,4/10/2019
7AC86E,earnings-guidance,100,50,4/10/2019
7E62B5,conference-call,100,50,4/10/2019
804708,executive-appointment,100,54,4/10/2019
8303CD,award,100,58,4/10/2019
85DA04,executive-appointment,100,54,4/10/2019
86A1B9,facility-open,100,65,4/10/2019
88611B,earnings,100,50,4/10/2019
88923D,award,100,58,4/10/2019
88923D,award,100,58,4/10/2019
8B3B0E,conference-call,100,50,4/10/2019
8B6E7E,award,100,58,4/10/2019
8B6E7E,award,100,58,4/10/2019
8B9B3B,legal-issues-defendant,100,22,4/10/2019
8B9B3B,legal-issues-defendant,100,22,4/10/2019
8C311A,earnings-guidance-up,100,83,4/10/2019
8E82A6,business-contract,100,69,4/10/2019
8E8E6E,note-sale,100,52,4/10/2019
8E9CD8,earnings,100,50,4/10/2019
91C82E,dividend,100,50,4/10/2019
92D3A0,dividend,100,50,4/10/2019
945DE6,dividend,100,50,4/10/2019
968966,partnership,100,61,4/10/2019
980C14,dividend,100,50,4/10/2019
9934AD,conference-call,100,50,4/10/2019
9B71A7,earnings,100,50,4/10/2019
9B71A7,earnings,100,50,4/10/2019
9B71A7,earnings,100,50,4/10/2019
9C5BA5,conference-call,100,50,4/10/2019
9CF9B1,earnings,100,50,4/10/2019
9FF5F1,earnings,100,50,4/10/2019
A1A317,conference-call,100,50,4/10/2019
A3AAA5,dividend,100,50,4/10/2019
A72FD9,earnings,100,50,4/10/2019
A74F6F,conference-call,100,50,4/10/2019
AA1EAA,conference-call,100,50,4/10/2019
AC642C,executive-appointment,100,54,4/10/2019
AC642C,executive-appointment,100,54,4/10/2019
AD23DE,executive-appointment,100,54,4/10/2019
AE4125,conference-call,100,50,4/10/2019
AFEC35,public-offering,100,43,4/10/2019
B54A74,earnings,100,50,4/10/2019
B8EF97,revenues,100,50,4/10/2019
BB58FF,conference-organizer,100,57,4/10/2019
BFCACF,conference-call,100,50,4/10/2019
C230FE,earnings,100,50,4/10/2019
C41C25,earnings,100,50,4/10/2019
C4706C,dividend,100,50,4/10/2019
C4C77F,dividend,100,50,4/10/2019
C5C0E9,earnings,100,50,4/10/2019
C65004,earnings,100,50,4/10/2019
C6C702,conference-call,100,50,4/10/2019
C7AE14,conference-call,100,50,4/10/2019
C99CC8,executive-resignation,100,44,4/10/2019
C9B932,earnings,100,50,4/10/2019
CD051C,conference-call,100,50,4/10/2019
CE4FD9,award,100,58,4/10/2019
CE96E7,product-release,100,64,4/10/2019
D06755,earnings,100,50,4/10/2019
D11C1C,public-offering,100,43,4/10/2019
D17C1B,revenue-volume,100,50,4/10/2019
D17F7E,earnings,100,50,4/10/2019
D1AE3B,executive-appointment,100,54,4/10/2019
D56E4C,conference-call,100,50,4/10/2019
D58A11,earnings,100,50,4/10/2019
D6EAA3,product-release,100,64,4/10/2019
D721C6,facility-open,100,65,4/10/2019
D7A953,earnings,100,50,4/10/2019
D9FC89,earnings-revision,100,29,4/10/2019
DB06B0,partnership,100,61,4/10/2019
DDC415,earnings,100,50,4/10/2019
DF6FDD,earnings,100,50,4/10/2019
E0207A,earnings,100,50,4/10/2019
E1E36F,earnings,100,50,4/10/2019
E21871,ownership-decrease-owner,100,46,4/10/2019
E21871,stake-acquiree,100,62,4/10/2019
E22FDE,fraud-defendant,100,20,4/10/2019
E8846E,legal-issues-defendant,100,22,4/10/2019
EDD234,conference-call,100,50,4/10/2019
F0027C,clinical-trials-start,100,64,4/10/2019
F209B4,legal-issues-defendant,100,22,4/10/2019
F30508,conference-call,100,50,4/10/2019
F46EC9,earnings,100,50,4/10/2019
F72E4B,executive-resignation,100,44,4/10/2019
F88A04,earnings,100,50,4/10/2019
FA36A4,acquisition-completed-acquirer,100,49,4/10/2019
FBD92D,buybacks,100,74,4/10/2019
0157B1,conference-call,100,50,4/11/2019
20751,regulatory-product-approval-granted,100,81,4/11/2019
083F72,award,100,58,4/11/2019
0E5223,conference-call,100,50,4/11/2019
1272B3,earnings,100,50,4/11/2019
1348C9,dividend,100,50,4/11/2019
152B9E,conference-call,100,50,4/11/2019
1A6A94,award,100,58,4/11/2019
1AC649,executive-appointment,100,54,4/11/2019
1BC12C,product-release,100,64,4/11/2019
1CD4B5,executive-appointment,100,54,4/11/2019
1DEBBE,award,100,58,4/11/2019
221445,conference-call,100,50,4/11/2019
221783,earnings,100,50,4/11/2019
238302,conference-call,100,50,4/11/2019
24FA23,clinical-trials,100,56,4/11/2019
25DD05,conference-call,100,50,4/11/2019
279916,partnership,100,61,4/11/2019
2ABF77,clinical-trials,100,56,4/11/2019
2BA977,conference-call,100,50,4/11/2019
2D643C,facility-open,100,65,4/11/2019
2DA92D,earnings,100,50,4/11/2019
2E2E6E,buybacks,100,74,4/11/2019
2F1299,partnership,100,61,4/11/2019
30DFD3,conference-call,100,50,4/11/2019
31643A,facility-open,100,65,4/11/2019
34A959,earnings,100,50,4/11/2019
35F4B5,conference-call,100,50,4/11/2019
367434,public-offering,100,43,4/11/2019
3798B9,earnings,100,50,4/11/2019
3A113F,product-release,100,64,4/11/2019
3BC360,conference-call,100,50,4/11/2019
3CCC90,business-contract,100,69,4/11/2019
3E149C,facility-sale,100,52,4/11/2019
4.03E+05,partnership,100,61,4/11/2019
423279,earnings-per-share-positive,100,69,4/11/2019
434F38,earnings,100,50,4/11/2019
43A060,legal-issues-defendant,100,22,4/11/2019
43A060,legal-issues-defendant,100,22,4/11/2019
43A060,legal-issues-defendant,100,22,4/11/2019
44A4FC,facility-open,100,65,4/11/2019
458D2C,revenue-volume,100,50,4/11/2019
46017C,conference-call,100,50,4/11/2019
468DD4,executive-appointment,100,54,4/11/2019
479930,earnings,100,50,4/11/2019
48F795,earnings,100,50,4/11/2019
4.91E+58,conference-call,100,50,4/11/2019
4A5C8D,stock-gain,100,63,4/11/2019
4A5C8D,stock-gain,100,63,4/11/2019
4A6F00,partnership,100,61,4/11/2019
4C1FA1,earnings,100,50,4/11/2019
4E5784,earnings,100,50,4/11/2019
4EE167,earnings,100,50,4/11/2019
50070E,award,100,58,4/11/2019
51D876,partnership,100,61,4/11/2019
56765E,earnings,100,50,4/11/2019
567F3D,dividend,100,50,4/11/2019
56B7C1,conference-call,100,50,4/11/2019
57A854,public-offering,100,43,4/11/2019
57F3DA,earnings,100,50,4/11/2019
5C2A47,award,100,58,4/11/2019
5D16CF,conference-call,100,50,4/11/2019
5D63F1,award,100,58,4/11/2019
5F1B7B,executive-resignation,100,44,4/11/2019
5F3D91,legal-issues-defendant,100,22,4/11/2019
5F9CE3,partnership,100,61,4/11/2019
605F40,conference-call,100,50,4/11/2019
62CDDE,conference-call,100,50,4/11/2019
64FF65,conference-call,100,50,4/11/2019
665618,conference-call,100,50,4/11/2019
66667F,business-contract,100,69,4/11/2019
698FF9,earnings-guidance,100,50,4/11/2019
69CE71,government-contract,100,69,4/11/2019
6CC55E,earnings,100,50,4/11/2019
6D0CAB,operating-earnings,100,50,4/11/2019
6DC1D7,conference-call,100,50,4/11/2019
72FCA3,award,100,58,4/11/2019
72FCA3,dividend,100,50,4/11/2019
73A71F,conference-call,100,50,4/11/2019
762A3E,conference-call,100,50,4/11/2019
7710F3,earnings,100,50,4/11/2019
771985,revenues,100,50,4/11/2019
7740DE,same-store-sales-down,100,43,4/11/2019
7A10FF,earnings,100,50,4/11/2019
7B9212,revenues,100,50,4/11/2019
7BAAE7,earnings,100,50,4/11/2019
7F3A5F,earnings,100,50,4/11/2019
8295B8,ipo-completed,100,76,4/11/2019
837C04,conference-call,100,50,4/11/2019
86A1B9,earnings,100,50,4/11/2019
895D56,partnership,100,61,4/11/2019
896771,earnings,100,50,4/11/2019
89F693,earnings,100,50,4/11/2019
89FBB1,dividend,100,50,4/11/2019
8C6C1B,executive-resignation,100,44,4/11/2019
8DBE73,conference-call,100,50,4/11/2019
8DE74B,conference-call,100,50,4/11/2019
900356,conference-call,100,50,4/11/2019
9043FE,earnings,100,50,4/11/2019
9043FE,earnings,100,50,4/11/2019
92D3A0,earnings,100,50,4/11/2019
94637C,award,100,58,4/11/2019
9470CC,executive-appointment,100,54,4/11/2019
96F126,award,100,58,4/11/2019
971F7B,earnings,100,50,4/11/2019
9.74E+08,earnings,100,50,4/11/2019
9A02C4,conference-call,100,50,4/11/2019
9B71A7,earnings,100,50,4/11/2019
9D30A8,earnings,100,50,4/11/2019
9D5D35,earnings,100,50,4/11/2019
9F03CF,executive-appointment,100,54,4/11/2019
A495F7,earnings,100,50,4/11/2019
A5151E,earnings,100,50,4/11/2019
A6213D,earnings,100,50,4/11/2019
A6828A,clinical-trials,100,56,4/11/2019
A70BF5,product-release,100,64,4/11/2019
AA5C8E,earnings,100,50,4/11/2019
AADE0B,conference-call,100,50,4/11/2019
ADD9DC,facility-open,100,65,4/11/2019
B13B68,conference-call,100,50,4/11/2019
B4B281,business-contract,100,69,4/11/2019
BB0587,conference-call,100,50,4/11/2019
BC5680,earnings,100,50,4/11/2019
BF79F5,conference-call,100,50,4/11/2019
C062D4,conference-call,100,50,4/11/2019
C4A241,facility-open,100,65,4/11/2019
C66A8C,earnings,100,50,4/11/2019
C8257F,conference-call,100,50,4/11/2019
C8A248,dividend,100,50,4/11/2019
CA1620,conference-call,100,50,4/11/2019
CA212F,earnings,100,50,4/11/2019
CA3CB9,conference-call,100,50,4/11/2019
CAC8D0,earnings,100,50,4/11/2019
CF6A5A,earnings,100,50,4/11/2019
CFF97C,partnership,100,61,4/11/2019
D1173F,earnings,100,50,4/11/2019
D1C26F,conference-participant,100,50,4/11/2019
D598E7,conference-call,100,50,4/11/2019
D64EDF,earnings,100,50,4/11/2019
D65A13,conference-call,100,50,4/11/2019
D8DA3D,conference-call,100,50,4/11/2019
DC6AA0,earnings,100,50,4/11/2019
DD3BB1,earnings,100,50,4/11/2019
DD7A96,conference-call,100,50,4/11/2019
DF204B,facility-open,100,65,4/11/2019
DF532D,partnership,100,61,4/11/2019
DF532D,partnership,100,61,4/11/2019
E05DC8,earnings,100,50,4/11/2019
E16133,conference-call,100,50,4/11/2019
E22FDE,legal-issues-defendant,100,22,4/11/2019
E22FDE,legal-issues-defendant,100,22,4/11/2019
E38906,stake-acquiree,100,62,4/11/2019
E74B55,conference-call,100,50,4/11/2019
E8C557,stake-acquirer,100,48,4/11/2019
E90C84,conference-call,100,50,4/11/2019
EB6965,conference-call,100,50,4/11/2019
ECDEB2,earnings-positive,100,69,4/11/2019
ED0D7C,conference-call,100,50,4/11/2019
EF77A3,earnings,100,50,4/11/2019
F51DB0,conference-call,100,50,4/11/2019
F721A7,earnings,100,50,4/11/2019
F721A7,earnings,100,50,4/11/2019
F7ADEB,conference-call,100,50,4/11/2019
FA918D,conference-call,100,50,4/11/2019
FB728F,conference-call,100,50,4/11/2019
FD4BBE,earnings,100,50,4/11/2019
FFA9B9,executive-appointment,100,54,4/11/2019
FFE543,earnings,100,50,4/11/2019
71860,earnings,100,50,4/12/2019
083F72,conference-call,100,50,4/12/2019
0BD4E8,conference-call,100,50,4/12/2019
0C4131,conference-call,100,50,4/12/2019
0D26E0,dividend,100,50,4/12/2019
12E454,executive-appointment,100,54,4/12/2019
14BA33,business-contract,100,69,4/12/2019
15A388,ipo-considered,100,60,4/12/2019
18D9FA,partnership,100,61,4/12/2019
1A5957,legal-issues-defendant,100,22,4/12/2019
1AF7E2,conference-call,100,50,4/12/2019
1AF7E2,index-listing,100,76,4/12/2019
1D9E55,partnership,100,61,4/12/2019
1D9E55,earnings,100,50,4/12/2019
1E9A6D,fundraising,100,64,4/12/2019
21268E,conference-call,100,50,4/12/2019
214051,business-contract,100,69,4/12/2019
26F99F,public-offering,100,43,4/12/2019
28DCF3,earnings,100,50,4/12/2019
2A9C0A,conference-call,100,50,4/12/2019
2C7505,clinical-trials-positive,100,87,4/12/2019
2D2D43,unit-acquisition-acquirer,100,49,4/12/2019
2EBA55,dividend,100,50,4/12/2019
31DB20,dividend,100,50,4/12/2019
367434,public-offering,100,43,4/12/2019
3696BF,conference-call,100,50,4/12/2019
417BF9,public-offering,100,43,4/12/2019
435ACE,legal-issues-defendant,100,22,4/12/2019
458D2C,earnings-guidance,100,50,4/12/2019
4649D5,conference-call,100,50,4/12/2019
4FB770,conference-call,100,50,4/12/2019
5225A4,conference-organizer,100,57,4/12/2019
52D936,partnership,100,61,4/12/2019
52D936,business-contract,100,69,4/12/2019
543900,business-contract,100,69,4/12/2019
55438C,legal-issues-defendant,100,22,4/12/2019
562853,conference-call,100,50,4/12/2019
5704AC,earnings,100,50,4/12/2019
57CAAB,earnings,100,50,4/12/2019
57F3DA,award,100,58,4/12/2019
59872F,legal-issues-defendant,100,22,4/12/2019
5B6C11,dividend,100,50,4/12/2019
5B7739,conference-call,100,50,4/12/2019
619882,earnings,100,50,4/12/2019
61B81B,earnings-positive,100,69,4/12/2019
61B81B,earnings-positive,100,69,4/12/2019
61B81B,earnings-positive,100,69,4/12/2019
61B81B,earnings-positive,100,69,4/12/2019
61B81B,earnings-positive,100,69,4/12/2019
61B81B,earnings-positive,100,69,4/12/2019
64636E,business-contract,100,69,4/12/2019
64636E,business-contract,100,69,4/12/2019
6B236C,conference-call,100,50,4/12/2019
6CDFC6,conference-call,100,50,4/12/2019
6D3B7B,earnings,100,50,4/12/2019
6F0096,conference-call,100,50,4/12/2019
6F0A63,conference-call,100,50,4/12/2019
726DDF,conference-call,100,50,4/12/2019
75F665,acquisition-completed-acquirer,100,49,4/12/2019
762B8D,dividend,100,50,4/12/2019
767F86,executive-appointment,100,54,4/12/2019
7ACFD4,partnership,100,61,4/12/2019
7D7716,award,100,58,4/12/2019
7F7C87,buybacks,100,74,4/12/2019
855DF7,conference-call,100,50,4/12/2019
8B9B3B,legal-issues-defendant,100,22,4/12/2019
8B9B3B,legal-issues-defendant,100,22,4/12/2019
8D4AE6,earnings,100,50,4/12/2019
93F143,earnings,100,50,4/12/2019
94637C,clinical-trials,100,56,4/12/2019
94637C,acquisition-acquirer,100,49,4/12/2019
9470CC,earnings,100,50,4/12/2019
97AF94,dividend,100,50,4/12/2019
990AD0,conference-organizer,100,57,4/12/2019
A16DEA,earnings,100,50,4/12/2019
A1EAC8,business-contract,100,69,4/12/2019
A5A4F5,acquisition-acquirer,100,49,4/12/2019
A6828A,regulatory-product-approval-granted,100,81,4/12/2019
A8CBDA,partnership,100,61,4/12/2019
A94718,conference-call,100,50,4/12/2019
B53C12,conference-call,100,50,4/12/2019
B5BA39,earnings,100,50,4/12/2019
B7BDA3,conference-call,100,50,4/12/2019
B9764A,earnings,100,50,4/12/2019
C7859D,earnings-up,100,68,4/12/2019
C7859D,earnings,100,50,4/12/2019
C7859D,earnings,100,50,4/12/2019
C7859D,earnings,100,50,4/12/2019
C7859D,earnings,100,50,4/12/2019
C99CC8,business-contract,100,69,4/12/2019
C9D866,ownership-decrease-owner,100,46,4/12/2019
D1C0B9,earnings,100,50,4/12/2019
D54E62,acquisition-acquirer,100,49,4/12/2019
D54E62,acquisition-acquirer,100,49,4/12/2019
D77F7E,earnings,100,50,4/12/2019
D7918D,earnings,100,50,4/12/2019
D90F43,ipo,100,71,4/12/2019
DB23C8,conference-participant,100,50,4/12/2019
DDCB34,executive-appointment,100,54,4/12/2019
E22FDE,legal-issues-defendant,100,22,4/12/2019
E22FDE,legal-issues-defendant,100,22,4/12/2019
E22FDE,legal-issues-defendant,100,22,4/12/2019
E22FDE,legal-issues-defendant,100,22,4/12/2019
E26FC3,partnership,100,61,4/12/2019
E4158B,earnings,100,50,4/12/2019
E592F0,earnings,100,50,4/12/2019
E8846E,earnings-positive,100,69,4/12/2019
E9C7C0,partnership,100,61,4/12/2019
EEEA9F,earnings,100,50,4/12/2019
EF7163,conference-call,100,50,4/12/2019
F0B2B5,award,100,58,4/12/2019
F11638,partnership,100,61,4/12/2019
F3FCC3,conference-call,100,50,4/12/2019
F8084B,earnings,100,50,4/12/2019
F83279,earnings,100,50,4/12/2019
F8BDCE,earnings,100,50,4/12/2019
F8BDCE,earnings,100,50,4/12/2019
F8DE55,legal-issues-defendant,100,22,4/12/2019
F93C8A,dividend,100,50,4/12/2019
FAAFA2,clinical-trials-start,100,64,4/12/2019
FC1B7B,earnings,100,50,4/12/2019
11A49E,clinical-trials,100,56,4/13/2019
43A060,legal-issues-defendant,100,22,4/13/2019
8B9B3B,legal-issues-defendant,100,22,4/13/2019
A47A7D,legal-issues-defendant,100,22,4/14/2019
002A99,orphan-drug-designation,100,76,4/15/2019
00D6B5,conference-call,100,50,4/15/2019
0142B5,conference-call,100,50,4/15/2019
03B8CF,partnership,100,61,4/15/2019
04996E,earnings,100,50,4/15/2019
98977,legal-issues-defendant,100,22,4/15/2019
0CC01F,earnings,100,50,4/15/2019
0DC050,earnings,100,50,4/15/2019
0FDE97,award,100,58,4/15/2019
10100E,regulatory-product-approval-granted,100,81,4/15/2019
1065BC,conference-call,100,50,4/15/2019
125212,patient-enrollment-complete,100,64,4/15/2019
147C38,executive-appointment,100,54,4/15/2019
147C38,dividend-up,100,81,4/15/2019
14833D,conference-participant,100,50,4/15/2019
165B86,business-contract,100,69,4/15/2019
190B91,earnings,100,50,4/15/2019
190BE6,partnership,100,61,4/15/2019
1EBF8D,partnership,100,61,4/15/2019
1F19C8,fundraising,100,64,4/15/2019
2158DF,earnings,100,50,4/15/2019
251988,legal-issues-defendant,100,22,4/15/2019
26F31D,executive-appointment,100,54,4/15/2019
26F31D,executive-appointment,100,54,4/15/2019
272704,earnings-up,100,59,4/15/2019
2BBE62,earnings,100,50,4/15/2019
2C35B5,executive-appointment,100,54,4/15/2019
2EC172,business-contract,100,69,4/15/2019
32DCB3,clinical-trials,100,56,4/15/2019
338544,executive-appointment,100,54,4/15/2019
338544,business-contract,100,69,4/15/2019
341759,clinical-trials,100,56,4/15/2019
3461CF,partnership,100,61,4/15/2019
3461CF,stake-acquirer,100,48,4/15/2019
36C09B,orphan-drug-designation,100,76,4/15/2019
370C50,analyst-ratings-change-positive,100,78,4/15/2019
383ADA,unit-acquisition-acquirer,100,49,4/15/2019
387541,dividend,100,50,4/15/2019
3ACF46,executive-appointment,100,54,4/15/2019
3B20AB,dividend,100,50,4/15/2019
3CBA2A,partnership,100,61,4/15/2019
3DB18B,earnings,100,50,4/15/2019
416291,dividend,100,50,4/15/2019
429BFB,conference-call,100,50,4/15/2019
43A060,legal-issues-defendant,100,22,4/15/2019
4455C4,conference-call,100,50,4/15/2019
44A4FC,acquisition-acquirer,100,49,4/15/2019
44A4FC,acquisition-acquirer,100,49,4/15/2019
44ED36,dividend,100,50,4/15/2019
45444E,earnings,100,50,4/15/2019
4BEB48,earnings,100,50,4/15/2019
4F783B,public-offering,100,43,4/15/2019
51D876,executive-appointment,100,54,4/15/2019
54DF47,conference-call,100,50,4/15/2019
55438C,stock-loss,100,40,4/15/2019
55438C,legal-issues-defendant,100,22,4/15/2019
5546DA,conference-call,100,50,4/15/2019
58CA9A,earnings,100,50,4/15/2019
59DB8C,partnership,100,61,4/15/2019
5B35C7,executive-appointment,100,54,4/15/2019
5FE4B6,conference-call,100,50,4/15/2019
6166D1,executive-appointment,100,54,4/15/2019
616E3B,acquisition-acquirer,100,49,4/15/2019
616E3B,acquisition-acquirer,100,49,4/15/2019
619882,conference-participant,100,50,4/15/2019
619882,dividend,100,50,4/15/2019
619882,conference-organizer,100,57,4/15/2019
61A586,earnings,100,50,4/15/2019
62EFEE,earnings,100,50,4/15/2019
65CF8E,conference-call,100,50,4/15/2019
6634D9,note-sale,100,52,4/15/2019
68B03F,earnings,100,50,4/15/2019
69C99E,clinical-trials-complete,100,56,4/15/2019
7032D0,earnings,100,50,4/15/2019
763DBE,business-contract,100,69,4/15/2019
78F9ED,legal-issues-defendant,100,22,4/15/2019
790C34,earnings,100,50,4/15/2019
7A51FE,conference-call,100,50,4/15/2019
7B492C,unit-acquisition-acquirer,100,49,4/15/2019
7C790D,conference-call,100,50,4/15/2019
7CBC40,earnings,100,50,4/15/2019
7CD98F,executive-resignation,100,44,4/15/2019
8.22E+27,conference-call,100,50,4/15/2019
83066C,conference-call,100,50,4/15/2019
860AB6,earnings,100,50,4/15/2019
8614A2,legal-issues-defendant,100,22,4/15/2019
8614A2,legal-issues-defendant,100,22,4/15/2019
8614A2,legal-issues-defendant,100,22,4/15/2019
88193E,conference-call,100,50,4/15/2019
8B6E7E,award,100,58,4/15/2019
8B9B3B,legal-issues-defendant,100,22,4/15/2019
8DBBE6,executive-appointment,100,54,4/15/2019
911ACB,name-change,100,49,4/15/2019
92D9C9,executive-appointment,100,54,4/15/2019
949D62,revenues,100,50,4/15/2019
9.86E+03,partnership,100,61,4/15/2019
9C8BC3,dividend,100,50,4/15/2019
9D5FA4,earnings,100,50,4/15/2019
9E298A,conference-call,100,50,4/15/2019
9F5997,conference-call,100,50,4/15/2019
9F62D1,earnings,100,50,4/15/2019
A01664,earnings,100,50,4/15/2019
A47A7D,legal-issues-defendant,100,22,4/15/2019
A52B6B,executive-appointment,100,54,4/15/2019
A5A4F5,acquisition-acquirer,100,49,4/15/2019
A63387,government-contract,100,69,4/15/2019
A6828A,partnership,100,61,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A746F6,earnings-per-share-positive,100,69,4/15/2019
A806FA,conference-call,100,50,4/15/2019
AA09AD,executive-appointment,100,54,4/15/2019
AAEE21,conference-call,100,50,4/15/2019
AC642C,conference-participant,100,50,4/15/2019
AC642C,conference-participant,100,50,4/15/2019
ACC7D3,conference-participant,100,50,4/15/2019
AEFC90,regulatory-product-approval-granted,100,81,4/15/2019
AFF7B4,dividend,100,50,4/15/2019
B2206F,earnings,100,50,4/15/2019
B2E6B5,conference-call,100,50,4/15/2019
B37FB4,unit-acquisition-acquiree,100,76,4/15/2019
B7FA9B,conference-call,100,50,4/15/2019
B9CD50,earnings,100,50,4/15/2019
BB02FB,conference-call,100,50,4/15/2019
BBBB41,facility-open,100,65,4/15/2019
BD682F,earnings,100,50,4/15/2019
BDD12C,earnings,100,50,4/15/2019
BDD12C,dividend-up,100,81,4/15/2019
BE7BA4,conference-call,100,50,4/15/2019
C0030A,earnings,100,50,4/15/2019
C4A912,conference-call,100,50,4/15/2019
C81E00,product-release,100,64,4/15/2019
C99CC8,earnings,100,50,4/15/2019
CAC8D0,executive-appointment,100,54,4/15/2019
CB6A9C,conference-call,100,50,4/15/2019
CE2791,conference-call,100,50,4/15/2019
CF7292,executive-appointment,100,54,4/15/2019
CFE5BE,merger-completed,100,66,4/15/2019
CFF97C,analyst-ratings-change-positive-rater,20,50,4/15/2019
D1AE3B,earnings,100,50,4/15/2019
D33D8C,earnings-up,100,68,4/15/2019
D33D8C,earnings-up,100,68,4/15/2019
D33D8C,earnings-up,100,68,4/15/2019
D33D8C,earnings-up,100,68,4/15/2019
D33D8C,earnings-up,100,68,4/15/2019
D3C794,earnings,100,50,4/15/2019
D45285,executive-appointment,100,54,4/15/2019
D4AC65,conference-organizer,100,57,4/15/2019
D57D99,earnings,100,50,4/15/2019
D6853F,government-contract,100,69,4/15/2019
DA199F,acquisition-acquirer,100,49,4/15/2019
DD9E41,earnings,100,50,4/15/2019
E15736,conference-call,100,50,4/15/2019
E15736,conference-call,100,50,4/15/2019
E21871,earnings,100,50,4/15/2019
E28D9C,conference-call,100,50,4/15/2019
E41190,executive-appointment,100,54,4/15/2019
E4CE73,product-release,100,64,4/15/2019
E68E62,public-offering,100,43,4/15/2019
E93A40,earnings,100,50,4/15/2019
EA62FC,conference-call,100,50,4/15/2019
ED79D9,product-release,100,64,4/15/2019
ED7F13,earnings,100,50,4/15/2019
EF5914,note-sale,100,52,4/15/2019
F179ED,earnings,100,50,4/15/2019
F24FF0,conference-call,100,50,4/15/2019
F3016C,earnings,100,50,4/15/2019
F85CC0,executive-appointment,100,54,4/15/2019
F8DE55,legal-issues-defendant,100,22,4/15/2019
F8DE55,earnings,100,50,4/15/2019
F8DE55,legal-issues-defendant,100,22,4/15/2019
FA40E2,business-contract,100,69,4/15/2019
FA40E2,legal-issues-defendant,100,22,4/15/2019
FA40E2,legal-issues-defendant,100,22,4/15/2019
FACCF6,earnings,100,50,4/15/2019
FAE021,earnings,100,50,4/15/2019
FD9526,facility-sale,100,52,4/15/2019
FE89E0,conference-call,100,50,4/15/2019
0157B1,executive-appointment,100,54,4/16/2019
0157B1,executive-appointment,100,54,4/16/2019
018C11,facility-open,100,65,4/16/2019
02870F,conference-call,100,50,4/16/2019
07C907,earnings,100,50,4/16/2019
07C907,earnings,100,50,4/16/2019
09062E,conference-call,100,50,4/16/2019
0AB700,dividend-up,100,81,4/16/2019
0AB700,earnings,100,50,4/16/2019
0F91FC,partnership,100,61,4/16/2019
108A2B,conference-call,100,50,4/16/2019
1201B5,executive-appointment,100,54,4/16/2019
16B183,partnership,100,61,4/16/2019
1834C0,conference-call,100,50,4/16/2019
1866B2,conference-call,100,50,4/16/2019
1921DD,partnership,100,61,4/16/2019
1DF15D,conference-call,100,50,4/16/2019
1FAF22,conference-participant,100,50,4/16/2019
205AD5,earnings,100,50,4/16/2019
214051,earnings,100,50,4/16/2019
222BF9,conference-call,100,50,4/16/2019
26D8ED,conference-call,100,50,4/16/2019
26F31D,earnings,100,50,4/16/2019
26F99F,public-offering,100,43,4/16/2019
270305,executive-appointment,100,54,4/16/2019
28AF37,earnings,100,50,4/16/2019
29A4CC,earnings,100,50,4/16/2019
29A4CC,earnings,100,50,4/16/2019
29A4CC,earnings,100,50,4/16/2019
29A4CC,earnings,100,50,4/16/2019
29A4CC,earnings,100,50,4/16/2019
29A4CC,earnings,100,50,4/16/2019
2A1009,clinical-trials,100,56,4/16/2019
2EB88B,facility-close,100,47,4/16/2019
301493,executive-resignation,100,44,4/16/2019
314D88,earnings,100,50,4/16/2019
3.14E+47,earnings-positive,100,69,4/16/2019
3.14E+47,earnings,100,50,4/16/2019
3.14E+47,earnings,100,50,4/16/2019
3.14E+47,earnings,100,50,4/16/2019
3.14E+47,earnings,100,50,4/16/2019
3.14E+47,earnings,100,50,4/16/2019
31AA84,earnings,100,50,4/16/2019
32F24A,conference-call,100,50,4/16/2019
3.30E+34,earnings-up,100,68,4/16/2019
3.30E+34,earnings-up,100,68,4/16/2019
3.30E+34,earnings-up,100,68,4/16/2019
33E9D5,earnings,100,50,4/16/2019
3461CF,dividend,100,50,4/16/2019
3.50E+27,conference-call,100,50,4/16/2019
373B06,earnings,100,50,4/16/2019
39692D,acquisition-acquirer,100,49,4/16/2019
39692D,acquisition-acquirer,100,49,4/16/2019
3AF7FD,conference-participant,100,50,4/16/2019
3C6CCC,earnings,100,50,4/16/2019
3DCECC,conference-call,100,50,4/16/2019
3ED92D,conference-call,100,50,4/16/2019
3F6A9C,conference-call,100,50,4/16/2019
3F96D5,earnings,100,50,4/16/2019
4.00E+163,legal-issues-defendant,100,22,4/16/2019
416291,conference-call,100,50,4/16/2019
42312F,earnings,100,50,4/16/2019
423279,board-meeting,100,51,4/16/2019
435ACE,legal-issues-defendant,100,22,4/16/2019
43E8F5,conference-call,100,50,4/16/2019
447FC6,conference-call,100,50,4/16/2019
4A6F00,partnership,100,61,4/16/2019
4C6C63,product-release,100,64,4/16/2019
4C6C63,product-release,100,64,4/16/2019
4F783B,public-offering,100,43,4/16/2019
51888A,earnings-per-share-positive,100,69,4/16/2019
51888A,earnings,100,50,4/16/2019
52015A,conference-call,100,50,4/16/2019
545272,conference-call,100,50,4/16/2019
5480A7,buybacks,100,74,4/16/2019
55438C,legal-issues-defendant,100,22,4/16/2019
57CAAB,fast-track-designation,100,81,4/16/2019
586FFD,conference-call,100,50,4/16/2019
58C2D4,earnings,100,50,4/16/2019
59872F,product-release,100,64,4/16/2019
59872F,legal-issues-defendant,100,22,4/16/2019
59C539,dividend,100,50,4/16/2019
5BFE94,conference-call,100,50,4/16/2019
5C8D61,earnings,100,50,4/16/2019
5CCDAD,earnings,100,50,4/16/2019
60DD84,executive-appointment,100,54,4/16/2019
657097,unit-acquisition-acquirer,100,49,4/16/2019
67A658,dividend,100,50,4/16/2019
67A658,dividend,100,50,4/16/2019
69345C,earnings,100,50,4/16/2019
6D3B7B,earnings,100,50,4/16/2019
713810,partnership,100,61,4/16/2019
722DE3,award,100,58,4/16/2019
7255D2,partnership,100,61,4/16/2019
7410C3,earnings,100,50,4/16/2019
7448A3,conference-call,100,50,4/16/2019
76B926,conference-call,100,50,4/16/2019
789A7D,conference-call,100,50,4/16/2019
79167B,conference-call,100,50,4/16/2019
797C20,conference-call,100,50,4/16/2019
7D35D8,earnings-guidance,100,50,4/16/2019
7EA323,partnership,100,61,4/16/2019
850779,earnings-per-share-positive,100,69,4/16/2019
850779,earnings-per-share,100,50,4/16/2019
850779,earnings-per-share,100,50,4/16/2019
85DA04,partnership,100,61,4/16/2019
8614A2,legal-issues-defendant,100,22,4/16/2019
8614A2,legal-issues-defendant,100,22,4/16/2019
8665BA,partnership,100,61,4/16/2019
89FBB1,executive-appointment,100,54,4/16/2019
8B9B3B,legal-issues-defendant,100,22,4/16/2019
8B9B3B,legal-issues-defendant,100,22,4/16/2019
8C5519,earnings,100,50,4/16/2019
8C5519,earnings,100,50,4/16/2019
8C5519,earnings,100,50,4/16/2019
8C5519,earnings,100,50,4/16/2019
8C5519,earnings,100,50,4/16/2019
8C5519,earnings,100,50,4/16/2019
8CF6DD,earnings,100,50,4/16/2019
8D4486,earnings,100,50,4/16/2019
8D4486,earnings,100,50,4/16/2019
8D4486,earnings,100,50,4/16/2019
8D4486,earnings,100,50,4/16/2019
8DDA23,dividend,100,50,4/16/2019
8FF2EF,earnings,100,50,4/16/2019
93965C,earnings,100,50,4/16/2019
949625,conference-call,100,50,4/16/2019
96F126,earnings,100,50,4/16/2019
97644E,earnings,100,50,4/16/2019
97AAF6,earnings,100,50,4/16/2019
990AD0,earnings,100,50,4/16/2019
990AD0,earnings,100,50,4/16/2019
990AD0,conference-organizer,100,57,4/16/2019
990AD0,conference-organizer,100,57,4/16/2019
9CA4C6,dividend,100,50,4/16/2019
9CA4C6,earnings-up,100,68,4/16/2019
9D4EC7,conference-call,100,50,4/16/2019
9E91C6,partnership,100,61,4/16/2019
9EA947,conference-call,100,50,4/16/2019
A23747,earnings,100,50,4/16/2019
A2CA3F,earnings,100,50,4/16/2019
A48593,executive-appointment,100,54,4/16/2019
A4D173,conference-call,100,50,4/16/2019
A4D173,conference-call,100,50,4/16/2019
A5A4F5,acquisition-acquirer,100,49,4/16/2019
A6828A,earnings,100,50,4/16/2019
A746F6,dividend,100,50,4/16/2019
A868C9,business-contract,100,69,4/16/2019
A9ED24,dividend,100,50,4/16/2019
AA98ED,conference-call,100,50,4/16/2019
AC775C,conference-call,100,50,4/16/2019
AD3008,earnings,100,50,4/16/2019
ADF092,award,100,58,4/16/2019
AE3113,earnings,100,50,4/16/2019
AEF2C3,conference-call,100,50,4/16/2019
AFD1CA,facility-open,100,65,4/16/2019
AFD1CA,conference-call,100,50,4/16/2019
AFDF2E,acquisition-completed-acquirer,100,49,4/16/2019
AFF43F,earnings,100,50,4/16/2019
AFF43F,dividend,100,50,4/16/2019
B1A85D,partnership,100,61,4/16/2019
B560AF,dividend,100,50,4/16/2019
B614F8,joint-venture,100,62,4/16/2019
B8A51F,regulatory-product-approval-granted,100,81,4/16/2019
B96DF5,earnings,100,50,4/16/2019
BD8517,earnings,100,50,4/16/2019
BDD12C,board-meeting,100,51,4/16/2019
BDE867,award,100,58,4/16/2019
C11C46,earnings,100,50,4/16/2019
C45CE7,earnings,100,50,4/16/2019
C584BE,business-contract,100,69,4/16/2019
C8257F,earnings,100,50,4/16/2019
C8257F,earnings,100,50,4/16/2019
C98CDB,earnings,100,50,4/16/2019
C9F39B,award,100,58,4/16/2019
CD06A2,earnings,100,50,4/16/2019
CD06A2,earnings,100,50,4/16/2019
CD2A4D,executive-appointment,100,54,4/16/2019
CEC5B9,conference-call,100,50,4/16/2019
CF211D,earnings,100,50,4/16/2019
CF351E,earnings,100,50,4/16/2019
CF9054,earnings,100,50,4/16/2019
D15833,executive-appointment,100,54,4/16/2019
D3CEDF,conference-call,100,50,4/16/2019
D4AC65,conference-call,100,50,4/16/2019
D5AF19,earnings,100,50,4/16/2019
D82EF3,conference-call,100,50,4/16/2019
D8442A,legal-issues-defendant,100,22,4/16/2019
DB06B0,earnings,100,50,4/16/2019
DF18E6,clinical-trials,100,56,4/16/2019
DF532D,earnings,100,50,4/16/2019
DF532D,earnings,100,50,4/16/2019
E22FDE,legal-issues-defendant,100,22,4/16/2019
E26FC3,earnings-up,100,68,4/16/2019
E38906,legal-issues-defendant,100,22,4/16/2019
E67C2C,earnings,100,50,4/16/2019
E68E62,public-offering,100,43,4/16/2019
E829E8,earnings,100,50,4/16/2019
E8C557,board-meeting,100,51,4/16/2019
E90C84,conference-call,100,50,4/16/2019
EB36DE,conference-call,100,50,4/16/2019
EB5E78,conference-call,100,50,4/16/2019
ECD263,earnings,100,50,4/16/2019
ECF4F8,conference-call,100,50,4/16/2019
ED79D9,conference-call,100,50,4/16/2019
F3816D,clinical-trials,100,56,4/16/2019
F3EDB4,dividend,100,50,4/16/2019
F5349B,earnings,100,50,4/16/2019
F6E248,partnership,100,61,4/16/2019
F8D759,acquisition-completed-acquiree,100,76,4/16/2019
F8DE55,legal-issues-defendant,100,22,4/16/2019
F8DE55,legal-issues-defendant,100,22,4/16/2019
F90EE5,executive-appointment,100,54,4/16/2019
FA40E2,dividend,100,50,4/16/2019
FA40E2,legal-issues-defendant,100,22,4/16/2019
FAEABE,earnings-per-share-positive,100,69,4/16/2019
FAEABE,earnings,100,50,4/16/2019
FAEABE,earnings,100,50,4/16/2019
FE89E0,asset-sale,100,62,4/16/2019
FF4343,award,100,58,4/16/2019
13528,earnings,100,50,4/17/2019
018C11,product-release,100,64,4/17/2019
03596A,earnings,100,50,4/17/2019
03D5F9,earnings,100,50,4/17/2019
03F5A4,earnings-positive,100,69,4/17/2019
06EE79,ipo-pricing,100,50,4/17/2019
75172,executive-appointment,100,54,4/17/2019
0B4D10,earnings,100,50,4/17/2019
0B9E6F,market-entry,100,57,4/17/2019
0CBC4D,product-release,100,64,4/17/2019
0CCCB7,conference-call,100,50,4/17/2019
0E64D4,business-contract,100,69,4/17/2019
0ED415,conference-call,100,50,4/17/2019
0F2BC9,conference-call,100,50,4/17/2019
0F91FC,conference-call,100,50,4/17/2019
10AE08,earnings,100,50,4/17/2019
10C19B,earnings,100,50,4/17/2019
10C19B,earnings,100,50,4/17/2019
10C19B,earnings,100,50,4/17/2019
10C19B,earnings,100,50,4/17/2019
10C19B,earnings,100,50,4/17/2019
149301,earnings,100,50,4/17/2019
152E1D,conference-call,100,50,4/17/2019
1748B3,earnings,100,50,4/17/2019
1748B3,earnings,100,50,4/17/2019
1748B3,earnings,100,50,4/17/2019
1748B3,earnings,100,50,4/17/2019
1748B3,earnings,100,50,4/17/2019
1.79E+10,conference-call,100,50,4/17/2019
19CAC7,earnings,100,50,4/17/2019
19CAC7,earnings,100,50,4/17/2019
1A2D9F,earnings,100,50,4/17/2019
1A5957,legal-issues-defendant,100,22,4/17/2019
1D5C51,conference-call,100,50,4/17/2019
1DEBBE,earnings,100,50,4/17/2019
1E04A5,earnings,100,50,4/17/2019
1E1125,conference-organizer,100,57,4/17/2019
1E9A6D,dividend-up,100,81,4/17/2019
202E5A,conference-call,100,50,4/17/2019
239106,conference-call,100,50,4/17/2019
2.45E+15,earnings,100,50,4/17/2019
24C48B,acquisition-acquirer,100,49,4/17/2019
24C48B,acquisition-acquirer,100,49,4/17/2019
25AB8E,conference-call,100,50,4/17/2019
2720AB,conference-call,100,50,4/17/2019
275300,earnings,100,50,4/17/2019
275300,earnings,100,50,4/17/2019
275300,earnings,100,50,4/17/2019
275300,earnings,100,50,4/17/2019
275300,earnings,100,50,4/17/2019
275300,earnings,100,50,4/17/2019
275300,earnings,100,50,4/17/2019
275300,earnings,100,50,4/17/2019
27BFA1,earnings,100,50,4/17/2019
27BFA1,earnings,100,50,4/17/2019
27BFA1,earnings,100,50,4/17/2019
27BFA1,earnings,100,50,4/17/2019
27BFA1,earnings,100,50,4/17/2019
27BFA1,earnings,100,50,4/17/2019
27C10F,market-entry,100,57,4/17/2019
295F9F,conference-call,100,50,4/17/2019
2C19A4,conference-call,100,50,4/17/2019
2C35B5,public-offering,100,43,4/17/2019
2DB344,earnings,100,50,4/17/2019
2EB04E,legal-issues-defendant,100,22,4/17/2019
2EB04E,legal-issues-defendant,100,22,4/17/2019
2EB04E,legal-issues-defendant,100,22,4/17/2019
2F7A7E,conference-call,100,50,4/17/2019
301493,conference-call,100,50,4/17/2019
31553A,earnings,100,50,4/17/2019
31553A,earnings,100,50,4/17/2019
31553A,earnings,100,50,4/17/2019
3159AA,conference-call,100,50,4/17/2019
31A7CC,earnings,100,50,4/17/2019
31A7CC,earnings,100,50,4/17/2019
31A7CC,earnings,100,50,4/17/2019
328250,conference-call,100,50,4/17/2019
32CB22,earnings,100,50,4/17/2019
342218,dividend,100,50,4/17/2019
349DA4,earnings,100,50,4/17/2019
34B411,earnings,100,50,4/17/2019
366A08,dividend,100,50,4/17/2019
372037,conference-call,100,50,4/17/2019
39FB23,acquisition-completed-acquirer,100,49,4/17/2019
3A1C46,earnings,100,50,4/17/2019
3AAEAE,ipo-pricing,100,50,4/17/2019
3C11C4,earnings,100,50,4/17/2019
3E149C,earnings-meet-expectations,100,59,4/17/2019
3E149C,earnings-meet-expectations,100,59,4/17/2019
408089,dividend,100,50,4/17/2019
408089,executive-appointment,100,54,4/17/2019
423279,dividend,100,50,4/17/2019
42AABD,conference-call,100,50,4/17/2019
435ACE,legal-issues-defendant,100,22,4/17/2019
435ACE,legal-issues-defendant,100,22,4/17/2019
435ACE,fraud-defendant,100,20,4/17/2019
43A060,fraud-defendant,100,20,4/17/2019
442769,market-entry,100,57,4/17/2019
4A6F00,executive-appointment,100,54,4/17/2019
4B3676,earnings,100,50,4/17/2019
50070E,conference-call,100,50,4/17/2019
51F541,conference-call,100,50,4/17/2019
520632,earnings,100,50,4/17/2019
520632,earnings,100,50,4/17/2019
520632,earnings,100,50,4/17/2019
520632,earnings,100,50,4/17/2019
5225A4,earnings,100,50,4/17/2019
5225A4,earnings,100,50,4/17/2019
5225A4,earnings,100,50,4/17/2019
5225A4,earnings,100,50,4/17/2019
5225A4,earnings,100,50,4/17/2019
525A1C,earnings,100,50,4/17/2019
53F491,earnings-per-share-positive,100,69,4/17/2019
56AFF4,operating-earnings,100,50,4/17/2019
57B174,conference-call,100,50,4/17/2019
589F5A,dividend,100,50,4/17/2019
58CA9A,dividend,100,50,4/17/2019
5968F9,product-release,100,64,4/17/2019
5968F9,campaign-ad-release,100,59,4/17/2019
59872F,legal-issues-defendant,100,22,4/17/2019
5A64D5,dividend,100,50,4/17/2019
5E7E82,partnership,100,61,4/17/2019
5EAA43,conference-call,100,50,4/17/2019
5F6D73,earnings,100,50,4/17/2019
5F6D73,earnings,100,50,4/17/2019
5F6D73,earnings,100,50,4/17/2019
5F6D73,earnings,100,50,4/17/2019
6166D1,earnings,100,50,4/17/2019
6166D1,earnings,100,50,4/17/2019
6166D1,earnings,100,50,4/17/2019
6166D1,earnings,100,50,4/17/2019
6166D1,earnings,100,50,4/17/2019
6166D1,earnings,100,50,4/17/2019
6166D1,earnings,100,50,4/17/2019
6.18E+08,earnings,100,50,4/17/2019
619882,executive-appointment,100,54,4/17/2019
622DBE,conference-call,100,50,4/17/2019
627186,regulatory-product-approval-granted,100,81,4/17/2019
62B20A,earnings,100,50,4/17/2019
639BD6,conference-participant,100,50,4/17/2019
6634D9,note-sale,100,52,4/17/2019
69CE71,conference-call,100,50,4/17/2019
6ABCB8,earnings,100,50,4/17/2019
6BC6F9,facility-open,100,65,4/17/2019
6CF43C,earnings,100,50,4/17/2019
6DDA15,earnings,100,50,4/17/2019
7273FF,earnings,100,50,4/17/2019
731675,partnership,100,61,4/17/2019
731675,conference-call,100,50,4/17/2019
75F982,business-contract,100,69,4/17/2019
75F982,business-contract,100,69,4/17/2019
762B8D,earnings,100,50,4/17/2019
775439,earnings,100,50,4/17/2019
7.83E+79,earnings,100,50,4/17/2019
7B6C88,conference-call,100,50,4/17/2019
7E3F8F,earnings,100,50,4/17/2019
8275FE,earnings,100,50,4/17/2019
82E58A,earnings-guidance,100,50,4/17/2019
85CDC9,earnings,100,50,4/17/2019
85DA04,earnings,100,50,4/17/2019
860AB6,conference-call,100,50,4/17/2019
8614A2,legal-issues-defendant,100,22,4/17/2019
87B81A,earnings,100,50,4/17/2019
8A0368,conference-call,100,50,4/17/2019
8B9B3B,fraud-defendant,100,20,4/17/2019
8D4486,earnings,100,50,4/17/2019
8D4486,award,100,58,4/17/2019
8F8F2F,executive-appointment,100,54,4/17/2019
907ED2,earnings,100,50,4/17/2019
9196A2,earnings,100,50,4/17/2019
9196A2,earnings,100,50,4/17/2019
9196A2,earnings,100,50,4/17/2019
9196A2,earnings,100,50,4/17/2019
92B047,earnings,100,50,4/17/2019
93633B,earnings,100,50,4/17/2019
93633B,earnings,100,50,4/17/2019
93633B,earnings,100,50,4/17/2019
93633B,earnings,100,50,4/17/2019
942165,earnings,100,50,4/17/2019
954A47,earnings-positive,100,69,4/17/2019
9.62E+76,earnings,100,50,4/17/2019
9.62E+76,earnings,100,50,4/17/2019
9.65E+09,conference-call,100,50,4/17/2019
96F126,business-contract,100,69,4/17/2019
9810C0,note-sale,100,52,4/17/2019
9.92E+94,earnings,100,50,4/17/2019
9B730A,executive-appointment,100,54,4/17/2019
9BB35A,conference-call,100,50,4/17/2019
9BF177,product-release,100,64,4/17/2019
9CE4C7,earnings,100,50,4/17/2019
9F6B1A,business-contract,100,69,4/17/2019
9F6B1A,business-contract,100,69,4/17/2019
A21649,conference-call,100,50,4/17/2019
A29A46,conference-call,100,50,4/17/2019
A29DBD,earnings,100,50,4/17/2019
A2CAF7,earnings,100,50,4/17/2019
A398F8,earnings,100,50,4/17/2019
A47A7D,legal-issues-defendant,100,22,4/17/2019
A5151E,market-entry,100,57,4/17/2019
A5A4F5,acquisition-acquirer,100,49,4/17/2019
A63387,business-contract,100,69,4/17/2019
A666C8,earnings,100,50,4/17/2019
A8AC4C,conference-call,100,50,4/17/2019
AA5C8E,dividend-up,100,72,4/17/2019
AA5C8E,dividend-up,100,72,4/17/2019
AA5C8E,dividend-up,100,72,4/17/2019
AA5C8E,dividend-up,100,72,4/17/2019
AA5C8E,dividend-up,100,72,4/17/2019
AA5C8E,dividend-up,100,72,4/17/2019
AABEA0,dividend,100,50,4/17/2019
AB7F05,earnings-up,100,68,4/17/2019
ADD9DC,legal-issues-defendant,100,22,4/17/2019
ADF1B0,conference-call,100,50,4/17/2019
B05118,product-release,100,64,4/17/2019
B1B10C,earnings,100,50,4/17/2019
B1B10C,earnings,100,50,4/17/2019
B1B10C,earnings,100,50,4/17/2019
B37FB4,partnership,100,61,4/17/2019
B72BE9,conference-call,100,50,4/17/2019
B8A51F,earnings,100,50,4/17/2019
BA218A,earnings-positive,100,69,4/17/2019
BA218A,earnings,100,50,4/17/2019
BA218A,earnings,100,50,4/17/2019
BA218A,earnings,100,50,4/17/2019
BA218A,earnings,100,50,4/17/2019
BB127B,product-release,100,64,4/17/2019
BCC55F,award,100,58,4/17/2019
BCC55F,award,100,58,4/17/2019
BCC55F,conference-call,100,50,4/17/2019
BD682F,dividend,100,50,4/17/2019
BDCC11,legal-issues-defendant,100,22,4/17/2019
BE379D,earnings,100,50,4/17/2019
C0BA36,conference-call,100,50,4/17/2019
C2F597,earnings,100,50,4/17/2019
C32A39,dividend,100,50,4/17/2019
C3BAE7,acquisition-completed-acquirer,100,49,4/17/2019
C66B44,conference-call,100,50,4/17/2019
C83B88,partnership,100,61,4/17/2019
C8A248,executive-appointment,100,54,4/17/2019
C8A248,executive-appointment,100,54,4/17/2019
C9B932,earnings,100,50,4/17/2019
C9B932,earnings,100,50,4/17/2019
C9F39B,earnings,100,50,4/17/2019
C9F39B,earnings,100,50,4/17/2019
C9F39B,earnings,100,50,4/17/2019
C9F39B,earnings,100,50,4/17/2019
C9F39B,earnings,100,50,4/17/2019
CDAA0E,earnings,100,50,4/17/2019
CE1002,dividend,100,50,4/17/2019
D07B07,patent-awarded,100,72,4/17/2019
D1AE3B,partnership,100,61,4/17/2019
D1AE3B,dividend,100,50,4/17/2019
D25249,conference-call,100,50,4/17/2019
D27FAB,conference-call,100,50,4/17/2019
D393DF,earnings,100,50,4/17/2019
D393DF,earnings,100,50,4/17/2019
D650A7,earnings,100,50,4/17/2019
D8442A,legal-issues-defendant,100,22,4/17/2019
D93A25,earnings,100,50,4/17/2019
DAFED3,acquisition-completed-acquirer,100,49,4/17/2019
DF204B,facility-open,100,65,4/17/2019
E0339F,earnings,100,50,4/17/2019
E0339F,earnings,100,50,4/17/2019
E0339F,earnings,100,50,4/17/2019
E06265,conference-call,100,50,4/17/2019
E074A0,earnings,100,50,4/17/2019
E16133,business-contract,100,69,4/17/2019
E19A99,earnings,100,50,4/17/2019
E22FDE,legal-issues-defendant,100,22,4/17/2019
E22FDE,legal-issues-defendant,100,22,4/17/2019
E3656D,conference-call,100,50,4/17/2019
E802CE,legal-issues-defendant,100,22,4/17/2019
E90C84,earnings,100,50,4/17/2019
E96E0B,earnings,100,50,4/17/2019
EAEBF3,dividend,100,50,4/17/2019
EBD89A,conference-call,100,50,4/17/2019
ED2A5E,conference-call,100,50,4/17/2019
EF5BED,earnings-positive,100,69,4/17/2019
EF5BED,earnings,100,50,4/17/2019
EF5BED,earnings,100,50,4/17/2019
EF5BED,earnings,100,50,4/17/2019
EF5BED,dividend,100,50,4/17/2019
EF76C8,dividend,100,50,4/17/2019
F1C04C,conference-call,100,50,4/17/2019
F7ADEB,award,100,58,4/17/2019
F82D37,revenues,100,50,4/17/2019
F82D37,earnings,100,50,4/17/2019
F82D37,earnings,100,50,4/17/2019
F93C8A,conference-call,100,50,4/17/2019
F95726,earnings,100,50,4/17/2019
FA35C6,earnings,100,50,4/17/2019
FFAB4A,earnings,100,50,4/17/2019
033B58,ipo-pricing,100,50,4/18/2019
43862,conference-call,100,50,4/18/2019
04EB2F,earnings,100,50,4/18/2019
06EF42,conference-call,100,50,4/18/2019
07EC43,conference-call,100,50,4/18/2019
083F72,dividend,100,50,4/18/2019
98977,legal-issues-defendant,100,22,4/18/2019
98977,earnings,100,50,4/18/2019
099A02,earnings,100,50,4/18/2019
099A02,earnings,100,50,4/18/2019
099C88,conference-call,100,50,4/18/2019
09F623,dividend-up,100,81,4/18/2019
0A7650,earnings-positive,100,69,4/18/2019
0A7650,earnings-positive,100,69,4/18/2019
0A7650,earnings-positive,100,69,4/18/2019
0A7650,earnings-positive,100,69,4/18/2019
0BB9E5,earnings,100,50,4/18/2019
0BC17A,dividend,100,50,4/18/2019
0BC17A,earnings,100,50,4/18/2019
0C136E,executive-resignation,100,44,4/18/2019
0C8D82,earnings,100,50,4/18/2019
0D26E0,earnings-positive,100,69,4/18/2019
0D26E0,earnings-positive,100,69,4/18/2019
0D26E0,earnings-positive,100,69,4/18/2019
0D26E0,earnings-positive,100,69,4/18/2019
0FABBD,conference-call,100,50,4/18/2019
105D00,earnings-up,100,77,4/18/2019
105D00,earnings-up,100,77,4/18/2019
108FDA,earnings,100,50,4/18/2019
126F95,earnings,100,50,4/18/2019
126F95,earnings,100,50,4/18/2019
126F95,earnings,100,50,4/18/2019
147C38,executive-appointment,100,54,4/18/2019
168A5D,executive-appointment,100,54,4/18/2019
1748F6,business-contract,100,69,4/18/2019
182B8C,conference-call,100,50,4/18/2019
182BE7,earnings,100,50,4/18/2019
184988,executive-appointment,100,54,4/18/2019
18EC17,earnings,100,50,4/18/2019
18EC17,earnings,100,50,4/18/2019
18EC17,earnings,100,50,4/18/2019
19C105,earnings,100,50,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A3E1B,earnings-positive,100,69,4/18/2019
1A5957,legal-issues-defendant,100,22,4/18/2019
1A6A94,dividend,100,50,4/18/2019
1D1B07,business-contract,100,69,4/18/2019
1D1B07,business-contract,100,69,4/18/2019
1D943E,earnings,100,50,4/18/2019
1F43A1,earnings,100,50,4/18/2019
1FC422,earnings,100,50,4/18/2019
219B21,conference-call,100,50,4/18/2019
21D903,legal-issues-defendant,100,22,4/18/2019
225CA2,conference-call,100,50,4/18/2019
227D48,conference-call,100,50,4/18/2019
249674,conference-call,100,50,4/18/2019
24CB56,earnings-positive,100,69,4/18/2019
24CB56,earnings,100,50,4/18/2019
24CB56,earnings,100,50,4/18/2019
24CB56,earnings,100,50,4/18/2019
24CB56,earnings,100,50,4/18/2019
24CB56,earnings,100,50,4/18/2019
24CB56,earnings,100,50,4/18/2019
24CB56,earnings,100,50,4/18/2019
24CB56,earnings,100,50,4/18/2019
251988,legal-issues-defendant,100,22,4/18/2019
267718,board-meeting,100,51,4/18/2019
26CC63,dividend,100,50,4/18/2019
2A1009,conference-call,100,50,4/18/2019
2C35B5,public-offering,100,43,4/18/2019
2DC88B,legal-issues-defendant,100,22,4/18/2019
2DC88B,legal-issues-defendant,100,22,4/18/2019
2DC88B,earnings,100,50,4/18/2019
2EB04E,legal-issues-defendant,100,22,4/18/2019
2EB88B,earnings,100,50,4/18/2019
2EBA55,conference-call,100,50,4/18/2019
2F6782,conference-call,100,50,4/18/2019
2F7474,earnings,100,50,4/18/2019
2F960F,unit-acquisition-acquirer,100,49,4/18/2019
31666F,earnings,100,50,4/18/2019
31803E,earnings,100,50,4/18/2019
3.30E+34,dividend-up,100,81,4/18/2019
343996,earnings,100,50,4/18/2019
343996,dividend,100,50,4/18/2019
343996,dividend,100,50,4/18/2019
34B411,market-entry,100,57,4/18/2019
370C50,dividend-up,100,65,4/18/2019
370C50,buybacks,100,74,4/18/2019
39FB23,earnings,100,50,4/18/2019
39FB23,earnings,100,50,4/18/2019
39FB23,earnings,100,50,4/18/2019
39FB23,dividend,100,50,4/18/2019
39FB23,executive-appointment,100,54,4/18/2019
3A3447,earnings,100,50,4/18/2019
3B20AB,earnings,100,50,4/18/2019
3B20AB,partnership,100,61,4/18/2019
3B20AB,partnership,100,61,4/18/2019
3C8A04,earnings,100,50,4/18/2019
3D9999,earnings-positive,100,69,4/18/2019
3E39A5,earnings-guidance,100,50,4/18/2019
3F4668,earnings,100,50,4/18/2019
3FBC9B,earnings,100,50,4/18/2019
4017AD,earnings,100,50,4/18/2019
4.03E+05,conference-call,100,50,4/18/2019
41A93D,earnings,100,50,4/18/2019
41EC04,conference-call,100,50,4/18/2019
420168,earnings,100,50,4/18/2019
435ACE,legal-issues-defendant,100,22,4/18/2019
435ACE,legal-issues-defendant,100,22,4/18/2019
43A060,legal-issues-defendant,100,22,4/18/2019
444CC8,conference-call,100,50,4/18/2019
448215,earnings,100,50,4/18/2019
449A26,earnings-positive,100,69,4/18/2019
449A26,dividend,100,50,4/18/2019
485445,earnings,100,50,4/18/2019
487B7A,earnings-up,100,68,4/18/2019
49914B,conference-call,100,50,4/18/2019
49CC59,conference-call,100,50,4/18/2019
4A3438,conference-call,100,50,4/18/2019
4A6F00,product-release,100,64,4/18/2019
4C37C5,earnings-per-share-positive,100,69,4/18/2019
4C37C5,earnings,100,50,4/18/2019
4C37C5,earnings,100,50,4/18/2019
4D203E,earnings,100,50,4/18/2019
4D203E,earnings,100,50,4/18/2019
4D203E,earnings,100,50,4/18/2019
4E913D,executive-appointment,100,54,4/18/2019
4EC4C1,unit-acquisition-acquirer,100,49,4/18/2019
4EC4C1,unit-acquisition-acquirer,100,49,4/18/2019
4EEE7E,earnings,100,50,4/18/2019
504FE2,product-release,100,64,4/18/2019
52B567,ipo-pricing,100,50,4/18/2019
52FB2F,earnings,100,50,4/18/2019
54F1D2,buybacks,100,74,4/18/2019
55438C,legal-issues-defendant,100,22,4/18/2019
55ACCB,earnings,100,50,4/18/2019
56632F,earnings,100,50,4/18/2019
5675EB,legal-issues-defendant,100,22,4/18/2019
5876DC,dividend,100,50,4/18/2019
58B46F,executive-appointment,100,54,4/18/2019
59872F,legal-issues-defendant,100,22,4/18/2019
59C539,earnings,100,50,4/18/2019
59DB8C,earnings,100,50,4/18/2019
5A64D5,conference-call,100,50,4/18/2019
5D43A7,buybacks,100,74,4/18/2019
5DE5A5,earnings-up,100,68,4/18/2019
5DE5A5,earnings,100,50,4/18/2019
5DE5A5,earnings,100,50,4/18/2019
5F2FF7,dividend,100,50,4/18/2019
5F3D91,legal-issues-defendant,100,22,4/18/2019
5F3D91,legal-issues-defendant,100,22,4/18/2019
601785,dividend,100,50,4/18/2019
60DD84,executive-appointment,100,54,4/18/2019
6137BF,acquisition-completed-acquirer,100,49,4/18/2019
622037,earnings,100,50,4/18/2019
62B1C6,dividend,100,50,4/18/2019
636639,earnings,100,50,4/18/2019
636639,earnings,100,50,4/18/2019
636639,earnings,100,50,4/18/2019
636931,earnings,100,50,4/18/2019
6474BA,earnings-positive,100,69,4/18/2019
6474BA,earnings,100,50,4/18/2019
6474BA,earnings,100,50,4/18/2019
6474BA,earnings,100,50,4/18/2019
6474BA,earnings,100,50,4/18/2019
6474BA,earnings,100,50,4/18/2019
6474BA,earnings,100,50,4/18/2019
6474BA,earnings,100,50,4/18/2019
6474BA,earnings,100,50,4/18/2019
64E615,conference-call,100,50,4/18/2019
6634D9,note-sale,100,52,4/18/2019
69CE71,legal-issues-defendant,100,22,4/18/2019
6C987C,earnings-up,100,60,4/18/2019
6D1ADF,conference-call,100,50,4/18/2019
6F3FA8,conference-call,100,50,4/18/2019
704B78,earnings,100,50,4/18/2019
713810,partnership,100,61,4/18/2019
71553E,earnings,100,50,4/18/2019
722D55,earnings,100,50,4/18/2019
726DDF,unit-acquisition-completed-acquirer,100,49,4/18/2019
729368,earnings,100,50,4/18/2019
73A71F,partnership,100,61,4/18/2019
73C521,earnings,100,50,4/18/2019
73C521,earnings,100,50,4/18/2019
73C521,earnings,100,50,4/18/2019
73C521,earnings,100,50,4/18/2019
73C521,earnings,100,50,4/18/2019
73C521,earnings,100,50,4/18/2019
7520CC,earnings,100,50,4/18/2019
75F982,dividend,100,50,4/18/2019
7710F3,partnership,100,61,4/18/2019
7.83E+79,merger-completed,100,66,4/18/2019
7B1E50,business-contract,100,69,4/18/2019
7BAAE7,dividend,100,50,4/18/2019
7F2922,earnings,100,50,4/18/2019
81222C,earnings,100,50,4/18/2019
82C202,earnings,100,50,4/18/2019
855DF7,dividend-up,100,81,4/18/2019
85DA04,partnership,100,61,4/18/2019
85DA04,partnership,100,61,4/18/2019
860AB6,executive-appointment,100,54,4/18/2019
8614A2,legal-issues-defendant,100,22,4/18/2019
89B2E7,earnings,100,50,4/18/2019
8B6E7E,conference-call,100,50,4/18/2019
8B9B3B,legal-issues-defendant,100,22,4/18/2019
8B9B3B,legal-issues-defendant,100,22,4/18/2019
8B9B3B,legal-issues-defendant,100,22,4/18/2019
8D4486,business-contract,100,69,4/18/2019
8D4486,business-contract,100,69,4/18/2019
8D4486,business-contract,100,69,4/18/2019
8DDA23,earnings-positive,100,69,4/18/2019
8E3F58,earnings,100,50,4/18/2019
9004C4,executive-appointment,100,54,4/18/2019
9004C4,conference-call,100,50,4/18/2019
9004C4,conference-call,100,50,4/18/2019
91E5EE,earnings,100,50,4/18/2019
92D3A0,stock-splits,100,49,4/18/2019
92D6A5,earnings,100,50,4/18/2019
93D207,partnership,100,61,4/18/2019
94563D,earnings,100,50,4/18/2019
94756D,earnings,100,50,4/18/2019
949D62,earnings,100,50,4/18/2019
97AAF6,dividend,100,50,4/18/2019
97FE80,earnings,100,50,4/18/2019
9.86E+03,earnings,100,50,4/18/2019
986AF6,executive-resignation,100,44,4/18/2019
989E2F,earnings,100,50,4/18/2019
989E2F,earnings,100,50,4/18/2019
98CEBB,earnings,100,50,4/18/2019
99028D,conference-call,100,50,4/18/2019
990AD0,conference-organizer,100,57,4/18/2019
9C25FF,conference-call,100,50,4/18/2019
9E98F2,earnings,100,50,4/18/2019
9E98F2,earnings,100,50,4/18/2019
9E98F2,earnings,100,50,4/18/2019
9F03CF,executive-appointment,100,54,4/18/2019
9F5CBB,conference-call,100,50,4/18/2019
A0F146,conference-call,100,50,4/18/2019
A247F5,product-release,100,64,4/18/2019
A47A7D,legal-issues-defendant,100,22,4/18/2019
A4B899,conference-call,100,50,4/18/2019
A52533,executive-appointment,100,54,4/18/2019
A63387,conference-call,100,50,4/18/2019
A7F0A5,earnings,100,50,4/18/2019
A8CBDA,dividend,100,50,4/18/2019
AB4A7E,earnings,100,50,4/18/2019
ACF77B,executive-appointment,100,54,4/18/2019
AD3C93,earnings,100,50,4/18/2019
AFD7DD,conference-call,100,50,4/18/2019
B09B1F,conference-call,100,50,4/18/2019
B0D41A,executive-appointment,100,54,4/18/2019
B1A85D,product-release,100,64,4/18/2019
B2D799,legal-issues-defendant,100,22,4/18/2019
B381D8,legal-issues-defendant,100,22,4/18/2019
B5766D,earnings-per-share-positive,100,69,4/18/2019
B5766D,earnings,100,50,4/18/2019
B5766D,earnings,100,50,4/18/2019
B5766D,earnings,100,50,4/18/2019
B5766D,earnings,100,50,4/18/2019
B5766D,earnings,100,50,4/18/2019
B76C82,settlement,100,56,4/18/2019
BB88B6,partnership,100,61,4/18/2019
BDCC11,legal-issues-defendant,100,22,4/18/2019
BDCC11,legal-issues-defendant,100,22,4/18/2019
BE14CF,conference-participant,100,50,4/18/2019
BFE02C,earnings-positive,100,69,4/18/2019
BFEA04,conference-call,100,50,4/18/2019
C0200F,earnings,100,50,4/18/2019
C0200F,earnings,100,50,4/18/2019
C38440,earnings,100,50,4/18/2019
C3BAE7,earnings,100,50,4/18/2019
C3CF29,earnings,100,50,4/18/2019
C5C137,partnership,100,61,4/18/2019
C62AA4,conference-call,100,50,4/18/2019
C8A248,product-release,100,64,4/18/2019
C8A248,product-release,100,64,4/18/2019
CAB222,conference-call,100,50,4/18/2019
CBBFBF,earnings,100,50,4/18/2019
CBDB4D,public-offering,100,43,4/18/2019
CC35BE,legal-issues-defendant,100,22,4/18/2019
CE96E7,executive-appointment,100,54,4/18/2019
CEC08B,earnings,100,50,4/18/2019
CFD4B6,conference-call,100,50,4/18/2019
CFF15D,conference-call,100,50,4/18/2019
D06996,earnings,100,50,4/18/2019
D0DE27,earnings,100,50,4/18/2019
D58A11,executive-appointment,100,54,4/18/2019
D8442A,legal-issues-defendant,100,22,4/18/2019
D854DD,conference-call,100,50,4/18/2019
D8F347,earnings-up,100,68,4/18/2019
D8F347,earnings-up,100,68,4/18/2019
DB7EC3,earnings,100,50,4/18/2019
DB7EC3,earnings,100,50,4/18/2019
DDB002,conference-call,100,50,4/18/2019
DDCB34,conference-call,100,50,4/18/2019
DDEA6A,earnings,100,50,4/18/2019
E124EB,earnings,100,50,4/18/2019
E124EB,earnings,100,50,4/18/2019
E124EB,earnings,100,50,4/18/2019
E124EB,earnings,100,50,4/18/2019
E22FDE,unit-acquisition-acquiree,100,76,4/18/2019
E22FDE,legal-issues-defendant,100,22,4/18/2019
E22FDE,legal-issues-defendant,100,22,4/18/2019
E2CFD2,conference-call,100,50,4/18/2019
E2F66E,conference-call,100,50,4/18/2019
E393B0,earnings-up,100,68,4/18/2019
E393B0,earnings-up,100,68,4/18/2019
E393B0,earnings-up,100,68,4/18/2019
E393B0,earnings-up,100,68,4/18/2019
E49AA3,earnings,100,50,4/18/2019
E68E62,public-offering,100,43,4/18/2019
E6A53A,earnings,100,50,4/18/2019
E72599,ipo-pricing,100,50,4/18/2019
E802CE,conference-call,100,50,4/18/2019
E802CE,legal-issues-defendant,100,22,4/18/2019
E84500,dividend-up,100,81,4/18/2019
E8846E,earnings-up,100,68,4/18/2019
E8B315,earnings-positive,100,69,4/18/2019
E8D221,dividend-up,100,55,4/18/2019
E94704,earnings,100,50,4/18/2019
E94704,earnings,100,50,4/18/2019
E94704,earnings,100,50,4/18/2019
E94704,earnings,100,50,4/18/2019
E94704,earnings,100,50,4/18/2019
EAEBF3,earnings,100,50,4/18/2019
EB2F14,earnings,100,50,4/18/2019
F30508,clinical-trials,100,56,4/18/2019
F32F88,conference-participant,100,50,4/18/2019
F4F46F,conference-call,100,50,4/18/2019
F4F46F,partnership,100,61,4/18/2019
F6DCE4,product-recall,100,29,4/18/2019
F6E248,earnings,100,50,4/18/2019
F702CA,earnings,100,50,4/18/2019
F702CA,earnings,100,50,4/18/2019
F702CA,earnings,100,50,4/18/2019
F702CA,earnings,100,50,4/18/2019
F702CA,earnings,100,50,4/18/2019
F8DE55,legal-issues-defendant,100,22,4/18/2019
FA36A4,dividend,100,50,4/18/2019
FACF19,dividend,100,50,4/18/2019
FB728F,dividend,100,50,4/18/2019
FC4550,earnings,100,50,4/18/2019
FC80E6,conference-call,100,50,4/18/2019
FD6926,conference-call,100,50,4/18/2019
099A92,acquisition-acquiree,100,76,4/19/2019
0FC848,trading-listing,100,61,4/19/2019
108BD2,earnings-up,100,69,4/19/2019
108BD2,earnings,100,50,4/19/2019
108BD2,earnings,100,50,4/19/2019
108BD2,earnings,100,50,4/19/2019
139303,conference-call,100,50,4/19/2019
1E5786,executive-appointment,100,54,4/19/2019
2CA60F,earnings,100,50,4/19/2019
2EB04E,legal-issues-defendant,100,22,4/19/2019
2F98A5,dividend,100,50,4/19/2019
319BE2,conference-call,100,50,4/19/2019
55438C,legal-issues-defendant,100,22,4/19/2019
5D63F1,dividend,100,50,4/19/2019
5D87DF,earnings,100,50,4/19/2019
633043,earnings,100,50,4/19/2019
647143,dividend,100,50,4/19/2019
66CB62,earnings,100,50,4/19/2019
69CE71,legal-issues-defendant,100,22,4/19/2019
6B5379,earnings,100,50,4/19/2019
6BC6F9,earnings,100,50,4/19/2019
72609A,conference-call,100,50,4/19/2019
726EEA,earnings,100,50,4/19/2019
746373,conference-participant,100,50,4/19/2019
7A3633,product-release,100,64,4/19/2019
7ACD98,conference-call,100,50,4/19/2019
7B1E50,executive-appointment,100,54,4/19/2019
7B4B91,conference-call,100,50,4/19/2019
7F0372,earnings,100,50,4/19/2019
8B9B3B,legal-issues-defendant,100,22,4/19/2019
8BFAA4,conference-call,100,50,4/19/2019
911ACB,earnings,100,50,4/19/2019
93D207,executive-appointment,100,54,4/19/2019
9981C6,earnings,100,50,4/19/2019
9D2790,strike,100,25,4/19/2019
A247F5,earnings,100,50,4/19/2019
AAC8B6,conference-call,100,50,4/19/2019
AAC8B6,conference-call,100,50,4/19/2019
AFEC35,executive-appointment,100,54,4/19/2019
B2D799,legal-issues-defendant,100,22,4/19/2019
BDCC11,legal-issues-defendant,100,22,4/19/2019
BEB756,dividend,100,50,4/19/2019
C9E107,dividend,100,50,4/19/2019
CC35BE,legal-issues-defendant,100,22,4/19/2019
D3FD6D,conference-call,100,50,4/19/2019
D90F43,stake-acquiree,100,62,4/19/2019
DAC66A,earnings,100,50,4/19/2019
DE20DF,executive-appointment,100,54,4/19/2019
E124EB,executive-appointment,100,54,4/19/2019
E22FDE,legal-issues-defendant,100,22,4/19/2019
E22FDE,legal-issues-defendant,100,22,4/19/2019
E8E899,conference-call,100,50,4/19/2019
EA4E68,earnings,100,50,4/19/2019
F5C78B,dividend,100,50,4/19/2019
F8DE55,legal-issues-defendant,100,22,4/19/2019
02870F,facility-open,100,65,4/22/2019
0325B7,business-contract,100,69,4/22/2019
0A7650,earnings,100,50,4/22/2019
0B13E8,conference-call,100,50,4/22/2019
0B2071,dividend-up,100,81,4/22/2019
0D03C8,earnings,100,50,4/22/2019
11A49E,executive-appointment,100,54,4/22/2019
1220D2,earnings,100,50,4/22/2019
15B10D,conference-call,100,50,4/22/2019
1748F6,executive-appointment,100,54,4/22/2019
1782D5,earnings,100,50,4/22/2019
184988,executive-appointment,100,54,4/22/2019
1B16C1,earnings,100,50,4/22/2019
1E5786,dividend-up,100,68,4/22/2019
1EBF8D,regulatory-product-approval-granted,100,81,4/22/2019
1EBF8D,regulatory-product-approval-granted,100,81,4/22/2019
1EBF8D,regulatory-product-approval-granted,100,81,4/22/2019
1EBF8D,regulatory-product-approval-granted,100,81,4/22/2019
1EBF8D,regulatory-product-approval-granted,100,81,4/22/2019
1FCC00,fundraising,100,64,4/22/2019
1FE3CB,dividend,100,50,4/22/2019
1FE3CB,operating-earnings,100,50,4/22/2019
206852,earnings,100,50,4/22/2019
20BEEA,earnings,100,50,4/22/2019
20BEEA,earnings,100,50,4/22/2019
20BEEA,earnings,100,50,4/22/2019
20BEEA,conference-call,100,50,4/22/2019
21D903,legal-issues-defendant,100,22,4/22/2019
228D42,partnership,100,61,4/22/2019
241AF7,conference-call,100,50,4/22/2019
2491BC,partnership,100,61,4/22/2019
2491BC,partnership,100,61,4/22/2019
27C10F,earnings,100,50,4/22/2019
28DCF3,earnings-up,100,90,4/22/2019
2ABF77,conference-call,100,50,4/22/2019
2B49F4,earnings,100,50,4/22/2019
2B49F4,earnings,100,50,4/22/2019
2B49F4,earnings,100,50,4/22/2019
2B49F4,earnings,100,50,4/22/2019
2DC88B,executive-appointment,100,54,4/22/2019
2E6514,product-release,100,64,4/22/2019
2E902B,earnings,100,50,4/22/2019
2E902B,earnings,100,50,4/22/2019
309922,earnings,100,50,4/22/2019
3461CF,sponsorship,100,57,4/22/2019
35B907,earnings,100,50,4/22/2019
35B907,earnings,100,50,4/22/2019
36A1CB,conference-call,100,50,4/22/2019
370C50,earnings,100,50,4/22/2019
382EAE,conference-call,100,50,4/22/2019
38FB49,earnings,100,50,4/22/2019
38FB49,earnings,100,50,4/22/2019
38FB49,earnings,100,50,4/22/2019
38FB49,earnings,100,50,4/22/2019
38FB49,earnings,100,50,4/22/2019
38FB49,earnings,100,50,4/22/2019
38FB49,earnings,100,50,4/22/2019
38FB49,earnings,100,50,4/22/2019
396D7C,executive-appointment,100,54,4/22/2019
3A4BDB,earnings-positive,100,69,4/22/2019
3AAEAE,ipo-completed,100,76,4/22/2019
3C3B6B,earnings,100,50,4/22/2019
3DE4D1,earnings,100,50,4/22/2019
425BDC,executive-appointment,100,54,4/22/2019
442769,conference-call,100,50,4/22/2019
45ABCC,revenue-volume-up,100,69,4/22/2019
4B49CF,product-release,100,64,4/22/2019
4C6C63,product-release,100,64,4/22/2019
4D371E,earnings,100,50,4/22/2019
4EEB00,partnership,100,61,4/22/2019
4F9926,product-release,100,64,4/22/2019
514067,conference-call,100,50,4/22/2019
5480A7,earnings,100,50,4/22/2019
548AC0,conference-call,100,50,4/22/2019
55CD6F,legal-issues-defendant,100,22,4/22/2019
57634F,earnings,100,50,4/22/2019
57DDB9,conference-call,100,50,4/22/2019
59A832,conference-call,100,50,4/22/2019
5EC388,earnings,100,50,4/22/2019
5F6D73,executive-resignation,100,44,4/22/2019
5FF95F,earnings,100,50,4/22/2019
605F40,business-contract,100,69,4/22/2019
610D47,earnings,100,50,4/22/2019
61E975,conference-call,100,50,4/22/2019
647143,earnings,100,50,4/22/2019
647143,earnings,100,50,4/22/2019
647143,earnings,100,50,4/22/2019
6.52E+64,executive-appointment,100,54,4/22/2019
6634D9,earnings,100,50,4/22/2019
66667F,partnership,100,61,4/22/2019
6BC6F9,product-release,100,64,4/22/2019
6BC6F9,product-release,100,64,4/22/2019
6CD55A,earnings,100,50,4/22/2019
6D3F35,conference-call,100,50,4/22/2019
6DD6BA,earnings,100,50,4/22/2019
6DD6BA,earnings,100,50,4/22/2019
6DD6BA,earnings,100,50,4/22/2019
6E8349,earnings,100,50,4/22/2019
6EB9DA,earnings,100,50,4/22/2019
6EB9DA,earnings,100,50,4/22/2019
6EB9DA,earnings,100,50,4/22/2019
6F3936,note-sale,100,52,4/22/2019
75F665,earnings,100,50,4/22/2019
75F665,earnings,100,50,4/22/2019
75F665,earnings,100,50,4/22/2019
790C34,partnership,100,61,4/22/2019
7A5097,conference-call,100,50,4/22/2019
7AC86E,partnership,100,61,4/22/2019
7C75FD,conference-call,100,50,4/22/2019
7DC1C4,earnings,100,50,4/22/2019
7DD8CC,conference-call,100,50,4/22/2019
7EA323,exchange-noncompliance,100,24,4/22/2019
7F3669,earnings,100,50,4/22/2019
7F3A5F,executive-appointment,100,54,4/22/2019
7F9E16,conference-call,100,50,4/22/2019
7FDE1C,business-contract,100,69,4/22/2019
7FEEE1,public-offering,100,43,4/22/2019
82F088,conference-call,100,50,4/22/2019
835C86,dividend,100,50,4/22/2019
859281,dividend,100,50,4/22/2019
859281,earnings,100,50,4/22/2019
859281,earnings,100,50,4/22/2019
859281,earnings,100,50,4/22/2019
859281,earnings,100,50,4/22/2019
859281,earnings,100,50,4/22/2019
85AD00,earnings,100,50,4/22/2019
85DE00,partnership,100,61,4/22/2019
868808,operating-earnings,100,50,4/22/2019
86A1B9,executive-appointment,100,54,4/22/2019
881190,earnings,100,50,4/22/2019
881190,earnings,100,50,4/22/2019
881190,earnings,100,50,4/22/2019
881190,earnings,100,50,4/22/2019
885758,earnings,100,50,4/22/2019
890FF4,earnings,100,50,4/22/2019
8A8E41,earnings,100,50,4/22/2019
8E93A4,earnings,100,50,4/22/2019
901327,earnings,100,50,4/22/2019
902255,earnings,100,50,4/22/2019
903AB4,earnings,100,50,4/22/2019
92D9C9,conference-call,100,50,4/22/2019
94563D,partnership,100,61,4/22/2019
94C0B5,earnings,100,50,4/22/2019
9592FB,partnership,100,61,4/22/2019
966DBE,earnings,100,50,4/22/2019
979451,earnings,100,50,4/22/2019
97B027,conference-call,100,50,4/22/2019
986AF6,conference-call,100,50,4/22/2019
997348,earnings,100,50,4/22/2019
997348,earnings,100,50,4/22/2019
9B71A7,executive-appointment,100,54,4/22/2019
9D2790,earnings,100,50,4/22/2019
9D5FA4,executive-appointment,100,54,4/22/2019
9E4A5F,earnings,100,50,4/22/2019
A398B9,business-contract,100,69,4/22/2019
A41450,earnings,100,50,4/22/2019
A65325,partnership,100,61,4/22/2019
A8CBDA,conference-participant,100,50,4/22/2019
AA247D,earnings,100,50,4/22/2019
AC642C,earnings,100,50,4/22/2019
AC642C,earnings,100,50,4/22/2019
ACC7D3,earnings,100,50,4/22/2019
AD1ACF,conference-call,100,50,4/22/2019
ADF1B0,earnings,100,50,4/22/2019
ADF1B0,earnings,100,50,4/22/2019
ADF1B0,earnings,100,50,4/22/2019
AEBB80,earnings,100,50,4/22/2019
B2F431,earnings-positive,100,69,4/22/2019
B5766D,dividend,100,50,4/22/2019
B7FA9B,conference-participant,100,50,4/22/2019
BDD12C,earnings-up,100,68,4/22/2019
BDF2BD,conference-call,100,50,4/22/2019
C1114B,conference-call,100,50,4/22/2019
C15DB3,executive-appointment,100,54,4/22/2019
C29715,earnings,100,50,4/22/2019
C29715,earnings,100,50,4/22/2019
C4FBDC,conference-call,100,50,4/22/2019
C598D7,revenue-up,100,71,4/22/2019
C598D7,revenues,100,50,4/22/2019
C598D7,revenues,100,50,4/22/2019
C74887,executive-appointment,100,54,4/22/2019
C941DC,executive-appointment,100,54,4/22/2019
CC6FF5,partnership,100,61,4/22/2019
CC6FF5,earnings,100,50,4/22/2019
CCB623,earnings,100,50,4/22/2019
CFE5BE,earnings,100,50,4/22/2019
CFE5BE,earnings,100,50,4/22/2019
CFE5BE,earnings,100,50,4/22/2019
CFE5BE,earnings,100,50,4/22/2019
CFE5BE,earnings,100,50,4/22/2019
CFE5BE,earnings,100,50,4/22/2019
CFE5BE,earnings,100,50,4/22/2019
CFE5BE,earnings,100,50,4/22/2019
D13F1C,conference-participant,100,50,4/22/2019
D8442A,legal-issues-defendant,100,22,4/22/2019
D9B1C9,unit-acquisition-acquirer,100,49,4/22/2019
DA90E1,earnings,100,50,4/22/2019
DBFB51,conference-call,100,50,4/22/2019
DC0066,regulatory-product-approval-granted,100,81,4/22/2019
E09997,conference-call,100,50,4/22/2019
E1E093,product-release,100,64,4/22/2019
E610CD,award,100,58,4/22/2019
E6EDED,earnings,100,50,4/22/2019
E70531,earnings,100,50,4/22/2019
E802CE,legal-issues-defendant,100,22,4/22/2019
E82A2D,conference-call,100,50,4/22/2019
E87676,dividend,100,50,4/22/2019
E8846E,legal-issues-defendant,100,22,4/22/2019
E9E6FD,unit-acquisition-acquirer,100,49,4/22/2019
E9E6FD,unit-acquisition-acquirer,100,49,4/22/2019
E9FF33,partnership,100,61,4/22/2019
EAA0A7,earnings,100,50,4/22/2019
EB61C4,earnings,100,50,4/22/2019
ECDEB2,earnings,100,50,4/22/2019
F04E05,earnings,100,50,4/22/2019
F0A9DE,earnings,100,50,4/22/2019
F31B13,earnings-up,100,68,4/22/2019
F44EA2,earnings,100,50,4/22/2019
F4E882,legal-issues-defendant,100,22,4/22/2019
F5C78B,earnings,100,50,4/22/2019
F748C7,product-release,100,64,4/22/2019
F80FF9,conference-call,100,50,4/22/2019
F8DE55,legal-issues-defendant,100,22,4/22/2019
FA40E2,legal-issues-defendant,100,22,4/22/2019
FE9C0D,fundraising,100,64,4/22/2019
0157B1,partnership,100,61,4/23/2019
0157B1,partnership,100,61,4/23/2019
31025,earnings,100,50,4/23/2019
31025,earnings,100,50,4/23/2019
31025,earnings,100,50,4/23/2019
31025,earnings,100,50,4/23/2019
03B431,conference-call,100,50,4/23/2019
053EFF,conference-call,100,50,4/23/2019
0C2A0D,earnings,100,50,4/23/2019
0C355F,conference-call,100,50,4/23/2019
0CE204,earnings,100,50,4/23/2019
0EF1AF,business-contract,100,69,4/23/2019
0FABBD,award,100,58,4/23/2019
0FC848,earnings,100,50,4/23/2019
102727,earnings,100,50,4/23/2019
102727,earnings,100,50,4/23/2019
102727,earnings,100,50,4/23/2019
102727,earnings,100,50,4/23/2019
14833D,earnings,100,50,4/23/2019
1E9A6D,earnings,100,50,4/23/2019
1F9D90,earnings,100,50,4/23/2019
225CA2,executive-appointment,100,54,4/23/2019
228D42,partnership,100,61,4/23/2019
228D42,partnership,100,61,4/23/2019
2491BC,earnings,100,50,4/23/2019
2491BC,earnings,100,50,4/23/2019
2491BC,earnings,100,50,4/23/2019
24C48B,conference-call,100,50,4/23/2019
251988,product-release,100,64,4/23/2019
251988,legal-issues-defendant,100,22,4/23/2019
25A6CC,earnings,100,50,4/23/2019
25A6CC,earnings,100,50,4/23/2019
25A6CC,earnings,100,50,4/23/2019
2667B6,earnings,100,50,4/23/2019
282C18,earnings,100,50,4/23/2019
28B730,earnings,100,50,4/23/2019
2.90E+62,partnership,100,61,4/23/2019
2B9DBB,earnings,100,50,4/23/2019
2BC05E,earnings,100,50,4/23/2019
2BC05E,earnings,100,50,4/23/2019
2BC05E,earnings,100,50,4/23/2019
2CB4C9,earnings,100,50,4/23/2019
2D643C,dividend,100,50,4/23/2019
2D643C,executive-appointment,100,54,4/23/2019
2E2E6E,earnings-up,100,68,4/23/2019
2E61CC,earnings,100,50,4/23/2019
2E89AE,earnings,100,50,4/23/2019
2F1299,conference-call,100,50,4/23/2019
2F5256,earnings,100,50,4/23/2019
2F9304,market-share-gain,100,81,4/23/2019
2F960F,conference-call,100,50,4/23/2019
315EB0,unit-acquisition-acquirer,100,49,4/23/2019
32C8CD,earnings,100,50,4/23/2019
387541,earnings,100,50,4/23/2019
389CFB,conference-call,100,50,4/23/2019
39BFF6,earnings,100,50,4/23/2019
39BFF6,earnings,100,50,4/23/2019
39BFF6,earnings,100,50,4/23/2019
3A3447,facility-open,100,65,4/23/2019
3A3948,earnings,100,50,4/23/2019
3BA1BF,conference-call,100,50,4/23/2019
3CCC90,earnings,100,50,4/23/2019
3CCC90,dividend,100,50,4/23/2019
3F6A9C,dividend,100,50,4/23/2019
408089,earnings,100,50,4/23/2019
408380,earnings,100,50,4/23/2019
40F7DE,legal-issues-defendant,100,22,4/23/2019
41785E,earnings,100,50,4/23/2019
423279,executive-appointment,100,54,4/23/2019
435ACE,dividend,100,50,4/23/2019
44740A,conference-call,100,50,4/23/2019
44A4FC,investment-investor,100,55,4/23/2019
44DDBD,conference-call,100,50,4/23/2019
4591D3,revenues,100,50,4/23/2019
492117,earnings,100,50,4/23/2019
49BBBC,product-release,100,64,4/23/2019
4A3438,executive-appointment,100,54,4/23/2019
4A6F00,partnership,100,61,4/23/2019
4A7C1F,name-change,100,49,4/23/2019
4B3DC9,earnings-positive,100,69,4/23/2019
4C37C5,dividend,100,50,4/23/2019
4C6C63,dividend,100,50,4/23/2019
4DD09F,earnings,100,50,4/23/2019
4EE14A,earnings,100,50,4/23/2019
4EE14A,earnings,100,50,4/23/2019
5065B1,credit-extension-provider,100,57,4/23/2019
55438C,board-meeting,100,51,4/23/2019
55438C,legal-issues-defendant,100,22,4/23/2019
56277A,conference-participant,100,50,4/23/2019
56AFF4,dividend,100,50,4/23/2019
583A75,earnings,100,50,4/23/2019
58CA9A,product-release,100,64,4/23/2019
596116,earnings,100,50,4/23/2019
5B3FA2,earnings,100,50,4/23/2019
5BC2F4,earnings-positive,100,69,4/23/2019
5BE42C,dividend,100,50,4/23/2019
5DA8B3,earnings,100,50,4/23/2019
5F60CE,earnings,100,50,4/23/2019
5F9CE3,earnings,100,50,4/23/2019
6137BF,earnings,100,50,4/23/2019
6137BF,earnings,100,50,4/23/2019
62B1C6,dividend,100,50,4/23/2019
665618,revenue-up,100,69,4/23/2019
665618,revenue-up,100,69,4/23/2019
694749,partnership,100,61,4/23/2019
69FDFC,partnership,100,61,4/23/2019
6B0E45,dividend,100,50,4/23/2019
6B0E45,dividend,100,50,4/23/2019
6C4D2F,dividend-up,100,81,4/23/2019
6C4D2F,dividend-up,100,81,4/23/2019
6C4D2F,dividend-up,100,81,4/23/2019
6C4D2F,dividend-up,100,81,4/23/2019
6C4D2F,dividend-up,100,81,4/23/2019
6C4D2F,dividend-up,100,81,4/23/2019
6D156D,earnings,100,50,4/23/2019
6D4636,conference-call,100,50,4/23/2019
6F0096,earnings,100,50,4/23/2019
6F0096,earnings,100,50,4/23/2019
6F0096,earnings,100,50,4/23/2019
701531,earnings,100,50,4/23/2019
717DB4,earnings,100,50,4/23/2019
7255D2,executive-appointment,100,54,4/23/2019
7262F2,earnings,100,50,4/23/2019
72EF75,earnings,100,50,4/23/2019
7520CC,stock-splits,100,49,4/23/2019
75F665,earnings-up,100,68,4/23/2019
75F665,earnings,100,50,4/23/2019
75F665,earnings,100,50,4/23/2019
75F665,earnings,100,50,4/23/2019
75F665,earnings,100,50,4/23/2019
75F665,earnings,100,50,4/23/2019
75F665,earnings,100,50,4/23/2019
75F665,earnings,100,50,4/23/2019
75F665,dividend,100,50,4/23/2019
765913,dividend,100,50,4/23/2019
77B8E9,patent-awarded,100,72,4/23/2019
78A1BB,earnings,100,50,4/23/2019
78A1BB,earnings,100,50,4/23/2019
78A1BB,earnings,100,50,4/23/2019
7B0BA6,dividend,100,50,4/23/2019
7B1E50,earnings,100,50,4/23/2019
7B1E50,settlement,100,56,4/23/2019
7B1E50,settlement,100,56,4/23/2019
7C62A3,conference-call,100,50,4/23/2019
7D35D8,earnings,100,50,4/23/2019
7D35D8,earnings,100,50,4/23/2019
7D35D8,earnings,100,50,4/23/2019
7D5FD6,earnings,100,50,4/23/2019
7E1D5D,partnership,100,61,4/23/2019
7E1D5D,award,100,58,4/23/2019
7F9984,conference-participant,100,50,4/23/2019
81F4BE,earnings,100,50,4/23/2019
81F4BE,earnings,100,50,4/23/2019
81F4BE,earnings,100,50,4/23/2019
81F4BE,earnings,100,50,4/23/2019
8377DB,earnings,100,50,4/23/2019
8377DB,earnings,100,50,4/23/2019
8377DB,earnings,100,50,4/23/2019
8377DB,earnings,100,50,4/23/2019
8377DB,earnings,100,50,4/23/2019
83A065,conference-call,100,50,4/23/2019
845655,conference-call,100,50,4/23/2019
845655,conference-call,100,50,4/23/2019
862941,earnings,100,50,4/23/2019
8A8E41,earnings,100,50,4/23/2019
8A8E41,earnings,100,50,4/23/2019
8A8E41,earnings,100,50,4/23/2019
8A8E41,earnings,100,50,4/23/2019
8A8E41,partnership,100,61,4/23/2019
8AB37F,conference-participant,100,50,4/23/2019
8B2C4A,earnings,100,50,4/23/2019
8B2C4A,earnings,100,50,4/23/2019
8B2C4A,earnings,100,50,4/23/2019
8B2C4A,earnings,100,50,4/23/2019
8B2C4A,earnings,100,50,4/23/2019
8B2C4A,earnings,100,50,4/23/2019
8B2C4A,earnings,100,50,4/23/2019
8BFE9A,earnings,100,50,4/23/2019
8CF6DD,dividend,100,50,4/23/2019
8CF6DD,executive-appointment,100,54,4/23/2019
8D4486,partnership,100,61,4/23/2019
8DAAB9,earnings-up,100,68,4/23/2019
8DCF18,conference-call,100,50,4/23/2019
8EEA28,dividend,100,50,4/23/2019
8F6995,earnings-guidance,100,50,4/23/2019
901327,legal-issues-defendant,100,22,4/23/2019
93F143,earnings,100,50,4/23/2019
93F143,earnings,100,50,4/23/2019
93F143,earnings,100,50,4/23/2019
944B2E,earnings,100,50,4/23/2019
9548BB,earnings-per-share-up,100,68,4/23/2019
9548BB,earnings,100,50,4/23/2019
9548BB,earnings,100,50,4/23/2019
95C575,earnings,100,50,4/23/2019
96F126,earnings,100,50,4/23/2019
96F126,earnings,100,50,4/23/2019
96F126,business-contract,100,69,4/23/2019
972356,earnings,100,50,4/23/2019
972356,earnings,100,50,4/23/2019
972356,earnings,100,50,4/23/2019
972356,earnings,100,50,4/23/2019
97AF94,earnings,100,50,4/23/2019
986AF6,earnings,100,50,4/23/2019
986AF6,earnings,100,50,4/23/2019
990AD0,hirings,100,65,4/23/2019
990AD0,conference-organizer,100,57,4/23/2019
99DC8D,conference-call,100,50,4/23/2019
9A2760,earnings,100,50,4/23/2019
9C8664,earnings,100,50,4/23/2019
9EA947,earnings,100,50,4/23/2019
9EA947,unit-acquisition-acquirer,100,49,4/23/2019
9F37C5,conference-call,100,50,4/23/2019
9F6B1A,business-contract,100,69,4/23/2019
A398B9,earnings,100,50,4/23/2019
A398B9,earnings,100,50,4/23/2019
A398B9,earnings,100,50,4/23/2019
A3F598,conference-call,100,50,4/23/2019
A47A7D,legal-issues-defendant,100,22,4/23/2019
A495F7,product-release,100,64,4/23/2019
A4D173,earnings,100,50,4/23/2019
A4D173,earnings,100,50,4/23/2019
A5A4F5,acquisition-acquirer,100,49,4/23/2019
A60354,conference-call,100,50,4/23/2019
A65325,dividend,100,50,4/23/2019
A65325,earnings-positive,100,69,4/23/2019
A666C8,executive-appointment,100,54,4/23/2019
A7102F,conference-call,100,50,4/23/2019
A8B137,earnings,100,50,4/23/2019
A8B137,earnings,100,50,4/23/2019
A8B137,earnings,100,50,4/23/2019
A8B137,earnings,100,50,4/23/2019
A8B137,earnings,100,50,4/23/2019
AA5C8E,trading-halt,100,43,4/23/2019
AC7C4F,award,100,58,4/23/2019
ACD9A4,earnings,100,50,4/23/2019
AD23DE,conference-call,100,50,4/23/2019
AE79CD,earnings,100,50,4/23/2019
B0998E,earnings,100,50,4/23/2019
B2DAF6,earnings,100,50,4/23/2019
B2DAF6,earnings,100,50,4/23/2019
B2DAF6,earnings,100,50,4/23/2019
B37FB4,earnings-up,100,68,4/23/2019
B48FC9,earnings,100,50,4/23/2019
B604DF,earnings,100,50,4/23/2019
B604DF,earnings,100,50,4/23/2019
B604DF,earnings,100,50,4/23/2019
B604DF,dividend,100,50,4/23/2019
B642E8,earnings,100,50,4/23/2019
B73395,conference-call,100,50,4/23/2019
B8F71F,earnings,100,50,4/23/2019
B96637,conference-call,100,50,4/23/2019
BB0587,executive-appointment,100,54,4/23/2019
BCC55F,partnership,100,61,4/23/2019
BD15E8,earnings,100,50,4/23/2019
BD9668,earnings-per-share-positive,100,69,4/23/2019
BD9668,earnings-per-share-positive,100,69,4/23/2019
BD9668,earnings-per-share-positive,100,69,4/23/2019
BD9668,earnings-per-share-positive,100,69,4/23/2019
BD9668,earnings-per-share-positive,100,69,4/23/2019
BE14CF,conference-participant,100,50,4/23/2019
C01737,patient-enrollment-start,100,58,4/23/2019
C32A39,earnings-per-share-positive,100,69,4/23/2019
C45CE7,earnings,100,50,4/23/2019
C72B8F,conference-call,100,50,4/23/2019
C81E00,operating-earnings,100,50,4/23/2019
C81E00,operating-earnings,100,50,4/23/2019
C97B2D,legal-issues-defendant,100,22,4/23/2019
C97B2D,regulatory-product-approval-granted,100,81,4/23/2019
C99CC8,product-release,100,64,4/23/2019
CBA33B,dividend,100,50,4/23/2019
CC8F6E,earnings,100,50,4/23/2019
CD06A2,dividend,100,50,4/23/2019
CDAF5B,operating-earnings,100,50,4/23/2019
CDC217,conference-call,100,50,4/23/2019
D04D9F,conference-call,100,50,4/23/2019
D06755,conference-participant,100,50,4/23/2019
D0C79E,legal-issues-defendant,100,22,4/23/2019
D1173F,earnings,100,50,4/23/2019
D1173F,earnings,100,50,4/23/2019
D1173F,earnings,100,50,4/23/2019
D1173F,earnings,100,50,4/23/2019
D1173F,earnings,100,50,4/23/2019
D139BC,earnings,100,50,4/23/2019
D13F1C,conference-call,100,50,4/23/2019
D17C1B,earnings,100,50,4/23/2019
D17C1B,earnings,100,50,4/23/2019
D17C1B,earnings,100,50,4/23/2019
D29F43,conference-call,100,50,4/23/2019
D4AC65,product-release,100,64,4/23/2019
D501DC,earnings,100,50,4/23/2019
D54E62,business-contract,100,69,4/23/2019
D6534D,conference-call,100,50,4/23/2019
D6EAA3,award,100,58,4/23/2019
D7918D,dividend,100,50,4/23/2019
D9B1C9,executive-appointment,100,54,4/23/2019
D9B1C9,dividend,100,50,4/23/2019
D9CAF0,earnings,100,50,4/23/2019
DAC66A,executive-appointment,100,54,4/23/2019
DB7FA7,dividend,100,50,4/23/2019
DBCA3F,executive-appointment,100,54,4/23/2019
DC486E,earnings,100,50,4/23/2019
DDB002,earnings,100,50,4/23/2019
DDC415,earnings,100,50,4/23/2019
DDC415,earnings,100,50,4/23/2019
DF204B,conference-call,100,50,4/23/2019
E09E2B,business-contract,100,69,4/23/2019
E09E2B,business-contract,100,69,4/23/2019
E30A8F,executive-appointment,100,54,4/23/2019
E5752F,earnings,100,50,4/23/2019
E5752F,executive-appointment,100,54,4/23/2019
E68C3D,executive-appointment,100,54,4/23/2019
E69BA5,conference-call,100,50,4/23/2019
E829E8,earnings-per-share-positive,100,69,4/23/2019
E87676,revenues,100,50,4/23/2019
E8846E,conference-organizer,100,57,4/23/2019
E8846E,dividend,100,50,4/23/2019
E8E899,partnership,100,61,4/23/2019
E93A40,executive-appointment,100,54,4/23/2019
E9E6FD,earnings,100,50,4/23/2019
E9FF33,earnings,100,50,4/23/2019
EB61C4,dividend,100,50,4/23/2019
EBD89A,credit-extension-recipient,100,69,4/23/2019
EC1AF3,conference-call,100,50,4/23/2019
ECDEB2,earnings,100,50,4/23/2019
ED0402,revenue-up,100,70,4/23/2019
ED0402,revenue-up,100,70,4/23/2019
ED0402,revenue-up,100,70,4/23/2019
ED0402,revenue-up,100,70,4/23/2019
ED4560,executive-resignation,100,44,4/23/2019
EDF5CA,earnings,100,50,4/23/2019
EDF5CA,earnings,100,50,4/23/2019
EDF5CA,earnings,100,50,4/23/2019
EDF5CA,earnings,100,50,4/23/2019
EDF5CA,earnings,100,50,4/23/2019
EDF5CA,earnings,100,50,4/23/2019
EEA6B3,operating-earnings,100,50,4/23/2019
EF1AD9,business-contract,100,69,4/23/2019
F04E05,dividend,100,50,4/23/2019
F18844,legal-issues-defendant,100,22,4/23/2019
F294DD,earnings,100,50,4/23/2019
F294DD,earnings,100,50,4/23/2019
F294DD,earnings,100,50,4/23/2019
F2E253,facility-open,100,65,4/23/2019
F30508,unit-acquisition-acquiree,100,76,4/23/2019
F40EE2,partnership,100,61,4/23/2019
F48947,earnings,100,50,4/23/2019
F57F6F,earnings,100,50,4/23/2019
F5A214,earnings,100,50,4/23/2019
F5D410,earnings-guidance-up,100,83,4/23/2019
F748C7,product-release,100,64,4/23/2019
FA044A,earnings,100,50,4/23/2019
FA40E2,legal-issues-defendant,100,22,4/23/2019
FADF1A,conference-call,100,50,4/23/2019
FDF799,earnings,100,50,4/23/2019
FE7A63,earnings,100,50,4/23/2019
FE7A63,earnings,100,50,4/23/2019
FE7A63,earnings,100,50,4/23/2019
FE7A63,earnings,100,50,4/23/2019
FE7A63,earnings,100,50,4/23/2019
FE7A63,earnings,100,50,4/23/2019
FE7A63,earnings,100,50,4/23/2019
FE9C0D,fundraising,100,64,4/23/2019
FF6644,earnings,100,50,4/23/2019
FF6644,earnings,100,50,4/23/2019
13528,partnership,100,61,4/24/2019
03CF95,earnings,100,50,4/24/2019
03CF95,earnings,100,50,4/24/2019
03CF95,earnings,100,50,4/24/2019
03CF95,earnings,100,50,4/24/2019
03CF95,earnings,100,50,4/24/2019
03CF95,earnings,100,50,4/24/2019
03FB17,dividend,100,50,4/24/2019
0560D8,earnings,100,50,4/24/2019
0624BE,partnership,100,61,4/24/2019
71860,earnings,100,50,4/24/2019
75172,conference-call,100,50,4/24/2019
081AB9,dividend-down,100,19,4/24/2019
081AB9,earnings,100,50,4/24/2019
0986B5,earnings,100,50,4/24/2019
98977,executive-appointment,100,54,4/24/2019
0B57D7,earnings,100,50,4/24/2019
0C136E,earnings,100,50,4/24/2019
0C4131,merger-failed,100,21,4/24/2019
0C4131,earnings-positive,100,69,4/24/2019
0C466B,revenues,100,50,4/24/2019
0C466B,revenues,100,50,4/24/2019
0C466B,revenues,100,50,4/24/2019
0CBC4D,earnings,100,50,4/24/2019
0DC050,earnings,100,50,4/24/2019
0DC050,earnings,100,50,4/24/2019
0DC050,earnings,100,50,4/24/2019
0E439E,earnings,100,50,4/24/2019
0E439E,earnings,100,50,4/24/2019
0E439E,earnings,100,50,4/24/2019
0E6027,earnings-positive,100,69,4/24/2019
0E6027,earnings,100,50,4/24/2019
10100E,earnings,100,50,4/24/2019
10673F,earnings,100,50,4/24/2019
10673F,earnings,100,50,4/24/2019
10943B,earnings,100,50,4/24/2019
1216D1,earnings,100,50,4/24/2019
126F95,buybacks,100,74,4/24/2019
1272B3,partnership,100,61,4/24/2019
1272B3,executive-appointment,100,54,4/24/2019
12731D,conference-call,100,50,4/24/2019
12E454,earnings,100,50,4/24/2019
12E454,earnings,100,50,4/24/2019
1348C9,earnings,100,50,4/24/2019
1348C9,earnings,100,50,4/24/2019
1348C9,earnings,100,50,4/24/2019
152B9E,earnings,100,50,4/24/2019
15789A,revenue-volume-up,100,52,4/24/2019
157D9F,conference-call,100,50,4/24/2019
159739,earnings,100,50,4/24/2019
159739,earnings,100,50,4/24/2019
165B3A,earnings-positive,100,69,4/24/2019
165B3A,earnings-positive,100,69,4/24/2019
165B3A,earnings-positive,100,69,4/24/2019
168A5D,partnership,100,61,4/24/2019
168A5D,partnership,100,61,4/24/2019
168A5D,product-release,100,64,4/24/2019
197019,earnings,100,50,4/24/2019
19BF16,earnings,100,50,4/24/2019
1C599A,earnings,100,50,4/24/2019
1CD708,earnings-up,100,68,4/24/2019
1D3A00,executive-appointment,100,54,4/24/2019
1DB6A6,buybacks,100,74,4/24/2019
1DE526,earnings,100,50,4/24/2019
1E1125,earnings,100,50,4/24/2019
1E8A99,earnings,100,50,4/24/2019
1EC3E8,executive-appointment,100,54,4/24/2019
1FA8F7,earnings,100,50,4/24/2019
2031CE,earnings-up,100,68,4/24/2019
2031CE,earnings-up,100,68,4/24/2019
2031CE,earnings-up,100,68,4/24/2019
2031CE,earnings-up,100,68,4/24/2019
2031CE,earnings-up,100,68,4/24/2019
2096DE,earnings,100,50,4/24/2019
2158DF,award,100,58,4/24/2019
21DED4,revenues,100,50,4/24/2019
21DED4,revenues,100,50,4/24/2019
21DED4,revenues,100,50,4/24/2019
21DED4,revenues,100,50,4/24/2019
21DED4,revenues,100,50,4/24/2019
21DED4,revenues,100,50,4/24/2019
221445,earnings,100,50,4/24/2019
221AD7,earnings,100,50,4/24/2019
228D42,partnership,100,61,4/24/2019
24D81E,earnings,100,50,4/24/2019
25102A,earnings,100,50,4/24/2019
25102A,earnings,100,50,4/24/2019
25102A,earnings,100,50,4/24/2019
25102A,earnings,100,50,4/24/2019
25102A,earnings,100,50,4/24/2019
25102A,dividend-up,100,57,4/24/2019
251988,legal-issues-defendant,100,22,4/24/2019
251988,earnings,100,50,4/24/2019
251988,earnings,100,50,4/24/2019
251988,earnings,100,50,4/24/2019
251988,earnings,100,50,4/24/2019
25DD05,earnings,100,50,4/24/2019
264EB3,earnings,100,50,4/24/2019
264EB3,earnings,100,50,4/24/2019
264EB3,earnings,100,50,4/24/2019
264EB3,earnings,100,50,4/24/2019
264EB3,earnings,100,50,4/24/2019
26FA41,revenue-up,100,69,4/24/2019
270305,merger,100,66,4/24/2019
270305,merger,100,66,4/24/2019
270305,merger-regulatory-approval,100,81,4/24/2019
270B78,earnings,100,50,4/24/2019
28DCF3,earnings,100,50,4/24/2019
2A17B1,earnings-up,100,68,4/24/2019
2A17B1,earnings-up,100,68,4/24/2019
2A17B1,earnings-up,100,68,4/24/2019
2B0AF4,earnings,100,50,4/24/2019
2B5483,earnings,100,50,4/24/2019
2D2D43,dividend,100,50,4/24/2019
2D643C,earnings,100,50,4/24/2019
2DDB22,earnings-guidance,100,50,4/24/2019
2E6514,earnings,100,50,4/24/2019
2EC172,conference-call,100,50,4/24/2019
2F94A5,earnings,100,50,4/24/2019
2FEA66,operating-earnings,100,50,4/24/2019
31AA84,executive-appointment,100,54,4/24/2019
33E8C7,earnings,100,50,4/24/2019
33E8C7,earnings,100,50,4/24/2019
3461CF,earnings,100,50,4/24/2019
34B411,dividend,100,50,4/24/2019
34B97A,conference-participant,100,50,4/24/2019
367434,executive-appointment,100,54,4/24/2019
37020C,conference-call,100,50,4/24/2019
3.73E+87,revenue-up,100,69,4/24/2019
3.73E+87,revenue-up,100,69,4/24/2019
3.73E+87,revenue-up,100,69,4/24/2019
37426C,earnings,100,50,4/24/2019
382EAE,joint-venture,100,62,4/24/2019
3A113F,earnings,100,50,4/24/2019
3A3447,facility-open,100,65,4/24/2019
3C3B6B,partnership,100,61,4/24/2019
3D9999,dividend,100,50,4/24/2019
40F7DE,legal-issues-defendant,100,22,4/24/2019
41B0E2,earnings,100,50,4/24/2019
422A82,regulatory-product-approval-granted,100,81,4/24/2019
425BDC,earnings,100,50,4/24/2019
427F32,conference-call,100,50,4/24/2019
43A060,earnings,100,50,4/24/2019
43A060,legal-issues-defendant,100,22,4/24/2019
442587,executive-appointment,100,54,4/24/2019
4455C4,earnings,100,50,4/24/2019
4455C4,earnings,100,50,4/24/2019
4455C4,earnings,100,50,4/24/2019
458D2C,earnings,100,50,4/24/2019
45ABCC,earnings,100,50,4/24/2019
468DD4,earnings,100,50,4/24/2019
47752F,earnings,100,50,4/24/2019
47752F,earnings,100,50,4/24/2019
47752F,earnings,100,50,4/24/2019
47752F,earnings,100,50,4/24/2019
4A5C8D,dividend,100,50,4/24/2019
4B3555,earnings,100,50,4/24/2019
4B5054,dividend,100,50,4/24/2019
4BD6DB,earnings,100,50,4/24/2019
4C1FA1,earnings,100,50,4/24/2019
4C1FA1,earnings,100,50,4/24/2019
4C1FA1,earnings,100,50,4/24/2019
4C1FA1,earnings,100,50,4/24/2019
4C5CC9,conference-call,100,50,4/24/2019
4C6C63,earnings,100,50,4/24/2019
4C6C63,earnings,100,50,4/24/2019
4C6C63,earnings,100,50,4/24/2019
4C6C63,earnings,100,50,4/24/2019
4C6C63,earnings,100,50,4/24/2019
4C6C63,earnings,100,50,4/24/2019
4D229C,earnings,100,50,4/24/2019
4D72C8,conference-call,100,50,4/24/2019
4D72C8,conference-call,100,50,4/24/2019
4D7BD8,earnings-up,100,68,4/24/2019
4D7BD8,earnings-up,100,68,4/24/2019
4D7BD8,earnings-up,100,68,4/24/2019
4D7BD8,earnings-up,100,68,4/24/2019
4D7BD8,earnings-up,100,68,4/24/2019
4D7BD8,earnings-up,100,68,4/24/2019
4D7BD8,earnings-up,100,68,4/24/2019
4D7BD8,earnings-up,100,68,4/24/2019
4D8313,earnings,100,50,4/24/2019
4D8313,earnings,100,50,4/24/2019
4D971D,dividend,100,50,4/24/2019
4D971D,earnings-up,100,68,4/24/2019
4D971D,earnings-up,100,68,4/24/2019
4D971D,earnings-up,100,68,4/24/2019
4D971D,earnings-up,100,68,4/24/2019
4D971D,earnings-up,100,68,4/24/2019
4E7C1F,earnings,100,50,4/24/2019
4E7C1F,earnings,100,50,4/24/2019
4E7C1F,earnings,100,50,4/24/2019
4EE14A,executive-appointment,100,54,4/24/2019
4EE14A,executive-appointment,100,54,4/24/2019
4F9487,earnings-positive,100,69,4/24/2019
4F9487,earnings-positive,100,69,4/24/2019
4F9487,earnings-positive,100,69,4/24/2019
4F9487,earnings-positive,100,69,4/24/2019
4F9487,earnings-positive,100,69,4/24/2019
4F9487,earnings-positive,100,69,4/24/2019
4F9487,earnings-positive,100,69,4/24/2019
5065B1,earnings,100,50,4/24/2019
513A86,earnings,100,50,4/24/2019
51888A,dividend,100,50,4/24/2019
51E682,earnings,100,50,4/24/2019
51F541,earnings,100,50,4/24/2019
532D47,earnings,100,50,4/24/2019
5.43E+08,earnings,100,50,4/24/2019
54A646,dividend,100,50,4/24/2019
553949,conference-call,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,earnings,100,50,4/24/2019
55438C,legal-issues-defendant,100,22,4/24/2019
5546DA,earnings-per-share-positive,100,69,4/24/2019
5546DA,earnings-per-share-positive,100,69,4/24/2019
5546DA,earnings-per-share-positive,100,69,4/24/2019
5546DA,earnings-per-share-positive,100,69,4/24/2019
55C289,earnings,100,50,4/24/2019
55C9B5,partnership,100,61,4/24/2019
56632F,asset-sale,100,62,4/24/2019
5675EB,earnings,100,50,4/24/2019
594402,earnings,100,50,4/24/2019
5968F9,fundraising,100,64,4/24/2019
5A9F54,earnings-up,100,68,4/24/2019
5A9F54,earnings-up,100,68,4/24/2019
5A9F54,earnings-up,100,68,4/24/2019
5AAE17,conference-call,100,50,4/24/2019
5B6C11,partnership,100,61,4/24/2019
5B97B2,earnings,100,50,4/24/2019
5D63F1,executive-appointment,100,54,4/24/2019
5DD48B,earnings,100,50,4/24/2019
5DD48B,earnings,100,50,4/24/2019
5F1B7B,joint-venture,100,62,4/24/2019
60DD84,revenue-up,100,69,4/24/2019
6.18E+08,award,100,58,4/24/2019
62EFEE,earnings-up,100,68,4/24/2019
64854A,conference-call,100,50,4/24/2019
64E346,executive-resignation,100,44,4/24/2019
6.52E+64,earnings-guidance,100,50,4/24/2019
6559D8,patient-enrollment-complete,100,64,4/24/2019
657097,unit-acquisition-acquirer,100,49,4/24/2019
65CF8E,dividend,100,50,4/24/2019
662682,earnings,100,50,4/24/2019
662682,business-contract,100,69,4/24/2019
6634D9,conference-participant,100,50,4/24/2019
673C9A,conference-call,100,50,4/24/2019
67529E,earnings-positive,100,69,4/24/2019
67529E,earnings-positive,100,69,4/24/2019
67529E,earnings-positive,100,69,4/24/2019
67529E,earnings-positive,100,69,4/24/2019
67529E,earnings-positive,100,69,4/24/2019
67529E,earnings-positive,100,69,4/24/2019
67529E,earnings-positive,100,69,4/24/2019
6A01DF,product-release,100,64,4/24/2019
6A961B,conference-call,100,50,4/24/2019
6ACFBF,dividend-up,100,60,4/24/2019
6BD606,conference-call,100,50,4/24/2019
6BD606,conference-call,100,50,4/24/2019
6C987C,earnings-up,100,60,4/24/2019
6CB7F9,earnings,100,50,4/24/2019
6CF43C,earnings,100,50,4/24/2019
6D3B7B,executive-appointment,100,54,4/24/2019
6.00E+19,business-contract,100,69,4/24/2019
6.00E+19,partnership,100,61,4/24/2019
6E1E61,earnings,100,50,4/24/2019
6E8864,conference-call,100,50,4/24/2019
6EB9DA,dividend-up,100,56,4/24/2019
6EB9DA,executive-appointment,100,54,4/24/2019
728737,earnings,100,50,4/24/2019
735388,earnings,100,50,4/24/2019
73BCBA,earnings,100,50,4/24/2019
73BCBA,earnings,100,50,4/24/2019
73BCBA,earnings,100,50,4/24/2019
73C521,dividend,100,50,4/24/2019
742AAB,conference-call,100,50,4/24/2019
762A3E,executive-appointment,100,54,4/24/2019
767F86,earnings,100,50,4/24/2019
767F86,earnings,100,50,4/24/2019
767F86,earnings,100,50,4/24/2019
767F86,earnings,100,50,4/24/2019
767F86,earnings,100,50,4/24/2019
767F86,earnings,100,50,4/24/2019
767F86,earnings,100,50,4/24/2019
767F86,earnings,100,50,4/24/2019
767F86,earnings,100,50,4/24/2019
7AB859,earnings,100,50,4/24/2019
7AB859,earnings,100,50,4/24/2019
7AB859,earnings,100,50,4/24/2019
7AB859,earnings,100,50,4/24/2019
7AB859,earnings,100,50,4/24/2019
7AC86E,earnings-up,100,68,4/24/2019
7AC86E,earnings,100,50,4/24/2019
7B0BA6,acquisition-acquiree,100,76,4/24/2019
7B492C,executive-appointment,100,54,4/24/2019
7B492C,conference-call,100,50,4/24/2019
7B9AFA,earnings,100,50,4/24/2019
7C4F43,earnings,100,50,4/24/2019
7E62B5,earnings,100,50,4/24/2019
7FD8B9,conference-call,100,50,4/24/2019
82B57E,earnings,100,50,4/24/2019
83598E,dividend,100,50,4/24/2019
8377DB,dividend,100,50,4/24/2019
838ADD,earnings,100,50,4/24/2019
838ADD,earnings,100,50,4/24/2019
838ADD,earnings,100,50,4/24/2019
838ADD,earnings,100,50,4/24/2019
838ADD,earnings,100,50,4/24/2019
860AB6,dividend,100,50,4/24/2019
860AB6,dividend,100,50,4/24/2019
8614A2,legal-issues-defendant,100,22,4/24/2019
8665BA,earnings,100,50,4/24/2019
877734,conference-call,100,50,4/24/2019
893904,earnings,100,50,4/24/2019
895D56,conference-call,100,50,4/24/2019
896771,earnings,100,50,4/24/2019
8BE916,earnings,100,50,4/24/2019
8C1238,conference-call,100,50,4/24/2019
8DBBE6,executive-appointment,100,54,4/24/2019
8E4250,earnings,100,50,4/24/2019
8E93A4,dividend,100,50,4/24/2019
8FF2EF,conference-call,100,50,4/24/2019
902670,dividend,100,50,4/24/2019
9.31E+77,conference-call,100,50,4/24/2019
93D207,earnings,100,50,4/24/2019
942165,dividend-up,100,81,4/24/2019
965360,earnings,100,50,4/24/2019
965360,earnings,100,50,4/24/2019
965360,earnings,100,50,4/24/2019
965360,earnings,100,50,4/24/2019
965360,earnings,100,50,4/24/2019
965360,earnings,100,50,4/24/2019
965360,earnings,100,50,4/24/2019
96F126,dividend,100,50,4/24/2019
977A1E,donation,100,54,4/24/2019
97FE80,executive-appointment,100,54,4/24/2019
9810C0,earnings,100,50,4/24/2019
990AD0,dividend,100,50,4/24/2019
9.92E+94,earnings,100,50,4/24/2019
9.92E+94,earnings,100,50,4/24/2019
9.92E+94,earnings,100,50,4/24/2019
9A02C4,earnings,100,50,4/24/2019
9A02C4,dividend-up,100,81,4/24/2019
9BB35A,dividend,100,50,4/24/2019
9BB35A,earnings-per-share-positive,100,69,4/24/2019
9BB35A,earnings-per-share,100,50,4/24/2019
9BB35A,earnings-per-share,100,50,4/24/2019
9CA432,joint-venture,100,62,4/24/2019
9CDA4F,earnings,100,50,4/24/2019
9D2790,partnership,100,61,4/24/2019
9D30A8,earnings,100,50,4/24/2019
9E575E,earnings,100,50,4/24/2019
9F37C5,dividend,100,50,4/24/2019
9F37C5,earnings,100,50,4/24/2019
9F6B1A,executive-appointment,100,54,4/24/2019
9FA83B,conference-call,100,50,4/24/2019
9FD2D9,conference-call,100,50,4/24/2019
A3AAA5,conference-call,100,50,4/24/2019
A429A5,earnings-up,100,68,4/24/2019
A429A5,earnings,100,50,4/24/2019
A429A5,earnings,100,50,4/24/2019
A429A5,earnings,100,50,4/24/2019
A47A7D,legal-issues-defendant,100,22,4/24/2019
A4CD53,earnings,100,50,4/24/2019
A5195E,earnings,100,50,4/24/2019
A52533,earnings,100,50,4/24/2019
A5A4F5,acquisition-acquirer,100,49,4/24/2019
A6213D,product-price-raise,100,57,4/24/2019
A63820,earnings,100,50,4/24/2019
A63820,earnings,100,50,4/24/2019
A63820,earnings,100,50,4/24/2019
A871B0,earnings,100,50,4/24/2019
AA09AD,partnership,100,61,4/24/2019
AA5C8E,trading-resumed,100,58,4/24/2019
AA847A,earnings,100,50,4/24/2019
AABEA0,earnings-up,100,71,4/24/2019
AADE0B,dividend,100,50,4/24/2019
AD23DE,acquisition-acquirer,100,49,4/24/2019
B08954,earnings,100,50,4/24/2019
B560AF,award,100,58,4/24/2019
B6082A,earnings,100,50,4/24/2019
B66928,earnings,100,50,4/24/2019
B7202A,conference-call,100,50,4/24/2019
B96637,earnings,100,50,4/24/2019
B96637,earnings,100,50,4/24/2019
BAAA60,earnings,100,50,4/24/2019
BB88B6,earnings,100,50,4/24/2019
BC4876,dividend,100,50,4/24/2019
BCC55F,award,100,58,4/24/2019
BCC55F,conference-participant,100,50,4/24/2019
BDE867,operating-earnings,100,50,4/24/2019
BFCACF,earnings,100,50,4/24/2019
BFEA04,acquisition-acquirer,100,49,4/24/2019
C05839,earnings,100,50,4/24/2019
C05839,earnings,100,50,4/24/2019
C05839,earnings,100,50,4/24/2019
C05839,earnings,100,50,4/24/2019
C27E19,operating-earnings,100,50,4/24/2019
C97B2D,earnings,100,50,4/24/2019
C97B2D,legal-issues-defendant,100,22,4/24/2019
C9A96E,conference-participant,100,50,4/24/2019
CA1620,conference-call,100,50,4/24/2019
CA212F,acquisition-interest-acquirer,100,46,4/24/2019
CA212F,acquisition-interest-acquirer,100,46,4/24/2019
CB88B3,earnings,100,50,4/24/2019
CB89EA,earnings,100,50,4/24/2019
CBA33B,earnings,100,50,4/24/2019
CBBFBF,dividend,100,50,4/24/2019
CC339B,earnings,100,50,4/24/2019
CD4DA8,dividend-up,100,81,4/24/2019
CD4DA8,earnings,100,50,4/24/2019
CD4DA8,earnings,100,50,4/24/2019
CD4DA8,earnings,100,50,4/24/2019
CD4DA8,earnings,100,50,4/24/2019
CD4DA8,earnings,100,50,4/24/2019
CD4DA8,earnings,100,50,4/24/2019
CE1002,earnings,100,50,4/24/2019
CE1002,earnings,100,50,4/24/2019
CE1002,earnings,100,50,4/24/2019
CE1002,earnings,100,50,4/24/2019
D09938,earnings,100,50,4/24/2019
D0DFE5,earnings,100,50,4/24/2019
D21D8A,earnings-up,100,68,4/24/2019
D21D8A,earnings-up,100,68,4/24/2019
D21D8A,earnings-up,100,68,4/24/2019
D21D8A,earnings-up,100,68,4/24/2019
D21D8A,earnings-up,100,68,4/24/2019
D21D8A,earnings-up,100,68,4/24/2019
D21D8A,earnings-up,100,68,4/24/2019
D42DBA,executive-appointment,100,54,4/24/2019
D437C3,executive-appointment,100,54,4/24/2019
D437C3,earnings,100,50,4/24/2019
D48275,earnings,100,50,4/24/2019
D54E62,dividend,100,50,4/24/2019
D58A11,earnings,100,50,4/24/2019
D58A11,earnings,100,50,4/24/2019
D58A11,earnings,100,50,4/24/2019
D5A350,earnings,100,50,4/24/2019
D6EAA3,dividend,100,50,4/24/2019
D7A953,earnings,100,50,4/24/2019
DB396B,earnings,100,50,4/24/2019
DB396B,earnings,100,50,4/24/2019
DB396B,earnings,100,50,4/24/2019
DB396B,dividend,100,50,4/24/2019
DC0998,earnings,100,50,4/24/2019
DC0998,earnings,100,50,4/24/2019
DC0998,earnings,100,50,4/24/2019
DC0998,earnings,100,50,4/24/2019
DCD97F,earnings,100,50,4/24/2019
DD3BB1,earnings,100,50,4/24/2019
DD7A96,earnings,100,50,4/24/2019
DF11D9,earnings,100,50,4/24/2019
DF18E6,executive-appointment,100,54,4/24/2019
E0339F,dividend,100,50,4/24/2019
E07573,dividend,100,50,4/24/2019
E22FDE,legal-issues-defendant,100,22,4/24/2019
E68C3D,earnings,100,50,4/24/2019
E70531,supply-guidance-increase,100,74,4/24/2019
E70531,dividend,100,50,4/24/2019
E71AE6,legal-issues-defendant,100,22,4/24/2019
E754F0,earnings,100,50,4/24/2019
E99180,earnings,100,50,4/24/2019
ECD263,note-sale,100,52,4/24/2019
ED0D7C,dividend,100,50,4/24/2019
ED9576,earnings,100,50,4/24/2019
ED9C04,partnership,100,61,4/24/2019
EF25A5,earnings,100,50,4/24/2019
F02D0A,dividend,100,50,4/24/2019
F0B2B5,executive-appointment,100,54,4/24/2019
F0B2B5,conference-call,100,50,4/24/2019
F1CD47,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F294DD,earnings,100,50,4/24/2019
F31B13,dividend-up,100,72,4/24/2019
F50BAB,earnings,100,50,4/24/2019
F50BAB,earnings,100,50,4/24/2019
F50BAB,earnings,100,50,4/24/2019
F72E4B,earnings,100,50,4/24/2019
F7902B,earnings,100,50,4/24/2019
F7902B,earnings,100,50,4/24/2019
F7FCA4,dividend,100,50,4/24/2019
F90EE5,executive-appointment,100,54,4/24/2019
FA840E,earnings,100,50,4/24/2019
FA918D,executive-appointment,100,54,4/24/2019
FA918D,dividend,100,50,4/24/2019
FBD92D,earnings,100,50,4/24/2019
FC1B7B,earnings,100,50,4/24/2019
FC9A88,earnings,100,50,4/24/2019
FCA54E,executive-appointment,100,54,4/24/2019
FD0CA4,earnings,100,50,4/24/2019
FD4E8D,revenues,100,50,4/24/2019
FD4E8D,revenues,100,50,4/24/2019
FD554E,executive-appointment,100,54,4/24/2019
FDC7E6,dividend,100,50,4/24/2019
FDC7E6,earnings,100,50,4/24/2019
FE1A1D,operating-earnings,100,50,4/24/2019
FEE4B0,dividend-up,100,81,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FF4343,earnings,100,50,4/24/2019
FFAB4A,dividend,100,50,4/24/2019
FFCD0E,revenue-up,100,54,4/24/2019
00698D,dividend,100,50,4/25/2019
9397,partnership,100,61,4/25/2019
13528,campaign-ad-release,100,59,4/25/2019
0157B1,revenue-up,100,67,4/25/2019
0157B1,revenue-up,100,67,4/25/2019
0157B1,revenue-up,100,67,4/25/2019
0157B1,revenue-up,100,67,4/25/2019
0157B1,revenue-up,100,67,4/25/2019
0157B1,revenue-up,100,67,4/25/2019
033B58,executive-appointment,100,54,4/25/2019
03B8CF,earnings,100,50,4/25/2019
03B8CF,earnings,100,50,4/25/2019
03B8CF,earnings,100,50,4/25/2019
03B8CF,earnings,100,50,4/25/2019
03B8CF,earnings,100,50,4/25/2019
03D5F9,settlement,100,56,4/25/2019
03D5F9,settlement,100,56,4/25/2019
55018,earnings-positive,100,69,4/25/2019
55018,earnings,100,50,4/25/2019
55018,earnings,100,50,4/25/2019
55018,earnings,100,50,4/25/2019
55018,earnings,100,50,4/25/2019
55018,earnings,100,50,4/25/2019
55018,earnings,100,50,4/25/2019
55018,earnings,100,50,4/25/2019
0560D8,dividend,100,50,4/25/2019
58828,operating-earnings,100,50,4/25/2019
61366,earnings,100,50,4/25/2019
75172,executive-appointment,100,54,4/25/2019
075CF7,earnings,100,50,4/25/2019
07CA6A,earnings,100,50,4/25/2019
07CA6A,earnings,100,50,4/25/2019
081AB9,conference-participant,100,50,4/25/2019
08A40F,earnings,100,50,4/25/2019
08A40F,earnings,100,50,4/25/2019
08A40F,earnings,100,50,4/25/2019
08A40F,earnings,100,50,4/25/2019
08A40F,earnings,100,50,4/25/2019
08A40F,earnings,100,50,4/25/2019
08A40F,earnings,100,50,4/25/2019
98977,legal-issues-defendant,100,22,4/25/2019
0A77DB,earnings,100,50,4/25/2019
0B9E6F,earnings,100,50,4/25/2019
0C6293,conference-call,100,50,4/25/2019
0E499E,earnings,100,50,4/25/2019
0ED415,earnings,100,50,4/25/2019
0ED415,earnings,100,50,4/25/2019
0ED415,earnings,100,50,4/25/2019
0EF1AF,conference-participant,100,50,4/25/2019
0F04E5,earnings,100,50,4/25/2019
0F04E5,earnings,100,50,4/25/2019
0F04E5,earnings,100,50,4/25/2019
0FC848,conference-participant,100,50,4/25/2019
0FDE97,executive-appointment,100,54,4/25/2019
102F04,earnings,100,50,4/25/2019
105D00,dividend-up,100,81,4/25/2019
105D00,executive-appointment,100,54,4/25/2019
1096C6,earnings,100,50,4/25/2019
1151F4,earnings,100,50,4/25/2019
1151F4,earnings,100,50,4/25/2019
1151F4,earnings,100,50,4/25/2019
1151F4,earnings,100,50,4/25/2019
1151F4,earnings,100,50,4/25/2019
119CB6,earnings-up,100,71,4/25/2019
1279ED,earnings,100,50,4/25/2019
14833D,conference-participant,100,50,4/25/2019
1490F3,earnings,100,50,4/25/2019
1490F3,earnings,100,50,4/25/2019
1490F3,earnings,100,50,4/25/2019
1490F3,earnings,100,50,4/25/2019
1490F3,earnings,100,50,4/25/2019
1490F3,earnings,100,50,4/25/2019
156A99,earnings,100,50,4/25/2019
15789A,earnings,100,50,4/25/2019
168A5D,partnership,100,61,4/25/2019
1.79E+10,dividend,100,50,4/25/2019
1.79E+10,earnings,100,50,4/25/2019
182B8C,earnings,100,50,4/25/2019
184866,earnings,100,50,4/25/2019
1AF7E2,earnings,100,50,4/25/2019
1AF7E2,earnings,100,50,4/25/2019
1B5FEA,earnings,100,50,4/25/2019
1CD09C,conference-call,100,50,4/25/2019
1DA44F,earnings,100,50,4/25/2019
1DB6A6,earnings,100,50,4/25/2019
1F2B5D,earnings,100,50,4/25/2019
1F2B5D,earnings,100,50,4/25/2019
1F2B5D,earnings,100,50,4/25/2019
1F2B5D,earnings,100,50,4/25/2019
1FAF22,earnings,100,50,4/25/2019
1FAF22,earnings,100,50,4/25/2019
1FAF22,earnings,100,50,4/25/2019
1FAF22,earnings,100,50,4/25/2019
20DC4E,earnings,100,50,4/25/2019
21D903,legal-issues-defendant,100,22,4/25/2019
24FA23,earnings,100,50,4/25/2019
25102A,facility-open,100,65,4/25/2019
253B2F,conference-call,100,50,4/25/2019
25529C,earnings,100,50,4/25/2019
272472,earnings-positive,100,69,4/25/2019
272472,earnings-positive,100,69,4/25/2019
272472,earnings-positive,100,69,4/25/2019
272472,earnings-positive,100,69,4/25/2019
272472,earnings-positive,100,69,4/25/2019
272472,earnings-positive,100,69,4/25/2019
272704,dividend,100,50,4/25/2019
284289,earnings,100,50,4/25/2019
28F905,conference-call,100,50,4/25/2019
297DA8,earnings,100,50,4/25/2019
29B702,earnings,100,50,4/25/2019
2.90E+62,earnings,100,50,4/25/2019
2.90E+62,earnings,100,50,4/25/2019
2.90E+62,earnings,100,50,4/25/2019
2.90E+62,earnings,100,50,4/25/2019
2.90E+62,earnings,100,50,4/25/2019
2.90E+62,dividend,100,50,4/25/2019
2A4131,earnings,100,50,4/25/2019
2BA977,earnings,100,50,4/25/2019
2BA977,earnings,100,50,4/25/2019
2BA977,earnings,100,50,4/25/2019
2BA977,earnings,100,50,4/25/2019
2BA977,earnings,100,50,4/25/2019
2BA977,earnings,100,50,4/25/2019
2BA977,earnings,100,50,4/25/2019
2C681C,conference-call,100,50,4/25/2019
2C681C,conference-call,100,50,4/25/2019
2DA92D,earnings,100,50,4/25/2019
2DC88B,legal-issues-defendant,100,22,4/25/2019
2E6514,buybacks,100,74,4/25/2019
2F94A5,dividend,100,50,4/25/2019
30DFD3,earnings,100,50,4/25/2019
319BE2,dividend-up,100,81,4/25/2019
319BE2,earnings,100,50,4/25/2019
31A7CC,dividend,100,50,4/25/2019
328250,earnings,100,50,4/25/2019
32F24A,executive-appointment,100,54,4/25/2019
3390DE,earnings,100,50,4/25/2019
343996,earnings,100,50,4/25/2019
343996,earnings,100,50,4/25/2019
3461CF,conference-organizer,100,57,4/25/2019
35AE32,earnings,100,50,4/25/2019
366A08,earnings,100,50,4/25/2019
366A08,earnings,100,50,4/25/2019
366A08,earnings,100,50,4/25/2019
366A08,earnings,100,50,4/25/2019
366A08,earnings,100,50,4/25/2019
366A08,earnings,100,50,4/25/2019
37B120,earnings,100,50,4/25/2019
3A3447,dividend,100,50,4/25/2019
3A94DF,earnings,100,50,4/25/2019
3B37F7,conference-call,100,50,4/25/2019
3B8484,earnings,100,50,4/25/2019
3BB616,earnings,100,50,4/25/2019
3BB616,earnings,100,50,4/25/2019
3BB616,earnings,100,50,4/25/2019
3CBA2A,earnings,100,50,4/25/2019
3CBA2A,earnings,100,50,4/25/2019
3CBA2A,earnings,100,50,4/25/2019
3CBA2A,earnings,100,50,4/25/2019
3CBA2A,earnings,100,50,4/25/2019
3CBA2A,earnings,100,50,4/25/2019
3CBA2A,earnings,100,50,4/25/2019
3E15F6,earnings,100,50,4/25/2019
3E15F6,earnings,100,50,4/25/2019
3E15F6,earnings,100,50,4/25/2019
3E15F6,earnings,100,50,4/25/2019
3E39A5,dividend,100,50,4/25/2019
3F4497,earnings,100,50,4/25/2019
416C55,earnings,100,50,4/25/2019
43A060,legal-issues-defendant,100,22,4/25/2019
44209A,earnings,100,50,4/25/2019
449217,earnings-positive,100,69,4/25/2019
449217,earnings,100,50,4/25/2019
449217,earnings,100,50,4/25/2019
449217,earnings,100,50,4/25/2019
449217,earnings,100,50,4/25/2019
44A4FC,partnership,100,61,4/25/2019
451D61,conference-call,100,50,4/25/2019
453282,earnings-per-share-positive,100,69,4/25/2019
4649D5,earnings,100,50,4/25/2019
46CF27,earnings,100,50,4/25/2019
46CF27,earnings,100,50,4/25/2019
46CF27,earnings,100,50,4/25/2019
46CF27,earnings,100,50,4/25/2019
46CF27,earnings,100,50,4/25/2019
46CF27,earnings,100,50,4/25/2019
46CF27,earnings,100,50,4/25/2019
479930,earnings,100,50,4/25/2019
47FCF2,earnings,100,50,4/25/2019
4806CE,earnings,100,50,4/25/2019
490D4B,executive-appointment,100,54,4/25/2019
4A2457,conference-call,100,50,4/25/2019
4C7DB5,earnings,100,50,4/25/2019
4D971D,executive-appointment,100,54,4/25/2019
4DD203,conference-call,100,50,4/25/2019
4EE167,earnings,100,50,4/25/2019
4EE167,earnings,100,50,4/25/2019
4FCC78,public-offering,100,43,4/25/2019
50070E,conference-call,100,50,4/25/2019
5088A5,partnership,100,61,4/25/2019
51527B,earnings,100,50,4/25/2019
51527B,earnings,100,50,4/25/2019
51527B,earnings,100,50,4/25/2019
51527B,earnings,100,50,4/25/2019
51527B,earnings,100,50,4/25/2019
51527B,earnings,100,50,4/25/2019
5487B1,conference-call,100,50,4/25/2019
5546DA,dividend-up,100,81,4/25/2019
556F08,earnings,100,50,4/25/2019
567F3D,earnings,100,50,4/25/2019
567F3D,earnings,100,50,4/25/2019
567F3D,earnings,100,50,4/25/2019
567F3D,earnings,100,50,4/25/2019
57356F,earnings,100,50,4/25/2019
57356F,earnings,100,50,4/25/2019
57356F,earnings,100,50,4/25/2019
57A854,earnings,100,50,4/25/2019
57F3DA,earnings,100,50,4/25/2019
57F3DA,earnings,100,50,4/25/2019
586BD7,conference-call,100,50,4/25/2019
586FFD,revenues,100,50,4/25/2019
586FFD,revenues,100,50,4/25/2019
589F5A,earnings,100,50,4/25/2019
58B46F,board-meeting,100,51,4/25/2019
58B46F,dividend,100,50,4/25/2019
59B229,earnings,100,50,4/25/2019
59B229,earnings,100,50,4/25/2019
59B229,earnings,100,50,4/25/2019
59B229,earnings,100,50,4/25/2019
5A423F,earnings,100,50,4/25/2019
5A64D5,earnings,100,50,4/25/2019
5BFE94,dividend,100,50,4/25/2019
5D02B7,earnings,100,50,4/25/2019
5D0337,earnings-up,100,68,4/25/2019
5D1329,conference-call,100,50,4/25/2019
5D16CF,earnings,100,50,4/25/2019
5D1956,earnings,100,50,4/25/2019
5D41E4,conference-call,100,50,4/25/2019
5E6959,earnings-up,100,68,4/25/2019
5F3D91,legal-issues-defendant,100,22,4/25/2019
5FE4B6,earnings,100,50,4/25/2019
5FE4B6,earnings,100,50,4/25/2019
5FF95F,legal-issues-defendant,100,22,4/25/2019
616E3B,earnings,100,50,4/25/2019
616E3B,earnings,100,50,4/25/2019
616E3B,earnings,100,50,4/25/2019
616E3B,earnings,100,50,4/25/2019
619882,conference-organizer,100,57,4/25/2019
619882,conference-organizer,100,57,4/25/2019
619882,conference-organizer,100,57,4/25/2019
622037,dividend-up,100,81,4/25/2019
6284B5,earnings,100,50,4/25/2019
6284B5,earnings,100,50,4/25/2019
6284B5,earnings,100,50,4/25/2019
641F17,earnings,100,50,4/25/2019
641F17,earnings,100,50,4/25/2019
641F17,earnings,100,50,4/25/2019
641F17,earnings,100,50,4/25/2019
641F17,earnings,100,50,4/25/2019
641F17,earnings,100,50,4/25/2019
662682,dividend-up,100,81,4/25/2019
665D7D,earnings,100,50,4/25/2019
673C9A,executive-appointment,100,54,4/25/2019
67B052,conference-call,100,50,4/25/2019
68586A,conference-call,100,50,4/25/2019
68E3E0,conference-call,100,50,4/25/2019
69CE71,partnership,100,61,4/25/2019
69CE71,legal-issues-defendant,100,22,4/25/2019
69E8E1,earnings,100,50,4/25/2019
69E8E1,earnings,100,50,4/25/2019
69E8E1,earnings,100,50,4/25/2019
69E8E1,earnings,100,50,4/25/2019
69E8E1,earnings,100,50,4/25/2019
6B5379,dividend-up,100,81,4/25/2019
6BDA0C,conference-call,100,50,4/25/2019
6C987C,dividend,100,50,4/25/2019
6CDFC6,earnings,100,50,4/25/2019
6DC1D7,earnings,100,50,4/25/2019
6E7060,conference-call,100,50,4/25/2019
6F39FC,conference-call,100,50,4/25/2019
71694D,conference-call,100,50,4/25/2019
72609A,earnings-up,100,68,4/25/2019
72CB93,earnings,100,50,4/25/2019
73529F,earnings,100,50,4/25/2019
73C9E2,earnings,100,50,4/25/2019
7448A3,earnings,100,50,4/25/2019
747219,conference-participant,100,50,4/25/2019
762A3E,earnings,100,50,4/25/2019
762A3E,dividend,100,50,4/25/2019
763724,conference-call,100,50,4/25/2019
76CEFB,earnings,100,50,4/25/2019
76F067,earnings,100,50,4/25/2019
791D59,partnership,100,61,4/25/2019
791D59,earnings,100,50,4/25/2019
791D59,earnings,100,50,4/25/2019
791D59,earnings,100,50,4/25/2019
791D59,earnings,100,50,4/25/2019
7A5D58,earnings,100,50,4/25/2019
7ADE57,partnership,100,61,4/25/2019
7B1156,conference-call,100,50,4/25/2019
7BAAE7,earnings-per-share-positive,100,69,4/25/2019
7BAAE7,earnings,100,50,4/25/2019
7BC92D,earnings,100,50,4/25/2019
7C75FD,dividend,100,50,4/25/2019
7D5384,earnings,100,50,4/25/2019
7D5384,earnings,100,50,4/25/2019
7D5384,earnings,100,50,4/25/2019
7D5384,earnings,100,50,4/25/2019
7E0EB0,earnings,100,50,4/25/2019
803FED,executive-appointment,100,54,4/25/2019
80C400,conference-call,100,50,4/25/2019
80D744,earnings,100,50,4/25/2019
8.10E+32,executive-appointment,100,54,4/25/2019
81A88D,earnings,100,50,4/25/2019
8.22E+27,earnings,100,50,4/25/2019
824CCA,earnings,100,50,4/25/2019
830BDB,earnings,100,50,4/25/2019
837C04,earnings-per-share-up,100,63,4/25/2019
837C04,dividend-up,100,81,4/25/2019
845533,earnings,100,50,4/25/2019
8817D5,earnings,100,50,4/25/2019
8817D5,earnings,100,50,4/25/2019
8AC740,conference-call,100,50,4/25/2019
8B3B0E,earnings,100,50,4/25/2019
8B6E7E,conference-participant,100,50,4/25/2019
8D4486,partnership,100,61,4/25/2019
8D4486,partnership,100,61,4/25/2019
8D4486,partnership,100,61,4/25/2019
8D4486,business-contract,100,69,4/25/2019
8D5145,earnings,100,50,4/25/2019
8DE56F,earnings,100,50,4/25/2019
8DE56F,earnings,100,50,4/25/2019
8E0E32,earnings,100,50,4/25/2019
8F3231,earnings,100,50,4/25/2019
8F6995,dividend,100,50,4/25/2019
903AB4,dividend-up,100,81,4/25/2019
922F0C,earnings-per-share-up,100,55,4/25/2019
934029,earnings,100,50,4/25/2019
93C130,earnings,100,50,4/25/2019
93C130,dividend,100,50,4/25/2019
943239,earnings,100,50,4/25/2019
94563D,earnings,100,50,4/25/2019
94563D,earnings,100,50,4/25/2019
94563D,earnings,100,50,4/25/2019
94563D,earnings,100,50,4/25/2019
945DE6,earnings,100,50,4/25/2019
945DE6,earnings,100,50,4/25/2019
945DE6,earnings,100,50,4/25/2019
945DE6,executive-appointment,100,54,4/25/2019
945DE6,executive-appointment,100,54,4/25/2019
94637C,earnings,100,50,4/25/2019
95DC1F,sponsorship,100,57,4/25/2019
9673BD,conference-call,100,50,4/25/2019
9.74E+08,earnings,100,50,4/25/2019
9.74E+08,earnings,100,50,4/25/2019
9.74E+08,earnings,100,50,4/25/2019
9.74E+08,earnings,100,50,4/25/2019
98D33E,dividend,100,50,4/25/2019
990AD0,conference-organizer,100,57,4/25/2019
9.97E+09,earnings,100,50,4/25/2019
9B5968,earnings,100,50,4/25/2019
9B5968,earnings,100,50,4/25/2019
9CE4C7,dividend,100,50,4/25/2019
9CF9B1,earnings,100,50,4/25/2019
9D307D,earnings,100,50,4/25/2019
9E298A,dividend,100,50,4/25/2019
9EA947,partnership,100,61,4/25/2019
9F03CF,earnings,100,50,4/25/2019
9F03CF,dividend,100,50,4/25/2019
9FB4B7,executive-appointment,100,54,4/25/2019
A02FB1,earnings,100,50,4/25/2019
A1BB98,earnings,100,50,4/25/2019
A204A7,earnings,100,50,4/25/2019
A4386C,dividend,100,50,4/25/2019
A48593,conference-call,100,50,4/25/2019
A5151E,earnings,100,50,4/25/2019
A5A4F5,acquisition-acquirer,100,49,4/25/2019
A5B913,earnings,100,50,4/25/2019
A5B913,earnings,100,50,4/25/2019
A5B913,earnings,100,50,4/25/2019
A6213D,earnings,100,50,4/25/2019
A631A3,legal-issues-defendant,100,22,4/25/2019
A6828A,dividend-up,100,81,4/25/2019
A79D88,earnings-guidance,100,50,4/25/2019
A79F7D,clinical-trials,100,56,4/25/2019
A806FA,dividend,100,50,4/25/2019
A8B137,dividend,100,50,4/25/2019
A8CBDA,earnings-positive,100,69,4/25/2019
A94637,revenues,100,50,4/25/2019
A94A7B,public-offering,100,43,4/25/2019
A99576,earnings,100,50,4/25/2019
AADE0B,earnings,100,50,4/25/2019
AC1952,earnings,100,50,4/25/2019
AC3584,earnings,100,50,4/25/2019
AD375D,earnings,100,50,4/25/2019
AD3C93,earnings,100,50,4/25/2019
AED6CF,conference-call,100,50,4/25/2019
AFD1CA,earnings,100,50,4/25/2019
B05118,earnings,100,50,4/25/2019
B076A1,conference-call,100,50,4/25/2019
B4F5F4,conference-call,100,50,4/25/2019
B8DD94,operating-earnings,100,50,4/25/2019
B96637,award,100,58,4/25/2019
BAAA60,dividend,100,50,4/25/2019
BAD655,conference-call,100,50,4/25/2019
BBAE2A,earnings,100,50,4/25/2019
BBBB41,dividend-up,100,81,4/25/2019
BBBB41,executive-appointment,100,54,4/25/2019
BBC05B,operating-earnings,100,50,4/25/2019
BC3AD2,earnings,100,50,4/25/2019
BC3AD2,earnings,100,50,4/25/2019
BC3AD2,earnings,100,50,4/25/2019
BC3AD2,earnings,100,50,4/25/2019
BC3AD2,earnings,100,50,4/25/2019
BC3AD2,earnings,100,50,4/25/2019
BC5680,earnings,100,50,4/25/2019
BC5680,earnings,100,50,4/25/2019
BCC13E,earnings,100,50,4/25/2019
BD682F,earnings,100,50,4/25/2019
BE14CF,earnings,100,50,4/25/2019
BEB756,earnings,100,50,4/25/2019
BF79F5,earnings,100,50,4/25/2019
BF79F5,earnings,100,50,4/25/2019
C01737,earnings,100,50,4/25/2019
C062D4,dividend,100,50,4/25/2019
C062D4,earnings,100,50,4/25/2019
C062D4,earnings,100,50,4/25/2019
C062D4,earnings,100,50,4/25/2019
C062D4,earnings,100,50,4/25/2019
C062D4,earnings,100,50,4/25/2019
C062D4,earnings,100,50,4/25/2019
C16A8F,dividend,100,50,4/25/2019
C32A39,executive-appointment,100,54,4/25/2019
C41C25,earnings,100,50,4/25/2019
C4706C,conference-call,100,50,4/25/2019
C5D2AE,earnings,100,50,4/25/2019
C624A1,earnings,100,50,4/25/2019
C624A1,earnings,100,50,4/25/2019
C83B88,earnings,100,50,4/25/2019
C83B88,earnings,100,50,4/25/2019
C83B88,earnings,100,50,4/25/2019
C83B88,earnings,100,50,4/25/2019
C83B88,earnings,100,50,4/25/2019
C83B88,earnings,100,50,4/25/2019
C8923A,earnings,100,50,4/25/2019
C8A059,earnings,100,50,4/25/2019
C951A2,product-release,100,64,4/25/2019
C97B2D,legal-issues-defendant,100,22,4/25/2019
C97B2D,legal-issues-defendant,100,22,4/25/2019
C97B2D,legal-issues-defendant,100,22,4/25/2019
C9E107,earnings-per-share-positive,100,69,4/25/2019
C9E4EC,earnings,100,50,4/25/2019
CA1620,partnership-terminated,100,36,4/25/2019
CB22CD,earnings,100,50,4/25/2019
CBFFDD,partnership,100,61,4/25/2019
CBFFDD,partnership,100,61,4/25/2019
CC176E,earnings,100,50,4/25/2019
CC35BE,facility-open,100,65,4/25/2019
CDAB24,earnings,100,50,4/25/2019
CDC817,earnings,100,50,4/25/2019
CDE51C,business-contract,100,69,4/25/2019
CDEDFE,earnings,100,50,4/25/2019
CF6A5A,earnings,100,50,4/25/2019
CFF57D,executive-appointment,100,54,4/25/2019
D0DFE5,earnings,100,50,4/25/2019
D1344A,earnings,100,50,4/25/2019
D15833,dividend,100,50,4/25/2019
D296C6,earnings,100,50,4/25/2019
D29B44,earnings,100,50,4/25/2019
D3F64D,earnings,100,50,4/25/2019
D3F64D,earnings,100,50,4/25/2019
D3F64D,earnings,100,50,4/25/2019
D3F64D,earnings,100,50,4/25/2019
D3F64D,earnings,100,50,4/25/2019
D3F64D,earnings,100,50,4/25/2019
D3F64D,earnings,100,50,4/25/2019
D3F64D,earnings,100,50,4/25/2019
D4070C,earnings,100,50,4/25/2019
D4463B,earnings,100,50,4/25/2019
D45285,conference-call,100,50,4/25/2019
D518D8,revenues,100,50,4/25/2019
D518D8,revenues,100,50,4/25/2019
D518D8,revenues,100,50,4/25/2019
D518D8,revenues,100,50,4/25/2019
D721C6,earnings,100,50,4/25/2019
D78BF1,earnings,100,50,4/25/2019
D7F569,earnings,100,50,4/25/2019
D9164D,dividend,100,50,4/25/2019
D9164D,earnings,100,50,4/25/2019
D96202,earnings,100,50,4/25/2019
D9B1C9,earnings,100,50,4/25/2019
D9B1C9,earnings,100,50,4/25/2019
DBCA3F,earnings,100,50,4/25/2019
DC0066,partnership,100,61,4/25/2019
DD0099,earnings-up,100,68,4/25/2019
DF6FDD,earnings,100,50,4/25/2019
E05026,conference-call,100,50,4/25/2019
E05DC8,earnings,100,50,4/25/2019
E06265,earnings,100,50,4/25/2019
E10D31,dividend,100,50,4/25/2019
E13782,earnings,100,50,4/25/2019
E1BD05,earnings,100,50,4/25/2019
E2CB7B,earnings,100,50,4/25/2019
E5D914,conference-call,100,50,4/25/2019
E6D89E,earnings,100,50,4/25/2019
E6D89E,earnings,100,50,4/25/2019
E6D89E,earnings,100,50,4/25/2019
E71AE6,legal-issues-defendant,100,22,4/25/2019
E82A2D,dividend,100,50,4/25/2019
E866D2,earnings-positive,100,69,4/25/2019
E866D2,earnings-positive,100,69,4/25/2019
E866D2,earnings-positive,100,69,4/25/2019
E866D2,earnings-positive,100,69,4/25/2019
E866D2,earnings-positive,100,69,4/25/2019
E866D2,earnings-positive,100,69,4/25/2019
E8846E,conference-organizer,100,57,4/25/2019
E8B21D,earnings,100,50,4/25/2019
E8B21D,earnings,100,50,4/25/2019
E8B21D,earnings,100,50,4/25/2019
E8B21D,earnings,100,50,4/25/2019
E94704,dividend,100,50,4/25/2019
EC99D0,earnings,100,50,4/25/2019
ED2EFD,dividend,100,50,4/25/2019
ED8676,earnings,100,50,4/25/2019
ED8676,dividend,100,50,4/25/2019
ED9C04,earnings,100,50,4/25/2019
EDF5CA,dividend,100,50,4/25/2019
EE1E44,earnings-up,100,68,4/25/2019
EF1AD9,dividend,100,50,4/25/2019
EF1AD9,earnings,100,50,4/25/2019
EF1AD9,earnings,100,50,4/25/2019
EF1AD9,earnings,100,50,4/25/2019
F0027C,earnings,100,50,4/25/2019
F0A9DE,facility-open,100,65,4/25/2019
F0B877,earnings,100,50,4/25/2019
F0EEFB,conference-call,100,50,4/25/2019
F11638,earnings,100,50,4/25/2019
F1C04C,operating-earnings,100,50,4/25/2019
F24FF0,earnings,100,50,4/25/2019
F48947,conference-participant,100,50,4/25/2019
F4D241,earnings,100,50,4/25/2019
F4E882,earnings,100,50,4/25/2019
F5349B,award,100,58,4/25/2019
F7935D,earnings,100,50,4/25/2019
F793FA,earnings,100,50,4/25/2019
F80389,earnings,100,50,4/25/2019
F88A04,earnings,100,50,4/25/2019
F8DE55,legal-issues-defendant,100,22,4/25/2019
FA918D,earnings,100,50,4/25/2019
FA918D,earnings,100,50,4/25/2019
FAE021,earnings,100,50,4/25/2019
FAE021,earnings,100,50,4/25/2019
FAE021,earnings,100,50,4/25/2019
FAEABE,executive-appointment,100,54,4/25/2019
FBDA0F,earnings,100,50,4/25/2019
FC1F9D,earnings,100,50,4/25/2019
FC80E6,earnings,100,50,4/25/2019
FD2565,conference-call,100,50,4/25/2019
FD4BBE,earnings,100,50,4/25/2019
FD4BBE,earnings,100,50,4/25/2019
FD4BBE,earnings,100,50,4/25/2019
FD9526,earnings-guidance-up,100,83,4/25/2019
FDC7E6,conference-participant,100,50,4/25/2019
FDF799,acquisition-acquirer,100,49,4/25/2019
FF5413,earnings-positive,100,69,4/25/2019
FF5413,earnings-positive,100,69,4/25/2019
FF5413,earnings-positive,100,69,4/25/2019
00D6B5,unit-acquisition-completed-acquiree,100,67,4/26/2019
01D03F,partnership,100,61,4/26/2019
51332,dividend,100,50,4/26/2019
099C88,government-contract,100,69,4/26/2019
0A0D9E,conference-participant,100,50,4/26/2019
0A9D0A,dividend-up,100,61,4/26/2019
0BD4E8,earnings,100,50,4/26/2019
0BD4E8,earnings,100,50,4/26/2019
0BD4E8,earnings,100,50,4/26/2019
0BD4E8,earnings,100,50,4/26/2019
0FDE97,earnings,100,50,4/26/2019
0FDE97,earnings,100,50,4/26/2019
0FDE97,earnings,100,50,4/26/2019
0FDE97,earnings,100,50,4/26/2019
0FDE97,earnings,100,50,4/26/2019
0FDE97,earnings,100,50,4/26/2019
0FDE97,earnings,100,50,4/26/2019
10AE08,earnings,100,50,4/26/2019
139303,earnings,100,50,4/26/2019
13C3E0,earnings-positive,100,69,4/26/2019
19C105,earnings,100,50,4/26/2019
19C105,earnings,100,50,4/26/2019
19C105,earnings,100,50,4/26/2019
19C105,dividend,100,50,4/26/2019
19CAC7,dividend,100,50,4/26/2019
1D1B07,executive-appointment,100,54,4/26/2019
1D1B07,executive-appointment,100,54,4/26/2019
1D3A00,dividend,100,50,4/26/2019
1D943E,award,100,58,4/26/2019
1EC3E8,earnings,100,50,4/26/2019
21022F,product-release,100,64,4/26/2019
21D903,legal-issues-defendant,100,22,4/26/2019
223216,ebitda-up,100,68,4/26/2019
270B78,dividend,100,50,4/26/2019
272472,dividend,100,50,4/26/2019
2B7A40,earnings-per-share-positive,100,69,4/26/2019
2B7A40,earnings-positive,100,69,4/26/2019
2B7A40,earnings-positive,100,69,4/26/2019
2B7A40,earnings-positive,100,69,4/26/2019
2D485F,award,100,58,4/26/2019
2EB04E,legal-issues-defendant,100,22,4/26/2019
32CB22,note-sale,100,52,4/26/2019
32CB22,note-sale,100,52,4/26/2019
338544,earnings-up,100,68,4/26/2019
339F20,earnings-up,100,68,4/26/2019
383ADA,earnings,100,50,4/26/2019
3.88E+02,earnings,100,50,4/26/2019
3B9886,executive-appointment,100,54,4/26/2019
4290EF,dividend,100,50,4/26/2019
43A060,legal-issues-defendant,100,22,4/26/2019
460C93,earnings,100,50,4/26/2019
4B5054,earnings,100,50,4/26/2019
4D371E,dividend,100,50,4/26/2019
4D371E,conference-participant,100,50,4/26/2019
504FE2,dividend,100,50,4/26/2019
556A57,dividend,100,50,4/26/2019
56277A,earnings,100,50,4/26/2019
562853,earnings,100,50,4/26/2019
57B174,partnership,100,61,4/26/2019
57EF50,dividend,100,50,4/26/2019
5B6C11,earnings,100,50,4/26/2019
5F3D91,legal-issues-defendant,100,22,4/26/2019
5F3D91,legal-issues-defendant,100,22,4/26/2019
619882,conference-organizer,100,57,4/26/2019
619882,conference-organizer,100,57,4/26/2019
61E975,dividend,100,50,4/26/2019
69CE71,legal-issues-defendant,100,22,4/26/2019
6.00E+19,conference-call,100,50,4/26/2019
7032D0,earnings,100,50,4/26/2019
72EF75,dividend,100,50,4/26/2019
72F0FC,dividend,100,50,4/26/2019
72F0FC,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7999F3,earnings,100,50,4/26/2019
7B0BA6,executive-appointment,100,54,4/26/2019
7B4B91,earnings,100,50,4/26/2019
7F3A5F,award,100,58,4/26/2019
7F3A5F,award,100,58,4/26/2019
7FC386,earnings,100,50,4/26/2019
7FDE1C,conference-call,100,50,4/26/2019
8.10E+205,conference-call,100,50,4/26/2019
81EAD4,operating-earnings,100,50,4/26/2019
835C86,earnings,100,50,4/26/2019
850779,dividend,100,50,4/26/2019
86478F,earnings,100,50,4/26/2019
88350F,earnings-per-share-up,100,68,4/26/2019
88350F,earnings-per-share-up,100,68,4/26/2019
88350F,earnings-per-share-up,100,68,4/26/2019
88350F,executive-appointment,100,54,4/26/2019
8AB37F,conference-call,100,50,4/26/2019
8D4486,partnership,100,61,4/26/2019
8D4486,partnership,100,61,4/26/2019
8D4486,partnership,100,61,4/26/2019
97B027,dividend,100,50,4/26/2019
99ACAD,dividend,100,50,4/26/2019
99ACAD,partnership,100,61,4/26/2019
9AF3DC,dividend,100,50,4/26/2019
9D6A24,dividend,100,50,4/26/2019
9EED50,earnings,100,50,4/26/2019
A2CA3F,buybacks,100,74,4/26/2019
A2CA3F,dividend,100,50,4/26/2019
A3800A,earnings,100,50,4/26/2019
A495F7,award,100,58,4/26/2019
A666C8,earnings,100,50,4/26/2019
A666C8,earnings,100,50,4/26/2019
A666C8,earnings,100,50,4/26/2019
A96867,buybacks,100,74,4/26/2019
AAEE21,executive-appointment,100,54,4/26/2019
B2D799,legal-issues-defendant,100,22,4/26/2019
B4C673,conference-call,100,50,4/26/2019
B619CB,earnings-positive,100,69,4/26/2019
B8EF97,dividend-up,100,81,4/26/2019
BB02FB,earnings-per-share-positive,100,69,4/26/2019
BB02FB,earnings-per-share,100,50,4/26/2019
BB02FB,earnings-per-share,100,50,4/26/2019
BB02FB,earnings-per-share,100,50,4/26/2019
BDEF34,earnings,100,50,4/26/2019
BDEF34,earnings,100,50,4/26/2019
BDEF34,earnings,100,50,4/26/2019
BDEF34,earnings,100,50,4/26/2019
BDEF34,earnings,100,50,4/26/2019
BDEF34,earnings,100,50,4/26/2019
C1CBA4,earnings-positive,100,69,4/26/2019
C5E100,conference-call,100,50,4/26/2019
C8FAC7,executive-appointment,100,54,4/26/2019
C97B2D,legal-issues-defendant,100,22,4/26/2019
C97B2D,legal-issues-defendant,100,22,4/26/2019
CBCC6A,earnings,100,50,4/26/2019
CBCC6A,earnings,100,50,4/26/2019
CBCC6A,conference-organizer,100,57,4/26/2019
CDC217,earnings,100,50,4/26/2019
CE4FD9,conference-call,100,50,4/26/2019
D3CEDF,facility-open,100,65,4/26/2019
D54E62,earnings-positive,100,69,4/26/2019
D54E62,earnings-positive,100,69,4/26/2019
D54E62,earnings-positive,100,69,4/26/2019
D7F569,executive-appointment,100,54,4/26/2019
D7F569,dividend,100,50,4/26/2019
D854F3,earnings,100,50,4/26/2019
DA0A9E,earnings,100,50,4/26/2019
DAFED3,earnings,100,50,4/26/2019
DAFED3,earnings,100,50,4/26/2019
DAFED3,earnings,100,50,4/26/2019
DB396B,legal-issues-defendant,100,22,4/26/2019
DD1BA1,earnings,100,50,4/26/2019
DE4924,conference-call,100,50,4/26/2019
E19A99,business-contract,100,69,4/26/2019
E30B34,earnings,100,50,4/26/2019
E30B34,earnings,100,50,4/26/2019
E30B34,earnings,100,50,4/26/2019
E30B34,earnings,100,50,4/26/2019
E35610,conference-participant,100,50,4/26/2019
E6E012,dividend,100,50,4/26/2019
E6E012,dividend,100,50,4/26/2019
E70531,earnings,100,50,4/26/2019
E70531,earnings,100,50,4/26/2019
E70531,earnings,100,50,4/26/2019
E70531,earnings,100,50,4/26/2019
E71AE6,legal-issues-defendant,100,22,4/26/2019
E959F3,dividend,100,50,4/26/2019
EAA0A7,product-release,100,64,4/26/2019
EB6965,earnings,100,50,4/26/2019
EB6965,earnings,100,50,4/26/2019
EB6965,earnings,100,50,4/26/2019
EB6965,earnings,100,50,4/26/2019
EB6965,earnings,100,50,4/26/2019
ED0D7C,earnings,100,50,4/26/2019
ED0D7C,earnings,100,50,4/26/2019
ED0D7C,earnings,100,50,4/26/2019
ED0D7C,earnings,100,50,4/26/2019
EE6F1C,dividend,100,50,4/26/2019
EFD406,conference-call,100,50,4/26/2019
F2526D,earnings,100,50,4/26/2019
F6FA6A,earnings,100,50,4/26/2019
FF4BA4,earnings,100,50,4/26/2019
FF4BA4,earnings,100,50,4/26/2019
FF4BA4,earnings,100,50,4/26/2019
FF4BA4,earnings,100,50,4/26/2019
FF4BA4,earnings,100,50,4/26/2019
FFCD0E,conference-call,100,50,4/26/2019
4C92B9,legal-issues-defendant,100,22,4/27/2019
790C34,earnings,100,50,4/27/2019
02870F,earnings-up,100,68,4/29/2019
02870F,earnings-up,100,68,4/29/2019
02870F,earnings-up,100,68,4/29/2019
02870F,earnings-up,100,68,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03B8CF,earnings,100,50,4/29/2019
03FAA6,business-contract,100,69,4/29/2019
04996E,executive-appointment,100,54,4/29/2019
04996E,earnings,100,50,4/29/2019
04996E,earnings,100,50,4/29/2019
07C69F,earnings,100,50,4/29/2019
0A6824,dividend,100,50,4/29/2019
0B400D,earnings-guidance,100,50,4/29/2019
0B7375,conference-call,100,50,4/29/2019
0FABBD,campaign-ad-release,100,59,4/29/2019
10100E,conference-participant,100,50,4/29/2019
108A2B,operating-earnings,100,50,4/29/2019
125212,earnings,100,50,4/29/2019
12731D,conference-call,100,50,4/29/2019
15A388,ipo,100,71,4/29/2019
168A5D,executive-appointment,100,54,4/29/2019
16F4D8,earnings,100,50,4/29/2019
16F4D8,earnings,100,50,4/29/2019
16F4D8,earnings,100,50,4/29/2019
16F4D8,earnings,100,50,4/29/2019
16FC89,earnings,100,50,4/29/2019
18D9FA,conference-call,100,50,4/29/2019
1921DD,partnership,100,61,4/29/2019
1A5957,legal-issues-defendant,100,22,4/29/2019
1A5957,legal-issues-defendant,100,22,4/29/2019
1BC12C,dividend,100,50,4/29/2019
1BDB2A,earnings,100,50,4/29/2019
1CF3A8,conference-call,100,50,4/29/2019
1E68B3,earnings,100,50,4/29/2019
1F716B,earnings,100,50,4/29/2019
1FC422,business-contract,100,69,4/29/2019
20DC4E,dividend,100,50,4/29/2019
21D903,legal-issues-defendant,100,22,4/29/2019
21D903,legal-issues-defendant,100,22,4/29/2019
228D42,partnership,100,61,4/29/2019
228D42,partnership,100,61,4/29/2019
2667B6,dividend,100,50,4/29/2019
270B78,executive-appointment,100,54,4/29/2019
2720AB,earnings,100,50,4/29/2019
27A791,earnings,100,50,4/29/2019
2A9C0A,earnings-positive,100,69,4/29/2019
2A9C0A,earnings,100,50,4/29/2019
2A9C0A,earnings,100,50,4/29/2019
2A9C0A,earnings,100,50,4/29/2019
2A9C0A,earnings,100,50,4/29/2019
2B7A40,conference-participant,100,50,4/29/2019
2CC71C,conference-call,100,50,4/29/2019
30AB63,earnings,100,50,4/29/2019
30E01D,earnings,100,50,4/29/2019
31DB20,earnings,100,50,4/29/2019
31F25C,earnings,100,50,4/29/2019
33AD83,partnership,100,61,4/29/2019
33FD66,earnings,100,50,4/29/2019
33FD66,earnings,100,50,4/29/2019
33FD66,earnings,100,50,4/29/2019
33FD66,earnings,100,50,4/29/2019
33FD66,earnings,100,50,4/29/2019
3461CF,executive-appointment,100,54,4/29/2019
3461CF,credit-rating-affirmation-rater,20,50,4/29/2019
367E1C,earnings,100,50,4/29/2019
385DD4,product-release,100,64,4/29/2019
385DD4,product-release,100,64,4/29/2019
3A3447,partnership,100,61,4/29/2019
3B2311,earnings,100,50,4/29/2019
3B50FE,product-release,100,64,4/29/2019
3DED49,conference-call,100,50,4/29/2019
3ED92D,executive-appointment,100,54,4/29/2019
41ED98,conference-call,100,50,4/29/2019
422A82,earnings,100,50,4/29/2019
422A82,earnings,100,50,4/29/2019
422A82,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
43A74A,earnings,100,50,4/29/2019
44A4FC,investment-investor,100,55,4/29/2019
46017C,conference-participant,100,50,4/29/2019
4806CE,facility-open,100,65,4/29/2019
4885C8,executive-appointment,100,54,4/29/2019
490D4B,earnings,100,50,4/29/2019
490D4B,earnings,100,50,4/29/2019
4.91E+58,loan-recipient,100,59,4/29/2019
494EB9,earnings,100,50,4/29/2019
4A2457,award,100,58,4/29/2019
4C7DB5,note-sale,100,52,4/29/2019
4D8E5E,earnings,100,50,4/29/2019
4FCC78,public-offering,100,43,4/29/2019
4FF163,business-contract,100,69,4/29/2019
504FE2,executive-appointment,100,54,4/29/2019
5088A5,earnings,100,50,4/29/2019
51E682,dividend,100,50,4/29/2019
539F49,orphan-drug-designation,100,76,4/29/2019
5403F8,earnings,100,50,4/29/2019
55438C,dividend,100,50,4/29/2019
55C9B5,executive-appointment,100,54,4/29/2019
56EA2B,revenue-up,100,62,4/29/2019
57634F,earnings,100,50,4/29/2019
594402,regulatory-product-approval-granted,100,81,4/29/2019
5968F9,earnings,100,50,4/29/2019
5BE42C,earnings-up,100,68,4/29/2019
5D63F1,partnership,100,61,4/29/2019
620381,clinical-trials,100,56,4/29/2019
64636E,executive-appointment,100,54,4/29/2019
64636E,executive-appointment,100,54,4/29/2019
65CF8E,earnings,100,50,4/29/2019
665440,conference-call,100,50,4/29/2019
6844D2,business-contract,100,69,4/29/2019
68B03F,earnings-up,100,68,4/29/2019
69C99E,earnings,100,50,4/29/2019
6B0784,conference-call,100,50,4/29/2019
6B5379,acquisition-acquirer,100,49,4/29/2019
6B5379,acquisition-acquirer,100,49,4/29/2019
6D4636,earnings,100,50,4/29/2019
6D4636,earnings,100,50,4/29/2019
6D6B40,earnings,100,50,4/29/2019
709AED,dividend,100,50,4/29/2019
709AED,earnings,100,50,4/29/2019
709AED,earnings,100,50,4/29/2019
709AED,earnings,100,50,4/29/2019
70CA28,conference-call,100,50,4/29/2019
741937,facility-open,100,65,4/29/2019
741937,executive-appointment,100,54,4/29/2019
7.44E+09,dividend,100,50,4/29/2019
7448A3,conference-participant,100,50,4/29/2019
756BB4,product-release,100,64,4/29/2019
767F86,earnings,100,50,4/29/2019
767F86,earnings,100,50,4/29/2019
769F40,earnings,100,50,4/29/2019
782B46,earnings,100,50,4/29/2019
791EC1,earnings,100,50,4/29/2019
79340A,earnings,100,50,4/29/2019
7AF907,executive-appointment,100,54,4/29/2019
7C4168,earnings,100,50,4/29/2019
7CBC40,earnings,100,50,4/29/2019
7CBC40,earnings,100,50,4/29/2019
7CBC40,earnings,100,50,4/29/2019
7CBC40,earnings,100,50,4/29/2019
7D5384,executive-appointment,100,54,4/29/2019
7F3665,earnings,100,50,4/29/2019
803FED,conference-call,100,50,4/29/2019
819492,earnings,100,50,4/29/2019
8195B7,conference-call,100,50,4/29/2019
83066C,earnings,100,50,4/29/2019
83066C,earnings,100,50,4/29/2019
83598E,acquisition-acquirer,100,49,4/29/2019
83598E,earnings,100,50,4/29/2019
83598E,earnings,100,50,4/29/2019
84A6B9,earnings,100,50,4/29/2019
84A6B9,earnings,100,50,4/29/2019
84A6B9,earnings,100,50,4/29/2019
84A6B9,earnings,100,50,4/29/2019
84A6B9,earnings,100,50,4/29/2019
84A6B9,earnings,100,50,4/29/2019
850779,conference-participant,100,50,4/29/2019
860AB6,earnings,100,50,4/29/2019
8614A2,legal-issues-defendant,100,22,4/29/2019
873DB9,dividend,100,50,4/29/2019
87486A,dividend,100,50,4/29/2019
8802B4,earnings,100,50,4/29/2019
8B4A45,facility-open,100,65,4/29/2019
8B9B3B,legal-issues-defendant,100,22,4/29/2019
8C1238,earnings,100,50,4/29/2019
8C1238,earnings,100,50,4/29/2019
8C1238,earnings,100,50,4/29/2019
8C1238,earnings,100,50,4/29/2019
8C1238,earnings,100,50,4/29/2019
8DCBBB,earnings,100,50,4/29/2019
8DCBBB,earnings,100,50,4/29/2019
8E82A6,conference-participant,100,50,4/29/2019
8E8E6E,earnings,100,50,4/29/2019
8F6995,earnings,100,50,4/29/2019
8F8F2F,acquisition-acquirer,100,49,4/29/2019
8F8F2F,earnings,100,50,4/29/2019
8F8F2F,earnings,100,50,4/29/2019
8FE7A5,earnings,100,50,4/29/2019
92005C,earnings,100,50,4/29/2019
9.39E+69,regulatory-product-approval-granted,100,81,4/29/2019
9507FF,earnings,100,50,4/29/2019
9592FB,earnings,100,50,4/29/2019
95DC1F,asset-sale,100,62,4/29/2019
968103,earnings,100,50,4/29/2019
968103,earnings,100,50,4/29/2019
968103,earnings,100,50,4/29/2019
968103,earnings,100,50,4/29/2019
968B00,earnings-positive,100,69,4/29/2019
968B00,earnings-positive,100,69,4/29/2019
979451,earnings,100,50,4/29/2019
97AAF6,demand-increase,100,83,4/29/2019
990AD0,earnings,100,50,4/29/2019
990AD0,conference-organizer,100,57,4/29/2019
9978F1,earnings,100,50,4/29/2019
9D4EC7,earnings,100,50,4/29/2019
9D4EC7,earnings,100,50,4/29/2019
9D4EC7,earnings,100,50,4/29/2019
9D5D35,earnings,100,50,4/29/2019
9D5D35,earnings,100,50,4/29/2019
9D5D35,earnings,100,50,4/29/2019
9D65C1,earnings,100,50,4/29/2019
9F18FA,earnings,100,50,4/29/2019
9F18FA,earnings,100,50,4/29/2019
A072C4,conference-call,100,50,4/29/2019
A1A317,earnings,100,50,4/29/2019
A1A317,earnings,100,50,4/29/2019
A1A317,earnings,100,50,4/29/2019
A398F8,conference-participant,100,50,4/29/2019
A47F2E,earnings,100,50,4/29/2019
A495F7,product-release,100,64,4/29/2019
A63387,executive-appointment,100,54,4/29/2019
A6828A,clinical-trials-filed,100,60,4/29/2019
A6828A,partnership,100,61,4/29/2019
A6828A,regulatory-product-application,100,69,4/29/2019
A8CBDA,conference-participant,100,50,4/29/2019
A9ED24,earnings,100,50,4/29/2019
A9ED24,earnings,100,50,4/29/2019
A9ED24,earnings,100,50,4/29/2019
A9ED24,earnings,100,50,4/29/2019
A9ED24,earnings,100,50,4/29/2019
AAC8B6,dividend,100,50,4/29/2019
AAC8B6,dividend,100,50,4/29/2019
AAEE21,earnings,100,50,4/29/2019
AB7726,earnings,100,50,4/29/2019
AC7AAE,earnings,100,50,4/29/2019
ACF0B4,conference-call,100,50,4/29/2019
B076A1,earnings,100,50,4/29/2019
B076A1,earnings,100,50,4/29/2019
B076A1,earnings,100,50,4/29/2019
B106FA,earnings,100,50,4/29/2019
B13B68,acquisition-completed-acquirer,100,49,4/29/2019
B1FC3B,business-contract,100,69,4/29/2019
B4C673,facility-open,100,65,4/29/2019
B72BE9,revenues,100,50,4/29/2019
B72BE9,revenues,100,50,4/29/2019
B72BE9,revenues,100,50,4/29/2019
BAD655,board-meeting,100,51,4/29/2019
BBBB41,facility-open,100,65,4/29/2019
BC4876,earnings,100,50,4/29/2019
BE645B,public-offering,100,43,4/29/2019
C01737,executive-appointment,100,54,4/29/2019
C0F70B,earnings,100,50,4/29/2019
C188F8,earnings,100,50,4/29/2019
C2F597,executive-appointment,100,54,4/29/2019
C9C62A,earnings,100,50,4/29/2019
CBCC6A,conference-organizer,100,57,4/29/2019
CBCC6A,executive-appointment,100,54,4/29/2019
CE4FD9,earnings,100,50,4/29/2019
CE5664,partnership,100,61,4/29/2019
CE96E7,earnings,100,50,4/29/2019
CE96E7,earnings,100,50,4/29/2019
CE96E7,earnings,100,50,4/29/2019
D25249,award,100,58,4/29/2019
D3C794,earnings,100,50,4/29/2019
D57D99,earnings,100,50,4/29/2019
D6144F,conference-call,100,50,4/29/2019
D697DE,earnings,100,50,4/29/2019
D721C6,executive-appointment,100,54,4/29/2019
D8DBA3,operating-earnings,100,50,4/29/2019
DAFED3,note-sale,100,52,4/29/2019
DAFED3,note-sale,100,52,4/29/2019
DC0998,product-release,100,64,4/29/2019
DC2F77,dividend,100,50,4/29/2019
DD9E41,earnings,100,50,4/29/2019
DD9E41,earnings,100,50,4/29/2019
DD9E41,earnings,100,50,4/29/2019
DD9E41,earnings,100,50,4/29/2019
DD9E41,earnings,100,50,4/29/2019
DF46C5,dividend,100,50,4/29/2019
DF46C5,earnings,100,50,4/29/2019
DF46C5,earnings,100,50,4/29/2019
DF46C5,earnings,100,50,4/29/2019
DF46C5,earnings,100,50,4/29/2019
E074A0,dividend,100,50,4/29/2019
E09997,executive-appointment,100,54,4/29/2019
E10D31,legal-issues-defendant,100,22,4/29/2019
E40FB6,earnings,100,50,4/29/2019
E40FB6,earnings,100,50,4/29/2019
E40FB6,earnings,100,50,4/29/2019
E40FB6,earnings,100,50,4/29/2019
E5F0A8,earnings-positive,100,69,4/29/2019
E5F0A8,earnings,100,50,4/29/2019
E5F0A8,earnings,100,50,4/29/2019
E5F0A8,earnings,100,50,4/29/2019
E6A53A,executive-appointment,100,54,4/29/2019
E74FED,executive-appointment,100,54,4/29/2019
E7BF32,earnings,100,50,4/29/2019
E84500,earnings,100,50,4/29/2019
E93A40,earnings,100,50,4/29/2019
EA62FC,dividend-up,100,81,4/29/2019
EBC84C,earnings,100,50,4/29/2019
EBC84C,earnings,100,50,4/29/2019
EBC84C,earnings,100,50,4/29/2019
EBC84C,earnings,100,50,4/29/2019
EBC84C,earnings,100,50,4/29/2019
EE6F1C,partnership,100,61,4/29/2019
EE6F1C,business-contract,100,69,4/29/2019
EE74E1,executive-appointment,100,54,4/29/2019
EEBCEF,dividend,100,50,4/29/2019
EF45B6,earnings,100,50,4/29/2019
EF76C8,earnings,100,50,4/29/2019
EF77A3,dividend,100,50,4/29/2019
F0027C,executive-appointment,100,54,4/29/2019
F3FCC3,dividend,100,50,4/29/2019
F4E882,legal-issues-defendant,100,22,4/29/2019
F6A945,earnings,100,50,4/29/2019
F7FCA4,earnings,100,50,4/29/2019
F7FCA4,earnings,100,50,4/29/2019
F7FCA4,earnings,100,50,4/29/2019
F8084B,earnings,100,50,4/29/2019
F8084B,earnings,100,50,4/29/2019
F85CC0,conference-participant,100,50,4/29/2019
F90EE5,earnings,100,50,4/29/2019
FA36A4,earnings,100,50,4/29/2019
FAEABE,dividend,100,50,4/29/2019
FB7724,earnings,100,50,4/29/2019
FE7A63,executive-appointment,100,54,4/29/2019
FF6644,dividend,100,50,4/29/2019
FFAB4A,earnings,100,50,4/29/2019
13528,dividend,100,50,4/30/2019
01478A,earnings,100,50,4/30/2019
02870F,partnership,100,61,4/30/2019
03542C,earnings,100,50,4/30/2019
03CF95,acquisition-regulatory-approval-acquirer,100,54,4/30/2019
03FB17,earnings,100,50,4/30/2019
03FB17,executive-appointment,100,54,4/30/2019
68396,earnings,100,50,4/30/2019
070B45,earnings,100,50,4/30/2019
07CA6A,partnership,100,61,4/30/2019
095A04,earnings,100,50,4/30/2019
099C88,business-contract,100,69,4/30/2019
09F623,earnings-up,100,72,4/30/2019
0A748B,earnings,100,50,4/30/2019
0A748B,earnings,100,50,4/30/2019
0B2071,earnings,100,50,4/30/2019
0BF198,conference-call,100,50,4/30/2019
0BF528,executive-appointment,100,54,4/30/2019
0CC62B,earnings,100,50,4/30/2019
0CC62B,earnings,100,50,4/30/2019
0CC62B,earnings,100,50,4/30/2019
0CC62B,earnings,100,50,4/30/2019
0CCCB7,executive-appointment,100,54,4/30/2019
0E2992,earnings,100,50,4/30/2019
0F0693,earnings,100,50,4/30/2019
0F65C9,earnings,100,50,4/30/2019
0F65C9,dividend,100,50,4/30/2019
0F91FC,earnings,100,50,4/30/2019
1065BC,earnings,100,50,4/30/2019
1080C0,earnings,100,50,4/30/2019
1272B3,earnings,100,50,4/30/2019
129DC8,earnings,100,50,4/30/2019
129DC8,earnings,100,50,4/30/2019
129DC8,earnings,100,50,4/30/2019
131443,earnings-up,100,68,4/30/2019
131443,earnings-up,100,68,4/30/2019
131443,earnings-up,100,68,4/30/2019
131443,earnings-up,100,68,4/30/2019
131443,earnings-up,100,68,4/30/2019
135B09,earnings-up,100,68,4/30/2019
135B09,earnings,100,50,4/30/2019
135B09,earnings,100,50,4/30/2019
135B09,earnings,100,50,4/30/2019
149301,dividend,100,50,4/30/2019
14BA06,earnings,100,50,4/30/2019
14BA33,earnings,100,50,4/30/2019
157CC1,earnings,100,50,4/30/2019
168A5D,partnership,100,61,4/30/2019
16B882,earnings,100,50,4/30/2019
182546,acquisition-acquirer,100,49,4/30/2019
1866B2,dividend,100,50,4/30/2019
188394,dividend,100,50,4/30/2019
190B91,earnings,100,50,4/30/2019
190B91,earnings,100,50,4/30/2019
190B91,earnings,100,50,4/30/2019
190B91,earnings,100,50,4/30/2019
1A3E1B,dividend,100,50,4/30/2019
1A5957,earnings,100,50,4/30/2019
1A5D5D,earnings,100,50,4/30/2019
1A5D5D,earnings,100,50,4/30/2019
1A5D5D,earnings,100,50,4/30/2019
1A5D5D,earnings,100,50,4/30/2019
1A5D5D,earnings,100,50,4/30/2019
1B16C1,conference-call,100,50,4/30/2019
1B5FEA,business-contract,100,69,4/30/2019
1BC12C,product-release,100,64,4/30/2019
1CD4B5,executive-appointment,100,54,4/30/2019
1DF15D,earnings,100,50,4/30/2019
1DF15D,earnings,100,50,4/30/2019
1DF15D,earnings,100,50,4/30/2019
1EBF8D,earnings,100,50,4/30/2019
1F716B,executive-appointment,100,54,4/30/2019
1F9258,business-contract,100,69,4/30/2019
1FE7F0,executive-appointment,100,54,4/30/2019
2082EA,conference-call,100,50,4/30/2019
2093B1,earnings,100,50,4/30/2019
214051,operating-earnings,100,50,4/30/2019
21D903,legal-issues-defendant,100,22,4/30/2019
222BF9,earnings,100,50,4/30/2019
2262BD,earnings,100,50,4/30/2019
228D42,partnership,100,61,4/30/2019
228D42,partnership,100,61,4/30/2019
22C58E,earnings,100,50,4/30/2019
24A89A,clinical-trials,100,56,4/30/2019
24A89A,clinical-trials,100,56,4/30/2019
24C48B,dividend,100,50,4/30/2019
24CB56,earnings,100,50,4/30/2019
24FA23,conference-participant,100,50,4/30/2019
251988,legal-issues-defendant,100,22,4/30/2019
25A6CC,conference-participant,100,50,4/30/2019
25AB8E,earnings,100,50,4/30/2019
267718,earnings,100,50,4/30/2019
267718,earnings,100,50,4/30/2019
267718,earnings,100,50,4/30/2019
267718,earnings,100,50,4/30/2019
267718,earnings,100,50,4/30/2019
267718,earnings,100,50,4/30/2019
267718,earnings,100,50,4/30/2019
267718,partnership,100,61,4/30/2019
26CC63,conference-participant,100,50,4/30/2019
26D8ED,earnings,100,50,4/30/2019
26F31D,earnings,100,50,4/30/2019
26F31D,earnings,100,50,4/30/2019
26F31D,earnings,100,50,4/30/2019
270305,earnings,100,50,4/30/2019
270305,earnings,100,50,4/30/2019
270305,earnings,100,50,4/30/2019
270305,dividend,100,50,4/30/2019
270305,earnings,100,50,4/30/2019
29B702,acquisition-completed-acquirer,100,49,4/30/2019
2AA6A8,conference-call,100,50,4/30/2019
2C3348,earnings,100,50,4/30/2019
2C35B5,conference-participant,100,50,4/30/2019
2DC88B,legal-issues-defendant,100,22,4/30/2019
2E0496,earnings,100,50,4/30/2019
2F24A5,earnings,100,50,4/30/2019
2F6782,dividend,100,50,4/30/2019
306623,conference-call,100,50,4/30/2019
31AA84,partnership,100,61,4/30/2019
31F25C,dividend,100,50,4/30/2019
332F87,earnings-per-share-up,100,72,4/30/2019
33AD83,product-release,100,64,4/30/2019
33E9D5,earnings,100,50,4/30/2019
3461CF,conference-participant,100,50,4/30/2019
349DA4,earnings,100,50,4/30/2019
34B97A,earnings,100,50,4/30/2019
34B97A,earnings,100,50,4/30/2019
34B97A,earnings,100,50,4/30/2019
34B97A,earnings,100,50,4/30/2019
34E9F9,earnings,100,50,4/30/2019
34E9F9,earnings,100,50,4/30/2019
34E9F9,earnings,100,50,4/30/2019
34E9F9,earnings,100,50,4/30/2019
36A1CB,earnings,100,50,4/30/2019
36A1CB,earnings,100,50,4/30/2019
373B06,earnings,100,50,4/30/2019
37727A,earnings,100,50,4/30/2019
37727A,earnings,100,50,4/30/2019
37727A,earnings,100,50,4/30/2019
37727A,earnings,100,50,4/30/2019
37727A,earnings,100,50,4/30/2019
37727A,earnings,100,50,4/30/2019
38FB49,dividend,100,50,4/30/2019
3BCF24,earnings-up,100,61,4/30/2019
3BE00F,earnings,100,50,4/30/2019
3BE00F,earnings,100,50,4/30/2019
3BE00F,earnings,100,50,4/30/2019
3F1C69,earnings,100,50,4/30/2019
3F868D,earnings,100,50,4/30/2019
3FACA7,earnings-positive,100,69,4/30/2019
3FACA7,earnings,100,50,4/30/2019
3FACA7,earnings,100,50,4/30/2019
3FACA7,earnings,100,50,4/30/2019
414FFF,business-contract,100,69,4/30/2019
41C528,conference-call,100,50,4/30/2019
420168,earnings,100,50,4/30/2019
429BFB,hirings,100,65,4/30/2019
429BFB,earnings,100,50,4/30/2019
43A060,legal-issues-defendant,100,22,4/30/2019
43E8F5,earnings,100,50,4/30/2019
44209A,conference-participant,100,50,4/30/2019
44DDBD,earnings,100,50,4/30/2019
467F2C,earnings,100,50,4/30/2019
485445,dividend,100,50,4/30/2019
49914B,earnings,100,50,4/30/2019
4A6F00,partnership,100,61,4/30/2019
4AC91D,partnership,100,61,4/30/2019
4B6EF9,dividend,100,50,4/30/2019
4B6EF9,earnings,100,50,4/30/2019
4BBA23,operating-earnings,100,50,4/30/2019
4BBA23,operating-earnings,100,50,4/30/2019
4BBA23,business-contract,100,69,4/30/2019
4BBA23,business-contract,100,69,4/30/2019
4C31F3,conference-call,100,50,4/30/2019
4C5CC9,dividend,100,50,4/30/2019
4FB770,earnings,100,50,4/30/2019
504FE2,earnings,100,50,4/30/2019
52015A,earnings,100,50,4/30/2019
53EF9E,earnings,100,50,4/30/2019
53EF9E,earnings,100,50,4/30/2019
54A713,unit-acquisition-acquirer,100,49,4/30/2019
54F271,earnings,100,50,4/30/2019
553949,earnings,100,50,4/30/2019
55C9B5,earnings,100,50,4/30/2019
564F3E,earnings,100,50,4/30/2019
56632F,earnings,100,50,4/30/2019
56632F,earnings,100,50,4/30/2019
56632F,earnings,100,50,4/30/2019
57CAAB,earnings,100,50,4/30/2019
57EF50,conference-call,100,50,4/30/2019
596116,earnings,100,50,4/30/2019
59DB8C,earnings,100,50,4/30/2019
5B15E1,earnings,100,50,4/30/2019
5CCDAD,earnings,100,50,4/30/2019
5D02B7,conference-call,100,50,4/30/2019
5D43A7,earnings,100,50,4/30/2019
5D43A7,earnings,100,50,4/30/2019
5D43A7,earnings,100,50,4/30/2019
5FF95F,legal-issues-defendant,100,22,4/30/2019
60EA12,dividend,100,50,4/30/2019
60EA12,earnings,100,50,4/30/2019
619882,conference-organizer,100,57,4/30/2019
61BCA7,earnings,100,50,4/30/2019
62B1C6,earnings,100,50,4/30/2019
63E8D5,earnings,100,50,4/30/2019
63E8D5,earnings,100,50,4/30/2019
641F17,dividend,100,50,4/30/2019
665D7D,regulatory-product-approval-granted,100,81,4/30/2019
67B923,earnings,100,50,4/30/2019
69345C,earnings,100,50,4/30/2019
69345C,earnings,100,50,4/30/2019
69345C,earnings,100,50,4/30/2019
69345C,earnings,100,50,4/30/2019
69494C,conference-call,100,50,4/30/2019
6B494E,earnings,100,50,4/30/2019
6B67BD,settlement,100,56,4/30/2019
6CC55E,earnings,100,50,4/30/2019
6D3F35,earnings,100,50,4/30/2019
6D3F35,earnings,100,50,4/30/2019
6D3F35,earnings,100,50,4/30/2019
6D3F35,earnings,100,50,4/30/2019
6D3F35,business-contract,100,69,4/30/2019
6E8349,earnings,100,50,4/30/2019
6F5DD2,conference-participant,100,50,4/30/2019
713810,partnership,100,61,4/30/2019
71B0CF,earnings,100,50,4/30/2019
722DE3,award,100,58,4/30/2019
7255D2,conference-call,100,50,4/30/2019
72C2CE,earnings,100,50,4/30/2019
72CB93,note-sale,100,52,4/30/2019
732449,earnings,100,50,4/30/2019
735388,dividend,100,50,4/30/2019
73A71F,dividend,100,50,4/30/2019
7410C3,earnings,100,50,4/30/2019
7.45E+28,earnings,100,50,4/30/2019
7.49E+07,executive-appointment,100,54,4/30/2019
752A70,earnings,100,50,4/30/2019
76B926,earnings,100,50,4/30/2019
76B926,earnings,100,50,4/30/2019
76F067,earnings,100,50,4/30/2019
76F067,earnings,100,50,4/30/2019
7823A3,earnings,100,50,4/30/2019
7823A3,earnings,100,50,4/30/2019
7823A3,earnings,100,50,4/30/2019
7823A3,earnings,100,50,4/30/2019
7823A3,earnings,100,50,4/30/2019
7823A3,earnings,100,50,4/30/2019
782B46,dividend,100,50,4/30/2019
782B46,dividend,100,50,4/30/2019
782B46,buybacks,100,74,4/30/2019
790C34,product-release,100,64,4/30/2019
79167B,acquisition-acquirer,100,49,4/30/2019
79167B,earnings,100,50,4/30/2019
79167B,earnings,100,50,4/30/2019
79167B,earnings,100,50,4/30/2019
79167B,earnings,100,50,4/30/2019
7A10FF,earnings,100,50,4/30/2019
7B0BA6,earnings,100,50,4/30/2019
7B0BA6,earnings,100,50,4/30/2019
7B0BA6,earnings,100,50,4/30/2019
7B0BA6,earnings,100,50,4/30/2019
7B0BA6,earnings,100,50,4/30/2019
7B0BA6,earnings,100,50,4/30/2019
7F9984,earnings-guidance,100,50,4/30/2019
7F9984,earnings,100,50,4/30/2019
7F9BE2,dividend,100,50,4/30/2019
80C400,earnings,100,50,4/30/2019
8303CD,earnings,100,50,4/30/2019
84AB66,earnings-positive,100,69,4/30/2019
850779,acquisition-acquirer,100,49,4/30/2019
850779,acquisition-acquirer,100,49,4/30/2019
85DE00,dividend,100,50,4/30/2019
85DE00,earnings,100,50,4/30/2019
86AA9C,earnings,100,50,4/30/2019
86BAC7,earnings,100,50,4/30/2019
880C0C,earnings,100,50,4/30/2019
893904,earnings,100,50,4/30/2019
8AB37F,partnership,100,61,4/30/2019
8AB85C,clinical-trials-positive,100,87,4/30/2019
8AC65D,earnings,100,50,4/30/2019
8D4486,dividend-up,100,81,4/30/2019
8D4486,dividend-up,100,81,4/30/2019
8E82A6,conference-participant,100,50,4/30/2019
8EEA28,earnings,100,50,4/30/2019
8FCA78,earnings,100,50,4/30/2019
8FCA78,earnings,100,50,4/30/2019
8FCA78,earnings,100,50,4/30/2019
900356,earnings,100,50,4/30/2019
9196A2,partnership,100,61,4/30/2019
92B625,conference-call,100,50,4/30/2019
940C3D,earnings,100,50,4/30/2019
945DE6,public-offering,100,43,4/30/2019
945DE6,public-offering,100,43,4/30/2019
9546A5,conference-call,100,50,4/30/2019
9.54E+32,earnings,100,50,4/30/2019
9.54E+32,earnings,100,50,4/30/2019
968B00,note-sale,100,52,4/30/2019
98CAED,dividend,100,50,4/30/2019
98CAED,earnings,100,50,4/30/2019
98CAED,earnings,100,50,4/30/2019
98CAED,earnings,100,50,4/30/2019
990AD0,conference-organizer,100,57,4/30/2019
990AD0,conference-organizer,100,57,4/30/2019
990AD0,conference-organizer,100,57,4/30/2019
990AD0,conference-organizer,100,57,4/30/2019
9A602D,earnings-per-share-positive,100,69,4/30/2019
9A602D,earnings-per-share-positive,100,69,4/30/2019
9A602D,earnings-per-share-positive,100,69,4/30/2019
9A602D,earnings-per-share-positive,100,69,4/30/2019
9A602D,earnings-per-share-positive,100,69,4/30/2019
9A602D,earnings-per-share-positive,100,69,4/30/2019
9B730A,conference-call,100,50,4/30/2019
9CE4C7,conference-participant,100,50,4/30/2019
9D6A24,earnings,100,50,4/30/2019
9F5CBB,dividend,100,50,4/30/2019
9F6B1A,earnings-guidance-up,100,83,4/30/2019
9F6B1A,earnings,100,50,4/30/2019
9F6B1A,earnings,100,50,4/30/2019
9F6B1A,earnings,100,50,4/30/2019
A05C43,earnings,100,50,4/30/2019
A072C4,business-contract,100,69,4/30/2019
A1EAC8,dividend,100,50,4/30/2019
A1EAC8,dividend,100,50,4/30/2019
A1EAC8,dividend,100,50,4/30/2019
A1EAC8,conference-call,100,50,4/30/2019
A23747,earnings,100,50,4/30/2019
A247F5,earnings-per-share-positive,100,69,4/30/2019
A247F5,earnings-per-share-positive,100,69,4/30/2019
A247F5,earnings-per-share-positive,100,69,4/30/2019
A28C54,business-contract,100,69,4/30/2019
A350C1,operating-earnings,100,50,4/30/2019
A350C1,operating-earnings,100,50,4/30/2019
A350C1,operating-earnings,100,50,4/30/2019
A350C1,operating-earnings,100,50,4/30/2019
A350C1,operating-earnings,100,50,4/30/2019
A350C1,operating-earnings,100,50,4/30/2019
A350C1,operating-earnings,100,50,4/30/2019
A41450,earnings,100,50,4/30/2019
A47A7D,earnings,100,50,4/30/2019
A4A612,earnings,100,50,4/30/2019
A4CD53,business-contract,100,69,4/30/2019
A4F67C,earnings,100,50,4/30/2019
A65325,executive-appointment,100,54,4/30/2019
A6ABE9,earnings-positive,100,69,4/30/2019
A790A5,dividend,100,50,4/30/2019
A79D88,earnings,100,50,4/30/2019
A79D88,earnings,100,50,4/30/2019
A7CCF0,earnings-up,100,68,4/30/2019
A7CCF0,earnings,100,50,4/30/2019
A94718,earnings,100,50,4/30/2019
AA09AD,earnings,100,50,4/30/2019
ACF77B,dividend,100,50,4/30/2019
AD9F1D,revenue-up,100,65,4/30/2019
AD9F1D,revenue-up,100,69,4/30/2019
AD9F1D,revenue-up,100,69,4/30/2019
AD9F1D,revenue-up,100,69,4/30/2019
AD9F1D,revenue-up,100,69,4/30/2019
AD9F1D,revenue-up,100,69,4/30/2019
AD9F1D,revenue-up,100,69,4/30/2019
AD9F1D,revenue-up,100,69,4/30/2019
AE3113,executive-appointment,100,54,4/30/2019
AE4EEB,earnings,100,50,4/30/2019
AED61E,acquisition-interest-acquirer,100,46,4/30/2019
AEF2C3,earnings,100,50,4/30/2019
AF93DE,conference-call,100,50,4/30/2019
AFF7B4,earnings,100,50,4/30/2019
AFF7B4,earnings,100,50,4/30/2019
AFF7B4,earnings,100,50,4/30/2019
B0D41A,earnings,100,50,4/30/2019
B0FE08,dividend-up,100,81,4/30/2019
B1A85D,executive-appointment,100,54,4/30/2019
B2D799,legal-issues-defendant,100,22,4/30/2019
B303A6,dividend,100,50,4/30/2019
B4703C,earnings-per-share-positive,100,69,4/30/2019
B4703C,earnings,100,50,4/30/2019
B614F8,patent-filing,100,64,4/30/2019
B6CD92,earnings-positive,100,69,4/30/2019
B6CD92,earnings-up,100,68,4/30/2019
B6CD92,earnings-up,100,68,4/30/2019
B6CD92,earnings-up,100,68,4/30/2019
B7202A,conference-participant,100,50,4/30/2019
B7FA9B,conference-call,100,50,4/30/2019
BAD655,earnings,100,50,4/30/2019
BB0587,earnings,100,50,4/30/2019
BB0587,earnings,100,50,4/30/2019
BB0587,earnings,100,50,4/30/2019
BB0587,earnings,100,50,4/30/2019
BB127B,partnership,100,61,4/30/2019
BB5142,earnings,100,50,4/30/2019
BB5271,earnings,100,50,4/30/2019
BC3AD2,earnings,100,50,4/30/2019
BD8517,earnings,100,50,4/30/2019
BE379D,conference-call,100,50,4/30/2019
BE645B,public-offering,100,43,4/30/2019
BE7BA4,earnings,100,50,4/30/2019
BE86A1,earnings,100,50,4/30/2019
C16A8F,earnings,100,50,4/30/2019
C16A8F,earnings,100,50,4/30/2019
C16A8F,earnings,100,50,4/30/2019
C188F8,product-release,100,64,4/30/2019
C2E426,earnings,100,50,4/30/2019
C38440,executive-appointment,100,54,4/30/2019
C3CF29,earnings,100,50,4/30/2019
C3CF29,earnings,100,50,4/30/2019
C3CF29,earnings,100,50,4/30/2019
C3F99F,earnings,100,50,4/30/2019
C4F567,revenues,100,50,4/30/2019
C4F567,revenues,100,50,4/30/2019
C4F567,revenues,100,50,4/30/2019
C4F567,revenues,100,50,4/30/2019
C564E4,conference-call,100,50,4/30/2019
C58D71,earnings,100,50,4/30/2019
C5C0E9,earnings,100,50,4/30/2019
C659EB,earnings,100,50,4/30/2019
C659EB,earnings,100,50,4/30/2019
C659EB,earnings,100,50,4/30/2019
C72B8F,earnings,100,50,4/30/2019
C83B88,conference-participant,100,50,4/30/2019
C85A72,revenue-up,100,81,4/30/2019
C85A72,revenue-up,100,81,4/30/2019
C85A72,revenue-up,100,81,4/30/2019
C85A72,revenue-up,100,81,4/30/2019
C941DC,earnings,100,50,4/30/2019
CB7AB2,facility-open,100,65,4/30/2019
CB9E13,conference-call,100,50,4/30/2019
CBA33B,acquisition-acquirer,100,49,4/30/2019
CC0C78,earnings,100,50,4/30/2019
CC35BE,earnings,100,50,4/30/2019
CCBBAD,earnings,100,50,4/30/2019
CE4FD9,earnings,100,50,4/30/2019
CE4FD9,earnings,100,50,4/30/2019
CE4FD9,earnings,100,50,4/30/2019
CE4FD9,earnings,100,50,4/30/2019
CE4FD9,earnings,100,50,4/30/2019
CF3FF9,earnings,100,50,4/30/2019
CF6A5A,executive-appointment,100,54,4/30/2019
D33D8C,dividend,100,50,4/30/2019
D56E4C,earnings,100,50,4/30/2019
D60BB2,earnings,100,50,4/30/2019
D64C6D,business-contract,100,69,4/30/2019
D6534D,earnings,100,50,4/30/2019
D6534D,earnings,100,50,4/30/2019
D7918D,operating-earnings,100,50,4/30/2019
D8442A,earnings,100,50,4/30/2019
D8442A,earnings,100,50,4/30/2019
D8442A,earnings,100,50,4/30/2019
D854F3,conference-participant,100,50,4/30/2019
D88EF3,earnings,100,50,4/30/2019
D88EF3,earnings,100,50,4/30/2019
D88EF3,earnings,100,50,4/30/2019
D88EF3,earnings,100,50,4/30/2019
D88EF3,earnings,100,50,4/30/2019
D88EF3,earnings,100,50,4/30/2019
D8ECA1,earnings,100,50,4/30/2019
D96202,executive-appointment,100,54,4/30/2019
DC2F77,earnings,100,50,4/30/2019
DEF058,earnings,100,50,4/30/2019
DF18E6,clinical-trials,100,56,4/30/2019
E00373,earnings,100,50,4/30/2019
E0207A,earnings,100,50,4/30/2019
E0207A,earnings,100,50,4/30/2019
E0207A,earnings,100,50,4/30/2019
E0207A,earnings,100,50,4/30/2019
E0647D,earnings,100,50,4/30/2019
E0647D,earnings,100,50,4/30/2019
E10D31,earnings,100,50,4/30/2019
E12A6E,earnings,100,50,4/30/2019
E15736,earnings,100,50,4/30/2019
E22FDE,legal-issues-defendant,100,22,4/30/2019
E30A8F,earnings,100,50,4/30/2019
E30A8F,earnings,100,50,4/30/2019
E30A8F,earnings,100,50,4/30/2019
E30A8F,earnings,100,50,4/30/2019
E3656D,executive-appointment,100,54,4/30/2019
E38906,earnings,100,50,4/30/2019
E68733,product-release,100,64,4/30/2019
E68E62,fundraising,100,64,4/30/2019
E69BA5,earnings,100,50,4/30/2019
E6A53A,earnings,100,50,4/30/2019
E6D89E,business-contract,100,69,4/30/2019
E6E012,earnings,100,50,4/30/2019
E6E012,earnings,100,50,4/30/2019
E6E012,earnings,100,50,4/30/2019
E6E012,earnings,100,50,4/30/2019
E6E012,earnings,100,50,4/30/2019
E74FED,earnings,100,50,4/30/2019
E8846E,conference-participant,100,50,4/30/2019
E8A49A,earnings,100,50,4/30/2019
E8E899,earnings,100,50,4/30/2019
EB36DE,earnings,100,50,4/30/2019
EBD89A,earnings,100,50,4/30/2019
EC70EC,earnings,100,50,4/30/2019
EC70EC,earnings,100,50,4/30/2019
EC70EC,earnings,100,50,4/30/2019
EC70EC,earnings,100,50,4/30/2019
EC70EC,earnings,100,50,4/30/2019
EC70EC,earnings,100,50,4/30/2019
ED79D9,business-contract,100,69,4/30/2019
EDF5CA,conference-participant,100,50,4/30/2019
EE967B,earnings,100,50,4/30/2019
EEEA9F,business-combination,100,54,4/30/2019
EEEA9F,business-combination,100,54,4/30/2019
EEEA9F,business-combination,100,54,4/30/2019
EEEA9F,earnings-up,100,68,4/30/2019
EEEA9F,earnings,100,50,4/30/2019
EEEA9F,earnings,100,50,4/30/2019
EEEA9F,earnings,100,50,4/30/2019
EF5914,earnings,100,50,4/30/2019
EF5BED,business-contract,100,69,4/30/2019
F0B2B5,earnings,100,50,4/30/2019
F179ED,earnings,100,50,4/30/2019
F179ED,earnings,100,50,4/30/2019
F179ED,earnings,100,50,4/30/2019
F179ED,earnings,100,50,4/30/2019
F179ED,earnings,100,50,4/30/2019
F30508,earnings,100,50,4/30/2019
F30508,earnings,100,50,4/30/2019
F30508,earnings,100,50,4/30/2019
F30508,earnings,100,50,4/30/2019
F30508,earnings,100,50,4/30/2019
F30508,earnings,100,50,4/30/2019
F39E1E,earnings,100,50,4/30/2019
F40EE2,earnings,100,50,4/30/2019
F4CDA3,conference-call,100,50,4/30/2019
F509E2,conference-call,100,50,4/30/2019
F58C23,conference-organizer,100,57,4/30/2019
F6E248,executive-resignation,100,44,4/30/2019
F8DE55,legal-issues-defendant,100,22,4/30/2019
F8DE55,dividend,100,50,4/30/2019
F8DE55,legal-issues-defendant,100,22,4/30/2019
FB7724,legal-issues-defendant,100,22,4/30/2019
FC1A6E,revenues,100,50,4/30/2019
FD0CA4,dividend,100,50,4/30/2019
FD6926,conference-participant,100,50,4/30/2019
FE89E0,earnings,100,50,4/30/2019
00067A,earnings,100,50,5/1/2019
00326E,earnings,100,50,5/1/2019
003B70,operating-earnings,100,50,5/1/2019
00698D,conference-participant,100,50,5/1/2019
00D6B5,asset-sale,100,62,5/1/2019
018C11,earnings,100,50,5/1/2019
01B8D6,ipo-pricing,100,50,5/1/2019
0325B7,conference-call,100,50,5/1/2019
03542C,conference-call,100,50,5/1/2019
03B8CF,legal-issues-defendant,100,22,5/1/2019
048B70,earnings,100,50,5/1/2019
048B70,earnings,100,50,5/1/2019
048B70,earnings,100,50,5/1/2019
048B70,earnings,100,50,5/1/2019
053EFF,earnings,100,50,5/1/2019
58828,earnings-per-share-up,100,70,5/1/2019
05AF14,executive-appointment,100,54,5/1/2019
95294,earnings,100,50,5/1/2019
98977,earnings,100,50,5/1/2019
099A92,earnings-up,100,68,5/1/2019
099C88,earnings,100,50,5/1/2019
099C88,earnings,100,50,5/1/2019
0A77DB,earnings,100,50,5/1/2019
0A9D0A,earnings,100,50,5/1/2019
0B4D10,earnings,100,50,5/1/2019
0BA8CE,earnings,100,50,5/1/2019
0BF528,partnership,100,61,5/1/2019
0BF528,conference-call,100,50,5/1/2019
0C2A0D,dividend-guidance,100,50,5/1/2019
0C466B,acquisition-completed-acquirer,100,49,5/1/2019
0CE7F6,partnership,100,61,5/1/2019
0DE3D5,earnings,100,50,5/1/2019
0DE3D5,earnings,100,50,5/1/2019
0DE3D5,earnings,100,50,5/1/2019
0DE3D5,earnings,100,50,5/1/2019
0DE3D5,earnings,100,50,5/1/2019
0EC508,earnings,100,50,5/1/2019
0FABBD,legal-issues-defendant,100,22,5/1/2019
106394,earnings,100,50,5/1/2019
1096C6,acquisition-completed-acquirer,100,49,5/1/2019
1096C6,acquisition-completed-acquirer,100,49,5/1/2019
11074E,earnings,100,50,5/1/2019
12731D,earnings,100,50,5/1/2019
12DE76,conference-call,100,50,5/1/2019
138DDE,earnings,100,50,5/1/2019
147C38,earnings,100,50,5/1/2019
149301,earnings,100,50,5/1/2019
14BA33,conference-participant,100,50,5/1/2019
14ED2B,dividend,100,50,5/1/2019
168A5D,executive-appointment,100,54,5/1/2019
16B183,operating-earnings,100,50,5/1/2019
16C544,earnings,100,50,5/1/2019
1748B3,executive-appointment,100,54,5/1/2019
1866B2,earnings,100,50,5/1/2019
197612,earnings,100,50,5/1/2019
1AB808,earnings,100,50,5/1/2019
1AB808,earnings,100,50,5/1/2019
1AB808,earnings,100,50,5/1/2019
1AC649,private-placement,100,56,5/1/2019
1B4F31,earnings,100,50,5/1/2019
1B637E,earnings,100,50,5/1/2019
1D5C51,earnings,100,50,5/1/2019
1DEBBE,buybacks,100,74,5/1/2019
1DEBBE,earnings,100,50,5/1/2019
1F19C8,revenue-up,100,72,5/1/2019
1F19C8,revenue-up,100,69,5/1/2019
1F19C8,revenue-up,100,69,5/1/2019
1F19C8,revenue-up,100,69,5/1/2019
1F19C8,revenue-up,100,69,5/1/2019
1F464F,executive-appointment,100,54,5/1/2019
1F464F,earnings-guidance,100,50,5/1/2019
1F464F,earnings-guidance-up,100,83,5/1/2019
1FA8F7,merger-completed,100,66,5/1/2019
1FAF22,conference-participant,100,50,5/1/2019
20D00A,operating-earnings,100,50,5/1/2019
2158DF,unit-acquisition-acquirer,100,49,5/1/2019
2158DF,earnings-up,100,68,5/1/2019
2158DF,earnings-up,100,68,5/1/2019
2158DF,earnings-up,100,68,5/1/2019
2158DF,earnings-up,100,68,5/1/2019
221783,acquisition-acquirer,100,49,5/1/2019
227F04,earnings,100,50,5/1/2019
23207A,conference-call,100,50,5/1/2019
2.45E+15,dividend,100,50,5/1/2019
24A89A,clinical-trials,100,56,5/1/2019
24A89A,clinical-trials,100,56,5/1/2019
24C48B,acquisition-acquirer,100,49,5/1/2019
263216,earnings,100,50,5/1/2019
263216,earnings,100,50,5/1/2019
263216,earnings,100,50,5/1/2019
263216,earnings,100,50,5/1/2019
263216,earnings,100,50,5/1/2019
263216,earnings,100,50,5/1/2019
270305,merger-completed,100,66,5/1/2019
270305,earnings,100,50,5/1/2019
27B191,conference-call,100,50,5/1/2019
27BFA1,dividend,100,50,5/1/2019
2950FF,earnings,100,50,5/1/2019
2950FF,earnings,100,50,5/1/2019
29CEBF,earnings,100,50,5/1/2019
29CEBF,earnings,100,50,5/1/2019
29CEBF,earnings,100,50,5/1/2019
29CEBF,earnings,100,50,5/1/2019
2BAE5F,earnings,100,50,5/1/2019
2BC05E,dividend,100,50,5/1/2019
2C7505,earnings,100,50,5/1/2019
2CD1E0,asset-sale,100,62,5/1/2019
2DDB22,earnings,100,50,5/1/2019
2F1299,dividend,100,50,5/1/2019
2F6782,conference-participant,100,50,5/1/2019
2F6782,earnings,100,50,5/1/2019
2F7474,acquisition-completed-acquirer,100,49,5/1/2019
2FDEE3,earnings,100,50,5/1/2019
30DE64,clinical-trials,100,56,5/1/2019
314D88,earnings,100,50,5/1/2019
315EB0,earnings,100,50,5/1/2019
315EB0,earnings,100,50,5/1/2019
315EB0,earnings,100,50,5/1/2019
315EB0,earnings,100,50,5/1/2019
315EB0,earnings,100,50,5/1/2019
315EB0,earnings,100,50,5/1/2019
315EB0,dividend,100,50,5/1/2019
3224CC,earnings,100,50,5/1/2019
3.20E+263,earnings,100,50,5/1/2019
32F24A,earnings,100,50,5/1/2019
32F943,earnings,100,50,5/1/2019
339F20,earnings,100,50,5/1/2019
342218,earnings,100,50,5/1/2019
342218,earnings,100,50,5/1/2019
3461CF,credit-rating-upgrade-rater,20,50,5/1/2019
35557B,earnings,100,50,5/1/2019
3.50E+27,earnings,100,50,5/1/2019
35F4B5,earnings-guidance-up,100,83,5/1/2019
35F4B5,earnings,100,50,5/1/2019
372037,dividend,100,50,5/1/2019
372037,earnings,100,50,5/1/2019
372037,earnings,100,50,5/1/2019
3A3447,earnings,100,50,5/1/2019
3A3447,earnings,100,50,5/1/2019
3A3447,earnings,100,50,5/1/2019
3A3447,earnings,100,50,5/1/2019
3A3447,earnings,100,50,5/1/2019
3B20AB,conference-participant,100,50,5/1/2019
3B37F7,earnings,100,50,5/1/2019
3B37F7,conference-organizer,100,57,5/1/2019
3D7971,business-contract,100,69,5/1/2019
3D7971,earnings,100,50,5/1/2019
3D7971,earnings,100,50,5/1/2019
3D7971,earnings,100,50,5/1/2019
3D7971,earnings,100,50,5/1/2019
3D7971,earnings,100,50,5/1/2019
3D7971,earnings,100,50,5/1/2019
3DDE54,earnings,100,50,5/1/2019
3DDE54,earnings,100,50,5/1/2019
3DDE54,earnings,100,50,5/1/2019
3DDE54,earnings,100,50,5/1/2019
3DDE54,earnings,100,50,5/1/2019
3F4668,executive-appointment,100,54,5/1/2019
4135F7,earnings,100,50,5/1/2019
41A93D,earnings-up,100,68,5/1/2019
41D61C,earnings,100,50,5/1/2019
422CE3,facility-open,100,65,5/1/2019
429BFB,conference-participant,100,50,5/1/2019
42AABD,earnings,100,50,5/1/2019
442769,earnings,100,50,5/1/2019
442769,earnings,100,50,5/1/2019
442769,earnings,100,50,5/1/2019
442769,earnings,100,50,5/1/2019
447FC6,earnings,100,50,5/1/2019
447FC6,earnings,100,50,5/1/2019
447FC6,earnings,100,50,5/1/2019
448BF3,conference-call,100,50,5/1/2019
45BC35,conference-participant,100,50,5/1/2019
4885C8,dividend,100,50,5/1/2019
490D4B,executive-appointment,100,54,5/1/2019
49A344,earnings,100,50,5/1/2019
49A344,earnings,100,50,5/1/2019
4D8124,dividend,100,50,5/1/2019
4F9487,conference-participant,100,50,5/1/2019
50070E,conference-organizer,100,57,5/1/2019
5088A5,acquisition-acquiree,100,76,5/1/2019
51D876,credit-rating-upgrade,100,65,5/1/2019
532D47,conference-participant,100,50,5/1/2019
5340D0,executive-appointment,100,54,5/1/2019
55438C,legal-issues-defendant,100,22,5/1/2019
55438C,executive-appointment,100,54,5/1/2019
56B7C1,earnings,100,50,5/1/2019
56FB7C,dividend-up,100,81,5/1/2019
57B174,executive-appointment,100,54,5/1/2019
583223,earnings,100,50,5/1/2019
586BD7,earnings,100,50,5/1/2019
587EDF,earnings,100,50,5/1/2019
589846,product-release,100,64,5/1/2019
594402,earnings,100,50,5/1/2019
5A0FF1,earnings,100,50,5/1/2019
5A0FF1,earnings,100,50,5/1/2019
5AAE17,earnings,100,50,5/1/2019
5AF08A,earnings,100,50,5/1/2019
5BFE94,earnings,100,50,5/1/2019
5C7601,earnings,100,50,5/1/2019
5D63F1,award,100,58,5/1/2019
5DD486,earnings,100,50,5/1/2019
5DE5A5,conference-participant,100,50,5/1/2019
5F3D91,conference-participant,100,50,5/1/2019
5F3E74,earnings,100,50,5/1/2019
605F40,earnings,100,50,5/1/2019
60FE03,clinical-trials-positive,100,87,5/1/2019
6.18E+08,earnings,100,50,5/1/2019
6.18E+08,earnings,100,50,5/1/2019
6.18E+08,earnings,100,50,5/1/2019
619882,conference-organizer,100,57,5/1/2019
619882,conference-organizer,100,57,5/1/2019
61B81B,credit-extension-provider,100,57,5/1/2019
61E975,earnings-positive,100,69,5/1/2019
639BD6,revenues,100,50,5/1/2019
639BD6,revenues,100,50,5/1/2019
639BD6,revenues,100,50,5/1/2019
64854A,earnings,100,50,5/1/2019
649CBD,earnings,100,50,5/1/2019
64E615,earnings,100,50,5/1/2019
64E615,earnings,100,50,5/1/2019
64E615,earnings,100,50,5/1/2019
64E615,earnings,100,50,5/1/2019
64FF65,earnings,100,50,5/1/2019
66749D,earnings-up,100,68,5/1/2019
66749D,earnings-up,100,68,5/1/2019
66749D,earnings-up,100,68,5/1/2019
66749D,earnings-up,100,68,5/1/2019
66E04A,earnings,100,50,5/1/2019
66E04A,earnings,100,50,5/1/2019
66E04A,earnings,100,50,5/1/2019
66E04A,earnings,100,50,5/1/2019
66E04A,earnings,100,50,5/1/2019
66E04A,earnings,100,50,5/1/2019
66E3C0,revenue-up,100,54,5/1/2019
66E3C0,revenue-up,100,54,5/1/2019
66ECFD,earnings,100,50,5/1/2019
67303E,executive-appointment,100,54,5/1/2019
6830FE,executive-appointment,100,54,5/1/2019
6844D2,partnership,100,61,5/1/2019
6925EB,conference-participant,100,50,5/1/2019
698FF9,earnings,100,50,5/1/2019
698FF9,earnings,100,50,5/1/2019
69CE71,earnings,100,50,5/1/2019
69CE71,earnings,100,50,5/1/2019
69CE71,earnings,100,50,5/1/2019
69CE71,earnings,100,50,5/1/2019
69CE71,earnings,100,50,5/1/2019
69CE71,earnings,100,50,5/1/2019
69CE71,earnings,100,50,5/1/2019
6A3C35,earnings,100,50,5/1/2019
6A3C35,earnings,100,50,5/1/2019
6A3C35,earnings,100,50,5/1/2019
6A3C35,earnings,100,50,5/1/2019
6A3C35,earnings,100,50,5/1/2019
6B0E45,earnings,100,50,5/1/2019
6BF593,earnings,100,50,5/1/2019
6D3B7B,dividend,100,50,5/1/2019
6DDA15,conference-participant,100,50,5/1/2019
6E7060,earnings,100,50,5/1/2019
6E7060,earnings,100,50,5/1/2019
6E7060,earnings,100,50,5/1/2019
6E7060,earnings,100,50,5/1/2019
6E7060,earnings,100,50,5/1/2019
6E7060,earnings,100,50,5/1/2019
6E7060,earnings,100,50,5/1/2019
6ED519,earnings,100,50,5/1/2019
6ED519,earnings,100,50,5/1/2019
6ED519,earnings,100,50,5/1/2019
6F30F9,earnings,100,50,5/1/2019
704B78,earnings,100,50,5/1/2019
705636,revenues,100,50,5/1/2019
719477,earnings,100,50,5/1/2019
722DE3,earnings-up,100,68,5/1/2019
722DE3,earnings,100,50,5/1/2019
7273FF,earnings,100,50,5/1/2019
73A213,earnings,100,50,5/1/2019
742AAB,earnings,100,50,5/1/2019
746373,earnings,100,50,5/1/2019
746373,earnings,100,50,5/1/2019
763724,earnings-up,100,68,5/1/2019
76BECC,conference-call,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
771985,earnings,100,50,5/1/2019
7740DE,business-contract,100,69,5/1/2019
782B46,dividend,100,50,5/1/2019
78F776,business-contract,100,69,5/1/2019
78F9ED,earnings,100,50,5/1/2019
78F9ED,earnings,100,50,5/1/2019
78F9ED,earnings,100,50,5/1/2019
78F9ED,earnings,100,50,5/1/2019
78F9ED,earnings,100,50,5/1/2019
78F9ED,earnings,100,50,5/1/2019
78F9ED,earnings,100,50,5/1/2019
78F9ED,earnings,100,50,5/1/2019
790D0D,earnings,100,50,5/1/2019
7A3633,earnings,100,50,5/1/2019
7A5D58,acquisition-completed-acquirer,100,49,5/1/2019
7B6C88,earnings,100,50,5/1/2019
7B9AFA,earnings,100,50,5/1/2019
7BC92D,conference-participant,100,50,5/1/2019
7C4F43,earnings,100,50,5/1/2019
7C75FD,earnings,100,50,5/1/2019
7D5FD6,conference-participant,100,50,5/1/2019
7DA412,earnings,100,50,5/1/2019
7DD584,earnings,100,50,5/1/2019
7E1D5D,partnership,100,61,5/1/2019
7E1D5D,partnership,100,61,5/1/2019
7E3F8F,earnings,100,50,5/1/2019
7E3F8F,earnings,100,50,5/1/2019
7E3F8F,earnings,100,50,5/1/2019
7F3665,unit-acquisition-acquirer,100,49,5/1/2019
7F3A5F,earnings,100,50,5/1/2019
7F9BE2,earnings,100,50,5/1/2019
805CD8,conference-call,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
8.10E+32,earnings,100,50,5/1/2019
810FAD,earnings,100,50,5/1/2019
835C86,operating-earnings,100,50,5/1/2019
838ADD,dividend,100,50,5/1/2019
83B1C8,earnings,100,50,5/1/2019
84920B,earnings,100,50,5/1/2019
85CDC9,earnings,100,50,5/1/2019
85CDC9,clinical-trials-start,100,64,5/1/2019
85CDC9,clinical-trials-start,100,64,5/1/2019
8665BA,acquisition-completed-acquirer,100,49,5/1/2019
86F123,conference-call,100,50,5/1/2019
873DB9,conference-participant,100,50,5/1/2019
87486A,earnings,100,50,5/1/2019
87486A,earnings,100,50,5/1/2019
87486A,earnings,100,50,5/1/2019
87486A,earnings,100,50,5/1/2019
87486A,executive-appointment,100,54,5/1/2019
87B81A,revenues,100,50,5/1/2019
87B81A,revenues,100,50,5/1/2019
87B81A,revenues,100,50,5/1/2019
87B81A,dividend,100,50,5/1/2019
88193E,earnings,100,50,5/1/2019
8A0368,earnings,100,50,5/1/2019
8A0368,earnings,100,50,5/1/2019
8A0368,earnings,100,50,5/1/2019
8A0368,earnings,100,50,5/1/2019
8B1E11,earnings,100,50,5/1/2019
8B3B0E,conference-participant,100,50,5/1/2019
8B9B3B,earnings,100,50,5/1/2019
8C311A,earnings,100,50,5/1/2019
8C5519,dividend,100,50,5/1/2019
8DBBE6,acquisition-acquirer,100,49,5/1/2019
8DBE73,revenues,100,50,5/1/2019
8DBE73,revenues,100,50,5/1/2019
8DBE73,revenues,100,50,5/1/2019
8E9CD8,earnings-up,100,68,5/1/2019
8E9CD8,earnings,100,50,5/1/2019
8E9CD8,earnings,100,50,5/1/2019
8E9CD8,earnings,100,50,5/1/2019
8E9CD8,earnings,100,50,5/1/2019
8EF425,earnings,100,50,5/1/2019
8EF425,earnings,100,50,5/1/2019
8EF425,earnings,100,50,5/1/2019
8EF425,earnings,100,50,5/1/2019
8EF425,earnings,100,50,5/1/2019
902255,dividend,100,50,5/1/2019
902670,earnings,100,50,5/1/2019
902670,earnings,100,50,5/1/2019
902670,earnings,100,50,5/1/2019
902670,earnings,100,50,5/1/2019
9196A2,acquisition-completed-acquirer,100,49,5/1/2019
92D9C9,earnings,100,50,5/1/2019
945DE6,public-offering,100,43,5/1/2019
945DE6,public-offering,100,43,5/1/2019
94637C,note-sale,100,52,5/1/2019
9470CC,earnings,100,50,5/1/2019
94C0B5,dividend-up,100,81,5/1/2019
9507FF,conference-participant,100,50,5/1/2019
9.54E+32,partnership,100,61,5/1/2019
958938,conference-call,100,50,5/1/2019
9.65E+09,earnings,100,50,5/1/2019
9.65E+09,unit-acquisition-acquirer,100,49,5/1/2019
966ACE,earnings,100,50,5/1/2019
968966,earnings,100,50,5/1/2019
9.74E+08,executive-resignation,100,44,5/1/2019
980C14,earnings,100,50,5/1/2019
990AD0,conference-organizer,100,57,5/1/2019
990AD0,conference-organizer,100,57,5/1/2019
990AD0,conference-organizer,100,57,5/1/2019
990AD0,conference-organizer,100,57,5/1/2019
990AD0,conference-organizer,100,57,5/1/2019
990AD0,conference-organizer,100,57,5/1/2019
990AD0,conference-organizer,100,57,5/1/2019
990AD0,conference-organizer,100,57,5/1/2019
9B4066,dividend,100,50,5/1/2019
9B5968,executive-appointment,100,54,5/1/2019
9BB35A,earnings,100,50,5/1/2019
9BB35A,earnings,100,50,5/1/2019
9BB35A,earnings,100,50,5/1/2019
9BB35A,earnings,100,50,5/1/2019
9BB35A,earnings,100,50,5/1/2019
9BB35A,executive-appointment,100,54,5/1/2019
9DDE1B,earnings,100,50,5/1/2019
9E3224,earnings,100,50,5/1/2019
9E4A5F,acquisition-acquirer,100,49,5/1/2019
9E4A5F,earnings,100,50,5/1/2019
A1E3B3,business-combination,100,54,5/1/2019
A29A46,earnings,100,50,5/1/2019
A38F30,earnings,100,50,5/1/2019
A398F8,earnings,100,50,5/1/2019
A3AAA5,earnings,100,50,5/1/2019
A4386C,earnings,100,50,5/1/2019
A4386C,earnings,100,50,5/1/2019
A4386C,earnings,100,50,5/1/2019
A70BF5,earnings,100,50,5/1/2019
A70BF5,earnings,100,50,5/1/2019
A70BF5,earnings,100,50,5/1/2019
A70BF5,earnings,100,50,5/1/2019
A70BF5,earnings,100,50,5/1/2019
A7102F,conference-participant,100,50,5/1/2019
A8AC4C,earnings,100,50,5/1/2019
AA1EAA,earnings,100,50,5/1/2019
AA3AB8,earnings,100,50,5/1/2019
AD1ACF,conference-participant,100,50,5/1/2019
AD3008,earnings,100,50,5/1/2019
AEBB80,earnings,100,50,5/1/2019
AF210D,joint-venture,100,62,5/1/2019
AFEC35,earnings,100,50,5/1/2019
B01111,earnings,100,50,5/1/2019
B04426,conference-call,100,50,5/1/2019
B09B1F,earnings-up,100,68,5/1/2019
B09B1F,earnings,100,50,5/1/2019
B09B1F,earnings,100,50,5/1/2019
B09B1F,earnings,100,50,5/1/2019
B1A85D,earnings,100,50,5/1/2019
B1FC3B,business-contract,100,69,5/1/2019
B2D799,legal-issues-defendant,100,22,5/1/2019
B33E77,earnings,100,50,5/1/2019
B381D8,legal-issues-defendant,100,22,5/1/2019
B3A166,conference-call,100,50,5/1/2019
B4B281,conference-call,100,50,5/1/2019
B4C673,earnings,100,50,5/1/2019
B4C673,earnings,100,50,5/1/2019
B4C673,earnings,100,50,5/1/2019
B4C673,earnings,100,50,5/1/2019
B4C673,earnings,100,50,5/1/2019
B4C673,earnings,100,50,5/1/2019
B6CD92,executive-appointment,100,54,5/1/2019
B77F14,conference-call,100,50,5/1/2019
B77F14,conference-call,100,50,5/1/2019
B7EB38,earnings,100,50,5/1/2019
B7EB38,earnings,100,50,5/1/2019
B83BCE,earnings,100,50,5/1/2019
B840EF,earnings,100,50,5/1/2019
B98EFA,operating-earnings,100,50,5/1/2019
BD15E8,executive-appointment,100,54,5/1/2019
BD8517,executive-appointment,100,54,5/1/2019
BD9668,merger-completed,100,66,5/1/2019
BDCC11,earnings,100,50,5/1/2019
BDE867,acquisition-completed-acquirer,100,49,5/1/2019
BDEF34,acquisition-completed-acquiree,100,76,5/1/2019
C0BA36,earnings,100,50,5/1/2019
C0BA36,earnings,100,50,5/1/2019
C230FE,earnings-per-share-positive,100,69,5/1/2019
C230FE,earnings-per-share,100,50,5/1/2019
C2E39B,earnings,100,50,5/1/2019
C4A432,conference-call,100,50,5/1/2019
C4F9C6,earnings,100,50,5/1/2019
C54140,earnings,100,50,5/1/2019
C598D7,buybacks,100,74,5/1/2019
C5C137,earnings,100,50,5/1/2019
C5F463,merger-completed,100,66,5/1/2019
C5F463,merger-completed,100,66,5/1/2019
C66B44,earnings,100,50,5/1/2019
C7AE14,earnings,100,50,5/1/2019
C81E00,conference-participant,100,50,5/1/2019
C81E00,conference-participant,100,50,5/1/2019
C941DC,public-offering,100,43,5/1/2019
C951A2,earnings,100,50,5/1/2019
C951A2,earnings,100,50,5/1/2019
C951A2,earnings,100,50,5/1/2019
C951A2,earnings,100,50,5/1/2019
C951A2,earnings,100,50,5/1/2019
C951A2,earnings,100,50,5/1/2019
C97B2D,conference-participant,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9D866,earnings,100,50,5/1/2019
C9E04B,conference-call,100,50,5/1/2019
CA14CC,earnings,100,50,5/1/2019
CA14CC,earnings,100,50,5/1/2019
CA99D7,conference-call,100,50,5/1/2019
CAC8D0,exchange-compliance,100,76,5/1/2019
CB7AB2,earnings,100,50,5/1/2019
CBBFBF,earnings-positive,100,69,5/1/2019
CBBFBF,earnings-positive,100,69,5/1/2019
CBBFBF,earnings-positive,100,69,5/1/2019
CBBFBF,earnings-positive,100,69,5/1/2019
CC8F6E,conference-participant,100,50,5/1/2019
CCB623,earnings,100,50,5/1/2019
CD2A4D,earnings,100,50,5/1/2019
CDE118,earnings,100,50,5/1/2019
CDE51C,earnings,100,50,5/1/2019
CE4E6D,conference-call,100,50,5/1/2019
CE5C6E,earnings,100,50,5/1/2019
CFF15D,earnings,100,50,5/1/2019
CFF15D,earnings,100,50,5/1/2019
CFF97C,merger,100,66,5/1/2019
CFF97C,merger,100,66,5/1/2019
D04D9F,earnings,100,50,5/1/2019
D06755,earnings,100,50,5/1/2019
D06755,earnings,100,50,5/1/2019
D06755,earnings,100,50,5/1/2019
D0DFE5,award,100,58,5/1/2019
D17C1B,executive-appointment,100,54,5/1/2019
D17F7E,earnings,100,50,5/1/2019
D17F7E,earnings,100,50,5/1/2019
D17F7E,earnings,100,50,5/1/2019
D17F7E,earnings,100,50,5/1/2019
D17F7E,earnings,100,50,5/1/2019
D17F7E,earnings,100,50,5/1/2019
D20C8F,earnings,100,50,5/1/2019
D296C6,earnings,100,50,5/1/2019
D29B44,conference-participant,100,50,5/1/2019
D2B9E5,earnings,100,50,5/1/2019
D2B9E5,earnings,100,50,5/1/2019
D2B9E5,earnings,100,50,5/1/2019
D4AC65,earnings,100,50,5/1/2019
D4AC65,earnings,100,50,5/1/2019
D4AC65,earnings,100,50,5/1/2019
D4AC65,earnings,100,50,5/1/2019
D4AC65,earnings,100,50,5/1/2019
D54E62,acquisition-completed-acquirer,100,49,5/1/2019
D56D6D,earnings,100,50,5/1/2019
D63B0F,unit-acquisition-acquirer,100,49,5/1/2019
D650A7,dividend,100,50,5/1/2019
D650A7,revenue-up,100,71,5/1/2019
D650A7,revenue-up,100,71,5/1/2019
D650A7,revenue-up,100,71,5/1/2019
D854DD,earnings,100,50,5/1/2019
D8DA3D,earnings,100,50,5/1/2019
D8DA3D,earnings,100,50,5/1/2019
D8DA3D,earnings,100,50,5/1/2019
D8DA3D,earnings,100,50,5/1/2019
D8DA3D,earnings,100,50,5/1/2019
D8DA3D,earnings,100,50,5/1/2019
D9E036,earnings,100,50,5/1/2019
D9FC89,earnings,100,50,5/1/2019
D9FC89,earnings,100,50,5/1/2019
D9FC89,earnings,100,50,5/1/2019
D9FC89,earnings,100,50,5/1/2019
DB396B,legal-issues-defendant,100,22,5/1/2019
DF1F7A,executive-appointment,100,54,5/1/2019
DF204B,conference-participant,100,50,5/1/2019
DF5F14,conference-call,100,50,5/1/2019
E07573,earnings,100,50,5/1/2019
E07573,earnings,100,50,5/1/2019
E07573,earnings,100,50,5/1/2019
E1BD05,revenue-up,100,77,5/1/2019
E1BD05,revenue-up,100,77,5/1/2019
E1E36F,earnings,100,50,5/1/2019
E1E36F,earnings,100,50,5/1/2019
E1E36F,earnings,100,50,5/1/2019
E1E36F,earnings,100,50,5/1/2019
E1E36F,earnings,100,50,5/1/2019
E21871,earnings,100,50,5/1/2019
E3E68E,earnings,100,50,5/1/2019
E41190,conference-call,100,50,5/1/2019
E5D914,earnings,100,50,5/1/2019
E5D914,earnings,100,50,5/1/2019
E5D914,earnings,100,50,5/1/2019
E6EDED,index-listing,100,76,5/1/2019
E71AE6,conference-call,100,50,5/1/2019
E802CE,earnings,100,50,5/1/2019
E802CE,earnings,100,50,5/1/2019
E96E0B,conference-participant,100,50,5/1/2019
ECA300,executive-appointment,100,54,5/1/2019
ECF4F8,earnings,100,50,5/1/2019
ED2A5E,earnings,100,50,5/1/2019
ED2A5E,earnings,100,50,5/1/2019
ED2A5E,earnings,100,50,5/1/2019
ED2A5E,earnings,100,50,5/1/2019
ED2A5E,earnings,100,50,5/1/2019
ED2A5E,earnings,100,50,5/1/2019
ED7F13,earnings,100,50,5/1/2019
EE6F1C,earnings-up,100,68,5/1/2019
EE6F1C,earnings,100,50,5/1/2019
EE6F1C,earnings,100,50,5/1/2019
EEBCEF,earnings,100,50,5/1/2019
F0EEFB,earnings,100,50,5/1/2019
F0EEFB,earnings,100,50,5/1/2019
F0EEFB,earnings,100,50,5/1/2019
F0EEFB,earnings,100,50,5/1/2019
F2E253,conference-call,100,50,5/1/2019
F2E253,dividend,100,50,5/1/2019
F3FCC3,earnings,100,50,5/1/2019
F3FCC3,earnings,100,50,5/1/2019
F3FCC3,earnings,100,50,5/1/2019
F3FCC3,earnings,100,50,5/1/2019
F3FCC3,earnings,100,50,5/1/2019
F46EC9,conference-participant,100,50,5/1/2019
F4E882,business-contract,100,69,5/1/2019
F57F6F,executive-appointment,100,54,5/1/2019
F6DE54,earnings,100,50,5/1/2019
F88A04,dividend,100,50,5/1/2019
F8BA6C,conference-participant,100,50,5/1/2019
F8C5D7,operating-earnings,100,50,5/1/2019
F9CAF8,conference-call,100,50,5/1/2019
FA35C6,earnings,100,50,5/1/2019
FA840E,conference-participant,100,50,5/1/2019
FCA54E,earnings,100,50,5/1/2019
FD554E,conference-call,100,50,5/1/2019
FE89E0,dividend,100,50,5/1/2019
FEC475,earnings,100,50,5/1/2019
FFA9B9,executive-appointment,100,54,5/1/2019
9397,earnings,100,50,5/2/2019
9397,earnings,100,50,5/2/2019
0142B5,earnings-per-share-positive,100,69,5/2/2019
20751,earnings,100,50,5/2/2019
02ACBD,conference-call,100,50,5/2/2019
02FC1A,legal-issues-defendant,100,22,5/2/2019
034B61,acquisition-acquirer,100,49,5/2/2019
03B8CF,legal-issues-defendant,100,22,5/2/2019
03D5F9,earnings,100,50,5/2/2019
03FAA6,earnings,100,50,5/2/2019
03FAA6,earnings,100,50,5/2/2019
03FAA6,earnings,100,50,5/2/2019
03FAA6,earnings,100,50,5/2/2019
03FAA6,earnings,100,50,5/2/2019
03FB17,note-sale,100,52,5/2/2019
48590,earnings,100,50,5/2/2019
0490C6,earnings,100,50,5/2/2019
054E7E,partnership,100,61,5/2/2019
054E7E,executive-appointment,100,54,5/2/2019
054E7E,earnings,100,50,5/2/2019
55018,dividend,100,50,5/2/2019
61366,earnings,100,50,5/2/2019
061A3B,earnings,100,50,5/2/2019
061A3B,earnings,100,50,5/2/2019
061A3B,earnings,100,50,5/2/2019
06A456,conference-call,100,50,5/2/2019
06EE79,earnings,100,50,5/2/2019
07EC43,earnings,100,50,5/2/2019
07EC43,earnings,100,50,5/2/2019
07EC43,earnings,100,50,5/2/2019
09062E,conference-participant,100,50,5/2/2019
099C88,business-contract,100,69,5/2/2019
099C88,business-contract,100,69,5/2/2019
09DE1F,award,100,58,5/2/2019
0A0D9E,earnings,100,50,5/2/2019
0A0D9E,earnings,100,50,5/2/2019
0A0D9E,earnings,100,50,5/2/2019
0BC853,earnings,100,50,5/2/2019
0C2A0D,earnings-up,100,68,5/2/2019
0E499E,revenues,100,50,5/2/2019
0FABBD,legal-issues-defendant,100,22,5/2/2019
0FABBD,earnings-guidance-up,100,83,5/2/2019
0FABBD,earnings,100,50,5/2/2019
0FABBD,earnings,100,50,5/2/2019
0FABBD,earnings,100,50,5/2/2019
12E454,product-release,100,64,5/2/2019
159AE4,earnings,100,50,5/2/2019
159AE4,earnings,100,50,5/2/2019
159AE4,earnings,100,50,5/2/2019
159AE4,earnings,100,50,5/2/2019
165B86,conference-call,100,50,5/2/2019
180DA0,earnings,100,50,5/2/2019
180DA0,earnings,100,50,5/2/2019
1AB023,conference-call,100,50,5/2/2019
1AB023,conference-call,100,50,5/2/2019
1AB023,conference-call,100,50,5/2/2019
1B637E,dividend,100,50,5/2/2019
1B9535,earnings,100,50,5/2/2019
1CB9D3,conference-call,100,50,5/2/2019
1D1B07,investment-investor,100,55,5/2/2019
1D1B07,investment-investor,100,55,5/2/2019
1D9E55,earnings,100,50,5/2/2019
1D9E55,earnings,100,50,5/2/2019
1D9E55,earnings,100,50,5/2/2019
1D9E55,earnings,100,50,5/2/2019
1F08A6,earnings,100,50,5/2/2019
1F9258,earnings,100,50,5/2/2019
219B21,earnings,100,50,5/2/2019
219B21,earnings,100,50,5/2/2019
219B21,earnings,100,50,5/2/2019
219B21,earnings,100,50,5/2/2019
219B21,earnings,100,50,5/2/2019
221783,earnings,100,50,5/2/2019
221783,earnings,100,50,5/2/2019
221783,earnings,100,50,5/2/2019
221783,earnings,100,50,5/2/2019
222BF9,dividend,100,50,5/2/2019
227D48,earnings,100,50,5/2/2019
227D48,earnings,100,50,5/2/2019
227D48,earnings,100,50,5/2/2019
227D48,earnings,100,50,5/2/2019
227F04,conference-participant,100,50,5/2/2019
228D42,partnership,100,61,5/2/2019
228D42,partnership,100,61,5/2/2019
228D42,partnership,100,61,5/2/2019
239106,operating-earnings-positive,100,69,5/2/2019
239106,earnings-per-share,100,50,5/2/2019
239106,earnings-per-share,100,50,5/2/2019
239106,earnings-per-share,100,50,5/2/2019
24FA23,earnings,100,50,5/2/2019
250BEE,earnings,100,50,5/2/2019
250BEE,earnings,100,50,5/2/2019
250BEE,earnings,100,50,5/2/2019
250BEE,earnings,100,50,5/2/2019
251988,acquisition-interest-acquirer,100,46,5/2/2019
251988,acquisition-interest-acquirer,100,46,5/2/2019
253B2F,earnings,100,50,5/2/2019
253B2F,earnings,100,50,5/2/2019
2571FA,earnings,100,50,5/2/2019
2571FA,earnings,100,50,5/2/2019
2571FA,earnings,100,50,5/2/2019
26F99F,earnings,100,50,5/2/2019
270B78,earnings,100,50,5/2/2019
2920D5,conference-participant,100,50,5/2/2019
2A1009,earnings,100,50,5/2/2019
2BDC1C,earnings,100,50,5/2/2019
2C19A4,earnings,100,50,5/2/2019
2C19A4,earnings,100,50,5/2/2019
2C19A4,earnings,100,50,5/2/2019
2C19A4,earnings,100,50,5/2/2019
2C681C,earnings,100,50,5/2/2019
2C681C,earnings,100,50,5/2/2019
2CC71C,earnings,100,50,5/2/2019
2D485F,dividend,100,50,5/2/2019
2D485F,executive-appointment,100,54,5/2/2019
2D485F,executive-appointment,100,54,5/2/2019
2D485F,earnings,100,50,5/2/2019
2D485F,earnings,100,50,5/2/2019
2D485F,earnings,100,50,5/2/2019
2D981A,earnings,100,50,5/2/2019
2DC88B,earnings,100,50,5/2/2019
2EB88B,earnings,100,50,5/2/2019
2EB88B,earnings,100,50,5/2/2019
2EB88B,earnings,100,50,5/2/2019
2EB88B,earnings,100,50,5/2/2019
2EB88B,earnings,100,50,5/2/2019
2EB88B,earnings,100,50,5/2/2019
2F9304,earnings,100,50,5/2/2019
2F9304,executive-appointment,100,54,5/2/2019
301493,earnings,100,50,5/2/2019
301493,earnings,100,50,5/2/2019
3159AA,earnings,100,50,5/2/2019
31803E,earnings,100,50,5/2/2019
3471C0,earnings,100,50,5/2/2019
3471C0,earnings,100,50,5/2/2019
3471C0,earnings,100,50,5/2/2019
3471C0,earnings,100,50,5/2/2019
34A959,revenues,100,50,5/2/2019
34E9F9,business-contract,100,69,5/2/2019
371B0A,earnings,100,50,5/2/2019
371C01,earnings,100,50,5/2/2019
371C01,earnings,100,50,5/2/2019
3798B9,earnings,100,50,5/2/2019
383ADA,earnings,100,50,5/2/2019
387375,earnings,100,50,5/2/2019
389CFB,earnings,100,50,5/2/2019
38C46F,dividend,100,50,5/2/2019
39692D,earnings,100,50,5/2/2019
396D7C,earnings,100,50,5/2/2019
3ACF46,earnings,100,50,5/2/2019
3ACF46,earnings,100,50,5/2/2019
3ACF46,earnings,100,50,5/2/2019
3ACF46,earnings,100,50,5/2/2019
3B37F7,conference-organizer,100,57,5/2/2019
3B37F7,note-sale,100,52,5/2/2019
3B37F7,note-sale,100,52,5/2/2019
3B8484,earnings,100,50,5/2/2019
3BC360,earnings,100,50,5/2/2019
3BC360,earnings,100,50,5/2/2019
3BC360,earnings,100,50,5/2/2019
3BC360,earnings,100,50,5/2/2019
3C7F5F,earnings,100,50,5/2/2019
3C7F5F,earnings,100,50,5/2/2019
3D9999,executive-appointment,100,54,5/2/2019
3DC887,earnings,100,50,5/2/2019
3DE4D1,dividend,100,50,5/2/2019
3ED92D,earnings,100,50,5/2/2019
3ED92D,earnings,100,50,5/2/2019
3ED92D,earnings,100,50,5/2/2019
3ED92D,earnings,100,50,5/2/2019
3ED92D,earnings,100,50,5/2/2019
3ED92D,earnings,100,50,5/2/2019
3ED92D,earnings,100,50,5/2/2019
3F6A9C,earnings,100,50,5/2/2019
401072,earnings,100,50,5/2/2019
4017AD,earnings,100,50,5/2/2019
415188,dividend,100,50,5/2/2019
415188,earnings,100,50,5/2/2019
41EC04,earnings,100,50,5/2/2019
41EC04,earnings,100,50,5/2/2019
41EC04,earnings,100,50,5/2/2019
434F38,earnings,100,50,5/2/2019
43A060,legal-issues-defendant,100,22,5/2/2019
442587,earnings,100,50,5/2/2019
442587,earnings,100,50,5/2/2019
44740A,earnings,100,50,5/2/2019
451D61,earnings,100,50,5/2/2019
451D61,regulatory-product-approval-granted,100,81,5/2/2019
46017C,earnings,100,50,5/2/2019
4.60E+06,earnings,100,50,5/2/2019
4885C8,earnings,100,50,5/2/2019
499C75,earnings,100,50,5/2/2019
49F4D0,earnings,100,50,5/2/2019
4A5C8D,settlement,100,56,5/2/2019
4BDCA7,conference-call,100,50,5/2/2019
4C350A,earnings,100,50,5/2/2019
4C350A,earnings,100,50,5/2/2019
4D8124,earnings,100,50,5/2/2019
4D8124,earnings,100,50,5/2/2019
4E2D94,earnings,100,50,5/2/2019
4E2D94,dividend,100,50,5/2/2019
4E5784,earnings,100,50,5/2/2019
4EEE7E,earnings,100,50,5/2/2019
4F0A80,earnings,100,50,5/2/2019
4F783B,dividend,100,50,5/2/2019
4FCC78,earnings,100,50,5/2/2019
50070E,conference-organizer,100,57,5/2/2019
514067,executive-appointment,100,54,5/2/2019
524CE4,earnings,100,50,5/2/2019
525A1C,earnings,100,50,5/2/2019
525A1C,earnings,100,50,5/2/2019
525A1C,earnings,100,50,5/2/2019
525A1C,earnings,100,50,5/2/2019
525A1C,earnings,100,50,5/2/2019
525A1C,earnings,100,50,5/2/2019
52B567,partnership,100,61,5/2/2019
52BF94,earnings,100,50,5/2/2019
52BF94,earnings,100,50,5/2/2019
52BF94,earnings,100,50,5/2/2019
52BF94,earnings,100,50,5/2/2019
546A27,earnings,100,50,5/2/2019
54A713,earnings,100,50,5/2/2019
55CD6F,operating-earnings,100,50,5/2/2019
55D0F3,earnings,100,50,5/2/2019
562853,conference-participant,100,50,5/2/2019
56765E,partnership,100,61,5/2/2019
56FB7C,executive-appointment,100,54,5/2/2019
5704AC,operating-earnings,100,50,5/2/2019
57B174,earnings,100,50,5/2/2019
57B174,earnings,100,50,5/2/2019
57B174,earnings,100,50,5/2/2019
57B174,earnings,100,50,5/2/2019
58C2D4,earnings,100,50,5/2/2019
5968F9,legal-issues-defendant,100,22,5/2/2019
59B229,partnership,100,61,5/2/2019
5A9A82,earnings,100,50,5/2/2019
5B3FA2,earnings,100,50,5/2/2019
5C8D61,earnings,100,50,5/2/2019
5C8D61,earnings,100,50,5/2/2019
5C8D61,earnings,100,50,5/2/2019
5D1329,earnings,100,50,5/2/2019
5D41E4,conference-participant,100,50,5/2/2019
5E1DF3,earnings,100,50,5/2/2019
619882,conference-organizer,100,57,5/2/2019
619882,partnership,100,61,5/2/2019
620381,public-offering,100,43,5/2/2019
633054,partnership,100,61,5/2/2019
63F892,earnings,100,50,5/2/2019
651C85,earnings,100,50,5/2/2019
6.52E+64,earnings,100,50,5/2/2019
67303E,earnings,100,50,5/2/2019
67B052,earnings,100,50,5/2/2019
68E3E0,earnings,100,50,5/2/2019
68E3E0,earnings,100,50,5/2/2019
68E3E0,earnings,100,50,5/2/2019
68E3E0,earnings,100,50,5/2/2019
68E3E0,earnings,100,50,5/2/2019
68E6E9,earnings,100,50,5/2/2019
69345C,partnership,100,61,5/2/2019
69494C,earnings,100,50,5/2/2019
6ABCB8,earnings,100,50,5/2/2019
6B5379,earnings,100,50,5/2/2019
6B5379,earnings,100,50,5/2/2019
6B5379,earnings,100,50,5/2/2019
6B67BD,earnings,100,50,5/2/2019
6BD606,dividend,100,50,5/2/2019
6BD606,dividend,100,50,5/2/2019
6CC55E,conference-participant,100,50,5/2/2019
6E705B,award,100,58,5/2/2019
6EA292,earnings,100,50,5/2/2019
6F22E7,business-contract,100,69,5/2/2019
6F92A9,earnings,100,50,5/2/2019
705636,dividend,100,50,5/2/2019
70FCEF,partnership,100,61,5/2/2019
713810,investment-investor,100,55,5/2/2019
726EEA,acquisition-completed-acquirer,100,49,5/2/2019
729368,earnings,100,50,5/2/2019
72FCA3,executive-appointment,100,54,5/2/2019
732449,executive-appointment,100,54,5/2/2019
73A71F,earnings,100,50,5/2/2019
741937,earnings,100,50,5/2/2019
741937,earnings,100,50,5/2/2019
741937,earnings,100,50,5/2/2019
7.44E+09,earnings-up,100,68,5/2/2019
7.44E+09,earnings,100,50,5/2/2019
7.44E+09,earnings,100,50,5/2/2019
7.44E+09,earnings,100,50,5/2/2019
767F86,dividend-up,100,81,5/2/2019
76D79A,earnings,100,50,5/2/2019
76D79A,public-offering,100,43,5/2/2019
76F067,partnership,100,61,5/2/2019
7710F3,earnings,100,50,5/2/2019
7710F3,earnings,100,50,5/2/2019
773A17,earnings,100,50,5/2/2019
789ADD,earnings,100,50,5/2/2019
789ADD,earnings,100,50,5/2/2019
789ADD,earnings,100,50,5/2/2019
789ADD,executive-appointment,100,54,5/2/2019
793C11,earnings,100,50,5/2/2019
7A2A49,partnership,100,61,5/2/2019
7B492C,earnings,100,50,5/2/2019
7B8CB5,earnings,100,50,5/2/2019
7BEA98,earnings,100,50,5/2/2019
7CD98F,earnings,100,50,5/2/2019
7D7716,earnings,100,50,5/2/2019
7D7716,earnings,100,50,5/2/2019
7D7716,earnings,100,50,5/2/2019
7D7716,earnings,100,50,5/2/2019
7D85A9,earnings,100,50,5/2/2019
7DC1C4,earnings,100,50,5/2/2019
81EAD4,business-contract,100,69,5/2/2019
81EAD4,earnings,100,50,5/2/2019
81EAD4,earnings,100,50,5/2/2019
81EAD4,earnings,100,50,5/2/2019
82C202,patient-enrollment-complete,100,64,5/2/2019
82C202,patient-enrollment-complete,100,64,5/2/2019
82C202,earnings,100,50,5/2/2019
83E0AC,dividend,100,50,5/2/2019
83E0AC,conference-call,100,50,5/2/2019
85DE00,conference-participant,100,50,5/2/2019
86A1B9,earnings-positive,100,69,5/2/2019
86A1B9,earnings-positive,100,69,5/2/2019
86A1B9,earnings-positive,100,69,5/2/2019
86A1B9,earnings-positive,100,69,5/2/2019
89FBB1,earnings,100,50,5/2/2019
89FBB1,earnings,100,50,5/2/2019
89FBB1,earnings,100,50,5/2/2019
8AC65D,conference-participant,100,50,5/2/2019
8AC740,earnings,100,50,5/2/2019
8B1E11,facility-open,100,65,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B1F37,earnings,100,50,5/2/2019
8B6E7E,earnings,100,50,5/2/2019
8B9B3B,legal-issues-defendant,100,22,5/2/2019
8BAA15,earnings,100,50,5/2/2019
8BAA15,earnings,100,50,5/2/2019
8DBBE6,earnings,100,50,5/2/2019
8DE56F,earnings,100,50,5/2/2019
8DE56F,earnings,100,50,5/2/2019
8DE74B,earnings-up,100,68,5/2/2019
8DE74B,earnings,100,50,5/2/2019
8DE74B,earnings,100,50,5/2/2019
8DE74B,earnings,100,50,5/2/2019
8E4F9A,conference-call,100,50,5/2/2019
8E82A6,executive-appointment,100,54,5/2/2019
902255,earnings,100,50,5/2/2019
902255,earnings,100,50,5/2/2019
905356,conference-call,100,50,5/2/2019
913437,earnings,100,50,5/2/2019
91E5EE,drilling,100,68,5/2/2019
92D757,product-release,100,64,5/2/2019
93AD2E,unit-acquisition-acquiree,100,76,5/2/2019
93AD2E,earnings,100,50,5/2/2019
947B0B,earnings,100,50,5/2/2019
949625,earnings,100,50,5/2/2019
94983E,earnings,100,50,5/2/2019
95C392,earnings,100,50,5/2/2019
9.62E+76,dividend-up,100,81,5/2/2019
9.62E+76,executive-resignation,100,44,5/2/2019
9.62E+76,executive-appointment,100,54,5/2/2019
965360,dividend,100,50,5/2/2019
9673BD,dividend,100,50,5/2/2019
967D92,earnings,100,50,5/2/2019
96A6CD,earnings,100,50,5/2/2019
96BFF4,earnings,100,50,5/2/2019
971334,earnings,100,50,5/2/2019
971334,earnings,100,50,5/2/2019
971334,earnings,100,50,5/2/2019
971334,earnings,100,50,5/2/2019
971F7B,earnings,100,50,5/2/2019
971F7B,earnings,100,50,5/2/2019
971F7B,earnings,100,50,5/2/2019
971F7B,earnings,100,50,5/2/2019
97AAF6,earnings,100,50,5/2/2019
97AAF6,earnings,100,50,5/2/2019
9.86E+03,earnings,100,50,5/2/2019
990AD0,conference-organizer,100,57,5/2/2019
990AD0,conference-organizer,100,57,5/2/2019
990AD0,conference-organizer,100,57,5/2/2019
990AD0,conference-organizer,100,57,5/2/2019
990AD0,conference-organizer,100,57,5/2/2019
9934AD,earnings,100,50,5/2/2019
9.97E+09,earnings,100,50,5/2/2019
9A602D,dividend,100,50,5/2/2019
9AF3DC,earnings,100,50,5/2/2019
9AF3DC,executive-appointment,100,54,5/2/2019
9C25FF,earnings,100,50,5/2/2019
9C5174,facility-open,100,65,5/2/2019
9C5174,revenues,100,50,5/2/2019
9C5174,revenues,100,50,5/2/2019
9CDA4F,earnings,100,50,5/2/2019
9E298A,earnings,100,50,5/2/2019
9E298A,earnings,100,50,5/2/2019
9E298A,earnings,100,50,5/2/2019
9E298A,earnings,100,50,5/2/2019
9F048E,earnings,100,50,5/2/2019
9F048E,earnings,100,50,5/2/2019
9F048E,earnings,100,50,5/2/2019
9F048E,earnings,100,50,5/2/2019
9F71E5,dividend,100,50,5/2/2019
A15C71,earnings,100,50,5/2/2019
A15C71,earnings,100,50,5/2/2019
A15C71,earnings,100,50,5/2/2019
A1BB98,earnings,100,50,5/2/2019
A1BB98,earnings,100,50,5/2/2019
A1BB98,earnings,100,50,5/2/2019
A1BB98,earnings,100,50,5/2/2019
A1BB98,earnings,100,50,5/2/2019
A1E3B3,business-combination,100,54,5/2/2019
A1EAC8,earnings,100,50,5/2/2019
A204A7,earnings,100,50,5/2/2019
A28675,earnings,100,50,5/2/2019
A3F598,earnings,100,50,5/2/2019
A3F598,earnings,100,50,5/2/2019
A3F598,earnings,100,50,5/2/2019
A43906,earnings,100,50,5/2/2019
A4B899,earnings,100,50,5/2/2019
A4BCDE,earnings,100,50,5/2/2019
A4D173,dividend,100,50,5/2/2019
A4D173,dividend,100,50,5/2/2019
A52533,earnings,100,50,5/2/2019
A52B6B,earnings,100,50,5/2/2019
A63387,earnings,100,50,5/2/2019
A75D43,earnings,100,50,5/2/2019
A7F0A5,earnings,100,50,5/2/2019
A806FA,earnings,100,50,5/2/2019
A806FA,earnings,100,50,5/2/2019
A806FA,earnings,100,50,5/2/2019
A868C9,business-contract,100,69,5/2/2019
A87CD6,earnings,100,50,5/2/2019
A87CD6,dividend,100,50,5/2/2019
A94637,revenues,100,50,5/2/2019
A94637,revenues,100,50,5/2/2019
AB4A7E,earnings,100,50,5/2/2019
ABBAD1,earnings,100,50,5/2/2019
AC3584,revenue-up,100,84,5/2/2019
AC3584,revenue-up,100,84,5/2/2019
AC642C,earnings,100,50,5/2/2019
AC642C,earnings,100,50,5/2/2019
ADD9DC,facility-open,100,65,5/2/2019
ADF092,earnings,100,50,5/2/2019
ADF092,earnings,100,50,5/2/2019
AE79CD,earnings,100,50,5/2/2019
AEF2C3,conference-participant,100,50,5/2/2019
AEFC90,conference-participant,100,50,5/2/2019
B01111,executive-appointment,100,54,5/2/2019
B0998E,earnings,100,50,5/2/2019
B0B969,conference-call,100,50,5/2/2019
B1DF3C,earnings,100,50,5/2/2019
B2256A,earnings,100,50,5/2/2019
B2D492,earnings,100,50,5/2/2019
B303A6,earnings,100,50,5/2/2019
B303A6,earnings,100,50,5/2/2019
B303A6,earnings,100,50,5/2/2019
B37FB4,product-release,100,64,5/2/2019
B3ED62,earnings,100,50,5/2/2019
B560AF,earnings,100,50,5/2/2019
B560AF,earnings,100,50,5/2/2019
B560AF,earnings,100,50,5/2/2019
B5BA39,earnings,100,50,5/2/2019
B5BA39,earnings,100,50,5/2/2019
B5BA39,earnings,100,50,5/2/2019
B5BA39,earnings,100,50,5/2/2019
B5BA39,earnings,100,50,5/2/2019
B5BA39,earnings,100,50,5/2/2019
B5BA39,dividend,100,50,5/2/2019
B5DE80,earnings,100,50,5/2/2019
B5DE80,earnings,100,50,5/2/2019
B66928,executive-appointment,100,54,5/2/2019
B77F14,earnings,100,50,5/2/2019
B77F14,earnings,100,50,5/2/2019
B77F14,earnings,100,50,5/2/2019
B80AD1,earnings,100,50,5/2/2019
B83D67,earnings,100,50,5/2/2019
B934BF,earnings,100,50,5/2/2019
BB127B,conference-call,100,50,5/2/2019
BB88B6,executive-resignation,100,44,5/2/2019
BBBB41,earnings,100,50,5/2/2019
BBBB41,earnings,100,50,5/2/2019
BBBB41,earnings,100,50,5/2/2019
BBBB41,earnings,100,50,5/2/2019
BBBB41,earnings,100,50,5/2/2019
BBC05B,credit-extension-recipient,100,69,5/2/2019
BDCC11,legal-issues-defendant,100,22,5/2/2019
BDEC1E,conference-call,100,50,5/2/2019
BFD0A7,conference-call,100,50,5/2/2019
BFEA04,earnings,100,50,5/2/2019
BFEA04,earnings,100,50,5/2/2019
BFEA04,earnings,100,50,5/2/2019
BFEA04,earnings,100,50,5/2/2019
C0030A,earnings,100,50,5/2/2019
C0030A,earnings,100,50,5/2/2019
C0030A,earnings,100,50,5/2/2019
C0030A,earnings,100,50,5/2/2019
C01737,earnings,100,50,5/2/2019
C01737,earnings,100,50,5/2/2019
C03C8B,earnings,100,50,5/2/2019
C03C8B,earnings,100,50,5/2/2019
C03C8B,earnings,100,50,5/2/2019
C03C8B,earnings,100,50,5/2/2019
C03C8B,earnings,100,50,5/2/2019
C2609A,dividend,100,50,5/2/2019
C29715,buybacks,100,74,5/2/2019
C2DD02,conference-call,100,50,5/2/2019
C38440,buybacks,100,74,5/2/2019
C38440,earnings,100,50,5/2/2019
C38440,earnings,100,50,5/2/2019
C3DE7D,earnings,100,50,5/2/2019
C45C1F,earnings,100,50,5/2/2019
C4A241,earnings,100,50,5/2/2019
C4A912,earnings,100,50,5/2/2019
C4A912,earnings,100,50,5/2/2019
C4A912,earnings,100,50,5/2/2019
C5E100,earnings,100,50,5/2/2019
C65004,acquisition-acquirer,100,49,5/2/2019
C66A8C,earnings,100,50,5/2/2019
C66A8C,earnings,100,50,5/2/2019
C66A8C,earnings,100,50,5/2/2019
C66A8C,earnings,100,50,5/2/2019
C6C702,earnings,100,50,5/2/2019
C8A248,earnings,100,50,5/2/2019
C8A248,earnings,100,50,5/2/2019
C8A248,earnings,100,50,5/2/2019
C8A248,earnings,100,50,5/2/2019
C8A248,earnings,100,50,5/2/2019
C941DC,public-offering,100,43,5/2/2019
C97B2D,legal-issues-defendant,100,22,5/2/2019
C97B2D,fraud-defendant,100,20,5/2/2019
C98CDB,earnings,100,50,5/2/2019
C99CC8,revenue-volume,100,50,5/2/2019
C99CC8,revenue-volume,100,50,5/2/2019
C99CC8,revenue-volume,100,50,5/2/2019
C99CC8,revenue-volume,100,50,5/2/2019
C99CC8,revenue-volume,100,50,5/2/2019
C9A96E,earnings,100,50,5/2/2019
C9E04B,product-release,100,64,5/2/2019
CA3CB9,earnings,100,50,5/2/2019
CAB222,earnings,100,50,5/2/2019
CB6A9C,earnings,100,50,5/2/2019
CB6A9C,earnings,100,50,5/2/2019
CB6A9C,earnings,100,50,5/2/2019
CB6A9C,earnings,100,50,5/2/2019
CB6A9C,earnings,100,50,5/2/2019
CC3EC4,earnings,100,50,5/2/2019
CDAA0E,conference-participant,100,50,5/2/2019
CE96E7,dividend,100,50,5/2/2019
CEC08B,earnings-positive,100,69,5/2/2019
CEC5B9,unit-acquisition-acquirer,100,49,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CEC5B9,earnings,100,50,5/2/2019
CFD4B6,earnings-positive,100,69,5/2/2019
CFD4B6,earnings-positive,100,69,5/2/2019
CFD4B6,earnings-positive,100,69,5/2/2019
CFF97C,earnings,100,50,5/2/2019
CFF97C,earnings,100,50,5/2/2019
CFF97C,earnings,100,50,5/2/2019
CFF97C,earnings,100,50,5/2/2019
D03C7A,earnings,100,50,5/2/2019
D06996,earnings,100,50,5/2/2019
D09938,earnings,100,50,5/2/2019
D0DE27,earnings,100,50,5/2/2019
D11C1C,conference-call,100,50,5/2/2019
D1C26F,business-contract,100,69,5/2/2019
D3FD6D,acquisition-acquirer,100,49,5/2/2019
D4070C,dividend,100,50,5/2/2019
D57D99,dividend,100,50,5/2/2019
D65A13,revenues,100,50,5/2/2019
D65A13,revenues,100,50,5/2/2019
D6853F,dividend,100,50,5/2/2019
D6853F,earnings,100,50,5/2/2019
D6853F,earnings,100,50,5/2/2019
D6853F,earnings,100,50,5/2/2019
D78CCD,conference-call,100,50,5/2/2019
D8760C,dividend,100,50,5/2/2019
D8C09D,earnings,100,50,5/2/2019
DA0CB8,earnings,100,50,5/2/2019
DA9443,earnings,100,50,5/2/2019
DB396B,legal-issues-defendant,100,22,5/2/2019
DB5CA5,dividend,100,50,5/2/2019
DB7014,operating-earnings,100,50,5/2/2019
DC0D18,earnings,100,50,5/2/2019
DC0D18,earnings,100,50,5/2/2019
DC0D18,earnings,100,50,5/2/2019
DC0D18,earnings,100,50,5/2/2019
DC1405,conference-participant,100,50,5/2/2019
DC5299,operating-earnings,100,50,5/2/2019
DD0F15,earnings,100,50,5/2/2019
DD3BB1,public-offering,100,43,5/2/2019
DDCB34,dividend,100,50,5/2/2019
DDCB34,earnings,100,50,5/2/2019
DDEA6A,operating-earnings,100,50,5/2/2019
DE20DF,operating-earnings,100,50,5/2/2019
DE4924,dividend,100,50,5/2/2019
DE4924,earnings,100,50,5/2/2019
DF11D9,dividend,100,50,5/2/2019
DF1F7A,earnings,100,50,5/2/2019
DF8855,business-combination,100,54,5/2/2019
DFADDB,earnings,100,50,5/2/2019
E09E2B,conference-call,100,50,5/2/2019
E2F66E,revenue-up,100,69,5/2/2019
E35610,earnings,100,50,5/2/2019
E35610,earnings,100,50,5/2/2019
E35610,earnings,100,50,5/2/2019
E49AA3,earnings,100,50,5/2/2019
E592F0,earnings,100,50,5/2/2019
E592F0,earnings,100,50,5/2/2019
E592F0,earnings,100,50,5/2/2019
E592F0,earnings,100,50,5/2/2019
E592F0,earnings,100,50,5/2/2019
E61888,conference-call,100,50,5/2/2019
E67C2C,earnings,100,50,5/2/2019
E68733,regulatory-product-approval-granted,100,81,5/2/2019
E68E62,clinical-trials,100,56,5/2/2019
E71AE6,patient-enrollment-complete,100,64,5/2/2019
E71AE6,patient-enrollment-complete,100,64,5/2/2019
E8C557,earnings,100,50,5/2/2019
E8E899,product-release,100,64,5/2/2019
E90C84,dividend,100,50,5/2/2019
E94704,conference-participant,100,50,5/2/2019
EB5E78,earnings,100,50,5/2/2019
EB5E78,earnings,100,50,5/2/2019
EB5E78,earnings,100,50,5/2/2019
EB5E78,earnings,100,50,5/2/2019
ED3CA8,earnings,100,50,5/2/2019
EE04F0,conference-call,100,50,5/2/2019
EF5BED,conference-participant,100,50,5/2/2019
F0027C,earnings,100,50,5/2/2019
F02D0A,earnings-per-share-positive,100,69,5/2/2019
F02D0A,earnings,100,50,5/2/2019
F0B2B5,executive-appointment,100,54,5/2/2019
F0B2B5,executive-appointment,100,54,5/2/2019
F0B2B5,executive-appointment,100,54,5/2/2019
F15E41,earnings,100,50,5/2/2019
F15E41,earnings,100,50,5/2/2019
F15E41,earnings,100,50,5/2/2019
F15E41,earnings,100,50,5/2/2019
F1CD47,conference-participant,100,50,5/2/2019
F3816D,earnings,100,50,5/2/2019
F40EE2,dividend,100,50,5/2/2019
F46EC9,earnings,100,50,5/2/2019
F46EC9,earnings,100,50,5/2/2019
F46EC9,earnings,100,50,5/2/2019
F46EC9,earnings,100,50,5/2/2019
F46EC9,earnings,100,50,5/2/2019
F47871,earnings,100,50,5/2/2019
F4CDA3,unit-acquisition-acquirer,100,49,5/2/2019
F4CDA3,unit-acquisition-acquirer,100,49,5/2/2019
F4F46F,earnings,100,50,5/2/2019
F51DB0,earnings,100,50,5/2/2019
F5D410,conference-participant,100,50,5/2/2019
F6E1B5,earnings,100,50,5/2/2019
F6E248,earnings,100,50,5/2/2019
F6E248,dividend,100,50,5/2/2019
F73DD1,dividend,100,50,5/2/2019
F80FF9,earnings,100,50,5/2/2019
F83279,earnings,100,50,5/2/2019
F83279,earnings,100,50,5/2/2019
F85CC0,earnings,100,50,5/2/2019
F85CC0,earnings,100,50,5/2/2019
F8BA6C,conference-participant,100,50,5/2/2019
F93C8A,earnings,100,50,5/2/2019
FAAFA2,earnings,100,50,5/2/2019
FAB97A,earnings,100,50,5/2/2019
FB7724,legal-issues-defendant,100,22,5/2/2019
FD39EB,earnings,100,50,5/2/2019
FD4588,earnings,100,50,5/2/2019
FD4588,earnings,100,50,5/2/2019
FD4588,earnings,100,50,5/2/2019
FD6926,earnings,100,50,5/2/2019
FD6926,earnings,100,50,5/2/2019
FD6926,earnings,100,50,5/2/2019
FD6926,earnings,100,50,5/2/2019
FEE4B0,earnings,100,50,5/2/2019
FEE4B0,earnings,100,50,5/2/2019
FEE4B0,earnings,100,50,5/2/2019
FEE4B0,earnings,100,50,5/2/2019
FF227B,earnings,100,50,5/2/2019
00FC70,conference-call,100,50,5/3/2019
01D03F,regulatory-product-approval-granted,100,81,5/3/2019
01D03F,regulatory-product-approval-granted,100,81,5/3/2019
43862,earnings,100,50,5/3/2019
0624BE,earnings,100,50,5/3/2019
099C88,product-release,100,64,5/3/2019
0C2A0D,executive-appointment,100,54,5/3/2019
0DBB81,earnings,100,50,5/3/2019
126F95,executive-appointment,100,54,5/3/2019
152AB9,legal-issues-defendant,100,22,5/3/2019
157D9F,earnings,100,50,5/3/2019
157D9F,earnings,100,50,5/3/2019
157D9F,earnings,100,50,5/3/2019
157D9F,earnings,100,50,5/3/2019
157D9F,earnings,100,50,5/3/2019
16B882,conference-call,100,50,5/3/2019
1834C0,dividend,100,50,5/3/2019
1A6A94,earnings,100,50,5/3/2019
1B16C1,earnings,100,50,5/3/2019
1F43A1,earnings,100,50,5/3/2019
1FE7F0,earnings,100,50,5/3/2019
1FE7F0,earnings,100,50,5/3/2019
1FE7F0,earnings,100,50,5/3/2019
1FE7F0,earnings,100,50,5/3/2019
1FE7F0,earnings,100,50,5/3/2019
1FE7F0,earnings,100,50,5/3/2019
22C58E,acquisition-acquirer,100,49,5/3/2019
2AE625,earnings,100,50,5/3/2019
2BF36E,earnings-positive,100,69,5/3/2019
2BF36E,earnings,100,50,5/3/2019
2BF36E,earnings,100,50,5/3/2019
2BF36E,earnings,100,50,5/3/2019
2D5011,ipo-pricing,100,50,5/3/2019
2E902B,conference-participant,100,50,5/3/2019
353DBB,dividend,100,50,5/3/2019
36A1CB,dividend,100,50,5/3/2019
39692D,acquisition-interest-acquirer,100,46,5/3/2019
3A4BDB,executive-resignation,100,44,5/3/2019
3A94DF,unit-acquisition-acquiree,100,76,5/3/2019
3A94DF,conference-participant,100,50,5/3/2019
41785E,fundraising,100,64,5/3/2019
4290EF,earnings,100,50,5/3/2019
49CC59,earnings,100,50,5/3/2019
4AE584,board-meeting,100,51,5/3/2019
4C3FE9,earnings,100,50,5/3/2019
50070E,conference-organizer,100,57,5/3/2019
507AE7,dividend,100,50,5/3/2019
519FE0,executive-appointment,100,54,5/3/2019
519FE0,note-sale,100,52,5/3/2019
52B567,earnings,100,50,5/3/2019
55C9B5,acquisition-acquirer,100,49,5/3/2019
5B7739,conference-participant,100,50,5/3/2019
5C2A47,earnings,100,50,5/3/2019
619882,earnings,100,50,5/3/2019
619882,conference-organizer,100,57,5/3/2019
636639,dividend,100,50,5/3/2019
64E615,conference-participant,100,50,5/3/2019
6634D9,note-sale,100,52,5/3/2019
6634D9,note-sale,100,52,5/3/2019
6810DE,earnings,100,50,5/3/2019
6A01DF,earnings,100,50,5/3/2019
6B236C,dividend,100,50,5/3/2019
6F6559,dividend-up,100,61,5/3/2019
726EEA,earnings,100,50,5/3/2019
726EEA,earnings,100,50,5/3/2019
726EEA,earnings,100,50,5/3/2019
726EEA,earnings,100,50,5/3/2019
743C70,earnings,100,50,5/3/2019
743C70,earnings,100,50,5/3/2019
76BD96,dividend,100,50,5/3/2019
76BD96,conference-call,100,50,5/3/2019
76D79A,public-offering,100,43,5/3/2019
789A7D,dividend,100,50,5/3/2019
797C20,dividend,100,50,5/3/2019
7ACBA4,earnings,100,50,5/3/2019
7BAAE7,dividend,100,50,5/3/2019
7BAAE7,executive-appointment,100,54,5/3/2019
7F2922,earnings,100,50,5/3/2019
7FDE1C,earnings,100,50,5/3/2019
8.10E+32,executive-appointment,100,54,5/3/2019
82E58A,earnings,100,50,5/3/2019
8.79E+06,earnings,100,50,5/3/2019
8D5145,dividend,100,50,5/3/2019
9087B9,dividend,100,50,5/3/2019
95F59E,earnings,100,50,5/3/2019
95F59E,earnings,100,50,5/3/2019
95F59E,earnings,100,50,5/3/2019
9.65E+07,conference-call,100,50,5/3/2019
965360,name-change,100,49,5/3/2019
977A1E,earnings,100,50,5/3/2019
977A1E,earnings,100,50,5/3/2019
977A1E,earnings,100,50,5/3/2019
98D33E,earnings,100,50,5/3/2019
990AD0,conference-organizer,100,57,5/3/2019
9981C6,earnings,100,50,5/3/2019
A0F146,executive-appointment,100,54,5/3/2019
A16DEA,conference-participant,100,50,5/3/2019
A3800A,dividend,100,50,5/3/2019
A6FC89,conference-call,100,50,5/3/2019
A80FE0,earnings,100,50,5/3/2019
ACD9A4,dividend,100,50,5/3/2019
AD9F1D,dividend,100,50,5/3/2019
B13B68,legal-issues-defendant,100,22,5/3/2019
B1FC3B,product-release,100,64,5/3/2019
B2AA0A,earnings,100,50,5/3/2019
B381D8,earnings,100,50,5/3/2019
B83BCE,conference-participant,100,50,5/3/2019
BB07E4,dividend,100,50,5/3/2019
BBAE2A,dividend,100,50,5/3/2019
BD44C9,earnings,100,50,5/3/2019
BE14CF,dividend,100,50,5/3/2019
C3BCD5,earnings,100,50,5/3/2019
C3BCD5,earnings,100,50,5/3/2019
C97B2D,legal-issues-defendant,100,22,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
C99CC8,earnings,100,50,5/3/2019
CBCC6A,conference-organizer,100,57,5/3/2019
CBDB4D,conference-call,100,50,5/3/2019
CC35BE,legal-issues-defendant,100,22,5/3/2019
CC35BE,legal-issues-defendant,100,22,5/3/2019
CE96E7,conference-participant,100,50,5/3/2019
D3FD6D,revenues,100,50,5/3/2019
D3FD6D,revenues,100,50,5/3/2019
D3FD6D,revenues,100,50,5/3/2019
D64EDF,earnings-above-expectations,100,88,5/3/2019
D64EDF,earnings,100,50,5/3/2019
D64EDF,earnings,100,50,5/3/2019
DA0A9E,dividend,100,50,5/3/2019
DB23C8,earnings,100,50,5/3/2019
DB23C8,earnings,100,50,5/3/2019
DB23C8,earnings,100,50,5/3/2019
DBEF02,earnings,100,50,5/3/2019
DDB002,conference-participant,100,50,5/3/2019
E26FC3,dividend,100,50,5/3/2019
E8846E,conference-organizer,100,57,5/3/2019
ECA300,buybacks,100,74,5/3/2019
ED3CA8,executive-resignation,100,44,5/3/2019
EDD234,partnership,100,61,5/3/2019
EE1E44,conference-participant,100,50,5/3/2019
EF7163,earnings,100,50,5/3/2019
F02170,executive-appointment,100,54,5/3/2019
F1529C,earnings,100,50,5/3/2019
F1529C,earnings,100,50,5/3/2019
F1C04C,dividend,100,50,5/3/2019
F5349B,unit-acquisition-acquirer,100,49,5/3/2019
F6A987,earnings,100,50,5/3/2019
FB7724,legal-issues-defendant,100,22,5/3/2019
FC4550,dividend,100,50,5/3/2019
251988,legal-issues-defendant,100,22,5/4/2019
43A060,legal-issues-defendant,100,22,5/4/2019
55438C,legal-issues-defendant,100,22,5/4/2019
55438C,legal-issues-defendant,100,22,5/4/2019
59872F,legal-issues-defendant,100,22,5/4/2019
AD1ACF,product-recall,100,29,5/4/2019
B381D8,legal-issues-defendant,100,22,5/4/2019
BDCC11,legal-issues-defendant,100,22,5/4/2019
E71AE6,legal-issues-defendant,100,22,5/4/2019
184866,clinical-trials,100,56,5/5/2019
367E1C,clinical-trials,100,56,5/5/2019
367E1C,clinical-trials,100,56,5/5/2019
367E1C,clinical-trials,100,56,5/5/2019
367E1C,clinical-trials,100,56,5/5/2019
CA212F,asset-sale,100,62,5/5/2019
EEA734,clinical-trials,100,56,5/5/2019
EEA734,clinical-trials,100,56,5/5/2019
F0B335,regulatory-product-approval-granted,100,81,5/5/2019
00067A,conference-participant,100,50,5/6/2019
002A99,earnings,100,50,5/6/2019
01B8D6,ipo-completed,100,76,5/6/2019
01D03F,regulatory-product-approval-granted,100,81,5/6/2019
01D03F,regulatory-product-approval-granted,100,81,5/6/2019
01D03F,partnership,100,61,5/6/2019
06C826,conference-participant,100,50,5/6/2019
07CA6A,unit-acquisition-acquiree,100,76,5/6/2019
07CA6A,unit-acquisition-acquiree,100,76,5/6/2019
07CA6A,unit-acquisition-acquiree,100,76,5/6/2019
07CA6A,unit-acquisition-acquiree,100,76,5/6/2019
07CA6A,unit-acquisition-acquiree,100,76,5/6/2019
09062E,executive-appointment,100,54,5/6/2019
0B7375,earnings,100,50,5/6/2019
0BC29E,earnings,100,50,5/6/2019
0BC29E,earnings,100,50,5/6/2019
0BC29E,earnings,100,50,5/6/2019
0BC29E,earnings,100,50,5/6/2019
0BC29E,earnings,100,50,5/6/2019
0BC29E,earnings,100,50,5/6/2019
0BC29E,earnings,100,50,5/6/2019
0E5223,operating-earnings,100,50,5/6/2019
0E5619,conference-call,100,50,5/6/2019
0EF1AF,conference-call,100,50,5/6/2019
0FE3A6,earnings,100,50,5/6/2019
0FE3A6,executive-appointment,100,54,5/6/2019
10AE08,campaign-ad-release,100,59,5/6/2019
1220D2,earnings,100,50,5/6/2019
13A782,earnings,100,50,5/6/2019
15B10D,earnings,100,50,5/6/2019
15B10D,earnings,100,50,5/6/2019
15B10D,earnings,100,50,5/6/2019
1880C5,conference-organizer,100,57,5/6/2019
188394,earnings,100,50,5/6/2019
1A6A94,executive-appointment,100,54,5/6/2019
1B5FEA,business-contract,100,69,5/6/2019
1B9535,conference-participant,100,50,5/6/2019
1CD708,dividend,100,50,5/6/2019
1D943E,earnings,100,50,5/6/2019
221445,buybacks,100,74,5/6/2019
228D42,product-release,100,64,5/6/2019
228D42,product-release,100,64,5/6/2019
228D42,product-release,100,64,5/6/2019
228D42,product-release,100,64,5/6/2019
228D42,product-release,100,64,5/6/2019
228D42,product-release,100,64,5/6/2019
228D42,partnership,100,61,5/6/2019
238302,earnings,100,50,5/6/2019
241AF7,earnings,100,50,5/6/2019
249674,earnings,100,50,5/6/2019
249674,earnings,100,50,5/6/2019
249674,earnings,100,50,5/6/2019
27A791,earnings,100,50,5/6/2019
27A791,earnings,100,50,5/6/2019
27A791,earnings,100,50,5/6/2019
27A791,earnings,100,50,5/6/2019
2920D5,earnings,100,50,5/6/2019
295F9F,earnings,100,50,5/6/2019
2EC172,acquisition-acquirer,100,49,5/6/2019
2F7A7E,earnings,100,50,5/6/2019
30DFD3,earnings,100,50,5/6/2019
30E01D,executive-appointment,100,54,5/6/2019
30E01D,stake-acquirer,100,48,5/6/2019
326EDD,earnings,100,50,5/6/2019
337024,revenues,100,50,5/6/2019
337024,revenues,100,50,5/6/2019
3461CF,analyst-ratings-change-positive-rater,20,50,5/6/2019
35AE32,acquisition-completed-acquirer,100,49,5/6/2019
36529A,earnings,100,50,5/6/2019
36E479,earnings,100,50,5/6/2019
3798B9,conference-participant,100,50,5/6/2019
37E18B,conference-call,100,50,5/6/2019
39D9DA,conference-call,100,50,5/6/2019
3AF7FD,earnings,100,50,5/6/2019
3AF7FD,dividend,100,50,5/6/2019
3B2311,earnings,100,50,5/6/2019
3B37F7,conference-organizer,100,57,5/6/2019
3B37F7,conference-organizer,100,57,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3BA1BF,earnings,100,50,5/6/2019
3C75D6,award,100,58,5/6/2019
3CBA2A,partnership,100,61,5/6/2019
3D6933,pretax-earnings-up,100,68,5/6/2019
3D6933,pretax-earnings-up,100,68,5/6/2019
3DB18B,earnings,100,50,5/6/2019
3F96D5,earnings,100,50,5/6/2019
4.03E+05,business-contract,100,69,5/6/2019
408380,earnings,100,50,5/6/2019
417BF9,conference-call,100,50,5/6/2019
435ACE,earnings,100,50,5/6/2019
45444E,earnings,100,50,5/6/2019
46A16E,earnings,100,50,5/6/2019
485445,earnings,100,50,5/6/2019
485445,earnings,100,50,5/6/2019
485445,earnings,100,50,5/6/2019
485445,earnings,100,50,5/6/2019
485445,earnings,100,50,5/6/2019
49F4D0,public-offering,100,43,5/6/2019
49F4D0,public-offering,100,43,5/6/2019
4A2457,product-release,100,64,5/6/2019
4A6F00,product-release,100,64,5/6/2019
4A6F00,partnership,100,61,5/6/2019
4A6F00,partnership,100,61,5/6/2019
4AE584,earnings,100,50,5/6/2019
4BDCA7,clinical-trials-start,100,64,5/6/2019
4C31F3,earnings,100,50,5/6/2019
4C31F3,earnings,100,50,5/6/2019
4E5784,conference-participant,100,50,5/6/2019
50070E,conference-organizer,100,57,5/6/2019
507AE7,earnings,100,50,5/6/2019
510EA1,earnings,100,50,5/6/2019
520632,product-release,100,64,5/6/2019
5403F8,earnings,100,50,5/6/2019
54512F,earnings,100,50,5/6/2019
546A9C,conference-call,100,50,5/6/2019
54F271,revenues,100,50,5/6/2019
57A854,earnings-up,100,68,5/6/2019
57A854,earnings,100,50,5/6/2019
57EF50,earnings,100,50,5/6/2019
57EF50,earnings,100,50,5/6/2019
57EF50,earnings,100,50,5/6/2019
58C2D4,partnership,100,61,5/6/2019
5968F9,earnings,100,50,5/6/2019
59872F,legal-issues-defendant,100,22,5/6/2019
59872F,conference-call,100,50,5/6/2019
59DB8C,public-offering,100,43,5/6/2019
5A53BF,earnings,100,50,5/6/2019
5A9F54,executive-appointment,100,54,5/6/2019
5B3415,earnings,100,50,5/6/2019
5B3415,earnings,100,50,5/6/2019
5B3FA2,public-offering,100,43,5/6/2019
5C2A47,earnings,100,50,5/6/2019
5C7601,executive-appointment,100,54,5/6/2019
5CCDAD,executive-appointment,100,54,5/6/2019
5E9934,public-offering,100,43,5/6/2019
5F60CE,earnings,100,50,5/6/2019
5FDBD0,operating-earnings,100,50,5/6/2019
6.18E+08,executive-appointment,100,54,5/6/2019
619882,conference-organizer,100,57,5/6/2019
619882,conference-organizer,100,57,5/6/2019
619882,conference-organizer,100,57,5/6/2019
61A586,earnings,100,50,5/6/2019
61E975,conference-participant,100,50,5/6/2019
620381,public-offering,100,43,5/6/2019
62B1C6,earnings,100,50,5/6/2019
633043,executive-appointment,100,54,5/6/2019
69C99E,clinical-trials,100,56,5/6/2019
6A171E,earnings,100,50,5/6/2019
6B236C,earnings,100,50,5/6/2019
6B494E,unit-acquisition-acquirer,100,49,5/6/2019
6D0CAB,earnings,100,50,5/6/2019
6E8864,conference-participant,100,50,5/6/2019
6ED519,dividend,100,50,5/6/2019
6F0A63,revenue-up,100,69,5/6/2019
6F3FA8,earnings,100,50,5/6/2019
6F3FA8,earnings,100,50,5/6/2019
6F3FA8,earnings,100,50,5/6/2019
6F3FA8,earnings,100,50,5/6/2019
717DB4,earnings,100,50,5/6/2019
717DB4,earnings,100,50,5/6/2019
717DB4,earnings,100,50,5/6/2019
717DB4,earnings,100,50,5/6/2019
726EEA,conference-participant,100,50,5/6/2019
73A213,earnings,100,50,5/6/2019
73A213,earnings,100,50,5/6/2019
73A213,earnings,100,50,5/6/2019
756045,unit-acquisition-acquirer,100,49,5/6/2019
76DD0C,earnings,100,50,5/6/2019
7712CB,dividend,100,50,5/6/2019
7712CB,earnings,100,50,5/6/2019
7712CB,earnings,100,50,5/6/2019
797C20,earnings,100,50,5/6/2019
7A2A49,conference-participant,100,50,5/6/2019
7A51FE,buybacks,100,74,5/6/2019
7A51FE,earnings,100,50,5/6/2019
7ACFD4,partnership,100,61,5/6/2019
7ADE57,acquisition-acquirer,100,49,5/6/2019
7B492C,partnership,100,61,5/6/2019
7B9AFA,conference-participant,100,50,5/6/2019
7BEA98,fast-track-designation,100,81,5/6/2019
7C790D,earnings,100,50,5/6/2019
803FED,earnings,100,50,5/6/2019
80D744,trading-halt,100,43,5/6/2019
80D744,trading-resumed,100,58,5/6/2019
82C202,business-contract,100,69,5/6/2019
830BDB,regulatory-product-approval-granted,100,81,5/6/2019
83A065,earnings,100,50,5/6/2019
85DA04,earnings,100,50,5/6/2019
85DA04,earnings,100,50,5/6/2019
85DA04,earnings,100,50,5/6/2019
85DA04,earnings,100,50,5/6/2019
85DE00,partnership,100,61,5/6/2019
8614A2,legal-issues-defendant,100,22,5/6/2019
8614A2,legal-issues-defendant,100,22,5/6/2019
88193E,conference-participant,100,50,5/6/2019
885758,earnings,100,50,5/6/2019
890FF4,earnings,100,50,5/6/2019
890FF4,earnings,100,50,5/6/2019
890FF4,earnings,100,50,5/6/2019
890FF4,earnings,100,50,5/6/2019
890FF4,earnings,100,50,5/6/2019
890FF4,earnings,100,50,5/6/2019
8AB85C,earnings,100,50,5/6/2019
8B2C4A,merger-regulatory-approval,100,81,5/6/2019
8B2C4A,merger-regulatory-approval,100,81,5/6/2019
8B8656,partnership,100,61,5/6/2019
8D4486,product-release,100,64,5/6/2019
8DCF18,executive-appointment,100,54,5/6/2019
915E7B,earnings,100,50,5/6/2019
91C82E,product-release,100,64,5/6/2019
91E5EE,earnings,100,50,5/6/2019
92B73F,dividend,100,50,5/6/2019
9368BE,earnings,100,50,5/6/2019
93965C,earnings,100,50,5/6/2019
93965C,earnings,100,50,5/6/2019
949D62,campaign-ad-release,100,59,5/6/2019
957A07,earnings,100,50,5/6/2019
95DC1F,product-release,100,64,5/6/2019
9.65E+09,unit-acquisition-acquirer,100,49,5/6/2019
965360,executive-appointment,100,54,5/6/2019
968966,dividend,100,50,5/6/2019
96F126,business-contract,100,69,5/6/2019
96F126,business-contract,100,69,5/6/2019
97B027,earnings-up,100,68,5/6/2019
97B027,earnings-up,100,68,5/6/2019
97B027,earnings-up,100,68,5/6/2019
98CEBB,earnings,100,50,5/6/2019
99028D,partnership,100,61,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
990AD0,partnership,100,61,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
990AD0,conference-organizer,100,57,5/6/2019
9B5968,business-contract,100,69,5/6/2019
9BB35A,conference-participant,100,50,5/6/2019
9C5BA5,earnings,100,50,5/6/2019
9D2790,earnings,100,50,5/6/2019
9D2790,earnings,100,50,5/6/2019
9D2790,earnings,100,50,5/6/2019
9D2790,earnings,100,50,5/6/2019
9D2790,earnings,100,50,5/6/2019
9D2790,earnings,100,50,5/6/2019
9D2790,earnings,100,50,5/6/2019
9D307D,partnership,100,61,5/6/2019
A01664,conference-participant,100,50,5/6/2019
A072C4,earnings,100,50,5/6/2019
A1E3B3,earnings,100,50,5/6/2019
A26C26,conference-participant,100,50,5/6/2019
A26EF7,earnings,100,50,5/6/2019
A26EF7,earnings,100,50,5/6/2019
A753BB,earnings,100,50,5/6/2019
A871B0,earnings,100,50,5/6/2019
A8FDE8,earnings,100,50,5/6/2019
A8FDE8,earnings,100,50,5/6/2019
A8FDE8,dividend,100,50,5/6/2019
AA09AD,partnership,100,61,5/6/2019
AC7AAE,earnings,100,50,5/6/2019
AD1ACF,earnings-up,100,68,5/6/2019
AD1ACF,earnings,100,50,5/6/2019
AD1ACF,earnings,100,50,5/6/2019
AD1ACF,earnings,100,50,5/6/2019
AD1ACF,earnings,100,50,5/6/2019
AD3C93,executive-appointment,100,54,5/6/2019
AD3C93,executive-appointment,100,54,5/6/2019
AF93DE,earnings,100,50,5/6/2019
B0FE08,earnings,100,50,5/6/2019
B0FE08,earnings,100,50,5/6/2019
B0FE08,earnings,100,50,5/6/2019
B0FE08,earnings,100,50,5/6/2019
B106FA,earnings,100,50,5/6/2019
B4C673,dividend,100,50,5/6/2019
B73395,earnings,100,50,5/6/2019
B73395,earnings,100,50,5/6/2019
B73395,earnings,100,50,5/6/2019
B73395,earnings,100,50,5/6/2019
B7FA9B,conference-participant,100,50,5/6/2019
B9764A,partnership,100,61,5/6/2019
B9CD50,earnings,100,50,5/6/2019
BA218A,executive-appointment,100,54,5/6/2019
BB5142,executive-appointment,100,54,5/6/2019
BB58FF,earnings,100,50,5/6/2019
BB88B6,partnership,100,61,5/6/2019
BB88B6,business-contract,100,69,5/6/2019
BCE9DA,earnings,100,50,5/6/2019
BCE9DA,earnings,100,50,5/6/2019
BDCC11,product-release,100,64,5/6/2019
BDCC11,legal-issues-defendant,100,22,5/6/2019
BDF85E,executive-appointment,100,54,5/6/2019
BFAEB4,executive-appointment,100,54,5/6/2019
BFE02C,conference-participant,100,50,5/6/2019
C01737,patient-enrollment-complete,100,64,5/6/2019
C1114B,earnings,100,50,5/6/2019
C1114B,earnings,100,50,5/6/2019
C1114B,earnings,100,50,5/6/2019
C11C46,earnings,100,50,5/6/2019
C188F8,earnings,100,50,5/6/2019
C230FE,executive-appointment,100,54,5/6/2019
C2E39B,executive-appointment,100,54,5/6/2019
C38440,conference-participant,100,50,5/6/2019
C4FBDC,earnings,100,50,5/6/2019
C564E4,earnings,100,50,5/6/2019
C584BE,earnings,100,50,5/6/2019
C5D2AE,acquisition-acquirer,100,49,5/6/2019
C66A8C,public-offering,100,43,5/6/2019
C7FC95,partnership,100,61,5/6/2019
C7FC95,partnership,100,61,5/6/2019
C97B2D,regulatory-product-approval-granted,100,81,5/6/2019
C97B2D,legal-issues-defendant,100,22,5/6/2019
C9C62A,earnings,100,50,5/6/2019
CA212F,earnings,100,50,5/6/2019
CB7AB2,conference-participant,100,50,5/6/2019
CBCC6A,conference-organizer,100,57,5/6/2019
CC35BE,legal-issues-defendant,100,22,5/6/2019
CDD75E,campaign-ad-release,100,59,5/6/2019
CFD4B6,dividend,100,50,5/6/2019
CFD4B6,conference-participant,100,50,5/6/2019
CFF97C,operating-earnings,100,50,5/6/2019
D08D2C,earnings,100,50,5/6/2019
D08D2C,earnings,100,50,5/6/2019
D08D2C,earnings,100,50,5/6/2019
D08D2C,earnings,100,50,5/6/2019
D08D2C,earnings,100,50,5/6/2019
D11C1C,analyst-ratings-change-positive,100,78,5/6/2019
D13F1C,revenue-up,100,74,5/6/2019
D13F1C,revenue-up,100,74,5/6/2019
D13F1C,revenue-up,100,74,5/6/2019
D13F1C,revenue-up,100,74,5/6/2019
D15833,conference-call,100,50,5/6/2019
D57D99,product-release,100,64,5/6/2019
D60BB2,dividend,100,50,5/6/2019
D6144F,earnings,100,50,5/6/2019
D697DE,market-entry,100,57,5/6/2019
D70365,earnings,100,50,5/6/2019
D854F3,conference-participant,100,50,5/6/2019
D93A25,conference-call,100,50,5/6/2019
DA91AE,earnings,100,50,5/6/2019
DB2E4E,legal-issues-defendant,100,22,5/6/2019
DB5CA5,dividend,100,50,5/6/2019
DB88A1,revenues,100,50,5/6/2019
DBFB51,earnings,100,50,5/6/2019
DBFB51,conference-call,100,50,5/6/2019
DD682D,earnings,100,50,5/6/2019
DF8855,business-contract,100,69,5/6/2019
E0647D,earnings,100,50,5/6/2019
E0647D,earnings,100,50,5/6/2019
E0647D,earnings,100,50,5/6/2019
E0647D,earnings,100,50,5/6/2019
E0647D,earnings,100,50,5/6/2019
E09997,earnings,100,50,5/6/2019
E1E093,acquisition-acquirer,100,49,5/6/2019
E1E093,acquisition-acquirer,100,49,5/6/2019
E22FDE,legal-issues-defendant,100,22,5/6/2019
E2CFD2,partnership,100,61,5/6/2019
E7BF32,earnings,100,50,5/6/2019
E7BF32,earnings,100,50,5/6/2019
E829E8,conference-participant,100,50,5/6/2019
EA62FC,earnings,100,50,5/6/2019
EB1E1A,clinical-trials-start,100,64,5/6/2019
EB43F4,earnings,100,50,5/6/2019
ED2EFD,earnings,100,50,5/6/2019
EDD234,executive-appointment,100,54,5/6/2019
EE74E1,earnings,100,50,5/6/2019
EE74E1,earnings,100,50,5/6/2019
EE74E1,earnings,100,50,5/6/2019
F02170,earnings,100,50,5/6/2019
F179ED,partnership,100,61,5/6/2019
F30508,dividend,100,50,5/6/2019
F32F88,dividend,100,50,5/6/2019
F44EA2,earnings,100,50,5/6/2019
F48947,executive-appointment,100,54,5/6/2019
F48947,earnings,100,50,5/6/2019
F48947,earnings,100,50,5/6/2019
F4CDA3,earnings,100,50,5/6/2019
F4CDA3,earnings,100,50,5/6/2019
F4CDA3,earnings,100,50,5/6/2019
F4CDA3,earnings,100,50,5/6/2019
F4CDA3,earnings,100,50,5/6/2019
F6581D,earnings,100,50,5/6/2019
F6DE54,patent-awarded,100,72,5/6/2019
F6E248,conference-participant,100,50,5/6/2019
F769E9,conference-call,100,50,5/6/2019
F7935D,private-placement,100,56,5/6/2019
F88147,earnings,100,50,5/6/2019
F88A04,partnership,100,61,5/6/2019
F8DE55,legal-issues-defendant,100,22,5/6/2019
FB7724,legal-issues-defendant,100,22,5/6/2019
FD6926,dividend,100,50,5/6/2019
FE609F,conference-call,100,50,5/6/2019
FFCD0E,earnings,100,50,5/6/2019
001F1B,revenues,100,50,5/7/2019
001F1B,revenues,100,50,5/7/2019
0325B7,earnings,100,50,5/7/2019
03542C,earnings,100,50,5/7/2019
03B431,earnings,100,50,5/7/2019
04EB2F,earnings,100,50,5/7/2019
68396,earnings,100,50,5/7/2019
06C826,conference-call,100,50,5/7/2019
06EF42,conference-participant,100,50,5/7/2019
07C907,dividend,100,50,5/7/2019
07EC43,partnership,100,61,5/7/2019
09062E,earnings,100,50,5/7/2019
095A04,earnings,100,50,5/7/2019
0A6824,earnings,100,50,5/7/2019
0AD2E3,earnings,100,50,5/7/2019
0B400D,earnings,100,50,5/7/2019
0B400D,earnings,100,50,5/7/2019
0B400D,earnings,100,50,5/7/2019
0BD970,earnings,100,50,5/7/2019
0BF198,earnings,100,50,5/7/2019
0C355F,earnings,100,50,5/7/2019
0C355F,earnings,100,50,5/7/2019
0C355F,earnings,100,50,5/7/2019
0C355F,earnings,100,50,5/7/2019
0C355F,earnings,100,50,5/7/2019
0C6861,conference-participant,100,50,5/7/2019
0DBB81,conference-participant,100,50,5/7/2019
0E439E,dividend,100,50,5/7/2019
0E499E,conference-participant,100,50,5/7/2019
102F04,executive-appointment,100,54,5/7/2019
102F04,earnings,100,50,5/7/2019
1080C0,earnings,100,50,5/7/2019
1201B5,earnings,100,50,5/7/2019
14833D,earnings,100,50,5/7/2019
152E1D,operating-earnings,100,50,5/7/2019
152E1D,operating-earnings,100,50,5/7/2019
152E1D,operating-earnings,100,50,5/7/2019
152E1D,operating-earnings,100,50,5/7/2019
152E1D,operating-earnings,100,50,5/7/2019
154272,earnings,100,50,5/7/2019
157CC1,earnings,100,50,5/7/2019
15A388,ipo-pricing,100,50,5/7/2019
168A5D,partnership,100,61,5/7/2019
1.79E+10,joint-venture,100,62,5/7/2019
1834C0,earnings,100,50,5/7/2019
184988,earnings,100,50,5/7/2019
18D9FA,earnings,100,50,5/7/2019
1A3E1B,conference-participant,100,50,5/7/2019
1CDD1C,earnings,100,50,5/7/2019
1D1B07,conference-participant,100,50,5/7/2019
1D1B07,conference-participant,100,50,5/7/2019
1E4FB9,earnings,100,50,5/7/2019
1E68B3,partnership,100,61,5/7/2019
1EA923,earnings,100,50,5/7/2019
1EA923,earnings,100,50,5/7/2019
1EA923,earnings,100,50,5/7/2019
1FAF22,dividend-up,100,81,5/7/2019
200D8B,product-release,100,64,5/7/2019
2082EA,earnings,100,50,5/7/2019
21022F,earnings,100,50,5/7/2019
21D903,legal-issues-defendant,100,22,5/7/2019
21DED4,dividend,100,50,5/7/2019
2262BD,earnings,100,50,5/7/2019
227D48,dividend,100,50,5/7/2019
228D42,product-release,100,64,5/7/2019
232053,earnings,100,50,5/7/2019
239106,conference-participant,100,50,5/7/2019
24C48B,earnings,100,50,5/7/2019
25102A,executive-appointment,100,54,5/7/2019
25102A,executive-appointment,100,54,5/7/2019
25102A,executive-appointment,100,54,5/7/2019
28B730,earnings,100,50,5/7/2019
2AA6A8,earnings,100,50,5/7/2019
2ABF77,earnings,100,50,5/7/2019
2ABF77,earnings,100,50,5/7/2019
2B8179,clinical-trials,100,56,5/7/2019
2C3348,earnings,100,50,5/7/2019
2CA60F,earnings,100,50,5/7/2019
2D5011,ipo-completed,100,76,5/7/2019
2DB344,buybacks,100,74,5/7/2019
2E61CC,business-contract,100,69,5/7/2019
2EB04E,earnings-up,100,68,5/7/2019
2EB04E,earnings-up,100,68,5/7/2019
2EB04E,earnings-up,100,68,5/7/2019
2EBA55,earnings,100,50,5/7/2019
2EC172,earnings,100,50,5/7/2019
2EC172,earnings,100,50,5/7/2019
2EC172,earnings,100,50,5/7/2019
2EC172,earnings,100,50,5/7/2019
2EC172,earnings,100,50,5/7/2019
2EC172,earnings,100,50,5/7/2019
2F1299,earnings,100,50,5/7/2019
2F1299,earnings,100,50,5/7/2019
2F1299,earnings,100,50,5/7/2019
2F1299,earnings,100,50,5/7/2019
2F1299,earnings,100,50,5/7/2019
2F1299,earnings,100,50,5/7/2019
2F1299,earnings,100,50,5/7/2019
2FF046,earnings,100,50,5/7/2019
2FF046,earnings,100,50,5/7/2019
2FF046,earnings,100,50,5/7/2019
30AB63,note-sale,100,52,5/7/2019
30DFD3,legal-issues-defendant,100,22,5/7/2019
30DFD3,legal-issues-defendant,100,22,5/7/2019
31803E,conference-participant,100,50,5/7/2019
3461CF,award,100,58,5/7/2019
367E1C,conference-participant,100,50,5/7/2019
37B618,earnings,100,50,5/7/2019
396D7C,conference-participant,100,50,5/7/2019
3A1C46,earnings,100,50,5/7/2019
3A94DF,unit-acquisition-acquiree,100,76,5/7/2019
3B318A,conference-participant,100,50,5/7/2019
3B37F7,conference-organizer,100,57,5/7/2019
3B37F7,note-sale,100,52,5/7/2019
3B37F7,conference-organizer,100,57,5/7/2019
3C11C4,earnings,100,50,5/7/2019
3C6CCC,earnings-up,100,68,5/7/2019
3C6CCC,earnings-up,100,68,5/7/2019
3C6CCC,earnings-up,100,68,5/7/2019
3C6CCC,earnings-up,100,68,5/7/2019
3DCECC,earnings,100,50,5/7/2019
3E39A5,revenues,100,50,5/7/2019
3ED92D,product-release,100,64,5/7/2019
3EE65E,earnings,100,50,5/7/2019
3EE65E,conference-participant,100,50,5/7/2019
3F1C69,earnings,100,50,5/7/2019
4.03E+05,earnings,100,50,5/7/2019
4.03E+05,earnings,100,50,5/7/2019
4.03E+05,earnings,100,50,5/7/2019
4.03E+05,dividend,100,50,5/7/2019
40B903,earnings,100,50,5/7/2019
41C528,earnings,100,50,5/7/2019
41C528,earnings,100,50,5/7/2019
435ACE,legal-issues-defendant,100,22,5/7/2019
435ACE,conference-participant,100,50,5/7/2019
43E8F5,conference-participant,100,50,5/7/2019
442769,conference-participant,100,50,5/7/2019
44A4FC,earnings,100,50,5/7/2019
44ED36,earnings,100,50,5/7/2019
4A2457,partnership,100,61,5/7/2019
4A2457,partnership,100,61,5/7/2019
4A6F00,partnership,100,61,5/7/2019
4A6F00,partnership,100,61,5/7/2019
4A6F00,product-release,100,64,5/7/2019
4AE584,revenue-up,100,69,5/7/2019
4AE584,revenue-up,100,69,5/7/2019
4AE584,revenue-up,100,69,5/7/2019
4AE584,earnings,100,50,5/7/2019
4B7006,earnings,100,50,5/7/2019
4D229C,earnings,100,50,5/7/2019
4D8313,product-release,100,64,5/7/2019
4DD09F,earnings,100,50,5/7/2019
4DD09F,earnings,100,50,5/7/2019
4DD09F,earnings,100,50,5/7/2019
4E3D15,operating-earnings,100,50,5/7/2019
4E6F5A,earnings,100,50,5/7/2019
4E7C1F,conference-participant,100,50,5/7/2019
4EEB00,conference-participant,100,50,5/7/2019
4F783B,earnings,100,50,5/7/2019
4F783B,earnings,100,50,5/7/2019
4F783B,earnings,100,50,5/7/2019
4F783B,earnings,100,50,5/7/2019
4F783B,earnings,100,50,5/7/2019
50070E,conference-organizer,100,57,5/7/2019
50070E,conference-organizer,100,57,5/7/2019
519FE0,earnings,100,50,5/7/2019
51F541,note-sale,100,52,5/7/2019
51F541,note-sale,100,52,5/7/2019
520632,conference-participant,100,50,5/7/2019
52D936,executive-appointment,100,54,5/7/2019
5340D0,earnings,100,50,5/7/2019
53A226,earnings,100,50,5/7/2019
545272,earnings,100,50,5/7/2019
54A713,dividend,100,50,5/7/2019
54F1D2,earnings,100,50,5/7/2019
550D01,earnings,100,50,5/7/2019
550D01,earnings,100,50,5/7/2019
55438C,legal-issues-defendant,100,22,5/7/2019
5546DA,trading-halt,100,43,5/7/2019
5546DA,trading-halt,100,43,5/7/2019
55C9B5,conference-participant,100,50,5/7/2019
56765E,earnings,100,50,5/7/2019
56FB7C,earnings,100,50,5/7/2019
583A75,revenue-volume,100,50,5/7/2019
589803,earnings,100,50,5/7/2019
58C2D4,conference-participant,100,50,5/7/2019
59872F,legal-issues-defendant,100,22,5/7/2019
59A832,earnings,100,50,5/7/2019
5B6C11,executive-appointment,100,54,5/7/2019
5CEE02,earnings,100,50,5/7/2019
5DD486,dividend,100,50,5/7/2019
5F1B7B,earnings,100,50,5/7/2019
5F60CE,earnings-positive,100,69,5/7/2019
619882,conference-organizer,100,57,5/7/2019
619882,conference-organizer,100,57,5/7/2019
619882,conference-organizer,100,57,5/7/2019
622DBE,earnings,100,50,5/7/2019
62A48D,conference-call,100,50,5/7/2019
62CDDE,earnings,100,50,5/7/2019
633043,earnings,100,50,5/7/2019
6634D9,note-sale,100,52,5/7/2019
665440,earnings,100,50,5/7/2019
665440,earnings,100,50,5/7/2019
665618,conference-participant,100,50,5/7/2019
665D7D,conference-participant,100,50,5/7/2019
66A667,conference-participant,100,50,5/7/2019
66A667,conference-participant,100,50,5/7/2019
673C9A,earnings,100,50,5/7/2019
676FFD,earnings,100,50,5/7/2019
68AB62,earnings,100,50,5/7/2019
6925EB,earnings,100,50,5/7/2019
6B6375,conference-call,100,50,5/7/2019
6BD606,earnings-positive,100,69,5/7/2019
6BD606,earnings-positive,100,69,5/7/2019
6CDFC6,partnership,100,61,5/7/2019
6D156D,earnings,100,50,5/7/2019
6DDA15,legal-issues-defendant,100,22,5/7/2019
6.00E+19,conference-call,100,50,5/7/2019
6E8864,operating-earnings,100,50,5/7/2019
6F39FC,earnings,100,50,5/7/2019
6F39FC,dividend,100,50,5/7/2019
701531,earnings,100,50,5/7/2019
70CA28,conference-participant,100,50,5/7/2019
713810,partnership,100,61,5/7/2019
71694D,earnings,100,50,5/7/2019
73C9E2,unit-acquisition-acquirer,100,49,5/7/2019
763DBE,earnings,100,50,5/7/2019
7712CB,earnings,100,50,5/7/2019
7712CB,earnings,100,50,5/7/2019
7712CB,earnings,100,50,5/7/2019
7712CB,earnings,100,50,5/7/2019
7712CB,dividend,100,50,5/7/2019
7734AC,dividend,100,50,5/7/2019
787D14,earnings,100,50,5/7/2019
787D14,earnings-guidance,100,50,5/7/2019
7A0EC4,partnership,100,61,5/7/2019
7A5097,product-release,100,64,5/7/2019
7A975D,conference-participant,100,50,5/7/2019
7ACD98,earnings,100,50,5/7/2019
7ACFD4,conference-call,100,50,5/7/2019
7B1156,buybacks,100,74,5/7/2019
7B6EB1,earnings,100,50,5/7/2019
7BFF81,conference-participant,100,50,5/7/2019
7C62A3,earnings,100,50,5/7/2019
7D97DE,legal-issues-defendant,100,22,5/7/2019
7E0EB0,award,100,58,5/7/2019
7E3F8F,note-sale,100,52,5/7/2019
7E3F8F,note-sale,100,52,5/7/2019
804708,partnership,100,61,5/7/2019
80D744,dividend,100,50,5/7/2019
82B57E,earnings,100,50,5/7/2019
82E58A,dividend,100,50,5/7/2019
82E58A,executive-appointment,100,54,5/7/2019
82F088,earnings,100,50,5/7/2019
83E0AC,earnings,100,50,5/7/2019
848C0B,earnings,100,50,5/7/2019
858942,earnings,100,50,5/7/2019
8614A2,legal-issues-defendant,100,22,5/7/2019
8665BA,conference-participant,100,50,5/7/2019
877734,earnings,100,50,5/7/2019
877734,earnings,100,50,5/7/2019
877734,earnings,100,50,5/7/2019
877734,earnings,100,50,5/7/2019
881190,dividend-up,100,81,5/7/2019
8A8E41,partnership,100,61,5/7/2019
8AB85C,executive-appointment,100,54,5/7/2019
8AC65D,partnership,100,61,5/7/2019
8B9B3B,conference-participant,100,50,5/7/2019
8D4486,business-contract,100,69,5/7/2019
8D4AE6,dividend-up,100,63,5/7/2019
8DCF18,earnings,100,50,5/7/2019
8DCF18,earnings,100,50,5/7/2019
8E10BF,earnings,100,50,5/7/2019
8E3F58,earnings,100,50,5/7/2019
9043FE,earnings,100,50,5/7/2019
9043FE,earnings,100,50,5/7/2019
9087B9,earnings,100,50,5/7/2019
913437,earnings,100,50,5/7/2019
92B625,earnings,100,50,5/7/2019
92D230,conference-call,100,50,5/7/2019
931AE7,earnings,100,50,5/7/2019
9.31E+77,earnings,100,50,5/7/2019
93AD2E,legal-issues-defendant,100,22,5/7/2019
93F143,dividend,100,50,5/7/2019
944B2E,earnings,100,50,5/7/2019
944B2E,earnings,100,50,5/7/2019
944B2E,earnings,100,50,5/7/2019
944B2E,earnings,100,50,5/7/2019
9548BB,dividend,100,50,5/7/2019
9548BB,executive-appointment,100,54,5/7/2019
97644E,earnings,100,50,5/7/2019
97644E,earnings,100,50,5/7/2019
97644E,earnings,100,50,5/7/2019
97644E,earnings,100,50,5/7/2019
977A1E,dividend,100,50,5/7/2019
97AAF6,public-offering,100,43,5/7/2019
97AF94,earnings,100,50,5/7/2019
980C14,dividend,100,50,5/7/2019
986AF6,board-meeting,100,51,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
990AD0,conference-organizer,100,57,5/7/2019
99ACAD,earnings,100,50,5/7/2019
99ACAD,earnings,100,50,5/7/2019
99ACAD,earnings,100,50,5/7/2019
99ACAD,earnings,100,50,5/7/2019
99DC8D,dividend,100,50,5/7/2019
99DC8D,earnings,100,50,5/7/2019
9B730A,earnings,100,50,5/7/2019
9C009A,earnings,100,50,5/7/2019
9C8BC3,earnings-guidance-meet-expectations,100,59,5/7/2019
9C8BC3,earnings-guidance-meet-expectations,100,59,5/7/2019
9C8BC3,earnings-guidance-meet-expectations,100,59,5/7/2019
9C8BC3,earnings-guidance-meet-expectations,100,59,5/7/2019
9CA432,earnings,100,50,5/7/2019
9CA4C6,buybacks,100,74,5/7/2019
9D4EC7,dividend-up,100,81,5/7/2019
9D4EC7,earnings,100,50,5/7/2019
9EBAFA,earnings,100,50,5/7/2019
9F18FA,earnings,100,50,5/7/2019
9F18FA,earnings,100,50,5/7/2019
9FB4B7,earnings,100,50,5/7/2019
9FF5F1,earnings,100,50,5/7/2019
A05C43,earnings,100,50,5/7/2019
A05C43,earnings,100,50,5/7/2019
A05C43,earnings,100,50,5/7/2019
A16DEA,earnings,100,50,5/7/2019
A16DEA,earnings,100,50,5/7/2019
A16DEA,earnings,100,50,5/7/2019
A16DEA,earnings,100,50,5/7/2019
A16DEA,earnings,100,50,5/7/2019
A16DEA,earnings,100,50,5/7/2019
A16DEA,earnings,100,50,5/7/2019
A16DEA,earnings,100,50,5/7/2019
A21649,earnings,100,50,5/7/2019
A5151E,business-contract,100,69,5/7/2019
A58224,conference-participant,100,50,5/7/2019
A5DD24,earnings,100,50,5/7/2019
A60354,earnings,100,50,5/7/2019
A60354,earnings,100,50,5/7/2019
A60354,earnings,100,50,5/7/2019
A6828A,executive-appointment,100,54,5/7/2019
A7102F,earnings-up,100,68,5/7/2019
A7102F,earnings,100,50,5/7/2019
A7102F,earnings,100,50,5/7/2019
A7102F,earnings,100,50,5/7/2019
A7102F,earnings,100,50,5/7/2019
A74F6F,revenues,100,50,5/7/2019
A74F6F,revenues,100,50,5/7/2019
A80FE0,conference-participant,100,50,5/7/2019
AAEE21,note-sale,100,52,5/7/2019
AC775C,earnings,100,50,5/7/2019
AC775C,earnings,100,50,5/7/2019
ACDF88,conference-call,100,50,5/7/2019
ADFB3A,earnings,100,50,5/7/2019
AE3113,executive-appointment,100,54,5/7/2019
AE7D16,earnings,100,50,5/7/2019
B0D41A,earnings,100,50,5/7/2019
B13B68,earnings,100,50,5/7/2019
B1A85D,earnings,100,50,5/7/2019
B1DF3C,conference-participant,100,50,5/7/2019
B2E6B5,dividend,100,50,5/7/2019
B2E6B5,earnings,100,50,5/7/2019
B2E6B5,earnings,100,50,5/7/2019
B2E6B5,earnings,100,50,5/7/2019
B37FB4,conference-participant,100,50,5/7/2019
B446B8,earnings,100,50,5/7/2019
B446B8,earnings,100,50,5/7/2019
B446B8,earnings,100,50,5/7/2019
B48FC9,revenue-up,100,79,5/7/2019
B48FC9,revenue-up,100,79,5/7/2019
B53C12,earnings,100,50,5/7/2019
B54A74,executive-appointment,100,54,5/7/2019
B54A74,earnings,100,50,5/7/2019
B642E8,earnings-up,100,68,5/7/2019
B72D2E,revenue-up,100,69,5/7/2019
B7FA9B,earnings,100,50,5/7/2019
B803B1,conference-participant,100,50,5/7/2019
B80AD1,conference-participant,100,50,5/7/2019
B83D67,conference-participant,100,50,5/7/2019
B8A51F,executive-appointment,100,54,5/7/2019
B9764A,earnings,100,50,5/7/2019
B98EFA,earnings,100,50,5/7/2019
BB88B6,partnership,100,61,5/7/2019
BC948D,conference-participant,100,50,5/7/2019
BCC13E,business-contract,100,69,5/7/2019
BCC13E,business-contract,100,69,5/7/2019
BCC13E,earnings,100,50,5/7/2019
BDA775,earnings,100,50,5/7/2019
BDCC11,legal-issues-defendant,100,22,5/7/2019
C15F8F,earnings,100,50,5/7/2019
C2609A,earnings,100,50,5/7/2019
C2E39B,earnings,100,50,5/7/2019
C2E39B,earnings,100,50,5/7/2019
C2E39B,earnings,100,50,5/7/2019
C3BAE7,earnings,100,50,5/7/2019
C3BAE7,earnings,100,50,5/7/2019
C3BAE7,earnings,100,50,5/7/2019
C3BAE7,earnings,100,50,5/7/2019
C3BAE7,earnings,100,50,5/7/2019
C3BCD5,dividend,100,50,5/7/2019
C3F99F,earnings,100,50,5/7/2019
C50B26,earnings,100,50,5/7/2019
C7FC95,acquisition-acquirer,100,49,5/7/2019
C7FC95,acquisition-acquirer,100,49,5/7/2019
C8257F,executive-appointment,100,54,5/7/2019
C8257F,award,100,58,5/7/2019
C8923A,earnings-up,100,68,5/7/2019
C8A059,earnings,100,50,5/7/2019
C8FAC7,earnings,100,50,5/7/2019
C941DC,public-offering,100,43,5/7/2019
C97B2D,conference-participant,100,50,5/7/2019
C97B2D,legal-issues-defendant,100,22,5/7/2019
C99CC8,award,100,58,5/7/2019
CA1620,conference-call,100,50,5/7/2019
CAD7D9,conference-participant,100,50,5/7/2019
CB22CD,dividend,100,50,5/7/2019
CC35BE,legal-issues-defendant,100,22,5/7/2019
CC3EC4,conference-participant,100,50,5/7/2019
CC8F6E,earnings,100,50,5/7/2019
CCBBAD,earnings,100,50,5/7/2019
CDAB24,earnings-up,100,68,5/7/2019
CDAB24,earnings-up,100,68,5/7/2019
CDAB24,earnings-up,100,68,5/7/2019
CDC217,executive-appointment,100,54,5/7/2019
CDC217,earnings,100,50,5/7/2019
CF351E,earnings,100,50,5/7/2019
CF351E,earnings,100,50,5/7/2019
CFF15D,dividend,100,50,5/7/2019
D11C1C,operating-earnings,100,50,5/7/2019
D15833,earnings-per-share-positive,100,69,5/7/2019
D25249,earnings,100,50,5/7/2019
D29B44,earnings,100,50,5/7/2019
D29B44,earnings,100,50,5/7/2019
D29B44,earnings,100,50,5/7/2019
D29B44,earnings,100,50,5/7/2019
D29B44,earnings,100,50,5/7/2019
D29F43,earnings,100,50,5/7/2019
D3CEDF,earnings,100,50,5/7/2019
D3CEDF,earnings,100,50,5/7/2019
D3CEDF,earnings,100,50,5/7/2019
D3CEDF,earnings,100,50,5/7/2019
D3CEDF,earnings,100,50,5/7/2019
D3DE34,earnings,100,50,5/7/2019
D63B0F,earnings,100,50,5/7/2019
D63B0F,earnings,100,50,5/7/2019
D63B0F,earnings,100,50,5/7/2019
D63B0F,dividend,100,50,5/7/2019
D81463,earnings,100,50,5/7/2019
D81463,earnings,100,50,5/7/2019
D854F3,executive-appointment,100,54,5/7/2019
DA199F,ipo-pricing,100,50,5/7/2019
DB06B0,product-release,100,64,5/7/2019
DB06B0,earnings,100,50,5/7/2019
DBB28E,executive-appointment,100,54,5/7/2019
DC1405,earnings,100,50,5/7/2019
DC2F77,conference-participant,100,50,5/7/2019
DF01B1,earnings-meet-expectations,100,59,5/7/2019
DF01B1,earnings,100,50,5/7/2019
DF01B1,earnings,100,50,5/7/2019
DF01B1,earnings,100,50,5/7/2019
DF204B,revenues,100,50,5/7/2019
E06265,dividend-up,100,56,5/7/2019
E074A0,earnings,100,50,5/7/2019
E124EB,dividend,100,50,5/7/2019
E15736,earnings,100,50,5/7/2019
E22FDE,legal-issues-defendant,100,22,5/7/2019
E38906,earnings,100,50,5/7/2019
E74B55,earnings,100,50,5/7/2019
E96E0B,earnings,100,50,5/7/2019
EAEA91,settlement,100,56,5/7/2019
EAEBF3,earnings,100,50,5/7/2019
EB43F4,trading-listing,100,61,5/7/2019
EC1AF3,earnings,100,50,5/7/2019
ECF709,earnings,100,50,5/7/2019
EDD234,partnership,100,61,5/7/2019
EE04F0,earnings,100,50,5/7/2019
EE04F0,earnings,100,50,5/7/2019
EE04F0,earnings,100,50,5/7/2019
EE04F0,earnings,100,50,5/7/2019
EEA6B3,executive-appointment,100,54,5/7/2019
EEA734,earnings,100,50,5/7/2019
EF5BED,partnership,100,61,5/7/2019
EFD406,earnings,100,50,5/7/2019
EFD406,earnings,100,50,5/7/2019
EFD406,earnings,100,50,5/7/2019
EFD406,earnings,100,50,5/7/2019
EFD406,earnings,100,50,5/7/2019
EFD406,earnings,100,50,5/7/2019
F0B335,sponsorship,100,57,5/7/2019
F1EB39,partnership,100,61,5/7/2019
F1EB39,partnership,100,61,5/7/2019
F2E253,earnings,100,50,5/7/2019
F2E253,earnings,100,50,5/7/2019
F2E253,earnings,100,50,5/7/2019
F2E253,earnings,100,50,5/7/2019
F2E253,earnings,100,50,5/7/2019
F3016C,earnings,100,50,5/7/2019
F3016C,earnings,100,50,5/7/2019
F3016C,earnings,100,50,5/7/2019
F569FD,earnings,100,50,5/7/2019
F57F6F,earnings,100,50,5/7/2019
F58C23,earnings,100,50,5/7/2019
F58C23,earnings,100,50,5/7/2019
F5C8AB,earnings-per-share-positive,100,69,5/7/2019
F5C8AB,earnings-per-share-positive,100,69,5/7/2019
F5C8AB,earnings-per-share,100,50,5/7/2019
F6FF0D,earnings,100,50,5/7/2019
FB7724,earnings,100,50,5/7/2019
FC4550,dividend,100,50,5/7/2019
FCA54E,earnings,100,50,5/7/2019
FD39EB,note-sale,100,52,5/7/2019
FD39EB,note-sale,100,52,5/7/2019
FD554E,earnings,100,50,5/7/2019
FDF28E,earnings,100,50,5/7/2019
FDF28E,executive-appointment,100,54,5/7/2019
FE609F,clinical-trials-complete,100,56,5/7/2019
FF5413,revenue-volume,100,50,5/7/2019
FF6644,conference-participant,100,50,5/7/2019
0142B5,business-contract,100,69,5/8/2019
0157B1,partnership,100,61,5/8/2019
01D03F,product-release,100,64,5/8/2019
01D03F,product-release,100,64,5/8/2019
01D03F,product-release,100,64,5/8/2019
01D03F,product-release,100,64,5/8/2019
02FC1A,conference-participant,100,50,5/8/2019
033B58,business-contract,100,69,5/8/2019
0358AF,earnings,100,50,5/8/2019
03596A,earnings,100,50,5/8/2019
04996E,conference-participant,100,50,5/8/2019
04CCCD,revenue-up,100,69,5/8/2019
053EFF,dividend,100,50,5/8/2019
0560D8,earnings,100,50,5/8/2019
06C826,earnings,100,50,5/8/2019
07CA6A,buybacks,100,74,5/8/2019
07CA6A,buybacks,100,74,5/8/2019
0A9D0A,acquisition-acquiree,100,76,5/8/2019
0A9D0A,earnings,100,50,5/8/2019
0C6293,earnings,100,50,5/8/2019
0C6293,earnings,100,50,5/8/2019
0CADBC,earnings,100,50,5/8/2019
0CCCB7,earnings,100,50,5/8/2019
0CCCB7,dividend-up,100,59,5/8/2019
0CE204,earnings,100,50,5/8/2019
0ED415,legal-issues-defendant,100,22,5/8/2019
0EF1AF,partnership,100,61,5/8/2019
0F2BC9,earnings-up,100,68,5/8/2019
0F2BC9,earnings-up,100,68,5/8/2019
0FC848,earnings,100,50,5/8/2019
10100E,earnings,100,50,5/8/2019
1080C0,conference-participant,100,50,5/8/2019
1096C6,earnings,100,50,5/8/2019
1279ED,earnings,100,50,5/8/2019
135B09,dividend,100,50,5/8/2019
138DDE,earnings,100,50,5/8/2019
143C9C,executive-appointment,100,54,5/8/2019
147098,earnings,100,50,5/8/2019
180DA0,dividend,100,50,5/8/2019
18D9FA,facility-sale,100,52,5/8/2019
19BF16,earnings,100,50,5/8/2019
19BF16,earnings,100,50,5/8/2019
19BF16,earnings,100,50,5/8/2019
19BF16,earnings,100,50,5/8/2019
1A5957,earnings,100,50,5/8/2019
1A5957,earnings,100,50,5/8/2019
1A5957,earnings,100,50,5/8/2019
1A5957,earnings,100,50,5/8/2019
1A5957,earnings,100,50,5/8/2019
1BC12C,press-conference-organizer,100,50,5/8/2019
1BC12C,business-contract,100,69,5/8/2019
1C599A,earnings,100,50,5/8/2019
1CB9D3,earnings,100,50,5/8/2019
1CD09C,conference-participant,100,50,5/8/2019
1CD4B5,clinical-trials-start,100,64,5/8/2019
1DA44F,legal-issues-defendant,100,22,5/8/2019
1DB6A6,dividend,100,50,5/8/2019
1E04A5,earnings,100,50,5/8/2019
1E68B3,note-sale,100,52,5/8/2019
1E7785,earnings,100,50,5/8/2019
1E7785,earnings,100,50,5/8/2019
1E7785,earnings,100,50,5/8/2019
1E7785,earnings,100,50,5/8/2019
1EBF8D,clinical-trials,100,56,5/8/2019
1EBF8D,clinical-trials,100,56,5/8/2019
1F3CFB,earnings,100,50,5/8/2019
1F464F,executive-appointment,100,54,5/8/2019
1F464F,earnings,100,50,5/8/2019
1FC422,earnings,100,50,5/8/2019
2003A5,earnings,100,50,5/8/2019
202E5A,earnings,100,50,5/8/2019
2096DE,earnings,100,50,5/8/2019
21268E,earnings,100,50,5/8/2019
21D903,earnings,100,50,5/8/2019
228D42,partnership,100,61,5/8/2019
232053,conference-participant,100,50,5/8/2019
25DD05,public-offering,100,43,5/8/2019
267718,acquisition-acquirer,100,49,5/8/2019
267718,acquisition-acquirer,100,49,5/8/2019
27C10F,earnings,100,50,5/8/2019
27C10F,earnings,100,50,5/8/2019
27C10F,earnings,100,50,5/8/2019
27C10F,earnings,100,50,5/8/2019
297DA8,earnings,100,50,5/8/2019
2.90E+62,executive-appointment,100,54,5/8/2019
2B8179,business-contract,100,69,5/8/2019
2B8179,earnings,100,50,5/8/2019
2BBE62,earnings,100,50,5/8/2019
2BBE62,earnings,100,50,5/8/2019
2BBE62,earnings,100,50,5/8/2019
2BC05E,conference-participant,100,50,5/8/2019
2C681C,reverse-stock-splits,100,51,5/8/2019
2C681C,reverse-stock-splits,100,51,5/8/2019
2CA60F,partnership,100,61,5/8/2019
2CBB58,conference-call,100,50,5/8/2019
2D2D43,acquisition-acquiree,100,76,5/8/2019
2D2D43,earnings,100,50,5/8/2019
2D643C,conference-participant,100,50,5/8/2019
2E1322,earnings,100,50,5/8/2019
2E1322,earnings,100,50,5/8/2019
2E61CC,business-contract,100,69,5/8/2019
2E61CC,business-contract,100,69,5/8/2019
2F960F,earnings,100,50,5/8/2019
306623,executive-appointment,100,54,5/8/2019
306623,earnings,100,50,5/8/2019
306623,dividend,100,50,5/8/2019
31DB20,earnings,100,50,5/8/2019
32CB22,executive-appointment,100,54,5/8/2019
32F943,business-contract,100,69,5/8/2019
32F943,earnings,100,50,5/8/2019
355B19,earnings,100,50,5/8/2019
35AE32,earnings,100,50,5/8/2019
35AE32,earnings,100,50,5/8/2019
35AE32,earnings,100,50,5/8/2019
35AE32,earnings,100,50,5/8/2019
366A08,executive-appointment,100,54,5/8/2019
36E479,earnings,100,50,5/8/2019
36E479,clinical-trials-start,100,64,5/8/2019
37020C,earnings-up,100,68,5/8/2019
37020C,earnings-up,100,68,5/8/2019
37020C,earnings-up,100,68,5/8/2019
37020C,earnings-up,100,68,5/8/2019
37020C,earnings-up,100,68,5/8/2019
37020C,earnings-up,100,68,5/8/2019
370C50,note-sale,100,52,5/8/2019
37426C,earnings,100,50,5/8/2019
37B120,earnings,100,50,5/8/2019
37E18B,operating-earnings,100,50,5/8/2019
384CD3,earnings,100,50,5/8/2019
3B37F7,conference-organizer,100,57,5/8/2019
3C75D6,earnings-up,100,68,5/8/2019
3C75D6,earnings,100,50,5/8/2019
3C75D6,earnings,100,50,5/8/2019
3F1C69,conference-participant,100,50,5/8/2019
3FACA7,dividend-up,100,81,5/8/2019
401072,conference-participant,100,50,5/8/2019
4.03E+05,partnership,100,61,5/8/2019
416291,earnings,100,50,5/8/2019
41C36B,earnings,100,50,5/8/2019
41ED98,earnings,100,50,5/8/2019
427F32,earnings,100,50,5/8/2019
4398A2,conference-participant,100,50,5/8/2019
43A060,earnings,100,50,5/8/2019
43A060,earnings,100,50,5/8/2019
43A060,earnings,100,50,5/8/2019
448215,earnings,100,50,5/8/2019
448BF3,earnings,100,50,5/8/2019
450ECB,partnership,100,61,5/8/2019
450ECB,partnership,100,61,5/8/2019
453282,executive-appointment,100,54,5/8/2019
45ABCC,revenue-up,100,76,5/8/2019
45ABCC,revenue-up,100,76,5/8/2019
45ABCC,revenue-up,100,76,5/8/2019
468DD4,earnings,100,50,5/8/2019
48F795,earnings,100,50,5/8/2019
4A2457,earnings,100,50,5/8/2019
4A3438,earnings,100,50,5/8/2019
4A3438,earnings,100,50,5/8/2019
4A3438,earnings,100,50,5/8/2019
4A5C8D,earnings,100,50,5/8/2019
4A5C8D,earnings,100,50,5/8/2019
4A6F00,product-release,100,64,5/8/2019
4A6F00,market-entry,100,57,5/8/2019
4AC91D,partnership,100,61,5/8/2019
4BDCA7,conference-participant,100,50,5/8/2019
4C37C5,dividend,100,50,5/8/2019
4C7DB5,ownership-increase-owner,100,56,5/8/2019
4CDA2B,conference-participant,100,50,5/8/2019
4EE14A,operating-earnings,100,50,5/8/2019
4EE14A,operating-earnings,100,50,5/8/2019
50070E,conference-organizer,100,57,5/8/2019
50070E,conference-organizer,100,57,5/8/2019
5065B1,earnings,100,50,5/8/2019
50D1EC,earnings,100,50,5/8/2019
513A86,earnings,100,50,5/8/2019
514067,earnings,100,50,5/8/2019
51B442,earnings,100,50,5/8/2019
51D876,revenue-up,100,69,5/8/2019
51D876,revenue-up,100,69,5/8/2019
51D876,revenue-up,100,69,5/8/2019
51D876,revenue-up,100,69,5/8/2019
51D876,revenue-up,100,69,5/8/2019
51F541,dividend,100,50,5/8/2019
53EF9E,dividend,100,50,5/8/2019
548AC0,earnings,100,50,5/8/2019
55438C,legal-issues-defendant,100,22,5/8/2019
586BD7,conference-participant,100,50,5/8/2019
587EDF,earnings,100,50,5/8/2019
589803,business-contract,100,69,5/8/2019
5B15E1,executive-appointment,100,54,5/8/2019
5B3FA2,public-offering,100,43,5/8/2019
5B7739,earnings,100,50,5/8/2019
5CEE02,earnings,100,50,5/8/2019
5D41E4,earnings,100,50,5/8/2019
5D41E4,earnings,100,50,5/8/2019
5EAA43,earnings,100,50,5/8/2019
619882,conference-organizer,100,57,5/8/2019
619882,conference-organizer,100,57,5/8/2019
619882,product-release,100,64,5/8/2019
619882,conference-organizer,100,57,5/8/2019
619882,conference-organizer,100,57,5/8/2019
619882,conference-organizer,100,57,5/8/2019
619882,conference-organizer,100,57,5/8/2019
619882,conference-organizer,100,57,5/8/2019
649CBD,earnings,100,50,5/8/2019
649CBD,earnings,100,50,5/8/2019
649CBD,earnings,100,50,5/8/2019
6559D8,earnings,100,50,5/8/2019
657097,earnings,100,50,5/8/2019
66CB62,operating-earnings,100,50,5/8/2019
68586A,conference-participant,100,50,5/8/2019
68E6E9,dividend,100,50,5/8/2019
6A961B,earnings,100,50,5/8/2019
6A961B,earnings,100,50,5/8/2019
6A961B,earnings,100,50,5/8/2019
6A961B,earnings,100,50,5/8/2019
6A961B,earnings,100,50,5/8/2019
6A961B,earnings,100,50,5/8/2019
6A961B,earnings,100,50,5/8/2019
6A961B,earnings,100,50,5/8/2019
6D0CAB,dividend,100,50,5/8/2019
6D1ADF,earnings,100,50,5/8/2019
6DC1D7,dividend-up,100,84,5/8/2019
6DDA15,earnings,100,50,5/8/2019
6DDA15,earnings,100,50,5/8/2019
6DDA15,earnings,100,50,5/8/2019
6DDA15,earnings,100,50,5/8/2019
6DDA15,earnings,100,50,5/8/2019
6DDA15,earnings,100,50,5/8/2019
6F22E7,conference-call,100,50,5/8/2019
6FCEF9,earnings,100,50,5/8/2019
713810,business-contract,100,69,5/8/2019
71553E,earnings,100,50,5/8/2019
71E2EF,earnings,100,50,5/8/2019
724F84,earnings,100,50,5/8/2019
7255D2,earnings,100,50,5/8/2019
72CB93,conference-participant,100,50,5/8/2019
732A9B,earnings,100,50,5/8/2019
732A9B,earnings,100,50,5/8/2019
7.45E+28,earnings,100,50,5/8/2019
747219,dividend,100,50,5/8/2019
756045,earnings,100,50,5/8/2019
76959C,earnings,100,50,5/8/2019
769F40,earnings,100,50,5/8/2019
76B926,dividend,100,50,5/8/2019
76BECC,earnings,100,50,5/8/2019
76BECC,earnings,100,50,5/8/2019
76BECC,earnings,100,50,5/8/2019
790D0D,dividend,100,50,5/8/2019
791D59,conference-participant,100,50,5/8/2019
79340A,conference-participant,100,50,5/8/2019
7A10FF,conference-participant,100,50,5/8/2019
7AF5B8,earnings,100,50,5/8/2019
7BFF81,earnings,100,50,5/8/2019
7D85A9,dividend,100,50,5/8/2019
7DD584,revenue-up,100,74,5/8/2019
7DD584,revenue-up,100,74,5/8/2019
7DD584,revenue-up,100,74,5/8/2019
7DD8CC,earnings,100,50,5/8/2019
7E1D5D,earnings,100,50,5/8/2019
7F3665,earnings,100,50,5/8/2019
7FD8B9,earnings,100,50,5/8/2019
805CD8,earnings,100,50,5/8/2019
818A2F,earnings,100,50,5/8/2019
824CCA,earnings,100,50,5/8/2019
824CCA,earnings,100,50,5/8/2019
824CCA,earnings,100,50,5/8/2019
82F088,conference-participant,100,50,5/8/2019
83A065,public-offering,100,43,5/8/2019
83A065,public-offering,100,43,5/8/2019
83B1C8,earnings,100,50,5/8/2019
8614A2,earnings,100,50,5/8/2019
8614A2,legal-issues-defendant,100,22,5/8/2019
862941,operating-earnings,100,50,5/8/2019
86F123,earnings-positive,100,69,5/8/2019
88611B,earnings,100,50,5/8/2019
895D56,operating-earnings,100,50,5/8/2019
8AB37F,revenue-up,100,72,5/8/2019
8AB37F,earnings,100,50,5/8/2019
8B9B3B,earnings,100,50,5/8/2019
8E82A6,dividend,100,50,5/8/2019
8E8E6E,executive-appointment,100,54,5/8/2019
8F3BCC,conference-participant,100,50,5/8/2019
90D6A5,earnings,100,50,5/8/2019
90D6A5,earnings,100,50,5/8/2019
90D6A5,earnings,100,50,5/8/2019
911CA9,earnings,100,50,5/8/2019
911CA9,earnings,100,50,5/8/2019
91C82E,facility-open,100,65,5/8/2019
92005C,earnings,100,50,5/8/2019
93D207,stake-acquirer,100,48,5/8/2019
93D207,conference-participant,100,50,5/8/2019
943239,partnership,100,61,5/8/2019
94637C,note-sale,100,52,5/8/2019
9507FF,earnings,100,50,5/8/2019
958938,earnings,100,50,5/8/2019
9592FB,earnings,100,50,5/8/2019
95A92E,earnings,100,50,5/8/2019
95F59E,conference-organizer,100,57,5/8/2019
9.65E+07,earnings,100,50,5/8/2019
9.65E+07,earnings,100,50,5/8/2019
9673BD,executive-appointment,100,54,5/8/2019
97644E,executive-appointment,100,54,5/8/2019
97FE80,earnings,100,50,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
990AD0,conference-organizer,100,57,5/8/2019
9A2760,acquisition-acquirer,100,49,5/8/2019
9A2760,earnings-up,100,68,5/8/2019
9A2760,earnings,100,50,5/8/2019
9A2760,earnings,100,50,5/8/2019
9A2760,earnings,100,50,5/8/2019
9B730A,conference-participant,100,50,5/8/2019
9C5BA5,conference-participant,100,50,5/8/2019
9D5FA4,earnings,100,50,5/8/2019
9DDE1B,earnings,100,50,5/8/2019
9E0811,earnings,100,50,5/8/2019
9E575E,earnings,100,50,5/8/2019
9E98F2,conference-participant,100,50,5/8/2019
9EF4CF,partnership,100,61,5/8/2019
9F048E,unit-acquisition-acquirer,100,49,5/8/2019
9F5CBB,earnings,100,50,5/8/2019
9FD2D9,earnings,100,50,5/8/2019
9FD2D9,earnings,100,50,5/8/2019
9FD2D9,earnings,100,50,5/8/2019
A01664,conference-participant,100,50,5/8/2019
A1E3B3,partnership,100,61,5/8/2019
A29DBD,earnings,100,50,5/8/2019
A3800A,executive-appointment,100,54,5/8/2019
A433A5,earnings,100,50,5/8/2019
A43906,conference-participant,100,50,5/8/2019
A47A7D,executive-appointment,100,54,5/8/2019
A47A7D,executive-appointment,100,54,5/8/2019
A5195E,earnings,100,50,5/8/2019
A6828A,business-contract,100,69,5/8/2019
A790A5,executive-appointment,100,54,5/8/2019
A79F7D,earnings,100,50,5/8/2019
AAC8B6,earnings,100,50,5/8/2019
AAC8B6,earnings,100,50,5/8/2019
AAC8B6,earnings,100,50,5/8/2019
AAC8B6,earnings,100,50,5/8/2019
AAC8B6,earnings,100,50,5/8/2019
AB4A7E,conference-participant,100,50,5/8/2019
AC7C4F,executive-appointment,100,54,5/8/2019
ACF0B4,earnings,100,50,5/8/2019
AE3113,earnings,100,50,5/8/2019
AE7D16,earnings,100,50,5/8/2019
AEFC90,earnings,100,50,5/8/2019
AFD7DD,earnings,100,50,5/8/2019
AFD7DD,earnings,100,50,5/8/2019
B01215,conference-call,100,50,5/8/2019
B01215,conference-call,100,50,5/8/2019
B04426,earnings,100,50,5/8/2019
B05000,executive-appointment,100,54,5/8/2019
B2206F,executive-appointment,100,54,5/8/2019
B2206F,executive-appointment,100,54,5/8/2019
B290A2,earnings,100,50,5/8/2019
B3A166,earnings,100,50,5/8/2019
B48D6A,earnings,100,50,5/8/2019
B5734D,reverse-stock-splits,100,51,5/8/2019
B66928,dividend,100,50,5/8/2019
B66928,earnings,100,50,5/8/2019
B66928,earnings,100,50,5/8/2019
B66928,earnings,100,50,5/8/2019
B66928,earnings,100,50,5/8/2019
B66928,earnings,100,50,5/8/2019
B66928,earnings,100,50,5/8/2019
B7202A,earnings,100,50,5/8/2019
B8A51F,partnership,100,61,5/8/2019
B8A51F,earnings,100,50,5/8/2019
B8EF97,revenues,100,50,5/8/2019
BCC55F,earnings,100,50,5/8/2019
BCC55F,earnings,100,50,5/8/2019
BCC55F,earnings,100,50,5/8/2019
BCC55F,earnings,100,50,5/8/2019
BDCC11,legal-issues-defendant,100,22,5/8/2019
BDE867,dividend,100,50,5/8/2019
BDEC1E,earnings,100,50,5/8/2019
BF79F5,dividend,100,50,5/8/2019
C06EB6,earnings,100,50,5/8/2019
C1114B,dividend,100,50,5/8/2019
C3EE99,conference-call,100,50,5/8/2019
C407A0,earnings,100,50,5/8/2019
C425AE,earnings,100,50,5/8/2019
C4F9C6,earnings,100,50,5/8/2019
C50B26,legal-issues-defendant,100,22,5/8/2019
C62AA4,earnings,100,50,5/8/2019
C65004,revenues,100,50,5/8/2019
C65004,revenues,100,50,5/8/2019
C66A8C,public-offering,100,43,5/8/2019
C8257F,award,100,58,5/8/2019
C83B88,dividend,100,50,5/8/2019
C9732E,earnings,100,50,5/8/2019
C9E04B,earnings,100,50,5/8/2019
CAB222,conference-participant,100,50,5/8/2019
CB89EA,earnings,100,50,5/8/2019
CB9E13,earnings,100,50,5/8/2019
CBB77B,executive-appointment,100,54,5/8/2019
CBFFDD,dividend,100,50,5/8/2019
CC176E,conference-participant,100,50,5/8/2019
CC35BE,earnings,100,50,5/8/2019
CC35BE,earnings,100,50,5/8/2019
CC35BE,earnings,100,50,5/8/2019
CC35BE,earnings,100,50,5/8/2019
CC35BE,earnings,100,50,5/8/2019
CD051C,earnings,100,50,5/8/2019
CD051C,earnings,100,50,5/8/2019
CD051C,earnings,100,50,5/8/2019
CD051C,earnings,100,50,5/8/2019
CD051C,earnings,100,50,5/8/2019
CDAA0E,earnings,100,50,5/8/2019
CDC817,executive-appointment,100,54,5/8/2019
CDC817,conference-participant,100,50,5/8/2019
CDE118,dividend-up,100,81,5/8/2019
CDFCC9,earnings,100,50,5/8/2019
CDFCC9,earnings,100,50,5/8/2019
CDFCC9,earnings,100,50,5/8/2019
CDFCC9,earnings,100,50,5/8/2019
CDFCC9,earnings,100,50,5/8/2019
CDFCC9,earnings,100,50,5/8/2019
CDFCC9,dividend,100,50,5/8/2019
CE2791,earnings,100,50,5/8/2019
CE4E6D,earnings-up,100,68,5/8/2019
CE4E6D,earnings-up,100,68,5/8/2019
CE4E6D,earnings-up,100,68,5/8/2019
CE4E6D,earnings-up,100,68,5/8/2019
CE5664,dividend-up,100,62,5/8/2019
CE5C6E,earnings,100,50,5/8/2019
CED4D0,earnings,100,50,5/8/2019
CF3FF9,earnings,100,50,5/8/2019
CFF97C,executive-appointment,100,54,5/8/2019
D07B07,earnings,100,50,5/8/2019
D0DE27,dividend-up,100,54,5/8/2019
D17F7E,dividend-up,100,81,5/8/2019
D1C26F,business-contract,100,69,5/8/2019
D2C0B6,earnings,100,50,5/8/2019
D3FA2C,earnings,100,50,5/8/2019
D4C0CB,ipo-pricing,100,50,5/8/2019
D518D8,executive-appointment,100,54,5/8/2019
D518D8,dividend,100,50,5/8/2019
D5B13D,earnings,100,50,5/8/2019
D697DE,conference-participant,100,50,5/8/2019
D854DD,dividend,100,50,5/8/2019
D854F3,dividend,100,50,5/8/2019
D93A25,strike,100,25,5/8/2019
DB2E4E,earnings,100,50,5/8/2019
DC1405,conference-participant,100,50,5/8/2019
DC6AA0,earnings,100,50,5/8/2019
DD682D,dividend,100,50,5/8/2019
DF18E6,earnings,100,50,5/8/2019
DF5F14,earnings,100,50,5/8/2019
E05026,earnings,100,50,5/8/2019
E11C41,earnings,100,50,5/8/2019
E124EB,award,100,58,5/8/2019
E124EB,conference-participant,100,50,5/8/2019
E19A99,earnings,100,50,5/8/2019
E20392,earnings,100,50,5/8/2019
E259C7,dividend,100,50,5/8/2019
E28D9C,earnings,100,50,5/8/2019
E4CE73,conference-call,100,50,5/8/2019
E5752F,earnings,100,50,5/8/2019
E5752F,earnings,100,50,5/8/2019
E5752F,earnings,100,50,5/8/2019
E5752F,earnings,100,50,5/8/2019
E5752F,earnings,100,50,5/8/2019
E5752F,earnings,100,50,5/8/2019
E610CD,earnings,100,50,5/8/2019
E610CD,earnings,100,50,5/8/2019
E61888,earnings,100,50,5/8/2019
E68E62,earnings,100,50,5/8/2019
EA62FC,conference-participant,100,50,5/8/2019
EA79C7,earnings,100,50,5/8/2019
EBC84C,conference-participant,100,50,5/8/2019
EBD89A,business-contract,100,69,5/8/2019
EC8116,earnings,100,50,5/8/2019
EDD234,earnings,100,50,5/8/2019
EEB5F9,earnings,100,50,5/8/2019
EF5BED,executive-appointment,100,54,5/8/2019
F0B335,business-contract,100,69,5/8/2019
F179ED,conference-participant,100,50,5/8/2019
F18844,dividend,100,50,5/8/2019
F18844,earnings,100,50,5/8/2019
F39E1E,executive-appointment,100,54,5/8/2019
F47871,conference-participant,100,50,5/8/2019
F4D241,earnings,100,50,5/8/2019
F5349B,earnings,100,50,5/8/2019
F5349B,dividend,100,50,5/8/2019
F5C8AB,dividend,100,50,5/8/2019
F6581D,earnings,100,50,5/8/2019
F6E248,partnership,100,61,5/8/2019
F7ADEB,conference-participant,100,50,5/8/2019
F7ADEB,earnings,100,50,5/8/2019
F9AA02,earnings,100,50,5/8/2019
FA840E,earnings,100,50,5/8/2019
FBD92D,earnings-up,100,68,5/8/2019
FBD92D,earnings,100,50,5/8/2019
FBD92D,earnings,100,50,5/8/2019
FC9869,earnings,100,50,5/8/2019
FD2565,earnings,100,50,5/8/2019
FDF799,earnings,100,50,5/8/2019
FDF799,earnings,100,50,5/8/2019
FDF799,earnings,100,50,5/8/2019
FE609F,earnings,100,50,5/8/2019
FE7A63,conference-participant,100,50,5/8/2019
FEE4B0,conference-participant,100,50,5/8/2019
FF5413,dividend,100,50,5/8/2019
002A99,earnings,100,50,5/9/2019
00D6B5,buybacks,100,74,5/9/2019
00D6B5,buybacks,100,74,5/9/2019
20751,earnings,100,50,5/9/2019
02ACBD,earnings,100,50,5/9/2019
02FC1A,earnings,100,50,5/9/2019
02FC1A,earnings,100,50,5/9/2019
03FAA6,business-contract,100,69,5/9/2019
0490C6,earnings,100,50,5/9/2019
0490C6,earnings,100,50,5/9/2019
0490C6,earnings,100,50,5/9/2019
05D148,earnings,100,50,5/9/2019
06C826,earnings,100,50,5/9/2019
75172,earnings,100,50,5/9/2019
84625,dividend-up,100,54,5/9/2019
0A6824,conference-participant,100,50,5/9/2019
0B13E8,earnings,100,50,5/9/2019
0B57D7,dividend,100,50,5/9/2019
0BD199,ipo-pricing,100,50,5/9/2019
0C6861,earnings,100,50,5/9/2019
0C8D82,acquisition-acquirer,100,49,5/9/2019
0C8D82,acquisition-acquirer,100,49,5/9/2019
0CE7F6,earnings,100,50,5/9/2019
0DC050,business-contract,100,69,5/9/2019
0DC050,business-contract,100,69,5/9/2019
0E5619,earnings,100,50,5/9/2019
0EF1AF,earnings,100,50,5/9/2019
0F0693,earnings,100,50,5/9/2019
11A49E,earnings,100,50,5/9/2019
13C3E0,product-release,100,64,5/9/2019
14391F,earnings,100,50,5/9/2019
14391F,earnings,100,50,5/9/2019
14391F,earnings,100,50,5/9/2019
15789A,earnings-up,100,68,5/9/2019
165B86,earnings,100,50,5/9/2019
16B882,earnings,100,50,5/9/2019
182BE7,earnings,100,50,5/9/2019
1834C0,unit-acquisition-acquirer,100,49,5/9/2019
184866,earnings,100,50,5/9/2019
1AB023,earnings,100,50,5/9/2019
1AB023,earnings,100,50,5/9/2019
1AB023,earnings,100,50,5/9/2019
1AC649,earnings,100,50,5/9/2019
1B5FEA,earnings,100,50,5/9/2019
1BDB2A,dividend,100,50,5/9/2019
1C2593,conference-call,100,50,5/9/2019
1CD09C,earnings,100,50,5/9/2019
1DA44F,dividend-up,100,81,5/9/2019
221783,conference-participant,100,50,5/9/2019
228D42,product-release,100,64,5/9/2019
23207A,earnings-up,100,92,5/9/2019
23207A,buybacks,100,74,5/9/2019
249674,conference-participant,100,50,5/9/2019
25DD05,public-offering,100,43,5/9/2019
263216,conference-participant,100,50,5/9/2019
26F99F,earnings,100,50,5/9/2019
28AF37,earnings,100,50,5/9/2019
28AF37,earnings,100,50,5/9/2019
28AF37,earnings,100,50,5/9/2019
28AF37,earnings,100,50,5/9/2019
28F905,earnings,100,50,5/9/2019
28F905,earnings,100,50,5/9/2019
28F905,earnings,100,50,5/9/2019
28F905,earnings,100,50,5/9/2019
28F905,earnings,100,50,5/9/2019
28F905,earnings,100,50,5/9/2019
28F905,earnings,100,50,5/9/2019
28F905,earnings,100,50,5/9/2019
2A1009,board-meeting,100,51,5/9/2019
2A6DBE,earnings,100,50,5/9/2019
2B5483,earnings,100,50,5/9/2019
2BA977,conference-call,100,50,5/9/2019
2BDC1C,earnings,100,50,5/9/2019
2C35B5,earnings,100,50,5/9/2019
2DA92D,executive-appointment,100,54,5/9/2019
2DA92D,dividend,100,50,5/9/2019
2DC88B,legal-issues-defendant,100,22,5/9/2019
2E89AE,earnings,100,50,5/9/2019
2E89AE,earnings,100,50,5/9/2019
30DE64,earnings,100,50,5/9/2019
3461CF,award,100,58,5/9/2019
34B411,fundraising,100,64,5/9/2019
3587B4,earnings,100,50,5/9/2019
3587B4,earnings,100,50,5/9/2019
3587B4,earnings,100,50,5/9/2019
3587B4,earnings,100,50,5/9/2019
36C09B,conference-call,100,50,5/9/2019
37E18B,exchange-compliance,100,76,5/9/2019
396D7C,earnings,100,50,5/9/2019
3B37F7,conference-organizer,100,57,5/9/2019
3B37F7,conference-organizer,100,57,5/9/2019
3B37F7,conference-organizer,100,57,5/9/2019
3C3B6B,earnings,100,50,5/9/2019
3C3B6B,executive-appointment,100,54,5/9/2019
3D9999,buybacks,100,74,5/9/2019
3DD5E2,operating-earnings,100,50,5/9/2019
3E70FC,earnings,100,50,5/9/2019
3FBC9B,earnings,100,50,5/9/2019
401072,earnings,100,50,5/9/2019
407878,earnings,100,50,5/9/2019
416C55,conference-participant,100,50,5/9/2019
41B53E,earnings,100,50,5/9/2019
41B53E,earnings,100,50,5/9/2019
41B53E,earnings,100,50,5/9/2019
444CC8,revenues,100,50,5/9/2019
450ECB,earnings,100,50,5/9/2019
4.60E+06,earnings,100,50,5/9/2019
47BA98,ipo-pricing,100,50,5/9/2019
47FCF2,earnings,100,50,5/9/2019
47FCF2,earnings,100,50,5/9/2019
47FCF2,earnings,100,50,5/9/2019
47FCF2,earnings,100,50,5/9/2019
47FCF2,earnings,100,50,5/9/2019
47FCF2,earnings,100,50,5/9/2019
47FCF2,earnings,100,50,5/9/2019
47FCF2,earnings,100,50,5/9/2019
494EB9,conference-participant,100,50,5/9/2019
49A344,facility-open,100,65,5/9/2019
4A2457,conference-participant,100,50,5/9/2019
4AC91D,partnership,100,61,5/9/2019
4AC91D,earnings,100,50,5/9/2019
4BDCA7,earnings,100,50,5/9/2019
4BEB48,earnings,100,50,5/9/2019
4BEB48,earnings,100,50,5/9/2019
4BEB48,earnings,100,50,5/9/2019
4BEB48,earnings,100,50,5/9/2019
4BEB48,conference-participant,100,50,5/9/2019
4C3FE9,earnings,100,50,5/9/2019
4D72C8,earnings,100,50,5/9/2019
4D72C8,earnings,100,50,5/9/2019
4DD203,revenue-up,100,54,5/9/2019
4E913D,partnership,100,61,5/9/2019
4EEB00,operating-earnings,100,50,5/9/2019
50070E,conference-organizer,100,57,5/9/2019
50070E,conference-organizer,100,57,5/9/2019
50070E,conference-organizer,100,57,5/9/2019
50070E,conference-organizer,100,57,5/9/2019
50070E,earnings,100,50,5/9/2019
52B567,earnings,100,50,5/9/2019
52B567,earnings,100,50,5/9/2019
52B567,earnings,100,50,5/9/2019
52FB2F,earnings,100,50,5/9/2019
52FB2F,earnings,100,50,5/9/2019
52FB2F,earnings,100,50,5/9/2019
52FB2F,earnings,100,50,5/9/2019
546A27,earnings,100,50,5/9/2019
5.47E+28,operating-earnings,100,50,5/9/2019
54B889,ipo-pricing,100,50,5/9/2019
54DF47,earnings,100,50,5/9/2019
55438C,legal-issues-defendant,100,22,5/9/2019
556F08,earnings,100,50,5/9/2019
55ACCB,earnings,100,50,5/9/2019
55ACCB,earnings,100,50,5/9/2019
55ACCB,earnings,100,50,5/9/2019
55D0F3,earnings,100,50,5/9/2019
58B46F,earnings-per-share-positive,100,69,5/9/2019
5B226B,earnings-up,100,68,5/9/2019
5B226B,earnings-up,100,68,5/9/2019
5B226B,earnings-up,100,68,5/9/2019
5D63F1,earnings,100,50,5/9/2019
5F3D91,earnings,100,50,5/9/2019
5F3D91,earnings,100,50,5/9/2019
5F3D91,earnings,100,50,5/9/2019
60FE03,earnings,100,50,5/9/2019
619882,conference-organizer,100,57,5/9/2019
619882,conference-organizer,100,57,5/9/2019
619882,conference-organizer,100,57,5/9/2019
619882,conference-organizer,100,57,5/9/2019
619882,conference-organizer,100,57,5/9/2019
620381,earnings,100,50,5/9/2019
629F0F,earnings,100,50,5/9/2019
64636E,conference-participant,100,50,5/9/2019
64636E,conference-participant,100,50,5/9/2019
64636E,conference-participant,100,50,5/9/2019
651C85,conference-participant,100,50,5/9/2019
6634D9,earnings,100,50,5/9/2019
66667F,revenue-up,100,92,5/9/2019
66667F,revenue-up,100,69,5/9/2019
67303E,clinical-trials,100,56,5/9/2019
67303E,clinical-trials,100,56,5/9/2019
6810DE,earnings,100,50,5/9/2019
68586A,earnings,100,50,5/9/2019
68BA15,earnings,100,50,5/9/2019
69C99E,earnings,100,50,5/9/2019
69FDFC,earnings,100,50,5/9/2019
6B0784,earnings,100,50,5/9/2019
6B6375,earnings,100,50,5/9/2019
6BC6F9,earnings,100,50,5/9/2019
6BC6F9,earnings,100,50,5/9/2019
6BC6F9,earnings,100,50,5/9/2019
6BDA0C,earnings,100,50,5/9/2019
6BDA0C,earnings,100,50,5/9/2019
6BDA0C,earnings,100,50,5/9/2019
6BDA0C,earnings,100,50,5/9/2019
6D2BF6,operating-earnings,100,50,5/9/2019
6D2BF6,partnership,100,61,5/9/2019
6F22E7,donation,100,54,5/9/2019
723548,earnings,100,50,5/9/2019
73C521,executive-appointment,100,54,5/9/2019
747219,earnings,100,50,5/9/2019
762B8D,earnings,100,50,5/9/2019
7740DE,same-store-sales-up,100,66,5/9/2019
789A7D,earnings,100,50,5/9/2019
7A3633,partnership,100,61,5/9/2019
7AC86E,dividend,100,50,5/9/2019
7AC86E,executive-appointment,100,54,5/9/2019
7B1156,earnings,100,50,5/9/2019
7B492C,executive-appointment,100,54,5/9/2019
7B9212,revenues,100,50,5/9/2019
7BC92D,earnings,100,50,5/9/2019
7BEA98,earnings,100,50,5/9/2019
7BFF81,dividend,100,50,5/9/2019
7D5FD6,dividend,100,50,5/9/2019
81222C,earnings,100,50,5/9/2019
8.10E+205,earnings,100,50,5/9/2019
834152,earnings,100,50,5/9/2019
83E0AC,conference-call,100,50,5/9/2019
845533,earnings,100,50,5/9/2019
84920B,earnings-positive,100,69,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86AA9C,earnings,100,50,5/9/2019
86BAC7,dividend-up,100,81,5/9/2019
873DB9,earnings,100,50,5/9/2019
873DB9,earnings,100,50,5/9/2019
873DB9,earnings,100,50,5/9/2019
873DB9,earnings,100,50,5/9/2019
873DB9,earnings,100,50,5/9/2019
873DB9,earnings,100,50,5/9/2019
873DB9,earnings,100,50,5/9/2019
877C0C,earnings,100,50,5/9/2019
8.79E+06,earnings,100,50,5/9/2019
88923D,earnings,100,50,5/9/2019
88923D,earnings,100,50,5/9/2019
88923D,earnings,100,50,5/9/2019
88923D,earnings,100,50,5/9/2019
88923D,earnings,100,50,5/9/2019
88923D,earnings,100,50,5/9/2019
89F693,earnings,100,50,5/9/2019
8B3B0E,dividend,100,50,5/9/2019
8BFAA4,earnings,100,50,5/9/2019
8BFAA4,earnings,100,50,5/9/2019
8BFAA4,earnings,100,50,5/9/2019
8C6C1B,conference-call,100,50,5/9/2019
8DAAB9,dividend-up,100,62,5/9/2019
8DE74B,dividend-up,100,81,5/9/2019
8E10BF,conference-participant,100,50,5/9/2019
8E4F9A,operating-earnings,100,50,5/9/2019
90D6A5,dividend,100,50,5/9/2019
922F0C,dividend,100,50,5/9/2019
925759,earnings,100,50,5/9/2019
925759,earnings,100,50,5/9/2019
92D230,earnings,100,50,5/9/2019
92D230,earnings,100,50,5/9/2019
92D230,earnings,100,50,5/9/2019
92D230,earnings,100,50,5/9/2019
92D230,earnings,100,50,5/9/2019
92D757,dividend,100,50,5/9/2019
934CC3,conference-call,100,50,5/9/2019
9.36E+10,partnership,100,61,5/9/2019
9.36E+10,partnership,100,61,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,earnings,100,50,5/9/2019
9.36E+10,partnership,100,61,5/9/2019
938D89,earnings,100,50,5/9/2019
943239,earnings,100,50,5/9/2019
9470CC,conference-participant,100,50,5/9/2019
94756D,conference-participant,100,50,5/9/2019
947B0B,earnings,100,50,5/9/2019
949D62,earnings,100,50,5/9/2019
95C392,facility-open,100,65,5/9/2019
966DBE,earnings,100,50,5/9/2019
966DBE,earnings,100,50,5/9/2019
966DBE,earnings,100,50,5/9/2019
966DBE,earnings,100,50,5/9/2019
966DBE,earnings,100,50,5/9/2019
9673BD,earnings,100,50,5/9/2019
96A6CD,earnings,100,50,5/9/2019
96BFF4,earnings,100,50,5/9/2019
96BFF4,earnings,100,50,5/9/2019
99028D,earnings,100,50,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
990AD0,conference-organizer,100,57,5/9/2019
994468,dividend,100,50,5/9/2019
9ABD30,earnings,100,50,5/9/2019
9B0C9C,earnings,100,50,5/9/2019
9D307D,earnings,100,50,5/9/2019
9E5C2C,earnings,100,50,5/9/2019
9E91C6,earnings,100,50,5/9/2019
9F5997,acquisition-acquiree,100,76,5/9/2019
9F5997,acquisition-acquiree,100,76,5/9/2019
9F5997,earnings,100,50,5/9/2019
9F5997,acquisition-acquirer,100,49,5/9/2019
A017F4,conference-participant,100,50,5/9/2019
A0F146,earnings,100,50,5/9/2019
A16DEA,asset-sale,100,62,5/9/2019
A1E3B3,partnership,100,61,5/9/2019
A28675,earnings,100,50,5/9/2019
A3800A,earnings,100,50,5/9/2019
A48593,earnings,100,50,5/9/2019
A495F7,earnings,100,50,5/9/2019
A4CD53,earnings,100,50,5/9/2019
A4CD53,earnings,100,50,5/9/2019
A5195E,clinical-trials-complete,100,56,5/9/2019
A5DD24,note-sale,100,52,5/9/2019
A753BB,earnings,100,50,5/9/2019
A7CCF0,executive-resignation,100,44,5/9/2019
A8E72A,conference-participant,100,50,5/9/2019
AA1EAA,credit-extension-recipient,100,69,5/9/2019
AC3584,conference-organizer,100,57,5/9/2019
AC642C,note-sale,100,52,5/9/2019
AC642C,note-sale,100,52,5/9/2019
AC7C4F,government-contract,100,69,5/9/2019
ACC7D3,earnings,100,50,5/9/2019
AD6141,earnings,100,50,5/9/2019
AE4125,earnings,100,50,5/9/2019
AE4125,earnings,100,50,5/9/2019
AED6CF,earnings,100,50,5/9/2019
AED6CF,earnings,100,50,5/9/2019
AED6CF,earnings,100,50,5/9/2019
AED6CF,earnings,100,50,5/9/2019
AED6CF,earnings,100,50,5/9/2019
AED6CF,earnings,100,50,5/9/2019
B05000,earnings,100,50,5/9/2019
B08C51,earnings,100,50,5/9/2019
B0B969,earnings,100,50,5/9/2019
B2206F,conference-participant,100,50,5/9/2019
B33E77,earnings,100,50,5/9/2019
B37FB4,dividend,100,50,5/9/2019
B381D8,earnings,100,50,5/9/2019
B54A74,conference-participant,100,50,5/9/2019
B7BDA3,earnings,100,50,5/9/2019
B7BDA3,earnings,100,50,5/9/2019
B7BDA3,earnings,100,50,5/9/2019
B803B1,earnings,100,50,5/9/2019
B80AD1,earnings,100,50,5/9/2019
B9CD50,conference-participant,100,50,5/9/2019
BA0442,private-placement,100,56,5/9/2019
BB0787,earnings,100,50,5/9/2019
BBC05B,operating-earnings,100,50,5/9/2019
BBF349,earnings,100,50,5/9/2019
BBF349,earnings,100,50,5/9/2019
BBF349,earnings,100,50,5/9/2019
BCE9DA,conference-participant,100,50,5/9/2019
BCE9DA,conference-participant,100,50,5/9/2019
BD9668,dividend-up,100,81,5/9/2019
BDF2BD,earnings,100,50,5/9/2019
BE14CF,conference-participant,100,50,5/9/2019
BE5935,earnings,100,50,5/9/2019
BFD0A7,executive-appointment,100,54,5/9/2019
BFD0A7,earnings,100,50,5/9/2019
BFD0A7,earnings,100,50,5/9/2019
BFD0A7,earnings,100,50,5/9/2019
C037A8,earnings,100,50,5/9/2019
C11C46,conference-participant,100,50,5/9/2019
C27E19,dividend,100,50,5/9/2019
C2DD02,earnings,100,50,5/9/2019
C2F597,conference-participant,100,50,5/9/2019
C36189,earnings,100,50,5/9/2019
C4706C,earnings,100,50,5/9/2019
C58D71,earnings,100,50,5/9/2019
C58D71,earnings,100,50,5/9/2019
C5D2AE,executive-appointment,100,54,5/9/2019
C659EB,dividend,100,50,5/9/2019
C941DC,conference-participant,100,50,5/9/2019
C9D866,conference-participant,100,50,5/9/2019
C9E4EC,earnings,100,50,5/9/2019
CA212F,dividend,100,50,5/9/2019
CA212F,acquisition-acquirer,100,49,5/9/2019
CA212F,acquisition-acquirer,100,49,5/9/2019
CBB77B,earnings-guidance-meet-expectations,100,59,5/9/2019
CBDB4D,earnings,100,50,5/9/2019
CBFFDD,earnings,100,50,5/9/2019
CBFFDD,trading-halt,100,43,5/9/2019
CC3EC4,earnings,100,50,5/9/2019
CDAF5B,dividend,100,50,5/9/2019
CDC817,earnings,100,50,5/9/2019
CDD75E,earnings,100,50,5/9/2019
CE5664,earnings,100,50,5/9/2019
CE5664,earnings,100,50,5/9/2019
CE5664,earnings,100,50,5/9/2019
CEC5B9,product-release,100,64,5/9/2019
CFF97C,dividend,100,50,5/9/2019
D06755,award,100,58,5/9/2019
D2B9E5,partnership,100,61,5/9/2019
D2E553,partnership,100,61,5/9/2019
D36B23,ipo-pricing,100,50,5/9/2019
D437C3,conference-participant,100,50,5/9/2019
D45285,earnings,100,50,5/9/2019
D45285,earnings,100,50,5/9/2019
D5938F,earnings,100,50,5/9/2019
D5A350,dividend,100,50,5/9/2019
D64C6D,dividend,100,50,5/9/2019
D6534D,dividend,100,50,5/9/2019
D697DE,earnings,100,50,5/9/2019
D6EAA3,earnings-positive,100,69,5/9/2019
D6EAA3,earnings,100,50,5/9/2019
D6EAA3,earnings,100,50,5/9/2019
D6EAA3,earnings,100,50,5/9/2019
D75910,conference-call,100,50,5/9/2019
D76AEF,revenues,100,50,5/9/2019
D77F7E,earnings,100,50,5/9/2019
D77F7E,executive-appointment,100,54,5/9/2019
D77F7E,executive-appointment,100,54,5/9/2019
D88EF3,note-sale,100,52,5/9/2019
D8ECA1,earnings,100,50,5/9/2019
D8ECA1,earnings,100,50,5/9/2019
D8ECA1,earnings,100,50,5/9/2019
D8ECA1,earnings,100,50,5/9/2019
D8ECA1,earnings,100,50,5/9/2019
D8ECA1,executive-appointment,100,54,5/9/2019
D90441,earnings,100,50,5/9/2019
D90F43,ipo-pricing,100,50,5/9/2019
DA199F,ipo-completed,100,76,5/9/2019
DB5CA5,earnings,100,50,5/9/2019
DBB28E,conference-call,100,50,5/9/2019
DC486E,partnership,100,61,5/9/2019
DC486E,dividend,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DD1BA1,earnings,100,50,5/9/2019
DE4924,note-sale,100,52,5/9/2019
DE5611,conference-call,100,50,5/9/2019
DF16DE,earnings,100,50,5/9/2019
E09E2B,partnership,100,61,5/9/2019
E09E2B,partnership,100,61,5/9/2019
E0D3BA,earnings,100,50,5/9/2019
E114F4,conference-call,100,50,5/9/2019
E13782,earnings,100,50,5/9/2019
E16133,earnings,100,50,5/9/2019
E21871,dividend,100,50,5/9/2019
E259C7,revenues,100,50,5/9/2019
E2CB7B,earnings,100,50,5/9/2019
E2CFD2,earnings-meet-expectations,100,59,5/9/2019
E3656D,earnings,100,50,5/9/2019
E41190,earnings,100,50,5/9/2019
E41190,earnings,100,50,5/9/2019
E41190,earnings,100,50,5/9/2019
E41190,earnings,100,50,5/9/2019
E49AA3,product-release,100,64,5/9/2019
E49AA3,product-release,100,64,5/9/2019
E68733,partnership,100,61,5/9/2019
E68733,partnership,100,61,5/9/2019
E68733,acquisition-acquirer,100,49,5/9/2019
E6BC2C,revenue-up,100,94,5/9/2019
E71AE6,earnings,100,50,5/9/2019
E754F0,earnings,100,50,5/9/2019
E82A2D,earnings,100,50,5/9/2019
E8C557,earnings,100,50,5/9/2019
EAA0A7,earnings,100,50,5/9/2019
EAA0A7,earnings,100,50,5/9/2019
EAA0A7,earnings,100,50,5/9/2019
EAA0A7,earnings,100,50,5/9/2019
EB43F4,earnings,100,50,5/9/2019
ED0D7C,conference-participant,100,50,5/9/2019
ED4560,earnings,100,50,5/9/2019
ED9576,dividend,100,50,5/9/2019
ED9C04,earnings,100,50,5/9/2019
ED9C04,earnings,100,50,5/9/2019
ED9C04,earnings,100,50,5/9/2019
ED9C04,earnings,100,50,5/9/2019
ED9C04,earnings,100,50,5/9/2019
ED9C04,earnings,100,50,5/9/2019
EF25A5,earnings,100,50,5/9/2019
EF25A5,earnings,100,50,5/9/2019
EF25A5,earnings,100,50,5/9/2019
EF25A5,acquisition-completed-acquirer,100,49,5/9/2019
EF25A5,product-release,100,64,5/9/2019
EF5914,earnings,100,50,5/9/2019
EF5BED,executive-appointment,100,54,5/9/2019
EF5BED,earnings,100,50,5/9/2019
F00285,earnings,100,50,5/9/2019
F05B1B,earnings,100,50,5/9/2019
F05B1B,earnings,100,50,5/9/2019
F3816D,earnings,100,50,5/9/2019
F47871,earnings,100,50,5/9/2019
F6DA75,earnings,100,50,5/9/2019
F6DE54,conference-participant,100,50,5/9/2019
F6E1B5,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F6FA6A,earnings,100,50,5/9/2019
F721A7,earnings,100,50,5/9/2019
F721A7,earnings,100,50,5/9/2019
F73DD1,earnings,100,50,5/9/2019
F73DD1,earnings,100,50,5/9/2019
F73DD1,earnings,100,50,5/9/2019
F73DD1,earnings,100,50,5/9/2019
F73DD1,earnings,100,50,5/9/2019
F769E9,earnings,100,50,5/9/2019
F7935D,earnings,100,50,5/9/2019
FAE021,board-meeting,100,51,5/9/2019
FAE021,dividend,100,50,5/9/2019
FB728F,earnings,100,50,5/9/2019
FC1F9D,dividend-up,100,81,5/9/2019
FC9869,earnings,100,50,5/9/2019
FDD3FC,earnings,100,50,5/9/2019
FF227B,earnings,100,50,5/9/2019
00D6B5,earnings,100,50,5/10/2019
0157B1,partnership,100,61,5/10/2019
03FAA6,conference-participant,100,50,5/10/2019
083F72,earnings,100,50,5/10/2019
84625,earnings,100,50,5/10/2019
84625,earnings,100,50,5/10/2019
0919B1,earnings,100,50,5/10/2019
0A59F8,partnership,100,61,5/10/2019
0A59F8,partnership,100,61,5/10/2019
0A59F8,partnership,100,61,5/10/2019
0A7650,earnings,100,50,5/10/2019
0E5619,conference-participant,100,50,5/10/2019
15A388,ipo-completed,100,76,5/10/2019
196D18,earnings,100,50,5/10/2019
24A89A,earnings,100,50,5/10/2019
24A89A,earnings,100,50,5/10/2019
25D3CE,earnings,100,50,5/10/2019
35F4B5,dividend,100,50,5/10/2019
36C09B,earnings,100,50,5/10/2019
385DD4,earnings,100,50,5/10/2019
385DD4,dividend-up,100,81,5/10/2019
3A1C46,conference-participant,100,50,5/10/2019
3B9886,conference-call,100,50,5/10/2019
3BE00F,dividend,100,50,5/10/2019
4.00E+163,earnings,100,50,5/10/2019
4398A2,earnings,100,50,5/10/2019
43A74A,conference-participant,100,50,5/10/2019
458D2C,revenue-volume,100,50,5/10/2019
4A6F00,product-release,100,64,5/10/2019
4A6F00,donation,100,54,5/10/2019
52B567,conference-participant,100,50,5/10/2019
52D936,executive-appointment,100,54,5/10/2019
54512F,earnings,100,50,5/10/2019
57B174,dividend,100,50,5/10/2019
59872F,legal-issues-defendant,100,22,5/10/2019
5B6C11,dividend,100,50,5/10/2019
5E9934,public-offering,100,43,5/10/2019
615B6D,ipo-pricing,100,50,5/10/2019
619882,conference-organizer,100,57,5/10/2019
619882,conference-organizer,100,57,5/10/2019
619882,conference-organizer,100,57,5/10/2019
619882,conference-organizer,100,57,5/10/2019
619882,conference-organizer,100,57,5/10/2019
66749D,dividend,100,50,5/10/2019
693ECD,earnings,100,50,5/10/2019
693ECD,earnings,100,50,5/10/2019
694749,earnings,100,50,5/10/2019
694749,earnings,100,50,5/10/2019
694749,earnings,100,50,5/10/2019
694749,earnings,100,50,5/10/2019
6B67BD,earnings,100,50,5/10/2019
6CB7F9,conference-participant,100,50,5/10/2019
6DDA15,partnership,100,61,5/10/2019
70CA28,business-contract,100,69,5/10/2019
726DDF,earnings,100,50,5/10/2019
76959C,conference-participant,100,50,5/10/2019
76BD96,dividend-up,100,81,5/10/2019
76BD96,earnings,100,50,5/10/2019
76BD96,earnings,100,50,5/10/2019
76F067,conference-participant,100,50,5/10/2019
78F776,earnings,100,50,5/10/2019
7F7C87,earnings,100,50,5/10/2019
82B57E,dividend,100,50,5/10/2019
83B1C8,conference-participant,100,50,5/10/2019
855DF7,earnings,100,50,5/10/2019
862941,conference-participant,100,50,5/10/2019
883D82,earnings,100,50,5/10/2019
8D0EEA,earnings,100,50,5/10/2019
8D9993,conference-call,100,50,5/10/2019
8FCA78,dividend,100,50,5/10/2019
91C82E,product-release,100,64,5/10/2019
92D757,earnings,100,50,5/10/2019
92D757,earnings,100,50,5/10/2019
940C3D,dividend,100,50,5/10/2019
94983E,buybacks,100,74,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
990AD0,conference-organizer,100,57,5/10/2019
9A2760,legal-issues-defendant,100,22,5/10/2019
9A2760,legal-issues-defendant,100,22,5/10/2019
9B71A7,legal-issues-defendant,100,22,5/10/2019
9CA432,conference-participant,100,50,5/10/2019
A1EAC8,executive-appointment,100,54,5/10/2019
A5195E,conference-participant,100,50,5/10/2019
A75D43,executive-appointment,100,54,5/10/2019
A868C9,business-contract,100,69,5/10/2019
AD1ACF,executive-appointment,100,54,5/10/2019
AD1ACF,dividend,100,50,5/10/2019
AD23DE,earnings,100,50,5/10/2019
AD23DE,earnings,100,50,5/10/2019
AD23DE,earnings,100,50,5/10/2019
AD23DE,earnings,100,50,5/10/2019
AD23DE,earnings,100,50,5/10/2019
AD23DE,earnings,100,50,5/10/2019
AD23DE,dividend,100,50,5/10/2019
AD3008,facility-open,100,65,5/10/2019
B05000,earnings,100,50,5/10/2019
B381D8,legal-issues-defendant,100,22,5/10/2019
B4F5F4,earnings,100,50,5/10/2019
B6082A,dividend,100,50,5/10/2019
BB0587,dividend,100,50,5/10/2019
BCE9DA,dividend,100,50,5/10/2019
BCE9DA,dividend,100,50,5/10/2019
BDE867,earnings,100,50,5/10/2019
BDE867,earnings,100,50,5/10/2019
BDE867,earnings,100,50,5/10/2019
BE645B,earnings,100,50,5/10/2019
C0200F,dividend-up,100,58,5/10/2019
C2609A,partnership,100,61,5/10/2019
C564E4,conference-participant,100,50,5/10/2019
C584BE,earnings,100,50,5/10/2019
C93C44,earnings,100,50,5/10/2019
CBA33B,executive-appointment,100,54,5/10/2019
CBFFDD,trading-resumed,100,58,5/10/2019
CBFFDD,government-contract,100,69,5/10/2019
CD051C,conference-participant,100,50,5/10/2019
CF6A5A,dividend,100,50,5/10/2019
CFF97C,conference-participant,100,50,5/10/2019
D139BC,conference-participant,100,50,5/10/2019
D17C1B,revenue-volume,100,50,5/10/2019
D25249,dividend,100,50,5/10/2019
D27FAB,earnings,100,50,5/10/2019
D5AF19,acquisition-completed-acquirer,100,49,5/10/2019
D63B0F,conference-participant,100,50,5/10/2019
D88EF3,note-sale,100,52,5/10/2019
DB23C8,partnership,100,61,5/10/2019
DC6EF3,earnings,100,50,5/10/2019
DE4924,public-offering-suspended,100,24,5/10/2019
DF1F7A,dividend,100,50,5/10/2019
E09556,patent-awarded,100,72,5/10/2019
E2CB7B,conference-participant,100,50,5/10/2019
E30B34,conference-participant,100,50,5/10/2019
E30B34,conference-participant,100,50,5/10/2019
E68733,earnings,100,50,5/10/2019
E71AE6,legal-issues-defendant,100,22,5/10/2019
E802CE,legal-issues-defendant,100,22,5/10/2019
E8B21D,dividend-up,100,81,5/10/2019
EC4E82,conference-participant,100,50,5/10/2019
EE967B,dividend,100,50,5/10/2019
F0B335,conference-participant,100,50,5/10/2019
F18844,partnership,100,61,5/10/2019
F3016C,conference-participant,100,50,5/10/2019
F43A11,partnership,100,61,5/10/2019
F4D241,conference-participant,100,50,5/10/2019
F509E2,earnings,100,50,5/10/2019
F72E4B,earnings,100,50,5/10/2019
F72E4B,earnings,100,50,5/10/2019
F82D37,reorganization-unit,100,53,5/10/2019
F90EE5,dividend-up,100,81,5/10/2019
FC80E6,dividend,100,50,5/10/2019
FEE4B0,buybacks,100,74,5/10/2019
55438C,legal-issues-defendant,100,22,5/11/2019
DB396B,legal-issues-defendant,100,22,5/11/2019
ECD263,partnership,100,61,5/12/2019
13528,earnings,100,50,5/13/2019
036C6F,legal-issues-defendant,100,22,5/13/2019
036C6F,legal-issues-defendant,100,22,5/13/2019
03B8CF,legal-issues-defendant,100,22,5/13/2019
05D148,clinical-trials,100,56,5/13/2019
099A92,dividend,100,50,5/13/2019
09DE1F,earnings,100,50,5/13/2019
0B57D7,executive-appointment,100,54,5/13/2019
0BD199,ipo-completed,100,76,5/13/2019
0F2BC9,executive-appointment,100,54,5/13/2019
0FABBD,conference-participant,100,50,5/13/2019
1220D2,partnership,100,61,5/13/2019
1220D2,partnership,100,61,5/13/2019
1490F3,dividend,100,50,5/13/2019
1880C5,earnings,100,50,5/13/2019
1A3E1B,executive-appointment,100,54,5/13/2019
1AE482,earnings,100,50,5/13/2019
1B6F77,ipo-pricing,100,50,5/13/2019
1CF3A8,earnings,100,50,5/13/2019
25102A,conference-participant,100,50,5/13/2019
251988,legal-issues-defendant,100,22,5/13/2019
26008A,conference-call,100,50,5/13/2019
2950FF,acquisition-acquirer,100,49,5/13/2019
306623,conference-participant,100,50,5/13/2019
31AA84,acquisition-acquirer,100,49,5/13/2019
31AA84,acquisition-acquirer,100,49,5/13/2019
341759,earnings,100,50,5/13/2019
3461CF,business-contract,100,69,5/13/2019
37020C,executive-death,100,31,5/13/2019
3A3447,facility-open,100,65,5/13/2019
3B2311,conference-participant,100,50,5/13/2019
3B37F7,conference-organizer,100,57,5/13/2019
3B37F7,conference-organizer,100,57,5/13/2019
3B37F7,conference-organizer,100,57,5/13/2019
3F4668,executive-appointment,100,54,5/13/2019
3F4668,executive-appointment,100,54,5/13/2019
408089,executive-death,100,31,5/13/2019
40F7DE,conference-participant,100,50,5/13/2019
416C55,conference-participant,100,50,5/13/2019
42EFC7,earnings,100,50,5/13/2019
435ACE,legal-issues-defendant,100,22,5/13/2019
43A060,legal-issues-defendant,100,22,5/13/2019
4595EF,conference-call,100,50,5/13/2019
47BA98,ipo-completed,100,76,5/13/2019
494EB9,dividend,100,50,5/13/2019
4A2457,business-contract,100,69,5/13/2019
4CDA2B,earnings,100,50,5/13/2019
50070E,conference-organizer,100,57,5/13/2019
50070E,conference-organizer,100,57,5/13/2019
546A27,conference-participant,100,50,5/13/2019
55438C,legal-issues-defendant,100,22,5/13/2019
55438C,legal-issues-defendant,100,22,5/13/2019
587EDF,executive-appointment,100,54,5/13/2019
589803,regulatory-product-approval-granted,100,81,5/13/2019
589803,regulatory-product-approval-granted,100,81,5/13/2019
589803,regulatory-product-approval-granted,100,81,5/13/2019
589803,regulatory-product-approval-granted,100,81,5/13/2019
59872F,legal-issues-defendant,100,22,5/13/2019
59DB8C,public-offering,100,43,5/13/2019
5A0FF1,conference-participant,100,50,5/13/2019
5AA3B1,earnings,100,50,5/13/2019
5AA3B1,earnings,100,50,5/13/2019
5B35C7,earnings,100,50,5/13/2019
5B3FA2,conference-participant,100,50,5/13/2019
5BE42C,acquisition-completed-acquirer,100,49,5/13/2019
5C7601,board-meeting,100,51,5/13/2019
60DD84,conference-participant,100,50,5/13/2019
619882,conference-organizer,100,57,5/13/2019
619882,conference-organizer,100,57,5/13/2019
619882,conference-organizer,100,57,5/13/2019
619882,conference-organizer,100,57,5/13/2019
619882,conference-organizer,100,57,5/13/2019
627186,clinical-trials,100,56,5/13/2019
6-Dec-05,earnings,100,50,5/13/2019
6.00E+19,settlement,100,56,5/13/2019
6.00E+19,earnings,100,50,5/13/2019
6E705B,product-release,100,64,5/13/2019
701531,executive-appointment,100,54,5/13/2019
719477,conference-participant,100,50,5/13/2019
726EEA,conference-participant,100,50,5/13/2019
72F0FC,executive-appointment,100,54,5/13/2019
746373,executive-appointment,100,54,5/13/2019
7.49E+07,earnings,100,50,5/13/2019
752A70,conference-participant,100,50,5/13/2019
762A3E,conference-organizer,100,57,5/13/2019
7AF907,earnings,100,50,5/13/2019
7E1D5D,partnership,100,61,5/13/2019
7F7C87,earnings,100,50,5/13/2019
7FEEE1,earnings,100,50,5/13/2019
8.10E+32,executive-appointment,100,54,5/13/2019
817ED9,earnings,100,50,5/13/2019
8195B7,earnings,100,50,5/13/2019
8275FE,executive-resignation,100,44,5/13/2019
82FD6D,conference-call,100,50,5/13/2019
8377DB,business-contract,100,69,5/13/2019
8614A2,legal-issues-defendant,100,22,5/13/2019
86A1B9,business-contract,100,69,5/13/2019
8B8656,conference-participant,100,50,5/13/2019
8B9B3B,legal-issues-defendant,100,22,5/13/2019
8F8F2F,dividend,100,50,5/13/2019
913437,earnings,100,50,5/13/2019
9.39E+69,earnings,100,50,5/13/2019
94983E,partnership,100,61,5/13/2019
94C0B5,partnership,100,61,5/13/2019
9.86E+03,conference-participant,100,50,5/13/2019
990AD0,conference-organizer,100,57,5/13/2019
990AD0,conference-organizer,100,57,5/13/2019
9A2760,legal-issues-defendant,100,22,5/13/2019
9B5968,product-release,100,64,5/13/2019
9B71A7,executive-appointment,100,54,5/13/2019
9B71A7,executive-appointment,100,54,5/13/2019
9E5C2C,conference-participant,100,50,5/13/2019
A01664,earnings,100,50,5/13/2019
A017F4,earnings,100,50,5/13/2019
A350C1,conference-participant,100,50,5/13/2019
A350C1,dividend,100,50,5/13/2019
A3F598,executive-resignation,100,44,5/13/2019
A63387,executive-appointment,100,54,5/13/2019
A7F0A5,executive-appointment,100,54,5/13/2019
AA09AD,merger-completed,100,66,5/13/2019
AD1ACF,product-release,100,64,5/13/2019
AEF2C3,legal-issues-defendant,100,22,5/13/2019
B381D8,legal-issues-defendant,100,22,5/13/2019
B4C673,executive-appointment,100,54,5/13/2019
B5734D,acquisition-completed-acquirer,100,49,5/13/2019
B642E8,executive-appointment,100,54,5/13/2019
B72D2E,settlement,100,56,5/13/2019
B8A51F,conference-participant,100,50,5/13/2019
BA218A,facility-open,100,65,5/13/2019
BB88B6,product-release,100,64,5/13/2019
BCC55F,executive-appointment,100,54,5/13/2019
BD15E8,acquisition-completed-acquirer,100,49,5/13/2019
BD9668,executive-appointment,100,54,5/13/2019
BDCC11,legal-issues-defendant,100,22,5/13/2019
C45C1F,conference-participant,100,50,5/13/2019
C4A241,conference-participant,100,50,5/13/2019
CBCC6A,conference-organizer,100,57,5/13/2019
CD2A4D,conference-participant,100,50,5/13/2019
CE5C6E,conference-participant,100,50,5/13/2019
CF6A5A,earnings,100,50,5/13/2019
CF6A5A,partnership,100,61,5/13/2019
D0DFE5,facility-open,100,65,5/13/2019
D36B23,public-offering,100,43,5/13/2019
D4C0CB,ipo-completed,100,76,5/13/2019
D76AEF,conference-call,100,50,5/13/2019
D82EF3,conference-participant,100,50,5/13/2019
DC0066,earnings,100,50,5/13/2019
DF204B,conference-participant,100,50,5/13/2019
DF42A0,conference-call,100,50,5/13/2019
E15736,ipo,100,71,5/13/2019
E15736,ipo,100,71,5/13/2019
E22FDE,legal-issues-defendant,100,22,5/13/2019
E28D9C,conference-participant,100,50,5/13/2019
E49AA3,dividend,100,50,5/13/2019
E7BF32,clinical-trials-positive,100,87,5/13/2019
E7BF32,clinical-trials-positive,100,87,5/13/2019
E802CE,legal-issues-defendant,100,22,5/13/2019
F02170,earnings,100,50,5/13/2019
F3016C,executive-appointment,100,54,5/13/2019
F46EC9,conference-participant,100,50,5/13/2019
F4D241,executive-appointment,100,54,5/13/2019
F5D410,board-meeting,100,51,5/13/2019
F6DE54,dividend,100,50,5/13/2019
F83279,acquisition-regulatory-approval-acquirer,100,54,5/13/2019
F88147,earnings,100,50,5/13/2019
F8DE55,legal-issues-defendant,100,22,5/13/2019
FA044A,settlement,100,56,5/13/2019
FACF19,partnership,100,61,5/13/2019
FD4588,acquisition-acquirer,100,49,5/13/2019
FE9C0D,orphan-drug-designation,100,76,5/13/2019
0142B5,dividend,100,50,5/14/2019
0157B1,partnership,100,61,5/14/2019
034B61,executive-appointment,100,54,5/14/2019
036C6F,legal-issues-defendant,100,22,5/14/2019
036C6F,legal-issues-defendant,100,22,5/14/2019
03B8CF,dividend,100,50,5/14/2019
75172,executive-appointment,100,54,5/14/2019
0968A5,conference-call,100,50,5/14/2019
0B4D10,dividend,100,50,5/14/2019
0D03C8,earnings,100,50,5/14/2019
0FC848,executive-appointment,100,54,5/14/2019
1151F4,product-release,100,64,5/14/2019
1201B5,revenue-up,100,93,5/14/2019
1201B5,revenue-up,100,93,5/14/2019
1201B5,revenue-up,100,93,5/14/2019
1220D2,conference-participant,100,50,5/14/2019
131443,dividend,100,50,5/14/2019
1348C9,note-sale,100,52,5/14/2019
157D9F,public-offering,100,43,5/14/2019
168A5D,partnership,100,61,5/14/2019
1921DD,business-contract,100,69,5/14/2019
196D18,conference-participant,100,50,5/14/2019
1CD4B5,earnings,100,50,5/14/2019
1DE526,conference-participant,100,50,5/14/2019
1F9258,conference-participant,100,50,5/14/2019
1F9D90,conference-participant,100,50,5/14/2019
21D903,legal-issues-defendant,100,22,5/14/2019
24A89A,clinical-trials,100,56,5/14/2019
24A89A,clinical-trials,100,56,5/14/2019
24CB56,conference-organizer,100,57,5/14/2019
2ABF77,conference-participant,100,50,5/14/2019
2B5483,conference-participant,100,50,5/14/2019
2CC60C,conference-call,100,50,5/14/2019
2E902B,conference-participant,100,50,5/14/2019
31803E,conference-participant,100,50,5/14/2019
32C8CD,earnings,100,50,5/14/2019
32DCB3,patent-awarded,100,72,5/14/2019
355B19,dividend,100,50,5/14/2019
3A3447,facility-open,100,65,5/14/2019
3AAEAE,executive-appointment,100,54,5/14/2019
3B318A,conference-call,100,50,5/14/2019
3B37F7,conference-organizer,100,57,5/14/2019
3B37F7,conference-organizer,100,57,5/14/2019
3B37F7,conference-organizer,100,57,5/14/2019
3B37F7,conference-organizer,100,57,5/14/2019
3B37F7,conference-organizer,100,57,5/14/2019
3C3B6B,conference-participant,100,50,5/14/2019
3C8A04,dividend,100,50,5/14/2019
3DC887,product-release,100,64,5/14/2019
3E15F6,dividend,100,50,5/14/2019
435ACE,legal-issues-defendant,100,22,5/14/2019
43A060,partnership,100,61,5/14/2019
442769,business-contract,100,69,5/14/2019
468DD4,public-offering,100,43,5/14/2019
48F795,legal-issues-defendant,100,22,5/14/2019
4AC91D,product-release,100,64,5/14/2019
4AC91D,product-release,100,64,5/14/2019
4C5CC9,business-contract,100,69,5/14/2019
4EE167,conference-participant,100,50,5/14/2019
50070E,conference-organizer,100,57,5/14/2019
50070E,conference-organizer,100,57,5/14/2019
519FE0,earnings,100,50,5/14/2019
539F49,earnings,100,50,5/14/2019
546A9C,earnings,100,50,5/14/2019
5480A7,dividend,100,50,5/14/2019
5546DA,executive-appointment,100,54,5/14/2019
564F3E,dividend,100,50,5/14/2019
5E6959,conference-participant,100,50,5/14/2019
5F9CE3,dividend,100,50,5/14/2019
5FF95F,legal-issues-defendant,100,22,5/14/2019
5FF95F,legal-issues-defendant,100,22,5/14/2019
616E3B,dividend,100,50,5/14/2019
633043,public-offering,100,43,5/14/2019
665D7D,conference-participant,100,50,5/14/2019
665D7D,settlement,100,56,5/14/2019
665D7D,clinical-trials,100,56,5/14/2019
67B923,earnings,100,50,5/14/2019
6.00E+19,executive-appointment,100,54,5/14/2019
6F5DD2,earnings,100,50,5/14/2019
71B0CF,earnings,100,50,5/14/2019
728737,dividend,100,50,5/14/2019
73C9E2,conference-participant,100,50,5/14/2019
747219,conference-participant,100,50,5/14/2019
756045,dividend-up,100,81,5/14/2019
762A3E,conference-organizer,100,57,5/14/2019
7.83E+79,executive-appointment,100,54,5/14/2019
787D14,conference-call,100,50,5/14/2019
7B0BA6,note-sale,100,52,5/14/2019
7B0BA6,note-sale,100,52,5/14/2019
7B6C88,executive-appointment,100,54,5/14/2019
7B6EB1,conference-participant,100,50,5/14/2019
7C790D,conference-participant,100,50,5/14/2019
7DA412,award,100,58,5/14/2019
7E3F8F,business-contract,100,69,5/14/2019
7F3A5F,executive-appointment,100,54,5/14/2019
7F9984,partnership,100,61,5/14/2019
80C400,executive-appointment,100,54,5/14/2019
819492,executive-appointment,100,54,5/14/2019
85DE00,conference-participant,100,50,5/14/2019
8614A2,legal-issues-defendant,100,22,5/14/2019
890FF4,conference-participant,100,50,5/14/2019
89E771,earnings,100,50,5/14/2019
89F693,award,100,58,5/14/2019
8AB85C,earnings,100,50,5/14/2019
8E0E32,dividend,100,50,5/14/2019
8E8E6E,product-release,100,64,5/14/2019
8EDACA,conference-call,100,50,5/14/2019
9004C4,earnings-positive,100,69,5/14/2019
91E5EE,conference-participant,100,50,5/14/2019
92D230,legal-issues-defendant,100,22,5/14/2019
938D89,earnings,100,50,5/14/2019
94637C,conference-participant,100,50,5/14/2019
94756D,conference-participant,100,50,5/14/2019
9546A5,earnings,100,50,5/14/2019
95C575,dividend,100,50,5/14/2019
95DC1F,partnership,100,61,5/14/2019
968B00,dividend,100,50,5/14/2019
96F126,partnership,100,61,5/14/2019
9A2760,legal-issues-defendant,100,22,5/14/2019
9B0C9C,conference-participant,100,50,5/14/2019
9E575E,conference-participant,100,50,5/14/2019
9F03CF,product-release,100,64,5/14/2019
9F37C5,dividend,100,50,5/14/2019
9F62D1,dividend,100,50,5/14/2019
9F62D1,dividend,100,50,5/14/2019
A017F4,fast-track-designation,100,81,5/14/2019
A1E3B3,product-release,100,64,5/14/2019
A1E3B3,product-release,100,64,5/14/2019
A4BCDE,conference-participant,100,50,5/14/2019
A6828A,conference-organizer,100,57,5/14/2019
A70BF5,dividend,100,50,5/14/2019
A79F7D,earnings,100,50,5/14/2019
A868C9,conference-participant,100,50,5/14/2019
AC7AAE,conference-participant,100,50,5/14/2019
AECCA9,conference-call,100,50,5/14/2019
AFDF2E,conference-call,100,50,5/14/2019
B01215,earnings,100,50,5/14/2019
B08C51,earnings,100,50,5/14/2019
B2206F,earnings,100,50,5/14/2019
B76C82,executive-appointment,100,54,5/14/2019
BF5959,conference-call,100,50,5/14/2019
C3EE99,award,100,58,5/14/2019
C4C77F,conference-call,100,50,5/14/2019
C4F9C6,conference-participant,100,50,5/14/2019
C83B88,business-contract,100,69,5/14/2019
C941DC,executive-appointment,100,54,5/14/2019
C97B2D,legal-issues-defendant,100,22,5/14/2019
C9881C,partnership,100,61,5/14/2019
CA1620,conference-participant,100,50,5/14/2019
CDC817,conference-participant,100,50,5/14/2019
D33270,business-contract,100,69,5/14/2019
D56D6D,dividend,100,50,5/14/2019
D69D42,earnings,100,50,5/14/2019
D6EAA3,conference-call,100,50,5/14/2019
D78BF1,dividend,100,50,5/14/2019
D8442A,legal-issues-defendant,100,22,5/14/2019
D8442A,legal-issues-defendant,100,22,5/14/2019
D90F43,legal-issues-defendant,100,22,5/14/2019
D90F43,business-contract,100,69,5/14/2019
D90F43,business-contract,100,69,5/14/2019
D90F43,business-contract,100,69,5/14/2019
D90F43,partnership,100,61,5/14/2019
DA48E4,dividend,100,50,5/14/2019
DC0066,conference-participant,100,50,5/14/2019
E124EB,partnership,100,61,5/14/2019
E1E093,regulatory-product-approval-granted,100,81,5/14/2019
E20392,board-meeting,100,51,5/14/2019
E38906,conference-participant,100,50,5/14/2019
E4CE73,product-release,100,64,5/14/2019
E4CE73,product-release,100,64,5/14/2019
E5752F,conference-participant,100,50,5/14/2019
E802CE,legal-issues-defendant,100,22,5/14/2019
E8A49A,executive-appointment,100,54,5/14/2019
EBC84C,conference-participant,100,50,5/14/2019
EC99D0,executive-appointment,100,54,5/14/2019
ED79D9,earnings,100,50,5/14/2019
EF5BED,legal-issues-defendant,100,22,5/14/2019
F0027C,conference-participant,100,50,5/14/2019
F1C04C,conference-participant,100,50,5/14/2019
F4E992,conference-participant,100,50,5/14/2019
F66B58,conference-call,100,50,5/14/2019
F93C8A,dividend,100,50,5/14/2019
FC1B7B,dividend-up,100,60,5/14/2019
FD4588,conference-participant,100,50,5/14/2019
FD9526,dividend,100,50,5/14/2019
FDD3FC,conference-participant,100,50,5/14/2019
FE7A63,executive-appointment,100,54,5/14/2019
FE9C0D,partnership,100,61,5/14/2019
FEC475,dividend,100,50,5/14/2019
00326D,conference-call,100,50,5/15/2019
00E601,dividend,100,50,5/15/2019
034B61,partnership,100,61,5/15/2019
036C6F,legal-issues-defendant,100,22,5/15/2019
099C88,government-contract,100,69,5/15/2019
099C88,dividend,100,50,5/15/2019
0E64D4,earnings,100,50,5/15/2019
106394,credit-extension-recipient,100,69,5/15/2019
1151F4,dividend,100,50,5/15/2019
12DE76,earnings,100,50,5/15/2019
12DE76,earnings,100,50,5/15/2019
12DE76,earnings,100,50,5/15/2019
12DE76,earnings,100,50,5/15/2019
12DE76,earnings,100,50,5/15/2019
13D576,earnings,100,50,5/15/2019
152FA5,earnings,100,50,5/15/2019
157CC1,conference-participant,100,50,5/15/2019
159AE4,conference-call,100,50,5/15/2019
184988,conference-organizer,100,57,5/15/2019
19BF16,conference-participant,100,50,5/15/2019
1D943E,unit-acquisition-acquirer,100,49,5/15/2019
1E1125,loan-provider,100,57,5/15/2019
1E1125,conference-organizer,100,57,5/15/2019
200D8B,earnings,100,50,5/15/2019
202E5A,executive-appointment,100,54,5/15/2019
2031CE,conference-participant,100,50,5/15/2019
23207A,executive-appointment,100,54,5/15/2019
24CB56,dividend,100,50,5/15/2019
251988,partnership,100,61,5/15/2019
267718,clinical-trials-positive,100,87,5/15/2019
26DC29,conference-call,100,50,5/15/2019
26E3BA,earnings,100,50,5/15/2019
2.89E+11,dividend,100,50,5/15/2019
29A4CC,dividend,100,50,5/15/2019
2BDC1C,product-release,100,64,5/15/2019
2BDC1C,product-release,100,64,5/15/2019
2BDC1C,product-release,100,64,5/15/2019
2EB04E,partnership,100,61,5/15/2019
3471C0,product-release,100,64,5/15/2019
36529A,conference-participant,100,50,5/15/2019
367434,partnership,100,61,5/15/2019
384CD3,buybacks,100,74,5/15/2019
397A8F,earnings,100,50,5/15/2019
3AAEAE,regulatory-product-approval-granted,100,81,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3B37F7,conference-organizer,100,57,5/15/2019
3DD5E2,conference-participant,100,50,5/15/2019
3E39A5,conference-participant,100,50,5/15/2019
3EE65E,conference-participant,100,50,5/15/2019
3EE65E,conference-participant,100,50,5/15/2019
407878,public-offering,100,43,5/15/2019
414FFF,conference-call,100,50,5/15/2019
435ACE,legal-issues-defendant,100,22,5/15/2019
44ED36,merger-regulatory-approval,100,81,5/15/2019
451D61,clinical-trials,100,56,5/15/2019
46CF27,executive-appointment,100,54,5/15/2019
4A2457,business-contract,100,69,5/15/2019
4A6F00,executive-appointment,100,54,5/15/2019
4AC91D,dividend,100,50,5/15/2019
4ECD1A,earnings,100,50,5/15/2019
4ECD1A,earnings,100,50,5/15/2019
4ECD1A,earnings,100,50,5/15/2019
5.43E+08,clinical-trials-positive,100,87,5/15/2019
5.43E+08,clinical-trials-positive,100,87,5/15/2019
55C9B5,partnership,100,61,5/15/2019
56632F,dividend,100,50,5/15/2019
567F3D,conference-participant,100,50,5/15/2019
57CAAB,partnership,100,61,5/15/2019
589846,conference-call,100,50,5/15/2019
5B3FA2,conference-participant,100,50,5/15/2019
5BC2F4,dividend,100,50,5/15/2019
5BC2F4,executive-appointment,100,54,5/15/2019
5C8D61,executive-appointment,100,54,5/15/2019
5D87DF,dividend,100,50,5/15/2019
5E9934,acquisition-completed-acquirer,100,49,5/15/2019
5E9934,acquisition-completed-acquirer,100,49,5/15/2019
5FE4B6,conference-participant,100,50,5/15/2019
5FF95F,legal-issues-defendant,100,22,5/15/2019
5FF95F,legal-issues-defendant,100,22,5/15/2019
616E3B,note-sale,100,52,5/15/2019
619882,conference-organizer,100,57,5/15/2019
619882,executive-appointment,100,54,5/15/2019
619882,dividend,100,50,5/15/2019
62A48D,earnings,100,50,5/15/2019
633043,public-offering,100,43,5/15/2019
665440,executive-appointment,100,54,5/15/2019
66ECFD,executive-appointment,100,54,5/15/2019
67B052,conference-participant,100,50,5/15/2019
6F22E7,fundraising,100,64,5/15/2019
6F22E7,earnings,100,50,5/15/2019
709AED,conference-participant,100,50,5/15/2019
713810,partnership,100,61,5/15/2019
7448A3,dividend,100,50,5/15/2019
762A3E,conference-organizer,100,57,5/15/2019
763DBE,conference-participant,100,50,5/15/2019
76BD96,public-offering,100,43,5/15/2019
76BD96,public-offering,100,43,5/15/2019
76DD0C,earnings,100,50,5/15/2019
76E80F,conference-call,100,50,5/15/2019
77B8E9,conference-participant,100,50,5/15/2019
787D14,earnings,100,50,5/15/2019
787D14,executive-appointment,100,54,5/15/2019
7999F3,dividend,100,50,5/15/2019
7999F3,dividend,100,50,5/15/2019
7A10FF,dividend,100,50,5/15/2019
7A51FE,dividend,100,50,5/15/2019
7ACFD4,earnings,100,50,5/15/2019
7ACFD4,earnings,100,50,5/15/2019
7ACFD4,earnings,100,50,5/15/2019
7ACFD4,earnings,100,50,5/15/2019
7ACFD4,earnings,100,50,5/15/2019
8.10E+32,dividend,100,50,5/15/2019
810FAD,conference-participant,100,50,5/15/2019
818A2F,dividend,100,50,5/15/2019
818A2F,dividend,100,50,5/15/2019
859D62,conference-call,100,50,5/15/2019
877C0C,conference-participant,100,50,5/15/2019
893904,ownership-decrease-held,100,49,5/15/2019
8A8E41,conference-participant,100,50,5/15/2019
8B4A45,facility-open,100,65,5/15/2019
8D4486,business-contract,100,69,5/15/2019
8D4486,partnership,100,61,5/15/2019
8FF2EF,dividend,100,50,5/15/2019
903AB4,facility-open,100,65,5/15/2019
92D230,legal-issues-defendant,100,22,5/15/2019
92D230,legal-issues-defendant,100,22,5/15/2019
92D230,legal-issues-defendant,100,22,5/15/2019
934029,conference-participant,100,50,5/15/2019
949D62,conference-participant,100,50,5/15/2019
954A47,dividend,100,50,5/15/2019
957A07,conference-participant,100,50,5/15/2019
96F126,executive-appointment,100,54,5/15/2019
99ACAD,partnership,100,61,5/15/2019
9B5968,partnership,100,61,5/15/2019
9B730A,facility-open,100,65,5/15/2019
9D307D,executive-appointment,100,54,5/15/2019
A072C4,business-contract,100,69,5/15/2019
A29DBD,conference-participant,100,50,5/15/2019
A2A9BA,earnings,100,50,5/15/2019
A2A9BA,earnings,100,50,5/15/2019
A3800A,conference-participant,100,50,5/15/2019
A72FD9,conference-participant,100,50,5/15/2019
A8E72A,earnings,100,50,5/15/2019
AC7C4F,business-contract,100,69,5/15/2019
AD9F1D,award,100,58,5/15/2019
B05000,award,100,58,5/15/2019
B076A1,buybacks,100,74,5/15/2019
B076A1,dividend,100,50,5/15/2019
B09B1F,conference-participant,100,50,5/15/2019
B0FE08,conference-participant,100,50,5/15/2019
B1FC3B,fundraising,100,64,5/15/2019
B2206F,product-release,100,64,5/15/2019
B33E77,partnership,100,61,5/15/2019
B37FB4,acquisition-acquirer,100,49,5/15/2019
B48FC9,conference-participant,100,50,5/15/2019
B54A74,conference-participant,100,50,5/15/2019
B76C82,earnings,100,50,5/15/2019
B7BBFF,conference-call,100,50,5/15/2019
BA218A,dividend,100,50,5/15/2019
BB127B,partnership,100,61,5/15/2019
BCC13E,conference-participant,100,50,5/15/2019
BD682F,dividend,100,50,5/15/2019
BDCC11,legal-issues-defendant,100,22,5/15/2019
BFE02C,dividend,100,50,5/15/2019
C06EB6,earnings,100,50,5/15/2019
C06EB6,earnings,100,50,5/15/2019
C06EB6,earnings,100,50,5/15/2019
C32A39,dividend,100,50,5/15/2019
C3BAE7,conference-participant,100,50,5/15/2019
C5C137,earnings,100,50,5/15/2019
C5C137,earnings,100,50,5/15/2019
C5C137,earnings,100,50,5/15/2019
C6C702,partnership,100,61,5/15/2019
C6C702,partnership,100,61,5/15/2019
C6C702,conference-participant,100,50,5/15/2019
C97B2D,conference-participant,100,50,5/15/2019
C9881C,partnership,100,61,5/15/2019
C98CDB,conference-participant,100,50,5/15/2019
CA99D7,earnings,100,50,5/15/2019
CB7AB2,conference-participant,100,50,5/15/2019
CCBBAD,dividend,100,50,5/15/2019
CD2DA4,conference-participant,100,50,5/15/2019
CE1002,facility-open,100,65,5/15/2019
CE4FD9,unit-acquisition-acquirer,100,49,5/15/2019
CE8A7B,earnings,100,50,5/15/2019
D25249,business-contract,100,69,5/15/2019
D33D8C,dividend,100,50,5/15/2019
D5938F,clinical-trials,100,56,5/15/2019
D697DE,award,100,58,5/15/2019
D697DE,award,100,58,5/15/2019
D697DE,conference-participant,100,50,5/15/2019
D721C6,dividend,100,50,5/15/2019
D77F7E,award,100,58,5/15/2019
D8442A,legal-issues-defendant,100,22,5/15/2019
D8DBA3,dividend,100,50,5/15/2019
D90F43,legal-issues-defendant,100,22,5/15/2019
D90F43,legal-issues-defendant,100,22,5/15/2019
DB88A1,product-release,100,64,5/15/2019
DF204B,product-release,100,64,5/15/2019
E20392,conference-participant,100,50,5/15/2019
E22FDE,legal-issues-defendant,100,22,5/15/2019
E68733,business-contract,100,69,5/15/2019
E6D89E,patent-infringement-plaintiff,100,47,5/15/2019
E71AE6,conference-participant,100,50,5/15/2019
E8846E,conference-participant,100,50,5/15/2019
E8C557,conference-participant,100,50,5/15/2019
EB43F4,conference-participant,100,50,5/15/2019
EB61C4,acquisition-acquirer,100,49,5/15/2019
EE1E44,dividend,100,50,5/15/2019
EEA6B3,conference-participant,100,50,5/15/2019
EF5BED,legal-issues-defendant,100,22,5/15/2019
EFA7B2,earnings,100,50,5/15/2019
F179ED,partnership,100,61,5/15/2019
F179ED,partnership,100,61,5/15/2019
F209B4,earnings,100,50,5/15/2019
F209B4,earnings,100,50,5/15/2019
F6A392,earnings,100,50,5/15/2019
F6A987,dividend,100,50,5/15/2019
F6E1B5,conference-participant,100,50,5/15/2019
F85CC0,dividend,100,50,5/15/2019
F85CC0,dividend,100,50,5/15/2019
FA840E,executive-appointment,100,54,5/15/2019
FD4588,award,100,58,5/15/2019
FFE543,conference-participant,100,50,5/15/2019
00698D,conference-call,100,50,5/16/2019
03B8CF,partnership,100,61,5/16/2019
06A456,conference-call,100,50,5/16/2019
06EE79,earnings,100,50,5/16/2019
099C88,business-contract,100,69,5/16/2019
0A59F8,partnership,100,61,5/16/2019
0BC29E,conference-participant,100,50,5/16/2019
0CCCB7,executive-appointment,100,54,5/16/2019
105D00,executive-appointment,100,54,5/16/2019
13C3E0,note-sale,100,52,5/16/2019
143C52,conference-call,100,50,5/16/2019
1782D5,executive-appointment,100,54,5/16/2019
1A3E1B,earnings,100,50,5/16/2019
1A6A94,earnings,100,50,5/16/2019
1D3A00,acquisition-bid-rejected-acquiree,100,18,5/16/2019
1D5C51,conference-participant,100,50,5/16/2019
1DDEDA,conference-call,100,50,5/16/2019
2093B1,dividend,100,50,5/16/2019
26DC29,conference-participant,100,50,5/16/2019
275300,dividend,100,50,5/16/2019
27B191,dividend,100,50,5/16/2019
284289,dividend,100,50,5/16/2019
2B9DBB,dividend,100,50,5/16/2019
2D643C,conference-participant,100,50,5/16/2019
2DB344,dividend,100,50,5/16/2019
2F98A5,earnings,100,50,5/16/2019
2FEA66,dividend,100,50,5/16/2019
30AB63,earnings-guidance,100,50,5/16/2019
3159AA,facility-open,100,65,5/16/2019
326EDD,dividend-up,100,57,5/16/2019
33AD83,conference-call,100,50,5/16/2019
341759,legal-issues-defendant,100,22,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3B37F7,conference-organizer,100,57,5/16/2019
3CCC90,executive-appointment,100,54,5/16/2019
3F868D,conference-participant,100,50,5/16/2019
3F96D5,conference-participant,100,50,5/16/2019
3FACA7,conference-participant,100,50,5/16/2019
407878,public-offering,100,43,5/16/2019
434F38,executive-appointment,100,54,5/16/2019
450ECB,conference-participant,100,50,5/16/2019
46017C,conference-participant,100,50,5/16/2019
4A6F00,product-release,100,64,5/16/2019
4B7006,award,100,58,5/16/2019
4B7006,award,100,58,5/16/2019
4F0A80,dividend,100,50,5/16/2019
51B442,earnings,100,50,5/16/2019
54DF47,public-offering,100,43,5/16/2019
553949,dividend,100,50,5/16/2019
58EA22,regulatory-product-approval-granted,100,81,5/16/2019
58EA22,regulatory-product-approval-granted,100,81,5/16/2019
59DB8C,conference-participant,100,50,5/16/2019
5A53BF,product-release,100,64,5/16/2019
5B35C7,dividend,100,50,5/16/2019
5B3FA2,award,100,58,5/16/2019
5B6C11,partnership,100,61,5/16/2019
5D63F1,partnership,100,61,5/16/2019
5FE4B6,dividend,100,50,5/16/2019
619882,conference-organizer,100,57,5/16/2019
61A586,credit-extension-recipient,100,69,5/16/2019
67303E,clinical-trials,100,56,5/16/2019
6830FE,earnings,100,50,5/16/2019
6A6BDC,executive-appointment,100,54,5/16/2019
6B236C,product-release,100,64,5/16/2019
6E8349,dividend,100,50,5/16/2019
6EB9DA,conference-participant,100,50,5/16/2019
6F3FA8,dividend,100,50,5/16/2019
7032D0,dividend,100,50,5/16/2019
713810,same-store-sales-up,100,53,5/16/2019
7239BB,conference-call,100,50,5/16/2019
73C521,executive-appointment,100,54,5/16/2019
762A3E,conference-organizer,100,57,5/16/2019
766047,acquisition-regulatory-approval-acquirer,100,54,5/16/2019
766047,dividend,100,50,5/16/2019
76F067,conference-participant,100,50,5/16/2019
773A17,revenue-up,100,64,5/16/2019
773A17,revenue-up,100,69,5/16/2019
773A17,revenue-up,100,69,5/16/2019
7A0EC4,earnings,100,50,5/16/2019
7B8CB5,dividend,100,50,5/16/2019
7BC92D,partnership,100,61,5/16/2019
7CD98F,dividend,100,50,5/16/2019
7D5FD6,buybacks,100,74,5/16/2019
830BDB,conference-participant,100,50,5/16/2019
838ADD,conference-participant,100,50,5/16/2019
85AD00,dividend,100,50,5/16/2019
8665BA,unit-acquisition-acquirer,100,49,5/16/2019
88D80A,earnings,100,50,5/16/2019
8D4486,partnership,100,61,5/16/2019
91C82E,product-release,100,64,5/16/2019
92B625,business-contract,100,69,5/16/2019
92D230,legal-issues-defendant,100,22,5/16/2019
94756D,buybacks,100,74,5/16/2019
95A92E,executive-appointment,100,54,5/16/2019
9.74E+08,product-release,100,64,5/16/2019
97FE80,public-offering,100,43,5/16/2019
980C14,facility-sale,100,52,5/16/2019
9810C0,dividend,100,50,5/16/2019
9B5968,dividend-up,100,81,5/16/2019
9B5968,dividend-up,100,81,5/16/2019
9C5174,conference-participant,100,50,5/16/2019
9D307D,executive-appointment,100,54,5/16/2019
9D6A24,note-sale,100,52,5/16/2019
9DDE1B,dividend,100,50,5/16/2019
9F71E5,conference-participant,100,50,5/16/2019
9FB4B7,conference-participant,100,50,5/16/2019
A3AAA5,dividend,100,50,5/16/2019
A403CF,earnings,100,50,5/16/2019
A433A5,conference-participant,100,50,5/16/2019
A4BCDE,earnings,100,50,5/16/2019
A5151E,executive-appointment,100,54,5/16/2019
A631A3,earnings,100,50,5/16/2019
A94637,executive-resignation,100,44,5/16/2019
A9ED24,dividend,100,50,5/16/2019
AA98ED,dividend,100,50,5/16/2019
AC3584,partnership,100,61,5/16/2019
ACDF88,conference-participant,100,50,5/16/2019
ADD9DC,facility-open,100,65,5/16/2019
ADF092,note-sale,100,52,5/16/2019
ADF092,note-sale,100,52,5/16/2019
AFDF2E,conference-call,100,50,5/16/2019
B13B68,investment-investor,100,55,5/16/2019
B1B10C,dividend,100,50,5/16/2019
B1FC3B,business-contract,100,69,5/16/2019
B2AA0A,acquisition-acquirer,100,49,5/16/2019
B33E77,partnership,100,61,5/16/2019
B33E77,partnership,100,61,5/16/2019
B33E77,partnership,100,61,5/16/2019
B4703C,legal-issues-defendant,100,22,5/16/2019
B4703C,legal-issues-defendant,100,22,5/16/2019
B72BE9,dividend,100,50,5/16/2019
B77F14,earnings-guidance,100,50,5/16/2019
B77F14,earnings-guidance,100,50,5/16/2019
BB0787,dividend,100,50,5/16/2019
BDEC1E,conference-participant,100,50,5/16/2019
BE645B,orphan-drug-designation,100,76,5/16/2019
BFE02C,partnership,100,61,5/16/2019
C07E05,earnings,100,50,5/16/2019
C188F8,legal-issues-defendant,100,22,5/16/2019
C2DD02,conference-participant,100,50,5/16/2019
C3F99F,patient-enrollment-start,100,58,5/16/2019
C3F99F,patient-enrollment-start,100,58,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C4452A,earnings,100,50,5/16/2019
C62AA4,dividend,100,50,5/16/2019
C8A248,dividend,100,50,5/16/2019
C99CC8,award,100,58,5/16/2019
CBFFDD,business-contract,100,69,5/16/2019
CC339B,unit-acquisition-acquirer,100,49,5/16/2019
CD2DA4,conference-participant,100,50,5/16/2019
CDFCC9,unit-acquisition-acquiree,100,76,5/16/2019
CF7292,conference-call,100,50,5/16/2019
D296C6,dividend,100,50,5/16/2019
D33270,executive-appointment,100,54,5/16/2019
D3F64D,dividend,100,50,5/16/2019
D6853F,executive-appointment,100,54,5/16/2019
D854DD,conference-participant,100,50,5/16/2019
D8DA3D,dividend,100,50,5/16/2019
D8F347,dividend,100,50,5/16/2019
DAFED3,dividend,100,50,5/16/2019
DB9829,earnings,100,50,5/16/2019
DD0F15,business-contract,100,69,5/16/2019
DD0F15,business-contract,100,69,5/16/2019
DD3BB1,acquisition-completed-acquirer,100,49,5/16/2019
DDEA6A,conference-participant,100,50,5/16/2019
DF11D9,conference-participant,100,50,5/16/2019
DF204B,facility-open,100,65,5/16/2019
DFADDB,clinical-trials-start,100,64,5/16/2019
E0207A,dividend,100,50,5/16/2019
E09E2B,earnings,100,50,5/16/2019
E09E2B,earnings,100,50,5/16/2019
E09E2B,earnings,100,50,5/16/2019
E261E9,earnings,100,50,5/16/2019
E8846E,conference-participant,100,50,5/16/2019
E8A49A,executive-appointment,100,54,5/16/2019
E8E899,partnership,100,61,5/16/2019
EC99D0,partnership,100,61,5/16/2019
ED8676,merger,100,66,5/16/2019
F1529C,earnings,100,50,5/16/2019
F1529C,dividend,100,50,5/16/2019
F1EB39,executive-resignation,100,44,5/16/2019
F294DD,dividend,100,50,5/16/2019
F30508,conference-participant,100,50,5/16/2019
F46EC9,dividend,100,50,5/16/2019
F47871,clinical-trials,100,56,5/16/2019
F47871,clinical-trials,100,56,5/16/2019
F48947,legal-issues-defendant,100,22,5/16/2019
F48947,legal-issues-defendant,100,22,5/16/2019
F6FF0D,legal-issues-defendant,100,22,5/16/2019
F88147,conference-participant,100,50,5/16/2019
F92DBC,business-contract,100,69,5/16/2019
F9CAF8,earnings,100,50,5/16/2019
F9CAF8,earnings,100,50,5/16/2019
F9CAF8,earnings,100,50,5/16/2019
F9CAF8,earnings,100,50,5/16/2019
FD4588,trading-listing,100,61,5/16/2019
FD9A97,earnings,100,50,5/16/2019
FFE543,executive-appointment,100,54,5/16/2019
00326D,earnings,100,50,5/17/2019
13528,campaign-ad-release,100,59,5/17/2019
13528,partnership,100,61,5/17/2019
07CA6A,unit-acquisition-acquirer,100,49,5/17/2019
07CA6A,acquisition-acquirer,100,49,5/17/2019
08A40F,facility-sale,100,52,5/17/2019
0C136E,dividend,100,50,5/17/2019
0E5223,conference-participant,100,50,5/17/2019
0F65C9,conference-participant,100,50,5/17/2019
129DC8,conference-participant,100,50,5/17/2019
12A3A3,dividend-up,100,81,5/17/2019
1B5FEA,conference-participant,100,50,5/17/2019
1DE526,conference-participant,100,50,5/17/2019
20BEEA,dividend,100,50,5/17/2019
228D42,partnership,100,61,5/17/2019
2667B6,executive-appointment,100,54,5/17/2019
2EB04E,legal-issues-defendant,100,22,5/17/2019
30DFD3,conference-participant,100,50,5/17/2019
3B37F7,conference-organizer,100,57,5/17/2019
3B37F7,conference-organizer,100,57,5/17/2019
407878,conference-participant,100,50,5/17/2019
431B74,earnings-positive,100,69,5/17/2019
431B74,earnings-positive,100,69,5/17/2019
431B74,earnings-positive,100,69,5/17/2019
431B74,earnings-positive,100,69,5/17/2019
431B74,earnings-positive,100,69,5/17/2019
431B74,earnings-positive,100,69,5/17/2019
431B74,earnings-positive,100,69,5/17/2019
431B74,earnings,100,50,5/17/2019
431B74,earnings,100,50,5/17/2019
431B74,earnings,100,50,5/17/2019
431B74,earnings,100,50,5/17/2019
431B74,earnings,100,50,5/17/2019
43A060,legal-issues-defendant,100,22,5/17/2019
43A74A,conference-participant,100,50,5/17/2019
44ED36,acquisition-acquirer,100,49,5/17/2019
468DD4,public-offering,100,43,5/17/2019
5546DA,trading-resumed,100,58,5/17/2019
5DD486,executive-appointment,100,54,5/17/2019
5FF95F,legal-issues-defendant,100,22,5/17/2019
619882,acquisition-acquirer,100,49,5/17/2019
64E615,award,100,58,5/17/2019
651C85,clinical-trials-filed,100,60,5/17/2019
6BDA0C,dividend,100,50,5/17/2019
787D14,executive-resignation,100,44,5/17/2019
7B6C88,facility-open,100,65,5/17/2019
7B6C88,facility-open,100,65,5/17/2019
817ED9,partnership,100,61,5/17/2019
817ED9,partnership,100,61,5/17/2019
83E0AC,trading-listing,100,61,5/17/2019
84A6B9,acquisition-completed-acquirer,100,49,5/17/2019
9196A2,fundraising,100,64,5/17/2019
91C82E,product-release,100,64,5/17/2019
92D230,legal-issues-defendant,100,22,5/17/2019
97FE80,public-offering,100,43,5/17/2019
9D30A8,conference-participant,100,50,5/17/2019
9E298A,conference-participant,100,50,5/17/2019
9E5C2C,note-sale,100,52,5/17/2019
A16DEA,dividend,100,50,5/17/2019
A1BB98,dividend,100,50,5/17/2019
A4B899,dividend,100,50,5/17/2019
A6828A,conference-participant,100,50,5/17/2019
B1FC3B,conference-participant,100,50,5/17/2019
B290A2,conference-participant,100,50,5/17/2019
B4703C,legal-issues-defendant,100,22,5/17/2019
B4703C,legal-issues-defendant,100,22,5/17/2019
BFD0A7,conference-participant,100,50,5/17/2019
BFE02C,conference-participant,100,50,5/17/2019
C11C46,legal-issues-defendant,100,22,5/17/2019
C4C77F,executive-resignation,100,44,5/17/2019
C5C137,dividend,100,50,5/17/2019
CBCC6A,partnership,100,61,5/17/2019
CFE5BE,dividend,100,50,5/17/2019
D07B07,public-offering,100,43,5/17/2019
D1C26F,product-release,100,64,5/17/2019
D21D8A,award,100,58,5/17/2019
D2B9E5,dividend,100,50,5/17/2019
D697DE,conference-participant,100,50,5/17/2019
DA90E1,unit-acquisition-acquirer,100,49,5/17/2019
DAC66A,dividend,100,50,5/17/2019
DBB28E,acquisition-acquirer,100,49,5/17/2019
DBB28E,acquisition-acquirer,100,49,5/17/2019
DD7A96,dividend,100,50,5/17/2019
E00373,note-sale,100,52,5/17/2019
E1E36F,dividend,100,50,5/17/2019
E30B34,executive-appointment,100,54,5/17/2019
E30B34,award,100,58,5/17/2019
E69BA5,dividend,100,50,5/17/2019
E8846E,dividend,100,50,5/17/2019
F18844,executive-appointment,100,54,5/17/2019
F48947,legal-issues-defendant,100,22,5/17/2019
F48947,legal-issues-defendant,100,22,5/17/2019
F48947,legal-issues-defendant,100,22,5/17/2019
F6FF0D,legal-issues-defendant,100,22,5/17/2019
F6FF0D,legal-issues-defendant,100,22,5/17/2019
FC8733,executive-appointment,100,54,5/17/2019
FF4343,dividend,100,50,5/17/2019
FF4BA4,dividend,100,50,5/17/2019
EEA6B3,partnership,100,61,5/18/2019
F8DE55,legal-issues-defendant,100,22,5/18/2019
003B70,private-placement,100,56,5/20/2019
033B58,earnings,100,50,5/20/2019
036C6F,dividend,100,50,5/20/2019
03FAA6,legal-issues-defendant,100,22,5/20/2019
048B70,conference-participant,100,50,5/20/2019
0BF198,public-offering,100,43,5/20/2019
0BF198,public-offering,100,43,5/20/2019
0C2A0D,award,100,58,5/20/2019
0EF1AF,conference-participant,100,50,5/20/2019
126F95,dividend,100,50,5/20/2019
1348C9,conference-participant,100,50,5/20/2019
15901B,conference-participant,100,50,5/20/2019
15B10D,conference-participant,100,50,5/20/2019
168A5D,partnership,100,61,5/20/2019
190B91,legal-issues-defendant,100,22,5/20/2019
1921DD,product-release,100,64,5/20/2019
197612,dividend,100,50,5/20/2019
1BDB2A,conference-participant,100,50,5/20/2019
1EBF8D,stake-acquiree,100,62,5/20/2019
2158DF,conference-participant,100,50,5/20/2019
21D903,legal-issues-defendant,100,22,5/20/2019
21F9CA,earnings,100,50,5/20/2019
221AD7,executive-resignation,100,44,5/20/2019
2.45E+15,executive-appointment,100,54,5/20/2019
251988,legal-issues-defendant,100,22,5/20/2019
25DD05,conference-participant,100,50,5/20/2019
28DCA8,product-release,100,64,5/20/2019
2920D5,earnings,100,50,5/20/2019
2920D5,earnings,100,50,5/20/2019
2EBC0B,facility-open,100,65,5/20/2019
2F24A5,hirings,100,65,5/20/2019
3159AA,conference-organizer,100,57,5/20/2019
37020C,conference-participant,100,50,5/20/2019
371B0A,conference-participant,100,50,5/20/2019
385DD4,campaign-ad-release,100,59,5/20/2019
3B20AB,conference-participant,100,50,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
3B37F7,conference-organizer,100,57,5/20/2019
407878,public-offering,100,43,5/20/2019
42312F,earnings,100,50,5/20/2019
435ACE,legal-issues-defendant,100,22,5/20/2019
43A060,legal-issues-defendant,100,22,5/20/2019
44A4FC,acquisition-completed-acquirer,100,49,5/20/2019
47BA98,public-offering,100,43,5/20/2019
4E7C1F,unit-acquisition-acquirer,100,49,5/20/2019
4ECD1A,dividend,100,50,5/20/2019
51D876,executive-appointment,100,54,5/20/2019
5340D0,conference-participant,100,50,5/20/2019
53E575,conference-call,100,50,5/20/2019
55438C,legal-issues-defendant,100,22,5/20/2019
55C289,dividend,100,50,5/20/2019
55C9B5,conference-participant,100,50,5/20/2019
59872F,legal-issues-defendant,100,22,5/20/2019
59872F,legal-issues-defendant,100,22,5/20/2019
5B97B2,unit-acquisition-acquirer,100,49,5/20/2019
5EAA43,dividend,100,50,5/20/2019
619882,conference-organizer,100,57,5/20/2019
657097,unit-acquisition-acquirer,100,49,5/20/2019
6F39FC,conference-participant,100,50,5/20/2019
719477,conference-call,100,50,5/20/2019
722DE3,acquisition-acquirer,100,49,5/20/2019
7239BB,executive-appointment,100,54,5/20/2019
756BB4,earnings,100,50,5/20/2019
75F665,dividend,100,50,5/20/2019
75F982,partnership,100,61,5/20/2019
76E80F,acquisition-acquirer,100,49,5/20/2019
7823A3,conference-participant,100,50,5/20/2019
7BFF81,executive-appointment,100,54,5/20/2019
7E1D5D,partnership,100,61,5/20/2019
7FDE1C,unit-acquisition-acquiree,100,76,5/20/2019
810FAD,dividend,100,50,5/20/2019
8614A2,legal-issues-defendant,100,22,5/20/2019
8665BA,investment-investor,100,55,5/20/2019
8B9B3B,legal-issues-defendant,100,22,5/20/2019
911CA9,clinical-trials,100,56,5/20/2019
9196A2,conference-organizer,100,57,5/20/2019
9196A2,partnership,100,61,5/20/2019
9.62E+76,partnership,100,61,5/20/2019
9D307D,partnership,100,61,5/20/2019
9EF4CF,earnings,100,50,5/20/2019
9EF4CF,executive-appointment,100,54,5/20/2019
A21649,dividend,100,50,5/20/2019
A5151E,conference-participant,100,50,5/20/2019
A6828A,partnership,100,61,5/20/2019
A6828A,executive-appointment,100,54,5/20/2019
A6828A,executive-appointment,100,54,5/20/2019
A94637,dividend,100,50,5/20/2019
AEFC90,index-listing,100,76,5/20/2019
AFDF2E,earnings,100,50,5/20/2019
AFDF2E,earnings,100,50,5/20/2019
AFF7B4,conference-participant,100,50,5/20/2019
B4703C,legal-issues-defendant,100,22,5/20/2019
B7EB38,conference-participant,100,50,5/20/2019
B98EFA,conference-participant,100,50,5/20/2019
BAD655,conference-participant,100,50,5/20/2019
BC5680,partnership,100,61,5/20/2019
BCC55F,award,100,58,5/20/2019
BDCC11,legal-issues-defendant,100,22,5/20/2019
BE86A1,executive-appointment,100,54,5/20/2019
C037A8,conference-participant,100,50,5/20/2019
C03C8B,conference-participant,100,50,5/20/2019
C22BE8,earnings,100,50,5/20/2019
C5D2AE,conference-participant,100,50,5/20/2019
C65004,conference-participant,100,50,5/20/2019
C81E00,regulatory-product-approval-granted,100,81,5/20/2019
C8257F,dividend,100,50,5/20/2019
C85A72,public-offering,100,43,5/20/2019
C97B2D,legal-issues-defendant,100,22,5/20/2019
CB22CD,conference-participant,100,50,5/20/2019
D56D6D,earnings,100,50,5/20/2019
D76AEF,earnings,100,50,5/20/2019
D78CCD,index-listing,100,76,5/20/2019
D8442A,legal-issues-defendant,100,22,5/20/2019
DB23C8,award,100,58,5/20/2019
DB396B,legal-issues-defendant,100,22,5/20/2019
E22FDE,legal-issues-defendant,100,22,5/20/2019
E72599,earnings,100,50,5/20/2019
E74B55,product-release,100,64,5/20/2019
E802CE,legal-issues-defendant,100,22,5/20/2019
E8B315,campaign-ad-release,100,59,5/20/2019
EB1E1A,clinical-trials-start,100,64,5/20/2019
EB7FBF,conference-call,100,50,5/20/2019
ECF709,executive-appointment,100,54,5/20/2019
EEA6B3,award,100,58,5/20/2019
EEEA9F,conference-participant,100,50,5/20/2019
F3EDB4,product-release,100,64,5/20/2019
F48947,legal-issues-defendant,100,22,5/20/2019
F51DB0,legal-issues-defendant,100,22,5/20/2019
F769E9,conference-participant,100,50,5/20/2019
F8DE55,legal-issues-defendant,100,22,5/20/2019
F8DE55,legal-issues-defendant,100,22,5/20/2019
F9CAF8,dividend,100,50,5/20/2019
FC9A88,executive-appointment,100,54,5/20/2019
FD39EB,acquisition-acquirer,100,49,5/20/2019
FE89E0,conference-call,100,50,5/20/2019
FEC475,executive-appointment,100,54,5/20/2019
9397,acquisition-acquirer,100,49,5/21/2019
0157B1,partnership,100,61,5/21/2019
0157B1,partnership,100,61,5/21/2019
0157B1,partnership,100,61,5/21/2019
0157B1,product-release,100,64,5/21/2019
31025,partnership,100,61,5/21/2019
054E7E,conference-participant,100,50,5/21/2019
06A456,executive-appointment,100,54,5/21/2019
07CA6A,acquisition-completed-acquirer,100,49,5/21/2019
07CA6A,acquisition-completed-acquirer,100,49,5/21/2019
07EC43,award,100,58,5/21/2019
083F72,conference-participant,100,50,5/21/2019
08A40F,executive-appointment,100,54,5/21/2019
0986B5,dividend,100,50,5/21/2019
0A59F8,executive-appointment,100,54,5/21/2019
0A7650,dividend,100,50,5/21/2019
0BD4E8,business-contract,100,69,5/21/2019
0CE7F6,dividend,100,50,5/21/2019
0F0440,earnings,100,50,5/21/2019
0F0440,earnings,100,50,5/21/2019
0FC848,executive-appointment,100,54,5/21/2019
147098,dividend,100,50,5/21/2019
152AB9,conference-participant,100,50,5/21/2019
15789A,conference-participant,100,50,5/21/2019
197612,executive-appointment,100,54,5/21/2019
1D3A00,conference-call,100,50,5/21/2019
1E7785,note-sale,100,52,5/21/2019
238302,conference-participant,100,50,5/21/2019
24A89A,regulatory-product-approval-granted,100,81,5/21/2019
24A89A,regulatory-product-approval-granted,100,81,5/21/2019
24CB56,conference-organizer,100,57,5/21/2019
26CC63,business-contract,100,69,5/21/2019
279916,earnings,100,50,5/21/2019
2CBB58,operating-earnings-up,100,63,5/21/2019
2CBB58,operating-earnings-up,100,63,5/21/2019
2CBB58,operating-earnings-up,100,63,5/21/2019
2CBB58,operating-earnings-up,100,63,5/21/2019
31DB20,dividend,100,50,5/21/2019
339F20,dividend-up,100,81,5/21/2019
3A3447,facility-open,100,65,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B37F7,conference-organizer,100,57,5/21/2019
3B50FE,conference-call,100,50,5/21/2019
3EE65E,acquisition-acquirer,100,49,5/21/2019
3EE65E,earnings,100,50,5/21/2019
414FFF,executive-appointment,100,54,5/21/2019
417BF9,earnings,100,50,5/21/2019
422CE3,earnings,100,50,5/21/2019
422CE3,earnings,100,50,5/21/2019
422CE3,earnings,100,50,5/21/2019
422CE3,earnings,100,50,5/21/2019
42EFC7,clinical-trials-start,100,64,5/21/2019
442769,business-contract,100,69,5/21/2019
4649D5,acquisition-interest-acquiree,100,82,5/21/2019
49F4D0,dividend,100,50,5/21/2019
4A3438,conference-participant,100,50,5/21/2019
4A6F00,partnership,100,61,5/21/2019
4A6F00,partnership,100,61,5/21/2019
4A6F00,market-entry,100,57,5/21/2019
4EEB00,conference-participant,100,50,5/21/2019
51F541,note-sale,100,52,5/21/2019
5340D0,earnings,100,50,5/21/2019
53A226,earnings,100,50,5/21/2019
53A226,partnership,100,61,5/21/2019
553949,executive-appointment,100,54,5/21/2019
55438C,legal-issues-defendant,100,22,5/21/2019
55438C,legal-issues-defendant,100,22,5/21/2019
59872F,legal-issues-defendant,100,22,5/21/2019
5B226B,dividend,100,50,5/21/2019
619882,dividend,100,50,5/21/2019
65D0AA,conference-participant,100,50,5/21/2019
665D7D,product-release,100,64,5/21/2019
66E04A,partnership,100,61,5/21/2019
6830FE,partnership,100,61,5/21/2019
68E3E0,dividend,100,50,5/21/2019
69C99E,clinical-trials,100,56,5/21/2019
69FDFC,partnership,100,61,5/21/2019
6B236C,merger-completed,100,66,5/21/2019
6D4636,partnership,100,61,5/21/2019
6.00E+19,business-contract,100,69,5/21/2019
719477,dividend-up,100,60,5/21/2019
731675,note-sale,100,52,5/21/2019
73F70F,conference-participant,100,50,5/21/2019
756045,executive-appointment,100,54,5/21/2019
7B8CB5,investment-investor,100,55,5/21/2019
85DE00,conference-participant,100,50,5/21/2019
8EDACA,earnings-guidance,100,50,5/21/2019
8EF425,dividend,100,50,5/21/2019
905356,earnings-per-share-positive,100,69,5/21/2019
905356,earnings,100,50,5/21/2019
905356,earnings,100,50,5/21/2019
9196A2,conference-organizer,100,57,5/21/2019
9196A2,conference-organizer,100,57,5/21/2019
91E5EE,dividend,100,50,5/21/2019
934029,executive-appointment,100,54,5/21/2019
93965C,conference-participant,100,50,5/21/2019
949625,conference-participant,100,50,5/21/2019
954004,conference-call,100,50,5/21/2019
97FE80,public-offering,100,43,5/21/2019
97FE80,conference-participant,100,50,5/21/2019
990AD0,conference-organizer,100,57,5/21/2019
990AD0,conference-organizer,100,57,5/21/2019
997348,acquisition-acquirer,100,49,5/21/2019
997348,dividend,100,50,5/21/2019
9BB35A,public-offering,100,43,5/21/2019
A1E3B3,product-release,100,64,5/21/2019
A1E3B3,product-release,100,64,5/21/2019
A47F2E,conference-participant,100,50,5/21/2019
A495F7,conference-organizer,100,57,5/21/2019
A631A3,conference-participant,100,50,5/21/2019
A6828A,business-contract,100,69,5/21/2019
A6828A,business-contract,100,69,5/21/2019
A868C9,conference-call,100,50,5/21/2019
A8CBDA,conference-participant,100,50,5/21/2019
A94A7B,partnership,100,61,5/21/2019
AA247D,legal-issues-defendant,100,22,5/21/2019
AADE0B,stake-acquirer,100,48,5/21/2019
AADE0B,unit-acquisition-acquirer,100,49,5/21/2019
AC7C4F,earnings-per-share-guidance,100,50,5/21/2019
ACDF88,earnings,100,50,5/21/2019
ACDF88,earnings,100,50,5/21/2019
ACDF88,earnings,100,50,5/21/2019
AD9F1D,facility-open,100,65,5/21/2019
B2256A,note-sale,100,52,5/21/2019
B604DF,earnings-guidance,100,50,5/21/2019
B9BDE8,credit-extension-recipient,100,69,5/21/2019
BB127B,revenue-down,100,30,5/21/2019
BB127B,revenue-down,100,30,5/21/2019
BB127B,revenue-down,100,30,5/21/2019
BDD12C,award,100,58,5/21/2019
BE7BA4,conference-participant,100,50,5/21/2019
BFE02C,conference-participant,100,50,5/21/2019
BFE02C,conference-participant,100,50,5/21/2019
C22BE8,dividend,100,50,5/21/2019
C356AC,dividend,100,50,5/21/2019
C3DE7D,earnings,100,50,5/21/2019
C45CE7,dividend-up,100,81,5/21/2019
C4A432,dividend,100,50,5/21/2019
C4F567,conference-organizer,100,57,5/21/2019
C5F463,partnership,100,61,5/21/2019
C659EB,conference-participant,100,50,5/21/2019
C8A248,conference-participant,100,50,5/21/2019
CB88B3,conference-participant,100,50,5/21/2019
D07B07,public-offering,100,43,5/21/2019
D1AE3B,dividend,100,50,5/21/2019
D64EDF,dividend,100,50,5/21/2019
D69D42,product-release,100,64,5/21/2019
D75910,earnings,100,50,5/21/2019
D75910,earnings,100,50,5/21/2019
D75910,earnings,100,50,5/21/2019
D75910,earnings,100,50,5/21/2019
D75910,earnings,100,50,5/21/2019
DAFED3,award,100,58,5/21/2019
DB9829,dividend,100,50,5/21/2019
DD7A96,executive-appointment,100,54,5/21/2019
DE20DF,facility-open,100,65,5/21/2019
DF46C5,acquisition-interest-acquirer,100,46,5/21/2019
DF6FDD,dividend,100,50,5/21/2019
E124EB,demand-increase,100,83,5/21/2019
E20BFE,product-release,100,64,5/21/2019
E20BFE,revenues,100,50,5/21/2019
E20BFE,revenues,100,50,5/21/2019
E22FDE,business-contract,100,69,5/21/2019
E22FDE,conference-participant,100,50,5/21/2019
E259C7,conference-participant,100,50,5/21/2019
E26FC3,executive-appointment,100,54,5/21/2019
E30B34,award,100,58,5/21/2019
E30B34,executive-appointment,100,54,5/21/2019
E30B34,executive-appointment,100,54,5/21/2019
E4158B,dividend,100,50,5/21/2019
E49AA3,legal-verdict-favored,100,78,5/21/2019
E8846E,executive-appointment,100,54,5/21/2019
EB2F14,dividend,100,50,5/21/2019
EBD89A,conference-participant,100,50,5/21/2019
ECA300,conference-call,100,50,5/21/2019
ECF709,same-store-sales-up,100,54,5/21/2019
ECF709,same-store-sales-up,100,62,5/21/2019
ECF709,same-store-sales-up,100,62,5/21/2019
F48947,legal-issues-defendant,100,22,5/21/2019
F4F46F,conference-participant,100,50,5/21/2019
F4F46F,partnership,100,61,5/21/2019
F57F6F,partnership,100,61,5/21/2019
F6DCE4,conference-call,100,50,5/21/2019
F6E248,conference-participant,100,50,5/21/2019
F6FF0D,legal-issues-defendant,100,22,5/21/2019
FB728F,earnings,100,50,5/21/2019
FC1F9D,conference-participant,100,50,5/21/2019
00698D,conference-participant,100,50,5/22/2019
9397,earnings-guidance-up,100,83,5/22/2019
00FC70,dividend,100,50,5/22/2019
01478A,dividend,100,50,5/22/2019
036C6F,legal-issues-defendant,100,22,5/22/2019
036C6F,legal-issues-defendant,100,22,5/22/2019
51332,hirings,100,65,5/22/2019
070B45,conference-participant,100,50,5/22/2019
07EC43,conference-participant,100,50,5/22/2019
98977,clinical-trials,100,56,5/22/2019
0BF198,public-offering,100,43,5/22/2019
0BF198,public-offering,100,43,5/22/2019
0C6861,product-release,100,64,5/22/2019
0FABBD,executive-appointment,100,54,5/22/2019
0FDE97,product-release,100,64,5/22/2019
10673F,dividend-up,100,81,5/22/2019
1096C6,conference-participant,100,50,5/22/2019
1272B3,partnership,100,61,5/22/2019
12DE76,executive-appointment,100,54,5/22/2019
14391F,public-offering,100,43,5/22/2019
1C599A,executive-appointment,100,54,5/22/2019
1D943E,legal-issues-defendant,100,22,5/22/2019
1E7785,conference-participant,100,50,5/22/2019
1E83DE,earnings,100,50,5/22/2019
1F464F,conference-participant,100,50,5/22/2019
200D8B,earnings,100,50,5/22/2019
2031CE,dividend-up,100,54,5/22/2019
228D42,partnership,100,61,5/22/2019
228D42,partnership,100,61,5/22/2019
251988,business-contract,100,69,5/22/2019
251988,donation,100,54,5/22/2019
275300,conference-participant,100,50,5/22/2019
292A70,dividend,100,50,5/22/2019
2B0AF4,dividend,100,50,5/22/2019
2BBE62,legal-issues-defendant,100,22,5/22/2019
2BF36E,dividend,100,50,5/22/2019
2CA60F,acquisition-completed-acquirer,100,49,5/22/2019
2E902B,dividend-up,100,70,5/22/2019
2F5256,dividend,100,50,5/22/2019
30CBF9,product-release,100,64,5/22/2019
33E9D5,public-offering,100,43,5/22/2019
3461CF,conference-participant,100,50,5/22/2019
37020C,executive-appointment,100,54,5/22/2019
39FB23,facility-open,100,65,5/22/2019
3B37F7,conference-organizer,100,57,5/22/2019
3C6CCC,conference-participant,100,50,5/22/2019
41785E,dividend,100,50,5/22/2019
420168,executive-appointment,100,54,5/22/2019
42978B,conference-call,100,50,5/22/2019
43E8F5,conference-participant,100,50,5/22/2019
49BBBC,earnings,100,50,5/22/2019
4AC91D,award,100,58,5/22/2019
4B3676,note-sale,100,52,5/22/2019
4E5784,conference-participant,100,50,5/22/2019
519FE0,executive-appointment,100,54,5/22/2019
5487B1,executive-appointment,100,54,5/22/2019
5487B1,dividend,100,50,5/22/2019
54B889,conference-call,100,50,5/22/2019
55C9B5,partnership,100,61,5/22/2019
56B7C1,note-sale,100,52,5/22/2019
5876DC,buybacks,100,74,5/22/2019
59872F,legal-issues-defendant,100,22,5/22/2019
5B3FA2,conference-participant,100,50,5/22/2019
61A586,conference-participant,100,50,5/22/2019
6284B5,dividend,100,50,5/22/2019
69345C,conference-participant,100,50,5/22/2019
6D4636,partnership,100,61,5/22/2019
6.00E+19,executive-appointment,100,54,5/22/2019
6FCEF9,earnings,100,50,5/22/2019
70CA28,conference-participant,100,50,5/22/2019
719B43,settlement,100,56,5/22/2019
726EEA,dividend,100,50,5/22/2019
728737,conference-participant,100,50,5/22/2019
747219,conference-participant,100,50,5/22/2019
76E80F,revenues,100,50,5/22/2019
76E80F,revenues,100,50,5/22/2019
76E80F,revenues,100,50,5/22/2019
7823A3,product-release,100,64,5/22/2019
78A1BB,dividend,100,50,5/22/2019
7A10FF,executive-appointment,100,54,5/22/2019
7E1D5D,earnings,100,50,5/22/2019
7E1D5D,earnings,100,50,5/22/2019
7E1D5D,earnings,100,50,5/22/2019
7E1D5D,earnings,100,50,5/22/2019
7E1D5D,earnings,100,50,5/22/2019
817ED9,dividend,100,50,5/22/2019
82F088,conference-participant,100,50,5/22/2019
895D56,conference-participant,100,50,5/22/2019
8AC65D,product-release,100,64,5/22/2019
8B4A45,earnings,100,50,5/22/2019
8C6C1B,dividend,100,50,5/22/2019
8EEA28,earnings,100,50,5/22/2019
9043FE,conference-participant,100,50,5/22/2019
9043FE,conference-participant,100,50,5/22/2019
9196A2,conference-organizer,100,57,5/22/2019
92D230,legal-issues-defendant,100,22,5/22/2019
934CC3,earnings,100,50,5/22/2019
94563D,partnership,100,61,5/22/2019
98A286,earnings,100,50,5/22/2019
990AD0,conference-organizer,100,57,5/22/2019
9A2760,conference-participant,100,50,5/22/2019
9A2760,legal-issues-defendant,100,22,5/22/2019
9B5968,executive-appointment,100,54,5/22/2019
9BB35A,public-offering,100,43,5/22/2019
A15C71,buybacks,100,74,5/22/2019
A1EAC8,conference-participant,100,50,5/22/2019
A398B9,conference-participant,100,50,5/22/2019
A72FD9,product-release,100,64,5/22/2019
A7F0A5,executive-appointment,100,54,5/22/2019
AD22F2,conference-call,100,50,5/22/2019
AD22F2,conference-call,100,50,5/22/2019
AD22F2,earnings,100,50,5/22/2019
AD22F2,earnings,100,50,5/22/2019
AD22F2,earnings,100,50,5/22/2019
AE79CD,executive-appointment,100,54,5/22/2019
AFF7B4,executive-resignation,100,44,5/22/2019
B2256A,note-sale,100,52,5/22/2019
B2D799,legal-issues-defendant,100,22,5/22/2019
B446B8,award,100,58,5/22/2019
B48FC9,conference-participant,100,50,5/22/2019
B4C673,conference-participant,100,50,5/22/2019
B614F8,revenue-volume,100,50,5/22/2019
B77F14,executive-appointment,100,54,5/22/2019
B7BBFF,earnings,100,50,5/22/2019
BC3AD2,dividend,100,50,5/22/2019
BDD12C,earnings-guidance-meet-expectations,100,59,5/22/2019
C9D866,conference-participant,100,50,5/22/2019
C9E04B,executive-appointment,100,54,5/22/2019
CB7AB2,award,100,58,5/22/2019
CBFFDD,award,100,58,5/22/2019
CFF15D,legal-issues-defendant,100,22,5/22/2019
CFF97C,facility-open,100,65,5/22/2019
D2C0B6,earnings,100,50,5/22/2019
D48275,conference-call,100,50,5/22/2019
D63B0F,unit-acquisition-acquirer,100,49,5/22/2019
D78CCD,earnings,100,50,5/22/2019
D81463,dividend,100,50,5/22/2019
D81463,dividend,100,50,5/22/2019
D90F43,partnership,100,61,5/22/2019
DF42A0,dividend-up,100,81,5/22/2019
DF42A0,earnings,100,50,5/22/2019
DF42A0,earnings,100,50,5/22/2019
DF42A0,earnings,100,50,5/22/2019
DF42A0,earnings,100,50,5/22/2019
E114F4,earnings,100,50,5/22/2019
E15736,public-offering,100,43,5/22/2019
E15736,public-offering,100,43,5/22/2019
E1C16B,award,100,58,5/22/2019
E35610,conference-participant,100,50,5/22/2019
E68C3D,earnings,100,50,5/22/2019
E6A53A,dividend,100,50,5/22/2019
E802CE,legal-issues-defendant,100,22,5/22/2019
E829E8,board-meeting,100,51,5/22/2019
ECDEB2,dividend,100,50,5/22/2019
ED79D9,dividend,100,50,5/22/2019
EF5BED,conference-participant,100,50,5/22/2019
F1529C,conference-participant,100,50,5/22/2019
F1CD47,dividend,100,50,5/22/2019
F39E1E,earnings,100,50,5/22/2019
F4E882,partnership,100,61,5/22/2019
F6DCE4,earnings,100,50,5/22/2019
F6DCE4,earnings,100,50,5/22/2019
F6DCE4,earnings,100,50,5/22/2019
F83279,unit-acquisition-completed-acquirer,100,49,5/22/2019
FD4588,acquisition-completed-acquirer,100,49,5/22/2019
00067A,conference-participant,100,50,5/23/2019
001F1B,legal-issues-defendant,100,22,5/23/2019
00FC70,earnings,100,50,5/23/2019
31025,award,100,58,5/23/2019
036C6F,legal-issues-defendant,100,22,5/23/2019
036C6F,legal-issues-defendant,100,22,5/23/2019
036C6F,legal-issues-defendant,100,22,5/23/2019
0624BE,dividend,100,50,5/23/2019
06EE79,executive-appointment,100,54,5/23/2019
95294,earnings-positive,100,69,5/23/2019
95294,executive-appointment,100,54,5/23/2019
0BC17A,conference-participant,100,50,5/23/2019
106394,acquisition-completed-acquirer,100,49,5/23/2019
126F95,executive-appointment,100,54,5/23/2019
16B183,dividend,100,50,5/23/2019
1B9535,conference-participant,100,50,5/23/2019
1C2593,earnings,100,50,5/23/2019
1DDEDA,earnings,100,50,5/23/2019
1FCC00,conference-call,100,50,5/23/2019
2158DF,product-release,100,64,5/23/2019
228D42,partnership,100,61,5/23/2019
228D42,partnership,100,61,5/23/2019
24CB56,conference-organizer,100,57,5/23/2019
24CB56,conference-organizer,100,57,5/23/2019
2AE625,conference-participant,100,50,5/23/2019
2B0AF4,executive-appointment,100,54,5/23/2019
2B49F4,conference-call,100,50,5/23/2019
2BD89C,business-contract,100,69,5/23/2019
2BF36E,conference-participant,100,50,5/23/2019
2CB4C9,dividend,100,50,5/23/2019
2DC88B,partnership,100,61,5/23/2019
2E61CC,partnership,100,61,5/23/2019
2EB04E,legal-issues-defendant,100,22,5/23/2019
2EB88B,acquisition-completed-acquirer,100,49,5/23/2019
2F9304,earnings,100,50,5/23/2019
3.50E+27,dividend,100,50,5/23/2019
3A3447,facility-open,100,65,5/23/2019
3CBA2A,conference-participant,100,50,5/23/2019
4017AD,dividend,100,50,5/23/2019
41785E,executive-appointment,100,54,5/23/2019
422CE3,dividend,100,50,5/23/2019
427F32,conference-participant,100,50,5/23/2019
429BFB,conference-participant,100,50,5/23/2019
42AABD,conference-participant,100,50,5/23/2019
43A060,executive-appointment,100,54,5/23/2019
4AC91D,earnings,100,50,5/23/2019
4AC91D,earnings,100,50,5/23/2019
4BDCA7,executive-appointment,100,54,5/23/2019
4C350A,conference-call,100,50,5/23/2019
4C6C63,partnership,100,61,5/23/2019
4FB770,dividend,100,50,5/23/2019
514067,conference-participant,100,50,5/23/2019
53E575,conference-call,100,50,5/23/2019
55438C,legal-issues-defendant,100,22,5/23/2019
586BD7,conference-participant,100,50,5/23/2019
59872F,legal-issues-defendant,100,22,5/23/2019
5B97B2,conference-participant,100,50,5/23/2019
5C7601,partnership,100,61,5/23/2019
5DE5A5,conference-participant,100,50,5/23/2019
5E7E82,earnings-above-expectations,100,88,5/23/2019
5EF130,conference-call,100,50,5/23/2019
5FE4B6,conference-participant,100,50,5/23/2019
5FF95F,legal-issues-defendant,100,22,5/23/2019
649CBD,partnership,100,61,5/23/2019
64E346,earnings,100,50,5/23/2019
665D7D,business-contract,100,69,5/23/2019
66A667,award,100,58,5/23/2019
66A667,award,100,58,5/23/2019
67A658,stake-acquiree,100,62,5/23/2019
6CC55E,conference-participant,100,50,5/23/2019
6E8349,product-release,100,64,5/23/2019
713810,partnership,100,61,5/23/2019
762A3E,conference-organizer,100,57,5/23/2019
766047,acquisition-completed-acquirer,100,49,5/23/2019
773A17,conference-participant,100,50,5/23/2019
7740DE,earnings-down,100,28,5/23/2019
78F9ED,dividend,100,50,5/23/2019
7A0EC4,conference-participant,100,50,5/23/2019
7A0EC4,conference-participant,100,50,5/23/2019
7A5097,award,100,58,5/23/2019
7B0BA6,conference-participant,100,50,5/23/2019
7CBC40,conference-participant,100,50,5/23/2019
7F3669,conference-participant,100,50,5/23/2019
7F3A5F,product-release,100,64,5/23/2019
8.10E+32,partnership,100,61,5/23/2019
8275FE,executive-appointment,100,54,5/23/2019
82FD6D,earnings,100,50,5/23/2019
82FD6D,buybacks,100,74,5/23/2019
8303CD,conference-participant,100,50,5/23/2019
859D62,dividend,100,50,5/23/2019
863350,earnings,100,50,5/23/2019
8665BA,dividend,100,50,5/23/2019
8BAA15,product-release,100,64,5/23/2019
8BE916,earnings,100,50,5/23/2019
8C6C1B,earnings,100,50,5/23/2019
8C6C1B,earnings,100,50,5/23/2019
90D6A5,dividend,100,50,5/23/2019
92005C,conference-participant,100,50,5/23/2019
92D230,legal-issues-defendant,100,22,5/23/2019
92D230,legal-issues-defendant,100,22,5/23/2019
9.54E+32,dividend,100,50,5/23/2019
967D92,dividend,100,50,5/23/2019
971334,dividend,100,50,5/23/2019
990AD0,conference-organizer,100,57,5/23/2019
9.97E+09,dividend,100,50,5/23/2019
9BF177,earnings,100,50,5/23/2019
9C25FF,partnership,100,61,5/23/2019
9C5BA5,dividend,100,50,5/23/2019
9D2790,dividend,100,50,5/23/2019
9D5FA4,conference-participant,100,50,5/23/2019
9F71E5,conference-participant,100,50,5/23/2019
A01664,product-release,100,64,5/23/2019
A350C1,business-contract,100,69,5/23/2019
A403CF,earnings,100,50,5/23/2019
A403CF,dividend,100,50,5/23/2019
A4386C,credit-extension-recipient,100,69,5/23/2019
A48593,buybacks,100,74,5/23/2019
A60354,dividend-up,100,81,5/23/2019
A631A3,conference-participant,100,50,5/23/2019
A761FE,conference-call,100,50,5/23/2019
AA98ED,conference-participant,100,50,5/23/2019
AC7C4F,business-contract,100,69,5/23/2019
ACDF88,dividend,100,50,5/23/2019
AD6141,dividend-up,100,81,5/23/2019
ADD9DC,facility-open,100,65,5/23/2019
AEBB80,conference-participant,100,50,5/23/2019
AFF43F,executive-appointment,100,54,5/23/2019
AFF7B4,buybacks,100,74,5/23/2019
B4B281,earnings,100,50,5/23/2019
B4B281,earnings,100,50,5/23/2019
B934BF,dividend-up,100,81,5/23/2019
B934BF,executive-appointment,100,54,5/23/2019
BB0787,conference-participant,100,50,5/23/2019
BDCC11,legal-issues-defendant,100,22,5/23/2019
BDEF34,dividend,100,50,5/23/2019
C0BA36,conference-participant,100,50,5/23/2019
C188F8,executive-appointment,100,54,5/23/2019
C188F8,legal-issues-defendant,100,22,5/23/2019
C4A432,earnings,100,50,5/23/2019
C4A432,earnings,100,50,5/23/2019
C4A432,earnings,100,50,5/23/2019
C5E100,award,100,58,5/23/2019
C659EB,acquisition-acquirer,100,49,5/23/2019
C8257F,executive-appointment,100,54,5/23/2019
C83B88,executive-appointment,100,54,5/23/2019
C85A72,conference-participant,100,50,5/23/2019
C8A248,reverse-stock-splits,100,51,5/23/2019
C93C44,rights-issue,100,43,5/23/2019
C9E107,conference-participant,100,50,5/23/2019
CA99D7,dividend-up,100,81,5/23/2019
CA99D7,executive-appointment,100,54,5/23/2019
CBFFDD,trading-halt,100,43,5/23/2019
CBFFDD,trading-resumed,100,58,5/23/2019
CF073E,ipo-pricing,100,50,5/23/2019
CFD4B6,conference-participant,100,50,5/23/2019
CFF97C,conference-participant,100,50,5/23/2019
CFF97C,product-release,100,64,5/23/2019
D03C7A,dividend,100,50,5/23/2019
D0909F,conference-participant,100,50,5/23/2019
D17C1B,executive-appointment,100,54,5/23/2019
D2C0B6,conference-participant,100,50,5/23/2019
D5AF19,dividend,100,50,5/23/2019
D76AEF,dividend,100,50,5/23/2019
D78CCD,spin-off,100,58,5/23/2019
D90F43,partnership,100,61,5/23/2019
D90F43,partnership,100,61,5/23/2019
D90F43,conference-call,100,50,5/23/2019
DB5CA5,executive-appointment,100,54,5/23/2019
DB9829,earnings,100,50,5/23/2019
DB9829,earnings,100,50,5/23/2019
DB9829,earnings,100,50,5/23/2019
DB9829,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBB28E,earnings,100,50,5/23/2019
DBEF02,executive-appointment,100,54,5/23/2019
DC437D,earnings,100,50,5/23/2019
DC437D,dividend,100,50,5/23/2019
DF204B,dividend,100,50,5/23/2019
E124EB,conference-participant,100,50,5/23/2019
E16133,conference-participant,100,50,5/23/2019
E21871,conference-participant,100,50,5/23/2019
E30B34,dividend,100,50,5/23/2019
E30B34,dividend,100,50,5/23/2019
E3E68E,award,100,58,5/23/2019
E5D914,product-release,100,64,5/23/2019
E68733,earnings,100,50,5/23/2019
E6EDED,dividend,100,50,5/23/2019
E754F0,conference-participant,100,50,5/23/2019
E8A49A,executive-appointment,100,54,5/23/2019
EBC84C,award,100,58,5/23/2019
EF1AD9,business-contract,100,69,5/23/2019
F11638,partnership,100,61,5/23/2019
F11638,revenue-up,100,62,5/23/2019
F11638,revenue-up,100,62,5/23/2019
F11638,revenue-up,100,62,5/23/2019
F11638,revenue-up,100,62,5/23/2019
F11638,revenue-up,100,62,5/23/2019
F11638,revenue-up,100,62,5/23/2019
F3FCC3,conference-participant,100,50,5/23/2019
F51DB0,legal-issues-defendant,100,22,5/23/2019
F51DB0,legal-issues-defendant,100,22,5/23/2019
F51DB0,legal-issues-defendant,100,22,5/23/2019
F57F6F,conference-participant,100,50,5/23/2019
F6FF0D,legal-issues-defendant,100,22,5/23/2019
F6FF0D,legal-issues-defendant,100,22,5/23/2019
F7ADEB,executive-appointment,100,54,5/23/2019
F8BA6C,clinical-trials-start,100,64,5/23/2019
FBD92D,partnership,100,61,5/23/2019
FC1A6E,conference-call,100,50,5/23/2019
FC1B7B,conference-participant,100,50,5/23/2019
FD2565,reorganization,100,53,5/23/2019
FD2565,reorganization,100,53,5/23/2019
001F1B,legal-issues-defendant,100,22,5/24/2019
001F1B,legal-issues-defendant,100,22,5/24/2019
001F1B,legal-issues-defendant,100,22,5/24/2019
001F1B,fraud-defendant,100,20,5/24/2019
001F1B,legal-issues-defendant,100,22,5/24/2019
001F1B,legal-issues-defendant,100,22,5/24/2019
001F1B,legal-issues-defendant,100,22,5/24/2019
02870F,dividend,100,50,5/24/2019
036C6F,fraud-defendant,100,20,5/24/2019
036C6F,legal-issues-defendant,100,22,5/24/2019
0BF198,public-offering,100,43,5/24/2019
0BF198,public-offering,100,43,5/24/2019
0CE7F6,earnings,100,50,5/24/2019
0E2992,dividend,100,50,5/24/2019
1748F6,earnings,100,50,5/24/2019
200D8B,buybacks,100,74,5/24/2019
202E5A,conference-participant,100,50,5/24/2019
24CB56,conference-organizer,100,57,5/24/2019
253B2F,dividend,100,50,5/24/2019
267718,clinical-trials,100,56,5/24/2019
2720AB,executive-appointment,100,54,5/24/2019
272704,acquisition-completed-acquirer,100,49,5/24/2019
2EB04E,legal-issues-defendant,100,22,5/24/2019
2EB04E,legal-issues-defendant,100,22,5/24/2019
3A1C46,conference-participant,100,50,5/24/2019
3A94DF,dividend-up,100,57,5/24/2019
3B9886,earnings,100,50,5/24/2019
3B9886,earnings,100,50,5/24/2019
3B9886,earnings,100,50,5/24/2019
3B9886,executive-appointment,100,54,5/24/2019
49A344,executive-appointment,100,54,5/24/2019
4B5054,executive-appointment,100,54,5/24/2019
50070E,conference-organizer,100,57,5/24/2019
50070E,conference-organizer,100,57,5/24/2019
5088A5,dividend,100,50,5/24/2019
54A713,acquisition-completed-acquirer,100,49,5/24/2019
59872F,legal-issues-defendant,100,22,5/24/2019
5C7601,dividend,100,50,5/24/2019
5E7E82,dividend,100,50,5/24/2019
713810,conference-participant,100,50,5/24/2019
762A3E,conference-organizer,100,57,5/24/2019
7740DE,dividend,100,50,5/24/2019
7B9212,earnings,100,50,5/24/2019
89F693,legal-issues-defendant,100,22,5/24/2019
89F693,award,100,58,5/24/2019
8B6E7E,legal-issues-defendant,100,22,5/24/2019
901327,dividend,100,50,5/24/2019
95DE39,earnings-positive,100,69,5/24/2019
95DE39,earnings-positive,100,69,5/24/2019
95DE39,earnings-positive,100,69,5/24/2019
95DE39,earnings-positive,100,69,5/24/2019
9B0C9C,conference-participant,100,50,5/24/2019
A6ABE9,buybacks,100,74,5/24/2019
A96867,dividend,100,50,5/24/2019
AFDF2E,legal-issues-defendant,100,22,5/24/2019
B5BA39,legal-issues-defendant,100,22,5/24/2019
B76C82,dividend,100,50,5/24/2019
B76C82,dividend,100,50,5/24/2019
BE14CF,business-contract,100,69,5/24/2019
BE14CF,executive-appointment,100,54,5/24/2019
BE5935,conference-participant,100,50,5/24/2019
C188F8,executive-resignation,100,44,5/24/2019
C425AE,conference-participant,100,50,5/24/2019
CC339B,award,100,58,5/24/2019
CDAA0E,conference-participant,100,50,5/24/2019
D25249,conference-participant,100,50,5/24/2019
D8442A,legal-issues-defendant,100,22,5/24/2019
DB88A1,legal-issues-defendant,100,22,5/24/2019
DB88A1,legal-issues-defendant,100,22,5/24/2019
E22FDE,executive-appointment,100,54,5/24/2019
E4CE73,executive-appointment,100,54,5/24/2019
F43A11,conference-call,100,50,5/24/2019
F48947,legal-issues-defendant,100,22,5/24/2019
F51DB0,legal-issues-defendant,100,22,5/24/2019
F6FF0D,legal-issues-defendant,100,22,5/24/2019
F8BA6C,conference-call,100,50,5/24/2019
8B6E7E,legal-issues-defendant,100,22,5/25/2019
AFDF2E,legal-issues-defendant,100,22,5/25/2019
DB88A1,legal-issues-defendant,100,22,5/25/2019
001F1B,legal-issues-defendant,100,22,5/27/2019
036C6F,legal-issues-defendant,100,22,5/27/2019
21D903,legal-issues-defendant,100,22,5/27/2019
25102A,acquisition-failed-acquirer,100,41,5/27/2019
25102A,acquisition-failed-acquirer,100,41,5/27/2019
251988,legal-issues-defendant,100,22,5/27/2019
2EB04E,legal-issues-defendant,100,22,5/27/2019
435ACE,legal-issues-defendant,100,22,5/27/2019
43A060,legal-issues-defendant,100,22,5/27/2019
55438C,legal-issues-defendant,100,22,5/27/2019
59872F,legal-issues-defendant,100,22,5/27/2019
7E1D5D,partnership,100,61,5/27/2019
830BDB,conference-call,100,50,5/27/2019
8614A2,legal-issues-defendant,100,22,5/27/2019
8B9B3B,legal-issues-defendant,100,22,5/27/2019
92D230,legal-issues-defendant,100,22,5/27/2019
AFDF2E,legal-issues-defendant,100,22,5/27/2019
B5BA39,legal-issues-defendant,100,22,5/27/2019
BDCC11,legal-issues-defendant,100,22,5/27/2019
C97B2D,legal-issues-defendant,100,22,5/27/2019
CFF15D,product-release,100,64,5/27/2019
D8442A,legal-issues-defendant,100,22,5/27/2019
DB88A1,legal-issues-defendant,100,22,5/27/2019
E09E2B,product-release,100,64,5/27/2019
E09E2B,product-release,100,64,5/27/2019
E22FDE,legal-issues-defendant,100,22,5/27/2019
E802CE,legal-issues-defendant,100,22,5/27/2019
F48947,legal-issues-defendant,100,22,5/27/2019
F51DB0,legal-issues-defendant,100,22,5/27/2019
F6FF0D,legal-issues-defendant,100,22,5/27/2019
001F1B,legal-issues-defendant,100,22,5/28/2019
0157B1,partnership,100,61,5/28/2019
0325B7,executive-appointment,100,54,5/28/2019
036C6F,legal-issues-defendant,100,22,5/28/2019
0968A5,earnings,100,50,5/28/2019
0BF528,conference-participant,100,50,5/28/2019
0CC62B,conference-participant,100,50,5/28/2019
0E499E,conference-participant,100,50,5/28/2019
0F2BC9,business-contract,100,69,5/28/2019
102F04,conference-participant,100,50,5/28/2019
125212,product-release,100,64,5/28/2019
12A3A3,executive-appointment,100,54,5/28/2019
159739,dividend,100,50,5/28/2019
159739,dividend,100,50,5/28/2019
159739,public-offering,100,43,5/28/2019
159739,public-offering,100,43,5/28/2019
15A388,earnings,100,50,5/28/2019
16B183,executive-appointment,100,54,5/28/2019
17EDA5,award,100,58,5/28/2019
1834C0,unit-acquisition-acquirer,100,49,5/28/2019
1AC649,conference-participant,100,50,5/28/2019
1B6F77,orphan-drug-designation,100,76,5/28/2019
1C2593,conference-participant,100,50,5/28/2019
1CD4B5,conference-participant,100,50,5/28/2019
1E1125,conference-organizer,100,57,5/28/2019
1E9A6D,conference-participant,100,50,5/28/2019
1EBF8D,dividend,100,50,5/28/2019
1F19C8,credit-extension-provider,100,57,5/28/2019
2082EA,conference-participant,100,50,5/28/2019
219B21,conference-participant,100,50,5/28/2019
227F04,business-contract,100,69,5/28/2019
239106,conference-participant,100,50,5/28/2019
24CB56,conference-organizer,100,57,5/28/2019
24FA23,conference-participant,100,50,5/28/2019
25102A,conference-participant,100,50,5/28/2019
26008A,earnings-up,100,68,5/28/2019
26008A,earnings-up,100,68,5/28/2019
26008A,earnings-up,100,68,5/28/2019
26008A,earnings-up,100,68,5/28/2019
263216,ownership-increase-owner,100,56,5/28/2019
2E902B,conference-participant,100,50,5/28/2019
3159AA,facility-open,100,65,5/28/2019
33E9D5,earnings,100,50,5/28/2019
396D7C,conference-participant,100,50,5/28/2019
3BE00F,conference-participant,100,50,5/28/2019
4.00E+163,acquisition-acquirer,100,49,5/28/2019
48F795,conference-participant,100,50,5/28/2019
4A6F00,market-entry,100,57,5/28/2019
4B7006,earnings,100,50,5/28/2019
4BEB48,conference-participant,100,50,5/28/2019
4FCC78,conference-participant,100,50,5/28/2019
51888A,unit-acquisition-acquirer,100,49,5/28/2019
519FE0,headquarters-change,100,50,5/28/2019
53E575,earnings,100,50,5/28/2019
5.43E+08,conference-call,100,50,5/28/2019
546A27,conference-participant,100,50,5/28/2019
54B889,earnings,100,50,5/28/2019
553949,executive-appointment,100,54,5/28/2019
58CA9A,conference-participant,100,50,5/28/2019
594402,conference-participant,100,50,5/28/2019
59872F,legal-issues-defendant,100,22,5/28/2019
59DB8C,conference-participant,100,50,5/28/2019
5D1329,executive-appointment,100,54,5/28/2019
5DE5A5,conference-participant,100,50,5/28/2019
5EF130,earnings-delayed,100,26,5/28/2019
60EA12,executive-appointment,100,54,5/28/2019
627186,trading-listing,100,61,5/28/2019
62CDDE,conference-participant,100,50,5/28/2019
68BA15,conference-participant,100,50,5/28/2019
6925EB,conference-participant,100,50,5/28/2019
6B236C,public-offering,100,43,5/28/2019
6B236C,public-offering,100,43,5/28/2019
6B6375,executive-appointment,100,54,5/28/2019
6CD55A,dividend,100,50,5/28/2019
6F0096,conference-participant,100,50,5/28/2019
6F3936,conference-call,100,50,5/28/2019
717DB4,executive-resignation,100,44,5/28/2019
722DE3,business-contract,100,69,5/28/2019
724F84,public-offering,100,43,5/28/2019
7255D2,business-contract,100,69,5/28/2019
763DBE,conference-participant,100,50,5/28/2019
76DD0C,conference-participant,100,50,5/28/2019
791EC1,unit-acquisition-acquirer,100,49,5/28/2019
7A2A49,conference-call,100,50,5/28/2019
7B0BA6,investment-investor,100,55,5/28/2019
7B8CB5,conference-participant,100,50,5/28/2019
7C790D,conference-participant,100,50,5/28/2019
7F2922,conference-participant,100,50,5/28/2019
858942,buybacks,100,74,5/28/2019
8614A2,unit-acquisition-acquirer,100,49,5/28/2019
86AA9C,legal-issues-defendant,100,22,5/28/2019
86AA9C,legal-issues-defendant,100,22,5/28/2019
86AA9C,legal-issues-defendant,100,22,5/28/2019
890FF4,conference-participant,100,50,5/28/2019
8BAA15,earnings-guidance,100,50,5/28/2019
8EEA28,conference-participant,100,50,5/28/2019
90D6A5,executive-appointment,100,54,5/28/2019
9196A2,conference-organizer,100,57,5/28/2019
9196A2,conference-organizer,100,57,5/28/2019
9196A2,conference-organizer,100,57,5/28/2019
94983E,conference-participant,100,50,5/28/2019
949D62,conference-participant,100,50,5/28/2019
95DC1F,unit-acquisition-acquiree,100,76,5/28/2019
968966,executive-appointment,100,54,5/28/2019
990AD0,conference-organizer,100,57,5/28/2019
990AD0,conference-organizer,100,57,5/28/2019
9.97E+09,stake-acquirer,100,48,5/28/2019
9D307D,conference-participant,100,50,5/28/2019
A21649,conference-participant,100,50,5/28/2019
A23747,conference-participant,100,50,5/28/2019
A247F5,conference-participant,100,50,5/28/2019
A4386C,conference-participant,100,50,5/28/2019
A52533,conference-participant,100,50,5/28/2019
A60354,conference-participant,100,50,5/28/2019
A6828A,executive-appointment,100,54,5/28/2019
A6828A,executive-appointment,100,54,5/28/2019
A7CCF0,buybacks,100,74,5/28/2019
A7F0A5,conference-participant,100,50,5/28/2019
A80FE0,conference-participant,100,50,5/28/2019
AA5C8E,conference-participant,100,50,5/28/2019
AA5C8E,conference-participant,100,50,5/28/2019
ADD9DC,earnings,100,50,5/28/2019
B2206F,conference-participant,100,50,5/28/2019
B37FB4,conference-participant,100,50,5/28/2019
B381D8,clinical-trials,100,56,5/28/2019
B4703C,legal-issues-defendant,100,22,5/28/2019
B4703C,legal-issues-defendant,100,22,5/28/2019
B4703C,legal-issues-defendant,100,22,5/28/2019
B5BA39,index-listing,100,76,5/28/2019
BB02FB,index-listing,100,76,5/28/2019
BB0587,conference-participant,100,50,5/28/2019
BDF85E,earnings,100,50,5/28/2019
C06EB6,conference-participant,100,50,5/28/2019
C425AE,conference-participant,100,50,5/28/2019
C6C702,award,100,58,5/28/2019
C6C702,award,100,58,5/28/2019
C85A72,partnership,100,61,5/28/2019
C93C44,rights-issue,100,43,5/28/2019
CAD7D9,executive-appointment,100,54,5/28/2019
CC35BE,executive-appointment,100,54,5/28/2019
CF073E,ipo-completed,100,76,5/28/2019
D13F1C,conference-participant,100,50,5/28/2019
D13F1C,executive-appointment,100,54,5/28/2019
D15833,dividend,100,50,5/28/2019
D3FD6D,acquisition-completed-acquirer,100,49,5/28/2019
D598E7,earnings,100,50,5/28/2019
D6853F,executive-appointment,100,54,5/28/2019
DA9443,conference-participant,100,50,5/28/2019
DB5CA5,donation,100,54,5/28/2019
DBB28E,facility-open,100,65,5/28/2019
DD1BA1,partnership,100,61,5/28/2019
DF11D9,executive-appointment,100,54,5/28/2019
E09E2B,earnings-up,100,68,5/28/2019
E15736,ipo-completed,100,76,5/28/2019
E15736,ipo-completed,100,76,5/28/2019
E22FDE,legal-issues-defendant,100,22,5/28/2019
E26FC3,executive-resignation,100,44,5/28/2019
E3E68E,award,100,58,5/28/2019
E5F0A8,acquisition-completed-acquirer,100,49,5/28/2019
E67C2C,conference-participant,100,50,5/28/2019
E8846E,executive-appointment,100,54,5/28/2019
E8C557,conference-participant,100,50,5/28/2019
E9C7C0,earnings,100,50,5/28/2019
ED3CA8,conference-participant,100,50,5/28/2019
F0B335,conference-participant,100,50,5/28/2019
F11638,acquisition-acquirer,100,49,5/28/2019
F30508,business-contract,100,69,5/28/2019
F32F88,conference-participant,100,50,5/28/2019
F47871,conference-participant,100,50,5/28/2019
F6E248,product-release,100,64,5/28/2019
F8BA6C,conference-participant,100,50,5/28/2019
F90EE5,note-sale,100,52,5/28/2019
FA40E2,asset-sale,100,62,5/28/2019
FD4588,conference-participant,100,50,5/28/2019
FD554E,dividend,100,50,5/28/2019
FEE4B0,executive-appointment,100,54,5/28/2019
001F1B,legal-issues-defendant,100,22,5/29/2019
0157B1,product-release,100,64,5/29/2019
0157B1,product-release,100,64,5/29/2019
01D03F,partnership,100,61,5/29/2019
01D03F,regulatory-product-approval-granted,100,81,5/29/2019
20751,conference-participant,100,50,5/29/2019
02FC1A,conference-participant,100,50,5/29/2019
31025,award,100,58,5/29/2019
036C6F,legal-issues-defendant,100,22,5/29/2019
0624BE,earnings,100,50,5/29/2019
95294,award,100,58,5/29/2019
0A59F8,executive-appointment,100,54,5/29/2019
0A6824,unit-acquisition-acquiree,100,76,5/29/2019
0A6824,asset-sale,100,62,5/29/2019
0A6824,unit-acquisition-acquiree,100,76,5/29/2019
0BC29E,executive-appointment,100,54,5/29/2019
0E3436,conference-participant,100,50,5/29/2019
0F0693,conference-participant,100,50,5/29/2019
136B26,merger,100,66,5/29/2019
136B26,merger,100,66,5/29/2019
159739,public-offering,100,43,5/29/2019
159739,public-offering,100,43,5/29/2019
190BE6,earnings,100,50,5/29/2019
1A3E1B,conference-participant,100,50,5/29/2019
1B16C1,legal-issues-defendant,100,22,5/29/2019
1B16C1,legal-issues-defendant,100,22,5/29/2019
1B16C1,legal-issues-defendant,100,22,5/29/2019
1CD09C,conference-participant,100,50,5/29/2019
1DDEDA,executive-appointment,100,54,5/29/2019
1F08A6,facility-open,100,65,5/29/2019
222BF9,buybacks,100,74,5/29/2019
228D42,partnership,100,61,5/29/2019
22C58E,conference-participant,100,50,5/29/2019
25102A,partnership,100,61,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
251988,earnings,100,50,5/29/2019
263216,dividend,100,50,5/29/2019
27B191,earnings,100,50,5/29/2019
2B0AF4,partnership,100,61,5/29/2019
2B8179,executive-appointment,100,54,5/29/2019
2CBB58,conference-participant,100,50,5/29/2019
2CC71C,conference-participant,100,50,5/29/2019
2D981A,conference-participant,100,50,5/29/2019
2F9304,conference-participant,100,50,5/29/2019
31643A,earnings,100,50,5/29/2019
31643A,earnings,100,50,5/29/2019
31643A,earnings,100,50,5/29/2019
3224CC,conference-participant,100,50,5/29/2019
371B0A,conference-participant,100,50,5/29/2019
384CD3,conference-participant,100,50,5/29/2019
3C7F5F,dividend,100,50,5/29/2019
3F1C69,clinical-trials-positive,100,87,5/29/2019
401072,conference-participant,100,50,5/29/2019
414FFF,revenues,100,50,5/29/2019
414FFF,revenues,100,50,5/29/2019
414FFF,revenues,100,50,5/29/2019
414FFF,revenues,100,50,5/29/2019
414FFF,revenues,100,50,5/29/2019
414FFF,revenues,100,50,5/29/2019
414FFF,revenues,100,50,5/29/2019
414FFF,revenues,100,50,5/29/2019
431B74,dividend,100,50,5/29/2019
431B74,dividend,100,50,5/29/2019
479930,conference-participant,100,50,5/29/2019
4F9926,partnership,100,61,5/29/2019
4F9926,partnership,100,61,5/29/2019
4F9926,partnership,100,61,5/29/2019
50070E,conference-organizer,100,57,5/29/2019
50070E,conference-organizer,100,57,5/29/2019
50070E,conference-organizer,100,57,5/29/2019
50070E,conference-organizer,100,57,5/29/2019
50D1EC,patent-awarded,100,72,5/29/2019
50D1EC,patent-awarded,100,72,5/29/2019
520632,fundraising,100,64,5/29/2019
532D47,conference-participant,100,50,5/29/2019
532D47,legal-issues-defendant,100,22,5/29/2019
567F3D,conference-participant,100,50,5/29/2019
589846,earnings,100,50,5/29/2019
5A53BF,conference-participant,100,50,5/29/2019
5D02B7,dividend,100,50,5/29/2019
5E7E82,partnership,100,61,5/29/2019
5F3D91,conference-participant,100,50,5/29/2019
5F3E74,public-offering,100,43,5/29/2019
61B81B,conference-participant,100,50,5/29/2019
64854A,conference-participant,100,50,5/29/2019
64E346,conference-participant,100,50,5/29/2019
6634D9,product-release,100,64,5/29/2019
665618,conference-participant,100,50,5/29/2019
6DC1D7,dividend-up,100,81,5/29/2019
6.00E+19,executive-appointment,100,54,5/29/2019
6F0A63,dividend,100,50,5/29/2019
724F84,public-offering,100,43,5/29/2019
732A9B,fast-track-designation,100,81,5/29/2019
73F70F,dividend,100,50,5/29/2019
766047,partnership,100,61,5/29/2019
76E80F,award,100,58,5/29/2019
7A5097,partnership,100,61,5/29/2019
7A5097,earnings,100,50,5/29/2019
7B492C,conference-participant,100,50,5/29/2019
7B9AFA,conference-participant,100,50,5/29/2019
7BAAE7,product-release,100,64,5/29/2019
7BFF81,conference-participant,100,50,5/29/2019
80D744,legal-issues-defendant,100,22,5/29/2019
819492,conference-participant,100,50,5/29/2019
82F088,partnership,100,61,5/29/2019
82FD6D,conference-participant,100,50,5/29/2019
834152,conference-participant,100,50,5/29/2019
8614A2,legal-issues-defendant,100,22,5/29/2019
8665BA,partnership,100,61,5/29/2019
86AA9C,legal-issues-defendant,100,22,5/29/2019
86AA9C,legal-issues-defendant,100,22,5/29/2019
885758,legal-issues-defendant,100,22,5/29/2019
885758,legal-issues-defendant,100,22,5/29/2019
89E771,earnings,100,50,5/29/2019
8B3B0E,conference-participant,100,50,5/29/2019
8BAA15,note-sale,100,52,5/29/2019
8E4F9A,facility-open,100,65,5/29/2019
8EDACA,conference-participant,100,50,5/29/2019
8FE7A5,conference-participant,100,50,5/29/2019
9196A2,conference-organizer,100,57,5/29/2019
9196A2,conference-organizer,100,57,5/29/2019
9.31E+77,conference-participant,100,50,5/29/2019
93D207,partnership,100,61,5/29/2019
95F59E,conference-participant,100,50,5/29/2019
9.65E+09,conference-participant,100,50,5/29/2019
965360,executive-appointment,100,54,5/29/2019
97693A,conference-call,100,50,5/29/2019
9.86E+03,product-release,100,64,5/29/2019
9.86E+03,product-release,100,64,5/29/2019
990AD0,conference-organizer,100,57,5/29/2019
990AD0,conference-organizer,100,57,5/29/2019
990AD0,conference-organizer,100,57,5/29/2019
990AD0,conference-organizer,100,57,5/29/2019
9.92E+94,dividend,100,50,5/29/2019
9B4066,unit-acquisition-acquirer,100,49,5/29/2019
9BBFA5,conference-call,100,50,5/29/2019
9E0811,earnings,100,50,5/29/2019
A1E3B3,earnings,100,50,5/29/2019
A1E3B3,earnings,100,50,5/29/2019
A1E3B3,earnings,100,50,5/29/2019
A1E3B3,earnings,100,50,5/29/2019
A204A7,conference-participant,100,50,5/29/2019
A21649,note-sale,100,52,5/29/2019
A26C26,conference-participant,100,50,5/29/2019
A37D68,earnings,100,50,5/29/2019
A3AAA5,conference-participant,100,50,5/29/2019
A52B6B,acquisition-interest-acquirer,100,46,5/29/2019
A52B6B,earnings,100,50,5/29/2019
A5E715,dividend,100,50,5/29/2019
A631A3,conference-participant,100,50,5/29/2019
A63387,conference-participant,100,50,5/29/2019
A63387,product-release,100,64,5/29/2019
A7102F,conference-participant,100,50,5/29/2019
A72FD9,earnings,100,50,5/29/2019
AA3AB8,earnings,100,50,5/29/2019
AED6CF,conference-participant,100,50,5/29/2019
AFF43F,conference-participant,100,50,5/29/2019
B01111,earnings,100,50,5/29/2019
B09B1F,conference-participant,100,50,5/29/2019
B4703C,legal-issues-defendant,100,22,5/29/2019
B4703C,legal-issues-defendant,100,22,5/29/2019
B4703C,legal-issues-defendant,100,22,5/29/2019
B48FC9,product-release,100,64,5/29/2019
B5BA39,legal-issues-defendant,100,22,5/29/2019
B7202A,conference-participant,100,50,5/29/2019
BB0787,executive-appointment,100,54,5/29/2019
BB127B,product-release,100,64,5/29/2019
BDCC11,legal-issues-defendant,100,22,5/29/2019
BFAEB4,award,100,58,5/29/2019
C01737,conference-participant,100,50,5/29/2019
C03C8B,conference-participant,100,50,5/29/2019
C062D4,conference-participant,100,50,5/29/2019
C2F597,conference-participant,100,50,5/29/2019
C624A1,conference-participant,100,50,5/29/2019
C6C702,business-contract,100,69,5/29/2019
C6C702,business-contract,100,69,5/29/2019
C8A248,conference-participant,100,50,5/29/2019
C9E4EC,conference-participant,100,50,5/29/2019
CDD75E,clinical-trials-filed,100,60,5/29/2019
CE1002,conference-participant,100,50,5/29/2019
CE4FD9,earnings,100,50,5/29/2019
CFD4B6,business-contract,100,69,5/29/2019
D07B07,conference-participant,100,50,5/29/2019
D2C0B6,conference-participant,100,50,5/29/2019
D65A13,conference-participant,100,50,5/29/2019
D78CCD,executive-appointment,100,54,5/29/2019
D9FC89,conference-participant,100,50,5/29/2019
DB7014,conference-participant,100,50,5/29/2019
DB88A1,earnings-up,100,68,5/29/2019
DB88A1,earnings-up,100,68,5/29/2019
DB88A1,earnings-up,100,68,5/29/2019
DB88A1,earnings-up,100,68,5/29/2019
DB88A1,earnings-up,100,68,5/29/2019
DB88A1,earnings-up,100,68,5/29/2019
DB88A1,earnings-up,100,68,5/29/2019
DB88A1,earnings-up,100,68,5/29/2019
DD1BA1,conference-participant,100,50,5/29/2019
DF532D,conference-participant,100,50,5/29/2019
E06265,conference-participant,100,50,5/29/2019
E09997,facility-close,100,47,5/29/2019
E20392,conference-participant,100,50,5/29/2019
E3656D,conference-participant,100,50,5/29/2019
E4CE73,earnings,100,50,5/29/2019
E68733,regulatory-product-approval-granted,100,81,5/29/2019
E6D89E,legal-issues-defendant,100,22,5/29/2019
E71AE6,conference-participant,100,50,5/29/2019
E7BF32,conference-participant,100,50,5/29/2019
E7BF32,conference-participant,100,50,5/29/2019
E82A2D,conference-participant,100,50,5/29/2019
E8846E,executive-appointment,100,54,5/29/2019
E96E0B,conference-participant,100,50,5/29/2019
EBC84C,conference-participant,100,50,5/29/2019
EF45B6,dividend,100,50,5/29/2019
F02170,conference-participant,100,50,5/29/2019
F11638,conference-participant,100,50,5/29/2019
F1529C,conference-participant,100,50,5/29/2019
F4D241,public-offering,100,43,5/29/2019
F6DCE4,product-recall,100,29,5/29/2019
F6E248,executive-appointment,100,54,5/29/2019
F90EE5,note-sale,100,52,5/29/2019
FD6926,conference-participant,100,50,5/29/2019
FD9A97,dividend,100,50,5/29/2019
FDE409,conference-participant,100,50,5/29/2019
FEE4B0,conference-participant,100,50,5/29/2019
001F1B,legal-issues-defendant,100,22,5/30/2019
00698D,earnings,100,50,5/30/2019
00D6B5,conference-call,100,50,5/30/2019
0157B1,partnership,100,61,5/30/2019
0157B1,partnership,100,61,5/30/2019
01B8D6,earnings,100,50,5/30/2019
036C6F,legal-issues-defendant,100,22,5/30/2019
036C6F,legal-issues-defendant,100,22,5/30/2019
68396,dividend,100,50,5/30/2019
06A456,earnings,100,50,5/30/2019
06A456,earnings,100,50,5/30/2019
06A456,earnings,100,50,5/30/2019
06EE79,conference-participant,100,50,5/30/2019
07EC43,executive-appointment,100,54,5/30/2019
0919B1,dividend,100,50,5/30/2019
0A0CF0,earnings-guidance,100,50,5/30/2019
0BF528,earnings-up,100,68,5/30/2019
0BF528,facility-open,100,65,5/30/2019
0C136E,product-release,100,64,5/30/2019
0DBB81,conference-participant,100,50,5/30/2019
0E3436,earnings,100,50,5/30/2019
0E3436,earnings,100,50,5/30/2019
12A3A3,conference-call,100,50,5/30/2019
12E454,partnership,100,61,5/30/2019
139303,conference-organizer,100,57,5/30/2019
143C52,earnings,100,50,5/30/2019
159739,conference-call,100,50,5/30/2019
159739,conference-call,100,50,5/30/2019
16FC89,dividend,100,50,5/30/2019
17EDA5,partnership,100,61,5/30/2019
184866,partnership,100,61,5/30/2019
196D18,conference-participant,100,50,5/30/2019
1A6A94,conference-participant,100,50,5/30/2019
1BC12C,partnership,100,61,5/30/2019
1D1B07,earnings,100,50,5/30/2019
1D1B07,earnings,100,50,5/30/2019
1FA886,partnership,100,61,5/30/2019
21F9CA,revenues,100,50,5/30/2019
227F04,product-release,100,64,5/30/2019
279916,conference-participant,100,50,5/30/2019
27A791,conference-participant,100,50,5/30/2019
2.90E+62,conference-participant,100,50,5/30/2019
2BAE5F,public-offering,100,43,5/30/2019
2BC05E,trading-halt,100,43,5/30/2019
2BF36E,conference-participant,100,50,5/30/2019
2C35B5,conference-participant,100,50,5/30/2019
2EB04E,legal-issues-defendant,100,22,5/30/2019
33AD83,earnings,100,50,5/30/2019
367E1C,conference-participant,100,50,5/30/2019
370C50,conference-participant,100,50,5/30/2019
37727A,conference-participant,100,50,5/30/2019
3DD5E2,partnership,100,61,5/30/2019
3ED92D,conference-participant,100,50,5/30/2019
420168,conference-participant,100,50,5/30/2019
434F38,executive-appointment,100,54,5/30/2019
43E8F5,partnership,100,61,5/30/2019
44A4FC,conference-participant,100,50,5/30/2019
4.60E+06,conference-participant,100,50,5/30/2019
4A6F00,business-contract,100,69,5/30/2019
4AC91D,product-release,100,64,5/30/2019
4AC91D,product-release,100,64,5/30/2019
4E6F5A,conference-participant,100,50,5/30/2019
4F9926,partnership,100,61,5/30/2019
50070E,executive-appointment,100,54,5/30/2019
50070E,executive-appointment,100,54,5/30/2019
539F49,conference-participant,100,50,5/30/2019
54F1D2,conference-organizer,100,57,5/30/2019
55CD6F,dividend,100,50,5/30/2019
55CD6F,executive-appointment,100,54,5/30/2019
589846,conference-participant,100,50,5/30/2019
59872F,executive-appointment,100,54,5/30/2019
59872F,earnings,100,50,5/30/2019
59F0B0,conference-participant,100,50,5/30/2019
5A53BF,regulatory-product-application,100,69,5/30/2019
5B15E1,conference-participant,100,50,5/30/2019
5D1329,conference-participant,100,50,5/30/2019
5DD486,executive-appointment,100,54,5/30/2019
5FF95F,legal-issues-defendant,100,22,5/30/2019
601785,conference-participant,100,50,5/30/2019
665618,conference-participant,100,50,5/30/2019
665D7D,clinical-trials,100,56,5/30/2019
66BDA1,stake-acquirer,100,48,5/30/2019
66BDA1,stake-acquirer,100,48,5/30/2019
67B052,conference-participant,100,50,5/30/2019
6830FE,earnings-up,100,68,5/30/2019
693ECD,patient-enrollment-start,100,58,5/30/2019
69FDFC,business-contract,100,69,5/30/2019
6B236C,conference-participant,100,50,5/30/2019
6F3936,partnership,100,61,5/30/2019
701531,conference-participant,100,50,5/30/2019
7239BB,earnings,100,50,5/30/2019
769F40,dividend,100,50,5/30/2019
76D79A,dividend,100,50,5/30/2019
7999F3,conference-participant,100,50,5/30/2019
7A10FF,unit-acquisition-acquiree,100,76,5/30/2019
7A5097,partnership,100,61,5/30/2019
7A5097,partnership,100,61,5/30/2019
7BFF81,executive-appointment,100,54,5/30/2019
7DD8CC,conference-participant,100,50,5/30/2019
7EA323,executive-appointment,100,54,5/30/2019
7F3669,partnership,100,61,5/30/2019
7FEEE1,conference-organizer,100,57,5/30/2019
8.10E+32,partnership,100,61,5/30/2019
817ED9,earnings,100,50,5/30/2019
817ED9,earnings,100,50,5/30/2019
817ED9,earnings,100,50,5/30/2019
817ED9,earnings,100,50,5/30/2019
8377DB,conference-participant,100,50,5/30/2019
8377DB,donation,100,54,5/30/2019
83B1C8,conference-participant,100,50,5/30/2019
855DF7,conference-participant,100,50,5/30/2019
86AA9C,legal-issues-defendant,100,22,5/30/2019
86AA9C,legal-issues-defendant,100,22,5/30/2019
885758,legal-issues-defendant,100,22,5/30/2019
8B6E7E,legal-issues-defendant,100,22,5/30/2019
8BAA15,note-sale,100,52,5/30/2019
8C5519,conference-participant,100,50,5/30/2019
9196A2,conference-organizer,100,57,5/30/2019
92D230,legal-issues-defendant,100,22,5/30/2019
93AD2E,legal-issues-defendant,100,22,5/30/2019
949D62,campaign-ad-release,100,59,5/30/2019
96B4FF,conference-participant,100,50,5/30/2019
972356,partnership,100,61,5/30/2019
9.74E+08,dividend,100,50,5/30/2019
979451,conference-participant,100,50,5/30/2019
98A286,earnings-per-share-positive,100,69,5/30/2019
990AD0,conference-organizer,100,57,5/30/2019
990AD0,conference-organizer,100,57,5/30/2019
9978F1,conference-participant,100,50,5/30/2019
9B0C9C,conference-participant,100,50,5/30/2019
9B5968,executive-appointment,100,54,5/30/2019
9BF177,conference-participant,100,50,5/30/2019
9C25FF,partnership,100,61,5/30/2019
9CDA4F,conference-participant,100,50,5/30/2019
A072C4,conference-participant,100,50,5/30/2019
A1E3B3,conference-participant,100,50,5/30/2019
A21649,public-offering,100,43,5/30/2019
A398F8,conference-participant,100,50,5/30/2019
A631A3,earnings,100,50,5/30/2019
A6FC89,earnings,100,50,5/30/2019
A6FC89,earnings,100,50,5/30/2019
A6FC89,earnings,100,50,5/30/2019
A6FC89,earnings,100,50,5/30/2019
A72AB6,earnings,100,50,5/30/2019
A761FE,earnings,100,50,5/30/2019
A761FE,earnings,100,50,5/30/2019
A7CCF0,executive-appointment,100,54,5/30/2019
A8E72A,conference-participant,100,50,5/30/2019
A9ED24,executive-appointment,100,54,5/30/2019
AD1ACF,executive-appointment,100,54,5/30/2019
AD23DE,conference-participant,100,50,5/30/2019
ADF092,business-contract,100,69,5/30/2019
AE4EEB,conference-participant,100,50,5/30/2019
B0D41A,conference-participant,100,50,5/30/2019
B3CB74,partnership,100,61,5/30/2019
B4703C,legal-issues-defendant,100,22,5/30/2019
B4703C,legal-issues-defendant,100,22,5/30/2019
B4703C,legal-issues-defendant,100,22,5/30/2019
B5DE80,conference-participant,100,50,5/30/2019
B80AD1,conference-participant,100,50,5/30/2019
B8EF97,earnings,100,50,5/30/2019
BB127B,partnership,100,61,5/30/2019
BB127B,board-meeting,100,51,5/30/2019
BDEC1E,conference-participant,100,50,5/30/2019
C07E05,earnings,100,50,5/30/2019
C0BA36,award,100,58,5/30/2019
C15F8F,executive-appointment,100,54,5/30/2019
C584BE,conference-participant,100,50,5/30/2019
C6C702,conference-participant,100,50,5/30/2019
C74887,conference-participant,100,50,5/30/2019
C85A72,conference-participant,100,50,5/30/2019
C951A2,partnership,100,61,5/30/2019
C9E107,executive-appointment,100,54,5/30/2019
CAB222,conference-participant,100,50,5/30/2019
CAC8D0,executive-appointment,100,54,5/30/2019
CC3EC4,government-contract-terminated,100,31,5/30/2019
CC6F6E,earnings,100,50,5/30/2019
CC6F6E,earnings,100,50,5/30/2019
CC6F6E,earnings,100,50,5/30/2019
CD2DA4,earnings,100,50,5/30/2019
CDAA0E,partnership,100,61,5/30/2019
CE4FD9,conference-participant,100,50,5/30/2019
CF7292,earnings,100,50,5/30/2019
CFF97C,partnership,100,61,5/30/2019
CFF97C,conference-participant,100,50,5/30/2019
D1CFC8,conference-call,100,50,5/30/2019
D33270,award,100,58,5/30/2019
D54E62,acquisition-acquiree,100,76,5/30/2019
D5B13D,conference-participant,100,50,5/30/2019
D64C6D,conference-call,100,50,5/30/2019
D90F43,earnings,100,50,5/30/2019
D90F43,earnings,100,50,5/30/2019
D90F43,earnings,100,50,5/30/2019
D90F43,earnings,100,50,5/30/2019
D90F43,earnings,100,50,5/30/2019
D90F43,earnings,100,50,5/30/2019
DA0CB8,dividend,100,50,5/30/2019
DA199F,executive-appointment,100,54,5/30/2019
DB88A1,legal-issues-defendant,100,22,5/30/2019
DC2B00,same-store-sales-up,100,54,5/30/2019
DDEA6A,conference-participant,100,50,5/30/2019
DE4924,conference-participant,100,50,5/30/2019
DE5611,conference-participant,100,50,5/30/2019
DF532D,conference-participant,100,50,5/30/2019
DF8855,business-contract,100,69,5/30/2019
E11C41,executive-resignation,100,44,5/30/2019
E28D9C,conference-participant,100,50,5/30/2019
E2CB7B,conference-participant,100,50,5/30/2019
E2CFD2,conference-participant,100,50,5/30/2019
E41190,executive-resignation,100,44,5/30/2019
E4CE73,conference-participant,100,50,5/30/2019
E4CE73,product-release,100,64,5/30/2019
E8846E,conference-participant,100,50,5/30/2019
E9C7C0,product-release,100,64,5/30/2019
EE6F1C,partnership,100,61,5/30/2019
EF1AD9,conference-participant,100,50,5/30/2019
F0A9DE,dividend,100,50,5/30/2019
F0A9DE,dividend,100,50,5/30/2019
F3816D,conference-participant,100,50,5/30/2019
F46EC9,conference-participant,100,50,5/30/2019
F48947,legal-issues-defendant,100,22,5/30/2019
F6FA6A,award,100,58,5/30/2019
F748C7,earnings,100,50,5/30/2019
FA36A4,conference-participant,100,50,5/30/2019
FB728F,conference-participant,100,50,5/30/2019
FC1A6E,conference-participant,100,50,5/30/2019
FD9A97,earnings,100,50,5/30/2019
FDD3FC,conference-participant,100,50,5/30/2019
FDF1C0,dividend,100,50,5/30/2019
FF227B,conference-participant,100,50,5/30/2019
036C6F,legal-issues-defendant,100,22,5/31/2019
03FAA6,conference-participant,100,50,5/31/2019
0A0D9E,note-sale,100,52,5/31/2019
0E5619,conference-participant,100,50,5/31/2019
129DC8,executive-appointment,100,54,5/31/2019
131443,partnership,100,61,5/31/2019
13A782,conference-participant,100,50,5/31/2019
152E1D,conference-participant,100,50,5/31/2019
1782D5,dividend,100,50,5/31/2019
1E1125,conference-organizer,100,57,5/31/2019
1E1125,conference-organizer,100,57,5/31/2019
1FCC00,dividend,100,50,5/31/2019
1FCC00,earnings,100,50,5/31/2019
1FCC00,earnings,100,50,5/31/2019
1FCC00,earnings,100,50,5/31/2019
21D903,legal-issues-defendant,100,22,5/31/2019
251988,legal-issues-defendant,100,22,5/31/2019
2BAE5F,public-offering,100,43,5/31/2019
2BC05E,trading-resumed,100,58,5/31/2019
2C7505,clinical-trials-start,100,64,5/31/2019
2E2E6E,dividend,100,50,5/31/2019
2EB04E,legal-issues-defendant,100,22,5/31/2019
3461CF,credit-rating-confirmation-rater,20,50,5/31/2019
385DD4,conference-participant,100,50,5/31/2019
3A6D90,executive-resignation,100,44,5/31/2019
3B318A,conference-participant,100,50,5/31/2019
3C11C4,conference-participant,100,50,5/31/2019
3C11C4,conference-participant,100,50,5/31/2019
3C7F5F,conference-participant,100,50,5/31/2019
3F1C69,conference-participant,100,50,5/31/2019
3F868D,conference-participant,100,50,5/31/2019
414FFF,acquisition-completed-acquirer,100,49,5/31/2019
45BC35,conference-participant,100,50,5/31/2019
4C7DB5,dividend,100,50,5/31/2019
4D371E,executive-appointment,100,54,5/31/2019
50070E,conference-organizer,100,57,5/31/2019
50070E,conference-organizer,100,57,5/31/2019
50070E,conference-organizer,100,57,5/31/2019
532D47,legal-issues-defendant,100,22,5/31/2019
53E575,conference-participant,100,50,5/31/2019
54DF47,dividend,100,50,5/31/2019
5BC2F4,award,100,58,5/31/2019
61E975,executive-resignation,100,44,5/31/2019
62EFEE,legal-issues-defendant,100,22,5/31/2019
665618,conference-participant,100,50,5/31/2019
6E1E61,buybacks,100,74,5/31/2019
7520CC,executive-appointment,100,54,5/31/2019
76959C,conference-participant,100,50,5/31/2019
7A975D,earnings,100,50,5/31/2019
7E2DE6,earnings,100,50,5/31/2019
804708,dividend,100,50,5/31/2019
80D744,legal-issues-defendant,100,22,5/31/2019
8614A2,legal-issues-defendant,100,22,5/31/2019
873DB9,conference-participant,100,50,5/31/2019
885758,legal-issues-defendant,100,22,5/31/2019
89E771,dividend,100,50,5/31/2019
8AB37F,conference-participant,100,50,5/31/2019
8B6E7E,legal-issues-defendant,100,22,5/31/2019
8E10BF,conference-participant,100,50,5/31/2019
8E93A4,facility-open,100,65,5/31/2019
9196A2,conference-organizer,100,57,5/31/2019
9196A2,conference-organizer,100,57,5/31/2019
945DE6,dividend,100,50,5/31/2019
98CAED,conference-participant,100,50,5/31/2019
9981C6,dividend,100,50,5/31/2019
9F5CBB,dividend,100,50,5/31/2019
A5195E,conference-participant,100,50,5/31/2019
A806FA,conference-participant,100,50,5/31/2019
A9ED24,conference-participant,100,50,5/31/2019
AC642C,conference-participant,100,50,5/31/2019
AC642C,conference-participant,100,50,5/31/2019
AEF2C3,legal-issues-defendant,100,22,5/31/2019
AEF2C3,legal-issues-defendant,100,22,5/31/2019
AEF2C3,legal-issues-defendant,100,22,5/31/2019
AEFC90,conference-participant,100,50,5/31/2019
AFDF2E,legal-issues-defendant,100,22,5/31/2019
B3CB74,conference-organizer,100,57,5/31/2019
B4703C,legal-issues-defendant,100,22,5/31/2019
C3F99F,conference-participant,100,50,5/31/2019
C4452A,dividend,100,50,5/31/2019
C564E4,conference-participant,100,50,5/31/2019
C7859D,dividend,100,50,5/31/2019
C8257F,executive-appointment,100,54,5/31/2019
D1173F,executive-appointment,100,54,5/31/2019
D2B9E5,conference-participant,100,50,5/31/2019
D58A11,conference-participant,100,50,5/31/2019
D5938F,conference-participant,100,50,5/31/2019
DD7A96,conference-participant,100,50,5/31/2019
DE5611,dividend-up,100,60,5/31/2019
E30B34,conference-participant,100,50,5/31/2019
E30B34,conference-participant,100,50,5/31/2019
ECA300,earnings,100,50,5/31/2019
EEB5F9,conference-participant,100,50,5/31/2019
F3D2EB,buybacks,100,74,5/31/2019
F43A11,earnings,100,50,5/31/2019
F4D241,public-offering,100,43,5/31/2019
F51DB0,legal-issues-defendant,100,22,5/31/2019
F5349B,partnership,100,61,5/31/2019
F5D410,executive-appointment,100,54,5/31/2019
F6E248,partnership,100,61,5/31/2019
F6E248,partnership,100,61,5/31/2019
F7902B,conference-participant,100,50,5/31/2019
55438C,legal-issues-defendant,100,22,6/1/2019
96B4FF,clinical-trials-start,100,64,6/1/2019
D5938F,clinical-trials,100,56,6/1/2019
DB88A1,legal-issues-defendant,100,22,6/1/2019
FD2565,clinical-trials,100,56,6/1/2019
D33270,partnership,100,61,6/2/2019
00D6B5,buybacks,100,74,6/3/2019
00E601,conference-participant,100,50,6/3/2019
0157B1,product-release,100,64,6/3/2019
0157B1,product-release,100,64,6/3/2019
01D03F,trading-listing,100,61,6/3/2019
0490C6,conference-participant,100,50,6/3/2019
55018,product-release,100,64,6/3/2019
070B45,acquisition-completed-acquirer,100,49,6/3/2019
078D52,revenue-up,100,69,6/3/2019
078D52,revenue-up,100,69,6/3/2019
07CA6A,executive-appointment,100,54,6/3/2019
07CA6A,executive-appointment,100,54,6/3/2019
07CA6A,executive-appointment,100,54,6/3/2019
099C88,conference-participant,100,50,6/3/2019
0A0D9E,conference-participant,100,50,6/3/2019
0B4D10,buybacks,100,74,6/3/2019
0B57D7,executive-appointment,100,54,6/3/2019
159AE4,conference-participant,100,50,6/3/2019
16B183,business-contract,100,69,6/3/2019
1834C0,conference-participant,100,50,6/3/2019
1CD4B5,clinical-trials-positive,100,87,6/3/2019
1CDD1C,executive-appointment,100,54,6/3/2019
1CF3A8,acquisition-completed-acquirer,100,49,6/3/2019
1CF3A8,acquisition-completed-acquirer,100,49,6/3/2019
1CF3A8,public-offering,100,43,6/3/2019
1EBF8D,trading-listing,100,61,6/3/2019
1EBF8D,trading-listing,100,61,6/3/2019
1EBF8D,regulatory-product-approval-granted,100,81,6/3/2019
1EBF8D,regulatory-product-approval-granted,100,81,6/3/2019
1F43A1,business-contract,100,69,6/3/2019
1FE7F0,conference-participant,100,50,6/3/2019
21D903,legal-issues-defendant,100,22,6/3/2019
24C48B,executive-appointment,100,54,6/3/2019
2667B6,executive-appointment,100,54,6/3/2019
2667B6,executive-appointment,100,54,6/3/2019
267718,business-contract,100,69,6/3/2019
26E3BA,conference-participant,100,50,6/3/2019
272704,public-offering,100,43,6/3/2019
2D485F,executive-appointment,100,54,6/3/2019
2D643C,donation,100,54,6/3/2019
2E36AD,business-contract,100,69,6/3/2019
2E902B,conference-participant,100,50,6/3/2019
2EB04E,legal-issues-defendant,100,22,6/3/2019
35AE32,executive-appointment,100,54,6/3/2019
36A1CB,executive-resignation,100,44,6/3/2019
384CD3,conference-participant,100,50,6/3/2019
39692D,partnership,100,61,6/3/2019
3B2311,conference-participant,100,50,6/3/2019
3B37F7,executive-appointment,100,54,6/3/2019
3C6CCC,conference-participant,100,50,6/3/2019
3DE4D1,partnership,100,61,6/3/2019
3DE4D1,partnership,100,61,6/3/2019
3F96D5,public-offering,100,43,6/3/2019
414FFF,business-contract,100,69,6/3/2019
42AABD,partnership,100,61,6/3/2019
435ACE,legal-issues-defendant,100,22,6/3/2019
43A060,legal-issues-defendant,100,22,6/3/2019
451D61,clinical-trials,100,56,6/3/2019
451D61,clinical-trials,100,56,6/3/2019
485445,acquisition-completed-acquirer,100,49,6/3/2019
4B3555,executive-appointment,100,54,6/3/2019
4BDCA7,clinical-trials-start,100,64,6/3/2019
4D203E,executive-appointment,100,54,6/3/2019
4DD09F,conference-participant,100,50,6/3/2019
4E5784,executive-appointment,100,54,6/3/2019
4EC4C1,executive-appointment,100,54,6/3/2019
4FB770,business-contract,100,69,6/3/2019
50070E,conference-organizer,100,57,6/3/2019
50070E,conference-organizer,100,57,6/3/2019
50070E,conference-organizer,100,57,6/3/2019
54512F,award,100,58,6/3/2019
54F1D2,conference-organizer,100,57,6/3/2019
55438C,legal-issues-defendant,100,22,6/3/2019
56277A,legal-issues-defendant,100,22,6/3/2019
56EA2B,dividend,100,50,6/3/2019
589846,conference-participant,100,50,6/3/2019
59872F,conference-participant,100,50,6/3/2019
59A832,dividend,100,50,6/3/2019
5A53BF,clinical-trials,100,56,6/3/2019
5A53BF,clinical-trials,100,56,6/3/2019
5C8D61,conference-participant,100,50,6/3/2019
5CEE02,facility-open,100,65,6/3/2019
5E9934,conference-call,100,50,6/3/2019
6166D1,partnership,100,61,6/3/2019
627186,asset-sale,100,62,6/3/2019
69345C,partnership,100,61,6/3/2019
69345C,conference-participant,100,50,6/3/2019
6A3C35,executive-appointment,100,54,6/3/2019
6F0096,dividend,100,50,6/3/2019
71553E,public-offering,100,43,6/3/2019
729368,conference-participant,100,50,6/3/2019
72FCA3,award,100,58,6/3/2019
7999F3,unit-acquisition-acquirer,100,49,6/3/2019
7999F3,public-offering,100,43,6/3/2019
7999F3,public-offering,100,43,6/3/2019
7A2A49,earnings,100,50,6/3/2019
7B492C,unit-acquisition-completed-acquirer,100,49,6/3/2019
7B8CB5,conference-participant,100,50,6/3/2019
7C790D,unit-acquisition-acquirer,100,49,6/3/2019
855DF7,unit-acquisition-acquirer,100,49,6/3/2019
85DE00,conference-participant,100,50,6/3/2019
8614A2,legal-issues-defendant,100,22,6/3/2019
8665BA,partnership,100,61,6/3/2019
8665BA,partnership,100,61,6/3/2019
8876D6,partnership,100,61,6/3/2019
8D4486,product-release,100,64,6/3/2019
8DBBE6,executive-appointment,100,54,6/3/2019
8E10BF,regulatory-product-approval-granted,100,81,6/3/2019
8EF425,dividend,100,50,6/3/2019
8F8F2F,acquisition-completed-acquirer,100,49,6/3/2019
9196A2,conference-organizer,100,57,6/3/2019
91E5EE,drilling,100,68,6/3/2019
92D230,legal-issues-defendant,100,22,6/3/2019
92D757,conference-participant,100,50,6/3/2019
949625,acquisition-completed-acquirer,100,49,6/3/2019
966ACE,conference-participant,100,50,6/3/2019
968103,dividend,100,50,6/3/2019
9.82E+06,business-contract,100,69,6/3/2019
990AD0,conference-organizer,100,57,6/3/2019
990AD0,product-release,100,64,6/3/2019
990AD0,conference-organizer,100,57,6/3/2019
990AD0,conference-organizer,100,57,6/3/2019
9A02C4,executive-appointment,100,54,6/3/2019
9B5968,unit-acquisition-completed-acquiree,100,67,6/3/2019
9B71A7,earnings,100,50,6/3/2019
9CA619,partnership,100,61,6/3/2019
9D5FA4,conference-participant,100,50,6/3/2019
9E4A5F,executive-appointment,100,54,6/3/2019
9F6B1A,loan-recipient,100,59,6/3/2019
9F71E5,executive-appointment,100,54,6/3/2019
A29DBD,executive-appointment,100,54,6/3/2019
A6828A,trading-listing,100,61,6/3/2019
A6828A,trading-listing,100,61,6/3/2019
A6828A,legal-verdict-disfavored,100,22,6/3/2019
A868C9,revenue-up,100,69,6/3/2019
A868C9,revenues,100,50,6/3/2019
A868C9,revenues,100,50,6/3/2019
A868C9,revenues,100,50,6/3/2019
A8E2FE,conference-participant,100,50,6/3/2019
AADE0B,unit-acquisition-completed-acquirer,100,49,6/3/2019
AD1ACF,unit-acquisition-completed-acquirer,100,49,6/3/2019
AD22F2,earnings,100,50,6/3/2019
AD22F2,earnings,100,50,6/3/2019
AD22F2,earnings,100,50,6/3/2019
AD22F2,earnings,100,50,6/3/2019
AD3008,conference-participant,100,50,6/3/2019
AD375D,conference-participant,100,50,6/3/2019
AE79CD,conference-participant,100,50,6/3/2019
AEF2C3,fraud-defendant,100,20,6/3/2019
B13B68,conference-participant,100,50,6/3/2019
B1FC3B,earnings,100,50,6/3/2019
B4703C,buybacks,100,74,6/3/2019
B48D6A,conference-participant,100,50,6/3/2019
B48FC9,product-release,100,64,6/3/2019
B73395,conference-participant,100,50,6/3/2019
B98EFA,conference-participant,100,50,6/3/2019
BBBB41,conference-participant,100,50,6/3/2019
BBF349,executive-appointment,100,54,6/3/2019
BC5680,note-sale,100,52,6/3/2019
BDCC11,legal-issues-defendant,100,22,6/3/2019
BEA527,product-release,100,64,6/3/2019
C0BA36,conference-participant,100,50,6/3/2019
C11C46,conference-participant,100,50,6/3/2019
C65004,regulatory-product-approval-granted,100,81,6/3/2019
C8A248,buybacks,100,74,6/3/2019
CAB222,executive-appointment,100,54,6/3/2019
CBFFDD,government-contract,100,69,6/3/2019
CDAA0E,executive-appointment,100,54,6/3/2019
CDFCC9,conference-participant,100,50,6/3/2019
CFD4B6,conference-participant,100,50,6/3/2019
D1173F,asset-sale,100,62,6/3/2019
D1173F,unit-acquisition-acquiree,100,76,6/3/2019
D2E553,executive-appointment,100,54,6/3/2019
D33270,acquisition-completed-acquirer,100,49,6/3/2019
D622D5,dividend,100,50,6/3/2019
D76AEF,executive-appointment,100,54,6/3/2019
D8442A,legal-issues-defendant,100,22,6/3/2019
D8442A,product-release,100,64,6/3/2019
D8442A,product-release,100,64,6/3/2019
D8442A,product-release,100,64,6/3/2019
DB23C8,conference-participant,100,50,6/3/2019
DB7014,asset-sale,100,62,6/3/2019
E0207A,conference-participant,100,50,6/3/2019
E22FDE,legal-issues-defendant,100,22,6/3/2019
E259C7,acquisition-acquirer,100,49,6/3/2019
E802CE,legal-issues-defendant,100,22,6/3/2019
E8E899,executive-appointment,100,54,6/3/2019
EB1E1A,fast-track-designation,100,81,6/3/2019
EBD89A,business-contract,100,69,6/3/2019
EBD89A,business-contract,100,69,6/3/2019
EC99D0,business-contract,100,69,6/3/2019
EC99D0,business-contract,100,69,6/3/2019
EE74E1,product-release,100,64,6/3/2019
EF5BED,product-release,100,64,6/3/2019
F02170,revenues,100,50,6/3/2019
F02170,revenues,100,50,6/3/2019
F02170,revenues,100,50,6/3/2019
F02170,revenues,100,50,6/3/2019
F0B2B5,executive-appointment,100,54,6/3/2019
F0B2B5,executive-appointment,100,54,6/3/2019
F1EB39,conference-participant,100,50,6/3/2019
F4D241,conference-participant,100,50,6/3/2019
F6E248,product-release,100,64,6/3/2019
F6E248,product-release,100,64,6/3/2019
F7902B,conference-participant,100,50,6/3/2019
FA36A4,earnings,100,50,6/3/2019
FAAFA2,conference-participant,100,50,6/3/2019
FAE021,executive-appointment,100,54,6/3/2019
FAE021,executive-appointment,100,54,6/3/2019
FBD92D,acquisition-completed-acquirer,100,49,6/3/2019
FD2565,conference-participant,100,50,6/3/2019
FD4588,conference-participant,100,50,6/3/2019
FD9A97,conference-participant,100,50,6/3/2019
FE7A63,executive-appointment,100,54,6/3/2019
FF6644,partnership,100,61,6/3/2019
001F1B,legal-issues-defendant,100,22,6/4/2019
00326D,executive-appointment,100,54,6/4/2019
02FC1A,legal-issues-defendant,100,22,6/4/2019
02FC1A,legal-issues-defendant,100,22,6/4/2019
02FC1A,legal-issues-defendant,100,22,6/4/2019
02FC1A,legal-issues-defendant,100,22,6/4/2019
02FC1A,legal-issues-defendant,100,22,6/4/2019
036C6F,legal-issues-defendant,100,22,6/4/2019
070B45,product-release,100,64,6/4/2019
07CA6A,conference-participant,100,50,6/4/2019
07CA6A,conference-participant,100,50,6/4/2019
095A04,regulatory-product-approval-granted,100,81,6/4/2019
0C355F,conference-participant,100,50,6/4/2019
1201B5,business-contract,100,69,6/4/2019
12DE76,partnership,100,61,6/4/2019
139303,conference-organizer,100,57,6/4/2019
139303,conference-organizer,100,57,6/4/2019
16F4D8,conference-participant,100,50,6/4/2019
17EDA5,partnership,100,61,6/4/2019
1880C5,conference-participant,100,50,6/4/2019
1B16C1,legal-issues-defendant,100,22,6/4/2019
1BC12C,award,100,58,6/4/2019
1D943E,conference-participant,100,50,6/4/2019
200D8B,conference-participant,100,50,6/4/2019
225CA2,partnership,100,61,6/4/2019
225CA2,partnership,100,61,6/4/2019
228D42,partnership,100,61,6/4/2019
26CC63,earnings,100,50,6/4/2019
279916,earnings,100,50,6/4/2019
2A1009,regulatory-product-approval-granted,100,81,6/4/2019
2A1009,regulatory-product-approval-granted,100,81,6/4/2019
2EB04E,legal-issues-defendant,100,22,6/4/2019
315EB0,product-release,100,64,6/4/2019
315EB0,product-release,100,64,6/4/2019
31803E,conference-participant,100,50,6/4/2019
32F943,conference-participant,100,50,6/4/2019
33E9D5,conference-participant,100,50,6/4/2019
3461CF,credit-rating-outlook-stable-rater,20,50,6/4/2019
3461CF,credit-rating-outlook-stable-rater,20,50,6/4/2019
35AE32,conference-participant,100,50,6/4/2019
367E1C,conference-participant,100,50,6/4/2019
36C09B,conference-participant,100,50,6/4/2019
37B618,unit-acquisition-acquirer,100,49,6/4/2019
38C46F,dividend,100,50,6/4/2019
3AAEAE,conference-participant,100,50,6/4/2019
3B50FE,earnings,100,50,6/4/2019
3C7F5F,partnership,100,61,6/4/2019
3D7971,dividend,100,50,6/4/2019
3DCECC,public-offering,100,43,6/4/2019
3DCECC,note-sale,100,52,6/4/2019
3F96D5,executive-appointment,100,54,6/4/2019
3FACA7,partnership,100,61,6/4/2019
4.03E+05,executive-appointment,100,54,6/4/2019
40B903,dividend,100,50,6/4/2019
41C36B,conference-participant,100,50,6/4/2019
427F32,dividend,100,50,6/4/2019
442769,business-contract,100,69,6/4/2019
449447,acquisition-acquirer,100,49,6/4/2019
45ABCC,facility-open,100,65,6/4/2019
4A6F00,partnership,100,61,6/4/2019
4AC91D,partnership,100,61,6/4/2019
4AC91D,partnership,100,61,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
50070E,conference-organizer,100,57,6/4/2019
504FE2,award,100,58,6/4/2019
532D47,buybacks,100,74,6/4/2019
55438C,stake-acquirer,100,48,6/4/2019
56EA2B,award,100,58,6/4/2019
57EF50,acquisition-completed-acquirer,100,49,6/4/2019
5B6C11,dividend,100,50,6/4/2019
609208,conference-call,100,50,6/4/2019
60EA12,conference-participant,100,50,6/4/2019
6137BF,conference-participant,100,50,6/4/2019
619882,conference-organizer,100,57,6/4/2019
627186,conference-participant,100,50,6/4/2019
68E6E9,earnings,100,50,6/4/2019
6CC55E,clinical-trials-start,100,64,6/4/2019
71553E,public-offering,100,43,6/4/2019
732A9B,partnership,100,61,6/4/2019
73A71F,award,100,58,6/4/2019
73A71F,executive-appointment,100,54,6/4/2019
73C521,executive-appointment,100,54,6/4/2019
73F70F,conference-call,100,50,6/4/2019
73F7F9,conference-call,100,50,6/4/2019
7999F3,public-offering,100,43,6/4/2019
7999F3,public-offering,100,43,6/4/2019
7AC86E,product-release,100,64,6/4/2019
7ADE57,conference-call,100,50,6/4/2019
7B9212,dividend,100,50,6/4/2019
7E1D5D,partnership,100,61,6/4/2019
826FD6,earnings,100,50,6/4/2019
862941,conference-participant,100,50,6/4/2019
86AA9C,legal-issues-defendant,100,22,6/4/2019
885758,legal-issues-defendant,100,22,6/4/2019
8AB37F,public-offering,100,43,6/4/2019
8B9B3B,legal-issues-defendant,100,22,6/4/2019
8BAA15,unit-acquisition-completed-acquirer,100,49,6/4/2019
8CF6DD,conference-participant,100,50,6/4/2019
8DCF18,conference-participant,100,50,6/4/2019
8E4F9A,fundraising,100,64,6/4/2019
911CA9,conference-participant,100,50,6/4/2019
9196A2,conference-organizer,100,57,6/4/2019
9196A2,conference-organizer,100,57,6/4/2019
9196A2,conference-organizer,100,57,6/4/2019
9196A2,conference-organizer,100,57,6/4/2019
92B73F,joint-venture,100,62,6/4/2019
92D230,legal-issues-defendant,100,22,6/4/2019
94637C,conference-participant,100,50,6/4/2019
954004,earnings,100,50,6/4/2019
9.65E+09,credit-extension-recipient,100,69,6/4/2019
990AD0,conference-organizer,100,57,6/4/2019
9E575E,conference-participant,100,50,6/4/2019
9F37C5,buybacks,100,74,6/4/2019
A63820,earnings,100,50,6/4/2019
A790A5,conference-call,100,50,6/4/2019
A8AC4C,conference-participant,100,50,6/4/2019
AA98ED,partnership,100,61,6/4/2019
AC7C4F,executive-resignation,100,44,6/4/2019
AD23DE,executive-appointment,100,54,6/4/2019
AD6141,asset-sale,100,62,6/4/2019
AECCA9,dividend,100,50,6/4/2019
AED61E,earnings,100,50,6/4/2019
AEF2C3,legal-issues-defendant,100,22,6/4/2019
AFDF2E,legal-issues-defendant,100,22,6/4/2019
B3CB74,conference-organizer,100,57,6/4/2019
B4703C,product-release,100,64,6/4/2019
B4703C,legal-issues-defendant,100,22,6/4/2019
B83BCE,earnings-guidance,100,50,6/4/2019
B8A51F,patient-enrollment-complete,100,64,6/4/2019
B96637,product-release,100,64,6/4/2019
BB127B,earnings-up,100,68,6/4/2019
BDCC11,legal-issues-defendant,100,22,6/4/2019
C037A8,conference-participant,100,50,6/4/2019
C48574,earnings,100,50,6/4/2019
C97B2D,legal-issues-defendant,100,22,6/4/2019
C9A96E,note-sale,100,52,6/4/2019
C9D866,partnership,100,61,6/4/2019
CDAF5B,dividend,100,50,6/4/2019
CFF97C,conference-participant,100,50,6/4/2019
CFF97C,conference-participant,100,50,6/4/2019
D1173F,unit-acquisition-acquiree,100,76,6/4/2019
D1AE3B,conference-call,100,50,6/4/2019
D42DBA,earnings,100,50,6/4/2019
D42DBA,earnings,100,50,6/4/2019
D64EDF,note-sale,100,52,6/4/2019
D8442A,partnership,100,61,6/4/2019
D8442A,legal-issues-defendant,100,22,6/4/2019
DE5611,earnings,100,50,6/4/2019
E124EB,executive-appointment,100,54,6/4/2019
E124EB,product-release,100,64,6/4/2019
E22FDE,executive-appointment,100,54,6/4/2019
E2CB7B,note-sale,100,52,6/4/2019
E8846E,conference-organizer,100,57,6/4/2019
E8A49A,conference-participant,100,50,6/4/2019
EB5E78,earnings-guidance,100,50,6/4/2019
EBD89A,conference-participant,100,50,6/4/2019
EE967B,public-offering,100,43,6/4/2019
F4D241,public-offering,100,43,6/4/2019
F4E882,business-contract,100,69,6/4/2019
F51DB0,legal-issues-defendant,100,22,6/4/2019
F66B58,earnings,100,50,6/4/2019
F6FF0D,legal-issues-defendant,100,22,6/4/2019
F793FA,facility-open,100,65,6/4/2019
FAB97A,executive-appointment,100,54,6/4/2019
FBD92D,product-release,100,64,6/4/2019
FC4550,dividend,100,50,6/4/2019
FC9A88,executive-appointment,100,54,6/4/2019
FE7A63,dividend,100,50,6/4/2019
00067A,conference-participant,100,50,6/5/2019
002A99,executive-appointment,100,54,6/5/2019
02FC1A,legal-issues-defendant,100,22,6/5/2019
02FC1A,legal-issues-defendant,100,22,6/5/2019
036C6F,legal-issues-defendant,100,22,6/5/2019
036C6F,legal-issues-defendant,100,22,6/5/2019
03B8CF,asset-sale,100,62,6/5/2019
0490C6,conference-participant,100,50,6/5/2019
0BD4E8,executive-appointment,100,54,6/5/2019
0C136E,partnership,100,61,6/5/2019
0C8D82,fundraising,100,64,6/5/2019
10100E,conference-participant,100,50,6/5/2019
12DE76,dividend,100,50,6/5/2019
12F98C,executive-appointment,100,54,6/5/2019
14BA06,dividend,100,50,6/5/2019
14BA33,dividend,100,50,6/5/2019
1748F6,earnings,100,50,6/5/2019
190B91,partnership,100,61,6/5/2019
1C2593,public-offering,100,43,6/5/2019
1CF3A8,public-offering,100,43,6/5/2019
1D943E,facility-open,100,65,6/5/2019
1E83DE,earnings,100,50,6/5/2019
205AD5,dividend-up,100,81,6/5/2019
221445,dividend,100,50,6/5/2019
228D42,partnership,100,61,6/5/2019
228D42,partnership,100,61,6/5/2019
292A70,earnings,100,50,6/5/2019
2B5483,product-release,100,64,6/5/2019
2C35B5,executive-appointment,100,54,6/5/2019
2CC60C,revenues,100,50,6/5/2019
32DCB3,conference-call,100,50,6/5/2019
339F20,dividend,100,50,6/5/2019
34B97A,public-offering,100,43,6/5/2019
3B318A,earnings,100,50,6/5/2019
3E39A5,conference-participant,100,50,6/5/2019
3F6A9C,conference-participant,100,50,6/5/2019
3F96D5,public-offering,100,43,6/5/2019
40F7DE,credit-extension-provider,100,57,6/5/2019
416C55,dividend,100,50,6/5/2019
43A060,legal-issues-defendant,100,22,6/5/2019
451D61,executive-resignation,100,44,6/5/2019
499C75,award,100,58,6/5/2019
4A2457,business-contract,100,69,6/5/2019
4C6C63,note-sale,100,52,6/5/2019
50070E,conference-organizer,100,57,6/5/2019
50070E,conference-organizer,100,57,6/5/2019
50070E,conference-organizer,100,57,6/5/2019
50070E,conference-organizer,100,57,6/5/2019
50070E,conference-organizer,100,57,6/5/2019
525A1C,partnership,100,61,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
543900,earnings,100,50,6/5/2019
553949,executive-appointment,100,54,6/5/2019
55C9B5,partnership,100,61,6/5/2019
55CD6F,partnership,100,61,6/5/2019
589846,product-release,100,64,6/5/2019
594402,conference-participant,100,50,6/5/2019
59C539,merger,100,66,6/5/2019
5AA3B1,public-offering,100,43,6/5/2019
5B97B2,product-release,100,64,6/5/2019
5BC2F4,executive-appointment,100,54,6/5/2019
5EF130,conference-call,100,50,6/5/2019
5FF95F,legal-issues-defendant,100,22,6/5/2019
6166D1,conference-call,100,50,6/5/2019
619882,partnership,100,61,6/5/2019
61A586,conference-participant,100,50,6/5/2019
61A586,public-offering,100,43,6/5/2019
636BBF,earnings,100,50,6/5/2019
636BBF,executive-appointment,100,54,6/5/2019
65D0AA,revenue-up,100,69,6/5/2019
6A961B,conference-participant,100,50,6/5/2019
6D156D,conference-participant,100,50,6/5/2019
6FCEF9,conference-participant,100,50,6/5/2019
70CA28,conference-participant,100,50,6/5/2019
70FCEF,earnings,100,50,6/5/2019
72CB93,conference-participant,100,50,6/5/2019
7.45E+28,conference-participant,100,50,6/5/2019
756BB4,earnings,100,50,6/5/2019
76DD0C,patent-awarded,100,72,6/5/2019
775439,earnings,100,50,6/5/2019
787D14,conference-participant,100,50,6/5/2019
789ADD,conference-participant,100,50,6/5/2019
791D59,award,100,58,6/5/2019
7B1156,conference-participant,100,50,6/5/2019
7FEEE1,conference-participant,100,50,6/5/2019
804708,executive-appointment,100,54,6/5/2019
830BDB,conference-participant,100,50,6/5/2019
859D62,earnings-positive,100,69,6/5/2019
859D62,earnings-positive,100,69,6/5/2019
859D62,earnings-positive,100,69,6/5/2019
859D62,earnings-positive,100,69,6/5/2019
859D62,earnings-positive,100,69,6/5/2019
859D62,earnings-positive,100,69,6/5/2019
8614A2,legal-issues-defendant,100,22,6/5/2019
87B81A,conference-participant,100,50,6/5/2019
880C0C,dividend,100,50,6/5/2019
8A8E41,partnership,100,61,6/5/2019
8AB37F,public-offering,100,43,6/5/2019
8B6E7E,legal-issues-defendant,100,22,6/5/2019
8B8656,earnings,100,50,6/5/2019
8B9B3B,legal-issues-defendant,100,22,6/5/2019
8EDACA,conference-participant,100,50,6/5/2019
9470CC,award,100,58,6/5/2019
9592FB,acquisition-acquirer,100,49,6/5/2019
968966,partnership,100,61,6/5/2019
972356,product-release,100,64,6/5/2019
9.82E+06,earnings,100,50,6/5/2019
990AD0,conference-organizer,100,57,6/5/2019
9BF177,earnings,100,50,6/5/2019
9D30A8,unit-acquisition-acquirer,100,49,6/5/2019
9EBAFA,acquisition-acquirer,100,49,6/5/2019
A1EAC8,executive-appointment,100,54,6/5/2019
A2C979,clinical-trials,100,56,6/5/2019
A37D68,earnings,100,50,6/5/2019
A43906,conference-participant,100,50,6/5/2019
A495F7,partnership,100,61,6/5/2019
A495F7,partnership,100,61,6/5/2019
A6FB29,earnings,100,50,6/5/2019
A790A5,earnings,100,50,6/5/2019
A94637,facility-open,100,65,6/5/2019
AA09AD,business-contract,100,69,6/5/2019
AECCA9,earnings,100,50,6/5/2019
AECCA9,earnings,100,50,6/5/2019
AECCA9,earnings,100,50,6/5/2019
AECCA9,earnings,100,50,6/5/2019
AECCA9,earnings,100,50,6/5/2019
AECCA9,earnings,100,50,6/5/2019
AEF2C3,legal-issues-defendant,100,22,6/5/2019
B05000,market-entry,100,57,6/5/2019
B05000,market-entry,100,57,6/5/2019
B1FC3B,earnings,100,50,6/5/2019
B1FC3B,dividend,100,50,6/5/2019
B3CB74,conference-organizer,100,57,6/5/2019
B5BA39,legal-issues-defendant,100,22,6/5/2019
B8EF97,revenues,100,50,6/5/2019
B9CD50,business-contract,100,69,6/5/2019
BDCC11,legal-issues-defendant,100,22,6/5/2019
C07E05,shareholder-rights-plan,100,43,6/5/2019
C15DB3,acquisition-completed-acquirer,100,49,6/5/2019
C188F8,clinical-trials-start,100,64,6/5/2019
C32A39,executive-appointment,100,54,6/5/2019
C4F9C6,patent-awarded,100,72,6/5/2019
C5D2AE,award,100,58,6/5/2019
C8923A,private-placement,100,56,6/5/2019
CBB77B,dividend,100,50,6/5/2019
CC6FF5,conference-participant,100,50,6/5/2019
CC8F6E,conference-participant,100,50,6/5/2019
CE5664,credit-extension-recipient,100,69,6/5/2019
CF211D,earnings,100,50,6/5/2019
CF6A5A,executive-appointment,100,54,6/5/2019
D0909F,dividend,100,50,6/5/2019
D75910,executive-appointment,100,54,6/5/2019
D8442A,product-recall,100,29,6/5/2019
DA91AE,dividend,100,50,6/5/2019
DB88A1,legal-issues-defendant,100,22,6/5/2019
DCD97F,dividend,100,50,6/5/2019
DDCB34,conference-participant,100,50,6/5/2019
E09556,conference-call,100,50,6/5/2019
E0F4E5,executive-appointment,100,54,6/5/2019
E4CE73,conference-participant,100,50,6/5/2019
E8846E,donation,100,54,6/5/2019
E8846E,donation,100,54,6/5/2019
EB2F14,executive-appointment,100,54,6/5/2019
F0027C,patient-enrollment-complete,100,64,6/5/2019
F3FCC3,earnings-guidance,100,50,6/5/2019
F46EC9,conference-participant,100,50,6/5/2019
F4CDA3,unit-acquisition-acquirer,100,49,6/5/2019
FD6926,conference-participant,100,50,6/5/2019
FEBFE1,earnings,100,50,6/5/2019
02FC1A,legal-issues-defendant,100,22,6/6/2019
02FC1A,legal-issues-defendant,100,22,6/6/2019
03B8CF,business-contract,100,69,6/6/2019
07EC43,conference-participant,100,50,6/6/2019
09F623,donation,100,54,6/6/2019
0B73A7,earnings,100,50,6/6/2019
0B73A7,earnings,100,50,6/6/2019
0BC29E,executive-appointment,100,54,6/6/2019
0BD4E8,dividend,100,50,6/6/2019
0BF198,conference-participant,100,50,6/6/2019
0F04E5,award,100,58,6/6/2019
0F04E5,award,100,58,6/6/2019
0FABBD,executive-appointment,100,54,6/6/2019
1272B3,partnership,100,61,6/6/2019
12DE76,conference-organizer,100,57,6/6/2019
15B10D,conference-participant,100,50,6/6/2019
16C544,dividend,100,50,6/6/2019
1AD9CC,earnings,100,50,6/6/2019
1DE526,executive-appointment,100,54,6/6/2019
1F08A6,facility-open,100,65,6/6/2019
1F9258,conference-participant,100,50,6/6/2019
225CA2,unit-acquisition-acquirer,100,49,6/6/2019
228D42,partnership,100,61,6/6/2019
228D42,partnership,100,61,6/6/2019
228D42,partnership,100,61,6/6/2019
228D42,partnership,100,61,6/6/2019
241AF7,dividend,100,50,6/6/2019
26DC29,earnings,100,50,6/6/2019
284289,product-release,100,64,6/6/2019
29A4CC,executive-appointment,100,54,6/6/2019
2CC60C,dividend,100,50,6/6/2019
2EC172,business-contract,100,69,6/6/2019
2F98A5,earnings,100,50,6/6/2019
3390DE,conference-participant,100,50,6/6/2019
36E479,clinical-trials-start,100,64,6/6/2019
371B0A,conference-participant,100,50,6/6/2019
3C7F5F,earnings,100,50,6/6/2019
3DCECC,note-sale,100,52,6/6/2019
416C55,executive-appointment,100,54,6/6/2019
42978B,dividend,100,50,6/6/2019
4676DF,business-contract,100,69,6/6/2019
47752F,product-release,100,64,6/6/2019
49914B,asset-sale,100,62,6/6/2019
49BBBC,product-release,100,64,6/6/2019
4A6F00,partnership,100,61,6/6/2019
4BEB48,award,100,58,6/6/2019
4E4E75,conference-call,100,50,6/6/2019
50070E,conference-organizer,100,57,6/6/2019
50070E,conference-organizer,100,57,6/6/2019
50070E,conference-organizer,100,57,6/6/2019
50070E,conference-organizer,100,57,6/6/2019
510EA1,clinical-trials-positive,100,87,6/6/2019
52BF94,conference-call,100,50,6/6/2019
52FB2F,conference-participant,100,50,6/6/2019
583A75,revenue-volume,100,50,6/6/2019
58C2D4,asset-sale,100,62,6/6/2019
5D02B7,asset-sale,100,62,6/6/2019
5EF130,revenues,100,50,6/6/2019
5EF130,earnings,100,50,6/6/2019
5EF130,earnings,100,50,6/6/2019
5F9CE3,legal-issues-defendant,100,22,6/6/2019
5FF95F,legal-issues-defendant,100,22,6/6/2019
60EA12,executive-appointment,100,54,6/6/2019
619882,conference-organizer,100,57,6/6/2019
620381,conference-participant,100,50,6/6/2019
636BBF,legal-issues-defendant,100,22,6/6/2019
636BBF,legal-issues-defendant,100,22,6/6/2019
64E346,conference-participant,100,50,6/6/2019
6830FE,product-release,100,64,6/6/2019
6E8864,executive-appointment,100,54,6/6/2019
6F3936,earnings,100,50,6/6/2019
6F3936,earnings,100,50,6/6/2019
6F3936,earnings,100,50,6/6/2019
6F3936,earnings,100,50,6/6/2019
6F3936,earnings,100,50,6/6/2019
6F3936,earnings,100,50,6/6/2019
722D55,executive-resignation,100,44,6/6/2019
732A9B,conference-participant,100,50,6/6/2019
747219,conference-participant,100,50,6/6/2019
7740DE,same-store-sales-up,100,51,6/6/2019
78F776,earnings,100,50,6/6/2019
7A0EC4,earnings,100,50,6/6/2019
7A10FF,conference-participant,100,50,6/6/2019
7AC86E,partnership,100,61,6/6/2019
7B4B91,dividend,100,50,6/6/2019
7B9212,revenues,100,50,6/6/2019
7DD8CC,award,100,58,6/6/2019
810FAD,conference-participant,100,50,6/6/2019
863350,earnings,100,50,6/6/2019
86AA9C,expenses-down,100,61,6/6/2019
86AA9C,expenses-down,100,61,6/6/2019
86AA9C,expenses-down,100,61,6/6/2019
86AA9C,expenses-down,100,61,6/6/2019
86AA9C,legal-issues-defendant,100,22,6/6/2019
86BAC7,board-meeting,100,51,6/6/2019
877C0C,conference-participant,100,50,6/6/2019
8A8E41,dividend,100,50,6/6/2019
8B6E7E,legal-issues-defendant,100,22,6/6/2019
8B6E7E,legal-issues-defendant,100,22,6/6/2019
8D0EEA,grant-recipient,100,63,6/6/2019
9196A2,conference-organizer,100,57,6/6/2019
93C130,buybacks,100,74,6/6/2019
94637C,earnings,100,50,6/6/2019
95DC1F,conference-call,100,50,6/6/2019
986AF6,dividend,100,50,6/6/2019
9D56F2,conference-call,100,50,6/6/2019
9D5D35,executive-appointment,100,54,6/6/2019
9E575E,executive-appointment,100,54,6/6/2019
9EF4CF,earnings,100,50,6/6/2019
9F6B1A,legal-issues-defendant,100,22,6/6/2019
A3AAA5,dividend,100,50,6/6/2019
A495F7,product-release,100,64,6/6/2019
A63387,business-contract,100,69,6/6/2019
A666C8,award,100,58,6/6/2019
A6828A,business-contract,100,69,6/6/2019
A72FD9,earnings,100,50,6/6/2019
A79F7D,executive-appointment,100,54,6/6/2019
A8CBDA,executive-resignation,100,44,6/6/2019
A8FDE8,conference-participant,100,50,6/6/2019
ADD9DC,facility-open,100,65,6/6/2019
B09B1F,executive-appointment,100,54,6/6/2019
B3CB74,conference-organizer,100,57,6/6/2019
B3CB74,conference-organizer,100,57,6/6/2019
B4703C,legal-issues-defendant,100,22,6/6/2019
B4703C,legal-issues-defendant,100,22,6/6/2019
B840EF,partnership,100,61,6/6/2019
B8F71F,dividend-up,100,81,6/6/2019
BC5680,note-sale,100,52,6/6/2019
C4452A,dividend,100,50,6/6/2019
C9E107,conference-participant,100,50,6/6/2019
C9E4EC,conference-participant,100,50,6/6/2019
CD4DA8,executive-appointment,100,54,6/6/2019
CE2791,award,100,58,6/6/2019
CE5664,conference-participant,100,50,6/6/2019
D064D5,earnings-up,100,68,6/6/2019
D06755,award,100,58,6/6/2019
D07B07,legal-issues-defendant,100,22,6/6/2019
D17C1B,market-entry,100,57,6/6/2019
D1C26F,earnings,100,50,6/6/2019
D1CFC8,partnership,100,61,6/6/2019
D64C6D,executive-appointment,100,54,6/6/2019
D64EDF,note-sale,100,52,6/6/2019
D76AEF,conference-participant,100,50,6/6/2019
DC5299,note-sale,100,52,6/6/2019
DDB002,conference-participant,100,50,6/6/2019
E2CB7B,conference-participant,100,50,6/6/2019
E68C3D,conference-participant,100,50,6/6/2019
E6E012,executive-appointment,100,54,6/6/2019
E6E012,executive-appointment,100,54,6/6/2019
E8846E,donation,100,54,6/6/2019
E8846E,executive-appointment,100,54,6/6/2019
EB5E78,conference-participant,100,50,6/6/2019
EB7FBF,conference-call,100,50,6/6/2019
ECA300,conference-participant,100,50,6/6/2019
EF5BED,executive-appointment,100,54,6/6/2019
F0B2B5,executive-appointment,100,54,6/6/2019
F48947,legal-issues-defendant,100,22,6/6/2019
F5349B,executive-appointment,100,54,6/6/2019
F5D410,conference-participant,100,50,6/6/2019
FA40E2,earnings,100,50,6/6/2019
FD4BBE,conference-participant,100,50,6/6/2019
FEC475,earnings,100,50,6/6/2019
FF5413,revenue-volume,100,50,6/6/2019
FF6644,product-release,100,64,6/6/2019
001F1B,revenues,100,50,6/7/2019
001F1B,revenues,100,50,6/7/2019
02FC1A,legal-issues-defendant,100,22,6/7/2019
0AD2E3,conference-participant,100,50,6/7/2019
0B400D,trading-halt,100,43,6/7/2019
10AE08,name-change,100,49,6/7/2019
1DE526,conference-participant,100,50,6/7/2019
1E83DE,conference-participant,100,50,6/7/2019
1F08A6,dividend,100,50,6/7/2019
26DC29,partnership,100,61,6/7/2019
275300,conference-participant,100,50,6/7/2019
2EBA55,dividend,100,50,6/7/2019
3A6D90,dividend,100,50,6/7/2019
3BB616,dividend-up,100,81,6/7/2019
435ACE,legal-issues-defendant,100,22,6/7/2019
448215,dividend-up,100,81,6/7/2019
4A6F00,regulatory-product-approval-granted,100,81,6/7/2019
4B3DC9,merger-regulatory-approval,100,81,6/7/2019
4D229C,legal-issues-defendant,100,22,6/7/2019
50070E,conference-organizer,100,57,6/7/2019
50070E,conference-organizer,100,57,6/7/2019
50070E,conference-organizer,100,57,6/7/2019
55438C,legal-issues-defendant,100,22,6/7/2019
55438C,legal-issues-defendant,100,22,6/7/2019
5C61CC,executive-appointment,100,54,6/7/2019
636BBF,legal-issues-defendant,100,22,6/7/2019
636BBF,legal-issues-defendant,100,22,6/7/2019
665D7D,conference-participant,100,50,6/7/2019
6F39FC,dividend,100,50,6/7/2019
71553E,public-offering,100,43,6/7/2019
726EEA,conference-participant,100,50,6/7/2019
75768D,conference-call,100,50,6/7/2019
76F067,conference-participant,100,50,6/7/2019
7823A3,partnership,100,61,6/7/2019
86AA9C,legal-issues-defendant,100,22,6/7/2019
8B6E7E,legal-issues-defendant,100,22,6/7/2019
8B6E7E,legal-issues-defendant,100,22,6/7/2019
9196A2,conference-organizer,100,57,6/7/2019
9A602D,product-release,100,64,6/7/2019
A47A7D,facility-open,100,65,6/7/2019
A4BCDE,dividend,100,50,6/7/2019
A4CD53,partnership,100,61,6/7/2019
A6213D,partnership,100,61,6/7/2019
AA7FE0,conference-call,100,50,6/7/2019
AEF2C3,legal-issues-defendant,100,22,6/7/2019
B762D3,earnings,100,50,6/7/2019
B762D3,earnings,100,50,6/7/2019
B762D3,earnings,100,50,6/7/2019
B8A51F,conference-participant,100,50,6/7/2019
BDF85E,conference-participant,100,50,6/7/2019
BFE02C,earnings,100,50,6/7/2019
C0BA36,conference-participant,100,50,6/7/2019
C9A96E,note-sale,100,52,6/7/2019
C9E107,executive-appointment,100,54,6/7/2019
CA1620,dividend,100,50,6/7/2019
CEDFD5,acquisition-completed-acquirer,100,49,6/7/2019
CEDFD5,acquisition-completed-acquirer,100,49,6/7/2019
CFD4B6,conference-participant,100,50,6/7/2019
D57D99,product-release,100,64,6/7/2019
D622D5,operating-earnings,100,50,6/7/2019
E802CE,legal-issues-defendant,100,22,6/7/2019
E8846E,conference-organizer,100,57,6/7/2019
EF5914,executive-appointment,100,54,6/7/2019
F66B58,executive-appointment,100,54,6/7/2019
FBDA0F,acquisition-acquirer,100,49,6/7/2019
FBDA0F,acquisition-acquirer,100,49,6/7/2019
636BBF,legal-issues-defendant,100,22,6/8/2019
8B6E7E,legal-issues-defendant,100,22,6/8/2019
AFDF2E,legal-issues-defendant,100,22,6/8/2019
DB06B0,partnership,100,61,6/8/2019
F02170,legal-issues-defendant,100,22,6/8/2019
202E5A,conference-participant,100,50,6/9/2019
002A99,conference-participant,100,50,6/10/2019
054B55,executive-appointment,100,54,6/10/2019
09DE1F,award,100,58,6/10/2019
0B400D,trading-resumed,100,58,6/10/2019
0BA2EF,earnings,100,50,6/10/2019
0BA2EF,earnings,100,50,6/10/2019
0C8D82,public-offering,100,43,6/10/2019
12E454,product-release,100,64,6/10/2019
1490F3,note-sale,100,52,6/10/2019
168A5D,facility-open,100,65,6/10/2019
1748F6,conference-participant,100,50,6/10/2019
18D9FA,fundraising,100,64,6/10/2019
190B91,note-sale,100,52,6/10/2019
1921DD,partnership,100,61,6/10/2019
1E9A6D,executive-appointment,100,54,6/10/2019
1F43A1,note-sale,100,52,6/10/2019
2158DF,partnership,100,61,6/10/2019
21D903,legal-issues-defendant,100,22,6/10/2019
221AD7,executive-appointment,100,54,6/10/2019
227F04,note-sale,100,52,6/10/2019
24C48B,acquisition-completed-acquirer,100,49,6/10/2019
25A6CC,conference-participant,100,50,6/10/2019
2667B6,dividend,100,50,6/10/2019
27BFA1,dividend,100,50,6/10/2019
2ABF77,conference-participant,100,50,6/10/2019
2EC172,conference-participant,100,50,6/10/2019
31553A,earnings,100,50,6/10/2019
3159AA,conference-organizer,100,57,6/10/2019
33E9D5,earnings,100,50,6/10/2019
382EAE,executive-appointment,100,54,6/10/2019
3FACA7,joint-venture,100,62,6/10/2019
414FFF,executive-appointment,100,54,6/10/2019
420168,dividend,100,50,6/10/2019
42312F,index-listing,100,76,6/10/2019
435ACE,legal-issues-defendant,100,22,6/10/2019
43A060,legal-issues-defendant,100,22,6/10/2019
44209A,reorganization-unit,100,53,6/10/2019
451D61,conference-participant,100,50,6/10/2019
458D2C,revenue-volume,100,50,6/10/2019
467F2C,conference-participant,100,50,6/10/2019
4.60E+06,index-listing,100,76,6/10/2019
4F9926,product-release,100,64,6/10/2019
50070E,conference-organizer,100,57,6/10/2019
50070E,conference-organizer,100,57,6/10/2019
50070E,conference-organizer,100,57,6/10/2019
50070E,conference-organizer,100,57,6/10/2019
507AE7,executive-appointment,100,54,6/10/2019
5225A4,conference-participant,100,50,6/10/2019
543900,executive-appointment,100,54,6/10/2019
54A713,unit-acquisition-acquirer,100,49,6/10/2019
54A713,public-offering,100,43,6/10/2019
55438C,legal-issues-defendant,100,22,6/10/2019
59F0B0,conference-call,100,50,6/10/2019
5C2A47,partnership,100,61,6/10/2019
5C7601,executive-appointment,100,54,6/10/2019
5C8D61,executive-appointment,100,54,6/10/2019
5D43A7,acquisition-acquirer,100,49,6/10/2019
5E9934,earnings,100,50,6/10/2019
62CDDE,conference-participant,100,50,6/10/2019
636BBF,legal-issues-defendant,100,22,6/10/2019
636BBF,legal-issues-defendant,100,22,6/10/2019
636BBF,legal-issues-defendant,100,22,6/10/2019
636BBF,legal-issues-defendant,100,22,6/10/2019
6559D8,public-offering,100,43,6/10/2019
66E04A,note-sale,100,52,6/10/2019
66E04A,note-sale,100,52,6/10/2019
6844D2,dividend,100,50,6/10/2019
69345C,product-release,100,64,6/10/2019
69345C,product-release,100,64,6/10/2019
69345C,product-release,100,64,6/10/2019
6B236C,debt-restructuring,100,59,6/10/2019
6C6D73,index-listing,100,76,6/10/2019
6E705B,executive-appointment,100,54,6/10/2019
6F5DD2,index-listing,100,76,6/10/2019
763724,acquisition-completed-acquiree,100,76,6/10/2019
817ED9,conference-participant,100,50,6/10/2019
8AB85C,clinical-trials-positive,100,87,6/10/2019
8B6E7E,legal-issues-defendant,100,22,6/10/2019
8B6E7E,legal-issues-defendant,100,22,6/10/2019
8BAA15,conference-call,100,50,6/10/2019
9196A2,conference-organizer,100,57,6/10/2019
9196A2,conference-organizer,100,57,6/10/2019
91E5EE,executive-resignation,100,44,6/10/2019
92D230,legal-issues-defendant,100,22,6/10/2019
954004,executive-appointment,100,54,6/10/2019
9592FB,conference-participant,100,50,6/10/2019
980C14,dividend,100,50,6/10/2019
9C25FF,partnership,100,61,6/10/2019
9F5997,note-sale,100,52,6/10/2019
A017F4,clinical-trials-start,100,64,6/10/2019
A26C26,earnings,100,50,6/10/2019
A4F67C,acquisition-acquirer,100,49,6/10/2019
A4F67C,public-offering,100,43,6/10/2019
A63387,business-contract,100,69,6/10/2019
A80FE0,note-sale,100,52,6/10/2019
ADF092,earnings,100,50,6/10/2019
AFDF2E,legal-issues-defendant,100,22,6/10/2019
B1B10C,earnings-guidance-up,100,83,6/10/2019
B33E77,award,100,58,6/10/2019
B3CB74,conference-organizer,100,57,6/10/2019
B3CB74,conference-organizer,100,57,6/10/2019
BB127B,acquisition-acquirer,100,49,6/10/2019
BB127B,acquisition-acquirer,100,49,6/10/2019
BB127B,acquisition-acquirer,100,49,6/10/2019
BCC55F,note-sale,100,52,6/10/2019
BFCACF,executive-appointment,100,54,6/10/2019
C16A8F,executive-appointment,100,54,6/10/2019
C7AE14,business-contract,100,69,6/10/2019
C7AE14,business-contract,100,69,6/10/2019
C97B2D,legal-issues-defendant,100,22,6/10/2019
C99CC8,partnership,100,61,6/10/2019
CBCC6A,conference-organizer,100,57,6/10/2019
CDFCC9,conference-participant,100,50,6/10/2019
CE5664,product-release,100,64,6/10/2019
D29B44,conference-participant,100,50,6/10/2019
D2E553,earnings,100,50,6/10/2019
D2E553,earnings,100,50,6/10/2019
D2E553,earnings,100,50,6/10/2019
D36B23,earnings,100,50,6/10/2019
D3CEDF,executive-appointment,100,54,6/10/2019
D437C3,award,100,58,6/10/2019
D4C0CB,conference-participant,100,50,6/10/2019
D8442A,legal-issues-defendant,100,22,6/10/2019
D9C07E,partnership,100,61,6/10/2019
E0207A,conference-participant,100,50,6/10/2019
E074A0,partnership,100,61,6/10/2019
E09556,earnings,100,50,6/10/2019
E16133,executive-resignation,100,44,6/10/2019
E22FDE,partnership,100,61,6/10/2019
E38906,business-contract,100,69,6/10/2019
E802CE,legal-issues-defendant,100,22,6/10/2019
E8C557,business-contract,100,69,6/10/2019
F02170,executive-appointment,100,54,6/10/2019
F02170,legal-issues-defendant,100,22,6/10/2019
F02170,legal-issues-defendant,100,22,6/10/2019
F02170,legal-issues-defendant,100,22,6/10/2019
F51DB0,legal-issues-defendant,100,22,6/10/2019
F569FD,conference-call,100,50,6/10/2019
F88147,trading-listing,100,61,6/10/2019
FA840E,executive-appointment,100,54,6/10/2019
FF6644,partnership,100,61,6/10/2019
FF6644,partnership,100,61,6/10/2019
FF6644,partnership,100,61,6/10/2019
001F1B,legal-issues-defendant,100,22,6/11/2019
13528,product-release,100,64,6/11/2019
01B8D6,earnings,100,50,6/11/2019
31025,partnership,100,61,6/11/2019
034B61,legal-issues-defendant,100,22,6/11/2019
036C6F,legal-issues-defendant,100,22,6/11/2019
03B431,earnings-guidance,100,50,6/11/2019
03D5F9,reorganization,100,53,6/11/2019
03D5F9,reorganization,100,53,6/11/2019
95294,unit-acquisition-regulatory-approval-acquirer,100,53,6/11/2019
95294,unit-acquisition-regulatory-approval-acquirer,100,53,6/11/2019
95294,unit-acquisition-regulatory-approval-acquirer,100,53,6/11/2019
95294,unit-acquisition-regulatory-approval-acquirer,100,53,6/11/2019
0B7375,conference-participant,100,50,6/11/2019
0F0440,donation,100,54,6/11/2019
11074E,conference-participant,100,50,6/11/2019
11074E,patient-enrollment-start,100,58,6/11/2019
1490F3,facility-open,100,65,6/11/2019
16F4D8,conference-participant,100,50,6/11/2019
17EDA5,executive-appointment,100,54,6/11/2019
17EDA5,partnership,100,61,6/11/2019
190B91,note-sale,100,52,6/11/2019
190B91,note-sale,100,52,6/11/2019
1D3A00,earnings,100,50,6/11/2019
1D3A00,earnings,100,50,6/11/2019
1D3A00,earnings,100,50,6/11/2019
1FAF22,conference-call,100,50,6/11/2019
2082EA,conference-participant,100,50,6/11/2019
221783,partnership,100,61,6/11/2019
228D42,partnership,100,61,6/11/2019
228D42,partnership,100,61,6/11/2019
228D42,business-contract,100,69,6/11/2019
228D42,business-contract,100,69,6/11/2019
2.45E+15,reorganization,100,53,6/11/2019
25A6CC,business-contract,100,69,6/11/2019
2A02DC,clinical-trials,100,56,6/11/2019
2EB04E,legal-issues-defendant,100,22,6/11/2019
2EBC0B,dividend,100,50,6/11/2019
2F24A5,executive-appointment,100,54,6/11/2019
2F5256,note-sale,100,52,6/11/2019
2F5256,note-sale,100,52,6/11/2019
315EB0,partnership,100,61,6/11/2019
32DCB3,conference-call,100,50,6/11/2019
370C50,product-price-raise,100,57,6/11/2019
385DD4,product-release,100,64,6/11/2019
39692D,legal-issues-defendant,100,22,6/11/2019
39BFF6,product-release,100,64,6/11/2019
448BF3,regulatory-product-approval-granted,100,81,6/11/2019
4A6F00,market-entry,100,57,6/11/2019
4AC91D,partnership,100,61,6/11/2019
4B49CF,unit-acquisition-acquiree,100,76,6/11/2019
4B49CF,earnings,100,50,6/11/2019
4E7C1F,product-release,100,64,6/11/2019
4F9926,partnership,100,61,6/11/2019
50D1EC,product-release,100,64,6/11/2019
51888A,acquisition-acquirer,100,49,6/11/2019
54A713,public-offering,100,43,6/11/2019
54DF47,acquisition-completed-acquirer,100,49,6/11/2019
56277A,dividend,100,50,6/11/2019
56EA2B,conference-call,100,50,6/11/2019
56EFC7,earnings,100,50,6/11/2019
56EFC7,earnings,100,50,6/11/2019
56EFC7,earnings,100,50,6/11/2019
56EFC7,earnings,100,50,6/11/2019
56EFC7,acquisition-acquirer,100,49,6/11/2019
58CA9A,earnings,100,50,6/11/2019
5D43A7,acquisition-acquirer,100,49,6/11/2019
619882,product-release,100,64,6/11/2019
619882,conference-organizer,100,57,6/11/2019
649CBD,conference-call,100,50,6/11/2019
69CE71,product-release,100,64,6/11/2019
713810,partnership,100,61,6/11/2019
713810,partnership,100,61,6/11/2019
7255D2,acquisition-acquirer,100,49,6/11/2019
7255D2,acquisition-acquirer,100,49,6/11/2019
7ADE57,earnings,100,50,6/11/2019
859D62,conference-participant,100,50,6/11/2019
86AA9C,legal-issues-defendant,100,22,6/11/2019
88193E,executive-appointment,100,54,6/11/2019
885758,legal-issues-defendant,100,22,6/11/2019
8AC740,dividend,100,50,6/11/2019
8BFAA4,dividend,100,50,6/11/2019
8D4486,business-contract,100,69,6/11/2019
8D4486,business-contract,100,69,6/11/2019
9004C4,dividend-suspended,100,13,6/11/2019
90B678,legal-issues-defendant,100,22,6/11/2019
9196A2,conference-organizer,100,57,6/11/2019
91C82E,conference-call,100,50,6/11/2019
9507FF,conference-participant,100,50,6/11/2019
96F126,product-release,100,64,6/11/2019
9B730A,conference-participant,100,50,6/11/2019
A15C71,facility-open,100,65,6/11/2019
A29DBD,conference-participant,100,50,6/11/2019
A6213D,legal-issues-defendant,100,22,6/11/2019
A63387,product-release,100,64,6/11/2019
A6828A,business-contract,100,69,6/11/2019
A6828A,business-contract,100,69,6/11/2019
AA98ED,executive-appointment,100,54,6/11/2019
B04426,conference-participant,100,50,6/11/2019
B08C51,conference-participant,100,50,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B3CB74,conference-organizer,100,57,6/11/2019
B4703C,legal-issues-defendant,100,22,6/11/2019
B4703C,legal-issues-defendant,100,22,6/11/2019
B4B281,executive-appointment,100,54,6/11/2019
B7BDA3,executive-appointment,100,54,6/11/2019
B85DCE,conference-participant,100,50,6/11/2019
B8F71F,executive-appointment,100,54,6/11/2019
BB5271,executive-appointment,100,54,6/11/2019
BB88B6,acquisition-acquiree,100,76,6/11/2019
BB88B6,acquisition-acquiree,100,76,6/11/2019
BCC55F,partnership,100,61,6/11/2019
BD682F,dividend,100,50,6/11/2019
BDCC11,legal-issues-defendant,100,22,6/11/2019
BFD0A7,executive-appointment,100,54,6/11/2019
C0030A,conference-participant,100,50,6/11/2019
C05839,dividend,100,50,6/11/2019
C2609A,public-offering,100,43,6/11/2019
C45C1F,conference-participant,100,50,6/11/2019
C7FC95,business-contract,100,69,6/11/2019
C97B2D,acquisition-completed-acquirer,100,49,6/11/2019
CC339B,dividend,100,50,6/11/2019
CDAB24,conference-participant,100,50,6/11/2019
CDE118,executive-appointment,100,54,6/11/2019
CF211D,earnings,100,50,6/11/2019
D29B44,partnership,100,61,6/11/2019
D33270,partnership,100,61,6/11/2019
D33270,partnership,100,61,6/11/2019
D42DBA,partnership,100,61,6/11/2019
D42DBA,partnership,100,61,6/11/2019
D6EAA3,unit-acquisition-acquirer,100,49,6/11/2019
D82EF3,partnership,100,61,6/11/2019
DB5CA5,award,100,58,6/11/2019
DC0998,product-release,100,64,6/11/2019
DDEA6A,conference-participant,100,50,6/11/2019
DF5F14,dividend,100,50,6/11/2019
DF8855,acquisition-completed-acquirer,100,49,6/11/2019
DF8855,acquisition-completed-acquirer,100,49,6/11/2019
E074A0,conference-participant,100,50,6/11/2019
E09E2B,partnership,100,61,6/11/2019
E30B34,executive-appointment,100,54,6/11/2019
E30B34,executive-appointment,100,54,6/11/2019
E3E68E,award,100,58,6/11/2019
EEA734,conference-participant,100,50,6/11/2019
F02170,legal-issues-defendant,100,22,6/11/2019
F05B1B,index-listing,100,76,6/11/2019
F179ED,conference-organizer,100,57,6/11/2019
F1EB39,acquisition-acquirer,100,49,6/11/2019
F1EB39,earnings,100,50,6/11/2019
F51DB0,legal-issues-defendant,100,22,6/11/2019
F6FF0D,legal-issues-defendant,100,22,6/11/2019
FBDA0F,buybacks,100,74,6/11/2019
FD554E,conference-participant,100,50,6/11/2019
FDC7E6,conference-participant,100,50,6/11/2019
FDD3FC,business-contract,100,69,6/11/2019
FDD3FC,business-contract,100,69,6/11/2019
FEC475,executive-appointment,100,54,6/11/2019
00326D,dividend,100,50,6/12/2019
13528,partnership,100,61,6/12/2019
0157B1,partnership,100,61,6/12/2019
02FC1A,legal-issues-defendant,100,22,6/12/2019
02FC1A,legal-issues-defendant,100,22,6/12/2019
0358AF,dividend,100,50,6/12/2019
03CF95,product-release,100,64,6/12/2019
03CF95,acquisition-regulatory-approval-acquirer,100,54,6/12/2019
0BF528,award,100,58,6/12/2019
0BF528,award,100,58,6/12/2019
0C136E,executive-appointment,100,54,6/12/2019
0C8D82,public-offering,100,43,6/12/2019
0C8D82,fundraising,100,64,6/12/2019
12E454,partnership,100,61,6/12/2019
15901B,business-contract,100,69,6/12/2019
165B86,conference-participant,100,50,6/12/2019
184866,conference-participant,100,50,6/12/2019
1880C5,legal-issues-plaintiff,100,44,6/12/2019
1B16C1,legal-issues-defendant,100,22,6/12/2019
1E7785,conference-participant,100,50,6/12/2019
1EC3E8,executive-appointment,100,54,6/12/2019
20D00A,executive-appointment,100,54,6/12/2019
227F04,note-sale,100,52,6/12/2019
228D42,dividend,100,50,6/12/2019
251988,product-release,100,64,6/12/2019
25DD05,dividend,100,50,6/12/2019
25DD05,dividend,100,50,6/12/2019
26008A,dividend,100,50,6/12/2019
282C18,buybacks,100,74,6/12/2019
2CC71C,public-offering,100,43,6/12/2019
2E0496,product-release,100,64,6/12/2019
2FDEE3,executive-appointment,100,54,6/12/2019
2FDEE3,dividend,100,50,6/12/2019
314D88,legal-issues-defendant,100,22,6/12/2019
3.14E+47,executive-appointment,100,54,6/12/2019
367434,partnership,100,61,6/12/2019
3B37F7,executive-appointment,100,54,6/12/2019
420168,note-sale,100,52,6/12/2019
42978B,revenues,100,50,6/12/2019
449A26,conference-call,100,50,6/12/2019
4A6F00,partnership,100,61,6/12/2019
4C37C5,partnership,100,61,6/12/2019
4E4E75,dividend,100,50,6/12/2019
5065B1,dividend,100,50,6/12/2019
51B442,credit-extension-recipient,100,69,6/12/2019
52015A,legal-issues-defendant,100,22,6/12/2019
532D47,legal-issues-defendant,100,22,6/12/2019
54B889,executive-appointment,100,54,6/12/2019
550D01,market-entry,100,57,6/12/2019
56EA2B,partnership,100,61,6/12/2019
5A53BF,conference-call,100,50,6/12/2019
5A9A82,executive-appointment,100,54,6/12/2019
5B6C11,dividend,100,50,6/12/2019
60EA12,executive-appointment,100,54,6/12/2019
619882,partnership,100,61,6/12/2019
619882,conference-organizer,100,57,6/12/2019
619882,conference-organizer,100,57,6/12/2019
636BBF,legal-issues-defendant,100,22,6/12/2019
636BBF,legal-issues-defendant,100,22,6/12/2019
63F892,stake-acquiree,100,62,6/12/2019
64E346,executive-appointment,100,54,6/12/2019
65D0AA,ipo-considered,100,60,6/12/2019
68AB62,conference-call,100,50,6/12/2019
6F6559,earnings,100,50,6/12/2019
728737,dividend,100,50,6/12/2019
728737,dividend,100,50,6/12/2019
72FCA3,earnings,100,50,6/12/2019
77B8E9,conference-participant,100,50,6/12/2019
7823A3,product-release,100,64,6/12/2019
791D59,product-release,100,64,6/12/2019
791EC1,acquisition-acquirer,100,49,6/12/2019
7A0EC4,partnership,100,61,6/12/2019
7B6C88,partnership,100,61,6/12/2019
7BEA98,clinical-trials,100,56,6/12/2019
7C4F43,conference-participant,100,50,6/12/2019
7C4F43,executive-appointment,100,54,6/12/2019
7E1D5D,regulatory-product-approval-granted,100,81,6/12/2019
7EA323,executive-appointment,100,54,6/12/2019
7FC386,dividend-up,100,81,6/12/2019
7FD8B9,credit-extension-recipient,100,69,6/12/2019
803FED,conference-participant,100,50,6/12/2019
804708,executive-appointment,100,54,6/12/2019
819492,executive-appointment,100,54,6/12/2019
86AA9C,legal-issues-defendant,100,22,6/12/2019
88193E,award,100,58,6/12/2019
885758,legal-issues-defendant,100,22,6/12/2019
8AB37F,conference-participant,100,50,6/12/2019
8B1E11,facility-open,100,65,6/12/2019
8FF2EF,earnings,100,50,6/12/2019
90B678,legal-issues-defendant,100,22,6/12/2019
925759,executive-appointment,100,54,6/12/2019
92B625,conference-participant,100,50,6/12/2019
950CDB,dividend-up,100,81,6/12/2019
95DC1F,acquisition-acquiree,100,76,6/12/2019
97693A,earnings,100,50,6/12/2019
97FE80,executive-appointment,100,54,6/12/2019
99ACAD,note-sale,100,52,6/12/2019
9F5997,note-sale,100,52,6/12/2019
9F71E5,acquisition-completed-acquirer,100,49,6/12/2019
A21649,dividend,100,50,6/12/2019
A247F5,executive-appointment,100,54,6/12/2019
A4F67C,public-offering,100,43,6/12/2019
A6213D,legal-issues-defendant,100,22,6/12/2019
A6FB29,earnings-up,100,68,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A6FB29,earnings,100,50,6/12/2019
A79D88,conference-participant,100,50,6/12/2019
AEF2C3,legal-issues-defendant,100,22,6/12/2019
AFDF2E,legal-issues-defendant,100,22,6/12/2019
AFF7B4,legal-issues-defendant,100,22,6/12/2019
B3CB74,conference-organizer,100,57,6/12/2019
B3CB74,conference-organizer,100,57,6/12/2019
B3CB74,conference-organizer,100,57,6/12/2019
B3CB74,conference-organizer,100,57,6/12/2019
B3CB74,conference-organizer,100,57,6/12/2019
B48FC9,partnership,100,61,6/12/2019
B5BA39,legal-issues-defendant,100,22,6/12/2019
BB5271,product-release,100,64,6/12/2019
BCC55F,note-sale,100,52,6/12/2019
BCC55F,award,100,58,6/12/2019
BDCC11,legal-issues-defendant,100,22,6/12/2019
BDF2BD,conference-participant,100,50,6/12/2019
C188F8,conference-participant,100,50,6/12/2019
C2E39B,public-offering,100,43,6/12/2019
C4452A,business-contract,100,69,6/12/2019
CB7AB2,award,100,58,6/12/2019
CC6FF5,conference-participant,100,50,6/12/2019
CD4DA8,executive-appointment,100,54,6/12/2019
D17C1B,revenue-volume,100,50,6/12/2019
D437C3,partnership,100,61,6/12/2019
D58A11,partnership,100,61,6/12/2019
E16133,public-offering,100,43,6/12/2019
E70531,facility-upgrade,100,65,6/12/2019
E7BF32,conference-participant,100,50,6/12/2019
E7BF32,conference-participant,100,50,6/12/2019
E9C7C0,partnership,100,61,6/12/2019
ECA300,executive-appointment,100,54,6/12/2019
EE6F1C,business-contract,100,69,6/12/2019
EF5BED,executive-appointment,100,54,6/12/2019
EF5BED,product-release,100,64,6/12/2019
EF77A3,earnings,100,50,6/12/2019
F0027C,clinical-trials-positive,100,87,6/12/2019
F02170,legal-issues-defendant,100,22,6/12/2019
F05B1B,executive-appointment,100,54,6/12/2019
F1529C,conference-call,100,50,6/12/2019
F3816D,clinical-trials,100,56,6/12/2019
F57F6F,conference-organizer,100,57,6/12/2019
F5D059,acquisition-acquirer,100,49,6/12/2019
F6DCE4,partnership,100,61,6/12/2019
FEC475,partnership,100,61,6/12/2019
FEE4B0,conference-participant,100,50,6/12/2019
FF227B,executive-appointment,100,54,6/12/2019
FFE543,legal-issues-defendant,100,22,6/12/2019
02FC1A,conference-participant,100,50,6/13/2019
03B8CF,business-contract,100,69,6/13/2019
05D148,conference-participant,100,50,6/13/2019
0624BE,conference-participant,100,50,6/13/2019
09062E,conference-participant,100,50,6/13/2019
099C88,government-contract,100,69,6/13/2019
09DE1F,earnings,100,50,6/13/2019
0B4D10,dividend,100,50,6/13/2019
0CC62B,conference-participant,100,50,6/13/2019
0CCCB7,award,100,58,6/13/2019
106394,dividend,100,50,6/13/2019
1065BC,note-sale,100,52,6/13/2019
1EBF8D,partnership,100,61,6/13/2019
1EBF8D,partnership,100,61,6/13/2019
1F43A1,dividend-up,100,81,6/13/2019
228D42,partnership,100,61,6/13/2019
2720AB,equity-shelf-registration,100,43,6/13/2019
274B8A,conference-call,100,50,6/13/2019
282C18,dividend,100,50,6/13/2019
29B702,executive-appointment,100,54,6/13/2019
29B702,executive-appointment,100,54,6/13/2019
2BAE5F,award,100,58,6/13/2019
2C7505,clinical-trials,100,56,6/13/2019
2C7505,clinical-trials,100,56,6/13/2019
2CB4C9,conference-participant,100,50,6/13/2019
31643A,facility-open,100,65,6/13/2019
34E9F9,credit-extension-recipient,100,69,6/13/2019
37B618,dividend,100,50,6/13/2019
39FB23,product-release,100,64,6/13/2019
53F491,dividend,100,50,6/13/2019
5.47E+28,public-offering,100,43,6/13/2019
5876DC,debt-extension-recipient,100,73,6/13/2019
605F40,acquisition-acquirer,100,49,6/13/2019
60EA12,conference-participant,100,50,6/13/2019
619882,conference-organizer,100,57,6/13/2019
619882,conference-organizer,100,57,6/13/2019
619882,conference-organizer,100,57,6/13/2019
619882,conference-organizer,100,57,6/13/2019
619882,conference-organizer,100,57,6/13/2019
619882,conference-organizer,100,57,6/13/2019
61B81B,conference-call,100,50,6/13/2019
636BBF,legal-issues-defendant,100,22,6/13/2019
6CF43C,dividend,100,50,6/13/2019
713810,partnership,100,61,6/13/2019
713810,partnership,100,61,6/13/2019
726DDF,stake-acquiree,100,62,6/13/2019
726DDF,stake-acquiree,100,62,6/13/2019
7771D7,earnings,100,50,6/13/2019
7999F3,stake-acquirer,100,48,6/13/2019
7999F3,stake-acquirer,100,48,6/13/2019
7A10FF,investment-investor,100,55,6/13/2019
7BEA98,conference-participant,100,50,6/13/2019
7E0EB0,conference-participant,100,50,6/13/2019
7F3665,unit-acquisition-completed-acquirer,100,49,6/13/2019
855DF7,earnings,100,50,6/13/2019
8614A2,legal-issues-defendant,100,22,6/13/2019
885758,legal-issues-defendant,100,22,6/13/2019
89B2E7,dividend,100,50,6/13/2019
8B1F37,dividend-up,100,81,6/13/2019
8B1F37,executive-appointment,100,54,6/13/2019
8B1F37,executive-appointment,100,54,6/13/2019
8B6E7E,legal-issues-defendant,100,22,6/13/2019
8B6E7E,legal-issues-defendant,100,22,6/13/2019
942633,dividend,100,50,6/13/2019
94637C,dividend,100,50,6/13/2019
990AD0,dividend,100,50,6/13/2019
A017F4,conference-participant,100,50,6/13/2019
A495F7,award,100,58,6/13/2019
A52B6B,acquisition-completed-acquirer,100,49,6/13/2019
A631A3,acquisition-interest-acquirer,100,46,6/13/2019
A6FE1C,acquisition-acquirer,100,49,6/13/2019
A868C9,public-offering,100,43,6/13/2019
AADE0B,unit-acquisition-acquirer,100,49,6/13/2019
AC7AAE,conference-participant,100,50,6/13/2019
AD1ACF,product-release,100,64,6/13/2019
ADD9DC,earnings,100,50,6/13/2019
AEBB80,dividend,100,50,6/13/2019
AEF2C3,legal-issues-defendant,100,22,6/13/2019
AFD1CA,conference-participant,100,50,6/13/2019
AFF7B4,note-sale,100,52,6/13/2019
B1A85D,business-contract,100,69,6/13/2019
B3CB74,conference-organizer,100,57,6/13/2019
B3CB74,conference-organizer,100,57,6/13/2019
B3CB74,conference-organizer,100,57,6/13/2019
B3CB74,conference-organizer,100,57,6/13/2019
B83D67,facility-open,100,65,6/13/2019
BDCC11,legal-issues-defendant,100,22,6/13/2019
BDF85E,dividend,100,50,6/13/2019
C2DD02,executive-appointment,100,54,6/13/2019
C2DD02,dividend,100,50,6/13/2019
C2E39B,public-offering,100,43,6/13/2019
C83B88,conference-call,100,50,6/13/2019
C951A2,award,100,58,6/13/2019
C9881C,conference-call,100,50,6/13/2019
C9F39B,dividend,100,50,6/13/2019
CAD7D9,executive-appointment,100,54,6/13/2019
CBCC6A,conference-organizer,100,57,6/13/2019
CBCC6A,conference-organizer,100,57,6/13/2019
CE5C6E,conference-participant,100,50,6/13/2019
CF6A5A,earnings,100,50,6/13/2019
CFD4B6,unit-acquisition-acquirer,100,49,6/13/2019
CFF57D,earnings,100,50,6/13/2019
D1C26F,earnings-up,100,68,6/13/2019
D1C26F,earnings-up,100,68,6/13/2019
D1C26F,earnings-up,100,68,6/13/2019
E20392,conference-participant,100,50,6/13/2019
E802CE,legal-issues-defendant,100,22,6/13/2019
E8846E,executive-appointment,100,54,6/13/2019
EC99D0,award,100,58,6/13/2019
EC99D0,award,100,58,6/13/2019
EEB5F9,conference-participant,100,50,6/13/2019
EF5BED,assets,100,50,6/13/2019
F02170,legal-issues-defendant,100,22,6/13/2019
F6DCE4,dividend-up,100,53,6/13/2019
F6E248,partnership,100,61,6/13/2019
FDE409,earnings,100,50,6/13/2019
FF6644,product-release,100,64,6/13/2019
01D03F,executive-appointment,100,54,6/14/2019
02FC1A,legal-issues-defendant,100,22,6/14/2019
0560D8,dividend-up,100,55,6/14/2019
95294,acquisition-completed-acquirer,100,49,6/14/2019
95294,acquisition-completed-acquirer,100,49,6/14/2019
95294,acquisition-completed-acquirer,100,49,6/14/2019
95294,acquisition-completed-acquirer,100,49,6/14/2019
95294,acquisition-completed-acquirer,100,49,6/14/2019
0B400D,trading-halt,100,43,6/14/2019
0E5619,conference-participant,100,50,6/14/2019
1080C0,clinical-trials-positive,100,87,6/14/2019
1080C0,clinical-trials-positive,100,87,6/14/2019
15901B,fundraising,100,64,6/14/2019
1AF7E2,dividend,100,50,6/14/2019
1FA886,business-contract,100,69,6/14/2019
21D903,legal-issues-defendant,100,22,6/14/2019
251988,facility-sale,100,52,6/14/2019
2CC71C,public-offering,100,43,6/14/2019
2EC172,partnership,100,61,6/14/2019
2F960F,dividend,100,50,6/14/2019
31AA84,award,100,58,6/14/2019
36529A,regulatory-product-application,100,69,6/14/2019
3D9999,partnership,100,61,6/14/2019
401072,regulatory-product-application,100,69,6/14/2019
4455C4,conference-participant,100,50,6/14/2019
453282,unit-acquisition-completed-acquirer,100,49,6/14/2019
4D8313,dividend,100,50,6/14/2019
520632,dividend,100,50,6/14/2019
54DF47,dividend,100,50,6/14/2019
56EA2B,partnership,100,61,6/14/2019
5BC2F4,executive-appointment,100,54,6/14/2019
5D1956,buybacks,100,74,6/14/2019
619882,conference-organizer,100,57,6/14/2019
619882,conference-organizer,100,57,6/14/2019
619882,dividend,100,50,6/14/2019
619882,conference-organizer,100,57,6/14/2019
619882,conference-organizer,100,57,6/14/2019
636BBF,legal-issues-defendant,100,22,6/14/2019
641F17,earnings,100,50,6/14/2019
657097,dividend,100,50,6/14/2019
65D0AA,conference-participant,100,50,6/14/2019
67303E,clinical-trials,100,56,6/14/2019
6A6BDC,earnings,100,50,6/14/2019
6BF593,dividend,100,50,6/14/2019
6D3B7B,dividend,100,50,6/14/2019
6FCEF9,dividend,100,50,6/14/2019
7E1D5D,buybacks,100,74,6/14/2019
826FD6,dividend,100,50,6/14/2019
83A065,dividend,100,50,6/14/2019
885758,legal-issues-defendant,100,22,6/14/2019
8B6E7E,legal-issues-defendant,100,22,6/14/2019
8E4250,conference-call,100,50,6/14/2019
94637C,clinical-trials,100,56,6/14/2019
949625,conference-participant,100,50,6/14/2019
95DC1F,legal-issues-defendant,100,22,6/14/2019
A495F7,product-release,100,64,6/14/2019
A6828A,clinical-trials,100,56,6/14/2019
A6828A,clinical-trials,100,56,6/14/2019
A6828A,clinical-trials,100,56,6/14/2019
A6828A,clinical-trials,100,56,6/14/2019
A6828A,clinical-trials,100,56,6/14/2019
A868C9,public-offering,100,43,6/14/2019
A871B0,executive-appointment,100,54,6/14/2019
AEF2C3,legal-issues-defendant,100,22,6/14/2019
B3CB74,conference-organizer,100,57,6/14/2019
B3CB74,conference-organizer,100,57,6/14/2019
B5BA39,executive-appointment,100,54,6/14/2019
B762D3,dividend,100,50,6/14/2019
BDCC11,legal-issues-defendant,100,22,6/14/2019
C16A8F,executive-appointment,100,54,6/14/2019
CF351E,dividend,100,50,6/14/2019
D139BC,dividend,100,50,6/14/2019
D1588D,executive-appointment,100,54,6/14/2019
D3FA2C,dividend,100,50,6/14/2019
D56D6D,executive-appointment,100,54,6/14/2019
D8442A,legal-issues-defendant,100,22,6/14/2019
D96202,conference-call,100,50,6/14/2019
DC5299,dividend,100,50,6/14/2019
E11C41,dividend,100,50,6/14/2019
E20392,conference-participant,100,50,6/14/2019
E802CE,legal-issues-defendant,100,22,6/14/2019
E802CE,legal-issues-defendant,100,22,6/14/2019
E829E8,executive-appointment,100,54,6/14/2019
E829E8,conference-call,100,50,6/14/2019
E959F3,earnings,100,50,6/14/2019
EA4E68,dividend,100,50,6/14/2019
ECD263,earnings,100,50,6/14/2019
EF7163,dividend,100,50,6/14/2019
F02170,legal-issues-defendant,100,22,6/14/2019
F02170,legal-issues-defendant,100,22,6/14/2019
F294DD,dividend,100,50,6/14/2019
F80389,dividend,100,50,6/14/2019
3DDE54,conference-participant,100,50,6/15/2019
6CC55E,clinical-trials-positive,100,87,6/15/2019
B290A2,clinical-trials,100,56,6/15/2019
B290A2,clinical-trials,100,56,6/15/2019
21D903,legal-issues-defendant,100,22,6/16/2019
B4703C,legal-issues-defendant,100,22,6/16/2019
D8442A,legal-issues-defendant,100,22,6/16/2019
E802CE,legal-issues-defendant,100,22,6/16/2019
F6FF0D,legal-issues-defendant,100,22,6/16/2019
00067A,executive-appointment,100,54,6/17/2019
001F1B,legal-issues-defendant,100,22,6/17/2019
00E601,earnings,100,50,6/17/2019
01D03F,legal-verdict-disfavored,100,22,6/17/2019
02870F,facility-open,100,65,6/17/2019
03596A,business-contract,100,69,6/17/2019
036C6F,legal-issues-defendant,100,22,6/17/2019
48590,partnership,100,61,6/17/2019
55018,conference-call,100,50,6/17/2019
0624BE,partnership,100,61,6/17/2019
06EF42,earnings,100,50,6/17/2019
09F623,conference-participant,100,50,6/17/2019
0B400D,trading-resumed,100,58,6/17/2019
0BF528,executive-appointment,100,54,6/17/2019
0CC01F,dividend,100,50,6/17/2019
0FABBD,conference-participant,100,50,6/17/2019
106394,business-contract,100,69,6/17/2019
138DDE,dividend,100,50,6/17/2019
16C7F0,merger,100,66,6/17/2019
16C7F0,merger,100,66,6/17/2019
16C7F0,acquisition-interest-acquirer,100,46,6/17/2019
190B91,note-sale,100,52,6/17/2019
190B91,public-offering,100,43,6/17/2019
1AB023,business-contract,100,69,6/17/2019
2082EA,executive-appointment,100,54,6/17/2019
20BEEA,earnings-guidance,100,50,6/17/2019
21D903,legal-issues-defendant,100,22,6/17/2019
221783,partnership,100,61,6/17/2019
25A6CC,acquisition-acquirer,100,49,6/17/2019
25A6CC,acquisition-acquirer,100,49,6/17/2019
267718,acquisition-acquirer,100,49,6/17/2019
267718,acquisition-acquirer,100,49,6/17/2019
267718,acquisition-acquirer,100,49,6/17/2019
267718,acquisition-acquirer,100,49,6/17/2019
267718,acquisition-acquirer,100,49,6/17/2019
267718,acquisition-acquirer,100,49,6/17/2019
26E3BA,business-contract,100,69,6/17/2019
26F99F,clinical-trials-positive,100,87,6/17/2019
2.90E+62,unit-acquisition-acquirer,100,49,6/17/2019
2C7505,patient-enrollment-complete,100,64,6/17/2019
2C7505,patient-enrollment-complete,100,64,6/17/2019
2EB04E,legal-issues-defendant,100,22,6/17/2019
30DE64,clinical-trials-positive,100,87,6/17/2019
30DFD3,trading-resumed,100,58,6/17/2019
32DCB3,private-placement,100,56,6/17/2019
339F20,executive-appointment,100,54,6/17/2019
35F4B5,executive-appointment,100,54,6/17/2019
36C09B,clinical-trials,100,56,6/17/2019
3CCC90,conference-call,100,50,6/17/2019
416291,dividend,100,50,6/17/2019
41ED98,shareholder-rights-plan,100,43,6/17/2019
44209A,award,100,58,6/17/2019
448BF3,executive-appointment,100,54,6/17/2019
44A4FC,partnership,100,61,6/17/2019
44A4FC,partnership,100,61,6/17/2019
45444E,conference-participant,100,50,6/17/2019
49914B,asset-sale,100,62,6/17/2019
4A3438,executive-appointment,100,54,6/17/2019
4B3555,executive-appointment,100,54,6/17/2019
4C37C5,partnership,100,61,6/17/2019
4C3FE9,public-offering,100,43,6/17/2019
4E7C1F,unit-acquisition-completed-acquirer,100,49,6/17/2019
50702E,conference-call,100,50,6/17/2019
520632,partnership,100,61,6/17/2019
543900,asset-sale,100,62,6/17/2019
54F271,executive-appointment,100,54,6/17/2019
553949,unit-acquisition-acquirer,100,49,6/17/2019
553949,unit-acquisition-acquirer,100,49,6/17/2019
56277A,conference-call,100,50,6/17/2019
5675EB,dividend,100,50,6/17/2019
5704AC,dividend,100,50,6/17/2019
5A64D5,partnership,100,61,6/17/2019
5A64D5,partnership,100,61,6/17/2019
5A9A82,executive-appointment,100,54,6/17/2019
5D63F1,campaign-ad-release,100,59,6/17/2019
5E6959,dividend,100,50,6/17/2019
5FDBD0,business-combination,100,54,6/17/2019
5FDBD0,business-combination,100,54,6/17/2019
5FDBD0,business-combination,100,54,6/17/2019
619882,conference-organizer,100,57,6/17/2019
63F892,product-release,100,64,6/17/2019
66667F,orphan-drug-designation,100,76,6/17/2019
6D0CAB,note-sale,100,52,6/17/2019
6E705B,business-contract,100,69,6/17/2019
793C11,executive-appointment,100,54,6/17/2019
7DD8CC,dividend,100,50,6/17/2019
7FDE1C,product-release,100,64,6/17/2019
805CD8,partnership,100,61,6/17/2019
805CD8,partnership,100,61,6/17/2019
86AA9C,legal-issues-defendant,100,22,6/17/2019
8BFAA4,credit-extension-recipient,100,69,6/17/2019
8DBBE6,acquisition-completed-acquirer,100,49,6/17/2019
8F3BCC,earnings,100,50,6/17/2019
9196A2,dividend,100,50,6/17/2019
92D230,legal-issues-defendant,100,22,6/17/2019
9470CC,partnership,100,61,6/17/2019
96F126,investment-investor,100,55,6/17/2019
986AF6,earnings-guidance,100,50,6/17/2019
9CA619,legal-issues-defendant,100,22,6/17/2019
A3F598,executive-appointment,100,54,6/17/2019
A6FC89,legal-issues-defendant,100,22,6/17/2019
A6FC89,legal-issues-defendant,100,22,6/17/2019
A6FC89,legal-issues-defendant,100,22,6/17/2019
A6FC89,fraud-defendant,100,20,6/17/2019
AA1EAA,dividend,100,50,6/17/2019
AC642C,executive-appointment,100,54,6/17/2019
AC642C,executive-appointment,100,54,6/17/2019
AE7D16,partnership,100,61,6/17/2019
B3CB74,conference-organizer,100,57,6/17/2019
B4C673,partnership,100,61,6/17/2019
B8F71F,executive-appointment,100,54,6/17/2019
BAD655,clinical-trials-start,100,64,6/17/2019
C2E39B,public-offering,100,43,6/17/2019
C8FAC7,product-release,100,64,6/17/2019
C97B2D,legal-issues-defendant,100,22,6/17/2019
CAC8D0,earnings,100,50,6/17/2019
CDD75E,public-offering,100,43,6/17/2019
CFD4B6,executive-appointment,100,54,6/17/2019
D2E553,dividend,100,50,6/17/2019
D8442A,legal-issues-defendant,100,22,6/17/2019
DC0066,regulatory-product-approval-granted,100,81,6/17/2019
DF8855,executive-resignation,100,44,6/17/2019
E0339F,earnings,100,50,6/17/2019
E09E2B,executive-appointment,100,54,6/17/2019
E0F4E5,executive-appointment,100,54,6/17/2019
E1E093,merger-regulatory-approval,100,81,6/17/2019
E2CB7B,business-contract,100,69,6/17/2019
E6D89E,legal-verdict-favored,100,78,6/17/2019
E802CE,legal-issues-defendant,100,22,6/17/2019
E8B21D,executive-appointment,100,54,6/17/2019
EA62FC,executive-appointment,100,54,6/17/2019
EAEBF3,conference-participant,100,50,6/17/2019
EC99D0,conference-call,100,50,6/17/2019
ED7F13,dividend,100,50,6/17/2019
EEA734,partnership,100,61,6/17/2019
F00285,executive-appointment,100,54,6/17/2019
F02170,legal-issues-defendant,100,22,6/17/2019
F02170,legal-issues-defendant,100,22,6/17/2019
F48947,legal-issues-defendant,100,22,6/17/2019
F51DB0,legal-issues-defendant,100,22,6/17/2019
F5D499,merger-completed,100,66,6/17/2019
F6FF0D,legal-issues-defendant,100,22,6/17/2019
FE7A63,buybacks,100,74,6/17/2019
02FC1A,legal-issues-defendant,100,22,6/18/2019
07EC43,unit-acquisition-acquirer,100,49,6/18/2019
07EC43,unit-acquisition-acquirer,100,49,6/18/2019
95294,facility-open,100,65,6/18/2019
98977,conference-participant,100,50,6/18/2019
1080C0,public-offering,100,43,6/18/2019
108A2B,dividend,100,50,6/18/2019
125212,conference-participant,100,50,6/18/2019
12E454,product-release,100,64,6/18/2019
152FA5,conference-participant,100,50,6/18/2019
15A388,earnings-positive,100,69,6/18/2019
165B86,acquisition-acquirer,100,49,6/18/2019
168A5D,partnership,100,61,6/18/2019
168A5D,fundraising,100,64,6/18/2019
168A5D,executive-appointment,100,54,6/18/2019
16F4D8,business-contract,100,69,6/18/2019
1CD4B5,public-offering,100,43,6/18/2019
1EBF8D,regulatory-product-approval-granted,100,81,6/18/2019
1EBF8D,regulatory-product-approval-granted,100,81,6/18/2019
1EBF8D,regulatory-product-approval-granted,100,81,6/18/2019
1EBF8D,regulatory-product-approval-granted,100,81,6/18/2019
1EBF8D,regulatory-product-approval-granted,100,81,6/18/2019
1FA886,partnership,100,61,6/18/2019
2158DF,partnership,100,61,6/18/2019
228D42,product-release,100,64,6/18/2019
24A89A,fast-track-designation,100,81,6/18/2019
24A89A,fast-track-designation,100,81,6/18/2019
25102A,facility-open,100,65,6/18/2019
25102A,facility-open,100,65,6/18/2019
267718,acquisition-acquirer,100,49,6/18/2019
26CC63,earnings,100,50,6/18/2019
26CC63,earnings,100,50,6/18/2019
26CC63,earnings,100,50,6/18/2019
26CC63,earnings,100,50,6/18/2019
26DC29,executive-appointment,100,54,6/18/2019
26F99F,legal-issues-defendant,100,22,6/18/2019
275300,dividend,100,50,6/18/2019
2.90E+62,business-contract,100,69,6/18/2019
2F24A5,earnings,100,50,6/18/2019
301493,conference-participant,100,50,6/18/2019
306623,note-sale,100,52,6/18/2019
306623,dividend-suspended,100,13,6/18/2019
3.14E+47,dividend,100,50,6/18/2019
31803E,conference-participant,100,50,6/18/2019
36C09B,conference-participant,100,50,6/18/2019
3C8A04,conference-call,100,50,6/18/2019
40F7DE,conference-participant,100,50,6/18/2019
416C55,facility-open,100,65,6/18/2019
46017C,note-sale,100,52,6/18/2019
46A16E,conference-participant,100,50,6/18/2019
4C6C63,partnership,100,61,6/18/2019
4C6C63,note-sale,100,52,6/18/2019
4E2D94,earnings-guidance,100,50,6/18/2019
504FE2,business-contract,100,69,6/18/2019
53F491,earnings,100,50,6/18/2019
546A27,business-contract,100,69,6/18/2019
54A713,public-offering,100,43,6/18/2019
5A0FF1,partnership,100,61,6/18/2019
5B97B2,dividend-guidance,100,50,6/18/2019
5CC29D,facility-open,100,65,6/18/2019
5CEE02,acquisition-interest-acquiree,100,82,6/18/2019
5EAA43,partnership,100,61,6/18/2019
5F1B7B,reorganization,100,53,6/18/2019
6166D1,dividend,100,50,6/18/2019
619882,conference-organizer,100,57,6/18/2019
66A667,earnings,100,50,6/18/2019
66A667,earnings,100,50,6/18/2019
6A3C35,supply-guidance-increase,100,74,6/18/2019
71B0CF,conference-participant,100,50,6/18/2019
73A71F,executive-appointment,100,54,6/18/2019
7BAAE7,executive-appointment,100,54,6/18/2019
7FDE1C,product-release,100,64,6/18/2019
803FED,executive-appointment,100,54,6/18/2019
8377DB,dividend-up,100,81,6/18/2019
85AD00,dividend,100,50,6/18/2019
873DB9,product-release,100,64,6/18/2019
885758,legal-issues-defendant,100,22,6/18/2019
8B6E7E,legal-issues-defendant,100,22,6/18/2019
8C5519,earnings,100,50,6/18/2019
8E10BF,conference-participant,100,50,6/18/2019
911AB8,investment-investor,100,55,6/18/2019
91E5EE,resource-discovery,100,88,6/18/2019
91E5EE,resource-discovery,100,88,6/18/2019
925759,conference-participant,100,50,6/18/2019
92D9C9,business-contract,100,69,6/18/2019
92D9C9,business-contract,100,69,6/18/2019
92D9C9,dividend,100,50,6/18/2019
966DBE,reorganization-complete,100,74,6/18/2019
9C5BA5,facility-close,100,47,6/18/2019
9C5BA5,executive-appointment,100,54,6/18/2019
9CA432,dividend,100,50,6/18/2019
9CA619,facility-open,100,65,6/18/2019
9CE4C7,award,100,58,6/18/2019
9E3224,dividend,100,50,6/18/2019
9F6B1A,partnership,100,61,6/18/2019
A398F8,note-sale,100,52,6/18/2019
A43906,conference-call,100,50,6/18/2019
A6828A,conference-call,100,50,6/18/2019
A6FC89,legal-issues-defendant,100,22,6/18/2019
A6FC89,legal-issues-defendant,100,22,6/18/2019
A790A5,earnings,100,50,6/18/2019
A790A5,earnings,100,50,6/18/2019
A790A5,earnings,100,50,6/18/2019
A790A5,earnings,100,50,6/18/2019
A8B137,conference-call,100,50,6/18/2019
A9ED24,dividend,100,50,6/18/2019
AC7C4F,business-contract,100,69,6/18/2019
AE4EEB,dividend,100,50,6/18/2019
B37FB4,earnings,100,50,6/18/2019
B3CB74,conference-organizer,100,57,6/18/2019
B3CB74,conference-organizer,100,57,6/18/2019
B3CB74,conference-organizer,100,57,6/18/2019
B3CB74,conference-organizer,100,57,6/18/2019
B4703C,legal-issues-defendant,100,22,6/18/2019
B5DE80,conference-call,100,50,6/18/2019
B642E8,dividend,100,50,6/18/2019
B98EFA,conference-participant,100,50,6/18/2019
B9CD50,executive-appointment,100,54,6/18/2019
B9CD50,executive-appointment,100,54,6/18/2019
BAD655,conference-participant,100,50,6/18/2019
BB127B,revenue-down,100,30,6/18/2019
BDE867,award,100,58,6/18/2019
C45C1F,clinical-trials,100,56,6/18/2019
C4F9C6,conference-participant,100,50,6/18/2019
C9881C,revenues,100,50,6/18/2019
C9881C,revenues,100,50,6/18/2019
C9881C,revenues,100,50,6/18/2019
CF3FF9,regulatory-product-application,100,69,6/18/2019
D11C1C,dividend,100,50,6/18/2019
D1588D,ipo-pricing,100,50,6/18/2019
D437C3,award,100,58,6/18/2019
D598E7,conference-call,100,50,6/18/2019
D6EAA3,acquisition-completed-acquirer,100,49,6/18/2019
D6EAA3,award,100,58,6/18/2019
D75910,dividend,100,50,6/18/2019
D7AC6E,dividend,100,50,6/18/2019
D90F43,partnership,100,61,6/18/2019
D9E036,executive-appointment,100,54,6/18/2019
DBB28E,partnership,100,61,6/18/2019
DD682D,partnership,100,61,6/18/2019
E09E2B,partnership,100,61,6/18/2019
E124EB,conference-call,100,50,6/18/2019
E30A8F,facility-open,100,65,6/18/2019
E592F0,product-release,100,64,6/18/2019
E8846E,conference-organizer,100,57,6/18/2019
E8A49A,award,100,58,6/18/2019
E8B21D,dividend,100,50,6/18/2019
F02170,legal-issues-defendant,100,22,6/18/2019
F02170,legal-issues-defendant,100,22,6/18/2019
F3D2EB,dividend,100,50,6/18/2019
F5349B,award,100,58,6/18/2019
F58C23,conference-participant,100,50,6/18/2019
F5D059,conference-call,100,50,6/18/2019
F88A04,hirings,100,65,6/18/2019
F93C8A,note-sale,100,52,6/18/2019
FC1B7B,partnership,100,61,6/18/2019
FFE543,partnership,100,61,6/18/2019
02ACBD,product-release,100,64,6/19/2019
02FC1A,legal-issues-defendant,100,22,6/19/2019
0BD4E8,business-contract,100,69,6/19/2019
0E499E,executive-appointment,100,54,6/19/2019
0E5619,settlement,100,56,6/19/2019
0E5619,settlement,100,56,6/19/2019
1216D1,dividend-up,100,81,6/19/2019
168A5D,partnership,100,61,6/19/2019
188394,conference-call,100,50,6/19/2019
190BE6,dividend,100,50,6/19/2019
1BC12C,conference-participant,100,50,6/19/2019
1CD4B5,public-offering,100,43,6/19/2019
1F19C8,credit-extension-provider,100,57,6/19/2019
1FA886,business-contract,100,69,6/19/2019
1FE7F0,executive-appointment,100,54,6/19/2019
200D8B,award,100,58,6/19/2019
205AD5,earnings,100,50,6/19/2019
205AD5,acquisition-interest-acquirer,100,46,6/19/2019
205AD5,unit-acquisition-acquirer,100,49,6/19/2019
251988,partnership,100,61,6/19/2019
292A70,earnings,100,50,6/19/2019
2D2D43,business-contract,100,69,6/19/2019
2D2D43,business-contract,100,69,6/19/2019
306623,note-sale,100,52,6/19/2019
315EB0,partnership,100,61,6/19/2019
342218,dividend,100,50,6/19/2019
3461CF,award,100,58,6/19/2019
44A4FC,unit-acquisition-acquirer,100,49,6/19/2019
44A4FC,unit-acquisition-acquirer,100,49,6/19/2019
44A4FC,acquisition-acquirer,100,49,6/19/2019
4C37C5,conference-call,100,50,6/19/2019
4C3FE9,public-offering,100,43,6/19/2019
520632,conference-call,100,50,6/19/2019
52B567,partnership,100,61,6/19/2019
545272,dividend,100,50,6/19/2019
56277A,executive-appointment,100,54,6/19/2019
58B46F,conference-call,100,50,6/19/2019
5DD486,conference-call,100,50,6/19/2019
62F41C,executive-appointment,100,54,6/19/2019
636BBF,legal-issues-defendant,100,22,6/19/2019
63E8D5,dividend,100,50,6/19/2019
65D0AA,clinical-trials-positive,100,87,6/19/2019
6-Dec-05,partnership,100,61,6/19/2019
726DDF,executive-appointment,100,54,6/19/2019
73C521,earnings,100,50,6/19/2019
73F7F9,earnings,100,50,6/19/2019
775439,dividend,100,50,6/19/2019
790C34,acquisition-completed-acquirer,100,49,6/19/2019
7A10FF,stake-acquirer,100,48,6/19/2019
7EA323,executive-appointment,100,54,6/19/2019
7F3A5F,note-sale,100,52,6/19/2019
86AA9C,legal-issues-defendant,100,22,6/19/2019
8C6C1B,facility-open,100,65,6/19/2019
8D4486,partnership,100,61,6/19/2019
911ACB,dividend,100,50,6/19/2019
93633B,dividend,100,50,6/19/2019
94637C,unit-acquisition-acquiree,100,76,6/19/2019
94637C,unit-acquisition-acquiree,100,76,6/19/2019
94637C,acquisition-acquiree,100,76,6/19/2019
94C0B5,conference-call,100,50,6/19/2019
9A602D,conference-call,100,50,6/19/2019
9B5968,executive-appointment,100,54,6/19/2019
9EBAFA,public-offering,100,43,6/19/2019
A398F8,note-sale,100,52,6/19/2019
A3AAA5,dividend,100,50,6/19/2019
A6FC89,legal-issues-defendant,100,22,6/19/2019
A6FC89,legal-issues-defendant,100,22,6/19/2019
A868C9,public-offering,100,43,6/19/2019
AC3584,public-offering,100,43,6/19/2019
AC7C4F,earnings-guidance,100,50,6/19/2019
ACC7D3,public-offering,100,43,6/19/2019
AECCA9,conference-call,100,50,6/19/2019
B2206F,executive-appointment,100,54,6/19/2019
B3CB74,conference-organizer,100,57,6/19/2019
B3CB74,conference-organizer,100,57,6/19/2019
BB0787,executive-appointment,100,54,6/19/2019
BDEC1E,conference-participant,100,50,6/19/2019
BFCACF,product-release,100,64,6/19/2019
C2E120,dividend,100,50,6/19/2019
C564E4,partnership,100,61,6/19/2019
C6C702,award,100,58,6/19/2019
C6C702,award,100,58,6/19/2019
CFF15D,product-release,100,64,6/19/2019
D17F7E,business-combination,100,54,6/19/2019
D17F7E,business-combination,100,54,6/19/2019
D17F7E,business-combination,100,54,6/19/2019
D17F7E,business-combination,100,54,6/19/2019
D1CFC8,earnings,100,50,6/19/2019
D21D8A,dividend,100,50,6/19/2019
D4070C,acquisition-acquirer,100,49,6/19/2019
D42DBA,product-release,100,64,6/19/2019
D4AC65,product-release,100,64,6/19/2019
D4AC65,partnership,100,61,6/19/2019
DBB28E,partnership,100,61,6/19/2019
DDC415,business-combination,100,54,6/19/2019
DDC415,business-combination,100,54,6/19/2019
DDC415,business-combination,100,54,6/19/2019
DDC415,business-combination,100,54,6/19/2019
E124EB,demand-decrease,100,17,6/19/2019
E19A99,acquisition-acquirer,100,49,6/19/2019
E49AA3,product-release,100,64,6/19/2019
E49AA3,product-release,100,64,6/19/2019
E61888,dividend,100,50,6/19/2019
EB7FBF,dividend,100,50,6/19/2019
ED2A5E,partnership,100,61,6/19/2019
EFD406,acquisition-interest-acquiree,100,82,6/19/2019
EFD406,unit-acquisition-acquiree,100,76,6/19/2019
F02170,legal-issues-defendant,100,22,6/19/2019
F02170,legal-issues-defendant,100,22,6/19/2019
F04E05,buybacks,100,74,6/19/2019
F30508,dividend,100,50,6/19/2019
F30508,dividend,100,50,6/19/2019
F5D410,conference-participant,100,50,6/19/2019
F6E248,partnership,100,61,6/19/2019
F6E248,partnership,100,61,6/19/2019
054B55,earnings,100,50,6/20/2019
0B4D10,public-offering,100,43,6/20/2019
0BA2EF,dividend,100,50,6/20/2019
0BD199,earnings,100,50,6/20/2019
0F65C9,conference-call,100,50,6/20/2019
152E1D,legal-issues-defendant,100,22,6/20/2019
15901B,index-listing,100,76,6/20/2019
1921DD,partnership,100,61,6/20/2019
1E68B3,unit-acquisition-acquirer,100,49,6/20/2019
1FA886,business-contract,100,69,6/20/2019
238302,dividend,100,50,6/20/2019
251988,executive-appointment,100,54,6/20/2019
25529C,buybacks,100,74,6/20/2019
27C10F,executive-appointment,100,54,6/20/2019
2D2D43,executive-appointment,100,54,6/20/2019
2D2D43,executive-resignation,100,44,6/20/2019
3696BF,buybacks,100,74,6/20/2019
37727A,dividend,100,50,6/20/2019
385DD4,business-contract,100,69,6/20/2019
39D9DA,conference-call,100,50,6/20/2019
3AAEAE,clinical-trials-start,100,64,6/20/2019
3B318A,conference-participant,100,50,6/20/2019
3C75D6,conference-participant,100,50,6/20/2019
4135F7,conference-call,100,50,6/20/2019
47752F,dividend,100,50,6/20/2019
4A2457,award,100,58,6/20/2019
4A2457,award,100,58,6/20/2019
4A6F00,conference-organizer,100,57,6/20/2019
4C2F17,ipo-pricing,100,50,6/20/2019
4EEB00,clinical-trials,100,56,6/20/2019
4EEE7E,business-contract,100,69,6/20/2019
543900,unit-acquisition-acquiree,100,76,6/20/2019
5.47E+28,partnership,100,61,6/20/2019
5.47E+28,partnership,100,61,6/20/2019
56EA2B,public-offering,100,43,6/20/2019
5C7601,earnings,100,50,6/20/2019
5DD48B,product-release,100,64,6/20/2019
61BCA7,executive-appointment,100,54,6/20/2019
61BCA7,executive-appointment,100,54,6/20/2019
627186,earnings,100,50,6/20/2019
633043,dividend,100,50,6/20/2019
636BBF,legal-issues-defendant,100,22,6/20/2019
6474BA,earnings,100,50,6/20/2019
665D7D,dividend,100,50,6/20/2019
66A667,acquisition-acquirer,100,49,6/20/2019
66A667,acquisition-acquirer,100,49,6/20/2019
6B236C,public-offering,100,43,6/20/2019
6B236C,public-offering,100,43,6/20/2019
70FCEF,earnings,100,50,6/20/2019
713810,business-contract,100,69,6/20/2019
732A9B,conference-participant,100,50,6/20/2019
746373,conference-call,100,50,6/20/2019
76D79A,note-sale,100,52,6/20/2019
771985,business-contract,100,69,6/20/2019
7AC86E,fundraising,100,64,6/20/2019
7AC86E,executive-appointment,100,54,6/20/2019
7AC86E,dividend,100,50,6/20/2019
7ACBA4,dividend,100,50,6/20/2019
84AB66,dividend,100,50,6/20/2019
86478F,dividend,100,50,6/20/2019
8C6C1B,facility-open,100,65,6/20/2019
90D6A5,conference-call,100,50,6/20/2019
91E5EE,private-placement,100,56,6/20/2019
947B0B,executive-appointment,100,54,6/20/2019
95DC1F,earnings,100,50,6/20/2019
95DC1F,earnings,100,50,6/20/2019
95DC1F,earnings,100,50,6/20/2019
95DC1F,earnings,100,50,6/20/2019
95F59E,executive-appointment,100,54,6/20/2019
9BBFA5,earnings,100,50,6/20/2019
9C25FF,product-release,100,64,6/20/2019
9CA432,conference-call,100,50,6/20/2019
9CE4C7,dividend,100,50,6/20/2019
9D6A24,conference-call,100,50,6/20/2019
9EBAFA,public-offering,100,43,6/20/2019
9FB4B7,public-offering,100,43,6/20/2019
A072C4,stake-acquiree,100,62,6/20/2019
A63387,executive-appointment,100,54,6/20/2019
A6FC89,legal-issues-defendant,100,22,6/20/2019
AC3584,public-offering,100,43,6/20/2019
B37FB4,executive-appointment,100,54,6/20/2019
BFCACF,product-release,100,64,6/20/2019
C65004,regulatory-investigation-completed,100,50,6/20/2019
C951A2,acquisition-interest-acquirer,100,46,6/20/2019
C951A2,stake-acquirer,100,48,6/20/2019
C9739A,ipo-pricing,100,50,6/20/2019
CC35BE,award,100,58,6/20/2019
CDAF5B,conference-call,100,50,6/20/2019
D139BC,public-offering,100,43,6/20/2019
D17C1B,business-contract,100,69,6/20/2019
D2E553,executive-appointment,100,54,6/20/2019
D63B0F,conference-participant,100,50,6/20/2019
D78CCD,executive-appointment,100,54,6/20/2019
D7AC6E,conference-call,100,50,6/20/2019
D854F3,conference-call,100,50,6/20/2019
D8DA3D,executive-appointment,100,54,6/20/2019
DA0A9E,conference-call,100,50,6/20/2019
DD0F15,executive-appointment,100,54,6/20/2019
E124EB,partnership,100,61,6/20/2019
E13782,conference-participant,100,50,6/20/2019
E5C910,ipo-pricing,100,50,6/20/2019
E8846E,conference-organizer,100,57,6/20/2019
E8846E,donation,100,54,6/20/2019
E8B315,dividend,100,50,6/20/2019
EB6965,dividend,100,50,6/20/2019
EB7FBF,earnings,100,50,6/20/2019
ECDEB2,dividend-up,100,81,6/20/2019
ED22DC,ipo-pricing,100,50,6/20/2019
EEA6B3,earnings,100,50,6/20/2019
F3816D,executive-appointment,100,54,6/20/2019
F4CDA3,dividend,100,50,6/20/2019
F5D410,earnings,100,50,6/20/2019
F80FF9,partnership,100,61,6/20/2019
F90EE5,executive-appointment,100,54,6/20/2019
FDE409,revenues,100,50,6/20/2019
001F1B,legal-issues-defendant,100,22,6/21/2019
0A9D0A,product-recall,100,29,6/21/2019
0E64D4,partnership,100,61,6/21/2019
1080C0,public-offering,100,43,6/21/2019
168A5D,executive-appointment,100,54,6/21/2019
1921DD,dividend,100,50,6/21/2019
1921DD,dividend,100,50,6/21/2019
1921DD,dividend,100,50,6/21/2019
1921DD,dividend,100,50,6/21/2019
1B6F77,earnings,100,50,6/21/2019
228D42,partnership,100,61,6/21/2019
24C48B,executive-appointment,100,54,6/21/2019
275300,credit-extension-recipient,100,69,6/21/2019
282C18,facility-open,100,65,6/21/2019
306623,private-placement,100,56,6/21/2019
35B907,dividend,100,50,6/21/2019
37020C,dividend,100,50,6/21/2019
3F4497,dividend,100,50,6/21/2019
3FACA7,earnings,100,50,6/21/2019
4C3FE9,public-offering,100,43,6/21/2019
4EC4C1,conference-call,100,50,6/21/2019
5088A5,executive-resignation,100,44,6/21/2019
56EA2B,public-offering,100,43,6/21/2019
57CAAB,regulatory-product-approval-granted,100,81,6/21/2019
57CAAB,regulatory-product-approval-granted,100,81,6/21/2019
589803,clinical-trials-positive,100,87,6/21/2019
589803,clinical-trials-positive,100,87,6/21/2019
5A53BF,clinical-trials,100,56,6/21/2019
5A53BF,clinical-trials,100,56,6/21/2019
5CC29D,business-contract,100,69,6/21/2019
6166D1,regulatory-stress-test,100,50,6/21/2019
619882,regulatory-stress-test,100,50,6/21/2019
636BBF,partnership,100,61,6/21/2019
657097,unit-acquisition-acquirer,100,49,6/21/2019
68BA15,conference-call,100,50,6/21/2019
6F30F9,dividend,100,50,6/21/2019
71B0CF,clinical-trials,100,56,6/21/2019
71E2EF,unit-acquisition-acquiree,100,76,6/21/2019
723548,dividend,100,50,6/21/2019
7A2A49,executive-appointment,100,54,6/21/2019
837C04,unit-acquisition-acquirer,100,49,6/21/2019
8817D5,conference-call,100,50,6/21/2019
8C6C1B,facility-open,100,65,6/21/2019
8D4486,partnership,100,61,6/21/2019
8E93A4,unit-acquisition-acquiree,100,76,6/21/2019
96F126,executive-appointment,100,54,6/21/2019
9D6A24,conference-call,100,50,6/21/2019
A63387,board-meeting,100,51,6/21/2019
A6FC89,legal-issues-defendant,100,22,6/21/2019
A6FE1C,unit-acquisition-acquirer,100,49,6/21/2019
AA09AD,legal-issues-defendant,100,22,6/21/2019
AA7FE0,earnings,100,50,6/21/2019
AA7FE0,earnings,100,50,6/21/2019
AA7FE0,earnings,100,50,6/21/2019
AA7FE0,earnings,100,50,6/21/2019
AEFC90,orphan-drug-designation,100,76,6/21/2019
B8F71F,earnings,100,50,6/21/2019
BBBB41,product-release,100,64,6/21/2019
BD9668,conference-call,100,50,6/21/2019
C0200F,award,100,58,6/21/2019
C4C77F,executive-appointment,100,54,6/21/2019
D139BC,public-offering,100,43,6/21/2019
D1588D,ipo-completed,100,76,6/21/2019
D8DA3D,legal-issues-defendant,100,22,6/21/2019
DD7A96,conference-call,100,50,6/21/2019
E68733,dividend-up,100,58,6/21/2019
E8846E,regulatory-stress-test,100,50,6/21/2019
EC8116,dividend,100,50,6/21/2019
F51DB0,legal-issues-defendant,100,22,6/21/2019
F748C7,dividend,100,50,6/21/2019
F82D37,conference-call,100,50,6/21/2019
FB728F,conference-participant,100,50,6/21/2019
FD9526,conference-call,100,50,6/21/2019
FF6644,conference-call,100,50,6/21/2019
02FC1A,legal-issues-defendant,100,22,6/22/2019
8B6E7E,legal-issues-defendant,100,22,6/22/2019
B4703C,legal-issues-defendant,100,22,6/22/2019
B4703C,legal-issues-defendant,100,22,6/22/2019
C8FAC7,legal-issues-defendant,100,22,6/22/2019
D5938F,clinical-trials,100,56,6/22/2019
F02170,legal-issues-defendant,100,22,6/22/2019
F51DB0,legal-issues-defendant,100,22,6/22/2019
636BBF,legal-issues-defendant,100,22,6/23/2019
A6FC89,legal-issues-defendant,100,22,6/23/2019
E7BF32,conference-call,100,50,6/23/2019
E7BF32,conference-call,100,50,6/23/2019
001F1B,legal-issues-defendant,100,22,6/24/2019
01478A,conference-call,100,50,6/24/2019
036C6F,legal-issues-defendant,100,22,6/24/2019
054E7E,executive-appointment,100,54,6/24/2019
55018,debt,100,50,6/24/2019
0E439E,earnings,100,50,6/24/2019
0E5619,conference-participant,100,50,6/24/2019
0F2BC9,business-contract,100,69,6/24/2019
106394,partnership,100,61,6/24/2019
106394,public-offering,100,43,6/24/2019
152FA5,executive-appointment,100,54,6/24/2019
16C544,note-sale,100,52,6/24/2019
16FC89,earnings,100,50,6/24/2019
184866,clinical-trials,100,56,6/24/2019
188394,investment-investor,100,55,6/24/2019
1B6F77,clinical-trials-start,100,64,6/24/2019
202E5A,executive-appointment,100,54,6/24/2019
25102A,executive-appointment,100,54,6/24/2019
25102A,executive-appointment,100,54,6/24/2019
25102A,conference-organizer,100,57,6/24/2019
251988,executive-appointment,100,54,6/24/2019
251988,earnings,100,50,6/24/2019
27C10F,executive-appointment,100,54,6/24/2019
2C19A4,merger,100,66,6/24/2019
2C19A4,merger,100,66,6/24/2019
2C7505,product-release,100,64,6/24/2019
2C7505,product-release,100,64,6/24/2019
2EB04E,legal-issues-defendant,100,22,6/24/2019
338544,executive-appointment,100,54,6/24/2019
33AD83,executive-appointment,100,54,6/24/2019
3471C0,note-sale,100,52,6/24/2019
34A959,business-combination,100,54,6/24/2019
34A959,business-combination,100,54,6/24/2019
34A959,business-combination,100,54,6/24/2019
34A959,partnership,100,61,6/24/2019
34A959,merger-delayed,100,38,6/24/2019
35B907,earnings,100,50,6/24/2019
35B907,earnings,100,50,6/24/2019
36529A,clinical-trials-positive,100,87,6/24/2019
3A3447,facility-open,100,65,6/24/2019
3B8484,acquisition-acquirer,100,49,6/24/2019
3C3B6B,product-release,100,64,6/24/2019
41A93D,acquisition-acquirer,100,49,6/24/2019
41A93D,acquisition-acquirer,100,49,6/24/2019
43A060,private-placement,100,56,6/24/2019
43A060,partnership,100,61,6/24/2019
43A74A,business-contract,100,69,6/24/2019
44A4FC,note-sale,100,52,6/24/2019
44A4FC,note-sale,100,52,6/24/2019
453282,conference-call,100,50,6/24/2019
47BA98,earnings,100,50,6/24/2019
4A6F00,partnership,100,61,6/24/2019
4C2F17,ipo-completed,100,76,6/24/2019
4C6C63,product-release,100,64,6/24/2019
54512F,product-release,100,64,6/24/2019
55438C,dividend,100,50,6/24/2019
5546DA,trading-halt,100,43,6/24/2019
5546DA,trading-resumed,100,58,6/24/2019
57356F,conference-call,100,50,6/24/2019
587EDF,unit-acquisition-acquirer,100,49,6/24/2019
58CA9A,executive-appointment,100,54,6/24/2019
5AA3B1,business-contract,100,69,6/24/2019
60DD84,index-listing,100,76,6/24/2019
6166D1,partnership,100,61,6/24/2019
616E3B,conference-call,100,50,6/24/2019
6.52E+64,partnership,100,61,6/24/2019
665D7D,clinical-trials,100,56,6/24/2019
69C99E,clinical-trials-start,100,64,6/24/2019
69CE71,business-contract,100,69,6/24/2019
6DBBBC,executive-appointment,100,54,6/24/2019
747219,note-sale,100,52,6/24/2019
762A3E,reorganization-unit,100,53,6/24/2019
773A17,executive-resignation,100,44,6/24/2019
7999F3,note-sale,100,52,6/24/2019
7999F3,note-sale,100,52,6/24/2019
7999F3,note-sale,100,52,6/24/2019
7AC86E,executive-appointment,100,54,6/24/2019
7AC86E,executive-appointment,100,54,6/24/2019
859281,buybacks,100,74,6/24/2019
8665BA,conference-call,100,50,6/24/2019
88350F,campaign-ad-release,100,59,6/24/2019
8C6C1B,facility-open,100,65,6/24/2019
92D230,legal-issues-defendant,100,22,6/24/2019
93C130,dividend,100,50,6/24/2019
93D207,partnership,100,61,6/24/2019
94983E,product-release,100,64,6/24/2019
9978F1,public-offering,100,43,6/24/2019
9BB35A,conference-call,100,50,6/24/2019
A247F5,executive-appointment,100,54,6/24/2019
A63387,executive-appointment,100,54,6/24/2019
A70BF5,earnings,100,50,6/24/2019
ACC7D3,public-offering,100,43,6/24/2019
AFDF2E,earnings-revision,100,29,6/24/2019
B1FC3B,business-contract,100,69,6/24/2019
B1FC3B,conference-participant,100,50,6/24/2019
B446B8,award,100,58,6/24/2019
B5766D,conference-call,100,50,6/24/2019
B604DF,trading-delisting,100,36,6/24/2019
BA218A,legal-issues-defendant,100,22,6/24/2019
BDCC11,executive-appointment,100,54,6/24/2019
C27E19,earnings,100,50,6/24/2019
C3BAE7,partnership,100,61,6/24/2019
C50B26,facility-open,100,65,6/24/2019
C5C0E9,merger,100,66,6/24/2019
C5C0E9,merger,100,66,6/24/2019
C5C0E9,merger,100,66,6/24/2019
C81E00,conference-call,100,50,6/24/2019
C81E00,conference-call,100,50,6/24/2019
C8257F,note-sale,100,52,6/24/2019
C8FAC7,legal-issues-defendant,100,22,6/24/2019
C8FAC7,legal-issues-defendant,100,22,6/24/2019
C97B2D,legal-issues-defendant,100,22,6/24/2019
CBB77B,earnings,100,50,6/24/2019
CEC5B9,ebitda-guidance-down,100,19,6/24/2019
CEC5B9,note-sale,100,52,6/24/2019
CEC5B9,note-sale,100,52,6/24/2019
D296C6,dividend,100,50,6/24/2019
D7AC6E,executive-resignation,100,44,6/24/2019
D8DA3D,legal-issues-defendant,100,22,6/24/2019
D8DA3D,regulatory-investigation,100,22,6/24/2019
D9B1C9,executive-appointment,100,54,6/24/2019
DC5299,conference-call,100,50,6/24/2019
E2F130,conference-call,100,50,6/24/2019
E3E68E,award,100,58,6/24/2019
E592F0,product-release,100,64,6/24/2019
E6EDED,conference-call,100,50,6/24/2019
E70531,asset-sale,100,62,6/24/2019
E8C557,executive-appointment,100,54,6/24/2019
ED22DC,ipo-completed,100,76,6/24/2019
ED4560,executive-appointment,100,54,6/24/2019
F48947,legal-issues-defendant,100,22,6/24/2019
F5D059,executive-appointment,100,54,6/24/2019
F6E248,partnership,100,61,6/24/2019
F6FF0D,legal-issues-defendant,100,22,6/24/2019
F7935D,regulatory-product-approval-granted,100,81,6/24/2019
F80389,business-contract,100,69,6/24/2019
FB728F,conference-participant,100,50,6/24/2019
00067A,partnership,100,61,6/25/2019
0157B1,partnership,100,61,6/25/2019
0157B1,partnership,100,61,6/25/2019
0157B1,partnership,100,61,6/25/2019
0157B1,partnership,100,61,6/25/2019
02FC1A,legal-issues-defendant,100,22,6/25/2019
0A7650,dividend,100,50,6/25/2019
0A7650,executive-appointment,100,54,6/25/2019
0C136E,earnings,100,50,6/25/2019
0CC01F,earnings,100,50,6/25/2019
0D03C8,public-offering,100,43,6/25/2019
106394,public-offering,100,43,6/25/2019
14BA06,earnings,100,50,6/25/2019
165B86,product-release,100,64,6/25/2019
168A5D,facility-open,100,65,6/25/2019
1748F6,executive-appointment,100,54,6/25/2019
1F716B,donation,100,54,6/25/2019
1FA8F7,executive-appointment,100,54,6/25/2019
1FCC00,executive-appointment,100,54,6/25/2019
21022F,facility-open,100,65,6/25/2019
2571FA,conference-call,100,50,6/25/2019
2E89AE,executive-appointment,100,54,6/25/2019
2F7474,dividend-up,100,81,6/25/2019
3390DE,conference-call,100,50,6/25/2019
33FD66,earnings,100,50,6/25/2019
385DD4,market-entry,100,57,6/25/2019
39FB23,executive-appointment,100,54,6/25/2019
3BCF24,dividend,100,50,6/25/2019
3D9999,earnings,100,50,6/25/2019
3DDE54,earnings,100,50,6/25/2019
3E15F6,conference-call,100,50,6/25/2019
4591D3,partnership,100,61,6/25/2019
49914B,conference-call,100,50,6/25/2019
49BBBC,earnings,100,50,6/25/2019
4A6F00,partnership,100,61,6/25/2019
4C7DB5,earnings,100,50,6/25/2019
50702E,earnings,100,50,6/25/2019
50702E,earnings,100,50,6/25/2019
50702E,earnings,100,50,6/25/2019
51888A,unit-acquisition-acquiree,100,76,6/25/2019
519FE0,public-offering,100,43,6/25/2019
5340D0,conference-participant,100,50,6/25/2019
55C9B5,earnings,100,50,6/25/2019
56EA2B,public-offering,100,43,6/25/2019
5C2A47,product-release,100,64,6/25/2019
5FF95F,legal-issues-defendant,100,22,6/25/2019
63F892,product-release,100,64,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
665D7D,acquisition-acquirer,100,49,6/25/2019
66ECFD,earnings,100,50,6/25/2019
6844D2,earnings,100,50,6/25/2019
6C4D2F,executive-appointment,100,54,6/25/2019
6C6D73,executive-appointment,100,54,6/25/2019
762A3E,executive-appointment,100,54,6/25/2019
7A5097,dividend,100,50,6/25/2019
7ACFD4,partnership,100,61,6/25/2019
7B4B91,executive-appointment,100,54,6/25/2019
7D5FD6,earnings,100,50,6/25/2019
7F3669,unit-acquisition-acquiree,100,76,6/25/2019
810FAD,partnership,100,61,6/25/2019
850779,earnings,100,50,6/25/2019
85AD00,conference-call,100,50,6/25/2019
85DE00,executive-appointment,100,54,6/25/2019
86AA9C,legal-issues-defendant,100,22,6/25/2019
885758,legal-issues-defendant,100,22,6/25/2019
8876D6,business-contract,100,69,6/25/2019
8B6E7E,legal-issues-defendant,100,22,6/25/2019
8C6C1B,facility-open,100,65,6/25/2019
8CF6DD,conference-call,100,50,6/25/2019
8E9CD8,credit-rating-upgrade,100,77,6/25/2019
911AB8,conference-call,100,50,6/25/2019
915E7B,conference-call,100,50,6/25/2019
91C82E,earnings-per-share-positive,100,69,6/25/2019
91C82E,earnings-per-share-positive,100,69,6/25/2019
91C82E,earnings-per-share-positive,100,69,6/25/2019
91C82E,earnings-per-share-positive,100,69,6/25/2019
91C82E,earnings-per-share-positive,100,69,6/25/2019
92B047,conference-call,100,50,6/25/2019
92D3A0,conference-call,100,50,6/25/2019
92D9C9,public-offering,100,43,6/25/2019
92D9C9,public-offering,100,43,6/25/2019
93D207,unit-acquisition-acquirer,100,49,6/25/2019
98CAED,earnings,100,50,6/25/2019
9978F1,public-offering,100,43,6/25/2019
99ACAD,earnings,100,50,6/25/2019
9CA619,executive-appointment,100,54,6/25/2019
9D307D,partnership,100,61,6/25/2019
9D30A8,partnership,100,61,6/25/2019
9D3360,executive-appointment,100,54,6/25/2019
9D56F2,dividend,100,50,6/25/2019
9F6B1A,earnings,100,50,6/25/2019
A1E3B3,business-contract,100,69,6/25/2019
A47A7D,product-release,100,64,6/25/2019
A47F2E,earnings,100,50,6/25/2019
A6213D,conference-call,100,50,6/25/2019
A63387,executive-appointment,100,54,6/25/2019
A63820,product-release,100,64,6/25/2019
A6FC89,legal-issues-defendant,100,22,6/25/2019
A868C9,business-contract,100,69,6/25/2019
AA09AD,product-release,100,64,6/25/2019
AA09AD,product-release,100,64,6/25/2019
AA09AD,product-release,100,64,6/25/2019
AA247D,facility-open,100,65,6/25/2019
AA98ED,conference-call,100,50,6/25/2019
AADE0B,stake-acquirer,100,48,6/25/2019
AD9F1D,facility-open,100,65,6/25/2019
B4703C,legal-issues-defendant,100,22,6/25/2019
BEB756,conference-call,100,50,6/25/2019
C062D4,partnership,100,61,6/25/2019
C624A1,public-offering,100,43,6/25/2019
C8FAC7,legal-issues-defendant,100,22,6/25/2019
C8FAC7,legal-issues-defendant,100,22,6/25/2019
CC0C78,executive-appointment,100,54,6/25/2019
CC176E,executive-appointment,100,54,6/25/2019
CC3EC4,executive-appointment,100,54,6/25/2019
CDE51C,partnership,100,61,6/25/2019
CFF97C,dividend,100,50,6/25/2019
CFF97C,credit-rating-upgrade-rater,20,50,6/25/2019
D08D2C,conference-call,100,50,6/25/2019
D139BC,public-offering,100,43,6/25/2019
D854DD,conference-participant,100,50,6/25/2019
D8DA3D,legal-issues-defendant,100,22,6/25/2019
D8DA3D,legal-issues-defendant,100,22,6/25/2019
D8DA3D,legal-issues-defendant,100,22,6/25/2019
D90F43,product-release,100,64,6/25/2019
DB88A1,award,100,58,6/25/2019
DD682D,executive-appointment,100,54,6/25/2019
DF6FDD,executive-appointment,100,54,6/25/2019
E10D31,conference-call,100,50,6/25/2019
E30B34,award,100,58,6/25/2019
E68733,note-sale,100,52,6/25/2019
E68733,note-sale,100,52,6/25/2019
E70531,business-contract,100,69,6/25/2019
E70531,business-contract,100,69,6/25/2019
E70531,business-contract,100,69,6/25/2019
E8C557,executive-resignation,100,44,6/25/2019
E8E899,partnership,100,61,6/25/2019
EF1AD9,conference-call,100,50,6/25/2019
F02170,legal-issues-defendant,100,22,6/25/2019
F18844,executive-appointment,100,54,6/25/2019
F1EB39,earnings,100,50,6/25/2019
F80389,conference-call,100,50,6/25/2019
F90EE5,credit-rating-upgrade,100,77,6/25/2019
F92DBC,facility-upgrade,100,65,6/25/2019
FC9A88,dividend,100,50,6/25/2019
FE7A63,earnings,100,50,6/25/2019
0157B1,partnership,100,61,6/26/2019
03596A,government-contract,100,69,6/26/2019
036C6F,legal-issues-defendant,100,22,6/26/2019
03B431,conference-participant,100,50,6/26/2019
03CF95,partnership,100,61,6/26/2019
03F5A4,dividend,100,50,6/26/2019
05AF14,executive-appointment,100,54,6/26/2019
05AF14,earnings,100,50,6/26/2019
95294,partnership,100,61,6/26/2019
0AB700,dividend,100,50,6/26/2019
0BC29E,earnings,100,50,6/26/2019
0BF198,public-offering,100,43,6/26/2019
0BF198,public-offering,100,43,6/26/2019
0CADBC,dividend,100,50,6/26/2019
0E2992,conference-call,100,50,6/26/2019
0EF1AF,executive-appointment,100,54,6/26/2019
16F4D8,conference-call,100,50,6/26/2019
1921DD,partnership,100,61,6/26/2019
1C2593,public-offering,100,43,6/26/2019
24A89A,executive-appointment,100,54,6/26/2019
24A89A,executive-appointment,100,54,6/26/2019
250BEE,conference-call,100,50,6/26/2019
272704,earnings,100,50,6/26/2019
27BFA1,conference-call,100,50,6/26/2019
28B730,product-release,100,64,6/26/2019
2B0AF4,conference-call,100,50,6/26/2019
2D485F,earnings,100,50,6/26/2019
366A08,legal-issues-defendant,100,22,6/26/2019
366A08,legal-issues-defendant,100,22,6/26/2019
367434,clinical-trials-start,100,64,6/26/2019
3A3447,product-release,100,64,6/26/2019
3C75D6,business-contract,100,69,6/26/2019
3C7F5F,partnership,100,61,6/26/2019
3D7971,asset-sale,100,62,6/26/2019
3D7971,asset-sale,100,62,6/26/2019
3F1C69,clinical-trials-start,100,64,6/26/2019
40F7DE,award,100,58,6/26/2019
40F7DE,earnings,100,50,6/26/2019
49A344,earnings,100,50,6/26/2019
49F4D0,dividend,100,50,6/26/2019
4A2457,business-contract,100,69,6/26/2019
4A6F00,partnership,100,61,6/26/2019
4AC91D,dividend,100,50,6/26/2019
4B3555,dividend,100,50,6/26/2019
4B49CF,earnings,100,50,6/26/2019
4B49CF,earnings,100,50,6/26/2019
4B49CF,earnings,100,50,6/26/2019
4B49CF,earnings,100,50,6/26/2019
4B49CF,earnings,100,50,6/26/2019
4F9487,dividend,100,50,6/26/2019
543900,dividend,100,50,6/26/2019
55438C,earnings,100,50,6/26/2019
55438C,conference-call,100,50,6/26/2019
5BC2F4,earnings,100,50,6/26/2019
5EC388,earnings,100,50,6/26/2019
5FF95F,legal-issues-defendant,100,22,6/26/2019
5FF95F,legal-issues-defendant,100,22,6/26/2019
609208,earnings,100,50,6/26/2019
619882,partnership,100,61,6/26/2019
6F6559,earnings,100,50,6/26/2019
717DB4,conference-participant,100,50,6/26/2019
71E2EF,unit-acquisition-acquiree,100,76,6/26/2019
72FCA3,earnings,100,50,6/26/2019
72FCA3,earnings,100,50,6/26/2019
72FCA3,earnings,100,50,6/26/2019
72FCA3,earnings,100,50,6/26/2019
742AAB,product-release,100,64,6/26/2019
747219,note-sale,100,52,6/26/2019
75768D,earnings,100,50,6/26/2019
75768D,earnings,100,50,6/26/2019
75768D,earnings,100,50,6/26/2019
75768D,earnings,100,50,6/26/2019
75768D,earnings,100,50,6/26/2019
75768D,earnings,100,50,6/26/2019
76E80F,partnership,100,61,6/26/2019
787D14,award,100,58,6/26/2019
7A0EC4,partnership,100,61,6/26/2019
7A975D,earnings,100,50,6/26/2019
7A975D,earnings,100,50,6/26/2019
7A975D,earnings,100,50,6/26/2019
7BFF81,executive-resignation,100,44,6/26/2019
7FDE1C,product-release,100,64,6/26/2019
80D744,trading-halt,100,43,6/26/2019
80D744,trading-resumed,100,58,6/26/2019
80D744,conference-call,100,50,6/26/2019
8303CD,award,100,58,6/26/2019
8AB85C,clinical-trials,100,56,6/26/2019
8C6C1B,facility-open,100,65,6/26/2019
91C82E,dividend,100,50,6/26/2019
97644E,partnership,100,61,6/26/2019
9.86E+03,award,100,58,6/26/2019
9C5174,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9CA619,earnings,100,50,6/26/2019
9F03CF,conference-call,100,50,6/26/2019
A1E3B3,business-contract,100,69,6/26/2019
A666C8,partnership,100,61,6/26/2019
A6FC89,legal-issues-defendant,100,22,6/26/2019
A6FC89,legal-issues-defendant,100,22,6/26/2019
A6FE1C,unit-acquisition-acquirer,100,49,6/26/2019
A94A7B,executive-appointment,100,54,6/26/2019
AA09AD,legal-issues-defendant,100,22,6/26/2019
AFF43F,earnings,100,50,6/26/2019
B33E77,patient-enrollment-complete,100,64,6/26/2019
B48D6A,clinical-trials,100,56,6/26/2019
B4C673,executive-appointment,100,54,6/26/2019
B6082A,conference-call,100,50,6/26/2019
C11C46,product-release,100,64,6/26/2019
C3BCD5,executive-appointment,100,54,6/26/2019
C5C137,legal-issues-defendant,100,22,6/26/2019
C624A1,public-offering,100,43,6/26/2019
C66B44,acquisition-acquirer,100,49,6/26/2019
C66B44,acquisition-acquirer,100,49,6/26/2019
C8FAC7,legal-issues-defendant,100,22,6/26/2019
C8FAC7,legal-issues-defendant,100,22,6/26/2019
C8FAC7,legal-issues-defendant,100,22,6/26/2019
C9E107,earnings,100,50,6/26/2019
CAC8D0,earnings,100,50,6/26/2019
CAC8D0,earnings,100,50,6/26/2019
CFF15D,partnership,100,61,6/26/2019
D0909F,earnings-guidance,100,50,6/26/2019
D15833,dividend,100,50,6/26/2019
D4463B,dividend,100,50,6/26/2019
D88EF3,note-sale,100,52,6/26/2019
D88EF3,note-sale,100,52,6/26/2019
D8DA3D,regulatory-investigation,100,22,6/26/2019
D8DA3D,legal-issues-defendant,100,22,6/26/2019
D90F43,product-release,100,64,6/26/2019
D93A25,joint-venture,100,62,6/26/2019
D93A25,conference-call,100,50,6/26/2019
DA48E4,business-contract,100,69,6/26/2019
DB5CA5,executive-appointment,100,54,6/26/2019
DC486E,earnings,100,50,6/26/2019
DD0099,acquisition-acquirer,100,49,6/26/2019
DD0099,acquisition-acquirer,100,49,6/26/2019
DD682D,partnership,100,61,6/26/2019
DF6FDD,executive-appointment,100,54,6/26/2019
E10D31,dividend,100,50,6/26/2019
E3E68E,award,100,58,6/26/2019
E5752F,partnership,100,61,6/26/2019
E959F3,earnings,100,50,6/26/2019
EF77A3,dividend,100,50,6/26/2019
F30508,fast-track-designation,100,81,6/26/2019
F88147,index-listing,100,76,6/26/2019
FC4550,conference-call,100,50,6/26/2019
FF4343,product-release,100,64,6/26/2019
001F1B,legal-issues-defendant,100,22,6/27/2019
02FC1A,legal-issues-defendant,100,22,6/27/2019
03B8CF,partnership,100,61,6/27/2019
03FB17,asset-sale,100,62,6/27/2019
55018,buybacks,100,74,6/27/2019
07EC43,executive-appointment,100,54,6/27/2019
95294,partnership,100,61,6/27/2019
95294,partnership,100,61,6/27/2019
95294,partnership,100,61,6/27/2019
0BC17A,conference-call,100,50,6/27/2019
0BC29E,executive-appointment,100,54,6/27/2019
102F04,campaign-ad-release,100,59,6/27/2019
119CB6,conference-call,100,50,6/27/2019
14BA06,asset-sale,100,62,6/27/2019
14ED2B,campaign-ad-release,100,59,6/27/2019
154272,patient-enrollment-start,100,58,6/27/2019
15A388,executive-appointment,100,54,6/27/2019
16C7F0,conference-call,100,50,6/27/2019
1921DD,business-contract,100,69,6/27/2019
19CAC7,conference-call,100,50,6/27/2019
1A9DE1,dividend,100,50,6/27/2019
1B5FEA,executive-appointment,100,54,6/27/2019
1BC12C,conference-call,100,50,6/27/2019
1D3A00,acquisition-bid-rejected-acquiree,100,18,6/27/2019
21022F,earnings,100,50,6/27/2019
251988,donation,100,54,6/27/2019
267718,dividend,100,50,6/27/2019
267718,executive-appointment,100,54,6/27/2019
26F31D,award,100,58,6/27/2019
270B78,conference-participant,100,50,6/27/2019
284289,credit-extension-recipient,100,69,6/27/2019
2.90E+62,earnings,100,50,6/27/2019
2C681C,partnership,100,61,6/27/2019
2C681C,partnership,100,61,6/27/2019
2F7474,conference-call,100,50,6/27/2019
30DE64,clinical-trials-start,100,64,6/27/2019
31F25C,conference-call,100,50,6/27/2019
3.20E+263,clinical-trials-start,100,64,6/27/2019
3461CF,award,100,58,6/27/2019
3461CF,credit-rating-upgrade-rater,20,50,6/27/2019
34B411,fundraising,100,64,6/27/2019
366A08,legal-issues-defendant,100,22,6/27/2019
37727A,conference-call,100,50,6/27/2019
384CD3,earnings,100,50,6/27/2019
387375,earnings,100,50,6/27/2019
3CCC90,regulatory-investigation,100,22,6/27/2019
3DCECC,partnership,100,61,6/27/2019
3F1C69,clinical-trials-start,100,64,6/27/2019
43A74A,earnings,100,50,6/27/2019
448BF3,clinical-trials-start,100,64,6/27/2019
448BF3,clinical-trials-start,100,64,6/27/2019
4A2457,business-contract,100,69,6/27/2019
4A5C8D,earnings,100,50,6/27/2019
4A7C1F,executive-appointment,100,54,6/27/2019
4B3555,earnings,100,50,6/27/2019
4BDCA7,executive-resignation,100,44,6/27/2019
4C37C5,market-entry,100,57,6/27/2019
4C37C5,market-entry,100,57,6/27/2019
4D371E,earnings,100,50,6/27/2019
4E4E75,earnings,100,50,6/27/2019
4FCC78,conference-call,100,50,6/27/2019
504FE2,conference-call,100,50,6/27/2019
532D47,legal-issues-defendant,100,22,6/27/2019
54A713,acquisition-completed-acquirer,100,49,6/27/2019
567F3D,conference-call,100,50,6/27/2019
5AF08A,earnings,100,50,6/27/2019
5DA8B3,partnership,100,61,6/27/2019
5F2FF7,earnings,100,50,6/27/2019
5FF95F,earnings,100,50,6/27/2019
601785,earnings,100,50,6/27/2019
6166D1,executive-appointment,100,54,6/27/2019
619882,earnings,100,50,6/27/2019
61B81B,partnership,100,61,6/27/2019
6284B5,executive-appointment,100,54,6/27/2019
636BBF,legal-issues-defendant,100,22,6/27/2019
64E615,executive-appointment,100,54,6/27/2019
6830FE,business-combination,100,54,6/27/2019
6844D2,legal-issues-defendant,100,22,6/27/2019
6844D2,legal-issues-defendant,100,22,6/27/2019
6844D2,legal-issues-defendant,100,22,6/27/2019
6D9ECA,ipo-pricing,100,50,6/27/2019
6-Dec-05,orphan-drug-designation,100,76,6/27/2019
6.00E+19,executive-appointment,100,54,6/27/2019
6EA292,dividend,100,50,6/27/2019
713810,business-contract,100,69,6/27/2019
73C521,buybacks,100,74,6/27/2019
741937,earnings,100,50,6/27/2019
7771D7,earnings,100,50,6/27/2019
7771D7,earnings,100,50,6/27/2019
7771D7,earnings,100,50,6/27/2019
7A975D,dividend,100,50,6/27/2019
7AB859,business-contract,100,69,6/27/2019
7BFF81,executive-appointment,100,54,6/27/2019
8.10E+32,executive-appointment,100,54,6/27/2019
8.10E+32,conference-call,100,50,6/27/2019
868808,dividend,100,50,6/27/2019
86AA9C,legal-issues-defendant,100,22,6/27/2019
885758,legal-issues-defendant,100,22,6/27/2019
8B6E7E,legal-issues-defendant,100,22,6/27/2019
8C6C1B,facility-open,100,65,6/27/2019
8D4486,executive-appointment,100,54,6/27/2019
8DA42F,ipo-pricing,100,50,6/27/2019
8E0E32,earnings,100,50,6/27/2019
8E4250,acquisition-completed-acquirer,100,49,6/27/2019
8F3231,executive-appointment,100,54,6/27/2019
901327,product-release,100,64,6/27/2019
94637C,partnership,100,61,6/27/2019
954004,partnership,100,61,6/27/2019
95DC1F,dividend-up,100,81,6/27/2019
967D92,conference-call,100,50,6/27/2019
96F126,dividend,100,50,6/27/2019
9978F1,public-offering,100,43,6/27/2019
9C25FF,settlement,100,56,6/27/2019
9C8664,buybacks,100,74,6/27/2019
9D3360,conference-call,100,50,6/27/2019
9D56F2,earnings,100,50,6/27/2019
9D56F2,earnings,100,50,6/27/2019
9D56F2,earnings,100,50,6/27/2019
9D56F2,earnings,100,50,6/27/2019
9D56F2,earnings,100,50,6/27/2019
9D5FA4,credit-rating-upgrade,100,64,6/27/2019
A26C26,dividend,100,50,6/27/2019
A5195E,patient-enrollment-start,100,58,6/27/2019
A6FC89,legal-issues-defendant,100,22,6/27/2019
A70BF5,buybacks,100,74,6/27/2019
A80FE0,conference-call,100,50,6/27/2019
A8CBDA,dividend-up,100,81,6/27/2019
A8CBDA,conference-call,100,50,6/27/2019
ADFB3A,clinical-trials-start,100,64,6/27/2019
AED61E,acquisition-acquirer,100,49,6/27/2019
AED61E,acquisition-acquirer,100,49,6/27/2019
AEFC90,fast-track-designation,100,81,6/27/2019
B05000,executive-appointment,100,54,6/27/2019
B290A2,patient-enrollment-complete,100,64,6/27/2019
B2D492,earnings,100,50,6/27/2019
B3ED62,conference-call,100,50,6/27/2019
B66928,facility-open,100,65,6/27/2019
BFD0A7,partnership,100,61,6/27/2019
BFD0A7,board-meeting,100,51,6/27/2019
BFE02C,buybacks,100,74,6/27/2019
C0200F,executive-appointment,100,54,6/27/2019
C4A432,partnership,100,61,6/27/2019
C58D71,index-listing,100,76,6/27/2019
C7859D,conference-call,100,50,6/27/2019
C85A72,credit-extension-recipient,100,69,6/27/2019
C8A248,dividend,100,50,6/27/2019
C8FAC7,legal-issues-defendant,100,22,6/27/2019
C8FAC7,legal-issues-defendant,100,22,6/27/2019
C8FAC7,legal-issues-defendant,100,22,6/27/2019
C941DC,earnings,100,50,6/27/2019
C9F39B,conference-call,100,50,6/27/2019
CBB77B,earnings,100,50,6/27/2019
CBB77B,earnings,100,50,6/27/2019
CE1002,award,100,58,6/27/2019
CE96E7,power-outage,100,47,6/27/2019
CFF57D,earnings,100,50,6/27/2019
CFF97C,credit-rating-affirmation-rater,20,50,6/27/2019
D64C6D,earnings,100,50,6/27/2019
D78BF1,earnings,100,50,6/27/2019
D8442A,product-recall,100,29,6/27/2019
D8442A,executive-appointment,100,54,6/27/2019
D88EF3,conference-call,100,50,6/27/2019
D8ECA1,product-release,100,64,6/27/2019
D95385,ipo-pricing,100,50,6/27/2019
E19A99,acquisition-completed-acquirer,100,49,6/27/2019
E68733,acquisition-completed-acquirer,100,49,6/27/2019
E68733,acquisition-completed-acquirer,100,49,6/27/2019
E829E8,award,100,58,6/27/2019
E8E899,earnings,100,50,6/27/2019
E9E6FD,unit-acquisition-regulatory-approval-acquirer,100,53,6/27/2019
EB1E1A,partnership,100,61,6/27/2019
EF5BED,dividend,100,50,6/27/2019
EF77A3,earnings,100,50,6/27/2019
F02170,legal-issues-defendant,100,22,6/27/2019
F04E05,executive-resignation,100,44,6/27/2019
F0EEFB,unit-acquisition-acquirer,100,49,6/27/2019
F3EDB4,earnings,100,50,6/27/2019
F48947,legal-issues-defendant,100,22,6/27/2019
F48947,executive-appointment,100,54,6/27/2019
F4E882,product-recall,100,29,6/27/2019
F7935D,product-release,100,64,6/27/2019
FA40E2,earnings,100,50,6/27/2019
FACF19,earnings,100,50,6/27/2019
FC01C0,conference-participant,100,50,6/27/2019
FD4588,conference-call,100,50,6/27/2019
FF4BA4,earnings,100,50,6/27/2019
07C69F,conference-call,100,50,6/28/2019
106394,public-offering,100,43,6/28/2019
10C19B,conference-call,100,50,6/28/2019
131443,business-contract,100,69,6/28/2019
131443,acquisition-acquirer,100,49,6/28/2019
184866,clinical-trials,100,56,6/28/2019
184866,clinical-trials,100,56,6/28/2019
1C2593,donation,100,54,6/28/2019
1D1B07,earnings,100,50,6/28/2019
1D1B07,earnings,100,50,6/28/2019
1D3A00,dividend,100,50,6/28/2019
228D42,partnership,100,61,6/28/2019
251988,dividend,100,50,6/28/2019
267718,regulatory-product-approval-granted,100,81,6/28/2019
267718,clinical-trials,100,56,6/28/2019
267718,clinical-trials,100,56,6/28/2019
28B730,spin-off,100,58,6/28/2019
29A4CC,conference-call,100,50,6/28/2019
2B7A40,earnings,100,50,6/28/2019
3461CF,award,100,58,6/28/2019
366A08,legal-issues-defendant,100,22,6/28/2019
366A08,legal-issues-defendant,100,22,6/28/2019
366A08,legal-issues-defendant,100,22,6/28/2019
39FB23,business-contract,100,69,6/28/2019
3F4497,conference-call,100,50,6/28/2019
40F7DE,revenue-up,100,69,6/28/2019
40F7DE,revenue-up,100,69,6/28/2019
40F7DE,revenue-up,100,69,6/28/2019
40F7DE,revenue-up,100,69,6/28/2019
490D4B,executive-appointment,100,54,6/28/2019
50702E,earnings,100,50,6/28/2019
55C9B5,conference-call,100,50,6/28/2019
55D0F3,board-meeting,100,51,6/28/2019
589803,regulatory-product-approval-granted,100,81,6/28/2019
589803,regulatory-product-approval-granted,100,81,6/28/2019
589803,regulatory-product-approval-granted,100,81,6/28/2019
589803,regulatory-product-approval-granted,100,81,6/28/2019
589803,regulatory-product-approval-granted,100,81,6/28/2019
5A0FF1,earnings,100,50,6/28/2019
5E6959,conference-call,100,50,6/28/2019
616E3B,acquisition-acquirer,100,49,6/28/2019
619882,partnership,100,61,6/28/2019
62EFEE,acquisition-completed-acquiree,100,76,6/28/2019
65D0AA,public-offering,100,43,6/28/2019
65D0AA,public-offering,100,43,6/28/2019
66A667,dividend,100,50,6/28/2019
66A667,dividend,100,50,6/28/2019
66A667,dividend,100,50,6/28/2019
66A667,dividend,100,50,6/28/2019
6844D2,legal-issues-defendant,100,22,6/28/2019
6844D2,fraud-defendant,100,20,6/28/2019
6844D2,legal-issues-defendant,100,22,6/28/2019
6D0CAB,asset-sale,100,62,6/28/2019
747219,note-sale,100,52,6/28/2019
765913,earnings,100,50,6/28/2019
7ADE57,dividend-up,100,81,6/28/2019
7D7716,earnings,100,50,6/28/2019
8195B7,index-listing,100,76,6/28/2019
83598E,facility-accident,100,36,6/28/2019
8665BA,asset-sale,100,62,6/28/2019
8665BA,unit-acquisition-completed-acquiree,100,67,6/28/2019
88350F,conference-call,100,50,6/28/2019
8C6C1B,facility-open,100,65,6/28/2019
8DA42F,ipo-pricing,100,50,6/28/2019
92D757,executive-appointment,100,54,6/28/2019
93D207,acquisition-acquirer,100,49,6/28/2019
942165,executive-resignation,100,44,6/28/2019
94756D,earnings,100,50,6/28/2019
96B4FF,earnings,100,50,6/28/2019
9E98F2,earnings,100,50,6/28/2019
9EF4CF,partnership,100,61,6/28/2019
9F5997,acquisition-completed-acquirer,100,49,6/28/2019
9F5CBB,dividend,100,50,6/28/2019
A495F7,product-release,100,64,6/28/2019
A6FE1C,business-contract,100,69,6/28/2019
ADD9DC,facility-open,100,65,6/28/2019
AFF7B4,conference-call,100,50,6/28/2019
B1B10C,conference-call,100,50,6/28/2019
BE14CF,regulatory-investigation-completed,100,50,6/28/2019
BE14CF,settlement,100,56,6/28/2019
C03C8B,conference-call,100,50,6/28/2019
C188F8,business-contract,100,69,6/28/2019
C54140,earnings,100,50,6/28/2019
C598D7,conference-call,100,50,6/28/2019
C8FAC7,fraud-defendant,100,20,6/28/2019
D1173F,conference-call,100,50,6/28/2019
D3CEDF,reverse-stock-splits,100,51,6/28/2019
E6D89E,patent-infringement-plaintiff,100,47,6/28/2019
E6E012,executive-appointment,100,54,6/28/2019
E6E012,executive-appointment,100,54,6/28/2019
E8846E,earnings,100,50,6/28/2019
E8846E,facility-open,100,65,6/28/2019
E9FF33,earnings,100,50,6/28/2019
EAEA91,dividend,100,50,6/28/2019
EB61C4,conference-call,100,50,6/28/2019
EBC84C,earnings,100,50,6/28/2019
F05B1B,index-listing,100,76,6/28/2019
F50BAB,conference-call,100,50,6/28/2019
FA35C6,conference-participant,100,50,6/28/2019
FACF19,facility-open,100,65,6/28/2019
001F1B,legal-issues-defendant,100,22,6/29/2019
636BBF,legal-issues-defendant,100,22,6/29/2019
9F03CF,business-contract,100,69,6/30/2019
9F03CF,business-contract,100,69,6/30/2019
9F03CF,business-contract,100,69,6/30/2019
00067A,earnings,100,50,7/1/2019
001F1B,legal-issues-defendant,100,22,7/1/2019
02FC1A,legal-issues-defendant,100,22,7/1/2019
0358AF,conference-participant,100,50,7/1/2019
036C6F,legal-issues-defendant,100,22,7/1/2019
036C6F,legal-issues-defendant,100,22,7/1/2019
04CCCD,dividend,100,50,7/1/2019
0624BE,partnership,100,61,7/1/2019
0624BE,partnership,100,61,7/1/2019
75172,unit-acquisition-completed-acquiree,100,67,7/1/2019
081AB9,buybacks,100,74,7/1/2019
081AB9,conference-call,100,50,7/1/2019
099C88,business-contract,100,69,7/1/2019
0C355F,partnership,100,61,7/1/2019
0C6861,dividend,100,50,7/1/2019
0C8D82,acquisition-acquirer,100,49,7/1/2019
0EF1AF,trading-listing,100,61,7/1/2019
10C19B,dividend-up,100,81,7/1/2019
1151F4,conference-call,100,50,7/1/2019
1272B3,executive-appointment,100,54,7/1/2019
12E454,earnings,100,50,7/1/2019
1490F3,executive-appointment,100,54,7/1/2019
1490F3,executive-appointment,100,54,7/1/2019
1782D5,executive-appointment,100,54,7/1/2019
1921DD,business-contract,100,69,7/1/2019
1CD09C,clinical-trials-filed,100,60,7/1/2019
1EBF8D,conference-call,100,50,7/1/2019
21D903,index-listing,100,76,7/1/2019
221AD7,earnings,100,50,7/1/2019
24C48B,acquisition-completed-acquirer,100,49,7/1/2019
25102A,trading-resumed,100,58,7/1/2019
267718,clinical-trials-positive,100,87,7/1/2019
267718,acquisition-completed-acquirer,100,49,7/1/2019
26F99F,index-listing,100,76,7/1/2019
28AF37,conference-organizer,100,57,7/1/2019
297DA8,acquisition-acquirer,100,49,7/1/2019
2BC05E,partnership,100,61,7/1/2019
2C19A4,dividend,100,50,7/1/2019
2C3348,partnership,100,61,7/1/2019
2D2D43,earnings,100,50,7/1/2019
2E61CC,partnership,100,61,7/1/2019
2EB04E,legal-issues-defendant,100,22,7/1/2019
315EB0,joint-venture,100,62,7/1/2019
315EB0,joint-venture,100,62,7/1/2019
315EB0,credit-rating-upgrade,100,77,7/1/2019
31643A,analyst-ratings-change-neutral,100,49,7/1/2019
326EDD,conference-call,100,50,7/1/2019
32CB22,conference-call,100,50,7/1/2019
32F24A,conference-call,100,50,7/1/2019
338544,conference-call,100,50,7/1/2019
34B411,earnings,100,50,7/1/2019
35AE32,executive-appointment,100,54,7/1/2019
371B0A,dividend-up,100,81,7/1/2019
37B618,unit-acquisition-acquirer,100,49,7/1/2019
39FB23,earnings,100,50,7/1/2019
41B53E,dividend,100,50,7/1/2019
450ECB,index-listing,100,76,7/1/2019
451D61,executive-appointment,100,54,7/1/2019
47752F,earnings,100,50,7/1/2019
4885C8,earnings,100,50,7/1/2019
490D4B,executive-appointment,100,54,7/1/2019
4.91E+58,acquisition-acquirer,100,49,7/1/2019
4.91E+58,acquisition-completed-acquirer,100,49,7/1/2019
49BBBC,executive-appointment,100,54,7/1/2019
4A6F00,partnership,100,61,7/1/2019
4A6F00,business-contract,100,69,7/1/2019
4D8E5E,merger-completed,100,66,7/1/2019
4FCC78,dividend,100,50,7/1/2019
4FCC78,product-release,100,64,7/1/2019
553949,acquisition-completed-acquirer,100,49,7/1/2019
56EFC7,acquisition-completed-acquirer,100,49,7/1/2019
58C2D4,product-release,100,64,7/1/2019
59B229,acquisition-completed-acquirer,100,49,7/1/2019
59B229,executive-appointment,100,54,7/1/2019
59C539,conference-call,100,50,7/1/2019
5CC29D,conference-call,100,50,7/1/2019
5CC29D,conference-call,100,50,7/1/2019
5E9934,index-listing,100,76,7/1/2019
60FE03,index-listing,100,76,7/1/2019
6166D1,bankruptcy,100,7,7/1/2019
62F41C,dividend,100,50,7/1/2019
62F41C,dividend,100,50,7/1/2019
62F41C,dividend,100,50,7/1/2019
63F892,earnings,100,50,7/1/2019
665618,dividend,100,50,7/1/2019
6844D2,legal-issues-defendant,100,22,7/1/2019
68586A,index-listing,100,76,7/1/2019
68BA15,dividend,100,50,7/1/2019
69C99E,index-listing,100,76,7/1/2019
69E8E1,conference-call,100,50,7/1/2019
69E8E1,conference-call,100,50,7/1/2019
69FDFC,award,100,58,7/1/2019
6BDA0C,executive-appointment,100,54,7/1/2019
6CDFC6,executive-appointment,100,54,7/1/2019
6D6B40,earnings,100,50,7/1/2019
6E1E61,conference-call,100,50,7/1/2019
723548,dividend,100,50,7/1/2019
742AAB,partnership,100,61,7/1/2019
750DFF,index-listing,100,76,7/1/2019
766047,executive-appointment,100,54,7/1/2019
76D79A,index-listing,100,76,7/1/2019
787D14,executive-appointment,100,54,7/1/2019
78F776,index-listing,100,76,7/1/2019
79167B,conference-call,100,50,7/1/2019
791EC1,conference-call,100,50,7/1/2019
7AC86E,executive-appointment,100,54,7/1/2019
7B6EB1,executive-appointment,100,54,7/1/2019
7B8CB5,asset-sale,100,62,7/1/2019
7DC1C4,index-listing,100,76,7/1/2019
810FAD,conference-call,100,50,7/1/2019
84A6B9,earnings,100,50,7/1/2019
86AA9C,legal-issues-defendant,100,22,7/1/2019
885758,legal-issues-defendant,100,22,7/1/2019
8B2C4A,acquisition-completed-acquirer,100,49,7/1/2019
8B6E7E,legal-issues-defendant,100,22,7/1/2019
8B8656,partnership,100,61,7/1/2019
8C6C1B,facility-open,100,65,7/1/2019
8D4486,partnership,100,61,7/1/2019
8D4486,partnership,100,61,7/1/2019
8E10BF,index-listing,100,76,7/1/2019
92D230,legal-issues-defendant,100,22,7/1/2019
93D207,earnings,100,50,7/1/2019
957A07,earnings,100,50,7/1/2019
9.62E+76,earnings,100,50,7/1/2019
96F126,earnings,100,50,7/1/2019
96F126,executive-appointment,100,54,7/1/2019
990AD0,product-release,100,64,7/1/2019
9B5968,executive-appointment,100,54,7/1/2019
9E5C2C,conference-call,100,50,7/1/2019
9F37C5,dividend,100,50,7/1/2019
9F5997,acquisition-acquiree,100,76,7/1/2019
A495F7,executive-appointment,100,54,7/1/2019
A4B899,earnings-guidance,100,50,7/1/2019
A4BCDE,acquisition-acquirer,100,49,7/1/2019
A5195E,executive-appointment,100,54,7/1/2019
A5B913,earnings,100,50,7/1/2019
A63820,award,100,58,7/1/2019
A6ABE9,business-contract,100,69,7/1/2019
A6FC89,legal-issues-defendant,100,22,7/1/2019
AD9F1D,conference-call,100,50,7/1/2019
B05000,index-listing,100,76,7/1/2019
B4703C,legal-issues-defendant,100,22,7/1/2019
B5DE80,unit-acquisition-acquirer,100,49,7/1/2019
B604DF,conference-call,100,50,7/1/2019
B7EB38,executive-resignation,100,44,7/1/2019
B803B1,dividend,100,50,7/1/2019
BB5271,conference-call,100,50,7/1/2019
BBAE2A,conference-call,100,50,7/1/2019
BDD12C,unit-acquisition-completed-acquiree,100,67,7/1/2019
BE86A1,dividend,100,50,7/1/2019
BEB756,executive-appointment,100,54,7/1/2019
BFAEB4,executive-appointment,100,54,7/1/2019
C230FE,earnings,100,50,7/1/2019
C2F597,index-listing,100,76,7/1/2019
C32A39,executive-appointment,100,54,7/1/2019
C4F567,conference-call,100,50,7/1/2019
C659EB,conference-call,100,50,7/1/2019
C74887,executive-appointment,100,54,7/1/2019
C7863D,conference-call,100,50,7/1/2019
C7AE14,dividend,100,50,7/1/2019
C8FAC7,legal-issues-defendant,100,22,7/1/2019
C941DC,executive-appointment,100,54,7/1/2019
C97B2D,conference-call,100,50,7/1/2019
CA3CB9,acquisition-completed-acquirer,100,49,7/1/2019
CAB222,business-contract,100,69,7/1/2019
CB89EA,index-listing,100,76,7/1/2019
CF6A5A,earnings,100,50,7/1/2019
D11C1C,unit-acquisition-acquirer,100,49,7/1/2019
D3F64D,conference-call,100,50,7/1/2019
D5AF19,earnings,100,50,7/1/2019
D6853F,conference-call,100,50,7/1/2019
D8DA3D,conference-call,100,50,7/1/2019
D95385,ipo-completed,100,76,7/1/2019
DA199F,acquisition-completed-acquirer,100,49,7/1/2019
DD0099,earnings,100,50,7/1/2019
DF11D9,conference-call,100,50,7/1/2019
DF1F7A,conference-call,100,50,7/1/2019
E12A6E,earnings,100,50,7/1/2019
E21871,earnings,100,50,7/1/2019
E2F130,dividend,100,50,7/1/2019
E35610,conference-call,100,50,7/1/2019
E38906,index-listing,100,76,7/1/2019
E41190,executive-appointment,100,54,7/1/2019
E592F0,business-contract,100,69,7/1/2019
E5F0A8,merger,100,66,7/1/2019
E8846E,acquisition-completed-acquiree,100,76,7/1/2019
EBC84C,unit-acquisition-acquirer,100,49,7/1/2019
EBC84C,unit-acquisition-acquirer,100,49,7/1/2019
EC8116,dividend,100,50,7/1/2019
F02170,legal-issues-defendant,100,22,7/1/2019
F1CD47,earnings,100,50,7/1/2019
F294DD,earnings,100,50,7/1/2019
F31B13,index-listing,100,76,7/1/2019
F48947,legal-issues-defendant,100,22,7/1/2019
F4D241,partnership,100,61,7/1/2019
F4F46F,executive-appointment,100,54,7/1/2019
F6FF0D,legal-issues-defendant,100,22,7/1/2019
F6FF0D,conference-call,100,50,7/1/2019
F80FF9,partnership,100,61,7/1/2019
FA35C6,earnings,100,50,7/1/2019
FC01C0,acquisition-completed-acquiree,100,76,7/1/2019
FDC7E6,buybacks,100,74,7/1/2019
FDC7E6,conference-call,100,50,7/1/2019
FEE4B0,earnings,100,50,7/1/2019
03CF95,partnership,100,61,7/2/2019
48590,earnings,100,50,7/2/2019
0A9D0A,acquisition-completed-acquirer,100,49,7/2/2019
0B400D,acquisition-acquiree,100,76,7/2/2019
0C136E,executive-appointment,100,54,7/2/2019
0C136E,executive-appointment,100,54,7/2/2019
0C6293,index-listing,100,76,7/2/2019
0C8D82,conference-call,100,50,7/2/2019
10943B,conference-call,100,50,7/2/2019
12E454,approval-rating-down,100,25,7/2/2019
12E454,campaign-ad-release,100,59,7/2/2019
1348C9,conference-call,100,50,7/2/2019
1490F3,conference-call,100,50,7/2/2019
1921DD,product-release,100,64,7/2/2019
1921DD,product-release,100,64,7/2/2019
1A2D9F,earnings,100,50,7/2/2019
1F716B,conference-call,100,50,7/2/2019
21D903,earnings,100,50,7/2/2019
22C58E,earnings,100,50,7/2/2019
24FA23,executive-appointment,100,54,7/2/2019
25102A,product-release,100,64,7/2/2019
2667B6,earnings,100,50,7/2/2019
2AE625,conference-call,100,50,7/2/2019
2D2D43,earnings,100,50,7/2/2019
2EB04E,earnings,100,50,7/2/2019
2F24A5,product-release,100,64,7/2/2019
2F6782,acquisition-acquirer,100,49,7/2/2019
315EB0,conference-call,100,50,7/2/2019
342218,conference-call,100,50,7/2/2019
34B97A,conference-call,100,50,7/2/2019
366A08,legal-issues-defendant,100,22,7/2/2019
370C50,conference-call,100,50,7/2/2019
38C46F,dividend,100,50,7/2/2019
3A3447,facility-open,100,65,7/2/2019
41785E,earnings,100,50,7/2/2019
41C36B,executive-appointment,100,54,7/2/2019
44A4FC,partnership,100,61,7/2/2019
45444E,stake-acquirer,100,48,7/2/2019
46CF27,earnings,100,50,7/2/2019
4.91E+58,executive-appointment,100,54,7/2/2019
4B49CF,asset-sale,100,62,7/2/2019
4B5054,conference-call,100,50,7/2/2019
4C3FE9,clinical-trials-start,100,64,7/2/2019
4C5CC9,unit-acquisition-completed-acquirer,100,49,7/2/2019
4EC4C1,earnings,100,50,7/2/2019
4EC4C1,earnings,100,50,7/2/2019
4EC4C1,earnings,100,50,7/2/2019
4EC4C1,earnings,100,50,7/2/2019
4FB770,conference-call,100,50,7/2/2019
524CE4,earnings,100,50,7/2/2019
532D47,conference-call,100,50,7/2/2019
55438C,legal-issues-defendant,100,22,7/2/2019
56B7C1,dividend,100,50,7/2/2019
57B174,conference-call,100,50,7/2/2019
59B229,earnings,100,50,7/2/2019
6.18E+08,index-listing,100,76,7/2/2019
61BCA7,earnings,100,50,7/2/2019
65D0AA,public-offering,100,43,7/2/2019
66A667,earnings,100,50,7/2/2019
67529E,conference-call,100,50,7/2/2019
6844D2,legal-issues-defendant,100,22,7/2/2019
6844D2,legal-issues-defendant,100,22,7/2/2019
6CC55E,partnership,100,61,7/2/2019
6CC55E,partnership,100,61,7/2/2019
71694D,acquisition-acquirer,100,49,7/2/2019
763724,dividend,100,50,7/2/2019
7A51FE,conference-call,100,50,7/2/2019
7E2DE6,earnings,100,50,7/2/2019
7FDE1C,executive-appointment,100,54,7/2/2019
835C86,index-listing,100,76,7/2/2019
86BAC7,index-listing,100,76,7/2/2019
873DB9,conference-call,100,50,7/2/2019
88923D,acquisition-acquirer,100,49,7/2/2019
88923D,acquisition-acquirer,100,49,7/2/2019
8BE916,earnings,100,50,7/2/2019
8C6C1B,facility-open,100,65,7/2/2019
8D5145,earnings,100,50,7/2/2019
8DA42F,ipo-completed,100,76,7/2/2019
9196A2,conference-call,100,50,7/2/2019
934029,conference-call,100,50,7/2/2019
93D207,partnership,100,61,7/2/2019
965360,earnings,100,50,7/2/2019
9810C0,conference-call,100,50,7/2/2019
986AF6,conference-call,100,50,7/2/2019
9CA4C6,conference-call,100,50,7/2/2019
9EED50,conference-call,100,50,7/2/2019
A350C1,conference-call,100,50,7/2/2019
A398B9,earnings,100,50,7/2/2019
A4386C,earnings,100,50,7/2/2019
A5628C,earnings,100,50,7/2/2019
A65325,conference-call,100,50,7/2/2019
A6FC89,legal-issues-defendant,100,22,7/2/2019
A868C9,acquisition-completed-acquirer,100,49,7/2/2019
A94A7B,executive-appointment,100,54,7/2/2019
A9ED24,conference-call,100,50,7/2/2019
AA09AD,legal-issues-defendant,100,22,7/2/2019
ABBAD1,conference-call,100,50,7/2/2019
ADFB3A,orphan-drug-designation,100,76,7/2/2019
ADFB3A,orphan-drug-designation,100,76,7/2/2019
AFD1CA,facility-open,100,65,7/2/2019
AFDF2E,dividend,100,50,7/2/2019
B840EF,earnings,100,50,7/2/2019
BD15E8,conference-call,100,50,7/2/2019
BDEC1E,executive-appointment,100,54,7/2/2019
BE14CF,conference-call,100,50,7/2/2019
C356AC,asset-sale,100,62,7/2/2019
C356AC,business-contract,100,69,7/2/2019
C5D2AE,earnings,100,50,7/2/2019
C951A2,earnings,100,50,7/2/2019
C9D866,conference-call,100,50,7/2/2019
CA212F,business-contract,100,69,7/2/2019
CC176E,earnings,100,50,7/2/2019
CD06A2,earnings,100,50,7/2/2019
CDAA0E,executive-appointment,100,54,7/2/2019
CDC817,executive-appointment,100,54,7/2/2019
D501DC,conference-call,100,50,7/2/2019
D54E62,conference-call,100,50,7/2/2019
D8DA3D,legal-issues-defendant,100,22,7/2/2019
DA199F,dividend,100,50,7/2/2019
DF532D,conference-call,100,50,7/2/2019
DFADDB,clinical-trials-start,100,64,7/2/2019
DFADDB,clinical-trials-start,100,64,7/2/2019
E4CE73,executive-appointment,100,54,7/2/2019
E5752F,executive-appointment,100,54,7/2/2019
E68733,note-sale,100,52,7/2/2019
E68733,note-sale,100,52,7/2/2019
E9E6FD,conference-call,100,50,7/2/2019
EB7FBF,executive-resignation,100,44,7/2/2019
ED22DC,clinical-trials-start,100,64,7/2/2019
ED2EFD,executive-resignation,100,44,7/2/2019
ED3CA8,conference-call,100,50,7/2/2019
ED9576,earnings,100,50,7/2/2019
EEEA9F,credit-extension-recipient,100,69,7/2/2019
EF1AD9,asset-sale,100,62,7/2/2019
F0B877,conference-call,100,50,7/2/2019
F0B877,conference-call,100,50,7/2/2019
F18844,legal-issues-defendant,100,22,7/2/2019
F48947,legal-issues-defendant,100,22,7/2/2019
F4D241,partnership,100,61,7/2/2019
F4E882,earnings,100,50,7/2/2019
F4E992,conference-call,100,50,7/2/2019
F8C5D7,conference-call,100,50,7/2/2019
FC4550,dividend,100,50,7/2/2019
FD0CA4,conference-call,100,50,7/2/2019
FEC475,conference-call,100,50,7/2/2019
018C11,conference-call,100,50,7/3/2019
01D03F,clinical-trials-positive,100,87,7/3/2019
31025,earnings,100,50,7/3/2019
0358AF,earnings,100,50,7/3/2019
0A7650,conference-call,100,50,7/3/2019
105D00,conference-call,100,50,7/3/2019
12DE76,partnership,100,61,7/3/2019
1748B3,conference-call,100,50,7/3/2019
1A6A94,conference-call,100,50,7/3/2019
1F08A6,conference-call,100,50,7/3/2019
1F9D90,earnings,100,50,7/3/2019
206852,conference-call,100,50,7/3/2019
25102A,conference-call,100,50,7/3/2019
25DD05,conference-call,100,50,7/3/2019
275300,conference-call,100,50,7/3/2019
28DCA8,earnings-guidance,100,50,7/3/2019
2A9C0A,conference-call,100,50,7/3/2019
2B9DBB,conference-call,100,50,7/3/2019
2D643C,conference-call,100,50,7/3/2019
2DB344,earnings,100,50,7/3/2019
3.14E+47,earnings,100,50,7/3/2019
353DBB,conference-call,100,50,7/3/2019
366A08,legal-issues-defendant,100,22,7/3/2019
3A3447,facility-open,100,65,7/3/2019
3C11C4,executive-appointment,100,54,7/3/2019
3DC887,earnings,100,50,7/3/2019
3ED92D,executive-resignation,100,44,7/3/2019
434F38,earnings,100,50,7/3/2019
442587,business-contract,100,69,7/3/2019
442587,business-contract,100,69,7/3/2019
47752F,executive-appointment,100,54,7/3/2019
4A6F00,partnership,100,61,7/3/2019
4A6F00,partnership,100,61,7/3/2019
4B6EF9,earnings,100,50,7/3/2019
4D8313,conference-call,100,50,7/3/2019
4FCC78,acquisition-completed-acquirer,100,49,7/3/2019
546A9C,conference-call,100,50,7/3/2019
55C9B5,partnership,100,61,7/3/2019
564F3E,earnings,100,50,7/3/2019
6284B5,conference-call,100,50,7/3/2019
62B20A,conference-call,100,50,7/3/2019
698FF9,earnings,100,50,7/3/2019
752A70,earnings,100,50,7/3/2019
76CEFB,earnings,100,50,7/3/2019
7A3633,earnings,100,50,7/3/2019
7F3A5F,note-sale,100,52,7/3/2019
87B81A,donation,100,54,7/3/2019
8C6C1B,facility-open,100,65,7/3/2019
8D4486,partnership,100,61,7/3/2019
8D4486,partnership,100,61,7/3/2019
8DCBBB,conference-call,100,50,7/3/2019
901327,executive-appointment,100,54,7/3/2019
9.36E+10,unit-acquisition-completed-acquiree,100,67,7/3/2019
93633B,buybacks,100,74,7/3/2019
980C14,conference-call,100,50,7/3/2019
9F5997,business-contract,100,69,7/3/2019
A1EAC8,conference-call,100,50,7/3/2019
A3F598,settlement,100,56,7/3/2019
A6213D,revenues,100,50,7/3/2019
A6FC89,legal-issues-defendant,100,22,7/3/2019
A75D43,conference-call,100,50,7/3/2019
AA09AD,legal-issues-defendant,100,22,7/3/2019
AA09AD,legal-issues-defendant,100,22,7/3/2019
AA09AD,legal-issues-defendant,100,22,7/3/2019
AA09AD,legal-issues-defendant,100,22,7/3/2019
B446B8,earnings,100,50,7/3/2019
B6CD92,dividend-up,100,81,7/3/2019
BA218A,conference-call,100,50,7/3/2019
BB127B,conference-participant,100,50,7/3/2019
BB5142,conference-call,100,50,7/3/2019
BB88B6,earnings,100,50,7/3/2019
C0200F,earnings,100,50,7/3/2019
C3EE99,earnings,100,50,7/3/2019
C8FAC7,legal-issues-defendant,100,22,7/3/2019
D5938F,executive-appointment,100,54,7/3/2019
D8442A,partnership,100,61,7/3/2019
D8442A,partnership,100,61,7/3/2019
D8760C,conference-call,100,50,7/3/2019
DA199F,earnings,100,50,7/3/2019
DB5CA5,earnings,100,50,7/3/2019
E30A8F,earnings,100,50,7/3/2019
E94704,conference-call,100,50,7/3/2019
E9C7C0,acquisition-completed-acquirer,100,49,7/3/2019
EDF5CA,conference-call,100,50,7/3/2019
F5D059,dividend,100,50,7/3/2019
F6A945,earnings,100,50,7/3/2019
FA044A,conference-call,100,50,7/3/2019
FA36A4,conference-call,100,50,7/3/2019
FAB97A,earnings,100,50,7/3/2019
FC9A88,conference-call,100,50,7/3/2019
5B6C11,dividend,100,50,7/4/2019
62F41C,dividend,100,50,7/4/2019
9.36E+10,business-contract,100,69,7/4/2019
AA09AD,legal-issues-defendant,100,22,7/4/2019
CFF97C,credit-rating-confirmation-rater,20,50,7/4/2019
0CC62B,conference-call,100,50,7/5/2019
1B5FEA,business-contract,100,69,7/5/2019
228D42,partnership,100,61,7/5/2019
5675EB,earnings,100,50,7/5/2019
5B6C11,earnings,100,50,7/5/2019
5FF95F,legal-issues-defendant,100,22,7/5/2019
6844D2,legal-issues-defendant,100,22,7/5/2019
75F982,business-contract,100,69,7/5/2019
8C6C1B,facility-open,100,65,7/5/2019
922F0C,earnings,100,50,7/5/2019
9F03CF,product-release,100,64,7/5/2019
A41450,dividend,100,50,7/5/2019
A6FC89,legal-issues-defendant,100,22,7/5/2019
A7102F,business-contract,100,69,7/5/2019
AA09AD,legal-issues-defendant,100,22,7/5/2019
B4703C,conference-call,100,50,7/5/2019
F7902B,earnings,100,50,7/5/2019
267718,clinical-trials,100,56,7/6/2019
69345C,product-release,100,64,7/7/2019
69345C,product-release,100,64,7/7/2019
001F1B,revenues,100,50,7/8/2019
001F1B,revenues,100,50,7/8/2019
001F1B,legal-issues-defendant,100,22,7/8/2019
001F1B,legal-issues-defendant,100,22,7/8/2019
00326D,conference-call,100,50,7/8/2019
00326E,conference-call,100,50,7/8/2019
02FC1A,legal-issues-defendant,100,22,7/8/2019
036C6F,legal-issues-defendant,100,22,7/8/2019
68396,executive-appointment,100,54,7/8/2019
07CA6A,conference-call,100,50,7/8/2019
07CA6A,conference-call,100,50,7/8/2019
099C88,business-contract,100,69,7/8/2019
0A9D0A,acquisition-completed-acquiree,100,76,7/8/2019
0CBC4D,earnings,100,50,7/8/2019
0DE3D5,conference-call,100,50,7/8/2019
1201B5,clinical-trials,100,56,7/8/2019
129DC8,executive-appointment,100,54,7/8/2019
147C38,earnings,100,50,7/8/2019
147C38,executive-appointment,100,54,7/8/2019
15A388,earnings,100,50,7/8/2019
182BE7,executive-resignation,100,44,7/8/2019
1E9A6D,executive-appointment,100,54,7/8/2019
1EBF8D,partnership,100,61,7/8/2019
1EBF8D,partnership,100,61,7/8/2019
1EBF8D,partnership,100,61,7/8/2019
1F352C,earnings,100,50,7/8/2019
1F43A1,investment-investor,100,55,7/8/2019
20BEEA,conference-call,100,50,7/8/2019
21268E,conference-call,100,50,7/8/2019
228D42,partnership,100,61,7/8/2019
297DA8,business-contract,100,69,7/8/2019
2ABF77,clinical-trials-start,100,64,7/8/2019
2B5483,executive-appointment,100,54,7/8/2019
2BF36E,executive-appointment,100,54,7/8/2019
2E36AD,government-contract,100,69,7/8/2019
2E902B,conference-call,100,50,7/8/2019
2EC172,executive-appointment,100,54,7/8/2019
30E01D,fundraising,100,64,7/8/2019
31643A,product-release,100,64,7/8/2019
3390DE,executive-appointment,100,54,7/8/2019
3.50E+27,conference-call,100,50,7/8/2019
367E1C,earnings,100,50,7/8/2019
371B0A,conference-call,100,50,7/8/2019
387541,conference-call,100,50,7/8/2019
3A113F,partnership,100,61,7/8/2019
3A1C46,earnings,100,50,7/8/2019
3DB18B,executive-appointment,100,54,7/8/2019
3FBC9B,unit-acquisition-acquiree,100,76,7/8/2019
4.03E+05,acquisition-completed-acquirer,100,49,7/8/2019
4.00E+163,conference-call,100,50,7/8/2019
42AABD,executive-appointment,100,54,7/8/2019
43A74A,earnings,100,50,7/8/2019
44740A,executive-appointment,100,54,7/8/2019
4649D5,acquisition-acquiree,100,76,7/8/2019
49A344,executive-appointment,100,54,7/8/2019
4A3438,acquisition-acquirer,100,49,7/8/2019
5088A5,earnings,100,50,7/8/2019
52015A,dividend,100,50,7/8/2019
5487B1,conference-call,100,50,7/8/2019
54F1D2,executive-appointment,100,54,7/8/2019
56B7C1,unit-acquisition-acquiree,100,76,7/8/2019
56EA2B,note-sale,100,52,7/8/2019
56EA2B,note-sale,100,52,7/8/2019
5704AC,executive-appointment,100,54,7/8/2019
589803,earnings,100,50,7/8/2019
5A0FF1,executive-appointment,100,54,7/8/2019
5BC2F4,executive-appointment,100,54,7/8/2019
5BE42C,conference-call,100,50,7/8/2019
5BFE94,conference-call,100,50,7/8/2019
5D63F1,earnings,100,50,7/8/2019
60DD84,conference-call,100,50,7/8/2019
610D47,conference-call,100,50,7/8/2019
62CDDE,conference-participant,100,50,7/8/2019
6844D2,legal-issues-defendant,100,22,7/8/2019
6B0E45,conference-call,100,50,7/8/2019
6B236C,conference-call,100,50,7/8/2019
6BF593,conference-call,100,50,7/8/2019
6CF43C,executive-appointment,100,54,7/8/2019
6D4636,executive-appointment,100,54,7/8/2019
6F0096,executive-appointment,100,54,7/8/2019
6F0A63,conference-call,100,50,7/8/2019
6F22E7,fundraising,100,64,7/8/2019
6F39FC,dividend,100,50,7/8/2019
717DB4,product-release,100,64,7/8/2019
71E2EF,earnings,100,50,7/8/2019
726EEA,acquisition-completed-acquirer,100,49,7/8/2019
7448A3,conference-call,100,50,7/8/2019
762A3E,partnership,100,61,7/8/2019
789A7D,conference-call,100,50,7/8/2019
79340A,earnings,100,50,7/8/2019
7AB859,conference-call,100,50,7/8/2019
7CD98F,earnings,100,50,7/8/2019
8.10E+32,dividend,100,50,7/8/2019
86AA9C,legal-issues-defendant,100,22,7/8/2019
87486A,conference-call,100,50,7/8/2019
885758,legal-issues-defendant,100,22,7/8/2019
89FBB1,dividend,100,50,7/8/2019
8B2C4A,conference-call,100,50,7/8/2019
8B6E7E,legal-issues-defendant,100,22,7/8/2019
8B6E7E,conference-call,100,50,7/8/2019
8B9B3B,patient-enrollment-complete,100,64,7/8/2019
8C6C1B,facility-open,100,65,7/8/2019
8E9CD8,earnings,100,50,7/8/2019
902670,conference-call,100,50,7/8/2019
9196A2,business-contract,100,69,7/8/2019
92D230,legal-issues-defendant,100,22,7/8/2019
92D6A5,asset-up,100,72,7/8/2019
9368BE,conference-call,100,50,7/8/2019
94563D,partnership,100,61,7/8/2019
94983E,acquisition-acquirer,100,49,7/8/2019
9.74E+08,executive-appointment,100,54,7/8/2019
990AD0,dividend,100,50,7/8/2019
9A2760,acquisition-completed-acquirer,100,49,7/8/2019
9ABD30,earnings,100,50,7/8/2019
9ABD30,revenues,100,50,7/8/2019
9AF3DC,conference-call,100,50,7/8/2019
9C8BC3,conference-call,100,50,7/8/2019
9D65C1,earnings,100,50,7/8/2019
9E91C6,partnership,100,61,7/8/2019
A01664,earnings,100,50,7/8/2019
A02FB1,conference-call,100,50,7/8/2019
A15C71,conference-call,100,50,7/8/2019
A3AAA5,dividend,100,50,7/8/2019
A5151E,earnings,100,50,7/8/2019
A6FC89,legal-issues-defendant,100,22,7/8/2019
A790A5,executive-appointment,100,54,7/8/2019
A87CD6,earnings,100,50,7/8/2019
AA09AD,award,100,58,7/8/2019
AA09AD,legal-issues-defendant,100,22,7/8/2019
AA1EAA,conference-call,100,50,7/8/2019
AAC8B6,dividend,100,50,7/8/2019
AAC8B6,dividend,100,50,7/8/2019
AFDF2E,earnings,100,50,7/8/2019
AFDF2E,earnings,100,50,7/8/2019
B2256A,conference-call,100,50,7/8/2019
B2E6B5,conference-call,100,50,7/8/2019
B33E77,patient-enrollment-complete,100,64,7/8/2019
B4703C,legal-issues-defendant,100,22,7/8/2019
B4703C,dividend,100,50,7/8/2019
B642E8,executive-appointment,100,54,7/8/2019
B642E8,executive-appointment,100,54,7/8/2019
B803B1,executive-appointment,100,54,7/8/2019
B8F71F,executive-appointment,100,54,7/8/2019
BDCC11,earnings,100,50,7/8/2019
BDEC1E,clinical-trials-positive,100,87,7/8/2019
C062D4,conference-call,100,50,7/8/2019
C0F70B,earnings,100,50,7/8/2019
C188F8,business-contract,100,69,7/8/2019
C32A39,conference-call,100,50,7/8/2019
C38440,executive-appointment,100,54,7/8/2019
C41C25,earnings,100,50,7/8/2019
C7FC95,acquisition-completed-acquirer,100,49,7/8/2019
C7FC95,acquisition-completed-acquirer,100,49,7/8/2019
C8FAC7,legal-issues-defendant,100,22,7/8/2019
C8FAC7,legal-issues-defendant,100,22,7/8/2019
C9739A,fast-track-designation,100,81,7/8/2019
CBB77B,business-contract,100,69,7/8/2019
CBFFDD,business-contract,100,69,7/8/2019
CC6FF5,earnings,100,50,7/8/2019
D29B44,acquisition-acquirer,100,49,7/8/2019
D2B9E5,earnings,100,50,7/8/2019
D501DC,dividend,100,50,7/8/2019
D56E4C,business-contract,100,69,7/8/2019
D56E4C,business-contract,100,69,7/8/2019
D78CCD,executive-appointment,100,54,7/8/2019
D7918D,public-offering,100,43,7/8/2019
D8C09D,conference-call,100,50,7/8/2019
DA91AE,note-sale,100,52,7/8/2019
DB396B,conference-call,100,50,7/8/2019
DB5CA5,dividend-up,100,81,7/8/2019
DB7FA7,conference-call,100,50,7/8/2019
DC0D18,earnings,100,50,7/8/2019
DEF058,earnings,100,50,7/8/2019
E0D3BA,earnings,100,50,7/8/2019
E11C41,conference-call,100,50,7/8/2019
E30B34,earnings,100,50,7/8/2019
E3E68E,conference-call,100,50,7/8/2019
E8A49A,earnings,100,50,7/8/2019
E8B315,conference-call,100,50,7/8/2019
EBD89A,business-contract,100,69,7/8/2019
ED0402,earnings,100,50,7/8/2019
ED4560,executive-appointment,100,54,7/8/2019
F02170,legal-issues-defendant,100,22,7/8/2019
F2E253,executive-appointment,100,54,7/8/2019
F48947,legal-issues-defendant,100,22,7/8/2019
F5C78B,conference-call,100,50,7/8/2019
F6FF0D,legal-issues-defendant,100,22,7/8/2019
F8084B,earnings,100,50,7/8/2019
F83279,earnings,100,50,7/8/2019
F88A04,earnings,100,50,7/8/2019
FDD3FC,executive-appointment,100,54,7/8/2019
FDF28E,earnings,100,50,7/8/2019
003B70,operating-earnings,100,50,7/9/2019
13528,earnings,100,50,7/9/2019
03596A,business-contract,100,69,7/9/2019
036C6F,revenue-up,100,60,7/9/2019
036C6F,legal-issues-defendant,100,22,7/9/2019
51332,product-release,100,64,7/9/2019
06C826,facility-open,100,65,7/9/2019
078D52,dividend,100,50,7/9/2019
09F623,conference-call,100,50,7/9/2019
0A0D9E,conference-call,100,50,7/9/2019
0BC853,conference-call,100,50,7/9/2019
0F0440,donation,100,54,7/9/2019
12DE76,acquisition-interest-acquirer,100,46,7/9/2019
12DE76,acquisition-interest-acquirer,100,46,7/9/2019
12E454,legal-issues-defendant,100,22,7/9/2019
139303,merger,100,66,7/9/2019
143C52,partnership,100,61,7/9/2019
1B16C1,legal-issues-defendant,100,22,7/9/2019
1BC12C,product-release,100,64,7/9/2019
1BC12C,product-release,100,64,7/9/2019
1DF15D,conference-call,100,50,7/9/2019
1EBF8D,regulatory-product-approval-granted,100,81,7/9/2019
2082EA,patient-enrollment-complete,100,64,7/9/2019
21DED4,conference-call,100,50,7/9/2019
228D42,partnership,100,61,7/9/2019
228D42,partnership,100,61,7/9/2019
25A6CC,earnings,100,50,7/9/2019
25AB8E,partnership,100,61,7/9/2019
2A6DBE,partnership,100,61,7/9/2019
2D76CE,revenues,100,50,7/9/2019
2D76CE,earnings,100,50,7/9/2019
2D76CE,earnings,100,50,7/9/2019
2E0496,earnings,100,50,7/9/2019
2E61CC,dividend,100,50,7/9/2019
2EB04E,legal-issues-defendant,100,22,7/9/2019
2F7A7E,conference-call,100,50,7/9/2019
34E9F9,dividend,100,50,7/9/2019
366A08,legal-issues-defendant,100,22,7/9/2019
371C01,conference-call,100,50,7/9/2019
389CFB,executive-appointment,100,54,7/9/2019
39BFF6,conference-call,100,50,7/9/2019
3BB616,earnings,100,50,7/9/2019
3BBD10,ipo,100,71,7/9/2019
3CCC90,business-contract,100,69,7/9/2019
3D6933,business-contract,100,69,7/9/2019
3D6933,business-contract,100,69,7/9/2019
3DE4D1,conference-call,100,50,7/9/2019
3DE4D1,executive-appointment,100,54,7/9/2019
3F1C69,clinical-trials-start,100,64,7/9/2019
425BDC,conference-call,100,50,7/9/2019
442587,business-contract,100,69,7/9/2019
442769,conference-call,100,50,7/9/2019
45444E,earnings,100,50,7/9/2019
467F2C,conference-call,100,50,7/9/2019
46A16E,executive-appointment,100,54,7/9/2019
4.91E+58,conference-call,100,50,7/9/2019
494EB9,earnings,100,50,7/9/2019
4A6F00,partnership,100,61,7/9/2019
4A6F00,partnership,100,61,7/9/2019
4A6F00,partnership,100,61,7/9/2019
4D8124,earnings,100,50,7/9/2019
4E5784,acquisition-interest-acquiree,100,82,7/9/2019
4E5784,acquisition-interest-acquiree,100,82,7/9/2019
4F0A80,acquisition-acquirer,100,49,7/9/2019
51527B,conference-call,100,50,7/9/2019
51E682,conference-call,100,50,7/9/2019
5546DA,conference-call,100,50,7/9/2019
57DDB9,index-listing,100,76,7/9/2019
5B35C7,earnings-up,100,68,7/9/2019
5D41E4,business-contract,100,69,7/9/2019
5F9CE3,earnings,100,50,7/9/2019
6137BF,conference-call,100,50,7/9/2019
61B81B,dividend-up,100,81,7/9/2019
657097,unit-acquisition-acquirer,100,49,7/9/2019
67B923,executive-appointment,100,54,7/9/2019
6844D2,legal-issues-defendant,100,22,7/9/2019
69CE71,business-contract,100,69,7/9/2019
6B494E,dividend,100,50,7/9/2019
6B494E,credit-extension-recipient,100,69,7/9/2019
70FCEF,award,100,58,7/9/2019
719477,conference-call,100,50,7/9/2019
722DE3,acquisition-completed-acquirer,100,49,7/9/2019
747219,earnings,100,50,7/9/2019
7B0BA6,partnership,100,61,7/9/2019
7B6EB1,earnings,100,50,7/9/2019
7D35D8,executive-appointment,100,54,7/9/2019
7DA412,earnings,100,50,7/9/2019
7E3F8F,earnings,100,50,7/9/2019
7EA323,earnings,100,50,7/9/2019
81222C,executive-appointment,100,54,7/9/2019
82E58A,dividend,100,50,7/9/2019
8303CD,conference-call,100,50,7/9/2019
834152,clinical-trials-start,100,64,7/9/2019
84A6B9,executive-appointment,100,54,7/9/2019
84A6B9,executive-appointment,100,54,7/9/2019
859281,earnings,100,50,7/9/2019
877C0C,earnings,100,50,7/9/2019
8802B4,conference-call,100,50,7/9/2019
881190,conference-call,100,50,7/9/2019
895D56,partnership,100,61,7/9/2019
8BE916,executive-appointment,100,54,7/9/2019
8C6C1B,facility-open,100,65,7/9/2019
8D4486,acquisition-completed-acquirer,100,49,7/9/2019
8D4486,acquisition-completed-acquirer,100,49,7/9/2019
8D4486,acquisition-completed-acquirer,100,49,7/9/2019
8D4486,acquisition-completed-acquirer,100,49,7/9/2019
8E0E32,dividend,100,50,7/9/2019
8E93A4,conference-call,100,50,7/9/2019
9043FE,earnings,100,50,7/9/2019
9548BB,earnings,100,50,7/9/2019
95C392,conference-call,100,50,7/9/2019
968103,earnings,100,50,7/9/2019
972356,partnership,100,61,7/9/2019
9C8664,conference-call,100,50,7/9/2019
9EBAFA,dividend-up,100,81,7/9/2019
A16DEA,earnings,100,50,7/9/2019
A2CAF7,investment-investor,100,55,7/9/2019
A3800A,executive-appointment,100,54,7/9/2019
A495F7,earnings,100,50,7/9/2019
A4A612,conference-call,100,50,7/9/2019
A52B6B,acquisition-completed-acquirer,100,49,7/9/2019
A6828A,partnership,100,61,7/9/2019
AA847A,conference-call,100,50,7/9/2019
ABB493,clinical-trials-start,100,64,7/9/2019
ACF77B,dividend,100,50,7/9/2019
AED61E,public-offering,100,43,7/9/2019
AFEC35,earnings,100,50,7/9/2019
BB88B6,partnership,100,61,7/9/2019
BE14CF,acquisition-completed-acquirer,100,49,7/9/2019
BFAEB4,conference-call,100,50,7/9/2019
C48574,revenue-up,100,69,7/9/2019
C48574,revenue-up,100,69,7/9/2019
C48574,revenue-up,100,69,7/9/2019
C48574,revenue-up,100,69,7/9/2019
C6C702,conference-call,100,50,7/9/2019
CA212F,earnings,100,50,7/9/2019
CA99D7,product-recall,100,29,7/9/2019
CAD7D9,conference-call,100,50,7/9/2019
CB22CD,conference-call,100,50,7/9/2019
CB7AB2,earnings,100,50,7/9/2019
CDE51C,earnings,100,50,7/9/2019
CF073E,executive-appointment,100,54,7/9/2019
CFF97C,conference-call,100,50,7/9/2019
D17C1B,earnings,100,50,7/9/2019
D54E62,legal-issues-dismissed-defendant,100,79,7/9/2019
D78CCD,conference-call,100,50,7/9/2019
D7918D,public-offering,100,43,7/9/2019
D7AC6E,earnings,100,50,7/9/2019
D8DA3D,legal-issues-defendant,100,22,7/9/2019
D90F43,conference-call,100,50,7/9/2019
DB06B0,earnings,100,50,7/9/2019
DC1405,earnings,100,50,7/9/2019
DCD97F,business-contract,100,69,7/9/2019
DD1BA1,executive-appointment,100,54,7/9/2019
DD682D,earnings,100,50,7/9/2019
DD9E41,earnings,100,50,7/9/2019
E15736,conference-call,100,50,7/9/2019
E15736,conference-call,100,50,7/9/2019
E15736,conference-call,100,50,7/9/2019
E2F130,earnings,100,50,7/9/2019
E30B34,earnings,100,50,7/9/2019
E67C2C,earnings,100,50,7/9/2019
E6E012,earnings,100,50,7/9/2019
E6E012,earnings,100,50,7/9/2019
E74B55,conference-call,100,50,7/9/2019
E87676,conference-call,100,50,7/9/2019
ED9C04,product-release,100,64,7/9/2019
EE6F1C,earnings,100,50,7/9/2019
EF1AD9,buybacks,100,74,7/9/2019
EF7163,conference-call,100,50,7/9/2019
F02170,legal-issues-defendant,100,22,7/9/2019
F3016C,earnings,100,50,7/9/2019
F30508,conference-call,100,50,7/9/2019
F3EDB4,business-contract,100,69,7/9/2019
F3EDB4,dividend,100,50,7/9/2019
F46EC9,earnings,100,50,7/9/2019
F5349B,product-release,100,64,7/9/2019
F5349B,note-sale,100,52,7/9/2019
F57F6F,executive-appointment,100,54,7/9/2019
F6E248,partnership,100,61,7/9/2019
F6FA6A,earnings,100,50,7/9/2019
F85CC0,earnings,100,50,7/9/2019
F85CC0,earnings,100,50,7/9/2019
F88A04,conference-participant,100,50,7/9/2019
FC1B7B,executive-appointment,100,54,7/9/2019
FC1F9D,conference-call,100,50,7/9/2019
FF5413,revenue-volume,100,50,7/9/2019
FFE543,earnings,100,50,7/9/2019
001F1B,operating-earnings,100,50,7/10/2019
0157B1,stock-loss,100,40,7/10/2019
048B70,conference-call,100,50,7/10/2019
58828,dividend,100,50,7/10/2019
07EC43,conference-call,100,50,7/10/2019
08A40F,executive-resignation,100,44,7/10/2019
099A92,conference-call,100,50,7/10/2019
0A59F8,product-release,100,64,7/10/2019
0B57D7,conference-call,100,50,7/10/2019
0BA8CE,executive-appointment,100,54,7/10/2019
0F0693,clinical-trials,100,56,7/10/2019
0F2BC9,business-contract,100,69,7/10/2019
135B09,conference-call,100,50,7/10/2019
1490F3,acquisition-completed-acquirer,100,49,7/10/2019
1A5D5D,partnership,100,61,7/10/2019
1AB808,earnings,100,50,7/10/2019
1B16C1,legal-issues-defendant,100,22,7/10/2019
1B16C1,legal-issues-defendant,100,22,7/10/2019
1B16C1,legal-issues-defendant,100,22,7/10/2019
1B4F31,earnings,100,50,7/10/2019
1D5C51,conference-call,100,50,7/10/2019
1D943E,business-contract,100,69,7/10/2019
1DE526,conference-call,100,50,7/10/2019
1E9A6D,earnings,100,50,7/10/2019
1F3CFB,executive-appointment,100,54,7/10/2019
1FE3CB,conference-call,100,50,7/10/2019
2096DE,acquisition-acquirer,100,49,7/10/2019
2158DF,earnings,100,50,7/10/2019
228D42,product-release,100,64,7/10/2019
2.45E+15,earnings,100,50,7/10/2019
284289,earnings,100,50,7/10/2019
295F9F,conference-call,100,50,7/10/2019
29B702,earnings,100,50,7/10/2019
2CB4C9,earnings,100,50,7/10/2019
2CBB58,conference-call,100,50,7/10/2019
309922,conference-call,100,50,7/10/2019
31666F,dividend,100,50,7/10/2019
33E8C7,earnings,100,50,7/10/2019
3461CF,dividend,100,50,7/10/2019
367E1C,regulatory-product-approval-granted,100,81,7/10/2019
382EAE,conference-call,100,50,7/10/2019
3A113F,conference-call,100,50,7/10/2019
3CBA2A,conference-call,100,50,7/10/2019
3DD5E2,conference-call,100,50,7/10/2019
3FACA7,dividend,100,50,7/10/2019
4017AD,executive-appointment,100,54,7/10/2019
408089,earnings,100,50,7/10/2019
49BBBC,note-sale,100,52,7/10/2019
49BBBC,note-sale,100,52,7/10/2019
4A6F00,stake-acquirer,100,48,7/10/2019
4AE584,executive-appointment,100,54,7/10/2019
4AE584,executive-appointment,100,54,7/10/2019
4BBA23,conference-call,100,50,7/10/2019
51D876,earnings,100,50,7/10/2019
5.43E+08,partnership,100,61,7/10/2019
5.43E+08,partnership,100,61,7/10/2019
546A9C,earnings,100,50,7/10/2019
56B7C1,conference-call,100,50,7/10/2019
5A423F,earnings,100,50,7/10/2019
5A9F54,executive-appointment,100,54,7/10/2019
5B97B2,earnings,100,50,7/10/2019
5C2A47,conference-call,100,50,7/10/2019
5DD48B,award,100,58,7/10/2019
5EAA43,conference-call,100,50,7/10/2019
5FF95F,legal-issues-defendant,100,22,7/10/2019
5FF95F,legal-issues-defendant,100,22,7/10/2019
605F40,conference-call,100,50,7/10/2019
6166D1,executive-appointment,100,54,7/10/2019
627186,earnings,100,50,7/10/2019
636639,executive-appointment,100,54,7/10/2019
639BD6,conference-call,100,50,7/10/2019
66749D,earnings,100,50,7/10/2019
69CE71,dividend,100,50,7/10/2019
6B0784,conference-call,100,50,7/10/2019
6B0784,conference-call,100,50,7/10/2019
6F0096,conference-call,100,50,7/10/2019
70CA28,revenue-guidance,100,50,7/10/2019
72CB93,earnings,100,50,7/10/2019
73C9E2,conference-call,100,50,7/10/2019
7.44E+09,conference-call,100,50,7/10/2019
7.40E+289,earnings,100,50,7/10/2019
7.40E+289,earnings,100,50,7/10/2019
7.40E+289,earnings,100,50,7/10/2019
7.40E+289,earnings,100,50,7/10/2019
767F86,earnings,100,50,7/10/2019
76D79A,conference-call,100,50,7/10/2019
789ADD,earnings,100,50,7/10/2019
78F9ED,conference-call,100,50,7/10/2019
7A10FF,earnings,100,50,7/10/2019
7AC86E,earnings,100,50,7/10/2019
7B0BA6,earnings,100,50,7/10/2019
7D5384,conference-call,100,50,7/10/2019
7E62B5,conference-call,100,50,7/10/2019
803FED,conference-call,100,50,7/10/2019
81A88D,earnings,100,50,7/10/2019
8.22E+27,conference-call,100,50,7/10/2019
82C202,clinical-trials-positive,100,87,7/10/2019
838ADD,earnings,100,50,7/10/2019
86A1B9,earnings,100,50,7/10/2019
877C0C,reorganization,100,53,7/10/2019
877C0C,reorganization,100,53,7/10/2019
88611B,earnings,100,50,7/10/2019
8876D6,partnership,100,61,7/10/2019
88923D,conference-call,100,50,7/10/2019
88923D,conference-call,100,50,7/10/2019
8AC65D,conference-call,100,50,7/10/2019
8B4A45,facility-open,100,65,7/10/2019
8C6C1B,facility-open,100,65,7/10/2019
8D4486,partnership,100,61,7/10/2019
8D4486,partnership,100,61,7/10/2019
900356,conference-call,100,50,7/10/2019
9087B9,earnings,100,50,7/10/2019
92D3A0,dividend,100,50,7/10/2019
9.36E+10,business-contract,100,69,7/10/2019
93633B,conference-call,100,50,7/10/2019
93AD2E,earnings,100,50,7/10/2019
9470CC,executive-appointment,100,54,7/10/2019
949625,buybacks,100,74,7/10/2019
94C0B5,executive-appointment,100,54,7/10/2019
965360,buybacks,100,74,7/10/2019
980C14,dividend,100,50,7/10/2019
990AD0,earnings,100,50,7/10/2019
9B5968,partnership,100,61,7/10/2019
9B71A7,earnings,100,50,7/10/2019
9B71A7,earnings,100,50,7/10/2019
9B71A7,earnings,100,50,7/10/2019
9C5BA5,conference-call,100,50,7/10/2019
9CE4C7,earnings,100,50,7/10/2019
9F048E,earnings,100,50,7/10/2019
9F62D1,executive-appointment,100,54,7/10/2019
9F71E5,partnership,100,61,7/10/2019
A1A317,conference-call,100,50,7/10/2019
A37D68,demand-decrease,100,17,7/10/2019
A3F598,conference-call,100,50,7/10/2019
A4B899,note-sale,100,52,7/10/2019
A4B899,note-sale,100,52,7/10/2019
A6828A,regulatory-product-approval-granted,100,81,7/10/2019
A746F6,conference-call,100,50,7/10/2019
A8AC4C,conference-call,100,50,7/10/2019
AA09AD,legal-issues-defendant,100,22,7/10/2019
AA09AD,legal-issues-defendant,100,22,7/10/2019
AA09AD,legal-issues-defendant,100,22,7/10/2019
AA09AD,legal-issues-defendant,100,22,7/10/2019
AA09AD,legal-issues-defendant,100,22,7/10/2019
AB7F05,earnings,100,50,7/10/2019
AC7AAE,regulatory-product-approval-granted,100,81,7/10/2019
AE4125,conference-call,100,50,7/10/2019
B1DF3C,earnings,100,50,7/10/2019
B2206F,product-release,100,64,7/10/2019
B2206F,earnings,100,50,7/10/2019
B4703C,executive-appointment,100,54,7/10/2019
B54A74,earnings,100,50,7/10/2019
B5BA39,legal-issues-defendant,100,22,7/10/2019
B7BBFF,dividend,100,50,7/10/2019
B83BCE,earnings,100,50,7/10/2019
B8EF97,revenues,100,50,7/10/2019
BBF349,earnings,100,50,7/10/2019
BCC55F,partnership,100,61,7/10/2019
BCC55F,partnership,100,61,7/10/2019
BCC55F,partnership,100,61,7/10/2019
BDD12C,executive-appointment,100,54,7/10/2019
C15DB3,acquisition-completed-acquirer,100,49,7/10/2019
C38440,earnings,100,50,7/10/2019
C4706C,dividend,100,50,7/10/2019
C4A241,conference-call,100,50,7/10/2019
C4C77F,dividend,100,50,7/10/2019
C66B44,conference-call,100,50,7/10/2019
CA212F,executive-appointment,100,54,7/10/2019
CA3CB9,earnings,100,50,7/10/2019
CB88B3,earnings,100,50,7/10/2019
CC8F6E,product-release,100,64,7/10/2019
CD2DA4,dividend,100,50,7/10/2019
CD4DA8,conference-call,100,50,7/10/2019
CE2791,conference-call,100,50,7/10/2019
CE5664,earnings,100,50,7/10/2019
CE96E7,earnings,100,50,7/10/2019
CFF97C,partnership,100,61,7/10/2019
D06755,earnings,100,50,7/10/2019
D17C1B,executive-appointment,100,54,7/10/2019
D17F7E,earnings,100,50,7/10/2019
D1AE3B,partnership,100,61,7/10/2019
D437C3,earnings,100,50,7/10/2019
D518D8,conference-call,100,50,7/10/2019
D6489C,executive-appointment,100,54,7/10/2019
D77F7E,earnings,100,50,7/10/2019
D7918D,earnings,100,50,7/10/2019
D7A953,earnings,100,50,7/10/2019
DB2E4E,acquisition-completed-acquirer,100,49,7/10/2019
DC0998,conference-call,100,50,7/10/2019
DC6AA0,earnings,100,50,7/10/2019
DDC415,earnings,100,50,7/10/2019
DF6FDD,executive-appointment,100,54,7/10/2019
E26FC3,dividend,100,50,7/10/2019
E5752F,product-release,100,64,7/10/2019
EDD234,conference-call,100,50,7/10/2019
F02170,legal-issues-defendant,100,22,7/10/2019
F02170,legal-issues-defendant,100,22,7/10/2019
F02D0A,earnings,100,50,7/10/2019
F209B4,merger-regulatory-approval,100,81,7/10/2019
F32F88,conference-call,100,50,7/10/2019
F3EDB4,earnings,100,50,7/10/2019
F40EE2,facility-open,100,65,7/10/2019
F40EE2,facility-open,100,65,7/10/2019
F4E992,earnings,100,50,7/10/2019
F5D410,award,100,58,7/10/2019
F7ADEB,conference-call,100,50,7/10/2019
F7ADEB,business-contract,100,69,7/10/2019
FACF19,dividend-up,100,81,7/10/2019
FC1B7B,conference-call,100,50,7/10/2019
FF5413,earnings,100,50,7/10/2019
00326D,earnings,100,50,7/11/2019
00326D,conference-call,100,50,7/11/2019
13528,dividend,100,50,7/11/2019
0157B1,product-release,100,64,7/11/2019
0157B1,conference-call,100,50,7/11/2019
033B58,regulatory-product-approval-granted,100,81,7/11/2019
71860,earnings,100,50,7/11/2019
95294,partnership,100,61,7/11/2019
0D26E0,dividend,100,50,7/11/2019
0ED415,conference-call,100,50,7/11/2019
0F04E5,earnings,100,50,7/11/2019
0F2BC9,conference-call,100,50,7/11/2019
0F91FC,conference-call,100,50,7/11/2019
1782D5,conference-call,100,50,7/11/2019
182B8C,conference-call,100,50,7/11/2019
1834C0,conference-call,100,50,7/11/2019
1B16C1,legal-issues-defendant,100,22,7/11/2019
1B9535,conference-call,100,50,7/11/2019
221445,executive-appointment,100,54,7/11/2019
238302,conference-call,100,50,7/11/2019
251988,award,100,58,7/11/2019
2720AB,conference-call,100,50,7/11/2019
29CEBF,conference-call,100,50,7/11/2019
2A17B1,conference-call,100,50,7/11/2019
2BF36E,conference-call,100,50,7/11/2019
2CC60C,business-contract,100,69,7/11/2019
2CC60C,business-contract,100,69,7/11/2019
2DA92D,conference-call,100,50,7/11/2019
2DC88B,earnings-guidance,100,50,7/11/2019
30DFD3,conference-call,100,50,7/11/2019
31803E,earnings,100,50,7/11/2019
328250,conference-call,100,50,7/11/2019
34A959,business-contract,100,69,7/11/2019
366A08,dividend,100,50,7/11/2019
3696BF,conference-call,100,50,7/11/2019
3798B9,earnings,100,50,7/11/2019
385DD4,business-contract,100,69,7/11/2019
3A3948,conference-call,100,50,7/11/2019
3BCF24,earnings,100,50,7/11/2019
3BE00F,earnings,100,50,7/11/2019
3DB18B,earnings,100,50,7/11/2019
3F1C69,clinical-trials-start,100,64,7/11/2019
415188,conference-call,100,50,7/11/2019
416C55,earnings,100,50,7/11/2019
41C36B,executive-appointment,100,54,7/11/2019
43E8F5,conference-call,100,50,7/11/2019
458D2C,conference-call,100,50,7/11/2019
458D2C,revenue-volume,100,50,7/11/2019
45ABCC,partnership,100,61,7/11/2019
46A16E,conference-call,100,50,7/11/2019
479930,earnings,100,50,7/11/2019
47BA98,conference-call,100,50,7/11/2019
4806CE,conference-call,100,50,7/11/2019
4.91E+58,fundraising,100,64,7/11/2019
49914B,acquisition-acquirer,100,49,7/11/2019
4B3DC9,conference-call,100,50,7/11/2019
4C1FA1,earnings,100,50,7/11/2019
4C6C63,partnership,100,61,7/11/2019
4C6C63,earnings,100,50,7/11/2019
4EE167,earnings,100,50,7/11/2019
4FF163,product-release,100,64,7/11/2019
519FE0,business-contract,100,69,7/11/2019
53A226,earnings,100,50,7/11/2019
55C9B5,partnership,100,61,7/11/2019
55C9B5,partnership,100,61,7/11/2019
56765E,earnings,100,50,7/11/2019
583A75,conference-call,100,50,7/11/2019
59F0B0,conference-call,100,50,7/11/2019
5D0337,earnings,100,50,7/11/2019
5D16CF,conference-call,100,50,7/11/2019
5F2FF7,earnings-positive,100,69,7/11/2019
5F2FF7,earnings-positive,100,69,7/11/2019
5F2FF7,earnings-positive,100,69,7/11/2019
5F2FF7,earnings-positive,100,69,7/11/2019
5F2FF7,earnings-positive,100,69,7/11/2019
5F2FF7,earnings-positive,100,69,7/11/2019
5FF95F,legal-issues-defendant,100,22,7/11/2019
62EFEE,earnings,100,50,7/11/2019
633043,earnings,100,50,7/11/2019
657097,public-offering,100,43,7/11/2019
665D7D,conference-call,100,50,7/11/2019
6A961B,executive-appointment,100,54,7/11/2019
6C6D73,executive-appointment,100,54,7/11/2019
6CB7F9,conference-call,100,50,7/11/2019
6CC55E,earnings,100,50,7/11/2019
6D0CAB,operating-earnings,100,50,7/11/2019
6DC1D7,conference-call,100,50,7/11/2019
6F6559,dividend,100,50,7/11/2019
7239BB,business-contract,100,69,7/11/2019
7255D2,business-contract,100,69,7/11/2019
7255D2,business-contract,100,69,7/11/2019
728737,dividend,100,50,7/11/2019
729368,earnings,100,50,7/11/2019
72C2CE,conference-call,100,50,7/11/2019
73529F,conference-call,100,50,7/11/2019
771985,revenues,100,50,7/11/2019
773A17,earnings,100,50,7/11/2019
7740DE,same-store-sales-up,100,58,7/11/2019
77B8E9,clinical-trials,100,56,7/11/2019
77B8E9,clinical-trials,100,56,7/11/2019
7823A3,earnings,100,50,7/11/2019
791D59,earnings,100,50,7/11/2019
7B9212,revenues,100,50,7/11/2019
7B9AFA,earnings,100,50,7/11/2019
7BAAE7,earnings,100,50,7/11/2019
7BC92D,partnership,100,61,7/11/2019
7CBC40,earnings,100,50,7/11/2019
7D97DE,conference-call,100,50,7/11/2019
7DA412,earnings,100,50,7/11/2019
810A4B,board-meeting,100,51,7/11/2019
837C04,conference-call,100,50,7/11/2019
85DE00,campaign-ad-release,100,59,7/11/2019
8665BA,dividend,100,50,7/11/2019
877C0C,legal-issues-defendant,100,22,7/11/2019
877C0C,legal-issues-defendant,100,22,7/11/2019
877C0C,legal-issues-defendant,100,22,7/11/2019
8B3B0E,conference-call,100,50,7/11/2019
8C6C1B,facility-open,100,65,7/11/2019
8D4AE6,earnings,100,50,7/11/2019
8D4AE6,partnership,100,61,7/11/2019
8DBBE6,conference-call,100,50,7/11/2019
8DBE73,conference-call,100,50,7/11/2019
8DE74B,conference-call,100,50,7/11/2019
8E82A6,earnings,100,50,7/11/2019
8F8F2F,conference-call,100,50,7/11/2019
91E5EE,earnings,100,50,7/11/2019
92B625,campaign-ad-release,100,59,7/11/2019
92D3A0,earnings,100,50,7/11/2019
93D207,partnership,100,61,7/11/2019
949625,conference-call,100,50,7/11/2019
949D62,earnings,100,50,7/11/2019
971F7B,earnings,100,50,7/11/2019
9.74E+08,earnings,100,50,7/11/2019
99028D,executive-appointment,100,54,7/11/2019
9D30A8,earnings,100,50,7/11/2019
A26C26,joint-venture,100,62,7/11/2019
A403CF,legal-issues-defendant,100,22,7/11/2019
A52B6B,executive-appointment,100,54,7/11/2019
A5A4F5,dividend,100,50,7/11/2019
A5A4F5,dividend,100,50,7/11/2019
A6213D,partnership,100,61,7/11/2019
A6213D,dividend,100,50,7/11/2019
A63387,product-release,100,64,7/11/2019
A74F6F,conference-call,100,50,7/11/2019
A806FA,conference-call,100,50,7/11/2019
AA5C8E,earnings,100,50,7/11/2019
AADE0B,conference-call,100,50,7/11/2019
AC3584,partnership,100,61,7/11/2019
AD9F1D,dividend-up,100,81,7/11/2019
AF210D,partnership,100,61,7/11/2019
AF210D,earnings,100,50,7/11/2019
B0FE08,conference-call,100,50,7/11/2019
B1B10C,dividend,100,50,7/11/2019
B2256A,note-sale,100,52,7/11/2019
B2256A,note-sale,100,52,7/11/2019
B5BA39,legal-issues-defendant,100,22,7/11/2019
B5BA39,legal-issues-defendant,100,22,7/11/2019
B66928,product-release,100,64,7/11/2019
B934BF,conference-call,100,50,7/11/2019
B96637,award,100,58,7/11/2019
BB02FB,conference-call,100,50,7/11/2019
BB58FF,reorganization,100,53,7/11/2019
BBBB41,conference-call,100,50,7/11/2019
BCC55F,award,100,58,7/11/2019
BCC55F,award,100,58,7/11/2019
BF79F5,conference-call,100,50,7/11/2019
C0030A,earnings,100,50,7/11/2019
C2609A,product-release,100,64,7/11/2019
C5E100,conference-call,100,50,7/11/2019
C66A8C,earnings,100,50,7/11/2019
C72B8F,legal-issues-defendant,100,22,7/11/2019
C8257F,conference-call,100,50,7/11/2019
C98CDB,earnings,100,50,7/11/2019
CA1620,conference-call,100,50,7/11/2019
CA212F,dividend-up,100,81,7/11/2019
CDAA0E,earnings,100,50,7/11/2019
CF6A5A,earnings,100,50,7/11/2019
D08D2C,dividend,100,50,7/11/2019
D17C1B,revenue-volume,100,50,7/11/2019
D25249,conference-call,100,50,7/11/2019
D63B0F,conference-call,100,50,7/11/2019
D65A13,conference-call,100,50,7/11/2019
D8DA3D,dividend,100,50,7/11/2019
D9164D,earnings,100,50,7/11/2019
DC486E,business-contract,100,69,7/11/2019
DD3BB1,earnings,100,50,7/11/2019
E05DC8,earnings,100,50,7/11/2019
E16133,conference-call,100,50,7/11/2019
E49AA3,acquisition-acquirer,100,49,7/11/2019
E5752F,award,100,58,7/11/2019
E5C910,executive-appointment,100,54,7/11/2019
E6D89E,revenue-guidance,100,50,7/11/2019
E74B55,business-contract,100,69,7/11/2019
E802CE,conference-call,100,50,7/11/2019
EB36DE,conference-call,100,50,7/11/2019
EB43F4,business-contract,100,69,7/11/2019
EB43F4,business-contract,100,69,7/11/2019
EB6965,unit-acquisition-acquirer,100,49,7/11/2019
EF1AD9,business-contract,100,69,7/11/2019
F47871,partnership,100,61,7/11/2019
F51DB0,conference-call,100,50,7/11/2019
F6E248,partnership,100,61,7/11/2019
F6E248,executive-appointment,100,54,7/11/2019
F721A7,earnings,100,50,7/11/2019
F721A7,earnings,100,50,7/11/2019
F748C7,partnership,100,61,7/11/2019
FA918D,conference-call,100,50,7/11/2019
FB728F,conference-call,100,50,7/11/2019
FC1B7B,earnings,100,50,7/11/2019
FD4BBE,earnings,100,50,7/11/2019
FD9A97,earnings,100,50,7/11/2019
FE89E0,dividend,100,50,7/11/2019
00D6B5,conference-call,100,50,7/12/2019
02870F,conference-call,100,50,7/12/2019
31025,partnership,100,61,7/12/2019
083F72,conference-call,100,50,7/12/2019
0C2A0D,earnings,100,50,7/12/2019
0C6861,conference-call,100,50,7/12/2019
0CCCB7,conference-call,100,50,7/12/2019
0FDE97,conference-call,100,50,7/12/2019
10AE08,earnings,100,50,7/12/2019
152B9E,conference-call,100,50,7/12/2019
1AF7E2,conference-call,100,50,7/12/2019
1B16C1,legal-issues-defendant,100,22,7/12/2019
1DA44F,conference-call,100,50,7/12/2019
28AC4E,ipo,100,71,7/12/2019
2EBA55,dividend,100,50,7/12/2019
35F4B5,conference-call,100,50,7/12/2019
39692D,partnership,100,61,7/12/2019
435ACE,conference-call,100,50,7/12/2019
5225A4,conference-organizer,100,57,7/12/2019
525A1C,earnings,100,50,7/12/2019
562853,conference-call,100,50,7/12/2019
5704AC,earnings,100,50,7/12/2019
57B174,dividend,100,50,7/12/2019
5D1956,earnings,100,50,7/12/2019
5FF95F,legal-issues-defendant,100,22,7/12/2019
620381,executive-appointment,100,54,7/12/2019
636BBF,legal-issues-defendant,100,22,7/12/2019
657097,public-offering,100,43,7/12/2019
6C4D2F,conference-call,100,50,7/12/2019
6CDFC6,conference-call,100,50,7/12/2019
6D0CAB,dividend,100,50,7/12/2019
6D3B7B,earnings,100,50,7/12/2019
726DDF,conference-call,100,50,7/12/2019
73A71F,conference-call,100,50,7/12/2019
762A3E,conference-call,100,50,7/12/2019
762B8D,dividend,100,50,7/12/2019
7ACD98,facility-open,100,65,7/12/2019
7B1E50,executive-appointment,100,54,7/12/2019
7F0372,earnings,100,50,7/12/2019
82E58A,executive-resignation,100,44,7/12/2019
838ADD,dividend,100,50,7/12/2019
855DF7,conference-call,100,50,7/12/2019
85AD00,merger-completed,100,66,7/12/2019
881190,executive-appointment,100,54,7/12/2019
8B6E7E,legal-issues-defendant,100,22,7/12/2019
8C6C1B,facility-open,100,65,7/12/2019
93F143,earnings,100,50,7/12/2019
94563D,legal-issues-defendant,100,22,7/12/2019
95F59E,earnings,100,50,7/12/2019
977A1E,conference-call,100,50,7/12/2019
97AF94,dividend,100,50,7/12/2019
9C25FF,conference-call,100,50,7/12/2019
9CF9B1,earnings,100,50,7/12/2019
A403CF,legal-issues-defendant,100,22,7/12/2019
A58224,conference-call,100,50,7/12/2019
A6213D,partnership,100,61,7/12/2019
A6213D,partnership,100,61,7/12/2019
A6828A,regulatory-product-application,100,69,7/12/2019
AA09AD,legal-issues-defendant,100,22,7/12/2019
AD3C93,acquisition-acquirer,100,49,7/12/2019
AD3C93,acquisition-acquirer,100,49,7/12/2019
AED61E,public-offering,100,43,7/12/2019
B05118,earnings,100,50,7/12/2019
B5BA39,legal-issues-defendant,100,22,7/12/2019
B5BA39,legal-issues-defendant,100,22,7/12/2019
B5BA39,legal-issues-defendant,100,22,7/12/2019
B803B1,conference-call,100,50,7/12/2019
BAAA60,conference-call,100,50,7/12/2019
BB127B,award,100,58,7/12/2019
BBBB41,dividend,100,50,7/12/2019
BC948D,conference-call,100,50,7/12/2019
BDE867,note-sale,100,52,7/12/2019
BDF85E,buybacks,100,74,7/12/2019
CD051C,conference-call,100,50,7/12/2019
CE69E9,facility-open,100,65,7/12/2019
CF351E,earnings-guidance,100,50,7/12/2019
D139BC,conference-call,100,50,7/12/2019
D3FA2C,conference-call,100,50,7/12/2019
D64EDF,business-contract,100,69,7/12/2019
D854DD,acquisition-acquirer,100,49,7/12/2019
D854DD,acquisition-acquirer,100,49,7/12/2019
D854DD,acquisition-acquirer,100,49,7/12/2019
D854DD,acquisition-acquirer,100,49,7/12/2019
D854DD,acquisition-acquirer,100,49,7/12/2019
D854DD,acquisition-acquirer,100,49,7/12/2019
DCD97F,conference-call,100,50,7/12/2019
DF01B1,conference-call,100,50,7/12/2019
E0207A,earnings,100,50,7/12/2019
E22FDE,conference-participant,100,50,7/12/2019
E4158B,earnings,100,50,7/12/2019
E592F0,earnings,100,50,7/12/2019
E829E8,executive-resignation,100,44,7/12/2019
E866D2,executive-appointment,100,54,7/12/2019
E866D2,fraud-defendant,100,20,7/12/2019
ECD263,executive-appointment,100,54,7/12/2019
F209B4,merger-completed,100,66,7/12/2019
F72E4B,executive-resignation,100,44,7/12/2019
F8BDCE,earnings,100,50,7/12/2019
F93C8A,dividend,100,50,7/12/2019
FC1736,earnings,100,50,7/12/2019
FF4343,conference-call,100,50,7/12/2019
168A5D,executive-appointment,100,54,7/13/2019
D8442A,business-contract,100,69,7/14/2019
DA199F,executive-appointment,100,54,7/14/2019
F6E248,partnership,100,61,7/14/2019
F6E248,partnership,100,61,7/14/2019
F6E248,partnership,100,61,7/14/2019
001F1B,legal-issues-defendant,100,22,7/15/2019
0142B5,conference-call,100,50,7/15/2019
0157B1,revenue-up,100,69,7/15/2019
02FC1A,legal-issues-defendant,100,22,7/15/2019
036C6F,legal-issues-defendant,100,22,7/15/2019
0919B1,conference-call,100,50,7/15/2019
0A1D77,business-contract,100,69,7/15/2019
0C4131,conference-call,100,50,7/15/2019
0C6861,dividend,100,50,7/15/2019
0CC01F,conference-call,100,50,7/15/2019
0CC01F,earnings,100,50,7/15/2019
0F0440,executive-appointment,100,54,7/15/2019
147C38,dividend,100,50,7/15/2019
168A5D,acquisition-acquirer,100,49,7/15/2019
184866,patient-enrollment-complete,100,64,7/15/2019
184866,patient-enrollment-complete,100,64,7/15/2019
190B91,earnings,100,50,7/15/2019
190B91,earnings,100,50,7/15/2019
1AC649,executive-appointment,100,54,7/15/2019
1BDB2A,conference-call,100,50,7/15/2019
1D9E55,earnings,100,50,7/15/2019
2158DF,executive-appointment,100,54,7/15/2019
21D903,executive-appointment,100,54,7/15/2019
222BF9,conference-call,100,50,7/15/2019
228D42,partnership,100,61,7/15/2019
228D42,partnership,100,61,7/15/2019
272704,earnings-positive,100,69,7/15/2019
2ABF77,conference-call,100,50,7/15/2019
2E0496,partnership,100,61,7/15/2019
2E902B,executive-appointment,100,54,7/15/2019
2F960F,conference-call,100,50,7/15/2019
31AA84,earnings,100,50,7/15/2019
3.20E+263,conference-participant,100,50,7/15/2019
3461CF,executive-appointment,100,54,7/15/2019
370C50,dividend,100,50,7/15/2019
372037,executive-appointment,100,54,7/15/2019
387541,dividend,100,50,7/15/2019
3A3447,facility-open,100,65,7/15/2019
3CBA2A,product-release,100,64,7/15/2019
3DD5E2,partnership,100,61,7/15/2019
408380,earnings,100,50,7/15/2019
416291,conference-call,100,50,7/15/2019
434F38,note-sale,100,52,7/15/2019
435ACE,executive-appointment,100,54,7/15/2019
44209A,earnings,100,50,7/15/2019
448215,public-offering,100,43,7/15/2019
449A26,acquisition-acquirer,100,49,7/15/2019
449A26,acquisition-acquirer,100,49,7/15/2019
44ED36,dividend,100,50,7/15/2019
4595EF,conference-call,100,50,7/15/2019
46A16E,executive-appointment,100,54,7/15/2019
48F795,earnings,100,50,7/15/2019
49A344,executive-appointment,100,54,7/15/2019
4A6F00,partnership,100,61,7/15/2019
4A6F00,legal-issues-defendant,100,22,7/15/2019
50070E,conference-call,100,50,7/15/2019
5065B1,unit-acquisition-acquiree,100,76,7/15/2019
5340D0,facility-open,100,65,7/15/2019
545272,conference-call,100,50,7/15/2019
57B174,executive-appointment,100,54,7/15/2019
5876DC,business-contract-terminated,100,31,7/15/2019
58CA9A,earnings,100,50,7/15/2019
58CA9A,conference-call,100,50,7/15/2019
59C539,executive-appointment,100,54,7/15/2019
5B7739,conference-call,100,50,7/15/2019
5C7601,executive-appointment,100,54,7/15/2019
5C8D61,earnings,100,50,7/15/2019
619882,dividend,100,50,7/15/2019
61A586,earnings,100,50,7/15/2019
665618,conference-call,100,50,7/15/2019
665D7D,acquisition-acquirer,100,49,7/15/2019
6844D2,legal-issues-defendant,100,22,7/15/2019
6BD606,conference-call,100,50,7/15/2019
6BD606,conference-call,100,50,7/15/2019
6ED519,conference-call,100,50,7/15/2019
7032D0,earnings,100,50,7/15/2019
72DF04,conference-call,100,50,7/15/2019
72DF04,earnings,100,50,7/15/2019
72FCA3,dividend-up,100,81,7/15/2019
73BCBA,conference-call,100,50,7/15/2019
7DC1C4,earnings,100,50,7/15/2019
7E1D5D,business-contract,100,69,7/15/2019
7F3669,earnings,100,50,7/15/2019
82C202,earnings,100,50,7/15/2019
877C0C,legal-issues-defendant,100,22,7/15/2019
88193E,conference-call,100,50,7/15/2019
885758,legal-issues-defendant,100,22,7/15/2019
8B6E7E,legal-issues-defendant,100,22,7/15/2019
8BAA15,earnings,100,50,7/15/2019
8C5519,earnings,100,50,7/15/2019
8C5519,earnings,100,50,7/15/2019
8C5519,earnings,100,50,7/15/2019
8C5519,earnings,100,50,7/15/2019
8C5519,earnings,100,50,7/15/2019
8C5519,earnings,100,50,7/15/2019
8C6C1B,facility-open,100,65,7/15/2019
8FE7A5,earnings,100,50,7/15/2019
92B625,partnership,100,61,7/15/2019
92D230,legal-issues-defendant,100,22,7/15/2019
93965C,earnings,100,50,7/15/2019
94563D,legal-issues-defendant,100,22,7/15/2019
9.97E+09,investment-investor,100,55,7/15/2019
9.97E+09,public-offering,100,43,7/15/2019
9.97E+09,investment-investor,100,55,7/15/2019
9D4EC7,conference-call,100,50,7/15/2019
9D4EC7,conference-call,100,50,7/15/2019
9E298A,conference-call,100,50,7/15/2019
9EA947,conference-call,100,50,7/15/2019
9F5997,conference-call,100,50,7/15/2019
9FF5F1,earnings,100,50,7/15/2019
A017F4,executive-appointment,100,54,7/15/2019
A29DBD,earnings,100,50,7/15/2019
A5E715,executive-death,100,31,7/15/2019
A6213D,earnings,100,50,7/15/2019
A666C8,dividend,100,50,7/15/2019
A6828A,dividend,100,50,7/15/2019
A6FC89,legal-issues-defendant,100,22,7/15/2019
A7CCF0,conference-call,100,50,7/15/2019
AA09AD,legal-issues-defendant,100,22,7/15/2019
AADE0B,executive-appointment,100,54,7/15/2019
AAEE21,conference-call,100,50,7/15/2019
AD3008,earnings,100,50,7/15/2019
AE3113,earnings,100,50,7/15/2019
AE7D16,earnings,100,50,7/15/2019
AFF7B4,dividend,100,50,7/15/2019
B4703C,legal-issues-defendant,100,22,7/15/2019
B5BA39,earnings,100,50,7/15/2019
B5BA39,legal-issues-defendant,100,22,7/15/2019
B5BA39,legal-issues-defendant,100,22,7/15/2019
B7EB38,earnings,100,50,7/15/2019
B7FA9B,conference-call,100,50,7/15/2019
B9764A,partnership,100,61,7/15/2019
B9CD50,earnings,100,50,7/15/2019
BB127B,award,100,58,7/15/2019
C11C46,earnings,100,50,7/15/2019
C2E120,earnings,100,50,7/15/2019
C3BAE7,acquisition-completed-acquirer,100,49,7/15/2019
C4452A,acquisition-completed-acquirer,100,49,7/15/2019
C4FBDC,acquisition-acquirer,100,49,7/15/2019
C5F463,product-release,100,64,7/15/2019
C8257F,dividend,100,50,7/15/2019
C99CC8,earnings,100,50,7/15/2019
CAC8D0,partnership,100,61,7/15/2019
CEC5B9,conference-call,100,50,7/15/2019
CF351E,earnings,100,50,7/15/2019
D06996,earnings,100,50,7/15/2019
D3C794,earnings,100,50,7/15/2019
D57D99,earnings,100,50,7/15/2019
D64EDF,acquisition-completed-acquirer,100,49,7/15/2019
D64EDF,acquisition-completed-acquirer,100,49,7/15/2019
D6534D,executive-appointment,100,54,7/15/2019
D82EF3,conference-call,100,50,7/15/2019
D8442A,business-contract,100,69,7/15/2019
DC2B00,executive-appointment,100,54,7/15/2019
DD1BA1,business-contract,100,69,7/15/2019
DD1BA1,business-contract,100,69,7/15/2019
DF18E6,executive-appointment,100,54,7/15/2019
E12A6E,dividend,100,50,7/15/2019
E30A8F,award,100,58,7/15/2019
E35610,conference-participant,100,50,7/15/2019
EA62FC,conference-call,100,50,7/15/2019
ED0402,business-contract,100,69,7/15/2019
EE74E1,earnings,100,50,7/15/2019
EEEA9F,earnings,100,50,7/15/2019
F00285,executive-appointment,100,54,7/15/2019
F02170,legal-issues-defendant,100,22,7/15/2019
F05B1B,patient-enrollment-start,100,58,7/15/2019
F05B1B,patient-enrollment-start,100,58,7/15/2019
F3816D,executive-appointment,100,54,7/15/2019
F43A11,settlement,100,56,7/15/2019
F48947,legal-issues-defendant,100,22,7/15/2019
F48947,earnings,100,50,7/15/2019
F6DCE4,executive-appointment,100,54,7/15/2019
F6FF0D,legal-issues-defendant,100,22,7/15/2019
F9CAF8,conference-call,100,50,7/15/2019
FAAFA2,executive-appointment,100,54,7/15/2019
FACCF6,earnings,100,50,7/15/2019
FAE021,earnings,100,50,7/15/2019
FC1736,revenue-up,100,69,7/15/2019
FC1736,earnings,100,50,7/15/2019
FC1736,earnings,100,50,7/15/2019
00698D,conference-organizer,100,57,7/16/2019
01D03F,business-contract,100,69,7/16/2019
01D03F,business-contract,100,69,7/16/2019
01D03F,business-contract,100,69,7/16/2019
01D03F,business-contract,100,69,7/16/2019
03596A,earnings,100,50,7/16/2019
070B45,earnings,100,50,7/16/2019
07CA6A,dividend,100,50,7/16/2019
07CA6A,dividend,100,50,7/16/2019
09062E,earnings,100,50,7/16/2019
0DC050,earnings,100,50,7/16/2019
108A2B,conference-call,100,50,7/16/2019
11074E,conference-call,100,50,7/16/2019
12DE76,partnership,100,61,7/16/2019
1348C9,dividend,100,50,7/16/2019
147C38,executive-appointment,100,54,7/16/2019
168A5D,executive-appointment,100,54,7/16/2019
1921DD,partnership,100,61,7/16/2019
1CDD1C,conference-call,100,50,7/16/2019
1F19C8,conference-call,100,50,7/16/2019
1FAF22,dividend,100,50,7/16/2019
21F9CA,earnings,100,50,7/16/2019
221445,conference-call,100,50,7/16/2019
227D48,conference-call,100,50,7/16/2019
239106,conference-call,100,50,7/16/2019
249674,conference-call,100,50,7/16/2019
24D81E,earnings,100,50,7/16/2019
251988,partnership,100,61,7/16/2019
251988,legal-issues-defendant,100,22,7/16/2019
25AB8E,conference-call,100,50,7/16/2019
26D8ED,conference-call,100,50,7/16/2019
26F31D,earnings,100,50,7/16/2019
272704,conference-call,100,50,7/16/2019
2.90E+62,business-contract,100,69,7/16/2019
2BA977,conference-call,100,50,7/16/2019
2BBE62,earnings,100,50,7/16/2019
2C7505,partnership,100,61,7/16/2019
2EB04E,legal-issues-defendant,100,22,7/16/2019
2F1299,conference-call,100,50,7/16/2019
2F6782,conference-call,100,50,7/16/2019
314D88,legal-issues-defendant,100,22,7/16/2019
3.14E+47,earnings-positive,100,69,7/16/2019
31643A,facility-open,100,65,7/16/2019
3461CF,asset-sale,100,62,7/16/2019
34A959,earnings,100,50,7/16/2019
366A08,legal-issues-defendant,100,22,7/16/2019
366A08,legal-issues-defendant,100,22,7/16/2019
373B06,earnings,100,50,7/16/2019
3A3447,facility-open,100,65,7/16/2019
3B20AB,dividend,100,50,7/16/2019
3B37F7,executive-appointment,100,54,7/16/2019
3B9886,executive-appointment,100,54,7/16/2019
3BC360,conference-call,100,50,7/16/2019
3C3B6B,earnings,100,50,7/16/2019
3C6CCC,earnings,100,50,7/16/2019
3CCC90,executive-appointment,100,54,7/16/2019
3D7971,award,100,58,7/16/2019
3DDE54,earnings,100,50,7/16/2019
3ED92D,conference-call,100,50,7/16/2019
3F4668,earnings,100,50,7/16/2019
3F6A9C,conference-call,100,50,7/16/2019
4.03E+05,conference-call,100,50,7/16/2019
41EC04,conference-call,100,50,7/16/2019
420168,earnings,100,50,7/16/2019
423279,earnings-per-share-positive,100,69,7/16/2019
42EFC7,executive-appointment,100,54,7/16/2019
43A060,partnership,100,61,7/16/2019
43F4A8,ipo,100,71,7/16/2019
450ECB,earnings,100,50,7/16/2019
490D4B,conference-call,100,50,7/16/2019
4B3DC9,merger-regulatory-approval,100,81,7/16/2019
4B49CF,dividend,100,50,7/16/2019
4BEB48,earnings,100,50,7/16/2019
4C5CC9,conference-call,100,50,7/16/2019
4C6C63,dividend,100,50,7/16/2019
4D72C8,merger-completed,100,66,7/16/2019
4D72C8,merger-completed,100,66,7/16/2019
4D971D,conference-call,100,50,7/16/2019
4E5784,legal-issues-defendant,100,22,7/16/2019
4EE14A,earnings,100,50,7/16/2019
4EE14A,earnings,100,50,7/16/2019
513A86,executive-appointment,100,54,7/16/2019
51888A,unit-acquisition-acquirer,100,49,7/16/2019
52015A,conference-call,100,50,7/16/2019
52B567,patent-awarded,100,72,7/16/2019
556F08,earnings,100,50,7/16/2019
59C539,dividend,100,50,7/16/2019
5A9F54,executive-appointment,100,54,7/16/2019
5CCDAD,earnings,100,50,7/16/2019
5F6D73,executive-appointment,100,54,7/16/2019
5FE4B6,conference-call,100,50,7/16/2019
6166D1,investment-investor,100,55,7/16/2019
619882,conference-call,100,50,7/16/2019
619882,earnings,100,50,7/16/2019
61BCA7,earnings,100,50,7/16/2019
636BBF,partnership,100,61,7/16/2019
636BBF,legal-issues-defendant,100,22,7/16/2019
64636E,executive-appointment,100,54,7/16/2019
64636E,executive-appointment,100,54,7/16/2019
64636E,executive-appointment,100,54,7/16/2019
64FF65,conference-call,100,50,7/16/2019
67B923,conference-call,100,50,7/16/2019
6844D2,legal-issues-defendant,100,22,7/16/2019
68B03F,earnings,100,50,7/16/2019
69345C,earnings,100,50,7/16/2019
69FDFC,partnership,100,61,7/16/2019
6ABCB8,earnings,100,50,7/16/2019
6C987C,buybacks,100,74,7/16/2019
6D3B7B,earnings,100,50,7/16/2019
71694D,conference-call,100,50,7/16/2019
722DE3,business-contract,100,69,7/16/2019
7410C3,earnings,100,50,7/16/2019
7710F3,executive-appointment,100,54,7/16/2019
7.83E+79,executive-appointment,100,54,7/16/2019
7.83E+79,earnings,100,50,7/16/2019
797C20,conference-call,100,50,7/16/2019
797C20,business-contract,100,69,7/16/2019
7A10FF,stake-acquirer,100,48,7/16/2019
7B1E50,dividend,100,50,7/16/2019
7B492C,executive-appointment,100,54,7/16/2019
7C790D,conference-call,100,50,7/16/2019
7CBC40,product-release,100,64,7/16/2019
7D35D8,conference-call,100,50,7/16/2019
804708,hirings,100,65,7/16/2019
830BDB,conference-call,100,50,7/16/2019
850779,earnings-per-share-positive,100,69,7/16/2019
850779,earnings-per-share,100,50,7/16/2019
850779,earnings-per-share,100,50,7/16/2019
850779,earnings-per-share,100,50,7/16/2019
860AB6,earnings,100,50,7/16/2019
860AB6,conference-call,100,50,7/16/2019
86AA9C,legal-issues-defendant,100,22,7/16/2019
8B8656,acquisition-completed-acquirer,100,49,7/16/2019
8C5519,conference-call,100,50,7/16/2019
8C6C1B,facility-open,100,65,7/16/2019
8D4486,partnership,100,61,7/16/2019
8D9993,conference-call,100,50,7/16/2019
8DDA23,dividend,100,50,7/16/2019
91E5EE,private-placement,100,56,7/16/2019
934029,clinical-trials-filed,100,60,7/16/2019
934029,clinical-trials-filed,100,60,7/16/2019
934029,conference-call,100,50,7/16/2019
934029,earnings,100,50,7/16/2019
9.39E+69,public-offering,100,43,7/16/2019
9470CC,earnings,100,50,7/16/2019
95C575,earnings,100,50,7/16/2019
968B00,earnings,100,50,7/16/2019
96F126,earnings,100,50,7/16/2019
97644E,settlement,100,56,7/16/2019
97AAF6,earnings,100,50,7/16/2019
9.97E+09,public-offering,100,43,7/16/2019
9A02C4,conference-call,100,50,7/16/2019
9BB35A,dividend,100,50,7/16/2019
9BB35A,earnings-per-share-positive,100,69,7/16/2019
9BB35A,earnings-per-share,100,50,7/16/2019
9BB35A,earnings-per-share,100,50,7/16/2019
9BB35A,conference-call,100,50,7/16/2019
9C8BC3,dividend,100,50,7/16/2019
9CA4C6,dividend-up,100,81,7/16/2019
9CA4C6,earnings-up,100,68,7/16/2019
9CA4C6,conference-call,100,50,7/16/2019
9E0811,earnings,100,50,7/16/2019
9EF4CF,earnings,100,50,7/16/2019
A23747,earnings,100,50,7/16/2019
A38F30,executive-appointment,100,54,7/16/2019
A3AAA5,conference-call,100,50,7/16/2019
A4D173,conference-call,100,50,7/16/2019
A4D173,conference-call,100,50,7/16/2019
A6828A,conference-call,100,50,7/16/2019
A6828A,earnings,100,50,7/16/2019
A7102F,acquisition-acquirer,100,49,7/16/2019
A72AB6,partnership,100,61,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A746F6,earnings-per-share-positive,100,69,7/16/2019
A868C9,business-contract,100,69,7/16/2019
AA09AD,legal-issues-defendant,100,22,7/16/2019
AA09AD,legal-issues-defendant,100,22,7/16/2019
AC775C,conference-call,100,50,7/16/2019
AC7C4F,business-contract,100,69,7/16/2019
ACC7D3,earnings,100,50,7/16/2019
ACF0B4,acquisition-acquirer,100,49,7/16/2019
AEFC90,orphan-drug-designation,100,76,7/16/2019
AFD1CA,conference-call,100,50,7/16/2019
AFF43F,dividend,100,50,7/16/2019
AFF43F,earnings,100,50,7/16/2019
B13B68,conference-call,100,50,7/16/2019
B1B10C,conference-call,100,50,7/16/2019
B1FC3B,fundraising,100,64,7/16/2019
B37FB4,executive-appointment,100,54,7/16/2019
B53C12,conference-call,100,50,7/16/2019
B560AF,dividend,100,50,7/16/2019
B5BA39,legal-issues-defendant,100,22,7/16/2019
B5BA39,legal-issues-defendant,100,22,7/16/2019
B72BE9,conference-call,100,50,7/16/2019
B96DF5,earnings,100,50,7/16/2019
BBBB41,conference-participant,100,50,7/16/2019
BC5680,earnings,100,50,7/16/2019
BCC55F,conference-call,100,50,7/16/2019
BDD12C,earnings,100,50,7/16/2019
BE7BA4,conference-call,100,50,7/16/2019
BFAEB4,earnings-up,100,68,7/16/2019
C3BAE7,conference-call,100,50,7/16/2019
C4A912,conference-call,100,50,7/16/2019
C62AA4,conference-call,100,50,7/16/2019
C7859D,earnings-up,100,68,7/16/2019
C7859D,earnings,100,50,7/16/2019
C7859D,earnings,100,50,7/16/2019
C7859D,earnings,100,50,7/16/2019
C7859D,earnings,100,50,7/16/2019
C7859D,earnings,100,50,7/16/2019
C7AE14,conference-call,100,50,7/16/2019
C8FAC7,legal-issues-defendant,100,22,7/16/2019
CD06A2,earnings,100,50,7/16/2019
CD06A2,earnings,100,50,7/16/2019
CD06A2,earnings,100,50,7/16/2019
CF9054,earnings,100,50,7/16/2019
D06755,earnings,100,50,7/16/2019
D33D8C,earnings-positive,100,69,7/16/2019
D33D8C,earnings-positive,100,69,7/16/2019
D33D8C,earnings-positive,100,69,7/16/2019
D33D8C,earnings-positive,100,69,7/16/2019
D33D8C,earnings-positive,100,69,7/16/2019
D33D8C,earnings-positive,100,69,7/16/2019
D3CEDF,conference-call,100,50,7/16/2019
D56E4C,conference-call,100,50,7/16/2019
D56E4C,conference-call,100,50,7/16/2019
D60BB2,executive-appointment,100,54,7/16/2019
D854F3,dividend,100,50,7/16/2019
D8DA3D,legal-issues-defendant,100,22,7/16/2019
DDB002,conference-call,100,50,7/16/2019
DF532D,earnings,100,50,7/16/2019
DF532D,earnings,100,50,7/16/2019
E26FC3,conference-call,100,50,7/16/2019
E26FC3,earnings,100,50,7/16/2019
E2CB7B,partnership,100,61,7/16/2019
E2CFD2,partnership,100,61,7/16/2019
E6D89E,market-entry,100,57,7/16/2019
E8846E,earnings-positive,100,69,7/16/2019
E8846E,conference-call,100,50,7/16/2019
E93A40,earnings,100,50,7/16/2019
E96E0B,earnings,100,50,7/16/2019
ED0D7C,conference-call,100,50,7/16/2019
EE967B,earnings,100,50,7/16/2019
F179ED,earnings,100,50,7/16/2019
F4E992,business-contract,100,69,7/16/2019
F5349B,executive-appointment,100,54,7/16/2019
F57F6F,earnings,100,50,7/16/2019
F6E248,earnings,100,50,7/16/2019
F80389,facility-sale,100,52,7/16/2019
FDF799,earnings,100,50,7/16/2019
FE7A63,earnings,100,50,7/16/2019
FE7A63,earnings,100,50,7/16/2019
FE7A63,earnings,100,50,7/16/2019
FE7A63,earnings,100,50,7/16/2019
FE7A63,earnings,100,50,7/16/2019
FE7A63,earnings,100,50,7/16/2019
FE7A63,earnings,100,50,7/16/2019
FE7A63,earnings,100,50,7/16/2019
0142B5,dividend,100,50,7/17/2019
01B8D6,earnings,100,50,7/17/2019
03F5A4,earnings-positive,100,69,7/17/2019
061A3B,earnings,100,50,7/17/2019
09062E,conference-participant,100,50,7/17/2019
099A02,earnings,100,50,7/17/2019
099A02,earnings,100,50,7/17/2019
0B4D10,earnings,100,50,7/17/2019
0E5223,conference-call,100,50,7/17/2019
10AE08,executive-appointment,100,54,7/17/2019
1216D1,buybacks,100,74,7/17/2019
1220D2,earnings,100,50,7/17/2019
149301,earnings,100,50,7/17/2019
1748B3,earnings,100,50,7/17/2019
1748B3,earnings,100,50,7/17/2019
1748B3,earnings,100,50,7/17/2019
1748B3,earnings,100,50,7/17/2019
1748B3,earnings,100,50,7/17/2019
1748B3,earnings,100,50,7/17/2019
1.79E+10,conference-call,100,50,7/17/2019
182BE7,earnings,100,50,7/17/2019
1A9DE1,earnings-up,100,68,7/17/2019
1A9DE1,earnings-up,100,68,7/17/2019
1A9DE1,earnings-up,100,68,7/17/2019
1D943E,earnings,100,50,7/17/2019
1DA44F,dividend-up,100,81,7/17/2019
1DEBBE,earnings,100,50,7/17/2019
221783,earnings,100,50,7/17/2019
228D42,product-release,100,64,7/17/2019
228D42,partnership,100,61,7/17/2019
228D42,partnership,100,61,7/17/2019
228D42,partnership,100,61,7/17/2019
2.45E+15,earnings,100,50,7/17/2019
24CB56,dividend-up,100,81,7/17/2019
251988,partnership,100,61,7/17/2019
275300,earnings,100,50,7/17/2019
275300,earnings,100,50,7/17/2019
275300,earnings,100,50,7/17/2019
275300,earnings,100,50,7/17/2019
275300,earnings,100,50,7/17/2019
275300,earnings,100,50,7/17/2019
275300,earnings,100,50,7/17/2019
275300,earnings,100,50,7/17/2019
275300,earnings,100,50,7/17/2019
27B191,conference-call,100,50,7/17/2019
27BFA1,earnings-per-share-positive,100,69,7/17/2019
27BFA1,earnings-per-share,100,50,7/17/2019
27BFA1,earnings-per-share,100,50,7/17/2019
27BFA1,earnings-per-share,100,50,7/17/2019
27BFA1,earnings-per-share,100,50,7/17/2019
27BFA1,earnings-per-share,100,50,7/17/2019
27BFA1,earnings-per-share,100,50,7/17/2019
27C10F,earnings,100,50,7/17/2019
2C19A4,conference-call,100,50,7/17/2019
2D643C,executive-appointment,100,54,7/17/2019
2DB344,conference-call,100,50,7/17/2019
2DB344,earnings,100,50,7/17/2019
2EBA55,conference-call,100,50,7/17/2019
2EBC0B,award,100,58,7/17/2019
2EC172,conference-call,100,50,7/17/2019
314D88,legal-issues-defendant,100,22,7/17/2019
314D88,earnings,100,50,7/17/2019
314D88,legal-issues-defendant,100,22,7/17/2019
3.14E+47,conference-call,100,50,7/17/2019
31553A,conference-call,100,50,7/17/2019
31553A,earnings,100,50,7/17/2019
31A7CC,earnings-up,100,68,7/17/2019
32C8CD,earnings,100,50,7/17/2019
32CB22,earnings,100,50,7/17/2019
3.30E+34,earnings-up,100,68,7/17/2019
3.30E+34,earnings-up,100,68,7/17/2019
3.30E+34,earnings-up,100,68,7/17/2019
349DA4,earnings,100,50,7/17/2019
34B411,earnings,100,50,7/17/2019
34E9F9,conference-call,100,50,7/17/2019
366A08,conference-call,100,50,7/17/2019
37020C,conference-call,100,50,7/17/2019
372037,conference-call,100,50,7/17/2019
3A3447,earnings,100,50,7/17/2019
3BBD10,ipo-pricing,100,50,7/17/2019
3BE00F,conference-participant,100,50,7/17/2019
3BE00F,conference-participant,100,50,7/17/2019
3C11C4,earnings,100,50,7/17/2019
3D7971,facility-open,100,65,7/17/2019
3F96D5,earnings,100,50,7/17/2019
408089,dividend,100,50,7/17/2019
416291,dividend,100,50,7/17/2019
42AABD,conference-call,100,50,7/17/2019
444CC8,conference-call,100,50,7/17/2019
448215,public-offering,100,43,7/17/2019
44A4FC,earnings,100,50,7/17/2019
46017C,conference-call,100,50,7/17/2019
4A2457,business-contract,100,69,7/17/2019
4A6F00,partnership,100,61,7/17/2019
4B3676,investment-investor,100,55,7/17/2019
4B3676,earnings,100,50,7/17/2019
4CDA2B,clinical-trials,100,56,7/17/2019
4E5784,legal-verdict-disfavored,100,22,7/17/2019
4EEB00,conference-call,100,50,7/17/2019
513A86,earnings,100,50,7/17/2019
51888A,earnings-per-share-positive,100,69,7/17/2019
51888A,earnings,100,50,7/17/2019
51888A,earnings,100,50,7/17/2019
520632,conference-call,100,50,7/17/2019
520632,earnings,100,50,7/17/2019
520632,earnings,100,50,7/17/2019
520632,earnings,100,50,7/17/2019
520632,earnings,100,50,7/17/2019
520632,earnings,100,50,7/17/2019
520632,earnings,100,50,7/17/2019
53E575,conference-call,100,50,7/17/2019
53F491,earnings-per-share-positive,100,69,7/17/2019
548AC0,conference-call,100,50,7/17/2019
56632F,earnings,100,50,7/17/2019
56AFF4,conference-call,100,50,7/17/2019
56AFF4,operating-earnings,100,50,7/17/2019
57CAAB,earnings,100,50,7/17/2019
5876DC,dividend,100,50,7/17/2019
589F5A,dividend,100,50,7/17/2019
58C2D4,facility-open,100,65,7/17/2019
5A423F,conference-participant,100,50,7/17/2019
5B226B,acquisition-acquirer,100,49,7/17/2019
5B226B,acquisition-acquirer,100,49,7/17/2019
5B3415,conference-call,100,50,7/17/2019
5D43A7,dividend,100,50,7/17/2019
5F60CE,earnings,100,50,7/17/2019
5F6D73,earnings,100,50,7/17/2019
5F6D73,earnings,100,50,7/17/2019
5F6D73,earnings,100,50,7/17/2019
5F6D73,earnings,100,50,7/17/2019
5F6D73,earnings,100,50,7/17/2019
5F9CE3,partnership,100,61,7/17/2019
60DD84,executive-appointment,100,54,7/17/2019
6166D1,earnings,100,50,7/17/2019
61B81B,earnings-positive,100,69,7/17/2019
61B81B,earnings,100,50,7/17/2019
61B81B,earnings,100,50,7/17/2019
61B81B,earnings,100,50,7/17/2019
61B81B,earnings,100,50,7/17/2019
61B81B,earnings,100,50,7/17/2019
61B81B,conference-call,100,50,7/17/2019
622DBE,conference-call,100,50,7/17/2019
62B20A,earnings,100,50,7/17/2019
65CF8E,earnings,100,50,7/17/2019
6634D9,earnings,100,50,7/17/2019
69CE71,clinical-trials-start,100,64,7/17/2019
6BC6F9,earnings,100,50,7/17/2019
6CF43C,earnings,100,50,7/17/2019
6D156D,earnings,100,50,7/17/2019
6D1ADF,conference-call,100,50,7/17/2019
6EB9DA,earnings-up,100,68,7/17/2019
6F39FC,public-offering,100,43,7/17/2019
6F39FC,public-offering,100,43,7/17/2019
7273FF,earnings,100,50,7/17/2019
731675,conference-call,100,50,7/17/2019
766047,executive-appointment,100,54,7/17/2019
775439,earnings,100,50,7/17/2019
790C34,earnings,100,50,7/17/2019
7C75FD,conference-call,100,50,7/17/2019
7CD98F,executive-appointment,100,54,7/17/2019
7DD8CC,conference-call,100,50,7/17/2019
7F7C87,executive-appointment,100,54,7/17/2019
7FD8B9,conference-call,100,50,7/17/2019
8275FE,earnings,100,50,7/17/2019
837C04,earnings,100,50,7/17/2019
83A065,public-offering,100,43,7/17/2019
83A065,public-offering,100,43,7/17/2019
850779,conference-call,100,50,7/17/2019
850779,conference-call,100,50,7/17/2019
85CDC9,earnings,100,50,7/17/2019
85DA04,earnings,100,50,7/17/2019
87B81A,earnings,100,50,7/17/2019
89F693,earnings,100,50,7/17/2019
8A0368,conference-call,100,50,7/17/2019
8B4A45,facility-open,100,65,7/17/2019
8C6C1B,facility-open,100,65,7/17/2019
8CF6DD,conference-call,100,50,7/17/2019
8CF6DD,earnings,100,50,7/17/2019
8D4486,earnings,100,50,7/17/2019
8D4486,earnings,100,50,7/17/2019
8D4486,earnings,100,50,7/17/2019
8D4486,earnings,100,50,7/17/2019
8D4486,earnings,100,50,7/17/2019
8D5145,acquisition-completed-acquirer,100,49,7/17/2019
8FF2EF,earnings,100,50,7/17/2019
92B047,earnings,100,50,7/17/2019
93633B,earnings,100,50,7/17/2019
93633B,earnings,100,50,7/17/2019
93633B,earnings,100,50,7/17/2019
93633B,earnings,100,50,7/17/2019
9.39E+69,public-offering,100,43,7/17/2019
93D207,dividend,100,50,7/17/2019
93F143,supply-decrease,100,28,7/17/2019
942165,earnings,100,50,7/17/2019
957A07,conference-participant,100,50,7/17/2019
9.62E+76,earnings,100,50,7/17/2019
9.62E+76,earnings,100,50,7/17/2019
9.62E+76,earnings,100,50,7/17/2019
9.65E+09,conference-call,100,50,7/17/2019
972356,earnings,100,50,7/17/2019
972356,earnings,100,50,7/17/2019
972356,earnings,100,50,7/17/2019
972356,earnings,100,50,7/17/2019
972356,earnings,100,50,7/17/2019
97693A,executive-appointment,100,54,7/17/2019
9.86E+03,earnings,100,50,7/17/2019
986AF6,conference-call,100,50,7/17/2019
990AD0,conference-call,100,50,7/17/2019
990AD0,earnings,100,50,7/17/2019
9.92E+94,earnings,100,50,7/17/2019
9.97E+09,note-sale,100,52,7/17/2019
9A2760,earnings,100,50,7/17/2019
9B5968,executive-appointment,100,54,7/17/2019
9BB35A,conference-call,100,50,7/17/2019
9C5174,product-release,100,64,7/17/2019
9D5D35,earnings,100,50,7/17/2019
9E575E,executive-appointment,100,54,7/17/2019
A21649,conference-call,100,50,7/17/2019
A2CAF7,earnings,100,50,7/17/2019
A398F8,earnings,100,50,7/17/2019
A41450,earnings,100,50,7/17/2019
A48593,conference-call,100,50,7/17/2019
A5A4F5,award,100,58,7/17/2019
A666C8,earnings,100,50,7/17/2019
A746F6,conference-call,100,50,7/17/2019
A9ED24,dividend,100,50,7/17/2019
AA09AD,product-release,100,64,7/17/2019
AA5C8E,conference-call,100,50,7/17/2019
AA5C8E,dividend,100,50,7/17/2019
AA5C8E,dividend,100,50,7/17/2019
AA5C8E,dividend,100,50,7/17/2019
AA5C8E,dividend,100,50,7/17/2019
AA5C8E,dividend,100,50,7/17/2019
AA5C8E,dividend,100,50,7/17/2019
AABEA0,dividend-up,100,60,7/17/2019
AAC8B6,conference-call,100,50,7/17/2019
AAC8B6,conference-call,100,50,7/17/2019
ABB493,ipo-pricing,100,50,7/17/2019
ACC7D3,conference-participant,100,50,7/17/2019
ADF1B0,conference-call,100,50,7/17/2019
AE3113,executive-appointment,100,54,7/17/2019
AFF43F,buybacks,100,74,7/17/2019
AFF43F,conference-call,100,50,7/17/2019
B0B969,conference-call,100,50,7/17/2019
B4C673,conference-call,100,50,7/17/2019
B6843B,ipo-considered,100,60,7/17/2019
B96637,conference-call,100,50,7/17/2019
BA218A,earnings-positive,100,69,7/17/2019
BA218A,earnings,100,50,7/17/2019
BA218A,earnings,100,50,7/17/2019
BA218A,earnings,100,50,7/17/2019
BA218A,earnings,100,50,7/17/2019
BA218A,earnings,100,50,7/17/2019
BCC55F,award,100,58,7/17/2019
BCC55F,award,100,58,7/17/2019
BD682F,dividend,100,50,7/17/2019
C2F597,earnings,100,50,7/17/2019
C32A39,dividend,100,50,7/17/2019
C45CE7,earnings,100,50,7/17/2019
C5C0E9,earnings,100,50,7/17/2019
C5E100,conference-participant,100,50,7/17/2019
C72B8F,conference-call,100,50,7/17/2019
C8257F,conference-call,100,50,7/17/2019
C8257F,earnings,100,50,7/17/2019
C83B88,partnership,100,61,7/17/2019
C9B932,earnings,100,50,7/17/2019
C9F39B,earnings,100,50,7/17/2019
C9F39B,earnings,100,50,7/17/2019
C9F39B,earnings,100,50,7/17/2019
C9F39B,earnings,100,50,7/17/2019
C9F39B,earnings,100,50,7/17/2019
C9F39B,earnings,100,50,7/17/2019
C9F39B,earnings,100,50,7/17/2019
CD4DA8,executive-appointment,100,54,7/17/2019
CE1002,dividend-up,100,81,7/17/2019
D17C1B,executive-appointment,100,54,7/17/2019
D1AE3B,dividend,100,50,7/17/2019
D1C26F,executive-appointment,100,54,7/17/2019
D27FAB,conference-call,100,50,7/17/2019
D2C0B6,award,100,58,7/17/2019
D4AC65,conference-call,100,50,7/17/2019
D5AF19,dividend,100,50,7/17/2019
D64EDF,earnings,100,50,7/17/2019
D721C6,dividend,100,50,7/17/2019
D93A25,conference-call,100,50,7/17/2019
D93A25,earnings,100,50,7/17/2019
D9FC89,executive-appointment,100,54,7/17/2019
DD0099,executive-appointment,100,54,7/17/2019
DF5F14,note-sale,100,52,7/17/2019
E0339F,conference-call,100,50,7/17/2019
E0339F,earnings,100,50,7/17/2019
E0339F,earnings,100,50,7/17/2019
E0339F,earnings,100,50,7/17/2019
E114F4,conference-call,100,50,7/17/2019
E30B34,executive-appointment,100,54,7/17/2019
E30B34,executive-appointment,100,54,7/17/2019
E35610,partnership,100,61,7/17/2019
E35610,executive-resignation,100,44,7/17/2019
E6A53A,earnings,100,50,7/17/2019
E6A53A,dividend,100,50,7/17/2019
E866D2,partnership,100,61,7/17/2019
E8846E,donation,100,54,7/17/2019
E96E0B,conference-participant,100,50,7/17/2019
EAEBF3,dividend,100,50,7/17/2019
EBD89A,business-contract,100,69,7/17/2019
EC99D0,award,100,58,7/17/2019
ECD263,earnings,100,50,7/17/2019
ED2A5E,conference-call,100,50,7/17/2019
ED9576,earnings,100,50,7/17/2019
EF25A5,earnings,100,50,7/17/2019
EF5BED,conference-call,100,50,7/17/2019
EF5BED,earnings-positive,100,69,7/17/2019
EF5BED,earnings,100,50,7/17/2019
EF5BED,earnings,100,50,7/17/2019
EF5BED,earnings,100,50,7/17/2019
EF5BED,dividend,100,50,7/17/2019
EF76C8,dividend,100,50,7/17/2019
F24FF0,earnings,100,50,7/17/2019
F39E1E,executive-appointment,100,54,7/17/2019
F3FCC3,earnings,100,50,7/17/2019
F40EE2,dividend,100,50,7/17/2019
F40EE2,dividend,100,50,7/17/2019
F57F6F,executive-appointment,100,54,7/17/2019
F6E248,executive-resignation,100,44,7/17/2019
F702CA,dividend,100,50,7/17/2019
F88147,trading-listing,100,61,7/17/2019
F88A04,partnership,100,61,7/17/2019
F93C8A,conference-call,100,50,7/17/2019
FA40E2,dividend,100,50,7/17/2019
FADF1A,executive-appointment,100,54,7/17/2019
FAEABE,earnings-per-share-up,100,68,7/17/2019
FDF799,legal-issues-defendant,100,22,7/17/2019
00326E,award,100,58,7/18/2019
00698D,dividend,100,50,7/18/2019
036C6F,executive-resignation,100,44,7/18/2019
03D5F9,earnings,100,50,7/18/2019
43862,conference-call,100,50,7/18/2019
04996E,business-contract,100,69,7/18/2019
55018,earnings-positive,100,69,7/18/2019
07C907,earnings,100,50,7/18/2019
07C907,earnings,100,50,7/18/2019
07C907,earnings,100,50,7/18/2019
07EC43,executive-appointment,100,54,7/18/2019
083F72,dividend,100,50,7/18/2019
0A0CF0,earnings,100,50,7/18/2019
0A59F8,partnership,100,61,7/18/2019
0A7650,earnings-positive,100,69,7/18/2019
0A7650,earnings-positive,100,69,7/18/2019
0A7650,earnings-positive,100,69,7/18/2019
0A7650,earnings-positive,100,69,7/18/2019
0A7650,earnings-positive,100,69,7/18/2019
0B2071,dividend,100,50,7/18/2019
0BB9E5,earnings,100,50,7/18/2019
0BC17A,dividend,100,50,7/18/2019
0BC17A,earnings,100,50,7/18/2019
0C8D82,earnings,100,50,7/18/2019
0EF1AF,executive-appointment,100,54,7/18/2019
105D00,earnings-positive,100,69,7/18/2019
105D00,earnings-positive,100,69,7/18/2019
105D00,earnings-positive,100,69,7/18/2019
105D00,earnings-positive,100,69,7/18/2019
105D00,earnings-positive,100,69,7/18/2019
105D00,earnings-positive,100,69,7/18/2019
105D00,earnings-positive,100,69,7/18/2019
1065BC,conference-call,100,50,7/18/2019
10C19B,earnings,100,50,7/18/2019
10C19B,earnings,100,50,7/18/2019
10C19B,earnings,100,50,7/18/2019
10C19B,earnings,100,50,7/18/2019
10C19B,earnings,100,50,7/18/2019
10C19B,earnings,100,50,7/18/2019
119CB6,dividend,100,50,7/18/2019
147C38,executive-appointment,100,54,7/18/2019
1748B3,conference-call,100,50,7/18/2019
17EDA5,dividend,100,50,7/18/2019
182B8C,conference-call,100,50,7/18/2019
18EC17,earnings,100,50,7/18/2019
18EC17,earnings,100,50,7/18/2019
18EC17,earnings,100,50,7/18/2019
19CAC7,earnings,100,50,7/18/2019
19CAC7,earnings,100,50,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,earnings-up,100,68,7/18/2019
1A3E1B,conference-call,100,50,7/18/2019
1A6A94,dividend,100,50,7/18/2019
1C599A,earnings,100,50,7/18/2019
1E04A5,earnings,100,50,7/18/2019
205AD5,earnings,100,50,7/18/2019
219B21,conference-call,100,50,7/18/2019
228D42,executive-appointment,100,54,7/18/2019
26CC63,dividend,100,50,7/18/2019
27BFA1,conference-call,100,50,7/18/2019
2950FF,earnings,100,50,7/18/2019
2950FF,earnings,100,50,7/18/2019
2A1009,conference-call,100,50,7/18/2019
2CA60F,earnings,100,50,7/18/2019
2DC88B,earnings,100,50,7/18/2019
2EB88B,earnings,100,50,7/18/2019
2F7474,earnings,100,50,7/18/2019
314D88,legal-issues-defendant,100,22,7/18/2019
314D88,legal-issues-defendant,100,22,7/18/2019
3159AA,conference-call,100,50,7/18/2019
31643A,facility-close,100,47,7/18/2019
31666F,earnings,100,50,7/18/2019
31DB20,dividend,100,50,7/18/2019
343996,dividend,100,50,7/18/2019
343996,dividend,100,50,7/18/2019
3461CF,award,100,58,7/18/2019
35AE32,earnings,100,50,7/18/2019
39FB23,earnings,100,50,7/18/2019
39FB23,earnings,100,50,7/18/2019
39FB23,earnings,100,50,7/18/2019
3A3447,dividend,100,50,7/18/2019
3B20AB,conference-call,100,50,7/18/2019
3B20AB,earnings,100,50,7/18/2019
3C8A04,earnings,100,50,7/18/2019
3DCECC,conference-call,100,50,7/18/2019
3FBC9B,earnings,100,50,7/18/2019
427F32,conference-call,100,50,7/18/2019
4290EF,product-release,100,64,7/18/2019
4455C4,conference-call,100,50,7/18/2019
44740A,executive-appointment,100,54,7/18/2019
449A26,earnings-positive,100,69,7/18/2019
449A26,dividend,100,50,7/18/2019
451D61,conference-call,100,50,7/18/2019
45ABCC,earnings,100,50,7/18/2019
4649D5,conference-call,100,50,7/18/2019
47BA98,dividend,100,50,7/18/2019
47FCF2,earnings,100,50,7/18/2019
487B7A,earnings-up,100,68,7/18/2019
490D4B,executive-appointment,100,54,7/18/2019
4D203E,earnings,100,50,7/18/2019
4D203E,earnings,100,50,7/18/2019
4D203E,earnings,100,50,7/18/2019
4EEE7E,earnings,100,50,7/18/2019
4F71DC,ipo-pricing,100,50,7/18/2019
51888A,conference-call,100,50,7/18/2019
51888A,dividend,100,50,7/18/2019
5225A4,earnings,100,50,7/18/2019
5225A4,earnings,100,50,7/18/2019
52FB2F,earnings,100,50,7/18/2019
5403F8,earnings,100,50,7/18/2019
55ACCB,earnings,100,50,7/18/2019
57F3DA,earnings,100,50,7/18/2019
58C2D4,earnings,100,50,7/18/2019
58CA9A,dividend,100,50,7/18/2019
59C539,earnings,100,50,7/18/2019
5AA3B1,partnership,100,61,7/18/2019
5BC2F4,dividend,100,50,7/18/2019
5BFE94,executive-appointment,100,54,7/18/2019
5BFE94,dividend,100,50,7/18/2019
5C2A47,partnership,100,61,7/18/2019
5CC29D,dividend,100,50,7/18/2019
5DE5A5,earnings-up,100,68,7/18/2019
5DE5A5,earnings,100,50,7/18/2019
5DE5A5,earnings,100,50,7/18/2019
619882,partnership,100,61,7/18/2019
61E975,conference-call,100,50,7/18/2019
61E975,dividend,100,50,7/18/2019
622037,earnings,100,50,7/18/2019
636639,earnings,100,50,7/18/2019
636639,earnings,100,50,7/18/2019
636639,earnings,100,50,7/18/2019
636639,earnings,100,50,7/18/2019
641F17,dividend,100,50,7/18/2019
6474BA,earnings-positive,100,69,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
6474BA,earnings,100,50,7/18/2019
64E615,conference-call,100,50,7/18/2019
651C85,executive-appointment,100,54,7/18/2019
665618,earnings-up,100,68,7/18/2019
665618,earnings-up,100,68,7/18/2019
6810DE,executive-appointment,100,54,7/18/2019
6A3C35,earnings-guidance-up,100,83,7/18/2019
6A3C35,earnings-guidance-up,100,83,7/18/2019
6B5379,earnings,100,50,7/18/2019
6B6375,public-offering,100,43,7/18/2019
6C6D73,executive-appointment,100,54,7/18/2019
6C987C,earnings-up,100,58,7/18/2019
6.00E+19,conference-call,100,50,7/18/2019
6E705B,product-resumed,100,52,7/18/2019
6E8864,conference-call,100,50,7/18/2019
71553E,earnings,100,50,7/18/2019
722D55,earnings,100,50,7/18/2019
731675,note-sale,100,52,7/18/2019
7520CC,earnings,100,50,7/18/2019
766047,dividend,100,50,7/18/2019
76B926,conference-call,100,50,7/18/2019
7710F3,earnings,100,50,7/18/2019
78F9ED,dividend-up,100,81,7/18/2019
7B6C88,conference-call,100,50,7/18/2019
7BAAE7,dividend,100,50,7/18/2019
7BFF81,executive-appointment,100,54,7/18/2019
7BFF81,executive-appointment,100,54,7/18/2019
7C62A3,conference-call,100,50,7/18/2019
7E1D5D,partnership,100,61,7/18/2019
7F2922,earnings,100,50,7/18/2019
7F3A5F,earnings,100,50,7/18/2019
819492,facility-open,100,65,7/18/2019
845655,conference-call,100,50,7/18/2019
845655,conference-call,100,50,7/18/2019
855DF7,dividend,100,50,7/18/2019
859281,dividend,100,50,7/18/2019
85DE00,conference-call,100,50,7/18/2019
89B2E7,earnings,100,50,7/18/2019
89FBB1,conference-call,100,50,7/18/2019
8C6C1B,facility-open,100,65,7/18/2019
8D4486,earnings,100,50,7/18/2019
8DDA23,earnings-positive,100,69,7/18/2019
8FE7A5,government-contract,100,69,7/18/2019
9196A2,conference-call,100,50,7/18/2019
9196A2,earnings,100,50,7/18/2019
9196A2,earnings,100,50,7/18/2019
9196A2,earnings,100,50,7/18/2019
9196A2,earnings,100,50,7/18/2019
92B047,conference-call,100,50,7/18/2019
92D6A5,earnings,100,50,7/18/2019
9.36E+10,business-contract,100,69,7/18/2019
9.36E+10,business-contract,100,69,7/18/2019
940C3D,unit-acquisition-acquiree,100,76,7/18/2019
94563D,legal-issues-defendant,100,22,7/18/2019
94637C,business-contract,100,69,7/18/2019
94637C,business-contract,100,69,7/18/2019
94756D,conference-participant,100,50,7/18/2019
949D62,campaign-ad-release,100,59,7/18/2019
9.54E+32,dividend,100,50,7/18/2019
965360,conference-call,100,50,7/18/2019
965360,earnings,100,50,7/18/2019
965360,dividend,100,50,7/18/2019
966DBE,earnings,100,50,7/18/2019
979451,earnings,100,50,7/18/2019
97AAF6,dividend,100,50,7/18/2019
986AF6,earnings,100,50,7/18/2019
986AF6,earnings,100,50,7/18/2019
98CEBB,earnings,100,50,7/18/2019
98D33E,dividend,100,50,7/18/2019
99028D,business-contract,100,69,7/18/2019
9B5968,executive-appointment,100,54,7/18/2019
9B5968,executive-appointment,100,54,7/18/2019
9D4EC7,conference-call,100,50,7/18/2019
9E4A5F,earnings,100,50,7/18/2019
9E98F2,earnings,100,50,7/18/2019
9E98F2,earnings,100,50,7/18/2019
9E98F2,earnings,100,50,7/18/2019
9F5CBB,conference-call,100,50,7/18/2019
A16DEA,dividend,100,50,7/18/2019
A247F5,earnings,100,50,7/18/2019
A2CAF7,conference-call,100,50,7/18/2019
A403CF,earnings,100,50,7/18/2019
A5628C,earnings-positive,100,69,7/18/2019
A63387,business-contract,100,69,7/18/2019
A7A0C8,ipo-pricing,100,50,7/18/2019
A7F0A5,earnings,100,50,7/18/2019
A8CBDA,dividend,100,50,7/18/2019
AA247D,earnings,100,50,7/18/2019
AD3C93,earnings,100,50,7/18/2019
AEBB80,earnings,100,50,7/18/2019
AED6CF,conference-call,100,50,7/18/2019
AFD7DD,conference-call,100,50,7/18/2019
B0998E,earnings,100,50,7/18/2019
B09B1F,conference-call,100,50,7/18/2019
B106FA,earnings,100,50,7/18/2019
B5766D,conference-call,100,50,7/18/2019
B5766D,earnings-per-share-positive,100,69,7/18/2019
B5766D,earnings,100,50,7/18/2019
B5766D,earnings,100,50,7/18/2019
B5766D,earnings,100,50,7/18/2019
B5766D,earnings,100,50,7/18/2019
B5766D,earnings,100,50,7/18/2019
B7BDA3,conference-call,100,50,7/18/2019
B7EB38,executive-appointment,100,54,7/18/2019
B8A51F,earnings,100,50,7/18/2019
BB0587,conference-call,100,50,7/18/2019
BB88B6,award,100,58,7/18/2019
BD682F,earnings,100,50,7/18/2019
BD8517,earnings,100,50,7/18/2019
C06EB6,legal-issues-dismissed-defendant,100,79,7/18/2019
C06EB6,legal-issues-dismissed-defendant,100,79,7/18/2019
C3CF29,earnings,100,50,7/18/2019
C41C25,earnings,100,50,7/18/2019
C598D7,dividend,100,50,7/18/2019
C65004,conference-participant,100,50,7/18/2019
C8A059,earnings,100,50,7/18/2019
CA1620,earnings-per-share-up,100,56,7/18/2019
CA212F,conference-call,100,50,7/18/2019
CB6A9C,conference-call,100,50,7/18/2019
CCB623,partnership,100,61,7/18/2019
CD4DA8,partnership,100,61,7/18/2019
CDE118,earnings,100,50,7/18/2019
CFD4B6,conference-call,100,50,7/18/2019
CFE5BE,executive-appointment,100,54,7/18/2019
D1AE3B,earnings,100,50,7/18/2019
D21D8A,executive-resignation,100,44,7/18/2019
D393DF,earnings,100,50,7/18/2019
D3FD6D,conference-call,100,50,7/18/2019
D650A7,earnings,100,50,7/18/2019
D721C6,earnings,100,50,7/18/2019
D78CCD,conference-call,100,50,7/18/2019
D8F347,conference-call,100,50,7/18/2019
D8F347,earnings-up,100,68,7/18/2019
D8F347,earnings,100,50,7/18/2019
D8F347,earnings,100,50,7/18/2019
DA0A9E,conference-call,100,50,7/18/2019
DA0A9E,dividend,100,50,7/18/2019
DA48E4,dividend,100,50,7/18/2019
DB88A1,government-contract,100,69,7/18/2019
DD3BB1,earnings,100,50,7/18/2019
DF5F14,public-offering,100,43,7/18/2019
DF6FDD,executive-appointment,100,54,7/18/2019
E074A0,earnings,100,50,7/18/2019
E124EB,earnings,100,50,7/18/2019
E124EB,earnings,100,50,7/18/2019
E124EB,earnings,100,50,7/18/2019
E124EB,earnings,100,50,7/18/2019
E124EB,conference-call,100,50,7/18/2019
E1BD05,earnings,100,50,7/18/2019
E1E36F,earnings,100,50,7/18/2019
E2CFD2,conference-call,100,50,7/18/2019
E2F66E,conference-call,100,50,7/18/2019
E3656D,conference-call,100,50,7/18/2019
E393B0,earnings-up,100,68,7/18/2019
E393B0,earnings-up,100,68,7/18/2019
E393B0,earnings-up,100,68,7/18/2019
E393B0,earnings-up,100,68,7/18/2019
E393B0,earnings-up,100,68,7/18/2019
E393B0,earnings-up,100,68,7/18/2019
E49AA3,earnings,100,50,7/18/2019
E70531,partnership,100,61,7/18/2019
E829E8,earnings,100,50,7/18/2019
E82A2D,conference-call,100,50,7/18/2019
E84500,dividend,100,50,7/18/2019
E8B315,earnings-positive,100,69,7/18/2019
E94704,earnings,100,50,7/18/2019
E94704,earnings,100,50,7/18/2019
E94704,earnings,100,50,7/18/2019
E94704,earnings,100,50,7/18/2019
E94704,earnings,100,50,7/18/2019
E9FF33,executive-appointment,100,54,7/18/2019
EAEBF3,earnings,100,50,7/18/2019
EB2F14,earnings,100,50,7/18/2019
EB5E78,conference-call,100,50,7/18/2019
EB61C4,dividend,100,50,7/18/2019
ECDEB2,earnings,100,50,7/18/2019
ECF4F8,conference-call,100,50,7/18/2019
ED5171,earnings,100,50,7/18/2019
ED7F13,earnings,100,50,7/18/2019
EF1AD9,dividend,100,50,7/18/2019
EF1AD9,earnings,100,50,7/18/2019
EF1AD9,earnings,100,50,7/18/2019
EF1AD9,earnings,100,50,7/18/2019
EF1AD9,earnings,100,50,7/18/2019
F4F46F,facility-close,100,47,7/18/2019
F4F46F,conference-call,100,50,7/18/2019
F5349B,note-sale,100,52,7/18/2019
F702CA,earnings,100,50,7/18/2019
F702CA,earnings,100,50,7/18/2019
F702CA,earnings,100,50,7/18/2019
F702CA,earnings,100,50,7/18/2019
F702CA,earnings,100,50,7/18/2019
F702CA,earnings,100,50,7/18/2019
FA36A4,dividend,100,50,7/18/2019
FB728F,dividend,100,50,7/18/2019
FC80E6,conference-call,100,50,7/18/2019
FD0CA4,earnings,100,50,7/18/2019
FD6926,conference-call,100,50,7/18/2019
FE609F,clinical-trials-start,100,64,7/18/2019
FF6644,conference-call,100,50,7/18/2019
FFAB4A,earnings,100,50,7/18/2019
001F1B,legal-issues-defendant,100,22,7/19/2019
00698D,executive-appointment,100,54,7/19/2019
04EB2F,earnings,100,50,7/19/2019
0A748B,facility-close,100,47,7/19/2019
0A7650,earnings,100,50,7/19/2019
0B13E8,executive-appointment,100,54,7/19/2019
0C355F,conference-call,100,50,7/19/2019
0D26E0,earnings,100,50,7/19/2019
0D26E0,earnings,100,50,7/19/2019
0D26E0,earnings,100,50,7/19/2019
0D26E0,earnings,100,50,7/19/2019
0D26E0,earnings,100,50,7/19/2019
108BD2,earnings,100,50,7/19/2019
139303,conference-call,100,50,7/19/2019
168A5D,executive-appointment,100,54,7/19/2019
1782D5,asset-sale,100,62,7/19/2019
188394,dividend,100,50,7/19/2019
19C105,earnings,100,50,7/19/2019
1E9A6D,dividend,100,50,7/19/2019
1F43A1,earnings,100,50,7/19/2019
223216,ebitda-up,100,57,7/19/2019
228D42,partnership,100,61,7/19/2019
28DCF3,earnings,100,50,7/19/2019
2DDB22,earnings-guidance,100,50,7/19/2019
3159AA,facility-open,100,65,7/19/2019
319BE2,conference-call,100,50,7/19/2019
339F20,earnings,100,50,7/19/2019
3D9999,earnings-positive,100,69,7/19/2019
3E39A5,earnings,100,50,7/19/2019
3F868D,conference-call,100,50,7/19/2019
4017AD,earnings,100,50,7/19/2019
44740A,conference-call,100,50,7/19/2019
494EB9,dividend,100,50,7/19/2019
49BBBC,shareholder-rights-plan-suspended,100,57,7/19/2019
4C37C5,earnings-per-share-positive,100,69,7/19/2019
4C37C5,earnings,100,50,7/19/2019
4C37C5,earnings,100,50,7/19/2019
4C7DB5,earnings,100,50,7/19/2019
5480A7,earnings,100,50,7/19/2019
5AA3B1,partnership,100,61,7/19/2019
5B35C7,earnings,100,50,7/19/2019
5B35C7,earnings,100,50,7/19/2019
5BC2F4,earnings-per-share-positive,100,69,7/19/2019
5BC2F4,earnings-per-share,100,50,7/19/2019
5BC2F4,earnings-per-share,100,50,7/19/2019
5BC2F4,earnings-per-share,100,50,7/19/2019
5BC2F4,earnings-per-share,100,50,7/19/2019
5BFE94,earnings,100,50,7/19/2019
5D87DF,earnings,100,50,7/19/2019
647143,dividend,100,50,7/19/2019
6.52E+64,earnings,100,50,7/19/2019
657097,business-contract,100,69,7/19/2019
66CB62,earnings,100,50,7/19/2019
6F39FC,conference-call,100,50,7/19/2019
704B78,earnings,100,50,7/19/2019
72F0FC,dividend,100,50,7/19/2019
72F0FC,earnings,100,50,7/19/2019
73C521,earnings,100,50,7/19/2019
73C521,earnings,100,50,7/19/2019
73C521,earnings,100,50,7/19/2019
73C521,earnings,100,50,7/19/2019
73C521,earnings,100,50,7/19/2019
73C521,earnings,100,50,7/19/2019
76BD96,conference-call,100,50,7/19/2019
7ACD98,conference-call,100,50,7/19/2019
7B4B91,conference-call,100,50,7/19/2019
7DC1C4,conference-participant,100,50,7/19/2019
7FDE1C,executive-appointment,100,54,7/19/2019
82FD6D,conference-call,100,50,7/19/2019
8614A2,conference-participant,100,50,7/19/2019
896771,conference-call,100,50,7/19/2019
8AC740,conference-call,100,50,7/19/2019
8C6C1B,facility-open,100,65,7/19/2019
902255,earnings,100,50,7/19/2019
911ACB,earnings,100,50,7/19/2019
9.39E+69,public-offering,100,43,7/19/2019
94563D,partnership,100,61,7/19/2019
94563D,legal-issues-defendant,100,22,7/19/2019
94563D,legal-issues-defendant,100,22,7/19/2019
94563D,legal-issues-defendant,100,22,7/19/2019
94563D,legal-issues-defendant,100,22,7/19/2019
94563D,legal-issues-defendant,100,22,7/19/2019
94563D,legal-issues-defendant,100,22,7/19/2019
989E2F,earnings,100,50,7/19/2019
989E2F,earnings,100,50,7/19/2019
989E2F,earnings,100,50,7/19/2019
9981C6,earnings,100,50,7/19/2019
9F62D1,earnings-per-share-up,100,66,7/19/2019
A6828A,regulatory-product-application,100,69,7/19/2019
A8CBDA,executive-appointment,100,54,7/19/2019
B2DAF6,earnings,100,50,7/19/2019
B642E8,earnings,100,50,7/19/2019
BA218A,legal-issues-defendant,100,22,7/19/2019
BA218A,legal-issues-defendant,100,22,7/19/2019
BDE867,operating-earnings,100,50,7/19/2019
BEB756,dividend,100,50,7/19/2019
BFE02C,earnings-positive,100,69,7/19/2019
C0200F,earnings,100,50,7/19/2019
C0200F,earnings,100,50,7/19/2019
C0200F,earnings,100,50,7/19/2019
C29715,earnings,100,50,7/19/2019
C29715,earnings,100,50,7/19/2019
C4FBDC,conference-call,100,50,7/19/2019
C9E107,dividend-up,100,57,7/19/2019
CC339B,earnings,100,50,7/19/2019
CFF15D,conference-call,100,50,7/19/2019
D04D9F,conference-call,100,50,7/19/2019
D13F1C,earnings,100,50,7/19/2019
D45285,conference-call,100,50,7/19/2019
D5AF19,earnings,100,50,7/19/2019
D721C6,earnings-up,100,65,7/19/2019
D8C09D,executive-resignation,100,44,7/19/2019
DD682D,dividend,100,50,7/19/2019
DDCB34,conference-call,100,50,7/19/2019
E0647D,earnings,100,50,7/19/2019
E0647D,earnings,100,50,7/19/2019
E1E36F,dividend,100,50,7/19/2019
E22FDE,business-contract,100,69,7/19/2019
E5D914,conference-call,100,50,7/19/2019
E8D221,dividend,100,50,7/19/2019
EB6965,conference-call,100,50,7/19/2019
ECD263,legal-issues-defendant,100,22,7/19/2019
ED9C04,earnings,100,50,7/19/2019
EDF5CA,conference-call,100,50,7/19/2019
F0EEFB,conference-call,100,50,7/19/2019
F509E2,conference-call,100,50,7/19/2019
F5C78B,dividend,100,50,7/19/2019
F6E248,business-contract,100,69,7/19/2019
F82D37,earnings-up,100,68,7/19/2019
FD39EB,dividend,100,50,7/19/2019
FD39EB,earnings,100,50,7/19/2019
94563D,legal-issues-defendant,100,22,7/20/2019
A871B0,business-contract,100,69,7/20/2019
ECD263,legal-issues-defendant,100,22,7/20/2019
001F1B,legal-issues-defendant,100,22,7/22/2019
002A99,clinical-trials,100,56,7/22/2019
02FC1A,legal-issues-defendant,100,22,7/22/2019
036C6F,legal-issues-defendant,100,22,7/22/2019
04EB2F,earnings,100,50,7/22/2019
08A40F,earnings-per-share-positive,100,69,7/22/2019
08A40F,earnings-per-share-positive,100,69,7/22/2019
08A40F,earnings-per-share-positive,100,69,7/22/2019
08A40F,earnings-per-share-positive,100,69,7/22/2019
08A40F,earnings-per-share-positive,100,69,7/22/2019
08A40F,earnings-per-share-positive,100,69,7/22/2019
08A40F,earnings-per-share-positive,100,69,7/22/2019
98977,earnings,100,50,7/22/2019
0AB700,earnings,100,50,7/22/2019
0AB700,earnings,100,50,7/22/2019
0B73A7,acquisition-acquirer,100,49,7/22/2019
0B73A7,acquisition-acquirer,100,49,7/22/2019
0B73A7,acquisition-acquirer,100,49,7/22/2019
0B73A7,acquisition-acquirer,100,49,7/22/2019
0B73A7,acquisition-acquirer,100,49,7/22/2019
0B73A7,acquisition-acquirer,100,49,7/22/2019
0BC29E,executive-appointment,100,54,7/22/2019
0E64D4,credit-extension-provider,100,57,7/22/2019
0FABBD,conference-call,100,50,7/22/2019
126F95,earnings,100,50,7/22/2019
126F95,earnings,100,50,7/22/2019
126F95,earnings,100,50,7/22/2019
126F95,earnings,100,50,7/22/2019
1279ED,earnings,100,50,7/22/2019
15789A,revenue-volume-up,100,55,7/22/2019
184866,clinical-trials,100,56,7/22/2019
1866B2,conference-call,100,50,7/22/2019
1921DD,partnership,100,61,7/22/2019
1DDEDA,conference-call,100,50,7/22/2019
1F19C8,executive-appointment,100,54,7/22/2019
1FE3CB,dividend,100,50,7/22/2019
1FE3CB,operating-earnings,100,50,7/22/2019
206852,earnings,100,50,7/22/2019
20BEEA,earnings,100,50,7/22/2019
20BEEA,earnings,100,50,7/22/2019
228D42,partnership,100,61,7/22/2019
228D42,partnership,100,61,7/22/2019
228D42,partnership,100,61,7/22/2019
232053,conference-participant,100,50,7/22/2019
2667B6,partnership,100,61,7/22/2019
267718,regulatory-product-approval-granted,100,81,7/22/2019
28DCF3,earnings-up,100,91,7/22/2019
297DA8,earnings,100,50,7/22/2019
2B49F4,earnings,100,50,7/22/2019
2B49F4,earnings,100,50,7/22/2019
2B49F4,earnings,100,50,7/22/2019
2B49F4,earnings,100,50,7/22/2019
2C19A4,executive-appointment,100,54,7/22/2019
2CBB58,acquisition-acquirer,100,49,7/22/2019
2E902B,earnings,100,50,7/22/2019
2F6782,acquisition-acquirer,100,49,7/22/2019
2F6782,acquisition-acquirer,100,49,7/22/2019
309922,earnings,100,50,7/22/2019
30E01D,earnings,100,50,7/22/2019
315EB0,facility-open,100,65,7/22/2019
31F25C,earnings,100,50,7/22/2019
366A08,legal-issues-defendant,100,22,7/22/2019
370C50,earnings,100,50,7/22/2019
37426C,conference-call,100,50,7/22/2019
38FB49,earnings,100,50,7/22/2019
38FB49,earnings,100,50,7/22/2019
38FB49,earnings,100,50,7/22/2019
38FB49,earnings,100,50,7/22/2019
38FB49,earnings,100,50,7/22/2019
38FB49,earnings,100,50,7/22/2019
38FB49,earnings,100,50,7/22/2019
38FB49,earnings,100,50,7/22/2019
39FB23,acquisition-acquirer,100,49,7/22/2019
3A4BDB,earnings-positive,100,69,7/22/2019
3A4BDB,earnings-positive,100,69,7/22/2019
3A4BDB,earnings-positive,100,69,7/22/2019
3A4BDB,earnings-positive,100,69,7/22/2019
3A4BDB,earnings-positive,100,69,7/22/2019
3AAEAE,conference-call,100,50,7/22/2019
3BBD10,ipo-completed,100,76,7/22/2019
415188,product-release,100,64,7/22/2019
429BFB,conference-call,100,50,7/22/2019
42DC93,earnings,100,50,7/22/2019
447FC6,conference-call,100,50,7/22/2019
448215,earnings,100,50,7/22/2019
49914B,earnings,100,50,7/22/2019
4A2457,conference-call,100,50,7/22/2019
4A6F00,partnership,100,61,7/22/2019
4A6F00,partnership,100,61,7/22/2019
4A6F00,partnership,100,61,7/22/2019
4D371E,earnings,100,50,7/22/2019
4F71DC,ipo-completed,100,76,7/22/2019
510EA6,government-contract,100,69,7/22/2019
519FE0,earnings,100,50,7/22/2019
51F541,conference-call,100,50,7/22/2019
57CAAB,regulatory-product-application,100,69,7/22/2019
5876DC,earnings,100,50,7/22/2019
587D25,note-sale,100,52,7/22/2019
59B229,executive-appointment,100,54,7/22/2019
5A53BF,executive-appointment,100,54,7/22/2019
5C2A47,unit-acquisition-acquirer,100,49,7/22/2019
5EC388,earnings,100,50,7/22/2019
5F2FF7,partnership,100,61,7/22/2019
5FF95F,earnings-positive,100,69,7/22/2019
6166D1,business-contract,100,69,7/22/2019
647143,earnings,100,50,7/22/2019
647143,earnings,100,50,7/22/2019
647143,earnings,100,50,7/22/2019
647143,earnings,100,50,7/22/2019
657097,earnings,100,50,7/22/2019
665440,conference-call,100,50,7/22/2019
6844D2,legal-issues-defendant,100,22,7/22/2019
6C4D2F,earnings,100,50,7/22/2019
6C4D2F,earnings,100,50,7/22/2019
6C4D2F,earnings,100,50,7/22/2019
6C4D2F,earnings,100,50,7/22/2019
6C4D2F,earnings,100,50,7/22/2019
6C4D2F,earnings,100,50,7/22/2019
6C4D2F,earnings,100,50,7/22/2019
6D3F35,conference-call,100,50,7/22/2019
6DDA15,earnings,100,50,7/22/2019
6E8349,earnings,100,50,7/22/2019
717DB4,earnings,100,50,7/22/2019
726EEA,earnings,100,50,7/22/2019
75F665,earnings,100,50,7/22/2019
75F665,earnings,100,50,7/22/2019
75F665,earnings,100,50,7/22/2019
769F40,executive-appointment,100,54,7/22/2019
7A2A49,conference-call,100,50,7/22/2019
7A2A49,conference-participant,100,50,7/22/2019
7F9E16,conference-call,100,50,7/22/2019
81222C,earnings,100,50,7/22/2019
82B57E,executive-appointment,100,54,7/22/2019
83066C,conference-call,100,50,7/22/2019
8377DB,dividend,100,50,7/22/2019
83A065,conference-call,100,50,7/22/2019
859281,earnings,100,50,7/22/2019
859281,earnings,100,50,7/22/2019
859281,earnings,100,50,7/22/2019
859281,earnings,100,50,7/22/2019
859281,earnings,100,50,7/22/2019
859281,earnings,100,50,7/22/2019
85AD00,earnings,100,50,7/22/2019
86AA9C,legal-issues-defendant,100,22,7/22/2019
873DB9,dividend,100,50,7/22/2019
877C0C,product-release,100,64,7/22/2019
8802B4,dividend,100,50,7/22/2019
88350F,executive-appointment,100,54,7/22/2019
88350F,earnings-per-share-up,100,68,7/22/2019
88350F,earnings-per-share-up,100,68,7/22/2019
88350F,earnings-per-share-up,100,68,7/22/2019
88350F,earnings-per-share-up,100,68,7/22/2019
885758,legal-issues-defendant,100,22,7/22/2019
890FF4,earnings,100,50,7/22/2019
8B6E7E,legal-issues-defendant,100,22,7/22/2019
8BAA15,unit-acquisition-acquiree,100,76,7/22/2019
8BFAA4,conference-call,100,50,7/22/2019
8C6C1B,facility-open,100,65,7/22/2019
8E3F58,earnings,100,50,7/22/2019
8E93A4,earnings,100,50,7/22/2019
9004C4,conference-call,100,50,7/22/2019
9004C4,conference-call,100,50,7/22/2019
901327,earnings,100,50,7/22/2019
903AB4,earnings,100,50,7/22/2019
907ED2,earnings,100,50,7/22/2019
92D9C9,conference-call,100,50,7/22/2019
94563D,legal-issues-defendant,100,22,7/22/2019
94C0B5,earnings,100,50,7/22/2019
9507FF,earnings,100,50,7/22/2019
954A47,earnings-positive,100,69,7/22/2019
957A07,executive-appointment,100,54,7/22/2019
972356,executive-appointment,100,54,7/22/2019
97B027,conference-call,100,50,7/22/2019
98CEBB,executive-appointment,100,54,7/22/2019
990AD0,facility-open,100,65,7/22/2019
990AD0,facility-open,100,65,7/22/2019
9CA432,executive-appointment,100,54,7/22/2019
9CA432,conference-call,100,50,7/22/2019
9EBAFA,unit-acquisition-acquirer,100,49,7/22/2019
9FB4B7,business-contract,100,69,7/22/2019
A0F146,conference-call,100,50,7/22/2019
A1EAC8,government-contract,100,69,7/22/2019
A29A46,conference-call,100,50,7/22/2019
A3800A,earnings,100,50,7/22/2019
A3BFAA,earnings,100,50,7/22/2019
A4CD53,earnings,100,50,7/22/2019
A5A4F5,award,100,58,7/22/2019
A6213D,legal-issues-defendant,100,22,7/22/2019
A6FC89,legal-issues-defendant,100,22,7/22/2019
A871B0,business-contract,100,69,7/22/2019
A8CBDA,executive-appointment,100,54,7/22/2019
A94A7B,partnership,100,61,7/22/2019
AA09AD,legal-issues-defendant,100,22,7/22/2019
AD1ACF,conference-call,100,50,7/22/2019
AD22F2,partnership,100,61,7/22/2019
AD23DE,settlement,100,56,7/22/2019
AD23DE,settlement,100,56,7/22/2019
AD23DE,conference-call,100,50,7/22/2019
ADF1B0,earnings,100,50,7/22/2019
ADF1B0,earnings,100,50,7/22/2019
AEF2C3,conference-call,100,50,7/22/2019
B2F431,earnings-positive,100,69,7/22/2019
B4703C,legal-issues-defendant,100,22,7/22/2019
B48D6A,executive-appointment,100,54,7/22/2019
B5766D,dividend,100,50,7/22/2019
B5BA39,legal-issues-defendant,100,22,7/22/2019
B5BA39,legal-issues-defendant,100,22,7/22/2019
B604DF,earnings,100,50,7/22/2019
B604DF,earnings,100,50,7/22/2019
B604DF,earnings,100,50,7/22/2019
B604DF,earnings,100,50,7/22/2019
B604DF,dividend-up,100,63,7/22/2019
BDD12C,earnings-up,100,68,7/22/2019
BFE02C,note-sale,100,52,7/22/2019
BFEA04,business-contract,100,69,7/22/2019
C03C8B,acquisition-acquirer,100,49,7/22/2019
C598D7,revenue-up,100,71,7/22/2019
C598D7,revenues,100,50,7/22/2019
C598D7,revenues,100,50,7/22/2019
C8923A,earnings,100,50,7/22/2019
C8FAC7,legal-issues-defendant,100,22,7/22/2019
CBBFBF,dividend,100,50,7/22/2019
CBFFDD,business-contract,100,69,7/22/2019
CBFFDD,legal-issues-defendant,100,22,7/22/2019
CC6FF5,earnings,100,50,7/22/2019
CE5664,product-release,100,64,7/22/2019
D1173F,asset-sale,100,62,7/22/2019
D29B44,earnings,100,50,7/22/2019
D3CEDF,product-release,100,64,7/22/2019
D48275,earnings,100,50,7/22/2019
D6534D,conference-call,100,50,7/22/2019
DAC66A,earnings,100,50,7/22/2019
DBFB51,conference-call,100,50,7/22/2019
DC2F77,dividend,100,50,7/22/2019
DF204B,conference-call,100,50,7/22/2019
DF46C5,dividend,100,50,7/22/2019
DF46C5,earnings,100,50,7/22/2019
DF46C5,earnings,100,50,7/22/2019
DF46C5,earnings,100,50,7/22/2019
DF46C5,earnings,100,50,7/22/2019
E09997,conference-call,100,50,7/22/2019
E19A99,earnings,100,50,7/22/2019
E19A99,business-contract,100,69,7/22/2019
E22FDE,business-contract,100,69,7/22/2019
E22FDE,business-contract,100,69,7/22/2019
E4158B,earnings-positive,100,69,7/22/2019
E4158B,earnings,100,50,7/22/2019
E4158B,earnings,100,50,7/22/2019
E4158B,earnings,100,50,7/22/2019
E4158B,earnings,100,50,7/22/2019
E68733,partnership,100,61,7/22/2019
E68733,partnership,100,61,7/22/2019
E87676,dividend,100,50,7/22/2019
E96E0B,product-release,100,64,7/22/2019
EBD89A,business-contract,100,69,7/22/2019
ECD263,legal-issues-defendant,100,22,7/22/2019
ECD263,legal-issues-defendant,100,22,7/22/2019
ECDEB2,earnings,100,50,7/22/2019
ED0D7C,dividend,100,50,7/22/2019
EFD406,conference-call,100,50,7/22/2019
EFD406,earnings,100,50,7/22/2019
F02170,legal-issues-defendant,100,22,7/22/2019
F24FF0,conference-call,100,50,7/22/2019
F5C78B,earnings-up,100,68,7/22/2019
F5C78B,earnings,100,50,7/22/2019
F5C78B,earnings,100,50,7/22/2019
F5C78B,earnings,100,50,7/22/2019
F5C78B,earnings,100,50,7/22/2019
F5D059,earnings,100,50,7/22/2019
F5D059,earnings,100,50,7/22/2019
F5D059,earnings,100,50,7/22/2019
F5D059,earnings,100,50,7/22/2019
F5D059,earnings,100,50,7/22/2019
F5D059,earnings,100,50,7/22/2019
F6DE54,dividend,100,50,7/22/2019
F6E248,business-contract,100,69,7/22/2019
F6FF0D,legal-issues-defendant,100,22,7/22/2019
F88A04,executive-appointment,100,54,7/22/2019
F90EE5,executive-appointment,100,54,7/22/2019
F93C8A,award,100,58,7/22/2019
F95726,earnings,100,50,7/22/2019
FAAFA2,executive-appointment,100,54,7/22/2019
FACF19,product-release,100,64,7/22/2019
FBD92D,earnings,100,50,7/22/2019
31025,revenue-up,100,69,7/23/2019
040DBB,earnings,100,50,7/23/2019
0490C6,earnings,100,50,7/23/2019
053EFF,conference-call,100,50,7/23/2019
099C88,conference-call,100,50,7/23/2019
0C6293,executive-appointment,100,54,7/23/2019
0CE204,earnings,100,50,7/23/2019
0F0693,clinical-trials-filed,100,60,7/23/2019
10100E,earnings,100,50,7/23/2019
102727,earnings,100,50,7/23/2019
102F04,earnings,100,50,7/23/2019
1348C9,earnings,100,50,7/23/2019
1348C9,earnings,100,50,7/23/2019
1348C9,earnings,100,50,7/23/2019
1348C9,earnings,100,50,7/23/2019
14833D,earnings,100,50,7/23/2019
16B183,partnership,100,61,7/23/2019
19BF16,earnings,100,50,7/23/2019
1A5D5D,merger-failed,100,21,7/23/2019
1A5D5D,merger-failed,100,21,7/23/2019
1B16C1,earnings,100,50,7/23/2019
1E9A6D,conference-call,100,50,7/23/2019
1E9A6D,earnings,100,50,7/23/2019
1EBF8D,dividend,100,50,7/23/2019
1FC422,earnings,100,50,7/23/2019
206852,executive-appointment,100,54,7/23/2019
206852,executive-appointment,100,54,7/23/2019
20BEEA,conference-call,100,50,7/23/2019
214051,acquisition-acquiree,100,76,7/23/2019
225CA2,conference-call,100,50,7/23/2019
241AF7,conference-call,100,50,7/23/2019
24C48B,conference-call,100,50,7/23/2019
24CB56,earnings-positive,100,69,7/23/2019
24CB56,earnings,100,50,7/23/2019
24CB56,earnings,100,50,7/23/2019
24CB56,earnings,100,50,7/23/2019
24CB56,earnings,100,50,7/23/2019
24CB56,earnings,100,50,7/23/2019
24CB56,earnings,100,50,7/23/2019
24CB56,earnings,100,50,7/23/2019
24CB56,earnings,100,50,7/23/2019
24CB56,earnings,100,50,7/23/2019
25102A,product-release,100,64,7/23/2019
25102A,product-release,100,64,7/23/2019
2667B6,conference-call,100,50,7/23/2019
2667B6,earnings,100,50,7/23/2019
267718,partnership,100,61,7/23/2019
282C18,earnings,100,50,7/23/2019
28B730,earnings,100,50,7/23/2019
28DCA8,executive-appointment,100,54,7/23/2019
292A70,partnership,100,61,7/23/2019
29A4CC,earnings,100,50,7/23/2019
29A4CC,earnings,100,50,7/23/2019
29A4CC,earnings,100,50,7/23/2019
29A4CC,earnings,100,50,7/23/2019
29A4CC,earnings,100,50,7/23/2019
29A4CC,earnings,100,50,7/23/2019
29A4CC,earnings,100,50,7/23/2019
2C7505,product-release,100,64,7/23/2019
2C7505,product-release,100,64,7/23/2019
2CBB58,revenue-up,100,66,7/23/2019
2CBB58,revenue-up,100,66,7/23/2019
2CBB58,revenue-up,100,66,7/23/2019
2CBB58,revenue-up,100,66,7/23/2019
2E2E6E,earnings,100,50,7/23/2019
2F5256,earnings,100,50,7/23/2019
2F98A5,dividend-up,100,81,7/23/2019
301493,executive-appointment,100,54,7/23/2019
31643A,unit-acquisition-acquirer,100,49,7/23/2019
332F87,earnings-per-share-up,100,69,7/23/2019
39BFF6,earnings,100,50,7/23/2019
39BFF6,earnings,100,50,7/23/2019
39BFF6,earnings,100,50,7/23/2019
3B50FE,partnership,100,61,7/23/2019
3CCC90,dividend-up,100,81,7/23/2019
3DE4D1,earnings,100,50,7/23/2019
3E15F6,dividend,100,50,7/23/2019
3F6A9C,dividend,100,50,7/23/2019
408089,earnings,100,50,7/23/2019
41785E,earnings,100,50,7/23/2019
41A93D,earnings,100,50,7/23/2019
41C528,conference-call,100,50,7/23/2019
4591D3,conference-call,100,50,7/23/2019
4A6F00,product-release,100,64,7/23/2019
4D72C8,conference-call,100,50,7/23/2019
4D72C8,conference-call,100,50,7/23/2019
4DD09F,earnings,100,50,7/23/2019
4F0A80,earnings,100,50,7/23/2019
510EA1,orphan-drug-designation,100,76,7/23/2019
510EA6,earnings,100,50,7/23/2019
510EA6,earnings,100,50,7/23/2019
514067,conference-call,100,50,7/23/2019
51B442,earnings,100,50,7/23/2019
54B889,conference-call,100,50,7/23/2019
56AFF4,dividend,100,50,7/23/2019
57634F,earnings,100,50,7/23/2019
57DDB9,conference-call,100,50,7/23/2019
596116,earnings,100,50,7/23/2019
59A832,conference-call,100,50,7/23/2019
5A64D5,conference-call,100,50,7/23/2019
5BE42C,dividend-up,100,81,7/23/2019
5CC29D,earnings,100,50,7/23/2019
5D41E4,conference-call,100,50,7/23/2019
5F1B7B,earnings,100,50,7/23/2019
5F9CE3,conference-call,100,50,7/23/2019
5F9CE3,earnings,100,50,7/23/2019
6137BF,conference-call,100,50,7/23/2019
6137BF,earnings,100,50,7/23/2019
627186,conference-participant,100,50,7/23/2019
636931,earnings,100,50,7/23/2019
64854A,conference-call,100,50,7/23/2019
662682,earnings,100,50,7/23/2019
6B0E45,dividend,100,50,7/23/2019
6CD55A,earnings,100,50,7/23/2019
6D4636,conference-call,100,50,7/23/2019
6DC1D7,credit-extension-recipient,100,69,7/23/2019
6E705B,partnership,100,61,7/23/2019
6F0096,earnings,100,50,7/23/2019
6F0096,earnings,100,50,7/23/2019
6F0096,earnings,100,50,7/23/2019
6F3FA8,conference-call,100,50,7/23/2019
701531,earnings,100,50,7/23/2019
7255D2,earnings,100,50,7/23/2019
72609A,conference-call,100,50,7/23/2019
726DDF,joint-venture,100,62,7/23/2019
72EF75,earnings,100,50,7/23/2019
752A70,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,earnings,100,50,7/23/2019
75F665,dividend,100,50,7/23/2019
765913,dividend,100,50,7/23/2019
769F40,earnings,100,50,7/23/2019
78A1BB,earnings,100,50,7/23/2019
7A3633,legal-issues-defendant,100,22,7/23/2019
7B1E50,earnings,100,50,7/23/2019
7D35D8,earnings,100,50,7/23/2019
7D35D8,earnings,100,50,7/23/2019
7D35D8,earnings,100,50,7/23/2019
7D5FD6,earnings,100,50,7/23/2019
7D5FD6,conference-call,100,50,7/23/2019
7E3F8F,award,100,58,7/23/2019
80C400,conference-call,100,50,7/23/2019
817ED9,executive-appointment,100,54,7/23/2019
81F4BE,partnership,100,61,7/23/2019
81F4BE,earnings,100,50,7/23/2019
81F4BE,earnings,100,50,7/23/2019
82F088,conference-call,100,50,7/23/2019
83066C,acquisition-completed-acquiree,100,76,7/23/2019
835C86,dividend,100,50,7/23/2019
8377DB,earnings,100,50,7/23/2019
8377DB,earnings,100,50,7/23/2019
8377DB,earnings,100,50,7/23/2019
8377DB,earnings,100,50,7/23/2019
8377DB,earnings,100,50,7/23/2019
845533,earnings,100,50,7/23/2019
84A6B9,earnings,100,50,7/23/2019
84A6B9,earnings,100,50,7/23/2019
84A6B9,earnings,100,50,7/23/2019
84A6B9,earnings,100,50,7/23/2019
84A6B9,earnings,100,50,7/23/2019
84A6B9,earnings,100,50,7/23/2019
84A6B9,earnings,100,50,7/23/2019
85DA04,earnings,100,50,7/23/2019
85DE00,business-contract,100,69,7/23/2019
862941,earnings,100,50,7/23/2019
86AA9C,legal-issues-defendant,100,22,7/23/2019
877C0C,legal-issues-defendant,100,22,7/23/2019
885758,earnings,100,50,7/23/2019
895D56,conference-call,100,50,7/23/2019
8A8E41,acquisition-acquirer,100,49,7/23/2019
8A8E41,facility-open,100,65,7/23/2019
8BE916,earnings-up,100,68,7/23/2019
8BE916,earnings-up,100,68,7/23/2019
8BE916,earnings-up,100,68,7/23/2019
8BE916,earnings-up,100,68,7/23/2019
8BE916,earnings-up,100,68,7/23/2019
8BE916,earnings-up,100,68,7/23/2019
8BE916,earnings-up,100,68,7/23/2019
8C311A,earnings,100,50,7/23/2019
8CF6DD,dividend,100,50,7/23/2019
8D9993,dividend,100,50,7/23/2019
8DAAB9,earnings-up,100,68,7/23/2019
8DCF18,conference-call,100,50,7/23/2019
8E82A6,executive-appointment,100,54,7/23/2019
8E93A4,conference-call,100,50,7/23/2019
8EEA28,dividend,100,50,7/23/2019
8F6995,conference-call,100,50,7/23/2019
903AB4,conference-call,100,50,7/23/2019
911AB8,executive-appointment,100,54,7/23/2019
9196A2,partnership,100,61,7/23/2019
9.31E+77,conference-call,100,50,7/23/2019
934029,public-offering,100,43,7/23/2019
93D207,conference-call,100,50,7/23/2019
93D207,earnings,100,50,7/23/2019
93F143,earnings,100,50,7/23/2019
93F143,earnings,100,50,7/23/2019
93F143,earnings,100,50,7/23/2019
93F143,earnings,100,50,7/23/2019
940C3D,executive-appointment,100,54,7/23/2019
94563D,legal-issues-defendant,100,22,7/23/2019
949D62,campaign-ad-release,100,59,7/23/2019
9548BB,earnings-per-share-up,100,68,7/23/2019
9548BB,earnings,100,50,7/23/2019
9548BB,earnings,100,50,7/23/2019
9592FB,regulatory-product-approval-granted,100,81,7/23/2019
96F126,earnings,100,50,7/23/2019
97AF94,earnings,100,50,7/23/2019
97FE80,earnings,100,50,7/23/2019
9934AD,conference-call,100,50,7/23/2019
9.97E+09,acquisition-acquirer,100,49,7/23/2019
997348,earnings,100,50,7/23/2019
997348,earnings,100,50,7/23/2019
99DC8D,conference-call,100,50,7/23/2019
9C25FF,executive-appointment,100,54,7/23/2019
9D30A8,executive-appointment,100,54,7/23/2019
9F37C5,conference-call,100,50,7/23/2019
9FD2D9,conference-call,100,50,7/23/2019
A05C43,earnings,100,50,7/23/2019
A23747,conference-participant,100,50,7/23/2019
A398B9,conference-call,100,50,7/23/2019
A398B9,earnings,100,50,7/23/2019
A398B9,earnings,100,50,7/23/2019
A398B9,earnings,100,50,7/23/2019
A403CF,executive-appointment,100,54,7/23/2019
A4B899,conference-call,100,50,7/23/2019
A4D173,conference-call,100,50,7/23/2019
A4D173,earnings,100,50,7/23/2019
A4D173,earnings,100,50,7/23/2019
A5195E,earnings,100,50,7/23/2019
A52533,earnings,100,50,7/23/2019
A5DD24,earnings,100,50,7/23/2019
A5E715,earnings,100,50,7/23/2019
A60354,conference-call,100,50,7/23/2019
A63387,conference-call,100,50,7/23/2019
A63820,earnings,100,50,7/23/2019
A63820,earnings,100,50,7/23/2019
A63820,earnings,100,50,7/23/2019
A65325,dividend,100,50,7/23/2019
A65325,earnings-positive,100,69,7/23/2019
A7102F,conference-call,100,50,7/23/2019
A868C9,conference-call,100,50,7/23/2019
A8B137,earnings,100,50,7/23/2019
A8B137,earnings,100,50,7/23/2019
A8B137,earnings,100,50,7/23/2019
A8B137,earnings,100,50,7/23/2019
A8B137,earnings,100,50,7/23/2019
A8CBDA,earnings-positive,100,69,7/23/2019
A94718,conference-call,100,50,7/23/2019
AA98ED,conference-call,100,50,7/23/2019
AA98ED,operating-earnings-up,100,68,7/23/2019
AB7726,earnings,100,50,7/23/2019
AC7C4F,business-contract,100,69,7/23/2019
ACD9A4,earnings,100,50,7/23/2019
AFD1CA,facility-open,100,65,7/23/2019
B04426,partnership,100,61,7/23/2019
B0FE08,dividend,100,50,7/23/2019
B37FB4,earnings-up,100,68,7/23/2019
B3A166,conference-call,100,50,7/23/2019
B48FC9,earnings,100,50,7/23/2019
B6CD92,earnings,100,50,7/23/2019
B73395,conference-call,100,50,7/23/2019
B8F71F,earnings,100,50,7/23/2019
B96637,conference-call,100,50,7/23/2019
BAD655,earnings,100,50,7/23/2019
BB5142,earnings,100,50,7/23/2019
BBC05B,operating-earnings,100,50,7/23/2019
BCC13E,earnings,100,50,7/23/2019
BD15E8,earnings,100,50,7/23/2019
BD9668,earnings,100,50,7/23/2019
BDD12C,conference-call,100,50,7/23/2019
BDF2BD,conference-call,100,50,7/23/2019
BFEA04,conference-call,100,50,7/23/2019
C0F70B,conference-participant,100,50,7/23/2019
C22BE8,product-release,100,64,7/23/2019
C32A39,earnings-per-share-positive,100,69,7/23/2019
C564E4,conference-call,100,50,7/23/2019
C58D71,clinical-trials-positive,100,87,7/23/2019
C598D7,conference-call,100,50,7/23/2019
C5D2AE,award,100,58,7/23/2019
C9D866,executive-appointment,100,54,7/23/2019
CAB222,conference-call,100,50,7/23/2019
CB89EA,earnings,100,50,7/23/2019
CBA33B,dividend,100,50,7/23/2019
CBCC6A,conference-organizer,100,57,7/23/2019
CD06A2,dividend,100,50,7/23/2019
CE1002,earnings,100,50,7/23/2019
CE1002,earnings,100,50,7/23/2019
CE1002,earnings,100,50,7/23/2019
CE1002,earnings,100,50,7/23/2019
CE1002,earnings,100,50,7/23/2019
CE1002,conference-call,100,50,7/23/2019
CEDFD5,conference-call,100,50,7/23/2019
CF211D,executive-appointment,100,54,7/23/2019
CF6A5A,earnings-up,100,68,7/23/2019
CFE5BE,earnings,100,50,7/23/2019
CFE5BE,earnings,100,50,7/23/2019
CFE5BE,earnings,100,50,7/23/2019
CFE5BE,earnings,100,50,7/23/2019
CFE5BE,earnings,100,50,7/23/2019
CFE5BE,earnings,100,50,7/23/2019
CFE5BE,earnings,100,50,7/23/2019
CFE5BE,earnings,100,50,7/23/2019
CFF97C,credit-rating-confirmation-rater,20,50,7/23/2019
D1173F,earnings,100,50,7/23/2019
D1173F,earnings,100,50,7/23/2019
D1173F,earnings,100,50,7/23/2019
D1173F,earnings,100,50,7/23/2019
D1173F,earnings,100,50,7/23/2019
D139BC,earnings,100,50,7/23/2019
D17C1B,earnings,100,50,7/23/2019
D17C1B,earnings,100,50,7/23/2019
D17C1B,earnings,100,50,7/23/2019
D437C3,executive-appointment,100,54,7/23/2019
D48275,conference-call,100,50,7/23/2019
D4AC65,product-release,100,64,7/23/2019
D501DC,earnings,100,50,7/23/2019
D60BB2,partnership,100,61,7/23/2019
D63B0F,investment-investor,100,55,7/23/2019
D697DE,earnings,100,50,7/23/2019
D6EAA3,dividend,100,50,7/23/2019
D78CCD,dividend,100,50,7/23/2019
D7918D,executive-appointment,100,54,7/23/2019
D7918D,dividend,100,50,7/23/2019
D854DD,conference-call,100,50,7/23/2019
D8DA3D,legal-issues-defendant,100,22,7/23/2019
D9164D,dividend,100,50,7/23/2019
D9164D,earnings,100,50,7/23/2019
D9B1C9,dividend,100,50,7/23/2019
DB5CA5,investment-investor,100,55,7/23/2019
DC486E,earnings,100,50,7/23/2019
DDB002,executive-appointment,100,54,7/23/2019
DDB002,executive-appointment,100,54,7/23/2019
DDB002,executive-appointment,100,54,7/23/2019
E00373,earnings,100,50,7/23/2019
E0339F,dividend,100,50,7/23/2019
E06265,conference-call,100,50,7/23/2019
E206B0,conference-call,100,50,7/23/2019
E30B34,conference-call,100,50,7/23/2019
E30B34,earnings,100,50,7/23/2019
E30B34,earnings,100,50,7/23/2019
E69BA5,conference-call,100,50,7/23/2019
E754F0,earnings,100,50,7/23/2019
E87676,conference-call,100,50,7/23/2019
E87676,revenue-up,100,69,7/23/2019
E87676,earnings,100,50,7/23/2019
E87676,earnings,100,50,7/23/2019
E8E899,conference-participant,100,50,7/23/2019
E90C84,conference-call,100,50,7/23/2019
E9E6FD,earnings,100,50,7/23/2019
E9FF33,earnings,100,50,7/23/2019
EA62FC,dividend,100,50,7/23/2019
EAA0A7,earnings,100,50,7/23/2019
EB61C4,earnings,100,50,7/23/2019
EC1AF3,conference-call,100,50,7/23/2019
ECD263,legal-issues-defendant,100,22,7/23/2019
ECD263,legal-issues-defendant,100,22,7/23/2019
ECDEB2,conference-call,100,50,7/23/2019
ECDEB2,earnings,100,50,7/23/2019
ED0402,conference-call,100,50,7/23/2019
ED0402,revenue-up,100,74,7/23/2019
ED0402,revenue-up,100,74,7/23/2019
ED0402,revenue-up,100,74,7/23/2019
ED0402,revenue-up,100,74,7/23/2019
EDF5CA,conference-call,100,50,7/23/2019
EF5914,earnings,100,50,7/23/2019
F04E05,dividend,100,50,7/23/2019
F0A9DE,earnings,100,50,7/23/2019
F1C04C,conference-call,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F294DD,earnings,100,50,7/23/2019
F44EA2,earnings,100,50,7/23/2019
F47871,legal-issues-defendant,100,22,7/23/2019
F4F46F,partnership,100,61,7/23/2019
F57F6F,demand-increase,100,83,7/23/2019
F57F6F,demand-increase,100,83,7/23/2019
F58C23,patient-enrollment-complete,100,64,7/23/2019
F5D410,earnings-guidance-up,100,83,7/23/2019
F5D410,conference-call,100,50,7/23/2019
F8DE55,dividend,100,50,7/23/2019
FA044A,earnings,100,50,7/23/2019
FA840E,earnings,100,50,7/23/2019
FA840E,conference-participant,100,50,7/23/2019
FAE021,partnership,100,61,7/23/2019
FC9A88,earnings-up,100,68,7/23/2019
FC9A88,earnings-up,100,68,7/23/2019
FC9A88,earnings-up,100,68,7/23/2019
FC9A88,earnings-up,100,68,7/23/2019
FC9A88,earnings-up,100,68,7/23/2019
FFCD0E,revenue-up,100,61,7/23/2019
0157B1,executive-appointment,100,54,7/24/2019
0157B1,partnership,100,61,7/24/2019
0325B7,conference-call,100,50,7/24/2019
03CF95,earnings,100,50,7/24/2019
03CF95,earnings,100,50,7/24/2019
03CF95,earnings,100,50,7/24/2019
03CF95,earnings,100,50,7/24/2019
03CF95,earnings,100,50,7/24/2019
03FAA6,earnings,100,50,7/24/2019
03FB17,earnings,100,50,7/24/2019
0560D8,earnings,100,50,7/24/2019
68396,earnings,100,50,7/24/2019
71860,earnings,100,50,7/24/2019
081AB9,earnings,100,50,7/24/2019
081AB9,conference-call,100,50,7/24/2019
09F623,dividend-up,100,81,7/24/2019
0A0CF0,dividend,100,50,7/24/2019
0A1D77,earnings,100,50,7/24/2019
0A77DB,earnings,100,50,7/24/2019
0B13E8,executive-appointment,100,54,7/24/2019
0B13E8,conference-call,100,50,7/24/2019
0BC29E,executive-appointment,100,54,7/24/2019
0C4131,earnings,100,50,7/24/2019
0C4131,earnings,100,50,7/24/2019
0C4131,earnings,100,50,7/24/2019
0C4131,earnings,100,50,7/24/2019
0C4131,earnings,100,50,7/24/2019
0CBC4D,earnings,100,50,7/24/2019
0CC62B,earnings,100,50,7/24/2019
0CC62B,earnings,100,50,7/24/2019
0CC62B,earnings,100,50,7/24/2019
0CC62B,earnings,100,50,7/24/2019
0CC62B,earnings,100,50,7/24/2019
0DBB81,executive-appointment,100,54,7/24/2019
0DC050,earnings,100,50,7/24/2019
0DC050,earnings,100,50,7/24/2019
0DC050,earnings,100,50,7/24/2019
0DC050,earnings,100,50,7/24/2019
0E439E,earnings,100,50,7/24/2019
0E439E,earnings,100,50,7/24/2019
0E439E,earnings,100,50,7/24/2019
0E6027,earnings-positive,100,69,7/24/2019
0E6027,earnings,100,50,7/24/2019
0EC508,earnings,100,50,7/24/2019
10100E,conference-participant,100,50,7/24/2019
10673F,earnings,100,50,7/24/2019
10673F,earnings,100,50,7/24/2019
1080C0,orphan-drug-designation,100,76,7/24/2019
12E454,earnings,100,50,7/24/2019
12E454,earnings,100,50,7/24/2019
12E454,earnings,100,50,7/24/2019
12F98C,product-release,100,64,7/24/2019
152B9E,earnings,100,50,7/24/2019
157D9F,conference-call,100,50,7/24/2019
159739,earnings,100,50,7/24/2019
159739,earnings,100,50,7/24/2019
165B3A,earnings-positive,100,69,7/24/2019
165B3A,earnings-positive,100,69,7/24/2019
165B3A,earnings-positive,100,69,7/24/2019
165B3A,earnings-positive,100,69,7/24/2019
16F4D8,earnings,100,50,7/24/2019
16F4D8,earnings,100,50,7/24/2019
16F4D8,earnings,100,50,7/24/2019
16F4D8,earnings,100,50,7/24/2019
16F4D8,earnings,100,50,7/24/2019
1866B2,investment-investor,100,55,7/24/2019
1866B2,note-sale,100,52,7/24/2019
1866B2,earnings,100,50,7/24/2019
197019,earnings,100,50,7/24/2019
197612,conference-participant,100,50,7/24/2019
1A2D9F,earnings,100,50,7/24/2019
1CD09C,conference-call,100,50,7/24/2019
1CD708,earnings-up,100,68,7/24/2019
1D1B07,note-sale,100,52,7/24/2019
1D1B07,note-sale,100,52,7/24/2019
1D5C51,earnings,100,50,7/24/2019
1DE526,earnings,100,50,7/24/2019
1E5786,dividend,100,50,7/24/2019
1E8A99,earnings,100,50,7/24/2019
1EBF8D,clinical-trials-start,100,64,7/24/2019
1EBF8D,clinical-trials-start,100,64,7/24/2019
1EBF8D,clinical-trials-start,100,64,7/24/2019
1FA8F7,earnings,100,50,7/24/2019
2031CE,earnings-up,100,68,7/24/2019
2031CE,earnings,100,50,7/24/2019
2031CE,earnings,100,50,7/24/2019
2031CE,earnings,100,50,7/24/2019
2031CE,earnings,100,50,7/24/2019
2031CE,earnings,100,50,7/24/2019
2096DE,earnings,100,50,7/24/2019
221AD7,earnings,100,50,7/24/2019
228D42,partnership,100,61,7/24/2019
25102A,earnings,100,50,7/24/2019
25102A,earnings,100,50,7/24/2019
25102A,earnings,100,50,7/24/2019
25102A,earnings,100,50,7/24/2019
25102A,earnings,100,50,7/24/2019
25102A,dividend,100,50,7/24/2019
251988,earnings,100,50,7/24/2019
251988,earnings,100,50,7/24/2019
251988,earnings,100,50,7/24/2019
251988,earnings,100,50,7/24/2019
251988,earnings,100,50,7/24/2019
25DD05,earnings,100,50,7/24/2019
264EB3,earnings-positive,100,69,7/24/2019
26FA41,revenue-up,100,69,7/24/2019
270B78,earnings,100,50,7/24/2019
2720AB,earnings,100,50,7/24/2019
28AC4E,ipo-pricing,100,50,7/24/2019
297DA8,conference-participant,100,50,7/24/2019
2A9C0A,earnings-positive,100,69,7/24/2019
2A9C0A,earnings,100,50,7/24/2019
2A9C0A,earnings,100,50,7/24/2019
2A9C0A,earnings,100,50,7/24/2019
2A9C0A,earnings,100,50,7/24/2019
2A9C0A,earnings,100,50,7/24/2019
2B0AF4,conference-call,100,50,7/24/2019
2B0AF4,earnings,100,50,7/24/2019
2BC05E,conference-call,100,50,7/24/2019
2CB4C9,earnings,100,50,7/24/2019
2D643C,conference-call,100,50,7/24/2019
2D643C,earnings,100,50,7/24/2019
2E0496,unit-acquisition-acquirer,100,49,7/24/2019
2E0496,unit-acquisition-acquirer,100,49,7/24/2019
2E6514,earnings-up,100,70,7/24/2019
2E6514,earnings-up,100,70,7/24/2019
2E6514,earnings-up,100,70,7/24/2019
2E6514,earnings-up,100,70,7/24/2019
2EC172,business-contract,100,69,7/24/2019
2F94A5,earnings,100,50,7/24/2019
314D88,legal-issues-defendant,100,22,7/24/2019
31A7CC,dividend-up,100,81,7/24/2019
326EDD,earnings,100,50,7/24/2019
3301B7,partnership,100,61,7/24/2019
339F20,earnings,100,50,7/24/2019
33E8C7,earnings,100,50,7/24/2019
33E8C7,earnings,100,50,7/24/2019
3461CF,stake-acquirer,100,48,7/24/2019
34B411,dividend-up,100,81,7/24/2019
367434,conference-participant,100,50,7/24/2019
3696BF,earnings,100,50,7/24/2019
36A1CB,conference-call,100,50,7/24/2019
3.73E+87,revenue-up,100,69,7/24/2019
3.73E+87,revenue-up,100,69,7/24/2019
3.73E+87,revenue-up,100,69,7/24/2019
387541,earnings,100,50,7/24/2019
389CFB,conference-call,100,50,7/24/2019
3A113F,earnings,100,50,7/24/2019
3A113F,conference-call,100,50,7/24/2019
3B2311,earnings,100,50,7/24/2019
3BA1BF,conference-call,100,50,7/24/2019
3CCC90,earnings,100,50,7/24/2019
3D9999,dividend,100,50,7/24/2019
3D9999,executive-appointment,100,54,7/24/2019
3F1C69,public-offering,100,43,7/24/2019
41785E,conference-call,100,50,7/24/2019
41B0E2,earnings,100,50,7/24/2019
425BDC,earnings,100,50,7/24/2019
448BF3,executive-appointment,100,54,7/24/2019
449A26,executive-appointment,100,54,7/24/2019
458D2C,earnings,100,50,7/24/2019
45ABCC,conference-participant,100,50,7/24/2019
46017C,conference-participant,100,50,7/24/2019
468DD4,earnings,100,50,7/24/2019
47752F,earnings,100,50,7/24/2019
47752F,earnings,100,50,7/24/2019
47752F,earnings,100,50,7/24/2019
47752F,earnings,100,50,7/24/2019
49CC59,conference-call,100,50,7/24/2019
4A6F00,stake-acquirer,100,48,7/24/2019
4A6F00,patent-infringement-defendant,100,26,7/24/2019
4B3555,earnings,100,50,7/24/2019
4B3DC9,earnings-positive,100,69,7/24/2019
4B6EF9,dividend,100,50,7/24/2019
4B6EF9,earnings,100,50,7/24/2019
4C1FA1,earnings,100,50,7/24/2019
4C1FA1,earnings,100,50,7/24/2019
4C1FA1,earnings,100,50,7/24/2019
4C1FA1,earnings,100,50,7/24/2019
4C37C5,dividend,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D7BD8,earnings,100,50,7/24/2019
4D8313,earnings,100,50,7/24/2019
4D8313,earnings,100,50,7/24/2019
4D8313,earnings,100,50,7/24/2019
4D971D,dividend,100,50,7/24/2019
4D971D,earnings,100,50,7/24/2019
4D971D,earnings,100,50,7/24/2019
4D971D,earnings,100,50,7/24/2019
4D971D,earnings,100,50,7/24/2019
4D971D,earnings,100,50,7/24/2019
4E7C1F,earnings,100,50,7/24/2019
4E7C1F,earnings,100,50,7/24/2019
4E7C1F,earnings,100,50,7/24/2019
4F9487,earnings-positive,100,69,7/24/2019
4F9487,earnings-positive,100,69,7/24/2019
4F9487,earnings-positive,100,69,7/24/2019
4F9487,earnings-positive,100,69,7/24/2019
4F9487,earnings-positive,100,69,7/24/2019
4F9487,earnings-positive,100,69,7/24/2019
4F9487,earnings-positive,100,69,7/24/2019
4F9487,earnings-positive,100,69,7/24/2019
4F9487,acquisition-acquirer,100,49,7/24/2019
5065B1,earnings,100,50,7/24/2019
52B567,legal-issues-defendant,100,22,7/24/2019
532D47,earnings,100,50,7/24/2019
5340D0,conference-participant,100,50,7/24/2019
53E575,earnings,100,50,7/24/2019
5.43E+08,earnings,100,50,7/24/2019
5480A7,conference-participant,100,50,7/24/2019
553949,conference-call,100,50,7/24/2019
55438C,earnings,100,50,7/24/2019
55438C,earnings,100,50,7/24/2019
55438C,earnings,100,50,7/24/2019
55438C,earnings,100,50,7/24/2019
55C289,earnings,100,50,7/24/2019
5675EB,earnings,100,50,7/24/2019
58C2D4,facility-close,100,47,7/24/2019
594402,earnings,100,50,7/24/2019
596116,conference-participant,100,50,7/24/2019
5A9F54,earnings-up,100,68,7/24/2019
5A9F54,earnings-up,100,68,7/24/2019
5A9F54,earnings-up,100,68,7/24/2019
5A9F54,earnings-up,100,68,7/24/2019
5AAE17,conference-call,100,50,7/24/2019
5AF08A,earnings,100,50,7/24/2019
5B3FA2,earnings,100,50,7/24/2019
5B97B2,earnings,100,50,7/24/2019
5DA8B3,earnings,100,50,7/24/2019
5DD48B,earnings,100,50,7/24/2019
5E7E82,executive-appointment,100,54,7/24/2019
5F3E74,earnings,100,50,7/24/2019
60DD84,revenue-up,100,69,7/24/2019
619882,acquisition-completed-acquirer,100,49,7/24/2019
61BCA7,award,100,58,7/24/2019
62A48D,executive-appointment,100,54,7/24/2019
62CDDE,market-entry,100,57,7/24/2019
6.52E+64,earnings,100,50,7/24/2019
662682,dividend,100,50,7/24/2019
66749D,conference-participant,100,50,7/24/2019
66BDA1,conference-call,100,50,7/24/2019
66E04A,earnings,100,50,7/24/2019
66E04A,earnings,100,50,7/24/2019
66E04A,earnings,100,50,7/24/2019
66E04A,earnings,100,50,7/24/2019
66E04A,earnings,100,50,7/24/2019
66E04A,earnings,100,50,7/24/2019
66E04A,earnings,100,50,7/24/2019
67529E,earnings-positive,100,69,7/24/2019
67529E,earnings-positive,100,69,7/24/2019
67529E,earnings-positive,100,69,7/24/2019
67529E,earnings-positive,100,69,7/24/2019
67529E,earnings-positive,100,69,7/24/2019
67529E,earnings-positive,100,69,7/24/2019
67529E,earnings-positive,100,69,7/24/2019
67529E,earnings-positive,100,69,7/24/2019
67A658,executive-appointment,100,54,7/24/2019
6BDA0C,conference-call,100,50,7/24/2019
6C6D73,executive-appointment,100,54,7/24/2019
6CB7F9,earnings,100,50,7/24/2019
6CF43C,earnings,100,50,7/24/2019
6D156D,conference-participant,100,50,7/24/2019
6DD6BA,earnings,100,50,7/24/2019
6DD6BA,earnings,100,50,7/24/2019
6DD6BA,earnings,100,50,7/24/2019
6E1E61,earnings,100,50,7/24/2019
6E7060,conference-call,100,50,7/24/2019
6EB9DA,earnings,100,50,7/24/2019
6EB9DA,earnings,100,50,7/24/2019
6EB9DA,earnings,100,50,7/24/2019
6F0096,conference-call,100,50,7/24/2019
7262F2,earnings,100,50,7/24/2019
728737,earnings,100,50,7/24/2019
73BCBA,earnings,100,50,7/24/2019
73BCBA,earnings,100,50,7/24/2019
73BCBA,earnings,100,50,7/24/2019
73BCBA,earnings,100,50,7/24/2019
742AAB,conference-call,100,50,7/24/2019
763724,conference-call,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
767F86,earnings,100,50,7/24/2019
7A51FE,executive-appointment,100,54,7/24/2019
7AB859,earnings,100,50,7/24/2019
7AB859,earnings,100,50,7/24/2019
7AB859,earnings,100,50,7/24/2019
7AB859,earnings,100,50,7/24/2019
7AB859,earnings,100,50,7/24/2019
7AB859,conference-call,100,50,7/24/2019
7AC86E,earnings-up,100,68,7/24/2019
7AC86E,earnings,100,50,7/24/2019
7AC86E,earnings,100,50,7/24/2019
7AC86E,conference-call,100,50,7/24/2019
7B9AFA,earnings,100,50,7/24/2019
7C75FD,dividend,100,50,7/24/2019
7D35D8,conference-call,100,50,7/24/2019
7E3F8F,earnings,100,50,7/24/2019
7E3F8F,earnings,100,50,7/24/2019
7E3F8F,earnings,100,50,7/24/2019
7E3F8F,earnings,100,50,7/24/2019
7E3F8F,conference-call,100,50,7/24/2019
7E62B5,earnings,100,50,7/24/2019
7FD8B9,conference-participant,100,50,7/24/2019
824CCA,earnings,100,50,7/24/2019
82E58A,conference-call,100,50,7/24/2019
838ADD,conference-call,100,50,7/24/2019
838ADD,earnings,100,50,7/24/2019
838ADD,earnings,100,50,7/24/2019
838ADD,earnings,100,50,7/24/2019
838ADD,earnings,100,50,7/24/2019
838ADD,earnings,100,50,7/24/2019
838ADD,earnings,100,50,7/24/2019
85DA04,partnership,100,61,7/24/2019
86478F,earnings,100,50,7/24/2019
8665BA,earnings,100,50,7/24/2019
8665BA,conference-call,100,50,7/24/2019
877C0C,legal-issues-defendant,100,22,7/24/2019
881190,earnings,100,50,7/24/2019
881190,earnings,100,50,7/24/2019
881190,earnings,100,50,7/24/2019
881190,earnings,100,50,7/24/2019
89F693,award,100,58,7/24/2019
8A0368,conference-participant,100,50,7/24/2019
8AB37F,conference-call,100,50,7/24/2019
8B1E11,joint-venture,100,62,7/24/2019
8C311A,conference-call,100,50,7/24/2019
8D4486,executive-appointment,100,54,7/24/2019
8D4AE6,earnings-up,100,68,7/24/2019
8D4AE6,earnings-up,100,68,7/24/2019
8D4AE6,earnings-up,100,68,7/24/2019
8D4AE6,earnings-up,100,68,7/24/2019
8E82A6,dividend,100,50,7/24/2019
8E93A4,dividend,100,50,7/24/2019
90D6A5,partnership,100,61,7/24/2019
911AB8,dividend,100,50,7/24/2019
934029,public-offering,100,43,7/24/2019
942165,dividend,100,50,7/24/2019
949D62,earnings,100,50,7/24/2019
95DC1F,donation,100,54,7/24/2019
9673BD,conference-call,100,50,7/24/2019
9.74E+08,earnings,100,50,7/24/2019
9.74E+08,earnings,100,50,7/24/2019
9.74E+08,earnings,100,50,7/24/2019
9.74E+08,earnings,100,50,7/24/2019
97644E,earnings,100,50,7/24/2019
9810C0,earnings,100,50,7/24/2019
98CAED,dividend,100,50,7/24/2019
98CAED,earnings,100,50,7/24/2019
98CAED,earnings,100,50,7/24/2019
98CAED,earnings,100,50,7/24/2019
98CAED,earnings,100,50,7/24/2019
9.92E+94,earnings,100,50,7/24/2019
9.92E+94,earnings,100,50,7/24/2019
9.92E+94,earnings,100,50,7/24/2019
9A02C4,earnings,100,50,7/24/2019
9A02C4,dividend,100,50,7/24/2019
9AF3DC,note-sale,100,52,7/24/2019
9AF3DC,note-sale,100,52,7/24/2019
9B730A,partnership,100,61,7/24/2019
9B730A,partnership,100,61,7/24/2019
9C5174,conference-participant,100,50,7/24/2019
9C8664,earnings,100,50,7/24/2019
9CE4C7,earnings,100,50,7/24/2019
9D307D,earnings,100,50,7/24/2019
9D30A8,earnings,100,50,7/24/2019
9D5FA4,earnings,100,50,7/24/2019
9EF4CF,partnership,100,61,7/24/2019
9F37C5,dividend,100,50,7/24/2019
9F37C5,earnings,100,50,7/24/2019
A47A7D,conference-participant,100,50,7/24/2019
A4BCDE,executive-appointment,100,54,7/24/2019
A52B6B,regulatory-product-approval-granted,100,81,7/24/2019
A6828A,joint-venture,100,62,7/24/2019
A6ABE9,earnings,100,50,7/24/2019
A6ABE9,conference-call,100,50,7/24/2019
A75D43,conference-participant,100,50,7/24/2019
A871B0,earnings,100,50,7/24/2019
A8AC4C,earnings-up,100,68,7/24/2019
A8B137,dividend,100,50,7/24/2019
AABEA0,earnings-up,100,68,7/24/2019
AADE0B,dividend,100,50,7/24/2019
AD23DE,earnings,100,50,7/24/2019
AD23DE,earnings,100,50,7/24/2019
AD23DE,earnings,100,50,7/24/2019
AD23DE,earnings,100,50,7/24/2019
AD23DE,earnings,100,50,7/24/2019
AD23DE,earnings,100,50,7/24/2019
B08954,earnings,100,50,7/24/2019
B08954,acquisition-acquirer,100,49,7/24/2019
B1FC3B,business-contract,100,69,7/24/2019
B48FC9,product-release,100,64,7/24/2019
B508E5,ipo-pricing,100,50,7/24/2019
B508E5,ipo-pricing,100,50,7/24/2019
B508E5,ipo-pricing,100,50,7/24/2019
B5BA39,legal-issues-defendant,100,22,7/24/2019
B6082A,earnings,100,50,7/24/2019
B66928,earnings,100,50,7/24/2019
B7202A,conference-call,100,50,7/24/2019
B96637,earnings,100,50,7/24/2019
B96637,earnings,100,50,7/24/2019
B96637,buybacks,100,74,7/24/2019
BA218A,legal-issues-defendant,100,22,7/24/2019
BA218A,legal-issues-defendant,100,22,7/24/2019
BAD9EA,merger,100,66,7/24/2019
BB88B6,earnings,100,50,7/24/2019
BC4876,dividend,100,50,7/24/2019
BE645B,orphan-drug-designation,100,76,7/24/2019
C05839,earnings,100,50,7/24/2019
C05839,earnings,100,50,7/24/2019
C05839,earnings,100,50,7/24/2019
C05839,earnings,100,50,7/24/2019
C05839,earnings,100,50,7/24/2019
C062D4,partnership,100,61,7/24/2019
C1114B,conference-call,100,50,7/24/2019
C38440,earnings,100,50,7/24/2019
C45CE7,earnings,100,50,7/24/2019
C624A1,earnings,100,50,7/24/2019
C624A1,earnings,100,50,7/24/2019
C97B2D,earnings,100,50,7/24/2019
C9B932,earnings,100,50,7/24/2019
C9B932,note-sale,100,52,7/24/2019
CA99D7,conference-call,100,50,7/24/2019
CB88B3,earnings,100,50,7/24/2019
CB9E13,conference-call,100,50,7/24/2019
CBA33B,earnings,100,50,7/24/2019
CCB623,earnings,100,50,7/24/2019
CCB623,conference-participant,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,earnings,100,50,7/24/2019
CD4DA8,conference-call,100,50,7/24/2019
CDAB24,conference-call,100,50,7/24/2019
CFE5BE,dividend,100,50,7/24/2019
CFF15D,dividend,100,50,7/24/2019
D0DFE5,earnings,100,50,7/24/2019
D1C26F,partnership,100,61,7/24/2019
D1C26F,partnership,100,61,7/24/2019
D21D8A,earnings-up,100,68,7/24/2019
D21D8A,earnings-up,100,68,7/24/2019
D21D8A,earnings-up,100,68,7/24/2019
D21D8A,earnings-up,100,68,7/24/2019
D21D8A,earnings-up,100,68,7/24/2019
D21D8A,earnings-up,100,68,7/24/2019
D21D8A,earnings-up,100,68,7/24/2019
D2B9E5,facility-open,100,65,7/24/2019
D33D8C,dividend,100,50,7/24/2019
D4463B,earnings,100,50,7/24/2019
D58A11,earnings,100,50,7/24/2019
D5A350,earnings,100,50,7/24/2019
D78CCD,earnings,100,50,7/24/2019
D78CCD,earnings,100,50,7/24/2019
D78CCD,earnings,100,50,7/24/2019
D78CCD,earnings,100,50,7/24/2019
D78CCD,earnings,100,50,7/24/2019
D78CCD,earnings,100,50,7/24/2019
D7A953,earnings,100,50,7/24/2019
D854DD,conference-participant,100,50,7/24/2019
D90F43,partnership,100,61,7/24/2019
D90F43,partnership,100,61,7/24/2019
D9C07E,earnings,100,50,7/24/2019
DA90E1,dividend,100,50,7/24/2019
DBB28E,investment-investor,100,55,7/24/2019
DC0998,earnings,100,50,7/24/2019
DC0998,earnings,100,50,7/24/2019
DC0998,earnings,100,50,7/24/2019
DC0998,earnings,100,50,7/24/2019
DCD97F,earnings,100,50,7/24/2019
DD3BB1,earnings,100,50,7/24/2019
DD7A96,earnings,100,50,7/24/2019
DDC415,earnings,100,50,7/24/2019
DF11D9,earnings,100,50,7/24/2019
DF6FDD,investment-investor,100,55,7/24/2019
E00373,conference-call,100,50,7/24/2019
E05026,conference-call,100,50,7/24/2019
E07573,dividend,100,50,7/24/2019
E5D914,earnings,100,50,7/24/2019
E5D914,earnings,100,50,7/24/2019
E6E012,dividend,100,50,7/24/2019
E6E012,dividend,100,50,7/24/2019
E6EDED,earnings,100,50,7/24/2019
E829E8,earnings,100,50,7/24/2019
E8846E,acquisition-acquiree,100,76,7/24/2019
E8E899,conference-participant,100,50,7/24/2019
E90C84,earnings,100,50,7/24/2019
EBD89A,business-contract,100,69,7/24/2019
ECD263,legal-issues-defendant,100,22,7/24/2019
ED9576,earnings,100,50,7/24/2019
F02170,award,100,58,7/24/2019
F0B2B5,conference-call,100,50,7/24/2019
F209B4,executive-appointment,100,54,7/24/2019
F24FF0,earnings,100,50,7/24/2019
F294DD,earnings,100,50,7/24/2019
F294DD,earnings,100,50,7/24/2019
F294DD,earnings,100,50,7/24/2019
F294DD,earnings,100,50,7/24/2019
F47871,legal-issues-defendant,100,22,7/24/2019
F72E4B,earnings,100,50,7/24/2019
F7902B,earnings,100,50,7/24/2019
F7902B,earnings,100,50,7/24/2019
F7FCA4,dividend-up,100,81,7/24/2019
FA918D,dividend,100,50,7/24/2019
FAE021,earnings,100,50,7/24/2019
FAE021,earnings,100,50,7/24/2019
FAE021,earnings,100,50,7/24/2019
FBDA0F,earnings,100,50,7/24/2019
FC1B7B,earnings,100,50,7/24/2019
FC4550,earnings,100,50,7/24/2019
FD2565,conference-call,100,50,7/24/2019
FD4E8D,revenues,100,50,7/24/2019
FD4E8D,revenues,100,50,7/24/2019
FD4E8D,revenues,100,50,7/24/2019
FDC7E6,conference-call,100,50,7/24/2019
FDC7E6,dividend,100,50,7/24/2019
FDC7E6,earnings,100,50,7/24/2019
FEE4B0,dividend,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FF4343,earnings,100,50,7/24/2019
FFAB4A,dividend,100,50,7/24/2019
9397,earnings,100,50,7/25/2019
0157B1,revenue-up,100,70,7/25/2019
0157B1,revenue-up,100,70,7/25/2019
0157B1,revenue-up,100,70,7/25/2019
0157B1,revenue-up,100,70,7/25/2019
0157B1,revenue-up,100,70,7/25/2019
0157B1,revenue-up,100,70,7/25/2019
01B8D6,conference-participant,100,50,7/25/2019
036C6F,earnings,100,50,7/25/2019
036C6F,earnings,100,50,7/25/2019
036C6F,earnings,100,50,7/25/2019
036C6F,earnings,100,50,7/25/2019
03B8CF,earnings,100,50,7/25/2019
03B8CF,earnings,100,50,7/25/2019
03B8CF,earnings,100,50,7/25/2019
03B8CF,earnings,100,50,7/25/2019
03B8CF,earnings,100,50,7/25/2019
51332,dividend,100,50,7/25/2019
55018,dividend,100,50,7/25/2019
61366,earnings,100,50,7/25/2019
07CA6A,earnings,100,50,7/25/2019
07CA6A,earnings,100,50,7/25/2019
0A0CF0,earnings,100,50,7/25/2019
0A0CF0,earnings,100,50,7/25/2019
0A0CF0,earnings,100,50,7/25/2019
0A0CF0,earnings,100,50,7/25/2019
0A0CF0,earnings,100,50,7/25/2019
0A7650,earnings-up,100,68,7/25/2019
0A77DB,conference-participant,100,50,7/25/2019
0A9D0A,earnings,100,50,7/25/2019
0B9E6F,earnings,100,50,7/25/2019
0BF198,conference-call,100,50,7/25/2019
0C136E,earnings,100,50,7/25/2019
0ED415,earnings,100,50,7/25/2019
0ED415,earnings,100,50,7/25/2019
0ED415,earnings,100,50,7/25/2019
0ED415,earnings,100,50,7/25/2019
0F04E5,earnings,100,50,7/25/2019
0F04E5,earnings,100,50,7/25/2019
0F04E5,earnings,100,50,7/25/2019
0F0693,earnings,100,50,7/25/2019
0FC848,earnings,100,50,7/25/2019
1080C0,earnings,100,50,7/25/2019
108FDA,earnings,100,50,7/25/2019
10943B,earnings,100,50,7/25/2019
1096C6,earnings,100,50,7/25/2019
119CB6,earnings-up,100,58,7/25/2019
1272B3,earnings,100,50,7/25/2019
129DC8,earnings,100,50,7/25/2019
129DC8,earnings,100,50,7/25/2019
129DC8,earnings,100,50,7/25/2019
138DDE,earnings,100,50,7/25/2019
13C3E0,earnings-positive,100,69,7/25/2019
156A99,earnings,100,50,7/25/2019
15789A,earnings,100,50,7/25/2019
159AE4,earnings,100,50,7/25/2019
159AE4,earnings,100,50,7/25/2019
168A5D,partnership,100,61,7/25/2019
1782D5,earnings,100,50,7/25/2019
1782D5,earnings,100,50,7/25/2019
1782D5,earnings,100,50,7/25/2019
1782D5,earnings,100,50,7/25/2019
1782D5,earnings,100,50,7/25/2019
1782D5,earnings,100,50,7/25/2019
1.79E+10,dividend,100,50,7/25/2019
1.79E+10,earnings,100,50,7/25/2019
17EDA5,stake-acquiree,100,62,7/25/2019
182B8C,earnings,100,50,7/25/2019
184866,earnings,100,50,7/25/2019
190B91,earnings,100,50,7/25/2019
190B91,earnings,100,50,7/25/2019
190B91,earnings,100,50,7/25/2019
190B91,earnings,100,50,7/25/2019
190B91,earnings,100,50,7/25/2019
1AF7E2,earnings,100,50,7/25/2019
1B4F31,market-entry,100,57,7/25/2019
1DB6A6,earnings,100,50,7/25/2019
1E68B3,executive-appointment,100,54,7/25/2019
1F08A6,executive-appointment,100,54,7/25/2019
1F2B5D,earnings,100,50,7/25/2019
1F2B5D,earnings,100,50,7/25/2019
1F2B5D,earnings,100,50,7/25/2019
1F2B5D,earnings,100,50,7/25/2019
1F2B5D,earnings,100,50,7/25/2019
1FAF22,earnings,100,50,7/25/2019
1FAF22,earnings,100,50,7/25/2019
1FAF22,earnings,100,50,7/25/2019
1FAF22,earnings,100,50,7/25/2019
1FAF22,earnings,100,50,7/25/2019
1FAF22,earnings,100,50,7/25/2019
200D8B,executive-appointment,100,54,7/25/2019
2031CE,conference-participant,100,50,7/25/2019
2082EA,conference-call,100,50,7/25/2019
20DC4E,earnings,100,50,7/25/2019
225CA2,product-release,100,64,7/25/2019
228D42,partnership,100,61,7/25/2019
24CB56,conference-organizer,100,57,7/25/2019
24FA23,earnings,100,50,7/25/2019
253B2F,conference-call,100,50,7/25/2019
25A6CC,earnings,100,50,7/25/2019
25A6CC,earnings,100,50,7/25/2019
25A6CC,earnings,100,50,7/25/2019
25A6CC,earnings,100,50,7/25/2019
2720AB,public-offering,100,43,7/25/2019
272472,earnings-up,100,68,7/25/2019
272472,earnings,100,50,7/25/2019
272472,earnings,100,50,7/25/2019
272472,earnings,100,50,7/25/2019
272472,earnings,100,50,7/25/2019
272472,earnings,100,50,7/25/2019
272472,earnings,100,50,7/25/2019
272704,dividend,100,50,7/25/2019
27A791,earnings,100,50,7/25/2019
284289,earnings,100,50,7/25/2019
28DCF3,earnings,100,50,7/25/2019
29B702,earnings,100,50,7/25/2019
2.90E+62,earnings,100,50,7/25/2019
2.90E+62,earnings,100,50,7/25/2019
2.90E+62,earnings,100,50,7/25/2019
2.90E+62,earnings,100,50,7/25/2019
2.90E+62,earnings,100,50,7/25/2019
2.90E+62,dividend,100,50,7/25/2019
2A17B1,earnings-up,100,68,7/25/2019
2A17B1,earnings-up,100,68,7/25/2019
2A17B1,earnings-up,100,68,7/25/2019
2AA6A8,clinical-trials-start,100,64,7/25/2019
2B9DBB,earnings,100,50,7/25/2019
2BDC1C,earnings,100,50,7/25/2019
2CB4C9,dividend,100,50,7/25/2019
2D485F,dividend-up,100,57,7/25/2019
2DA92D,earnings,100,50,7/25/2019
2F5256,dividend,100,50,7/25/2019
301493,conference-call,100,50,7/25/2019
30DFD3,earnings,100,50,7/25/2019
314D88,legal-issues-defendant,100,22,7/25/2019
31643A,facility-open,100,65,7/25/2019
319BE2,dividend,100,50,7/25/2019
319BE2,earnings,100,50,7/25/2019
31DB20,earnings,100,50,7/25/2019
31F25C,legal-issues-defendant,100,22,7/25/2019
31F25C,legal-issues-defendant,100,22,7/25/2019
31F25C,dividend,100,50,7/25/2019
31F25C,legal-issues-defendant,100,22,7/25/2019
328250,earnings,100,50,7/25/2019
349DA4,conference-participant,100,50,7/25/2019
366A08,earnings,100,50,7/25/2019
366A08,earnings,100,50,7/25/2019
366A08,earnings,100,50,7/25/2019
366A08,earnings,100,50,7/25/2019
366A08,earnings,100,50,7/25/2019
366A08,earnings,100,50,7/25/2019
371C01,earnings,100,50,7/25/2019
371C01,earnings,100,50,7/25/2019
3.88E+02,dividend,100,50,7/25/2019
39692D,earnings,100,50,7/25/2019
3A3948,earnings,100,50,7/25/2019
3A94DF,earnings-up,100,68,7/25/2019
3AAEAE,executive-appointment,100,54,7/25/2019
3B8484,earnings,100,50,7/25/2019
3CBA2A,earnings,100,50,7/25/2019
3CBA2A,earnings,100,50,7/25/2019
3CBA2A,earnings,100,50,7/25/2019
3CBA2A,earnings,100,50,7/25/2019
3CBA2A,earnings,100,50,7/25/2019
3CBA2A,earnings,100,50,7/25/2019
3CBA2A,earnings,100,50,7/25/2019
3CCC90,business-contract,100,69,7/25/2019
3DE4D1,partnership,100,61,7/25/2019
3E15F6,earnings,100,50,7/25/2019
3E15F6,earnings,100,50,7/25/2019
3E15F6,earnings,100,50,7/25/2019
3E15F6,earnings,100,50,7/25/2019
3F4497,earnings,100,50,7/25/2019
3F6A9C,partnership,100,61,7/25/2019
401072,earnings,100,50,7/25/2019
416C55,earnings,100,50,7/25/2019
429BFB,conference-participant,100,50,7/25/2019
434F38,earnings,100,50,7/25/2019
435ACE,dividend,100,50,7/25/2019
43E8F5,earnings,100,50,7/25/2019
43F4A8,ipo-pricing,100,50,7/25/2019
442587,partnership,100,61,7/25/2019
44740A,earnings,100,50,7/25/2019
449217,earnings-positive,100,69,7/25/2019
449217,earnings,100,50,7/25/2019
449217,earnings,100,50,7/25/2019
449217,earnings,100,50,7/25/2019
449217,earnings,100,50,7/25/2019
449217,earnings,100,50,7/25/2019
453282,earnings-per-share-positive,100,69,7/25/2019
4595EF,earnings,100,50,7/25/2019
46CF27,earnings,100,50,7/25/2019
46CF27,earnings,100,50,7/25/2019
46CF27,earnings,100,50,7/25/2019
46CF27,earnings,100,50,7/25/2019
46CF27,earnings,100,50,7/25/2019
46CF27,earnings,100,50,7/25/2019
46CF27,earnings,100,50,7/25/2019
46CF27,earnings,100,50,7/25/2019
479930,earnings,100,50,7/25/2019
47BA98,acquisition-acquirer,100,49,7/25/2019
47BA98,earnings,100,50,7/25/2019
4A3438,conference-call,100,50,7/25/2019
4A5C8D,facility-open,100,65,7/25/2019
4BD6DB,earnings,100,50,7/25/2019
4C6C63,partnership,100,61,7/25/2019
4DD09F,executive-appointment,100,54,7/25/2019
4DD203,conference-call,100,50,7/25/2019
4EE167,earnings,100,50,7/25/2019
5088A5,unit-acquisition-acquiree,100,76,7/25/2019
53A226,earnings,100,50,7/25/2019
54B889,conference-participant,100,50,7/25/2019
54DF47,conference-call,100,50,7/25/2019
55438C,partnership,100,61,7/25/2019
55438C,partnership,100,61,7/25/2019
5546DA,earnings-per-share-positive,100,69,7/25/2019
5546DA,earnings-per-share-positive,100,69,7/25/2019
5546DA,earnings-per-share-positive,100,69,7/25/2019
5546DA,earnings-per-share-positive,100,69,7/25/2019
556A57,dividend,100,50,7/25/2019
564F3E,earnings,100,50,7/25/2019
567F3D,earnings,100,50,7/25/2019
567F3D,earnings,100,50,7/25/2019
567F3D,earnings,100,50,7/25/2019
567F3D,earnings,100,50,7/25/2019
57356F,earnings,100,50,7/25/2019
57356F,earnings,100,50,7/25/2019
57356F,earnings,100,50,7/25/2019
57B174,earnings,100,50,7/25/2019
57B174,earnings,100,50,7/25/2019
57B174,earnings,100,50,7/25/2019
57B174,earnings,100,50,7/25/2019
57DDB9,conference-call,100,50,7/25/2019
57DDB9,earnings,100,50,7/25/2019
586BD7,conference-call,100,50,7/25/2019
589F5A,earnings,100,50,7/25/2019
5968F9,earnings,100,50,7/25/2019
59B229,earnings,100,50,7/25/2019
59B229,earnings,100,50,7/25/2019
59B229,earnings,100,50,7/25/2019
59B229,earnings,100,50,7/25/2019
59DB8C,earnings,100,50,7/25/2019
5A53BF,regulatory-product-approval-granted,100,81,7/25/2019
5B3FA2,conference-participant,100,50,7/25/2019
5B97B2,conference-participant,100,50,7/25/2019
5D0337,earnings,100,50,7/25/2019
5D1329,conference-call,100,50,7/25/2019
5D16CF,earnings,100,50,7/25/2019
5D1956,conference-participant,100,50,7/25/2019
5D1956,earnings,100,50,7/25/2019
5E6959,earnings-up,100,68,7/25/2019
5FE4B6,earnings,100,50,7/25/2019
5FE4B6,earnings,100,50,7/25/2019
616E3B,earnings,100,50,7/25/2019
616E3B,earnings,100,50,7/25/2019
622037,dividend,100,50,7/25/2019
62CDDE,conference-call,100,50,7/25/2019
63E8D5,earnings,100,50,7/25/2019
641F17,earnings,100,50,7/25/2019
641F17,earnings,100,50,7/25/2019
641F17,earnings,100,50,7/25/2019
641F17,earnings,100,50,7/25/2019
641F17,earnings,100,50,7/25/2019
641F17,earnings,100,50,7/25/2019
65CF8E,dividend-up,100,81,7/25/2019
65CF8E,dividend-up,100,81,7/25/2019
67A658,buybacks,100,74,7/25/2019
67B052,fundraising,100,64,7/25/2019
68586A,conference-call,100,50,7/25/2019
68E3E0,conference-call,100,50,7/25/2019
69E8E1,earnings,100,50,7/25/2019
69E8E1,earnings,100,50,7/25/2019
69E8E1,earnings,100,50,7/25/2019
69E8E1,earnings,100,50,7/25/2019
69E8E1,earnings,100,50,7/25/2019
6ACFBF,earnings,100,50,7/25/2019
6CDFC6,earnings,100,50,7/25/2019
6DC1D7,earnings,100,50,7/25/2019
6E8349,earnings,100,50,7/25/2019
71B0CF,earnings,100,50,7/25/2019
722DE3,index-listing,100,76,7/25/2019
724F84,earnings,100,50,7/25/2019
726DDF,acquisition-acquirer,100,49,7/25/2019
726DDF,unit-acquisition-acquirer,100,49,7/25/2019
726DDF,acquisition-acquirer,100,49,7/25/2019
72CB93,earnings,100,50,7/25/2019
735388,earnings,100,50,7/25/2019
73C9E2,earnings,100,50,7/25/2019
7448A3,earnings,100,50,7/25/2019
748EB6,ipo-pricing,100,50,7/25/2019
762A3E,dividend,100,50,7/25/2019
76CEFB,earnings,100,50,7/25/2019
76DD0C,executive-appointment,100,54,7/25/2019
76F067,earnings,100,50,7/25/2019
773A17,revenue-up,100,63,7/25/2019
773A17,revenue-up,100,69,7/25/2019
773A17,revenue-up,100,69,7/25/2019
77B8E9,executive-appointment,100,54,7/25/2019
791D59,earnings,100,50,7/25/2019
791D59,earnings,100,50,7/25/2019
791D59,earnings,100,50,7/25/2019
791D59,earnings,100,50,7/25/2019
791D59,earnings,100,50,7/25/2019
791EC1,unit-acquisition-acquirer,100,49,7/25/2019
7A5D58,earnings,100,50,7/25/2019
7AB859,business-contract,100,69,7/25/2019
7B0BA6,dividend,100,50,7/25/2019
7B1156,conference-call,100,50,7/25/2019
7BAAE7,earnings-per-share-positive,100,69,7/25/2019
7BAAE7,earnings,100,50,7/25/2019
7C4F43,earnings,100,50,7/25/2019
7CBC40,earnings,100,50,7/25/2019
7CBC40,earnings,100,50,7/25/2019
7CBC40,earnings,100,50,7/25/2019
7CBC40,earnings,100,50,7/25/2019
7D5384,earnings,100,50,7/25/2019
7D5384,earnings,100,50,7/25/2019
7D5384,earnings,100,50,7/25/2019
7D5384,earnings,100,50,7/25/2019
7DC1C4,earnings,100,50,7/25/2019
7E0EB0,earnings,100,50,7/25/2019
7F9984,conference-participant,100,50,7/25/2019
805CD8,conference-call,100,50,7/25/2019
80C400,earnings,100,50,7/25/2019
80D744,earnings,100,50,7/25/2019
81A88D,earnings,100,50,7/25/2019
8.10E+205,conference-call,100,50,7/25/2019
8.22E+27,earnings,100,50,7/25/2019
82F088,conference-participant,100,50,7/25/2019
83598E,dividend,100,50,7/25/2019
837C04,earnings-positive,100,69,7/25/2019
837C04,earnings,100,50,7/25/2019
837C04,earnings,100,50,7/25/2019
837C04,earnings,100,50,7/25/2019
837C04,earnings,100,50,7/25/2019
837C04,earnings,100,50,7/25/2019
837C04,earnings,100,50,7/25/2019
837C04,dividend,100,50,7/25/2019
84920B,earnings,100,50,7/25/2019
859D62,executive-appointment,100,54,7/25/2019
860AB6,dividend,100,50,7/25/2019
860AB6,dividend,100,50,7/25/2019
86AA9C,conference-call,100,50,7/25/2019
8817D5,earnings,100,50,7/25/2019
895D56,conference-participant,100,50,7/25/2019
89F693,executive-appointment,100,54,7/25/2019
8B3B0E,earnings,100,50,7/25/2019
8B4A45,facility-open,100,65,7/25/2019
8C1238,conference-call,100,50,7/25/2019
8D5145,earnings,100,50,7/25/2019
8DA42F,conference-call,100,50,7/25/2019
8DCF18,conference-participant,100,50,7/25/2019
8DE74B,earnings-up,100,68,7/25/2019
8E0E32,earnings,100,50,7/25/2019
8E4250,earnings,100,50,7/25/2019
8E8E6E,earnings,100,50,7/25/2019
8F3231,earnings,100,50,7/25/2019
8F3BCC,conference-call,100,50,7/25/2019
8F3BCC,earnings-per-share-positive,100,69,7/25/2019
9043FE,earnings,100,50,7/25/2019
9043FE,earnings,100,50,7/25/2019
911AB8,earnings,100,50,7/25/2019
922F0C,earnings-per-share-up,100,54,7/25/2019
93C130,earnings,100,50,7/25/2019
93C130,dividend,100,50,7/25/2019
943239,earnings,100,50,7/25/2019
944B2E,earnings,100,50,7/25/2019
94563D,legal-issues-defendant,100,22,7/25/2019
94563D,earnings,100,50,7/25/2019
94563D,earnings,100,50,7/25/2019
94563D,earnings,100,50,7/25/2019
94563D,earnings,100,50,7/25/2019
94637C,earnings,100,50,7/25/2019
94756D,earnings,100,50,7/25/2019
98CEBB,conference-participant,100,50,7/25/2019
990AD0,executive-appointment,100,54,7/25/2019
990AD0,dividend,100,50,7/25/2019
9.97E+09,earnings,100,50,7/25/2019
99ACAD,dividend,100,50,7/25/2019
9C25FF,earnings,100,50,7/25/2019
9CF9B1,earnings,100,50,7/25/2019
9DDE1B,earnings,100,50,7/25/2019
9E298A,dividend,100,50,7/25/2019
9F03CF,earnings,100,50,7/25/2019
9F03CF,dividend,100,50,7/25/2019
9F6B1A,earnings,100,50,7/25/2019
9F6B1A,earnings,100,50,7/25/2019
9F6B1A,earnings,100,50,7/25/2019
9F6B1A,earnings,100,50,7/25/2019
9FB4B7,earnings,100,50,7/25/2019
A02FB1,earnings,100,50,7/25/2019
A1BB98,earnings,100,50,7/25/2019
A204A7,earnings,100,50,7/25/2019
A433A5,earnings,100,50,7/25/2019
A4386C,dividend,100,50,7/25/2019
A5151E,earnings,100,50,7/25/2019
A5B913,earnings,100,50,7/25/2019
A5B913,earnings,100,50,7/25/2019
A5B913,earnings,100,50,7/25/2019
A6828A,clinical-trials,100,56,7/25/2019
A6FE1C,unit-acquisition-acquirer,100,49,7/25/2019
A806FA,dividend,100,50,7/25/2019
A94637,revenues,100,50,7/25/2019
A99576,earnings,100,50,7/25/2019
AA09AD,earnings,100,50,7/25/2019
AADE0B,earnings,100,50,7/25/2019
AB4A7E,conference-call,100,50,7/25/2019
AB7F05,earnings-up,100,68,7/25/2019
ABBAD1,earnings,100,50,7/25/2019
ABEE43,earnings-per-share-positive,100,69,7/25/2019
ABEE43,earnings-per-share-positive,100,69,7/25/2019
ABEE43,earnings-per-share-positive,100,69,7/25/2019
ABEE43,earnings-per-share-positive,100,69,7/25/2019
ABEE43,earnings-per-share-positive,100,69,7/25/2019
AC1952,earnings,100,50,7/25/2019
AC1952,buybacks,100,74,7/25/2019
AC3584,earnings,100,50,7/25/2019
AC642C,earnings,100,50,7/25/2019
AC642C,earnings,100,50,7/25/2019
AD3C93,earnings,100,50,7/25/2019
AFD1CA,earnings,100,50,7/25/2019
B076A1,conference-call,100,50,7/25/2019
B0B969,earnings,100,50,7/25/2019
B1B10C,earnings,100,50,7/25/2019
B1B10C,earnings,100,50,7/25/2019
B1B10C,earnings,100,50,7/25/2019
B1B10C,earnings,100,50,7/25/2019
B381D8,earnings,100,50,7/25/2019
B446B8,earnings,100,50,7/25/2019
B446B8,earnings,100,50,7/25/2019
B446B8,earnings,100,50,7/25/2019
B4C673,executive-appointment,100,54,7/25/2019
B4F5F4,conference-call,100,50,7/25/2019
B619CB,earnings-positive,100,69,7/25/2019
B7BBFF,conference-call,100,50,7/25/2019
B83BCE,earnings,100,50,7/25/2019
BA218A,legal-issues-defendant,100,22,7/25/2019
BA218A,legal-issues-defendant,100,22,7/25/2019
BA218A,legal-issues-defendant,100,22,7/25/2019
BA218A,legal-issues-defendant,100,22,7/25/2019
BA218A,legal-issues-defendant,100,22,7/25/2019
BB0787,campaign-ad-release,100,59,7/25/2019
BC3AD2,earnings,100,50,7/25/2019
BC3AD2,earnings,100,50,7/25/2019
BC3AD2,earnings,100,50,7/25/2019
BC3AD2,earnings,100,50,7/25/2019
BC3AD2,earnings,100,50,7/25/2019
BC3AD2,earnings,100,50,7/25/2019
BC3AD2,earnings,100,50,7/25/2019
BC3AD2,earnings,100,50,7/25/2019
BCC55F,business-contract,100,69,7/25/2019
BCC55F,conference-participant,100,50,7/25/2019
BCE9DA,earnings,100,50,7/25/2019
BCE9DA,earnings,100,50,7/25/2019
BD682F,earnings,100,50,7/25/2019
BDEF34,earnings,100,50,7/25/2019
BDEF34,earnings,100,50,7/25/2019
BDEF34,earnings,100,50,7/25/2019
BDEF34,earnings,100,50,7/25/2019
BDEF34,earnings,100,50,7/25/2019
BDEF34,earnings,100,50,7/25/2019
BDEF34,earnings,100,50,7/25/2019
BE379D,earnings,100,50,7/25/2019
BEB756,earnings,100,50,7/25/2019
BF79F5,earnings,100,50,7/25/2019
BF79F5,earnings,100,50,7/25/2019
BF79F5,earnings,100,50,7/25/2019
BFD0A7,conference-call,100,50,7/25/2019
C0030A,earnings-positive,100,69,7/25/2019
C0030A,earnings,100,50,7/25/2019
C0030A,earnings,100,50,7/25/2019
C0030A,earnings,100,50,7/25/2019
C0030A,earnings,100,50,7/25/2019
C01737,earnings,100,50,7/25/2019
C062D4,dividend,100,50,7/25/2019
C16A8F,dividend,100,50,7/25/2019
C1CBA4,earnings-positive,100,69,7/25/2019
C1CBA4,earnings-positive,100,69,7/25/2019
C1CBA4,earnings-positive,100,69,7/25/2019
C1CBA4,earnings-positive,100,69,7/25/2019
C1CBA4,earnings-positive,100,69,7/25/2019
C1CBA4,earnings-positive,100,69,7/25/2019
C1CBA4,earnings-positive,100,69,7/25/2019
C1CBA4,earnings-positive,100,69,7/25/2019
C58D71,public-offering,100,43,7/25/2019
C5D2AE,earnings,100,50,7/25/2019
C81E00,operating-earnings,100,50,7/25/2019
C81E00,operating-earnings,100,50,7/25/2019
C8257F,executive-appointment,100,54,7/25/2019
C83B88,earnings,100,50,7/25/2019
C83B88,earnings,100,50,7/25/2019
C83B88,earnings,100,50,7/25/2019
C83B88,earnings,100,50,7/25/2019
C83B88,earnings,100,50,7/25/2019
C83B88,earnings,100,50,7/25/2019
C83B88,earnings,100,50,7/25/2019
C83B88,dividend,100,50,7/25/2019
C8A248,earnings,100,50,7/25/2019
C8FAC7,earnings,100,50,7/25/2019
C8FAC7,earnings,100,50,7/25/2019
C97B2D,conference-participant,100,50,7/25/2019
C98CDB,award,100,58,7/25/2019
C99CC8,business-contract,100,69,7/25/2019
C9E107,earnings-per-share-positive,100,69,7/25/2019
C9E4EC,earnings,100,50,7/25/2019
CB22CD,earnings,100,50,7/25/2019
CB89EA,conference-participant,100,50,7/25/2019
CBCC6A,conference-organizer,100,57,7/25/2019
CC3EC4,earnings,100,50,7/25/2019
CDC817,earnings,100,50,7/25/2019
CDEDFE,earnings,100,50,7/25/2019
CE8251,executive-appointment,100,54,7/25/2019
CE8251,executive-appointment,100,54,7/25/2019
CF6A5A,earnings,100,50,7/25/2019
CFF15D,partnership,100,61,7/25/2019
CFF57D,executive-appointment,100,54,7/25/2019
D1344A,earnings,100,50,7/25/2019
D15833,dividend,100,50,7/25/2019
D1C26F,public-offering,100,43,7/25/2019
D33D8C,unit-acquisition-acquirer,100,49,7/25/2019
D33D8C,unit-acquisition-acquirer,100,49,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D3F64D,earnings,100,50,7/25/2019
D4070C,earnings,100,50,7/25/2019
D518D8,revenues,100,50,7/25/2019
D518D8,earnings,100,50,7/25/2019
D518D8,earnings,100,50,7/25/2019
D518D8,earnings,100,50,7/25/2019
D518D8,earnings,100,50,7/25/2019
D78BF1,earnings,100,50,7/25/2019
D82EF3,product-release,100,64,7/25/2019
D8442A,stake-acquirer,100,48,7/25/2019
D8F347,dividend-up,100,60,7/25/2019
D96202,earnings,100,50,7/25/2019
D96202,dividend-up,100,81,7/25/2019
D9B1C9,earnings,100,50,7/25/2019
D9B1C9,earnings,100,50,7/25/2019
D9B1C9,earnings,100,50,7/25/2019
DA90E1,earnings,100,50,7/25/2019
DB396B,earnings,100,50,7/25/2019
DB396B,earnings,100,50,7/25/2019
DB396B,earnings,100,50,7/25/2019
DB396B,dividend,100,50,7/25/2019
DBCA3F,earnings,100,50,7/25/2019
DC1405,executive-appointment,100,54,7/25/2019
DC5299,operating-earnings,100,50,7/25/2019
DD0099,earnings-up,100,68,7/25/2019
DD0F15,earnings,100,50,7/25/2019
DD1BA1,earnings,100,50,7/25/2019
DD3BB1,regulatory-investigation,100,22,7/25/2019
DF18E6,conference-call,100,50,7/25/2019
DF6FDD,earnings,100,50,7/25/2019
E05DC8,earnings,100,50,7/25/2019
E10D31,earnings,100,50,7/25/2019
E1BD05,revenue-up,100,75,7/25/2019
E1BD05,revenue-up,100,75,7/25/2019
E28D9C,conference-call,100,50,7/25/2019
E4CE73,partnership,100,61,7/25/2019
E5752F,earnings,100,50,7/25/2019
E68C3D,earnings,100,50,7/25/2019
E866D2,revenues,100,50,7/25/2019
E866D2,revenues,100,50,7/25/2019
E866D2,revenues,100,50,7/25/2019
E866D2,revenues,100,50,7/25/2019
E866D2,revenues,100,50,7/25/2019
E866D2,revenues,100,50,7/25/2019
E8A49A,executive-appointment,100,54,7/25/2019
E8B21D,earnings,100,50,7/25/2019
E8B21D,earnings,100,50,7/25/2019
E8B21D,earnings,100,50,7/25/2019
E8B21D,earnings,100,50,7/25/2019
E8B21D,earnings,100,50,7/25/2019
E99180,earnings,100,50,7/25/2019
EBC84C,earnings,100,50,7/25/2019
EBC84C,earnings,100,50,7/25/2019
EBC84C,earnings,100,50,7/25/2019
EBC84C,earnings,100,50,7/25/2019
EBC84C,earnings,100,50,7/25/2019
EBC84C,earnings,100,50,7/25/2019
EC99D0,earnings,100,50,7/25/2019
ED0D7C,earnings,100,50,7/25/2019
ED0D7C,earnings,100,50,7/25/2019
ED0D7C,earnings,100,50,7/25/2019
ED0D7C,earnings,100,50,7/25/2019
ED0D7C,earnings,100,50,7/25/2019
ED2EFD,dividend,100,50,7/25/2019
ED79D9,conference-call,100,50,7/25/2019
ED8676,earnings,100,50,7/25/2019
ED8676,dividend,100,50,7/25/2019
EDF5CA,dividend,100,50,7/25/2019
F0027C,earnings,100,50,7/25/2019
F02D0A,dividend,100,50,7/25/2019
F04E05,earnings,100,50,7/25/2019
F0B2B5,product-release,100,64,7/25/2019
F0B877,earnings,100,50,7/25/2019
F31B13,dividend-up,100,72,7/25/2019
F47871,legal-issues-defendant,100,22,7/25/2019
F47871,legal-issues-defendant,100,22,7/25/2019
F4E882,earnings,100,50,7/25/2019
F5D499,product-release,100,64,7/25/2019
F793FA,earnings,100,50,7/25/2019
F80389,earnings,100,50,7/25/2019
F88A04,earnings,100,50,7/25/2019
FA918D,earnings,100,50,7/25/2019
FA918D,earnings,100,50,7/25/2019
FAB97A,executive-appointment,100,54,7/25/2019
FADF1A,conference-call,100,50,7/25/2019
FC1F9D,earnings,100,50,7/25/2019
FC80E6,earnings,100,50,7/25/2019
FD4BBE,earnings,100,50,7/25/2019
FD4BBE,earnings,100,50,7/25/2019
FD4BBE,earnings,100,50,7/25/2019
FD4BBE,earnings,100,50,7/25/2019
FD9526,earnings-guidance-up,100,83,7/25/2019
FF6644,conference-participant,100,50,7/25/2019
034B61,partnership,100,61,7/26/2019
55018,partnership,100,61,7/26/2019
075CF7,earnings,100,50,7/26/2019
95294,earnings,100,50,7/26/2019
0986B5,earnings,100,50,7/26/2019
0FDE97,earnings,100,50,7/26/2019
0FDE97,earnings,100,50,7/26/2019
0FDE97,earnings,100,50,7/26/2019
0FDE97,earnings,100,50,7/26/2019
0FDE97,earnings,100,50,7/26/2019
0FDE97,earnings,100,50,7/26/2019
0FDE97,earnings,100,50,7/26/2019
10AE08,earnings,100,50,7/26/2019
129DC8,conference-participant,100,50,7/26/2019
139303,earnings,100,50,7/26/2019
156A99,executive-resignation,100,44,7/26/2019
16B882,earnings,100,50,7/26/2019
1866B2,note-sale,100,52,7/26/2019
19C105,earnings,100,50,7/26/2019
19C105,earnings,100,50,7/26/2019
19C105,earnings,100,50,7/26/2019
19C105,dividend,100,50,7/26/2019
1BC12C,business-contract,100,69,7/26/2019
1CF3A8,conference-call,100,50,7/26/2019
1DF15D,earnings,100,50,7/26/2019
1DF15D,earnings,100,50,7/26/2019
1DF15D,earnings,100,50,7/26/2019
1DF15D,earnings,100,50,7/26/2019
1EC3E8,earnings,100,50,7/26/2019
2491BC,earnings,100,50,7/26/2019
2491BC,earnings,100,50,7/26/2019
2491BC,earnings,100,50,7/26/2019
2491BC,earnings,100,50,7/26/2019
272472,dividend,100,50,7/26/2019
28F905,conference-call,100,50,7/26/2019
2D643C,dividend-up,100,59,7/26/2019
2DDB22,earnings,100,50,7/26/2019
2DDB22,executive-appointment,100,54,7/26/2019
2F6782,dividend,100,50,7/26/2019
314D88,legal-issues-defendant,100,22,7/26/2019
31DB20,earnings,100,50,7/26/2019
31F25C,legal-issues-defendant,100,22,7/26/2019
31F25C,buybacks,100,74,7/26/2019
338544,earnings,100,50,7/26/2019
341759,private-placement,100,56,7/26/2019
353DBB,earnings,100,50,7/26/2019
353DBB,earnings,100,50,7/26/2019
353DBB,earnings,100,50,7/26/2019
383ADA,earnings,100,50,7/26/2019
3.88E+02,earnings,100,50,7/26/2019
39692D,acquisition-acquirer,100,49,7/26/2019
3E39A5,dividend,100,50,7/26/2019
3FACA7,earnings-positive,100,69,7/26/2019
3FACA7,earnings,100,50,7/26/2019
3FACA7,earnings,100,50,7/26/2019
3FACA7,earnings,100,50,7/26/2019
460C93,earnings,100,50,7/26/2019
492117,earnings,100,50,7/26/2019
4A2457,conference-participant,100,50,7/26/2019
4A6F00,partnership,100,61,7/26/2019
4D203E,conference-participant,100,50,7/26/2019
4D229C,earnings,100,50,7/26/2019
4D371E,dividend,100,50,7/26/2019
4E5784,legal-issues-defendant,100,22,7/26/2019
514067,legal-issues-defendant,100,22,7/26/2019
51888A,business-contract-terminated,100,31,7/26/2019
54F271,earnings,100,50,7/26/2019
56277A,earnings,100,50,7/26/2019
562853,earnings,100,50,7/26/2019
57DDB9,conference-call,100,50,7/26/2019
57EF50,dividend,100,50,7/26/2019
587D25,note-sale,100,52,7/26/2019
5BE42C,executive-appointment,100,54,7/26/2019
5EF130,executive-appointment,100,54,7/26/2019
619882,conference-organizer,100,57,7/26/2019
619882,partnership,100,61,7/26/2019
6284B5,dividend,100,50,7/26/2019
63E8D5,buybacks,100,74,7/26/2019
665D7D,earnings,100,50,7/26/2019
68BA15,acquisition-acquirer,100,49,7/26/2019
69CE71,conference-call,100,50,7/26/2019
6E7060,dividend,100,50,7/26/2019
7032D0,earnings,100,50,7/26/2019
72EF75,dividend,100,50,7/26/2019
762A3E,earnings,100,50,7/26/2019
7999F3,executive-appointment,100,54,7/26/2019
7999F3,executive-appointment,100,54,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7999F3,earnings,100,50,7/26/2019
7B4B91,earnings,100,50,7/26/2019
7FC386,earnings,100,50,7/26/2019
7FDE1C,conference-call,100,50,7/26/2019
81EAD4,operating-earnings,100,50,7/26/2019
82FD6D,executive-appointment,100,54,7/26/2019
877C0C,legal-issues-defendant,100,22,7/26/2019
885758,legal-issues-defendant,100,22,7/26/2019
8B2C4A,earnings,100,50,7/26/2019
8B2C4A,earnings,100,50,7/26/2019
8B2C4A,earnings,100,50,7/26/2019
8B2C4A,earnings,100,50,7/26/2019
8B2C4A,earnings,100,50,7/26/2019
8B2C4A,earnings,100,50,7/26/2019
8B2C4A,earnings,100,50,7/26/2019
8B2C4A,earnings,100,50,7/26/2019
8E4F9A,executive-appointment,100,54,7/26/2019
8FCA78,acquisition-acquirer,100,49,7/26/2019
934029,public-offering,100,43,7/26/2019
94637C,regulatory-product-approval-granted,100,81,7/26/2019
9.54E+32,earnings,100,50,7/26/2019
9.54E+32,earnings,100,50,7/26/2019
97B027,dividend,100,50,7/26/2019
9AF3DC,product-release,100,64,7/26/2019
9AF3DC,dividend,100,50,7/26/2019
9C5BA5,earnings,100,50,7/26/2019
9D2790,dividend,100,50,7/26/2019
9D6A24,dividend,100,50,7/26/2019
9EED50,buybacks,100,74,7/26/2019
9EED50,earnings,100,50,7/26/2019
A28675,earnings,100,50,7/26/2019
A2CA3F,dividend,100,50,7/26/2019
A5E715,conference-participant,100,50,7/26/2019
A6828A,clinical-trials-positive,100,87,7/26/2019
AD375D,earnings,100,50,7/26/2019
B1A85D,earnings,100,50,7/26/2019
BA218A,legal-issues-defendant,100,22,7/26/2019
BA218A,legal-issues-defendant,100,22,7/26/2019
BAD9EA,merger,100,66,7/26/2019
C1CBA4,dividend,100,50,7/26/2019
C58D71,public-offering,100,43,7/26/2019
C8FAC7,legal-issues-defendant,100,22,7/26/2019
C9C62A,earnings,100,50,7/26/2019
CBB77B,executive-appointment,100,54,7/26/2019
CBCC6A,earnings,100,50,7/26/2019
CBCC6A,earnings,100,50,7/26/2019
CBCC6A,buybacks,100,74,7/26/2019
CBCC6A,buybacks,100,74,7/26/2019
CC35BE,earnings,100,50,7/26/2019
CDAF5B,debt-restructuring,100,59,7/26/2019
D1C26F,earnings,100,50,7/26/2019
D7F569,dividend,100,50,7/26/2019
D7F569,earnings,100,50,7/26/2019
D88EF3,earnings,100,50,7/26/2019
D88EF3,earnings,100,50,7/26/2019
D88EF3,earnings,100,50,7/26/2019
D88EF3,earnings,100,50,7/26/2019
D88EF3,earnings,100,50,7/26/2019
D88EF3,earnings,100,50,7/26/2019
DA0A9E,earnings,100,50,7/26/2019
DAFED3,earnings,100,50,7/26/2019
DAFED3,earnings,100,50,7/26/2019
DAFED3,earnings,100,50,7/26/2019
DAFED3,earnings,100,50,7/26/2019
DBEF02,earnings,100,50,7/26/2019
DE4924,conference-call,100,50,7/26/2019
DE5611,dividend,100,50,7/26/2019
E0207A,executive-appointment,100,54,7/26/2019
E1BD05,executive-appointment,100,54,7/26/2019
E40FB6,earnings,100,50,7/26/2019
E40FB6,earnings,100,50,7/26/2019
E40FB6,earnings,100,50,7/26/2019
E40FB6,earnings,100,50,7/26/2019
E40FB6,earnings,100,50,7/26/2019
E5F0A8,earnings-positive,100,69,7/26/2019
E5F0A8,earnings,100,50,7/26/2019
E5F0A8,earnings,100,50,7/26/2019
E5F0A8,earnings,100,50,7/26/2019
E61888,conference-call,100,50,7/26/2019
E8D221,earnings,100,50,7/26/2019
EA4E68,earnings,100,50,7/26/2019
EB6965,earnings,100,50,7/26/2019
EB6965,earnings,100,50,7/26/2019
EB6965,earnings,100,50,7/26/2019
EB6965,earnings,100,50,7/26/2019
EB6965,earnings,100,50,7/26/2019
EB6965,earnings,100,50,7/26/2019
F2526D,earnings,100,50,7/26/2019
F47871,legal-issues-defendant,100,22,7/26/2019
F47871,legal-issues-defendant,100,22,7/26/2019
F47871,legal-issues-defendant,100,22,7/26/2019
FB7724,earnings,100,50,7/26/2019
FD0CA4,dividend,100,50,7/26/2019
FD9A97,earnings,100,50,7/26/2019
FDF799,legal-issues-defendant,100,22,7/26/2019
FF4BA4,earnings,100,50,7/26/2019
FF4BA4,earnings,100,50,7/26/2019
FF4BA4,earnings,100,50,7/26/2019
FF4BA4,earnings,100,50,7/26/2019
FF4BA4,earnings,100,50,7/26/2019
FF4BA4,earnings,100,50,7/26/2019
FF6644,dividend,100,50,7/26/2019
FFCD0E,conference-call,100,50,7/26/2019
A8E72A,clinical-trials,100,56,7/27/2019
AA09AD,legal-issues-defendant,100,22,7/27/2019
BA218A,legal-issues-defendant,100,22,7/27/2019
A6213D,award,100,58,7/28/2019
01478A,earnings,100,50,7/29/2019
02870F,earnings,100,50,7/29/2019
02870F,earnings,100,50,7/29/2019
02870F,earnings,100,50,7/29/2019
02870F,earnings,100,50,7/29/2019
02FC1A,legal-issues-defendant,100,22,7/29/2019
03B8CF,settlement,100,56,7/29/2019
03B8CF,legal-issues-defendant,100,22,7/29/2019
04EB2F,earnings,100,50,7/29/2019
054E7E,conference-participant,100,50,7/29/2019
06EE79,earnings,100,50,7/29/2019
095A04,earnings,100,50,7/29/2019
0A6824,dividend,100,50,7/29/2019
0B400D,earnings,100,50,7/29/2019
0BD4E8,earnings,100,50,7/29/2019
0C6293,conference-call,100,50,7/29/2019
0DBB81,earnings,100,50,7/29/2019
102F04,business-contract,100,69,7/29/2019
108A2B,operating-earnings,100,50,7/29/2019
15B10D,conference-call,100,50,7/29/2019
18EC17,executive-appointment,100,54,7/29/2019
190B91,conference-call,100,50,7/29/2019
197612,earnings,100,50,7/29/2019
197612,earnings,100,50,7/29/2019
197612,earnings,100,50,7/29/2019
197612,earnings,100,50,7/29/2019
197612,earnings,100,50,7/29/2019
197612,earnings,100,50,7/29/2019
197612,earnings,100,50,7/29/2019
1BDB2A,conference-participant,100,50,7/29/2019
1DDEDA,earnings,100,50,7/29/2019
1E68B3,earnings,100,50,7/29/2019
1EBF8D,regulatory-product-review-positive,100,73,7/29/2019
20DC4E,dividend,100,50,7/29/2019
222BF9,earnings,100,50,7/29/2019
2491BC,executive-appointment,100,54,7/29/2019
24CB56,conference-organizer,100,57,7/29/2019
267718,earnings,100,50,7/29/2019
267718,earnings,100,50,7/29/2019
267718,earnings,100,50,7/29/2019
267718,earnings,100,50,7/29/2019
267718,earnings,100,50,7/29/2019
267718,earnings,100,50,7/29/2019
267718,earnings,100,50,7/29/2019
267718,earnings,100,50,7/29/2019
267718,conference-call,100,50,7/29/2019
26D8ED,executive-appointment,100,54,7/29/2019
28DCF3,conference-participant,100,50,7/29/2019
29B702,conference-participant,100,50,7/29/2019
2D5011,earnings,100,50,7/29/2019
2F6782,earnings,100,50,7/29/2019
306623,conference-call,100,50,7/29/2019
30AB63,earnings,100,50,7/29/2019
31F25C,legal-issues-defendant,100,22,7/29/2019
343996,earnings,100,50,7/29/2019
366A08,legal-issues-defendant,100,22,7/29/2019
367E1C,earnings,100,50,7/29/2019
36E479,regulatory-product-review-positive,100,73,7/29/2019
370C50,product-price-raise,100,57,7/29/2019
3A1C46,earnings,100,50,7/29/2019
3A3447,facility-open,100,65,7/29/2019
3A4BDB,dividend,100,50,7/29/2019
3AAEAE,executive-appointment,100,54,7/29/2019
3AF7FD,dividend,100,50,7/29/2019
3BB616,earnings,100,50,7/29/2019
3DED49,conference-call,100,50,7/29/2019
3F1C69,public-offering,100,43,7/29/2019
3F4668,executive-appointment,100,54,7/29/2019
408380,earnings,100,50,7/29/2019
42EFC7,award,100,58,7/29/2019
442769,conference-participant,100,50,7/29/2019
4455C4,earnings,100,50,7/29/2019
4455C4,earnings,100,50,7/29/2019
4455C4,earnings,100,50,7/29/2019
45BC35,business-combination,100,54,7/29/2019
45BC35,business-combination,100,54,7/29/2019
45BC35,business-combination,100,54,7/29/2019
485445,earnings,100,50,7/29/2019
4.91E+58,asset-sale,100,62,7/29/2019
494EB9,earnings,100,50,7/29/2019
4A2457,conference-participant,100,50,7/29/2019
4D8E5E,earnings,100,50,7/29/2019
4EC4C1,unit-acquisition-completed-acquirer,100,49,7/29/2019
4EE167,facility-open,100,65,7/29/2019
504FE2,dividend-up,100,56,7/29/2019
5088A5,earnings,100,50,7/29/2019
514067,conference-participant,100,50,7/29/2019
51F541,earnings,100,50,7/29/2019
52B567,earnings,100,50,7/29/2019
54512F,earnings,100,50,7/29/2019
56632F,earnings,100,50,7/29/2019
56632F,earnings,100,50,7/29/2019
56632F,earnings,100,50,7/29/2019
56EA2B,revenue-up,100,65,7/29/2019
57A854,legal-issues-defendant,100,22,7/29/2019
587EDF,earnings,100,50,7/29/2019
5BE42C,earnings-up,100,68,7/29/2019
5C8D61,earnings,100,50,7/29/2019
5C8D61,earnings,100,50,7/29/2019
5C8D61,earnings,100,50,7/29/2019
5D02B7,earnings,100,50,7/29/2019
5EF130,conference-call,100,50,7/29/2019
5FDBD0,operating-earnings,100,50,7/29/2019
5FE4B6,conference-participant,100,50,7/29/2019
61BCA7,earnings,100,50,7/29/2019
657097,unit-acquisition-acquirer,100,49,7/29/2019
657097,unit-acquisition-acquirer,100,49,7/29/2019
6844D2,legal-issues-defendant,100,22,7/29/2019
68B03F,earnings,100,50,7/29/2019
694749,earnings,100,50,7/29/2019
6D4636,earnings,100,50,7/29/2019
6D4636,earnings,100,50,7/29/2019
6D4636,earnings,100,50,7/29/2019
6D6B40,earnings,100,50,7/29/2019
6DD6BA,executive-appointment,100,54,7/29/2019
6E705B,partnership,100,61,7/29/2019
6ED519,settlement,100,56,7/29/2019
709AED,dividend,100,50,7/29/2019
709AED,earnings,100,50,7/29/2019
709AED,earnings,100,50,7/29/2019
709AED,earnings,100,50,7/29/2019
724F84,public-offering,100,43,7/29/2019
732A9B,executive-appointment,100,54,7/29/2019
748EB6,ipo-completed,100,76,7/29/2019
787D14,product-release,100,64,7/29/2019
791EC1,earnings,100,50,7/29/2019
79340A,earnings,100,50,7/29/2019
793C11,executive-appointment,100,54,7/29/2019
7C4168,earnings,100,50,7/29/2019
7D5384,executive-appointment,100,54,7/29/2019
7E3F8F,note-sale,100,52,7/29/2019
7E62B5,public-offering,100,43,7/29/2019
7F3669,earnings,100,50,7/29/2019
7FDE1C,earnings,100,50,7/29/2019
850779,dividend,100,50,7/29/2019
85DA04,earnings,100,50,7/29/2019
85DA04,earnings,100,50,7/29/2019
85DA04,earnings,100,50,7/29/2019
85DA04,earnings,100,50,7/29/2019
860AB6,earnings,100,50,7/29/2019
86F123,conference-call,100,50,7/29/2019
877C0C,settlement,100,56,7/29/2019
877C0C,settlement,100,56,7/29/2019
8.79E+06,earnings,100,50,7/29/2019
8802B4,earnings,100,50,7/29/2019
885758,legal-issues-defendant,100,22,7/29/2019
8B6E7E,legal-issues-defendant,100,22,7/29/2019
8BAA15,product-release,100,64,7/29/2019
8BFE9A,conference-call,100,50,7/29/2019
8D5145,conference-participant,100,50,7/29/2019
8F8F2F,earnings,100,50,7/29/2019
8FE7A5,earnings,100,50,7/29/2019
94563D,legal-issues-defendant,100,22,7/29/2019
94563D,legal-issues-defendant,100,22,7/29/2019
94637C,acquisition-regulatory-approval-acquirer,100,54,7/29/2019
9507FF,earnings,100,50,7/29/2019
95DC1F,partnership,100,61,7/29/2019
95DE39,earnings-positive,100,69,7/29/2019
95DE39,earnings-positive,100,69,7/29/2019
95DE39,earnings-positive,100,69,7/29/2019
95DE39,earnings-positive,100,69,7/29/2019
979451,earnings,100,50,7/29/2019
9AF3DC,unit-acquisition-completed-acquiree,100,67,7/29/2019
9AF3DC,unit-acquisition-completed-acquiree,100,67,7/29/2019
9CDA4F,earnings,100,50,7/29/2019
9D2790,earnings,100,50,7/29/2019
9D4EC7,earnings,100,50,7/29/2019
9D4EC7,earnings,100,50,7/29/2019
9D4EC7,earnings,100,50,7/29/2019
9D4EC7,earnings,100,50,7/29/2019
9D5D35,earnings,100,50,7/29/2019
9D5D35,earnings,100,50,7/29/2019
9D5D35,earnings,100,50,7/29/2019
9D65C1,earnings,100,50,7/29/2019
9E575E,earnings,100,50,7/29/2019
9EF4CF,earnings,100,50,7/29/2019
9F18FA,earnings,100,50,7/29/2019
9F18FA,earnings,100,50,7/29/2019
9F71E5,product-release,100,64,7/29/2019
A1A317,earnings,100,50,7/29/2019
A1A317,earnings,100,50,7/29/2019
A1A317,earnings,100,50,7/29/2019
A1A317,earnings,100,50,7/29/2019
A2CA3F,earnings,100,50,7/29/2019
A350C1,operating-earnings,100,50,7/29/2019
A350C1,operating-earnings,100,50,7/29/2019
A350C1,operating-earnings,100,50,7/29/2019
A350C1,operating-earnings,100,50,7/29/2019
A350C1,operating-earnings,100,50,7/29/2019
A350C1,operating-earnings,100,50,7/29/2019
A350C1,operating-earnings,100,50,7/29/2019
A47F2E,earnings,100,50,7/29/2019
A6828A,regulatory-product-application,100,69,7/29/2019
A6FC89,legal-issues-defendant,100,22,7/29/2019
A8E2FE,clinical-trials,100,56,7/29/2019
AA09AD,legal-issues-defendant,100,22,7/29/2019
AAEE21,earnings,100,50,7/29/2019
ACF0B4,conference-call,100,50,7/29/2019
B4703C,legal-issues-defendant,100,22,7/29/2019
B508E5,ipo-completed,100,76,7/29/2019
B508E5,ipo-completed,100,76,7/29/2019
B508E5,ipo-completed,100,76,7/29/2019
B5BA39,legal-issues-defendant,100,22,7/29/2019
B72BE9,revenues,100,50,7/29/2019
B72BE9,revenues,100,50,7/29/2019
B72BE9,revenues,100,50,7/29/2019
B8A51F,conference-participant,100,50,7/29/2019
BA218A,legal-issues-defendant,100,22,7/29/2019
BA218A,legal-issues-defendant,100,22,7/29/2019
BC4876,earnings,100,50,7/29/2019
BE14CF,earnings,100,50,7/29/2019
C062D4,earnings,100,50,7/29/2019
C062D4,earnings,100,50,7/29/2019
C062D4,earnings,100,50,7/29/2019
C062D4,earnings,100,50,7/29/2019
C062D4,earnings,100,50,7/29/2019
C062D4,earnings,100,50,7/29/2019
C0BA36,conference-call,100,50,7/29/2019
C0F70B,earnings,100,50,7/29/2019
C2E39B,earnings,100,50,7/29/2019
C36189,clinical-trials-positive,100,87,7/29/2019
C4706C,conference-call,100,50,7/29/2019
C8FAC7,legal-issues-defendant,100,22,7/29/2019
CAC8D0,partnership,100,61,7/29/2019
CC0C78,earnings,100,50,7/29/2019
CCBBAD,earnings,100,50,7/29/2019
CDAF5B,operating-earnings,100,50,7/29/2019
CDE51C,patent-awarded,100,72,7/29/2019
CFD4B6,conference-participant,100,50,7/29/2019
D06996,earnings,100,50,7/29/2019
D0DFE5,earnings,100,50,7/29/2019
D21D8A,buybacks,100,74,7/29/2019
D296C6,earnings,100,50,7/29/2019
D3C794,earnings,100,50,7/29/2019
D57D99,earnings,100,50,7/29/2019
D58A11,conference-participant,100,50,7/29/2019
D598E7,earnings,100,50,7/29/2019
D854F3,product-release,100,64,7/29/2019
D8ECA1,earnings,100,50,7/29/2019
DB5CA5,dividend,100,50,7/29/2019
DD1BA1,partnership,100,61,7/29/2019
DD9E41,earnings,100,50,7/29/2019
DD9E41,earnings,100,50,7/29/2019
DD9E41,earnings,100,50,7/29/2019
DD9E41,earnings,100,50,7/29/2019
DD9E41,earnings,100,50,7/29/2019
DD9E41,earnings,100,50,7/29/2019
E0207A,earnings,100,50,7/29/2019
E0207A,earnings,100,50,7/29/2019
E0207A,earnings,100,50,7/29/2019
E0207A,earnings,100,50,7/29/2019
E074A0,earnings,100,50,7/29/2019
E10D31,public-offering,100,43,7/29/2019
E2CB7B,earnings,100,50,7/29/2019
E41190,conference-call,100,50,7/29/2019
E6D89E,earnings,100,50,7/29/2019
E6D89E,earnings,100,50,7/29/2019
E6D89E,earnings,100,50,7/29/2019
E6D89E,earnings,100,50,7/29/2019
E70531,earnings,100,50,7/29/2019
E72599,conference-call,100,50,7/29/2019
E7BF32,earnings,100,50,7/29/2019
E7BF32,earnings,100,50,7/29/2019
E84500,earnings,100,50,7/29/2019
E8A49A,executive-appointment,100,54,7/29/2019
ECD263,legal-issues-defendant,100,22,7/29/2019
ECDEB2,merger-completed,100,66,7/29/2019
ED0402,business-contract,100,69,7/29/2019
ED3CA8,earnings,100,50,7/29/2019
ED8676,conference-participant,100,50,7/29/2019
EEBCEF,dividend,100,50,7/29/2019
F02170,legal-issues-defendant,100,22,7/29/2019
F32F88,dividend,100,50,7/29/2019
F39E1E,product-release,100,64,7/29/2019
F39E1E,earnings,100,50,7/29/2019
F47871,legal-issues-defendant,100,22,7/29/2019
F47871,legal-issues-defendant,100,22,7/29/2019
F4D241,earnings,100,50,7/29/2019
F6A945,earnings,100,50,7/29/2019
F7935D,earnings,100,50,7/29/2019
F7FCA4,earnings,100,50,7/29/2019
F7FCA4,earnings,100,50,7/29/2019
F7FCA4,earnings,100,50,7/29/2019
F7FCA4,earnings,100,50,7/29/2019
F8BA6C,partnership,100,61,7/29/2019
FFAB4A,earnings,100,50,7/29/2019
03B8CF,legal-issues-defendant,100,22,7/30/2019
03B8CF,legal-issues-defendant,100,22,7/30/2019
03B8CF,legal-issues-defendant,100,22,7/30/2019
048B70,earnings,100,50,7/30/2019
048B70,earnings,100,50,7/30/2019
048B70,earnings,100,50,7/30/2019
048B70,earnings,100,50,7/30/2019
04996E,conference-participant,100,50,7/30/2019
55018,legal-issues-defendant,100,22,7/30/2019
55018,legal-issues-defendant,100,22,7/30/2019
55018,legal-issues-defendant,100,22,7/30/2019
61366,partnership,100,61,7/30/2019
070B45,earnings,100,50,7/30/2019
078D52,revenues,100,50,7/30/2019
078D52,revenues,100,50,7/30/2019
0986B5,buybacks,100,74,7/30/2019
09F623,earnings-up,100,61,7/30/2019
0B2071,earnings,100,50,7/30/2019
0C2A0D,dividend-guidance,100,50,7/30/2019
0C6861,executive-appointment,100,54,7/30/2019
0E499E,earnings,100,50,7/30/2019
0F2BC9,business-contract,100,69,7/30/2019
0F65C9,earnings,100,50,7/30/2019
0F65C9,dividend,100,50,7/30/2019
1201B5,partnership,100,61,7/30/2019
12A3A3,conference-participant,100,50,7/30/2019
131443,earnings,100,50,7/30/2019
131443,earnings,100,50,7/30/2019
131443,earnings,100,50,7/30/2019
131443,earnings,100,50,7/30/2019
131443,earnings,100,50,7/30/2019
131443,earnings,100,50,7/30/2019
135B09,earnings-up,100,68,7/30/2019
139303,executive-appointment,100,54,7/30/2019
13A782,earnings,100,50,7/30/2019
1490F3,market-entry,100,57,7/30/2019
1490F3,market-entry,100,57,7/30/2019
1490F3,earnings,100,50,7/30/2019
1490F3,earnings,100,50,7/30/2019
149301,dividend,100,50,7/30/2019
14BA33,earnings,100,50,7/30/2019
152AB9,earnings,100,50,7/30/2019
152E1D,conference-call,100,50,7/30/2019
157CC1,earnings,100,50,7/30/2019
15901B,business-contract,100,69,7/30/2019
16FC89,earnings,100,50,7/30/2019
180DA0,earnings,100,50,7/30/2019
180DA0,earnings,100,50,7/30/2019
180DA0,earnings,100,50,7/30/2019
1866B2,dividend,100,50,7/30/2019
188394,earnings,100,50,7/30/2019
1921DD,partnership,100,61,7/30/2019
1A3E1B,merger-regulatory-approval,100,81,7/30/2019
1A3E1B,merger-regulatory-approval,100,81,7/30/2019
1A3E1B,dividend,100,50,7/30/2019
1A5957,earnings,100,50,7/30/2019
1A5D5D,earnings,100,50,7/30/2019
1B5FEA,earnings,100,50,7/30/2019
1BDB2A,earnings,100,50,7/30/2019
1BDB2A,dividend,100,50,7/30/2019
1D9E55,earnings,100,50,7/30/2019
1DA44F,earnings,100,50,7/30/2019
1EBF8D,earnings,100,50,7/30/2019
1F716B,earnings,100,50,7/30/2019
1F9D90,earnings,100,50,7/30/2019
2093B1,earnings,100,50,7/30/2019
21DED4,dividend,100,50,7/30/2019
21F9CA,revenues,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
225CA2,earnings,100,50,7/30/2019
228D42,partnership,100,61,7/30/2019
22C58E,earnings,100,50,7/30/2019
22C58E,executive-appointment,100,54,7/30/2019
249674,business-contract,100,69,7/30/2019
251988,partnership,100,61,7/30/2019
25AB8E,earnings,100,50,7/30/2019
267718,earnings,100,50,7/30/2019
267718,acquisition-completed-acquirer,100,49,7/30/2019
267718,acquisition-completed-acquirer,100,49,7/30/2019
26D8ED,earnings,100,50,7/30/2019
26F31D,executive-appointment,100,54,7/30/2019
26F31D,earnings,100,50,7/30/2019
26F31D,earnings,100,50,7/30/2019
26F31D,earnings,100,50,7/30/2019
26F31D,earnings,100,50,7/30/2019
270305,dividend,100,50,7/30/2019
270305,earnings,100,50,7/30/2019
270305,earnings,100,50,7/30/2019
270305,earnings,100,50,7/30/2019
270305,earnings,100,50,7/30/2019
2AA6A8,conference-call,100,50,7/30/2019
2BA977,earnings,100,50,7/30/2019
2CA60F,earnings,100,50,7/30/2019
2E0496,earnings,100,50,7/30/2019
2E61CC,earnings,100,50,7/30/2019
2EC172,earnings,100,50,7/30/2019
2EC172,earnings,100,50,7/30/2019
2EC172,earnings,100,50,7/30/2019
2EC172,earnings,100,50,7/30/2019
2EC172,earnings,100,50,7/30/2019
2EC172,earnings,100,50,7/30/2019
2F24A5,earnings,100,50,7/30/2019
30CBF9,product-release,100,64,7/30/2019
3390DE,earnings,100,50,7/30/2019
33FD66,earnings,100,50,7/30/2019
33FD66,earnings,100,50,7/30/2019
33FD66,earnings,100,50,7/30/2019
33FD66,earnings,100,50,7/30/2019
33FD66,earnings,100,50,7/30/2019
33FD66,earnings,100,50,7/30/2019
349DA4,earnings,100,50,7/30/2019
34B97A,earnings,100,50,7/30/2019
34B97A,earnings,100,50,7/30/2019
34B97A,earnings,100,50,7/30/2019
34B97A,earnings,100,50,7/30/2019
34E9F9,earnings,100,50,7/30/2019
34E9F9,earnings,100,50,7/30/2019
34E9F9,earnings,100,50,7/30/2019
34E9F9,earnings,100,50,7/30/2019
35F4B5,earnings-guidance-up,100,83,7/30/2019
35F4B5,earnings,100,50,7/30/2019
367434,orphan-drug-designation,100,76,7/30/2019
37020C,earnings,100,50,7/30/2019
37020C,earnings,100,50,7/30/2019
37020C,earnings,100,50,7/30/2019
37020C,earnings,100,50,7/30/2019
37020C,earnings,100,50,7/30/2019
37020C,earnings,100,50,7/30/2019
373B06,earnings,100,50,7/30/2019
37727A,earnings-guidance-up,100,83,7/30/2019
37727A,earnings,100,50,7/30/2019
37727A,earnings,100,50,7/30/2019
37727A,earnings,100,50,7/30/2019
37727A,earnings,100,50,7/30/2019
37727A,earnings,100,50,7/30/2019
37727A,earnings,100,50,7/30/2019
37727A,earnings,100,50,7/30/2019
387375,conference-participant,100,50,7/30/2019
38FB49,dividend,100,50,7/30/2019
396D7C,earnings,100,50,7/30/2019
3A1C46,public-offering,100,43,7/30/2019
3A3447,facility-open,100,65,7/30/2019
3BB616,earnings,100,50,7/30/2019
3BB616,earnings,100,50,7/30/2019
3BB616,earnings,100,50,7/30/2019
3BCF24,earnings-up,100,58,7/30/2019
3BE00F,earnings,100,50,7/30/2019
3BE00F,earnings,100,50,7/30/2019
3BE00F,earnings,100,50,7/30/2019
41EC04,earnings,100,50,7/30/2019
41EC04,earnings,100,50,7/30/2019
41EC04,earnings,100,50,7/30/2019
420168,earnings,100,50,7/30/2019
422A82,product-release,100,64,7/30/2019
427F32,earnings,100,50,7/30/2019
43A060,earnings,100,50,7/30/2019
44209A,earnings,100,50,7/30/2019
442769,market-entry,100,57,7/30/2019
448BF3,conference-call,100,50,7/30/2019
453282,dividend,100,50,7/30/2019
467F2C,earnings,100,50,7/30/2019
4.91E+58,earnings-up,100,68,7/30/2019
4A3438,fraud-defendant,100,20,7/30/2019
4A6F00,partnership,100,61,7/30/2019
4BBA23,operating-earnings,100,50,7/30/2019
4BDCA7,conference-call,100,50,7/30/2019
4C2F17,earnings,100,50,7/30/2019
4C31F3,conference-call,100,50,7/30/2019
4C5CC9,dividend,100,50,7/30/2019
4C6C63,earnings,100,50,7/30/2019
4C6C63,earnings,100,50,7/30/2019
4C6C63,earnings,100,50,7/30/2019
4C6C63,earnings,100,50,7/30/2019
4C6C63,earnings,100,50,7/30/2019
4C6C63,earnings,100,50,7/30/2019
4C6C63,earnings,100,50,7/30/2019
4C6C63,earnings,100,50,7/30/2019
4FB770,earnings,100,50,7/30/2019
4FCC78,acquisition-completed-acquirer,100,49,7/30/2019
50070E,conference-call,100,50,7/30/2019
504FE2,earnings,100,50,7/30/2019
50702E,conference-call,100,50,7/30/2019
519FE0,earnings,100,50,7/30/2019
51E682,earnings,100,50,7/30/2019
52015A,earnings,100,50,7/30/2019
53EF9E,earnings,100,50,7/30/2019
53EF9E,earnings,100,50,7/30/2019
54DF47,acquisition-completed-acquirer,100,49,7/30/2019
553949,earnings,100,50,7/30/2019
55C9B5,earnings,100,50,7/30/2019
57634F,earnings,100,50,7/30/2019
57A854,conference-call,100,50,7/30/2019
57EF50,conference-call,100,50,7/30/2019
583A75,earnings,100,50,7/30/2019
586BD7,earnings,100,50,7/30/2019
596116,earnings,100,50,7/30/2019
5A423F,earnings,100,50,7/30/2019
5B15E1,earnings,100,50,7/30/2019
5B6C11,earnings,100,50,7/30/2019
5CCDAD,earnings,100,50,7/30/2019
5D1329,conference-participant,100,50,7/30/2019
5D41E4,conference-participant,100,50,7/30/2019
5F60CE,earnings,100,50,7/30/2019
619882,conference-organizer,100,57,7/30/2019
619882,conference-participant,100,50,7/30/2019
619882,business-contract,100,69,7/30/2019
619882,conference-organizer,100,57,7/30/2019
62B1C6,earnings,100,50,7/30/2019
62B1C6,dividend,100,50,7/30/2019
62EFEE,earnings-up,100,68,7/30/2019
64636E,conference-participant,100,50,7/30/2019
64636E,conference-participant,100,50,7/30/2019
64636E,conference-participant,100,50,7/30/2019
649CBD,earnings,100,50,7/30/2019
67B052,conference-call,100,50,7/30/2019
67B923,earnings,100,50,7/30/2019
68E3E0,dividend,100,50,7/30/2019
69345C,earnings,100,50,7/30/2019
69345C,earnings,100,50,7/30/2019
69345C,earnings,100,50,7/30/2019
69345C,earnings,100,50,7/30/2019
69494C,conference-call,100,50,7/30/2019
69C99E,earnings,100,50,7/30/2019
6B236C,earnings,100,50,7/30/2019
6B494E,earnings,100,50,7/30/2019
6CC55E,earnings,100,50,7/30/2019
6E705B,executive-appointment,100,54,7/30/2019
70CA28,conference-participant,100,50,7/30/2019
724F84,public-offering,100,43,7/30/2019
72609A,earnings-up,100,68,7/30/2019
75768D,dividend,100,50,7/30/2019
765913,conference-participant,100,50,7/30/2019
76F067,earnings,100,50,7/30/2019
7823A3,earnings,100,50,7/30/2019
7823A3,earnings,100,50,7/30/2019
7823A3,earnings,100,50,7/30/2019
7823A3,earnings,100,50,7/30/2019
7823A3,earnings,100,50,7/30/2019
782B46,earnings,100,50,7/30/2019
782B46,dividend,100,50,7/30/2019
789ADD,dividend,100,50,7/30/2019
79167B,earnings,100,50,7/30/2019
79167B,earnings,100,50,7/30/2019
79167B,earnings,100,50,7/30/2019
79167B,earnings,100,50,7/30/2019
7A10FF,earnings,100,50,7/30/2019
7B9AFA,conference-participant,100,50,7/30/2019
7D7716,earnings,100,50,7/30/2019
7D7716,earnings,100,50,7/30/2019
7D7716,earnings,100,50,7/30/2019
7D7716,earnings,100,50,7/30/2019
7D7716,earnings,100,50,7/30/2019
7E3F8F,note-sale,100,52,7/30/2019
7E62B5,public-offering,100,43,7/30/2019
7F9984,earnings,100,50,7/30/2019
7F9984,earnings,100,50,7/30/2019
7F9BE2,dividend,100,50,7/30/2019
7F9BE2,earnings,100,50,7/30/2019
82B57E,earnings,100,50,7/30/2019
82C202,earnings,100,50,7/30/2019
8303CD,earnings,100,50,7/30/2019
86BAC7,earnings,100,50,7/30/2019
87486A,dividend,100,50,7/30/2019
877734,conference-call,100,50,7/30/2019
877C0C,legal-issues-defendant,100,22,7/30/2019
880C0C,earnings,100,50,7/30/2019
88193E,earnings,100,50,7/30/2019
8AC65D,earnings,100,50,7/30/2019
8B9B3B,earnings,100,50,7/30/2019
8C1238,earnings,100,50,7/30/2019
8D4486,dividend,100,50,7/30/2019
8D4486,dividend,100,50,7/30/2019
8E10BF,earnings,100,50,7/30/2019
8E4F9A,conference-call,100,50,7/30/2019
8EEA28,earnings,100,50,7/30/2019
8FCA78,earnings,100,50,7/30/2019
8FCA78,earnings,100,50,7/30/2019
8FCA78,earnings,100,50,7/30/2019
8FCA78,earnings,100,50,7/30/2019
9087B9,dividend,100,50,7/30/2019
92005C,earnings,100,50,7/30/2019
92005C,clinical-trials,100,56,7/30/2019
92D9C9,earnings,100,50,7/30/2019
9.36E+10,business-contract,100,69,7/30/2019
93965C,earnings,100,50,7/30/2019
93D207,executive-appointment,100,54,7/30/2019
940C3D,business-contract,100,69,7/30/2019
945DE6,earnings,100,50,7/30/2019
945DE6,earnings,100,50,7/30/2019
945DE6,earnings,100,50,7/30/2019
945DE6,earnings,100,50,7/30/2019
949D62,public-offering,100,43,7/30/2019
95DC1F,executive-appointment,100,54,7/30/2019
9.62E+76,business-contract,100,69,7/30/2019
9810C0,product-release,100,64,7/30/2019
9934AD,earnings,100,50,7/30/2019
9A602D,earnings-per-share-positive,100,69,7/30/2019
9A602D,earnings-per-share-positive,100,69,7/30/2019
9A602D,earnings-per-share-positive,100,69,7/30/2019
9A602D,earnings-per-share-positive,100,69,7/30/2019
9A602D,earnings-per-share-positive,100,69,7/30/2019
9A602D,earnings-per-share-positive,100,69,7/30/2019
9B5968,earnings,100,50,7/30/2019
9B5968,earnings,100,50,7/30/2019
9B730A,conference-call,100,50,7/30/2019
9BB35A,earnings,100,50,7/30/2019
9BB35A,earnings,100,50,7/30/2019
9BB35A,earnings,100,50,7/30/2019
9BB35A,earnings,100,50,7/30/2019
9BB35A,earnings,100,50,7/30/2019
9BB35A,earnings,100,50,7/30/2019
9BB35A,earnings,100,50,7/30/2019
9D65C1,conference-participant,100,50,7/30/2019
9FF5F1,partnership,100,61,7/30/2019
9FF5F1,product-release,100,64,7/30/2019
A05C43,earnings,100,50,7/30/2019
A05C43,earnings,100,50,7/30/2019
A072C4,conference-call,100,50,7/30/2019
A1EAC8,dividend,100,50,7/30/2019
A23747,earnings,100,50,7/30/2019
A26EF7,conference-participant,100,50,7/30/2019
A29A46,earnings,100,50,7/30/2019
A41450,earnings,100,50,7/30/2019
A429A5,earnings-up,100,68,7/30/2019
A429A5,earnings,100,50,7/30/2019
A429A5,earnings,100,50,7/30/2019
A429A5,earnings,100,50,7/30/2019
A429A5,earnings,100,50,7/30/2019
A4A612,earnings,100,50,7/30/2019
A4F67C,earnings,100,50,7/30/2019
A631A3,partnership,100,61,7/30/2019
A7CCF0,earnings-up,100,68,7/30/2019
A7CCF0,earnings,100,50,7/30/2019
A7CCF0,earnings,100,50,7/30/2019
A87CD6,earnings-per-share-positive,100,69,7/30/2019
A87CD6,earnings-per-share-positive,100,69,7/30/2019
A87CD6,earnings-per-share-positive,100,69,7/30/2019
A87CD6,earnings-per-share-positive,100,69,7/30/2019
A87CD6,earnings-per-share-positive,100,69,7/30/2019
AD9F1D,revenue-up,100,57,7/30/2019
AD9F1D,revenue-up,100,69,7/30/2019
AD9F1D,revenue-up,100,69,7/30/2019
AD9F1D,revenue-up,100,69,7/30/2019
AD9F1D,revenue-up,100,69,7/30/2019
AD9F1D,revenue-up,100,69,7/30/2019
AD9F1D,revenue-up,100,69,7/30/2019
AD9F1D,revenue-up,100,69,7/30/2019
AE4EEB,earnings,100,50,7/30/2019
AFEC35,executive-appointment,100,54,7/30/2019
AFF7B4,earnings,100,50,7/30/2019
AFF7B4,earnings,100,50,7/30/2019
AFF7B4,earnings,100,50,7/30/2019
B076A1,earnings,100,50,7/30/2019
B076A1,earnings,100,50,7/30/2019
B076A1,earnings,100,50,7/30/2019
B076A1,earnings,100,50,7/30/2019
B0D41A,earnings,100,50,7/30/2019
B2206F,earnings,100,50,7/30/2019
B303A6,dividend,100,50,7/30/2019
B33E77,earnings,100,50,7/30/2019
B3ED62,executive-appointment,100,54,7/30/2019
B4703C,earnings-per-share-positive,100,69,7/30/2019
B4703C,earnings,100,50,7/30/2019
B48D6A,public-offering,100,43,7/30/2019
B560AF,earnings,100,50,7/30/2019
B560AF,earnings,100,50,7/30/2019
B560AF,earnings,100,50,7/30/2019
B5BA39,product-release,100,64,7/30/2019
B77F14,conference-call,100,50,7/30/2019
B80AD1,earnings,100,50,7/30/2019
B83D67,earnings,100,50,7/30/2019
B8DD94,conference-participant,100,50,7/30/2019
B9764A,earnings,100,50,7/30/2019
B98EFA,operating-earnings,100,50,7/30/2019
BB5271,earnings,100,50,7/30/2019
BBAE2A,earnings,100,50,7/30/2019
BBBB41,earnings,100,50,7/30/2019
BBBB41,earnings,100,50,7/30/2019
BBBB41,earnings,100,50,7/30/2019
BBBB41,earnings,100,50,7/30/2019
BBBB41,earnings,100,50,7/30/2019
BBBB41,earnings,100,50,7/30/2019
BBC05B,operating-earnings,100,50,7/30/2019
BC3AD2,earnings,100,50,7/30/2019
BC3AD2,earnings,100,50,7/30/2019
BC5680,earnings,100,50,7/30/2019
BC5680,earnings,100,50,7/30/2019
BD682F,public-offering,100,43,7/30/2019
C3BCD5,executive-appointment,100,54,7/30/2019
C3CF29,earnings,100,50,7/30/2019
C3CF29,earnings,100,50,7/30/2019
C3CF29,earnings,100,50,7/30/2019
C3CF29,earnings,100,50,7/30/2019
C3F99F,earnings,100,50,7/30/2019
C45C1F,executive-appointment,100,54,7/30/2019
C4A241,award,100,58,7/30/2019
C4A241,earnings,100,50,7/30/2019
C4A912,earnings,100,50,7/30/2019
C4A912,earnings,100,50,7/30/2019
C4A912,earnings,100,50,7/30/2019
C4A912,earnings,100,50,7/30/2019
C4F567,revenues,100,50,7/30/2019
C4F567,executive-appointment,100,54,7/30/2019
C4F9C6,earnings,100,50,7/30/2019
C5C0E9,earnings,100,50,7/30/2019
C659EB,earnings,100,50,7/30/2019
C659EB,earnings,100,50,7/30/2019
C659EB,earnings,100,50,7/30/2019
C659EB,earnings,100,50,7/30/2019
C72B8F,earnings,100,50,7/30/2019
C83B88,product-release,100,64,7/30/2019
C85A72,revenue-up,100,81,7/30/2019
C85A72,revenue-up,100,81,7/30/2019
C85A72,revenue-up,100,81,7/30/2019
C85A72,revenue-up,100,81,7/30/2019
C941DC,earnings,100,50,7/30/2019
C99CC8,earnings,100,50,7/30/2019
C99CC8,earnings,100,50,7/30/2019
C99CC8,earnings,100,50,7/30/2019
C99CC8,earnings,100,50,7/30/2019
C99CC8,earnings,100,50,7/30/2019
C9B932,note-sale,100,52,7/30/2019
CA3CB9,unit-acquisition-acquiree,100,76,7/30/2019
CA3CB9,earnings,100,50,7/30/2019
CAD7D9,executive-appointment,100,54,7/30/2019
CAD7D9,earnings,100,50,7/30/2019
CE4E6D,conference-call,100,50,7/30/2019
CE5664,earnings,100,50,7/30/2019
CE5664,earnings,100,50,7/30/2019
CE5664,earnings,100,50,7/30/2019
CEC08B,earnings,100,50,7/30/2019
D04D9F,earnings,100,50,7/30/2019
D6144F,conference-call,100,50,7/30/2019
D6534D,earnings,100,50,7/30/2019
D6853F,business-contract,100,69,7/30/2019
D69D42,earnings,100,50,7/30/2019
D7918D,operating-earnings,100,50,7/30/2019
D8442A,earnings,100,50,7/30/2019
D8442A,earnings,100,50,7/30/2019
D8DA3D,legal-issues-defendant,100,22,7/30/2019
D8DBA3,earnings,100,50,7/30/2019
D8ECA1,dividend,100,50,7/30/2019
D90F43,partnership,100,61,7/30/2019
DA91AE,dividend,100,50,7/30/2019
DB06B0,earnings,100,50,7/30/2019
DB06B0,earnings,100,50,7/30/2019
DB06B0,earnings,100,50,7/30/2019
DB06B0,earnings,100,50,7/30/2019
DB06B0,earnings,100,50,7/30/2019
DB88A1,award,100,58,7/30/2019
DDEA6A,earnings,100,50,7/30/2019
DEF058,earnings-up,100,68,7/30/2019
DEF058,earnings-up,100,68,7/30/2019
DEF058,earnings-up,100,68,7/30/2019
DEF058,earnings-up,100,68,7/30/2019
DF42A0,conference-call,100,50,7/30/2019
E12A6E,earnings,100,50,7/30/2019
E15736,earnings,100,50,7/30/2019
E28D9C,acquisition-acquirer,100,49,7/30/2019
E30A8F,earnings,100,50,7/30/2019
E30A8F,earnings,100,50,7/30/2019
E30A8F,earnings,100,50,7/30/2019
E30A8F,earnings,100,50,7/30/2019
E30A8F,earnings,100,50,7/30/2019
E38906,earnings,100,50,7/30/2019
E69BA5,earnings,100,50,7/30/2019
E6A53A,earnings,100,50,7/30/2019
E6E012,earnings,100,50,7/30/2019
E6E012,earnings,100,50,7/30/2019
E6E012,earnings,100,50,7/30/2019
E6E012,earnings,100,50,7/30/2019
E6E012,earnings,100,50,7/30/2019
E8A49A,earnings,100,50,7/30/2019
E93A40,earnings,100,50,7/30/2019
E99180,business-contract,100,69,7/30/2019
EB1E1A,orphan-drug-designation,100,76,7/30/2019
EB36DE,earnings,100,50,7/30/2019
EC70EC,earnings,100,50,7/30/2019
EC70EC,earnings,100,50,7/30/2019
EC70EC,earnings,100,50,7/30/2019
EC70EC,earnings,100,50,7/30/2019
EC70EC,earnings,100,50,7/30/2019
EC70EC,earnings,100,50,7/30/2019
EE04F0,conference-call,100,50,7/30/2019
EE967B,earnings,100,50,7/30/2019
EEA734,conference-participant,100,50,7/30/2019
EF76C8,earnings,100,50,7/30/2019
F0B2B5,earnings,100,50,7/30/2019
F0B335,earnings,100,50,7/30/2019
F1C04C,operating-earnings,100,50,7/30/2019
F2E253,conference-call,100,50,7/30/2019
F30508,earnings,100,50,7/30/2019
F30508,earnings,100,50,7/30/2019
F40EE2,earnings-up,100,68,7/30/2019
F40EE2,earnings-up,100,68,7/30/2019
F40EE2,earnings-up,100,68,7/30/2019
F47871,earnings,100,50,7/30/2019
F4CDA3,conference-call,100,50,7/30/2019
F57F6F,earnings,100,50,7/30/2019
F66B58,conference-participant,100,50,7/30/2019
F6DE54,earnings,100,50,7/30/2019
F6E248,earnings,100,50,7/30/2019
F6E248,dividend,100,50,7/30/2019
F748C7,partnership,100,61,7/30/2019
F90EE5,earnings,100,50,7/30/2019
F9CAF8,earnings,100,50,7/30/2019
F9CAF8,earnings,100,50,7/30/2019
F9CAF8,earnings,100,50,7/30/2019
FA36A4,earnings,100,50,7/30/2019
FC1A6E,revenues,100,50,7/30/2019
FC9A88,executive-appointment,100,54,7/30/2019
FCA54E,earnings,100,50,7/30/2019
FE89E0,earnings,100,50,7/30/2019
00067A,earnings,100,50,7/31/2019
00326E,earnings,100,50,7/31/2019
018C11,earnings,100,50,7/31/2019
03B8CF,legal-issues-defendant,100,22,7/31/2019
03B8CF,legal-issues-defendant,100,22,7/31/2019
03D5F9,earnings,100,50,7/31/2019
053EFF,earnings,100,50,7/31/2019
55018,legal-issues-defendant,100,22,7/31/2019
68396,earnings,100,50,7/31/2019
07C69F,earnings,100,50,7/31/2019
07EC43,earnings,100,50,7/31/2019
07EC43,earnings,100,50,7/31/2019
07EC43,earnings,100,50,7/31/2019
07EC43,earnings,100,50,7/31/2019
081AB9,index-listing,100,76,7/31/2019
98977,earnings,100,50,7/31/2019
099A92,earnings-up,100,68,7/31/2019
099C88,earnings,100,50,7/31/2019
0A9D0A,dividend,100,50,7/31/2019
0B4D10,earnings,100,50,7/31/2019
0B57D7,earnings,100,50,7/31/2019
0B7375,conference-call,100,50,7/31/2019
0BA8CE,earnings,100,50,7/31/2019
0BD4E8,business-contract,100,69,7/31/2019
0BF528,conference-call,100,50,7/31/2019
0C2A0D,earnings-up,100,68,7/31/2019
0D03C8,earnings,100,50,7/31/2019
0E2992,earnings-per-share-positive,100,69,7/31/2019
0EF1AF,conference-participant,100,50,7/31/2019
0F91FC,earnings,100,50,7/31/2019
102727,earnings,100,50,7/31/2019
106394,earnings,100,50,7/31/2019
1065BC,earnings,100,50,7/31/2019
1220D2,earnings,100,50,7/31/2019
12731D,conference-call,100,50,7/31/2019
12731D,conference-call,100,50,7/31/2019
12DE76,conference-call,100,50,7/31/2019
147C38,earnings,100,50,7/31/2019
149301,earnings,100,50,7/31/2019
149301,executive-appointment,100,54,7/31/2019
15A388,acquisition-completed-acquirer,100,49,7/31/2019
15B10D,conference-participant,100,50,7/31/2019
165B86,conference-call,100,50,7/31/2019
180DA0,executive-appointment,100,54,7/31/2019
1834C0,note-sale,100,52,7/31/2019
184866,clinical-trials,100,56,7/31/2019
184866,clinical-trials,100,56,7/31/2019
1866B2,earnings,100,50,7/31/2019
1866B2,earnings,100,50,7/31/2019
1866B2,earnings,100,50,7/31/2019
1866B2,earnings,100,50,7/31/2019
1866B2,earnings,100,50,7/31/2019
1880C5,conference-call,100,50,7/31/2019
18D9FA,conference-call,100,50,7/31/2019
1AB808,earnings-up,100,68,7/31/2019
1AB808,earnings,100,50,7/31/2019
1AB808,earnings,100,50,7/31/2019
1AB808,earnings,100,50,7/31/2019
1AB808,clinical-trials,100,56,7/31/2019
1AC649,clinical-trials,100,56,7/31/2019
1AC649,earnings,100,50,7/31/2019
1B16C1,conference-call,100,50,7/31/2019
1B637E,earnings,100,50,7/31/2019
1BC12C,dividend,100,50,7/31/2019
1CB9D3,conference-call,100,50,7/31/2019
1D5C51,conference-participant,100,50,7/31/2019
1EBF8D,business-contract,100,69,7/31/2019
1F08A6,earnings,100,50,7/31/2019
20D00A,operating-earnings,100,50,7/31/2019
221445,earnings,100,50,7/31/2019
221AD7,buybacks,100,74,7/31/2019
227F04,earnings,100,50,7/31/2019
228D42,partnership,100,61,7/31/2019
228D42,partnership,100,61,7/31/2019
24CB56,conference-organizer,100,57,7/31/2019
24CB56,earnings,100,50,7/31/2019
24CB56,conference-organizer,100,57,7/31/2019
250BEE,dividend,100,50,7/31/2019
26DC29,revenue-volume-up,100,69,7/31/2019
275300,conference-participant,100,50,7/31/2019
27BFA1,dividend,100,50,7/31/2019
28DCA8,earnings,100,50,7/31/2019
2950FF,earnings,100,50,7/31/2019
2950FF,earnings,100,50,7/31/2019
2BAE5F,earnings,100,50,7/31/2019
2BAE5F,earnings,100,50,7/31/2019
2BAE5F,earnings,100,50,7/31/2019
2C681C,partnership,100,61,7/31/2019
2C681C,partnership,100,61,7/31/2019
2CA60F,legal-issues-defendant,100,22,7/31/2019
2CA60F,legal-issues-defendant,100,22,7/31/2019
2D2D43,settlement,100,56,7/31/2019
2D2D43,dividend,100,50,7/31/2019
2D981A,conference-participant,100,50,7/31/2019
2EB88B,partnership,100,61,7/31/2019
2EB88B,business-contract,100,69,7/31/2019
2EB88B,business-contract,100,69,7/31/2019
2EB88B,partnership,100,61,7/31/2019
2F1299,dividend,100,50,7/31/2019
2F7A7E,earnings,100,50,7/31/2019
2FEA66,operating-earnings,100,50,7/31/2019
314D88,earnings,100,50,7/31/2019
315EB0,earnings,100,50,7/31/2019
315EB0,earnings,100,50,7/31/2019
315EB0,earnings,100,50,7/31/2019
315EB0,earnings,100,50,7/31/2019
315EB0,earnings,100,50,7/31/2019
315EB0,earnings,100,50,7/31/2019
315EB0,earnings,100,50,7/31/2019
315EB0,dividend,100,50,7/31/2019
31F25C,legal-issues-defendant,100,22,7/31/2019
3224CC,earnings,100,50,7/31/2019
3.20E+263,earnings,100,50,7/31/2019
32F24A,earnings,100,50,7/31/2019
32F943,earnings,100,50,7/31/2019
3461CF,earnings,100,50,7/31/2019
3.50E+27,earnings,100,50,7/31/2019
366A08,stake-acquirer,100,48,7/31/2019
372037,dividend,100,50,7/31/2019
372037,earnings,100,50,7/31/2019
3798B9,earnings,100,50,7/31/2019
3798B9,conference-participant,100,50,7/31/2019
37E18B,conference-call,100,50,7/31/2019
384CD3,earnings,100,50,7/31/2019
3A3447,earnings,100,50,7/31/2019
3A3447,earnings,100,50,7/31/2019
3A3447,earnings,100,50,7/31/2019
3A3447,earnings,100,50,7/31/2019
3A3447,earnings,100,50,7/31/2019
3AAEAE,clinical-trials-start,100,64,7/31/2019
3AAEAE,conference-participant,100,50,7/31/2019
3BC360,earnings,100,50,7/31/2019
3BC360,earnings,100,50,7/31/2019
3BC360,earnings,100,50,7/31/2019
3BC360,earnings,100,50,7/31/2019
3D7971,earnings,100,50,7/31/2019
3D7971,earnings,100,50,7/31/2019
3D7971,earnings,100,50,7/31/2019
3D7971,earnings,100,50,7/31/2019
3D7971,earnings,100,50,7/31/2019
3D7971,earnings,100,50,7/31/2019
3DB18B,earnings,100,50,7/31/2019
3DB18B,earnings,100,50,7/31/2019
3DD5E2,operating-earnings,100,50,7/31/2019
3F1C69,earnings,100,50,7/31/2019
3F868D,earnings,100,50,7/31/2019
4017AD,earnings,100,50,7/31/2019
4135F7,earnings,100,50,7/31/2019
41D61C,earnings,100,50,7/31/2019
41ED98,conference-call,100,50,7/31/2019
442587,earnings,100,50,7/31/2019
442587,earnings,100,50,7/31/2019
442769,earnings,100,50,7/31/2019
442769,earnings,100,50,7/31/2019
442769,earnings,100,50,7/31/2019
442769,earnings,100,50,7/31/2019
44A4FC,partnership,100,61,7/31/2019
44A4FC,partnership,100,61,7/31/2019
44DDBD,conference-call,100,50,7/31/2019
450ECB,partnership,100,61,7/31/2019
4.60E+06,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
47FCF2,earnings,100,50,7/31/2019
4885C8,dividend,100,50,7/31/2019
4.91E+58,executive-appointment,100,54,7/31/2019
49A344,earnings,100,50,7/31/2019
49A344,earnings,100,50,7/31/2019
49A344,earnings,100,50,7/31/2019
4A2457,earnings,100,50,7/31/2019
4A3438,legal-issues-defendant,100,22,7/31/2019
4A3438,legal-issues-defendant,100,22,7/31/2019
4A5C8D,earnings,100,50,7/31/2019
4A5C8D,earnings,100,50,7/31/2019
4AE584,earnings,100,50,7/31/2019
4B5054,dividend,100,50,7/31/2019
4C37C5,acquisition-acquirer,100,49,7/31/2019
4C5CC9,earnings-guidance-up,100,83,7/31/2019
4C5CC9,earnings-guidance-up,100,83,7/31/2019
4C5CC9,earnings-guidance-up,100,83,7/31/2019
4C5CC9,earnings-guidance-up,100,83,7/31/2019
4D8124,dividend,100,50,7/31/2019
513A86,earnings,100,50,7/31/2019
51B442,earnings,100,50,7/31/2019
520632,partnership,100,61,7/31/2019
525A1C,product-release,100,64,7/31/2019
52B567,legal-issues-defendant,100,22,7/31/2019
52B567,legal-issues-defendant,100,22,7/31/2019
5340D0,earnings,100,50,7/31/2019
54A646,dividend,100,50,7/31/2019
55C9B5,partnership,100,61,7/31/2019
56B7C1,earnings,100,50,7/31/2019
57CAAB,earnings,100,50,7/31/2019
57F3DA,earnings,100,50,7/31/2019
586BD7,earnings,100,50,7/31/2019
587D25,merger-completed,100,66,7/31/2019
587EDF,earnings,100,50,7/31/2019
58B46F,dividend,100,50,7/31/2019
594402,earnings,100,50,7/31/2019
5A0FF1,earnings,100,50,7/31/2019
5AAE17,earnings,100,50,7/31/2019
5B7739,product-release,100,64,7/31/2019
5C7601,earnings,100,50,7/31/2019
5D43A7,earnings,100,50,7/31/2019
5D43A7,earnings,100,50,7/31/2019
5D43A7,earnings,100,50,7/31/2019
5D43A7,earnings,100,50,7/31/2019
5DD486,earnings,100,50,7/31/2019
5DE5A5,conference-participant,100,50,7/31/2019
5EAA43,earnings,100,50,7/31/2019
5F60CE,earnings-positive,100,69,7/31/2019
601785,dividend,100,50,7/31/2019
605F40,earnings,100,50,7/31/2019
61E975,earnings-positive,100,69,7/31/2019
639BD6,revenues,100,50,7/31/2019
639BD6,revenues,100,50,7/31/2019
639BD6,revenues,100,50,7/31/2019
64854A,earnings,100,50,7/31/2019
65CF8E,earnings,100,50,7/31/2019
65CF8E,earnings,100,50,7/31/2019
66749D,earnings-up,100,68,7/31/2019
66749D,earnings,100,50,7/31/2019
66749D,earnings,100,50,7/31/2019
66749D,earnings,100,50,7/31/2019
66749D,earnings,100,50,7/31/2019
66E3C0,revenue-up,100,58,7/31/2019
66E3C0,revenue-up,100,58,7/31/2019
66ECFD,earnings,100,50,7/31/2019
6ABCB8,earnings,100,50,7/31/2019
6B0E45,earnings,100,50,7/31/2019
6D156D,earnings,100,50,7/31/2019
6E7060,earnings,100,50,7/31/2019
6E7060,earnings,100,50,7/31/2019
6E7060,earnings,100,50,7/31/2019
6E7060,earnings,100,50,7/31/2019
6E7060,earnings,100,50,7/31/2019
6E7060,earnings,100,50,7/31/2019
6E7060,earnings,100,50,7/31/2019
6E7060,earnings,100,50,7/31/2019
6EB9DA,dividend,100,50,7/31/2019
6ED519,earnings,100,50,7/31/2019
6ED519,earnings,100,50,7/31/2019
6ED519,earnings,100,50,7/31/2019
6F22E7,conference-call,100,50,7/31/2019
701531,conference-participant,100,50,7/31/2019
722DE3,earnings-up,100,68,7/31/2019
722DE3,earnings,100,50,7/31/2019
7273FF,earnings,100,50,7/31/2019
729368,earnings,100,50,7/31/2019
73A213,conference-participant,100,50,7/31/2019
73A71F,dividend,100,50,7/31/2019
742AAB,earnings,100,50,7/31/2019
7.44E+09,dividend,100,50,7/31/2019
746373,earnings,100,50,7/31/2019
746373,earnings,100,50,7/31/2019
756045,executive-resignation,100,44,7/31/2019
762A3E,conference-organizer,100,57,7/31/2019
763724,earnings-up,100,68,7/31/2019
76B926,earnings,100,50,7/31/2019
789ADD,earnings,100,50,7/31/2019
789ADD,earnings,100,50,7/31/2019
789ADD,earnings,100,50,7/31/2019
789ADD,earnings,100,50,7/31/2019
78F9ED,earnings,100,50,7/31/2019
78F9ED,earnings,100,50,7/31/2019
78F9ED,earnings,100,50,7/31/2019
78F9ED,earnings,100,50,7/31/2019
78F9ED,earnings,100,50,7/31/2019
78F9ED,earnings,100,50,7/31/2019
78F9ED,earnings,100,50,7/31/2019
78F9ED,earnings,100,50,7/31/2019
78F9ED,executive-resignation,100,44,7/31/2019
790D0D,earnings,100,50,7/31/2019
7B0BA6,acquisition-completed-acquirer,100,49,7/31/2019
7B0BA6,acquisition-completed-acquirer,100,49,7/31/2019
7B6EB1,unit-acquisition-acquirer,100,49,7/31/2019
7BEA98,conference-participant,100,50,7/31/2019
7C75FD,earnings,100,50,7/31/2019
7DA412,earnings,100,50,7/31/2019
7DD584,conference-participant,100,50,7/31/2019
7F3A5F,partnership,100,61,7/31/2019
7F3A5F,acquisition-acquiree,100,76,7/31/2019
8.10E+32,executive-appointment,100,54,7/31/2019
8.10E+32,buybacks,100,74,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8.10E+32,earnings,100,50,7/31/2019
8195B7,partnership,100,61,7/31/2019
83066C,trading-resumed,100,58,7/31/2019
83B1C8,earnings,100,50,7/31/2019
85CDC9,partnership,100,61,7/31/2019
85CDC9,earnings,100,50,7/31/2019
8.73E+09,unit-acquisition-completed-acquirer,100,49,7/31/2019
87486A,buybacks,100,74,7/31/2019
87486A,earnings,100,50,7/31/2019
87486A,earnings,100,50,7/31/2019
87486A,earnings,100,50,7/31/2019
87486A,earnings,100,50,7/31/2019
87B81A,revenues,100,50,7/31/2019
87B81A,revenues,100,50,7/31/2019
87B81A,revenues,100,50,7/31/2019
87B81A,revenues,100,50,7/31/2019
87B81A,dividend,100,50,7/31/2019
896771,earnings,100,50,7/31/2019
8A0368,earnings,100,50,7/31/2019
8A0368,earnings,100,50,7/31/2019
8A0368,earnings,100,50,7/31/2019
8A0368,earnings,100,50,7/31/2019
8A8E41,earnings,100,50,7/31/2019
8B1E11,earnings,100,50,7/31/2019
8DBE73,revenues,100,50,7/31/2019
8DBE73,revenues,100,50,7/31/2019
8DBE73,revenues,100,50,7/31/2019
8DCBBB,earnings,100,50,7/31/2019
8E10BF,conference-participant,100,50,7/31/2019
8E4F9A,conference-participant,100,50,7/31/2019
8E9CD8,earnings-up,100,68,7/31/2019
8E9CD8,earnings,100,50,7/31/2019
8E9CD8,earnings,100,50,7/31/2019
8E9CD8,earnings,100,50,7/31/2019
8E9CD8,earnings,100,50,7/31/2019
8EF425,earnings,100,50,7/31/2019
8EF425,earnings,100,50,7/31/2019
8EF425,earnings,100,50,7/31/2019
8EF425,earnings,100,50,7/31/2019
8EF425,earnings,100,50,7/31/2019
8EF425,earnings,100,50,7/31/2019
8F6995,earnings,100,50,7/31/2019
8FF2EF,conference-call,100,50,7/31/2019
900356,earnings,100,50,7/31/2019
901327,earnings,100,50,7/31/2019
901327,earnings,100,50,7/31/2019
901327,earnings,100,50,7/31/2019
901327,earnings,100,50,7/31/2019
902670,dividend,100,50,7/31/2019
913437,earnings,100,50,7/31/2019
9196A2,partnership,100,61,7/31/2019
91E5EE,earnings,100,50,7/31/2019
9.36E+10,fundraising,100,64,7/31/2019
940C3D,earnings,100,50,7/31/2019
94563D,legal-issues-defendant,100,22,7/31/2019
949D62,public-offering,100,43,7/31/2019
94C0B5,dividend,100,50,7/31/2019
958938,conference-call,100,50,7/31/2019
958938,executive-appointment,100,54,7/31/2019
9.65E+09,earnings,100,50,7/31/2019
977A1E,earnings,100,50,7/31/2019
977A1E,earnings,100,50,7/31/2019
977A1E,earnings,100,50,7/31/2019
977A1E,dividend,100,50,7/31/2019
980C14,earnings,100,50,7/31/2019
9.86E+03,earnings,100,50,7/31/2019
9B4066,dividend-up,100,81,7/31/2019
9B730A,business-contract,100,69,7/31/2019
9C5174,executive-appointment,100,54,7/31/2019
9E4A5F,executive-appointment,100,54,7/31/2019
9EA947,earnings,100,50,7/31/2019
9F5997,earnings,100,50,7/31/2019
9F5CBB,dividend,100,50,7/31/2019
9FA83B,conference-call,100,50,7/31/2019
A247F5,buybacks,100,74,7/31/2019
A247F5,earnings-per-share-positive,100,69,7/31/2019
A247F5,earnings-per-share-positive,100,69,7/31/2019
A247F5,earnings-per-share-positive,100,69,7/31/2019
A38F30,earnings,100,50,7/31/2019
A398F8,earnings,100,50,7/31/2019
A3AAA5,earnings,100,50,7/31/2019
A4386C,earnings,100,50,7/31/2019
A4386C,earnings,100,50,7/31/2019
A4386C,earnings,100,50,7/31/2019
A4386C,earnings,100,50,7/31/2019
A47A7D,earnings,100,50,7/31/2019
A60318,ipo-pricing,100,50,7/31/2019
A63387,conference-participant,100,50,7/31/2019
A6FC89,legal-issues-defendant,100,22,7/31/2019
A70BF5,earnings,100,50,7/31/2019
A70BF5,earnings,100,50,7/31/2019
A70BF5,earnings,100,50,7/31/2019
A70BF5,earnings,100,50,7/31/2019
A70BF5,earnings,100,50,7/31/2019
A70BF5,earnings,100,50,7/31/2019
A79D88,earnings,100,50,7/31/2019
A79D88,earnings,100,50,7/31/2019
A79F7D,earnings,100,50,7/31/2019
A80FE0,earnings,100,50,7/31/2019
A87CD6,dividend,100,50,7/31/2019
A9ED24,earnings,100,50,7/31/2019
A9ED24,earnings,100,50,7/31/2019
AA1EAA,earnings,100,50,7/31/2019
AA3AB8,earnings,100,50,7/31/2019
AA847A,earnings,100,50,7/31/2019
AA98ED,dividend,100,50,7/31/2019
AC7AAE,earnings,100,50,7/31/2019
AD3008,earnings,100,50,7/31/2019
AF210D,executive-appointment,100,54,7/31/2019
AF93DE,conference-call,100,50,7/31/2019
B04426,conference-call,100,50,7/31/2019
B09B1F,earnings-up,100,68,7/31/2019
B09B1F,earnings,100,50,7/31/2019
B09B1F,earnings,100,50,7/31/2019
B13B68,earnings,100,50,7/31/2019
B1FC3B,product-release,100,64,7/31/2019
B2206F,conference-participant,100,50,7/31/2019
B290A2,earnings,100,50,7/31/2019
B2AA0A,earnings,100,50,7/31/2019
B72D2E,earnings,100,50,7/31/2019
B72D2E,stake-acquirer,100,48,7/31/2019
B72D2E,stake-acquirer,100,48,7/31/2019
B840EF,earnings,100,50,7/31/2019
B9764A,partnership,100,61,7/31/2019
BA218A,legal-issues-defendant,100,22,7/31/2019
BAAA60,earnings,100,50,7/31/2019
BB02FB,earnings-per-share-positive,100,69,7/31/2019
BB02FB,earnings-per-share,100,50,7/31/2019
BB02FB,earnings-per-share,100,50,7/31/2019
BB02FB,earnings-per-share,100,50,7/31/2019
BB02FB,earnings-per-share,100,50,7/31/2019
BB02FB,partnership,100,61,7/31/2019
BB127B,conference-call,100,50,7/31/2019
BB58FF,conference-organizer,100,57,7/31/2019
BD682F,public-offering,100,43,7/31/2019
C11C46,conference-participant,100,50,7/31/2019
C16A8F,earnings,100,50,7/31/2019
C16A8F,earnings,100,50,7/31/2019
C16A8F,earnings,100,50,7/31/2019
C16A8F,earnings,100,50,7/31/2019
C230FE,earnings-per-share-up,100,68,7/31/2019
C230FE,earnings,100,50,7/31/2019
C2609A,business-contract,100,69,7/31/2019
C2E426,earnings,100,50,7/31/2019
C356AC,earnings,100,50,7/31/2019
C45CE7,dividend,100,50,7/31/2019
C4A912,conference-participant,100,50,7/31/2019
C54140,earnings,100,50,7/31/2019
C5C137,earnings,100,50,7/31/2019
C5D2AE,conference-participant,100,50,7/31/2019
C66B44,earnings,100,50,7/31/2019
C72B8F,award,100,58,7/31/2019
C85A72,facility-open,100,65,7/31/2019
C951A2,earnings,100,50,7/31/2019
C951A2,earnings,100,50,7/31/2019
C951A2,earnings,100,50,7/31/2019
C951A2,earnings,100,50,7/31/2019
C951A2,earnings,100,50,7/31/2019
C951A2,earnings,100,50,7/31/2019
C99CC8,earnings,100,50,7/31/2019
C99CC8,earnings,100,50,7/31/2019
C99CC8,earnings,100,50,7/31/2019
C99CC8,earnings,100,50,7/31/2019
C99CC8,earnings,100,50,7/31/2019
C99CC8,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9D866,earnings,100,50,7/31/2019
C9E04B,conference-call,100,50,7/31/2019
CA14CC,earnings,100,50,7/31/2019
CA14CC,earnings,100,50,7/31/2019
CA14CC,earnings,100,50,7/31/2019
CA212F,earnings,100,50,7/31/2019
CA212F,partnership,100,61,7/31/2019
CA212F,partnership,100,61,7/31/2019
CA212F,partnership,100,61,7/31/2019
CA212F,partnership,100,61,7/31/2019
CBBFBF,earnings-positive,100,69,7/31/2019
CBBFBF,earnings-positive,100,69,7/31/2019
CBBFBF,earnings-positive,100,69,7/31/2019
CBBFBF,earnings-positive,100,69,7/31/2019
CBCC6A,conference-organizer,100,57,7/31/2019
CD2A4D,earnings,100,50,7/31/2019
CDAA0E,executive-appointment,100,54,7/31/2019
CDC217,earnings,100,50,7/31/2019
CDE51C,earnings,100,50,7/31/2019
CE4FD9,earnings,100,50,7/31/2019
CE4FD9,earnings,100,50,7/31/2019
CE4FD9,earnings,100,50,7/31/2019
CE4FD9,earnings,100,50,7/31/2019
CE4FD9,partnership,100,61,7/31/2019
CE4FD9,partnership,100,61,7/31/2019
CE5C6E,earnings,100,50,7/31/2019
CE96E7,product-release,100,64,7/31/2019
CE96E7,earnings,100,50,7/31/2019
CE96E7,earnings,100,50,7/31/2019
CE96E7,earnings,100,50,7/31/2019
CE96E7,earnings,100,50,7/31/2019
CF3FF9,earnings,100,50,7/31/2019
CFF15D,earnings,100,50,7/31/2019
CFF15D,earnings,100,50,7/31/2019
D06755,earnings,100,50,7/31/2019
D06755,earnings,100,50,7/31/2019
D06755,earnings,100,50,7/31/2019
D08D2C,earnings,100,50,7/31/2019
D08D2C,earnings,100,50,7/31/2019
D08D2C,earnings,100,50,7/31/2019
D08D2C,earnings,100,50,7/31/2019
D08D2C,earnings,100,50,7/31/2019
D0909F,earnings,100,50,7/31/2019
D09938,earnings,100,50,7/31/2019
D17F7E,earnings,100,50,7/31/2019
D17F7E,earnings,100,50,7/31/2019
D17F7E,earnings,100,50,7/31/2019
D17F7E,earnings,100,50,7/31/2019
D17F7E,earnings,100,50,7/31/2019
D17F7E,earnings,100,50,7/31/2019
D20C8F,earnings,100,50,7/31/2019
D25249,earnings,100,50,7/31/2019
D29F43,earnings,100,50,7/31/2019
D29F43,buybacks,100,74,7/31/2019
D2B9E5,earnings,100,50,7/31/2019
D2B9E5,earnings,100,50,7/31/2019
D2B9E5,earnings,100,50,7/31/2019
D437C3,conference-participant,100,50,7/31/2019
D4AC65,earnings,100,50,7/31/2019
D4AC65,earnings,100,50,7/31/2019
D4AC65,earnings,100,50,7/31/2019
D4AC65,earnings,100,50,7/31/2019
D4AC65,earnings,100,50,7/31/2019
D4C0CB,conference-participant,100,50,7/31/2019
D54E62,dividend,100,50,7/31/2019
D56D6D,earnings,100,50,7/31/2019
D56E4C,earnings,100,50,7/31/2019
D56E4C,earnings,100,50,7/31/2019
D57D99,dividend,100,50,7/31/2019
D5AF19,fundraising,100,64,7/31/2019
D63B0F,executive-appointment,100,54,7/31/2019
D6489C,award,100,58,7/31/2019
D6853F,dividend,100,50,7/31/2019
D854DD,earnings,100,50,7/31/2019
D9FC89,earnings,100,50,7/31/2019
D9FC89,earnings,100,50,7/31/2019
D9FC89,earnings,100,50,7/31/2019
D9FC89,earnings,100,50,7/31/2019
DA91AE,conference-participant,100,50,7/31/2019
DC2F77,earnings,100,50,7/31/2019
DC437D,earnings,100,50,7/31/2019
DF11D9,dividend,100,50,7/31/2019
E06265,earnings,100,50,7/31/2019
E07573,earnings,100,50,7/31/2019
E07573,earnings,100,50,7/31/2019
E07573,earnings,100,50,7/31/2019
E114F4,ownership-decrease-owner,100,46,7/31/2019
E114F4,earnings,100,50,7/31/2019
E114F4,earnings,100,50,7/31/2019
E114F4,earnings,100,50,7/31/2019
E20392,conference-participant,100,50,7/31/2019
E21871,earnings,100,50,7/31/2019
E259C7,dividend,100,50,7/31/2019
E4CE73,conference-call,100,50,7/31/2019
E70531,dividend,100,50,7/31/2019
E802CE,earnings,100,50,7/31/2019
E82A2D,dividend,100,50,7/31/2019
E866D2,dividend,100,50,7/31/2019
E8846E,earnings-up,100,74,7/31/2019
E8846E,executive-appointment,100,54,7/31/2019
E8C557,earnings,100,50,7/31/2019
EB43F4,business-contract,100,69,7/31/2019
ECD263,legal-issues-defendant,100,22,7/31/2019
ED2A5E,earnings,100,50,7/31/2019
ED2A5E,earnings,100,50,7/31/2019
ED2A5E,earnings,100,50,7/31/2019
ED2A5E,earnings,100,50,7/31/2019
ED2A5E,earnings,100,50,7/31/2019
ED2A5E,earnings,100,50,7/31/2019
ED2A5E,earnings,100,50,7/31/2019
ED2EFD,earnings,100,50,7/31/2019
EE6F1C,earnings-guidance,100,50,7/31/2019
EE74E1,earnings,100,50,7/31/2019
EE74E1,earnings,100,50,7/31/2019
EE74E1,earnings,100,50,7/31/2019
EE74E1,earnings,100,50,7/31/2019
EEBCEF,earnings,100,50,7/31/2019
EEEA9F,earnings,100,50,7/31/2019
EEEA9F,earnings,100,50,7/31/2019
EF5BED,earnings,100,50,7/31/2019
F0B335,business-contract,100,69,7/31/2019
F0EEFB,earnings,100,50,7/31/2019
F0EEFB,earnings,100,50,7/31/2019
F1529C,dividend-up,100,81,7/31/2019
F15E41,earnings,100,50,7/31/2019
F15E41,earnings,100,50,7/31/2019
F15E41,earnings,100,50,7/31/2019
F15E41,earnings,100,50,7/31/2019
F15E41,earnings,100,50,7/31/2019
F179ED,earnings,100,50,7/31/2019
F179ED,earnings,100,50,7/31/2019
F179ED,earnings,100,50,7/31/2019
F179ED,earnings,100,50,7/31/2019
F179ED,earnings,100,50,7/31/2019
F1CD47,earnings,100,50,7/31/2019
F294DD,dividend,100,50,7/31/2019
F2E253,dividend,100,50,7/31/2019
F32F88,earnings,100,50,7/31/2019
F3816D,conference-participant,100,50,7/31/2019
F3FCC3,earnings,100,50,7/31/2019
F3FCC3,earnings,100,50,7/31/2019
F3FCC3,earnings,100,50,7/31/2019
F3FCC3,earnings,100,50,7/31/2019
F3FCC3,earnings,100,50,7/31/2019
F3FCC3,earnings,100,50,7/31/2019
F47871,legal-issues-defendant,100,22,7/31/2019
F50BAB,earnings,100,50,7/31/2019
F50BAB,earnings,100,50,7/31/2019
F50BAB,earnings,100,50,7/31/2019
F50BAB,earnings,100,50,7/31/2019
F6E1B5,earnings,100,50,7/31/2019
F73DD1,earnings,100,50,7/31/2019
F8084B,earnings,100,50,7/31/2019
F8C5D7,operating-earnings,100,50,7/31/2019
F92DBC,asset-sale,100,62,7/31/2019
FA35C6,earnings,100,50,7/31/2019
FA35C6,earnings,100,50,7/31/2019
FAAFA2,conference-participant,100,50,7/31/2019
FACF19,partnership,100,61,7/31/2019
FBD92D,conference-call,100,50,7/31/2019
FC1B7B,executive-appointment,100,54,7/31/2019
FD554E,conference-call,100,50,7/31/2019
FE1A1D,operating-earnings,100,50,7/31/2019
FEC475,earnings,100,50,7/31/2019
FF5413,earnings-positive,100,69,7/31/2019
FF5413,earnings-positive,100,69,7/31/2019
002A99,earnings,100,50,8/1/2019
9397,acquisition-completed-acquirer,100,49,8/1/2019
0142B5,earnings-per-share-positive,100,69,8/1/2019
20751,earnings,100,50,8/1/2019
02ACBD,conference-call,100,50,8/1/2019
03B8CF,legal-issues-defendant,100,22,8/1/2019
03B8CF,asset-sale,100,62,8/1/2019
03B8CF,legal-issues-defendant,100,22,8/1/2019
55018,legal-issues-defendant,100,22,8/1/2019
55018,legal-issues-defendant,100,22,8/1/2019
55018,legal-issues-defendant,100,22,8/1/2019
05D148,patient-enrollment-complete,100,64,8/1/2019
61366,earnings,100,50,8/1/2019
061A3B,earnings,100,50,8/1/2019
075CF7,executive-appointment,100,54,8/1/2019
07CA6A,executive-appointment,100,54,8/1/2019
07CA6A,executive-appointment,100,54,8/1/2019
099A92,executive-appointment,100,54,8/1/2019
0A0D9E,executive-appointment,100,54,8/1/2019
0A0D9E,earnings,100,50,8/1/2019
0A0D9E,earnings,100,50,8/1/2019
0A0D9E,earnings,100,50,8/1/2019
0A59F8,note-sale,100,52,8/1/2019
0A77DB,earnings,100,50,8/1/2019
0B7375,conference-participant,100,50,8/1/2019
0BC853,earnings,100,50,8/1/2019
0BF198,earnings,100,50,8/1/2019
0C355F,earnings,100,50,8/1/2019
0C355F,earnings,100,50,8/1/2019
0C355F,earnings,100,50,8/1/2019
0C355F,earnings,100,50,8/1/2019
0C355F,earnings,100,50,8/1/2019
0C355F,earnings,100,50,8/1/2019
0FE3A6,conference-call,100,50,8/1/2019
105D00,dividend,100,50,8/1/2019
1080C0,earnings,100,50,8/1/2019
1151F4,earnings,100,50,8/1/2019
1151F4,earnings,100,50,8/1/2019
1151F4,earnings,100,50,8/1/2019
1151F4,earnings,100,50,8/1/2019
1151F4,earnings,100,50,8/1/2019
1151F4,earnings,100,50,8/1/2019
13A782,partnership,100,61,8/1/2019
14BA33,trading-listing,100,61,8/1/2019
157CC1,regulatory-product-approval-granted,100,81,8/1/2019
16B183,operating-earnings,100,50,8/1/2019
16C544,earnings,100,50,8/1/2019
1834C0,dividend,100,50,8/1/2019
1834C0,earnings,100,50,8/1/2019
184988,earnings,100,50,8/1/2019
196D18,executive-appointment,100,54,8/1/2019
1AB023,conference-call,100,50,8/1/2019
1AB023,conference-call,100,50,8/1/2019
1AB023,conference-call,100,50,8/1/2019
1B4F31,earnings,100,50,8/1/2019
1B9535,earnings,100,50,8/1/2019
1DEBBE,earnings,100,50,8/1/2019
1E04A5,earnings,100,50,8/1/2019
1E04A5,executive-appointment,100,54,8/1/2019
1F19C8,market-entry,100,57,8/1/2019
1F464F,conference-participant,100,50,8/1/2019
1F9258,earnings,100,50,8/1/2019
1FA886,partnership,100,61,8/1/2019
202E5A,conference-participant,100,50,8/1/2019
202E5A,earnings,100,50,8/1/2019
21022F,earnings,100,50,8/1/2019
219B21,earnings,100,50,8/1/2019
219B21,earnings,100,50,8/1/2019
219B21,earnings,100,50,8/1/2019
219B21,earnings,100,50,8/1/2019
219B21,earnings,100,50,8/1/2019
21DED4,revenues,100,50,8/1/2019
21DED4,revenues,100,50,8/1/2019
21DED4,revenues,100,50,8/1/2019
21DED4,revenues,100,50,8/1/2019
21DED4,revenues,100,50,8/1/2019
21DED4,revenues,100,50,8/1/2019
221AD7,executive-appointment,100,54,8/1/2019
222BF9,dividend,100,50,8/1/2019
227D48,earnings-guidance-up,100,83,8/1/2019
227F04,partnership,100,61,8/1/2019
239106,operating-earnings-positive,100,69,8/1/2019
239106,earnings-per-share,100,50,8/1/2019
239106,earnings-per-share,100,50,8/1/2019
2.45E+15,executive-appointment,100,54,8/1/2019
2.45E+15,dividend,100,50,8/1/2019
24C48B,earnings,100,50,8/1/2019
24CB56,conference-participant,100,50,8/1/2019
24CB56,conference-organizer,100,57,8/1/2019
24FA23,earnings,100,50,8/1/2019
250BEE,earnings,100,50,8/1/2019
250BEE,earnings,100,50,8/1/2019
250BEE,earnings,100,50,8/1/2019
250BEE,earnings,100,50,8/1/2019
250BEE,earnings,100,50,8/1/2019
253B2F,earnings,100,50,8/1/2019
25529C,earnings,100,50,8/1/2019
2571FA,earnings,100,50,8/1/2019
2571FA,earnings,100,50,8/1/2019
2571FA,earnings,100,50,8/1/2019
267718,joint-venture,100,62,8/1/2019
267718,business-contract,100,69,8/1/2019
270305,merger-regulatory-approval,100,81,8/1/2019
270305,merger-regulatory-approval,100,81,8/1/2019
270B78,earnings,100,50,8/1/2019
270B78,dividend,100,50,8/1/2019
275300,note-sale,100,52,8/1/2019
275300,note-sale,100,52,8/1/2019
2A1009,earnings,100,50,8/1/2019
2A1009,earnings,100,50,8/1/2019
2A1009,earnings,100,50,8/1/2019
2A1009,earnings,100,50,8/1/2019
2A1009,earnings,100,50,8/1/2019
2AE625,earnings,100,50,8/1/2019
2B7A40,earnings-per-share-positive,100,69,8/1/2019
2B7A40,earnings-positive,100,69,8/1/2019
2B7A40,earnings-positive,100,69,8/1/2019
2B7A40,earnings-positive,100,69,8/1/2019
2BDC1C,earnings,100,50,8/1/2019
2C19A4,earnings,100,50,8/1/2019
2C19A4,earnings,100,50,8/1/2019
2C19A4,earnings,100,50,8/1/2019
2C19A4,earnings,100,50,8/1/2019
2C19A4,earnings,100,50,8/1/2019
2C3348,earnings,100,50,8/1/2019
2C681C,conference-call,100,50,8/1/2019
2C681C,conference-call,100,50,8/1/2019
2CA60F,legal-issues-defendant,100,22,8/1/2019
2CA60F,legal-issues-defendant,100,22,8/1/2019
2CA60F,legal-issues-defendant,100,22,8/1/2019
2CC71C,conference-call,100,50,8/1/2019
2CC71C,conference-participant,100,50,8/1/2019
2D2D43,earnings,100,50,8/1/2019
2D981A,earnings,100,50,8/1/2019
2DC88B,earnings,100,50,8/1/2019
2EB88B,business-contract,100,69,8/1/2019
2EB88B,business-contract,100,69,8/1/2019
2EB88B,executive-appointment,100,54,8/1/2019
2EB88B,operating-earnings-positive,100,69,8/1/2019
2F7474,acquisition-completed-acquirer,100,49,8/1/2019
30AB63,regulatory-investigation,100,22,8/1/2019
30CBF9,earnings,100,50,8/1/2019
3159AA,earnings,100,50,8/1/2019
31DB20,unit-acquisition-acquiree,100,76,8/1/2019
3471C0,earnings,100,50,8/1/2019
34B97A,executive-appointment,100,54,8/1/2019
35557B,earnings,100,50,8/1/2019
383ADA,earnings,100,50,8/1/2019
387375,earnings,100,50,8/1/2019
3A1C46,public-offering,100,43,8/1/2019
3ACF46,earnings,100,50,8/1/2019
3ACF46,earnings,100,50,8/1/2019
3ACF46,earnings,100,50,8/1/2019
3ACF46,earnings,100,50,8/1/2019
3ACF46,earnings,100,50,8/1/2019
3AF7FD,unit-acquisition-acquirer,100,49,8/1/2019
3B2311,earnings,100,50,8/1/2019
3B37F7,earnings-up,100,68,8/1/2019
3B37F7,earnings-up,100,68,8/1/2019
3B37F7,earnings-up,100,68,8/1/2019
3C7F5F,dividend,100,50,8/1/2019
3DC887,earnings,100,50,8/1/2019
3DDE54,earnings,100,50,8/1/2019
3DDE54,earnings,100,50,8/1/2019
3DDE54,earnings,100,50,8/1/2019
3DDE54,earnings,100,50,8/1/2019
3DDE54,earnings,100,50,8/1/2019
3DDE54,earnings,100,50,8/1/2019
3DE4D1,dividend,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3ED92D,earnings,100,50,8/1/2019
3F6A9C,earnings,100,50,8/1/2019
401072,earnings,100,50,8/1/2019
415188,dividend,100,50,8/1/2019
415188,earnings,100,50,8/1/2019
4290EF,earnings,100,50,8/1/2019
42AABD,partnership,100,61,8/1/2019
450ECB,partnership,100,61,8/1/2019
450ECB,partnership,100,61,8/1/2019
451D61,earnings,100,50,8/1/2019
45ABCC,revenue-up,100,76,8/1/2019
45ABCC,revenue-up,100,76,8/1/2019
45ABCC,revenue-up,100,76,8/1/2019
4649D5,earnings,100,50,8/1/2019
4806CE,earnings,100,50,8/1/2019
4806CE,earnings,100,50,8/1/2019
4806CE,earnings,100,50,8/1/2019
4885C8,earnings,100,50,8/1/2019
499C75,earnings,100,50,8/1/2019
49F4D0,earnings,100,50,8/1/2019
4A3438,legal-issues-defendant,100,22,8/1/2019
4A3438,legal-issues-defendant,100,22,8/1/2019
4B3DC9,merger-completed,100,66,8/1/2019
4BDCA7,conference-participant,100,50,8/1/2019
4C3FE9,earnings,100,50,8/1/2019
4D8124,earnings,100,50,8/1/2019
4E2D94,earnings,100,50,8/1/2019
4E2D94,dividend,100,50,8/1/2019
4EEE7E,earnings,100,50,8/1/2019
4F783B,dividend,100,50,8/1/2019
50070E,earnings,100,50,8/1/2019
504FE2,buybacks,100,74,8/1/2019
504FE2,conference-participant,100,50,8/1/2019
504FE2,index-listing,100,76,8/1/2019
507AE7,dividend,100,50,8/1/2019
50D1EC,conference-participant,100,50,8/1/2019
510EA1,earnings,100,50,8/1/2019
51D876,earnings,100,50,8/1/2019
51D876,earnings,100,50,8/1/2019
51D876,earnings,100,50,8/1/2019
51D876,earnings,100,50,8/1/2019
51D876,earnings,100,50,8/1/2019
524CE4,earnings,100,50,8/1/2019
525A1C,earnings,100,50,8/1/2019
52BF94,executive-resignation,100,44,8/1/2019
52BF94,earnings,100,50,8/1/2019
52BF94,earnings,100,50,8/1/2019
52BF94,earnings,100,50,8/1/2019
54512F,earnings,100,50,8/1/2019
546A27,earnings,100,50,8/1/2019
548AC0,earnings,100,50,8/1/2019
54A713,earnings,100,50,8/1/2019
54F271,revenues,100,50,8/1/2019
556F08,earnings,100,50,8/1/2019
55ACCB,earnings,100,50,8/1/2019
55ACCB,earnings,100,50,8/1/2019
55ACCB,earnings,100,50,8/1/2019
55D0F3,earnings,100,50,8/1/2019
56632F,asset-sale,100,62,8/1/2019
56632F,executive-resignation,100,44,8/1/2019
56632F,dividend,100,50,8/1/2019
56FB7C,dividend-up,100,81,8/1/2019
5704AC,operating-earnings,100,50,8/1/2019
58CA9A,business-contract,100,69,8/1/2019
59DB8C,earnings,100,50,8/1/2019
5A64D5,earnings,100,50,8/1/2019
5B6C11,product-price-cut,100,49,8/1/2019
5B6C11,dividend,100,50,8/1/2019
5D1329,earnings,100,50,8/1/2019
5F1B7B,earnings,100,50,8/1/2019
5F3E74,product-release,100,64,8/1/2019
6284B5,earnings,100,50,8/1/2019
6284B5,earnings,100,50,8/1/2019
6284B5,earnings,100,50,8/1/2019
6284B5,earnings,100,50,8/1/2019
636639,dividend-up,100,52,8/1/2019
63F892,earnings,100,50,8/1/2019
64E615,earnings,100,50,8/1/2019
64E615,earnings,100,50,8/1/2019
64E615,earnings,100,50,8/1/2019
64E615,earnings,100,50,8/1/2019
651C85,earnings,100,50,8/1/2019
651C85,public-offering,100,43,8/1/2019
67303E,earnings,100,50,8/1/2019
68BA15,earnings,100,50,8/1/2019
68E3E0,earnings,100,50,8/1/2019
68E3E0,earnings,100,50,8/1/2019
68E3E0,earnings,100,50,8/1/2019
68E3E0,earnings,100,50,8/1/2019
68E3E0,earnings,100,50,8/1/2019
68E6E9,earnings,100,50,8/1/2019
69494C,earnings,100,50,8/1/2019
6A3C35,earnings,100,50,8/1/2019
6A3C35,earnings,100,50,8/1/2019
6A3C35,earnings,100,50,8/1/2019
6A3C35,earnings,100,50,8/1/2019
6A3C35,earnings,100,50,8/1/2019
6B0784,earnings,100,50,8/1/2019
6B5379,earnings,100,50,8/1/2019
6B6375,conference-call,100,50,8/1/2019
6B67BD,earnings,100,50,8/1/2019
6BD606,dividend,100,50,8/1/2019
6BD606,dividend,100,50,8/1/2019
6D3B7B,dividend,100,50,8/1/2019
6D4636,product-release,100,64,8/1/2019
6D4636,product-release,100,64,8/1/2019
6-Dec-05,public-offering,100,43,8/1/2019
6.00E+19,settlement,100,56,8/1/2019
6.00E+19,earnings,100,50,8/1/2019
6E8864,operating-earnings,100,50,8/1/2019
6F92A9,earnings,100,50,8/1/2019
704B78,earnings,100,50,8/1/2019
713810,partnership,100,61,8/1/2019
719477,earnings,100,50,8/1/2019
719477,earnings,100,50,8/1/2019
719477,earnings,100,50,8/1/2019
71E2EF,business-contract,100,69,8/1/2019
71E2EF,dividend,100,50,8/1/2019
72C2CE,earnings,100,50,8/1/2019
73A71F,earnings,100,50,8/1/2019
741937,earnings,100,50,8/1/2019
741937,earnings,100,50,8/1/2019
741937,earnings,100,50,8/1/2019
7.45E+28,earnings,100,50,8/1/2019
7.49E+07,executive-appointment,100,54,8/1/2019
766047,earnings-positive,100,69,8/1/2019
76BECC,conference-call,100,50,8/1/2019
773A17,conference-participant,100,50,8/1/2019
787D14,conference-call,100,50,8/1/2019
791EC1,dividend,100,50,8/1/2019
793C11,earnings,100,50,8/1/2019
7A3633,business-contract,100,69,8/1/2019
7A3633,earnings,100,50,8/1/2019
7A3633,business-contract,100,69,8/1/2019
7AB859,product-release,100,64,8/1/2019
7B6C88,earnings,100,50,8/1/2019
7B8CB5,earnings,100,50,8/1/2019
7BEA98,earnings,100,50,8/1/2019
7C4F43,earnings,100,50,8/1/2019
7C62A3,earnings,100,50,8/1/2019
7CD98F,earnings,100,50,8/1/2019
7D85A9,earnings,100,50,8/1/2019
7E1D5D,product-release,100,64,8/1/2019
7F3665,earnings,100,50,8/1/2019
805CD8,earnings,100,50,8/1/2019
81EAD4,earnings,100,50,8/1/2019
81EAD4,earnings,100,50,8/1/2019
81EAD4,earnings,100,50,8/1/2019
82FD6D,earnings,100,50,8/1/2019
830BDB,earnings,100,50,8/1/2019
83E0AC,conference-call,100,50,8/1/2019
859D62,executive-appointment,100,54,8/1/2019
86A1B9,earnings-positive,100,69,8/1/2019
86A1B9,partnership,100,61,8/1/2019
893904,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8A8E41,earnings,100,50,8/1/2019
8AC740,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B1F37,earnings,100,50,8/1/2019
8B6E7E,earnings,100,50,8/1/2019
8BAA15,earnings,100,50,8/1/2019
8BAA15,earnings,100,50,8/1/2019
8D4486,product-release,100,64,8/1/2019
8D4486,product-release,100,64,8/1/2019
8D4486,product-release,100,64,8/1/2019
8DE56F,earnings,100,50,8/1/2019
8DE56F,earnings,100,50,8/1/2019
8E82A6,business-contract,100,69,8/1/2019
902255,dividend,100,50,8/1/2019
905356,conference-call,100,50,8/1/2019
915E7B,earnings,100,50,8/1/2019
92B625,conference-call,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
9.36E+10,earnings,100,50,8/1/2019
93AD2E,unit-acquisition-completed-acquiree,100,67,8/1/2019
947B0B,earnings,100,50,8/1/2019
94983E,earnings,100,50,8/1/2019
9546A5,conference-call,100,50,8/1/2019
9548BB,dividend-up,100,72,8/1/2019
95C392,earnings,100,50,8/1/2019
9673BD,dividend,100,50,8/1/2019
967D92,earnings,100,50,8/1/2019
96BFF4,earnings,100,50,8/1/2019
971334,earnings,100,50,8/1/2019
971334,earnings,100,50,8/1/2019
971334,earnings,100,50,8/1/2019
971334,earnings,100,50,8/1/2019
971F7B,earnings,100,50,8/1/2019
971F7B,earnings,100,50,8/1/2019
971F7B,earnings,100,50,8/1/2019
971F7B,earnings,100,50,8/1/2019
97AAF6,earnings,100,50,8/1/2019
97AAF6,earnings,100,50,8/1/2019
97AAF6,earnings,100,50,8/1/2019
9.97E+09,earnings,100,50,8/1/2019
9A602D,dividend,100,50,8/1/2019
9ABD30,earnings,100,50,8/1/2019
9AF3DC,earnings,100,50,8/1/2019
9C009A,earnings,100,50,8/1/2019
9D30A8,acquisition-completed-acquirer,100,49,8/1/2019
9D5FA4,earnings,100,50,8/1/2019
9D6A24,earnings,100,50,8/1/2019
9D6A24,earnings,100,50,8/1/2019
9DDE1B,earnings,100,50,8/1/2019
9E298A,earnings,100,50,8/1/2019
9E298A,earnings,100,50,8/1/2019
9E298A,earnings,100,50,8/1/2019
9E298A,earnings,100,50,8/1/2019
9E3224,earnings,100,50,8/1/2019
9E4A5F,earnings,100,50,8/1/2019
9F048E,earnings,100,50,8/1/2019
9F048E,earnings,100,50,8/1/2019
9F048E,earnings,100,50,8/1/2019
9F048E,earnings,100,50,8/1/2019
9F048E,earnings,100,50,8/1/2019
9F048E,earnings,100,50,8/1/2019
9F71E5,dividend,100,50,8/1/2019
9FB4B7,earnings,100,50,8/1/2019
A15C71,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A16DEA,earnings,100,50,8/1/2019
A1BB98,earnings,100,50,8/1/2019
A1BB98,earnings,100,50,8/1/2019
A1BB98,earnings,100,50,8/1/2019
A1BB98,earnings,100,50,8/1/2019
A1BB98,earnings,100,50,8/1/2019
A1BB98,earnings,100,50,8/1/2019
A1EAC8,earnings,100,50,8/1/2019
A204A7,earnings,100,50,8/1/2019
A28675,earnings,100,50,8/1/2019
A403CF,earnings,100,50,8/1/2019
A43906,earnings,100,50,8/1/2019
A495F7,product-release,100,64,8/1/2019
A4D173,dividend,100,50,8/1/2019
A4D173,dividend,100,50,8/1/2019
A52533,earnings,100,50,8/1/2019
A6FE1C,unit-acquisition-acquirer,100,49,8/1/2019
A7A0C8,conference-participant,100,50,8/1/2019
A7F0A5,earnings,100,50,8/1/2019
A806FA,earnings,100,50,8/1/2019
A806FA,earnings,100,50,8/1/2019
A806FA,earnings,100,50,8/1/2019
A806FA,earnings,100,50,8/1/2019
A80FE0,conference-participant,100,50,8/1/2019
A8FDE8,earnings,100,50,8/1/2019
A8FDE8,earnings,100,50,8/1/2019
A8FDE8,dividend,100,50,8/1/2019
A94637,revenues,100,50,8/1/2019
A94637,revenues,100,50,8/1/2019
AADE0B,unit-acquisition-acquirer,100,49,8/1/2019
AC642C,earnings,100,50,8/1/2019
AC642C,earnings,100,50,8/1/2019
ACD9A4,dividend,100,50,8/1/2019
AEBB80,earnings,100,50,8/1/2019
AF210D,note-sale,100,52,8/1/2019
B05118,earnings,100,50,8/1/2019
B0998E,earnings-up,100,68,8/1/2019
B0998E,earnings,100,50,8/1/2019
B0998E,earnings,100,50,8/1/2019
B1A85D,earnings,100,50,8/1/2019
B1DF3C,earnings,100,50,8/1/2019
B1DF3C,executive-appointment,100,54,8/1/2019
B1FC3B,conference-participant,100,50,8/1/2019
B2256A,earnings,100,50,8/1/2019
B2D492,earnings,100,50,8/1/2019
B303A6,earnings,100,50,8/1/2019
B303A6,earnings,100,50,8/1/2019
B303A6,earnings,100,50,8/1/2019
B303A6,earnings,100,50,8/1/2019
B37FB4,executive-appointment,100,54,8/1/2019
B381D8,earnings,100,50,8/1/2019
B3ED62,earnings,100,50,8/1/2019
B4C673,earnings,100,50,8/1/2019
B4C673,earnings,100,50,8/1/2019
B4C673,earnings,100,50,8/1/2019
B4C673,earnings,100,50,8/1/2019
B4C673,earnings,100,50,8/1/2019
B4C673,earnings,100,50,8/1/2019
B4C673,earnings,100,50,8/1/2019
B5DE80,earnings,100,50,8/1/2019
B614F8,product-release,100,64,8/1/2019
B7EB38,earnings,100,50,8/1/2019
B83BCE,conference-participant,100,50,8/1/2019
B83D67,acquisition-acquiree,100,76,8/1/2019
B83D67,acquisition-acquiree,100,76,8/1/2019
B8DD94,conference-call,100,50,8/1/2019
B934BF,earnings,100,50,8/1/2019
B9CD50,acquisition-acquirer,100,49,8/1/2019
BA0442,earnings,100,50,8/1/2019
BA218A,legal-issues-defendant,100,22,8/1/2019
BA218A,legal-issues-defendant,100,22,8/1/2019
BAAA60,dividend,100,50,8/1/2019
BB127B,acquisition-acquiree,100,76,8/1/2019
BB127B,acquisition-completed-acquirer,100,49,8/1/2019
BB127B,acquisition-completed-acquirer,100,49,8/1/2019
BC5680,legal-issues-defendant,100,22,8/1/2019
BCC13E,conference-participant,100,50,8/1/2019
BD8517,earnings,100,50,8/1/2019
BE7BA4,earnings,100,50,8/1/2019
C01737,earnings,100,50,8/1/2019
C06EB6,earnings,100,50,8/1/2019
C188F8,executive-appointment,100,54,8/1/2019
C2609A,dividend,100,50,8/1/2019
C2DD02,conference-call,100,50,8/1/2019
C2E39B,earnings,100,50,8/1/2019
C2E39B,earnings,100,50,8/1/2019
C564E4,clinical-trials-filed,100,60,8/1/2019
C564E4,earnings,100,50,8/1/2019
C584BE,earnings,100,50,8/1/2019
C58D71,earnings,100,50,8/1/2019
C5E100,earnings,100,50,8/1/2019
C66A8C,earnings,100,50,8/1/2019
C66A8C,earnings,100,50,8/1/2019
C66A8C,earnings,100,50,8/1/2019
C66A8C,earnings,100,50,8/1/2019
C66A8C,earnings,100,50,8/1/2019
C8923A,earnings-up,100,68,8/1/2019
C8A248,earnings,100,50,8/1/2019
C8A248,earnings,100,50,8/1/2019
C8A248,earnings,100,50,8/1/2019
C8A248,earnings,100,50,8/1/2019
C8A248,earnings,100,50,8/1/2019
C8A248,earnings,100,50,8/1/2019
C8A248,earnings,100,50,8/1/2019
C8A248,executive-appointment,100,54,8/1/2019
C8FAC7,partnership,100,61,8/1/2019
C98CDB,earnings,100,50,8/1/2019
C9A96E,earnings,100,50,8/1/2019
CA1620,executive-appointment,100,54,8/1/2019
CB22CD,dividend,100,50,8/1/2019
CB6A9C,earnings,100,50,8/1/2019
CB6A9C,earnings,100,50,8/1/2019
CB6A9C,earnings,100,50,8/1/2019
CB6A9C,earnings,100,50,8/1/2019
CB6A9C,earnings,100,50,8/1/2019
CB6A9C,earnings,100,50,8/1/2019
CB9E13,earnings,100,50,8/1/2019
CBDB4D,conference-call,100,50,8/1/2019
CBFFDD,dividend,100,50,8/1/2019
CD4DA8,note-sale,100,52,8/1/2019
CDAA0E,earnings,100,50,8/1/2019
CDE118,earnings,100,50,8/1/2019
CEC5B9,earnings,100,50,8/1/2019
CEC5B9,earnings,100,50,8/1/2019
CEC5B9,earnings,100,50,8/1/2019
CEDFD5,unit-acquisition-completed-acquiree,100,67,8/1/2019
CEDFD5,unit-acquisition-completed-acquiree,100,67,8/1/2019
CFD4B6,earnings-positive,100,69,8/1/2019
CFF97C,earnings,100,50,8/1/2019
CFF97C,earnings,100,50,8/1/2019
CFF97C,earnings,100,50,8/1/2019
CFF97C,earnings,100,50,8/1/2019
CFF97C,earnings,100,50,8/1/2019
CFF97C,conference-participant,100,50,8/1/2019
D03C7A,earnings,100,50,8/1/2019
D0DE27,earnings,100,50,8/1/2019
D1588D,conference-participant,100,50,8/1/2019
D3FD6D,revenues,100,50,8/1/2019
D3FD6D,revenues,100,50,8/1/2019
D3FD6D,revenues,100,50,8/1/2019
D4070C,dividend,100,50,8/1/2019
D4070C,dividend,100,50,8/1/2019
D4463B,note-sale,100,52,8/1/2019
D4463B,note-sale,100,52,8/1/2019
D650A7,dividend,100,50,8/1/2019
D65A13,revenues,100,50,8/1/2019
D65A13,revenues,100,50,8/1/2019
D65A13,revenues,100,50,8/1/2019
D6853F,earnings,100,50,8/1/2019
D6853F,earnings,100,50,8/1/2019
D6853F,earnings,100,50,8/1/2019
D8760C,dividend,100,50,8/1/2019
D8C09D,earnings,100,50,8/1/2019
DA9443,earnings,100,50,8/1/2019
DB7014,operating-earnings,100,50,8/1/2019
DC0D18,earnings,100,50,8/1/2019
DC0D18,earnings,100,50,8/1/2019
DC0D18,earnings,100,50,8/1/2019
DC0D18,earnings,100,50,8/1/2019
DC437D,dividend,100,50,8/1/2019
DD0F15,earnings,100,50,8/1/2019
DDCB34,dividend,100,50,8/1/2019
DDCB34,earnings,100,50,8/1/2019
DE20DF,operating-earnings,100,50,8/1/2019
DE4924,dividend,100,50,8/1/2019
DE4924,earnings,100,50,8/1/2019
DF18E6,executive-appointment,100,54,8/1/2019
DF1F7A,earnings,100,50,8/1/2019
DF5F14,conference-call,100,50,8/1/2019
DFADDB,earnings,100,50,8/1/2019
E09E2B,conference-call,100,50,8/1/2019
E0D3BA,earnings,100,50,8/1/2019
E13782,earnings,100,50,8/1/2019
E28D9C,business-contract,100,69,8/1/2019
E2F66E,earnings,100,50,8/1/2019
E35610,earnings,100,50,8/1/2019
E35610,earnings,100,50,8/1/2019
E35610,earnings,100,50,8/1/2019
E3E68E,earnings,100,50,8/1/2019
E3E68E,earnings,100,50,8/1/2019
E49AA3,earnings,100,50,8/1/2019
E4CE73,product-release,100,64,8/1/2019
E71AE6,conference-call,100,50,8/1/2019
E74FED,earnings,100,50,8/1/2019
E866D2,partnership,100,61,8/1/2019
E866D2,product-release,100,64,8/1/2019
E866D2,partnership,100,61,8/1/2019
E866D2,executive-appointment,100,54,8/1/2019
E866D2,executive-appointment,100,54,8/1/2019
E8846E,conference-organizer,100,57,8/1/2019
E8846E,donation,100,54,8/1/2019
E8B21D,index-listing,100,76,8/1/2019
ECD263,legal-issues-defendant,100,22,8/1/2019
ECD263,legal-issues-defendant,100,22,8/1/2019
ED7F13,earnings,100,50,8/1/2019
ED9576,dividend,100,50,8/1/2019
EE6F1C,business-contract,100,69,8/1/2019
EE967B,conference-participant,100,50,8/1/2019
EF7163,earnings,100,50,8/1/2019
EFD406,earnings,100,50,8/1/2019
EFD406,earnings,100,50,8/1/2019
EFD406,earnings,100,50,8/1/2019
EFD406,earnings,100,50,8/1/2019
EFD406,earnings,100,50,8/1/2019
EFD406,earnings,100,50,8/1/2019
F0027C,earnings,100,50,8/1/2019
F02170,legal-issues-defendant,100,22,8/1/2019
F02D0A,earnings-up,100,68,8/1/2019
F02D0A,earnings,100,50,8/1/2019
F11638,earnings,100,50,8/1/2019
F1529C,product-release,100,64,8/1/2019
F3016C,earnings,100,50,8/1/2019
F3016C,earnings,100,50,8/1/2019
F3016C,earnings,100,50,8/1/2019
F3016C,earnings,100,50,8/1/2019
F3816D,earnings,100,50,8/1/2019
F3FCC3,dividend,100,50,8/1/2019
F44EA2,dividend-up,100,61,8/1/2019
F46EC9,earnings-up,100,55,8/1/2019
F46EC9,earnings,100,50,8/1/2019
F46EC9,earnings,100,50,8/1/2019
F46EC9,earnings,100,50,8/1/2019
F46EC9,earnings,100,50,8/1/2019
F46EC9,earnings,100,50,8/1/2019
F46EC9,earnings,100,50,8/1/2019
F48947,earnings,100,50,8/1/2019
F48947,earnings,100,50,8/1/2019
F4CDA3,earnings,100,50,8/1/2019
F4CDA3,earnings,100,50,8/1/2019
F4CDA3,earnings,100,50,8/1/2019
F4CDA3,earnings,100,50,8/1/2019
F4CDA3,earnings,100,50,8/1/2019
F4CDA3,earnings,100,50,8/1/2019
F4CDA3,earnings,100,50,8/1/2019
F4CDA3,unit-acquisition-acquirer,100,49,8/1/2019
F4CDA3,unit-acquisition-acquirer,100,49,8/1/2019
F4E882,note-sale,100,52,8/1/2019
F4E882,note-sale,100,52,8/1/2019
F4F46F,earnings,100,50,8/1/2019
F51DB0,earnings,100,50,8/1/2019
F721A7,earnings,100,50,8/1/2019
F7902B,conference-participant,100,50,8/1/2019
F85CC0,earnings,100,50,8/1/2019
F85CC0,earnings,100,50,8/1/2019
F88147,earnings,100,50,8/1/2019
F8BA6C,conference-participant,100,50,8/1/2019
F93C8A,earnings,100,50,8/1/2019
FAAFA2,earnings,100,50,8/1/2019
FAB97A,earnings,100,50,8/1/2019
FC9869,earnings,100,50,8/1/2019
FC9869,earnings,100,50,8/1/2019
FD4588,earnings,100,50,8/1/2019
FD4588,earnings,100,50,8/1/2019
FD4588,earnings,100,50,8/1/2019
FD6926,clinical-trials,100,56,8/1/2019
FD6926,earnings,100,50,8/1/2019
FD6926,earnings,100,50,8/1/2019
FD6926,earnings,100,50,8/1/2019
FD6926,earnings,100,50,8/1/2019
FD6926,earnings,100,50,8/1/2019
FD6926,earnings,100,50,8/1/2019
FD6926,dividend,100,50,8/1/2019
FDF799,earnings,100,50,8/1/2019
FDF799,earnings,100,50,8/1/2019
FDF799,earnings,100,50,8/1/2019
FEE4B0,earnings-up,100,68,8/1/2019
FEE4B0,earnings-up,100,68,8/1/2019
FEE4B0,earnings-up,100,68,8/1/2019
FEE4B0,earnings-up,100,68,8/1/2019
FEE4B0,earnings-up,100,68,8/1/2019
FF227B,earnings,100,50,8/1/2019
002A99,earnings,100,50,8/2/2019
13528,earnings,100,50,8/2/2019
0325B7,earnings,100,50,8/2/2019
03542C,earnings,100,50,8/2/2019
03B8CF,legal-issues-defendant,100,22,8/2/2019
43862,earnings,100,50,8/2/2019
55018,legal-issues-defendant,100,22,8/2/2019
0624BE,earnings,100,50,8/2/2019
71860,conference-participant,100,50,8/2/2019
0A59F8,earnings,100,50,8/2/2019
0A748B,earnings,100,50,8/2/2019
0BD4E8,earnings,100,50,8/2/2019
0BD4E8,earnings,100,50,8/2/2019
0BD4E8,earnings,100,50,8/2/2019
0BD4E8,earnings,100,50,8/2/2019
0E64D4,earnings,100,50,8/2/2019
0E64D4,earnings,100,50,8/2/2019
0E64D4,earnings,100,50,8/2/2019
0E64D4,earnings,100,50,8/2/2019
152AB9,merger-regulatory-approval,100,81,8/2/2019
1921DD,unit-acquisition-acquiree,100,76,8/2/2019
1A6A94,earnings,100,50,8/2/2019
1B16C1,legal-issues-defendant,100,22,8/2/2019
1B16C1,legal-issues-defendant,100,22,8/2/2019
1E83DE,conference-participant,100,50,8/2/2019
1F43A1,earnings,100,50,8/2/2019
1FE7F0,earnings,100,50,8/2/2019
1FE7F0,earnings,100,50,8/2/2019
1FE7F0,earnings,100,50,8/2/2019
1FE7F0,earnings,100,50,8/2/2019
1FE7F0,earnings,100,50,8/2/2019
1FE7F0,earnings,100,50,8/2/2019
21153F,buybacks,100,74,8/2/2019
21153F,buybacks,100,74,8/2/2019
24CB56,conference-organizer,100,57,8/2/2019
2BF36E,earnings-up,100,68,8/2/2019
2BF36E,earnings,100,50,8/2/2019
2BF36E,earnings,100,50,8/2/2019
2BF36E,earnings,100,50,8/2/2019
2BF36E,earnings,100,50,8/2/2019
2CA60F,legal-issues-defendant,100,22,8/2/2019
2CA60F,conference-participant,100,50,8/2/2019
353DBB,dividend-up,100,57,8/2/2019
3587B4,legal-issues-defendant,100,22,8/2/2019
3587B4,legal-issues-defendant,100,22,8/2/2019
3587B4,legal-issues-defendant,100,22,8/2/2019
35F4B5,dividend,100,50,8/2/2019
36E479,earnings,100,50,8/2/2019
37B120,earnings,100,50,8/2/2019
38C46F,dividend,100,50,8/2/2019
423279,dividend,100,50,8/2/2019
427F32,dividend,100,50,8/2/2019
450ECB,executive-appointment,100,54,8/2/2019
45BC35,conference-participant,100,50,8/2/2019
4A3438,legal-issues-defendant,100,22,8/2/2019
4A3438,legal-issues-defendant,100,22,8/2/2019
4A3438,legal-issues-defendant,100,22,8/2/2019
4B5054,earnings,100,50,8/2/2019
4C350A,earnings,100,50,8/2/2019
4C350A,earnings,100,50,8/2/2019
52B567,legal-issues-defendant,100,22,8/2/2019
543900,business-contract,100,69,8/2/2019
543900,business-contract,100,69,8/2/2019
583223,earnings,100,50,8/2/2019
5DE5A5,executive-appointment,100,54,8/2/2019
636BBF,legal-issues-defendant,100,22,8/2/2019
6B236C,dividend,100,50,8/2/2019
726EEA,earnings-up,100,68,8/2/2019
726EEA,earnings-up,100,68,8/2/2019
726EEA,earnings-up,100,68,8/2/2019
726EEA,earnings-up,100,68,8/2/2019
73A71F,unit-acquisition-acquirer,100,49,8/2/2019
743C70,earnings,100,50,8/2/2019
743C70,earnings,100,50,8/2/2019
76BD96,dividend-up,100,81,8/2/2019
76BD96,earnings,100,50,8/2/2019
76BD96,earnings,100,50,8/2/2019
76F067,dividend,100,50,8/2/2019
7823A3,conference-participant,100,50,8/2/2019
789A7D,earnings,100,50,8/2/2019
789A7D,earnings,100,50,8/2/2019
789A7D,earnings,100,50,8/2/2019
7ACBA4,earnings,100,50,8/2/2019
7ACD98,hirings,100,65,8/2/2019
7B8CB5,dividend,100,50,8/2/2019
7BC92D,earnings,100,50,8/2/2019
7F2922,earnings,100,50,8/2/2019
848C0B,earnings,100,50,8/2/2019
8FF2EF,dividend,100,50,8/2/2019
92B73F,dividend,100,50,8/2/2019
940C3D,dividend,100,50,8/2/2019
949D62,conference-participant,100,50,8/2/2019
949D62,public-offering,100,43,8/2/2019
9592FB,earnings,100,50,8/2/2019
95F59E,earnings,100,50,8/2/2019
95F59E,earnings,100,50,8/2/2019
95F59E,earnings,100,50,8/2/2019
95F59E,earnings,100,50,8/2/2019
9.65E+07,conference-call,100,50,8/2/2019
9.86E+03,conference-participant,100,50,8/2/2019
98D33E,earnings,100,50,8/2/2019
9981C6,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
9E9147,earnings,100,50,8/2/2019
A4BCDE,earnings,100,50,8/2/2019
A52B6B,earnings,100,50,8/2/2019
A6FC89,conference-participant,100,50,8/2/2019
AB7726,dividend,100,50,8/2/2019
AE79CD,earnings,100,50,8/2/2019
AE7D16,earnings,100,50,8/2/2019
B4B281,conference-call,100,50,8/2/2019
B642E8,earnings,100,50,8/2/2019
B642E8,earnings,100,50,8/2/2019
B77F14,earnings,100,50,8/2/2019
B77F14,earnings,100,50,8/2/2019
BA0442,trading-delisting,100,36,8/2/2019
BB58FF,conference-participant,100,50,8/2/2019
BD8517,conference-participant,100,50,8/2/2019
C0200F,buybacks,100,74,8/2/2019
C3BCD5,earnings,100,50,8/2/2019
C3DE7D,earnings,100,50,8/2/2019
C9C62A,earnings,100,50,8/2/2019
CBFFDD,executive-appointment,100,54,8/2/2019
CBFFDD,conference-participant,100,50,8/2/2019
CF351E,earnings,100,50,8/2/2019
CF351E,earnings,100,50,8/2/2019
CF351E,earnings,100,50,8/2/2019
D11C1C,conference-call,100,50,8/2/2019
D54E62,earnings-positive,100,69,8/2/2019
D54E62,earnings-positive,100,69,8/2/2019
D54E62,earnings-positive,100,69,8/2/2019
D54E62,earnings-positive,100,69,8/2/2019
D64EDF,earnings-above-expectations,100,88,8/2/2019
D64EDF,earnings,100,50,8/2/2019
D64EDF,earnings,100,50,8/2/2019
D64EDF,earnings,100,50,8/2/2019
D854F3,acquisition-acquirer,100,49,8/2/2019
D854F3,earnings,100,50,8/2/2019
D8DA3D,earnings,100,50,8/2/2019
D8DA3D,earnings,100,50,8/2/2019
D8DA3D,earnings,100,50,8/2/2019
D8DA3D,earnings,100,50,8/2/2019
D8DA3D,earnings,100,50,8/2/2019
D8DA3D,earnings,100,50,8/2/2019
DB23C8,earnings,100,50,8/2/2019
DB23C8,earnings,100,50,8/2/2019
DB23C8,earnings,100,50,8/2/2019
DF204B,revenue-up,100,69,8/2/2019
E70531,earnings,100,50,8/2/2019
E70531,earnings,100,50,8/2/2019
E70531,earnings,100,50,8/2/2019
E70531,earnings,100,50,8/2/2019
E70531,earnings,100,50,8/2/2019
E8846E,conference-organizer,100,57,8/2/2019
E8B21D,index-listing,100,76,8/2/2019
E959F3,dividend,100,50,8/2/2019
EBC84C,dividend,100,50,8/2/2019
EE04F0,earnings,100,50,8/2/2019
EE04F0,earnings,100,50,8/2/2019
EE04F0,earnings,100,50,8/2/2019
EE04F0,earnings,100,50,8/2/2019
EF45B6,earnings,100,50,8/2/2019
F1529C,earnings,100,50,8/2/2019
F1529C,earnings,100,50,8/2/2019
F1C04C,dividend,100,50,8/2/2019
F1CD47,dividend,100,50,8/2/2019
F47871,legal-issues-defendant,100,22,8/2/2019
F5349B,note-sale,100,52,8/2/2019
F73DD1,dividend,100,50,8/2/2019
FAB97A,earnings,100,50,8/2/2019
FACF19,merger-regulatory-approval,100,81,8/2/2019
FDD3FC,earnings,100,50,8/2/2019
03B8CF,acquisition-acquiree,100,76,8/3/2019
0BD970,earnings,100,50,8/3/2019
3587B4,legal-issues-defendant,100,22,8/3/2019
3587B4,legal-issues-defendant,100,22,8/3/2019
BA218A,legal-issues-defendant,100,22,8/3/2019
BA218A,legal-issues-defendant,100,22,8/3/2019
C01737,clinical-trials,100,56,8/3/2019
790C34,earnings,100,50,8/4/2019
7BFF81,acquisition-acquirer,100,49,8/4/2019
B2206F,legal-issues-defendant,100,22,8/4/2019
003B70,operating-earnings,100,50,8/5/2019
01D03F,executive-appointment,100,54,8/5/2019
01D03F,executive-appointment,100,54,8/5/2019
02FC1A,legal-issues-defendant,100,22,8/5/2019
02FC1A,earnings,100,50,8/5/2019
02FC1A,earnings,100,50,8/5/2019
03B8CF,legal-issues-defendant,100,22,8/5/2019
040DBB,earnings,100,50,8/5/2019
04EB2F,earnings,100,50,8/5/2019
054B55,executive-appointment,100,54,8/5/2019
07EC43,conference-participant,100,50,8/5/2019
095A04,executive-appointment,100,54,8/5/2019
099A92,dividend,100,50,8/5/2019
09DE1F,product-release,100,64,8/5/2019
09F623,conference-participant,100,50,8/5/2019
0B7375,earnings,100,50,8/5/2019
0E5223,operating-earnings,100,50,8/5/2019
0E5619,conference-call,100,50,8/5/2019
0F04E5,conference-participant,100,50,8/5/2019
0F0693,settlement,100,56,8/5/2019
0FE3A6,earnings,100,50,8/5/2019
11A49E,earnings,100,50,8/5/2019
139303,acquisition-completed-acquirer,100,49,8/5/2019
13D576,acquisition-completed-acquirer,100,49,8/5/2019
15901B,earnings,100,50,8/5/2019
15901B,earnings,100,50,8/5/2019
15B10D,earnings,100,50,8/5/2019
15B10D,earnings,100,50,8/5/2019
15B10D,earnings,100,50,8/5/2019
17EDA5,partnership,100,61,8/5/2019
1921DD,unit-acquisition-completed-acquiree,100,67,8/5/2019
1B16C1,earnings,100,50,8/5/2019
1B16C1,legal-issues-defendant,100,22,8/5/2019
1D943E,earnings,100,50,8/5/2019
1E4FB9,earnings,100,50,8/5/2019
1E9A6D,executive-appointment,100,54,8/5/2019
1F19C8,market-entry,100,57,8/5/2019
21245F,conference-call,100,50,8/5/2019
2158DF,conference-participant,100,50,8/5/2019
2158DF,earnings-up,100,68,8/5/2019
2158DF,earnings-up,100,68,8/5/2019
2158DF,earnings-up,100,68,8/5/2019
2158DF,earnings-up,100,68,8/5/2019
238302,earnings,100,50,8/5/2019
241AF7,earnings,100,50,8/5/2019
249674,earnings,100,50,8/5/2019
249674,earnings,100,50,8/5/2019
249674,earnings,100,50,8/5/2019
249674,earnings,100,50,8/5/2019
24CB56,conference-organizer,100,57,8/5/2019
24CB56,conference-organizer,100,57,8/5/2019
24CB56,conference-organizer,100,57,8/5/2019
2571FA,conference-participant,100,50,8/5/2019
279916,executive-appointment,100,54,8/5/2019
27A791,earnings,100,50,8/5/2019
27A791,earnings,100,50,8/5/2019
27A791,earnings,100,50,8/5/2019
27A791,earnings,100,50,8/5/2019
27A791,executive-appointment,100,54,8/5/2019
295F9F,earnings,100,50,8/5/2019
297DA8,earnings,100,50,8/5/2019
29CEBF,earnings,100,50,8/5/2019
29CEBF,earnings,100,50,8/5/2019
29CEBF,earnings,100,50,8/5/2019
29CEBF,earnings,100,50,8/5/2019
2C35B5,conference-participant,100,50,8/5/2019
2C681C,settlement,100,56,8/5/2019
2C681C,settlement,100,56,8/5/2019
2F5256,conference-participant,100,50,8/5/2019
2F9304,earnings,100,50,8/5/2019
2F98A5,earnings,100,50,8/5/2019
306623,earnings,100,50,8/5/2019
31803E,conference-participant,100,50,8/5/2019
337024,earnings,100,50,8/5/2019
337024,earnings,100,50,8/5/2019
337024,earnings,100,50,8/5/2019
343996,earnings,100,50,8/5/2019
3587B4,legal-issues-defendant,100,22,8/5/2019
36529A,earnings,100,50,8/5/2019
366A08,legal-issues-defendant,100,22,8/5/2019
37426C,earnings,100,50,8/5/2019
37B120,earnings,100,50,8/5/2019
385DD4,earnings,100,50,8/5/2019
385DD4,product-release,100,64,8/5/2019
389CFB,earnings,100,50,8/5/2019
3ACF46,conference-participant,100,50,8/5/2019
40F7DE,conference-call,100,50,8/5/2019
415188,partnership,100,61,8/5/2019
429BFB,earnings,100,50,8/5/2019
435ACE,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
43A74A,earnings,100,50,8/5/2019
450ECB,earnings,100,50,8/5/2019
46A16E,earnings,100,50,8/5/2019
485445,earnings,100,50,8/5/2019
485445,earnings,100,50,8/5/2019
485445,earnings,100,50,8/5/2019
485445,earnings,100,50,8/5/2019
485445,earnings,100,50,8/5/2019
485445,earnings,100,50,8/5/2019
490D4B,earnings,100,50,8/5/2019
4.91E+58,executive-appointment,100,54,8/5/2019
49BBBC,executive-appointment,100,54,8/5/2019
4A2457,government-contract,100,69,8/5/2019
4C31F3,earnings,100,50,8/5/2019
4C350A,conference-call,100,50,8/5/2019
4D229C,earnings,100,50,8/5/2019
4D8124,product-release,100,64,8/5/2019
4DD09F,executive-appointment,100,54,8/5/2019
553949,executive-appointment,100,54,8/5/2019
57EF50,earnings,100,50,8/5/2019
57EF50,earnings,100,50,8/5/2019
57EF50,earnings,100,50,8/5/2019
59872F,conference-call,100,50,8/5/2019
5B3415,earnings,100,50,8/5/2019
619882,conference-organizer,100,57,8/5/2019
619882,conference-organizer,100,57,8/5/2019
61A586,earnings,100,50,8/5/2019
64FF65,earnings,100,50,8/5/2019
665618,conference-participant,100,50,8/5/2019
665D7D,regulatory-product-application,100,69,8/5/2019
6830FE,executive-appointment,100,54,8/5/2019
6844D2,legal-issues-defendant,100,22,8/5/2019
693ECD,earnings,100,50,8/5/2019
694749,earnings,100,50,8/5/2019
694749,earnings,100,50,8/5/2019
694749,earnings,100,50,8/5/2019
694749,earnings,100,50,8/5/2019
698FF9,earnings,100,50,8/5/2019
6A171E,executive-appointment,100,54,8/5/2019
6A171E,earnings,100,50,8/5/2019
6BD606,earnings-positive,100,69,8/5/2019
6BD606,earnings-positive,100,69,8/5/2019
6D0CAB,earnings,100,50,8/5/2019
6F39FC,earnings,100,50,8/5/2019
6F3FA8,earnings,100,50,8/5/2019
6F3FA8,earnings,100,50,8/5/2019
6F3FA8,earnings,100,50,8/5/2019
6F3FA8,earnings,100,50,8/5/2019
717DB4,earnings,100,50,8/5/2019
717DB4,earnings,100,50,8/5/2019
717DB4,earnings,100,50,8/5/2019
717DB4,earnings,100,50,8/5/2019
717DB4,earnings,100,50,8/5/2019
7239BB,executive-appointment,100,54,8/5/2019
732A9B,earnings,100,50,8/5/2019
7.44E+09,earnings,100,50,8/5/2019
763724,unit-acquisition-acquirer,100,49,8/5/2019
7712CB,dividend,100,50,8/5/2019
7712CB,earnings,100,50,8/5/2019
7712CB,earnings,100,50,8/5/2019
7712CB,earnings,100,50,8/5/2019
7712CB,earnings,100,50,8/5/2019
7712CB,earnings,100,50,8/5/2019
7712CB,earnings,100,50,8/5/2019
7712CB,dividend,100,50,8/5/2019
77F01E,partnership,100,61,8/5/2019
789A7D,public-offering,100,43,8/5/2019
797C20,earnings,100,50,8/5/2019
7A2A49,earnings,100,50,8/5/2019
7A5097,product-release,100,64,8/5/2019
7A51FE,earnings,100,50,8/5/2019
7C790D,earnings,100,50,8/5/2019
7E3F8F,executive-appointment,100,54,8/5/2019
7E3F8F,executive-appointment,100,54,8/5/2019
7EA323,earnings,100,50,8/5/2019
7F3A5F,earnings,100,50,8/5/2019
803FED,earnings,100,50,8/5/2019
82E58A,note-sale,100,52,8/5/2019
83066C,earnings,100,50,8/5/2019
834152,earnings,100,50,8/5/2019
83A065,earnings,100,50,8/5/2019
85DA04,award,100,58,8/5/2019
86F123,earnings-positive,100,69,8/5/2019
877C0C,earnings,100,50,8/5/2019
8.79E+06,earnings,100,50,8/5/2019
890FF4,earnings,100,50,8/5/2019
890FF4,earnings,100,50,8/5/2019
890FF4,earnings,100,50,8/5/2019
890FF4,earnings,100,50,8/5/2019
890FF4,earnings,100,50,8/5/2019
890FF4,earnings,100,50,8/5/2019
8A0368,buybacks,100,74,8/5/2019
8AB85C,earnings,100,50,8/5/2019
8B6E7E,legal-issues-defendant,100,22,8/5/2019
8D4486,partnership,100,61,8/5/2019
8DE56F,buybacks,100,74,8/5/2019
8DE56F,buybacks,100,74,8/5/2019
8DE74B,dividend,100,50,8/5/2019
8E3F58,executive-appointment,100,54,8/5/2019
8E3F58,earnings,100,50,8/5/2019
8EF425,note-sale,100,52,8/5/2019
8EF425,note-sale,100,52,8/5/2019
90D6A5,earnings,100,50,8/5/2019
90D6A5,earnings,100,50,8/5/2019
90D6A5,earnings,100,50,8/5/2019
90D6A5,earnings,100,50,8/5/2019
92B625,partnership,100,61,8/5/2019
938D89,earnings,100,50,8/5/2019
94563D,legal-issues-defendant,100,22,8/5/2019
957A07,earnings,100,50,8/5/2019
9592FB,conference-participant,100,50,8/5/2019
968103,earnings,100,50,8/5/2019
968B00,earnings-positive,100,69,8/5/2019
968B00,earnings-positive,100,69,8/5/2019
97B027,earnings,100,50,8/5/2019
97B027,earnings,100,50,8/5/2019
97B027,earnings,100,50,8/5/2019
9810C0,conference-participant,100,50,8/5/2019
98CEBB,earnings,100,50,8/5/2019
9978F1,earnings,100,50,8/5/2019
99ACAD,earnings,100,50,8/5/2019
99ACAD,earnings,100,50,8/5/2019
9C5174,revenues,100,50,8/5/2019
9C5174,revenues,100,50,8/5/2019
9D30A8,conference-participant,100,50,8/5/2019
9E575E,earnings,100,50,8/5/2019
9F5997,conference-participant,100,50,8/5/2019
A01664,earnings,100,50,8/5/2019
A1E3B3,earnings,100,50,8/5/2019
A350C1,dividend,100,50,8/5/2019
A3800A,dividend,100,50,8/5/2019
A495F7,earnings,100,50,8/5/2019
A60318,ipo-completed,100,76,8/5/2019
A63387,dividend,100,50,8/5/2019
A7102F,stake-acquirer,100,48,8/5/2019
AA09AD,legal-issues-defendant,100,22,8/5/2019
AA247D,loan-provider,100,57,8/5/2019
AA98ED,partnership,100,61,8/5/2019
AC7AAE,conference-participant,100,50,8/5/2019
ACC7D3,clinical-trials-start,100,64,8/5/2019
AD1ACF,earnings,100,50,8/5/2019
AEF2C3,earnings,100,50,8/5/2019
AEFC90,earnings,100,50,8/5/2019
B01111,earnings,100,50,8/5/2019
B01215,conference-call,100,50,8/5/2019
B0FE08,earnings,100,50,8/5/2019
B0FE08,earnings,100,50,8/5/2019
B0FE08,earnings,100,50,8/5/2019
B0FE08,earnings,100,50,8/5/2019
B106FA,earnings,100,50,8/5/2019
B1DF3C,conference-participant,100,50,8/5/2019
B2206F,award,100,58,8/5/2019
B5BA39,legal-issues-defendant,100,22,8/5/2019
B73395,earnings,100,50,8/5/2019
B73395,earnings,100,50,8/5/2019
B73395,earnings,100,50,8/5/2019
B73395,earnings,100,50,8/5/2019
B73395,earnings,100,50,8/5/2019
B7FA9B,earnings-up,100,68,8/5/2019
B7FA9B,earnings,100,50,8/5/2019
B7FA9B,earnings,100,50,8/5/2019
B7FA9B,earnings,100,50,8/5/2019
B7FA9B,earnings,100,50,8/5/2019
B8DD94,executive-appointment,100,54,8/5/2019
B96637,business-contract,100,69,8/5/2019
B98EFA,loan-recipient,100,59,8/5/2019
B9CD50,earnings,100,50,8/5/2019
BA218A,legal-issues-defendant,100,22,8/5/2019
BB58FF,earnings,100,50,8/5/2019
BBF349,executive-appointment,100,54,8/5/2019
BC5680,partnership,100,61,8/5/2019
BDEC1E,conference-call,100,50,8/5/2019
BF5959,business-contract,100,69,8/5/2019
C11C46,earnings,100,50,8/5/2019
C16A8F,buybacks,100,74,8/5/2019
C62AA4,earnings,100,50,8/5/2019
C6C702,conference-participant,100,50,8/5/2019
C8FAC7,legal-issues-defendant,100,22,8/5/2019
C9732E,earnings,100,50,8/5/2019
C9732E,public-offering,100,43,8/5/2019
C9E04B,product-release,100,64,8/5/2019
C9E04B,product-release,100,64,8/5/2019
C9E04B,product-release,100,64,8/5/2019
CDE51C,partnership,100,61,8/5/2019
CDFCC9,market-entry,100,57,8/5/2019
CE4E6D,earnings-up,100,68,8/5/2019
CE4E6D,earnings-up,100,68,8/5/2019
CE4E6D,earnings-up,100,68,8/5/2019
CE4E6D,earnings-up,100,68,8/5/2019
CEC08B,acquisition-acquirer,100,49,8/5/2019
CEC08B,acquisition-acquirer,100,49,8/5/2019
CEC08B,acquisition-acquirer,100,49,8/5/2019
CEC08B,earnings-positive,100,69,8/5/2019
CF3FF9,executive-appointment,100,54,8/5/2019
CFF97C,partnership,100,61,8/5/2019
D13F1C,earnings,100,50,8/5/2019
D13F1C,earnings,100,50,8/5/2019
D13F1C,earnings,100,50,8/5/2019
D13F1C,earnings,100,50,8/5/2019
D13F1C,earnings,100,50,8/5/2019
D13F1C,earnings,100,50,8/5/2019
D15833,conference-call,100,50,8/5/2019
D6144F,conference-participant,100,50,8/5/2019
D6EAA3,executive-appointment,100,54,8/5/2019
D76AEF,conference-call,100,50,8/5/2019
D77F7E,earnings,100,50,8/5/2019
D77F7E,earnings,100,50,8/5/2019
D77F7E,earnings,100,50,8/5/2019
D77F7E,earnings,100,50,8/5/2019
D77F7E,earnings,100,50,8/5/2019
D77F7E,executive-appointment,100,54,8/5/2019
D9E036,earnings,100,50,8/5/2019
DA0CB8,earnings,100,50,8/5/2019
DA48E4,unit-acquisition-completed-acquirer,100,49,8/5/2019
DA91AE,earnings,100,50,8/5/2019
DBFB51,earnings,100,50,8/5/2019
DCD97F,unit-acquisition-acquiree,100,76,8/5/2019
DF16DE,earnings,100,50,8/5/2019
E0647D,earnings,100,50,8/5/2019
E0647D,earnings,100,50,8/5/2019
E0647D,earnings,100,50,8/5/2019
E0647D,earnings,100,50,8/5/2019
E0647D,earnings,100,50,8/5/2019
E09556,patent-awarded,100,72,8/5/2019
E09997,earnings,100,50,8/5/2019
E11C41,earnings,100,50,8/5/2019
E38906,earnings,100,50,8/5/2019
E610CD,earnings,100,50,8/5/2019
E610CD,earnings,100,50,8/5/2019
E67C2C,partnership,100,61,8/5/2019
E67C2C,earnings,100,50,8/5/2019
E7BF32,earnings,100,50,8/5/2019
E866D2,partnership,100,61,8/5/2019
E9C7C0,earnings,100,50,8/5/2019
E9C7C0,earnings,100,50,8/5/2019
E9C7C0,earnings,100,50,8/5/2019
E9C7C0,earnings,100,50,8/5/2019
E9C7C0,earnings,100,50,8/5/2019
E9C7C0,earnings,100,50,8/5/2019
EA62FC,earnings,100,50,8/5/2019
EB43F4,earnings,100,50,8/5/2019
EBC84C,unit-acquisition-acquirer,100,49,8/5/2019
EBD89A,conference-participant,100,50,8/5/2019
ECD263,legal-issues-defendant,100,22,8/5/2019
ED2EFD,acquisition-completed-acquirer,100,49,8/5/2019
EEA734,conference-call,100,50,8/5/2019
EF25A5,legal-issues-defendant,100,22,8/5/2019
F02170,legal-issues-defendant,100,22,8/5/2019
F179ED,partnership,100,61,8/5/2019
F1EB39,conference-participant,100,50,8/5/2019
F3016C,conference-participant,100,50,8/5/2019
F44EA2,earnings,100,50,8/5/2019
F47871,legal-issues-defendant,100,22,8/5/2019
F6A987,earnings,100,50,8/5/2019
F72E4B,acquisition-acquirer,100,49,8/5/2019
FA840E,earnings,100,50,8/5/2019
FC1F9D,partnership,100,61,8/5/2019
FC4550,dividend,100,50,8/5/2019
FC8733,revenue-up,100,92,8/5/2019
FC8733,revenue-up,100,92,8/5/2019
FC8733,revenue-up,100,92,8/5/2019
FD4588,product-release,100,64,8/5/2019
FFCD0E,earnings,100,50,8/5/2019
00D6B5,earnings,100,50,8/6/2019
20751,conference-participant,100,50,8/6/2019
03542C,earnings,100,50,8/6/2019
03596A,earnings,100,50,8/6/2019
03B431,earnings,100,50,8/6/2019
03B8CF,legal-issues-defendant,100,22,8/6/2019
03B8CF,legal-issues-defendant,100,22,8/6/2019
03B8CF,dividend,100,50,8/6/2019
04996E,earnings,100,50,8/6/2019
04996E,earnings,100,50,8/6/2019
054E7E,earnings,100,50,8/6/2019
55018,legal-issues-defendant,100,22,8/6/2019
55018,legal-issues-defendant,100,22,8/6/2019
06C826,conference-call,100,50,8/6/2019
070B45,business-contract,100,69,8/6/2019
078D52,public-offering,100,43,8/6/2019
09062E,earnings,100,50,8/6/2019
09062E,earnings,100,50,8/6/2019
09062E,earnings,100,50,8/6/2019
0919B1,earnings,100,50,8/6/2019
099C88,conference-participant,100,50,8/6/2019
0A6824,earnings,100,50,8/6/2019
0AD2E3,earnings-up,100,68,8/6/2019
0AD2E3,earnings-up,100,68,8/6/2019
0B13E8,earnings,100,50,8/6/2019
0BD4E8,legal-issues-defendant,100,22,8/6/2019
0CE204,earnings,100,50,8/6/2019
0FABBD,earnings-guidance-up,100,83,8/6/2019
0FABBD,earnings,100,50,8/6/2019
0FABBD,earnings,100,50,8/6/2019
0FABBD,earnings,100,50,8/6/2019
0FABBD,earnings,100,50,8/6/2019
10100E,earnings,100,50,8/6/2019
102F04,earnings,100,50,8/6/2019
11074E,earnings,100,50,8/6/2019
12DE76,acquisition-interest-acquirer,100,46,8/6/2019
147C38,executive-appointment,100,54,8/6/2019
14833D,earnings,100,50,8/6/2019
1490F3,executive-appointment,100,54,8/6/2019
14BA06,earnings,100,50,8/6/2019
152B9E,executive-appointment,100,54,8/6/2019
152E1D,operating-earnings,100,50,8/6/2019
152E1D,operating-earnings,100,50,8/6/2019
152E1D,operating-earnings,100,50,8/6/2019
152E1D,operating-earnings,100,50,8/6/2019
152E1D,operating-earnings,100,50,8/6/2019
152E1D,operating-earnings,100,50,8/6/2019
157CC1,earnings,100,50,8/6/2019
157CC1,earnings,100,50,8/6/2019
18D9FA,earnings,100,50,8/6/2019
1CB9D3,earnings,100,50,8/6/2019
1CDD1C,earnings,100,50,8/6/2019
1DDEDA,acquisition-completed-acquirer,100,49,8/6/2019
1DEBBE,executive-appointment,100,54,8/6/2019
1E1125,acquisition-completed-acquirer,100,49,8/6/2019
1EA923,earnings,100,50,8/6/2019
1EA923,earnings,100,50,8/6/2019
1EA923,earnings,100,50,8/6/2019
20403D,earnings,100,50,8/6/2019
21153F,product-price-cut,100,49,8/6/2019
21268E,earnings,100,50,8/6/2019
21D903,executive-appointment,100,54,8/6/2019
24CB56,conference-organizer,100,57,8/6/2019
24CB56,conference-organizer,100,57,8/6/2019
24CB56,conference-organizer,100,57,8/6/2019
25A6CC,legal-issues-defendant,100,22,8/6/2019
25AB8E,product-release,100,64,8/6/2019
263216,business-contract,100,69,8/6/2019
26F99F,earnings,100,50,8/6/2019
28B730,earnings,100,50,8/6/2019
2920D5,dividend-up,100,81,8/6/2019
2920D5,earnings,100,50,8/6/2019
2AA6A8,executive-appointment,100,54,8/6/2019
2AA6A8,earnings,100,50,8/6/2019
2ABF77,earnings,100,50,8/6/2019
2ABF77,earnings,100,50,8/6/2019
2C7505,earnings,100,50,8/6/2019
2CA60F,legal-issues-defendant,100,22,8/6/2019
2CA60F,legal-issues-defendant,100,22,8/6/2019
2CBB58,partnership,100,61,8/6/2019
2CC71C,executive-appointment,100,54,8/6/2019
2CC71C,earnings,100,50,8/6/2019
2D485F,earnings,100,50,8/6/2019
2D485F,earnings,100,50,8/6/2019
2D485F,earnings,100,50,8/6/2019
2EBA55,earnings,100,50,8/6/2019
2EC172,note-sale,100,52,8/6/2019
2F1299,earnings,100,50,8/6/2019
2F1299,earnings,100,50,8/6/2019
2F1299,earnings,100,50,8/6/2019
2F1299,earnings,100,50,8/6/2019
2F1299,earnings,100,50,8/6/2019
2F1299,earnings,100,50,8/6/2019
2F1299,earnings,100,50,8/6/2019
2F1299,earnings,100,50,8/6/2019
2FF046,earnings,100,50,8/6/2019
2FF046,earnings,100,50,8/6/2019
2FF046,earnings,100,50,8/6/2019
2FF046,earnings,100,50,8/6/2019
306623,conference-participant,100,50,8/6/2019
30DE64,earnings,100,50,8/6/2019
31803E,earnings,100,50,8/6/2019
34A959,revenues,100,50,8/6/2019
3587B4,legal-issues-defendant,100,22,8/6/2019
3587B4,legal-issues-defendant,100,22,8/6/2019
36A1CB,dividend-up,100,70,8/6/2019
36A1CB,earnings,100,50,8/6/2019
36A1CB,earnings,100,50,8/6/2019
396D7C,conference-participant,100,50,8/6/2019
3AAEAE,operating-earnings,100,50,8/6/2019
3AF7FD,conference-call,100,50,8/6/2019
3BBD10,earnings,100,50,8/6/2019
3C11C4,earnings,100,50,8/6/2019
3C6CCC,earnings,100,50,8/6/2019
3C6CCC,earnings,100,50,8/6/2019
3C6CCC,earnings,100,50,8/6/2019
3C6CCC,earnings,100,50,8/6/2019
3CCC90,product-release,100,64,8/6/2019
3D6933,pretax-earnings-positive,100,69,8/6/2019
3D7971,dividend,100,50,8/6/2019
3DE4D1,partnership,100,61,8/6/2019
3E70FC,earnings,100,50,8/6/2019
3F96D5,earnings,100,50,8/6/2019
401072,conference-participant,100,50,8/6/2019
4.03E+05,earnings,100,50,8/6/2019
4.03E+05,earnings,100,50,8/6/2019
4.03E+05,earnings,100,50,8/6/2019
4.03E+05,earnings,100,50,8/6/2019
4.03E+05,dividend,100,50,8/6/2019
40B903,earnings,100,50,8/6/2019
4.00E+163,earnings,100,50,8/6/2019
40F7DE,product-release,100,64,8/6/2019
41A93D,earnings-guidance-up,100,83,8/6/2019
41C528,earnings,100,50,8/6/2019
42AABD,earnings,100,50,8/6/2019
42AABD,conference-participant,100,50,8/6/2019
43A060,earnings,100,50,8/6/2019
43A060,earnings,100,50,8/6/2019
43A060,earnings,100,50,8/6/2019
43A060,earnings,100,50,8/6/2019
44ED36,earnings,100,50,8/6/2019
4591D3,revenue-up,100,61,8/6/2019
4591D3,revenues,100,50,8/6/2019
4591D3,revenues,100,50,8/6/2019
4591D3,revenues,100,50,8/6/2019
45ABCC,revenue-down,100,30,8/6/2019
4A2457,award,100,58,8/6/2019
4A3438,legal-issues-defendant,100,22,8/6/2019
4A3438,legal-issues-defendant,100,22,8/6/2019
4A3438,legal-issues-defendant,100,22,8/6/2019
4A3438,legal-issues-defendant,100,22,8/6/2019
4A7C1F,revenue-up,100,69,8/6/2019
4A7C1F,earnings,100,50,8/6/2019
4BDCA7,earnings,100,50,8/6/2019
4BF3D6,conference-participant,100,50,8/6/2019
4DD09F,earnings,100,50,8/6/2019
4DD09F,earnings,100,50,8/6/2019
4DD09F,earnings,100,50,8/6/2019
4DD09F,earnings,100,50,8/6/2019
4E3D15,operating-earnings,100,50,8/6/2019
4E5784,earnings,100,50,8/6/2019
4EEB00,executive-appointment,100,54,8/6/2019
4F783B,earnings,100,50,8/6/2019
4F783B,earnings,100,50,8/6/2019
4F783B,earnings,100,50,8/6/2019
4F783B,earnings,100,50,8/6/2019
4F783B,earnings,100,50,8/6/2019
50D1EC,earnings,100,50,8/6/2019
514067,earnings,100,50,8/6/2019
545272,earnings,100,50,8/6/2019
545272,executive-appointment,100,54,8/6/2019
54B889,earnings,100,50,8/6/2019
54F1D2,earnings,100,50,8/6/2019
550D01,earnings,100,50,8/6/2019
56765E,earnings,100,50,8/6/2019
56AFF4,investment-investor,100,55,8/6/2019
56FB7C,earnings,100,50,8/6/2019
589803,clinical-trials-positive,100,87,8/6/2019
589803,clinical-trials-positive,100,87,8/6/2019
589803,clinical-trials-positive,100,87,8/6/2019
589803,earnings,100,50,8/6/2019
58C2D4,earnings,100,50,8/6/2019
594402,conference-participant,100,50,8/6/2019
5968F9,earnings,100,50,8/6/2019
59A832,earnings,100,50,8/6/2019
5A53BF,conference-participant,100,50,8/6/2019
5A9A82,earnings,100,50,8/6/2019
5B3FA2,fundraising,100,64,8/6/2019
5C2A47,partnership,100,61,8/6/2019
5D41E4,executive-appointment,100,54,8/6/2019
5D41E4,acquisition-completed-acquirer,100,49,8/6/2019
5D41E4,earnings,100,50,8/6/2019
5D63F1,earnings,100,50,8/6/2019
60EA12,dividend,100,50,8/6/2019
60EA12,earnings,100,50,8/6/2019
620381,conference-participant,100,50,8/6/2019
622DBE,earnings,100,50,8/6/2019
62B1C6,earnings,100,50,8/6/2019
62CDDE,earnings,100,50,8/6/2019
633043,earnings,100,50,8/6/2019
6559D8,earnings,100,50,8/6/2019
66CB62,operating-earnings,100,50,8/6/2019
676FFD,earnings,100,50,8/6/2019
6810DE,earnings,100,50,8/6/2019
68AB62,earnings,100,50,8/6/2019
6925EB,conference-participant,100,50,8/6/2019
6A01DF,earnings,100,50,8/6/2019
6A961B,conference-participant,100,50,8/6/2019
6BDA0C,dividend-up,100,81,8/6/2019
6BF593,earnings,100,50,8/6/2019
6BF593,earnings,100,50,8/6/2019
6D3F35,earnings,100,50,8/6/2019
6D3F35,earnings,100,50,8/6/2019
6D3F35,earnings,100,50,8/6/2019
6D3F35,earnings,100,50,8/6/2019
6D3F35,earnings,100,50,8/6/2019
6ED519,dividend,100,50,8/6/2019
701531,earnings,100,50,8/6/2019
71B0CF,conference-participant,100,50,8/6/2019
722D55,earnings,100,50,8/6/2019
7255D2,earnings,100,50,8/6/2019
72CB93,conference-participant,100,50,8/6/2019
73529F,earnings,100,50,8/6/2019
73F70F,conference-call,100,50,8/6/2019
747219,dividend,100,50,8/6/2019
787D14,earnings,100,50,8/6/2019
789A7D,public-offering,100,43,8/6/2019
790C34,business-contract,100,69,8/6/2019
790D0D,dividend,100,50,8/6/2019
7AF5B8,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B0BA6,earnings,100,50,8/6/2019
7B6EB1,earnings,100,50,8/6/2019
7C4F43,conference-participant,100,50,8/6/2019
7FD8B9,earnings,100,50,8/6/2019
82E58A,earnings,100,50,8/6/2019
82F088,earnings,100,50,8/6/2019
8303CD,executive-appointment,100,54,8/6/2019
83E0AC,earnings,100,50,8/6/2019
845533,earnings,100,50,8/6/2019
84920B,product-release,100,64,8/6/2019
858942,earnings,100,50,8/6/2019
85DE00,dividend,100,50,8/6/2019
85DE00,earnings,100,50,8/6/2019
873DB9,earnings,100,50,8/6/2019
873DB9,earnings,100,50,8/6/2019
873DB9,earnings,100,50,8/6/2019
873DB9,earnings,100,50,8/6/2019
873DB9,earnings,100,50,8/6/2019
873DB9,earnings,100,50,8/6/2019
873DB9,earnings,100,50,8/6/2019
877734,earnings-up,100,68,8/6/2019
877734,earnings,100,50,8/6/2019
877734,earnings,100,50,8/6/2019
877734,earnings,100,50,8/6/2019
881190,dividend,100,50,8/6/2019
89FBB1,earnings,100,50,8/6/2019
89FBB1,earnings,100,50,8/6/2019
89FBB1,earnings,100,50,8/6/2019
8AB85C,conference-participant,100,50,8/6/2019
8B4A45,facility-upgrade,100,65,8/6/2019
8B8656,conference-participant,100,50,8/6/2019
8B9B3B,earnings,100,50,8/6/2019
8D5145,buybacks,100,74,8/6/2019
8DBBE6,earnings,100,50,8/6/2019
8DCF18,earnings,100,50,8/6/2019
8DCF18,earnings,100,50,8/6/2019
8E10BF,earnings,100,50,8/6/2019
8E4F9A,operating-earnings,100,50,8/6/2019
902255,earnings,100,50,8/6/2019
902255,earnings,100,50,8/6/2019
902255,earnings,100,50,8/6/2019
9087B9,earnings,100,50,8/6/2019
923D93,business-contract,100,69,8/6/2019
923D93,business-contract,100,69,8/6/2019
92D230,conference-call,100,50,8/6/2019
931AE7,earnings,100,50,8/6/2019
9.31E+77,earnings,100,50,8/6/2019
9.39E+69,conference-participant,100,50,8/6/2019
945DE6,public-offering,100,43,8/6/2019
9470CC,earnings,100,50,8/6/2019
9507FF,public-offering,100,43,8/6/2019
95C392,product-release,100,64,8/6/2019
968966,earnings,100,50,8/6/2019
968966,dividend,100,50,8/6/2019
968B00,dividend,100,50,8/6/2019
96B4FF,conference-participant,100,50,8/6/2019
97644E,earnings,100,50,8/6/2019
97644E,earnings,100,50,8/6/2019
97644E,earnings,100,50,8/6/2019
97644E,earnings,100,50,8/6/2019
97644E,earnings,100,50,8/6/2019
97AF94,earnings,100,50,8/6/2019
994468,dividend,100,50,8/6/2019
99DC8D,dividend,100,50,8/6/2019
99DC8D,earnings,100,50,8/6/2019
9BB35A,public-offering,100,43,8/6/2019
9C5BA5,earnings,100,50,8/6/2019
9CA432,earnings,100,50,8/6/2019
9D4EC7,dividend,100,50,8/6/2019
9D4EC7,executive-appointment,100,54,8/6/2019
9E0811,earnings-up,100,68,8/6/2019
9E91C6,earnings,100,50,8/6/2019
9F18FA,earnings,100,50,8/6/2019
9F18FA,earnings,100,50,8/6/2019
9FD2D9,earnings,100,50,8/6/2019
9FD2D9,earnings,100,50,8/6/2019
9FD2D9,earnings,100,50,8/6/2019
9FF5F1,earnings,100,50,8/6/2019
A072C4,executive-appointment,100,54,8/6/2019
A072C4,earnings,100,50,8/6/2019
A26EF7,assets,100,50,8/6/2019
A26EF7,assets,100,50,8/6/2019
A48593,earnings,100,50,8/6/2019
A4B899,earnings,100,50,8/6/2019
A4CD53,earnings,100,50,8/6/2019
A4CD53,earnings,100,50,8/6/2019
A4CD53,earnings,100,50,8/6/2019
A5195E,earnings,100,50,8/6/2019
A5DD24,earnings,100,50,8/6/2019
A60354,earnings,100,50,8/6/2019
A60354,earnings,100,50,8/6/2019
A60354,earnings,100,50,8/6/2019
A6213D,conference-participant,100,50,8/6/2019
A631A3,partnership,100,61,8/6/2019
A63387,earnings,100,50,8/6/2019
A6828A,award,100,58,8/6/2019
A6FC89,legal-issues-defendant,100,22,8/6/2019
A7102F,earnings-up,100,68,8/6/2019
A7102F,earnings,100,50,8/6/2019
A7102F,earnings,100,50,8/6/2019
A7102F,earnings,100,50,8/6/2019
A7102F,earnings,100,50,8/6/2019
A74F6F,revenues,100,50,8/6/2019
A74F6F,revenues,100,50,8/6/2019
A868C9,revenues,100,50,8/6/2019
A868C9,revenues,100,50,8/6/2019
A868C9,revenues,100,50,8/6/2019
A94718,earnings,100,50,8/6/2019
AC775C,earnings,100,50,8/6/2019
AC775C,earnings,100,50,8/6/2019
AC775C,earnings,100,50,8/6/2019
ACDF88,conference-call,100,50,8/6/2019
AD375D,public-offering,100,43,8/6/2019
ADF092,earnings,100,50,8/6/2019
AF93DE,earnings,100,50,8/6/2019
B08C51,earnings,100,50,8/6/2019
B0D41A,earnings,100,50,8/6/2019
B2206F,award,100,58,8/6/2019
B2206F,legal-issues-defendant,100,22,8/6/2019
B33E77,private-placement,100,56,8/6/2019
B33E77,private-placement,100,56,8/6/2019
B3A166,earnings,100,50,8/6/2019
B48FC9,revenues,100,50,8/6/2019
B53C12,earnings,100,50,8/6/2019
B54A74,earnings,100,50,8/6/2019
B80AD1,earnings,100,50,8/6/2019
B83D67,note-sale,100,52,8/6/2019
B8A51F,earnings,100,50,8/6/2019
B8F71F,dividend,100,50,8/6/2019
B98EFA,earnings-up,100,68,8/6/2019
B98EFA,earnings,100,50,8/6/2019
B98EFA,earnings,100,50,8/6/2019
B9CD50,conference-participant,100,50,8/6/2019
BA218A,legal-issues-defendant,100,22,8/6/2019
BAD655,earnings,100,50,8/6/2019
BB0587,earnings,100,50,8/6/2019
BCC13E,earnings,100,50,8/6/2019
BCC55F,earnings,100,50,8/6/2019
BCC55F,earnings,100,50,8/6/2019
BCC55F,earnings,100,50,8/6/2019
BCC55F,earnings,100,50,8/6/2019
BCE9DA,earnings,100,50,8/6/2019
BCE9DA,earnings,100,50,8/6/2019
BDA775,earnings,100,50,8/6/2019
BDEC1E,conference-participant,100,50,8/6/2019
BFEA04,earnings,100,50,8/6/2019
BFEA04,earnings,100,50,8/6/2019
BFEA04,earnings,100,50,8/6/2019
BFEA04,earnings,100,50,8/6/2019
C03C8B,earnings,100,50,8/6/2019
C03C8B,earnings,100,50,8/6/2019
C03C8B,earnings,100,50,8/6/2019
C03C8B,earnings,100,50,8/6/2019
C03C8B,earnings,100,50,8/6/2019
C03C8B,earnings,100,50,8/6/2019
C1114B,executive-resignation,100,44,8/6/2019
C2609A,earnings,100,50,8/6/2019
C3BAE7,earnings,100,50,8/6/2019
C3BAE7,earnings,100,50,8/6/2019
C3BAE7,earnings,100,50,8/6/2019
C3BAE7,earnings,100,50,8/6/2019
C3BAE7,earnings,100,50,8/6/2019
C3BAE7,earnings,100,50,8/6/2019
C3F99F,earnings,100,50,8/6/2019
C407A0,earnings,100,50,8/6/2019
C4A432,conference-call,100,50,8/6/2019
C4F9C6,earnings,100,50,8/6/2019
C72B8F,legal-issues-defendant,100,22,8/6/2019
C7AE14,earnings,100,50,8/6/2019
CAB222,earnings,100,50,8/6/2019
CB7AB2,earnings,100,50,8/6/2019
CB89EA,earnings,100,50,8/6/2019
CBFFDD,earnings,100,50,8/6/2019
CC0C78,revenues,100,50,8/6/2019
CC176E,earnings,100,50,8/6/2019
CC176E,executive-appointment,100,54,8/6/2019
CC6FF5,partnership,100,61,8/6/2019
CC6FF5,partnership,100,61,8/6/2019
CC8F6E,earnings,100,50,8/6/2019
CCB623,earnings,100,50,8/6/2019
CDC817,conference-participant,100,50,8/6/2019
CDFCC9,dividend,100,50,8/6/2019
CDFCC9,earnings,100,50,8/6/2019
CDFCC9,earnings,100,50,8/6/2019
CDFCC9,earnings,100,50,8/6/2019
CDFCC9,earnings,100,50,8/6/2019
CDFCC9,earnings,100,50,8/6/2019
CED4D0,earnings,100,50,8/6/2019
CF6A5A,dividend,100,50,8/6/2019
D03C7A,public-offering,100,43,8/6/2019
D1173F,executive-resignation,100,44,8/6/2019
D11C1C,operating-earnings,100,50,8/6/2019
D15833,earnings-positive,100,69,8/6/2019
D1588D,orphan-drug-designation,100,76,8/6/2019
D1C26F,earnings-up,100,68,8/6/2019
D1C26F,earnings-up,100,68,8/6/2019
D1C26F,earnings-up,100,68,8/6/2019
D296C6,earnings,100,50,8/6/2019
D29B44,earnings,100,50,8/6/2019
D29B44,earnings,100,50,8/6/2019
D29B44,earnings,100,50,8/6/2019
D29B44,earnings,100,50,8/6/2019
D29B44,earnings,100,50,8/6/2019
D29B44,executive-appointment,100,54,8/6/2019
D2C0B6,earnings,100,50,8/6/2019
D3CEDF,earnings,100,50,8/6/2019
D3CEDF,earnings,100,50,8/6/2019
D3CEDF,earnings,100,50,8/6/2019
D3CEDF,earnings,100,50,8/6/2019
D3CEDF,earnings,100,50,8/6/2019
D3CEDF,product-release,100,64,8/6/2019
D3DE34,earnings,100,50,8/6/2019
D3DE34,earnings,100,50,8/6/2019
D3DE34,earnings,100,50,8/6/2019
D3DE34,earnings,100,50,8/6/2019
D3DE34,earnings,100,50,8/6/2019
D4463B,trading-halt,100,43,8/6/2019
D598E7,partnership,100,61,8/6/2019
D5B13D,conference-participant,100,50,8/6/2019
D6144F,earnings,100,50,8/6/2019
D65A13,legal-issues-defendant,100,22,8/6/2019
D65A13,legal-issues-defendant,100,22,8/6/2019
D6EAA3,earnings,100,50,8/6/2019
D6EAA3,earnings,100,50,8/6/2019
D6EAA3,earnings,100,50,8/6/2019
D6EAA3,earnings,100,50,8/6/2019
D6EAA3,earnings,100,50,8/6/2019
D70365,earnings,100,50,8/6/2019
D81463,earnings,100,50,8/6/2019
D81463,earnings,100,50,8/6/2019
D81463,dividend,100,50,8/6/2019
DB5CA5,earnings,100,50,8/6/2019
DB9F70,merger,100,66,8/6/2019
DC1405,earnings,100,50,8/6/2019
DD682D,earnings,100,50,8/6/2019
DDEA6A,operating-earnings,100,50,8/6/2019
DE5611,conference-participant,100,50,8/6/2019
DEF058,buybacks,100,74,8/6/2019
E15736,earnings,100,50,8/6/2019
E15736,earnings,100,50,8/6/2019
E20392,earnings,100,50,8/6/2019
E754F0,earnings,100,50,8/6/2019
E829E8,unit-acquisition-acquirer,100,49,8/6/2019
E96E0B,earnings,100,50,8/6/2019
EAA0A7,earnings,100,50,8/6/2019
EAA0A7,earnings,100,50,8/6/2019
EAA0A7,earnings,100,50,8/6/2019
EAA0A7,earnings,100,50,8/6/2019
EC1AF3,earnings,100,50,8/6/2019
EC4E82,acquisition-completed-acquirer,100,49,8/6/2019
ECD263,legal-issues-defendant,100,22,8/6/2019
ECF4F8,earnings,100,50,8/6/2019
ED4560,earnings,100,50,8/6/2019
EDD234,executive-appointment,100,54,8/6/2019
EF5914,earnings,100,50,8/6/2019
F02170,earnings,100,50,8/6/2019
F0B2B5,partnership,100,61,8/6/2019
F0B2B5,executive-appointment,100,54,8/6/2019
F0B335,conference-participant,100,50,8/6/2019
F2E253,earnings,100,50,8/6/2019
F2E253,earnings,100,50,8/6/2019
F2E253,earnings,100,50,8/6/2019
F2E253,earnings,100,50,8/6/2019
F2E253,earnings,100,50,8/6/2019
F2E253,earnings,100,50,8/6/2019
F47871,earnings,100,50,8/6/2019
F47871,legal-issues-defendant,100,22,8/6/2019
F5C8AB,earnings-per-share-positive,100,69,8/6/2019
F5C8AB,earnings-per-share,100,50,8/6/2019
F5C8AB,earnings-per-share,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FA6A,earnings,100,50,8/6/2019
F6FF0D,earnings,100,50,8/6/2019
F6FF0D,earnings,100,50,8/6/2019
F6FF0D,earnings,100,50,8/6/2019
F88A04,dividend,100,50,8/6/2019
FDF28E,earnings,100,50,8/6/2019
FDF799,legal-issues-defendant,100,22,8/6/2019
FEC475,dividend,100,50,8/6/2019
FF227B,conference-participant,100,50,8/6/2019
00067A,executive-appointment,100,54,8/7/2019
001F1B,revenues,100,50,8/7/2019
0157B1,patent-infringement-defendant,100,26,8/7/2019
01B8D6,earnings,100,50,8/7/2019
0358AF,revenue-up,100,69,8/7/2019
03B8CF,unit-acquisition-acquiree,100,76,8/7/2019
03FB17,dividend,100,50,8/7/2019
0560D8,earnings,100,50,8/7/2019
06C826,earnings,100,50,8/7/2019
06C826,earnings,100,50,8/7/2019
095A04,earnings,100,50,8/7/2019
0A9D0A,executive-resignation,100,44,8/7/2019
0B13E8,public-offering,100,43,8/7/2019
0BC29E,earnings,100,50,8/7/2019
0BC29E,earnings,100,50,8/7/2019
0BC29E,earnings,100,50,8/7/2019
0BC29E,earnings,100,50,8/7/2019
0BC29E,earnings,100,50,8/7/2019
0BC29E,earnings,100,50,8/7/2019
0BC29E,earnings,100,50,8/7/2019
0BC29E,earnings,100,50,8/7/2019
0BD199,conference-participant,100,50,8/7/2019
0C2A0D,conference-participant,100,50,8/7/2019
0C6293,earnings,100,50,8/7/2019
0C6293,earnings,100,50,8/7/2019
0C6293,earnings,100,50,8/7/2019
0C6861,earnings,100,50,8/7/2019
0CADBC,earnings,100,50,8/7/2019
0CCCB7,dividend,100,50,8/7/2019
0CE7F6,earnings,100,50,8/7/2019
0DBB81,clinical-trials-positive,100,87,8/7/2019
0DE3D5,earnings,100,50,8/7/2019
0DE3D5,earnings,100,50,8/7/2019
0DE3D5,earnings,100,50,8/7/2019
0DE3D5,earnings,100,50,8/7/2019
0DE3D5,earnings,100,50,8/7/2019
0E439E,dividend,100,50,8/7/2019
0E499E,conference-participant,100,50,8/7/2019
0E5619,earnings,100,50,8/7/2019
0F2BC9,earnings-up,100,68,8/7/2019
0F2BC9,earnings-up,100,68,8/7/2019
0F2BC9,earnings-up,100,68,8/7/2019
102F04,executive-resignation,100,44,8/7/2019
1080C0,conference-participant,100,50,8/7/2019
1096C6,earnings,100,50,8/7/2019
11074E,conference-participant,100,50,8/7/2019
11A49E,executive-appointment,100,54,8/7/2019
12731D,earnings,100,50,8/7/2019
12731D,earnings,100,50,8/7/2019
12731D,earnings,100,50,8/7/2019
12731D,earnings,100,50,8/7/2019
12731D,earnings,100,50,8/7/2019
1279ED,earnings,100,50,8/7/2019
138DDE,earnings,100,50,8/7/2019
13D576,buybacks,100,74,8/7/2019
147098,earnings,100,50,8/7/2019
152AB9,merger-completed,100,66,8/7/2019
154272,earnings,100,50,8/7/2019
165B86,earnings,100,50,8/7/2019
165B86,earnings,100,50,8/7/2019
182BE7,earnings,100,50,8/7/2019
1880C5,earnings,100,50,8/7/2019
19BF16,earnings,100,50,8/7/2019
19BF16,earnings,100,50,8/7/2019
19BF16,earnings,100,50,8/7/2019
19BF16,earnings,100,50,8/7/2019
1A5957,earnings,100,50,8/7/2019
1A5957,earnings,100,50,8/7/2019
1A5957,earnings,100,50,8/7/2019
1A5957,earnings,100,50,8/7/2019
1AE9D5,conference-call,100,50,8/7/2019
1C599A,earnings,100,50,8/7/2019
1CD4B5,conference-participant,100,50,8/7/2019
1DB6A6,dividend,100,50,8/7/2019
1E7785,earnings,100,50,8/7/2019
1E7785,earnings,100,50,8/7/2019
1E7785,earnings,100,50,8/7/2019
1E7785,earnings,100,50,8/7/2019
1E7785,earnings,100,50,8/7/2019
1F19C8,revenue-up,100,62,8/7/2019
1F19C8,revenue-up,100,62,8/7/2019
1F19C8,revenue-up,100,62,8/7/2019
1F19C8,revenue-up,100,62,8/7/2019
1F19C8,revenue-up,100,62,8/7/2019
1F19C8,revenue-up,100,62,8/7/2019
1F3CFB,earnings,100,50,8/7/2019
1F464F,earnings,100,50,8/7/2019
1FC422,earnings,100,50,8/7/2019
2003A5,earnings,100,50,8/7/2019
200D8B,earnings,100,50,8/7/2019
200D8B,earnings,100,50,8/7/2019
200D8B,earnings,100,50,8/7/2019
202E5A,earnings,100,50,8/7/2019
2082EA,earnings,100,50,8/7/2019
2096DE,earnings,100,50,8/7/2019
21D903,earnings,100,50,8/7/2019
221783,earnings,100,50,8/7/2019
221783,earnings,100,50,8/7/2019
221783,earnings,100,50,8/7/2019
221783,earnings,100,50,8/7/2019
221783,earnings,100,50,8/7/2019
263216,earnings,100,50,8/7/2019
27B191,earnings,100,50,8/7/2019
27B191,earnings,100,50,8/7/2019
27B191,dividend,100,50,8/7/2019
27C10F,earnings,100,50,8/7/2019
27C10F,earnings,100,50,8/7/2019
27C10F,earnings,100,50,8/7/2019
27C10F,earnings,100,50,8/7/2019
2B0AF4,dividend,100,50,8/7/2019
2B8179,earnings,100,50,8/7/2019
2C3348,earnings,100,50,8/7/2019
2C681C,earnings,100,50,8/7/2019
2C681C,earnings,100,50,8/7/2019
2EB04E,earnings-up,100,68,8/7/2019
2EB04E,earnings-up,100,68,8/7/2019
2EB04E,earnings-up,100,68,8/7/2019
2EB04E,earnings-up,100,68,8/7/2019
2EC172,note-sale,100,52,8/7/2019
2F960F,earnings,100,50,8/7/2019
2FDEE3,earnings,100,50,8/7/2019
31643A,earnings,100,50,8/7/2019
31DB20,earnings,100,50,8/7/2019
32F943,earnings,100,50,8/7/2019
355B19,earnings,100,50,8/7/2019
3587B4,executive-appointment,100,54,8/7/2019
35AE32,earnings,100,50,8/7/2019
35AE32,earnings,100,50,8/7/2019
35AE32,earnings,100,50,8/7/2019
35AE32,earnings,100,50,8/7/2019
36C09B,conference-call,100,50,8/7/2019
36E479,earnings,100,50,8/7/2019
37B618,earnings,100,50,8/7/2019
37E18B,operating-earnings,100,50,8/7/2019
382EAE,operating-earnings,100,50,8/7/2019
396D7C,earnings,100,50,8/7/2019
3C75D6,earnings-up,100,68,8/7/2019
3C75D6,earnings,100,50,8/7/2019
3C75D6,earnings,100,50,8/7/2019
3DCECC,earnings,100,50,8/7/2019
3EE65E,earnings,100,50,8/7/2019
3F1C69,earnings,100,50,8/7/2019
401072,regulatory-product-approval-granted,100,81,8/7/2019
417BF9,conference-call,100,50,8/7/2019
41C36B,earnings,100,50,8/7/2019
4398A2,earnings,100,50,8/7/2019
43A060,partnership,100,61,8/7/2019
444CC8,revenue-up,100,72,8/7/2019
447FC6,earnings,100,50,8/7/2019
448215,earnings,100,50,8/7/2019
44DDBD,earnings,100,50,8/7/2019
45444E,earnings,100,50,8/7/2019
468DD4,earnings,100,50,8/7/2019
485445,legal-issues-defendant,100,22,8/7/2019
485445,legal-issues-defendant,100,22,8/7/2019
48F795,earnings,100,50,8/7/2019
4A2457,business-contract,100,69,8/7/2019
4A6F00,partnership,100,61,8/7/2019
4AC91D,business-contract,100,69,8/7/2019
4EE14A,operating-earnings,100,50,8/7/2019
4EE14A,operating-earnings,100,50,8/7/2019
50070E,acquisition-acquiree,100,76,8/7/2019
5065B1,earnings,100,50,8/7/2019
51888A,unit-acquisition-acquiree,100,76,8/7/2019
52B567,legal-issues-defendant,100,22,8/7/2019
5403F8,earnings,100,50,8/7/2019
5487B1,earnings,100,50,8/7/2019
5487B1,earnings,100,50,8/7/2019
5487B1,earnings,100,50,8/7/2019
5487B1,earnings,100,50,8/7/2019
5487B1,earnings,100,50,8/7/2019
5487B1,earnings,100,50,8/7/2019
54A713,dividend,100,50,8/7/2019
54A713,dividend,100,50,8/7/2019
54DF47,credit-extension-recipient,100,69,8/7/2019
553949,dividend,100,50,8/7/2019
55CD6F,operating-earnings,100,50,8/7/2019
56EFC7,earnings,100,50,8/7/2019
583A75,revenue-volume,100,50,8/7/2019
5876DC,earnings,100,50,8/7/2019
58B46F,earnings-per-share-positive,100,69,8/7/2019
5AA3B1,conference-call,100,50,8/7/2019
5B3FA2,earnings,100,50,8/7/2019
5B7739,earnings,100,50,8/7/2019
5C2A47,earnings,100,50,8/7/2019
5C7601,dividend,100,50,8/7/2019
5C7601,executive-death,100,31,8/7/2019
5CEE02,earnings,100,50,8/7/2019
5D02B7,conference-call,100,50,8/7/2019
5DD486,dividend,100,50,8/7/2019
5F2FF7,executive-appointment,100,54,8/7/2019
5F3E74,earnings,100,50,8/7/2019
5F3E74,earnings,100,50,8/7/2019
619882,conference-organizer,100,57,8/7/2019
62A48D,conference-call,100,50,8/7/2019
657097,earnings,100,50,8/7/2019
665440,earnings,100,50,8/7/2019
665440,earnings,100,50,8/7/2019
665440,earnings,100,50,8/7/2019
66ECFD,dividend,100,50,8/7/2019
69CE71,earnings,100,50,8/7/2019
69CE71,earnings,100,50,8/7/2019
69CE71,earnings,100,50,8/7/2019
69CE71,earnings,100,50,8/7/2019
69CE71,earnings,100,50,8/7/2019
69CE71,earnings,100,50,8/7/2019
69CE71,earnings,100,50,8/7/2019
69CE71,earnings,100,50,8/7/2019
6B67BD,earnings,100,50,8/7/2019
6BC6F9,earnings,100,50,8/7/2019
6BDA0C,earnings,100,50,8/7/2019
6BDA0C,earnings,100,50,8/7/2019
6BDA0C,earnings,100,50,8/7/2019
6BDA0C,earnings,100,50,8/7/2019
6D1ADF,earnings,100,50,8/7/2019
6D2BF6,earnings,100,50,8/7/2019
6DDA15,earnings,100,50,8/7/2019
6DDA15,earnings,100,50,8/7/2019
6DDA15,earnings,100,50,8/7/2019
6DDA15,earnings,100,50,8/7/2019
6DDA15,earnings,100,50,8/7/2019
6DDA15,earnings,100,50,8/7/2019
6DDA15,earnings,100,50,8/7/2019
6-Dec-05,earnings,100,50,8/7/2019
6E8864,note-sale,100,52,8/7/2019
6EA292,earnings,100,50,8/7/2019
6F0A63,earnings-up,100,68,8/7/2019
6F22E7,earnings,100,50,8/7/2019
6F30F9,earnings,100,50,8/7/2019
6F39FC,dividend,100,50,8/7/2019
71B0CF,executive-appointment,100,54,8/7/2019
71E2EF,earnings,100,50,8/7/2019
723548,earnings,100,50,8/7/2019
7262F2,earnings,100,50,8/7/2019
726EEA,dividend,100,50,8/7/2019
732A9B,conference-participant,100,50,8/7/2019
735388,dividend,100,50,8/7/2019
7410C3,earnings,100,50,8/7/2019
756045,earnings,100,50,8/7/2019
76959C,earnings,100,50,8/7/2019
769F40,earnings,100,50,8/7/2019
76D79A,earnings,100,50,8/7/2019
76DD0C,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
771985,earnings,100,50,8/7/2019
7823A3,product-release,100,64,8/7/2019
7ACD98,earnings,100,50,8/7/2019
7AF907,earnings,100,50,8/7/2019
7B492C,conference-call,100,50,8/7/2019
7DD8CC,earnings,100,50,8/7/2019
7E1D5D,earnings,100,50,8/7/2019
7EA323,conference-call,100,50,8/7/2019
805CD8,conference-participant,100,50,8/7/2019
810FAD,earnings,100,50,8/7/2019
818A2F,earnings,100,50,8/7/2019
818A2F,earnings,100,50,8/7/2019
818A2F,dividend,100,50,8/7/2019
818A2F,dividend,100,50,8/7/2019
824CCA,earnings,100,50,8/7/2019
824CCA,earnings,100,50,8/7/2019
824CCA,earnings,100,50,8/7/2019
82B57E,executive-appointment,100,54,8/7/2019
82B57E,earnings,100,50,8/7/2019
83B1C8,earnings,100,50,8/7/2019
84920B,earnings-up,100,68,8/7/2019
84920B,earnings-up,100,68,8/7/2019
84920B,earnings-up,100,68,8/7/2019
84920B,earnings-up,100,68,8/7/2019
85DA04,business-contract,100,69,8/7/2019
8614A2,earnings,100,50,8/7/2019
862941,operating-earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86AA9C,earnings,100,50,8/7/2019
86BAC7,dividend,100,50,8/7/2019
88611B,earnings,100,50,8/7/2019
8AB37F,revenue-up,100,69,8/7/2019
8AB37F,earnings,100,50,8/7/2019
8B6E7E,executive-appointment,100,54,8/7/2019
8D4AE6,dividend,100,50,8/7/2019
8DAAB9,dividend,100,50,8/7/2019
8E4F9A,public-offering,100,43,8/7/2019
902670,earnings,100,50,8/7/2019
902670,earnings,100,50,8/7/2019
902670,earnings,100,50,8/7/2019
902670,earnings,100,50,8/7/2019
911CA9,earnings,100,50,8/7/2019
911CA9,earnings,100,50,8/7/2019
92005C,earnings,100,50,8/7/2019
925759,earnings,100,50,8/7/2019
92B625,earnings,100,50,8/7/2019
9368BE,earnings,100,50,8/7/2019
945DE6,public-offering,100,43,8/7/2019
949625,dividend,100,50,8/7/2019
958938,earnings,100,50,8/7/2019
9592FB,earnings,100,50,8/7/2019
95A92E,earnings,100,50,8/7/2019
95C392,note-sale,100,52,8/7/2019
9673BD,earnings,100,50,8/7/2019
968966,partnership,100,61,8/7/2019
9934AD,partnership,100,61,8/7/2019
9A2760,earnings-up,100,68,8/7/2019
9A2760,earnings,100,50,8/7/2019
9A2760,earnings,100,50,8/7/2019
9A2760,earnings,100,50,8/7/2019
9B4066,unit-acquisition-acquirer,100,49,8/7/2019
9B730A,earnings,100,50,8/7/2019
9BB35A,public-offering,100,43,8/7/2019
9D307D,earnings,100,50,8/7/2019
9DDE1B,dividend,100,50,8/7/2019
9EBAFA,earnings,100,50,8/7/2019
9F18FA,asset-sale,100,62,8/7/2019
9F18FA,asset-sale,100,62,8/7/2019
A1BB98,dividend,100,50,8/7/2019
A21649,earnings,100,50,8/7/2019
A29DBD,earnings,100,50,8/7/2019
A3F598,earnings,100,50,8/7/2019
A3F598,earnings,100,50,8/7/2019
A3F598,earnings,100,50,8/7/2019
A3F598,earnings,100,50,8/7/2019
A6FC89,conference-call,100,50,8/7/2019
A753BB,partnership,100,61,8/7/2019
A871B0,earnings,100,50,8/7/2019
A87CD6,buybacks,100,74,8/7/2019
AAC8B6,earnings,100,50,8/7/2019
AAC8B6,earnings,100,50,8/7/2019
AAC8B6,earnings,100,50,8/7/2019
AAC8B6,earnings,100,50,8/7/2019
AAC8B6,earnings,100,50,8/7/2019
AAC8B6,earnings,100,50,8/7/2019
AC7AAE,earnings,100,50,8/7/2019
ACC7D3,earnings,100,50,8/7/2019
ACF0B4,earnings,100,50,8/7/2019
AD375D,public-offering,100,43,8/7/2019
ADFB3A,earnings,100,50,8/7/2019
AE3113,earnings,100,50,8/7/2019
AED6CF,earnings,100,50,8/7/2019
AED6CF,earnings,100,50,8/7/2019
AED6CF,earnings,100,50,8/7/2019
AED6CF,earnings,100,50,8/7/2019
AED6CF,earnings,100,50,8/7/2019
AED6CF,earnings,100,50,8/7/2019
AED6CF,earnings,100,50,8/7/2019
AFD7DD,earnings,100,50,8/7/2019
AFD7DD,earnings,100,50,8/7/2019
B04426,earnings,100,50,8/7/2019
B2E6B5,dividend,100,50,8/7/2019
B2E6B5,executive-appointment,100,54,8/7/2019
B2E6B5,earnings,100,50,8/7/2019
B2E6B5,earnings,100,50,8/7/2019
B2E6B5,earnings,100,50,8/7/2019
B46E12,executive-appointment,100,54,8/7/2019
B48D6A,executive-appointment,100,54,8/7/2019
B66928,dividend,100,50,8/7/2019
B66928,earnings,100,50,8/7/2019
B66928,earnings,100,50,8/7/2019
B7202A,earnings,100,50,8/7/2019
B8EF97,revenues,100,50,8/7/2019
B96637,business-contract,100,69,8/7/2019
B9764A,partnership,100,61,8/7/2019
BD9668,dividend,100,50,8/7/2019
BDCC11,earnings,100,50,8/7/2019
BDE867,dividend,100,50,8/7/2019
BDEC1E,earnings,100,50,8/7/2019
C1114B,earnings,100,50,8/7/2019
C1114B,earnings,100,50,8/7/2019
C1114B,earnings,100,50,8/7/2019
C1114B,earnings,100,50,8/7/2019
C15F8F,earnings,100,50,8/7/2019
C32A39,executive-appointment,100,54,8/7/2019
C36189,conference-participant,100,50,8/7/2019
C3BCD5,dividend,100,50,8/7/2019
C3EE99,conference-call,100,50,8/7/2019
C4A241,revenues,100,50,8/7/2019
C4FBDC,earnings,100,50,8/7/2019
C65004,earnings,100,50,8/7/2019
C659EB,conference-participant,100,50,8/7/2019
C9739A,conference-participant,100,50,8/7/2019
C9D866,conference-participant,100,50,8/7/2019
C9E04B,earnings,100,50,8/7/2019
CA99D7,earnings,100,50,8/7/2019
CBDB4D,earnings,100,50,8/7/2019
CC35BE,executive-appointment,100,54,8/7/2019
CD051C,earnings,100,50,8/7/2019
CDC217,earnings,100,50,8/7/2019
CDE118,dividend,100,50,8/7/2019
CE2791,earnings,100,50,8/7/2019
CE5C6E,earnings,100,50,8/7/2019
CE5C6E,earnings,100,50,8/7/2019
CE96E7,dividend,100,50,8/7/2019
CF3FF9,earnings,100,50,8/7/2019
D03C7A,public-offering,100,43,8/7/2019
D09938,earnings,100,50,8/7/2019
D17F7E,dividend-up,100,81,8/7/2019
D3FA2C,earnings,100,50,8/7/2019
D437C3,conference-participant,100,50,8/7/2019
D58A11,earnings,100,50,8/7/2019
D58A11,earnings,100,50,8/7/2019
D58A11,earnings,100,50,8/7/2019
D5A350,dividend,100,50,8/7/2019
D5B13D,earnings,100,50,8/7/2019
D65A13,legal-issues-defendant,100,22,8/7/2019
D65A13,legal-issues-defendant,100,22,8/7/2019
D65A13,legal-issues-defendant,100,22,8/7/2019
D75910,conference-call,100,50,8/7/2019
D88EF3,business-contract,100,69,8/7/2019
D90441,earnings,100,50,8/7/2019
D90441,earnings,100,50,8/7/2019
D90441,earnings,100,50,8/7/2019
DA48E4,business-contract,100,69,8/7/2019
DAFED3,dividend,100,50,8/7/2019
DB2E4E,earnings,100,50,8/7/2019
DB7EC3,earnings,100,50,8/7/2019
DB7EC3,earnings,100,50,8/7/2019
DC486E,legal-issues-defendant,100,22,8/7/2019
DC6AA0,earnings,100,50,8/7/2019
DCD97F,executive-appointment,100,54,8/7/2019
DCD97F,dividend,100,50,8/7/2019
DF01B1,earnings,100,50,8/7/2019
DF01B1,earnings,100,50,8/7/2019
DF01B1,earnings,100,50,8/7/2019
DF01B1,earnings,100,50,8/7/2019
DF42A0,dividend,100,50,8/7/2019
DF42A0,earnings,100,50,8/7/2019
DF5F14,earnings,100,50,8/7/2019
E05026,earnings,100,50,8/7/2019
E07573,note-sale,100,52,8/7/2019
E19A99,business-contract,100,69,8/7/2019
E19A99,earnings,100,50,8/7/2019
E1C16B,public-offering,100,43,8/7/2019
E1E36F,earnings,100,50,8/7/2019
E1E36F,earnings,100,50,8/7/2019
E1E36F,earnings,100,50,8/7/2019
E1E36F,earnings,100,50,8/7/2019
E1E36F,earnings,100,50,8/7/2019
E28D9C,earnings,100,50,8/7/2019
E41190,earnings,100,50,8/7/2019
E41190,earnings,100,50,8/7/2019
E41190,earnings,100,50,8/7/2019
E41190,earnings,100,50,8/7/2019
E5752F,earnings,100,50,8/7/2019
E5752F,earnings,100,50,8/7/2019
E5752F,earnings,100,50,8/7/2019
E5752F,earnings,100,50,8/7/2019
E5752F,earnings,100,50,8/7/2019
E5752F,earnings,100,50,8/7/2019
E61888,earnings,100,50,8/7/2019
E68E62,earnings,100,50,8/7/2019
E69BA5,dividend,100,50,8/7/2019
E74B55,earnings,100,50,8/7/2019
E82A2D,earnings,100,50,8/7/2019
E8C557,earnings,100,50,8/7/2019
EA79C7,earnings,100,50,8/7/2019
EB5E78,earnings,100,50,8/7/2019
EB5E78,earnings,100,50,8/7/2019
EB5E78,earnings,100,50,8/7/2019
EB5E78,earnings,100,50,8/7/2019
EBD89A,business-contract,100,69,8/7/2019
EEB5F9,earnings,100,50,8/7/2019
EF5BED,executive-appointment,100,54,8/7/2019
F00285,earnings,100,50,8/7/2019
F1C04C,conference-participant,100,50,8/7/2019
F5349B,earnings,100,50,8/7/2019
F5349B,dividend,100,50,8/7/2019
F569FD,earnings,100,50,8/7/2019
F58C23,conference-participant,100,50,8/7/2019
F6581D,earnings,100,50,8/7/2019
F6E1B5,earnings,100,50,8/7/2019
F72E4B,earnings,100,50,8/7/2019
F7935D,earnings,100,50,8/7/2019
F7ADEB,partnership,100,61,8/7/2019
F7ADEB,earnings,100,50,8/7/2019
F90EE5,dividend,100,50,8/7/2019
F9AA02,earnings,100,50,8/7/2019
FACF19,merger-completed,100,66,8/7/2019
FB7724,earnings,100,50,8/7/2019
FD2565,earnings,100,50,8/7/2019
FD2565,public-offering,100,43,8/7/2019
FD39EB,earnings,100,50,8/7/2019
FD554E,earnings,100,50,8/7/2019
FD6926,award,100,58,8/7/2019
FD9A97,dividend-up,100,81,8/7/2019
FDF28E,product-release,100,64,8/7/2019
FE609F,conference-call,100,50,8/7/2019
FF5413,dividend,100,50,8/7/2019
FF5413,business-contract,100,69,8/7/2019
00067A,note-sale,100,52,8/8/2019
00067A,note-sale,100,52,8/8/2019
002A99,earnings,100,50,8/8/2019
20751,earnings,100,50,8/8/2019
02ACBD,earnings,100,50,8/8/2019
036C6F,executive-appointment,100,54,8/8/2019
03FAA6,earnings,100,50,8/8/2019
03FAA6,earnings,100,50,8/8/2019
03FAA6,earnings,100,50,8/8/2019
03FAA6,earnings,100,50,8/8/2019
03FAA6,earnings,100,50,8/8/2019
03FAA6,earnings,100,50,8/8/2019
48590,earnings,100,50,8/8/2019
0490C6,earnings,100,50,8/8/2019
0490C6,earnings,100,50,8/8/2019
0490C6,earnings,100,50,8/8/2019
0490C6,earnings,100,50,8/8/2019
04CCCD,earnings,100,50,8/8/2019
04EB2F,acquisition-acquirer,100,49,8/8/2019
054B55,acquisition-acquirer,100,49,8/8/2019
05D148,earnings,100,50,8/8/2019
0624BE,executive-appointment,100,54,8/8/2019
84625,earnings,100,50,8/8/2019
84625,earnings,100,50,8/8/2019
95294,earnings,100,50,8/8/2019
95294,earnings,100,50,8/8/2019
95294,earnings,100,50,8/8/2019
95294,earnings,100,50,8/8/2019
099C88,acquisition-acquirer,100,49,8/8/2019
09DE1F,unit-acquisition-acquirer,100,49,8/8/2019
09DE1F,unit-acquisition-acquirer,100,49,8/8/2019
09DE1F,earnings,100,50,8/8/2019
0A9D0A,earnings,100,50,8/8/2019
0B13E8,public-offering,100,43,8/8/2019
0B400D,earnings,100,50,8/8/2019
0B400D,earnings,100,50,8/8/2019
0B400D,earnings,100,50,8/8/2019
0CCCB7,earnings,100,50,8/8/2019
0D03C8,earnings,100,50,8/8/2019
0E499E,earnings,100,50,8/8/2019
0F0693,earnings,100,50,8/8/2019
0FC848,earnings,100,50,8/8/2019
10C19B,executive-appointment,100,54,8/8/2019
1272B3,earnings,100,50,8/8/2019
14391F,earnings,100,50,8/8/2019
14391F,earnings,100,50,8/8/2019
14391F,earnings,100,50,8/8/2019
14391F,earnings,100,50,8/8/2019
152FA5,conference-participant,100,50,8/8/2019
15789A,earnings,100,50,8/8/2019
157D9F,earnings,100,50,8/8/2019
157D9F,earnings,100,50,8/8/2019
157D9F,earnings,100,50,8/8/2019
157D9F,earnings,100,50,8/8/2019
157D9F,earnings,100,50,8/8/2019
15901B,conference-call,100,50,8/8/2019
184866,earnings,100,50,8/8/2019
1AB023,earnings,100,50,8/8/2019
1AB023,earnings,100,50,8/8/2019
1AB023,earnings,100,50,8/8/2019
1C2593,conference-call,100,50,8/8/2019
1CB9D3,legal-issues-defendant,100,22,8/8/2019
1CB9D3,legal-issues-plaintiff,100,44,8/8/2019
1CD09C,earnings,100,50,8/8/2019
1CF3A8,earnings,100,50,8/8/2019
1D943E,conference-participant,100,50,8/8/2019
1D9E55,note-sale,100,52,8/8/2019
232053,earnings,100,50,8/8/2019
25AB8E,acquisition-acquirer,100,49,8/8/2019
26DC29,executive-appointment,100,54,8/8/2019
275300,dividend,100,50,8/8/2019
28AF37,earnings,100,50,8/8/2019
2A4131,earnings,100,50,8/8/2019
2A6DBE,earnings,100,50,8/8/2019
2B5483,partnership,100,61,8/8/2019
2B5483,earnings,100,50,8/8/2019
2B7A40,dividend,100,50,8/8/2019
2BBE62,earnings,100,50,8/8/2019
2BBE62,earnings,100,50,8/8/2019
2BBE62,earnings,100,50,8/8/2019
2BBE62,earnings,100,50,8/8/2019
2C35B5,earnings,100,50,8/8/2019
2CA60F,legal-issues-defendant,100,22,8/8/2019
2CA60F,legal-issues-defendant,100,22,8/8/2019
2CA60F,legal-issues-defendant,100,22,8/8/2019
2E1322,earnings,100,50,8/8/2019
2E89AE,earnings,100,50,8/8/2019
301493,earnings,100,50,8/8/2019
31F25C,legal-issues-defendant,100,22,8/8/2019
32C8CD,earnings,100,50,8/8/2019
342218,earnings-down,100,28,8/8/2019
3461CF,debt-reduction,100,74,8/8/2019
3461CF,credit-rating-upgrade-rater,20,50,8/8/2019
3587B4,earnings,100,50,8/8/2019
371B0A,earnings-up,100,68,8/8/2019
385DD4,dividend,100,50,8/8/2019
39D9DA,executive-resignation,100,44,8/8/2019
39FB23,investment-investor,100,55,8/8/2019
3B2311,conference-participant,100,50,8/8/2019
3B8484,earnings-up,100,68,8/8/2019
3C3B6B,earnings,100,50,8/8/2019
3C3B6B,executive-appointment,100,54,8/8/2019
3C7F5F,earnings,100,50,8/8/2019
3E39A5,revenues,100,50,8/8/2019
40F7DE,earnings,100,50,8/8/2019
416291,earnings,100,50,8/8/2019
41785E,dividend,100,50,8/8/2019
41B53E,earnings,100,50,8/8/2019
41B53E,earnings,100,50,8/8/2019
41B53E,earnings,100,50,8/8/2019
41ED98,earnings,100,50,8/8/2019
422A82,dividend,100,50,8/8/2019
43F4A8,earnings,100,50,8/8/2019
448BF3,regulatory-product-review-positive,100,73,8/8/2019
448BF3,earnings,100,50,8/8/2019
458D2C,revenue-volume,100,50,8/8/2019
46017C,earnings,100,50,8/8/2019
4.60E+06,acquisition-completed-acquirer,100,49,8/8/2019
4.60E+06,earnings,100,50,8/8/2019
485445,legal-issues-defendant,100,22,8/8/2019
485445,legal-issues-defendant,100,22,8/8/2019
49A344,acquisition-acquirer,100,49,8/8/2019
49CC59,earnings,100,50,8/8/2019
49F4D0,public-offering,100,43,8/8/2019
4A2457,business-contract,100,69,8/8/2019
4A3438,earnings,100,50,8/8/2019
4A3438,earnings,100,50,8/8/2019
4A3438,earnings,100,50,8/8/2019
4A3438,earnings,100,50,8/8/2019
4AC91D,earnings,100,50,8/8/2019
4AE584,revenue-up,100,69,8/8/2019
4AE584,revenue-up,100,69,8/8/2019
4AE584,revenue-up,100,69,8/8/2019
4AE584,revenue-up,100,69,8/8/2019
4AE584,earnings,100,50,8/8/2019
4AE584,earnings,100,50,8/8/2019
4B7006,earnings,100,50,8/8/2019
4BEB48,earnings,100,50,8/8/2019
4BEB48,earnings,100,50,8/8/2019
4BEB48,earnings,100,50,8/8/2019
4BEB48,earnings,100,50,8/8/2019
4BF3D6,earnings,100,50,8/8/2019
4C3FE9,earnings,100,50,8/8/2019
4DD203,earnings,100,50,8/8/2019
4E7C1F,board-meeting,100,51,8/8/2019
4EEB00,operating-earnings,100,50,8/8/2019
4FCC78,earnings,100,50,8/8/2019
52B567,partnership,100,61,8/8/2019
52B567,partnership,100,61,8/8/2019
52FB2F,earnings,100,50,8/8/2019
52FB2F,earnings,100,50,8/8/2019
52FB2F,earnings,100,50,8/8/2019
52FB2F,earnings,100,50,8/8/2019
52FB2F,earnings,100,50,8/8/2019
53EF9E,dividend,100,50,8/8/2019
5.43E+08,conference-participant,100,50,8/8/2019
546A27,earnings,100,50,8/8/2019
5.47E+28,operating-earnings,100,50,8/8/2019
54DF47,earnings,100,50,8/8/2019
55D0F3,earnings,100,50,8/8/2019
562853,dividend,100,50,8/8/2019
57A854,earnings-up,100,68,8/8/2019
5A64D5,executive-appointment,100,54,8/8/2019
5B226B,revenue-up,100,66,8/8/2019
5B226B,revenue-up,100,66,8/8/2019
5B226B,revenue-up,100,66,8/8/2019
5C2A47,earnings,100,50,8/8/2019
5CEE02,executive-appointment,100,54,8/8/2019
5E1DF3,earnings,100,50,8/8/2019
5E6959,acquisition-acquirer,100,49,8/8/2019
5EF130,earnings,100,50,8/8/2019
5EF130,earnings,100,50,8/8/2019
5EF130,earnings,100,50,8/8/2019
5F3D91,earnings,100,50,8/8/2019
60FE03,earnings,100,50,8/8/2019
619882,conference-organizer,100,57,8/8/2019
620381,earnings,100,50,8/8/2019
64636E,earnings,100,50,8/8/2019
649CBD,earnings,100,50,8/8/2019
649CBD,earnings,100,50,8/8/2019
649CBD,earnings,100,50,8/8/2019
6559D8,clinical-trials-start,100,64,8/8/2019
6634D9,earnings,100,50,8/8/2019
6810DE,earnings,100,50,8/8/2019
68586A,earnings,100,50,8/8/2019
6925EB,earnings,100,50,8/8/2019
69C99E,earnings,100,50,8/8/2019
6B6375,earnings,100,50,8/8/2019
6D2BF6,private-placement,100,56,8/8/2019
6D2BF6,earnings,100,50,8/8/2019
6E8864,note-sale,100,52,8/8/2019
705636,dividend,100,50,8/8/2019
705636,revenues,100,50,8/8/2019
71553E,earnings,100,50,8/8/2019
71B0CF,earnings,100,50,8/8/2019
7.45E+28,earnings,100,50,8/8/2019
747219,earnings,100,50,8/8/2019
763DBE,earnings,100,50,8/8/2019
76BECC,earnings,100,50,8/8/2019
76BECC,earnings,100,50,8/8/2019
76BECC,earnings,100,50,8/8/2019
76BECC,earnings,100,50,8/8/2019
7710F3,earnings,100,50,8/8/2019
7710F3,earnings,100,50,8/8/2019
7734AC,dividend,100,50,8/8/2019
7740DE,same-store-sales-up,100,54,8/8/2019
791EC1,unit-acquisition-acquirer,100,49,8/8/2019
7B1156,earnings,100,50,8/8/2019
7B9212,revenues,100,50,8/8/2019
7BC92D,acquisition-acquirer,100,49,8/8/2019
7BC92D,earnings,100,50,8/8/2019
7BEA98,earnings,100,50,8/8/2019
7D85A9,dividend,100,50,8/8/2019
7E3F8F,buybacks,100,74,8/8/2019
7F3665,earnings,100,50,8/8/2019
81222C,earnings,100,50,8/8/2019
8195B7,earnings,100,50,8/8/2019
8.10E+205,earnings,100,50,8/8/2019
82F088,fraud-defendant,100,20,8/8/2019
83598E,executive-appointment,100,54,8/8/2019
83E0AC,conference-call,100,50,8/8/2019
877C0C,legal-issues-defendant,100,22,8/8/2019
88923D,earnings,100,50,8/8/2019
88923D,earnings,100,50,8/8/2019
88923D,earnings,100,50,8/8/2019
88923D,earnings,100,50,8/8/2019
88923D,earnings,100,50,8/8/2019
88923D,earnings,100,50,8/8/2019
895D56,operating-earnings,100,50,8/8/2019
89F693,unit-acquisition-acquiree,100,76,8/8/2019
89F693,unit-acquisition-acquiree,100,76,8/8/2019
89F693,unit-acquisition-acquiree,100,76,8/8/2019
89F693,asset-sale,100,62,8/8/2019
8AC65D,conference-participant,100,50,8/8/2019
8BFAA4,earnings,100,50,8/8/2019
8BFAA4,earnings,100,50,8/8/2019
8BFAA4,earnings,100,50,8/8/2019
8C6C1B,conference-call,100,50,8/8/2019
8DE56F,earnings,100,50,8/8/2019
8DE56F,earnings,100,50,8/8/2019
8FCA78,acquisition-acquiree,100,76,8/8/2019
8FCA78,dividend,100,50,8/8/2019
922F0C,executive-appointment,100,54,8/8/2019
922F0C,dividend,100,50,8/8/2019
92D230,earnings,100,50,8/8/2019
92D230,earnings,100,50,8/8/2019
92D230,earnings,100,50,8/8/2019
92D230,earnings,100,50,8/8/2019
92D230,earnings,100,50,8/8/2019
92D230,earnings,100,50,8/8/2019
92D230,earnings,100,50,8/8/2019
92D757,dividend,100,50,8/8/2019
92D9C9,public-offering,100,43,8/8/2019
92D9C9,public-offering,100,43,8/8/2019
938D89,earnings,100,50,8/8/2019
9.39E+69,earnings,100,50,8/8/2019
943239,executive-resignation,100,44,8/8/2019
943239,earnings,100,50,8/8/2019
944B2E,earnings,100,50,8/8/2019
944B2E,earnings,100,50,8/8/2019
944B2E,earnings,100,50,8/8/2019
944B2E,earnings,100,50,8/8/2019
944B2E,earnings,100,50,8/8/2019
944B2E,earnings,100,50,8/8/2019
947B0B,earnings,100,50,8/8/2019
949625,earnings,100,50,8/8/2019
9507FF,public-offering,100,43,8/8/2019
9.65E+07,earnings,100,50,8/8/2019
9.65E+07,earnings,100,50,8/8/2019
966ACE,earnings,100,50,8/8/2019
966DBE,earnings,100,50,8/8/2019
966DBE,earnings,100,50,8/8/2019
966DBE,earnings,100,50,8/8/2019
966DBE,earnings,100,50,8/8/2019
966DBE,earnings,100,50,8/8/2019
96A6CD,earnings,100,50,8/8/2019
96BFF4,revenues,100,50,8/8/2019
96BFF4,revenues,100,50,8/8/2019
97FE80,executive-appointment,100,54,8/8/2019
97FE80,earnings,100,50,8/8/2019
99028D,conference-call,100,50,8/8/2019
9B0C9C,earnings,100,50,8/8/2019
9BF177,business-contract,100,69,8/8/2019
9CDA4F,earnings,100,50,8/8/2019
9E5C2C,earnings,100,50,8/8/2019
9F5CBB,earnings,100,50,8/8/2019
A017F4,earnings,100,50,8/8/2019
A23747,partnership,100,61,8/8/2019
A3800A,earnings,100,50,8/8/2019
A403CF,dividend,100,50,8/8/2019
A52B6B,conference-organizer,100,57,8/8/2019
A631A3,earnings,100,50,8/8/2019
A6828A,conference-participant,100,50,8/8/2019
A753BB,earnings-guidance-meet-expectations,100,59,8/8/2019
A75D43,earnings,100,50,8/8/2019
A806FA,executive-appointment,100,54,8/8/2019
A8B137,partnership,100,61,8/8/2019
A8E72A,conference-participant,100,50,8/8/2019
AB4A7E,earnings-up,100,68,8/8/2019
AB4A7E,earnings-up,100,68,8/8/2019
AB4A7E,earnings-up,100,68,8/8/2019
AC3584,revenue-up,100,88,8/8/2019
AC3584,revenue-up,100,88,8/8/2019
AC3584,revenue-up,100,88,8/8/2019
AD6141,earnings,100,50,8/8/2019
AD6141,dividend,100,50,8/8/2019
AE4125,earnings,100,50,8/8/2019
AE79CD,earnings,100,50,8/8/2019
AE79CD,conference-participant,100,50,8/8/2019
AECCA9,conference-call,100,50,8/8/2019
AEFC90,clinical-trials-start,100,64,8/8/2019
B01215,earnings,100,50,8/8/2019
B05000,revenue-up,100,91,8/8/2019
B05000,revenue-up,100,69,8/8/2019
B33E77,earnings,100,50,8/8/2019
B37FB4,dividend,100,50,8/8/2019
B48D6A,earnings,100,50,8/8/2019
B508E5,conference-call,100,50,8/8/2019
B5BA39,earnings,100,50,8/8/2019
B5BA39,dividend,100,50,8/8/2019
B7BBFF,earnings,100,50,8/8/2019
B7BDA3,earnings,100,50,8/8/2019
B7BDA3,earnings,100,50,8/8/2019
B803B1,earnings,100,50,8/8/2019
B96637,conference-participant,100,50,8/8/2019
BB0787,conference-call,100,50,8/8/2019
BBF349,earnings,100,50,8/8/2019
BBF349,earnings,100,50,8/8/2019
BBF349,earnings,100,50,8/8/2019
BBF349,earnings,100,50,8/8/2019
BD44C9,earnings,100,50,8/8/2019
BDCC11,executive-appointment,100,54,8/8/2019
BDF2BD,earnings-positive,100,69,8/8/2019
BDF2BD,earnings,100,50,8/8/2019
BDF2BD,earnings,100,50,8/8/2019
BDF2BD,earnings,100,50,8/8/2019
BDF2BD,earnings,100,50,8/8/2019
BDF2BD,earnings,100,50,8/8/2019
BE14CF,conference-participant,100,50,8/8/2019
BE379D,conference-call,100,50,8/8/2019
BE5935,earnings,100,50,8/8/2019
BE5935,executive-appointment,100,54,8/8/2019
BFD0A7,earnings,100,50,8/8/2019
BFD0A7,earnings,100,50,8/8/2019
BFD0A7,earnings,100,50,8/8/2019
C06EB6,revenue-up,100,69,8/8/2019
C06EB6,revenue-up,100,69,8/8/2019
C06EB6,revenue-up,100,69,8/8/2019
C2DD02,earnings,100,50,8/8/2019
C356AC,dividend,100,50,8/8/2019
C356AC,earnings,100,50,8/8/2019
C356AC,earnings,100,50,8/8/2019
C356AC,earnings,100,50,8/8/2019
C356AC,earnings,100,50,8/8/2019
C356AC,earnings,100,50,8/8/2019
C356AC,earnings,100,50,8/8/2019
C356AC,earnings,100,50,8/8/2019
C36189,earnings,100,50,8/8/2019
C3BAE7,conference-participant,100,50,8/8/2019
C4706C,earnings,100,50,8/8/2019
C50B26,earnings,100,50,8/8/2019
C584BE,earnings,100,50,8/8/2019
C58D71,earnings,100,50,8/8/2019
C58D71,earnings,100,50,8/8/2019
C659EB,dividend,100,50,8/8/2019
C6C702,earnings,100,50,8/8/2019
C8A059,earnings,100,50,8/8/2019
C9E4EC,earnings,100,50,8/8/2019
CA212F,acquisition-completed-acquirer,100,49,8/8/2019
CC35BE,earnings,100,50,8/8/2019
CC35BE,earnings,100,50,8/8/2019
CC35BE,earnings,100,50,8/8/2019
CC35BE,earnings,100,50,8/8/2019
CC35BE,earnings,100,50,8/8/2019
CDC817,earnings,100,50,8/8/2019
CDD75E,earnings,100,50,8/8/2019
D07B07,earnings,100,50,8/8/2019
D518D8,dividend,100,50,8/8/2019
D63B0F,earnings,100,50,8/8/2019
D63B0F,earnings,100,50,8/8/2019
D63B0F,earnings,100,50,8/8/2019
D63B0F,dividend,100,50,8/8/2019
D64C6D,dividend,100,50,8/8/2019
D65A13,legal-issues-defendant,100,22,8/8/2019
D697DE,earnings,100,50,8/8/2019
D6EAA3,acquisition-completed-acquirer,100,49,8/8/2019
D78CCD,earnings,100,50,8/8/2019
D8ECA1,earnings,100,50,8/8/2019
D8ECA1,earnings,100,50,8/8/2019
D8ECA1,earnings,100,50,8/8/2019
D8ECA1,earnings,100,50,8/8/2019
D90F43,earnings,100,50,8/8/2019
D90F43,earnings,100,50,8/8/2019
D90F43,earnings,100,50,8/8/2019
D90F43,earnings,100,50,8/8/2019
D90F43,earnings,100,50,8/8/2019
D90F43,earnings,100,50,8/8/2019
D90F43,legal-issues-defendant,100,22,8/8/2019
D90F43,legal-issues-defendant,100,22,8/8/2019
DD0F15,clinical-trials-start,100,64,8/8/2019
DD1BA1,earnings,100,50,8/8/2019
DD682D,executive-appointment,100,54,8/8/2019
DF18E6,earnings,100,50,8/8/2019
DF6FDD,earnings,100,50,8/8/2019
DFADDB,earnings,100,50,8/8/2019
E0207A,buybacks,100,74,8/8/2019
E11C41,executive-appointment,100,54,8/8/2019
E16133,earnings,100,50,8/8/2019
E16133,buybacks,100,74,8/8/2019
E259C7,revenues,100,50,8/8/2019
E26FC3,product-release,100,64,8/8/2019
E26FC3,product-release,100,64,8/8/2019
E2CB7B,earnings,100,50,8/8/2019
E3656D,earnings,100,50,8/8/2019
E71AE6,earnings,100,50,8/8/2019
E72599,earnings,100,50,8/8/2019
E74B55,partnership,100,61,8/8/2019
E8846E,conference-organizer,100,57,8/8/2019
E94704,dividend,100,50,8/8/2019
EAA0A7,conference-participant,100,50,8/8/2019
EAEBF3,earnings,100,50,8/8/2019
EAEBF3,conference-participant,100,50,8/8/2019
EB43F4,earnings,100,50,8/8/2019
EC8116,earnings,100,50,8/8/2019
ED9C04,earnings,100,50,8/8/2019
ED9C04,earnings,100,50,8/8/2019
ED9C04,earnings,100,50,8/8/2019
ED9C04,earnings,100,50,8/8/2019
ED9C04,earnings,100,50,8/8/2019
ED9C04,earnings,100,50,8/8/2019
ED9C04,executive-appointment,100,54,8/8/2019
EF25A5,earnings,100,50,8/8/2019
EF25A5,earnings,100,50,8/8/2019
EF25A5,earnings,100,50,8/8/2019
EF25A5,earnings,100,50,8/8/2019
F05B1B,earnings,100,50,8/8/2019
F05B1B,earnings,100,50,8/8/2019
F0B335,business-contract,100,69,8/8/2019
F3816D,earnings,100,50,8/8/2019
F4D241,earnings,100,50,8/8/2019
F509E2,earnings,100,50,8/8/2019
F6581D,earnings,100,50,8/8/2019
F6DA75,earnings,100,50,8/8/2019
F73DD1,earnings,100,50,8/8/2019
F73DD1,earnings,100,50,8/8/2019
F73DD1,earnings,100,50,8/8/2019
F73DD1,earnings,100,50,8/8/2019
F73DD1,earnings,100,50,8/8/2019
F73DD1,earnings,100,50,8/8/2019
F83279,earnings,100,50,8/8/2019
F83279,earnings,100,50,8/8/2019
F9AA02,executive-appointment,100,54,8/8/2019
F9CAF8,dividend,100,50,8/8/2019
FAE021,dividend,100,50,8/8/2019
FB728F,earnings,100,50,8/8/2019
FBD92D,earnings,100,50,8/8/2019
FBD92D,earnings,100,50,8/8/2019
FBD92D,earnings,100,50,8/8/2019
FC1F9D,dividend,100,50,8/8/2019
FF227B,earnings,100,50,8/8/2019
FF5413,revenue-volume,100,50,8/8/2019
036C6F,earnings,100,50,8/9/2019
036C6F,earnings,100,50,8/9/2019
036C6F,earnings,100,50,8/9/2019
036C6F,earnings,100,50,8/9/2019
083F72,earnings,100,50,8/9/2019
84625,dividend,100,50,8/9/2019
0C8D82,executive-appointment,100,54,8/9/2019
0F0693,conference-participant,100,50,8/9/2019
12A3A3,dividend,100,50,8/9/2019
16B882,earnings,100,50,8/9/2019
19CAC7,dividend-up,100,81,8/9/2019
205AD5,partnership,100,61,8/9/2019
24A89A,earnings,100,50,8/9/2019
24A89A,earnings,100,50,8/9/2019
24CB56,conference-organizer,100,57,8/9/2019
24CB56,conference-organizer,100,57,8/9/2019
25A6CC,legal-issues-defendant,100,22,8/9/2019
25A6CC,legal-issues-defendant,100,22,8/9/2019
25D3CE,earnings,100,50,8/9/2019
26E3BA,earnings,100,50,8/9/2019
2CA60F,legal-issues-defendant,100,22,8/9/2019
2CA60F,legal-issues-defendant,100,22,8/9/2019
2CA60F,legal-issues-defendant,100,22,8/9/2019
2CA60F,legal-issues-defendant,100,22,8/9/2019
3587B4,legal-issues-defendant,100,22,8/9/2019
36C09B,earnings,100,50,8/9/2019
3B20AB,conference-participant,100,50,8/9/2019
3B9886,conference-call,100,50,8/9/2019
3E39A5,conference-participant,100,50,8/9/2019
449447,revenues,100,50,8/9/2019
449447,revenues,100,50,8/9/2019
485445,legal-issues-defendant,100,22,8/9/2019
49F4D0,public-offering,100,43,8/9/2019
4A2457,award,100,58,8/9/2019
4A3438,conference-participant,100,50,8/9/2019
4E3D15,facility-sale,100,52,8/9/2019
4E6F5A,earnings,100,50,8/9/2019
4F9926,product-release,100,64,8/9/2019
4F9926,product-release,100,64,8/9/2019
504FE2,executive-appointment,100,54,8/9/2019
51E682,dividend,100,50,8/9/2019
52BF94,conference-call,100,50,8/9/2019
586BD7,conference-participant,100,50,8/9/2019
587D25,earnings,100,50,8/9/2019
58CA9A,conference-participant,100,50,8/9/2019
5AA3B1,earnings,100,50,8/9/2019
5AA3B1,earnings,100,50,8/9/2019
619882,conference-organizer,100,57,8/9/2019
619882,conference-organizer,100,57,8/9/2019
619882,conference-organizer,100,57,8/9/2019
64E615,conference-participant,100,50,8/9/2019
6.52E+64,earnings,100,50,8/9/2019
66749D,dividend,100,50,8/9/2019
66749D,conference-participant,100,50,8/9/2019
6A6BDC,earnings,100,50,8/9/2019
726DDF,earnings,100,50,8/9/2019
76CEFB,buybacks,100,74,8/9/2019
76F067,legal-verdict-favored,100,78,8/9/2019
789A7D,dividend,100,50,8/9/2019
78F776,earnings,100,50,8/9/2019
7BAAE7,dividend,100,50,8/9/2019
7F7C87,earnings,100,50,8/9/2019
817ED9,business-contract,100,69,8/9/2019
82F088,legal-issues-defendant,100,22,8/9/2019
82F088,legal-issues-defendant,100,22,8/9/2019
855DF7,earnings,100,50,8/9/2019
883D82,earnings,100,50,8/9/2019
8D0EEA,earnings,100,50,8/9/2019
8E4F9A,public-offering,100,43,8/9/2019
8F3231,merger,100,66,8/9/2019
8F3231,merger,100,66,8/9/2019
8F3231,merger,100,66,8/9/2019
8F8F2F,dividend,100,50,8/9/2019
95C392,note-sale,100,52,8/9/2019
980C14,dividend,100,50,8/9/2019
9FF5F1,buybacks,100,74,8/9/2019
A21649,dividend,100,50,8/9/2019
AA5C8E,conference-participant,100,50,8/9/2019
AD1ACF,dividend,100,50,8/9/2019
AD23DE,dividend,100,50,8/9/2019
B2256A,executive-appointment,100,54,8/9/2019
B303A6,grant-recipient,100,63,8/9/2019
B4C673,dividend,100,50,8/9/2019
B4F5F4,earnings,100,50,8/9/2019
BA218A,buybacks,100,74,8/9/2019
BAD9EA,earnings,100,50,8/9/2019
BDE867,earnings,100,50,8/9/2019
BDE867,earnings,100,50,8/9/2019
BDE867,earnings,100,50,8/9/2019
BDE867,earnings,100,50,8/9/2019
BE645B,earnings,100,50,8/9/2019
C66B44,acquisition-completed-acquirer,100,49,8/9/2019
C66B44,acquisition-completed-acquirer,100,49,8/9/2019
C93C44,earnings,100,50,8/9/2019
C9E107,dividend,100,50,8/9/2019
D27FAB,earnings,100,50,8/9/2019
D45285,earnings,100,50,8/9/2019
D57D99,conference-participant,100,50,8/9/2019
D65A13,legal-issues-defendant,100,22,8/9/2019
D65A13,legal-issues-defendant,100,22,8/9/2019
D65A13,legal-issues-defendant,100,22,8/9/2019
DB23C8,conference-participant,100,50,8/9/2019
DB5CA5,executive-appointment,100,54,8/9/2019
DB9F70,merger-completed,100,66,8/9/2019
DC6EF3,earnings,100,50,8/9/2019
DD7A96,dividend,100,50,8/9/2019
DF1F7A,dividend,100,50,8/9/2019
EB43F4,conference-participant,100,50,8/9/2019
EEA734,earnings,100,50,8/9/2019
F179ED,conference-participant,100,50,8/9/2019
F30508,legal-verdict-favored,100,78,8/9/2019
F5A214,acquisition-acquirer,100,49,8/9/2019
F6E248,regulatory-product-approval-granted,100,81,8/9/2019
F702CA,acquisition-completed-acquirer,100,49,8/9/2019
F8BA6C,conference-participant,100,50,8/9/2019
FFAB4A,unit-acquisition-acquiree,100,76,8/9/2019
649CBD,legal-issues-defendant,100,22,8/10/2019
6DDA15,legal-issues-defendant,100,22,8/10/2019
A6FC89,legal-issues-defendant,100,22,8/10/2019
55018,legal-issues-defendant,100,22,8/11/2019
0B400D,legal-issues-defendant,100,22,8/11/2019
033B58,earnings,100,50,8/12/2019
06A456,executive-appointment,100,54,8/12/2019
06CB5B,earnings,100,50,8/12/2019
06EE79,earnings,100,50,8/12/2019
09F623,note-sale,100,52,8/12/2019
0BD199,earnings,100,50,8/12/2019
0EF1AF,conference-call,100,50,8/12/2019
1080C0,executive-appointment,100,54,8/12/2019
125212,earnings,100,50,8/12/2019
1748F6,executive-appointment,100,54,8/12/2019
197612,buybacks,100,74,8/12/2019
1B16C1,legal-issues-defendant,100,22,8/12/2019
1B6F77,earnings,100,50,8/12/2019
1D3A00,conference-call,100,50,8/12/2019
1EBF8D,partnership,100,61,8/12/2019
1F19C8,credit-extension-provider,100,57,8/12/2019
21153F,executive-appointment,100,54,8/12/2019
21153F,executive-appointment,100,54,8/12/2019
221783,public-offering,100,43,8/12/2019
221783,public-offering,100,43,8/12/2019
228D42,partnership,100,61,8/12/2019
228D42,partnership,100,61,8/12/2019
228D42,partnership,100,61,8/12/2019
24CB56,conference-organizer,100,57,8/12/2019
24CB56,conference-organizer,100,57,8/12/2019
26008A,conference-call,100,50,8/12/2019
26E3BA,product-release,100,64,8/12/2019
26E3BA,product-release,100,64,8/12/2019
27C10F,buybacks,100,74,8/12/2019
2A02DC,earnings,100,50,8/12/2019
3587B4,legal-issues-defendant,100,22,8/12/2019
366A08,legal-issues-defendant,100,22,8/12/2019
37727A,joint-venture,100,62,8/12/2019
37727A,public-offering,100,43,8/12/2019
41A93D,note-sale,100,52,8/12/2019
43A74A,note-sale,100,52,8/12/2019
43A74A,note-sale,100,52,8/12/2019
449447,legal-issues-defendant,100,22,8/12/2019
4.60E+06,conference-participant,100,50,8/12/2019
485445,legal-issues-defendant,100,22,8/12/2019
4BEB48,award,100,58,8/12/2019
4CDA2B,earnings,100,50,8/12/2019
50070E,partnership,100,61,8/12/2019
50070E,business-contract,100,69,8/12/2019
519FE0,earnings,100,50,8/12/2019
519FE0,earnings,100,50,8/12/2019
519FE0,earnings,100,50,8/12/2019
519FE0,earnings,100,50,8/12/2019
519FE0,earnings,100,50,8/12/2019
52B567,earnings,100,50,8/12/2019
52B567,earnings,100,50,8/12/2019
52B567,earnings,100,50,8/12/2019
5A423F,acquisition-acquirer,100,49,8/12/2019
5C2A47,conference-participant,100,50,8/12/2019
5C7601,note-sale,100,52,8/12/2019
5E6959,acquisition-acquirer,100,49,8/12/2019
6166D1,partnership,100,61,8/12/2019
636BBF,business-contract,100,69,8/12/2019
636BBF,business-contract,100,69,8/12/2019
64636E,patient-enrollment-start,100,58,8/12/2019
64636E,patient-enrollment-start,100,58,8/12/2019
657097,partnership,100,61,8/12/2019
66667F,revenue-up,100,90,8/12/2019
6844D2,legal-issues-defendant,100,22,8/12/2019
6A961B,dividend,100,50,8/12/2019
6.00E+19,executive-appointment,100,54,8/12/2019
6F6559,product-release,100,64,8/12/2019
72609A,acquisition-acquirer,100,49,8/12/2019
756045,executive-appointment,100,54,8/12/2019
762A3E,conference-organizer,100,57,8/12/2019
7999F3,note-sale,100,52,8/12/2019
7999F3,note-sale,100,52,8/12/2019
7999F3,note-sale,100,52,8/12/2019
7A0EC4,partnership,100,61,8/12/2019
7A5097,conference-call,100,50,8/12/2019
7B1E50,sponsorship,100,57,8/12/2019
7FEEE1,earnings,100,50,8/12/2019
80D744,facility-open,100,65,8/12/2019
8.10E+32,joint-venture,100,62,8/12/2019
81222C,executive-resignation,100,44,8/12/2019
817ED9,earnings,100,50,8/12/2019
82F088,legal-issues-defendant,100,22,8/12/2019
82F088,legal-issues-defendant,100,22,8/12/2019
838ADD,executive-appointment,100,54,8/12/2019
86F123,business-contract,100,69,8/12/2019
885758,earnings,100,50,8/12/2019
893904,earnings,100,50,8/12/2019
8AB85C,earnings,100,50,8/12/2019
8AC65D,executive-appointment,100,54,8/12/2019
94983E,dividend,100,50,8/12/2019
98CEBB,business-contract,100,69,8/12/2019
9A602D,acquisition-acquirer,100,49,8/12/2019
9CDA4F,conference-participant,100,50,8/12/2019
9D2790,earnings,100,50,8/12/2019
9EA947,dividend,100,50,8/12/2019
A01983,merger,100,66,8/12/2019
A2C979,earnings,100,50,8/12/2019
A3AAA5,dividend,100,50,8/12/2019
A403CF,legal-issues-defendant,100,22,8/12/2019
A6FC89,legal-issues-defendant,100,22,8/12/2019
A790A5,conference-call,100,50,8/12/2019
AA09AD,legal-issues-defendant,100,22,8/12/2019
AA09AD,executive-appointment,100,54,8/12/2019
AD1ACF,executive-appointment,100,54,8/12/2019
AD22F2,conference-call,100,50,8/12/2019
B5BA39,legal-issues-defendant,100,22,8/12/2019
B7BBFF,executive-appointment,100,54,8/12/2019
BA218A,legal-issues-defendant,100,22,8/12/2019
BB5271,note-sale,100,52,8/12/2019
BE645B,conference-participant,100,50,8/12/2019
BF5959,conference-call,100,50,8/12/2019
BF5959,conference-call,100,50,8/12/2019
BF5959,conference-call,100,50,8/12/2019
BF5959,conference-call,100,50,8/12/2019
C3BCD5,note-sale,100,52,8/12/2019
C659EB,executive-appointment,100,54,8/12/2019
C6C702,award,100,58,8/12/2019
C6C702,award,100,58,8/12/2019
C81E00,acquisition-acquirer,100,49,8/12/2019
C81E00,acquisition-acquirer,100,49,8/12/2019
C83B88,executive-appointment,100,54,8/12/2019
CAC8D0,executive-appointment,100,54,8/12/2019
CB7AB2,public-offering,100,43,8/12/2019
CB7AB2,note-sale,100,52,8/12/2019
CDFCC9,conference-participant,100,50,8/12/2019
CF073E,earnings,100,50,8/12/2019
D17C1B,campaign-ad-release,100,59,8/12/2019
D17C1B,revenue-volume,100,50,8/12/2019
D36B23,earnings,100,50,8/12/2019
D65A13,legal-issues-defendant,100,22,8/12/2019
D78BF1,award,100,58,8/12/2019
D95385,earnings,100,50,8/12/2019
DC0066,earnings,100,50,8/12/2019
DD682D,executive-appointment,100,54,8/12/2019
DE5611,conference-call,100,50,8/12/2019
E13782,earnings,100,50,8/12/2019
E261E9,earnings,100,50,8/12/2019
E2CFD2,executive-appointment,100,54,8/12/2019
E49AA3,product-release,100,64,8/12/2019
E67C2C,legal-issues-defendant,100,22,8/12/2019
ECD263,legal-issues-defendant,100,22,8/12/2019
ED22DC,earnings,100,50,8/12/2019
F47871,legal-issues-defendant,100,22,8/12/2019
FBDA0F,legal-issues-defendant,100,22,8/12/2019
FE609F,earnings,100,50,8/12/2019
00698D,conference-call,100,50,8/13/2019
00FC70,conference-call,100,50,8/13/2019
13528,partnership,100,61,8/13/2019
0157B1,market-entry,100,57,8/13/2019
0157B1,partnership,100,61,8/13/2019
0157B1,partnership,100,61,8/13/2019
036C6F,auditor-appointment,100,50,8/13/2019
03B8CF,legal-issues-defendant,100,22,8/13/2019
03FB17,earnings,100,50,8/13/2019
07C907,dividend,100,50,8/13/2019
84625,buybacks,100,74,8/13/2019
091B6C,executive-appointment,100,54,8/13/2019
091B6C,executive-appointment,100,54,8/13/2019
099C88,award,100,58,8/13/2019
0A59F8,partnership,100,61,8/13/2019
0EF1AF,partnership,100,61,8/13/2019
0F65C9,acquisition-acquirer,100,49,8/13/2019
12E454,partnership,100,61,8/13/2019
138DDE,public-offering,100,43,8/13/2019
1490F3,dividend,100,50,8/13/2019
15A388,earnings-positive,100,69,8/13/2019
1B5FEA,earnings,100,50,8/13/2019
1B5FEA,earnings,100,50,8/13/2019
1B5FEA,earnings,100,50,8/13/2019
1FAF22,conference-participant,100,50,8/13/2019
228D42,investment-investor,100,55,8/13/2019
26F99F,earnings,100,50,8/13/2019
278C18,earnings,100,50,8/13/2019
2B49F4,dividend,100,50,8/13/2019
2C7505,business-contract,100,69,8/13/2019
2C7505,business-contract,100,69,8/13/2019
2CA60F,legal-issues-defendant,100,22,8/13/2019
30AB63,note-sale,100,52,8/13/2019
3587B4,legal-issues-defendant,100,22,8/13/2019
37727A,public-offering,100,43,8/13/2019
384CD3,partnership,100,61,8/13/2019
384CD3,business-contract,100,69,8/13/2019
3C7F5F,business-combination,100,54,8/13/2019
3C7F5F,business-combination,100,54,8/13/2019
3C7F5F,business-combination,100,54,8/13/2019
3C8A04,dividend,100,50,8/13/2019
407878,earnings,100,50,8/13/2019
41A93D,note-sale,100,52,8/13/2019
42EFC7,earnings,100,50,8/13/2019
442769,partnership,100,61,8/13/2019
45ABCC,facility-open,100,65,8/13/2019
468DD4,public-offering,100,43,8/13/2019
485445,legal-issues-defendant,100,22,8/13/2019
485445,legal-issues-defendant,100,22,8/13/2019
485445,legal-issues-defendant,100,22,8/13/2019
4A3438,legal-issues-defendant,100,22,8/13/2019
4BEB48,conference-participant,100,50,8/13/2019
4C2F17,earnings,100,50,8/13/2019
539F49,earnings,100,50,8/13/2019
5480A7,dividend,100,50,8/13/2019
56277A,conference-participant,100,50,8/13/2019
589803,regulatory-product-approval-granted,100,81,8/13/2019
589803,regulatory-product-approval-granted,100,81,8/13/2019
5A423F,acquisition-completed-acquirer,100,49,8/13/2019
60DD84,unit-acquisition-acquirer,100,49,8/13/2019
649CBD,legal-issues-defendant,100,22,8/13/2019
6.52E+64,executive-appointment,100,54,8/13/2019
673C9A,conference-call,100,50,8/13/2019
693ECD,earnings,100,50,8/13/2019
693ECD,earnings,100,50,8/13/2019
69FDFC,earnings,100,50,8/13/2019
6E705B,executive-appointment,100,54,8/13/2019
6FCEF9,earnings,100,50,8/13/2019
71694D,earnings,100,50,8/13/2019
72609A,acquisition-acquirer,100,49,8/13/2019
728737,dividend,100,50,8/13/2019
732449,earnings,100,50,8/13/2019
73BCBA,executive-appointment,100,54,8/13/2019
76DD0C,earnings,100,50,8/13/2019
78A1BB,acquisition-acquirer,100,49,8/13/2019
7A2A49,partnership,100,61,8/13/2019
7ACFD4,earnings,100,50,8/13/2019
7ACFD4,earnings,100,50,8/13/2019
7ACFD4,earnings,100,50,8/13/2019
7ACFD4,earnings,100,50,8/13/2019
7ACFD4,earnings,100,50,8/13/2019
7F3669,executive-appointment,100,54,8/13/2019
7F7C87,earnings,100,50,8/13/2019
85DE00,partnership,100,61,8/13/2019
86478F,executive-appointment,100,54,8/13/2019
89E771,earnings,100,50,8/13/2019
89F693,conference-participant,100,50,8/13/2019
8BFE9A,earnings,100,50,8/13/2019
8BFE9A,earnings,100,50,8/13/2019
8BFE9A,earnings,100,50,8/13/2019
8BFE9A,earnings,100,50,8/13/2019
8BFE9A,earnings,100,50,8/13/2019
8D4486,partnership,100,61,8/13/2019
8DA42F,earnings,100,50,8/13/2019
8DA42F,earnings,100,50,8/13/2019
8E4F9A,public-offering,100,43,8/13/2019
913437,earnings,100,50,8/13/2019
9507FF,public-offering,100,43,8/13/2019
9546A5,earnings,100,50,8/13/2019
95C575,dividend,100,50,8/13/2019
9F62D1,dividend,100,50,8/13/2019
A47F2E,conference-participant,100,50,8/13/2019
A52533,executive-appointment,100,54,8/13/2019
A631A3,award,100,58,8/13/2019
A6FC89,legal-issues-defendant,100,22,8/13/2019
A9ED24,dividend,100,50,8/13/2019
B37FB4,product-release,100,64,8/13/2019
B5DE80,note-sale,100,52,8/13/2019
B83D67,business-contract,100,69,8/13/2019
B83D67,business-contract,100,69,8/13/2019
B8EF97,dividend,100,50,8/13/2019
B9BDE8,earnings,100,50,8/13/2019
BA0442,partnership,100,61,8/13/2019
BDEF34,dividend,100,50,8/13/2019
C0BA36,earnings,100,50,8/13/2019
C27E19,dividend,100,50,8/13/2019
C564E4,conference-participant,100,50,8/13/2019
C8FAC7,legal-issues-defendant,100,22,8/13/2019
CC8F6E,earnings,100,50,8/13/2019
CF6A5A,earnings,100,50,8/13/2019
D60BB2,partnership,100,61,8/13/2019
D90F43,partnership,100,61,8/13/2019
DBB28E,conference-call,100,50,8/13/2019
DCD97F,award,100,58,8/13/2019
DD0099,dividend,100,50,8/13/2019
E06265,dividend,100,50,8/13/2019
E35610,note-sale,100,52,8/13/2019
E49AA3,executive-appointment,100,54,8/13/2019
E5C910,earnings,100,50,8/13/2019
E68733,earnings,100,50,8/13/2019
E68733,earnings,100,50,8/13/2019
E8846E,conference-organizer,100,57,8/13/2019
E8846E,conference-organizer,100,57,8/13/2019
EB36DE,stake-acquiree,100,62,8/13/2019
EB36DE,asset-sale,100,62,8/13/2019
EF5BED,conference-participant,100,50,8/13/2019
F39E1E,earnings,100,50,8/13/2019
F4CDA3,unit-acquisition-acquirer,100,49,8/13/2019
F4E882,legal-issues-defendant,100,22,8/13/2019
F6A987,dividend,100,50,8/13/2019
F7ADEB,conference-participant,100,50,8/13/2019
F80FF9,conference-call,100,50,8/13/2019
F82D37,dividend,100,50,8/13/2019
F88147,earnings,100,50,8/13/2019
F93C8A,dividend,100,50,8/13/2019
FBD92D,executive-appointment,100,54,8/13/2019
FCA54E,earnings,100,50,8/13/2019
FD9526,dividend,100,50,8/13/2019
FDD3FC,clinical-trials-positive,100,87,8/13/2019
FDD3FC,public-offering,100,43,8/13/2019
0157B1,legal-issues-dismissed-plaintiff,100,44,8/14/2019
053EFF,dividend,100,50,8/14/2019
55018,legal-issues-defendant,100,22,8/14/2019
06A456,conference-call,100,50,8/14/2019
07EC43,award,100,58,8/14/2019
0968A5,conference-call,100,50,8/14/2019
0B4D10,dividend,100,50,8/14/2019
0BC29E,executive-appointment,100,54,8/14/2019
0BD4E8,legal-issues-defendant,100,22,8/14/2019
0BD4E8,legal-issues-defendant,100,22,8/14/2019
0BD4E8,legal-issues-defendant,100,22,8/14/2019
0BD4E8,legal-issues-defendant,100,22,8/14/2019
0BD4E8,legal-issues-defendant,100,22,8/14/2019
0EF1AF,earnings,100,50,8/14/2019
0F0440,donation,100,54,8/14/2019
1065BC,dividend,100,50,8/14/2019
12DE76,earnings,100,50,8/14/2019
138DDE,public-offering,100,43,8/14/2019
152FA5,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
182546,earnings,100,50,8/14/2019
1CD4B5,earnings,100,50,8/14/2019
1F2B5D,conference-participant,100,50,8/14/2019
1FAF22,conference-participant,100,50,8/14/2019
251988,partnership,100,61,8/14/2019
25A6CC,legal-issues-defendant,100,22,8/14/2019
263216,dividend,100,50,8/14/2019
26DC29,conference-call,100,50,8/14/2019
28AC4E,partnership,100,61,8/14/2019
292A70,dividend,100,50,8/14/2019
2C7505,clinical-trials,100,56,8/14/2019
2C7505,clinical-trials,100,56,8/14/2019
2CC60C,conference-call,100,50,8/14/2019
2D643C,executive-appointment,100,54,8/14/2019
341759,earnings,100,50,8/14/2019
34B411,merger-regulatory-approval,100,81,8/14/2019
39FB23,acquisition-completed-acquirer,100,49,8/14/2019
3B37F7,executive-appointment,100,54,8/14/2019
414FFF,conference-call,100,50,8/14/2019
42312F,earnings,100,50,8/14/2019
4398A2,earnings,100,50,8/14/2019
485445,legal-issues-defendant,100,22,8/14/2019
485445,legal-issues-defendant,100,22,8/14/2019
485445,legal-issues-defendant,100,22,8/14/2019
4A6F00,partnership,100,61,8/14/2019
4A6F00,legal-issues-defendant,100,22,8/14/2019
4F1432,partnership,100,61,8/14/2019
504FE2,partnership,100,61,8/14/2019
50702E,earnings,100,50,8/14/2019
514067,legal-issues-defendant,100,22,8/14/2019
51F541,dividend,100,50,8/14/2019
520632,partnership,100,61,8/14/2019
52B567,legal-issues-defendant,100,22,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
52D936,earnings,100,50,8/14/2019
57DDB9,partnership,100,61,8/14/2019
586FFD,conference-call,100,50,8/14/2019
589803,clinical-trials-positive,100,87,8/14/2019
589846,conference-call,100,50,8/14/2019
5A64D5,dividend,100,50,8/14/2019
6.18E+08,earnings,100,50,8/14/2019
6.18E+08,earnings,100,50,8/14/2019
6.18E+08,earnings,100,50,8/14/2019
62A48D,earnings,100,50,8/14/2019
649CBD,legal-issues-defendant,100,22,8/14/2019
649CBD,legal-issues-defendant,100,22,8/14/2019
66667F,reorganization-unit,100,53,8/14/2019
6F5DD2,earnings,100,50,8/14/2019
71694D,executive-appointment,100,54,8/14/2019
717DB4,conference-participant,100,50,8/14/2019
7239BB,conference-call,100,50,8/14/2019
7448A3,executive-appointment,100,54,8/14/2019
747219,conference-participant,100,50,8/14/2019
7.49E+07,earnings,100,50,8/14/2019
762B8D,earnings,100,50,8/14/2019
76E80F,conference-call,100,50,8/14/2019
7D85A9,executive-appointment,100,54,8/14/2019
80D744,dividend,100,50,8/14/2019
817ED9,dividend,100,50,8/14/2019
819492,earnings,100,50,8/14/2019
859D62,earnings,100,50,8/14/2019
86478F,acquisition-acquirer,100,49,8/14/2019
86478F,earnings,100,50,8/14/2019
8665BA,product-release,100,64,8/14/2019
88D80A,earnings,100,50,8/14/2019
8C84DF,ipo-pricing,100,50,8/14/2019
8FF2EF,earnings,100,50,8/14/2019
8FF57A,earnings,100,50,8/14/2019
9196A2,conference-organizer,100,57,8/14/2019
934CC3,earnings,100,50,8/14/2019
9.62E+76,dividend,100,50,8/14/2019
96B4FF,earnings,100,50,8/14/2019
990AD0,conference-organizer,100,57,8/14/2019
9C5BA5,dividend,100,50,8/14/2019
9FA83B,earnings,100,50,8/14/2019
A2A9BA,earnings,100,50,8/14/2019
A3F598,settlement,100,56,8/14/2019
A5A4F5,award,100,58,8/14/2019
A79F7D,earnings,100,50,8/14/2019
A8E72A,earnings,100,50,8/14/2019
B05000,executive-appointment,100,54,8/14/2019
B05118,product-release,100,64,8/14/2019
B08C51,earnings,100,50,8/14/2019
B0D41A,patent-awarded,100,72,8/14/2019
B3CB74,conference-organizer,100,57,8/14/2019
B614F8,revenue-up,100,69,8/14/2019
BA0442,acquisition-acquirer,100,49,8/14/2019
BA0442,earnings,100,50,8/14/2019
BB58FF,conference-participant,100,50,8/14/2019
BD682F,dividend,100,50,8/14/2019
BFCACF,conference-call,100,50,8/14/2019
C03C8B,acquisition-completed-acquirer,100,49,8/14/2019
C4FBDC,acquisition-completed-acquirer,100,49,8/14/2019
C564E4,partnership,100,61,8/14/2019
C5C137,earnings,100,50,8/14/2019
C5C137,earnings,100,50,8/14/2019
C5C137,earnings,100,50,8/14/2019
C5C137,earnings,100,50,8/14/2019
C65004,earnings,100,50,8/14/2019
C9739A,earnings,100,50,8/14/2019
CB7AB2,public-offering,100,43,8/14/2019
CB7AB2,note-sale,100,52,8/14/2019
CC3EC4,earnings,100,50,8/14/2019
CE8A7B,earnings,100,50,8/14/2019
CF6A5A,product-release,100,64,8/14/2019
CFF97C,credit-rating-upgrade-rater,20,50,8/14/2019
D1588D,earnings,100,50,8/14/2019
D6534D,dividend-up,100,81,8/14/2019
D65A13,legal-issues-defendant,100,22,8/14/2019
D76AEF,earnings,100,50,8/14/2019
D88EF3,partnership,100,61,8/14/2019
D90F43,legal-issues-defendant,100,22,8/14/2019
DAFED3,executive-appointment,100,54,8/14/2019
E20392,executive-appointment,100,54,8/14/2019
E20392,executive-appointment,100,54,8/14/2019
E21871,dividend,100,50,8/14/2019
E30B34,dividend,100,50,8/14/2019
E30B34,dividend,100,50,8/14/2019
E74FED,legal-issues-defendant,100,22,8/14/2019
E829E8,dividend,100,50,8/14/2019
E82A2D,conference-participant,100,50,8/14/2019
EBD89A,conference-call,100,50,8/14/2019
ED79D9,earnings,100,50,8/14/2019
F209B4,earnings,100,50,8/14/2019
F6A392,earnings,100,50,8/14/2019
F6E1B5,private-placement,100,56,8/14/2019
F80FF9,conference-call,100,50,8/14/2019
F88147,business-contract,100,69,8/14/2019
FC80E6,dividend,100,50,8/14/2019
01D03F,regulatory-product-approval-granted,100,81,8/15/2019
01D03F,regulatory-product-approval-granted,100,81,8/15/2019
036C6F,dividend-up,100,81,8/15/2019
03B431,executive-appointment,100,54,8/15/2019
03CF95,partnership,100,61,8/15/2019
58828,conference-call,100,50,8/15/2019
75172,conference-call,100,50,8/15/2019
0986B5,dividend,100,50,8/15/2019
0A59F8,earnings,100,50,8/15/2019
0A59F8,earnings,100,50,8/15/2019
0A59F8,earnings,100,50,8/15/2019
0A59F8,earnings,100,50,8/15/2019
0A59F8,earnings,100,50,8/15/2019
0A59F8,earnings,100,50,8/15/2019
0BD4E8,legal-issues-defendant,100,22,8/15/2019
0BD4E8,legal-issues-defendant,100,22,8/15/2019
0BD4E8,legal-issues-defendant,100,22,8/15/2019
0BF528,award,100,58,8/15/2019
0C6293,conference-participant,100,50,8/15/2019
135B09,dividend,100,50,8/15/2019
143C52,conference-call,100,50,8/15/2019
1921DD,partnership,100,61,8/15/2019
1D1B07,conference-participant,100,50,8/15/2019
1D1B07,conference-participant,100,50,8/15/2019
1F716B,partnership,100,61,8/15/2019
1FAF22,partnership,100,61,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
21153F,earnings,100,50,8/15/2019
23207A,product-release,100,64,8/15/2019
251988,partnership,100,61,8/15/2019
284289,dividend-up,100,58,8/15/2019
284289,executive-appointment,100,54,8/15/2019
2.89E+11,dividend,100,50,8/15/2019
2B9DBB,dividend,100,50,8/15/2019
2CA60F,legal-issues-defendant,100,22,8/15/2019
33AD83,partnership,100,61,8/15/2019
33AD83,conference-call,100,50,8/15/2019
3A3447,facility-open,100,65,8/15/2019
468DD4,public-offering,100,43,8/15/2019
485445,legal-issues-defendant,100,22,8/15/2019
485445,legal-issues-defendant,100,22,8/15/2019
4A3438,legal-issues-defendant,100,22,8/15/2019
4ECD1A,earnings,100,50,8/15/2019
4ECD1A,earnings,100,50,8/15/2019
4ECD1A,earnings,100,50,8/15/2019
4EEB00,executive-appointment,100,54,8/15/2019
504FE2,unit-acquisition-completed-acquirer,100,49,8/15/2019
54F271,buybacks,100,74,8/15/2019
56277A,conference-participant,100,50,8/15/2019
567F3D,dividend,100,50,8/15/2019
58B46F,note-sale,100,52,8/15/2019
59A832,award,100,58,8/15/2019
5D02B7,dividend,100,50,8/15/2019
5F2FF7,partnership,100,61,8/15/2019
5F9CE3,dividend,100,50,8/15/2019
619882,dividend,100,50,8/15/2019
6284B5,facility-open,100,65,8/15/2019
673C9A,executive-appointment,100,54,8/15/2019
6830FE,earnings,100,50,8/15/2019
69CE71,legal-issues-defendant,100,22,8/15/2019
6B0784,legal-issues-defendant,100,22,8/15/2019
6B5379,dividend,100,50,8/15/2019
6-Dec-05,earnings,100,50,8/15/2019
6F0A63,note-sale,100,52,8/15/2019
6F0A63,note-sale,100,52,8/15/2019
713810,same-store-sales-up,100,53,8/15/2019
73F7F9,conference-call,100,50,8/15/2019
76B926,dividend,100,50,8/15/2019
78F9ED,legal-issues-defendant,100,22,8/15/2019
7A0EC4,earnings,100,50,8/15/2019
7A51FE,dividend,100,50,8/15/2019
8.10E+32,dividend,100,50,8/15/2019
82FD6D,acquisition-acquirer,100,49,8/15/2019
85DE00,conference-participant,100,50,8/15/2019
877734,executive-appointment,100,54,8/15/2019
8BFAA4,facility-close,100,47,8/15/2019
8FF57A,government-contract,100,69,8/15/2019
905356,earnings-per-share-positive,100,69,8/15/2019
905356,earnings,100,50,8/15/2019
9196A2,conference-organizer,100,57,8/15/2019
934CC3,legal-issues-defendant,100,22,8/15/2019
934CC3,legal-issues-defendant,100,22,8/15/2019
934CC3,legal-issues-defendant,100,22,8/15/2019
971334,dividend,100,50,8/15/2019
9.97E+09,dividend-up,100,54,8/15/2019
9978F1,executive-appointment,100,54,8/15/2019
9CE4C7,partnership,100,61,8/15/2019
A4BCDE,earnings,100,50,8/15/2019
A63387,product-release,100,64,8/15/2019
AEF2C3,legal-issues-defendant,100,22,8/15/2019
B01111,partnership,100,61,8/15/2019
B2DAF6,earnings,100,50,8/15/2019
B7BDA3,legal-issues-defendant,100,22,8/15/2019
BB0587,dividend,100,50,8/15/2019
BB0787,earnings,100,50,8/15/2019
BFE02C,earnings,100,50,8/15/2019
C03C8B,conference-participant,100,50,8/15/2019
C1114B,partnership,100,61,8/15/2019
C62AA4,dividend,100,50,8/15/2019
CF7292,conference-call,100,50,8/15/2019
CFF57D,conference-call,100,50,8/15/2019
D13F1C,executive-appointment,100,54,8/15/2019
D1C0B9,acquisition-completed-acquirer,100,49,8/15/2019
D4463B,note-sale,100,52,8/15/2019
D90F43,legal-issues-defendant,100,22,8/15/2019
DB9829,earnings,100,50,8/15/2019
DC2B00,conference-call,100,50,8/15/2019
DD682D,note-sale,100,52,8/15/2019
DD682D,public-offering,100,43,8/15/2019
DEF058,facility-open,100,65,8/15/2019
DF204B,dividend,100,50,8/15/2019
E09997,facility-close,100,47,8/15/2019
E09E2B,earnings,100,50,8/15/2019
E09E2B,earnings,100,50,8/15/2019
E09E2B,earnings,100,50,8/15/2019
E35610,note-sale,100,52,8/15/2019
E35610,public-offering,100,43,8/15/2019
E592F0,earnings,100,50,8/15/2019
E866D2,product-release,100,64,8/15/2019
E9C7C0,executive-appointment,100,54,8/15/2019
EAEA91,operating-earnings-up,100,68,8/15/2019
EB1E1A,executive-appointment,100,54,8/15/2019
F46EC9,dividend,100,50,8/15/2019
F5349B,executive-appointment,100,54,8/15/2019
F7ADEB,business-contract,100,69,8/15/2019
FAE021,stake-acquirer,100,48,8/15/2019
FD9A97,conference-participant,100,50,8/15/2019
FDD3FC,public-offering,100,43,8/15/2019
00E601,dividend,100,50,8/16/2019
0624BE,conference-participant,100,50,8/16/2019
0BD4E8,legal-issues-defendant,100,22,8/16/2019
0BD4E8,award,100,58,8/16/2019
1AE9D5,trading-delisting,100,36,8/16/2019
2DB344,dividend,100,50,8/16/2019
328250,acquisition-acquirer,100,49,8/16/2019
355B19,dividend-up,100,81,8/16/2019
3A3447,facility-open,100,65,8/16/2019
431B74,earnings-positive,100,69,8/16/2019
431B74,earnings-positive,100,69,8/16/2019
431B74,earnings-positive,100,69,8/16/2019
431B74,earnings-positive,100,69,8/16/2019
431B74,earnings-positive,100,69,8/16/2019
431B74,earnings-positive,100,69,8/16/2019
431B74,earnings-positive,100,69,8/16/2019
431B74,earnings,100,50,8/16/2019
431B74,earnings,100,50,8/16/2019
431B74,earnings,100,50,8/16/2019
431B74,earnings,100,50,8/16/2019
431B74,earnings,100,50,8/16/2019
50070E,conference-organizer,100,57,8/16/2019
5088A5,dividend,100,50,8/16/2019
53A226,dividend,100,50,8/16/2019
6844D2,dividend,100,50,8/16/2019
6F3936,conference-call,100,50,8/16/2019
71694D,buybacks,100,74,8/16/2019
76E80F,dividend,100,50,8/16/2019
86DFBD,earnings,100,50,8/16/2019
88611B,dividend,100,50,8/16/2019
8C311A,conference-participant,100,50,8/16/2019
9004C4,board-meeting,100,51,8/16/2019
934CC3,legal-issues-defendant,100,22,8/16/2019
934CC3,legal-issues-defendant,100,22,8/16/2019
934CC3,legal-issues-defendant,100,22,8/16/2019
9.39E+69,executive-appointment,100,54,8/16/2019
9B0C9C,legal-issues-defendant,100,22,8/16/2019
A4B899,dividend-up,100,55,8/16/2019
B6CD92,trading-listing,100,61,8/16/2019
C07E05,earnings,100,50,8/16/2019
CA99D7,dividend,100,50,8/16/2019
D56D6D,dividend-up,100,81,8/16/2019
DA9443,conference-participant,100,50,8/16/2019
E0207A,dividend,100,50,8/16/2019
E68C3D,product-release,100,64,8/16/2019
E8846E,dividend,100,50,8/16/2019
FDE409,earnings,100,50,8/16/2019
FF4343,dividend,100,50,8/16/2019
FF4BA4,dividend,100,50,8/16/2019
0BD4E8,legal-issues-defendant,100,22,8/17/2019
9397,business-contract,100,69,8/19/2019
00D6B5,dividend,100,50,8/19/2019
04EB2F,legal-issues-defendant,100,22,8/19/2019
55018,legal-issues-defendant,100,22,8/19/2019
71860,earnings,100,50,8/19/2019
147098,dividend-up,100,65,8/19/2019
14ED2B,dividend,100,50,8/19/2019
157CC1,clinical-trials-positive,100,87,8/19/2019
168A5D,partnership,100,61,8/19/2019
1B16C1,legal-issues-defendant,100,22,8/19/2019
1B637E,unit-acquisition-acquirer,100,49,8/19/2019
1D5C51,conference-participant,100,50,8/19/2019
2093B1,dividend,100,50,8/19/2019
214051,earnings,100,50,8/19/2019
228D42,partnership,100,61,8/19/2019
25A6CC,executive-appointment,100,54,8/19/2019
25D3CE,executive-appointment,100,54,8/19/2019
28AC4E,earnings,100,50,8/19/2019
2.90E+62,business-contract,100,69,8/19/2019
2CA60F,conference-participant,100,50,8/19/2019
33AD83,product-release,100,64,8/19/2019
33AD83,product-release,100,64,8/19/2019
366A08,legal-issues-defendant,100,22,8/19/2019
3A3447,facility-open,100,65,8/19/2019
3B8484,acquisition-acquirer,100,49,8/19/2019
3DD5E2,conference-participant,100,50,8/19/2019
420168,note-sale,100,52,8/19/2019
43A74A,executive-appointment,100,54,8/19/2019
4E4E75,conference-call,100,50,8/19/2019
4F71DC,conference-call,100,50,8/19/2019
4F9926,acquisition-acquirer,100,49,8/19/2019
5704AC,executive-appointment,100,54,8/19/2019
586FFD,executive-appointment,100,54,8/19/2019
5E6959,acquisition-completed-acquirer,100,49,8/19/2019
5EAA43,dividend,100,50,8/19/2019
605F40,executive-appointment,100,54,8/19/2019
616E3B,dividend,100,50,8/19/2019
633043,note-sale,100,52,8/19/2019
6844D2,legal-issues-defendant,100,22,8/19/2019
7410C3,executive-appointment,100,54,8/19/2019
756BB4,earnings,100,50,8/19/2019
75F665,dividend,100,50,8/19/2019
7710F3,clinical-trials,100,56,8/19/2019
7AB859,joint-venture,100,62,8/19/2019
7CD98F,conference-participant,100,50,8/19/2019
7EA323,exchange-noncompliance,100,24,8/19/2019
83066C,conference-participant,100,50,8/19/2019
86F123,executive-appointment,100,54,8/19/2019
885758,product-release,100,64,8/19/2019
8B8656,executive-resignation,100,44,8/19/2019
8EEA28,earnings,100,50,8/19/2019
92B047,executive-appointment,100,54,8/19/2019
92D9C9,investment-investor,100,55,8/19/2019
95DC1F,executive-appointment,100,54,8/19/2019
97B027,conference-participant,100,50,8/19/2019
990AD0,business-contract,100,69,8/19/2019
9D30A8,business-contract,100,69,8/19/2019
9E98F2,product-release,100,64,8/19/2019
A1E3B3,executive-appointment,100,54,8/19/2019
A26C26,earnings,100,50,8/19/2019
A4CD53,conference-participant,100,50,8/19/2019
A7A0C8,clinical-trials-start,100,64,8/19/2019
A8CBDA,conference-participant,100,50,8/19/2019
AA09AD,legal-issues-defendant,100,22,8/19/2019
B1B10C,business-contract,100,69,8/19/2019
B1B10C,business-contract,100,69,8/19/2019
B33E77,patient-enrollment-complete,100,64,8/19/2019
B5BA39,legal-issues-defendant,100,22,8/19/2019
BA218A,legal-issues-defendant,100,22,8/19/2019
C0030A,partnership,100,61,8/19/2019
C15DB3,dividend,100,50,8/19/2019
C4452A,dividend,100,50,8/19/2019
C4706C,conference-participant,100,50,8/19/2019
C97B2D,acquisition-completed-acquirer,100,49,8/19/2019
CAC8D0,business-contract,100,69,8/19/2019
CE4FD9,conference-call,100,50,8/19/2019
D03C7A,dividend,100,50,8/19/2019
D90F43,legal-issues-defendant,100,22,8/19/2019
DF6FDD,buybacks,100,74,8/19/2019
E20392,asset-sale,100,62,8/19/2019
E70531,partnership,100,61,8/19/2019
E70531,partnership,100,61,8/19/2019
E74B55,executive-appointment,100,54,8/19/2019
EC1AF3,conference-participant,100,50,8/19/2019
EC99D0,note-sale,100,52,8/19/2019
ECD263,legal-issues-defendant,100,22,8/19/2019
ED79D9,award,100,58,8/19/2019
F1EB39,government-contract,100,69,8/19/2019
F4CDA3,executive-appointment,100,54,8/19/2019
F5349B,executive-appointment,100,54,8/19/2019
F769E9,conference-participant,100,50,8/19/2019
FACF19,hirings,100,65,8/19/2019
FBD92D,conference-participant,100,50,8/19/2019
FDD3FC,public-offering,100,43,8/19/2019
0157B1,partnership,100,61,8/20/2019
02FC1A,clinical-trials,100,56,8/20/2019
03B8CF,legal-issues-defendant,100,22,8/20/2019
07EC43,partnership,100,61,8/20/2019
95294,partnership,100,61,8/20/2019
0BC29E,executive-appointment,100,54,8/20/2019
0BD4E8,legal-issues-defendant,100,22,8/20/2019
0CE7F6,dividend,100,50,8/20/2019
0F0440,earnings,100,50,8/20/2019
0F0440,earnings,100,50,8/20/2019
10673F,dividend,100,50,8/20/2019
10C19B,legal-issues-defendant,100,22,8/20/2019
126F95,dividend,100,50,8/20/2019
13C3E0,business-contract,100,69,8/20/2019
159AE4,conference-call,100,50,8/20/2019
1CB9D3,legal-issues-plaintiff,100,44,8/20/2019
1E9A6D,executive-appointment,100,54,8/20/2019
2082EA,clinical-trials-start,100,64,8/20/2019
228D42,partnership,100,61,8/20/2019
26DC29,conference-participant,100,50,8/20/2019
28AF37,asset-sale,100,62,8/20/2019
28AF37,earnings,100,50,8/20/2019
2B49F4,conference-participant,100,50,8/20/2019
2F94A5,dividend,100,50,8/20/2019
314D88,legal-issues-defendant,100,22,8/20/2019
3461CF,award,100,58,8/20/2019
3587B4,legal-issues-defendant,100,22,8/20/2019
3B318A,conference-call,100,50,8/20/2019
3E149C,executive-appointment,100,54,8/20/2019
40B903,earnings,100,50,8/20/2019
40B903,earnings,100,50,8/20/2019
40B903,earnings,100,50,8/20/2019
422CE3,dividend,100,50,8/20/2019
43A060,product-release,100,64,8/20/2019
485445,conference-participant,100,50,8/20/2019
4A3438,legal-issues-defendant,100,22,8/20/2019
4A6F00,partnership,100,61,8/20/2019
4B3676,acquisition-acquiree,100,76,8/20/2019
57CAAB,business-contract,100,69,8/20/2019
57DDB9,facility-open,100,65,8/20/2019
5968F9,regulatory-investigation,100,22,8/20/2019
59B229,executive-appointment,100,54,8/20/2019
59F0B0,conference-call,100,50,8/20/2019
5EAA43,executive-appointment,100,54,8/20/2019
616E3B,executive-appointment,100,54,8/20/2019
69C99E,executive-appointment,100,54,8/20/2019
76B926,conference-participant,100,50,8/20/2019
8303CD,conference-participant,100,50,8/20/2019
83066C,partnership,100,61,8/20/2019
83066C,partnership,100,61,8/20/2019
8614A2,conference-participant,100,50,8/20/2019
9004C4,earnings-up,100,68,8/20/2019
9087B9,conference-participant,100,50,8/20/2019
9196A2,conference-organizer,100,57,8/20/2019
934CC3,legal-issues-defendant,100,22,8/20/2019
940C3D,business-contract,100,69,8/20/2019
965360,conference-participant,100,50,8/20/2019
97FE80,product-release,100,64,8/20/2019
9B0C9C,conference-participant,100,50,8/20/2019
9B4066,unit-acquisition-acquirer,100,49,8/20/2019
A2CAF7,buybacks,100,74,8/20/2019
A6FC89,executive-appointment,100,54,8/20/2019
A70BF5,conference-participant,100,50,8/20/2019
A790A5,earnings,100,50,8/20/2019
A790A5,earnings,100,50,8/20/2019
A8B137,legal-issues-defendant,100,22,8/20/2019
AA09AD,legal-issues-defendant,100,22,8/20/2019
ACDF88,earnings,100,50,8/20/2019
ACDF88,earnings,100,50,8/20/2019
ACDF88,earnings,100,50,8/20/2019
AD9F1D,award,100,58,8/20/2019
ADD9DC,earnings,100,50,8/20/2019
B5734D,executive-appointment,100,54,8/20/2019
B73395,conference-participant,100,50,8/20/2019
B9764A,earnings,100,50,8/20/2019
BDD12C,dividend,100,50,8/20/2019
C188F8,conference-call,100,50,8/20/2019
C4C77F,conference-call,100,50,8/20/2019
C5D2AE,note-sale,100,52,8/20/2019
C8FAC7,legal-issues-defendant,100,22,8/20/2019
C97B2D,conference-participant,100,50,8/20/2019
CC8F6E,legal-issues-defendant,100,22,8/20/2019
CE5664,dividend,100,50,8/20/2019
D1588D,patient-enrollment-start,100,58,8/20/2019
D1AE3B,dividend,100,50,8/20/2019
D2C0B6,earnings,100,50,8/20/2019
D42DBA,buybacks,100,74,8/20/2019
D56D6D,earnings,100,50,8/20/2019
D60BB2,earnings,100,50,8/20/2019
D75910,earnings,100,50,8/20/2019
D75910,earnings,100,50,8/20/2019
D75910,earnings,100,50,8/20/2019
D75910,earnings,100,50,8/20/2019
D82EF3,product-release,100,64,8/20/2019
DBB28E,partnership,100,61,8/20/2019
DC486E,product-release,100,64,8/20/2019
DF8855,earnings,100,50,8/20/2019
DF8855,earnings,100,50,8/20/2019
DF8855,earnings,100,50,8/20/2019
DF8855,earnings,100,50,8/20/2019
DF8855,earnings,100,50,8/20/2019
DF8855,earnings,100,50,8/20/2019
E20BFE,earnings,100,50,8/20/2019
E20BFE,earnings,100,50,8/20/2019
E4158B,dividend,100,50,8/20/2019
E49AA3,patent-infringement-plaintiff,100,47,8/20/2019
E68733,earnings,100,50,8/20/2019
E68733,earnings,100,50,8/20/2019
E68733,earnings,100,50,8/20/2019
E8846E,conference-organizer,100,57,8/20/2019
E8B21D,partnership,100,61,8/20/2019
E8B21D,partnership,100,61,8/20/2019
EC99D0,note-sale,100,52,8/20/2019
EE6F1C,dividend,100,50,8/20/2019
F02170,executive-death,100,31,8/20/2019
F47871,legal-issues-defendant,100,22,8/20/2019
F5D410,conference-participant,100,50,8/20/2019
F6DCE4,conference-call,100,50,8/20/2019
F85CC0,executive-appointment,100,54,8/20/2019
F85CC0,executive-appointment,100,54,8/20/2019
01478A,dividend,100,50,8/21/2019
054E7E,conference-participant,100,50,8/21/2019
58828,earnings-per-share,100,50,8/21/2019
081AB9,conference-participant,100,50,8/21/2019
099C88,dividend,100,50,8/21/2019
0A9D0A,settlement,100,56,8/21/2019
0BC29E,conference-participant,100,50,8/21/2019
1151F4,dividend,100,50,8/21/2019
131443,executive-resignation,100,44,8/21/2019
168A5D,product-release,100,64,8/21/2019
17EDA5,executive-appointment,100,54,8/21/2019
197612,dividend,100,50,8/21/2019
1AE9D5,revenue-up,100,69,8/21/2019
1AE9D5,revenues,100,50,8/21/2019
1B5FEA,conference-participant,100,50,8/21/2019
1E83DE,earnings,100,50,8/21/2019
2031CE,dividend,100,50,8/21/2019
228D42,partnership,100,61,8/21/2019
274B8A,conference-call,100,50,8/21/2019
278C18,executive-appointment,100,54,8/21/2019
2ABF77,conference-participant,100,50,8/21/2019
2CA60F,legal-issues-defendant,100,22,8/21/2019
2DA92D,executive-appointment,100,54,8/21/2019
2DA92D,dividend,100,50,8/21/2019
2F9304,earnings,100,50,8/21/2019
3159AA,facility-open,100,65,8/21/2019
31643A,executive-appointment,100,54,8/21/2019
342218,executive-resignation,100,44,8/21/2019
34B97A,conference-participant,100,50,8/21/2019
397A8F,earnings,100,50,8/21/2019
3A113F,conference-participant,100,50,8/21/2019
3A3447,conference-participant,100,50,8/21/2019
3AF7FD,conference-participant,100,50,8/21/2019
3CBA2A,conference-participant,100,50,8/21/2019
3E39A5,conference-participant,100,50,8/21/2019
3EE65E,conference-participant,100,50,8/21/2019
3F1C69,business-contract,100,69,8/21/2019
3F1C69,business-contract,100,69,8/21/2019
4017AD,dividend,100,50,8/21/2019
4.00E+163,conference-participant,100,50,8/21/2019
422CE3,earnings,100,50,8/21/2019
422CE3,earnings,100,50,8/21/2019
422CE3,earnings,100,50,8/21/2019
422CE3,earnings,100,50,8/21/2019
485445,legal-issues-defendant,100,22,8/21/2019
49F4D0,dividend,100,50,8/21/2019
4A6F00,partnership,100,61,8/21/2019
4A6F00,partnership,100,61,8/21/2019
4A6F00,partnership,100,61,8/21/2019
4A6F00,partnership,100,61,8/21/2019
4A6F00,partnership,100,61,8/21/2019
4A6F00,partnership,100,61,8/21/2019
4C6C63,product-release,100,64,8/21/2019
4D72C8,executive-appointment,100,54,8/21/2019
4D72C8,executive-appointment,100,54,8/21/2019
4E7C1F,unit-acquisition-acquirer,100,49,8/21/2019
4E7C1F,executive-appointment,100,54,8/21/2019
4EE167,partnership,100,61,8/21/2019
50070E,conference-organizer,100,57,8/21/2019
50070E,conference-organizer,100,57,8/21/2019
53A226,conference-participant,100,50,8/21/2019
5403F8,executive-appointment,100,54,8/21/2019
55C9B5,partnership,100,61,8/21/2019
5D87DF,dividend,100,50,8/21/2019
649CBD,legal-issues-defendant,100,22,8/21/2019
649CBD,legal-issues-defendant,100,22,8/21/2019
6A961B,conference-participant,100,50,8/21/2019
6F0A63,dividend,100,50,8/21/2019
6F3FA8,conference-participant,100,50,8/21/2019
76BD96,executive-appointment,100,54,8/21/2019
76E80F,revenues,100,50,8/21/2019
76E80F,revenues,100,50,8/21/2019
76E80F,revenues,100,50,8/21/2019
78A1BB,dividend,100,50,8/21/2019
791D59,conference-participant,100,50,8/21/2019
7A0EC4,conference-participant,100,50,8/21/2019
7A5097,earnings,100,50,8/21/2019
7E1D5D,earnings,100,50,8/21/2019
7E1D5D,earnings,100,50,8/21/2019
7E1D5D,earnings,100,50,8/21/2019
7E1D5D,earnings,100,50,8/21/2019
7E1D5D,earnings,100,50,8/21/2019
7E3F8F,conference-participant,100,50,8/21/2019
7F3669,conference-participant,100,50,8/21/2019
8.10E+32,executive-appointment,100,54,8/21/2019
82F088,legal-issues-defendant,100,22,8/21/2019
863350,facility-open,100,65,8/21/2019
863350,earnings,100,50,8/21/2019
873DB9,conference-participant,100,50,8/21/2019
8AC65D,executive-appointment,100,54,8/21/2019
8C6C1B,dividend,100,50,8/21/2019
8EDACA,conference-call,100,50,8/21/2019
901327,dividend,100,50,8/21/2019
9196A2,conference-organizer,100,57,8/21/2019
9196A2,conference-organizer,100,57,8/21/2019
934CC3,legal-issues-defendant,100,22,8/21/2019
965360,executive-appointment,100,54,8/21/2019
9D2790,conference-call,100,50,8/21/2019
9D56F2,conference-participant,100,50,8/21/2019
9D5FA4,credit-rating-outlook-stable,100,51,8/21/2019
9E98F2,exchange-noncompliance,100,24,8/21/2019
A247F5,executive-appointment,100,54,8/21/2019
A29DBD,conference-participant,100,50,8/21/2019
A38F30,executive-appointment,100,54,8/21/2019
A631A3,conference-participant,100,50,8/21/2019
A7102F,conference-participant,100,50,8/21/2019
A761FE,conference-call,100,50,8/21/2019
A8FDE8,conference-participant,100,50,8/21/2019
AA5C8E,acquisition-acquiree,100,76,8/21/2019
AB4A7E,conference-participant,100,50,8/21/2019
AFF7B4,conference-participant,100,50,8/21/2019
B0FE08,merger-completed,100,66,8/21/2019
B6082A,dividend,100,50,8/21/2019
B8F71F,conference-participant,100,50,8/21/2019
BC5680,partnership,100,61,8/21/2019
BFCACF,earnings,100,50,8/21/2019
C32A39,dividend,100,50,8/21/2019
C3DE7D,earnings,100,50,8/21/2019
C5E100,conference-participant,100,50,8/21/2019
C81E00,conference-participant,100,50,8/21/2019
C81E00,conference-participant,100,50,8/21/2019
CB22CD,conference-participant,100,50,8/21/2019
CC8F6E,legal-issues-defendant,100,22,8/21/2019
CCBBAD,dividend,100,50,8/21/2019
CE96E7,conference-participant,100,50,8/21/2019
D25249,fundraising,100,64,8/21/2019
D5938F,earnings,100,50,8/21/2019
D64EDF,facility-close,100,47,8/21/2019
D65A13,legal-issues-defendant,100,22,8/21/2019
D65A13,legal-issues-defendant,100,22,8/21/2019
D78BF1,conference-participant,100,50,8/21/2019
D854DD,dividend,100,50,8/21/2019
D854F3,conference-participant,100,50,8/21/2019
D8DBA3,dividend,100,50,8/21/2019
DB5CA5,investment-investor,100,55,8/21/2019
DC1405,conference-participant,100,50,8/21/2019
DDCB34,conference-participant,100,50,8/21/2019
E4CE73,conference-participant,100,50,8/21/2019
E4CE73,earnings,100,50,8/21/2019
E68C3D,earnings,100,50,8/21/2019
E8846E,conference-organizer,100,57,8/21/2019
E8846E,conference-organizer,100,57,8/21/2019
E8846E,conference-organizer,100,57,8/21/2019
E8846E,conference-organizer,100,57,8/21/2019
E96E0B,conference-participant,100,50,8/21/2019
ECA300,conference-call,100,50,8/21/2019
EE6F1C,product-release,100,64,8/21/2019
EEB5F9,conference-participant,100,50,8/21/2019
F05B1B,fast-track-designation,100,81,8/21/2019
F1EB39,conference-call,100,50,8/21/2019
F30508,business-contract,100,69,8/21/2019
F4F46F,conference-participant,100,50,8/21/2019
F6DCE4,earnings,100,50,8/21/2019
F6DCE4,earnings,100,50,8/21/2019
F6DCE4,earnings,100,50,8/21/2019
F80FF9,earnings,100,50,8/21/2019
FA840E,conference-participant,100,50,8/21/2019
FC1B7B,dividend,100,50,8/21/2019
FD6926,conference-participant,100,50,8/21/2019
FF5413,executive-appointment,100,54,8/21/2019
0157B1,product-release,100,64,8/22/2019
0157B1,partnership,100,61,8/22/2019
036C6F,legal-issues-defendant,100,22,8/22/2019
68396,dividend,100,50,8/22/2019
099C88,partnership,100,61,8/22/2019
0A7650,dividend,100,50,8/22/2019
0A9D0A,conference-participant,100,50,8/22/2019
0C8D82,business-contract,100,69,8/22/2019
159739,acquisition-acquirer,100,49,8/22/2019
1C2593,earnings,100,50,8/22/2019
1FCC00,conference-call,100,50,8/22/2019
202E5A,conference-participant,100,50,8/22/2019
205AD5,acquisition-interest-acquirer,100,46,8/22/2019
21D903,conference-participant,100,50,8/22/2019
23207A,conference-call,100,50,8/22/2019
267718,investment-investor,100,55,8/22/2019
279916,earnings,100,50,8/22/2019
29A4CC,dividend,100,50,8/22/2019
2CA60F,executive-resignation,100,44,8/22/2019
314D88,legal-issues-defendant,100,22,8/22/2019
3.30E+34,executive-appointment,100,54,8/22/2019
3A3447,unit-acquisition-acquirer,100,49,8/22/2019
3A3447,unit-acquisition-acquirer,100,49,8/22/2019
407878,conference-participant,100,50,8/22/2019
422CE3,executive-appointment,100,54,8/22/2019
43E8F5,conference-participant,100,50,8/22/2019
49BBBC,earnings,100,50,8/22/2019
4AC91D,earnings,100,50,8/22/2019
4AC91D,earnings,100,50,8/22/2019
4AC91D,earnings,100,50,8/22/2019
4AC91D,earnings,100,50,8/22/2019
4AC91D,earnings,100,50,8/22/2019
4AC91D,earnings,100,50,8/22/2019
4BEB48,award,100,58,8/22/2019
4ECD1A,dividend-up,100,81,8/22/2019
50070E,buybacks,100,74,8/22/2019
50070E,conference-organizer,100,57,8/22/2019
50070E,conference-organizer,100,57,8/22/2019
52B567,legal-issues-defendant,100,22,8/22/2019
55CD6F,dividend,100,50,8/22/2019
56EFC7,dividend,100,50,8/22/2019
5D43A7,conference-call,100,50,8/22/2019
5FE4B6,dividend,100,50,8/22/2019
649CBD,legal-issues-defendant,100,22,8/22/2019
649CBD,legal-issues-defendant,100,22,8/22/2019
6844D2,product-release,100,64,8/22/2019
68AB62,executive-appointment,100,54,8/22/2019
68E3E0,conference-participant,100,50,8/22/2019
6C987C,dividend,100,50,8/22/2019
6CC55E,conference-participant,100,50,8/22/2019
6DC1D7,unit-acquisition-acquirer,100,49,8/22/2019
6.00E+19,business-contract,100,69,8/22/2019
6E8349,dividend,100,50,8/22/2019
701531,clinical-trials,100,56,8/22/2019
726DDF,conference-participant,100,50,8/22/2019
73F70F,dividend,100,50,8/22/2019
7448A3,conference-participant,100,50,8/22/2019
748EB6,conference-call,100,50,8/22/2019
75F982,business-contract,100,69,8/22/2019
7740DE,earnings-up,100,68,8/22/2019
7B492C,earnings,100,50,8/22/2019
7CD98F,dividend,100,50,8/22/2019
7DD584,earnings,100,50,8/22/2019
7FD8B9,conference-participant,100,50,8/22/2019
80D744,legal-issues-defendant,100,22,8/22/2019
80D744,legal-issues-defendant,100,22,8/22/2019
8.10E+32,executive-appointment,100,54,8/22/2019
817ED9,earnings,100,50,8/22/2019
817ED9,earnings,100,50,8/22/2019
817ED9,earnings,100,50,8/22/2019
817ED9,earnings,100,50,8/22/2019
81A88D,conference-participant,100,50,8/22/2019
82BB33,earnings,100,50,8/22/2019
82F088,conference-participant,100,50,8/22/2019
8303CD,conference-participant,100,50,8/22/2019
863350,facility-open,100,65,8/22/2019
895D56,partnership,100,61,8/22/2019
89FBB1,conference-participant,100,50,8/22/2019
8B8656,partnership,100,61,8/22/2019
8C6C1B,earnings,100,50,8/22/2019
8C6C1B,earnings,100,50,8/22/2019
8D4486,product-release,100,64,8/22/2019
954004,conference-call,100,50,8/22/2019
954A47,dividend,100,50,8/22/2019
971F7B,conference-participant,100,50,8/22/2019
97693A,conference-call,100,50,8/22/2019
98A286,earnings,100,50,8/22/2019
990AD0,conference-organizer,100,57,8/22/2019
9B4066,unit-acquisition-acquirer,100,49,8/22/2019
9B5968,executive-appointment,100,54,8/22/2019
9BF177,earnings,100,50,8/22/2019
A01664,conference-participant,100,50,8/22/2019
A15C71,partnership,100,61,8/22/2019
A403CF,legal-issues-defendant,100,22,8/22/2019
A52B6B,conference-participant,100,50,8/22/2019
A6213D,executive-appointment,100,54,8/22/2019
A631A3,earnings,100,50,8/22/2019
A631A3,acquisition-acquirer,100,49,8/22/2019
A631A3,acquisition-acquirer,100,49,8/22/2019
A631A3,acquisition-acquirer,100,49,8/22/2019
A631A3,acquisition-acquirer,100,49,8/22/2019
A6828A,clinical-trials-positive,100,87,8/22/2019
A72FD9,earnings,100,50,8/22/2019
AA98ED,unit-acquisition-acquirer,100,49,8/22/2019
AA98ED,unit-acquisition-acquirer,100,49,8/22/2019
AA98ED,unit-acquisition-acquirer,100,49,8/22/2019
AA98ED,unit-acquisition-acquirer,100,49,8/22/2019
ACDF88,conference-participant,100,50,8/22/2019
ACDF88,dividend,100,50,8/22/2019
B01111,earnings,100,50,8/22/2019
B05000,conference-participant,100,50,8/22/2019
B1FC3B,conference-participant,100,50,8/22/2019
B1FC3B,conference-participant,100,50,8/22/2019
B4703C,legal-issues-defendant,100,22,8/22/2019
B4B281,earnings,100,50,8/22/2019
B4B281,earnings,100,50,8/22/2019
B4B281,earnings,100,50,8/22/2019
B4C673,product-release,100,64,8/22/2019
B508E5,earnings,100,50,8/22/2019
B8DD94,earnings,100,50,8/22/2019
B934BF,dividend,100,50,8/22/2019
BB127B,earnings-up,100,68,8/22/2019
BD15E8,dividend,100,50,8/22/2019
BFD0A7,conference-participant,100,50,8/22/2019
C037A8,conference-call,100,50,8/22/2019
C0F70B,conference-participant,100,50,8/22/2019
C22BE8,earnings,100,50,8/22/2019
C4A432,earnings,100,50,8/22/2019
C4A432,earnings,100,50,8/22/2019
C4A432,earnings,100,50,8/22/2019
CC8F6E,legal-issues-defendant,100,22,8/22/2019
CC8F6E,legal-issues-defendant,100,22,8/22/2019
CDAA0E,conference-organizer,100,57,8/22/2019
CDE51C,executive-appointment,100,54,8/22/2019
D07B07,campaign-ad-release,100,59,8/22/2019
D07B07,campaign-ad-release,100,59,8/22/2019
D1C26F,conference-participant,100,50,8/22/2019
D78BF1,dividend,100,50,8/22/2019
D8ECA1,executive-resignation,100,44,8/22/2019
D8ECA1,executive-resignation,100,44,8/22/2019
D8ECA1,executive-appointment,100,54,8/22/2019
D9B1C9,executive-appointment,100,54,8/22/2019
DB9829,earnings,100,50,8/22/2019
DB9829,earnings,100,50,8/22/2019
DB9829,earnings,100,50,8/22/2019
DB9829,earnings,100,50,8/22/2019
DC486E,earnings,100,50,8/22/2019
DD682D,note-sale,100,52,8/22/2019
DF204B,conference-participant,100,50,8/22/2019
E10D31,dividend,100,50,8/22/2019
E16133,conference-participant,100,50,8/22/2019
E1C16B,conference-participant,100,50,8/22/2019
E38906,conference-participant,100,50,8/22/2019
E82A2D,conference-participant,100,50,8/22/2019
E8846E,conference-organizer,100,57,8/22/2019
ECF709,earnings,100,50,8/22/2019
ED2A5E,conference-participant,100,50,8/22/2019
EFD406,acquisition-interest-acquiree,100,82,8/22/2019
F11638,revenue-up,100,65,8/22/2019
F11638,revenue-up,100,65,8/22/2019
F11638,revenue-up,100,65,8/22/2019
F11638,revenue-up,100,65,8/22/2019
F11638,revenue-up,100,65,8/22/2019
F11638,revenue-up,100,65,8/22/2019
F40EE2,executive-appointment,100,54,8/22/2019
F40EE2,executive-appointment,100,54,8/22/2019
F66B58,conference-call,100,50,8/22/2019
FBD92D,partnership,100,61,8/22/2019
FDF1C0,dividend,100,50,8/22/2019
0157B1,business-contract,100,69,8/23/2019
02870F,buybacks,100,74,8/23/2019
0358AF,conference-participant,100,50,8/23/2019
0358AF,conference-participant,100,50,8/23/2019
03B8CF,legal-issues-defendant,100,22,8/23/2019
0624BE,dividend,100,50,8/23/2019
0B400D,legal-issues-defendant,100,22,8/23/2019
0BD199,executive-appointment,100,54,8/23/2019
0CE7F6,earnings,100,50,8/23/2019
28AC4E,legal-issues-defendant,100,22,8/23/2019
2BC05E,dividend,100,50,8/23/2019
2E89AE,conference-participant,100,50,8/23/2019
31643A,dividend,100,50,8/23/2019
3.50E+27,dividend,100,50,8/23/2019
3.50E+27,executive-appointment,100,54,8/23/2019
39692D,conference-participant,100,50,8/23/2019
3B9886,earnings,100,50,8/23/2019
3B9886,earnings,100,50,8/23/2019
3B9886,earnings,100,50,8/23/2019
5CEE02,conference-organizer,100,57,8/23/2019
649CBD,legal-issues-defendant,100,22,8/23/2019
79340A,executive-appointment,100,54,8/23/2019
7B9212,earnings,100,50,8/23/2019
7B9212,earnings,100,50,8/23/2019
803FED,conference-participant,100,50,8/23/2019
8295B8,exchange-noncompliance,100,24,8/23/2019
83B1C8,conference-participant,100,50,8/23/2019
9196A2,conference-organizer,100,57,8/23/2019
93F143,dividend,100,50,8/23/2019
A47A7D,conference-participant,100,50,8/23/2019
A96867,dividend-up,100,60,8/23/2019
AA09AD,legal-issues-defendant,100,22,8/23/2019
AA98ED,acquisition-acquirer,100,49,8/23/2019
BB0787,business-contract,100,69,8/23/2019
BCE9DA,dividend,100,50,8/23/2019
BCE9DA,dividend,100,50,8/23/2019
C07E05,earnings,100,50,8/23/2019
C5C137,dividend,100,50,8/23/2019
C8FAC7,partnership,100,61,8/23/2019
CFF15D,executive-resignation,100,44,8/23/2019
D76AEF,dividend,100,50,8/23/2019
DCD97F,facility-upgrade,100,65,8/23/2019
DCD97F,business-contract,100,69,8/23/2019
E0339F,legal-issues-defendant,100,22,8/23/2019
E0339F,legal-issues-defendant,100,22,8/23/2019
E0339F,legal-issues-defendant,100,22,8/23/2019
E35610,conference-participant,100,50,8/23/2019
E35610,conference-participant,100,50,8/23/2019
E68733,dividend,100,50,8/23/2019
E68733,dividend,100,50,8/23/2019
EB7D6C,legal-issues-defendant,100,22,8/23/2019
ECD263,business-contract,100,69,8/23/2019
F30508,clinical-trials,100,56,8/23/2019
F30508,clinical-trials,100,56,8/23/2019
F5349B,acquisition-completed-acquirer,100,49,8/23/2019
F6E248,partnership,100,61,8/23/2019
F6E248,partnership,100,61,8/23/2019
F6E248,partnership,100,61,8/23/2019
FC1F9D,business-contract,100,69,8/23/2019
FC4550,dividend,100,50,8/23/2019
835C86,earnings,100,50,8/24/2019
9E98F2,legal-issues-defendant,100,22,8/24/2019
E0339F,legal-issues-defendant,100,22,8/24/2019
F6DCE4,partnership,100,61,8/25/2019
F6DCE4,partnership,100,61,8/25/2019
00067A,conference-participant,100,50,8/26/2019
01B8D6,conference-participant,100,50,8/26/2019
03B8CF,legal-issues-defendant,100,22,8/26/2019
0AD2E3,conference-participant,100,50,8/26/2019
0B57D7,executive-resignation,100,44,8/26/2019
0B57D7,executive-resignation,100,44,8/26/2019
0BC17A,conference-participant,100,50,8/26/2019
0F04E5,conference-participant,100,50,8/26/2019
10100E,conference-participant,100,50,8/26/2019
12DE76,acquisition-interest-acquirer,100,46,8/26/2019
168A5D,partnership,100,61,8/26/2019
1866B2,conference-participant,100,50,8/26/2019
18D9FA,conference-participant,100,50,8/26/2019
1921DD,business-contract,100,69,8/26/2019
1B16C1,legal-issues-defendant,100,22,8/26/2019
1BDB2A,conference-participant,100,50,8/26/2019
1E9A6D,executive-appointment,100,54,8/26/2019
2082EA,executive-appointment,100,54,8/26/2019
20BEEA,dividend,100,50,8/26/2019
2158DF,executive-appointment,100,54,8/26/2019
251988,strike,100,25,8/26/2019
263216,trading-halt,100,43,8/26/2019
2950FF,acquisition-acquirer,100,49,8/26/2019
2950FF,unit-acquisition-acquirer,100,49,8/26/2019
2A17B1,dividend,100,50,8/26/2019
2BAE5F,award,100,58,8/26/2019
2E0496,acquisition-acquirer,100,49,8/26/2019
2EB04E,conference-participant,100,50,8/26/2019
2F1299,executive-resignation,100,44,8/26/2019
301493,conference-participant,100,50,8/26/2019
315EB0,partnership,100,61,8/26/2019
3461CF,conference-participant,100,50,8/26/2019
366A08,legal-issues-defendant,100,22,8/26/2019
37020C,conference-participant,100,50,8/26/2019
371B0A,conference-participant,100,50,8/26/2019
3A3447,facility-open,100,65,8/26/2019
423279,earnings,100,50,8/26/2019
4A6F00,partnership,100,61,8/26/2019
4C2F17,conference-participant,100,50,8/26/2019
4FB770,dividend,100,50,8/26/2019
545272,conference-participant,100,50,8/26/2019
550D01,market-entry,100,57,8/26/2019
55C289,dividend,100,50,8/26/2019
55C9B5,partnership,100,61,8/26/2019
59A832,dividend,100,50,8/26/2019
5A423F,conference-participant,100,50,8/26/2019
5B226B,dividend,100,50,8/26/2019
5D43A7,partnership,100,61,8/26/2019
5DD48B,product-release,100,64,8/26/2019
5E9934,conference-call,100,50,8/26/2019
6844D2,legal-issues-defendant,100,22,8/26/2019
6C9A4F,partnership,100,61,8/26/2019
6-Dec-05,conference-participant,100,50,8/26/2019
6E7060,facility-sale,100,52,8/26/2019
713810,stock-loss,100,40,8/26/2019
713810,executive-appointment,100,54,8/26/2019
71E2EF,product-release,100,64,8/26/2019
76F067,business-contract,100,69,8/26/2019
76F067,acquisition-acquirer,100,49,8/26/2019
76F067,acquisition-acquirer,100,49,8/26/2019
76F067,acquisition-acquirer,100,49,8/26/2019
793C11,executive-appointment,100,54,8/26/2019
7B0BA6,executive-appointment,100,54,8/26/2019
7B492C,executive-appointment,100,54,8/26/2019
7B9AFA,conference-participant,100,50,8/26/2019
7C790D,acquisition-acquirer,100,49,8/26/2019
810FAD,dividend,100,50,8/26/2019
8303CD,conference-participant,100,50,8/26/2019
83598E,earnings,100,50,8/26/2019
83598E,executive-resignation,100,44,8/26/2019
88193E,conference-participant,100,50,8/26/2019
8876D6,stock-loss,100,40,8/26/2019
8B9B3B,acquisition-acquirer,100,49,8/26/2019
8B9B3B,acquisition-acquirer,100,49,8/26/2019
8D5145,executive-resignation,100,44,8/26/2019
8DCF18,conference-participant,100,50,8/26/2019
9196A2,conference-organizer,100,57,8/26/2019
9196A2,conference-organizer,100,57,8/26/2019
9196A2,conference-organizer,100,57,8/26/2019
9196A2,conference-organizer,100,57,8/26/2019
9196A2,conference-organizer,100,57,8/26/2019
9.31E+77,conference-participant,100,50,8/26/2019
949D62,conference-participant,100,50,8/26/2019
954A47,executive-appointment,100,54,8/26/2019
968966,asset-sale,100,62,8/26/2019
968966,unit-acquisition-acquiree,100,76,8/26/2019
9F37C5,dividend,100,50,8/26/2019
A3800A,conference-participant,100,50,8/26/2019
A5A4F5,partnership,100,61,8/26/2019
A631A3,partnership,100,61,8/26/2019
A7A0C8,earnings,100,50,8/26/2019
ACC7D3,conference-participant,100,50,8/26/2019
AD22F2,earnings,100,50,8/26/2019
AD22F2,earnings,100,50,8/26/2019
AD22F2,earnings,100,50,8/26/2019
AD22F2,earnings,100,50,8/26/2019
AD22F2,earnings,100,50,8/26/2019
AFDF2E,acquisition-acquirer,100,49,8/26/2019
B3A166,conference-participant,100,50,8/26/2019
B5BA39,legal-issues-defendant,100,22,8/26/2019
B8A51F,conference-participant,100,50,8/26/2019
BA218A,legal-issues-defendant,100,22,8/26/2019
BEA527,partnership,100,61,8/26/2019
C83B88,partnership,100,61,8/26/2019
C9D866,business-contract,100,69,8/26/2019
CBFFDD,conference-participant,100,50,8/26/2019
CC0C78,conference-participant,100,50,8/26/2019
CF7292,partnership,100,61,8/26/2019
CFD4B6,conference-participant,100,50,8/26/2019
D1C26F,conference-participant,100,50,8/26/2019
D437C3,executive-resignation,100,44,8/26/2019
D60BB2,dividend,100,50,8/26/2019
D6EAA3,conference-call,100,50,8/26/2019
D77F7E,business-contract,100,69,8/26/2019
DCD97F,business-contract,100,69,8/26/2019
DEF058,executive-appointment,100,54,8/26/2019
E0339F,legal-issues-defendant,100,22,8/26/2019
E0339F,legal-issues-defendant,100,22,8/26/2019
E2CFD2,conference-participant,100,50,8/26/2019
E5C910,executive-appointment,100,54,8/26/2019
E8846E,conference-organizer,100,57,8/26/2019
E8846E,conference-participant,100,50,8/26/2019
E8846E,conference-organizer,100,57,8/26/2019
EB5E78,executive-appointment,100,54,8/26/2019
EB5E78,conference-participant,100,50,8/26/2019
EBD89A,earnings,100,50,8/26/2019
ECD263,legal-issues-defendant,100,22,8/26/2019
ED79D9,acquisition-completed-acquirer,100,49,8/26/2019
EE1E44,dividend,100,50,8/26/2019
F1CD47,conference-participant,100,50,8/26/2019
F30508,regulatory-product-approval-granted,100,81,8/26/2019
F30508,regulatory-product-approval-granted,100,81,8/26/2019
F47871,legal-issues-defendant,100,22,8/26/2019
F6E248,conference-participant,100,50,8/26/2019
FE89E0,conference-call,100,50,8/26/2019
00067A,business-contract,100,69,8/27/2019
054B55,unit-acquisition-acquirer,100,49,8/27/2019
054B55,unit-acquisition-acquirer,100,49,8/27/2019
054B55,unit-acquisition-acquirer,100,49,8/27/2019
054B55,unit-acquisition-acquirer,100,49,8/27/2019
0968A5,earnings,100,50,8/27/2019
099A92,partnership,100,61,8/27/2019
0BD4E8,legal-issues-defendant,100,22,8/27/2019
131443,partnership,100,61,8/27/2019
17EDA5,executive-appointment,100,54,8/27/2019
184866,partnership,100,61,8/27/2019
1BDB2A,award,100,58,8/27/2019
1D943E,legal-issues-defendant,100,22,8/27/2019
25102A,conference-participant,100,50,8/27/2019
26008A,operating-earnings,100,50,8/27/2019
26008A,operating-earnings,100,50,8/27/2019
26008A,operating-earnings,100,50,8/27/2019
26008A,operating-earnings,100,50,8/27/2019
263216,trading-resumed,100,58,8/27/2019
26D8ED,conference-participant,100,50,8/27/2019
2CA60F,legal-issues-defendant,100,22,8/27/2019
2F98A5,earnings,100,50,8/27/2019
33AD83,partnership,100,61,8/27/2019
3461CF,credit-rating-affirmation-rater,20,50,8/27/2019
3A3447,facility-open,100,65,8/27/2019
3AF7FD,earnings,100,50,8/27/2019
3EE65E,earnings,100,50,8/27/2019
3F96D5,conference-participant,100,50,8/27/2019
41785E,conference-participant,100,50,8/27/2019
42978B,conference-call,100,50,8/27/2019
431B74,dividend,100,50,8/27/2019
431B74,dividend,100,50,8/27/2019
44A4FC,earnings,100,50,8/27/2019
467F2C,legal-issues-defendant,100,22,8/27/2019
485445,legal-issues-defendant,100,22,8/27/2019
4A3438,legal-issues-defendant,100,22,8/27/2019
4A6F00,partnership,100,61,8/27/2019
4A6F00,partnership,100,61,8/27/2019
4A6F00,partnership,100,61,8/27/2019
4F0A80,dividend,100,50,8/27/2019
4FCC78,acquisition-completed-acquirer,100,49,8/27/2019
50070E,conference-organizer,100,57,8/27/2019
5088A5,unit-acquisition-acquiree,100,76,8/27/2019
5487B1,conference-participant,100,50,8/27/2019
5704AC,conference-participant,100,50,8/27/2019
586FFD,earnings,100,50,8/27/2019
5876DC,executive-appointment,100,54,8/27/2019
5C7601,executive-appointment,100,54,8/27/2019
62CDDE,conference-participant,100,50,8/27/2019
64E346,earnings,100,50,8/27/2019
65CF8E,facility-open,100,65,8/27/2019
65CF8E,facility-open,100,65,8/27/2019
6634D9,credit-extension-recipient,100,69,8/27/2019
665D7D,conference-participant,100,50,8/27/2019
673C9A,earnings,100,50,8/27/2019
6C4D2F,dividend,100,50,8/27/2019
6CD55A,dividend,100,50,8/27/2019
6D156D,conference-participant,100,50,8/27/2019
6DDA15,legal-issues-defendant,100,22,8/27/2019
70FCEF,earnings,100,50,8/27/2019
719477,conference-call,100,50,8/27/2019
729368,conference-participant,100,50,8/27/2019
73C9E2,executive-appointment,100,54,8/27/2019
747219,conference-participant,100,50,8/27/2019
748EB6,conference-participant,100,50,8/27/2019
76D79A,dividend,100,50,8/27/2019
7710F3,board-meeting,100,51,8/27/2019
7F3669,acquisition-completed-acquirer,100,49,8/27/2019
82F088,legal-issues-defendant,100,22,8/27/2019
8665BA,partnership,100,61,8/27/2019
8A0368,legal-issues-defendant,100,22,8/27/2019
8B3B0E,conference-participant,100,50,8/27/2019
8BFAA4,executive-appointment,100,54,8/27/2019
8E4250,asset-sale,100,62,8/27/2019
9196A2,conference-organizer,100,57,8/27/2019
9196A2,conference-organizer,100,57,8/27/2019
9196A2,conference-organizer,100,57,8/27/2019
9196A2,conference-organizer,100,57,8/27/2019
92005C,conference-participant,100,50,8/27/2019
934CC3,legal-issues-defendant,100,22,8/27/2019
934CC3,legal-issues-defendant,100,22,8/27/2019
94563D,conference-participant,100,50,8/27/2019
94637C,partnership,100,61,8/27/2019
9.54E+32,partnership,100,61,8/27/2019
957A07,conference-participant,100,50,8/27/2019
95C392,partnership,100,61,8/27/2019
9B0C9C,conference-participant,100,50,8/27/2019
A1E3B3,earnings,100,50,8/27/2019
A1E3B3,earnings,100,50,8/27/2019
A43906,conference-participant,100,50,8/27/2019
A5E715,dividend,100,50,8/27/2019
A60354,dividend,100,50,8/27/2019
A631A3,partnership,100,61,8/27/2019
A631A3,partnership,100,61,8/27/2019
A631A3,partnership,100,61,8/27/2019
A72FD9,conference-participant,100,50,8/27/2019
A790A5,dividend,100,50,8/27/2019
A8FDE8,conference-participant,100,50,8/27/2019
AA09AD,legal-issues-defendant,100,22,8/27/2019
AECCA9,dividend,100,50,8/27/2019
AFD1CA,facility-open,100,65,8/27/2019
B13B68,partnership,100,61,8/27/2019
B2206F,conference-participant,100,50,8/27/2019
B9764A,conference-participant,100,50,8/27/2019
BA218A,legal-issues-defendant,100,22,8/27/2019
BC5680,partnership,100,61,8/27/2019
BDF85E,earnings,100,50,8/27/2019
BE645B,business-contract,100,69,8/27/2019
BFE02C,dividend,100,50,8/27/2019
C06EB6,trading-listing,100,61,8/27/2019
C188F8,business-contract,100,69,8/27/2019
C188F8,earnings,100,50,8/27/2019
C22BE8,dividend,100,50,8/27/2019
C3BCD5,conference-participant,100,50,8/27/2019
C72B8F,conference-participant,100,50,8/27/2019
CBFFDD,business-contract,100,69,8/27/2019
CC339B,dividend,100,50,8/27/2019
CCB623,conference-participant,100,50,8/27/2019
CD051C,conference-participant,100,50,8/27/2019
D56E4C,asset-sale,100,62,8/27/2019
D56E4C,asset-sale,100,62,8/27/2019
D64C6D,conference-call,100,50,8/27/2019
D65A13,legal-issues-defendant,100,22,8/27/2019
DBB28E,earnings,100,50,8/27/2019
DBB28E,earnings,100,50,8/27/2019
DBB28E,earnings,100,50,8/27/2019
DBB28E,earnings,100,50,8/27/2019
DBB28E,earnings,100,50,8/27/2019
DBB28E,earnings,100,50,8/27/2019
DBB28E,earnings,100,50,8/27/2019
DBB28E,earnings,100,50,8/27/2019
DBB28E,earnings,100,50,8/27/2019
E0339F,legal-issues-defendant,100,22,8/27/2019
E074A0,dividend,100,50,8/27/2019
E1C16B,dividend,100,50,8/27/2019
E26FC3,executive-appointment,100,54,8/27/2019
E2F130,product-release,100,64,8/27/2019
E67C2C,conference-participant,100,50,8/27/2019
E8846E,conference-organizer,100,57,8/27/2019
E96E0B,conference-participant,100,50,8/27/2019
ED2A5E,conference-participant,100,50,8/27/2019
EF5BED,executive-appointment,100,54,8/27/2019
F0EEFB,conference-participant,100,50,8/27/2019
F2E253,executive-appointment,100,54,8/27/2019
F43A11,conference-call,100,50,8/27/2019
F46EC9,conference-participant,100,50,8/27/2019
F5349B,executive-appointment,100,54,8/27/2019
F5D499,partnership,100,61,8/27/2019
F88A04,executive-appointment,100,54,8/27/2019
FC01C0,conference-participant,100,50,8/27/2019
FC8733,product-release,100,64,8/27/2019
FDF799,executive-appointment,100,54,8/27/2019
06A456,earnings,100,50,8/28/2019
06EF42,business-contract,100,69,8/28/2019
07EC43,conference-participant,100,50,8/28/2019
0BC29E,conference-participant,100,50,8/28/2019
0BF528,earnings,100,50,8/28/2019
0CC62B,conference-participant,100,50,8/28/2019
0F04E5,trading-halt,100,43,8/28/2019
102727,buybacks,100,74,8/28/2019
11074E,conference-participant,100,50,8/28/2019
159739,dividend,100,50,8/28/2019
159739,dividend,100,50,8/28/2019
159739,conference-call,100,50,8/28/2019
159739,conference-call,100,50,8/28/2019
16F4D8,conference-participant,100,50,8/28/2019
1880C5,conference-participant,100,50,8/28/2019
190BE6,earnings,100,50,8/28/2019
1B6F77,conference-participant,100,50,8/28/2019
1D3A00,earnings,100,50,8/28/2019
1D3A00,earnings,100,50,8/28/2019
1D3A00,earnings,100,50,8/28/2019
1D3A00,earnings,100,50,8/28/2019
1E7785,conference-participant,100,50,8/28/2019
1F3CFB,conference-participant,100,50,8/28/2019
1F9D90,executive-appointment,100,54,8/28/2019
214051,award,100,58,8/28/2019
225CA2,dividend,100,50,8/28/2019
228D42,product-release,100,64,8/28/2019
24FA23,conference-participant,100,50,8/28/2019
275300,conference-participant,100,50,8/28/2019
2B49F4,conference-call,100,50,8/28/2019
2D643C,conference-participant,100,50,8/28/2019
2D643C,executive-appointment,100,54,8/28/2019
2E36AD,conference-participant,100,50,8/28/2019
2E89AE,patient-enrollment-complete,100,64,8/28/2019
326EDD,executive-appointment,100,54,8/28/2019
33E9D5,earnings,100,50,8/28/2019
367E1C,conference-participant,100,50,8/28/2019
396D7C,conference-participant,100,50,8/28/2019
3A4BDB,executive-appointment,100,54,8/28/2019
3AAEAE,conference-participant,100,50,8/28/2019
3BA1BF,conference-participant,100,50,8/28/2019
3BA1BF,conference-participant,100,50,8/28/2019
3C3B6B,conference-participant,100,50,8/28/2019
3DD5E2,conference-participant,100,50,8/28/2019
401072,conference-participant,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
414FFF,earnings,100,50,8/28/2019
43A060,partnership,100,61,8/28/2019
448BF3,conference-participant,100,50,8/28/2019
4A6F00,partnership,100,61,8/28/2019
4BF3D6,conference-participant,100,50,8/28/2019
4C3FE9,conference-participant,100,50,8/28/2019
4D371E,conference-participant,100,50,8/28/2019
50D1EC,conference-participant,100,50,8/28/2019
53F491,conference-participant,100,50,8/28/2019
54A646,dividend,100,50,8/28/2019
556A57,buybacks,100,74,8/28/2019
56EFC7,earnings,100,50,8/28/2019
589846,earnings,100,50,8/28/2019
59872F,earnings,100,50,8/28/2019
5C7601,conference-participant,100,50,8/28/2019
5F2FF7,conference-participant,100,50,8/28/2019
6137BF,conference-participant,100,50,8/28/2019
61B81B,conference-participant,100,50,8/28/2019
64854A,patient-enrollment-complete,100,64,8/28/2019
649CBD,legal-issues-defendant,100,22,8/28/2019
64E346,conference-participant,100,50,8/28/2019
6B6375,conference-participant,100,50,8/28/2019
6E8864,conference-participant,100,50,8/28/2019
6F3936,earnings,100,50,8/28/2019
6F3936,earnings,100,50,8/28/2019
6F3936,earnings,100,50,8/28/2019
6F3936,earnings,100,50,8/28/2019
6F3936,earnings,100,50,8/28/2019
6F3936,earnings,100,50,8/28/2019
6F3936,earnings,100,50,8/28/2019
6FCEF9,earnings,100,50,8/28/2019
704B78,conference-participant,100,50,8/28/2019
7239BB,earnings,100,50,8/28/2019
7273FF,executive-appointment,100,54,8/28/2019
73A213,earnings,100,50,8/28/2019
73F70F,earnings,100,50,8/28/2019
762A3E,conference-organizer,100,57,8/28/2019
762A3E,conference-organizer,100,57,8/28/2019
763DBE,conference-participant,100,50,8/28/2019
789ADD,conference-participant,100,50,8/28/2019
791D59,partnership,100,61,8/28/2019
7A3633,patent-infringement-defendant,100,26,8/28/2019
7BC92D,conference-participant,100,50,8/28/2019
7BC92D,award,100,58,8/28/2019
7C790D,conference-participant,100,50,8/28/2019
7E0EB0,conference-participant,100,50,8/28/2019
7E1D5D,conference-participant,100,50,8/28/2019
7E1D5D,conference-participant,100,50,8/28/2019
7F3669,executive-appointment,100,54,8/28/2019
819492,conference-participant,100,50,8/28/2019
81EAD4,product-release,100,64,8/28/2019
830BDB,conference-participant,100,50,8/28/2019
859D62,earnings,100,50,8/28/2019
859D62,earnings,100,50,8/28/2019
859D62,earnings,100,50,8/28/2019
859D62,earnings,100,50,8/28/2019
859D62,earnings,100,50,8/28/2019
895D56,conference-participant,100,50,8/28/2019
89E771,earnings,100,50,8/28/2019
8B4A45,facility-upgrade,100,65,8/28/2019
8BAA15,patent-infringement-plaintiff,100,47,8/28/2019
8EDACA,earnings-guidance,100,50,8/28/2019
9196A2,conference-organizer,100,57,8/28/2019
9196A2,conference-organizer,100,57,8/28/2019
9196A2,conference-organizer,100,57,8/28/2019
9196A2,conference-organizer,100,57,8/28/2019
9196A2,conference-organizer,100,57,8/28/2019
9196A2,conference-organizer,100,57,8/28/2019
925759,conference-participant,100,50,8/28/2019
92D757,earnings,100,50,8/28/2019
934CC3,legal-issues-defendant,100,22,8/28/2019
990AD0,conference-organizer,100,57,8/28/2019
990AD0,award,100,58,8/28/2019
990AD0,conference-organizer,100,57,8/28/2019
990AD0,conference-organizer,100,57,8/28/2019
9B0C9C,partnership,100,61,8/28/2019
9B730A,conference-participant,100,50,8/28/2019
9BB35A,conference-participant,100,50,8/28/2019
9E3224,buybacks,100,74,8/28/2019
9E575E,conference-participant,100,50,8/28/2019
9E5C2C,conference-participant,100,50,8/28/2019
9E98F2,legal-issues-defendant,100,22,8/28/2019
9EF4CF,partnership,100,61,8/28/2019
A6FB29,earnings,100,50,8/28/2019
A6FC89,earnings,100,50,8/28/2019
A6FC89,earnings,100,50,8/28/2019
A6FC89,earnings,100,50,8/28/2019
A6FC89,earnings,100,50,8/28/2019
A6FC89,earnings,100,50,8/28/2019
A761FE,earnings,100,50,8/28/2019
A8B137,facility-open,100,65,8/28/2019
AA3AB8,earnings,100,50,8/28/2019
ABB493,earnings,100,50,8/28/2019
AD23DE,partnership,100,61,8/28/2019
AD6141,conference-participant,100,50,8/28/2019
ADF092,conference-participant,100,50,8/28/2019
AECCA9,earnings,100,50,8/28/2019
AECCA9,earnings,100,50,8/28/2019
AECCA9,earnings,100,50,8/28/2019
AECCA9,earnings,100,50,8/28/2019
AECCA9,earnings,100,50,8/28/2019
AECCA9,earnings,100,50,8/28/2019
AED61E,acquisition-acquirer,100,49,8/28/2019
AFF43F,conference-participant,100,50,8/28/2019
B04426,conference-participant,100,50,8/28/2019
B290A2,conference-participant,100,50,8/28/2019
B2D799,legal-issues-defendant,100,22,8/28/2019
B614F8,conference-participant,100,50,8/28/2019
B73395,conference-participant,100,50,8/28/2019
B83D67,conference-participant,100,50,8/28/2019
BD15E8,market-entry,100,57,8/28/2019
C188F8,business-contract,100,69,8/28/2019
C3F99F,conference-participant,100,50,8/28/2019
C425AE,earnings,100,50,8/28/2019
C425AE,executive-resignation,100,44,8/28/2019
C4F9C6,conference-participant,100,50,8/28/2019
C54140,conference-participant,100,50,8/28/2019
C83B88,conference-participant,100,50,8/28/2019
C8923A,conference-participant,100,50,8/28/2019
C8FAC7,facility-open,100,65,8/28/2019
C941DC,conference-participant,100,50,8/28/2019
CDD75E,conference-participant,100,50,8/28/2019
CE5C6E,conference-participant,100,50,8/28/2019
D15833,dividend,100,50,8/28/2019
D2C0B6,buybacks,100,74,8/28/2019
D5938F,earnings,100,50,8/28/2019
D5938F,earnings,100,50,8/28/2019
DB88A1,earnings,100,50,8/28/2019
DD1BA1,award,100,58,8/28/2019
DEF058,executive-appointment,100,54,8/28/2019
E21871,conference-participant,100,50,8/28/2019
E22FDE,legal-issues-defendant,100,22,8/28/2019
E4CE73,conference-participant,100,50,8/28/2019
E8846E,conference-organizer,100,57,8/28/2019
E8846E,conference-organizer,100,57,8/28/2019
E8846E,conference-organizer,100,57,8/28/2019
E8846E,conference-organizer,100,57,8/28/2019
E8846E,conference-organizer,100,57,8/28/2019
E8846E,conference-organizer,100,57,8/28/2019
E8846E,conference-organizer,100,57,8/28/2019
EEA734,conference-participant,100,50,8/28/2019
EF25A5,conference-participant,100,50,8/28/2019
EF45B6,dividend,100,50,8/28/2019
F02170,revenues,100,50,8/28/2019
F02170,revenues,100,50,8/28/2019
F02170,revenues,100,50,8/28/2019
F02170,revenues,100,50,8/28/2019
F02170,revenues,100,50,8/28/2019
F18844,dividend,100,50,8/28/2019
F18844,earnings,100,50,8/28/2019
F47871,conference-participant,100,50,8/28/2019
F58C23,conference-participant,100,50,8/28/2019
F6E248,stake-acquirer,100,48,8/28/2019
F6E248,stake-acquirer,100,48,8/28/2019
F748C7,earnings,100,50,8/28/2019
FD6926,conference-participant,100,50,8/28/2019
FF227B,conference-participant,100,50,8/28/2019
00698D,earnings,100,50,8/29/2019
0157B1,business-contract,100,69,8/29/2019
01D03F,regulatory-product-approval-granted,100,81,8/29/2019
033B58,conference-participant,100,50,8/29/2019
48781,note-acquisition,100,66,8/29/2019
0624BE,earnings,100,50,8/29/2019
75172,earnings,100,50,8/29/2019
09062E,executive-appointment,100,54,8/29/2019
09F623,conference-participant,100,50,8/29/2019
0B57D7,dividend-up,100,81,8/29/2019
0B7375,conference-participant,100,50,8/29/2019
0BF528,executive-appointment,100,54,8/29/2019
0E3436,earnings,100,50,8/29/2019
0E3436,earnings,100,50,8/29/2019
0E5223,conference-participant,100,50,8/29/2019
0E5619,conference-participant,100,50,8/29/2019
0EF1AF,conference-participant,100,50,8/29/2019
0F04E5,trading-resumed,100,58,8/29/2019
0F2BC9,business-contract,100,69,8/29/2019
12A3A3,conference-call,100,50,8/29/2019
131443,business-contract,100,69,8/29/2019
143C52,earnings,100,50,8/29/2019
152AB9,conference-participant,100,50,8/29/2019
15A388,business-contract,100,69,8/29/2019
196D18,conference-participant,100,50,8/29/2019
1A3E1B,conference-participant,100,50,8/29/2019
1C2593,conference-participant,100,50,8/29/2019
1F9D90,conference-participant,100,50,8/29/2019
221783,conference-participant,100,50,8/29/2019
2262BD,earnings,100,50,8/29/2019
251988,partnership,100,61,8/29/2019
28AC4E,legal-issues-defendant,100,22,8/29/2019
2AA6A8,conference-participant,100,50,8/29/2019
2C3348,clinical-trials-complete,100,56,8/29/2019
2C35B5,conference-participant,100,50,8/29/2019
2D981A,conference-participant,100,50,8/29/2019
2E2E6E,dividend,100,50,8/29/2019
30AB63,earnings-guidance,100,50,8/29/2019
30DE64,conference-participant,100,50,8/29/2019
32DCB3,clinical-trials-start,100,64,8/29/2019
33AD83,earnings,100,50,8/29/2019
33AD83,earnings,100,50,8/29/2019
33AD83,earnings,100,50,8/29/2019
33AD83,earnings,100,50,8/29/2019
349DA4,conference-participant,100,50,8/29/2019
3A3447,facility-open,100,65,8/29/2019
3A6D90,executive-appointment,100,54,8/29/2019
3DCECC,partnership,100,61,8/29/2019
3E39A5,conference-participant,100,50,8/29/2019
431B74,executive-appointment,100,54,8/29/2019
431B74,executive-appointment,100,54,8/29/2019
451D61,conference-participant,100,50,8/29/2019
4A6F00,partnership,100,61,8/29/2019
4B7006,earnings,100,50,8/29/2019
4D229C,fundraising,100,64,8/29/2019
4E4E75,operating-earnings,100,50,8/29/2019
4EC4C1,executive-appointment,100,54,8/29/2019
50070E,conference-organizer,100,57,8/29/2019
50070E,conference-organizer,100,57,8/29/2019
50070E,conference-organizer,100,57,8/29/2019
50070E,conference-organizer,100,57,8/29/2019
504FE2,conference-participant,100,50,8/29/2019
510EA1,regulatory-product-approval-granted,100,81,8/29/2019
5.43E+08,conference-participant,100,50,8/29/2019
543900,executive-appointment,100,54,8/29/2019
55C9B5,partnership,100,61,8/29/2019
57DDB9,partnership,100,61,8/29/2019
5A53BF,conference-participant,100,50,8/29/2019
5CEE02,conference-organizer,100,57,8/29/2019
5D43A7,partnership,100,61,8/29/2019
5E7E82,earnings-above-expectations,100,88,8/29/2019
649CBD,legal-issues-defendant,100,22,8/29/2019
665D7D,product-discontinued,100,48,8/29/2019
6830FE,executive-appointment,100,54,8/29/2019
6830FE,earnings,100,50,8/29/2019
68AB62,conference-participant,100,50,8/29/2019
6E705B,conference-participant,100,50,8/29/2019
6F3FA8,dividend,100,50,8/29/2019
713810,conference-participant,100,50,8/29/2019
735388,executive-appointment,100,54,8/29/2019
73F7F9,earnings,100,50,8/29/2019
762A3E,conference-organizer,100,57,8/29/2019
762A3E,conference-organizer,100,57,8/29/2019
77B8E9,conference-participant,100,50,8/29/2019
7823A3,conference-participant,100,50,8/29/2019
787D14,product-release,100,64,8/29/2019
7ADE57,conference-call,100,50,8/29/2019
82C202,conference-participant,100,50,8/29/2019
8AB37F,conference-participant,100,50,8/29/2019
8E82A6,conference-participant,100,50,8/29/2019
9196A2,conference-organizer,100,57,8/29/2019
9196A2,conference-organizer,100,57,8/29/2019
9196A2,conference-organizer,100,57,8/29/2019
9196A2,conference-organizer,100,57,8/29/2019
9196A2,conference-organizer,100,57,8/29/2019
9196A2,conference-organizer,100,57,8/29/2019
9.39E+69,conference-participant,100,50,8/29/2019
93D207,conference-participant,100,50,8/29/2019
9.54E+32,business-contract,100,69,8/29/2019
95DC1F,conference-call,100,50,8/29/2019
98A286,earnings-per-share-positive,100,69,8/29/2019
99028D,earnings,100,50,8/29/2019
990AD0,conference-organizer,100,57,8/29/2019
997348,dividend,100,50,8/29/2019
9BBFA5,conference-call,100,50,8/29/2019
9C5BA5,conference-participant,100,50,8/29/2019
9E98F2,legal-issues-defendant,100,22,8/29/2019
9F5CBB,dividend,100,50,8/29/2019
9F5CBB,partnership,100,61,8/29/2019
A1E3B3,business-contract,100,69,8/29/2019
A1E3B3,business-contract,100,69,8/29/2019
A38F30,note-sale,100,52,8/29/2019
A5DD24,conference-participant,100,50,8/29/2019
A63387,conference-participant,100,50,8/29/2019
A6828A,conference-participant,100,50,8/29/2019
A72AB6,earnings-above-expectations,100,88,8/29/2019
A72FD9,earnings,100,50,8/29/2019
AA09AD,legal-issues-defendant,100,22,8/29/2019
AD3C93,executive-appointment,100,54,8/29/2019
AD6141,conference-participant,100,50,8/29/2019
AD9F1D,executive-appointment,100,54,8/29/2019
AE7D16,facility-open,100,65,8/29/2019
B08C51,partnership,100,61,8/29/2019
B08C51,partnership,100,61,8/29/2019
B0D41A,conference-participant,100,50,8/29/2019
B614F8,stock-gain,100,63,8/29/2019
B80AD1,conference-participant,100,50,8/29/2019
BAD655,conference-participant,100,50,8/29/2019
BC3AD2,dividend,100,50,8/29/2019
BC5680,executive-appointment,100,54,8/29/2019
BE14CF,conference-participant,100,50,8/29/2019
BE645B,conference-participant,100,50,8/29/2019
C5D2AE,conference-participant,100,50,8/29/2019
C5E100,acquisition-regulatory-approval-acquirer,100,54,8/29/2019
C83B88,conference-participant,100,50,8/29/2019
C9E107,conference-participant,100,50,8/29/2019
CBB77B,earnings,100,50,8/29/2019
CBDB4D,executive-appointment,100,54,8/29/2019
CC6F6E,earnings,100,50,8/29/2019
CC6F6E,earnings,100,50,8/29/2019
CC6F6E,earnings,100,50,8/29/2019
CC8F6E,legal-issues-defendant,100,22,8/29/2019
CF7292,earnings,100,50,8/29/2019
CFF57D,earnings,100,50,8/29/2019
CFF57D,earnings,100,50,8/29/2019
CFF57D,earnings,100,50,8/29/2019
CFF57D,earnings,100,50,8/29/2019
CFF97C,conference-participant,100,50,8/29/2019
D1C26F,partnership,100,61,8/29/2019
D1CFC8,conference-call,100,50,8/29/2019
D2E553,partnership,100,61,8/29/2019
D3F64D,dividend,100,50,8/29/2019
D5938F,conference-participant,100,50,8/29/2019
DC2B00,earnings,100,50,8/29/2019
DC2B00,executive-appointment,100,54,8/29/2019
DDCB34,conference-participant,100,50,8/29/2019
E0339F,legal-issues-defendant,100,22,8/29/2019
E49AA3,dividend,100,50,8/29/2019
E6EDED,dividend-up,100,81,8/29/2019
E74B55,partnership,100,61,8/29/2019
E866D2,conference-participant,100,50,8/29/2019
E8846E,conference-organizer,100,57,8/29/2019
E8846E,conference-organizer,100,57,8/29/2019
E8846E,conference-organizer,100,57,8/29/2019
E8846E,conference-organizer,100,57,8/29/2019
E8846E,conference-organizer,100,57,8/29/2019
E8846E,conference-organizer,100,57,8/29/2019
E8846E,conference-organizer,100,57,8/29/2019
EE967B,dividend,100,50,8/29/2019
EF25A5,award,100,58,8/29/2019
F0027C,conference-participant,100,50,8/29/2019
F0A9DE,dividend-up,100,81,8/29/2019
F0B335,clinical-trials-positive,100,87,8/29/2019
F179ED,partnership,100,61,8/29/2019
F5349B,stake-acquirer,100,48,8/29/2019
F90EE5,executive-appointment,100,54,8/29/2019
FAAFA2,conference-participant,100,50,8/29/2019
FC1A6E,conference-participant,100,50,8/29/2019
FD554E,dividend,100,50,8/29/2019
FDE409,revenue-up,100,69,8/29/2019
FDE409,revenue-up,100,69,8/29/2019
FDE409,revenue-up,100,69,8/29/2019
FFE543,conference-participant,100,50,8/29/2019
FFE543,conference-participant,100,50,8/29/2019
108BD2,merger-regulatory-approval,100,81,8/30/2019
1782D5,dividend,100,50,8/30/2019
1E1125,conference-organizer,100,57,8/30/2019
1FCC00,dividend,100,50,8/30/2019
1FCC00,earnings,100,50,8/30/2019
1FCC00,earnings,100,50,8/30/2019
1FCC00,earnings,100,50,8/30/2019
251988,business-contract,100,69,8/30/2019
253B2F,dividend,100,50,8/30/2019
2BF36E,conference-participant,100,50,8/30/2019
2E1322,partnership,100,61,8/30/2019
32F943,legal-issues-defendant,100,22,8/30/2019
370C50,product-price-raise,100,57,8/30/2019
3A94DF,dividend,100,50,8/30/2019
3B20AB,analyst-ratings-change-positive,100,78,8/30/2019
3B2311,conference-participant,100,50,8/30/2019
41A93D,acquisition-completed-acquirer,100,49,8/30/2019
4290EF,dividend,100,50,8/30/2019
45BC35,conference-participant,100,50,8/30/2019
50070E,conference-organizer,100,57,8/30/2019
543900,earnings,100,50,8/30/2019
54DF47,dividend,100,50,8/30/2019
56277A,legal-issues-defendant,100,22,8/30/2019
57356F,conference-participant,100,50,8/30/2019
586BD7,conference-participant,100,50,8/30/2019
58CA9A,conference-organizer,100,57,8/30/2019
59DB8C,conference-participant,100,50,8/30/2019
5E7E82,dividend,100,50,8/30/2019
629F0F,conference-participant,100,50,8/30/2019
636639,board-meeting,100,51,8/30/2019
649CBD,legal-issues-defendant,100,22,8/30/2019
649CBD,legal-issues-defendant,100,22,8/30/2019
762A3E,conference-organizer,100,57,8/30/2019
7740DE,dividend,100,50,8/30/2019
7B492C,conference-participant,100,50,8/30/2019
804708,dividend,100,50,8/30/2019
80D744,legal-issues-defendant,100,22,8/30/2019
834152,executive-appointment,100,54,8/30/2019
8377DB,conference-participant,100,50,8/30/2019
8BFAA4,dividend,100,50,8/30/2019
8DA42F,legal-issues-defendant,100,22,8/30/2019
907ED2,executive-appointment,100,54,8/30/2019
90D6A5,dividend,100,50,8/30/2019
9196A2,conference-organizer,100,57,8/30/2019
92B625,conference-participant,100,50,8/30/2019
9470CC,conference-participant,100,50,8/30/2019
A631A3,conference-participant,100,50,8/30/2019
AADE0B,unit-acquisition-acquirer,100,49,8/30/2019
AED61E,acquisition-completed-acquirer,100,49,8/30/2019
AEFC90,conference-participant,100,50,8/30/2019
B5766D,donation,100,54,8/30/2019
BE7BA4,conference-participant,100,50,8/30/2019
C564E4,conference-participant,100,50,8/30/2019
C5F463,partnership,100,61,8/30/2019
C7859D,dividend,100,50,8/30/2019
CC8F6E,legal-issues-defendant,100,22,8/30/2019
CC8F6E,conference-participant,100,50,8/30/2019
D95385,conference-participant,100,50,8/30/2019
E22FDE,conference-participant,100,50,8/30/2019
E41190,conference-participant,100,50,8/30/2019
E8846E,conference-organizer,100,57,8/30/2019
E8846E,conference-organizer,100,57,8/30/2019
EB1E1A,executive-appointment,100,54,8/30/2019
F7FCA4,conference-participant,100,50,8/30/2019
F83279,acquisition-completed-acquirer,100,49,8/30/2019
FD554E,conference-participant,100,50,8/30/2019
55018,legal-issues-defendant,100,22,8/31/2019
934CC3,legal-issues-defendant,100,22,8/31/2019
01D03F,clinical-trials-positive,100,87,9/2/2019
01D03F,clinical-trials-positive,100,87,9/2/2019
1B16C1,legal-issues-defendant,100,22,9/2/2019
4E6F5A,conference-call,100,50,9/2/2019
543900,business-contract,100,69,9/2/2019
55438C,business-contract,100,69,9/2/2019
7F3A5F,partnership,100,61,9/2/2019
8C6C1B,facility-open,100,65,9/2/2019
A6213D,partnership,100,61,9/2/2019
B5BA39,legal-issues-defendant,100,22,9/2/2019
BA218A,legal-issues-defendant,100,22,9/2/2019
ECD263,legal-issues-defendant,100,22,9/2/2019
003B70,unit-acquisition-acquirer,100,49,9/3/2019
0157B1,market-entry,100,57,9/3/2019
20751,conference-participant,100,50,9/3/2019
03B8CF,legal-issues-defendant,100,22,9/3/2019
03FAA6,conference-participant,100,50,9/3/2019
04EB2F,legal-issues-defendant,100,22,9/3/2019
95294,award,100,58,9/3/2019
0BC29E,executive-appointment,100,54,9/3/2019
0BF198,conference-participant,100,50,9/3/2019
0BF528,note-sale,100,52,9/3/2019
0BF528,private-placement,100,56,9/3/2019
0DBB81,conference-participant,100,50,9/3/2019
0E2992,dividend,100,50,9/3/2019
1080C0,clinical-trials-positive,100,87,9/3/2019
125212,conference-participant,100,50,9/3/2019
157CC1,conference-participant,100,50,9/3/2019
184866,conference-participant,100,50,9/3/2019
184988,conference-participant,100,50,9/3/2019
196D18,executive-appointment,100,54,9/3/2019
1C599A,note-sale,100,52,9/3/2019
1CD09C,orphan-drug-designation,100,76,9/3/2019
1CD09C,conference-participant,100,50,9/3/2019
1D3A00,partnership,100,61,9/3/2019
1D9E55,conference-participant,100,50,9/3/2019
1E1125,conference-organizer,100,57,9/3/2019
1E9A6D,conference-participant,100,50,9/3/2019
1EBF8D,product-release,100,64,9/3/2019
1EBF8D,product-release,100,64,9/3/2019
1EBF8D,product-release,100,64,9/3/2019
1F08A6,conference-participant,100,50,9/3/2019
2082EA,conference-participant,100,50,9/3/2019
2082EA,note-sale,100,52,9/3/2019
22C58E,conference-participant,100,50,9/3/2019
2.45E+15,executive-appointment,100,54,9/3/2019
251988,business-contract,100,69,9/3/2019
251988,executive-appointment,100,54,9/3/2019
25A6CC,conference-participant,100,50,9/3/2019
2667B6,conference-participant,100,50,9/3/2019
26CC63,business-contract,100,69,9/3/2019
26E3BA,conference-participant,100,50,9/3/2019
2.90E+62,conference-participant,100,50,9/3/2019
2A1009,business-contract,100,69,9/3/2019
2B8179,conference-participant,100,50,9/3/2019
2E902B,conference-participant,100,50,9/3/2019
30AB63,conference-participant,100,50,9/3/2019
30DFD3,conference-participant,100,50,9/3/2019
31553A,award,100,58,9/3/2019
31803E,conference-participant,100,50,9/3/2019
32CB22,conference-participant,100,50,9/3/2019
32F943,conference-participant,100,50,9/3/2019
33AD83,conference-participant,100,50,9/3/2019
343996,unit-acquisition-acquirer,100,49,9/3/2019
34B411,merger-completed,100,66,9/3/2019
387375,conference-participant,100,50,9/3/2019
3AAEAE,public-offering,100,43,9/3/2019
3B50FE,conference-call,100,50,9/3/2019
3C75D6,buybacks,100,74,9/3/2019
3ED92D,analyst-ratings-change-positive-rater,20,50,9/3/2019
3F96D5,partnership,100,61,9/3/2019
3F96D5,partnership,100,61,9/3/2019
4.03E+05,unit-acquisition-acquirer,100,49,9/3/2019
407878,executive-appointment,100,54,9/3/2019
42EFC7,conference-participant,100,50,9/3/2019
43A74A,conference-participant,100,50,9/3/2019
444CC8,buybacks,100,74,9/3/2019
447FC6,executive-appointment,100,54,9/3/2019
448215,executive-appointment,100,54,9/3/2019
453282,conference-participant,100,50,9/3/2019
4649D5,unit-acquisition-acquiree,100,76,9/3/2019
4649D5,unit-acquisition-acquiree,100,76,9/3/2019
49A344,government-contract,100,69,9/3/2019
4A3438,legal-issues-defendant,100,22,9/3/2019
4AE584,unit-acquisition-acquirer,100,49,9/3/2019
4B3555,executive-resignation,100,44,9/3/2019
4C7DB5,dividend,100,50,9/3/2019
4CDA2B,conference-participant,100,50,9/3/2019
4D8124,executive-appointment,100,54,9/3/2019
50D1EC,executive-appointment,100,54,9/3/2019
51888A,unit-acquisition-acquirer,100,49,9/3/2019
523039,ipo-considered,100,60,9/3/2019
53EF9E,executive-resignation,100,44,9/3/2019
553949,acquisition-completed-acquirer,100,49,9/3/2019
56277A,dividend,100,50,9/3/2019
56B7C1,conference-participant,100,50,9/3/2019
56EA2B,note-sale,100,52,9/3/2019
56EA2B,note-sale,100,52,9/3/2019
587D25,conference-participant,100,50,9/3/2019
589846,product-release,100,64,9/3/2019
5B35C7,dividend,100,50,9/3/2019
5D43A7,partnership,100,61,9/3/2019
5DE5A5,conference-participant,100,50,9/3/2019
5F1B7B,legal-issues-defendant,100,22,9/3/2019
61E975,conference-participant,100,50,9/3/2019
639BD6,conference-participant,100,50,9/3/2019
649CBD,legal-issues-defendant,100,22,9/3/2019
67303E,clinical-trials,100,56,9/3/2019
67B052,conference-participant,100,50,9/3/2019
68586A,conference-participant,100,50,9/3/2019
69C99E,conference-participant,100,50,9/3/2019
6CD55A,stock-splits,100,49,9/3/2019
6D9B53,earnings-guidance,100,50,9/3/2019
6F0096,dividend,100,50,9/3/2019
6F5DD2,conference-participant,100,50,9/3/2019
6F6559,product-release,100,64,9/3/2019
717DB4,executive-appointment,100,54,9/3/2019
7273FF,executive-appointment,100,54,9/3/2019
73A213,earnings,100,50,9/3/2019
748EB6,earnings,100,50,9/3/2019
762A3E,conference-organizer,100,57,9/3/2019
765913,conference-participant,100,50,9/3/2019
76DD0C,conference-participant,100,50,9/3/2019
7B1156,conference-participant,100,50,9/3/2019
7C790D,public-offering,100,43,9/3/2019
7D35D8,executive-appointment,100,54,9/3/2019
7DA412,public-offering,100,43,9/3/2019
7DA412,public-offering,100,43,9/3/2019
7DA412,buybacks,100,74,9/3/2019
7DA412,buybacks,100,74,9/3/2019
7DD584,revenue-up,100,76,9/3/2019
7DD584,revenue-up,100,76,9/3/2019
7DD584,revenue-up,100,76,9/3/2019
7EA323,earnings,100,50,9/3/2019
7F3669,unit-acquisition-acquirer,100,49,9/3/2019
8.10E+32,award,100,58,9/3/2019
81F4BE,acquisition-completed-acquirer,100,49,9/3/2019
834152,conference-participant,100,50,9/3/2019
85CDC9,conference-participant,100,50,9/3/2019
862941,conference-participant,100,50,9/3/2019
8665BA,partnership,100,61,9/3/2019
877C0C,conference-participant,100,50,9/3/2019
8B4A45,executive-appointment,100,54,9/3/2019
8C6C1B,facility-open,100,65,9/3/2019
8CF6DD,conference-participant,100,50,9/3/2019
8EF425,dividend,100,50,9/3/2019
90D6A5,dividend,100,50,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
9196A2,conference-organizer,100,57,9/3/2019
91E5EE,conference-participant,100,50,9/3/2019
93965C,conference-participant,100,50,9/3/2019
94637C,conference-participant,100,50,9/3/2019
947B0B,conference-participant,100,50,9/3/2019
968966,partnership,100,61,9/3/2019
971F7B,executive-appointment,100,54,9/3/2019
989E2F,partnership,100,61,9/3/2019
990AD0,conference-organizer,100,57,9/3/2019
990AD0,conference-organizer,100,57,9/3/2019
990AD0,conference-organizer,100,57,9/3/2019
9B4066,unit-acquisition-acquirer,100,49,9/3/2019
9B4066,facility-sale,100,52,9/3/2019
9C5174,note-sale,100,52,9/3/2019
9D30A8,product-release,100,64,9/3/2019
9D30A8,product-release,100,64,9/3/2019
9DDE1B,public-offering,100,43,9/3/2019
A017F4,conference-participant,100,50,9/3/2019
A05C43,conference-participant,100,50,9/3/2019
A247F5,conference-participant,100,50,9/3/2019
A26EF7,conference-participant,100,50,9/3/2019
A398B9,partnership,100,61,9/3/2019
A4A612,ownership-decrease-owner,100,46,9/3/2019
A5195E,conference-participant,100,50,9/3/2019
A63820,earnings,100,50,9/3/2019
A666C8,conference-participant,100,50,9/3/2019
A70BF5,dividend,100,50,9/3/2019
A7A0C8,conference-participant,100,50,9/3/2019
A80FE0,business-contract,100,69,9/3/2019
A94A7B,credit-extension-recipient,100,69,9/3/2019
AA09AD,legal-issues-defendant,100,22,9/3/2019
AB7726,conference-participant,100,50,9/3/2019
AC1952,conference-participant,100,50,9/3/2019
AE79CD,conference-participant,100,50,9/3/2019
AED61E,earnings,100,50,9/3/2019
AFF7B4,conference-participant,100,50,9/3/2019
B0D41A,regulatory-product-approval-granted,100,81,9/3/2019
B0D41A,regulatory-product-approval-granted,100,81,9/3/2019
B13B68,conference-participant,100,50,9/3/2019
B290A2,clinical-trials-start,100,64,9/3/2019
B303A6,executive-appointment,100,54,9/3/2019
B303A6,award,100,58,9/3/2019
B33E77,conference-participant,100,50,9/3/2019
B48D6A,conference-participant,100,50,9/3/2019
B4C673,partnership,100,61,9/3/2019
B5DE80,conference-participant,100,50,9/3/2019
B7202A,conference-participant,100,50,9/3/2019
BA0442,executive-appointment,100,54,9/3/2019
BE7BA4,unit-acquisition-completed-acquirer,100,49,9/3/2019
C15F8F,conference-participant,100,50,9/3/2019
C2E39B,board-meeting,100,51,9/3/2019
C356AC,note-sale,100,52,9/3/2019
C356AC,executive-appointment,100,54,9/3/2019
C36189,partnership,100,61,9/3/2019
C38440,conference-participant,100,50,9/3/2019
C3BAE7,executive-appointment,100,54,9/3/2019
C45C1F,conference-participant,100,50,9/3/2019
C48574,conference-participant,100,50,9/3/2019
C85A72,conference-participant,100,50,9/3/2019
C85A72,conference-participant,100,50,9/3/2019
CBFFDD,business-contract,100,69,9/3/2019
CDAA0E,acquisition-completed-acquirer,100,49,9/3/2019
CDFCC9,conference-participant,100,50,9/3/2019
CDFCC9,earnings-guidance-meet-expectations,100,59,9/3/2019
CF211D,earnings,100,50,9/3/2019
CF3FF9,conference-participant,100,50,9/3/2019
CFF97C,acquisition-acquirer,100,49,9/3/2019
D1C0B9,hirings,100,65,9/3/2019
D1C26F,executive-appointment,100,54,9/3/2019
D29B44,conference-participant,100,50,9/3/2019
D36B23,conference-participant,100,50,9/3/2019
D64EDF,dividend,100,50,9/3/2019
D65A13,conference-participant,100,50,9/3/2019
D65A13,legal-issues-defendant,100,22,9/3/2019
D96202,unit-acquisition-completed-acquiree,100,67,9/3/2019
DAFED3,conference-participant,100,50,9/3/2019
DD1BA1,conference-participant,100,50,9/3/2019
E09E2B,partnership,100,61,9/3/2019
E28D9C,conference-participant,100,50,9/3/2019
E41190,executive-appointment,100,54,9/3/2019
E6A53A,facility-sale,100,52,9/3/2019
E6A53A,facility-sale,100,52,9/3/2019
E845D9,acquisition-acquirer,100,49,9/3/2019
E845D9,acquisition-acquirer,100,49,9/3/2019
E845D9,acquisition-acquirer,100,49,9/3/2019
E866D2,conference-participant,100,50,9/3/2019
E8846E,conference-organizer,100,57,9/3/2019
E8846E,conference-organizer,100,57,9/3/2019
E90C84,dividend,100,50,9/3/2019
EB7D6C,legal-issues-defendant,100,22,9/3/2019
ED3CA8,conference-participant,100,50,9/3/2019
F02170,conference-participant,100,50,9/3/2019
F0B877,executive-appointment,100,54,9/3/2019
F0EEFB,unit-acquisition-acquirer,100,49,9/3/2019
F3816D,conference-participant,100,50,9/3/2019
F43A11,earnings,100,50,9/3/2019
F47871,legal-issues-defendant,100,22,9/3/2019
F80FF9,legal-issues-defendant,100,22,9/3/2019
F88147,conference-participant,100,50,9/3/2019
FAAFA2,clinical-trials,100,56,9/3/2019
FD0CA4,conference-participant,100,50,9/3/2019
00067A,partnership,100,61,9/4/2019
0157B1,product-release,100,64,9/4/2019
034B61,conference-participant,100,50,9/4/2019
03B8CF,acquisition-acquiree,100,76,9/4/2019
05D148,conference-participant,100,50,9/4/2019
0BC29E,partnership,100,61,9/4/2019
0BD4E8,legal-issues-defendant,100,22,9/4/2019
0BD4E8,legal-issues-defendant,100,22,9/4/2019
0C2A0D,credit-extension-recipient,100,69,9/4/2019
0E64D4,conference-organizer,100,57,9/4/2019
1065BC,conference-participant,100,50,9/4/2019
1220D2,conference-participant,100,50,9/4/2019
12E454,product-release,100,64,9/4/2019
13A782,conference-participant,100,50,9/4/2019
14BA33,conference-participant,100,50,9/4/2019
14ED2B,executive-appointment,100,54,9/4/2019
152FA5,conference-participant,100,50,9/4/2019
157D9F,executive-appointment,100,54,9/4/2019
184988,clinical-trials-start,100,64,9/4/2019
1AB808,partnership,100,61,9/4/2019
1AF7E2,dividend-up,100,81,9/4/2019
1B5FEA,conference-participant,100,50,9/4/2019
1CD4B5,conference-participant,100,50,9/4/2019
1CD708,dividend,100,50,9/4/2019
1D1B07,earnings,100,50,9/4/2019
1D1B07,earnings,100,50,9/4/2019
1E83DE,earnings,100,50,9/4/2019
1EBF8D,regulatory-product-approval-granted,100,81,9/4/2019
1EBF8D,regulatory-product-approval-granted,100,81,9/4/2019
1EBF8D,regulatory-product-approval-granted,100,81,9/4/2019
1EBF8D,regulatory-product-approval-granted,100,81,9/4/2019
1EBF8D,regulatory-product-approval-granted,100,81,9/4/2019
1F19C8,executive-appointment,100,54,9/4/2019
1FAF22,conference-call,100,50,9/4/2019
1FCC00,conference-participant,100,50,9/4/2019
206852,conference-participant,100,50,9/4/2019
23207A,executive-appointment,100,54,9/4/2019
251988,partnership,100,61,9/4/2019
275300,conference-participant,100,50,9/4/2019
2.89E+11,public-offering,100,43,9/4/2019
2A6DBE,conference-participant,100,50,9/4/2019
2AE625,conference-participant,100,50,9/4/2019
2CA60F,legal-issues-defendant,100,22,9/4/2019
2CC60C,revenues,100,50,9/4/2019
2DC88B,conference-participant,100,50,9/4/2019
301493,executive-appointment,100,54,9/4/2019
31803E,clinical-trials,100,56,9/4/2019
3.20E+263,conference-participant,100,50,9/4/2019
3461CF,executive-appointment,100,54,9/4/2019
35557B,conference-participant,100,50,9/4/2019
36529A,clinical-trials-start,100,64,9/4/2019
36E479,clinical-trials-start,100,64,9/4/2019
38C46F,dividend,100,50,9/4/2019
3A3447,facility-open,100,65,9/4/2019
3B37F7,earnings-guidance-up,100,83,9/4/2019
3BA1BF,executive-appointment,100,54,9/4/2019
3BA1BF,conference-participant,100,50,9/4/2019
415188,partnership,100,61,9/4/2019
44740A,conference-participant,100,50,9/4/2019
44740A,executive-appointment,100,54,9/4/2019
46017C,conference-participant,100,50,9/4/2019
485445,legal-issues-defendant,100,22,9/4/2019
49F4D0,conference-participant,100,50,9/4/2019
50070E,conference-organizer,100,57,9/4/2019
50070E,conference-organizer,100,57,9/4/2019
504FE2,conference-participant,100,50,9/4/2019
513A86,executive-appointment,100,54,9/4/2019
5487B1,dividend,100,50,9/4/2019
54DF47,acquisition-completed-acquirer,100,49,9/4/2019
56EA2B,dividend,100,50,9/4/2019
59872F,conference-participant,100,50,9/4/2019
5A53BF,executive-appointment,100,54,9/4/2019
5B6C11,dividend,100,50,9/4/2019
5D41E4,conference-participant,100,50,9/4/2019
60FE03,conference-participant,100,50,9/4/2019
6284B5,note-sale,100,52,9/4/2019
6284B5,note-sale,100,52,9/4/2019
636BBF,earnings,100,50,9/4/2019
636BBF,acquisition-acquirer,100,49,9/4/2019
649CBD,legal-issues-defendant,100,22,9/4/2019
649CBD,legal-issues-defendant,100,22,9/4/2019
6.52E+64,executive-appointment,100,54,9/4/2019
665D7D,partnership,100,61,9/4/2019
66A667,executive-appointment,100,54,9/4/2019
66A667,executive-appointment,100,54,9/4/2019
6BD3C1,earnings,100,50,9/4/2019
6D156D,partnership,100,61,9/4/2019
6D156D,public-offering,100,43,9/4/2019
6F92A9,conference-participant,100,50,9/4/2019
70FCEF,executive-appointment,100,54,9/4/2019
728737,conference-participant,100,50,9/4/2019
72CB93,product-release,100,64,9/4/2019
7.45E+28,clinical-trials-filed,100,60,9/4/2019
747219,conference-participant,100,50,9/4/2019
7999F3,fundraising,100,64,9/4/2019
7999F3,fundraising,100,64,9/4/2019
7AF5B8,clinical-trials-start,100,64,9/4/2019
7BFF81,business-contract,100,69,9/4/2019
7BFF81,conference-participant,100,50,9/4/2019
7C790D,public-offering,100,43,9/4/2019
7DA412,public-offering,100,43,9/4/2019
7DA412,public-offering,100,43,9/4/2019
7DD8CC,public-offering,100,43,9/4/2019
7F7464,patient-enrollment-start,100,58,9/4/2019
7F7464,patient-enrollment-start,100,58,9/4/2019
7F9E16,conference-participant,100,50,9/4/2019
7FC386,dividend,100,50,9/4/2019
819492,conference-participant,100,50,9/4/2019
82F088,legal-issues-defendant,100,22,9/4/2019
82FD6D,award,100,58,9/4/2019
863350,earnings,100,50,9/4/2019
8AB85C,executive-appointment,100,54,9/4/2019
8B4A45,earnings,100,50,9/4/2019
8B8656,earnings,100,50,9/4/2019
8B8656,partnership,100,61,9/4/2019
8C6C1B,facility-open,100,65,9/4/2019
8D0EEA,conference-participant,100,50,9/4/2019
8DCBBB,note-sale,100,52,9/4/2019
8DCBBB,note-sale,100,52,9/4/2019
8DCBBB,note-sale,100,52,9/4/2019
8E10BF,orphan-drug-designation,100,76,9/4/2019
900356,note-sale,100,52,9/4/2019
903AB4,dividend,100,50,9/4/2019
9196A2,conference-organizer,100,57,9/4/2019
9196A2,conference-organizer,100,57,9/4/2019
9196A2,conference-organizer,100,57,9/4/2019
9196A2,conference-organizer,100,57,9/4/2019
9196A2,conference-organizer,100,57,9/4/2019
9196A2,conference-organizer,100,57,9/4/2019
9196A2,conference-organizer,100,57,9/4/2019
9196A2,conference-organizer,100,57,9/4/2019
934CC3,legal-issues-defendant,100,22,9/4/2019
93965C,partnership,100,61,9/4/2019
94756D,executive-appointment,100,54,9/4/2019
95C392,partnership,100,61,9/4/2019
9810C0,dividend,100,50,9/4/2019
990AD0,conference-organizer,100,57,9/4/2019
990AD0,conference-organizer,100,57,9/4/2019
9B4066,unit-acquisition-acquirer,100,49,9/4/2019
9B4066,unit-acquisition-acquirer,100,49,9/4/2019
9B5968,executive-appointment,100,54,9/4/2019
9B730A,business-contract,100,69,9/4/2019
9BB35A,public-offering,100,43,9/4/2019
9C5174,note-sale,100,52,9/4/2019
9DDE1B,public-offering,100,43,9/4/2019
9E575E,conference-participant,100,50,9/4/2019
9FB4B7,conference-participant,100,50,9/4/2019
A1E3B3,conference-participant,100,50,9/4/2019
A26C26,unit-acquisition-acquiree,100,76,9/4/2019
A52B6B,acquisition-interest-acquirer,100,46,9/4/2019
A52B6B,earnings,100,50,9/4/2019
A7A0C8,executive-appointment,100,54,9/4/2019
A868C9,business-contract,100,69,9/4/2019
AA7FE0,hirings,100,65,9/4/2019
AC3584,partnership,100,61,9/4/2019
ADD9DC,executive-resignation,100,44,9/4/2019
AFF7B4,note-sale,100,52,9/4/2019
B37FB4,conference-participant,100,50,9/4/2019
B48FC9,note-sale,100,52,9/4/2019
B4C673,note-sale,100,52,9/4/2019
B9CD50,executive-appointment,100,54,9/4/2019
BB0787,executive-appointment,100,54,9/4/2019
BB07E4,note-sale,100,52,9/4/2019
BCC13E,conference-participant,100,50,9/4/2019
BCC55F,executive-appointment,100,54,9/4/2019
BCC55F,partnership,100,61,9/4/2019
BF5959,executive-appointment,100,54,9/4/2019
BFE02C,conference-participant,100,50,9/4/2019
C2609A,conference-participant,100,50,9/4/2019
C2DD02,dividend,100,50,9/4/2019
C2DD02,buybacks,100,74,9/4/2019
C2E39B,award,100,58,9/4/2019
C3BAE7,conference-participant,100,50,9/4/2019
C564E4,clinical-trials-positive,100,87,9/4/2019
C5D2AE,business-combination,100,54,9/4/2019
C6C702,public-offering,100,43,9/4/2019
C9739A,conference-participant,100,50,9/4/2019
C9D866,conference-participant,100,50,9/4/2019
CB7AB2,partnership,100,61,9/4/2019
CBB77B,dividend,100,50,9/4/2019
CBDB4D,conference-participant,100,50,9/4/2019
CC0C78,conference-participant,100,50,9/4/2019
CCB623,loan-recipient,100,59,9/4/2019
CDAF5B,dividend,100,50,9/4/2019
CE1002,conference-participant,100,50,9/4/2019
CE4FD9,executive-appointment,100,54,9/4/2019
CEC5B9,buybacks,100,74,9/4/2019
CF6A5A,product-release,100,64,9/4/2019
CFF57D,public-offering,100,43,9/4/2019
D0909F,dividend,100,50,9/4/2019
D20C8F,executive-appointment,100,54,9/4/2019
D6144F,acquisition-acquirer,100,49,9/4/2019
D622D5,dividend,100,50,9/4/2019
D8DA3D,legal-issues-defendant,100,22,9/4/2019
DA0CB8,executive-appointment,100,54,9/4/2019
DB88A1,earnings,100,50,9/4/2019
DB88A1,earnings,100,50,9/4/2019
DB88A1,earnings,100,50,9/4/2019
DB88A1,earnings,100,50,9/4/2019
DB88A1,earnings,100,50,9/4/2019
DB88A1,earnings,100,50,9/4/2019
DB88A1,earnings,100,50,9/4/2019
DB88A1,earnings,100,50,9/4/2019
DD7A96,product-release,100,64,9/4/2019
DF18E6,conference-call,100,50,9/4/2019
E0339F,legal-issues-defendant,100,22,9/4/2019
E124EB,note-sale,100,52,9/4/2019
E866D2,product-release,100,64,9/4/2019
E866D2,product-release,100,64,9/4/2019
E8A49A,acquisition-acquirer,100,49,9/4/2019
EAA0A7,conference-participant,100,50,9/4/2019
ED22DC,conference-participant,100,50,9/4/2019
EEEA9F,conference-participant,100,50,9/4/2019
EF5BED,executive-appointment,100,54,9/4/2019
F1529C,conference-participant,100,50,9/4/2019
F1EB39,earnings,100,50,9/4/2019
F2E253,campaign-ad-release,100,59,9/4/2019
F3816D,executive-appointment,100,54,9/4/2019
F46EC9,conference-participant,100,50,9/4/2019
F46EC9,conference-participant,100,50,9/4/2019
F4CDA3,unit-acquisition-acquirer,100,49,9/4/2019
F4D241,conference-participant,100,50,9/4/2019
F4E992,partnership,100,61,9/4/2019
F8BA6C,conference-participant,100,50,9/4/2019
FA40E2,facility-open,100,65,9/4/2019
FC4550,dividend,100,50,9/4/2019
FD0CA4,executive-appointment,100,54,9/4/2019
FE7A63,dividend,100,50,9/4/2019
00FC70,dividend-up,100,81,9/5/2019
0BF528,note-sale,100,52,9/5/2019
0BF528,partnership,100,61,9/5/2019
14391F,public-offering,100,43,9/5/2019
1A5957,product-release,100,64,9/5/2019
1AD9CC,earnings,100,50,9/5/2019
1B4F31,market-entry,100,57,9/5/2019
1C599A,note-sale,100,52,9/5/2019
1CD4B5,executive-appointment,100,54,9/5/2019
1DF15D,buybacks,100,74,9/5/2019
1E1125,conference-organizer,100,57,9/5/2019
1EBF8D,conference-participant,100,50,9/5/2019
1F43A1,partnership,100,61,9/5/2019
1FC422,award,100,58,9/5/2019
21022F,executive-resignation,100,44,9/5/2019
227D48,dividend,100,50,9/5/2019
228D42,partnership,100,61,9/5/2019
241AF7,dividend,100,50,9/5/2019
25102A,executive-appointment,100,54,9/5/2019
25102A,executive-appointment,100,54,9/5/2019
25D3CE,conference-participant,100,50,9/5/2019
26DC29,earnings,100,50,9/5/2019
279916,earnings,100,50,9/5/2019
279916,executive-appointment,100,54,9/5/2019
2.89E+11,public-offering,100,43,9/5/2019
2CB4C9,unit-acquisition-acquiree,100,76,9/5/2019
2CB4C9,unit-acquisition-acquiree,100,76,9/5/2019
2E61CC,executive-appointment,100,54,9/5/2019
32F943,legal-issues-defendant,100,22,9/5/2019
32F943,legal-issues-defendant,100,22,9/5/2019
3471C0,conference-participant,100,50,9/5/2019
34A959,legal-issues-defendant,100,22,9/5/2019
36E479,conference-participant,100,50,9/5/2019
3B2311,credit-extension-recipient,100,69,9/5/2019
3C75D6,executive-appointment,100,54,9/5/2019
3ED92D,conference-participant,100,50,9/5/2019
416C55,conference-participant,100,50,9/5/2019
417BF9,earnings,100,50,9/5/2019
41EC04,executive-appointment,100,54,9/5/2019
420168,conference-participant,100,50,9/5/2019
42978B,revenues,100,50,9/5/2019
449447,acquisition-acquirer,100,49,9/5/2019
44A4FC,facility-open,100,65,9/5/2019
467F2C,conference-participant,100,50,9/5/2019
490D4B,executive-appointment,100,54,9/5/2019
4F9926,product-release,100,64,9/5/2019
50070E,conference-organizer,100,57,9/5/2019
50070E,conference-organizer,100,57,9/5/2019
510EA1,conference-participant,100,50,9/5/2019
543900,product-release,100,64,9/5/2019
55C9B5,conference-participant,100,50,9/5/2019
562853,buybacks,100,74,9/5/2019
567F3D,conference-participant,100,50,9/5/2019
58CA9A,facility-open,100,65,9/5/2019
59B229,executive-resignation,100,44,9/5/2019
59C539,merger-regulatory-approval,100,81,9/5/2019
5B6C11,dividend,100,50,9/5/2019
627186,earnings,100,50,9/5/2019
6559D8,conference-participant,100,50,9/5/2019
68E6E9,earnings,100,50,9/5/2019
69345C,conference-participant,100,50,9/5/2019
69C99E,clinical-trials-positive,100,87,9/5/2019
6B236C,conference-participant,100,50,9/5/2019
6D156D,public-offering,100,43,9/5/2019
6D9B53,conference-participant,100,50,9/5/2019
6F0096,conference-participant,100,50,9/5/2019
70FCEF,earnings,100,50,9/5/2019
722D55,conference-participant,100,50,9/5/2019
756BB4,earnings,100,50,9/5/2019
76F067,conference-participant,100,50,9/5/2019
7740DE,same-store-sales-up,100,53,9/5/2019
7A0EC4,earnings,100,50,9/5/2019
7ADE57,earnings,100,50,9/5/2019
7ADE57,earnings,100,50,9/5/2019
7ADE57,earnings,100,50,9/5/2019
7ADE57,earnings,100,50,9/5/2019
7ADE57,earnings,100,50,9/5/2019
7B9212,revenues,100,50,9/5/2019
7D5FD6,dividend,100,50,9/5/2019
7DD8CC,public-offering,100,43,9/5/2019
7EA323,conference-call,100,50,9/5/2019
80D744,conference-participant,100,50,9/5/2019
8.10E+205,executive-appointment,100,54,9/5/2019
8665BA,executive-appointment,100,54,9/5/2019
89F693,partnership,100,61,9/5/2019
8A8E41,product-release,100,64,9/5/2019
8A8E41,product-release,100,64,9/5/2019
8A8E41,dividend-up,100,81,9/5/2019
8BFE9A,conference-participant,100,50,9/5/2019
8C6C1B,facility-open,100,65,9/5/2019
9087B9,conference-participant,100,50,9/5/2019
911AB8,note-sale,100,52,9/5/2019
9196A2,conference-organizer,100,57,9/5/2019
9196A2,conference-organizer,100,57,9/5/2019
9196A2,conference-organizer,100,57,9/5/2019
9196A2,conference-organizer,100,57,9/5/2019
9196A2,conference-organizer,100,57,9/5/2019
9196A2,conference-organizer,100,57,9/5/2019
9196A2,conference-organizer,100,57,9/5/2019
92D757,earnings,100,50,9/5/2019
931AE7,conference-participant,100,50,9/5/2019
954004,facility-open,100,65,9/5/2019
954004,earnings,100,50,9/5/2019
97693A,earnings,100,50,9/5/2019
9.82E+06,earnings,100,50,9/5/2019
986AF6,dividend,100,50,9/5/2019
990AD0,conference-organizer,100,57,9/5/2019
9.92E+94,executive-appointment,100,54,9/5/2019
9BB35A,public-offering,100,43,9/5/2019
9BB35A,conference-participant,100,50,9/5/2019
9BB35A,acquisition-acquirer,100,49,9/5/2019
9BF177,earnings,100,50,9/5/2019
9E98F2,legal-issues-defendant,100,22,9/5/2019
A05C43,partnership,100,61,9/5/2019
A1EAC8,business-contract,100,69,9/5/2019
A4BCDE,dividend,100,50,9/5/2019
A65325,conference-call,100,50,9/5/2019
A6828A,partnership,100,61,9/5/2019
A7102F,business-contract,100,69,9/5/2019
A80FE0,conference-participant,100,50,9/5/2019
A80FE0,conference-participant,100,50,9/5/2019
AD1ACF,investment-investor,100,55,9/5/2019
AD22F2,buybacks,100,74,9/5/2019
ADD9DC,facility-open,100,65,9/5/2019
B2206F,partnership,100,61,9/5/2019
B37FB4,conference-participant,100,50,9/5/2019
B5BA39,legal-issues-defendant,100,22,9/5/2019
B66928,conference-participant,100,50,9/5/2019
B72BE9,dividend,100,50,9/5/2019
B8EF97,revenues,100,50,9/5/2019
BB58FF,conference-participant,100,50,9/5/2019
BB88B6,award,100,58,9/5/2019
BD15E8,executive-appointment,100,54,9/5/2019
BDF2BD,conference-participant,100,50,9/5/2019
C01737,conference-participant,100,50,9/5/2019
C07E05,executive-appointment,100,54,9/5/2019
C425AE,conference-participant,100,50,9/5/2019
C45CE7,executive-appointment,100,54,9/5/2019
C4C77F,executive-appointment,100,54,9/5/2019
C4FBDC,dividend,100,50,9/5/2019
C58D71,conference-participant,100,50,9/5/2019
C5D2AE,partnership,100,61,9/5/2019
C66B44,executive-appointment,100,54,9/5/2019
C6C702,public-offering,100,43,9/5/2019
C83B88,partnership,100,61,9/5/2019
C98CDB,partnership,100,61,9/5/2019
C99CC8,business-contract,100,69,9/5/2019
CBB77B,earnings,100,50,9/5/2019
CBB77B,earnings,100,50,9/5/2019
CDC817,executive-appointment,100,54,9/5/2019
CDD75E,executive-appointment,100,54,9/5/2019
CFF57D,public-offering,100,43,9/5/2019
D064D5,earnings,100,50,9/5/2019
D06755,conference-participant,100,50,9/5/2019
D25249,dividend,100,50,9/5/2019
D296C6,dividend,100,50,9/5/2019
D29B44,partnership,100,61,9/5/2019
D622D5,operating-earnings,100,50,9/5/2019
D9164D,note-sale,100,52,9/5/2019
DA9443,conference-participant,100,50,9/5/2019
DB9829,partnership,100,61,9/5/2019
DB9829,partnership,100,61,9/5/2019
DC486E,dividend,100,50,9/5/2019
DC486E,dividend,100,50,9/5/2019
DE5611,earnings,100,50,9/5/2019
E0207A,conference-participant,100,50,9/5/2019
E0207A,conference-participant,100,50,9/5/2019
E49AA3,public-offering,100,43,9/5/2019
E8B315,executive-appointment,100,54,9/5/2019
EA62FC,conference-participant,100,50,9/5/2019
EC8116,public-offering,100,43,9/5/2019
ED79D9,note-sale,100,52,9/5/2019
ED79D9,note-sale,100,52,9/5/2019
EF77A3,earnings,100,50,9/5/2019
F0B335,patient-enrollment-complete,100,64,9/5/2019
F0B335,patient-enrollment-complete,100,64,9/5/2019
F179ED,conference-participant,100,50,9/5/2019
F66B58,earnings,100,50,9/5/2019
FA40E2,earnings,100,50,9/5/2019
FAE021,executive-appointment,100,54,9/5/2019
FC1F9D,partnership,100,61,9/5/2019
FC1F9D,partnership,100,61,9/5/2019
FE7A63,executive-appointment,100,54,9/5/2019
00FC70,earnings,100,50,9/6/2019
01D03F,regulatory-product-approval-granted,100,81,9/6/2019
070B45,conference-participant,100,50,9/6/2019
12DE76,acquisition-completed-acquirer,100,49,9/6/2019
190B91,conference-participant,100,50,9/6/2019
1921DD,dividend,100,50,9/6/2019
1921DD,dividend,100,50,9/6/2019
1921DD,dividend,100,50,9/6/2019
1CD708,executive-resignation,100,44,9/6/2019
1E83DE,conference-participant,100,50,9/6/2019
1FE7F0,executive-appointment,100,54,9/6/2019
2B5483,earnings-guidance-meet-expectations,100,59,9/6/2019
2C681C,conference-participant,100,50,9/6/2019
2C681C,conference-participant,100,50,9/6/2019
31DB20,dividend-suspended,100,13,9/6/2019
326EDD,conference-participant,100,50,9/6/2019
32F943,legal-issues-defendant,100,22,9/6/2019
3AAEAE,public-offering,100,43,9/6/2019
422CE3,facility-open,100,65,9/6/2019
4DD203,market-entry,100,57,9/6/2019
50070E,conference-organizer,100,57,9/6/2019
50070E,conference-organizer,100,57,9/6/2019
51D876,conference-participant,100,50,9/6/2019
55438C,partnership,100,61,9/6/2019
5546DA,buybacks,100,74,9/6/2019
5E9934,conference-call,100,50,9/6/2019
609208,conference-call,100,50,9/6/2019
619882,conference-organizer,100,57,9/6/2019
62CDDE,conference-participant,100,50,9/6/2019
636BBF,legal-issues-defendant,100,22,9/6/2019
651C85,conference-participant,100,50,9/6/2019
665D7D,dividend,100,50,9/6/2019
67A658,dividend,100,50,9/6/2019
67A658,dividend,100,50,9/6/2019
6E705B,conference-participant,100,50,9/6/2019
6E705B,campaign-ad-release,100,59,9/6/2019
6F3936,buybacks,100,74,9/6/2019
75768D,conference-call,100,50,9/6/2019
78F776,trading-listing,100,61,9/6/2019
7A5097,dividend,100,50,9/6/2019
7B4B91,dividend,100,50,9/6/2019
817ED9,sponsorship,100,57,9/6/2019
838ADD,conference-participant,100,50,9/6/2019
890FF4,business-contract,100,69,9/6/2019
89B2E7,dividend,100,50,9/6/2019
89E771,dividend,100,50,9/6/2019
8C6C1B,facility-open,100,65,9/6/2019
9196A2,conference-organizer,100,57,9/6/2019
9196A2,conference-organizer,100,57,9/6/2019
9196A2,conference-organizer,100,57,9/6/2019
9196A2,conference-organizer,100,57,9/6/2019
9196A2,conference-organizer,100,57,9/6/2019
9196A2,conference-organizer,100,57,9/6/2019
986AF6,executive-resignation,100,44,9/6/2019
990AD0,conference-organizer,100,57,9/6/2019
990AD0,conference-organizer,100,57,9/6/2019
9C25FF,conference-participant,100,50,9/6/2019
9D65C1,executive-appointment,100,54,9/6/2019
A631A3,product-release,100,64,9/6/2019
A6FC89,conference-participant,100,50,9/6/2019
A746F6,public-offering,100,43,9/6/2019
A746F6,public-offering,100,43,9/6/2019
A8E72A,conference-participant,100,50,9/6/2019
AA98ED,conference-participant,100,50,9/6/2019
AD375D,conference-participant,100,50,9/6/2019
B48FC9,note-sale,100,52,9/6/2019
B642E8,dividend,100,50,9/6/2019
B762D3,earnings,100,50,9/6/2019
B762D3,earnings,100,50,9/6/2019
B762D3,earnings,100,50,9/6/2019
C98CDB,partnership,100,61,9/6/2019
D63B0F,conference-participant,100,50,9/6/2019
DB23C8,conference-participant,100,50,9/6/2019
DB5CA5,unit-acquisition-completed-acquiree,100,67,9/6/2019
DB7014,unit-acquisition-acquirer,100,49,9/6/2019
DB7014,conference-participant,100,50,9/6/2019
E261E9,buybacks,100,74,9/6/2019
E70531,business-contract,100,69,9/6/2019
E70531,business-contract,100,69,9/6/2019
E70531,partnership,100,61,9/6/2019
EB43F4,conference-participant,100,50,9/6/2019
ECA300,earnings,100,50,9/6/2019
F3EDB4,business-contract,100,69,9/6/2019
F46EC9,conference-participant,100,50,9/6/2019
F67165,conference-participant,100,50,9/6/2019
FACF19,executive-appointment,100,54,9/6/2019
4FB770,conference-participant,100,50,9/7/2019
6D9B53,conference-participant,100,50,9/7/2019
8DA42F,legal-issues-defendant,100,22,9/7/2019
990AD0,conference-organizer,100,57,9/7/2019
B5BA39,legal-issues-defendant,100,22,9/7/2019
03596A,product-release,100,64,9/8/2019
C8FAC7,fundraising,100,64,9/8/2019
001F1B,revenues,100,50,9/9/2019
001F1B,revenues,100,50,9/9/2019
03B8CF,legal-issues-defendant,100,22,9/9/2019
09DE1F,business-contract,100,69,9/9/2019
0B4D10,dividend,100,50,9/9/2019
0BA2EF,earnings,100,50,9/9/2019
0BA2EF,earnings,100,50,9/9/2019
125212,clinical-trials-positive,100,87,9/9/2019
131443,acquisition-completed-acquirer,100,49,9/9/2019
131443,business-contract,100,69,9/9/2019
152E1D,conference-participant,100,50,9/9/2019
182BE7,conference-participant,100,50,9/9/2019
1AB808,clinical-trials,100,56,9/9/2019
1B16C1,legal-issues-defendant,100,22,9/9/2019
1E83DE,executive-appointment,100,54,9/9/2019
1F08A6,business-contract,100,69,9/9/2019
2158DF,partnership,100,61,9/9/2019
228D42,partnership,100,61,9/9/2019
2667B6,legal-issues-defendant,100,22,9/9/2019
267718,clinical-trials-positive,100,87,9/9/2019
2E61CC,partnership,100,61,9/9/2019
2E902B,conference-participant,100,50,9/9/2019
306623,ownership-decrease-owner,100,46,9/9/2019
32C8CD,public-offering,100,43,9/9/2019
32F943,legal-issues-defendant,100,22,9/9/2019
3C3B6B,partnership,100,61,9/9/2019
3ED92D,acquisition-acquirer,100,49,9/9/2019
3ED92D,executive-appointment,100,54,9/9/2019
3F4668,acquisition-acquirer,100,49,9/9/2019
448215,dividend,100,50,9/9/2019
44ED36,public-offering,100,43,9/9/2019
4A3438,legal-issues-defendant,100,22,9/9/2019
4A6F00,partnership,100,61,9/9/2019
4A6F00,partnership,100,61,9/9/2019
4A7C1F,revenue-guidance,100,50,9/9/2019
4C2F17,business-contract,100,69,9/9/2019
4C6C63,conference-participant,100,50,9/9/2019
4CDA2B,clinical-trials-start,100,64,9/9/2019
4F71DC,earnings,100,50,9/9/2019
50070E,conference-organizer,100,57,9/9/2019
520632,product-release,100,64,9/9/2019
5403F8,executive-appointment,100,54,9/9/2019
56277A,campaign-ad-release,100,59,9/9/2019
583A75,revenue-volume,100,50,9/9/2019
596116,facility-open,100,65,9/9/2019
59B229,investment-investor,100,55,9/9/2019
5D16CF,note-sale,100,52,9/9/2019
5DD48B,product-release,100,64,9/9/2019
5EAA43,note-sale,100,52,9/9/2019
5EAA43,note-sale,100,52,9/9/2019
5EC388,merger,100,66,9/9/2019
6166D1,unit-acquisition-acquirer,100,49,9/9/2019
622DBE,conference-participant,100,50,9/9/2019
62B1C6,executive-resignation,100,44,9/9/2019
62B1C6,executive-resignation,100,44,9/9/2019
641F17,earnings,100,50,9/9/2019
64E346,partnership,100,61,9/9/2019
6.52E+64,reorganization,100,53,9/9/2019
6634D9,partnership,100,61,9/9/2019
66667F,conference-participant,100,50,9/9/2019
693ECD,executive-appointment,100,54,9/9/2019
6B494E,fundraising,100,64,9/9/2019
6B6375,clinical-trials,100,56,9/9/2019
6BC6F9,executive-appointment,100,54,9/9/2019
6D9ECA,business-contract,100,69,9/9/2019
6F39FC,dividend,100,50,9/9/2019
73A213,conference-participant,100,50,9/9/2019
76D79A,note-sale,100,52,9/9/2019
76F067,partnership,100,61,9/9/2019
7999F3,conference-participant,100,50,9/9/2019
7A0EC4,partnership,100,61,9/9/2019
7C790D,public-offering,100,43,9/9/2019
7E1D5D,partnership,100,61,9/9/2019
7F3665,executive-death,100,31,9/9/2019
7F3A5F,executive-appointment,100,54,9/9/2019
81222C,conference-participant,100,50,9/9/2019
82FD6D,conference-participant,100,50,9/9/2019
830BDB,conference-participant,100,50,9/9/2019
83A065,dividend,100,50,9/9/2019
83B1C8,executive-appointment,100,54,9/9/2019
8665BA,business-contract,100,69,9/9/2019
8.79E+06,executive-appointment,100,54,9/9/2019
880C0C,dividend,100,50,9/9/2019
8B9B3B,acquisition-completed-acquirer,100,49,9/9/2019
8C5519,dividend,100,50,9/9/2019
8C6C1B,facility-open,100,65,9/9/2019
9196A2,conference-organizer,100,57,9/9/2019
9196A2,conference-organizer,100,57,9/9/2019
92D757,legal-issues-defendant,100,22,9/9/2019
92D757,legal-issues-defendant,100,22,9/9/2019
92D757,insider-buy,100,61,9/9/2019
92D757,legal-issues-defendant,100,22,9/9/2019
92D757,legal-issues-defendant,100,22,9/9/2019
93AD2E,executive-appointment,100,54,9/9/2019
9592FB,product-release,100,64,9/9/2019
9.74E+08,executive-resignation,100,44,9/9/2019
977A1E,donation,100,54,9/9/2019
990AD0,conference-organizer,100,57,9/9/2019
9B5968,executive-appointment,100,54,9/9/2019
9BF177,executive-appointment,100,54,9/9/2019
9E0811,public-offering,100,43,9/9/2019
A01200,ipo,100,71,9/9/2019
A1E3B3,partnership,100,61,9/9/2019
A1EAC8,executive-appointment,100,54,9/9/2019
A26C26,earnings,100,50,9/9/2019
A350C1,conference-participant,100,50,9/9/2019
A4386C,unit-acquisition-acquirer,100,49,9/9/2019
A6213D,facility-open,100,65,9/9/2019
A8FDE8,conference-participant,100,50,9/9/2019
AADE0B,unit-acquisition-acquirer,100,49,9/9/2019
AD3008,conference-participant,100,50,9/9/2019
AD375D,business-contract,100,69,9/9/2019
ADFB3A,conference-participant,100,50,9/9/2019
AE7D16,product-release,100,64,9/9/2019
B5734D,earnings,100,50,9/9/2019
B5BA39,legal-issues-defendant,100,22,9/9/2019
B98EFA,conference-participant,100,50,9/9/2019
BA218A,legal-issues-defendant,100,22,9/9/2019
BAD655,conference-participant,100,50,9/9/2019
BB127B,conference-participant,100,50,9/9/2019
BE14CF,note-sale,100,52,9/9/2019
BE14CF,note-sale,100,52,9/9/2019
BE645B,conference-participant,100,50,9/9/2019
C48574,revenue-up,100,69,9/9/2019
C48574,revenue-up,100,69,9/9/2019
C48574,revenue-up,100,69,9/9/2019
C54140,conference-participant,100,50,9/9/2019
C74887,earnings,100,50,9/9/2019
CAC8D0,earnings,100,50,9/9/2019
CB7AB2,executive-appointment,100,54,9/9/2019
CB7AB2,partnership,100,61,9/9/2019
CDAB24,executive-resignation,100,44,9/9/2019
CDC817,public-offering,100,43,9/9/2019
CE4E6D,executive-appointment,100,54,9/9/2019
CE4FD9,conference-participant,100,50,9/9/2019
CF211D,earnings,100,50,9/9/2019
CFF97C,credit-rating-upgrade-rater,20,50,9/9/2019
D1AE3B,conference-call,100,50,9/9/2019
D598E7,conference-participant,100,50,9/9/2019
D6EAA3,note-sale,100,52,9/9/2019
D90F43,facility-open,100,65,9/9/2019
D96202,strike,100,25,9/9/2019
DB88A1,legal-issues-defendant,100,22,9/9/2019
DD7A96,conference-participant,100,50,9/9/2019
E8846E,donation,100,54,9/9/2019
E9E6FD,unit-acquisition-acquirer,100,49,9/9/2019
ECD263,legal-issues-defendant,100,22,9/9/2019
EE74E1,partnership,100,61,9/9/2019
F1C04C,conference-participant,100,50,9/9/2019
F30508,business-contract,100,69,9/9/2019
F47871,legal-issues-defendant,100,22,9/9/2019
F5D410,acquisition-acquiree,100,76,9/9/2019
FAAFA2,partnership,100,61,9/9/2019
FAAFA2,partnership,100,61,9/9/2019
FC1736,earnings,100,50,9/9/2019
0157B1,partnership,100,61,9/10/2019
01D03F,product-release,100,64,9/10/2019
01D03F,product-release,100,64,9/10/2019
01D03F,product-release,100,64,9/10/2019
01D03F,product-release,100,64,9/10/2019
0358AF,conference-participant,100,50,9/10/2019
71860,product-release,100,64,9/10/2019
95294,legal-issues-defendant,100,22,9/10/2019
0BD4E8,legal-issues-defendant,100,22,9/10/2019
12DE76,partnership,100,61,9/10/2019
15B10D,product-release,100,64,9/10/2019
16C544,note-sale,100,52,9/10/2019
1921DD,partnership,100,61,9/10/2019
1D943E,acquisition-completed-acquirer,100,49,9/10/2019
1D943E,acquisition-completed-acquirer,100,49,9/10/2019
1F08A6,dividend,100,50,9/10/2019
1F716B,donation,100,54,9/10/2019
1FAF22,acquisition-acquirer,100,49,9/10/2019
21153F,executive-appointment,100,54,9/10/2019
21153F,executive-appointment,100,54,9/10/2019
21DED4,note-sale,100,52,9/10/2019
221783,acquisition-acquirer,100,49,9/10/2019
2262BD,executive-appointment,100,54,9/10/2019
2262BD,earnings,100,50,9/10/2019
228D42,partnership,100,61,9/10/2019
284289,conference-participant,100,50,9/10/2019
28AC4E,legal-issues-defendant,100,22,9/10/2019
297DA8,product-release,100,64,9/10/2019
2A02DC,conference-call,100,50,9/10/2019
2C7505,clinical-trials,100,56,9/10/2019
2C7505,clinical-trials,100,56,9/10/2019
2CA60F,legal-issues-defendant,100,22,9/10/2019
2EBC0B,dividend,100,50,9/10/2019
2F7A7E,merger-regulatory-approval,100,81,9/10/2019
2FEA66,executive-appointment,100,54,9/10/2019
30DE64,regulatory-product-approval-granted,100,81,9/10/2019
33AD83,product-release,100,64,9/10/2019
3ACF46,executive-appointment,100,54,9/10/2019
3C75D6,conference-participant,100,50,9/10/2019
408380,partnership,100,61,9/10/2019
40F7DE,conference-participant,100,50,9/10/2019
44ED36,public-offering,100,43,9/10/2019
458D2C,revenue-volume,100,50,9/10/2019
485445,legal-issues-defendant,100,22,9/10/2019
4BDCA7,executive-appointment,100,54,9/10/2019
50070E,partnership,100,61,9/10/2019
50070E,partnership,100,61,9/10/2019
556F08,business-contract,100,69,9/10/2019
5704AC,dividend-up,100,81,9/10/2019
57CAAB,conference-participant,100,50,9/10/2019
5F9CE3,executive-appointment,100,54,9/10/2019
649CBD,legal-issues-defendant,100,22,9/10/2019
66A667,acquisition-acquirer,100,49,9/10/2019
673C9A,conference-participant,100,50,9/10/2019
69CE71,partnership,100,61,9/10/2019
6A171E,conference-participant,100,50,9/10/2019
6D156D,public-offering,100,43,9/10/2019
6D4636,executive-appointment,100,54,9/10/2019
6DC1D7,dividend,100,50,9/10/2019
6EA292,public-offering,100,43,9/10/2019
704B78,conference-participant,100,50,9/10/2019
71E2EF,unit-acquisition-acquiree,100,76,9/10/2019
73BCBA,product-release,100,64,9/10/2019
73C9E2,partnership,100,61,9/10/2019
766047,executive-appointment,100,54,9/10/2019
79340A,conference-participant,100,50,9/10/2019
7B0BA6,partnership,100,61,9/10/2019
7B0BA6,product-release,100,64,9/10/2019
804708,merger-failed,100,21,9/10/2019
804708,merger-failed,100,21,9/10/2019
8.10E+32,executive-appointment,100,54,9/10/2019
82E58A,dividend-up,100,81,9/10/2019
82F088,legal-issues-defendant,100,22,9/10/2019
83A065,public-offering,100,43,9/10/2019
890FF4,executive-appointment,100,54,9/10/2019
8B6E7E,note-sale,100,52,9/10/2019
8B6E7E,note-sale,100,52,9/10/2019
8C6C1B,facility-open,100,65,9/10/2019
8FCA78,facility-open,100,65,9/10/2019
9196A2,conference-organizer,100,57,9/10/2019
9196A2,conference-organizer,100,57,9/10/2019
9196A2,conference-organizer,100,57,9/10/2019
92D757,legal-issues-defendant,100,22,9/10/2019
92D757,legal-issues-defendant,100,22,9/10/2019
92D757,legal-issues-defendant,100,22,9/10/2019
934CC3,legal-issues-defendant,100,22,9/10/2019
934CC3,legal-issues-defendant,100,22,9/10/2019
940C3D,public-offering,100,43,9/10/2019
980C14,dividend,100,50,9/10/2019
990AD0,legal-issues-defendant,100,22,9/10/2019
9BB35A,merger-failed,100,21,9/10/2019
9BB35A,merger-failed,100,21,9/10/2019
9E0811,public-offering,100,43,9/10/2019
9E5C2C,note-sale,100,52,9/10/2019
9F6B1A,facility-open,100,65,9/10/2019
A52B6B,product-release,100,64,9/10/2019
A5A4F5,business-contract,100,69,9/10/2019
A63387,executive-appointment,100,54,9/10/2019
A6FB29,earnings-up,100,68,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A6FB29,earnings,100,50,9/10/2019
A75D43,product-release,100,64,9/10/2019
A868C9,business-contract,100,69,9/10/2019
A871B0,conference-participant,100,50,9/10/2019
AA7FE0,hirings,100,65,9/10/2019
AA7FE0,conference-call,100,50,9/10/2019
ACC7D3,conference-participant,100,50,9/10/2019
AD1ACF,executive-appointment,100,54,9/10/2019
AD9F1D,facility-open,100,65,9/10/2019
ADF092,partnership,100,61,9/10/2019
C062D4,note-sale,100,52,9/10/2019
C5C137,partnership,100,61,9/10/2019
CB7AB2,partnership,100,61,9/10/2019
CBCC6A,conference-organizer,100,57,9/10/2019
CBFFDD,conference-participant,100,50,9/10/2019
CE96E7,acquisition-acquirer,100,49,9/10/2019
CEDFD5,business-contract,100,69,9/10/2019
CFF97C,partnership,100,61,9/10/2019
CFF97C,analyst-ratings-change-neutral-rater,20,50,9/10/2019
D1AE3B,partnership,100,61,9/10/2019
D33270,product-release,100,64,9/10/2019
D42DBA,earnings,100,50,9/10/2019
D48275,conference-call,100,50,9/10/2019
D56E4C,executive-appointment,100,54,9/10/2019
D56E4C,executive-appointment,100,54,9/10/2019
D75910,note-sale,100,52,9/10/2019
D8442A,product-release,100,64,9/10/2019
D8442A,product-release,100,64,9/10/2019
D8442A,product-release,100,64,9/10/2019
D8442A,product-release,100,64,9/10/2019
D8442A,product-release,100,64,9/10/2019
DD1BA1,conference-participant,100,50,9/10/2019
DD9E41,note-sale,100,52,9/10/2019
DF5F14,dividend,100,50,9/10/2019
DF6FDD,partnership,100,61,9/10/2019
E0339F,legal-issues-defendant,100,22,9/10/2019
E124EB,dividend,100,50,9/10/2019
E68E62,clinical-trials,100,56,9/10/2019
E69BA5,conference-participant,100,50,9/10/2019
E829E8,unit-acquisition-acquirer,100,49,9/10/2019
ECF4F8,note-sale,100,52,9/10/2019
ECF4F8,note-sale,100,52,9/10/2019
ED79D9,partnership,100,61,9/10/2019
EE6F1C,product-release,100,64,9/10/2019
F1EB39,product-release,100,64,9/10/2019
F5D059,conference-call,100,50,9/10/2019
FAB97A,patent-infringement-plaintiff,100,47,9/10/2019
FD0CA4,executive-appointment,100,54,9/10/2019
FF5413,revenue-volume,100,50,9/10/2019
00326D,dividend,100,50,9/11/2019
09062E,note-sale,100,52,9/11/2019
95294,partnership,100,61,9/11/2019
95294,partnership,100,61,9/11/2019
95294,executive-appointment,100,54,9/11/2019
0BA2EF,dividend,100,50,9/11/2019
0FDE97,executive-appointment,100,54,9/11/2019
14BA06,dividend,100,50,9/11/2019
14BA33,conference-participant,100,50,9/11/2019
165B86,product-release,100,64,9/11/2019
1880C5,public-offering,100,43,9/11/2019
1CD09C,regulatory-product-approval-granted,100,81,9/11/2019
1EBF8D,product-release,100,64,9/11/2019
1F9258,public-offering,100,43,9/11/2019
1F9258,acquisition-acquirer,100,49,9/11/2019
1F9D90,executive-resignation,100,44,9/11/2019
227D48,conference-participant,100,50,9/11/2019
273BA3,product-release,100,64,9/11/2019
326EDD,dividend,100,50,9/11/2019
33E9D5,earnings,100,50,9/11/2019
349DA4,business-contract,100,69,9/11/2019
349DA4,business-contract,100,69,9/11/2019
367E1C,executive-appointment,100,54,9/11/2019
37B618,dividend,100,50,9/11/2019
384CD3,dividend,100,50,9/11/2019
39692D,note-sale,100,52,9/11/2019
39692D,note-sale,100,52,9/11/2019
3B8484,note-sale,100,52,9/11/2019
4A2457,conference-participant,100,50,9/11/2019
4A5C8D,partnership,100,61,9/11/2019
4B49CF,earnings,100,50,9/11/2019
50070E,conference-organizer,100,57,9/11/2019
53EF9E,conference-participant,100,50,9/11/2019
55C9B5,partnership,100,61,9/11/2019
5FE4B6,conference-participant,100,50,9/11/2019
66E3C0,conference-participant,100,50,9/11/2019
6A961B,earnings,100,50,9/11/2019
6F3936,partnership,100,61,9/11/2019
71E2EF,unit-acquisition-acquiree,100,76,9/11/2019
728737,dividend,100,50,9/11/2019
728737,dividend,100,50,9/11/2019
728737,executive-appointment,100,54,9/11/2019
72FCA3,earnings,100,50,9/11/2019
762B8D,earnings,100,50,9/11/2019
763724,acquisition-acquirer,100,49,9/11/2019
771985,conference-participant,100,50,9/11/2019
775439,earnings,100,50,9/11/2019
77B8E9,conference-participant,100,50,9/11/2019
789A7D,note-sale,100,52,9/11/2019
791D59,business-contract,100,69,9/11/2019
7B0BA6,award,100,58,9/11/2019
7B8CB5,note-sale,100,52,9/11/2019
7BC92D,unit-acquisition-acquirer,100,49,9/11/2019
7D5FD6,product-release,100,64,9/11/2019
7DD8CC,unit-acquisition-acquirer,100,49,9/11/2019
7E1D5D,product-release,100,64,9/11/2019
7F3669,acquisition-acquirer,100,49,9/11/2019
8275FE,merger-completed,100,66,9/11/2019
83A065,public-offering,100,43,9/11/2019
8AC740,dividend,100,50,9/11/2019
8BFE9A,conference-participant,100,50,9/11/2019
8C6C1B,facility-open,100,65,9/11/2019
8EDACA,conference-participant,100,50,9/11/2019
92D757,legal-issues-defendant,100,22,9/11/2019
940C3D,public-offering,100,43,9/11/2019
94637C,dividend,100,50,9/11/2019
94C0B5,conference-call,100,50,9/11/2019
9673BD,buybacks,100,74,9/11/2019
9.74E+08,dividend,100,50,9/11/2019
97644E,campaign-ad-release,100,59,9/11/2019
9B0C9C,conference-participant,100,50,9/11/2019
9B5968,executive-appointment,100,54,9/11/2019
9D5FA4,patent-infringement-plaintiff,100,47,9/11/2019
9E91C6,note-sale,100,52,9/11/2019
9EF4CF,fundraising,100,64,9/11/2019
9EF4CF,fundraising,100,64,9/11/2019
A3AAA5,dividend,100,50,9/11/2019
A6828A,executive-appointment,100,54,9/11/2019
AC7C4F,business-contract,100,69,9/11/2019
ACF77B,dividend,100,50,9/11/2019
AD3C93,legal-issues-defendant,100,22,9/11/2019
AFF7B4,note-sale,100,52,9/11/2019
B076A1,dividend,100,50,9/11/2019
B0D41A,public-offering,100,43,9/11/2019
B1FC3B,fundraising,100,64,9/11/2019
B290A2,note-sale,100,52,9/11/2019
B614F8,revenue-guidance-up,100,83,9/11/2019
C9F39B,dividend,100,50,9/11/2019
CA1620,dividend-up,100,53,9/11/2019
CAD7D9,conference-call,100,50,9/11/2019
CDAF5B,dividend,100,50,9/11/2019
CDC817,public-offering,100,43,9/11/2019
CF351E,dividend,100,50,9/11/2019
D1588D,index-listing,100,76,9/11/2019
D6EAA3,note-sale,100,52,9/11/2019
D8442A,product-release,100,64,9/11/2019
D96202,executive-appointment,100,54,9/11/2019
DA0A9E,executive-appointment,100,54,9/11/2019
DD7A96,executive-appointment,100,54,9/11/2019
DD9E41,note-sale,100,52,9/11/2019
E5752F,partnership,100,61,9/11/2019
E829E8,unit-acquisition-acquirer,100,49,9/11/2019
EB6965,dividend,100,50,9/11/2019
ED0D7C,conference-participant,100,50,9/11/2019
ED9C04,business-contract,100,69,9/11/2019
EEA6B3,earnings,100,50,9/11/2019
F0B335,patient-enrollment-complete,100,64,9/11/2019
F3EDB4,earnings,100,50,9/11/2019
F7935D,clinical-trials-start,100,64,9/11/2019
FD9A97,conference-participant,100,50,9/11/2019
00E601,earnings,100,50,9/12/2019
13528,product-release,100,64,9/12/2019
03CF95,product-release,100,64,9/12/2019
04996E,executive-appointment,100,54,9/12/2019
0919B1,dividend,100,50,9/12/2019
09DE1F,earnings,100,50,9/12/2019
106394,dividend-up,100,53,9/12/2019
1201B5,acquisition-acquirer,100,49,9/12/2019
1201B5,acquisition-acquirer,100,49,9/12/2019
12DE76,partnership,100,61,9/12/2019
147C38,executive-appointment,100,54,9/12/2019
16B183,dividend,100,50,9/12/2019
16C544,dividend,100,50,9/12/2019
1748F6,earnings,100,50,9/12/2019
188394,conference-call,100,50,9/12/2019
1921DD,regulatory-product-approval-granted,100,81,9/12/2019
1921DD,note-sale,100,52,9/12/2019
1921DD,note-sale,100,52,9/12/2019
1921DD,note-sale,100,52,9/12/2019
1921DD,note-sale,100,52,9/12/2019
1B637E,dividend,100,50,9/12/2019
1F9258,public-offering,100,43,9/12/2019
205AD5,legal-issues-defendant,100,22,9/12/2019
228D42,partnership,100,61,9/12/2019
228D42,partnership,100,61,9/12/2019
228D42,partnership,100,61,9/12/2019
23207A,earnings,100,50,9/12/2019
23207A,earnings,100,50,9/12/2019
23207A,earnings,100,50,9/12/2019
25DD05,dividend,100,50,9/12/2019
25DD05,dividend,100,50,9/12/2019
267718,partnership,100,61,9/12/2019
282C18,dividend,100,50,9/12/2019
2CBB58,conference-participant,100,50,9/12/2019
2F7A7E,index-listing,100,76,9/12/2019
2F9304,partnership,100,61,9/12/2019
32C8CD,public-offering,100,43,9/12/2019
33E9D5,trading-halt,100,43,9/12/2019
33E9D5,trading-resumed,100,58,9/12/2019
33E9D5,conference-participant,100,50,9/12/2019
367434,clinical-trials,100,56,9/12/2019
3B37F7,executive-appointment,100,54,9/12/2019
3CCC90,executive-appointment,100,54,9/12/2019
42AABD,acquisition-acquirer,100,49,9/12/2019
458D2C,partnership,100,61,9/12/2019
4A7C1F,legal-issues-defendant,100,22,9/12/2019
4B3555,dividend,100,50,9/12/2019
4B6EF9,note-sale,100,52,9/12/2019
4C2F17,executive-appointment,100,54,9/12/2019
4E5784,product-release,100,64,9/12/2019
4E6F5A,regulatory-product-approval-granted,100,81,9/12/2019
4E6F5A,regulatory-product-approval-granted,100,81,9/12/2019
50070E,conference-organizer,100,57,9/12/2019
50070E,conference-organizer,100,57,9/12/2019
50070E,conference-organizer,100,57,9/12/2019
5065B1,dividend-up,100,60,9/12/2019
520632,dividend,100,50,9/12/2019
523039,ipo-pricing,100,50,9/12/2019
52B567,business-contract,100,69,9/12/2019
52B567,legal-issues-defendant,100,22,9/12/2019
59872F,executive-appointment,100,54,9/12/2019
5D16CF,note-sale,100,52,9/12/2019
5D41E4,conference-participant,100,50,9/12/2019
5E6959,partnership,100,61,9/12/2019
5E6959,partnership,100,61,9/12/2019
5F9CE3,partnership,100,61,9/12/2019
629F0F,earnings,100,50,9/12/2019
62F41C,executive-resignation,100,44,9/12/2019
649CBD,legal-issues-defendant,100,22,9/12/2019
657097,unit-acquisition-acquirer,100,49,9/12/2019
66A667,earnings,100,50,9/12/2019
66A667,earnings,100,50,9/12/2019
68E3E0,note-sale,100,52,9/12/2019
6ABCB8,dividend,100,50,9/12/2019
6BF593,note-sale,100,52,9/12/2019
6C6D73,business-contract,100,69,9/12/2019
704B78,sponsorship,100,57,9/12/2019
713810,partnership,100,61,9/12/2019
7239BB,executive-appointment,100,54,9/12/2019
756045,conference-participant,100,50,9/12/2019
762B8D,conference-participant,100,50,9/12/2019
766047,dividend,100,50,9/12/2019
7710F3,partnership,100,61,9/12/2019
7771D7,executive-appointment,100,54,9/12/2019
7B8CB5,note-sale,100,52,9/12/2019
7BFF81,executive-appointment,100,54,9/12/2019
7CD98F,executive-resignation,100,44,9/12/2019
7E1D5D,conference-participant,100,50,9/12/2019
7FDE1C,business-contract,100,69,9/12/2019
7FEEE1,executive-appointment,100,54,9/12/2019
87B81A,note-sale,100,52,9/12/2019
87B81A,note-sale,100,52,9/12/2019
8B1F37,dividend,100,50,9/12/2019
8C6C1B,facility-open,100,65,9/12/2019
92D757,business-contract,100,69,9/12/2019
92D757,legal-issues-defendant,100,22,9/12/2019
93D207,acquisition-completed-acquirer,100,49,9/12/2019
943239,facility-open,100,65,9/12/2019
94637C,earnings,100,50,9/12/2019
95DC1F,earnings,100,50,9/12/2019
95DC1F,earnings,100,50,9/12/2019
95DC1F,earnings,100,50,9/12/2019
95DC1F,earnings,100,50,9/12/2019
95DC1F,earnings,100,50,9/12/2019
97644E,note-sale,100,52,9/12/2019
990AD0,dividend,100,50,9/12/2019
9CA432,note-sale,100,52,9/12/2019
9CA432,conference-participant,100,50,9/12/2019
9CDD72,name-change,100,49,9/12/2019
9E0811,public-offering,100,43,9/12/2019
A16DEA,market-entry,100,57,9/12/2019
A21649,dividend,100,50,9/12/2019
A43906,dividend,100,50,9/12/2019
A60354,conference-participant,100,50,9/12/2019
A63387,facility-open,100,65,9/12/2019
A666C8,executive-appointment,100,54,9/12/2019
A72AB6,donation,100,54,9/12/2019
A8E72A,clinical-trials,100,56,9/12/2019
AA1EAA,dividend,100,50,9/12/2019
AC7C4F,award,100,58,9/12/2019
ADD9DC,earnings,100,50,9/12/2019
AE3113,partnership,100,61,9/12/2019
AE79CD,executive-appointment,100,54,9/12/2019
AEBB80,dividend,100,50,9/12/2019
B0D41A,public-offering,100,43,9/12/2019
B1FC3B,business-contract,100,69,9/12/2019
B2DAF6,executive-appointment,100,54,9/12/2019
BB0787,partnership,100,61,9/12/2019
C037A8,earnings,100,50,9/12/2019
C0BA36,partnership,100,61,9/12/2019
C230FE,facility-open,100,65,9/12/2019
C2609A,business-contract,100,69,9/12/2019
C3DE7D,executive-appointment,100,54,9/12/2019
C425AE,conference-participant,100,50,9/12/2019
C5D2AE,executive-appointment,100,54,9/12/2019
C83B88,conference-call,100,50,9/12/2019
C9881C,conference-call,100,50,9/12/2019
CF6A5A,earnings,100,50,9/12/2019
D17C1B,revenue-volume,100,50,9/12/2019
D90F43,note-sale,100,52,9/12/2019
DBB28E,partnership,100,61,9/12/2019
DBCA3F,executive-appointment,100,54,9/12/2019
DD9E41,partnership,100,61,9/12/2019
E074A0,conference-participant,100,50,9/12/2019
E13782,note-sale,100,52,9/12/2019
E30B34,conference-participant,100,50,9/12/2019
E30B34,conference-participant,100,50,9/12/2019
E3E68E,business-contract,100,69,9/12/2019
E3E68E,business-contract,100,69,9/12/2019
E592F0,buybacks,100,74,9/12/2019
E866D2,executive-appointment,100,54,9/12/2019
E8846E,partnership,100,61,9/12/2019
E8846E,conference-organizer,100,57,9/12/2019
E94704,conference-participant,100,50,9/12/2019
EB1E1A,ipo-pricing,100,50,9/12/2019
EF5BED,executive-appointment,100,54,9/12/2019
EF77A3,conference-participant,100,50,9/12/2019
F57F6F,conference-organizer,100,57,9/12/2019
F6581D,public-offering,100,43,9/12/2019
F769E9,earnings,100,50,9/12/2019
FC1F9D,executive-appointment,100,54,9/12/2019
FDF28E,conference-participant,100,50,9/12/2019
FEE4B0,facility-open,100,65,9/12/2019
FF4BA4,partnership,100,61,9/12/2019
01D03F,business-contract,100,69,9/13/2019
09062E,note-sale,100,52,9/13/2019
0BD4E8,conference-participant,100,50,9/13/2019
0BD4E8,dividend,100,50,9/13/2019
12E454,partnership,100,61,9/13/2019
17EDA5,dividend,100,50,9/13/2019
1AE482,earnings,100,50,9/13/2019
1AE482,earnings,100,50,9/13/2019
1AE482,earnings,100,50,9/13/2019
1BC12C,business-contract,100,69,9/13/2019
1D943E,award,100,58,9/13/2019
1F9258,acquisition-acquirer,100,49,9/13/2019
1FE7F0,conference-participant,100,50,9/13/2019
2667B6,executive-appointment,100,54,9/13/2019
2EBA55,dividend,100,50,9/13/2019
2F960F,dividend,100,50,9/13/2019
3461CF,business-contract,100,69,9/13/2019
40B903,dividend,100,50,9/13/2019
4E7C1F,partnership,100,61,9/13/2019
4F9926,product-release,100,64,9/13/2019
4F9926,product-release,100,64,9/13/2019
50070E,conference-organizer,100,57,9/13/2019
5.43E+08,legal-issues-defendant,100,22,9/13/2019
54DF47,dividend,100,50,9/13/2019
56277A,conference-participant,100,50,9/13/2019
57DDB9,conference-participant,100,50,9/13/2019
5D63F1,dividend,100,50,9/13/2019
619882,dividend,100,50,9/13/2019
61B81B,conference-call,100,50,9/13/2019
6.52E+64,settlement,100,56,9/13/2019
657097,dividend,100,50,9/13/2019
68AB62,conference-call,100,50,9/13/2019
69CE71,legal-issues-defendant,100,22,9/13/2019
6BF593,dividend,100,50,9/13/2019
6D3B7B,dividend,100,50,9/13/2019
76F067,conference-participant,100,50,9/13/2019
7710F3,legal-issues-defendant,100,22,9/13/2019
79340A,embargo-lifted-issuer,100,56,9/13/2019
850779,acquisition-regulatory-approval-acquirer,100,54,9/13/2019
8B6E7E,conference-participant,100,50,9/13/2019
8C6C1B,facility-open,100,65,9/13/2019
8D4486,business-contract,100,69,9/13/2019
8FF2EF,earnings,100,50,9/13/2019
990AD0,conference-organizer,100,57,9/13/2019
9BB35A,acquisition-completed-acquirer,100,49,9/13/2019
9CA432,note-sale,100,52,9/13/2019
A403CF,note-sale,100,52,9/13/2019
A6FB29,note-sale,100,52,9/13/2019
A8CBDA,executive-appointment,100,54,9/13/2019
AAC8B6,executive-appointment,100,54,9/13/2019
AAC8B6,executive-appointment,100,54,9/13/2019
B762D3,dividend,100,50,9/13/2019
BD682F,dividend,100,50,9/13/2019
C2DD02,dividend,100,50,9/13/2019
CBBFBF,conference-participant,100,50,9/13/2019
CEDFD5,clinical-trials-suspended,100,24,9/13/2019
CFF97C,credit-rating-set-rater,20,50,9/13/2019
D3FA2C,dividend,100,50,9/13/2019
D69D42,dividend,100,50,9/13/2019
D6EAA3,note-sale,100,52,9/13/2019
D88EF3,conference-call,100,50,9/13/2019
DA0CB8,dividend,100,50,9/13/2019
DCD97F,executive-appointment,100,54,9/13/2019
E49AA3,facility-open,100,65,9/13/2019
E8846E,donation,100,54,9/13/2019
E8D221,earnings,100,50,9/13/2019
EA4E68,dividend,100,50,9/13/2019
F294DD,dividend,100,50,9/13/2019
F43A11,facility-open,100,65,9/13/2019
FDE409,conference-participant,100,50,9/13/2019
FDF28E,acquisition-completed-acquirer,100,49,9/13/2019
0157B1,partnership,100,61,9/14/2019
52B567,legal-issues-defendant,100,22,9/14/2019
69CE71,legal-issues-defendant,100,22,9/14/2019
4E7C1F,product-release,100,64,9/15/2019
5.43E+08,legal-issues-defendant,100,22,9/15/2019
73BCBA,partnership,100,61,9/15/2019
A753BB,ebitda-guidance-down,100,19,9/15/2019
ECD263,legal-issues-defendant,100,22,9/15/2019
EE6F1C,unit-acquisition-completed-acquiree,100,67,9/15/2019
01D03F,regulatory-product-approval-granted,100,81,9/16/2019
03542C,dividend,100,50,9/16/2019
03542C,executive-appointment,100,54,9/16/2019
03B8CF,legal-issues-defendant,100,22,9/16/2019
05D148,orphan-drug-designation,100,76,9/16/2019
0BD4E8,legal-issues-defendant,100,22,9/16/2019
0C466B,unit-acquisition-acquirer,100,49,9/16/2019
0CC01F,dividend,100,50,9/16/2019
0FDE97,executive-appointment,100,54,9/16/2019
105D00,executive-appointment,100,54,9/16/2019
1080C0,clinical-trials-start,100,64,9/16/2019
125212,clinical-trials-start,100,64,9/16/2019
136B26,executive-appointment,100,54,9/16/2019
138DDE,dividend,100,50,9/16/2019
139303,executive-appointment,100,54,9/16/2019
147C38,donation,100,54,9/16/2019
1490F3,partnership,100,61,9/16/2019
1490F3,partnership,100,61,9/16/2019
14BA06,executive-appointment,100,54,9/16/2019
154272,regulatory-product-application,100,69,9/16/2019
17EDA5,partnership,100,61,9/16/2019
1834C0,conference-participant,100,50,9/16/2019
184866,clinical-trials,100,56,9/16/2019
184866,clinical-trials,100,56,9/16/2019
1A2D9F,executive-appointment,100,54,9/16/2019
1C2593,executive-appointment,100,54,9/16/2019
1C599A,executive-appointment,100,54,9/16/2019
1E83DE,executive-appointment,100,54,9/16/2019
1E8A99,dividend,100,50,9/16/2019
1F19C8,credit-extension-provider,100,57,9/16/2019
1F716B,donation,100,54,9/16/2019
1F9258,public-offering,100,43,9/16/2019
227F04,partnership,100,61,9/16/2019
292A70,acquisition-acquirer,100,49,9/16/2019
2C7505,clinical-trials-start,100,64,9/16/2019
2CA60F,legal-issues-defendant,100,22,9/16/2019
2D2D43,earnings,100,50,9/16/2019
2EBC0B,facility-open,100,65,9/16/2019
301493,public-offering,100,43,9/16/2019
31553A,earnings,100,50,9/16/2019
31F25C,legal-issues-defendant,100,22,9/16/2019
3461CF,executive-appointment,100,54,9/16/2019
3461CF,business-contract,100,69,9/16/2019
372037,executive-appointment,100,54,9/16/2019
39692D,business-contract,100,69,9/16/2019
39692D,product-release,100,64,9/16/2019
3B37F7,executive-appointment,100,54,9/16/2019
408380,executive-appointment,100,54,9/16/2019
485445,facility-open,100,65,9/16/2019
485445,legal-issues-defendant,100,22,9/16/2019
49A344,business-contract,100,69,9/16/2019
4A3438,legal-issues-defendant,100,22,9/16/2019
4E7C1F,executive-appointment,100,54,9/16/2019
4FB770,partnership,100,61,9/16/2019
50070E,conference-organizer,100,57,9/16/2019
50070E,conference-organizer,100,57,9/16/2019
520632,partnership,100,61,9/16/2019
520632,executive-appointment,100,54,9/16/2019
520632,executive-appointment,100,54,9/16/2019
5.43E+08,legal-issues-defendant,100,22,9/16/2019
54F271,executive-appointment,100,54,9/16/2019
55C9B5,conference-organizer,100,57,9/16/2019
55C9B5,conference-organizer,100,57,9/16/2019
5675EB,dividend,100,50,9/16/2019
58B46F,conference-call,100,50,9/16/2019
58CA9A,earnings,100,50,9/16/2019
5C8D61,conference-participant,100,50,9/16/2019
5CC29D,conference-call,100,50,9/16/2019
5E9934,earnings,100,50,9/16/2019
662682,partnership,100,61,9/16/2019
66ECFD,earnings,100,50,9/16/2019
69CE71,legal-issues-defendant,100,22,9/16/2019
6B5379,acquisition-completed-acquirer,100,49,9/16/2019
6BDA0C,executive-appointment,100,54,9/16/2019
6CF43C,dividend,100,50,9/16/2019
6D2BF6,executive-appointment,100,54,9/16/2019
6E705B,business-contract,100,69,9/16/2019
73A213,conference-participant,100,50,9/16/2019
7710F3,legal-issues-defendant,100,22,9/16/2019
7710F3,legal-issues-defendant,100,22,9/16/2019
7710F3,legal-issues-defendant,100,22,9/16/2019
787D14,executive-appointment,100,54,9/16/2019
787D14,executive-appointment,100,54,9/16/2019
7999F3,conference-participant,100,50,9/16/2019
7ACD98,award,100,58,9/16/2019
7BC92D,acquisition-completed-acquirer,100,49,9/16/2019
7DD8CC,dividend,100,50,9/16/2019
7E0EB0,business-contract-terminated,100,31,9/16/2019
7F3665,executive-appointment,100,54,9/16/2019
80C400,executive-appointment,100,54,9/16/2019
826FD6,dividend,100,50,9/16/2019
82E58A,executive-appointment,100,54,9/16/2019
82F088,legal-issues-defendant,100,22,9/16/2019
82FD6D,award,100,58,9/16/2019
8BFAA4,executive-appointment,100,54,9/16/2019
8C6C1B,facility-open,100,65,9/16/2019
8DA42F,conference-participant,100,50,9/16/2019
911AB8,note-sale,100,52,9/16/2019
9196A2,dividend,100,50,9/16/2019
934CC3,legal-issues-defendant,100,22,9/16/2019
93D207,partnership,100,61,9/16/2019
940C3D,public-offering,100,43,9/16/2019
9548BB,executive-appointment,100,54,9/16/2019
967D92,dividend,100,50,9/16/2019
9.74E+08,executive-appointment,100,54,9/16/2019
97644E,conference-participant,100,50,9/16/2019
986AF6,earnings-guidance,100,50,9/16/2019
9B4066,note-sale,100,52,9/16/2019
9CA432,dividend,100,50,9/16/2019
9D56F2,conference-call,100,50,9/16/2019
9E0811,executive-appointment,100,54,9/16/2019
9FA83B,note-sale,100,52,9/16/2019
9FA83B,note-sale,100,52,9/16/2019
A398B9,business-contract,100,69,9/16/2019
A43906,business-contract,100,69,9/16/2019
A631A3,partnership,100,61,9/16/2019
A6828A,regulatory-product-application,100,69,9/16/2019
A6828A,regulatory-product-application,100,69,9/16/2019
A6FE1C,facility-close,100,47,9/16/2019
A72AB6,executive-appointment,100,54,9/16/2019
A7A0BD,merger,100,66,9/16/2019
ACC7D3,conference-participant,100,50,9/16/2019
B1B10C,award,100,58,9/16/2019
B3CB74,business-contract,100,69,9/16/2019
B46E12,dividend-up,100,60,9/16/2019
B5DE80,conference-call,100,50,9/16/2019
B7BDA3,business-contract,100,69,9/16/2019
B8F71F,earnings,100,50,9/16/2019
BA218A,legal-issues-defendant,100,22,9/16/2019
BFE02C,earnings,100,50,9/16/2019
C2E39B,product-release,100,64,9/16/2019
C2F597,conference-participant,100,50,9/16/2019
C3DE7D,product-release,100,64,9/16/2019
C98CDB,executive-appointment,100,54,9/16/2019
C99CC8,executive-appointment,100,54,9/16/2019
CBCC6A,conference-organizer,100,57,9/16/2019
CBCC6A,conference-organizer,100,57,9/16/2019
CBCC6A,conference-organizer,100,57,9/16/2019
CC8F6E,partnership,100,61,9/16/2019
CFF15D,stake-acquirer,100,48,9/16/2019
D0909F,resource-discovery,100,88,9/16/2019
D139BC,dividend,100,50,9/16/2019
D17F7E,note-sale,100,52,9/16/2019
D6489C,partnership,100,61,9/16/2019
D6489C,partnership,100,61,9/16/2019
D6489C,partnership,100,61,9/16/2019
D6489C,partnership,100,61,9/16/2019
D65A13,legal-issues-defendant,100,22,9/16/2019
D88EF3,executive-appointment,100,54,9/16/2019
D96202,conference-call,100,50,9/16/2019
DA199F,dividend,100,50,9/16/2019
DC5299,dividend,100,50,9/16/2019
DDB002,conference-participant,100,50,9/16/2019
E11C41,dividend,100,50,9/16/2019
E261E9,conference-participant,100,50,9/16/2019
E30B34,partnership,100,61,9/16/2019
E3656D,public-offering,100,43,9/16/2019
E68733,business-contract,100,69,9/16/2019
E68733,business-contract,100,69,9/16/2019
E70531,resource-discovery,100,88,9/16/2019
E802CE,legal-issues-dismissed-defendant,100,79,9/16/2019
E8846E,conference-organizer,100,57,9/16/2019
EB43F4,clinical-trials-positive,100,87,9/16/2019
EBC84C,unit-acquisition-acquirer,100,49,9/16/2019
EBC84C,acquisition-completed-acquirer,100,49,9/16/2019
ECA300,conference-participant,100,50,9/16/2019
ECD263,earnings,100,50,9/16/2019
ED7F13,dividend,100,50,9/16/2019
EDD234,reverse-stock-splits,100,51,9/16/2019
EF5BED,executive-appointment,100,54,9/16/2019
EF7163,dividend,100,50,9/16/2019
EFD406,partnership,100,61,9/16/2019
F47871,business-contract,100,69,9/16/2019
F47871,business-contract,100,69,9/16/2019
F47871,legal-issues-defendant,100,22,9/16/2019
F5D410,conference-participant,100,50,9/16/2019
F5D410,executive-appointment,100,54,9/16/2019
F769E9,executive-appointment,100,54,9/16/2019
F80389,dividend,100,50,9/16/2019
FAE021,partnership,100,61,9/16/2019
FC1736,revenues,100,50,9/16/2019
FC1736,revenues,100,50,9/16/2019
FD4588,conference-call,100,50,9/16/2019
FEC475,executive-resignation,100,44,9/16/2019
FEC475,regulatory-investigation,100,22,9/16/2019
FEE4B0,index-listing,100,76,9/16/2019
0157B1,partnership,100,61,9/17/2019
018C11,facility-open,100,65,9/17/2019
070B45,product-release,100,64,9/17/2019
0A0D9E,product-release,100,64,9/17/2019
0A748B,buybacks,100,74,9/17/2019
0B400D,legal-issues-defendant,100,22,9/17/2019
0B400D,legal-issues-defendant,100,22,9/17/2019
0B400D,legal-issues-defendant,100,22,9/17/2019
0BD4E8,legal-issues-defendant,100,22,9/17/2019
0E499E,patient-enrollment-complete,100,64,9/17/2019
0F0440,donation,100,54,9/17/2019
108A2B,dividend,100,50,9/17/2019
1151F4,partnership,100,61,9/17/2019
1151F4,partnership,100,61,9/17/2019
1201B5,conference-participant,100,50,9/17/2019
12DE76,partnership,100,61,9/17/2019
135B09,unit-acquisition-acquirer,100,49,9/17/2019
157D9F,product-release,100,64,9/17/2019
168A5D,partnership,100,61,9/17/2019
1AC649,public-offering,100,43,9/17/2019
1B6F77,clinical-trials,100,56,9/17/2019
1E04A5,campaign-ad-release,100,59,9/17/2019
1EBF8D,regulatory-product-approval-granted,100,81,9/17/2019
20BEEA,earnings-guidance,100,50,9/17/2019
21DED4,conference-call,100,50,9/17/2019
227F04,conference-participant,100,50,9/17/2019
228D42,business-contract,100,69,9/17/2019
228D42,partnership,100,61,9/17/2019
241AF7,conference-organizer,100,57,9/17/2019
2571FA,conference-participant,100,50,9/17/2019
267718,partnership,100,61,9/17/2019
297DA8,buybacks,100,74,9/17/2019
2CA60F,legal-issues-defendant,100,22,9/17/2019
2CC60C,dividend,100,50,9/17/2019
2F24A5,earnings,100,50,9/17/2019
3.14E+47,dividend,100,50,9/17/2019
31F25C,legal-issues-defendant,100,22,9/17/2019
31F25C,legal-issues-defendant,100,22,9/17/2019
32DCB3,patient-enrollment-complete,100,64,9/17/2019
32F943,legal-issues-defendant,100,22,9/17/2019
32F943,legal-issues-defendant,100,22,9/17/2019
33AD83,product-release,100,64,9/17/2019
33AD83,partnership,100,61,9/17/2019
3461CF,credit-rating-affirmation-rater,20,50,9/17/2019
367434,conference-participant,100,50,9/17/2019
3A94DF,unit-acquisition-acquirer,100,49,9/17/2019
3B50FE,earnings,100,50,9/17/2019
3B50FE,earnings,100,50,9/17/2019
3B50FE,earnings,100,50,9/17/2019
3B8484,note-sale,100,52,9/17/2019
3BB616,dividend,100,50,9/17/2019
3BB616,executive-appointment,100,54,9/17/2019
3BE00F,executive-appointment,100,54,9/17/2019
3C8A04,conference-call,100,50,9/17/2019
3D7971,business-contract,100,69,9/17/2019
3F4497,dividend,100,50,9/17/2019
416291,dividend,100,50,9/17/2019
420168,dividend,100,50,9/17/2019
449A26,acquisition-acquiree,100,76,9/17/2019
449A26,conference-call,100,50,9/17/2019
44ED36,note-sale,100,52,9/17/2019
4A6F00,partnership,100,61,9/17/2019
4A6F00,partnership,100,61,9/17/2019
4C6C63,product-release,100,64,9/17/2019
4E4E75,dividend,100,50,9/17/2019
4E6F5A,conference-participant,100,50,9/17/2019
50070E,conference-organizer,100,57,9/17/2019
50070E,conference-organizer,100,57,9/17/2019
523039,ipo-completed,100,76,9/17/2019
5.43E+08,legal-issues-defendant,100,22,9/17/2019
5.43E+08,legal-issues-defendant,100,22,9/17/2019
5.43E+08,legal-issues-defendant,100,22,9/17/2019
5.43E+08,legal-issues-defendant,100,22,9/17/2019
55C9B5,dividend,100,50,9/17/2019
56EA2B,business-contract,100,69,9/17/2019
596116,conference-participant,100,50,9/17/2019
5B97B2,dividend-guidance,100,50,9/17/2019
5C2A47,product-release,100,64,9/17/2019
5D16CF,note-sale,100,52,9/17/2019
6166D1,dividend,100,50,9/17/2019
6166D1,executive-appointment,100,54,9/17/2019
619882,dividend,100,50,9/17/2019
62CDDE,conference-participant,100,50,9/17/2019
649CBD,legal-issues-defendant,100,22,9/17/2019
66A667,acquisition-completed-acquirer,100,49,9/17/2019
66A667,acquisition-completed-acquirer,100,49,9/17/2019
66E04A,product-release,100,64,9/17/2019
67B052,executive-appointment,100,54,9/17/2019
6830FE,executive-appointment,100,54,9/17/2019
6844D2,earnings,100,50,9/17/2019
6844D2,earnings,100,50,9/17/2019
69CE71,legal-issues-defendant,100,22,9/17/2019
6A171E,conference-call,100,50,9/17/2019
6B236C,public-offering,100,43,9/17/2019
6B236C,public-offering,100,43,9/17/2019
6EA292,public-offering,100,43,9/17/2019
7032D0,executive-appointment,100,54,9/17/2019
719477,dividend,100,50,9/17/2019
722DE3,business-contract,100,69,9/17/2019
742AAB,partnership,100,61,9/17/2019
7710F3,legal-issues-defendant,100,22,9/17/2019
7710F3,legal-issues-defendant,100,22,9/17/2019
7710F3,legal-issues-defendant,100,22,9/17/2019
78F776,earnings,100,50,9/17/2019
78F9ED,facility-open,100,65,9/17/2019
790C34,product-release,100,64,9/17/2019
7A975D,earnings,100,50,9/17/2019
7B1E50,dividend,100,50,9/17/2019
7B9212,dividend,100,50,9/17/2019
7E1D5D,partnership,100,61,9/17/2019
805CD8,conference-participant,100,50,9/17/2019
810FAD,conference-participant,100,50,9/17/2019
834152,regulatory-product-approval-granted,100,81,9/17/2019
8377DB,dividend,100,50,9/17/2019
838ADD,conference-participant,100,50,9/17/2019
85AD00,dividend,100,50,9/17/2019
87B81A,index-listing,100,76,9/17/2019
8C6C1B,facility-open,100,65,9/17/2019
8D4486,award,100,58,9/17/2019
8E82A6,conference-participant,100,50,9/17/2019
900356,business-contract,100,69,9/17/2019
9087B9,conference-participant,100,50,9/17/2019
91C82E,conference-call,100,50,9/17/2019
92D757,legal-issues-defendant,100,22,9/17/2019
93D207,product-release,100,64,9/17/2019
93D207,product-release,100,64,9/17/2019
942633,dividend,100,50,9/17/2019
98CEBB,partnership,100,61,9/17/2019
98CEBB,partnership,100,61,9/17/2019
990AD0,unit-acquisition-acquiree,100,76,9/17/2019
9B5968,product-release,100,64,9/17/2019
9B5968,executive-appointment,100,54,9/17/2019
9BB35A,executive-appointment,100,54,9/17/2019
9E3224,dividend-up,100,81,9/17/2019
9E98F2,legal-issues-defendant,100,22,9/17/2019
9FB4B7,clinical-trials,100,56,9/17/2019
A4B899,partnership,100,61,9/17/2019
A5DD24,partnership,100,61,9/17/2019
A6213D,conference-call,100,50,9/17/2019
A70BF5,investment-investor,100,55,9/17/2019
A9ED24,dividend,100,50,9/17/2019
B04426,executive-appointment,100,54,9/17/2019
B09B1F,conference-participant,100,50,9/17/2019
B2D492,earnings,100,50,9/17/2019
B48D6A,conference-participant,100,50,9/17/2019
B4C673,partnership,100,61,9/17/2019
B54A74,executive-appointment,100,54,9/17/2019
B77F14,executive-appointment,100,54,9/17/2019
B840EF,executive-appointment,100,54,9/17/2019
B840EF,executive-appointment,100,54,9/17/2019
BFAEB4,conference-call,100,50,9/17/2019
C11C46,executive-appointment,100,54,9/17/2019
C3DE7D,product-release,100,64,9/17/2019
C3DE7D,product-release,100,64,9/17/2019
C9881C,revenue-up,100,69,9/17/2019
C9881C,revenue-up,100,69,9/17/2019
C9881C,revenue-up,100,69,9/17/2019
C99CC8,conference-participant,100,50,9/17/2019
CAB222,public-offering,100,43,9/17/2019
CAB222,note-sale,100,52,9/17/2019
CB89EA,executive-appointment,100,54,9/17/2019
CF3FF9,executive-resignation,100,44,9/17/2019
D25249,note-sale,100,52,9/17/2019
D25249,note-sale,100,52,9/17/2019
D296C6,dividend,100,50,9/17/2019
D2B9E5,facility-open,100,65,9/17/2019
D6489C,partnership,100,61,9/17/2019
D6489C,partnership,100,61,9/17/2019
D65A13,legal-issues-defendant,100,22,9/17/2019
D78BF1,award,100,58,9/17/2019
D8442A,reorganization-unit,100,53,9/17/2019
D8442A,legal-issues-defendant,100,22,9/17/2019
D88EF3,conference-participant,100,50,9/17/2019
D88EF3,executive-appointment,100,54,9/17/2019
D90F43,partnership,100,61,9/17/2019
DB9829,dividend,100,50,9/17/2019
DD1BA1,partnership,100,61,9/17/2019
DDEA6A,conference-participant,100,50,9/17/2019
E0339F,legal-issues-defendant,100,22,9/17/2019
E0339F,earnings,100,50,9/17/2019
E13782,executive-resignation,100,44,9/17/2019
E35610,executive-appointment,100,54,9/17/2019
E5D914,product-release,100,64,9/17/2019
E5D914,product-release,100,64,9/17/2019
E68733,product-release,100,64,9/17/2019
E68733,product-release,100,64,9/17/2019
E6EDED,conference-call,100,50,9/17/2019
EB1E1A,ipo-completed,100,76,9/17/2019
EF1AD9,business-contract,100,69,9/17/2019
EF77A3,earnings,100,50,9/17/2019
F0027C,patient-enrollment-complete,100,64,9/17/2019
F1529C,headquarters-change,100,50,9/17/2019
F3D2EB,dividend,100,50,9/17/2019
F3EDB4,business-contract,100,69,9/17/2019
F47871,legal-issues-defendant,100,22,9/17/2019
F5C78B,acquisition-acquirer,100,49,9/17/2019
F5C78B,acquisition-acquirer,100,49,9/17/2019
F5D410,partnership,100,61,9/17/2019
F5D499,conference-call,100,50,9/17/2019
F8BA6C,conference-participant,100,50,9/17/2019
FC9A88,acquisition-acquirer,100,49,9/17/2019
95294,legal-issues-defendant,100,22,9/18/2019
0A0CF0,dividend,100,50,9/18/2019
0B400D,legal-issues-defendant,100,22,9/18/2019
0B400D,legal-issues-defendant,100,22,9/18/2019
0B400D,legal-issues-defendant,100,22,9/18/2019
0B400D,legal-issues-defendant,100,22,9/18/2019
0B400D,legal-issues-defendant,100,22,9/18/2019
133644,ipo-pricing,100,50,9/18/2019
168A5D,sponsorship,100,57,9/18/2019
16F4D8,business-contract,100,69,9/18/2019
1.79E+10,conference-call,100,50,9/18/2019
18A98C,clinical-trials-start,100,64,9/18/2019
1AC649,public-offering,100,43,9/18/2019
1D9E55,merger-completed,100,66,9/18/2019
1E9A6D,executive-appointment,100,54,9/18/2019
1F19C8,credit-extension-provider,100,57,9/18/2019
1F43A1,dividend-up,100,81,9/18/2019
21153F,dividend,100,50,9/18/2019
21153F,dividend,100,50,9/18/2019
228D42,dividend-up,100,81,9/18/2019
238302,dividend,100,50,9/18/2019
2F7A7E,acquisition-completed-acquirer,100,49,9/18/2019
3.14E+47,earnings,100,50,9/18/2019
31F25C,legal-issues-defendant,100,22,9/18/2019
31F25C,legal-issues-defendant,100,22,9/18/2019
31F25C,legal-issues-defendant,100,22,9/18/2019
349DA4,conference-participant,100,50,9/18/2019
366A08,conference-organizer,100,57,9/18/2019
367434,executive-appointment,100,54,9/18/2019
36E479,conference-participant,100,50,9/18/2019
3B37F7,note-sale,100,52,9/18/2019
3DE4D1,executive-appointment,100,54,9/18/2019
47BA98,executive-resignation,100,44,9/18/2019
485445,conference-participant,100,50,9/18/2019
4.91E+58,executive-appointment,100,54,9/18/2019
4A6F00,partnership,100,61,9/18/2019
4C37C5,conference-call,100,50,9/18/2019
4D371E,earnings,100,50,9/18/2019
4E2D94,earnings-guidance,100,50,9/18/2019
50D1EC,note-sale,100,52,9/18/2019
519FE0,partnership,100,61,9/18/2019
520632,conference-call,100,50,9/18/2019
56EA2B,conference-call,100,50,9/18/2019
609208,earnings,100,50,9/18/2019
6166D1,conference-call,100,50,9/18/2019
622DBE,executive-appointment,100,54,9/18/2019
6284B5,partnership,100,61,9/18/2019
63E8D5,dividend,100,50,9/18/2019
6559D8,public-offering,100,43,9/18/2019
67303E,clinical-trials,100,56,9/18/2019
68BA15,headquarters-change,100,50,9/18/2019
69FDFC,business-contract,100,69,9/18/2019
6D3B7B,merger,100,66,9/18/2019
6D9B53,conference-participant,100,50,9/18/2019
6DBBBC,executive-appointment,100,54,9/18/2019
6F3FA8,executive-appointment,100,54,9/18/2019
6F6559,earnings,100,50,9/18/2019
7710F3,legal-issues-defendant,100,22,9/18/2019
775439,dividend-up,100,56,9/18/2019
791EC1,unit-acquisition-acquirer,100,49,9/18/2019
7ACBA4,dividend,100,50,9/18/2019
863350,facility-open,100,65,9/18/2019
8B3B0E,dividend,100,50,9/18/2019
8C6C1B,facility-open,100,65,9/18/2019
8D4486,facility-open,100,65,9/18/2019
8D4486,facility-open,100,65,9/18/2019
8D4486,facility-open,100,65,9/18/2019
8D4486,business-contract,100,69,9/18/2019
8DA42F,legal-issues-defendant,100,22,9/18/2019
911ACB,dividend,100,50,9/18/2019
91C82E,product-release,100,64,9/18/2019
92D757,legal-issues-defendant,100,22,9/18/2019
93633B,dividend,100,50,9/18/2019
9B5968,dividend,100,50,9/18/2019
9B5968,dividend,100,50,9/18/2019
9B71A7,earnings,100,50,9/18/2019
9BF177,conference-participant,100,50,9/18/2019
9CA619,earnings,100,50,9/18/2019
A01200,ipo-pricing,100,50,9/18/2019
A1BB98,conference-participant,100,50,9/18/2019
A247F5,partnership,100,61,9/18/2019
A403CF,note-sale,100,52,9/18/2019
A4386C,note-sale,100,52,9/18/2019
A5A4F5,executive-appointment,100,54,9/18/2019
A6828A,conference-call,100,50,9/18/2019
A6FB29,earnings-guidance-up,100,83,9/18/2019
AEEB76,ipo-pricing,100,50,9/18/2019
B0D41A,public-offering,100,43,9/18/2019
B381D8,executive-appointment,100,54,9/18/2019
B5BA39,partnership,100,61,9/18/2019
B5BA39,partnership,100,61,9/18/2019
B6082A,conference-call,100,50,9/18/2019
BCC13E,conference-participant,100,50,9/18/2019
C4452A,executive-appointment,100,54,9/18/2019
C72B8F,partnership,100,61,9/18/2019
C72B8F,partnership,100,61,9/18/2019
CAB222,public-offering,100,43,9/18/2019
CAB222,note-sale,100,52,9/18/2019
CDC217,conference-participant,100,50,9/18/2019
D06755,award,100,58,9/18/2019
D0DE27,dividend,100,50,9/18/2019
D17F7E,credit-extension-recipient,100,69,9/18/2019
D1AE3B,partnership,100,61,9/18/2019
D21D8A,dividend,100,50,9/18/2019
D60BB2,campaign-ad-release,100,59,9/18/2019
D6489C,product-release,100,64,9/18/2019
D6489C,partnership,100,61,9/18/2019
D88EF3,note-sale,100,52,9/18/2019
D88EF3,note-sale,100,52,9/18/2019
D9B1C9,executive-appointment,100,54,9/18/2019
DB23C8,unit-acquisition-acquiree,100,76,9/18/2019
DB5CA5,business-contract,100,69,9/18/2019
DB9829,partnership,100,61,9/18/2019
DDCB34,conference-participant,100,50,9/18/2019
E0F4E5,business-contract,100,69,9/18/2019
E0F4E5,business-contract,100,69,9/18/2019
E0F4E5,business-contract,100,69,9/18/2019
E0F4E5,business-contract,100,69,9/18/2019
E3656D,public-offering,100,43,9/18/2019
E4CE73,product-release,100,64,9/18/2019
E70531,partnership,100,61,9/18/2019
EAA0A7,product-release,100,64,9/18/2019
EC99D0,conference-call,100,50,9/18/2019
ED79D9,dividend,100,50,9/18/2019
F02170,partnership,100,61,9/18/2019
F58C23,conference-call,100,50,9/18/2019
F6FF0D,joint-venture,100,62,9/18/2019
F85CC0,dividend,100,50,9/18/2019
F85CC0,dividend,100,50,9/18/2019
F90EE5,executive-appointment,100,54,9/18/2019
00698D,dividend,100,50,9/19/2019
13528,fundraising,100,64,9/19/2019
31025,facility-open,100,65,9/19/2019
03CF95,note-sale,100,52,9/19/2019
03CF95,note-sale,100,52,9/19/2019
054B55,name-change,100,49,9/19/2019
054E7E,conference-participant,100,50,9/19/2019
0B400D,legal-issues-defendant,100,22,9/19/2019
0E499E,executive-appointment,100,54,9/19/2019
14391F,buybacks,100,74,9/19/2019
14BA33,dividend,100,50,9/19/2019
16FC89,dividend,100,50,9/19/2019
19BF16,conference-participant,100,50,9/19/2019
1C2593,executive-appointment,100,54,9/19/2019
202E5A,executive-appointment,100,54,9/19/2019
221AD7,business-contract,100,69,9/19/2019
221AD7,business-contract,100,69,9/19/2019
228D42,partnership,100,61,9/19/2019
24CB56,executive-resignation,100,44,9/19/2019
25DD05,conference-participant,100,50,9/19/2019
26E3BA,executive-appointment,100,54,9/19/2019
275300,dividend,100,50,9/19/2019
297DA8,executive-appointment,100,54,9/19/2019
2C681C,conference-participant,100,50,9/19/2019
2C681C,conference-participant,100,50,9/19/2019
2E902B,dividend,100,50,9/19/2019
2EBC0B,award,100,58,9/19/2019
2FEA66,dividend,100,50,9/19/2019
3.73E+87,executive-appointment,100,54,9/19/2019
37727A,dividend,100,50,9/19/2019
385DD4,business-contract,100,69,9/19/2019
387541,executive-appointment,100,54,9/19/2019
39D9DA,conference-call,100,50,9/19/2019
3B37F7,conference-organizer,100,57,9/19/2019
3C7F5F,legal-issues-defendant,100,22,9/19/2019
41ED98,stake-acquiree,100,62,9/19/2019
41ED98,stake-acquiree,100,62,9/19/2019
47752F,dividend,100,50,9/19/2019
4A2457,business-contract,100,69,9/19/2019
4A6F00,regulatory-product-approval-granted,100,81,9/19/2019
4A6F00,partnership,100,61,9/19/2019
4EE14A,business-contract,100,69,9/19/2019
4EE14A,business-contract,100,69,9/19/2019
4EE14A,business-contract,100,69,9/19/2019
4EE14A,business-contract,100,69,9/19/2019
4EEE7E,award,100,58,9/19/2019
514067,conference-participant,100,50,9/19/2019
51888A,business-contract-terminated,100,31,9/19/2019
52B567,legal-issues-defendant,100,22,9/19/2019
5.43E+08,legal-issues-defendant,100,22,9/19/2019
543900,executive-resignation,100,44,9/19/2019
545272,dividend,100,50,9/19/2019
56277A,business-contract,100,69,9/19/2019
5BC2F4,dividend,100,50,9/19/2019
5C7601,earnings,100,50,9/19/2019
5D1956,conference-participant,100,50,9/19/2019
5DD486,conference-call,100,50,9/19/2019
619882,conference-participant,100,50,9/19/2019
61BCA7,earnings,100,50,9/19/2019
633043,dividend,100,50,9/19/2019
66E3C0,conference-participant,100,50,9/19/2019
68586A,conference-participant,100,50,9/19/2019
69CE71,legal-issues-defendant,100,22,9/19/2019
6BC6F9,partnership,100,61,9/19/2019
6EA292,dividend,100,50,9/19/2019
6FCEF9,executive-appointment,100,54,9/19/2019
70CA28,facility-open,100,65,9/19/2019
75F982,partnership,100,61,9/19/2019
7710F3,legal-issues-defendant,100,22,9/19/2019
7AF907,conference-participant,100,50,9/19/2019
803FED,conference-participant,100,50,9/19/2019
8.10E+32,business-contract,100,69,9/19/2019
82F088,conference-participant,100,50,9/19/2019
83066C,conference-participant,100,50,9/19/2019
84AB66,dividend,100,50,9/19/2019
877734,conference-participant,100,50,9/19/2019
885758,legal-issues-defendant,100,22,9/19/2019
8B2C4A,dividend-up,100,81,9/19/2019
8C5519,earnings,100,50,9/19/2019
8C6C1B,facility-open,100,65,9/19/2019
8D5145,conference-participant,100,50,9/19/2019
8DA42F,legal-issues-defendant,100,22,9/19/2019
8FF2EF,executive-appointment,100,54,9/19/2019
92D757,legal-issues-defendant,100,22,9/19/2019
9.54E+32,dividend-up,100,58,9/19/2019
95DC1F,dividend,100,50,9/19/2019
977A1E,donation,100,54,9/19/2019
990AD0,conference-organizer,100,57,9/19/2019
9BBFA5,earnings,100,50,9/19/2019
9CA432,note-sale,100,52,9/19/2019
9DDE1B,note-sale,100,52,9/19/2019
A70BF5,earnings,100,50,9/19/2019
A8B137,partnership,100,61,9/19/2019
A94A7B,clinical-trials-start,100,64,9/19/2019
AB7726,sponsorship,100,57,9/19/2019
ADF092,partnership,100,61,9/19/2019
AE4EEB,dividend,100,50,9/19/2019
B05000,market-entry,100,57,9/19/2019
B2D799,legal-issues-defendant,100,22,9/19/2019
B614F8,product-release,100,64,9/19/2019
BA218A,legal-issues-defendant,100,22,9/19/2019
BDE867,unit-acquisition-completed-acquirer,100,49,9/19/2019
BDE867,unit-acquisition-completed-acquirer,100,49,9/19/2019
C05839,dividend,100,50,9/19/2019
C1114B,conference-participant,100,50,9/19/2019
C9739A,index-listing,100,76,9/19/2019
CE96E7,unit-acquisition-acquiree,100,76,9/19/2019
CF7292,executive-appointment,100,54,9/19/2019
CFF97C,credit-rating-set-rater,20,50,9/19/2019
D1CFC8,earnings,100,50,9/19/2019
D3CEDF,executive-appointment,100,54,9/19/2019
D54E62,supply-guidance-increase,100,74,9/19/2019
D598E7,conference-call,100,50,9/19/2019
D697DE,award,100,58,9/19/2019
D697DE,award,100,58,9/19/2019
D6EAA3,unit-acquisition-completed-acquirer,100,49,9/19/2019
D854F3,conference-call,100,50,9/19/2019
D93A25,executive-appointment,100,54,9/19/2019
DA0A9E,conference-call,100,50,9/19/2019
E09997,facility-close,100,47,9/19/2019
E592F0,product-release,100,64,9/19/2019
E754F0,executive-appointment,100,54,9/19/2019
E8B315,dividend,100,50,9/19/2019
ECDEB2,dividend,100,50,9/19/2019
F294DD,earnings,100,50,9/19/2019
F5D499,partnership,100,61,9/19/2019
F6DCE4,dividend,100,50,9/19/2019
F93C8A,public-offering,100,43,9/19/2019
FF6644,conference-call,100,50,9/19/2019
03CF95,partnership,100,61,9/20/2019
106394,acquisition-completed-acquirer,100,49,9/20/2019
119CB6,conference-call,100,50,9/20/2019
1279ED,conference-participant,100,50,9/20/2019
12DE76,dividend,100,50,9/20/2019
133644,ipo-completed,100,76,9/20/2019
205AD5,earnings,100,50,9/20/2019
251988,business-contract,100,69,9/20/2019
2667B6,partnership,100,61,9/20/2019
272472,buybacks,100,74,9/20/2019
297DA8,executive-appointment,100,54,9/20/2019
31F25C,legal-issues-defendant,100,22,9/20/2019
339F20,dividend,100,50,9/20/2019
33FD66,earnings,100,50,9/20/2019
36C09B,conference-participant,100,50,9/20/2019
3798B9,award,100,58,9/20/2019
38FB49,stock-splits,100,49,9/20/2019
3B37F7,conference-organizer,100,57,9/20/2019
3BE00F,dividend,100,50,9/20/2019
3F6A9C,donation,100,54,9/20/2019
3FACA7,earnings,100,50,9/20/2019
408089,earnings,100,50,9/20/2019
47752F,executive-appointment,100,54,9/20/2019
4C31F3,conference-participant,100,50,9/20/2019
4D8313,dividend,100,50,9/20/2019
53E575,conference-participant,100,50,9/20/2019
53F491,dividend,100,50,9/20/2019
57DDB9,conference-participant,100,50,9/20/2019
589803,regulatory-product-approval-granted,100,81,9/20/2019
589803,regulatory-product-approval-granted,100,81,9/20/2019
589803,regulatory-product-approval-granted,100,81,9/20/2019
589803,regulatory-product-approval-granted,100,81,9/20/2019
589803,regulatory-product-approval-granted,100,81,9/20/2019
589803,regulatory-product-approval-granted,100,81,9/20/2019
5AA3B1,business-contract,100,69,9/20/2019
5BC2F4,executive-appointment,100,54,9/20/2019
5DD48B,partnership,100,61,9/20/2019
5E6959,dividend,100,50,9/20/2019
6E705B,partnership,100,61,9/20/2019
6F30F9,dividend,100,50,9/20/2019
6FCEF9,dividend,100,50,9/20/2019
7999F3,dividend,100,50,9/20/2019
855DF7,acquisition-completed-acquirer,100,49,9/20/2019
85AD00,conference-call,100,50,9/20/2019
8817D5,conference-call,100,50,9/20/2019
8C6C1B,facility-open,100,65,9/20/2019
8DA42F,legal-issues-defendant,100,22,9/20/2019
8E4250,conference-call,100,50,9/20/2019
9043FE,note-sale,100,52,9/20/2019
9043FE,note-sale,100,52,9/20/2019
92005C,conference-participant,100,50,9/20/2019
9E91C6,private-placement,100,56,9/20/2019
A52B6B,acquisition-completed-acquirer,100,49,9/20/2019
B1FC3B,business-contract,100,69,9/20/2019
B1FC3B,earnings,100,50,9/20/2019
B4C673,business-contract,100,69,9/20/2019
B4C673,business-contract,100,69,9/20/2019
BDF85E,dividend-up,100,57,9/20/2019
C0BA36,index-listing,100,76,9/20/2019
C3DE7D,award,100,58,9/20/2019
C5F463,market-entry,100,57,9/20/2019
CC35BE,partnership,100,61,9/20/2019
CFF97C,credit-rating-affirmation-rater,20,50,9/20/2019
D11C1C,dividend,100,50,9/20/2019
D1C26F,partnership,100,61,9/20/2019
E1E093,regulatory-product-review-positive,100,73,9/20/2019
E1E093,regulatory-product-review-positive,100,73,9/20/2019
E1E093,regulatory-product-review-positive,100,73,9/20/2019
E1E093,regulatory-product-review-positive,100,73,9/20/2019
E22FDE,conference-participant,100,50,9/20/2019
E61888,dividend,100,50,9/20/2019
ECD263,legal-issues-defendant,100,22,9/20/2019
EF5BED,business-contract,100,69,9/20/2019
F4CDA3,dividend,100,50,9/20/2019
F748C7,dividend,100,50,9/20/2019
F82D37,conference-call,100,50,9/20/2019
FA35C6,executive-appointment,100,54,9/20/2019
FA40E2,dividend,100,50,9/20/2019
DB2E4E,business-contract,100,69,9/21/2019
03B8CF,legal-issues-defendant,100,22,9/22/2019
00067A,executive-appointment,100,54,9/23/2019
0157B1,market-entry,100,57,9/23/2019
036C6F,conference-participant,100,50,9/23/2019
03B8CF,partnership,100,61,9/23/2019
040DBB,dividend,100,50,9/23/2019
48590,product-release,100,64,9/23/2019
48781,executive-appointment,100,54,9/23/2019
06A456,executive-appointment,100,54,9/23/2019
06EE79,public-offering,100,43,9/23/2019
09F623,index-listing,100,76,9/23/2019
0BD4E8,executive-appointment,100,54,9/23/2019
0BD4E8,legal-issues-defendant,100,22,9/23/2019
0C136E,earnings,100,50,9/23/2019
0CC01F,award,100,58,9/23/2019
0E439E,earnings,100,50,9/23/2019
205AD5,executive-resignation,100,44,9/23/2019
21D903,partnership,100,61,9/23/2019
21DED4,dividend,100,50,9/23/2019
228D42,partnership,100,61,9/23/2019
28DCF3,acquisition-acquiree,100,76,9/23/2019
2CA60F,legal-issues-defendant,100,22,9/23/2019
2D643C,executive-appointment,100,54,9/23/2019
2DA92D,executive-appointment,100,54,9/23/2019
2F1299,partnership,100,61,9/23/2019
315EB0,executive-appointment,100,54,9/23/2019
34A959,legal-issues-defendant,100,22,9/23/2019
34B411,acquisition-acquirer,100,49,9/23/2019
34B97A,executive-appointment,100,54,9/23/2019
35557B,business-contract,100,69,9/23/2019
367434,executive-appointment,100,54,9/23/2019
371B0A,conference-participant,100,50,9/23/2019
39FB23,executive-appointment,100,54,9/23/2019
3B37F7,conference-organizer,100,57,9/23/2019
3B37F7,note-sale,100,52,9/23/2019
3B8484,acquisition-acquirer,100,49,9/23/2019
485445,legal-issues-defendant,100,22,9/23/2019
49A344,earnings,100,50,9/23/2019
4A3438,legal-issues-defendant,100,22,9/23/2019
4EE167,conference-participant,100,50,9/23/2019
4FCC78,conference-call,100,50,9/23/2019
507AE7,legal-issues-defendant,100,22,9/23/2019
52B567,legal-issues-defendant,100,22,9/23/2019
5.43E+08,legal-issues-defendant,100,22,9/23/2019
56277A,conference-call,100,50,9/23/2019
587D25,unit-acquisition-acquirer,100,49,9/23/2019
6166D1,business-contract,100,69,9/23/2019
6.52E+64,business-contract,100,69,9/23/2019
69CE71,legal-issues-defendant,100,22,9/23/2019
69CE71,legal-issues-defendant,100,22,9/23/2019
6CC55E,conference-call,100,50,9/23/2019
6D0CAB,facility-open,100,65,9/23/2019
6D3F35,product-release,100,64,9/23/2019
6D3F35,product-release,100,64,9/23/2019
6E8864,business-contract,100,69,9/23/2019
6E8864,business-contract,100,69,9/23/2019
704B78,conference-participant,100,50,9/23/2019
732449,executive-appointment,100,54,9/23/2019
73C521,earnings,100,50,9/23/2019
75768D,name-change,100,49,9/23/2019
763DBE,conference-participant,100,50,9/23/2019
7ACFD4,executive-appointment,100,54,9/23/2019
7B0BA6,business-contract,100,69,9/23/2019
817ED9,conference-participant,100,50,9/23/2019
819492,executive-appointment,100,54,9/23/2019
82F088,legal-issues-defendant,100,22,9/23/2019
834152,conference-participant,100,50,9/23/2019
850779,acquisition-completed-acquirer,100,49,9/23/2019
88193E,award,100,58,9/23/2019
890FF4,award,100,58,9/23/2019
8BAA15,partnership,100,61,9/23/2019
8C6C1B,facility-open,100,65,9/23/2019
8DCF18,conference-participant,100,50,9/23/2019
90D6A5,executive-appointment,100,54,9/23/2019
9196A2,executive-appointment,100,54,9/23/2019
92D9C9,dividend,100,50,9/23/2019
934CC3,legal-issues-defendant,100,22,9/23/2019
97644E,credit-extension-recipient,100,69,9/23/2019
98CAED,earnings,100,50,9/23/2019
99ACAD,unit-acquisition-acquirer,100,49,9/23/2019
9F03CF,unit-acquisition-acquirer,100,49,9/23/2019
A47A7D,executive-appointment,100,54,9/23/2019
A495F7,award,100,58,9/23/2019
A5195E,executive-appointment,100,54,9/23/2019
A70BF5,market-entry,100,57,9/23/2019
AB4A7E,conference-participant,100,50,9/23/2019
AC7C4F,award,100,58,9/23/2019
AD23DE,partnership,100,61,9/23/2019
AD375D,dividend,100,50,9/23/2019
AEEB76,ipo-completed,100,76,9/23/2019
AFDF2E,earnings-revision,100,29,9/23/2019
B76C82,credit-rating-set,100,51,9/23/2019
BA218A,legal-issues-defendant,100,22,9/23/2019
BDD12C,legal-issues-defendant,100,22,9/23/2019
BDE867,executive-appointment,100,54,9/23/2019
BE645B,clinical-trials,100,56,9/23/2019
C32A39,buybacks,100,74,9/23/2019
C3F99F,clinical-trials,100,56,9/23/2019
C4A432,dividend,100,50,9/23/2019
C5F463,unit-acquisition-acquiree,100,76,9/23/2019
C7863D,public-offering,100,43,9/23/2019
C7FC95,business-contract,100,69,9/23/2019
C83B88,product-release,100,64,9/23/2019
C8A248,unit-acquisition-acquirer,100,49,9/23/2019
CB7AB2,partnership,100,61,9/23/2019
CBB77B,shareholder-rights-plan-suspended,100,57,9/23/2019
CFD4B6,executive-appointment,100,54,9/23/2019
D07B07,conference-participant,100,50,9/23/2019
D5938F,sponsorship,100,57,9/23/2019
D6144F,conference-participant,100,50,9/23/2019
D65A13,legal-issues-defendant,100,22,9/23/2019
D77F7E,asset-sale,100,62,9/23/2019
D8442A,stock-loss,100,40,9/23/2019
D8442A,stock-loss,100,40,9/23/2019
D8ECA1,executive-appointment,100,54,9/23/2019
DA48E4,legal-issues-defendant,100,22,9/23/2019
DC0066,conference-participant,100,50,9/23/2019
DC5299,note-sale,100,52,9/23/2019
DE4924,conference-participant,100,50,9/23/2019
DE4924,conference-participant,100,50,9/23/2019
DF532D,trading-listing,100,61,9/23/2019
E2CB7B,executive-appointment,100,54,9/23/2019
E4CE73,product-release,100,64,9/23/2019
E6D89E,executive-appointment,100,54,9/23/2019
EB7FBF,conference-call,100,50,9/23/2019
F0027C,executive-appointment,100,54,9/23/2019
F11638,product-release,100,64,9/23/2019
F1529C,conference-call,100,50,9/23/2019
F1529C,conference-call,100,50,9/23/2019
F1CD47,executive-appointment,100,54,9/23/2019
F2E253,market-entry,100,57,9/23/2019
F47871,legal-issues-defendant,100,22,9/23/2019
F5D410,conference-call,100,50,9/23/2019
F5D499,earnings,100,50,9/23/2019
F5D499,earnings,100,50,9/23/2019
F5D499,earnings,100,50,9/23/2019
F7FCA4,conference-participant,100,50,9/23/2019
F82D37,executive-appointment,100,54,9/23/2019
FD0CA4,conference-participant,100,50,9/23/2019
01D03F,partnership,100,61,9/24/2019
036C6F,conference-call,100,50,9/24/2019
036C6F,conference-call,100,50,9/24/2019
0490C6,conference-participant,100,50,9/24/2019
55018,conference-call,100,50,9/24/2019
07C69F,dividend,100,50,9/24/2019
099C88,business-contract,100,69,9/24/2019
0A7650,dividend,100,50,9/24/2019
0B400D,legal-issues-defendant,100,22,9/24/2019
0B400D,legal-issues-defendant,100,22,9/24/2019
0B73A7,acquisition-completed-acquirer,100,49,9/24/2019
0B73A7,acquisition-completed-acquirer,100,49,9/24/2019
0B73A7,acquisition-completed-acquirer,100,49,9/24/2019
0B73A7,acquisition-completed-acquirer,100,49,9/24/2019
0CADBC,dividend,100,50,9/24/2019
0E499E,index-listing,100,76,9/24/2019
0EF1AF,note-sale,100,52,9/24/2019
0F0693,conference-participant,100,50,9/24/2019
15A388,market-entry,100,57,9/24/2019
1A3E1B,earnings,100,50,9/24/2019
1F08A6,note-sale,100,52,9/24/2019
1F9258,conference-participant,100,50,9/24/2019
21D903,earnings,100,50,9/24/2019
221783,executive-appointment,100,54,9/24/2019
228D42,partnership,100,61,9/24/2019
22C58E,executive-appointment,100,54,9/24/2019
251988,earnings,100,50,9/24/2019
267718,orphan-drug-designation,100,76,9/24/2019
267718,dividend,100,50,9/24/2019
26F99F,clinical-trials-complete,100,56,9/24/2019
28DCA8,award,100,58,9/24/2019
2920D5,earnings,100,50,9/24/2019
2D981A,patient-enrollment-complete,100,64,9/24/2019
2FDEE3,dividend,100,50,9/24/2019
31F25C,legal-issues-defendant,100,22,9/24/2019
32F24A,conference-call,100,50,9/24/2019
32F943,legal-issues-defendant,100,22,9/24/2019
3461CF,executive-appointment,100,54,9/24/2019
34A959,legal-issues-defendant,100,22,9/24/2019
34A959,legal-issues-defendant,100,22,9/24/2019
385DD4,business-contract,100,69,9/24/2019
39692D,fundraising,100,64,9/24/2019
3ACF46,conference-participant,100,50,9/24/2019
3B37F7,conference-organizer,100,57,9/24/2019
3B37F7,conference-organizer,100,57,9/24/2019
3BCF24,dividend,100,50,9/24/2019
3F4497,conference-call,100,50,9/24/2019
41EC04,partnership,100,61,9/24/2019
422CE3,facility-open,100,65,9/24/2019
43A060,regulatory-investigation,100,22,9/24/2019
44A4FC,business-contract,100,69,9/24/2019
44A4FC,business-contract,100,69,9/24/2019
44A4FC,business-contract,100,69,9/24/2019
49914B,conference-call,100,50,9/24/2019
49F4D0,dividend,100,50,9/24/2019
510EA6,earnings,100,50,9/24/2019
510EA6,earnings,100,50,9/24/2019
5.43E+08,legal-issues-defendant,100,22,9/24/2019
550D01,facility-open,100,65,9/24/2019
57DDB9,partnership,100,61,9/24/2019
5B6C11,facility-upgrade,100,65,9/24/2019
5BC2F4,earnings,100,50,9/24/2019
5D63F1,executive-appointment,100,54,9/24/2019
601785,earnings,100,50,9/24/2019
636BBF,product-release,100,64,9/24/2019
636BBF,product-release,100,64,9/24/2019
6474BA,earnings,100,50,9/24/2019
649CBD,legal-issues-defendant,100,22,9/24/2019
66E04A,facility-open,100,65,9/24/2019
68B03F,acquisition-acquirer,100,49,9/24/2019
68B03F,acquisition-acquirer,100,49,9/24/2019
68B03F,acquisition-acquirer,100,49,9/24/2019
6A3C35,dividend,100,50,9/24/2019
6D9ECA,partnership,100,61,9/24/2019
723548,dividend,100,50,9/24/2019
73BCBA,product-release,100,64,9/24/2019
7710F3,legal-issues-defendant,100,22,9/24/2019
7710F3,legal-issues-defendant,100,22,9/24/2019
789ADD,earnings,100,50,9/24/2019
7AF907,clinical-trials,100,56,9/24/2019
803FED,conference-participant,100,50,9/24/2019
817ED9,executive-appointment,100,54,9/24/2019
850779,earnings,100,50,9/24/2019
868808,dividend,100,50,9/24/2019
89F693,product-release,100,64,9/24/2019
8B6E7E,note-sale,100,52,9/24/2019
8C6C1B,facility-open,100,65,9/24/2019
8D4486,executive-appointment,100,54,9/24/2019
8D4486,executive-appointment,100,54,9/24/2019
8F3BCC,public-offering,100,43,9/24/2019
9004C4,government-contract,100,69,9/24/2019
92D757,legal-issues-defendant,100,22,9/24/2019
93AD2E,earnings,100,50,9/24/2019
93D207,market-entry,100,57,9/24/2019
94637C,regulatory-product-approval-granted,100,81,9/24/2019
98CEBB,business-contract,100,69,9/24/2019
9A602D,conference-call,100,50,9/24/2019
9CA619,dividend,100,50,9/24/2019
9D56F2,dividend,100,50,9/24/2019
9E98F2,partnership,100,61,9/24/2019
9F03CF,conference-call,100,50,9/24/2019
9F37C5,dividend,100,50,9/24/2019
9F5997,business-contract,100,69,9/24/2019
9F6B1A,earnings,100,50,9/24/2019
A16DEA,product-release,100,64,9/24/2019
A16DEA,product-release,100,64,9/24/2019
A16DEA,product-release,100,64,9/24/2019
A16DEA,product-release,100,64,9/24/2019
A1EAC8,note-sale,100,52,9/24/2019
A247F5,partnership,100,61,9/24/2019
A3800A,partnership,100,61,9/24/2019
A43906,conference-call,100,50,9/24/2019
A47F2E,earnings,100,50,9/24/2019
A4CD53,executive-appointment,100,54,9/24/2019
A5195E,conference-participant,100,50,9/24/2019
A6213D,earnings,100,50,9/24/2019
A6828A,product-release,100,64,9/24/2019
A7F0A5,partnership,100,61,9/24/2019
A7F0A5,partnership,100,61,9/24/2019
A87CD6,conference-participant,100,50,9/24/2019
A8B137,conference-call,100,50,9/24/2019
AA7FE0,earnings,100,50,9/24/2019
AA7FE0,earnings,100,50,9/24/2019
AA7FE0,earnings,100,50,9/24/2019
AA7FE0,earnings,100,50,9/24/2019
AA7FE0,earnings,100,50,9/24/2019
AA98ED,conference-call,100,50,9/24/2019
AC7C4F,earnings,100,50,9/24/2019
ACDF88,partnership,100,61,9/24/2019
AEBB80,conference-participant,100,50,9/24/2019
AFF43F,executive-appointment,100,54,9/24/2019
B1FC3B,earnings,100,50,9/24/2019
B1FC3B,dividend,100,50,9/24/2019
B37FB4,earnings,100,50,9/24/2019
B72BE9,product-release,100,64,9/24/2019
B8DD94,asset-sale,100,62,9/24/2019
BB02FB,product-release,100,64,9/24/2019
BB02FB,product-release,100,64,9/24/2019
BFAEB4,earnings,100,50,9/24/2019
C188F8,note-sale,100,52,9/24/2019
C27E19,earnings,100,50,9/24/2019
CBDB4D,partnership,100,61,9/24/2019
CDD75E,conference-participant,100,50,9/24/2019
CF7292,conference-participant,100,50,9/24/2019
CFF15D,partnership,100,61,9/24/2019
D04D9F,partnership,100,61,9/24/2019
D04D9F,partnership,100,61,9/24/2019
D11C1C,acquisition-acquirer,100,49,9/24/2019
D2C0B6,shareholder-rights-plan,100,43,9/24/2019
D64C6D,earnings,100,50,9/24/2019
D6853F,executive-resignation,100,44,9/24/2019
D75910,dividend,100,50,9/24/2019
DBB28E,product-release,100,64,9/24/2019
DBCA3F,credit-extension-provider,100,57,9/24/2019
E0339F,legal-issues-defendant,100,22,9/24/2019
E12A6E,public-offering,100,43,9/24/2019
E4CE73,product-release,100,64,9/24/2019
E6D89E,partnership,100,61,9/24/2019
E7BF32,business-contract,100,69,9/24/2019
E7BF32,business-contract,100,69,9/24/2019
E7BF32,business-contract,100,69,9/24/2019
EC8116,dividend,100,50,9/24/2019
EC99D0,product-release,100,64,9/24/2019
ECF709,same-store-sales-up,100,53,9/24/2019
ECF709,same-store-sales-up,100,62,9/24/2019
ECF709,same-store-sales-up,100,62,9/24/2019
F5D410,investment-investor,100,55,9/24/2019
F702CA,partnership,100,61,9/24/2019
FC9A88,dividend,100,50,9/24/2019
FDC08C,ipo,100,71,9/24/2019
FE7A63,earnings,100,50,9/24/2019
0157B1,product-release,100,64,9/25/2019
0157B1,product-release,100,64,9/25/2019
0157B1,product-release,100,64,9/25/2019
0157B1,product-release,100,64,9/25/2019
01D03F,partnership,100,61,9/25/2019
01D03F,partnership,100,61,9/25/2019
02870F,award,100,58,9/25/2019
02FC1A,conference-participant,100,50,9/25/2019
033B58,hirings,100,65,9/25/2019
0358AF,dividend,100,50,9/25/2019
03F5A4,dividend,100,50,9/25/2019
03FAA6,partnership,100,61,9/25/2019
05AF14,earnings,100,50,9/25/2019
05AF14,dividend,100,50,9/25/2019
07EC43,executive-appointment,100,54,9/25/2019
0A1D77,executive-appointment,100,54,9/25/2019
0A59F8,partnership,100,61,9/25/2019
0AB700,dividend,100,50,9/25/2019
0E2992,conference-call,100,50,9/25/2019
0F04E5,executive-resignation,100,44,9/25/2019
12DE76,partnership,100,61,9/25/2019
14BA06,earnings,100,50,9/25/2019
16C7F0,conference-call,100,50,9/25/2019
1880C5,conference-participant,100,50,9/25/2019
1CD09C,conference-participant,100,50,9/25/2019
1D1B07,executive-appointment,100,54,9/25/2019
1D1B07,executive-appointment,100,54,9/25/2019
2082EA,conference-participant,100,50,9/25/2019
24C48B,partnership,100,61,9/25/2019
24FA23,conference-participant,100,50,9/25/2019
25102A,conference-call,100,50,9/25/2019
25AB8E,partnership,100,61,9/25/2019
2.90E+62,business-contract,100,69,9/25/2019
2B7A40,partnership,100,61,9/25/2019
2B8179,conference-participant,100,50,9/25/2019
2BA977,merger-failed,100,21,9/25/2019
2BA977,merger-failed,100,21,9/25/2019
2BA977,merger-failed,100,21,9/25/2019
2BA977,legal-issues-defendant,100,22,9/25/2019
2BF36E,executive-appointment,100,54,9/25/2019
2E61CC,award,100,58,9/25/2019
2F7474,dividend-up,100,81,9/25/2019
2F7A7E,conference-call,100,50,9/25/2019
3159AA,facility-open,100,65,9/25/2019
32F943,earnings,100,50,9/25/2019
3461CF,award,100,58,9/25/2019
34A959,legal-issues-defendant,100,22,9/25/2019
34A959,legal-issues-defendant,100,22,9/25/2019
3B20AB,partnership,100,61,9/25/2019
3B9886,executive-appointment,100,54,9/25/2019
3C11C4,note-sale,100,52,9/25/2019
3C11C4,note-sale,100,52,9/25/2019
3CCC90,conference-call,100,50,9/25/2019
4B49CF,earnings,100,50,9/25/2019
4B49CF,earnings,100,50,9/25/2019
4B49CF,earnings,100,50,9/25/2019
4B49CF,earnings,100,50,9/25/2019
4B49CF,earnings,100,50,9/25/2019
4C3FE9,conference-participant,100,50,9/25/2019
4C6C63,partnership,100,61,9/25/2019
4F9487,dividend,100,50,9/25/2019
51888A,unit-acquisition-acquirer,100,49,9/25/2019
520632,legal-verdict-favored,100,78,9/25/2019
52D936,public-offering,100,43,9/25/2019
52D936,public-offering,100,43,9/25/2019
543900,dividend,100,50,9/25/2019
54DF47,public-offering,100,43,9/25/2019
55438C,business-contract,100,69,9/25/2019
55438C,earnings,100,50,9/25/2019
55438C,conference-call,100,50,9/25/2019
55C9B5,business-contract,100,69,9/25/2019
616E3B,conference-call,100,50,9/25/2019
622DBE,legal-issues-defendant,100,22,9/25/2019
6284B5,facility-open,100,65,9/25/2019
64E346,executive-appointment,100,54,9/25/2019
6559D8,conference-participant,100,50,9/25/2019
66E04A,market-entry,100,57,9/25/2019
6CC55E,clinical-trials-start,100,64,9/25/2019
71B0CF,executive-appointment,100,54,9/25/2019
72FCA3,earnings,100,50,9/25/2019
72FCA3,earnings,100,50,9/25/2019
72FCA3,earnings,100,50,9/25/2019
72FCA3,earnings,100,50,9/25/2019
787D14,conference-participant,100,50,9/25/2019
7C62A3,note-sale,100,52,9/25/2019
7C62A3,note-sale,100,52,9/25/2019
7E1D5D,partnership,100,61,9/25/2019
8303CD,partnership,100,61,9/25/2019
83B1C8,conference-participant,100,50,9/25/2019
83E0AC,dividend,100,50,9/25/2019
85CDC9,conference-participant,100,50,9/25/2019
86478F,award,100,58,9/25/2019
8665BA,note-sale,100,52,9/25/2019
88193E,product-release,100,64,9/25/2019
8B8656,partnership,100,61,9/25/2019
8C6C1B,facility-open,100,65,9/25/2019
8C84DF,earnings,100,50,9/25/2019
8D4486,unit-acquisition-acquiree,100,76,9/25/2019
8E10BF,public-offering,100,43,9/25/2019
8E93A4,executive-appointment,100,54,9/25/2019
8F3BCC,public-offering,100,43,9/25/2019
9043FE,note-sale,100,52,9/25/2019
9043FE,note-sale,100,52,9/25/2019
907ED2,dividend-up,100,81,9/25/2019
925759,award,100,58,9/25/2019
92D9C9,asset-sale,100,62,9/25/2019
92D9C9,acquisition-regulatory-approval-acquirer,100,54,9/25/2019
9.31E+77,conference-participant,100,50,9/25/2019
934CC3,legal-issues-defendant,100,22,9/25/2019
949D62,campaign-ad-release,100,59,9/25/2019
95DC1F,facility-open,100,65,9/25/2019
97B027,conference-participant,100,50,9/25/2019
9.86E+03,conference-participant,100,50,9/25/2019
990AD0,patent-awarded,100,72,9/25/2019
9E575E,conference-participant,100,50,9/25/2019
A1A317,grant-recipient,100,63,9/25/2019
A63387,partnership,100,61,9/25/2019
A6828A,product-release,100,64,9/25/2019
AC7C4F,business-contract,100,69,9/25/2019
ADF1B0,executive-appointment,100,54,9/25/2019
AE79CD,conference-participant,100,50,9/25/2019
AED6CF,investment-investor,100,55,9/25/2019
B66928,conference-participant,100,50,9/25/2019
B7202A,conference-participant,100,50,9/25/2019
BA218A,dividend,100,50,9/25/2019
BB02FB,product-release,100,64,9/25/2019
BD15E8,partnership,100,61,9/25/2019
C188F8,note-sale,100,52,9/25/2019
C32A39,donation,100,54,9/25/2019
C58D71,conference-participant,100,50,9/25/2019
C81E00,clinical-trials,100,56,9/25/2019
C81E00,conference-call,100,50,9/25/2019
C81E00,conference-call,100,50,9/25/2019
C8257F,executive-appointment,100,54,9/25/2019
C8257F,executive-appointment,100,54,9/25/2019
C85A72,conference-participant,100,50,9/25/2019
C8A248,executive-appointment,100,54,9/25/2019
C8FAC7,ipo-pricing,100,50,9/25/2019
CA1620,merger-failed,100,21,9/25/2019
CA1620,merger-failed,100,21,9/25/2019
CA1620,merger-failed,100,21,9/25/2019
CB22CD,conference-participant,100,50,9/25/2019
CBDB4D,partnership,100,61,9/25/2019
CE5C6E,conference-participant,100,50,9/25/2019
CFB6CA,executive-appointment,100,54,9/25/2019
CFF97C,partnership,100,61,9/25/2019
D4463B,dividend,100,50,9/25/2019
D4AC65,partnership,100,61,9/25/2019
D54E62,award,100,58,9/25/2019
D93A25,conference-call,100,50,9/25/2019
DA199F,board-meeting,100,51,9/25/2019
DBB28E,acquisition-completed-acquirer,100,49,9/25/2019
DC486E,earnings,100,50,9/25/2019
DC486E,earnings,100,50,9/25/2019
DD0099,earnings,100,50,9/25/2019
DF11D9,conference-call,100,50,9/25/2019
E0207A,unit-acquisition-acquirer,100,49,9/25/2019
E12A6E,public-offering,100,43,9/25/2019
E38906,conference-participant,100,50,9/25/2019
E4CE73,partnership,100,61,9/25/2019
E8846E,donation,100,54,9/25/2019
E99180,dividend,100,50,9/25/2019
E9C7C0,partnership,100,61,9/25/2019
EAA0A7,product-release,100,64,9/25/2019
EEA734,conference-participant,100,50,9/25/2019
EF1AD9,conference-call,100,50,9/25/2019
F1EB39,executive-appointment,100,54,9/25/2019
F3816D,conference-participant,100,50,9/25/2019
F3EDB4,dividend,100,50,9/25/2019
F3EDB4,earnings,100,50,9/25/2019
F3EDB4,earnings,100,50,9/25/2019
F3EDB4,earnings,100,50,9/25/2019
F58C23,conference-participant,100,50,9/25/2019
F80389,conference-call,100,50,9/25/2019
F83279,dividend-up,100,81,9/25/2019
FDD3FC,conference-participant,100,50,9/25/2019
FF4BA4,earnings,100,50,9/25/2019
FF6644,product-release,100,64,9/25/2019
002A99,clinical-trials-start,100,64,9/26/2019
01478A,conference-call,100,50,9/26/2019
0157B1,legal-issues-defendant,100,22,9/26/2019
02ACBD,product-release,100,64,9/26/2019
06EE79,public-offering,100,43,9/26/2019
0B73A7,earnings,100,50,9/26/2019
0B73A7,earnings,100,50,9/26/2019
0BC17A,conference-call,100,50,9/26/2019
0F65C9,conference-call,100,50,9/26/2019
1151F4,conference-call,100,50,9/26/2019
1201B5,revenue-up,100,91,9/26/2019
1201B5,revenue-up,100,91,9/26/2019
1201B5,revenue-up,100,91,9/26/2019
131443,partnership,100,61,9/26/2019
131443,partnership,100,61,9/26/2019
184866,conference-participant,100,50,9/26/2019
1A9DE1,dividend,100,50,9/26/2019
1E7785,note-sale,100,52,9/26/2019
1F9258,conference-participant,100,50,9/26/2019
238302,executive-appointment,100,54,9/26/2019
251988,dividend,100,50,9/26/2019
25D3CE,conference-participant,100,50,9/26/2019
27C10F,executive-appointment,100,54,9/26/2019
28F905,partnership,100,61,9/26/2019
2B7A40,business-contract,100,69,9/26/2019
2BA977,legal-issues-defendant,100,22,9/26/2019
2D981A,conference-participant,100,50,9/26/2019
2E36AD,conference-participant,100,50,9/26/2019
2EB88B,executive-resignation,100,44,9/26/2019
2F6782,unit-acquisition-acquiree,100,76,9/26/2019
2F7474,conference-call,100,50,9/26/2019
3471C0,partnership,100,61,9/26/2019
36E479,conference-participant,100,50,9/26/2019
384CD3,earnings,100,50,9/26/2019
39FB23,regulatory-investigation-completed,100,50,9/26/2019
3B37F7,conference-organizer,100,57,9/26/2019
3B37F7,conference-organizer,100,57,9/26/2019
3B37F7,conference-organizer,100,57,9/26/2019
3B8484,note-sale,100,52,9/26/2019
3BA1BF,executive-appointment,100,54,9/26/2019
3F1C69,conference-participant,100,50,9/26/2019
43A74A,business-contract,100,69,9/26/2019
453282,conference-call,100,50,9/26/2019
48F795,product-release,100,64,9/26/2019
49BBBC,earnings,100,50,9/26/2019
4A6F00,partnership,100,61,9/26/2019
4B5054,conference-call,100,50,9/26/2019
4BDCA7,conference-participant,100,50,9/26/2019
4C2F17,government-contract,100,69,9/26/2019
4C3FE9,conference-call,100,50,9/26/2019
4C6C63,product-release,100,64,9/26/2019
504FE2,conference-call,100,50,9/26/2019
539F49,conference-participant,100,50,9/26/2019
54DF47,public-offering,100,43,9/26/2019
55C9B5,partnership,100,61,9/26/2019
567F3D,conference-call,100,50,9/26/2019
587D25,partnership,100,61,9/26/2019
5CC29D,dividend,100,50,9/26/2019
5F2FF7,earnings,100,50,9/26/2019
5F3D91,conference-participant,100,50,9/26/2019
60FE03,conference-participant,100,50,9/26/2019
6166D1,investment-investor,100,55,9/26/2019
622DBE,legal-issues-defendant,100,22,9/26/2019
6559D8,executive-appointment,100,54,9/26/2019
67B052,conference-participant,100,50,9/26/2019
68E3E0,public-offering,100,43,9/26/2019
6B494E,public-offering,100,43,9/26/2019
6C6D73,executive-appointment,100,54,9/26/2019
6-Dec-05,public-offering,100,43,9/26/2019
701531,conference-participant,100,50,9/26/2019
71B0CF,partnership,100,61,9/26/2019
728737,public-offering,100,43,9/26/2019
7.44E+09,note-sale,100,52,9/26/2019
75F665,executive-appointment,100,54,9/26/2019
766047,executive-appointment,100,54,9/26/2019
7AB859,business-contract,100,69,9/26/2019
7ADE57,dividend,100,50,9/26/2019
7D5FD6,earnings,100,50,9/26/2019
7DC1C4,executive-appointment,100,54,9/26/2019
7E0EB0,executive-appointment,100,54,9/26/2019
7E1D5D,partnership,100,61,9/26/2019
7E1D5D,partnership,100,61,9/26/2019
7FEEE1,conference-participant,100,50,9/26/2019
819492,conference-participant,100,50,9/26/2019
885758,partnership,100,61,9/26/2019
89F693,award,100,58,9/26/2019
8B9B3B,clinical-trials-filed,100,60,9/26/2019
8BE916,earnings,100,50,9/26/2019
8BFAA4,executive-resignation,100,44,9/26/2019
8C6C1B,facility-open,100,65,9/26/2019
8CF6DD,conference-call,100,50,9/26/2019
8D0EEA,product-release,100,64,9/26/2019
8D0EEA,product-release,100,64,9/26/2019
8DBBE6,note-sale,100,52,9/26/2019
8DBBE6,note-sale,100,52,9/26/2019
8E10BF,public-offering,100,43,9/26/2019
8EF425,dividend,100,50,9/26/2019
903AB4,executive-resignation,100,44,9/26/2019
91E5EE,conference-participant,100,50,9/26/2019
92B047,conference-call,100,50,9/26/2019
92B625,conference-participant,100,50,9/26/2019
92D3A0,conference-call,100,50,9/26/2019
94756D,earnings,100,50,9/26/2019
95C392,award,100,58,9/26/2019
967D92,conference-call,100,50,9/26/2019
96F126,dividend,100,50,9/26/2019
9D3360,conference-call,100,50,9/26/2019
9D6A24,conference-call,100,50,9/26/2019
9F6B1A,business-contract,100,69,9/26/2019
9FB4B7,conference-participant,100,50,9/26/2019
A01200,business-contract,100,69,9/26/2019
A072C4,conference-participant,100,50,9/26/2019
A26C26,dividend,100,50,9/26/2019
A26EF7,conference-participant,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A5A4F5,earnings,100,50,9/26/2019
A6FC89,executive-appointment,100,54,9/26/2019
ABB493,conference-participant,100,50,9/26/2019
AD9F1D,facility-open,100,65,9/26/2019
ADD9DC,facility-open,100,65,9/26/2019
B290A2,conference-participant,100,50,9/26/2019
B6843B,ipo-pricing,100,50,9/26/2019
B9764A,legal-issues-defendant,100,22,9/26/2019
BE645B,conference-participant,100,50,9/26/2019
BEB756,executive-appointment,100,54,9/26/2019
C11C46,executive-appointment,100,54,9/26/2019
C2E120,dividend,100,50,9/26/2019
C74887,conference-participant,100,50,9/26/2019
C7863D,public-offering,100,43,9/26/2019
C9B932,index-listing,100,76,9/26/2019
C9E107,earnings,100,50,9/26/2019
CAC8D0,earnings,100,50,9/26/2019
CFF15D,partnership,100,61,9/26/2019
D15833,dividend,100,50,9/26/2019
D1C26F,conference-participant,100,50,9/26/2019
D7AC6E,conference-call,100,50,9/26/2019
D8F347,executive-resignation,100,44,9/26/2019
D90F43,partnership,100,61,9/26/2019
D90F43,partnership,100,61,9/26/2019
D9E036,product-release,100,64,9/26/2019
DA199F,earnings,100,50,9/26/2019
DA199F,dividend,100,50,9/26/2019
DA9443,conference-participant,100,50,9/26/2019
DD0F15,conference-participant,100,50,9/26/2019
E0207A,business-contract,100,69,9/26/2019
E13782,business-contract,100,69,9/26/2019
E30B34,award,100,58,9/26/2019
E4CE73,partnership,100,61,9/26/2019
E68733,clinical-trials,100,56,9/26/2019
E68733,clinical-trials,100,56,9/26/2019
E70531,asset-sale,100,62,9/26/2019
E70531,donation,100,54,9/26/2019
E7BF32,conference-call,100,50,9/26/2019
E7BF32,conference-call,100,50,9/26/2019
E8846E,earnings,100,50,9/26/2019
E8B21D,dividend,100,50,9/26/2019
E8C557,conference-participant,100,50,9/26/2019
E8E899,earnings,100,50,9/26/2019
E959F3,earnings,100,50,9/26/2019
EB6965,executive-appointment,100,54,9/26/2019
EEB5F9,conference-participant,100,50,9/26/2019
F209B4,conference-participant,100,50,9/26/2019
F30508,product-release,100,64,9/26/2019
F5349B,executive-appointment,100,54,9/26/2019
F58C23,earnings,100,50,9/26/2019
F58C23,earnings,100,50,9/26/2019
F5D410,business-contract,100,69,9/26/2019
F5D410,business-contract,100,69,9/26/2019
F5D499,executive-appointment,100,54,9/26/2019
F6E1B5,conference-participant,100,50,9/26/2019
F80389,facility-sale,100,52,9/26/2019
F80389,facility-sale,100,52,9/26/2019
F88147,conference-participant,100,50,9/26/2019
FA40E2,earnings,100,50,9/26/2019
FA40E2,earnings,100,50,9/26/2019
FA40E2,earnings,100,50,9/26/2019
FA40E2,earnings,100,50,9/26/2019
FA40E2,earnings,100,50,9/26/2019
FA40E2,earnings,100,50,9/26/2019
FAAFA2,executive-appointment,100,54,9/26/2019
FDF799,patent-infringement-plaintiff,100,47,9/26/2019
01D03F,clinical-trials,100,56,9/27/2019
01D03F,regulatory-product-approval-granted,100,81,9/27/2019
01D03F,regulatory-product-approval-granted,100,81,9/27/2019
48590,partnership,100,61,9/27/2019
48781,executive-appointment,100,54,9/27/2019
07C69F,conference-call,100,50,9/27/2019
0B57D7,facility-open,100,65,9/27/2019
10943B,conference-call,100,50,9/27/2019
10C19B,conference-call,100,50,9/27/2019
267718,clinical-trials-positive,100,87,9/27/2019
267718,executive-resignation,100,44,9/27/2019
2A1009,grant-recipient,100,63,9/27/2019
2C35B5,conference-participant,100,50,9/27/2019
2EB04E,earnings,100,50,9/27/2019
36529A,patent-awarded,100,72,9/27/2019
3D9999,earnings,100,50,9/27/2019
4.91E+58,fundraising,100,64,9/27/2019
4C7DB5,earnings,100,50,9/27/2019
4D8313,partnership,100,61,9/27/2019
50070E,acquisition-completed-acquirer,100,49,9/27/2019
50070E,business-contract,100,69,9/27/2019
52BF94,executive-appointment,100,54,9/27/2019
5AF08A,earnings,100,50,9/27/2019
5E6959,conference-call,100,50,9/27/2019
61A586,executive-appointment,100,54,9/27/2019
657097,business-contract,100,69,9/27/2019
665D7D,regulatory-product-approval-granted,100,81,9/27/2019
665D7D,regulatory-product-approval-granted,100,81,9/27/2019
66A667,dividend,100,50,9/27/2019
66A667,dividend,100,50,9/27/2019
67303E,executive-appointment,100,54,9/27/2019
6925EB,conference-participant,100,50,9/27/2019
6A171E,conference-participant,100,50,9/27/2019
6CC55E,clinical-trials-positive,100,87,9/27/2019
6CC55E,clinical-trials-positive,100,87,9/27/2019
72FCA3,facility-open,100,65,9/27/2019
73529F,conference-call,100,50,9/27/2019
81F4BE,executive-appointment,100,54,9/27/2019
83B1C8,regulatory-product-application,100,69,9/27/2019
83B1C8,clinical-trials-filed,100,60,9/27/2019
859D62,executive-appointment,100,54,9/27/2019
8C6C1B,facility-open,100,65,9/27/2019
96A6CD,conference-participant,100,50,9/27/2019
9981C6,dividend-up,100,81,9/27/2019
9E98F2,earnings,100,50,9/27/2019
9EF4CF,partnership,100,61,9/27/2019
A26C26,revenue-up,100,69,9/27/2019
A6FE1C,unit-acquisition-acquirer,100,49,9/27/2019
A8E2FE,reverse-stock-splits,100,51,9/27/2019
AADE0B,unit-acquisition-acquirer,100,49,9/27/2019
AE7D16,partnership,100,61,9/27/2019
BBBB41,executive-appointment,100,54,9/27/2019
BCC13E,conference-participant,100,50,9/27/2019
BE86A1,dividend-up,100,56,9/27/2019
C65004,acquisition-completed-acquirer,100,49,9/27/2019
C66A8C,facility-open,100,65,9/27/2019
C66B44,award,100,58,9/27/2019
C8923A,conference-participant,100,50,9/27/2019
CAB222,conference-participant,100,50,9/27/2019
CC8F6E,legal-issues-defendant,100,22,9/27/2019
CC8F6E,legal-issues-defendant,100,22,9/27/2019
CE4FD9,partnership,100,61,9/27/2019
D77F7E,executive-resignation,100,44,9/27/2019
E13782,conference-participant,100,50,9/27/2019
E22FDE,conference-call,100,50,9/27/2019
E5752F,award,100,58,9/27/2019
E8846E,executive-appointment,100,54,9/27/2019
EF5BED,executive-appointment,100,54,9/27/2019
F569FD,conference-participant,100,50,9/27/2019
F6A945,earnings,100,50,9/27/2019
F6FA6A,earnings,100,50,9/27/2019
FC1B7B,expenses-guidance-down,100,61,9/27/2019
FD4588,partnership,100,61,9/27/2019
FD9526,facility-sale,100,52,9/27/2019
FEC475,executive-resignation,100,44,9/27/2019
FF227B,conference-participant,100,50,9/27/2019
FF6644,dividend-guidance-up,100,60,9/27/2019
97FE80,legal-issues-defendant,100,22,9/28/2019
D8ECA1,legal-issues-defendant,100,22,9/28/2019
DC2B00,facility-open,100,65,9/28/2019
01D03F,regulatory-product-approval-granted,100,81,9/30/2019
01D03F,clinical-trials-positive,100,87,9/30/2019
01D03F,clinical-trials-positive,100,87,9/30/2019
01D03F,clinical-trials-positive,100,87,9/30/2019
04CCCD,dividend,100,50,9/30/2019
0BC853,executive-appointment,100,54,9/30/2019
0C6861,dividend,100,50,9/30/2019
0CC01F,earnings,100,50,9/30/2019
0D03C8,conference-participant,100,50,9/30/2019
15A388,business-contract,100,69,9/30/2019
16FC89,earnings,100,50,9/30/2019
17EDA5,executive-appointment,100,54,9/30/2019
184988,conference-participant,100,50,9/30/2019
19CAC7,conference-call,100,50,9/30/2019
1AC649,conference-participant,100,50,9/30/2019
1CDD1C,credit-extension-recipient,100,69,9/30/2019
1EBF8D,conference-participant,100,50,9/30/2019
1F716B,conference-call,100,50,9/30/2019
202E5A,clinical-trials,100,56,9/30/2019
21022F,earnings,100,50,9/30/2019
263216,executive-appointment,100,54,9/30/2019
27BFA1,conference-call,100,50,9/30/2019
2CA60F,product-release,100,64,9/30/2019
2DC88B,credit-extension-recipient,100,69,9/30/2019
2E902B,executive-appointment,100,54,9/30/2019
2F7474,acquisition-acquirer,100,49,9/30/2019
36529A,conference-participant,100,50,9/30/2019
367434,clinical-trials-positive,100,87,9/30/2019
367E1C,executive-appointment,100,54,9/30/2019
370C50,conference-call,100,50,9/30/2019
370C50,product-price-raise,100,57,9/30/2019
37727A,conference-call,100,50,9/30/2019
39FB23,earnings,100,50,9/30/2019
3A3447,facility-open,100,65,9/30/2019
3AAEAE,regulatory-product-approval-granted,100,81,9/30/2019
3B37F7,conference-organizer,100,57,9/30/2019
3B50FE,dividend,100,50,9/30/2019
3ED92D,business-contract,100,69,9/30/2019
427F32,executive-appointment,100,54,9/30/2019
42DC93,earnings,100,50,9/30/2019
4A5C8D,unit-acquisition-completed-acquiree,100,67,9/30/2019
4A5C8D,earnings,100,50,9/30/2019
520632,patent-infringement-defendant,100,26,9/30/2019
52D936,acquisition-acquirer,100,49,9/30/2019
53A226,executive-appointment,100,54,9/30/2019
546A9C,conference-call,100,50,9/30/2019
54DF47,public-offering,100,43,9/30/2019
553949,acquisition-completed-acquirer,100,49,9/30/2019
55C9B5,partnership,100,61,9/30/2019
55C9B5,partnership,100,61,9/30/2019
55C9B5,conference-call,100,50,9/30/2019
57356F,conference-call,100,50,9/30/2019
57CAAB,partnership,100,61,9/30/2019
58EA22,clinical-trials-start,100,64,9/30/2019
5D1329,conference-participant,100,50,9/30/2019
5D16CF,acquisition-completed-acquirer,100,49,9/30/2019
5EAA43,executive-appointment,100,54,9/30/2019
5F3D91,patient-enrollment-start,100,58,9/30/2019
62B1C6,executive-appointment,100,54,9/30/2019
6810DE,conference-participant,100,50,9/30/2019
70FCEF,acquisition-acquirer,100,49,9/30/2019
717DB4,executive-appointment,100,54,9/30/2019
722DE3,executive-appointment,100,54,9/30/2019
7239BB,unit-acquisition-acquirer,100,49,9/30/2019
726DDF,unit-acquisition-acquiree,100,76,9/30/2019
726DDF,unit-acquisition-acquiree,100,76,9/30/2019
765913,earnings,100,50,9/30/2019
77B8E9,patent-awarded,100,72,9/30/2019
79340A,earnings,100,50,9/30/2019
7C62A3,note-sale,100,52,9/30/2019
7E1D5D,product-release,100,64,9/30/2019
805CD8,conference-participant,100,50,9/30/2019
805CD8,conference-participant,100,50,9/30/2019
819492,executive-appointment,100,54,9/30/2019
8.22E+27,executive-resignation,100,44,9/30/2019
8665BA,conference-call,100,50,9/30/2019
8AB85C,conference-participant,100,50,9/30/2019
8B2C4A,conference-call,100,50,9/30/2019
8C6C1B,facility-open,100,65,9/30/2019
8DA42F,legal-issues-defendant,100,22,9/30/2019
8F6995,dividend,100,50,9/30/2019
8FCA78,acquisition-completed-acquirer,100,49,9/30/2019
9043FE,note-sale,100,52,9/30/2019
9043FE,note-sale,100,52,9/30/2019
93D207,partnership,100,61,9/30/2019
957A07,earnings,100,50,9/30/2019
958938,executive-appointment,100,54,9/30/2019
968103,earnings,100,50,9/30/2019
96A6CD,business-contract,100,69,9/30/2019
986AF6,conference-call,100,50,9/30/2019
9B730A,conference-participant,100,50,9/30/2019
9C5174,earnings,100,50,9/30/2019
9CA432,conference-call,100,50,9/30/2019
9F5CBB,dividend,100,50,9/30/2019
9F71E5,business-contract,100,69,9/30/2019
9FD2D9,asset-sale,100,62,9/30/2019
A4CD53,conference-participant,100,50,9/30/2019
A6828A,business-contract,100,69,9/30/2019
A6828A,business-contract,100,69,9/30/2019
A80FE0,note-sale,100,52,9/30/2019
A8CBDA,conference-call,100,50,9/30/2019
AA3AB8,executive-appointment,100,54,9/30/2019
ADF092,partnership,100,61,9/30/2019
AE7D16,executive-appointment,100,54,9/30/2019
AEFC90,conference-participant,100,50,9/30/2019
AFDF2E,acquisition-acquirer,100,49,9/30/2019
B05000,executive-appointment,100,54,9/30/2019
B08C51,buybacks,100,74,9/30/2019
B2206F,business-contract,100,69,9/30/2019
B642E8,ownership-decrease-owner,100,46,9/30/2019
B6843B,ipo-completed,100,76,9/30/2019
B803B1,dividend,100,50,9/30/2019
BD9668,conference-call,100,50,9/30/2019
BDEC1E,conference-participant,100,50,9/30/2019
BFCACF,executive-appointment,100,54,9/30/2019
C03C8B,conference-call,100,50,9/30/2019
C2609A,executive-appointment,100,54,9/30/2019
C598D7,conference-call,100,50,9/30/2019
C83B88,partnership,100,61,9/30/2019
C9D866,conference-call,100,50,9/30/2019
C9F39B,conference-call,100,50,9/30/2019
CC176E,earnings,100,50,9/30/2019
CC8F6E,legal-issues-defendant,100,22,9/30/2019
CDAF5B,conference-call,100,50,9/30/2019
CEC08B,merger,100,66,9/30/2019
CF3FF9,conference-participant,100,50,9/30/2019
D1588D,conference-participant,100,50,9/30/2019
D2E553,earnings,100,50,9/30/2019
D2E553,earnings,100,50,9/30/2019
D2E553,earnings,100,50,9/30/2019
D57D99,campaign-ad-release,100,59,9/30/2019
D8ECA1,legal-issues-defendant,100,22,9/30/2019
DD0F15,fast-track-designation,100,81,9/30/2019
E9C7C0,partnership,100,61,9/30/2019
E9FF33,earnings,100,50,9/30/2019
EAEA91,dividend,100,50,9/30/2019
ECA300,buybacks,100,74,9/30/2019
ED4560,conference-participant,100,50,9/30/2019
F0B877,conference-call,100,50,9/30/2019
F5D410,executive-appointment,100,54,9/30/2019
F66B58,executive-appointment,100,54,9/30/2019
F90EE5,executive-appointment,100,54,9/30/2019
FAAFA2,executive-appointment,100,54,9/30/2019
FC4550,conference-call,100,50,9/30/2019
FD2565,conference-participant,100,50,9/30/2019
FE7A63,executive-appointment,100,54,9/30/2019
FEE4B0,earnings,100,50,9/30/2019
FFAB4A,asset-sale,100,62,9/30/2019
00067A,executive-appointment,100,54,10/1/2019
002A99,award,100,58,10/1/2019
018C11,conference-call,100,50,10/1/2019
02FC1A,clinical-trials-filed,100,60,10/1/2019
02FC1A,executive-appointment,100,54,10/1/2019
02FC1A,executive-appointment,100,54,10/1/2019
078D52,dividend,100,50,10/1/2019
0A1D77,partnership,100,61,10/1/2019
0BC853,executive-appointment,100,54,10/1/2019
10C19B,dividend-up,100,81,10/1/2019
12E454,earnings,100,50,10/1/2019
1490F3,public-offering,100,43,10/1/2019
1490F3,conference-call,100,50,10/1/2019
1748F6,earnings,100,50,10/1/2019
17EDA5,executive-appointment,100,54,10/1/2019
1EBF8D,conference-call,100,50,10/1/2019
221AD7,earnings,100,50,10/1/2019
2667B6,earnings,100,50,10/1/2019
272704,earnings,100,50,10/1/2019
28AF37,executive-appointment,100,54,10/1/2019
28DCA8,executive-appointment,100,54,10/1/2019
28DCA8,earnings-guidance,100,50,10/1/2019
2A6DBE,clinical-trials,100,56,10/1/2019
2A9C0A,acquisition-completed-acquirer,100,49,10/1/2019
2AA6A8,conference-participant,100,50,10/1/2019
2AE625,conference-call,100,50,10/1/2019
2C19A4,dividend,100,50,10/1/2019
2F1299,business-contract,100,69,10/1/2019
2F7474,acquisition-acquirer,100,49,10/1/2019
30DE64,executive-appointment,100,54,10/1/2019
32DCB3,clinical-trials-complete,100,56,10/1/2019
338544,conference-call,100,50,10/1/2019
343996,executive-appointment,100,54,10/1/2019
34B411,earnings,100,50,10/1/2019
34B97A,acquisition-completed-acquirer,100,49,10/1/2019
3.73E+87,partnership,100,61,10/1/2019
39BFF6,conference-call,100,50,10/1/2019
3A3447,facility-open,100,65,10/1/2019
3B20AB,unit-acquisition-completed-acquirer,100,49,10/1/2019
3B318A,earnings,100,50,10/1/2019
3B50FE,donation,100,54,10/1/2019
3BB616,earnings,100,50,10/1/2019
3C7F5F,earnings,100,50,10/1/2019
3DCECC,acquisition-acquirer,100,49,10/1/2019
3E15F6,conference-call,100,50,10/1/2019
41785E,earnings,100,50,10/1/2019
41B53E,dividend,100,50,10/1/2019
420168,joint-venture,100,62,10/1/2019
420168,joint-venture,100,62,10/1/2019
43A060,partnership,100,61,10/1/2019
448BF3,regulatory-product-approval-granted,100,81,10/1/2019
46CF27,earnings,100,50,10/1/2019
490D4B,executive-appointment,100,54,10/1/2019
4A2457,business-contract,100,69,10/1/2019
4A6F00,business-contract,100,69,10/1/2019
4C31F3,merger-regulatory-approval,100,81,10/1/2019
4E2D94,stake-acquirer,100,48,10/1/2019
51D876,acquisition-completed-acquirer,100,49,10/1/2019
52B567,business-contract,100,69,10/1/2019
532D47,conference-call,100,50,10/1/2019
55C9B5,partnership,100,61,10/1/2019
57CAAB,executive-appointment,100,54,10/1/2019
59B229,earnings,100,50,10/1/2019
59C539,conference-call,100,50,10/1/2019
5B7739,partnership,100,61,10/1/2019
5CCDAD,credit-extension-recipient,100,69,10/1/2019
5CEE02,merger-regulatory-approval,100,81,10/1/2019
5EC388,earnings,100,50,10/1/2019
5FDBD0,conference-call,100,50,10/1/2019
5FF95F,earnings,100,50,10/1/2019
61B81B,unit-acquisition-acquiree,100,76,10/1/2019
622037,executive-appointment,100,54,10/1/2019
62B1C6,executive-appointment,100,54,10/1/2019
63F892,earnings,100,50,10/1/2019
649CBD,executive-appointment,100,54,10/1/2019
65CF8E,product-release,100,64,10/1/2019
65CF8E,product-release,100,64,10/1/2019
665618,dividend,100,50,10/1/2019
68586A,campaign-ad-release,100,59,10/1/2019
68BA15,dividend,100,50,10/1/2019
6BDA0C,acquisition-completed-acquirer,100,49,10/1/2019
6BF593,conference-call,100,50,10/1/2019
6E1E61,conference-call,100,50,10/1/2019
701531,executive-appointment,100,54,10/1/2019
7032D0,executive-appointment,100,54,10/1/2019
719477,conference-call,100,50,10/1/2019
723548,dividend,100,50,10/1/2019
747219,executive-appointment,100,54,10/1/2019
762A3E,executive-appointment,100,54,10/1/2019
762A3E,executive-appointment,100,54,10/1/2019
763724,dividend,100,50,10/1/2019
789A7D,conference-call,100,50,10/1/2019
7A3633,partnership,100,61,10/1/2019
7ACFD4,fraud-defendant,100,20,10/1/2019
7ACFD4,partnership,100,61,10/1/2019
7ACFD4,legal-issues-defendant,100,22,10/1/2019
7ACFD4,legal-issues-defendant,100,22,10/1/2019
7ACFD4,legal-issues-defendant,100,22,10/1/2019
7ACFD4,legal-issues-defendant,100,22,10/1/2019
7B6EB1,acquisition-acquirer,100,49,10/1/2019
7D85A9,business-contract,100,69,10/1/2019
810FAD,conference-call,100,50,10/1/2019
82B57E,executive-appointment,100,54,10/1/2019
837C04,unit-acquisition-acquirer,100,49,10/1/2019
8665BA,acquisition-completed-acquirer,100,49,10/1/2019
880C0C,conference-call,100,50,10/1/2019
890FF4,business-contract,100,69,10/1/2019
8C6C1B,facility-open,100,65,10/1/2019
8E0E32,earnings,100,50,10/1/2019
8E93A4,unit-acquisition-acquiree,100,76,10/1/2019
9196A2,executive-appointment,100,54,10/1/2019
92D757,executive-resignation,100,44,10/1/2019
949625,conference-call,100,50,10/1/2019
9.62E+76,earnings,100,50,10/1/2019
96B4FF,conference-participant,100,50,10/1/2019
97644E,unit-acquisition-acquiree,100,76,10/1/2019
97644E,business-contract,100,69,10/1/2019
97FE80,legal-issues-defendant,100,22,10/1/2019
97FE80,legal-issues-defendant,100,22,10/1/2019
97FE80,legal-issues-defendant,100,22,10/1/2019
980C14,conference-call,100,50,10/1/2019
997348,merger-completed,100,66,10/1/2019
9A02C4,asset-sale,100,62,10/1/2019
9B5968,executive-appointment,100,54,10/1/2019
9CA4C6,conference-call,100,50,10/1/2019
9D30A8,product-release,100,64,10/1/2019
9D56F2,earnings,100,50,10/1/2019
9D56F2,earnings,100,50,10/1/2019
9D56F2,earnings,100,50,10/1/2019
9D56F2,earnings,100,50,10/1/2019
9D56F2,earnings,100,50,10/1/2019
9E5C2C,conference-call,100,50,10/1/2019
9E98F2,legal-issues-defendant,100,22,10/1/2019
9F37C5,dividend,100,50,10/1/2019
A01200,product-release,100,64,10/1/2019
A350C1,conference-call,100,50,10/1/2019
A4386C,business-contract,100,69,10/1/2019
A4386C,credit-rating-upgrade,100,77,10/1/2019
A5B913,earnings,100,50,10/1/2019
A6213D,joint-venture,100,62,10/1/2019
A63387,executive-appointment,100,54,10/1/2019
A6828A,settlement,100,56,10/1/2019
A79F7D,investment-investor,100,55,10/1/2019
A806FA,partnership,100,61,10/1/2019
A80FE0,conference-call,100,50,10/1/2019
A8B137,product-release,100,64,10/1/2019
AADE0B,conference-call,100,50,10/1/2019
AB7F05,earnings,100,50,10/1/2019
AD375D,business-contract,100,69,10/1/2019
AD9F1D,conference-call,100,50,10/1/2019
AE7D16,partnership,100,61,10/1/2019
AFF43F,earnings,100,50,10/1/2019
AFF7B4,conference-call,100,50,10/1/2019
B05118,partnership,100,61,10/1/2019
B13B68,executive-appointment,100,54,10/1/2019
B3ED62,conference-call,100,50,10/1/2019
B5766D,conference-call,100,50,10/1/2019
B604DF,conference-call,100,50,10/1/2019
BAD655,conference-participant,100,50,10/1/2019
BB5142,conference-call,100,50,10/1/2019
BBAE2A,conference-call,100,50,10/1/2019
BCC55F,executive-appointment,100,54,10/1/2019
C11C46,executive-appointment,100,54,10/1/2019
C188F8,business-contract,100,69,10/1/2019
C32A39,conference-call,100,50,10/1/2019
C7859D,conference-call,100,50,10/1/2019
C7AE14,dividend,100,50,10/1/2019
C81E00,trading-listing,100,61,10/1/2019
C9739A,conference-participant,100,50,10/1/2019
C97B2D,conference-call,100,50,10/1/2019
C9A96E,executive-appointment,100,54,10/1/2019
CAD7D9,earnings,100,50,10/1/2019
CBCC6A,executive-appointment,100,54,10/1/2019
CC6FF5,partnership,100,61,10/1/2019
CC8F6E,legal-issues-defendant,100,22,10/1/2019
CC8F6E,legal-issues-defendant,100,22,10/1/2019
CC8F6E,legal-issues-defendant,100,22,10/1/2019
CC8F6E,legal-issues-defendant,100,22,10/1/2019
D064D5,dividend,100,50,10/1/2019
D0C79E,executive-appointment,100,54,10/1/2019
D36B23,clinical-trials,100,56,10/1/2019
D3F64D,conference-call,100,50,10/1/2019
D501DC,conference-call,100,50,10/1/2019
D54E62,partnership,100,61,10/1/2019
D54E62,donation,100,54,10/1/2019
D54E62,conference-call,100,50,10/1/2019
D57D99,product-release,100,64,10/1/2019
D5AF19,earnings,100,50,10/1/2019
D78BF1,earnings,100,50,10/1/2019
D8ECA1,conference-organizer,100,57,10/1/2019
D8ECA1,legal-issues-defendant,100,22,10/1/2019
D8ECA1,legal-issues-defendant,100,22,10/1/2019
D8ECA1,legal-issues-defendant,100,22,10/1/2019
D9E036,executive-appointment,100,54,10/1/2019
DA48E4,business-contract,100,69,10/1/2019
DAFED3,executive-appointment,100,54,10/1/2019
DC5299,conference-call,100,50,10/1/2019
DD9E41,product-release,100,64,10/1/2019
DF1F7A,conference-call,100,50,10/1/2019
DF532D,conference-call,100,50,10/1/2019
E10D31,conference-call,100,50,10/1/2019
E35610,conference-call,100,50,10/1/2019
E5752F,spin-off,100,58,10/1/2019
E7BF32,clinical-trials,100,56,10/1/2019
E7BF32,clinical-trials,100,56,10/1/2019
E845D9,acquisition-completed-acquirer,100,49,10/1/2019
E845D9,acquisition-completed-acquirer,100,49,10/1/2019
EBC84C,earnings,100,50,10/1/2019
EC8116,dividend,100,50,10/1/2019
EEB5F9,private-placement,100,56,10/1/2019
F47871,business-contract,100,69,10/1/2019
F4CDA3,spin-off,100,58,10/1/2019
F4D241,conference-participant,100,50,10/1/2019
F58C23,partnership,100,61,10/1/2019
F5D499,executive-appointment,100,54,10/1/2019
FA36A4,conference-call,100,50,10/1/2019
FD9526,conference-call,100,50,10/1/2019
FDC7E6,buybacks,100,74,10/1/2019
FEE4B0,award,100,58,10/1/2019
FF4343,executive-appointment,100,54,10/1/2019
00067A,market-entry,100,57,10/2/2019
00326E,executive-appointment,100,54,10/2/2019
018C11,acquisition-completed-acquirer,100,49,10/2/2019
02FC1A,clinical-trials-positive,100,87,10/2/2019
07CA6A,conference-participant,100,50,10/2/2019
07CA6A,conference-participant,100,50,10/2/2019
07EC43,conference-call,100,50,10/2/2019
0B57D7,conference-call,100,50,10/2/2019
0BC853,conference-call,100,50,10/2/2019
0CC62B,conference-call,100,50,10/2/2019
1201B5,business-contract,100,69,10/2/2019
129DC8,conference-call,100,50,10/2/2019
16F4D8,conference-call,100,50,10/2/2019
18A98C,clinical-trials-start,100,64,10/2/2019
1B9535,conference-call,100,50,10/2/2019
1F08A6,conference-call,100,50,10/2/2019
228D42,partnership,100,61,10/2/2019
2571FA,conference-call,100,50,10/2/2019
275300,conference-call,100,50,10/2/2019
29CEBF,conference-call,100,50,10/2/2019
2A9C0A,conference-call,100,50,10/2/2019
2BA977,legal-issues-defendant,100,22,10/2/2019
2D643C,conference-call,100,50,10/2/2019
2DB344,earnings,100,50,10/2/2019
2E0496,acquisition-acquirer,100,49,10/2/2019
2F9304,business-contract,100,69,10/2/2019
31803E,conference-participant,100,50,10/2/2019
32CB22,conference-call,100,50,10/2/2019
341759,conference-participant,100,50,10/2/2019
342218,conference-call,100,50,10/2/2019
3461CF,business-contract,100,69,10/2/2019
36C09B,conference-participant,100,50,10/2/2019
38C46F,dividend,100,50,10/2/2019
3A3447,facility-open,100,65,10/2/2019
3B37F7,conference-organizer,100,57,10/2/2019
3B37F7,conference-organizer,100,57,10/2/2019
3B37F7,conference-organizer,100,57,10/2/2019
3B37F7,public-offering,100,43,10/2/2019
3DD5E2,executive-appointment,100,54,10/2/2019
3ED92D,acquisition-completed-acquirer,100,49,10/2/2019
3F4497,business-contract,100,69,10/2/2019
416C55,joint-venture,100,62,10/2/2019
416C55,joint-venture,100,62,10/2/2019
43E8F5,acquisition-acquirer,100,49,10/2/2019
43E8F5,acquisition-acquirer,100,49,10/2/2019
43E8F5,acquisition-acquirer,100,49,10/2/2019
442769,credit-extension-recipient,100,69,10/2/2019
448215,index-listing,100,76,10/2/2019
47752F,earnings,100,50,10/2/2019
485445,partnership,100,61,10/2/2019
485445,partnership,100,61,10/2/2019
4A2457,business-contract,100,69,10/2/2019
4A6F00,partnership,100,61,10/2/2019
4B6EF9,earnings,100,50,10/2/2019
4C7DB5,index-listing,100,76,10/2/2019
4D8124,earnings,100,50,10/2/2019
4D8313,conference-call,100,50,10/2/2019
51E682,conference-call,100,50,10/2/2019
53F491,earnings,100,50,10/2/2019
556F08,credit-extension-provider,100,57,10/2/2019
56B7C1,dividend,100,50,10/2/2019
5CC29D,earnings,100,50,10/2/2019
5F60CE,buybacks,100,74,10/2/2019
5FDBD0,partnership,100,61,10/2/2019
616E3B,executive-appointment,100,54,10/2/2019
619882,conference-organizer,100,57,10/2/2019
639BD6,earnings,100,50,10/2/2019
66A667,earnings,100,50,10/2/2019
67529E,conference-call,100,50,10/2/2019
6CB7F9,executive-appointment,100,54,10/2/2019
6-Dec-05,conference-participant,100,50,10/2/2019
6F6559,earnings,100,50,10/2/2019
6F6559,earnings,100,50,10/2/2019
6F6559,earnings,100,50,10/2/2019
6F6559,earnings,100,50,10/2/2019
72FCA3,facility-open,100,65,10/2/2019
746373,conference-call,100,50,10/2/2019
747219,earnings,100,50,10/2/2019
762A3E,award,100,58,10/2/2019
7D7716,earnings,100,50,10/2/2019
7E1D5D,partnership,100,61,10/2/2019
7E1D5D,acquisition-completed-acquirer,100,49,10/2/2019
7F9E16,acquisition-completed-acquirer,100,49,10/2/2019
82C202,business-contract,100,69,10/2/2019
8AB85C,legal-issues-defendant,100,22,10/2/2019
8BAA15,earnings-guidance,100,50,10/2/2019
8C6C1B,facility-open,100,65,10/2/2019
8D5145,earnings,100,50,10/2/2019
901327,award,100,58,10/2/2019
90D6A5,conference-call,100,50,10/2/2019
91C82E,earnings-per-share-positive,100,69,10/2/2019
91C82E,earnings-per-share-positive,100,69,10/2/2019
91C82E,earnings-per-share-positive,100,69,10/2/2019
91C82E,earnings-per-share-positive,100,69,10/2/2019
91C82E,earnings-per-share-positive,100,69,10/2/2019
92B73F,unit-acquisition-acquiree,100,76,10/2/2019
92D9C9,unit-acquisition-completed-acquirer,100,49,10/2/2019
93D207,earnings,100,50,10/2/2019
949625,dividend,100,50,10/2/2019
94983E,unit-acquisition-acquirer,100,49,10/2/2019
954004,partnership,100,61,10/2/2019
97FE80,legal-issues-defendant,100,22,10/2/2019
9B71A7,earnings,100,50,10/2/2019
9B71A7,earnings,100,50,10/2/2019
9B71A7,earnings,100,50,10/2/2019
9EED50,conference-call,100,50,10/2/2019
A28C54,executive-appointment,100,54,10/2/2019
A3800A,legal-issues-defendant,100,22,10/2/2019
A5628C,earnings,100,50,10/2/2019
A6828A,regulatory-product-application,100,69,10/2/2019
A6828A,clinical-trials-filed,100,60,10/2/2019
A6828A,clinical-trials-filed,100,60,10/2/2019
A8AC4C,conference-call,100,50,10/2/2019
A99576,earnings,100,50,10/2/2019
ADF092,earnings,100,50,10/2/2019
AE7D16,product-release,100,64,10/2/2019
B08C51,executive-appointment,100,54,10/2/2019
B381D8,legal-issues-defendant,100,22,10/2/2019
B6CD92,dividend,100,50,10/2/2019
B9BDE8,conference-participant,100,50,10/2/2019
BA218A,conference-call,100,50,10/2/2019
BAD655,facility-upgrade,100,65,10/2/2019
BB5271,conference-call,100,50,10/2/2019
BB88B6,earnings,100,50,10/2/2019
BE14CF,conference-call,100,50,10/2/2019
BEB756,conference-call,100,50,10/2/2019
BFD0A7,conference-participant,100,50,10/2/2019
C06EB6,patient-enrollment-start,100,58,10/2/2019
C06EB6,patient-enrollment-start,100,58,10/2/2019
C3EE99,earnings,100,50,10/2/2019
C3F99F,credit-extension-recipient,100,69,10/2/2019
C407A0,executive-appointment,100,54,10/2/2019
C4F9C6,partnership,100,61,10/2/2019
C564E4,conference-participant,100,50,10/2/2019
C659EB,conference-call,100,50,10/2/2019
C7863D,conference-call,100,50,10/2/2019
CAD7D9,earnings,100,50,10/2/2019
CB89EA,executive-appointment,100,54,10/2/2019
CB89EA,executive-appointment,100,54,10/2/2019
CC8F6E,legal-issues-defendant,100,22,10/2/2019
CC8F6E,legal-issues-defendant,100,22,10/2/2019
CD06A2,earnings,100,50,10/2/2019
CF6A5A,partnership,100,61,10/2/2019
CF6A5A,partnership,100,61,10/2/2019
CF6A5A,partnership,100,61,10/2/2019
CF6A5A,earnings,100,50,10/2/2019
D11C1C,market-entry,100,57,10/2/2019
D33270,executive-appointment,100,54,10/2/2019
D36B23,executive-appointment,100,54,10/2/2019
D6853F,conference-call,100,50,10/2/2019
D7918D,earnings,100,50,10/2/2019
D8ECA1,legal-issues-defendant,100,22,10/2/2019
DF6FDD,partnership,100,61,10/2/2019
DF6FDD,partnership,100,61,10/2/2019
E0D3BA,earnings,100,50,10/2/2019
E21871,earnings,100,50,10/2/2019
E67C2C,executive-appointment,100,54,10/2/2019
E74B55,conference-call,100,50,10/2/2019
E829E8,conference-call,100,50,10/2/2019
ED5171,earnings,100,50,10/2/2019
EF1AD9,index-listing,100,76,10/2/2019
EF7163,public-offering,100,43,10/2/2019
EF77A3,dividend,100,50,10/2/2019
F30508,conference-call,100,50,10/2/2019
F40EE2,dividend,100,50,10/2/2019
F40EE2,dividend,100,50,10/2/2019
F4D241,clinical-trials-positive,100,87,10/2/2019
F5D059,earnings,100,50,10/2/2019
F5D059,earnings,100,50,10/2/2019
F5D059,earnings,100,50,10/2/2019
F5D059,earnings,100,50,10/2/2019
F5D059,earnings,100,50,10/2/2019
FD0CA4,conference-call,100,50,10/2/2019
FDC08C,ipo-pricing,100,50,10/2/2019
FDD3FC,executive-appointment,100,54,10/2/2019
02FC1A,public-offering,100,43,10/3/2019
31025,earnings,100,50,10/3/2019
0358AF,earnings,100,50,10/3/2019
55018,legal-issues-defendant,100,22,10/3/2019
55018,legal-issues-defendant,100,22,10/3/2019
55018,legal-issues-defendant,100,22,10/3/2019
0A59F8,earnings,100,50,10/3/2019
0AAD90,ipo-pricing,100,50,10/3/2019
0C2A0D,partnership,100,61,10/3/2019
0F2BC9,business-contract,100,69,10/3/2019
0FABBD,debt-reduction,100,74,10/3/2019
105D00,conference-call,100,50,10/3/2019
147C38,earnings,100,50,10/3/2019
1748B3,conference-call,100,50,10/3/2019
1A2D9F,earnings,100,50,10/3/2019
1C2593,partnership,100,61,10/3/2019
1D1B07,earnings,100,50,10/3/2019
1EBF8D,partnership,100,61,10/3/2019
1EBF8D,partnership,100,61,10/3/2019
228D42,product-release,100,64,10/3/2019
22C58E,executive-appointment,100,54,10/3/2019
22C58E,earnings,100,50,10/3/2019
232053,product-release,100,64,10/3/2019
25DD05,conference-call,100,50,10/3/2019
267718,partnership,100,61,10/3/2019
29A4CC,conference-call,100,50,10/3/2019
2.90E+62,earnings,100,50,10/3/2019
2B0AF4,conference-call,100,50,10/3/2019
2B9DBB,conference-call,100,50,10/3/2019
2BA977,legal-issues-defendant,100,22,10/3/2019
2BDC1C,orphan-drug-designation,100,76,10/3/2019
2D485F,earnings,100,50,10/3/2019
2E36AD,clinical-trials-complete,100,56,10/3/2019
2F1299,partnership,100,61,10/3/2019
2F960F,credit-extension-recipient,100,69,10/3/2019
2F98A5,product-recall,100,29,10/3/2019
315EB0,conference-call,100,50,10/3/2019
31643A,unit-acquisition-acquirer,100,49,10/3/2019
32C8CD,executive-appointment,100,54,10/3/2019
3461CF,product-release,100,64,10/3/2019
34B97A,conference-call,100,50,10/3/2019
353DBB,conference-call,100,50,10/3/2019
3.50E+27,conference-call,100,50,10/3/2019
387375,earnings,100,50,10/3/2019
3A3447,facility-open,100,65,10/3/2019
3A3948,conference-call,100,50,10/3/2019
3B37F7,conference-organizer,100,57,10/3/2019
3DC887,earnings,100,50,10/3/2019
4.00E+163,unit-acquisition-acquiree,100,76,10/3/2019
4.00E+163,unit-acquisition-acquiree,100,76,10/3/2019
416C55,joint-venture,100,62,10/3/2019
427F32,executive-resignation,100,44,10/3/2019
434F38,earnings,100,50,10/3/2019
43A060,partnership,100,61,10/3/2019
44A4FC,executive-appointment,100,54,10/3/2019
4885C8,earnings,100,50,10/3/2019
4885C8,earnings,100,50,10/3/2019
4A2457,government-contract,100,69,10/3/2019
4A5C8D,partnership,100,61,10/3/2019
4AC91D,earnings-guidance,100,50,10/3/2019
4AC91D,earnings-guidance,100,50,10/3/2019
4AC91D,earnings-guidance,100,50,10/3/2019
4B3555,earnings,100,50,10/3/2019
4B49CF,dividend,100,50,10/3/2019
4C3FE9,patient-enrollment-complete,100,64,10/3/2019
4C6C63,earnings,100,50,10/3/2019
4D8124,executive-appointment,100,54,10/3/2019
4FCC78,dividend,100,50,10/3/2019
50070E,conference-call,100,50,10/3/2019
504FE2,executive-appointment,100,54,10/3/2019
524CE4,earnings,100,50,10/3/2019
52B567,legal-issues-defendant,100,22,10/3/2019
550D01,conference-call,100,50,10/3/2019
55438C,partnership,100,61,10/3/2019
5A0FF1,earnings,100,50,10/3/2019
60EA12,earnings,100,50,10/3/2019
61B81B,dividend,100,50,10/3/2019
627186,earnings,100,50,10/3/2019
6284B5,conference-call,100,50,10/3/2019
62B20A,conference-call,100,50,10/3/2019
69345C,partnership,100,61,10/3/2019
69CE71,dividend,100,50,10/3/2019
69E8E1,conference-call,100,50,10/3/2019
69E8E1,conference-call,100,50,10/3/2019
69FDFC,partnership,100,61,10/3/2019
6B0E45,conference-call,100,50,10/3/2019
6D0CAB,executive-appointment,100,54,10/3/2019
6E705B,product-release,100,64,10/3/2019
713810,product-release,100,64,10/3/2019
72FCA3,dividend,100,50,10/3/2019
73BCBA,partnership,100,61,10/3/2019
752A70,earnings,100,50,10/3/2019
76CEFB,earnings,100,50,10/3/2019
7823A3,partnership,100,61,10/3/2019
7823A3,product-release,100,64,10/3/2019
7ACFD4,legal-issues-defendant,100,22,10/3/2019
7BC92D,conference-participant,100,50,10/3/2019
810A4B,conference-participant,100,50,10/3/2019
81A88D,earnings,100,50,10/3/2019
826FD6,earnings,100,50,10/3/2019
834152,asset-sale,100,62,10/3/2019
84A6B9,earnings,100,50,10/3/2019
85DA04,partnership,100,61,10/3/2019
873DB9,conference-call,100,50,10/3/2019
877C0C,partnership,100,61,10/3/2019
8C6C1B,facility-open,100,65,10/3/2019
8DBBE6,conference-call,100,50,10/3/2019
8E4250,conference-call,100,50,10/3/2019
8E8E6E,business-contract,100,69,10/3/2019
9043FE,earnings,100,50,10/3/2019
9043FE,earnings,100,50,10/3/2019
911AB8,conference-call,100,50,10/3/2019
9196A2,conference-call,100,50,10/3/2019
91C82E,dividend,100,50,10/3/2019
922F0C,earnings,100,50,10/3/2019
9.39E+69,conference-participant,100,50,10/3/2019
954004,product-release,100,64,10/3/2019
95C392,award,100,58,10/3/2019
965360,earnings,100,50,10/3/2019
9.74E+08,partnership,100,61,10/3/2019
97FE80,legal-issues-defendant,100,22,10/3/2019
9AF3DC,conference-call,100,50,10/3/2019
9D5D35,partnership,100,61,10/3/2019
A1A317,conference-call,100,50,10/3/2019
A4386C,earnings,100,50,10/3/2019
AADE0B,unit-acquisition-acquirer,100,49,10/3/2019
AADE0B,unit-acquisition-acquirer,100,49,10/3/2019
AB7726,conference-participant,100,50,10/3/2019
AC7C4F,business-contract,100,69,10/3/2019
ADF1B0,partnership,100,61,10/3/2019
B05000,product-release,100,64,10/3/2019
B1FC3B,executive-appointment,100,54,10/3/2019
B446B8,earnings,100,50,10/3/2019
B4703C,conference-call,100,50,10/3/2019
B614F8,product-release,100,64,10/3/2019
B8EF97,earnings,100,50,10/3/2019
B9764A,legal-issues-defendant,100,22,10/3/2019
C03C8B,executive-appointment,100,54,10/3/2019
C03C8B,dividend,100,50,10/3/2019
C230FE,facility-open,100,65,10/3/2019
C5C137,hirings,100,65,10/3/2019
C5D2AE,earnings,100,50,10/3/2019
C5E100,acquisition-completed-acquirer,100,49,10/3/2019
C5E100,acquisition-completed-acquirer,100,49,10/3/2019
C8A248,unit-acquisition-acquirer,100,49,10/3/2019
C8A248,unit-acquisition-acquirer,100,49,10/3/2019
C94CFC,ipo-pricing,100,50,10/3/2019
C951A2,partnership,100,61,10/3/2019
C951A2,partnership,100,61,10/3/2019
CAC8D0,executive-appointment,100,54,10/3/2019
CB22CD,conference-call,100,50,10/3/2019
CBDB4D,conference-call,100,50,10/3/2019
CE5664,earnings,100,50,10/3/2019
D1173F,conference-call,100,50,10/3/2019
D4AC65,acquisition-acquirer,100,49,10/3/2019
D5938F,clinical-trials,100,56,10/3/2019
D70365,conference-call,100,50,10/3/2019
D8442A,partnership,100,61,10/3/2019
D8760C,conference-call,100,50,10/3/2019
D8DA3D,dividend,100,50,10/3/2019
D8ECA1,legal-issues-defendant,100,22,10/3/2019
D8ECA1,legal-issues-defendant,100,22,10/3/2019
D90F43,partnership,100,61,10/3/2019
DB396B,conference-call,100,50,10/3/2019
DC2F77,earnings,100,50,10/3/2019
DD682D,partnership,100,61,10/3/2019
E12A6E,earnings,100,50,10/3/2019
E26FC3,dividend,100,50,10/3/2019
E3E68E,conference-call,100,50,10/3/2019
E3E68E,conference-call,100,50,10/3/2019
E3E68E,conference-call,100,50,10/3/2019
E94704,conference-call,100,50,10/3/2019
ED22DC,partnership,100,61,10/3/2019
ED22DC,partnership,100,61,10/3/2019
ED79D9,executive-appointment,100,54,10/3/2019
EF7163,public-offering,100,43,10/3/2019
F02D0A,earnings,100,50,10/3/2019
F30508,trading-delisting,100,36,10/3/2019
F30508,trading-delisting,100,36,10/3/2019
F509E2,executive-appointment,100,54,10/3/2019
F5D059,dividend-up,100,81,10/3/2019
F88A04,business-contract,100,69,10/3/2019
FC1B7B,conference-call,100,50,10/3/2019
FC4550,dividend,100,50,10/3/2019
FC9A88,conference-call,100,50,10/3/2019
FCA54E,executive-appointment,100,54,10/3/2019
FEC475,conference-call,100,50,10/3/2019
FFA9B9,executive-appointment,100,54,10/3/2019
02FC1A,public-offering,100,43,10/4/2019
55018,legal-issues-defendant,100,22,10/4/2019
0A59F8,conference-call,100,50,10/4/2019
0A7650,conference-call,100,50,10/4/2019
0C136E,dividend,100,50,10/4/2019
0C2A0D,earnings,100,50,10/4/2019
0C8D82,conference-call,100,50,10/4/2019
1A6A94,conference-call,100,50,10/4/2019
1D1B07,executive-appointment,100,54,10/4/2019
1D1B07,executive-appointment,100,54,10/4/2019
1F9D90,conference-call,100,50,10/4/2019
20BEEA,conference-call,100,50,10/4/2019
227D48,conference-call,100,50,10/4/2019
250BEE,conference-call,100,50,10/4/2019
2BA977,legal-issues-defendant,100,22,10/4/2019
2BA977,legal-issues-defendant,100,22,10/4/2019
30DFD3,conference-organizer,100,57,10/4/2019
315EB0,market-entry,100,57,10/4/2019
31F25C,conference-call,100,50,10/4/2019
32F943,clinical-trials-positive,100,87,10/4/2019
3BCF24,earnings,100,50,10/4/2019
3FACA7,buybacks,100,74,10/4/2019
4A5C8D,product-release,100,64,10/4/2019
4FB770,conference-call,100,50,10/4/2019
519FE0,dividend,100,50,10/4/2019
5487B1,conference-call,100,50,10/4/2019
5675EB,earnings,100,50,10/4/2019
56EFC7,stake-acquirer,100,48,10/4/2019
5B6C11,dividend,100,50,10/4/2019
5D1956,earnings,100,50,10/4/2019
5F9CE3,earnings,100,50,10/4/2019
60DD84,conference-call,100,50,10/4/2019
622DBE,legal-issues-defendant,100,22,10/4/2019
622DBE,legal-issues-defendant,100,22,10/4/2019
622DBE,legal-issues-defendant,100,22,10/4/2019
6B0784,conference-call,100,50,10/4/2019
6B0784,conference-call,100,50,10/4/2019
71E2EF,facility-open,100,65,10/4/2019
72FCA3,award,100,58,10/4/2019
7ACFD4,legal-issues-defendant,100,22,10/4/2019
7BFF81,business-contract,100,69,10/4/2019
7F9BE2,executive-death,100,31,10/4/2019
88350F,conference-call,100,50,10/4/2019
8AB85C,legal-issues-defendant,100,22,10/4/2019
8C6C1B,facility-open,100,65,10/4/2019
8DCBBB,conference-call,100,50,10/4/2019
915E7B,conference-call,100,50,10/4/2019
92D757,legal-issues-defendant,100,22,10/4/2019
9810C0,conference-call,100,50,10/4/2019
99ACAD,earnings,100,50,10/4/2019
A02FB1,conference-call,100,50,10/4/2019
A7A0C8,clinical-trials,100,56,10/4/2019
A87CD6,earnings,100,50,10/4/2019
A8CBDA,spin-off,100,58,10/4/2019
AA5C8E,campaign-ad-release,100,59,10/4/2019
AADE0B,stake-acquirer,100,48,10/4/2019
AD9F1D,dividend,100,50,10/4/2019
AE4125,executive-appointment,100,54,10/4/2019
AFDF2E,dividend,100,50,10/4/2019
B05000,partnership,100,61,10/4/2019
B83BCE,earnings,100,50,10/4/2019
B83BCE,conference-participant,100,50,10/4/2019
BAAA60,conference-call,100,50,10/4/2019
C0200F,earnings,100,50,10/4/2019
C83B88,executive-appointment,100,54,10/4/2019
CC6FF5,earnings,100,50,10/4/2019
CFD4B6,partnership,100,61,10/4/2019
CFF97C,conference-call,100,50,10/4/2019
D08D2C,conference-call,100,50,10/4/2019
D0909F,acquisition-acquiree,100,76,10/4/2019
D2B9E5,earnings,100,50,10/4/2019
D501DC,dividend,100,50,10/4/2019
D77F7E,earnings,100,50,10/4/2019
D78CCD,conference-call,100,50,10/4/2019
DA0CB8,conference-call,100,50,10/4/2019
E05DC8,executive-appointment,100,54,10/4/2019
E13782,executive-appointment,100,54,10/4/2019
E30B34,spin-off,100,58,10/4/2019
E30B34,earnings,100,50,10/4/2019
E30B34,earnings,100,50,10/4/2019
EDF5CA,conference-call,100,50,10/4/2019
EF5BED,product-release,100,64,10/4/2019
F50BAB,conference-call,100,50,10/4/2019
F721A7,earnings,100,50,10/4/2019
F721A7,earnings,100,50,10/4/2019
F7902B,earnings,100,50,10/4/2019
F88A04,earnings,100,50,10/4/2019
FA044A,conference-call,100,50,10/4/2019
FAE021,facility-open,100,65,10/4/2019
FF5413,revenue-volume,100,50,10/4/2019
55018,legal-issues-defendant,100,22,10/5/2019
251988,partnership,100,61,10/5/2019
622DBE,legal-issues-defendant,100,22,10/5/2019
622DBE,legal-issues-defendant,100,22,10/5/2019
70FCEF,executive-appointment,100,54,10/5/2019
7ACFD4,legal-issues-defendant,100,22,10/5/2019
D8ECA1,legal-issues-defendant,100,22,10/5/2019
D90F43,legal-issues-defendant,100,22,10/5/2019
2BA977,legal-issues-defendant,100,22,10/6/2019
7BFF81,business-contract,100,69,10/6/2019
7FDE1C,business-contract,100,69,10/6/2019
97FE80,legal-issues-defendant,100,22,10/6/2019
A2C979,conference-call,100,50,10/6/2019
001F1B,revenues,100,50,10/7/2019
001F1B,revenues,100,50,10/7/2019
13528,note-sale,100,52,10/7/2019
0157B1,product-release,100,64,10/7/2019
0157B1,product-release,100,64,10/7/2019
03FB17,executive-appointment,100,54,10/7/2019
48590,earnings,100,50,10/7/2019
51332,earnings,100,50,10/7/2019
55018,legal-issues-defendant,100,22,10/7/2019
05AF14,unit-acquisition-acquirer,100,49,10/7/2019
07CA6A,conference-call,100,50,10/7/2019
07CA6A,conference-call,100,50,10/7/2019
0AAD90,ipo-completed,100,76,10/7/2019
0BF528,partnership,100,61,10/7/2019
0C4131,conference-call,100,50,10/7/2019
0CBC4D,earnings,100,50,10/7/2019
0DE3D5,conference-call,100,50,10/7/2019
131443,dividend,100,50,10/7/2019
16C544,partnership,100,61,10/7/2019
182BE7,product-recall,100,29,10/7/2019
1921DD,partnership,100,61,10/7/2019
1DA44F,conference-call,100,50,10/7/2019
206852,conference-call,100,50,10/7/2019
2082EA,executive-appointment,100,54,10/7/2019
267718,business-contract,100,69,10/7/2019
26DC29,partnership,100,61,10/7/2019
270305,note-sale,100,52,10/7/2019
272704,acquisition-completed-acquirer,100,49,10/7/2019
29CEBF,credit-rating-set,100,37,10/7/2019
2AA6A8,business-contract,100,69,10/7/2019
2AA6A8,business-contract,100,69,10/7/2019
2BA977,legal-issues-defendant,100,22,10/7/2019
2CA60F,partnership,100,61,10/7/2019
2E902B,conference-call,100,50,10/7/2019
2EBC0B,award,100,58,10/7/2019
2F1299,executive-appointment,100,54,10/7/2019
2F5256,conference-call,100,50,10/7/2019
37020C,dividend,100,50,10/7/2019
37B618,unit-acquisition-acquirer,100,49,10/7/2019
3DD5E2,conference-call,100,50,10/7/2019
3FACA7,executive-appointment,100,54,10/7/2019
408380,earnings,100,50,10/7/2019
4135F7,earnings,100,50,10/7/2019
420168,earnings,100,50,10/7/2019
434F38,partnership,100,61,10/7/2019
43A74A,executive-appointment,100,54,10/7/2019
442769,product-release,100,64,10/7/2019
46A16E,conference-call,100,50,10/7/2019
47FCF2,partnership,100,61,10/7/2019
494EB9,earnings,100,50,10/7/2019
5088A5,earnings,100,50,10/7/2019
52015A,dividend,100,50,10/7/2019
524CE4,unit-acquisition-acquirer,100,49,10/7/2019
55438C,legal-issues-defendant,100,22,10/7/2019
564F3E,earnings,100,50,10/7/2019
5675EB,acquisition-acquirer,100,49,10/7/2019
5704AC,earnings,100,50,10/7/2019
58EA22,executive-appointment,100,54,10/7/2019
5B3FA2,acquisition-acquirer,100,49,10/7/2019
5B3FA2,acquisition-acquirer,100,49,10/7/2019
5BE42C,conference-call,100,50,10/7/2019
5BFE94,conference-call,100,50,10/7/2019
622DBE,legal-issues-defendant,100,22,10/7/2019
622DBE,legal-issues-defendant,100,22,10/7/2019
649CBD,clinical-trials-start,100,64,10/7/2019
65D0AA,public-offering,100,43,10/7/2019
68BA15,conference-call,100,50,10/7/2019
694749,credit-extension-recipient,100,69,10/7/2019
6F39FC,dividend,100,50,10/7/2019
762A3E,conference-call,100,50,10/7/2019
77B8E9,patent-awarded,100,72,10/7/2019
7AB859,partnership,100,61,10/7/2019
7AB859,conference-call,100,50,10/7/2019
7B6C88,product-release,100,64,10/7/2019
7B6EB1,earnings,100,50,10/7/2019
7CD98F,earnings,100,50,10/7/2019
7DC1C4,earnings,100,50,10/7/2019
7E2DE6,earnings-guidance,100,50,10/7/2019
7E2DE6,public-offering,100,43,10/7/2019
7F3A5F,earnings,100,50,10/7/2019
805CD8,legal-issues-defendant,100,22,10/7/2019
8.10E+32,conference-call,100,50,10/7/2019
830BDB,executive-appointment,100,54,10/7/2019
859281,earnings,100,50,10/7/2019
87486A,conference-call,100,50,10/7/2019
8AB37F,business-contract,100,69,10/7/2019
8B9B3B,clinical-trials-positive,100,87,10/7/2019
8C6C1B,facility-open,100,65,10/7/2019
8DA42F,partnership,100,61,10/7/2019
8E93A4,conference-call,100,50,10/7/2019
902670,conference-call,100,50,10/7/2019
9087B9,conference-participant,100,50,10/7/2019
9368BE,conference-call,100,50,10/7/2019
9.54E+32,partnership,100,61,10/7/2019
9.74E+08,partnership,100,61,10/7/2019
977A1E,conference-call,100,50,10/7/2019
9B5968,product-release,100,64,10/7/2019
9C8BC3,conference-call,100,50,10/7/2019
9D65C1,earnings,100,50,10/7/2019
9EBAFA,unit-acquisition-acquirer,100,49,10/7/2019
9EED50,index-listing,100,76,10/7/2019
9F048E,earnings,100,50,10/7/2019
9FB4B7,patient-enrollment-complete,100,64,10/7/2019
A16DEA,earnings,100,50,10/7/2019
A3800A,legal-issues-defendant,100,22,10/7/2019
A3F598,conference-call,100,50,10/7/2019
A60354,executive-appointment,100,54,10/7/2019
A6828A,regulatory-product-approval-granted,100,81,10/7/2019
A7CCF0,award,100,58,10/7/2019
A8E72A,clinical-trials,100,56,10/7/2019
AA7FE0,executive-appointment,100,54,10/7/2019
AC7C4F,business-contract,100,69,10/7/2019
AF210D,product-release,100,64,10/7/2019
AFDF2E,business-contract,100,69,10/7/2019
B1B10C,conference-call,100,50,10/7/2019
B77F14,buybacks,100,74,10/7/2019
B96637,conference-call,100,50,10/7/2019
BBBB41,conference-call,100,50,10/7/2019
BC5680,partnership,100,61,10/7/2019
BD15E8,conference-call,100,50,10/7/2019
C062D4,conference-call,100,50,10/7/2019
C07E05,executive-appointment,100,54,10/7/2019
C230FE,earnings,100,50,10/7/2019
C3BAE7,acquisition-completed-acquirer,100,49,10/7/2019
C3CF29,executive-appointment,100,54,10/7/2019
C41C25,earnings,100,50,10/7/2019
C50B26,unit-acquisition-completed-acquirer,100,49,10/7/2019
CAB222,partnership,100,61,10/7/2019
CB7AB2,earnings,100,50,10/7/2019
CBCC6A,executive-appointment,100,54,10/7/2019
CD4DA8,conference-call,100,50,10/7/2019
CDE51C,earnings,100,50,10/7/2019
D1C0B9,earnings,100,50,10/7/2019
D3FA2C,conference-call,100,50,10/7/2019
D4AC65,partnership,100,61,10/7/2019
D78BF1,award,100,58,10/7/2019
D7A953,executive-appointment,100,54,10/7/2019
D8442A,product-release,100,64,10/7/2019
D8C09D,conference-call,100,50,10/7/2019
D9164D,earnings,100,50,10/7/2019
DB5CA5,earnings,100,50,10/7/2019
DC0D18,earnings,100,50,10/7/2019
DD682D,earnings,100,50,10/7/2019
DD7A96,conference-call,100,50,10/7/2019
E15736,note-sale,100,52,10/7/2019
E4CE73,public-offering,100,43,10/7/2019
E4CE73,public-offering,100,43,10/7/2019
E67C2C,earnings,100,50,10/7/2019
E6D89E,partnership,100,61,10/7/2019
E6D89E,partnership,100,61,10/7/2019
E802CE,conference-call,100,50,10/7/2019
E8A49A,earnings,100,50,10/7/2019
E8B315,conference-call,100,50,10/7/2019
ED0402,earnings,100,50,10/7/2019
EEBCEF,unit-acquisition-acquirer,100,49,10/7/2019
F1CD47,earnings,100,50,10/7/2019
F5C78B,conference-call,100,50,10/7/2019
F6E248,executive-appointment,100,54,10/7/2019
F7ADEB,earnings,100,50,10/7/2019
F83279,earnings,100,50,10/7/2019
FC1B7B,conference-call,100,50,10/7/2019
FE7A63,facility-open,100,65,10/7/2019
FE89E0,dividend-up,100,76,10/7/2019
FF6644,executive-appointment,100,54,10/7/2019
00326D,conference-call,100,50,10/8/2019
00326D,executive-appointment,100,54,10/8/2019
0157B1,partnership,100,61,10/8/2019
01D03F,partnership,100,61,10/8/2019
036C6F,revenue-up,100,62,10/8/2019
081AB9,conference-call,100,50,10/8/2019
099A92,dividend,100,50,10/8/2019
09F623,conference-call,100,50,10/8/2019
0AAD90,ipo-completed,100,76,10/8/2019
0D03C8,earnings,100,50,10/8/2019
0E5619,partnership,100,61,10/8/2019
0FDE97,conference-call,100,50,10/8/2019
11074E,conference-call,100,50,10/8/2019
1348C9,conference-call,100,50,10/8/2019
15789A,unit-acquisition-acquiree,100,76,10/8/2019
157D9F,conference-call,100,50,10/8/2019
168A5D,partnership,100,61,10/8/2019
18D9FA,partnership,100,61,10/8/2019
1BDB2A,conference-call,100,50,10/8/2019
1CDD1C,conference-call,100,50,10/8/2019
1D9E55,product-release,100,64,10/8/2019
1D9E55,earnings,100,50,10/8/2019
1EBF8D,partnership,100,61,10/8/2019
1EBF8D,partnership,100,61,10/8/2019
1EBF8D,partnership,100,61,10/8/2019
1FC422,executive-appointment,100,54,10/8/2019
20D00A,executive-appointment,100,54,10/8/2019
24D81E,earnings,100,50,10/8/2019
284289,earnings,100,50,10/8/2019
29B702,earnings,100,50,10/8/2019
2CB4C9,earnings,100,50,10/8/2019
2E0496,earnings,100,50,10/8/2019
2E0496,earnings,100,50,10/8/2019
2E61CC,dividend,100,50,10/8/2019
2E61CC,executive-appointment,100,54,10/8/2019
3159AA,product-release,100,64,10/8/2019
315EB0,executive-appointment,100,54,10/8/2019
31F25C,legal-issues-defendant,100,22,10/8/2019
326EDD,conference-call,100,50,10/8/2019
32C8CD,executive-appointment,100,54,10/8/2019
33AD83,partnership,100,61,10/8/2019
371B0A,conference-call,100,50,10/8/2019
371C01,conference-call,100,50,10/8/2019
387541,conference-call,100,50,10/8/2019
39692D,partnership,100,61,10/8/2019
39692D,partnership,100,61,10/8/2019
3B20AB,dividend,100,50,10/8/2019
3DE4D1,conference-call,100,50,10/8/2019
4.00E+163,stake-acquirer,100,48,10/8/2019
41B0E2,conference-call,100,50,10/8/2019
422CE3,product-release,100,64,10/8/2019
449217,dividend-up,100,81,10/8/2019
450ECB,fundraising,100,64,10/8/2019
458D2C,revenue-volume,100,50,10/8/2019
458D2C,conference-call,100,50,10/8/2019
4591D3,conference-call,100,50,10/8/2019
45BC35,conference-call,100,50,10/8/2019
467F2C,conference-call,100,50,10/8/2019
490D4B,conference-call,100,50,10/8/2019
4A2457,business-contract,100,69,10/8/2019
4A6F00,partnership,100,61,10/8/2019
4C6C63,executive-appointment,100,54,10/8/2019
4E2D94,executive-appointment,100,54,10/8/2019
4F9926,business-contract,100,69,10/8/2019
52B567,acquisition-completed-acquirer,100,49,10/8/2019
55438C,stake-acquirer,100,48,10/8/2019
55ACCB,legal-issues-defendant,100,22,10/8/2019
55C9B5,product-release,100,64,10/8/2019
56B7C1,conference-call,100,50,10/8/2019
583A75,conference-call,100,50,10/8/2019
5A423F,earnings,100,50,10/8/2019
5B35C7,earnings-up,100,68,10/8/2019
5B35C7,earnings-up,100,68,10/8/2019
5B35C7,earnings-up,100,68,10/8/2019
5C8D61,earnings,100,50,10/8/2019
5E7E82,partnership,100,61,10/8/2019
5F1B7B,legal-issues-dismissed-defendant,100,79,10/8/2019
609208,acquisition-acquirer,100,49,10/8/2019
615B6D,conference-call,100,50,10/8/2019
665D7D,conference-call,100,50,10/8/2019
698FF9,earnings,100,50,10/8/2019
6B494E,dividend,100,50,10/8/2019
6D0CAB,operating-earnings,100,50,10/8/2019
7255D2,partnership,100,61,10/8/2019
72CB93,earnings,100,50,10/8/2019
72FCA3,credit-extension-provider,100,57,10/8/2019
73C9E2,conference-call,100,50,10/8/2019
741937,earnings,100,50,10/8/2019
7.44E+09,conference-call,100,50,10/8/2019
7712CB,earnings,100,50,10/8/2019
789ADD,legal-issues-defendant,100,22,10/8/2019
7D97DE,conference-call,100,50,10/8/2019
8303CD,conference-call,100,50,10/8/2019
85DE00,conference-call,100,50,10/8/2019
86478F,earnings,100,50,10/8/2019
8802B4,conference-call,100,50,10/8/2019
881190,conference-call,100,50,10/8/2019
88923D,conference-call,100,50,10/8/2019
88923D,conference-call,100,50,10/8/2019
8AC65D,conference-call,100,50,10/8/2019
8C6C1B,facility-open,100,65,10/8/2019
8E0E32,dividend-up,100,52,10/8/2019
8F3BCC,earnings,100,50,10/8/2019
934029,conference-call,100,50,10/8/2019
9.36E+10,fundraising,100,64,10/8/2019
9.39E+69,clinical-trials-start,100,64,10/8/2019
94563D,partnership,100,61,10/8/2019
9548BB,earnings,100,50,10/8/2019
95C392,conference-call,100,50,10/8/2019
95F59E,earnings,100,50,10/8/2019
968B00,earnings,100,50,10/8/2019
9.74E+08,product-release,100,64,10/8/2019
97693A,product-release,100,64,10/8/2019
990AD0,dividend,100,50,10/8/2019
9BB35A,conference-call,100,50,10/8/2019
9C8664,conference-call,100,50,10/8/2019
9EBAFA,dividend-up,100,81,10/8/2019
A398B9,earnings,100,50,10/8/2019
A47A7D,partnership,100,61,10/8/2019
A631A3,acquisition-completed-acquirer,100,49,10/8/2019
A63387,executive-appointment,100,54,10/8/2019
A666C8,dividend,100,50,10/8/2019
A9ED24,conference-call,100,50,10/8/2019
AA1EAA,conference-call,100,50,10/8/2019
ABBAD1,conference-call,100,50,10/8/2019
AD3C93,legal-issues-defendant,100,22,10/8/2019
AFDF2E,conference-call,100,50,10/8/2019
B2256A,conference-call,100,50,10/8/2019
B2E6B5,conference-call,100,50,10/8/2019
B4C673,conference-call,100,50,10/8/2019
B53C12,conference-call,100,50,10/8/2019
B85DCE,executive-appointment,100,54,10/8/2019
BBF349,earnings,100,50,10/8/2019
C16A8F,conference-call,100,50,10/8/2019
C3BAE7,earnings,100,50,10/8/2019
C54140,earnings,100,50,10/8/2019
C54140,partnership,100,61,10/8/2019
C7AE14,conference-call,100,50,10/8/2019
C941DC,earnings,100,50,10/8/2019
C9739A,partnership,100,61,10/8/2019
CC6FF5,partnership,100,61,10/8/2019
CD051C,conference-call,100,50,10/8/2019
CDE118,earnings,100,50,10/8/2019
CFF57D,executive-appointment,100,54,10/8/2019
D0909F,earnings-guidance,100,50,10/8/2019
D17C1B,earnings,100,50,10/8/2019
D17F7E,earnings,100,50,10/8/2019
D63B0F,conference-call,100,50,10/8/2019
D6489C,award,100,58,10/8/2019
D7AC6E,dividend,100,50,10/8/2019
D82EF3,product-release,100,64,10/8/2019
D88EF3,executive-appointment,100,54,10/8/2019
D90F43,legal-issues-defendant,100,22,10/8/2019
DB06B0,earnings,100,50,10/8/2019
DB7FA7,conference-call,100,50,10/8/2019
DC1405,earnings,100,50,10/8/2019
DCD97F,conference-call,100,50,10/8/2019
DDC415,earnings,100,50,10/8/2019
DEF058,earnings,100,50,10/8/2019
E0207A,partnership,100,61,10/8/2019
E1E093,clinical-trials,100,56,10/8/2019
E68C3D,partnership,100,61,10/8/2019
E6A53A,executive-appointment,100,54,10/8/2019
E6D89E,earnings,100,50,10/8/2019
EB61C4,conference-call,100,50,10/8/2019
ECF709,buybacks,100,74,10/8/2019
ED9576,earnings,100,50,10/8/2019
EE74E1,award,100,58,10/8/2019
EF5BED,executive-appointment,100,54,10/8/2019
F3016C,earnings,100,50,10/8/2019
F3016C,earnings,100,50,10/8/2019
F3FCC3,note-sale,100,52,10/8/2019
F4E882,earnings,100,50,10/8/2019
F6E248,clinical-trials-filed,100,60,10/8/2019
F7902B,executive-appointment,100,54,10/8/2019
F80389,business-contract,100,69,10/8/2019
FC1F9D,conference-call,100,50,10/8/2019
FDC7E6,conference-call,100,50,10/8/2019
FDF28E,earnings,100,50,10/8/2019
FFE543,earnings,100,50,10/8/2019
003B70,operating-earnings,100,50,10/9/2019
061A3B,executive-appointment,100,54,10/9/2019
099A92,conference-call,100,50,10/9/2019
0BC29E,executive-appointment,100,54,10/9/2019
0CCCB7,asset-sale,100,62,10/9/2019
0D26E0,dividend,100,50,10/9/2019
135B09,conference-call,100,50,10/9/2019
143C52,hirings,100,65,10/9/2019
154272,executive-appointment,100,54,10/9/2019
15A388,earnings,100,50,10/9/2019
16C7F0,merger-regulatory-approval,100,81,10/9/2019
1AB808,earnings,100,50,10/9/2019
1B4F31,earnings,100,50,10/9/2019
1E9A6D,earnings,100,50,10/9/2019
21DED4,executive-appointment,100,54,10/9/2019
228D42,partnership,100,61,10/9/2019
2.45E+15,earnings,100,50,10/9/2019
251988,unit-acquisition-acquiree,100,76,10/9/2019
253B2F,executive-appointment,100,54,10/9/2019
2950FF,earnings,100,50,10/9/2019
2950FF,earnings,100,50,10/9/2019
2A1009,conference-call,100,50,10/9/2019
2BA977,legal-issues-defendant,100,22,10/9/2019
2CBB58,conference-call,100,50,10/9/2019
31643A,conference-organizer,100,57,10/9/2019
31666F,dividend,100,50,10/9/2019
31803E,earnings,100,50,10/9/2019
3390DE,conference-call,100,50,10/9/2019
366A08,dividend,100,50,10/9/2019
382EAE,conference-call,100,50,10/9/2019
3A113F,conference-call,100,50,10/9/2019
3DC887,business-contract,100,69,10/9/2019
44A4FC,earnings,100,50,10/9/2019
450ECB,earnings,100,50,10/9/2019
4806CE,settlement,100,56,10/9/2019
485445,legal-issues-defendant,100,22,10/9/2019
51D876,earnings,100,50,10/9/2019
5480A7,stock-splits,100,49,10/9/2019
58EA22,conference-participant,100,50,10/9/2019
58EA22,executive-appointment,100,54,10/9/2019
5A64D5,dividend,100,50,10/9/2019
5B97B2,earnings,100,50,10/9/2019
5D43A7,executive-appointment,100,54,10/9/2019
605F40,conference-call,100,50,10/9/2019
6137BF,conference-call,100,50,10/9/2019
61E975,dividend,100,50,10/9/2019
622DBE,legal-issues-defendant,100,22,10/9/2019
633043,earnings,100,50,10/9/2019
657097,unit-acquisition-acquirer,100,49,10/9/2019
65D0AA,public-offering,100,43,10/9/2019
67303E,business-contract,100,69,10/9/2019
6B236C,conference-call,100,50,10/9/2019
6C4D2F,conference-call,100,50,10/9/2019
6D9B53,conference-participant,100,50,10/9/2019
6F0096,conference-call,100,50,10/9/2019
6F0A63,conference-call,100,50,10/9/2019
722DE3,business-contract,100,69,10/9/2019
729368,earnings,100,50,10/9/2019
72C2CE,conference-call,100,50,10/9/2019
73A71F,legal-issues-defendant,100,22,10/9/2019
752A70,unit-acquisition-acquiree,100,76,10/9/2019
75F982,revenue-up,100,66,10/9/2019
75F982,revenue-up,100,66,10/9/2019
767F86,earnings,100,50,10/9/2019
767F86,dividend,100,50,10/9/2019
78F9ED,conference-call,100,50,10/9/2019
790C34,earnings,100,50,10/9/2019
7A3633,earnings,100,50,10/9/2019
7AC86E,executive-appointment,100,54,10/9/2019
7C75FD,acquisition-acquirer,100,49,10/9/2019
7DA412,earnings,100,50,10/9/2019
80D744,conference-call,100,50,10/9/2019
82E58A,executive-appointment,100,54,10/9/2019
830BDB,conference-call,100,50,10/9/2019
838ADD,earnings,100,50,10/9/2019
86F123,executive-resignation,100,44,10/9/2019
877C0C,earnings,100,50,10/9/2019
88611B,earnings,100,50,10/9/2019
896771,acquisition-completed-acquirer,100,49,10/9/2019
8C6C1B,facility-open,100,65,10/9/2019
8FE7A5,earnings,100,50,10/9/2019
92D757,executive-appointment,100,54,10/9/2019
934CC3,legal-issues-defendant,100,22,10/9/2019
93633B,conference-call,100,50,10/9/2019
971F7B,earnings,100,50,10/9/2019
97FE80,legal-issues-defendant,100,22,10/9/2019
990AD0,earnings,100,50,10/9/2019
99B61C,patient-enrollment-start,100,58,10/9/2019
9B71A7,executive-appointment,100,54,10/9/2019
9CE4C7,product-release,100,64,10/9/2019
9CE4C7,earnings,100,50,10/9/2019
9D30A8,earnings,100,50,10/9/2019
9EA947,conference-call,100,50,10/9/2019
A01200,product-release,100,64,10/9/2019
A247F5,executive-appointment,100,54,10/9/2019
A26C26,unit-acquisition-acquiree,100,76,10/9/2019
A26C26,unit-acquisition-acquiree,100,76,10/9/2019
A631A3,executive-appointment,100,54,10/9/2019
A746F6,conference-call,100,50,10/9/2019
AA847A,conference-call,100,50,10/9/2019
AC3584,business-contract,100,69,10/9/2019
AC3584,buybacks,100,74,10/9/2019
AE4125,conference-call,100,50,10/9/2019
AF210D,earnings,100,50,10/9/2019
B54A74,earnings,100,50,10/9/2019
B7BDA3,conference-call,100,50,10/9/2019
B840EF,earnings,100,50,10/9/2019
B8EF97,revenues,100,50,10/9/2019
BB5271,partnership,100,61,10/9/2019
C41C25,executive-appointment,100,54,10/9/2019
C99CC8,earnings,100,50,10/9/2019
CBB77B,executive-appointment,100,54,10/9/2019
CBFFDD,facility-open,100,65,10/9/2019
D06755,earnings,100,50,10/9/2019
D437C3,earnings,100,50,10/9/2019
D7A953,earnings,100,50,10/9/2019
D8ECA1,legal-issues-defendant,100,22,10/9/2019
D90F43,conference-call,100,50,10/9/2019
DC6AA0,earnings,100,50,10/9/2019
DD3BB1,earnings,100,50,10/9/2019
DD682D,partnership,100,61,10/9/2019
DDB002,conference-call,100,50,10/9/2019
E11C41,conference-call,100,50,10/9/2019
E124EB,conference-call,100,50,10/9/2019
E15736,conference-call,100,50,10/9/2019
E15736,conference-call,100,50,10/9/2019
E15736,conference-call,100,50,10/9/2019
E1E36F,earnings,100,50,10/9/2019
E2F130,conference-call,100,50,10/9/2019
E30A8F,product-release,100,64,10/9/2019
E30A8F,product-release,100,64,10/9/2019
E30A8F,partnership,100,61,10/9/2019
E30A8F,partnership,100,61,10/9/2019
E6E012,earnings,100,50,10/9/2019
E6E012,earnings,100,50,10/9/2019
ECF709,executive-appointment,100,54,10/9/2019
ED0D7C,conference-call,100,50,10/9/2019
EDD234,conference-call,100,50,10/9/2019
F32F88,conference-call,100,50,10/9/2019
F5349B,earnings,100,50,10/9/2019
F6DCE4,executive-appointment,100,54,10/9/2019
F85CC0,earnings,100,50,10/9/2019
F85CC0,earnings,100,50,10/9/2019
FA35C6,acquisition-acquirer,100,49,10/9/2019
FF4BA4,award,100,58,10/9/2019
00067A,partnership,100,61,10/10/2019
00326D,earnings,100,50,10/10/2019
0157B1,facility-open,100,65,10/10/2019
0157B1,conference-call,100,50,10/10/2019
03B431,conference-call,100,50,10/10/2019
07EC43,executive-appointment,100,54,10/10/2019
09DE1F,product-release,100,64,10/10/2019
0A59F8,partnership,100,61,10/10/2019
0DC050,earnings,100,50,10/10/2019
0F0440,executive-appointment,100,54,10/10/2019
0F2BC9,conference-call,100,50,10/10/2019
152B9E,conference-call,100,50,10/10/2019
1B5FEA,conference-participant,100,50,10/10/2019
1FE3CB,conference-call,100,50,10/10/2019
202E5A,reorganization,100,53,10/10/2019
21268E,conference-call,100,50,10/10/2019
223552,ipo-pricing,100,50,10/10/2019
225CA2,executive-appointment,100,54,10/10/2019
228D42,partnership,100,61,10/10/2019
228D42,partnership,100,61,10/10/2019
238302,conference-call,100,50,10/10/2019
24A89A,legal-issues-defendant,100,22,10/10/2019
2667B6,product-recall,100,29,10/10/2019
2667B6,dividend,100,50,10/10/2019
26F31D,earnings,100,50,10/10/2019
2720AB,conference-call,100,50,10/10/2019
2A17B1,conference-call,100,50,10/10/2019
2B7A40,earnings,100,50,10/10/2019
2BA977,legal-issues-defendant,100,22,10/10/2019
2DC88B,earnings,100,50,10/10/2019
2F1299,partnership,100,61,10/10/2019
309922,conference-call,100,50,10/10/2019
31DB20,product-price-raise,100,57,10/10/2019
328250,conference-call,100,50,10/10/2019
32DCB3,private-placement,100,56,10/10/2019
33E8C7,earnings,100,50,10/10/2019
34A959,earnings,100,50,10/10/2019
35F4B5,conference-call,100,50,10/10/2019
3BE00F,earnings,100,50,10/10/2019
415188,conference-call,100,50,10/10/2019
45444E,earnings,100,50,10/10/2019
479930,earnings,100,50,10/10/2019
47BA98,conference-call,100,50,10/10/2019
4806CE,conference-call,100,50,10/10/2019
4.91E+58,conference-call,100,50,10/10/2019
4A2457,government-contract,100,69,10/10/2019
4C1FA1,earnings,100,50,10/10/2019
4C6C63,dividend-up,100,60,10/10/2019
4EE167,earnings,100,50,10/10/2019
50070E,conference-organizer,100,57,10/10/2019
51527B,conference-call,100,50,10/10/2019
53A226,earnings,100,50,10/10/2019
53E575,conference-call,100,50,10/10/2019
546A9C,earnings,100,50,10/10/2019
55438C,partnership,100,61,10/10/2019
5546DA,conference-call,100,50,10/10/2019
56277A,legal-issues-defendant,100,22,10/10/2019
56765E,earnings,100,50,10/10/2019
589803,earnings,100,50,10/10/2019
5A64D5,conference-call,100,50,10/10/2019
5B3415,conference-call,100,50,10/10/2019
5C2A47,conference-call,100,50,10/10/2019
5D16CF,conference-call,100,50,10/10/2019
5D41E4,conference-participant,100,50,10/10/2019
5F2FF7,earnings-positive,100,69,10/10/2019
5F2FF7,earnings-positive,100,69,10/10/2019
6137BF,investment-investor,100,55,10/10/2019
619882,partnership,100,61,10/10/2019
619882,partnership,100,61,10/10/2019
619882,conference-participant,100,50,10/10/2019
619882,conference-participant,100,50,10/10/2019
636639,partnership,100,61,10/10/2019
64636E,patient-enrollment-complete,100,64,10/10/2019
64636E,patient-enrollment-complete,100,64,10/10/2019
649CBD,legal-issues-defendant,100,22,10/10/2019
68BA15,acquisition-acquirer,100,49,10/10/2019
6ABCB8,legal-issues-defendant,100,22,10/10/2019
6CC55E,earnings,100,50,10/10/2019
6D6B40,earnings,100,50,10/10/2019
6ED519,conference-call,100,50,10/10/2019
6F6559,award,100,58,10/10/2019
713810,executive-appointment,100,54,10/10/2019
7255D2,partnership,100,61,10/10/2019
726EEA,dividend,100,50,10/10/2019
728737,dividend,100,50,10/10/2019
73A71F,legal-issues-defendant,100,22,10/10/2019
73BCBA,conference-call,100,50,10/10/2019
76BD96,note-sale,100,52,10/10/2019
76D79A,conference-call,100,50,10/10/2019
771985,revenues,100,50,10/10/2019
773A17,earnings,100,50,10/10/2019
7740DE,same-store-sales-up,100,55,10/10/2019
790C34,business-contract,100,69,10/10/2019
790C34,business-contract,100,69,10/10/2019
791D59,earnings,100,50,10/10/2019
797C20,conference-call,100,50,10/10/2019
7A10FF,earnings,100,50,10/10/2019
7A51FE,conference-call,100,50,10/10/2019
7B9212,revenues,100,50,10/10/2019
7BAAE7,earnings,100,50,10/10/2019
7C75FD,conference-call,100,50,10/10/2019
7CBC40,earnings,100,50,10/10/2019
837C04,earnings,100,50,10/10/2019
83A065,public-offering,100,43,10/10/2019
86A1B9,earnings,100,50,10/10/2019
86F123,business-contract,100,69,10/10/2019
896771,conference-call,100,50,10/10/2019
89F693,earnings,100,50,10/10/2019
8AB85C,legal-issues-defendant,100,22,10/10/2019
8B4A45,facility-upgrade,100,65,10/10/2019
8C6C1B,facility-open,100,65,10/10/2019
8D4AE6,earnings,100,50,10/10/2019
8DBE73,conference-call,100,50,10/10/2019
8DE74B,conference-call,100,50,10/10/2019
8E82A6,earnings,100,50,10/10/2019
8E9CD8,earnings,100,50,10/10/2019
9196A2,executive-appointment,100,54,10/10/2019
92D3A0,dividend,100,50,10/10/2019
934029,clinical-trials-start,100,64,10/10/2019
93F143,earnings,100,50,10/10/2019
949D62,earnings,100,50,10/10/2019
94A326,executive-appointment,100,54,10/10/2019
950AB7,ipo-pricing,100,50,10/10/2019
950CDB,earnings,100,50,10/10/2019
9.74E+08,earnings,100,50,10/10/2019
980C14,dividend,100,50,10/10/2019
98CEBB,earnings,100,50,10/10/2019
9E98F2,revenues,100,50,10/10/2019
A01664,earnings,100,50,10/10/2019
A15C71,conference-call,100,50,10/10/2019
A1EAC8,conference-call,100,50,10/10/2019
A5151E,earnings,100,50,10/10/2019
A6213D,dividend,100,50,10/10/2019
A6FE1C,unit-acquisition-acquirer,100,49,10/10/2019
AA5C8E,earnings,100,50,10/10/2019
ACC7D3,earnings,100,50,10/10/2019
AFEC35,earnings,100,50,10/10/2019
B05118,earnings,100,50,10/10/2019
B0FE08,conference-call,100,50,10/10/2019
B1A85D,partnership,100,61,10/10/2019
B1B10C,dividend-up,100,81,10/10/2019
B1DF3C,earnings,100,50,10/10/2019
B2DAF6,earnings,100,50,10/10/2019
B7BBFF,dividend,100,50,10/10/2019
B7EB38,earnings,100,50,10/10/2019
B85DCE,executive-appointment,100,54,10/10/2019
B934BF,conference-call,100,50,10/10/2019
B934BF,conference-call,100,50,10/10/2019
B9764A,earnings,100,50,10/10/2019
B98EFA,conference-participant,100,50,10/10/2019
BB0587,conference-call,100,50,10/10/2019
BB88B6,award,100,58,10/10/2019
BBF349,executive-appointment,100,54,10/10/2019
BDD12C,executive-appointment,100,54,10/10/2019
BE645B,award,100,58,10/10/2019
BF79F5,conference-call,100,50,10/10/2019
C05839,executive-appointment,100,54,10/10/2019
C0F70B,earnings,100,50,10/10/2019
C356AC,earnings,100,50,10/10/2019
C38440,earnings,100,50,10/10/2019
C4706C,dividend-up,100,62,10/10/2019
C4C77F,dividend-up,100,81,10/10/2019
C6C702,conference-call,100,50,10/10/2019
C7FC95,business-contract,100,69,10/10/2019
C7FC95,business-contract,100,69,10/10/2019
C8257F,conference-call,100,50,10/10/2019
C83B88,executive-appointment,100,54,10/10/2019
C8A248,dividend,100,50,10/10/2019
C951A2,earnings,100,50,10/10/2019
C98CDB,earnings,100,50,10/10/2019
C9A96E,conference-organizer,100,57,10/10/2019
C9A96E,conference-organizer,100,57,10/10/2019
CA1620,conference-call,100,50,10/10/2019
CA212F,earnings,100,50,10/10/2019
CA3CB9,earnings,100,50,10/10/2019
CE2791,conference-call,100,50,10/10/2019
CF6A5A,earnings,100,50,10/10/2019
CFF97C,analyst-ratings-change-positive-rater,20,50,10/10/2019
D08D2C,dividend,100,50,10/10/2019
D17C1B,revenue-volume,100,50,10/10/2019
D1AE3B,investment-investor,100,55,10/10/2019
D25249,conference-call,100,50,10/10/2019
D2E553,dividend-up,100,52,10/10/2019
D56E4C,conference-call,100,50,10/10/2019
D56E4C,conference-call,100,50,10/10/2019
D58A11,earnings,100,50,10/10/2019
D6489C,facility-open,100,65,10/10/2019
D65A13,conference-call,100,50,10/10/2019
D82EF3,conference-call,100,50,10/10/2019
D8DA3D,conference-call,100,50,10/10/2019
DD0F15,clinical-trials-start,100,64,10/10/2019
DF01B1,earnings,100,50,10/10/2019
DF204B,facility-open,100,65,10/10/2019
DF6FDD,earnings,100,50,10/10/2019
E05DC8,earnings,100,50,10/10/2019
E074A0,earnings,100,50,10/10/2019
E16133,conference-call,100,50,10/10/2019
E96E0B,patient-enrollment-start,100,58,10/10/2019
E9E6FD,conference-call,100,50,10/10/2019
EBD89A,conference-call,100,50,10/10/2019
ECD263,partnership,100,61,10/10/2019
ECD263,partnership,100,61,10/10/2019
ED1A74,executive-appointment,100,54,10/10/2019
ED3CA8,conference-call,100,50,10/10/2019
EF7163,conference-call,100,50,10/10/2019
F30508,executive-appointment,100,54,10/10/2019
F44EA2,earnings,100,50,10/10/2019
F4D241,revenues,100,50,10/10/2019
F51DB0,conference-call,100,50,10/10/2019
F6E248,earnings,100,50,10/10/2019
FA918D,conference-call,100,50,10/10/2019
FAB97A,earnings,100,50,10/10/2019
FB728F,conference-call,100,50,10/10/2019
FD4BBE,earnings,100,50,10/10/2019
FE9C0D,executive-appointment,100,54,10/10/2019
FEC475,acquisition-completed-acquirer,100,49,10/10/2019
FFAB4A,earnings,100,50,10/10/2019
0157B1,market-entry,100,57,10/11/2019
03B8CF,acquisition-completed-acquirer,100,49,10/11/2019
95294,dividend,100,50,10/11/2019
0BD4E8,award,100,58,10/11/2019
0C6861,conference-call,100,50,10/11/2019
0CCCB7,conference-call,100,50,10/11/2019
0E5223,conference-call,100,50,10/11/2019
12DE76,acquisition-completed-acquirer,100,49,10/11/2019
131443,executive-appointment,100,54,10/11/2019
1FA886,partnership,100,61,10/11/2019
1FA886,partnership,100,61,10/11/2019
1FCC00,executive-appointment,100,54,10/11/2019
21153F,executive-appointment,100,54,10/11/2019
21153F,executive-appointment,100,54,10/11/2019
251988,earnings,100,50,10/11/2019
2667B6,merger-regulatory-approval,100,81,10/11/2019
28DCF3,earnings,100,50,10/11/2019
2D981A,clinical-trials,100,56,10/11/2019
31666F,executive-appointment,100,54,10/11/2019
366A08,conference-call,100,50,10/11/2019
3696BF,conference-call,100,50,10/11/2019
416291,conference-call,100,50,10/11/2019
43A74A,earnings,100,50,10/11/2019
492117,executive-resignation,100,44,10/11/2019
4A2457,business-contract,100,69,10/11/2019
4B3676,acquisition-interest-acquirer,100,46,10/11/2019
50D1EC,award,100,58,10/11/2019
5225A4,conference-organizer,100,57,10/11/2019
543900,asset-sale,100,62,10/11/2019
562853,conference-call,100,50,10/11/2019
57B174,dividend,100,50,10/11/2019
5B6C11,earnings,100,50,10/11/2019
5B97B2,executive-appointment,100,54,10/11/2019
622DBE,acquisition-interest-acquiree,100,82,10/11/2019
665618,conference-call,100,50,10/11/2019
66749D,conference-call,100,50,10/11/2019
6CB7F9,conference-call,100,50,10/11/2019
6CDFC6,conference-call,100,50,10/11/2019
6D3B7B,earnings,100,50,10/11/2019
6E8864,product-release,100,64,10/11/2019
73A71F,legal-issues-defendant,100,22,10/11/2019
7448A3,conference-call,100,50,10/11/2019
762B8D,dividend,100,50,10/11/2019
7823A3,earnings,100,50,10/11/2019
789A7D,dividend-up,100,81,10/11/2019
7B1E50,partnership,100,61,10/11/2019
7B9AFA,earnings,100,50,10/11/2019
7BFF81,executive-resignation,100,44,10/11/2019
7D35D8,conference-call,100,50,10/11/2019
7E2DE6,earnings,100,50,10/11/2019
7E62B5,conference-call,100,50,10/11/2019
7F0372,earnings,100,50,10/11/2019
855DF7,conference-call,100,50,10/11/2019
8B3B0E,conference-call,100,50,10/11/2019
8BAA15,earnings,100,50,10/11/2019
8C6C1B,facility-open,100,65,10/11/2019
92D3A0,earnings,100,50,10/11/2019
93D207,partnership,100,61,10/11/2019
97AF94,dividend,100,50,10/11/2019
9B730A,clinical-trials-positive,100,87,10/11/2019
9CF9B1,earnings,100,50,10/11/2019
9D5D35,earnings,100,50,10/11/2019
9E98F2,legal-issues-defendant,100,22,10/11/2019
9F5997,conference-call,100,50,10/11/2019
A3800A,executive-resignation,100,44,10/11/2019
A3AAA5,dividend,100,50,10/11/2019
A3F598,settlement,100,56,10/11/2019
A41450,dividend,100,50,10/11/2019
A58224,conference-call,100,50,10/11/2019
A6FE1C,unit-acquisition-acquirer,100,49,10/11/2019
B1FC3B,conference-participant,100,50,10/11/2019
B4703C,dividend-up,100,81,10/11/2019
B803B1,conference-call,100,50,10/11/2019
B9764A,legal-issues-defendant,100,22,10/11/2019
BC948D,conference-call,100,50,10/11/2019
C66A8C,earnings,100,50,10/11/2019
CF351E,earnings,100,50,10/11/2019
D139BC,conference-call,100,50,10/11/2019
D78BF1,legal-verdict-disfavored,100,22,10/11/2019
D78BF1,legal-verdict-disfavored,100,22,10/11/2019
D854DD,fundraising,100,64,10/11/2019
D854DD,fundraising,100,64,10/11/2019
DC0998,conference-call,100,50,10/11/2019
E4158B,earnings,100,50,10/11/2019
E592F0,earnings,100,50,10/11/2019
ED9C04,unit-acquisition-acquirer,100,49,10/11/2019
EE967B,earnings,100,50,10/11/2019
F3FCC3,earnings,100,50,10/11/2019
F85CC0,earnings,100,50,10/11/2019
F85CC0,earnings,100,50,10/11/2019
F8BDCE,earnings,100,50,10/11/2019
F8BDCE,earnings,100,50,10/11/2019
FAE021,award,100,58,10/11/2019
FF4343,conference-call,100,50,10/11/2019
6CC55E,clinical-trials-positive,100,87,10/12/2019
458D2C,legal-issues-defendant,100,22,10/13/2019
7B9AFA,unit-acquisition-acquirer,100,49,10/13/2019
A3800A,legal-issues-defendant,100,22,10/13/2019
0142B5,conference-call,100,50,10/14/2019
01D03F,partnership,100,61,10/14/2019
03596A,unit-acquisition-acquiree,100,76,10/14/2019
03B8CF,partnership,100,61,10/14/2019
03FB17,earnings,100,50,10/14/2019
0A59F8,partnership,100,61,10/14/2019
0F04E5,earnings,100,50,10/14/2019
1201B5,private-placement,100,56,10/14/2019
1201B5,unit-acquisition-acquirer,100,49,10/14/2019
1201B5,unit-acquisition-acquirer,100,49,10/14/2019
1A5957,earnings,100,50,10/14/2019
1AF7E2,conference-call,100,50,10/14/2019
1E1125,conference-organizer,100,57,10/14/2019
221445,conference-call,100,50,10/14/2019
222BF9,conference-call,100,50,10/14/2019
2EB88B,earnings,100,50,10/14/2019
315EB0,executive-appointment,100,54,10/14/2019
31F25C,legal-issues-defendant,100,22,10/14/2019
34E9F9,dividend,100,50,10/14/2019
367E1C,earnings,100,50,10/14/2019
396D7C,executive-appointment,100,54,10/14/2019
42AABD,patent-awarded,100,72,10/14/2019
431B74,acquisition-acquirer,100,49,10/14/2019
431B74,acquisition-acquirer,100,49,10/14/2019
44209A,earnings,100,50,10/14/2019
44ED36,dividend,100,50,10/14/2019
453282,acquisition-regulatory-approval-acquirer,100,54,10/14/2019
4595EF,conference-call,100,50,10/14/2019
4.60E+06,patent-awarded,100,72,10/14/2019
47752F,executive-appointment,100,54,10/14/2019
492117,unit-acquisition-acquirer,100,49,10/14/2019
520632,partnership,100,61,10/14/2019
57B174,executive-appointment,100,54,10/14/2019
5D63F1,earnings,100,50,10/14/2019
610D47,conference-call,100,50,10/14/2019
61A586,earnings,100,50,10/14/2019
694749,executive-appointment,100,54,10/14/2019
6BC6F9,earnings,100,50,10/14/2019
6D4636,executive-appointment,100,54,10/14/2019
6D9ECA,merger-failed,100,21,10/14/2019
7032D0,earnings,100,50,10/14/2019
70FCEF,executive-appointment,100,54,10/14/2019
71E2EF,earnings,100,50,10/14/2019
726DDF,conference-call,100,50,10/14/2019
73A71F,legal-issues-defendant,100,22,10/14/2019
750DFF,stake-acquiree,100,62,10/14/2019
79167B,conference-call,100,50,10/14/2019
791EC1,executive-appointment,100,54,10/14/2019
7ACFD4,legal-issues-defendant,100,22,10/14/2019
7D7716,award,100,58,10/14/2019
7F3669,earnings,100,50,10/14/2019
804708,conference-call,100,50,10/14/2019
838ADD,dividend,100,50,10/14/2019
860AB6,earnings,100,50,10/14/2019
88193E,conference-call,100,50,10/14/2019
89FBB1,conference-call,100,50,10/14/2019
8B6E7E,award,100,58,10/14/2019
8C6C1B,facility-open,100,65,10/14/2019
900356,conference-call,100,50,10/14/2019
900356,partnership,100,61,10/14/2019
9087B9,conference-call,100,50,10/14/2019
94756D,credit-extension-recipient,100,69,10/14/2019
9507FF,earnings,100,50,10/14/2019
9D4EC7,conference-call,100,50,10/14/2019
9D4EC7,conference-call,100,50,10/14/2019
9D4EC7,conference-call,100,50,10/14/2019
9DDE1B,unit-acquisition-acquirer,100,49,10/14/2019
9E575E,executive-appointment,100,54,10/14/2019
9EF4CF,earnings,100,50,10/14/2019
9F03CF,executive-appointment,100,54,10/14/2019
A4A612,conference-call,100,50,10/14/2019
A63387,executive-appointment,100,54,10/14/2019
A74F6F,conference-call,100,50,10/14/2019
A806FA,conference-call,100,50,10/14/2019
A8E2FE,clinical-trials,100,56,10/14/2019
AAEE21,conference-call,100,50,10/14/2019
AD23DE,conference-call,100,50,10/14/2019
B1FC3B,business-contract,100,69,10/14/2019
B48D6A,clinical-trials,100,56,10/14/2019
B7FA9B,conference-call,100,50,10/14/2019
B9CD50,earnings,100,50,10/14/2019
BA0442,acquisition-acquirer,100,49,10/14/2019
BDD12C,dividend,100,50,10/14/2019
BDE867,executive-appointment,100,54,10/14/2019
C38440,executive-appointment,100,54,10/14/2019
C564E4,regulatory-product-approval-granted,100,81,10/14/2019
C83B88,executive-appointment,100,54,10/14/2019
CB22CD,facility-open,100,65,10/14/2019
CF3FF9,conference-participant,100,50,10/14/2019
CFF97C,product-release,100,64,10/14/2019
D06996,earnings,100,50,10/14/2019
D3C794,earnings,100,50,10/14/2019
D57D99,earnings,100,50,10/14/2019
D6534D,conference-call,100,50,10/14/2019
D7AC6E,product-release,100,64,10/14/2019
D8ECA1,legal-issues-defendant,100,22,10/14/2019
DB5CA5,partnership,100,61,10/14/2019
DD9E41,earnings,100,50,10/14/2019
E0207A,earnings,100,50,10/14/2019
E802CE,revenue-volume,100,50,10/14/2019
E8A49A,executive-appointment,100,54,10/14/2019
E93A40,earnings,100,50,10/14/2019
EA62FC,conference-call,100,50,10/14/2019
ED8676,acquisition-completed-acquirer,100,49,10/14/2019
F05B1B,unit-acquisition-acquiree,100,76,10/14/2019
F4E992,dividend,100,50,10/14/2019
F6FF0D,conference-call,100,50,10/14/2019
F702CA,executive-appointment,100,54,10/14/2019
F702CA,dividend,100,50,10/14/2019
F8084B,earnings,100,50,10/14/2019
F82D37,executive-appointment,100,54,10/14/2019
F93C8A,dividend,100,50,10/14/2019
FAE021,earnings,100,50,10/14/2019
FF4BA4,award,100,58,10/14/2019
FF5413,earnings,100,50,10/14/2019
00326E,conference-call,100,50,10/15/2019
00D6B5,conference-call,100,50,10/15/2019
02870F,facility-open,100,65,10/15/2019
03542C,revenue-up,100,69,10/15/2019
070B45,earnings,100,50,10/15/2019
07CA6A,dividend-up,100,81,10/15/2019
07CA6A,dividend-up,100,81,10/15/2019
09062E,earnings,100,50,10/15/2019
0919B1,conference-call,100,50,10/15/2019
0A0D9E,conference-call,100,50,10/15/2019
0A59F8,partnership,100,61,10/15/2019
0A9D0A,earnings,100,50,10/15/2019
0DBB81,public-offering,100,43,10/15/2019
0F0440,donation,100,54,10/15/2019
0F0693,legal-issues-plaintiff,100,44,10/15/2019
0F91FC,conference-call,100,50,10/15/2019
108A2B,conference-call,100,50,10/15/2019
10AE08,earnings,100,50,10/15/2019
149301,earnings,100,50,10/15/2019
15789A,earnings,100,50,10/15/2019
1A2D9F,executive-appointment,100,54,10/15/2019
205AD5,earnings,100,50,10/15/2019
21245F,executive-resignation,100,44,10/15/2019
214051,earnings,100,50,10/15/2019
2158DF,earnings,100,50,10/15/2019
221783,earnings,100,50,10/15/2019
228D42,business-contract,100,69,10/15/2019
239106,conference-call,100,50,10/15/2019
24A89A,clinical-trials,100,56,10/15/2019
263216,executive-appointment,100,54,10/15/2019
26F31D,partnership,100,61,10/15/2019
26F99F,clinical-trials-start,100,64,10/15/2019
2AA6A8,partnership,100,61,10/15/2019
2C681C,clinical-trials-start,100,64,10/15/2019
2C681C,clinical-trials-start,100,64,10/15/2019
2EBA55,dividend,100,50,10/15/2019
3.14E+47,buybacks,100,74,10/15/2019
3.30E+34,earnings-up,100,68,10/15/2019
3.30E+34,earnings-up,100,68,10/15/2019
3.30E+34,earnings-up,100,68,10/15/2019
37020C,conference-call,100,50,10/15/2019
370C50,legal-issues-plaintiff,100,44,10/15/2019
373B06,earnings,100,50,10/15/2019
387541,dividend,100,50,10/15/2019
39692D,partnership,100,61,10/15/2019
3A1C46,earnings,100,50,10/15/2019
3B37F7,dividend,100,50,10/15/2019
3C75D6,credit-extension-recipient,100,69,10/15/2019
3ED92D,conference-call,100,50,10/15/2019
4017AD,earnings,100,50,10/15/2019
43A060,product-release,100,64,10/15/2019
447FC6,conference-call,100,50,10/15/2019
448BF3,executive-appointment,100,54,10/15/2019
4A5C8D,partnership,100,61,10/15/2019
4B3DC9,executive-appointment,100,54,10/15/2019
4BEB48,earnings,100,50,10/15/2019
4C5CC9,conference-call,100,50,10/15/2019
4D72C8,conference-call,100,50,10/15/2019
4D72C8,conference-call,100,50,10/15/2019
4D971D,conference-call,100,50,10/15/2019
4E2D94,note-sale,100,52,10/15/2019
4EE14A,earnings,100,50,10/15/2019
4EE14A,earnings,100,50,10/15/2019
4FF163,business-contract,100,69,10/15/2019
52015A,conference-call,100,50,10/15/2019
520632,business-contract,100,69,10/15/2019
55ACCB,earnings,100,50,10/15/2019
589F5A,dividend,100,50,10/15/2019
58CA9A,earnings,100,50,10/15/2019
58EA22,conference-participant,100,50,10/15/2019
5CCDAD,earnings,100,50,10/15/2019
5FDBD0,executive-appointment,100,54,10/15/2019
5FDBD0,executive-appointment,100,54,10/15/2019
5FE4B6,conference-call,100,50,10/15/2019
60EA12,product-release,100,64,10/15/2019
619882,earnings,100,50,10/15/2019
619882,dividend,100,50,10/15/2019
6634D9,partnership,100,61,10/15/2019
67B923,conference-call,100,50,10/15/2019
68B03F,business-contract,100,69,10/15/2019
68B03F,earnings,100,50,10/15/2019
69345C,earnings,100,50,10/15/2019
6C6D73,facility-open,100,65,10/15/2019
6E705B,business-contract,100,69,10/15/2019
71694D,conference-call,100,50,10/15/2019
722DE3,business-contract,100,69,10/15/2019
72DF04,earnings,100,50,10/15/2019
73A71F,conference-call,100,50,10/15/2019
73A71F,legal-issues-defendant,100,22,10/15/2019
747219,conference-participant,100,50,10/15/2019
769F40,earnings,100,50,10/15/2019
76BD96,note-sale,100,52,10/15/2019
7710F3,earnings,100,50,10/15/2019
790C34,partnership,100,61,10/15/2019
7A0EC4,business-contract,100,69,10/15/2019
7AC86E,earnings,100,50,10/15/2019
7ACD98,conference-call,100,50,10/15/2019
7ADE57,partnership,100,61,10/15/2019
7B0BA6,earnings,100,50,10/15/2019
7C790D,conference-call,100,50,10/15/2019
810FAD,product-release,100,64,10/15/2019
8.22E+27,conference-call,100,50,10/15/2019
82C202,executive-appointment,100,54,10/15/2019
850779,earnings-per-share-positive,100,69,10/15/2019
850779,earnings-per-share,100,50,10/15/2019
850779,earnings-per-share,100,50,10/15/2019
850779,earnings-per-share,100,50,10/15/2019
8A0368,conference-call,100,50,10/15/2019
8AB85C,clinical-trials,100,56,10/15/2019
8C5519,earnings,100,50,10/15/2019
8C5519,earnings,100,50,10/15/2019
8C5519,earnings,100,50,10/15/2019
8C5519,earnings,100,50,10/15/2019
8C5519,earnings,100,50,10/15/2019
8C5519,earnings,100,50,10/15/2019
8D4486,partnership,100,61,10/15/2019
8D4486,business-contract,100,69,10/15/2019
8D4486,partnership,100,61,10/15/2019
8D4486,partnership,100,61,10/15/2019
8D9993,conference-call,100,50,10/15/2019
8DBE73,acquisition-completed-acquirer,100,49,10/15/2019
8DDA23,dividend,100,50,10/15/2019
8E3F58,earnings,100,50,10/15/2019
8E8E6E,unit-acquisition-acquiree,100,76,10/15/2019
8F8F2F,conference-call,100,50,10/15/2019
8FF57A,government-contract,100,69,10/15/2019
92D757,executive-appointment,100,54,10/15/2019
96B4FF,clinical-trials,100,56,10/15/2019
96F126,earnings,100,50,10/15/2019
9ABD30,earnings,100,50,10/15/2019
9BF177,business-contract,100,69,10/15/2019
9CA4C6,dividend,100,50,10/15/2019
9CA4C6,earnings-up,100,68,10/15/2019
9E0811,earnings,100,50,10/15/2019
9FD2D9,conference-call,100,50,10/15/2019
9FF5F1,earnings,100,50,10/15/2019
A23747,earnings,100,50,10/15/2019
A3800A,earnings,100,50,10/15/2019
A6828A,earnings,100,50,10/15/2019
A72AB6,executive-appointment,100,54,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A746F6,earnings-per-share-positive,100,69,10/15/2019
A753BB,executive-appointment,100,54,10/15/2019
A75D43,earnings,100,50,10/15/2019
A871B0,executive-appointment,100,54,10/15/2019
A8E2FE,clinical-trials,100,56,10/15/2019
AB7F05,earnings-up,100,68,10/15/2019
AD3008,earnings,100,50,10/15/2019
AE3113,executive-appointment,100,54,10/15/2019
AE3113,earnings,100,50,10/15/2019
AFD1CA,conference-call,100,50,10/15/2019
AFF43F,dividend,100,50,10/15/2019
AFF7B4,dividend,100,50,10/15/2019
B0998E,earnings,100,50,10/15/2019
B1FC3B,government-contract,100,69,10/15/2019
B2206F,partnership,100,61,10/15/2019
B2206F,earnings,100,50,10/15/2019
B303A6,executive-appointment,100,54,10/15/2019
B77F14,business-contract,100,69,10/15/2019
B8A51F,revenue-guidance-meet-expectations,100,59,10/15/2019
B96DF5,earnings,100,50,10/15/2019
BC5680,earnings,100,50,10/15/2019
BFCACF,conference-call,100,50,10/15/2019
BFD0A7,business-contract,100,69,10/15/2019
C3CF29,executive-appointment,100,54,10/15/2019
C4A241,conference-call,100,50,10/15/2019
C7859D,earnings-up,100,68,10/15/2019
C7859D,earnings,100,50,10/15/2019
C7859D,earnings,100,50,10/15/2019
C7859D,earnings,100,50,10/15/2019
C7859D,earnings,100,50,10/15/2019
C7859D,earnings,100,50,10/15/2019
C8257F,earnings,100,50,10/15/2019
C9E04B,executive-appointment,100,54,10/15/2019
CAB222,conference-call,100,50,10/15/2019
CDC217,conference-participant,100,50,10/15/2019
CE1002,dividend,100,50,10/15/2019
CE96E7,earnings,100,50,10/15/2019
CF9054,partnership,100,61,10/15/2019
CFF15D,dividend,100,50,10/15/2019
D33D8C,earnings-per-share-positive,100,69,10/15/2019
D33D8C,earnings-per-share-positive,100,69,10/15/2019
D33D8C,earnings-per-share-positive,100,69,10/15/2019
D33D8C,earnings-per-share-positive,100,69,10/15/2019
D33D8C,earnings-per-share-positive,100,69,10/15/2019
D33D8C,earnings-per-share-positive,100,69,10/15/2019
D3CEDF,conference-call,100,50,10/15/2019
D518D8,conference-call,100,50,10/15/2019
D5AF19,earnings,100,50,10/15/2019
D64EDF,earnings,100,50,10/15/2019
D721C6,facility-open,100,65,10/15/2019
D88EF3,note-sale,100,52,10/15/2019
D88EF3,note-sale,100,52,10/15/2019
D8ECA1,legal-issues-defendant,100,22,10/15/2019
D90F43,partnership,100,61,10/15/2019
DF532D,earnings,100,50,10/15/2019
DF532D,earnings,100,50,10/15/2019
E09556,earnings,100,50,10/15/2019
E12A6E,dividend,100,50,10/15/2019
E30A8F,earnings,100,50,10/15/2019
E30B34,executive-appointment,100,54,10/15/2019
E30B34,executive-appointment,100,54,10/15/2019
E4CE73,partnership,100,61,10/15/2019
E87676,conference-call,100,50,10/15/2019
E8846E,earnings-positive,100,69,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
E8846E,earnings,100,50,10/15/2019
EB36DE,conference-call,100,50,10/15/2019
ED3CA8,executive-appointment,100,54,10/15/2019
ED9576,earnings,100,50,10/15/2019
ED9C04,partnership,100,61,10/15/2019
EEEA9F,earnings,100,50,10/15/2019
F179ED,earnings,100,50,10/15/2019
F5D499,conference-participant,100,50,10/15/2019
F6E248,executive-appointment,100,54,10/15/2019
F7D8AE,ipo,100,71,10/15/2019
F88A04,partnership,100,61,10/15/2019
FACCF6,earnings,100,50,10/15/2019
FAEABE,earnings-per-share-positive,100,69,10/15/2019
FAEABE,earnings-up,100,68,10/15/2019
FAEABE,earnings-up,100,68,10/15/2019
FDE409,business-contract,100,69,10/15/2019
FDF28E,executive-resignation,100,44,10/15/2019
0157B1,partnership,100,61,10/16/2019
01B8D6,earnings,100,50,10/16/2019
01D03F,revenue-up,100,69,10/16/2019
03D5F9,earnings,100,50,10/16/2019
03F5A4,earnings-positive,100,69,10/16/2019
0A59F8,partnership,100,61,10/16/2019
0B4D10,earnings,100,50,10/16/2019
0C355F,conference-call,100,50,10/16/2019
0DBB81,public-offering,100,43,10/16/2019
1065BC,conference-call,100,50,10/16/2019
1220D2,earnings,100,50,10/16/2019
12F98C,executive-appointment,100,54,10/16/2019
131443,product-release,100,64,10/16/2019
147C38,partnership,100,61,10/16/2019
152AB9,earnings,100,50,10/16/2019
16B183,conference-call,100,50,10/16/2019
1748B3,earnings,100,50,10/16/2019
1748B3,earnings,100,50,10/16/2019
1748B3,earnings,100,50,10/16/2019
1748B3,earnings,100,50,10/16/2019
1748B3,earnings,100,50,10/16/2019
1748B3,earnings,100,50,10/16/2019
1834C0,conference-call,100,50,10/16/2019
190B91,earnings,100,50,10/16/2019
1D5C51,conference-call,100,50,10/16/2019
1DA44F,dividend-up,100,81,10/16/2019
1DE526,conference-call,100,50,10/16/2019
1F716B,acquisition-acquirer,100,49,10/16/2019
20BEEA,earnings,100,50,10/16/2019
20BEEA,earnings,100,50,10/16/2019
20BEEA,earnings,100,50,10/16/2019
2.45E+15,earnings,100,50,10/16/2019
25AB8E,partnership,100,61,10/16/2019
26CC63,executive-appointment,100,54,10/16/2019
26D8ED,conference-call,100,50,10/16/2019
272704,earnings-up,100,68,10/16/2019
272704,earnings,100,50,10/16/2019
272704,earnings,100,50,10/16/2019
272704,earnings,100,50,10/16/2019
272704,earnings,100,50,10/16/2019
272704,earnings,100,50,10/16/2019
272704,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
275300,earnings,100,50,10/16/2019
27B191,conference-call,100,50,10/16/2019
27BFA1,earnings-per-share-positive,100,69,10/16/2019
27BFA1,earnings-per-share,100,50,10/16/2019
27BFA1,earnings-per-share,100,50,10/16/2019
27BFA1,earnings-per-share,100,50,10/16/2019
27BFA1,earnings-per-share,100,50,10/16/2019
27BFA1,earnings-per-share,100,50,10/16/2019
27BFA1,earnings-per-share,100,50,10/16/2019
2B7A40,partnership,100,61,10/16/2019
2BA977,legal-issues-defendant,100,22,10/16/2019
2CA60F,earnings,100,50,10/16/2019
2CA60F,executive-appointment,100,54,10/16/2019
2DA92D,earnings,100,50,10/16/2019
2DB344,earnings,100,50,10/16/2019
2EBA55,conference-call,100,50,10/16/2019
31553A,earnings,100,50,10/16/2019
31A7CC,earnings,100,50,10/16/2019
31A7CC,earnings,100,50,10/16/2019
31A7CC,earnings,100,50,10/16/2019
32CB22,earnings,100,50,10/16/2019
341759,legal-issues-defendant,100,22,10/16/2019
349DA4,earnings,100,50,10/16/2019
370C50,dividend,100,50,10/16/2019
3798B9,earnings,100,50,10/16/2019
3B20AB,earnings,100,50,10/16/2019
3C3B6B,earnings,100,50,10/16/2019
3CBA2A,conference-call,100,50,10/16/2019
3D9999,partnership,100,61,10/16/2019
3DCECC,executive-appointment,100,54,10/16/2019
401072,business-contract,100,69,10/16/2019
408089,dividend,100,50,10/16/2019
423279,earnings-per-share-positive,100,69,10/16/2019
42DC93,unit-acquisition-acquirer,100,49,10/16/2019
442769,conference-call,100,50,10/16/2019
448215,earnings,100,50,10/16/2019
48F795,earnings,100,50,10/16/2019
490D4B,executive-appointment,100,54,10/16/2019
4A6F00,partnership,100,61,10/16/2019
4A6F00,partnership,100,61,10/16/2019
4B3676,earnings,100,50,10/16/2019
4BBA23,conference-call,100,50,10/16/2019
4C37C5,dividend,100,50,10/16/2019
51888A,earnings-per-share-positive,100,69,10/16/2019
51888A,earnings,100,50,10/16/2019
51888A,earnings,100,50,10/16/2019
51F541,conference-call,100,50,10/16/2019
520632,earnings,100,50,10/16/2019
520632,earnings,100,50,10/16/2019
520632,earnings,100,50,10/16/2019
520632,earnings,100,50,10/16/2019
520632,earnings,100,50,10/16/2019
520632,earnings,100,50,10/16/2019
52B567,legal-issues-defendant,100,22,10/16/2019
53C421,ipo-pricing,100,50,10/16/2019
53F491,earnings-per-share-positive,100,69,10/16/2019
54B889,conference-call,100,50,10/16/2019
553949,partnership,100,61,10/16/2019
553949,partnership,100,61,10/16/2019
56AFF4,operating-earnings,100,50,10/16/2019
58CA9A,acquisition-acquirer,100,49,10/16/2019
5D0337,earnings,100,50,10/16/2019
5F3E74,earnings,100,50,10/16/2019
5F6D73,earnings,100,50,10/16/2019
5F6D73,earnings,100,50,10/16/2019
5F6D73,earnings,100,50,10/16/2019
5F6D73,earnings,100,50,10/16/2019
5F6D73,earnings,100,50,10/16/2019
60DD84,executive-appointment,100,54,10/16/2019
6166D1,earnings,100,50,10/16/2019
6.18E+08,earnings,100,50,10/16/2019
619882,product-release,100,64,10/16/2019
61B81B,earnings-positive,100,69,10/16/2019
61B81B,earnings-positive,100,69,10/16/2019
61B81B,earnings-positive,100,69,10/16/2019
61B81B,earnings-positive,100,69,10/16/2019
61B81B,earnings-positive,100,69,10/16/2019
61B81B,earnings-positive,100,69,10/16/2019
61B81B,earnings-positive,100,69,10/16/2019
620381,executive-appointment,100,54,10/16/2019
622DBE,conference-call,100,50,10/16/2019
62CDDE,conference-call,100,50,10/16/2019
649CBD,clinical-trials-start,100,64,10/16/2019
649CBD,legal-issues-defendant,100,22,10/16/2019
64FF65,conference-call,100,50,10/16/2019
69C99E,patient-enrollment-complete,100,64,10/16/2019
6ABCB8,earnings,100,50,10/16/2019
6D1ADF,conference-call,100,50,10/16/2019
6D3B7B,earnings,100,50,10/16/2019
6DBBBC,award,100,58,10/16/2019
6DBBBC,conference-call,100,50,10/16/2019
6DC1D7,conference-call,100,50,10/16/2019
6.00E+19,conference-call,100,50,10/16/2019
6F39FC,public-offering,100,43,10/16/2019
701531,earnings,100,50,10/16/2019
704B78,earnings,100,50,10/16/2019
722D55,earnings,100,50,10/16/2019
7273FF,earnings,100,50,10/16/2019
73A71F,legal-issues-defendant,100,22,10/16/2019
73C521,dividend,100,50,10/16/2019
7410C3,earnings,100,50,10/16/2019
76B926,conference-call,100,50,10/16/2019
773A17,award,100,58,10/16/2019
775439,earnings,100,50,10/16/2019
7823A3,executive-appointment,100,54,10/16/2019
791EC1,conference-call,100,50,10/16/2019
7D35D8,legal-issues-defendant,100,22,10/16/2019
7E3F8F,earnings,100,50,10/16/2019
7F2922,earnings,100,50,10/16/2019
7F3A5F,executive-appointment,100,54,10/16/2019
8275FE,earnings,100,50,10/16/2019
85CDC9,earnings,100,50,10/16/2019
85DA04,earnings,100,50,10/16/2019
860AB6,conference-call,100,50,10/16/2019
8CF6DD,earnings,100,50,10/16/2019
8D4486,product-release,100,64,10/16/2019
8D4486,earnings,100,50,10/16/2019
8D4486,earnings,100,50,10/16/2019
8D4486,earnings,100,50,10/16/2019
8D4486,earnings,100,50,10/16/2019
8D4486,earnings,100,50,10/16/2019
8FF2EF,earnings,100,50,10/16/2019
92B047,earnings,100,50,10/16/2019
93633B,earnings,100,50,10/16/2019
93633B,earnings,100,50,10/16/2019
93633B,earnings,100,50,10/16/2019
93633B,earnings,100,50,10/16/2019
942165,earnings,100,50,10/16/2019
950CDB,dividend,100,50,10/16/2019
9.62E+76,earnings,100,50,10/16/2019
9.62E+76,earnings,100,50,10/16/2019
9.62E+76,earnings,100,50,10/16/2019
9.65E+09,conference-call,100,50,10/16/2019
9673BD,executive-appointment,100,54,10/16/2019
96F126,partnership,100,61,10/16/2019
989E2F,public-offering,100,43,10/16/2019
99028D,conference-call,100,50,10/16/2019
990AD0,earnings,100,50,10/16/2019
990AD0,earnings,100,50,10/16/2019
990AD0,earnings,100,50,10/16/2019
9.92E+94,earnings,100,50,10/16/2019
9C5BA5,dividend,100,50,10/16/2019
9C8BC3,dividend,100,50,10/16/2019
9D5FA4,earnings,100,50,10/16/2019
9DDE1B,acquisition-acquiree,100,76,10/16/2019
9F71E5,acquisition-completed-acquirer,100,49,10/16/2019
A21649,conference-call,100,50,10/16/2019
A28C54,business-contract,100,69,10/16/2019
A398F8,earnings,100,50,10/16/2019
A495F7,earnings,100,50,10/16/2019
A4D173,conference-call,100,50,10/16/2019
A4D173,conference-call,100,50,10/16/2019
A7102F,legal-issues-dismissed-defendant,100,79,10/16/2019
A7E2AB,executive-appointment,100,54,10/16/2019
A8AC4C,earnings,100,50,10/16/2019
A8B137,partnership,100,61,10/16/2019
AA5C8E,dividend,100,50,10/16/2019
AA5C8E,dividend,100,50,10/16/2019
AA5C8E,dividend,100,50,10/16/2019
AA5C8E,dividend,100,50,10/16/2019
AA5C8E,dividend,100,50,10/16/2019
AA5C8E,dividend,100,50,10/16/2019
AA5C8E,dividend,100,50,10/16/2019
AABEA0,dividend,100,50,10/16/2019
AAC8B6,conference-call,100,50,10/16/2019
AAC8B6,conference-call,100,50,10/16/2019
AC775C,conference-call,100,50,10/16/2019
AC7C4F,business-contract,100,69,10/16/2019
ADF1B0,conference-call,100,50,10/16/2019
AE7D16,earnings,100,50,10/16/2019
AED6CF,conference-call,100,50,10/16/2019
AEF2C3,conference-call,100,50,10/16/2019
B48D6A,clinical-trials-positive,100,87,10/16/2019
B5BA39,earnings,100,50,10/16/2019
BA218A,earnings-positive,100,69,10/16/2019
BA218A,earnings,100,50,10/16/2019
BA218A,earnings,100,50,10/16/2019
BA218A,earnings,100,50,10/16/2019
BA218A,earnings,100,50,10/16/2019
BA218A,earnings,100,50,10/16/2019
BD682F,earnings,100,50,10/16/2019
BD8517,earnings,100,50,10/16/2019
BDD12C,earnings,100,50,10/16/2019
BF79F5,ownership-increase-owner,100,56,10/16/2019
C0030A,earnings,100,50,10/16/2019
C11C46,earnings,100,50,10/16/2019
C32A39,dividend,100,50,10/16/2019
C45CE7,earnings,100,50,10/16/2019
C72B8F,partnership,100,61,10/16/2019
C8A059,earnings,100,50,10/16/2019
C9B932,earnings,100,50,10/16/2019
C9F39B,earnings,100,50,10/16/2019
C9F39B,earnings,100,50,10/16/2019
C9F39B,earnings,100,50,10/16/2019
C9F39B,earnings,100,50,10/16/2019
C9F39B,earnings,100,50,10/16/2019
C9F39B,earnings,100,50,10/16/2019
C9F39B,earnings,100,50,10/16/2019
CB6A9C,conference-call,100,50,10/16/2019
CD06A2,earnings,100,50,10/16/2019
CD06A2,earnings,100,50,10/16/2019
CD2A4D,conference-participant,100,50,10/16/2019
CE5664,product-release,100,64,10/16/2019
CEC08B,dividend,100,50,10/16/2019
D1588D,executive-appointment,100,54,10/16/2019
D17F7E,dividend,100,50,10/16/2019
D27FAB,conference-call,100,50,10/16/2019
D393DF,earnings,100,50,10/16/2019
D393DF,earnings,100,50,10/16/2019
D3DE34,executive-appointment,100,54,10/16/2019
D3DE34,executive-appointment,100,54,10/16/2019
D4AC65,conference-call,100,50,10/16/2019
D518D8,executive-appointment,100,54,10/16/2019
D93A25,earnings,100,50,10/16/2019
D9B1C9,executive-appointment,100,54,10/16/2019
DEF058,legal-issues-defendant,100,22,10/16/2019
DF01B1,conference-participant,100,50,10/16/2019
E26FC3,earnings,100,50,10/16/2019
E30B34,executive-appointment,100,54,10/16/2019
E30B34,award,100,58,10/16/2019
E3E68E,executive-appointment,100,54,10/16/2019
E3E68E,executive-appointment,100,54,10/16/2019
E49AA3,earnings,100,50,10/16/2019
E754F0,earnings,100,50,10/16/2019
E829E8,earnings,100,50,10/16/2019
E8E899,partnership,100,61,10/16/2019
EAEBF3,dividend,100,50,10/16/2019
EB2F14,executive-resignation,100,44,10/16/2019
ECA300,executive-appointment,100,54,10/16/2019
ECD263,earnings,100,50,10/16/2019
ECDEB2,earnings,100,50,10/16/2019
ECF709,executive-resignation,100,44,10/16/2019
ED2A5E,conference-call,100,50,10/16/2019
ED7F13,earnings,100,50,10/16/2019
EF25A5,earnings,100,50,10/16/2019
EF5BED,dividend,100,50,10/16/2019
EF5BED,earnings-positive,100,69,10/16/2019
EF5BED,earnings,100,50,10/16/2019
EF5BED,earnings,100,50,10/16/2019
EF5BED,earnings,100,50,10/16/2019
EF76C8,dividend,100,50,10/16/2019
F1C04C,conference-call,100,50,10/16/2019
F30508,clinical-trials,100,56,10/16/2019
FA35C6,product-release,100,64,10/16/2019
FD9A97,earnings,100,50,10/16/2019
FDC08C,dividend,100,50,10/16/2019
FEE4B0,facility-open,100,65,10/16/2019
00067A,earnings,100,50,10/17/2019
03CF95,partnership,100,61,10/17/2019
61366,earnings,100,50,10/17/2019
07C907,earnings,100,50,10/17/2019
07C907,earnings,100,50,10/17/2019
07C907,earnings,100,50,10/17/2019
083F72,dividend-up,100,81,10/17/2019
0A7650,earnings-up,100,68,10/17/2019
0A7650,earnings-up,100,68,10/17/2019
0A7650,earnings-up,100,68,10/17/2019
0A7650,earnings-up,100,68,10/17/2019
0A7650,earnings-up,100,68,10/17/2019
0BB9E5,earnings,100,50,10/17/2019
0BC17A,dividend,100,50,10/17/2019
0BC17A,earnings,100,50,10/17/2019
0BC29E,conference-call,100,50,10/17/2019
0C8D82,earnings,100,50,10/17/2019
0E5223,executive-appointment,100,54,10/17/2019
0ED415,conference-call,100,50,10/17/2019
105D00,earnings-positive,100,69,10/17/2019
105D00,earnings,100,50,10/17/2019
105D00,earnings,100,50,10/17/2019
105D00,earnings,100,50,10/17/2019
105D00,earnings,100,50,10/17/2019
105D00,earnings,100,50,10/17/2019
105D00,earnings,100,50,10/17/2019
10C19B,earnings,100,50,10/17/2019
10C19B,earnings,100,50,10/17/2019
10C19B,earnings,100,50,10/17/2019
10C19B,earnings,100,50,10/17/2019
10C19B,earnings,100,50,10/17/2019
10C19B,earnings,100,50,10/17/2019
10C19B,earnings,100,50,10/17/2019
119CB6,dividend,100,50,10/17/2019
1201B5,clinical-trials-positive,100,87,10/17/2019
12DE76,executive-appointment,100,54,10/17/2019
131443,executive-appointment,100,54,10/17/2019
139303,conference-call,100,50,10/17/2019
15901B,executive-appointment,100,54,10/17/2019
18EC17,earnings,100,50,10/17/2019
18EC17,earnings,100,50,10/17/2019
18EC17,earnings,100,50,10/17/2019
19CAC7,earnings,100,50,10/17/2019
19CAC7,earnings,100,50,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A3E1B,earnings-positive,100,69,10/17/2019
1A6A94,dividend,100,50,10/17/2019
1C599A,earnings,100,50,10/17/2019
1E5786,earnings,100,50,10/17/2019
1E5786,earnings,100,50,10/17/2019
1E5786,earnings,100,50,10/17/2019
1E5786,earnings,100,50,10/17/2019
1E5786,earnings,100,50,10/17/2019
1E5786,earnings,100,50,10/17/2019
1E9A6D,dividend,100,50,10/17/2019
200D8B,business-contract,100,69,10/17/2019
2096DE,earnings,100,50,10/17/2019
20BEEA,conference-call,100,50,10/17/2019
219B21,conference-call,100,50,10/17/2019
228D42,partnership,100,61,10/17/2019
249674,conference-call,100,50,10/17/2019
24CB56,earnings-positive,100,69,10/17/2019
24CB56,earnings,100,50,10/17/2019
24CB56,earnings,100,50,10/17/2019
24CB56,earnings,100,50,10/17/2019
24CB56,earnings,100,50,10/17/2019
24CB56,earnings,100,50,10/17/2019
24CB56,earnings,100,50,10/17/2019
24CB56,earnings,100,50,10/17/2019
24CB56,earnings,100,50,10/17/2019
24CB56,earnings,100,50,10/17/2019
267718,partnership,100,61,10/17/2019
267718,partnership,100,61,10/17/2019
26CC63,dividend,100,50,10/17/2019
275300,dividend,100,50,10/17/2019
295F9F,conference-call,100,50,10/17/2019
2BA977,conference-call,100,50,10/17/2019
2BBE62,earnings,100,50,10/17/2019
2BDC1C,earnings,100,50,10/17/2019
2F7474,earnings,100,50,10/17/2019
301493,conference-call,100,50,10/17/2019
314D88,earnings,100,50,10/17/2019
31666F,earnings,100,50,10/17/2019
3.30E+34,dividend,100,50,10/17/2019
343996,dividend,100,50,10/17/2019
343996,dividend,100,50,10/17/2019
3461CF,credit-rating-upgrade-rater,20,50,10/17/2019
372037,conference-call,100,50,10/17/2019
389CFB,conference-call,100,50,10/17/2019
39FB23,earnings,100,50,10/17/2019
39FB23,earnings,100,50,10/17/2019
39FB23,earnings,100,50,10/17/2019
39FB23,dividend,100,50,10/17/2019
3A3948,earnings,100,50,10/17/2019
3B20AB,donation,100,54,10/17/2019
3BBD10,earnings,100,50,10/17/2019
3C6CCC,earnings,100,50,10/17/2019
3C8A04,earnings,100,50,10/17/2019
3D9999,partnership,100,61,10/17/2019
3DCECC,conference-call,100,50,10/17/2019
3F6A9C,conference-call,100,50,10/17/2019
3FBC9B,earnings,100,50,10/17/2019
416291,dividend,100,50,10/17/2019
41EC04,conference-call,100,50,10/17/2019
43E8F5,conference-call,100,50,10/17/2019
4455C4,conference-call,100,50,10/17/2019
449A26,earnings-positive,100,69,10/17/2019
449A26,dividend,100,50,10/17/2019
451D61,conference-call,100,50,10/17/2019
47BA98,dividend,100,50,10/17/2019
47FCF2,earnings,100,50,10/17/2019
485445,earnings,100,50,10/17/2019
487B7A,dividend,100,50,10/17/2019
494EB9,executive-resignation,100,44,10/17/2019
49BBBC,executive-appointment,100,54,10/17/2019
4A6F00,business-contract,100,69,10/17/2019
4C37C5,product-release,100,64,10/17/2019
4E2D94,note-sale,100,52,10/17/2019
4EEE7E,earnings,100,50,10/17/2019
5225A4,earnings,100,50,10/17/2019
5225A4,earnings,100,50,10/17/2019
5225A4,earnings,100,50,10/17/2019
5225A4,earnings,100,50,10/17/2019
5225A4,earnings,100,50,10/17/2019
52FB2F,earnings,100,50,10/17/2019
532D47,acquisition-acquirer,100,49,10/17/2019
53F491,conference-organizer,100,57,10/17/2019
545272,conference-call,100,50,10/17/2019
55D0F3,business-contract,100,69,10/17/2019
56632F,dividend,100,50,10/17/2019
56B7C1,award,100,58,10/17/2019
57B174,executive-appointment,100,54,10/17/2019
57F3DA,earnings,100,50,10/17/2019
58B46F,dividend,100,50,10/17/2019
5BFE94,dividend-up,100,81,10/17/2019
5D43A7,dividend,100,50,10/17/2019
5DE5A5,earnings-up,100,68,10/17/2019
5DE5A5,earnings,100,50,10/17/2019
5DE5A5,earnings,100,50,10/17/2019
5EAA43,conference-call,100,50,10/17/2019
601785,dividend,100,50,10/17/2019
6166D1,product-release,100,64,10/17/2019
622037,earnings,100,50,10/17/2019
62B1C6,executive-appointment,100,54,10/17/2019
62B20A,earnings,100,50,10/17/2019
636639,earnings,100,50,10/17/2019
636639,earnings,100,50,10/17/2019
636639,earnings,100,50,10/17/2019
636639,earnings,100,50,10/17/2019
6474BA,earnings-positive,100,69,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
6474BA,earnings,100,50,10/17/2019
665618,revenue-up,100,69,10/17/2019
665618,revenue-up,100,69,10/17/2019
6C987C,earnings-up,100,58,10/17/2019
6CF43C,earnings,100,50,10/17/2019
6D0CAB,product-release,100,64,10/17/2019
6D3F35,product-release,100,64,10/17/2019
6D3F35,product-release,100,64,10/17/2019
6D9ECA,clinical-trials,100,56,10/17/2019
6F6559,dividend,100,50,10/17/2019
71553E,earnings,100,50,10/17/2019
731675,conference-call,100,50,10/17/2019
732A9B,clinical-trials,100,56,10/17/2019
73A71F,legal-issues-defendant,100,22,10/17/2019
73F70F,executive-appointment,100,54,10/17/2019
7.40E+289,dividend,100,50,10/17/2019
7520CC,earnings,100,50,10/17/2019
762B8D,earnings,100,50,10/17/2019
7BAAE7,dividend,100,50,10/17/2019
7BFF81,acquisition-completed-acquirer,100,49,10/17/2019
7C62A3,conference-call,100,50,10/17/2019
7CBC40,business-contract,100,69,10/17/2019
7D5384,conference-call,100,50,10/17/2019
7E1D5D,product-release,100,64,10/17/2019
855DF7,dividend,100,50,10/17/2019
859281,dividend,100,50,10/17/2019
87B81A,earnings,100,50,10/17/2019
89B2E7,earnings,100,50,10/17/2019
8AC65D,award,100,58,10/17/2019
8B8656,partnership,100,61,10/17/2019
8B8656,partnership,100,61,10/17/2019
8D4486,earnings,100,50,10/17/2019
8D4486,earnings,100,50,10/17/2019
8DDA23,earnings-positive,100,69,10/17/2019
902255,earnings,100,50,10/17/2019
9196A2,earnings,100,50,10/17/2019
9196A2,earnings,100,50,10/17/2019
9196A2,earnings,100,50,10/17/2019
9196A2,earnings,100,50,10/17/2019
92D6A5,earnings,100,50,10/17/2019
92D757,business-contract,100,69,10/17/2019
92D9C9,conference-call,100,50,10/17/2019
940C3D,name-change,100,49,10/17/2019
94563D,earnings,100,50,10/17/2019
94637C,partnership,100,61,10/17/2019
94637C,partnership,100,61,10/17/2019
94756D,conference-participant,100,50,10/17/2019
965360,earnings,100,50,10/17/2019
966DBE,earnings,100,50,10/17/2019
979451,earnings,100,50,10/17/2019
97AAF6,dividend,100,50,10/17/2019
989E2F,earnings,100,50,10/17/2019
989E2F,earnings,100,50,10/17/2019
989E2F,earnings,100,50,10/17/2019
9AF3DC,partnership,100,61,10/17/2019
9C25FF,conference-call,100,50,10/17/2019
9D6A24,executive-appointment,100,54,10/17/2019
9E4A5F,earnings,100,50,10/17/2019
9F62D1,earnings-per-share-up,100,63,10/17/2019
9FB4B7,conference-participant,100,50,10/17/2019
A01200,market-entry,100,57,10/17/2019
A26C26,product-release,100,64,10/17/2019
A41450,earnings,100,50,10/17/2019
A4CD53,earnings,100,50,10/17/2019
A52533,earnings,100,50,10/17/2019
A5628C,earnings-positive,100,69,10/17/2019
A6213D,business-contract,100,69,10/17/2019
A65325,executive-appointment,100,54,10/17/2019
A666C8,earnings,100,50,10/17/2019
A6828A,dividend,100,50,10/17/2019
A8CBDA,dividend,100,50,10/17/2019
A8E2FE,trading-listing,100,61,10/17/2019
AA247D,earnings,100,50,10/17/2019
AA98ED,partnership,100,61,10/17/2019
AADE0B,acquisition-completed-acquirer,100,49,10/17/2019
AD3C93,earnings,100,50,10/17/2019
AEBB80,earnings,100,50,10/17/2019
AFF7B4,legal-issues-defendant,100,22,10/17/2019
B1DF3C,award,100,58,10/17/2019
B1FC3B,business-contract,100,69,10/17/2019
B4C673,partnership,100,61,10/17/2019
B8F71F,executive-appointment,100,54,10/17/2019
BD682F,dividend,100,50,10/17/2019
BDF2BD,conference-call,100,50,10/17/2019
BE379D,clinical-trials,100,56,10/17/2019
C0030A,credit-extension-recipient,100,69,10/17/2019
C2609A,business-contract,100,69,10/17/2019
C32A39,earnings-up,100,68,10/17/2019
C32A39,earnings-up,100,68,10/17/2019
C32A39,earnings-up,100,68,10/17/2019
C32A39,earnings-up,100,68,10/17/2019
C32A39,earnings-up,100,68,10/17/2019
C32A39,earnings-up,100,68,10/17/2019
C32A39,earnings-up,100,68,10/17/2019
C32A39,earnings-up,100,68,10/17/2019
C3CF29,earnings,100,50,10/17/2019
C41C25,earnings,100,50,10/17/2019
C9E107,executive-appointment,100,54,10/17/2019
CA1620,earnings,100,50,10/17/2019
CBBFBF,earnings,100,50,10/17/2019
CBDB4D,public-offering,100,43,10/17/2019
CDAA0E,earnings,100,50,10/17/2019
CDAB24,award,100,58,10/17/2019
CF9054,earnings,100,50,10/17/2019
CFD4B6,conference-call,100,50,10/17/2019
D15833,earnings,100,50,10/17/2019
D17C1B,partnership,100,61,10/17/2019
D1AE3B,earnings,100,50,10/17/2019
D437C3,product-release,100,64,10/17/2019
D48275,earnings,100,50,10/17/2019
D56D6D,conference-participant,100,50,10/17/2019
D6489C,award,100,58,10/17/2019
D650A7,earnings,100,50,10/17/2019
D7AC6E,earnings,100,50,10/17/2019
D8ECA1,legal-issues-defendant,100,22,10/17/2019
D8F347,earnings,100,50,10/17/2019
D8F347,earnings,100,50,10/17/2019
D8F347,earnings,100,50,10/17/2019
D9E036,business-contract,100,69,10/17/2019
DA0A9E,dividend,100,50,10/17/2019
DB23C8,facility-open,100,65,10/17/2019
E0339F,earnings,100,50,10/17/2019
E0339F,earnings,100,50,10/17/2019
E0339F,earnings,100,50,10/17/2019
E0339F,earnings,100,50,10/17/2019
E28D9C,conference-call,100,50,10/17/2019
E2F66E,conference-call,100,50,10/17/2019
E393B0,earnings-up,100,68,10/17/2019
E393B0,earnings-up,100,68,10/17/2019
E393B0,earnings-up,100,68,10/17/2019
E393B0,earnings-up,100,68,10/17/2019
E393B0,earnings-up,100,68,10/17/2019
E393B0,earnings-up,100,68,10/17/2019
E5752F,partnership,100,61,10/17/2019
E5D914,earnings,100,50,10/17/2019
E5D914,earnings,100,50,10/17/2019
E68733,product-release,100,64,10/17/2019
E68733,product-release,100,64,10/17/2019
E82A2D,conference-call,100,50,10/17/2019
E84500,dividend,100,50,10/17/2019
E8846E,executive-appointment,100,54,10/17/2019
E8B315,earnings-positive,100,69,10/17/2019
E94704,earnings,100,50,10/17/2019
E94704,earnings,100,50,10/17/2019
E94704,earnings,100,50,10/17/2019
E94704,earnings,100,50,10/17/2019
E94704,earnings,100,50,10/17/2019
E94704,earnings,100,50,10/17/2019
E96E0B,earnings,100,50,10/17/2019
EAEBF3,earnings,100,50,10/17/2019
EB2F14,earnings,100,50,10/17/2019
EB6965,conference-call,100,50,10/17/2019
EC4E82,conference-participant,100,50,10/17/2019
ECF4F8,conference-call,100,50,10/17/2019
ED9C04,earnings,100,50,10/17/2019
EE74E1,earnings,100,50,10/17/2019
F02170,award,100,58,10/17/2019
F24FF0,earnings,100,50,10/17/2019
F24FF0,conference-call,100,50,10/17/2019
F46EC9,earnings,100,50,10/17/2019
F46EC9,dividend,100,50,10/17/2019
F48947,earnings,100,50,10/17/2019
F4E992,partnership,100,61,10/17/2019
F4F46F,conference-call,100,50,10/17/2019
F5349B,business-contract,100,69,10/17/2019
F57F6F,earnings,100,50,10/17/2019
F5C78B,dividend,100,50,10/17/2019
F5D410,partnership,100,61,10/17/2019
F702CA,earnings,100,50,10/17/2019
F702CA,earnings,100,50,10/17/2019
F702CA,earnings,100,50,10/17/2019
F702CA,earnings,100,50,10/17/2019
F702CA,earnings,100,50,10/17/2019
F702CA,earnings,100,50,10/17/2019
F8BA6C,conference-call,100,50,10/17/2019
FA35C6,earnings,100,50,10/17/2019
FA36A4,dividend,100,50,10/17/2019
FA40E2,partnership,100,61,10/17/2019
FA840E,earnings,100,50,10/17/2019
FACF19,partnership,100,61,10/17/2019
FB728F,dividend,100,50,10/17/2019
FC80E6,conference-call,100,50,10/17/2019
FD39EB,dividend,100,50,10/17/2019
FD6926,conference-call,100,50,10/17/2019
FDF799,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
FF6644,earnings,100,50,10/17/2019
0157B1,partnership,100,61,10/18/2019
43862,conference-call,100,50,10/18/2019
099A02,earnings-up,100,68,10/18/2019
099A02,earnings,100,50,10/18/2019
0BD4E8,conference-call,100,50,10/18/2019
0D26E0,earnings-up,100,64,10/18/2019
0D26E0,earnings-up,100,64,10/18/2019
0D26E0,earnings-up,100,64,10/18/2019
0D26E0,earnings-up,100,64,10/18/2019
0D26E0,earnings-up,100,64,10/18/2019
0DBB81,public-offering,100,43,10/18/2019
0F65C9,conference-participant,100,50,10/18/2019
10673F,earnings,100,50,10/18/2019
10673F,earnings,100,50,10/18/2019
108BD2,earnings,100,50,10/18/2019
108FDA,earnings,100,50,10/18/2019
12731D,executive-appointment,100,54,10/18/2019
12731D,executive-appointment,100,54,10/18/2019
14ED2B,partnership,100,61,10/18/2019
154272,clinical-trials,100,56,10/18/2019
1B16C1,conference-call,100,50,10/18/2019
1F19C8,conference-call,100,50,10/18/2019
1F43A1,earnings,100,50,10/18/2019
25A6CC,earnings,100,50,10/18/2019
26DC29,legal-issues-defendant,100,22,10/18/2019
26DC29,legal-issues-defendant,100,22,10/18/2019
26DC29,legal-issues-defendant,100,22,10/18/2019
2C19A4,conference-call,100,50,10/18/2019
2CB4C9,dividend,100,50,10/18/2019
2EC172,conference-call,100,50,10/18/2019
2FDEE3,award,100,58,10/18/2019
3461CF,credit-rating-upgrade-rater,20,50,10/18/2019
34B97A,executive-appointment,100,54,10/18/2019
355B19,dividend,100,50,10/18/2019
371C01,executive-appointment,100,54,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-interest-acquirer,100,46,10/18/2019
385DD4,acquisition-acquirer,100,49,10/18/2019
3BC360,conference-call,100,50,10/18/2019
3D9999,earnings-positive,100,69,10/18/2019
3E39A5,earnings,100,50,10/18/2019
3F868D,conference-call,100,50,10/18/2019
435ACE,earnings,100,50,10/18/2019
4C37C5,earnings-per-share-positive,100,69,10/18/2019
4C37C5,earnings,100,50,10/18/2019
4C37C5,earnings,100,50,10/18/2019
4D203E,earnings,100,50,10/18/2019
4D203E,earnings,100,50,10/18/2019
4D203E,earnings,100,50,10/18/2019
4EC4C1,conference-call,100,50,10/18/2019
50070E,executive-appointment,100,54,10/18/2019
525A1C,earnings,100,50,10/18/2019
5480A7,earnings,100,50,10/18/2019
57B174,conference-call,100,50,10/18/2019
589803,business-contract,100,69,10/18/2019
5BC2F4,earnings-per-share-positive,100,69,10/18/2019
5BC2F4,earnings-per-share,100,50,10/18/2019
5BC2F4,earnings-per-share,100,50,10/18/2019
5BC2F4,earnings-per-share,100,50,10/18/2019
5BC2F4,earnings-per-share,100,50,10/18/2019
5BFE94,earnings,100,50,10/18/2019
6166D1,executive-appointment,100,54,10/18/2019
61E975,conference-call,100,50,10/18/2019
62B1C6,executive-appointment,100,54,10/18/2019
62B1C6,earnings,100,50,10/18/2019
62B1C6,earnings,100,50,10/18/2019
647143,dividend,100,50,10/18/2019
6634D9,earnings,100,50,10/18/2019
66CB62,earnings,100,50,10/18/2019
6B0E45,dividend,100,50,10/18/2019
6E8349,earnings,100,50,10/18/2019
713810,acquisition-completed-acquirer,100,49,10/18/2019
72F0FC,dividend-up,100,81,10/18/2019
72F0FC,earnings,100,50,10/18/2019
742AAB,investment-investor,100,55,10/18/2019
76BD96,conference-call,100,50,10/18/2019
7AC86E,acquisition-acquirer,100,49,10/18/2019
7B4B91,conference-call,100,50,10/18/2019
82FD6D,conference-call,100,50,10/18/2019
8377DB,acquisition-completed-acquirer,100,49,10/18/2019
83A065,conference-call,100,50,10/18/2019
8B2C4A,earnings,100,50,10/18/2019
8B2C4A,earnings,100,50,10/18/2019
8B2C4A,earnings,100,50,10/18/2019
8B2C4A,earnings,100,50,10/18/2019
8B2C4A,earnings,100,50,10/18/2019
8B2C4A,earnings,100,50,10/18/2019
8B2C4A,earnings,100,50,10/18/2019
8B2C4A,earnings,100,50,10/18/2019
8BFE9A,conference-participant,100,50,10/18/2019
8E9CD8,credit-rating-upgrade,100,77,10/18/2019
911ACB,earnings,100,50,10/18/2019
934CC3,partnership,100,61,10/18/2019
954A47,earnings-positive,100,69,10/18/2019
977A1E,partnership,100,61,10/18/2019
97AAF6,earnings,100,50,10/18/2019
9AF3DC,dividend,100,50,10/18/2019
9E98F2,legal-issues-defendant,100,22,10/18/2019
9E98F2,legal-issues-defendant,100,22,10/18/2019
9E98F2,legal-issues-defendant,100,22,10/18/2019
9F5CBB,conference-call,100,50,10/18/2019
A26C26,product-release,100,64,10/18/2019
A2C979,conference-participant,100,50,10/18/2019
A3AAA5,conference-call,100,50,10/18/2019
A6FE1C,unit-acquisition-acquirer,100,49,10/18/2019
A6FE1C,facility-close,100,47,10/18/2019
A7CCF0,conference-call,100,50,10/18/2019
A9ED24,dividend,100,50,10/18/2019
AD6141,auditor-appointment,100,50,10/18/2019
AF210D,settlement,100,56,10/18/2019
AFD7DD,conference-call,100,50,10/18/2019
B5766D,earnings,100,50,10/18/2019
B642E8,earnings,100,50,10/18/2019
B8EF97,dividend,100,50,10/18/2019
BE7BA4,conference-call,100,50,10/18/2019
BEB756,note-sale,100,52,10/18/2019
BEB756,dividend,100,50,10/18/2019
BEB756,earnings,100,50,10/18/2019
BFE02C,earnings-positive,100,69,10/18/2019
C0200F,earnings,100,50,10/18/2019
C0200F,earnings,100,50,10/18/2019
C0200F,earnings,100,50,10/18/2019
C29715,earnings,100,50,10/18/2019
C29715,earnings,100,50,10/18/2019
CBBFBF,award,100,58,10/18/2019
CBBFBF,award,100,58,10/18/2019
CC339B,earnings,100,50,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
D721C6,earnings-positive,100,69,10/18/2019
DB396B,partnership,100,61,10/18/2019
DDCB34,conference-call,100,50,10/18/2019
E1E36F,dividend,100,50,10/18/2019
E68733,product-release,100,64,10/18/2019
E8D221,dividend,100,50,10/18/2019
E90C84,conference-call,100,50,10/18/2019
F6581D,executive-appointment,100,54,10/18/2019
F82D37,earnings-up,100,68,10/18/2019
F82D37,earnings,100,50,10/18/2019
F82D37,earnings,100,50,10/18/2019
F9CAF8,conference-call,100,50,10/18/2019
FFE543,award,100,58,10/18/2019
80D744,legal-issues-defendant,100,22,10/19/2019
00067A,partnership,100,61,10/21/2019
03FAA6,earnings,100,50,10/21/2019
04996E,earnings,100,50,10/21/2019
04EB2F,earnings,100,50,10/21/2019
06EE79,earnings,100,50,10/21/2019
08A40F,earnings-per-share-positive,100,69,10/21/2019
08A40F,earnings-per-share-positive,100,69,10/21/2019
08A40F,earnings-per-share-positive,100,69,10/21/2019
08A40F,earnings-per-share-positive,100,69,10/21/2019
08A40F,earnings-per-share-positive,100,69,10/21/2019
08A40F,earnings-per-share-positive,100,69,10/21/2019
08A40F,earnings-per-share-positive,100,69,10/21/2019
08A40F,earnings-per-share-positive,100,69,10/21/2019
099C88,conference-call,100,50,10/21/2019
0C4131,earnings,100,50,10/21/2019
0C4131,earnings,100,50,10/21/2019
0C4131,earnings,100,50,10/21/2019
0C4131,earnings,100,50,10/21/2019
0C4131,earnings,100,50,10/21/2019
0C6861,conference-call,100,50,10/21/2019
0C6861,board-meeting,100,51,10/21/2019
0CC01F,executive-appointment,100,54,10/21/2019
0CC01F,earnings,100,50,10/21/2019
0CC01F,dividend-up,100,67,10/21/2019
126F95,earnings,100,50,10/21/2019
126F95,earnings,100,50,10/21/2019
126F95,earnings,100,50,10/21/2019
126F95,earnings,100,50,10/21/2019
147C38,dividend,100,50,10/21/2019
1782D5,conference-call,100,50,10/21/2019
1782D5,asset-sale,100,62,10/21/2019
17EDA5,partnership,100,61,10/21/2019
17EDA5,partnership,100,61,10/21/2019
188394,conference-call,100,50,10/21/2019
1BC12C,campaign-ad-release,100,59,10/21/2019
1DF15D,conference-call,100,50,10/21/2019
1F08A6,credit-rating-upgrade,100,77,10/21/2019
1FE3CB,dividend,100,50,10/21/2019
1FE3CB,operating-earnings,100,50,10/21/2019
228D42,partnership,100,61,10/21/2019
228D42,partnership,100,61,10/21/2019
228D42,partnership,100,61,10/21/2019
228D42,partnership,100,61,10/21/2019
228D42,partnership,100,61,10/21/2019
228D42,partnership,100,61,10/21/2019
24CB56,conference-participant,100,50,10/21/2019
24CB56,conference-participant,100,50,10/21/2019
25102A,executive-resignation,100,44,10/21/2019
25102A,executive-resignation,100,44,10/21/2019
25AB8E,conference-call,100,50,10/21/2019
267718,product-release,100,64,10/21/2019
26DC29,legal-issues-defendant,100,22,10/21/2019
26DC29,legal-issues-defendant,100,22,10/21/2019
26DC29,legal-issues-defendant,100,22,10/21/2019
26DC29,legal-issues-defendant,100,22,10/21/2019
27A791,earnings,100,50,10/21/2019
282C18,earnings,100,50,10/21/2019
28DCF3,earnings-up,100,91,10/21/2019
2ABF77,conference-participant,100,50,10/21/2019
2B49F4,earnings,100,50,10/21/2019
2B49F4,earnings,100,50,10/21/2019
2B49F4,earnings,100,50,10/21/2019
2B49F4,earnings,100,50,10/21/2019
2E902B,earnings,100,50,10/21/2019
2E902B,earnings,100,50,10/21/2019
309922,earnings,100,50,10/21/2019
30E01D,earnings,100,50,10/21/2019
319BE2,conference-call,100,50,10/21/2019
32CB22,note-sale,100,52,10/21/2019
32CB22,note-sale,100,52,10/21/2019
339F20,earnings,100,50,10/21/2019
3461CF,credit-rating-upgrade-rater,20,50,10/21/2019
34B411,earnings-up,100,68,10/21/2019
370C50,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
38FB49,earnings,100,50,10/21/2019
39FB23,executive-appointment,100,54,10/21/2019
3A3447,facility-open,100,65,10/21/2019
3AAEAE,conference-call,100,50,10/21/2019
408380,earnings,100,50,10/21/2019
414FFF,executive-appointment,100,54,10/21/2019
42AABD,product-release,100,64,10/21/2019
43A060,business-contract,100,69,10/21/2019
44740A,executive-appointment,100,54,10/21/2019
49914B,earnings,100,50,10/21/2019
4BEB48,acquisition-acquirer,100,49,10/21/2019
4D371E,earnings,100,50,10/21/2019
50070E,partnership,100,61,10/21/2019
504FE2,product-release,100,64,10/21/2019
51B442,earnings,100,50,10/21/2019
52D936,spin-off,100,58,10/21/2019
53C421,ipo-completed,100,76,10/21/2019
55438C,partnership,100,61,10/21/2019
55438C,dividend,100,50,10/21/2019
56632F,earnings,100,50,10/21/2019
57CAAB,earnings,100,50,10/21/2019
57DDB9,conference-call,100,50,10/21/2019
583A75,executive-appointment,100,54,10/21/2019
586FFD,conference-call,100,50,10/21/2019
5876DC,dividend,100,50,10/21/2019
5A423F,conference-participant,100,50,10/21/2019
5B7739,conference-call,100,50,10/21/2019
5D43A7,partnership,100,61,10/21/2019
5EAA43,partnership,100,61,10/21/2019
5EC388,earnings,100,50,10/21/2019
5FF95F,earnings-positive,100,69,10/21/2019
622DBE,legal-issues-defendant,100,22,10/21/2019
647143,earnings,100,50,10/21/2019
647143,earnings,100,50,10/21/2019
647143,earnings,100,50,10/21/2019
647143,earnings,100,50,10/21/2019
69C99E,patient-enrollment-complete,100,64,10/21/2019
6A3C35,earnings,100,50,10/21/2019
6B5379,earnings,100,50,10/21/2019
6C4D2F,earnings,100,50,10/21/2019
6C4D2F,earnings,100,50,10/21/2019
6C4D2F,earnings,100,50,10/21/2019
6C4D2F,earnings,100,50,10/21/2019
6C4D2F,earnings,100,50,10/21/2019
6C4D2F,earnings,100,50,10/21/2019
6C4D2F,earnings,100,50,10/21/2019
6C4D2F,earnings,100,50,10/21/2019
6DD6BA,earnings,100,50,10/21/2019
6DD6BA,earnings,100,50,10/21/2019
6DD6BA,earnings,100,50,10/21/2019
6DD6BA,earnings,100,50,10/21/2019
717DB4,earnings,100,50,10/21/2019
722DE3,business-contract,100,69,10/21/2019
7239BB,facility-open,100,65,10/21/2019
726EEA,earnings,100,50,10/21/2019
72FCA3,note-sale,100,52,10/21/2019
72FCA3,note-sale,100,52,10/21/2019
72FCA3,note-sale,100,52,10/21/2019
756BB4,executive-appointment,100,54,10/21/2019
75F665,earnings,100,50,10/21/2019
75F665,earnings,100,50,10/21/2019
75F665,earnings,100,50,10/21/2019
78A1BB,executive-appointment,100,54,10/21/2019
7A2A49,conference-call,100,50,10/21/2019
7B492C,conference-call,100,50,10/21/2019
7BFF81,partnership,100,61,10/21/2019
7BFF81,executive-appointment,100,54,10/21/2019
7D85A9,partnership,100,61,10/21/2019
7DD8CC,conference-call,100,50,10/21/2019
8.10E+205,executive-appointment,100,54,10/21/2019
83066C,conference-call,100,50,10/21/2019
8377DB,investment-investor,100,55,10/21/2019
850779,buybacks,100,74,10/21/2019
859281,earnings,100,50,10/21/2019
859281,earnings,100,50,10/21/2019
859281,earnings,100,50,10/21/2019
859281,earnings,100,50,10/21/2019
859281,earnings,100,50,10/21/2019
859281,earnings,100,50,10/21/2019
85AD00,acquisition-acquirer,100,49,10/21/2019
85AD00,earnings,100,50,10/21/2019
88350F,partnership,100,61,10/21/2019
890FF4,earnings,100,50,10/21/2019
89FBB1,dividend,100,50,10/21/2019
8AC740,conference-call,100,50,10/21/2019
8B6E7E,conference-call,100,50,10/21/2019
8C84DF,earnings,100,50,10/21/2019
8D4486,partnership,100,61,10/21/2019
8D4486,partnership,100,61,10/21/2019
8DCF18,conference-call,100,50,10/21/2019
8E93A4,earnings,100,50,10/21/2019
901327,earnings,100,50,10/21/2019
903AB4,earnings,100,50,10/21/2019
911AB8,ownership-increase-owner,100,56,10/21/2019
92B73F,unit-acquisition-acquiree,100,76,10/21/2019
93965C,earnings,100,50,10/21/2019
94563D,partnership,100,61,10/21/2019
94C0B5,earnings,100,50,10/21/2019
97B027,conference-call,100,50,10/21/2019
9.86E+03,executive-appointment,100,54,10/21/2019
9.86E+03,earnings,100,50,10/21/2019
986AF6,conference-call,100,50,10/21/2019
990AD0,conference-organizer,100,57,10/21/2019
99ACAD,product-release,100,64,10/21/2019
9D2790,earnings,100,50,10/21/2019
9D30A8,business-contract,100,69,10/21/2019
9E98F2,legal-issues-defendant,100,22,10/21/2019
9E98F2,legal-issues-defendant,100,22,10/21/2019
9F6B1A,partnership,100,61,10/21/2019
A2CA3F,earnings,100,50,10/21/2019
A3BFAA,earnings,100,50,10/21/2019
A58224,board-meeting,100,51,10/21/2019
A6FE1C,unit-acquisition-acquirer,100,49,10/21/2019
ADF1B0,earnings,100,50,10/21/2019
ADF1B0,earnings,100,50,10/21/2019
ADF1B0,earnings,100,50,10/21/2019
AFF43F,earnings,100,50,10/21/2019
AFF7B4,executive-appointment,100,54,10/21/2019
B13B68,note-sale,100,52,10/21/2019
B13B68,conference-call,100,50,10/21/2019
B1FC3B,business-contract,100,69,10/21/2019
B2DAF6,executive-appointment,100,54,10/21/2019
B2F431,earnings-positive,100,69,10/21/2019
B48D6A,conference-participant,100,50,10/21/2019
B604DF,earnings,100,50,10/21/2019
B604DF,earnings,100,50,10/21/2019
B604DF,earnings,100,50,10/21/2019
B604DF,earnings,100,50,10/21/2019
B604DF,dividend,100,50,10/21/2019
B803B1,board-meeting,100,51,10/21/2019
B8DD94,conference-call,100,50,10/21/2019
BB02FB,conference-call,100,50,10/21/2019
BC948D,board-meeting,100,51,10/21/2019
BDE867,operating-earnings,100,50,10/21/2019
C037A8,conference-call,100,50,10/21/2019
C2E120,earnings,100,50,10/21/2019
C4706C,award,100,58,10/21/2019
C624A1,patient-enrollment-complete,100,64,10/21/2019
C81E00,acquisition-completed-acquirer,100,49,10/21/2019
C81E00,acquisition-completed-acquirer,100,49,10/21/2019
C8923A,earnings,100,50,10/21/2019
CC6FF5,earnings,100,50,10/21/2019
CDAF5B,public-offering,100,43,10/21/2019
CDAF5B,earnings,100,50,10/21/2019
D04D9F,conference-call,100,50,10/21/2019
D0DFE5,earnings,100,50,10/21/2019
D1C26F,executive-appointment,100,54,10/21/2019
D4463B,executive-appointment,100,54,10/21/2019
D45285,conference-call,100,50,10/21/2019
D697DE,earnings,100,50,10/21/2019
D721C6,earnings,100,50,10/21/2019
D8760C,earnings-up,100,75,10/21/2019
D8760C,earnings-up,100,68,10/21/2019
D8760C,earnings-up,100,68,10/21/2019
D8760C,earnings-up,100,68,10/21/2019
D8760C,earnings-up,100,68,10/21/2019
D8760C,earnings-up,100,68,10/21/2019
D88EF3,partnership,100,61,10/21/2019
DBFB51,conference-call,100,50,10/21/2019
E09E2B,partnership,100,61,10/21/2019
E09E2B,partnership,100,61,10/21/2019
E09E2B,partnership,100,61,10/21/2019
E0F4E5,executive-appointment,100,54,10/21/2019
E124EB,business-contract,100,69,10/21/2019
E124EB,business-contract,100,69,10/21/2019
E2CFD2,conference-call,100,50,10/21/2019
E4158B,earnings-positive,100,69,10/21/2019
E4158B,earnings,100,50,10/21/2019
E4158B,earnings,100,50,10/21/2019
E4158B,earnings,100,50,10/21/2019
E4158B,earnings,100,50,10/21/2019
E68733,executive-appointment,100,54,10/21/2019
E68733,executive-appointment,100,54,10/21/2019
ECDEB2,earnings,100,50,10/21/2019
F0EEFB,conference-call,100,50,10/21/2019
F294DD,acquisition-acquirer,100,49,10/21/2019
F30508,dividend,100,50,10/21/2019
F40EE2,partnership,100,61,10/21/2019
F40EE2,partnership,100,61,10/21/2019
F46EC9,conference-participant,100,50,10/21/2019
F5C78B,earnings-up,100,68,10/21/2019
F5C78B,earnings,100,50,10/21/2019
F5C78B,earnings,100,50,10/21/2019
F5C78B,earnings,100,50,10/21/2019
F5C78B,earnings,100,50,10/21/2019
F95726,earnings,100,50,10/21/2019
FAE021,product-release,100,64,10/21/2019
FAE021,partnership,100,61,10/21/2019
FBDA0F,acquisition-regulatory-approval-acquirer,100,54,10/21/2019
FBDA0F,merger-regulatory-approval,100,81,10/21/2019
02FC1A,regulatory-product-approval-granted,100,81,10/22/2019
31025,revenue-up,100,69,10/22/2019
31025,earnings,100,50,10/22/2019
31025,earnings,100,50,10/22/2019
31025,earnings,100,50,10/22/2019
03596A,earnings,100,50,10/22/2019
03B8CF,campaign-ad-release,100,59,10/22/2019
03D5F9,partnership,100,61,10/22/2019
040DBB,earnings,100,50,10/22/2019
053EFF,conference-call,100,50,10/22/2019
58828,operating-earnings,100,50,10/22/2019
099C88,dividend,100,50,10/22/2019
0A0D9E,partnership,100,61,10/22/2019
0A7650,earnings,100,50,10/22/2019
0C2A0D,dividend,100,50,10/22/2019
0FABBD,conference-call,100,50,10/22/2019
1065BC,facility-open,100,65,10/22/2019
12F98C,product-release,100,64,10/22/2019
14833D,earnings,100,50,10/22/2019
14BA33,conference-participant,100,50,10/22/2019
17EDA5,partnership,100,61,10/22/2019
182BE7,earnings,100,50,10/22/2019
1A3E1B,dividend,100,50,10/22/2019
1B16C1,earnings,100,50,10/22/2019
1DDEDA,conference-call,100,50,10/22/2019
1E04A5,earnings,100,50,10/22/2019
1E9A6D,earnings,100,50,10/22/2019
206852,product-release,100,64,10/22/2019
21F9CA,earnings,100,50,10/22/2019
225CA2,conference-call,100,50,10/22/2019
228D42,acquisition-acquiree,100,76,10/22/2019
228D42,acquisition-acquiree,100,76,10/22/2019
228D42,partnership,100,61,10/22/2019
241AF7,conference-call,100,50,10/22/2019
25102A,executive-appointment,100,54,10/22/2019
2667B6,earnings,100,50,10/22/2019
2720AB,earnings,100,50,10/22/2019
27C10F,earnings,100,50,10/22/2019
28AF37,earnings,100,50,10/22/2019
28F905,revenue-guidance,100,50,10/22/2019
28F905,executive-appointment,100,54,10/22/2019
2C3348,public-offering,100,43,10/22/2019
2CB4C9,earnings,100,50,10/22/2019
2CBB58,operating-earnings,100,50,10/22/2019
2CBB58,operating-earnings,100,50,10/22/2019
2CBB58,operating-earnings,100,50,10/22/2019
2CBB58,operating-earnings,100,50,10/22/2019
2D643C,dividend,100,50,10/22/2019
2E2E6E,earnings,100,50,10/22/2019
2E2E6E,earnings-up,100,68,10/22/2019
2E2E6E,earnings-up,100,68,10/22/2019
2E2E6E,earnings-up,100,68,10/22/2019
2E2E6E,earnings-up,100,68,10/22/2019
2E2E6E,earnings-up,100,68,10/22/2019
2E61CC,earnings,100,50,10/22/2019
2E6514,earnings,100,50,10/22/2019
2E6514,earnings,100,50,10/22/2019
2E6514,earnings,100,50,10/22/2019
2E6514,earnings,100,50,10/22/2019
2F1299,conference-call,100,50,10/22/2019
2F5256,earnings,100,50,10/22/2019
2F6782,conference-call,100,50,10/22/2019
3.14E+47,earnings-positive,100,69,10/22/2019
3.14E+47,earnings,100,50,10/22/2019
3.14E+47,earnings,100,50,10/22/2019
3.14E+47,earnings,100,50,10/22/2019
3.14E+47,earnings,100,50,10/22/2019
3.14E+47,earnings,100,50,10/22/2019
3.14E+47,earnings,100,50,10/22/2019
3.14E+47,earnings,100,50,10/22/2019
3461CF,dividend,100,50,10/22/2019
3798B9,partnership,100,61,10/22/2019
39BFF6,earnings,100,50,10/22/2019
39BFF6,earnings,100,50,10/22/2019
39BFF6,earnings,100,50,10/22/2019
3A3447,facility-open,100,65,10/22/2019
3B2311,earnings,100,50,10/22/2019
3BB616,earnings,100,50,10/22/2019
3BB616,earnings,100,50,10/22/2019
3BB616,earnings,100,50,10/22/2019
3CCC90,dividend,100,50,10/22/2019
3DE4D1,earnings,100,50,10/22/2019
3F4668,earnings,100,50,10/22/2019
3F6A9C,dividend,100,50,10/22/2019
3F96D5,earnings,100,50,10/22/2019
4017AD,business-contract,100,69,10/22/2019
408089,earnings,100,50,10/22/2019
416C55,earnings,100,50,10/22/2019
41785E,earnings,100,50,10/22/2019
41EC04,executive-appointment,100,54,10/22/2019
427F32,conference-call,100,50,10/22/2019
44740A,conference-call,100,50,10/22/2019
492117,earnings,100,50,10/22/2019
4AE584,earnings,100,50,10/22/2019
4BAF2E,clinical-trials,100,56,10/22/2019
4C6C63,business-contract,100,69,10/22/2019
4C6C63,business-contract,100,69,10/22/2019
4D229C,earnings,100,50,10/22/2019
4DD09F,earnings,100,50,10/22/2019
5225A4,note-sale,100,52,10/22/2019
54A646,earnings-positive,100,69,10/22/2019
54A646,earnings-positive,100,69,10/22/2019
54A646,earnings-positive,100,69,10/22/2019
55438C,demand-increase,100,83,10/22/2019
55438C,executive-appointment,100,54,10/22/2019
55C9B5,product-release,100,64,10/22/2019
55C9B5,acquisition-acquirer,100,49,10/22/2019
56EFC7,executive-appointment,100,54,10/22/2019
583A75,earnings,100,50,10/22/2019
58C2D4,earnings,100,50,10/22/2019
58CA9A,dividend,100,50,10/22/2019
59A832,conference-call,100,50,10/22/2019
59C539,dividend-up,100,81,10/22/2019
5C2A47,business-contract,100,69,10/22/2019
5C7601,executive-appointment,100,54,10/22/2019
5F9CE3,earnings,100,50,10/22/2019
5FDBD0,merger-regulatory-approval,100,81,10/22/2019
627186,executive-resignation,100,44,10/22/2019
63F892,executive-appointment,100,54,10/22/2019
6559D8,clinical-trials,100,56,10/22/2019
657097,unit-acquisition-acquirer,100,49,10/22/2019
6634D9,partnership,100,61,10/22/2019
6634D9,partnership,100,61,10/22/2019
6634D9,partnership,100,61,10/22/2019
6ABCB8,earnings,100,50,10/22/2019
6BD606,conference-call,100,50,10/22/2019
6BD606,conference-call,100,50,10/22/2019
6CC55E,conference-participant,100,50,10/22/2019
6D156D,earnings,100,50,10/22/2019
6D4636,conference-call,100,50,10/22/2019
6DBBBC,unit-acquisition-acquirer,100,49,10/22/2019
6DDA15,earnings,100,50,10/22/2019
6E8864,conference-call,100,50,10/22/2019
72609A,conference-call,100,50,10/22/2019
72CB93,executive-appointment,100,54,10/22/2019
72EF75,earnings,100,50,10/22/2019
73C521,earnings,100,50,10/22/2019
73C521,earnings,100,50,10/22/2019
73C521,earnings,100,50,10/22/2019
73C521,earnings,100,50,10/22/2019
73C521,earnings,100,50,10/22/2019
73C521,earnings,100,50,10/22/2019
752A70,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,earnings,100,50,10/22/2019
75F665,dividend,100,50,10/22/2019
765913,dividend,100,50,10/22/2019
76F067,dividend,100,50,10/22/2019
76F067,executive-resignation,100,44,10/22/2019
7.83E+79,earnings,100,50,10/22/2019
7A2A49,conference-participant,100,50,10/22/2019
7A5097,conference-call,100,50,10/22/2019
7ACFD4,executive-appointment,100,54,10/22/2019
7ACFD4,executive-resignation,100,44,10/22/2019
7AF907,public-offering,100,43,10/22/2019
7B0BA6,business-contract,100,69,10/22/2019
7D35D8,earnings,100,50,10/22/2019
7D35D8,earnings,100,50,10/22/2019
7D35D8,earnings,100,50,10/22/2019
7D5FD6,earnings,100,50,10/22/2019
7E1D5D,product-release,100,64,10/22/2019
7F3669,unit-acquisition-completed-acquiree,100,67,10/22/2019
7F3669,unit-acquisition-completed-acquiree,100,67,10/22/2019
803FED,conference-call,100,50,10/22/2019
8.10E+32,dividend,100,50,10/22/2019
81222C,earnings,100,50,10/22/2019
81F4BE,earnings,100,50,10/22/2019
81F4BE,earnings,100,50,10/22/2019
81F4BE,earnings,100,50,10/22/2019
81F4BE,earnings,100,50,10/22/2019
81F4BE,earnings,100,50,10/22/2019
81F4BE,earnings,100,50,10/22/2019
82C202,earnings,100,50,10/22/2019
82F088,conference-call,100,50,10/22/2019
835C86,dividend,100,50,10/22/2019
8377DB,earnings,100,50,10/22/2019
8377DB,earnings,100,50,10/22/2019
8377DB,earnings,100,50,10/22/2019
8377DB,earnings,100,50,10/22/2019
8377DB,earnings,100,50,10/22/2019
845533,earnings,100,50,10/22/2019
84920B,product-release,100,64,10/22/2019
877734,conference-call,100,50,10/22/2019
8AB37F,conference-call,100,50,10/22/2019
8C311A,earnings,100,50,10/22/2019
8D9993,dividend,100,50,10/22/2019
8DAAB9,earnings-up,100,68,10/22/2019
8E4F9A,conference-call,100,50,10/22/2019
907ED2,earnings,100,50,10/22/2019
911AB8,dividend,100,50,10/22/2019
92B047,note-sale,100,52,10/22/2019
92B047,note-sale,100,52,10/22/2019
9.39E+69,executive-appointment,100,54,10/22/2019
93D207,unit-acquisition-completed-acquirer,100,49,10/22/2019
93D207,unit-acquisition-completed-acquirer,100,49,10/22/2019
93D207,market-entry,100,57,10/22/2019
93F143,earnings,100,50,10/22/2019
93F143,earnings,100,50,10/22/2019
93F143,earnings,100,50,10/22/2019
93F143,earnings,100,50,10/22/2019
93F143,earnings,100,50,10/22/2019
9548BB,earnings-per-share-up,100,68,10/22/2019
9548BB,earnings,100,50,10/22/2019
9548BB,earnings,100,50,10/22/2019
9.54E+32,earnings,100,50,10/22/2019
9.54E+32,earnings,100,50,10/22/2019
95C575,earnings,100,50,10/22/2019
96F126,earnings,100,50,10/22/2019
96F126,earnings,100,50,10/22/2019
97AF94,earnings,100,50,10/22/2019
986AF6,earnings,100,50,10/22/2019
986AF6,earnings,100,50,10/22/2019
986AF6,earnings,100,50,10/22/2019
990AD0,conference-organizer,100,57,10/22/2019
990AD0,dividend,100,50,10/22/2019
99ACAD,dividend,100,50,10/22/2019
9F37C5,conference-call,100,50,10/22/2019
A0F146,conference-call,100,50,10/22/2019
A23747,conference-participant,100,50,10/22/2019
A350C1,credit-extension-recipient,100,69,10/22/2019
A47A7D,product-release,100,64,10/22/2019
A47A7D,product-release,100,64,10/22/2019
A4B899,conference-call,100,50,10/22/2019
A60318,earnings,100,50,10/22/2019
A60354,conference-call,100,50,10/22/2019
A63820,earnings,100,50,10/22/2019
A63820,earnings,100,50,10/22/2019
A63820,earnings,100,50,10/22/2019
A65325,dividend,100,50,10/22/2019
A65325,earnings-positive,100,69,10/22/2019
A70BF5,executive-appointment,100,54,10/22/2019
A7102F,conference-call,100,50,10/22/2019
A868C9,conference-call,100,50,10/22/2019
A871B0,earnings,100,50,10/22/2019
A8B137,earnings,100,50,10/22/2019
A8B137,earnings,100,50,10/22/2019
A8B137,earnings,100,50,10/22/2019
A8B137,earnings,100,50,10/22/2019
A8B137,earnings,100,50,10/22/2019
A8CBDA,earnings-positive,100,69,10/22/2019
AA98ED,earnings,100,50,10/22/2019
AB7726,earnings,100,50,10/22/2019
ACD9A4,earnings,100,50,10/22/2019
AD1ACF,conference-call,100,50,10/22/2019
AE4EEB,earnings,100,50,10/22/2019
B05000,executive-appointment,100,54,10/22/2019
B09B1F,conference-call,100,50,10/22/2019
B0B969,conference-call,100,50,10/22/2019
B1B10C,earnings,100,50,10/22/2019
B1B10C,earnings,100,50,10/22/2019
B1B10C,earnings,100,50,10/22/2019
B1B10C,earnings,100,50,10/22/2019
B37FB4,earnings-up,100,68,10/22/2019
B508E5,conference-call,100,50,10/22/2019
B5766D,earnings-per-share-positive,100,69,10/22/2019
B5766D,earnings,100,50,10/22/2019
B5766D,earnings,100,50,10/22/2019
B5766D,earnings,100,50,10/22/2019
B5766D,earnings,100,50,10/22/2019
B5766D,earnings,100,50,10/22/2019
B6843B,earnings,100,50,10/22/2019
B8F71F,earnings,100,50,10/22/2019
B96637,conference-call,100,50,10/22/2019
BB5142,earnings,100,50,10/22/2019
BB88B6,partnership,100,61,10/22/2019
BB88B6,executive-appointment,100,54,10/22/2019
BBC05B,operating-earnings,100,50,10/22/2019
BCC13E,earnings,100,50,10/22/2019
BCE9DA,earnings,100,50,10/22/2019
BCE9DA,earnings,100,50,10/22/2019
BD15E8,earnings,100,50,10/22/2019
BD8517,conference-participant,100,50,10/22/2019
BD9668,earnings,100,50,10/22/2019
BDD12C,earnings-up,100,68,10/22/2019
BFEA04,conference-call,100,50,10/22/2019
C03C8B,conference-participant,100,50,10/22/2019
C07E05,earnings,100,50,10/22/2019
C22BE8,business-contract,100,69,10/22/2019
C41C25,dividend,100,50,10/22/2019
C4A912,conference-call,100,50,10/22/2019
C62AA4,conference-call,100,50,10/22/2019
C72B8F,conference-call,100,50,10/22/2019
C941DC,earnings,100,50,10/22/2019
CBA33B,dividend,100,50,10/22/2019
CBBFBF,partnership,100,61,10/22/2019
CD051C,index-listing,100,76,10/22/2019
CDAF5B,public-offering,100,43,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,earnings,100,50,10/22/2019
CFE5BE,dividend,100,50,10/22/2019
D06755,conference-participant,100,50,10/22/2019
D1173F,business-contract,100,69,10/22/2019
D17C1B,earnings,100,50,10/22/2019
D17C1B,earnings,100,50,10/22/2019
D17C1B,earnings,100,50,10/22/2019
D3FD6D,conference-call,100,50,10/22/2019
D60BB2,executive-appointment,100,54,10/22/2019
D64C6D,executive-appointment,100,54,10/22/2019
D6EAA3,dividend,100,50,10/22/2019
D7918D,dividend,100,50,10/22/2019
D9B1C9,dividend-up,100,81,10/22/2019
D9E036,business-contract,100,69,10/22/2019
DC486E,earnings,100,50,10/22/2019
DDC415,earnings,100,50,10/22/2019
DDC415,earnings,100,50,10/22/2019
DF204B,conference-call,100,50,10/22/2019
E0647D,earnings,100,50,10/22/2019
E09E2B,partnership,100,61,10/22/2019
E19A99,earnings,100,50,10/22/2019
E30B34,earnings,100,50,10/22/2019
E30B34,earnings,100,50,10/22/2019
E41190,conference-call,100,50,10/22/2019
E5F0A8,acquisition-completed-acquirer,100,49,10/22/2019
E69BA5,conference-call,100,50,10/22/2019
E829E8,earnings,100,50,10/22/2019
E829E8,earnings,100,50,10/22/2019
E829E8,earnings,100,50,10/22/2019
E829E8,earnings,100,50,10/22/2019
E87676,dividend,100,50,10/22/2019
E8846E,stake-acquirer,100,48,10/22/2019
E8846E,donation,100,54,10/22/2019
E8846E,conference-participant,100,50,10/22/2019
E8846E,dividend,100,50,10/22/2019
E90C84,conference-call,100,50,10/22/2019
E94704,conference-participant,100,50,10/22/2019
E9FF33,earnings,100,50,10/22/2019
EAA0A7,partnership,100,61,10/22/2019
EAA0A7,earnings,100,50,10/22/2019
EB5E78,conference-call,100,50,10/22/2019
EB61C4,dividend-up,100,54,10/22/2019
EB7FBF,dividend,100,50,10/22/2019
ECD263,note-sale,100,52,10/22/2019
ED0402,revenue-up,100,65,10/22/2019
ED0402,revenue-up,100,65,10/22/2019
ED0402,revenue-up,100,65,10/22/2019
ED0402,revenue-up,100,65,10/22/2019
ED0D7C,dividend,100,50,10/22/2019
EDF5CA,earnings,100,50,10/22/2019
EDF5CA,earnings,100,50,10/22/2019
EDF5CA,earnings,100,50,10/22/2019
EDF5CA,earnings,100,50,10/22/2019
EDF5CA,earnings,100,50,10/22/2019
EDF5CA,earnings,100,50,10/22/2019
EDF5CA,earnings,100,50,10/22/2019
F04E05,dividend,100,50,10/22/2019
F04E05,executive-appointment,100,54,10/22/2019
F1EB39,business-contract,100,69,10/22/2019
F24FF0,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F294DD,earnings,100,50,10/22/2019
F39E1E,earnings,100,50,10/22/2019
F5A214,earnings-positive,100,69,10/22/2019
F5A214,earnings-positive,100,69,10/22/2019
F5A214,earnings-positive,100,69,10/22/2019
F5A214,earnings-positive,100,69,10/22/2019
F5D410,earnings,100,50,10/22/2019
F5D410,business-contract,100,69,10/22/2019
F5D410,executive-appointment,100,54,10/22/2019
F8C5D7,conference-call,100,50,10/22/2019
F8DE55,dividend,100,50,10/22/2019
FAE021,earnings,100,50,10/22/2019
FAE021,earnings,100,50,10/22/2019
FAE021,earnings,100,50,10/22/2019
FAE021,executive-resignation,100,44,10/22/2019
FAE021,partnership,100,61,10/22/2019
FB7724,earnings,100,50,10/22/2019
FC9A88,earnings,100,50,10/22/2019
FD0CA4,earnings,100,50,10/22/2019
FD39EB,earnings,100,50,10/22/2019
FE7A63,earnings,100,50,10/22/2019
FE7A63,earnings,100,50,10/22/2019
FE7A63,earnings,100,50,10/22/2019
FE7A63,earnings,100,50,10/22/2019
FE7A63,earnings,100,50,10/22/2019
FE7A63,earnings,100,50,10/22/2019
FE7A63,earnings,100,50,10/22/2019
FE7A63,earnings,100,50,10/22/2019
FFE543,revenue-up,100,69,10/22/2019
002A99,clinical-trials-start,100,64,10/23/2019
0142B5,dividend,100,50,10/23/2019
0157B1,partnership,100,61,10/23/2019
0157B1,legal-issues-defendant,100,22,10/23/2019
01B8D6,conference-call,100,50,10/23/2019
03CF95,earnings,100,50,10/23/2019
03CF95,earnings,100,50,10/23/2019
03CF95,earnings,100,50,10/23/2019
03CF95,earnings,100,50,10/23/2019
03CF95,earnings,100,50,10/23/2019
48590,partnership,100,61,10/23/2019
054B55,acquisition-completed-acquirer,100,49,10/23/2019
07EC43,legal-issues-defendant,100,22,10/23/2019
081AB9,earnings,100,50,10/23/2019
0986B5,earnings,100,50,10/23/2019
09DE1F,partnership,100,61,10/23/2019
09F623,dividend-up,100,81,10/23/2019
0A77DB,earnings,100,50,10/23/2019
0A9D0A,product-recall,100,29,10/23/2019
0AB700,earnings,100,50,10/23/2019
0B13E8,conference-call,100,50,10/23/2019
0B57D7,earnings,100,50,10/23/2019
0BC17A,conference-participant,100,50,10/23/2019
0BD199,partnership,100,61,10/23/2019
0BF198,conference-call,100,50,10/23/2019
0C136E,earnings,100,50,10/23/2019
0C466B,earnings,100,50,10/23/2019
0C466B,earnings,100,50,10/23/2019
0C466B,earnings,100,50,10/23/2019
0CBC4D,earnings,100,50,10/23/2019
0CC62B,earnings,100,50,10/23/2019
0CC62B,earnings,100,50,10/23/2019
0CC62B,earnings,100,50,10/23/2019
0CC62B,earnings,100,50,10/23/2019
0CC62B,earnings,100,50,10/23/2019
0CE204,earnings,100,50,10/23/2019
0CE7F6,facility-open,100,65,10/23/2019
0E439E,earnings,100,50,10/23/2019
0E439E,earnings,100,50,10/23/2019
0E439E,earnings,100,50,10/23/2019
0E6027,earnings-positive,100,69,10/23/2019
0E6027,earnings,100,50,10/23/2019
1279ED,conference-call,100,50,10/23/2019
152B9E,dividend,100,50,10/23/2019
15789A,revenue-volume-up,100,51,10/23/2019
15901B,conference-call,100,50,10/23/2019
159739,earnings,100,50,10/23/2019
159739,earnings,100,50,10/23/2019
165B3A,earnings-positive,100,69,10/23/2019
165B3A,earnings-positive,100,69,10/23/2019
165B3A,earnings-positive,100,69,10/23/2019
165B3A,earnings-positive,100,69,10/23/2019
1782D5,earnings,100,50,10/23/2019
1782D5,earnings,100,50,10/23/2019
1782D5,earnings,100,50,10/23/2019
1782D5,earnings,100,50,10/23/2019
1782D5,earnings,100,50,10/23/2019
1782D5,earnings,100,50,10/23/2019
1.79E+10,conference-call,100,50,10/23/2019
17EDA5,partnership,100,61,10/23/2019
1834C0,unit-acquisition-acquirer,100,49,10/23/2019
1866B2,conference-call,100,50,10/23/2019
19BF16,earnings,100,50,10/23/2019
1A9DE1,earnings-positive,100,69,10/23/2019
1A9DE1,earnings-positive,100,69,10/23/2019
1A9DE1,earnings-positive,100,69,10/23/2019
1BDB2A,earnings,100,50,10/23/2019
1CD09C,conference-call,100,50,10/23/2019
1CD708,earnings-up,100,68,10/23/2019
1E5786,dividend,100,50,10/23/2019
1E8A99,earnings,100,50,10/23/2019
1EC3E8,executive-appointment,100,54,10/23/2019
1FA8F7,earnings,100,50,10/23/2019
1FC422,earnings,100,50,10/23/2019
2031CE,earnings,100,50,10/23/2019
2031CE,earnings,100,50,10/23/2019
2031CE,earnings,100,50,10/23/2019
2031CE,earnings,100,50,10/23/2019
2031CE,earnings,100,50,10/23/2019
2031CE,earnings,100,50,10/23/2019
2031CE,earnings,100,50,10/23/2019
2031CE,earnings,100,50,10/23/2019
21DED4,revenues,100,50,10/23/2019
21DED4,revenues,100,50,10/23/2019
21DED4,revenues,100,50,10/23/2019
21DED4,revenues,100,50,10/23/2019
21DED4,revenues,100,50,10/23/2019
21DED4,revenues,100,50,10/23/2019
21DED4,revenues,100,50,10/23/2019
221AD7,earnings,100,50,10/23/2019
24C48B,conference-call,100,50,10/23/2019
25102A,earnings,100,50,10/23/2019
25102A,earnings,100,50,10/23/2019
25102A,earnings,100,50,10/23/2019
25102A,earnings,100,50,10/23/2019
25102A,earnings,100,50,10/23/2019
25102A,dividend,100,50,10/23/2019
25529C,earnings,100,50,10/23/2019
25DD05,earnings,100,50,10/23/2019
264EB3,earnings,100,50,10/23/2019
264EB3,earnings,100,50,10/23/2019
264EB3,earnings,100,50,10/23/2019
264EB3,earnings,100,50,10/23/2019
264EB3,earnings,100,50,10/23/2019
264EB3,earnings,100,50,10/23/2019
2667B6,merger,100,66,10/23/2019
270B78,earnings,100,50,10/23/2019
292A70,earnings,100,50,10/23/2019
29A4CC,earnings,100,50,10/23/2019
2A9C0A,buybacks,100,74,10/23/2019
2B9DBB,earnings,100,50,10/23/2019
2C19A4,merger-regulatory-approval,100,81,10/23/2019
2D643C,earnings,100,50,10/23/2019
31F25C,earnings,100,50,10/23/2019
326EDD,earnings,100,50,10/23/2019
33E8C7,earnings,100,50,10/23/2019
33E8C7,earnings,100,50,10/23/2019
342218,dividend-up,100,81,10/23/2019
3471C0,earnings,100,50,10/23/2019
34B411,dividend,100,50,10/23/2019
34B97A,conference-participant,100,50,10/23/2019
34E9F9,conference-call,100,50,10/23/2019
3696BF,earnings,100,50,10/23/2019
36A1CB,executive-appointment,100,54,10/23/2019
3.73E+87,earnings,100,50,10/23/2019
3.73E+87,earnings,100,50,10/23/2019
3.73E+87,earnings,100,50,10/23/2019
387541,earnings,100,50,10/23/2019
3A3447,earnings,100,50,10/23/2019
3CCC90,earnings,100,50,10/23/2019
3D7971,business-contract,100,69,10/23/2019
3D9999,dividend,100,50,10/23/2019
41785E,buybacks,100,74,10/23/2019
41A93D,earnings,100,50,10/23/2019
41B0E2,earnings,100,50,10/23/2019
425BDC,earnings,100,50,10/23/2019
429BFB,conference-call,100,50,10/23/2019
42AABD,conference-call,100,50,10/23/2019
45ABCC,earnings,100,50,10/23/2019
46017C,conference-call,100,50,10/23/2019
468DD4,earnings,100,50,10/23/2019
47752F,earnings,100,50,10/23/2019
47752F,earnings,100,50,10/23/2019
47752F,earnings,100,50,10/23/2019
47752F,earnings,100,50,10/23/2019
4A2457,business-contract,100,69,10/23/2019
4A5C8D,dividend,100,50,10/23/2019
4B3555,earnings,100,50,10/23/2019
4B6EF9,dividend,100,50,10/23/2019
4B6EF9,earnings,100,50,10/23/2019
4C1FA1,earnings,100,50,10/23/2019
4C1FA1,earnings,100,50,10/23/2019
4C1FA1,earnings,100,50,10/23/2019
4C1FA1,earnings,100,50,10/23/2019
4C7DB5,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D7BD8,earnings,100,50,10/23/2019
4D8313,earnings,100,50,10/23/2019
4D8313,earnings,100,50,10/23/2019
4D8313,earnings,100,50,10/23/2019
4D971D,dividend,100,50,10/23/2019
4D971D,earnings,100,50,10/23/2019
4D971D,earnings,100,50,10/23/2019
4D971D,earnings,100,50,10/23/2019
4D971D,earnings,100,50,10/23/2019
4D971D,earnings,100,50,10/23/2019
4E7C1F,earnings,100,50,10/23/2019
4E7C1F,earnings,100,50,10/23/2019
4E7C1F,earnings,100,50,10/23/2019
4E7C1F,earnings,100,50,10/23/2019
4E7C1F,business-contract,100,69,10/23/2019
4F0A80,earnings,100,50,10/23/2019
4F9487,earnings-positive,100,69,10/23/2019
4F9487,earnings-positive,100,69,10/23/2019
4F9487,earnings-positive,100,69,10/23/2019
4F9487,earnings-positive,100,69,10/23/2019
4F9487,earnings-positive,100,69,10/23/2019
4F9487,earnings-positive,100,69,10/23/2019
4F9487,earnings-positive,100,69,10/23/2019
4F9487,earnings-positive,100,69,10/23/2019
5065B1,earnings,100,50,10/23/2019
513A86,earnings,100,50,10/23/2019
514067,conference-call,100,50,10/23/2019
532D47,earnings,100,50,10/23/2019
5403F8,earnings,100,50,10/23/2019
543900,executive-resignation,100,44,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55438C,earnings,100,50,10/23/2019
55C289,earnings,100,50,10/23/2019
564F3E,settlement,100,56,10/23/2019
56632F,executive-resignation,100,44,10/23/2019
56632F,executive-resignation,100,44,10/23/2019
56632F,executive-appointment,100,54,10/23/2019
56632F,executive-appointment,100,54,10/23/2019
5675EB,dividend,100,50,10/23/2019
5675EB,earnings,100,50,10/23/2019
5675EB,product-release,100,64,10/23/2019
5876DC,earnings,100,50,10/23/2019
594402,earnings,100,50,10/23/2019
5968F9,earnings,100,50,10/23/2019
5968F9,public-offering,100,43,10/23/2019
59C539,executive-appointment,100,54,10/23/2019
5A9F54,earnings-up,100,68,10/23/2019
5A9F54,earnings-up,100,68,10/23/2019
5A9F54,earnings-up,100,68,10/23/2019
5A9F54,earnings-up,100,68,10/23/2019
5AAE17,conference-call,100,50,10/23/2019
5AF08A,earnings,100,50,10/23/2019
5B97B2,earnings,100,50,10/23/2019
5BE42C,dividend,100,50,10/23/2019
5D41E4,conference-call,100,50,10/23/2019
5D43A7,facility-open,100,65,10/23/2019
5DA8B3,earnings,100,50,10/23/2019
5DD48B,earnings,100,50,10/23/2019
5DD48B,earnings,100,50,10/23/2019
5EAA43,business-contract,100,69,10/23/2019
5F2FF7,partnership,100,61,10/23/2019
60DD84,revenue-up,100,69,10/23/2019
6137BF,earnings,100,50,10/23/2019
6137BF,earnings,100,50,10/23/2019
616E3B,earnings,100,50,10/23/2019
616E3B,earnings,100,50,10/23/2019
616E3B,earnings,100,50,10/23/2019
616E3B,earnings,100,50,10/23/2019
616E3B,earnings,100,50,10/23/2019
62EFEE,earnings,100,50,10/23/2019
657097,unit-acquisition-acquirer,100,49,10/23/2019
657097,unit-acquisition-acquirer,100,49,10/23/2019
662682,earnings,100,50,10/23/2019
66E04A,earnings,100,50,10/23/2019
66E04A,earnings,100,50,10/23/2019
66E04A,earnings,100,50,10/23/2019
66E04A,earnings,100,50,10/23/2019
66E04A,earnings,100,50,10/23/2019
66E04A,earnings,100,50,10/23/2019
66E04A,earnings,100,50,10/23/2019
67529E,earnings-up,100,68,10/23/2019
67529E,earnings-up,100,68,10/23/2019
67529E,earnings-up,100,68,10/23/2019
67529E,earnings-up,100,68,10/23/2019
67529E,earnings-up,100,68,10/23/2019
67529E,earnings-up,100,68,10/23/2019
67529E,earnings-up,100,68,10/23/2019
694749,earnings,100,50,10/23/2019
69CE71,conference-call,100,50,10/23/2019
69FDFC,partnership,100,61,10/23/2019
6A961B,conference-call,100,50,10/23/2019
6ACFBF,earnings,100,50,10/23/2019
6B5379,dividend,100,50,10/23/2019
6CB7F9,earnings,100,50,10/23/2019
6CC55E,award,100,58,10/23/2019
6E1E61,earnings,100,50,10/23/2019
6E7060,conference-call,100,50,10/23/2019
6EB9DA,earnings,100,50,10/23/2019
6EB9DA,earnings,100,50,10/23/2019
6EB9DA,earnings,100,50,10/23/2019
6F0096,earnings,100,50,10/23/2019
6F0096,earnings,100,50,10/23/2019
6F0096,earnings,100,50,10/23/2019
6F39FC,conference-call,100,50,10/23/2019
6F3FA8,conference-call,100,50,10/23/2019
724F84,acquisition-acquirer,100,49,10/23/2019
7262F2,earnings,100,50,10/23/2019
73BCBA,earnings,100,50,10/23/2019
73BCBA,earnings,100,50,10/23/2019
73BCBA,earnings,100,50,10/23/2019
763724,conference-call,100,50,10/23/2019
766047,dividend,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
767F86,earnings,100,50,10/23/2019
77B8E9,patent-awarded,100,72,10/23/2019
7A3633,executive-appointment,100,54,10/23/2019
7A3633,partnership,100,61,10/23/2019
7A975D,earnings,100,50,10/23/2019
7A975D,earnings,100,50,10/23/2019
7A975D,earnings,100,50,10/23/2019
7AB859,earnings,100,50,10/23/2019
7AB859,earnings,100,50,10/23/2019
7AB859,earnings,100,50,10/23/2019
7AB859,earnings,100,50,10/23/2019
7AB859,earnings,100,50,10/23/2019
7B6C88,conference-call,100,50,10/23/2019
7B9AFA,earnings,100,50,10/23/2019
7BAAE7,partnership,100,61,10/23/2019
7C75FD,dividend,100,50,10/23/2019
7E1D5D,partnership,100,61,10/23/2019
7E62B5,earnings,100,50,10/23/2019
7FD8B9,conference-call,100,50,10/23/2019
818A2F,dividend,100,50,10/23/2019
818A2F,dividend,100,50,10/23/2019
830BDB,earnings,100,50,10/23/2019
8377DB,stock-loss,100,40,10/23/2019
838ADD,earnings,100,50,10/23/2019
838ADD,earnings,100,50,10/23/2019
838ADD,earnings,100,50,10/23/2019
838ADD,earnings,100,50,10/23/2019
838ADD,earnings,100,50,10/23/2019
838ADD,earnings,100,50,10/23/2019
8614A2,conference-call,100,50,10/23/2019
862941,conference-call,100,50,10/23/2019
8665BA,earnings,100,50,10/23/2019
8665BA,partnership,100,61,10/23/2019
86AA9C,conference-call,100,50,10/23/2019
881190,earnings,100,50,10/23/2019
881190,earnings,100,50,10/23/2019
881190,earnings,100,50,10/23/2019
881190,earnings,100,50,10/23/2019
885758,earnings,100,50,10/23/2019
8BE916,earnings-up,100,68,10/23/2019
8BE916,earnings-up,100,68,10/23/2019
8BE916,earnings-up,100,68,10/23/2019
8BE916,earnings-up,100,68,10/23/2019
8BE916,earnings-up,100,68,10/23/2019
8BE916,earnings-up,100,68,10/23/2019
8BE916,earnings-up,100,68,10/23/2019
8BFE9A,conference-participant,100,50,10/23/2019
8C1238,buybacks,100,74,10/23/2019
8C1238,conference-call,100,50,10/23/2019
8D4AE6,earnings-up,100,68,10/23/2019
8D4AE6,earnings-up,100,68,10/23/2019
8D4AE6,earnings-up,100,68,10/23/2019
8D4AE6,earnings-up,100,68,10/23/2019
8E93A4,dividend,100,50,10/23/2019
8EEA28,dividend,100,50,10/23/2019
911AB8,unit-acquisition-acquirer,100,49,10/23/2019
9196A2,award,100,58,10/23/2019
92005C,earnings,100,50,10/23/2019
925759,award,100,58,10/23/2019
942165,dividend,100,50,10/23/2019
944B2E,earnings,100,50,10/23/2019
945DE6,dividend,100,50,10/23/2019
9470CC,earnings,100,50,10/23/2019
9546A5,settlement,100,56,10/23/2019
9592FB,earnings,100,50,10/23/2019
96F126,business-contract,100,69,10/23/2019
972356,earnings,100,50,10/23/2019
972356,earnings,100,50,10/23/2019
972356,earnings,100,50,10/23/2019
972356,earnings,100,50,10/23/2019
972356,earnings,100,50,10/23/2019
97644E,earnings,100,50,10/23/2019
9.86E+03,partnership,100,61,10/23/2019
98CAED,dividend-up,100,81,10/23/2019
98CAED,earnings,100,50,10/23/2019
98CAED,earnings,100,50,10/23/2019
98CAED,earnings,100,50,10/23/2019
98CAED,earnings,100,50,10/23/2019
98CEBB,conference-participant,100,50,10/23/2019
9.92E+94,earnings,100,50,10/23/2019
9.92E+94,earnings,100,50,10/23/2019
9.92E+94,earnings,100,50,10/23/2019
9934AD,conference-call,100,50,10/23/2019
9A02C4,earnings,100,50,10/23/2019
9A02C4,dividend,100,50,10/23/2019
9C8664,earnings,100,50,10/23/2019
9CE4C7,earnings,100,50,10/23/2019
9D30A8,earnings,100,50,10/23/2019
9DDE1B,earnings,100,50,10/23/2019
9E575E,clinical-trials,100,56,10/23/2019
9F37C5,dividend,100,50,10/23/2019
9F37C5,earnings,100,50,10/23/2019
9FA83B,conference-call,100,50,10/23/2019
9FD2D9,conference-participant,100,50,10/23/2019
A01200,conference-call,100,50,10/23/2019
A1A317,earnings,100,50,10/23/2019
A1A317,earnings,100,50,10/23/2019
A1A317,earnings,100,50,10/23/2019
A1A317,earnings,100,50,10/23/2019
A1EAC8,business-contract,100,69,10/23/2019
A2CAF7,earnings,100,50,10/23/2019
A398F8,conference-participant,100,50,10/23/2019
A403CF,earnings,100,50,10/23/2019
A4386C,dividend,100,50,10/23/2019
A48593,conference-call,100,50,10/23/2019
A4D173,earnings,100,50,10/23/2019
A4D173,earnings,100,50,10/23/2019
A6213D,operating-earnings,100,50,10/23/2019
A99576,earnings,100,50,10/23/2019
AABEA0,earnings-up,100,61,10/23/2019
AADE0B,dividend,100,50,10/23/2019
AC7C4F,partnership,100,61,10/23/2019
ACC7D3,legal-issues-defendant,100,22,10/23/2019
AD23DE,earnings,100,50,10/23/2019
AD23DE,earnings,100,50,10/23/2019
AD23DE,earnings,100,50,10/23/2019
AD23DE,earnings,100,50,10/23/2019
AD23DE,earnings,100,50,10/23/2019
AD23DE,earnings,100,50,10/23/2019
B08954,earnings,100,50,10/23/2019
B13B68,note-sale,100,52,10/23/2019
B48FC9,earnings,100,50,10/23/2019
B6082A,earnings,100,50,10/23/2019
B66928,earnings,100,50,10/23/2019
B7202A,conference-call,100,50,10/23/2019
B96637,earnings,100,50,10/23/2019
B96637,earnings,100,50,10/23/2019
BAAA60,earnings,100,50,10/23/2019
BB88B6,earnings,100,50,10/23/2019
BBAE2A,earnings,100,50,10/23/2019
BCC55F,conference-call,100,50,10/23/2019
BFCACF,earnings,100,50,10/23/2019
C05839,earnings,100,50,10/23/2019
C05839,earnings,100,50,10/23/2019
C05839,earnings,100,50,10/23/2019
C05839,earnings,100,50,10/23/2019
C05839,earnings,100,50,10/23/2019
C1114B,conference-call,100,50,10/23/2019
C16A8F,dividend,100,50,10/23/2019
C2609A,business-contract,100,69,10/23/2019
C27E19,operating-earnings,100,50,10/23/2019
C2F597,executive-appointment,100,54,10/23/2019
C2F597,earnings,100,50,10/23/2019
C45CE7,earnings,100,50,10/23/2019
C5E100,conference-call,100,50,10/23/2019
C66B44,partnership,100,61,10/23/2019
C97B2D,earnings,100,50,10/23/2019
C9B932,earnings,100,50,10/23/2019
C9B932,earnings,100,50,10/23/2019
CA99D7,conference-call,100,50,10/23/2019
CA99D7,conference-call,100,50,10/23/2019
CB89EA,partnership,100,61,10/23/2019
CB89EA,earnings,100,50,10/23/2019
CB9E13,conference-call,100,50,10/23/2019
CBA33B,earnings,100,50,10/23/2019
CBBFBF,executive-appointment,100,54,10/23/2019
CBBFBF,dividend,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CD4DA8,earnings,100,50,10/23/2019
CEC08B,merger,100,66,10/23/2019
CFF15D,conference-call,100,50,10/23/2019
CFF97C,credit-rating-upgrade-rater,20,50,10/23/2019
D139BC,earnings,100,50,10/23/2019
D13F1C,earnings,100,50,10/23/2019
D15833,dividend-up,100,91,10/23/2019
D21D8A,earnings,100,50,10/23/2019
D21D8A,earnings,100,50,10/23/2019
D21D8A,earnings,100,50,10/23/2019
D21D8A,earnings,100,50,10/23/2019
D21D8A,earnings,100,50,10/23/2019
D21D8A,earnings,100,50,10/23/2019
D21D8A,earnings,100,50,10/23/2019
D33D8C,dividend,100,50,10/23/2019
D33D8C,dividend,100,50,10/23/2019
D4070C,campaign-ad-release,100,59,10/23/2019
D4070C,campaign-ad-release,100,59,10/23/2019
D42DBA,partnership,100,61,10/23/2019
D437C3,earnings,100,50,10/23/2019
D437C3,earnings,100,50,10/23/2019
D437C3,earnings,100,50,10/23/2019
D437C3,earnings,100,50,10/23/2019
D437C3,earnings,100,50,10/23/2019
D437C3,earnings,100,50,10/23/2019
D437C3,earnings,100,50,10/23/2019
D4463B,earnings,100,50,10/23/2019
D5A350,earnings,100,50,10/23/2019
D650A7,conference-participant,100,50,10/23/2019
D76AEF,conference-call,100,50,10/23/2019
D78CCD,dividend,100,50,10/23/2019
D7A953,earnings,100,50,10/23/2019
DA90E1,dividend,100,50,10/23/2019
DC0998,earnings,100,50,10/23/2019
DC0998,earnings,100,50,10/23/2019
DC0998,earnings,100,50,10/23/2019
DC0998,earnings,100,50,10/23/2019
DCD97F,earnings,100,50,10/23/2019
DD1BA1,earnings,100,50,10/23/2019
DD3BB1,earnings,100,50,10/23/2019
DD7A96,earnings,100,50,10/23/2019
DF11D9,earnings,100,50,10/23/2019
DF8855,earnings,100,50,10/23/2019
E00373,earnings,100,50,10/23/2019
E0339F,dividend,100,50,10/23/2019
E0339F,executive-appointment,100,54,10/23/2019
E05026,conference-call,100,50,10/23/2019
E07573,dividend,100,50,10/23/2019
E22FDE,earnings,100,50,10/23/2019
E2CB7B,earnings,100,50,10/23/2019
E49AA3,product-release,100,64,10/23/2019
E592F0,partnership,100,61,10/23/2019
E5A3B6,clinical-trials-start,100,64,10/23/2019
E6EDED,earnings,100,50,10/23/2019
E70531,business-contract,100,69,10/23/2019
E72599,conference-call,100,50,10/23/2019
E74B55,partnership,100,61,10/23/2019
E90C84,earnings,100,50,10/23/2019
E90C84,earnings,100,50,10/23/2019
E99180,earnings,100,50,10/23/2019
EA4E68,earnings,100,50,10/23/2019
EB7FBF,earnings,100,50,10/23/2019
EBC84C,award,100,58,10/23/2019
EC1AF3,conference-call,100,50,10/23/2019
ED2EFD,dividend-up,100,81,10/23/2019
ED9576,earnings,100,50,10/23/2019
F0B2B5,conference-call,100,50,10/23/2019
F1C04C,operating-earnings,100,50,10/23/2019
F294DD,earnings,100,50,10/23/2019
F294DD,earnings,100,50,10/23/2019
F294DD,earnings,100,50,10/23/2019
F294DD,earnings,100,50,10/23/2019
F2BC3D,ipo-pricing,100,50,10/23/2019
F2E253,conference-call,100,50,10/23/2019
F30508,executive-resignation,100,44,10/23/2019
F30508,earnings,100,50,10/23/2019
F30508,earnings,100,50,10/23/2019
F30508,earnings,100,50,10/23/2019
F30508,earnings,100,50,10/23/2019
F30508,earnings,100,50,10/23/2019
F30508,earnings,100,50,10/23/2019
F30508,earnings,100,50,10/23/2019
F3816D,clinical-trials,100,56,10/23/2019
F7902B,earnings,100,50,10/23/2019
F7902B,earnings,100,50,10/23/2019
F7FCA4,dividend,100,50,10/23/2019
FA918D,dividend,100,50,10/23/2019
FACF19,dividend,100,50,10/23/2019
FC4550,earnings,100,50,10/23/2019
FC9A88,acquisition-acquirer,100,49,10/23/2019
FC9A88,acquisition-acquirer,100,49,10/23/2019
FD4588,partnership,100,61,10/23/2019
FD4E8D,revenues,100,50,10/23/2019
FD4E8D,revenues,100,50,10/23/2019
FD4E8D,revenues,100,50,10/23/2019
FDC7E6,dividend,100,50,10/23/2019
FDC7E6,earnings,100,50,10/23/2019
FE1A1D,operating-earnings,100,50,10/23/2019
FEC475,executive-appointment,100,54,10/23/2019
FEE4B0,dividend,100,50,10/23/2019
FF4343,earnings,100,50,10/23/2019
FF4343,earnings-up,100,68,10/23/2019
FF4343,earnings-up,100,68,10/23/2019
FF4343,earnings-up,100,68,10/23/2019
FF4343,earnings-up,100,68,10/23/2019
FF4343,earnings-up,100,68,10/23/2019
FF4343,earnings-up,100,68,10/23/2019
FF4343,earnings-up,100,68,10/23/2019
FF4343,earnings-up,100,68,10/23/2019
FF4343,earnings,100,50,10/23/2019
FF4343,earnings,100,50,10/23/2019
FF4343,earnings,100,50,10/23/2019
FFAB4A,dividend-up,100,81,10/23/2019
9397,earnings,100,50,10/24/2019
9397,earnings,100,50,10/24/2019
0142B5,buybacks,100,74,10/24/2019
0157B1,revenue-up,100,71,10/24/2019
0157B1,revenue-up,100,71,10/24/2019
0157B1,revenue-up,100,71,10/24/2019
0157B1,revenue-up,100,71,10/24/2019
0157B1,revenue-up,100,71,10/24/2019
0157B1,revenue-up,100,71,10/24/2019
0157B1,revenue-up,100,71,10/24/2019
03B8CF,earnings,100,50,10/24/2019
03B8CF,earnings,100,50,10/24/2019
03B8CF,earnings,100,50,10/24/2019
03B8CF,earnings,100,50,10/24/2019
03B8CF,earnings,100,50,10/24/2019
51332,dividend,100,50,10/24/2019
55018,earnings-positive,100,69,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
55018,earnings,100,50,10/24/2019
0560D8,earnings,100,50,10/24/2019
61366,earnings,100,50,10/24/2019
061A3B,earnings,100,50,10/24/2019
71860,earnings,100,50,10/24/2019
75172,conference-call,100,50,10/24/2019
07CA6A,earnings,100,50,10/24/2019
07CA6A,earnings,100,50,10/24/2019
07EC43,executive-appointment,100,54,10/24/2019
0A7650,earnings-up,100,68,10/24/2019
0B2071,dividend,100,50,10/24/2019
0C6293,conference-call,100,50,10/24/2019
0DC050,earnings,100,50,10/24/2019
0DC050,earnings,100,50,10/24/2019
0DC050,earnings,100,50,10/24/2019
0DC050,earnings,100,50,10/24/2019
0F04E5,earnings,100,50,10/24/2019
0F04E5,earnings,100,50,10/24/2019
0F04E5,earnings,100,50,10/24/2019
0F91FC,earnings,100,50,10/24/2019
102F04,earnings,100,50,10/24/2019
10943B,earnings,100,50,10/24/2019
1096C6,earnings,100,50,10/24/2019
1151F4,earnings,100,50,10/24/2019
1151F4,earnings,100,50,10/24/2019
1151F4,earnings,100,50,10/24/2019
1151F4,earnings,100,50,10/24/2019
1151F4,earnings,100,50,10/24/2019
1151F4,earnings,100,50,10/24/2019
1151F4,earnings,100,50,10/24/2019
119CB6,earnings-per-share-positive,100,69,10/24/2019
13C3E0,earnings-positive,100,69,10/24/2019
13C3E0,earnings-positive,100,69,10/24/2019
159AE4,earnings,100,50,10/24/2019
159AE4,earnings,100,50,10/24/2019
159AE4,earnings,100,50,10/24/2019
184866,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1A2D9F,earnings,100,50,10/24/2019
1AF7E2,earnings,100,50,10/24/2019
1AF7E2,earnings,100,50,10/24/2019
1D943E,earnings,100,50,10/24/2019
1DB6A6,earnings,100,50,10/24/2019
1FAF22,legal-issues-defendant,100,22,10/24/2019
1FAF22,legal-issues-defendant,100,22,10/24/2019
202E5A,earnings,100,50,10/24/2019
2082EA,patient-enrollment-complete,100,64,10/24/2019
20DC4E,earnings,100,50,10/24/2019
225CA2,dividend,100,50,10/24/2019
2262BD,earnings,100,50,10/24/2019
2491BC,earnings,100,50,10/24/2019
2491BC,earnings,100,50,10/24/2019
2491BC,earnings,100,50,10/24/2019
2491BC,earnings,100,50,10/24/2019
249B39,earnings-positive,100,69,10/24/2019
251988,product-release,100,64,10/24/2019
253B2F,conference-call,100,50,10/24/2019
25D3CE,conference-participant,100,50,10/24/2019
26DC29,legal-issues-defendant,100,22,10/24/2019
270B78,dividend,100,50,10/24/2019
272472,earnings,100,50,10/24/2019
272704,dividend,100,50,10/24/2019
284289,earnings,100,50,10/24/2019
297DA8,earnings,100,50,10/24/2019
29B702,earnings,100,50,10/24/2019
2.90E+62,earnings,100,50,10/24/2019
2.90E+62,earnings,100,50,10/24/2019
2.90E+62,earnings,100,50,10/24/2019
2.90E+62,earnings,100,50,10/24/2019
2.90E+62,earnings,100,50,10/24/2019
2.90E+62,dividend,100,50,10/24/2019
2A17B1,earnings-up,100,68,10/24/2019
2A17B1,earnings-up,100,68,10/24/2019
2A17B1,earnings-up,100,68,10/24/2019
2B5483,earnings,100,50,10/24/2019
2BF36E,conference-call,100,50,10/24/2019
2DA92D,earnings,100,50,10/24/2019
2E61CC,commodity-buy,100,55,10/24/2019
2F94A5,earnings,100,50,10/24/2019
2F960F,conference-call,100,50,10/24/2019
306623,conference-call,100,50,10/24/2019
30DFD3,earnings,100,50,10/24/2019
319BE2,dividend,100,50,10/24/2019
319BE2,earnings,100,50,10/24/2019
31A7CC,dividend,100,50,10/24/2019
31DB20,earnings,100,50,10/24/2019
31F25C,dividend,100,50,10/24/2019
326EDD,acquisition-completed-acquirer,100,49,10/24/2019
328250,earnings,100,50,10/24/2019
32C8CD,conference-call,100,50,10/24/2019
32F24A,earnings,100,50,10/24/2019
32F943,earnings,100,50,10/24/2019
35AE32,earnings,100,50,10/24/2019
36A1CB,conference-call,100,50,10/24/2019
371C01,earnings,100,50,10/24/2019
371C01,earnings,100,50,10/24/2019
383ADA,executive-appointment,100,54,10/24/2019
3.88E+02,earnings,100,50,10/24/2019
396D7C,earnings,100,50,10/24/2019
3A113F,earnings,100,50,10/24/2019
3A3447,facility-open,100,65,10/24/2019
3AF7FD,conference-call,100,50,10/24/2019
3C11C4,earnings,100,50,10/24/2019
3CCC90,executive-appointment,100,54,10/24/2019
3DB18B,earnings,100,50,10/24/2019
3E15F6,earnings,100,50,10/24/2019
3E15F6,earnings,100,50,10/24/2019
3E15F6,earnings,100,50,10/24/2019
3E15F6,earnings,100,50,10/24/2019
3EE65E,product-release,100,64,10/24/2019
3FBC9B,executive-appointment,100,54,10/24/2019
4.00E+163,earnings,100,50,10/24/2019
422CE3,market-entry,100,57,10/24/2019
422CE3,market-entry,100,57,10/24/2019
434F38,earnings,100,50,10/24/2019
43F4A8,earnings,100,50,10/24/2019
4455C4,earnings,100,50,10/24/2019
4455C4,earnings,100,50,10/24/2019
4455C4,earnings,100,50,10/24/2019
4455C4,earnings,100,50,10/24/2019
449217,earnings-positive,100,69,10/24/2019
449217,earnings,100,50,10/24/2019
449217,earnings,100,50,10/24/2019
449217,earnings,100,50,10/24/2019
449217,earnings,100,50,10/24/2019
449217,earnings,100,50,10/24/2019
44DDBD,conference-call,100,50,10/24/2019
453282,earnings-per-share-positive,100,69,10/24/2019
458D2C,earnings,100,50,10/24/2019
4595EF,earnings,100,50,10/24/2019
4649D5,conference-call,100,50,10/24/2019
46CF27,earnings,100,50,10/24/2019
46CF27,earnings,100,50,10/24/2019
46CF27,earnings,100,50,10/24/2019
46CF27,earnings,100,50,10/24/2019
46CF27,earnings,100,50,10/24/2019
46CF27,earnings,100,50,10/24/2019
46CF27,earnings,100,50,10/24/2019
46CF27,earnings,100,50,10/24/2019
479930,earnings,100,50,10/24/2019
47BA98,earnings,100,50,10/24/2019
4.91E+58,fundraising,100,64,10/24/2019
49BBBC,product-release,100,64,10/24/2019
49CC59,conference-call,100,50,10/24/2019
4A3438,conference-call,100,50,10/24/2019
4A6F00,partnership,100,61,10/24/2019
4BD6DB,earnings,100,50,10/24/2019
4C2F17,conference-participant,100,50,10/24/2019
4E913D,earnings-up,100,60,10/24/2019
4E913D,earnings-up,100,60,10/24/2019
4EE167,earnings,100,50,10/24/2019
4EE167,earnings,100,50,10/24/2019
4F9926,analyst-ratings-set-positive,100,78,10/24/2019
50702E,conference-call,100,50,10/24/2019
51527B,earnings,100,50,10/24/2019
51E682,earnings,100,50,10/24/2019
53A226,earnings,100,50,10/24/2019
54DF47,conference-call,100,50,10/24/2019
553949,conference-call,100,50,10/24/2019
5546DA,earnings-per-share-positive,100,69,10/24/2019
5546DA,earnings-per-share-positive,100,69,10/24/2019
5546DA,earnings-per-share-positive,100,69,10/24/2019
5546DA,earnings-per-share-positive,100,69,10/24/2019
5546DA,earnings-per-share-positive,100,69,10/24/2019
556A57,dividend,100,50,10/24/2019
55C9B5,partnership,100,61,10/24/2019
567F3D,earnings,100,50,10/24/2019
567F3D,earnings,100,50,10/24/2019
567F3D,earnings,100,50,10/24/2019
567F3D,earnings,100,50,10/24/2019
567F3D,earnings,100,50,10/24/2019
57356F,earnings,100,50,10/24/2019
57356F,earnings,100,50,10/24/2019
57356F,earnings,100,50,10/24/2019
57356F,earnings,100,50,10/24/2019
57CAAB,business-contract,100,69,10/24/2019
57DDB9,joint-venture,100,62,10/24/2019
57EF50,conference-call,100,50,10/24/2019
58CA9A,executive-appointment,100,54,10/24/2019
596116,earnings,100,50,10/24/2019
5968F9,public-offering,100,43,10/24/2019
59B229,earnings,100,50,10/24/2019
59B229,earnings,100,50,10/24/2019
59B229,earnings,100,50,10/24/2019
59B229,earnings,100,50,10/24/2019
59B229,earnings,100,50,10/24/2019
59C539,earnings,100,50,10/24/2019
5A64D5,earnings,100,50,10/24/2019
5B3FA2,earnings,100,50,10/24/2019
5CEE02,analyst-ratings-set-positive-rater,20,50,10/24/2019
5D1329,conference-call,100,50,10/24/2019
5D16CF,earnings,100,50,10/24/2019
5D1956,earnings,100,50,10/24/2019
5E6959,earnings-up,100,68,10/24/2019
5F60CE,earnings,100,50,10/24/2019
5FE4B6,earnings,100,50,10/24/2019
5FE4B6,earnings,100,50,10/24/2019
622037,dividend,100,50,10/24/2019
633054,campaign-ad-release,100,59,10/24/2019
63E8D5,earnings,100,50,10/24/2019
63E8D5,earnings,100,50,10/24/2019
641F17,earnings,100,50,10/24/2019
641F17,earnings,100,50,10/24/2019
641F17,earnings,100,50,10/24/2019
641F17,earnings,100,50,10/24/2019
641F17,earnings,100,50,10/24/2019
641F17,earnings,100,50,10/24/2019
64E615,conference-call,100,50,10/24/2019
657097,earnings,100,50,10/24/2019
662682,dividend,100,50,10/24/2019
665D7D,partnership,100,61,10/24/2019
665D7D,conference-participant,100,50,10/24/2019
68586A,conference-call,100,50,10/24/2019
69E8E1,earnings,100,50,10/24/2019
69E8E1,earnings,100,50,10/24/2019
69E8E1,earnings,100,50,10/24/2019
69E8E1,earnings,100,50,10/24/2019
69E8E1,earnings,100,50,10/24/2019
6BDA0C,conference-call,100,50,10/24/2019
6CD55A,earnings,100,50,10/24/2019
6CDFC6,earnings,100,50,10/24/2019
6CF43C,earnings,100,50,10/24/2019
6E705B,partnership,100,61,10/24/2019
6E705B,partnership,100,61,10/24/2019
6E8349,earnings,100,50,10/24/2019
71B0CF,earnings,100,50,10/24/2019
724F84,earnings,100,50,10/24/2019
72CB93,earnings,100,50,10/24/2019
73529F,earnings,100,50,10/24/2019
73C9E2,earnings,100,50,10/24/2019
7448A3,earnings,100,50,10/24/2019
7.40E+289,earnings,100,50,10/24/2019
762A3E,earnings,100,50,10/24/2019
763724,acquisition-completed-acquirer,100,49,10/24/2019
76CEFB,earnings,100,50,10/24/2019
76F067,earnings,100,50,10/24/2019
7734AC,earnings,100,50,10/24/2019
773A17,revenue-up,100,69,10/24/2019
773A17,revenue-up,100,69,10/24/2019
773A17,revenue-up,100,69,10/24/2019
7771D7,earnings,100,50,10/24/2019
78A1BB,earnings,100,50,10/24/2019
791D59,earnings,100,50,10/24/2019
7A3633,partnership,100,61,10/24/2019
7A3633,partnership,100,61,10/24/2019
7AB859,business-contract,100,69,10/24/2019
7B0BA6,dividend,100,50,10/24/2019
7B1156,conference-call,100,50,10/24/2019
7BAAE7,earnings-per-share-positive,100,69,10/24/2019
7BAAE7,earnings,100,50,10/24/2019
7C4F43,clinical-trials,100,56,10/24/2019
7C4F43,clinical-trials,100,56,10/24/2019
7CBC40,earnings,100,50,10/24/2019
7CBC40,earnings,100,50,10/24/2019
7CBC40,earnings,100,50,10/24/2019
7CBC40,earnings,100,50,10/24/2019
7D35D8,legal-issues-defendant,100,22,10/24/2019
7DC1C4,earnings,100,50,10/24/2019
7E0EB0,earnings,100,50,10/24/2019
7F3665,earnings,100,50,10/24/2019
7F9E16,conference-call,100,50,10/24/2019
80D744,earnings,100,50,10/24/2019
81A88D,earnings,100,50,10/24/2019
8.22E+27,earnings,100,50,10/24/2019
824CCA,earnings,100,50,10/24/2019
82E58A,conference-call,100,50,10/24/2019
83598E,dividend-up,100,60,10/24/2019
837C04,earnings,100,50,10/24/2019
837C04,dividend,100,50,10/24/2019
845655,conference-call,100,50,10/24/2019
845655,conference-call,100,50,10/24/2019
86F123,conference-call,100,50,10/24/2019
8817D5,earnings-up,100,68,10/24/2019
895D56,conference-call,100,50,10/24/2019
8A8E41,earnings,100,50,10/24/2019
8A8E41,joint-venture,100,62,10/24/2019
8AB37F,conference-participant,100,50,10/24/2019
8B3B0E,earnings,100,50,10/24/2019
8C311A,conference-participant,100,50,10/24/2019
8D5145,earnings,100,50,10/24/2019
8DE74B,earnings-up,100,68,10/24/2019
8DE74B,earnings,100,50,10/24/2019
8DE74B,earnings,100,50,10/24/2019
8DE74B,earnings,100,50,10/24/2019
8E4250,earnings,100,50,10/24/2019
8E82A6,earnings,100,50,10/24/2019
8F3231,earnings,100,50,10/24/2019
9004C4,conference-call,100,50,10/24/2019
9043FE,earnings,100,50,10/24/2019
9043FE,earnings,100,50,10/24/2019
922F0C,earnings,100,50,10/24/2019
9.31E+77,conference-call,100,50,10/24/2019
9.39E+69,orphan-drug-designation,100,76,10/24/2019
93C130,earnings,100,50,10/24/2019
93C130,dividend,100,50,10/24/2019
943239,earnings,100,50,10/24/2019
94563D,revenue-up,100,69,10/24/2019
94756D,earnings,100,50,10/24/2019
95DE39,earnings-up,100,71,10/24/2019
965360,dividend,100,50,10/24/2019
9673BD,conference-call,100,50,10/24/2019
96B4FF,patient-enrollment-start,100,58,10/24/2019
96F126,business-contract,100,69,10/24/2019
96F126,business-contract,100,69,10/24/2019
9.74E+08,earnings,100,50,10/24/2019
9.74E+08,earnings,100,50,10/24/2019
9.74E+08,earnings,100,50,10/24/2019
9.74E+08,earnings,100,50,10/24/2019
979451,earnings,100,50,10/24/2019
9.97E+09,earnings,100,50,10/24/2019
997348,earnings,100,50,10/24/2019
997348,earnings,100,50,10/24/2019
9A2760,earnings,100,50,10/24/2019
9BF177,partnership,100,61,10/24/2019
9BF177,partnership,100,61,10/24/2019
9CF9B1,settlement,100,56,10/24/2019
9CF9B1,earnings,100,50,10/24/2019
9E98F2,conference-participant,100,50,10/24/2019
9F03CF,earnings,100,50,10/24/2019
9F03CF,dividend,100,50,10/24/2019
9F048E,conference-call,100,50,10/24/2019
9F6B1A,earnings,100,50,10/24/2019
9F6B1A,earnings,100,50,10/24/2019
9F6B1A,earnings,100,50,10/24/2019
9F6B1A,earnings,100,50,10/24/2019
A02FB1,earnings,100,50,10/24/2019
A204A7,earnings,100,50,10/24/2019
A247F5,earnings,100,50,10/24/2019
A29DBD,earnings,100,50,10/24/2019
A433A5,earnings,100,50,10/24/2019
A5B913,earnings,100,50,10/24/2019
A5B913,earnings,100,50,10/24/2019
A5B913,earnings,100,50,10/24/2019
A631A3,partnership,100,61,10/24/2019
A7F0A5,earnings,100,50,10/24/2019
A806FA,dividend,100,50,10/24/2019
A871B0,executive-appointment,100,54,10/24/2019
A8B137,dividend,100,50,10/24/2019
A94637,revenues,100,50,10/24/2019
AA7FE0,executive-appointment,100,54,10/24/2019
AADE0B,earnings,100,50,10/24/2019
AB4A7E,conference-call,100,50,10/24/2019
ABEE43,earnings-per-share-up,100,88,10/24/2019
ABEE43,earnings-per-share,100,50,10/24/2019
ABEE43,earnings-per-share,100,50,10/24/2019
ABEE43,earnings-per-share,100,50,10/24/2019
ABEE43,earnings-per-share,100,50,10/24/2019
ABEE43,earnings-per-share,100,50,10/24/2019
ABEE43,earnings-per-share,100,50,10/24/2019
ABEE43,earnings-per-share,100,50,10/24/2019
ABEE43,earnings-per-share,100,50,10/24/2019
AC1952,earnings,100,50,10/24/2019
AC642C,earnings,100,50,10/24/2019
AC642C,earnings,100,50,10/24/2019
AC7C4F,business-contract,100,69,10/24/2019
AD375D,earnings,100,50,10/24/2019
AD3C93,earnings,100,50,10/24/2019
AFD1CA,earnings,100,50,10/24/2019
B05000,executive-appointment,100,54,10/24/2019
B076A1,conference-call,100,50,10/24/2019
B106FA,earnings,100,50,10/24/2019
B619CB,earnings-positive,100,69,10/24/2019
B6CD92,earnings-positive,100,69,10/24/2019
B6CD92,earnings-up,100,68,10/24/2019
B6CD92,earnings-up,100,68,10/24/2019
B6CD92,earnings-up,100,68,10/24/2019
B6CD92,earnings-up,100,68,10/24/2019
B83BCE,earnings,100,50,10/24/2019
BAAA60,dividend,100,50,10/24/2019
BB5142,executive-appointment,100,54,10/24/2019
BBBB41,dividend,100,50,10/24/2019
BC3AD2,earnings,100,50,10/24/2019
BC3AD2,earnings,100,50,10/24/2019
BC3AD2,earnings,100,50,10/24/2019
BC3AD2,earnings,100,50,10/24/2019
BC3AD2,earnings,100,50,10/24/2019
BC3AD2,earnings,100,50,10/24/2019
BC3AD2,earnings,100,50,10/24/2019
BC3AD2,earnings,100,50,10/24/2019
BC4876,dividend,100,50,10/24/2019
BCC55F,conference-participant,100,50,10/24/2019
BD682F,earnings,100,50,10/24/2019
BDCC11,earnings,100,50,10/24/2019
BE645B,clinical-trials-start,100,64,10/24/2019
BEB756,earnings,100,50,10/24/2019
BF79F5,earnings,100,50,10/24/2019
BF79F5,earnings,100,50,10/24/2019
BF79F5,earnings,100,50,10/24/2019
C062D4,dividend,100,50,10/24/2019
C11C46,executive-appointment,100,54,10/24/2019
C1CBA4,earnings-positive,100,69,10/24/2019
C1CBA4,earnings-up,100,68,10/24/2019
C1CBA4,earnings-up,100,68,10/24/2019
C1CBA4,earnings-up,100,68,10/24/2019
C1CBA4,earnings-up,100,68,10/24/2019
C1CBA4,earnings-up,100,68,10/24/2019
C1CBA4,earnings-up,100,68,10/24/2019
C1CBA4,earnings-up,100,68,10/24/2019
C230FE,facility-open,100,65,10/24/2019
C2E39B,earnings,100,50,10/24/2019
C38440,earnings,100,50,10/24/2019
C38440,earnings,100,50,10/24/2019
C598D7,dividend-up,100,56,10/24/2019
C5D2AE,earnings,100,50,10/24/2019
C7859D,conference-participant,100,50,10/24/2019
C83B88,earnings,100,50,10/24/2019
C83B88,earnings,100,50,10/24/2019
C83B88,earnings,100,50,10/24/2019
C83B88,earnings,100,50,10/24/2019
C83B88,earnings,100,50,10/24/2019
C83B88,earnings,100,50,10/24/2019
C83B88,earnings,100,50,10/24/2019
C83B88,dividend,100,50,10/24/2019
C8A248,earnings,100,50,10/24/2019
C9E107,earnings-per-share-positive,100,69,10/24/2019
C9E107,dividend,100,50,10/24/2019
C9E4EC,earnings,100,50,10/24/2019
CB22CD,earnings,100,50,10/24/2019
CC3EC4,earnings,100,50,10/24/2019
CCB623,earnings,100,50,10/24/2019
CDAB24,earnings,100,50,10/24/2019
CDC217,earnings,100,50,10/24/2019
CDEDFE,earnings,100,50,10/24/2019
CE1002,earnings,100,50,10/24/2019
CE1002,earnings,100,50,10/24/2019
CE1002,earnings,100,50,10/24/2019
CE1002,earnings,100,50,10/24/2019
CE1002,earnings,100,50,10/24/2019
CE96E7,product-release,100,64,10/24/2019
CF6A5A,earnings,100,50,10/24/2019
D1344A,earnings,100,50,10/24/2019
D1C26F,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D3F64D,earnings,100,50,10/24/2019
D4070C,earnings,100,50,10/24/2019
D4070C,earnings,100,50,10/24/2019
D501DC,earnings,100,50,10/24/2019
D57D99,dividend,100,50,10/24/2019
D6489C,award,100,58,10/24/2019
D78BF1,earnings,100,50,10/24/2019
D78CCD,conference-call,100,50,10/24/2019
D8760C,dividend,100,50,10/24/2019
D9B1C9,earnings,100,50,10/24/2019
D9B1C9,earnings,100,50,10/24/2019
D9B1C9,earnings,100,50,10/24/2019
DA90E1,earnings,100,50,10/24/2019
DA91AE,conference-participant,100,50,10/24/2019
DBCA3F,earnings,100,50,10/24/2019
DD0099,earnings-up,100,68,10/24/2019
DE5611,conference-participant,100,50,10/24/2019
DF18E6,clinical-trials-start,100,64,10/24/2019
DF6FDD,earnings,100,50,10/24/2019
E05DC8,earnings,100,50,10/24/2019
E09997,conference-call,100,50,10/24/2019
E0F4E5,investment-recipient,100,73,10/24/2019
E10D31,dividend,100,50,10/24/2019
E124EB,earnings,100,50,10/24/2019
E124EB,earnings,100,50,10/24/2019
E124EB,earnings,100,50,10/24/2019
E124EB,earnings,100,50,10/24/2019
E35610,product-release,100,64,10/24/2019
E38906,earnings,100,50,10/24/2019
E40FB6,buybacks,100,74,10/24/2019
E40FB6,earnings,100,50,10/24/2019
E40FB6,earnings,100,50,10/24/2019
E40FB6,earnings,100,50,10/24/2019
E40FB6,earnings,100,50,10/24/2019
E40FB6,earnings,100,50,10/24/2019
E40FB6,earnings,100,50,10/24/2019
E6D89E,earnings,100,50,10/24/2019
E6D89E,earnings,100,50,10/24/2019
E6D89E,earnings,100,50,10/24/2019
E6D89E,earnings,100,50,10/24/2019
E866D2,earnings-up,100,68,10/24/2019
E866D2,earnings-up,100,68,10/24/2019
E866D2,earnings-up,100,68,10/24/2019
E866D2,earnings-up,100,68,10/24/2019
E866D2,earnings-up,100,68,10/24/2019
E866D2,earnings-up,100,68,10/24/2019
E959F3,earnings,100,50,10/24/2019
EA62FC,dividend,100,50,10/24/2019
EB1E1A,clinical-trials-start,100,64,10/24/2019
EBD89A,earnings,100,50,10/24/2019
EC99D0,buybacks,100,74,10/24/2019
EC99D0,earnings,100,50,10/24/2019
ED0D7C,earnings,100,50,10/24/2019
ED0D7C,earnings,100,50,10/24/2019
ED0D7C,earnings,100,50,10/24/2019
ED0D7C,earnings,100,50,10/24/2019
ED0D7C,earnings,100,50,10/24/2019
ED7F13,index-listing,100,76,10/24/2019
ED8676,earnings,100,50,10/24/2019
ED8676,dividend,100,50,10/24/2019
EDF5CA,dividend,100,50,10/24/2019
EE04F0,product-release,100,64,10/24/2019
EE1E44,earnings-up,100,68,10/24/2019
EE1E44,earnings-up,100,68,10/24/2019
EE1E44,earnings-up,100,68,10/24/2019
EE1E44,earnings-up,100,68,10/24/2019
EE1E44,earnings-up,100,68,10/24/2019
EE1E44,earnings-up,100,68,10/24/2019
EF1AD9,dividend,100,50,10/24/2019
EF1AD9,earnings,100,50,10/24/2019
EF1AD9,earnings,100,50,10/24/2019
EF1AD9,earnings,100,50,10/24/2019
EF1AD9,earnings,100,50,10/24/2019
EF77A3,conference-participant,100,50,10/24/2019
EFD406,conference-call,100,50,10/24/2019
F02D0A,dividend,100,50,10/24/2019
F04E05,earnings,100,50,10/24/2019
F0B2B5,executive-appointment,100,54,10/24/2019
F0B2B5,executive-appointment,100,54,10/24/2019
F0B2B5,executive-appointment,100,54,10/24/2019
F3816D,clinical-trials,100,56,10/24/2019
F6E248,earnings,100,50,10/24/2019
F6E248,dividend,100,50,10/24/2019
F7935D,earnings,100,50,10/24/2019
F80389,earnings,100,50,10/24/2019
F88A04,operating-earnings,100,50,10/24/2019
F88A04,earnings,100,50,10/24/2019
F88A04,earnings,100,50,10/24/2019
F88A04,earnings,100,50,10/24/2019
F93C8A,conference-call,100,50,10/24/2019
FA918D,earnings,100,50,10/24/2019
FA918D,earnings,100,50,10/24/2019
FAE021,product-release,100,64,10/24/2019
FBD92D,earnings,100,50,10/24/2019
FBDA0F,earnings,100,50,10/24/2019
FC01C0,conference-call,100,50,10/24/2019
FC1B7B,earnings,100,50,10/24/2019
FC1F9D,earnings,100,50,10/24/2019
FC80E6,earnings,100,50,10/24/2019
FD2565,conference-call,100,50,10/24/2019
FD4BBE,earnings,100,50,10/24/2019
FD4BBE,earnings,100,50,10/24/2019
FD4BBE,earnings,100,50,10/24/2019
FD4BBE,earnings,100,50,10/24/2019
FD9526,earnings,100,50,10/24/2019
FDC08C,earnings,100,50,10/24/2019
FDC08C,earnings,100,50,10/24/2019
FDC08C,earnings,100,50,10/24/2019
FDC08C,earnings,100,50,10/24/2019
FDC08C,earnings,100,50,10/24/2019
02870F,conference-call,100,50,10/25/2019
0560D8,dividend,100,50,10/25/2019
083F72,conference-call,100,50,10/25/2019
0BD4E8,earnings,100,50,10/25/2019
0BD4E8,earnings,100,50,10/25/2019
0BD4E8,earnings,100,50,10/25/2019
0BD4E8,earnings,100,50,10/25/2019
0E499E,earnings,100,50,10/25/2019
0FDE97,earnings,100,50,10/25/2019
0FDE97,earnings,100,50,10/25/2019
0FDE97,earnings,100,50,10/25/2019
0FDE97,earnings,100,50,10/25/2019
0FDE97,earnings,100,50,10/25/2019
0FDE97,earnings,100,50,10/25/2019
0FDE97,earnings,100,50,10/25/2019
1272B3,earnings,100,50,10/25/2019
152E1D,conference-call,100,50,10/25/2019
156A99,earnings,100,50,10/25/2019
16B882,earnings,100,50,10/25/2019
19C105,earnings,100,50,10/25/2019
1A3E1B,conference-participant,100,50,10/25/2019
1EC3E8,earnings-up,100,68,10/25/2019
1FAF22,legal-issues-defendant,100,22,10/25/2019
223216,revenue-up,100,57,10/25/2019
26DC29,legal-issues-defendant,100,22,10/25/2019
272472,dividend,100,50,10/25/2019
297DA8,conference-participant,100,50,10/25/2019
2DDB22,earnings-guidance,100,50,10/25/2019
2E0445,ipo-pricing,100,50,10/25/2019
2F98A5,dividend,100,50,10/25/2019
32DCB3,clinical-trials-positive,100,87,10/25/2019
338544,earnings,100,50,10/25/2019
339F20,earnings,100,50,10/25/2019
353DBB,earnings,100,50,10/25/2019
353DBB,earnings,100,50,10/25/2019
353DBB,earnings,100,50,10/25/2019
367434,earnings,100,50,10/25/2019
383ADA,earnings,100,50,10/25/2019
3A3447,facility-open,100,65,10/25/2019
3B8484,earnings,100,50,10/25/2019
3E39A5,dividend,100,50,10/25/2019
3FACA7,earnings-positive,100,69,10/25/2019
3FACA7,earnings,100,50,10/25/2019
3FACA7,earnings,100,50,10/25/2019
3FACA7,earnings,100,50,10/25/2019
435ACE,dividend,100,50,10/25/2019
460C93,earnings,100,50,10/25/2019
4D371E,dividend,100,50,10/25/2019
4D8124,award,100,58,10/25/2019
4E2D94,fundraising,100,64,10/25/2019
4EC4C1,earnings,100,50,10/25/2019
504FE2,dividend,100,50,10/25/2019
55438C,executive-appointment,100,54,10/25/2019
562853,earnings,100,50,10/25/2019
57634F,earnings,100,50,10/25/2019
589F5A,earnings,100,50,10/25/2019
59DB8C,executive-appointment,100,54,10/25/2019
64854A,conference-call,100,50,10/25/2019
6.52E+64,legal-issues-defendant,100,22,10/25/2019
6.52E+64,legal-issues-defendant,100,22,10/25/2019
68E3E0,conference-call,100,50,10/25/2019
693ECD,conference-participant,100,50,10/25/2019
6CBF41,ipo-pricing,100,50,10/25/2019
6E7060,dividend,100,50,10/25/2019
7032D0,earnings,100,50,10/25/2019
722D55,conference-participant,100,50,10/25/2019
72DF04,award,100,58,10/25/2019
72EF75,dividend,100,50,10/25/2019
762A3E,dividend,100,50,10/25/2019
7823A3,legal-issues-defendant,100,22,10/25/2019
7823A3,legal-issues-defendant,100,22,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7999F3,earnings,100,50,10/25/2019
7A5D58,earnings,100,50,10/25/2019
7AF907,public-offering,100,43,10/25/2019
7B4B91,earnings,100,50,10/25/2019
7C4168,dividend,100,50,10/25/2019
7D35D8,legal-issues-defendant,100,22,10/25/2019
7D35D8,legal-issues-defendant,100,22,10/25/2019
7D35D8,legal-issues-defendant,100,22,10/25/2019
7D35D8,fraud-defendant,100,20,10/25/2019
7FC386,earnings,100,50,10/25/2019
81EAD4,operating-earnings,100,50,10/25/2019
8275FE,executive-appointment,100,54,10/25/2019
860AB6,dividend,100,50,10/25/2019
860AB6,dividend,100,50,10/25/2019
8A8E41,earnings-up,100,68,10/25/2019
8A8E41,earnings-up,100,68,10/25/2019
8A8E41,earnings-up,100,68,10/25/2019
8A8E41,earnings-up,100,68,10/25/2019
8A8E41,earnings-up,100,68,10/25/2019
8A8E41,earnings-up,100,68,10/25/2019
8A8E41,earnings-up,100,68,10/25/2019
8A8E41,earnings-up,100,68,10/25/2019
8BFE9A,conference-call,100,50,10/25/2019
8FCA78,earnings,100,50,10/25/2019
8FCA78,earnings,100,50,10/25/2019
8FCA78,earnings,100,50,10/25/2019
8FCA78,earnings,100,50,10/25/2019
911AB8,supply-guidance-increase,100,74,10/25/2019
91E5EE,earnings,100,50,10/25/2019
92D9C9,earnings,100,50,10/25/2019
96F126,executive-appointment,100,54,10/25/2019
9BB35A,conference-call,100,50,10/25/2019
9E9147,earnings,100,50,10/25/2019
9EED50,earnings,100,50,10/25/2019
A017F4,clinical-trials,100,56,10/25/2019
A3800A,dividend,100,50,10/25/2019
A403CF,conference-participant,100,50,10/25/2019
A666C8,earnings,100,50,10/25/2019
A666C8,earnings,100,50,10/25/2019
A666C8,earnings,100,50,10/25/2019
A666C8,earnings,100,50,10/25/2019
AADE0B,stake-acquirer,100,48,10/25/2019
ABBAD1,earnings,100,50,10/25/2019
B8F71F,executive-appointment,100,54,10/25/2019
BB5271,executive-appointment,100,54,10/25/2019
BCE9DA,executive-appointment,100,54,10/25/2019
BCE9DA,executive-appointment,100,54,10/25/2019
BE14CF,dividend,100,50,10/25/2019
BEA527,public-offering,100,43,10/25/2019
C062D4,conference-participant,100,50,10/25/2019
C4A432,executive-resignation,100,44,10/25/2019
C4FBDC,conference-call,100,50,10/25/2019
C5C137,partnership,100,61,10/25/2019
C5C137,dividend,100,50,10/25/2019
C8A248,partnership,100,61,10/25/2019
C8FAC7,earnings,100,50,10/25/2019
CB7AB2,award,100,58,10/25/2019
CBCC6A,earnings,100,50,10/25/2019
CBCC6A,earnings,100,50,10/25/2019
CDE118,earnings,100,50,10/25/2019
CF073E,conference-participant,100,50,10/25/2019
D29B44,earnings,100,50,10/25/2019
D78BF1,award,100,58,10/25/2019
D78CCD,earnings,100,50,10/25/2019
D78CCD,earnings,100,50,10/25/2019
D78CCD,earnings,100,50,10/25/2019
D78CCD,earnings,100,50,10/25/2019
D78CCD,earnings,100,50,10/25/2019
D78CCD,earnings,100,50,10/25/2019
D78CCD,earnings,100,50,10/25/2019
D7F569,earnings,100,50,10/25/2019
D7F569,dividend-up,100,57,10/25/2019
D88EF3,earnings,100,50,10/25/2019
D88EF3,earnings,100,50,10/25/2019
D88EF3,earnings,100,50,10/25/2019
D88EF3,earnings,100,50,10/25/2019
D88EF3,earnings,100,50,10/25/2019
D88EF3,earnings,100,50,10/25/2019
DA0A9E,earnings,100,50,10/25/2019
DAFED3,earnings,100,50,10/25/2019
DAFED3,earnings,100,50,10/25/2019
DAFED3,earnings,100,50,10/25/2019
DAFED3,earnings,100,50,10/25/2019
DB396B,earnings,100,50,10/25/2019
DB396B,earnings,100,50,10/25/2019
DB396B,earnings,100,50,10/25/2019
DB396B,dividend,100,50,10/25/2019
DB5CA5,dividend,100,50,10/25/2019
DBEF02,earnings,100,50,10/25/2019
E3E68E,partnership,100,61,10/25/2019
E3E68E,partnership,100,61,10/25/2019
E598FB,ipo-pricing,100,50,10/25/2019
E6E012,dividend-up,100,58,10/25/2019
E6E012,dividend-up,100,58,10/25/2019
E829E8,facility-open,100,65,10/25/2019
E8E899,buybacks,100,74,10/25/2019
ECDEB2,earnings,100,50,10/25/2019
EE6F1C,dividend,100,50,10/25/2019
F294DD,dividend-up,100,81,10/25/2019
F4CDA3,conference-call,100,50,10/25/2019
F7902B,executive-appointment,100,54,10/25/2019
F793FA,earnings,100,50,10/25/2019
FD0CA4,dividend,100,50,10/25/2019
FF4BA4,earnings,100,50,10/25/2019
FF4BA4,earnings,100,50,10/25/2019
FF4BA4,earnings,100,50,10/25/2019
FF4BA4,earnings,100,50,10/25/2019
FF4BA4,earnings,100,50,10/25/2019
FF6644,conference-participant,100,50,10/25/2019
7823A3,legal-issues-defendant,100,22,10/26/2019
7823A3,legal-issues-defendant,100,22,10/26/2019
7D35D8,legal-issues-defendant,100,22,10/26/2019
7D35D8,legal-issues-defendant,100,22,10/26/2019
451D61,clinical-trials,100,56,10/27/2019
6.52E+64,legal-issues-defendant,100,22,10/27/2019
790C34,earnings,100,50,10/27/2019
8C5519,acquisition-acquirer,100,49,10/27/2019
8C5519,acquisition-acquirer,100,49,10/27/2019
8C5519,acquisition-acquirer,100,49,10/27/2019
8C5519,acquisition-acquirer,100,49,10/27/2019
00326E,executive-appointment,100,54,10/28/2019
018C11,product-release,100,64,10/28/2019
02FC1A,regulatory-product-approval-granted,100,81,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
03B8CF,earnings,100,50,10/28/2019
58828,earnings-per-share,100,50,10/28/2019
075CF7,earnings,100,50,10/28/2019
98977,executive-appointment,100,54,10/28/2019
0B7375,conference-call,100,50,10/28/2019
0F0693,earnings,100,50,10/28/2019
10100E,earnings,100,50,10/28/2019
108A2B,operating-earnings,100,50,10/28/2019
11A49E,executive-appointment,100,54,10/28/2019
12731D,conference-call,100,50,10/28/2019
12731D,conference-call,100,50,10/28/2019
129DC8,executive-appointment,100,54,10/28/2019
1921DD,business-contract,100,69,10/28/2019
197612,earnings,100,50,10/28/2019
197612,earnings,100,50,10/28/2019
197612,earnings,100,50,10/28/2019
197612,earnings,100,50,10/28/2019
197612,earnings,100,50,10/28/2019
197612,earnings,100,50,10/28/2019
197612,earnings,100,50,10/28/2019
1AB023,conference-call,100,50,10/28/2019
1AB023,conference-call,100,50,10/28/2019
1AB023,conference-call,100,50,10/28/2019
1B5FEA,partnership,100,61,10/28/2019
1BC12C,dividend,100,50,10/28/2019
1BDB2A,conference-participant,100,50,10/28/2019
1D9E55,business-contract,100,69,10/28/2019
1DDEDA,earnings,100,50,10/28/2019
1F9258,acquisition-completed-acquirer,100,49,10/28/2019
206852,earnings,100,50,10/28/2019
20DC4E,dividend,100,50,10/28/2019
222BF9,earnings,100,50,10/28/2019
228D42,partnership,100,61,10/28/2019
251988,earnings-guidance,100,50,10/28/2019
251988,earnings-guidance,100,50,10/28/2019
251988,earnings-guidance,100,50,10/28/2019
251988,earnings-guidance,100,50,10/28/2019
251988,earnings-guidance,100,50,10/28/2019
251988,earnings-guidance,100,50,10/28/2019
267718,product-release,100,64,10/28/2019
26F31D,earnings,100,50,10/28/2019
26F31D,earnings,100,50,10/28/2019
26F31D,earnings,100,50,10/28/2019
26F31D,earnings,100,50,10/28/2019
27A791,earnings,100,50,10/28/2019
27A791,earnings,100,50,10/28/2019
27A791,earnings,100,50,10/28/2019
27A791,earnings,100,50,10/28/2019
2A6DBE,executive-appointment,100,54,10/28/2019
2AA6A8,executive-appointment,100,54,10/28/2019
2B49F4,business-contract,100,69,10/28/2019
2FEA66,operating-earnings,100,50,10/28/2019
30AB63,earnings,100,50,10/28/2019
3301B7,acquisition-acquirer,100,49,10/28/2019
3461CF,stake-acquirer,100,48,10/28/2019
34B411,fundraising,100,64,10/28/2019
353DBB,dividend,100,50,10/28/2019
37B120,earnings,100,50,10/28/2019
382EAE,executive-resignation,100,44,10/28/2019
3A3447,facility-open,100,65,10/28/2019
3A4BDB,earnings-positive,100,69,10/28/2019
3A4BDB,earnings-positive,100,69,10/28/2019
3A4BDB,earnings-positive,100,69,10/28/2019
3A4BDB,earnings-positive,100,69,10/28/2019
3A4BDB,earnings-positive,100,69,10/28/2019
3C7F5F,merger,100,66,10/28/2019
3C7F5F,merger,100,66,10/28/2019
43A060,business-contract,100,69,10/28/2019
43A060,partnership,100,61,10/28/2019
43A060,earnings,100,50,10/28/2019
490D4B,earnings,100,50,10/28/2019
490D4B,earnings,100,50,10/28/2019
494EB9,earnings,100,50,10/28/2019
4A2457,conference-call,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4B3DC9,earnings,100,50,10/28/2019
4C31F3,conference-call,100,50,10/28/2019
4D8E5E,earnings,100,50,10/28/2019
4DD203,conference-call,100,50,10/28/2019
4EE14A,index-listing,100,76,10/28/2019
4F0A80,acquisition-completed-acquirer,100,49,10/28/2019
5088A5,earnings,100,50,10/28/2019
53EF9E,earnings,100,50,10/28/2019
53EF9E,earnings,100,50,10/28/2019
55438C,congressional-testimony-summoned,100,50,10/28/2019
556F08,earnings,100,50,10/28/2019
56EA2B,revenue-up,100,64,10/28/2019
58CA9A,business-contract,100,69,10/28/2019
5BE42C,earnings,100,50,10/28/2019
5C8D61,earnings,100,50,10/28/2019
5C8D61,earnings,100,50,10/28/2019
5C8D61,earnings,100,50,10/28/2019
5D02B7,earnings,100,50,10/28/2019
619882,partnership,100,61,10/28/2019
61B81B,acquisition-completed-acquiree,100,76,10/28/2019
61B81B,acquisition-completed-acquiree,100,76,10/28/2019
622DBE,legal-issues-defendant,100,22,10/28/2019
62B1C6,credit-extension-recipient,100,69,10/28/2019
636931,earnings,100,50,10/28/2019
651C85,earnings,100,50,10/28/2019
6.52E+64,legal-issues-defendant,100,22,10/28/2019
66667F,conference-participant,100,50,10/28/2019
68B03F,earnings,100,50,10/28/2019
69C99E,clinical-trials,100,56,10/28/2019
6D3F35,conference-call,100,50,10/28/2019
6D4636,earnings,100,50,10/28/2019
6D6B40,earnings,100,50,10/28/2019
6E705B,product-release,100,64,10/28/2019
6F0096,executive-appointment,100,54,10/28/2019
709AED,dividend-up,100,81,10/28/2019
709AED,earnings,100,50,10/28/2019
722DE3,business-contract,100,69,10/28/2019
73C9E2,conference-participant,100,50,10/28/2019
742AAB,executive-appointment,100,54,10/28/2019
7448A3,conference-participant,100,50,10/28/2019
748EB6,conference-call,100,50,10/28/2019
77B8E9,patent-awarded,100,72,10/28/2019
79340A,earnings,100,50,10/28/2019
7AB859,partnership,100,61,10/28/2019
7AC86E,earnings-up,100,68,10/28/2019
7AC86E,earnings,100,50,10/28/2019
7AC86E,earnings,100,50,10/28/2019
7ACD98,acquisition-acquirer,100,49,10/28/2019
7C4168,earnings,100,50,10/28/2019
7C75FD,acquisition-acquirer,100,49,10/28/2019
7C75FD,earnings,100,50,10/28/2019
7D35D8,legal-issues-defendant,100,22,10/28/2019
7E1542,ipo,100,71,10/28/2019
7E1542,ipo,100,71,10/28/2019
80C400,conference-call,100,50,10/28/2019
835C86,earnings,100,50,10/28/2019
84A6B9,earnings,100,50,10/28/2019
84A6B9,earnings,100,50,10/28/2019
84A6B9,earnings,100,50,10/28/2019
84A6B9,earnings,100,50,10/28/2019
84A6B9,earnings,100,50,10/28/2019
84A6B9,earnings,100,50,10/28/2019
84A6B9,earnings,100,50,10/28/2019
850779,dividend,100,50,10/28/2019
860AB6,earnings,100,50,10/28/2019
8802B4,earnings,100,50,10/28/2019
893904,earnings,100,50,10/28/2019
8AB37F,product-release,100,64,10/28/2019
8AB85C,clinical-trials,100,56,10/28/2019
8AB85C,legal-issues-defendant,100,22,10/28/2019
8C1238,earnings,100,50,10/28/2019
8C1238,earnings,100,50,10/28/2019
8C1238,earnings,100,50,10/28/2019
8C1238,earnings,100,50,10/28/2019
8DA42F,conference-call,100,50,10/28/2019
8E4250,business-contract,100,69,10/28/2019
8F8F2F,earnings,100,50,10/28/2019
8F8F2F,earnings,100,50,10/28/2019
8FE7A5,earnings,100,50,10/28/2019
905356,award,100,58,10/28/2019
968B00,earnings-positive,100,69,10/28/2019
968B00,earnings-positive,100,69,10/28/2019
97B027,dividend,100,50,10/28/2019
990AD0,conference-organizer,100,57,10/28/2019
990AD0,conference-organizer,100,57,10/28/2019
9978F1,clinical-trials,100,56,10/28/2019
9D4EC7,earnings,100,50,10/28/2019
9D4EC7,earnings,100,50,10/28/2019
9D4EC7,earnings,100,50,10/28/2019
9D4EC7,earnings,100,50,10/28/2019
9D5D35,earnings,100,50,10/28/2019
9D5D35,earnings,100,50,10/28/2019
9D5D35,earnings,100,50,10/28/2019
9E575E,earnings,100,50,10/28/2019
9EF4CF,earnings,100,50,10/28/2019
9F03CF,note-sale,100,52,10/28/2019
9F18FA,earnings,100,50,10/28/2019
9F18FA,earnings,100,50,10/28/2019
A47F2E,earnings,100,50,10/28/2019
A5195E,clinical-trials,100,56,10/28/2019
A6FE1C,unit-acquisition-acquirer,100,49,10/28/2019
A94637,facility-open,100,65,10/28/2019
A94718,conference-call,100,50,10/28/2019
A96867,earnings-up,100,78,10/28/2019
A96867,earnings-up,100,78,10/28/2019
A96867,earnings-up,100,78,10/28/2019
A96867,earnings-up,100,78,10/28/2019
A96867,earnings-up,100,78,10/28/2019
A96867,earnings-up,100,78,10/28/2019
A96867,earnings-up,100,78,10/28/2019
A96867,earnings-up,100,78,10/28/2019
AAEE21,earnings,100,50,10/28/2019
ABB493,executive-appointment,100,54,10/28/2019
AC7C4F,business-contract,100,69,10/28/2019
ADF092,partnership,100,61,10/28/2019
B1FC3B,fundraising,100,64,10/28/2019
B642E8,business-contract,100,69,10/28/2019
B77F14,conference-call,100,50,10/28/2019
BB0587,executive-appointment,100,54,10/28/2019
BB5271,earnings,100,50,10/28/2019
BC4876,earnings,100,50,10/28/2019
BC5680,earnings,100,50,10/28/2019
BC5680,earnings,100,50,10/28/2019
BDEF34,earnings,100,50,10/28/2019
BDEF34,earnings,100,50,10/28/2019
BDEF34,earnings,100,50,10/28/2019
BDEF34,earnings,100,50,10/28/2019
BDEF34,earnings,100,50,10/28/2019
BDEF34,earnings,100,50,10/28/2019
BDEF34,earnings,100,50,10/28/2019
BDEF34,earnings,100,50,10/28/2019
BE14CF,earnings,100,50,10/28/2019
BFAEB4,product-release,100,64,10/28/2019
BFE02C,partnership,100,61,10/28/2019
BFE02C,conference-participant,100,50,10/28/2019
C0F70B,earnings,100,50,10/28/2019
C11C46,partnership,100,61,10/28/2019
C598D7,revenue-up,100,66,10/28/2019
C598D7,revenues,100,50,10/28/2019
C598D7,revenues,100,50,10/28/2019
C65004,earnings,100,50,10/28/2019
C83B88,executive-appointment,100,54,10/28/2019
C99CC8,business-contract,100,69,10/28/2019
CCBBAD,earnings,100,50,10/28/2019
CD06A2,dividend,100,50,10/28/2019
CD2A4D,credit-extension-recipient,100,69,10/28/2019
CD4DA8,executive-appointment,100,54,10/28/2019
CE4FD9,earnings,100,50,10/28/2019
CE4FD9,earnings,100,50,10/28/2019
CE4FD9,earnings,100,50,10/28/2019
CE4FD9,earnings,100,50,10/28/2019
CE4FD9,earnings,100,50,10/28/2019
CF3FF9,earnings,100,50,10/28/2019
D06996,earnings,100,50,10/28/2019
D0DFE5,earnings,100,50,10/28/2019
D15833,conference-call,100,50,10/28/2019
D296C6,earnings,100,50,10/28/2019
D3C794,earnings,100,50,10/28/2019
D57D99,earnings,100,50,10/28/2019
D8442A,product-release,100,64,10/28/2019
D8442A,product-release,100,64,10/28/2019
D9164D,dividend,100,50,10/28/2019
D9164D,earnings,100,50,10/28/2019
DAC66A,earnings,100,50,10/28/2019
DC2F77,dividend,100,50,10/28/2019
DD9E41,earnings,100,50,10/28/2019
DD9E41,earnings,100,50,10/28/2019
DD9E41,earnings,100,50,10/28/2019
DD9E41,earnings,100,50,10/28/2019
DD9E41,earnings,100,50,10/28/2019
DD9E41,earnings,100,50,10/28/2019
DF46C5,dividend,100,50,10/28/2019
DF46C5,earnings,100,50,10/28/2019
DF46C5,earnings,100,50,10/28/2019
DF46C5,earnings,100,50,10/28/2019
DF46C5,earnings,100,50,10/28/2019
E09E2B,partnership,100,61,10/28/2019
E124EB,conference-participant,100,50,10/28/2019
E3E68E,earnings,100,50,10/28/2019
E3E68E,earnings,100,50,10/28/2019
E3E68E,earnings,100,50,10/28/2019
E5752F,partnership,100,61,10/28/2019
E5F0A8,earnings-positive,100,69,10/28/2019
E5F0A8,earnings,100,50,10/28/2019
E5F0A8,earnings,100,50,10/28/2019
E5F0A8,earnings,100,50,10/28/2019
E70531,earnings,100,50,10/28/2019
E7BF32,earnings,100,50,10/28/2019
E7BF32,earnings,100,50,10/28/2019
E8846E,earnings-up,100,76,10/28/2019
E93A40,earnings,100,50,10/28/2019
EB43F4,clinical-trials-filed,100,60,10/28/2019
EE04F0,conference-call,100,50,10/28/2019
EEEA9F,earnings,100,50,10/28/2019
EEEA9F,earnings,100,50,10/28/2019
EEEA9F,earnings,100,50,10/28/2019
EEEA9F,earnings,100,50,10/28/2019
EEEA9F,earnings,100,50,10/28/2019
F2526D,earnings,100,50,10/28/2019
F47871,earnings,100,50,10/28/2019
F5349B,executive-appointment,100,54,10/28/2019
F6A945,earnings,100,50,10/28/2019
F6E248,partnership,100,61,10/28/2019
F72E4B,earnings,100,50,10/28/2019
F7935D,partnership,100,61,10/28/2019
F7FCA4,earnings,100,50,10/28/2019
F7FCA4,earnings,100,50,10/28/2019
F7FCA4,earnings,100,50,10/28/2019
FACF19,earnings-meet-expectations,100,59,10/28/2019
FACF19,executive-appointment,100,54,10/28/2019
FDD3FC,earnings,100,50,10/28/2019
FFAB4A,earnings,100,50,10/28/2019
FFCD0E,revenue-up,100,58,10/28/2019
001F1B,earnings,100,50,10/29/2019
01478A,earnings,100,50,10/29/2019
0157B1,partnership,100,61,10/29/2019
0157B1,partnership,100,61,10/29/2019
018C11,earnings,100,50,10/29/2019
58828,dividend,100,50,10/29/2019
070B45,earnings,100,50,10/29/2019
07C69F,earnings,100,50,10/29/2019
95294,earnings,100,50,10/29/2019
095A04,earnings,100,50,10/29/2019
09F623,earnings,100,50,10/29/2019
09F623,earnings,100,50,10/29/2019
09F623,earnings,100,50,10/29/2019
09F623,earnings,100,50,10/29/2019
0B9E6F,earnings,100,50,10/29/2019
0BA8CE,earnings,100,50,10/29/2019
0BD4E8,note-sale,100,52,10/29/2019
0C4131,acquisition-acquirer,100,49,10/29/2019
0C4131,acquisition-acquirer,100,49,10/29/2019
0F65C9,earnings,100,50,10/29/2019
0F65C9,dividend-up,100,64,10/29/2019
102727,earnings,100,50,10/29/2019
102727,earnings,100,50,10/29/2019
102727,earnings,100,50,10/29/2019
102727,earnings,100,50,10/29/2019
105D00,note-sale,100,52,10/29/2019
10AE08,earnings,100,50,10/29/2019
11074E,earnings,100,50,10/29/2019
125212,earnings,100,50,10/29/2019
129DC8,earnings,100,50,10/29/2019
129DC8,earnings,100,50,10/29/2019
129DC8,earnings,100,50,10/29/2019
129DC8,earnings,100,50,10/29/2019
131443,earnings,100,50,10/29/2019
131443,earnings,100,50,10/29/2019
131443,earnings,100,50,10/29/2019
131443,earnings,100,50,10/29/2019
131443,earnings,100,50,10/29/2019
131443,earnings,100,50,10/29/2019
1348C9,earnings,100,50,10/29/2019
1348C9,earnings,100,50,10/29/2019
1348C9,earnings,100,50,10/29/2019
135B09,earnings-up,100,68,10/29/2019
138DDE,earnings,100,50,10/29/2019
1490F3,business-combination,100,54,10/29/2019
1490F3,business-combination,100,54,10/29/2019
1490F3,business-combination,100,54,10/29/2019
1490F3,earnings,100,50,10/29/2019
1490F3,earnings,100,50,10/29/2019
1490F3,earnings,100,50,10/29/2019
1490F3,earnings,100,50,10/29/2019
1490F3,earnings,100,50,10/29/2019
1490F3,earnings,100,50,10/29/2019
149301,dividend,100,50,10/29/2019
14BA33,earnings,100,50,10/29/2019
152FA5,clinical-trials,100,56,10/29/2019
180DA0,earnings,100,50,10/29/2019
180DA0,earnings,100,50,10/29/2019
180DA0,earnings,100,50,10/29/2019
1A5D5D,earnings,100,50,10/29/2019
1B4F31,executive-appointment,100,54,10/29/2019
1BDB2A,dividend,100,50,10/29/2019
1DA44F,earnings,100,50,10/29/2019
1E1125,conference-organizer,100,57,10/29/2019
1E1125,conference-organizer,100,57,10/29/2019
1E1125,conference-organizer,100,57,10/29/2019
1E1125,conference-organizer,100,57,10/29/2019
1E1125,conference-organizer,100,57,10/29/2019
1E7785,conference-participant,100,50,10/29/2019
1EBF8D,earnings,100,50,10/29/2019
1F3CFB,earnings,100,50,10/29/2019
1F716B,earnings,100,50,10/29/2019
1F9D90,earnings,100,50,10/29/2019
1FAF22,conference-participant,100,50,10/29/2019
20D00A,operating-earnings,100,50,10/29/2019
21245F,conference-call,100,50,10/29/2019
21245F,executive-appointment,100,54,10/29/2019
214051,operating-earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
225CA2,earnings,100,50,10/29/2019
22C58E,earnings,100,50,10/29/2019
267718,earnings,100,50,10/29/2019
267718,earnings,100,50,10/29/2019
267718,earnings,100,50,10/29/2019
267718,earnings,100,50,10/29/2019
267718,earnings,100,50,10/29/2019
267718,earnings,100,50,10/29/2019
267718,earnings,100,50,10/29/2019
267718,earnings,100,50,10/29/2019
270305,earnings,100,50,10/29/2019
270305,earnings,100,50,10/29/2019
270305,earnings,100,50,10/29/2019
270305,earnings,100,50,10/29/2019
270305,dividend,100,50,10/29/2019
29CEBF,earnings,100,50,10/29/2019
29CEBF,earnings,100,50,10/29/2019
29CEBF,earnings,100,50,10/29/2019
29CEBF,earnings,100,50,10/29/2019
2A9C0A,earnings-positive,100,69,10/29/2019
2A9C0A,earnings,100,50,10/29/2019
2A9C0A,earnings,100,50,10/29/2019
2A9C0A,earnings,100,50,10/29/2019
2A9C0A,earnings,100,50,10/29/2019
2A9C0A,earnings,100,50,10/29/2019
2BDC1C,earnings,100,50,10/29/2019
2D5011,earnings,100,50,10/29/2019
2D981A,patient-enrollment-complete,100,64,10/29/2019
2E0496,earnings,100,50,10/29/2019
2F24A5,earnings,100,50,10/29/2019
33FD66,earnings,100,50,10/29/2019
33FD66,earnings,100,50,10/29/2019
33FD66,earnings,100,50,10/29/2019
33FD66,earnings,100,50,10/29/2019
33FD66,earnings,100,50,10/29/2019
34B97A,earnings,100,50,10/29/2019
34B97A,earnings,100,50,10/29/2019
34B97A,earnings,100,50,10/29/2019
34B97A,earnings,100,50,10/29/2019
34B97A,earnings,100,50,10/29/2019
37020C,earnings,100,50,10/29/2019
37020C,earnings,100,50,10/29/2019
37020C,earnings,100,50,10/29/2019
37020C,earnings,100,50,10/29/2019
37020C,earnings,100,50,10/29/2019
37020C,earnings,100,50,10/29/2019
37020C,earnings,100,50,10/29/2019
37020C,earnings,100,50,10/29/2019
373B06,earnings,100,50,10/29/2019
37727A,earnings,100,50,10/29/2019
37727A,earnings,100,50,10/29/2019
37727A,earnings,100,50,10/29/2019
37727A,earnings,100,50,10/29/2019
37727A,earnings,100,50,10/29/2019
37727A,earnings,100,50,10/29/2019
37727A,earnings,100,50,10/29/2019
37727A,earnings,100,50,10/29/2019
38FB49,dividend,100,50,10/29/2019
396D7C,clinical-trials-start,100,64,10/29/2019
3BCF24,earnings-up,100,53,10/29/2019
3BE00F,earnings,100,50,10/29/2019
3BE00F,earnings,100,50,10/29/2019
3BE00F,earnings,100,50,10/29/2019
3CBA2A,investment-investor,100,55,10/29/2019
3D7971,business-contract,100,69,10/29/2019
3F1C69,earnings,100,50,10/29/2019
401072,earnings,100,50,10/29/2019
4.03E+05,conference-call,100,50,10/29/2019
420168,earnings,100,50,10/29/2019
4398A2,public-offering,100,43,10/29/2019
43E8F5,conference-participant,100,50,10/29/2019
44209A,earnings,100,50,10/29/2019
442769,partnership,100,61,10/29/2019
447FC6,earnings,100,50,10/29/2019
447FC6,earnings,100,50,10/29/2019
447FC6,earnings,100,50,10/29/2019
44DDBD,earnings,100,50,10/29/2019
453282,dividend-up,100,81,10/29/2019
45BC35,revenue-up,100,88,10/29/2019
45BC35,revenues,100,50,10/29/2019
45BC35,product-release,100,64,10/29/2019
45BC35,product-release,100,64,10/29/2019
467F2C,earnings,100,50,10/29/2019
48F795,conference-participant,100,50,10/29/2019
49914B,executive-appointment,100,54,10/29/2019
49BBBC,partnership,100,61,10/29/2019
4A2457,conference-participant,100,50,10/29/2019
4BDCA7,conference-call,100,50,10/29/2019
4C5CC9,dividend,100,50,10/29/2019
4E7C1F,executive-appointment,100,54,10/29/2019
4FB770,earnings,100,50,10/29/2019
504FE2,earnings,100,50,10/29/2019
50D1EC,partnership,100,61,10/29/2019
513A86,trading-listing,100,61,10/29/2019
51888A,unit-acquisition-acquirer,100,49,10/29/2019
52015A,earnings,100,50,10/29/2019
54B889,buybacks,100,74,10/29/2019
54B889,earnings,100,50,10/29/2019
55C9B5,earnings,100,50,10/29/2019
55D0F3,earnings,100,50,10/29/2019
564F3E,earnings,100,50,10/29/2019
587D25,conference-participant,100,50,10/29/2019
587D25,conference-call,100,50,10/29/2019
596116,earnings,100,50,10/29/2019
5968F9,public-offering,100,43,10/29/2019
59872F,partnership,100,61,10/29/2019
5AA3B1,conference-call,100,50,10/29/2019
5CCDAD,partnership,100,61,10/29/2019
5CCDAD,earnings,100,50,10/29/2019
5E6959,conference-participant,100,50,10/29/2019
5E9934,conference-participant,100,50,10/29/2019
619882,conference-organizer,100,57,10/29/2019
61BCA7,earnings,100,50,10/29/2019
62B1C6,credit-extension-recipient,100,69,10/29/2019
633054,partnership,100,61,10/29/2019
6.52E+64,legal-issues-defendant,100,22,10/29/2019
6559D8,conference-call,100,50,10/29/2019
66A667,partnership,100,61,10/29/2019
66E3C0,revenue-up,100,62,10/29/2019
67B052,conference-call,100,50,10/29/2019
67B923,earnings,100,50,10/29/2019
69345C,earnings,100,50,10/29/2019
69345C,earnings,100,50,10/29/2019
69345C,earnings,100,50,10/29/2019
69345C,earnings,100,50,10/29/2019
69C99E,earnings,100,50,10/29/2019
69CE71,conference-participant,100,50,10/29/2019
6B236C,earnings,100,50,10/29/2019
6B5379,acquisition-completed-acquirer,100,49,10/29/2019
6C6D73,executive-appointment,100,54,10/29/2019
6CBF41,ipo-completed,100,76,10/29/2019
6CC55E,earnings,100,50,10/29/2019
6DBBBC,dividend,100,50,10/29/2019
6DDA15,business-contract,100,69,10/29/2019
6F0096,conference-participant,100,50,10/29/2019
6F5DD2,conference-participant,100,50,10/29/2019
704B78,revenue-up,100,69,10/29/2019
704B78,revenue-up,100,69,10/29/2019
713810,business-contract,100,69,10/29/2019
7255D2,earnings,100,50,10/29/2019
72609A,earnings,100,50,10/29/2019
72609A,earnings,100,50,10/29/2019
72609A,earnings,100,50,10/29/2019
726EEA,conference-participant,100,50,10/29/2019
735388,earnings,100,50,10/29/2019
73A71F,legal-issues-defendant,100,22,10/29/2019
7.44E+09,dividend-up,100,56,10/29/2019
748EB6,clinical-trials,100,56,10/29/2019
76F067,earnings,100,50,10/29/2019
76F067,earnings,100,50,10/29/2019
7823A3,legal-issues-defendant,100,22,10/29/2019
7823A3,earnings,100,50,10/29/2019
7823A3,earnings,100,50,10/29/2019
7823A3,earnings,100,50,10/29/2019
7823A3,earnings,100,50,10/29/2019
7823A3,earnings,100,50,10/29/2019
7823A3,earnings,100,50,10/29/2019
782B46,earnings,100,50,10/29/2019
7A10FF,earnings,100,50,10/29/2019
7A975D,dividend,100,50,10/29/2019
7B492C,earnings,100,50,10/29/2019
7C4F43,clinical-trials,100,56,10/29/2019
7D35D8,legal-issues-defendant,100,22,10/29/2019
7DD584,earnings,100,50,10/29/2019
7E2DE6,earnings,100,50,10/29/2019
7F9984,earnings,100,50,10/29/2019
7F9BE2,dividend,100,50,10/29/2019
805CD8,executive-appointment,100,54,10/29/2019
82B57E,earnings,100,50,10/29/2019
8303CD,earnings,100,50,10/29/2019
83B1C8,earnings,100,50,10/29/2019
85DE00,dividend,100,50,10/29/2019
85DE00,earnings,100,50,10/29/2019
86A1B9,executive-appointment,100,54,10/29/2019
88350F,earnings,100,50,10/29/2019
88350F,earnings,100,50,10/29/2019
88350F,earnings,100,50,10/29/2019
88350F,earnings,100,50,10/29/2019
8A8E41,partnership,100,61,10/29/2019
8AC65D,earnings,100,50,10/29/2019
8BFAA4,earnings,100,50,10/29/2019
8D4486,dividend,100,50,10/29/2019
8D4486,dividend,100,50,10/29/2019
8DE56F,earnings,100,50,10/29/2019
8DE56F,earnings,100,50,10/29/2019
8E82A6,dividend,100,50,10/29/2019
8EEA28,earnings,100,50,10/29/2019
934029,earnings,100,50,10/29/2019
934CC3,partnership,100,61,10/29/2019
9507FF,earnings,100,50,10/29/2019
95DC1F,executive-resignation,100,44,10/29/2019
966ACE,executive-appointment,100,54,10/29/2019
96A6CD,earnings,100,50,10/29/2019
97FE80,earnings,100,50,10/29/2019
990AD0,earnings,100,50,10/29/2019
990AD0,conference-organizer,100,57,10/29/2019
990AD0,conference-organizer,100,57,10/29/2019
9A602D,earnings-per-share-positive,100,69,10/29/2019
9A602D,earnings-per-share-positive,100,69,10/29/2019
9A602D,earnings-per-share-positive,100,69,10/29/2019
9A602D,earnings-per-share-positive,100,69,10/29/2019
9A602D,earnings-per-share-positive,100,69,10/29/2019
9A602D,earnings-per-share-positive,100,69,10/29/2019
9A602D,earnings-per-share-positive,100,69,10/29/2019
9AF3DC,earnings,100,50,10/29/2019
9B5968,earnings,100,50,10/29/2019
9B5968,earnings,100,50,10/29/2019
9B730A,conference-call,100,50,10/29/2019
9BB35A,earnings-per-share-positive,100,69,10/29/2019
9BB35A,earnings-per-share,100,50,10/29/2019
9BB35A,earnings-per-share,100,50,10/29/2019
9BB35A,earnings-per-share,100,50,10/29/2019
9BB35A,dividend-up,100,56,10/29/2019
9D307D,partnership,100,61,10/29/2019
9EA947,partnership,100,61,10/29/2019
9F18FA,note-sale,100,52,10/29/2019
9F18FA,note-sale,100,52,10/29/2019
9F18FA,note-sale,100,52,10/29/2019
9F18FA,note-sale,100,52,10/29/2019
9F5997,earnings,100,50,10/29/2019
A05C43,earnings,100,50,10/29/2019
A072C4,conference-call,100,50,10/29/2019
A23747,earnings,100,50,10/29/2019
A2C979,executive-appointment,100,54,10/29/2019
A398B9,earnings,100,50,10/29/2019
A398B9,earnings,100,50,10/29/2019
A398B9,earnings,100,50,10/29/2019
A41450,earnings,100,50,10/29/2019
A43906,conference-participant,100,50,10/29/2019
A47A7D,earnings,100,50,10/29/2019
A4CD53,executive-appointment,100,54,10/29/2019
A4F67C,earnings,100,50,10/29/2019
A5195E,earnings,100,50,10/29/2019
A5DD24,earnings,100,50,10/29/2019
A5E715,earnings-per-share-positive,100,69,10/29/2019
A65325,public-offering,100,43,10/29/2019
A7102F,conference-participant,100,50,10/29/2019
A79D88,earnings,100,50,10/29/2019
A87CD6,dividend-up,100,81,10/29/2019
A9ED24,earnings,100,50,10/29/2019
A9ED24,earnings,100,50,10/29/2019
A9ED24,earnings,100,50,10/29/2019
A9ED24,earnings,100,50,10/29/2019
AA09AD,earnings,100,50,10/29/2019
AA09AD,earnings-guidance,100,50,10/29/2019
ABBAD1,executive-appointment,100,54,10/29/2019
ACF0B4,conference-call,100,50,10/29/2019
AD9F1D,revenue-up,100,53,10/29/2019
AD9F1D,revenues,100,50,10/29/2019
AD9F1D,revenues,100,50,10/29/2019
AD9F1D,revenues,100,50,10/29/2019
AD9F1D,revenues,100,50,10/29/2019
AD9F1D,revenues,100,50,10/29/2019
AD9F1D,revenues,100,50,10/29/2019
AD9F1D,revenues,100,50,10/29/2019
AD9F1D,revenues,100,50,10/29/2019
AEEB76,earnings,100,50,10/29/2019
AEF2C3,earnings,100,50,10/29/2019
AFF7B4,earnings,100,50,10/29/2019
AFF7B4,earnings,100,50,10/29/2019
AFF7B4,earnings,100,50,10/29/2019
AFF7B4,earnings,100,50,10/29/2019
B076A1,earnings,100,50,10/29/2019
B076A1,earnings,100,50,10/29/2019
B076A1,earnings,100,50,10/29/2019
B076A1,earnings,100,50,10/29/2019
B0D41A,earnings,100,50,10/29/2019
B1A85D,earnings,100,50,10/29/2019
B1FC3B,fundraising,100,64,10/29/2019
B2DAF6,earnings,100,50,10/29/2019
B33E77,earnings,100,50,10/29/2019
B446B8,earnings-up,100,68,10/29/2019
B446B8,earnings-up,100,68,10/29/2019
B446B8,earnings-up,100,68,10/29/2019
B4703C,earnings-per-share-positive,100,69,10/29/2019
B4703C,earnings,100,50,10/29/2019
B4B281,conference-call,100,50,10/29/2019
B5766D,dividend,100,50,10/29/2019
B5766D,buybacks,100,74,10/29/2019
B72BE9,conference-call,100,50,10/29/2019
B8F71F,executive-appointment,100,54,10/29/2019
BB5271,award,100,58,10/29/2019
BBBB41,earnings,100,50,10/29/2019
BBBB41,earnings,100,50,10/29/2019
BBBB41,earnings,100,50,10/29/2019
BBBB41,earnings,100,50,10/29/2019
BBBB41,earnings,100,50,10/29/2019
BBBB41,earnings,100,50,10/29/2019
BBC05B,operating-earnings,100,50,10/29/2019
BC3AD2,earnings,100,50,10/29/2019
BC3AD2,earnings,100,50,10/29/2019
BDEC1E,conference-call,100,50,10/29/2019
BFAEB4,dividend-up,100,81,10/29/2019
BFD0A7,conference-call,100,50,10/29/2019
C0BA36,conference-call,100,50,10/29/2019
C2609A,business-contract,100,69,10/29/2019
C3BAE7,conference-participant,100,50,10/29/2019
C3CF29,earnings,100,50,10/29/2019
C3CF29,earnings,100,50,10/29/2019
C3CF29,earnings,100,50,10/29/2019
C3CF29,earnings,100,50,10/29/2019
C3F99F,earnings,100,50,10/29/2019
C4A241,earnings-up,100,68,10/29/2019
C4A241,earnings,100,50,10/29/2019
C4A241,earnings,100,50,10/29/2019
C4A241,earnings,100,50,10/29/2019
C4F567,revenues,100,50,10/29/2019
C58D71,earnings,100,50,10/29/2019
C5F463,partnership,100,61,10/29/2019
C659EB,earnings,100,50,10/29/2019
C659EB,earnings,100,50,10/29/2019
C659EB,earnings,100,50,10/29/2019
C659EB,earnings,100,50,10/29/2019
C72B8F,earnings,100,50,10/29/2019
C7AE14,earnings,100,50,10/29/2019
C81E00,operating-earnings,100,50,10/29/2019
C81E00,operating-earnings,100,50,10/29/2019
C83B88,executive-appointment,100,54,10/29/2019
C83B88,business-contract,100,69,10/29/2019
C85A72,revenue-up,100,81,10/29/2019
C85A72,revenue-up,100,81,10/29/2019
C85A72,revenue-up,100,81,10/29/2019
C85A72,revenue-up,100,81,10/29/2019
C99CC8,revenue-up,100,69,10/29/2019
C99CC8,revenue-up,100,69,10/29/2019
C99CC8,revenue-up,100,69,10/29/2019
C99CC8,revenue-up,100,69,10/29/2019
C99CC8,revenue-up,100,69,10/29/2019
CAB222,earnings,100,50,10/29/2019
CAD7D9,credit-extension-recipient,100,69,10/29/2019
CBFFDD,executive-appointment,100,54,10/29/2019
CBFFDD,dividend,100,50,10/29/2019
CC35BE,earnings,100,50,10/29/2019
CD4DA8,executive-appointment,100,54,10/29/2019
CDC817,earnings,100,50,10/29/2019
CE5664,earnings,100,50,10/29/2019
CE5664,earnings,100,50,10/29/2019
CE5664,earnings,100,50,10/29/2019
CFF97C,credit-rating-affirmation-rater,20,50,10/29/2019
CFF97C,credit-rating-affirmation-rater,20,50,10/29/2019
CFF97C,revenue-up,100,59,10/29/2019
CFF97C,revenue-up,100,59,10/29/2019
CFF97C,revenue-up,100,59,10/29/2019
CFF97C,revenue-up,100,59,10/29/2019
CFF97C,revenue-up,100,59,10/29/2019
D04D9F,earnings,100,50,10/29/2019
D17F7E,earnings,100,50,10/29/2019
D17F7E,earnings,100,50,10/29/2019
D17F7E,earnings,100,50,10/29/2019
D17F7E,earnings,100,50,10/29/2019
D17F7E,earnings,100,50,10/29/2019
D17F7E,earnings,100,50,10/29/2019
D20C8F,earnings,100,50,10/29/2019
D64C6D,asset-sale,100,62,10/29/2019
D6534D,earnings,100,50,10/29/2019
D6534D,earnings,100,50,10/29/2019
D77F7E,business-contract,100,69,10/29/2019
D77F7E,business-contract,100,69,10/29/2019
D7918D,operating-earnings,100,50,10/29/2019
D854F3,conference-participant,100,50,10/29/2019
DB06B0,partnership,100,61,10/29/2019
DB06B0,earnings,100,50,10/29/2019
DB06B0,earnings,100,50,10/29/2019
DB06B0,earnings,100,50,10/29/2019
DB06B0,earnings,100,50,10/29/2019
DB06B0,earnings,100,50,10/29/2019
DB5CA5,investment-investor,100,55,10/29/2019
DDB002,earnings,100,50,10/29/2019
DDEA6A,earnings,100,50,10/29/2019
DEF058,earnings,100,50,10/29/2019
DF16DE,clinical-trials,100,56,10/29/2019
E06265,conference-call,100,50,10/29/2019
E09E2B,product-release,100,64,10/29/2019
E10D31,earnings,100,50,10/29/2019
E114F4,conference-call,100,50,10/29/2019
E15736,earnings,100,50,10/29/2019
E2F130,earnings,100,50,10/29/2019
E30A8F,earnings,100,50,10/29/2019
E30A8F,earnings,100,50,10/29/2019
E30A8F,earnings,100,50,10/29/2019
E30A8F,earnings,100,50,10/29/2019
E30A8F,earnings,100,50,10/29/2019
E598FB,ipo-completed,100,76,10/29/2019
E68C3D,acquisition-acquirer,100,49,10/29/2019
E69BA5,earnings,100,50,10/29/2019
E6E012,earnings,100,50,10/29/2019
E6E012,earnings,100,50,10/29/2019
E6E012,earnings,100,50,10/29/2019
E6E012,earnings,100,50,10/29/2019
E6E012,earnings,100,50,10/29/2019
E82A2D,dividend,100,50,10/29/2019
E87676,revenue-up,100,69,10/29/2019
E87676,earnings,100,50,10/29/2019
E8A49A,earnings,100,50,10/29/2019
E8B21D,earnings,100,50,10/29/2019
E8B21D,earnings,100,50,10/29/2019
E8B21D,earnings,100,50,10/29/2019
E8B21D,earnings,100,50,10/29/2019
E8B21D,earnings,100,50,10/29/2019
E8B21D,earnings,100,50,10/29/2019
E9E6FD,earnings,100,50,10/29/2019
EA62FC,conference-participant,100,50,10/29/2019
EB36DE,earnings,100,50,10/29/2019
EB43F4,regulatory-product-review-positive,100,73,10/29/2019
EBC84C,earnings,100,50,10/29/2019
EBC84C,earnings,100,50,10/29/2019
EBC84C,earnings,100,50,10/29/2019
EBC84C,earnings,100,50,10/29/2019
EBC84C,earnings,100,50,10/29/2019
EBC84C,earnings,100,50,10/29/2019
EC70EC,earnings,100,50,10/29/2019
EC70EC,earnings,100,50,10/29/2019
EC70EC,earnings,100,50,10/29/2019
EC70EC,earnings,100,50,10/29/2019
EC70EC,earnings,100,50,10/29/2019
EC70EC,earnings,100,50,10/29/2019
EE967B,earnings,100,50,10/29/2019
EF5914,earnings,100,50,10/29/2019
F00285,executive-appointment,100,54,10/29/2019
F0A9DE,earnings,100,50,10/29/2019
F0B335,earnings,100,50,10/29/2019
F1529C,conference-participant,100,50,10/29/2019
F1C04C,award,100,58,10/29/2019
F40EE2,earnings,100,50,10/29/2019
F40EE2,earnings,100,50,10/29/2019
F4E882,earnings,100,50,10/29/2019
F4E882,executive-appointment,100,54,10/29/2019
F6DE54,earnings,100,50,10/29/2019
F7ADEB,conference-participant,100,50,10/29/2019
F95726,market-entry,100,57,10/29/2019
F95726,market-entry,100,57,10/29/2019
FA044A,earnings,100,50,10/29/2019
FA36A4,earnings,100,50,10/29/2019
FAEABE,dividend,100,50,10/29/2019
FD554E,conference-call,100,50,10/29/2019
FD9A97,dividend,100,50,10/29/2019
FDE409,conference-participant,100,50,10/29/2019
FE89E0,earnings,100,50,10/29/2019
00698D,conference-participant,100,50,10/30/2019
01D03F,regulatory-product-approval-granted,100,81,10/30/2019
20751,earnings,100,50,10/30/2019
02ACBD,conference-call,100,50,10/30/2019
03D5F9,earnings,100,50,10/30/2019
048B70,conference-call,100,50,10/30/2019
053EFF,earnings,100,50,10/30/2019
06A456,product-release,100,64,10/30/2019
07EC43,earnings,100,50,10/30/2019
07EC43,earnings,100,50,10/30/2019
07EC43,earnings,100,50,10/30/2019
07EC43,earnings,100,50,10/30/2019
95294,executive-appointment,100,54,10/30/2019
98977,earnings,100,50,10/30/2019
099A92,earnings,100,50,10/30/2019
099C88,earnings,100,50,10/30/2019
099C88,earnings,100,50,10/30/2019
0B2071,earnings,100,50,10/30/2019
0B4D10,earnings,100,50,10/30/2019
0BD4E8,note-sale,100,52,10/30/2019
0BD970,earnings,100,50,10/30/2019
0BF198,earnings,100,50,10/30/2019
0C2A0D,earnings,100,50,10/30/2019
0C355F,revenues,100,50,10/30/2019
0C355F,earnings,100,50,10/30/2019
0C355F,earnings,100,50,10/30/2019
0C355F,earnings,100,50,10/30/2019
0C355F,earnings,100,50,10/30/2019
0C355F,public-offering,100,43,10/30/2019
0E2992,earnings-per-share-positive,100,69,10/30/2019
0EC508,earnings,100,50,10/30/2019
1065BC,earnings,100,50,10/30/2019
1080C0,earnings,100,50,10/30/2019
1151F4,public-offering,100,43,10/30/2019
1220D2,earnings,100,50,10/30/2019
1279ED,executive-appointment,100,54,10/30/2019
12DE76,conference-call,100,50,10/30/2019
12E454,earnings,100,50,10/30/2019
12E454,earnings,100,50,10/30/2019
12E454,executive-resignation,100,44,10/30/2019
139303,earnings,100,50,10/30/2019
147C38,earnings,100,50,10/30/2019
149301,earnings,100,50,10/30/2019
159739,unit-acquisition-completed-acquirer,100,49,10/30/2019
159739,unit-acquisition-completed-acquirer,100,49,10/30/2019
165B86,conference-call,100,50,10/30/2019
16B183,operating-earnings,100,50,10/30/2019
16C544,earnings,100,50,10/30/2019
16F4D8,earnings,100,50,10/30/2019
16F4D8,earnings,100,50,10/30/2019
16F4D8,earnings,100,50,10/30/2019
16F4D8,earnings,100,50,10/30/2019
16F4D8,earnings,100,50,10/30/2019
1.79E+10,acquisition-acquiree,100,76,10/30/2019
1.79E+10,acquisition-acquiree,100,76,10/30/2019
182BE7,product-recall,100,29,10/30/2019
1880C5,clinical-trials,100,56,10/30/2019
197019,earnings,100,50,10/30/2019
197612,conference-participant,100,50,10/30/2019
1AB808,earnings,100,50,10/30/2019
1AB808,earnings,100,50,10/30/2019
1AB808,earnings,100,50,10/30/2019
1AB808,earnings,100,50,10/30/2019
1AE9D5,conference-call,100,50,10/30/2019
1B4F31,earnings,100,50,10/30/2019
1B4F31,earnings,100,50,10/30/2019
1B4F31,earnings,100,50,10/30/2019
1B4F31,earnings,100,50,10/30/2019
1B4F31,earnings,100,50,10/30/2019
1B4F31,earnings,100,50,10/30/2019
1B5FEA,earnings,100,50,10/30/2019
1B637E,earnings,100,50,10/30/2019
1B9535,earnings,100,50,10/30/2019
1C2593,index-listing,100,76,10/30/2019
1CB9D3,conference-call,100,50,10/30/2019
1D5C51,earnings,100,50,10/30/2019
1DF15D,earnings,100,50,10/30/2019
1DF15D,earnings,100,50,10/30/2019
1DF15D,earnings,100,50,10/30/2019
1DF15D,earnings,100,50,10/30/2019
1E1125,conference-organizer,100,57,10/30/2019
1E1125,conference-organizer,100,57,10/30/2019
1E1125,conference-organizer,100,57,10/30/2019
1E68B3,earnings,100,50,10/30/2019
1E7785,earnings,100,50,10/30/2019
1E7785,earnings,100,50,10/30/2019
1E7785,earnings,100,50,10/30/2019
1E7785,earnings,100,50,10/30/2019
1E7785,earnings,100,50,10/30/2019
1E83DE,conference-participant,100,50,10/30/2019
1F08A6,earnings,100,50,10/30/2019
1F19C8,credit-extension-provider,100,57,10/30/2019
200D8B,earnings,100,50,10/30/2019
2082EA,executive-appointment,100,54,10/30/2019
2082EA,conference-call,100,50,10/30/2019
2093B1,earnings,100,50,10/30/2019
21022F,earnings,100,50,10/30/2019
221445,earnings,100,50,10/30/2019
222BF9,dividend-up,100,81,10/30/2019
227D48,earnings,100,50,10/30/2019
227D48,earnings,100,50,10/30/2019
227D48,earnings,100,50,10/30/2019
227D48,earnings,100,50,10/30/2019
227F04,earnings,100,50,10/30/2019
2.45E+15,executive-appointment,100,54,10/30/2019
249674,earnings,100,50,10/30/2019
250BEE,dividend,100,50,10/30/2019
251988,business-contract,100,69,10/30/2019
251988,business-contract,100,69,10/30/2019
2571FA,facility-open,100,65,10/30/2019
25A6CC,earnings,100,50,10/30/2019
25A6CC,earnings,100,50,10/30/2019
25A6CC,earnings,100,50,10/30/2019
25A6CC,earnings,100,50,10/30/2019
26D8ED,earnings,100,50,10/30/2019
26FA41,revenues,100,50,10/30/2019
270B78,earnings,100,50,10/30/2019
28DCA8,earnings,100,50,10/30/2019
28F905,conference-call,100,50,10/30/2019
2950FF,earnings,100,50,10/30/2019
2950FF,earnings,100,50,10/30/2019
2A02DC,clinical-trials,100,56,10/30/2019
2A02DC,clinical-trials,100,56,10/30/2019
2B0AF4,earnings,100,50,10/30/2019
2B8179,clinical-trials-start,100,64,10/30/2019
2C19A4,earnings,100,50,10/30/2019
2C19A4,earnings,100,50,10/30/2019
2C19A4,earnings,100,50,10/30/2019
2C19A4,earnings,100,50,10/30/2019
2C19A4,earnings,100,50,10/30/2019
2C19A4,earnings,100,50,10/30/2019
2CA60F,executive-appointment,100,54,10/30/2019
2D2D43,dividend,100,50,10/30/2019
2EB04E,earnings-up,100,68,10/30/2019
2EB04E,earnings-up,100,68,10/30/2019
2EB04E,earnings-up,100,68,10/30/2019
2EB04E,earnings-up,100,68,10/30/2019
2F6782,dividend,100,50,10/30/2019
2F94A5,dividend,100,50,10/30/2019
2FDEE3,earnings,100,50,10/30/2019
315EB0,earnings,100,50,10/30/2019
315EB0,earnings,100,50,10/30/2019
315EB0,earnings,100,50,10/30/2019
315EB0,earnings,100,50,10/30/2019
315EB0,earnings,100,50,10/30/2019
315EB0,earnings,100,50,10/30/2019
315EB0,earnings,100,50,10/30/2019
315EB0,dividend,100,50,10/30/2019
31F25C,legal-issues-defendant,100,22,10/30/2019
3224CC,earnings,100,50,10/30/2019
3.20E+263,earnings,100,50,10/30/2019
3390DE,earnings,100,50,10/30/2019
343996,earnings,100,50,10/30/2019
3461CF,earnings,100,50,10/30/2019
3471C0,conference-participant,100,50,10/30/2019
349DA4,earnings,100,50,10/30/2019
370C50,product-price-raise,100,57,10/30/2019
384CD3,earnings,100,50,10/30/2019
39FB23,investment-investor,100,55,10/30/2019
3A3447,facility-open,100,65,10/30/2019
3ACF46,earnings,100,50,10/30/2019
3ACF46,earnings,100,50,10/30/2019
3ACF46,earnings,100,50,10/30/2019
3ACF46,earnings,100,50,10/30/2019
3ACF46,earnings,100,50,10/30/2019
3B37F7,earnings-up,100,68,10/30/2019
3B37F7,earnings-up,100,68,10/30/2019
3B37F7,earnings-up,100,68,10/30/2019
3BA1BF,conference-call,100,50,10/30/2019
3BC360,earnings,100,50,10/30/2019
3BC360,earnings,100,50,10/30/2019
3BC360,earnings,100,50,10/30/2019
3BC360,earnings,100,50,10/30/2019
3CBA2A,earnings,100,50,10/30/2019
3D9999,conference-participant,100,50,10/30/2019
3F4497,earnings,100,50,10/30/2019
3F868D,earnings,100,50,10/30/2019
4017AD,earnings,100,50,10/30/2019
415188,dividend,100,50,10/30/2019
415188,earnings,100,50,10/30/2019
416C55,dividend-up,100,55,10/30/2019
41D61C,earnings,100,50,10/30/2019
425BDC,unit-acquisition-acquiree,100,76,10/30/2019
427F32,dividend,100,50,10/30/2019
4398A2,public-offering,100,43,10/30/2019
44209A,product-release,100,64,10/30/2019
442769,earnings,100,50,10/30/2019
442769,earnings,100,50,10/30/2019
442769,earnings,100,50,10/30/2019
442769,earnings,100,50,10/30/2019
444CC8,conference-call,100,50,10/30/2019
448BF3,conference-call,100,50,10/30/2019
450ECB,partnership,100,61,10/30/2019
450ECB,partnership,100,61,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
47FCF2,earnings,100,50,10/30/2019
485445,executive-appointment,100,54,10/30/2019
4885C8,dividend,100,50,10/30/2019
49A344,earnings,100,50,10/30/2019
49A344,earnings,100,50,10/30/2019
49A344,earnings,100,50,10/30/2019
4A5C8D,earnings,100,50,10/30/2019
4B5054,dividend,100,50,10/30/2019
4C2F17,earnings,100,50,10/30/2019
4D8124,dividend,100,50,10/30/2019
4E5784,earnings,100,50,10/30/2019
4EE14A,index-listing,100,76,10/30/2019
4EE14A,index-listing,100,76,10/30/2019
504FE2,conference-participant,100,50,10/30/2019
507AE7,earnings,100,50,10/30/2019
519FE0,earnings,100,50,10/30/2019
51B442,earnings,100,50,10/30/2019
51F541,earnings,100,50,10/30/2019
5340D0,earnings,100,50,10/30/2019
53A226,conference-participant,100,50,10/30/2019
5.43E+08,earnings,100,50,10/30/2019
54A646,dividend,100,50,10/30/2019
54A646,buybacks,100,74,10/30/2019
553949,earnings,100,50,10/30/2019
55438C,product-release,100,64,10/30/2019
55438C,product-release,100,64,10/30/2019
56632F,earnings,100,50,10/30/2019
56632F,earnings,100,50,10/30/2019
56632F,earnings,100,50,10/30/2019
567F3D,conference-participant,100,50,10/30/2019
56B7C1,earnings,100,50,10/30/2019
57A854,conference-call,100,50,10/30/2019
57CAAB,earnings,100,50,10/30/2019
57EF50,dividend,100,50,10/30/2019
57F3DA,earnings,100,50,10/30/2019
594402,earnings,100,50,10/30/2019
5A423F,earnings,100,50,10/30/2019
5AAE17,earnings,100,50,10/30/2019
5C7601,earnings,100,50,10/30/2019
5D0337,earnings,100,50,10/30/2019
5DD486,earnings,100,50,10/30/2019
5DE5A5,conference-participant,100,50,10/30/2019
5F1B7B,earnings,100,50,10/30/2019
5F3E74,executive-appointment,100,54,10/30/2019
5F3E74,earnings,100,50,10/30/2019
5F3E74,earnings,100,50,10/30/2019
605F40,earnings,100,50,10/30/2019
6.18E+08,earnings,100,50,10/30/2019
6.18E+08,earnings,100,50,10/30/2019
6.18E+08,earnings,100,50,10/30/2019
619882,conference-organizer,100,57,10/30/2019
619882,partnership,100,61,10/30/2019
619882,conference-organizer,100,57,10/30/2019
61E975,earnings-positive,100,69,10/30/2019
62A48D,conference-call,100,50,10/30/2019
639BD6,revenues,100,50,10/30/2019
639BD6,revenues,100,50,10/30/2019
639BD6,revenues,100,50,10/30/2019
641F17,dividend,100,50,10/30/2019
649CBD,earnings,100,50,10/30/2019
657097,unit-acquisition-acquirer,100,49,10/30/2019
657097,unit-acquisition-acquirer,100,49,10/30/2019
6634D9,conference-participant,100,50,10/30/2019
665440,conference-call,100,50,10/30/2019
66749D,earnings-up,100,68,10/30/2019
66749D,earnings-up,100,68,10/30/2019
66749D,earnings-up,100,68,10/30/2019
66749D,earnings-up,100,68,10/30/2019
66749D,earnings-up,100,68,10/30/2019
66A667,conference-participant,100,50,10/30/2019
66A667,conference-participant,100,50,10/30/2019
66ECFD,earnings,100,50,10/30/2019
673C9A,conference-call,100,50,10/30/2019
68E3E0,dividend,100,50,10/30/2019
6A6BDC,partnership,100,61,10/30/2019
6B0E45,earnings,100,50,10/30/2019
6B494E,earnings,100,50,10/30/2019
6B6375,earnings,100,50,10/30/2019
6BD606,dividend-up,100,81,10/30/2019
6BD606,dividend-up,100,81,10/30/2019
6DBBBC,earnings-up,100,68,10/30/2019
6DBBBC,earnings,100,50,10/30/2019
6DBBBC,earnings,100,50,10/30/2019
6DBBBC,earnings,100,50,10/30/2019
6DBBBC,earnings,100,50,10/30/2019
6DC1D7,earnings,100,50,10/30/2019
6DDA15,conference-participant,100,50,10/30/2019
6E705B,partnership,100,61,10/30/2019
6E7060,earnings,100,50,10/30/2019
6E7060,earnings,100,50,10/30/2019
6E7060,earnings,100,50,10/30/2019
6E7060,earnings,100,50,10/30/2019
6E7060,earnings,100,50,10/30/2019
6E7060,earnings,100,50,10/30/2019
6E7060,earnings,100,50,10/30/2019
6E7060,earnings,100,50,10/30/2019
6EB9DA,dividend,100,50,10/30/2019
6ED519,earnings,100,50,10/30/2019
6ED519,earnings,100,50,10/30/2019
6ED519,earnings,100,50,10/30/2019
701531,earnings,100,50,10/30/2019
709AED,conference-participant,100,50,10/30/2019
722D55,earnings,100,50,10/30/2019
7273FF,earnings,100,50,10/30/2019
728737,earnings,100,50,10/30/2019
729368,earnings,100,50,10/30/2019
72C2CE,earnings,100,50,10/30/2019
731675,revenues,100,50,10/30/2019
731675,revenues,100,50,10/30/2019
731675,revenues,100,50,10/30/2019
732449,earnings,100,50,10/30/2019
73A213,earnings,100,50,10/30/2019
73A71F,dividend,100,50,10/30/2019
747219,legal-issues-defendant,100,22,10/30/2019
747219,legal-issues-defendant,100,22,10/30/2019
763724,earnings,100,50,10/30/2019
76B926,earnings,100,50,10/30/2019
76B926,earnings,100,50,10/30/2019
76BECC,conference-call,100,50,10/30/2019
782B46,dividend,100,50,10/30/2019
789ADD,dividend,100,50,10/30/2019
790D0D,earnings,100,50,10/30/2019
793C11,partnership,100,61,10/30/2019
7CBC40,conference-participant,100,50,10/30/2019
7DA412,earnings,100,50,10/30/2019
7E3F8F,earnings,100,50,10/30/2019
7E3F8F,earnings,100,50,10/30/2019
7E3F8F,earnings,100,50,10/30/2019
7E3F8F,earnings,100,50,10/30/2019
80C400,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
8.10E+32,earnings,100,50,10/30/2019
810FAD,earnings,100,50,10/30/2019
819492,earnings,100,50,10/30/2019
84AB66,earnings-positive,100,69,10/30/2019
85CDC9,earnings,100,50,10/30/2019
86478F,earnings,100,50,10/30/2019
86BAC7,earnings,100,50,10/30/2019
86F123,conference-call,100,50,10/30/2019
880C0C,earnings,100,50,10/30/2019
88193E,earnings,100,50,10/30/2019
8876D6,partnership,100,61,10/30/2019
896771,investment-investor,100,55,10/30/2019
896771,investment-investor,100,55,10/30/2019
896771,earnings,100,50,10/30/2019
8A0368,earnings,100,50,10/30/2019
8A0368,earnings,100,50,10/30/2019
8A0368,earnings,100,50,10/30/2019
8A0368,earnings,100,50,10/30/2019
8A8E41,partnership,100,61,10/30/2019
8AC65D,conference-participant,100,50,10/30/2019
8B1E11,earnings,100,50,10/30/2019
8DBE73,revenues,100,50,10/30/2019
8DBE73,revenues,100,50,10/30/2019
8DBE73,revenues,100,50,10/30/2019
8DBE73,revenues,100,50,10/30/2019
8DBE73,revenues,100,50,10/30/2019
8DBE73,revenues,100,50,10/30/2019
8DBE73,revenues,100,50,10/30/2019
8DBE73,revenues,100,50,10/30/2019
8DCBBB,earnings,100,50,10/30/2019
8DCBBB,earnings,100,50,10/30/2019
8E8E6E,earnings,100,50,10/30/2019
8EF425,earnings,100,50,10/30/2019
8EF425,earnings,100,50,10/30/2019
8EF425,earnings,100,50,10/30/2019
8EF425,earnings,100,50,10/30/2019
8EF425,earnings,100,50,10/30/2019
8EF425,earnings,100,50,10/30/2019
8FF2EF,conference-call,100,50,10/30/2019
900356,earnings,100,50,10/30/2019
901327,earnings,100,50,10/30/2019
901327,earnings,100,50,10/30/2019
901327,earnings,100,50,10/30/2019
901327,earnings,100,50,10/30/2019
901327,earnings,100,50,10/30/2019
901327,earnings,100,50,10/30/2019
902670,dividend,100,50,10/30/2019
9196A2,conference-organizer,100,57,10/30/2019
92B625,conference-call,100,50,10/30/2019
940C3D,earnings,100,50,10/30/2019
94208D,index-listing,100,76,10/30/2019
94637C,conference-participant,100,50,10/30/2019
950AB7,earnings,100,50,10/30/2019
958938,conference-call,100,50,10/30/2019
9.65E+09,earnings,100,50,10/30/2019
968103,earnings,100,50,10/30/2019
971F7B,earnings,100,50,10/30/2019
971F7B,earnings,100,50,10/30/2019
971F7B,earnings,100,50,10/30/2019
971F7B,earnings,100,50,10/30/2019
97FE80,partnership,100,61,10/30/2019
9A2760,conference-participant,100,50,10/30/2019
9B4066,dividend,100,50,10/30/2019
9B71A7,award,100,58,10/30/2019
9DDE1B,earnings,100,50,10/30/2019
9EA947,earnings,100,50,10/30/2019
9FB4B7,earnings,100,50,10/30/2019
A1BB98,earnings,100,50,10/30/2019
A398F8,earnings,100,50,10/30/2019
A429A5,operating-earnings,100,50,10/30/2019
A4386C,name-change,100,49,10/30/2019
A4A612,earnings,100,50,10/30/2019
A65325,public-offering,100,43,10/30/2019
A6ABE9,earnings,100,50,10/30/2019
A70BF5,earnings,100,50,10/30/2019
A70BF5,earnings,100,50,10/30/2019
A70BF5,earnings,100,50,10/30/2019
A70BF5,earnings,100,50,10/30/2019
A70BF5,earnings,100,50,10/30/2019
A70BF5,earnings,100,50,10/30/2019
A7CCF0,earnings,100,50,10/30/2019
A7CCF0,earnings,100,50,10/30/2019
A94637,facility-open,100,65,10/30/2019
AA1EAA,earnings,100,50,10/30/2019
AA847A,earnings,100,50,10/30/2019
AD3008,earnings,100,50,10/30/2019
AF93DE,conference-call,100,50,10/30/2019
B0998E,earnings,100,50,10/30/2019
B09B1F,earnings-up,100,68,10/30/2019
B09B1F,earnings,100,50,10/30/2019
B09B1F,earnings,100,50,10/30/2019
B2206F,partnership,100,61,10/30/2019
B2206F,earnings,100,50,10/30/2019
B2AA0A,earnings,100,50,10/30/2019
B2D492,earnings,100,50,10/30/2019
B4C673,earnings,100,50,10/30/2019
B4C673,earnings,100,50,10/30/2019
B4C673,earnings,100,50,10/30/2019
B4C673,earnings,100,50,10/30/2019
B4C673,earnings,100,50,10/30/2019
B4C673,earnings,100,50,10/30/2019
B4C673,earnings,100,50,10/30/2019
B5DE80,earnings,100,50,10/30/2019
B5DE80,earnings,100,50,10/30/2019
B72D2E,revenues,100,50,10/30/2019
B73395,conference-call,100,50,10/30/2019
B77F14,earnings,100,50,10/30/2019
B77F14,earnings,100,50,10/30/2019
B77F14,earnings,100,50,10/30/2019
B77F14,earnings,100,50,10/30/2019
B83D67,business-contract,100,69,10/30/2019
B934BF,earnings,100,50,10/30/2019
B98EFA,operating-earnings,100,50,10/30/2019
BA0442,earnings,100,50,10/30/2019
BAD655,earnings,100,50,10/30/2019
BBAE2A,dividend,100,50,10/30/2019
BC5680,legal-issues-defendant,100,22,10/30/2019
BCC55F,facility-open,100,65,10/30/2019
BD8517,earnings,100,50,10/30/2019
BDF2BD,business-contract,100,69,10/30/2019
BFE02C,conference-participant,100,50,10/30/2019
C062D4,earnings,100,50,10/30/2019
C062D4,earnings,100,50,10/30/2019
C062D4,earnings,100,50,10/30/2019
C062D4,earnings,100,50,10/30/2019
C062D4,earnings,100,50,10/30/2019
C062D4,earnings,100,50,10/30/2019
C062D4,earnings,100,50,10/30/2019
C188F8,earnings,100,50,10/30/2019
C230FE,earnings-per-share-up,100,68,10/30/2019
C230FE,earnings,100,50,10/30/2019
C2E426,earnings,100,50,10/30/2019
C48574,conference-participant,100,50,10/30/2019
C564E4,conference-call,100,50,10/30/2019
C66B44,earnings,100,50,10/30/2019
C8923A,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C99CC8,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9D866,earnings,100,50,10/30/2019
C9E04B,conference-call,100,50,10/30/2019
CA14CC,earnings,100,50,10/30/2019
CA14CC,earnings,100,50,10/30/2019
CA14CC,earnings,100,50,10/30/2019
CB88B3,earnings,100,50,10/30/2019
CB9E13,earnings,100,50,10/30/2019
CBDB4D,conference-call,100,50,10/30/2019
CC8F6E,earnings,100,50,10/30/2019
CDAF5B,operating-earnings,100,50,10/30/2019
CDE51C,earnings,100,50,10/30/2019
CE1002,conference-participant,100,50,10/30/2019
CE4E6D,conference-call,100,50,10/30/2019
CE96E7,earnings,100,50,10/30/2019
CE96E7,earnings,100,50,10/30/2019
CE96E7,earnings,100,50,10/30/2019
CE96E7,earnings,100,50,10/30/2019
D06755,earnings,100,50,10/30/2019
D06755,earnings,100,50,10/30/2019
D06755,earnings,100,50,10/30/2019
D08D2C,earnings,100,50,10/30/2019
D08D2C,earnings,100,50,10/30/2019
D08D2C,earnings,100,50,10/30/2019
D08D2C,earnings,100,50,10/30/2019
D08D2C,earnings,100,50,10/30/2019
D0909F,earnings,100,50,10/30/2019
D15833,earnings,100,50,10/30/2019
D29F43,earnings,100,50,10/30/2019
D2B9E5,earnings,100,50,10/30/2019
D2B9E5,earnings,100,50,10/30/2019
D2B9E5,earnings,100,50,10/30/2019
D4AC65,earnings,100,50,10/30/2019
D4AC65,earnings,100,50,10/30/2019
D4AC65,earnings,100,50,10/30/2019
D4AC65,earnings,100,50,10/30/2019
D4AC65,earnings,100,50,10/30/2019
D4AC65,earnings,100,50,10/30/2019
D54E62,dividend,100,50,10/30/2019
D58A11,earnings,100,50,10/30/2019
D58A11,earnings,100,50,10/30/2019
D58A11,earnings,100,50,10/30/2019
D64EDF,dividend,100,50,10/30/2019
D6853F,dividend,100,50,10/30/2019
D81463,earnings,100,50,10/30/2019
D81463,earnings,100,50,10/30/2019
D81463,dividend,100,50,10/30/2019
D81463,dividend,100,50,10/30/2019
D8442A,earnings,100,50,10/30/2019
D8442A,earnings,100,50,10/30/2019
D8442A,earnings,100,50,10/30/2019
D854DD,conference-participant,100,50,10/30/2019
D8DBA3,operating-earnings,100,50,10/30/2019
D96202,earnings,100,50,10/30/2019
D9B1C9,executive-appointment,100,54,10/30/2019
D9FC89,earnings,100,50,10/30/2019
D9FC89,earnings,100,50,10/30/2019
D9FC89,earnings,100,50,10/30/2019
D9FC89,earnings,100,50,10/30/2019
DB23C8,business-contract,100,69,10/30/2019
DB7014,operating-earnings,100,50,10/30/2019
DB9829,conference-participant,100,50,10/30/2019
DC2F77,earnings,100,50,10/30/2019
DC437D,earnings,100,50,10/30/2019
DDB002,conference-participant,100,50,10/30/2019
DF18E6,executive-appointment,100,54,10/30/2019
E07573,earnings,100,50,10/30/2019
E07573,earnings,100,50,10/30/2019
E07573,earnings,100,50,10/30/2019
E124EB,note-sale,100,52,10/30/2019
E12A6E,earnings,100,50,10/30/2019
E1BD05,earnings,100,50,10/30/2019
E1E36F,earnings,100,50,10/30/2019
E1E36F,earnings,100,50,10/30/2019
E1E36F,earnings,100,50,10/30/2019
E1E36F,earnings,100,50,10/30/2019
E1E36F,earnings,100,50,10/30/2019
E21871,earnings,100,50,10/30/2019
E259C7,revenue-up,100,69,10/30/2019
E259C7,revenue-up,100,69,10/30/2019
E259C7,revenue-up,100,69,10/30/2019
E259C7,revenue-up,100,69,10/30/2019
E259C7,revenue-up,100,69,10/30/2019
E2F130,dividend,100,50,10/30/2019
E3656D,conference-participant,100,50,10/30/2019
E49AA3,earnings,100,50,10/30/2019
E592F0,earnings,100,50,10/30/2019
E592F0,earnings,100,50,10/30/2019
E592F0,earnings,100,50,10/30/2019
E5D914,earnings,100,50,10/30/2019
E5D914,earnings,100,50,10/30/2019
E5D914,earnings,100,50,10/30/2019
E5D914,earnings,100,50,10/30/2019
E5D914,earnings,100,50,10/30/2019
E5D914,earnings,100,50,10/30/2019
E68733,product-release,100,64,10/30/2019
E68733,product-release,100,64,10/30/2019
E70531,dividend,100,50,10/30/2019
E74B55,earnings,100,50,10/30/2019
E802CE,earnings,100,50,10/30/2019
E802CE,earnings,100,50,10/30/2019
E802CE,earnings,100,50,10/30/2019
E802CE,earnings,100,50,10/30/2019
E802CE,earnings,100,50,10/30/2019
E84500,earnings,100,50,10/30/2019
E8846E,donation,100,54,10/30/2019
E8C557,earnings,100,50,10/30/2019
EB61C4,earnings,100,50,10/30/2019
ED0D7C,conference-participant,100,50,10/30/2019
ED2A5E,earnings,100,50,10/30/2019
ED2A5E,earnings,100,50,10/30/2019
ED2A5E,earnings,100,50,10/30/2019
ED2A5E,earnings,100,50,10/30/2019
ED2A5E,earnings,100,50,10/30/2019
ED2A5E,earnings,100,50,10/30/2019
ED2A5E,earnings,100,50,10/30/2019
ED4560,dividend,100,50,10/30/2019
ED79D9,partnership,100,61,10/30/2019
ED7F13,earnings,100,50,10/30/2019
EE6F1C,earnings-up,100,68,10/30/2019
EE6F1C,earnings,100,50,10/30/2019
EE6F1C,earnings,100,50,10/30/2019
EE6F1C,earnings,100,50,10/30/2019
EE74E1,earnings,100,50,10/30/2019
EE74E1,earnings,100,50,10/30/2019
EE74E1,earnings,100,50,10/30/2019
EE74E1,earnings,100,50,10/30/2019
EEA734,conference-call,100,50,10/30/2019
EF76C8,earnings,100,50,10/30/2019
F0B2B5,earnings,100,50,10/30/2019
F0EEFB,earnings,100,50,10/30/2019
F0EEFB,earnings,100,50,10/30/2019
F0EEFB,earnings,100,50,10/30/2019
F0EEFB,earnings,100,50,10/30/2019
F15E41,earnings,100,50,10/30/2019
F15E41,earnings,100,50,10/30/2019
F15E41,earnings,100,50,10/30/2019
F15E41,earnings,100,50,10/30/2019
F179ED,earnings,100,50,10/30/2019
F179ED,earnings,100,50,10/30/2019
F179ED,earnings,100,50,10/30/2019
F179ED,earnings,100,50,10/30/2019
F179ED,earnings,100,50,10/30/2019
F1CD47,earnings,100,50,10/30/2019
F2E253,dividend,100,50,10/30/2019
F31B13,dividend,100,50,10/30/2019
F32F88,earnings,100,50,10/30/2019
F4CDA3,earnings,100,50,10/30/2019
F4CDA3,earnings,100,50,10/30/2019
F4CDA3,earnings,100,50,10/30/2019
F4CDA3,earnings,100,50,10/30/2019
F4CDA3,earnings,100,50,10/30/2019
F4CDA3,earnings,100,50,10/30/2019
F4CDA3,earnings,100,50,10/30/2019
F4D241,earnings,100,50,10/30/2019
F50BAB,earnings,100,50,10/30/2019
F50BAB,earnings,100,50,10/30/2019
F50BAB,earnings,100,50,10/30/2019
F50BAB,earnings,100,50,10/30/2019
F57F6F,conference-participant,100,50,10/30/2019
F721A7,earnings,100,50,10/30/2019
F721A7,earnings,100,50,10/30/2019
F72E4B,executive-appointment,100,54,10/30/2019
F7935D,orphan-drug-designation,100,76,10/30/2019
FA35C6,earnings,100,50,10/30/2019
FAAFA2,earnings,100,50,10/30/2019
FC1F9D,conference-participant,100,50,10/30/2019
FD9A97,earnings,100,50,10/30/2019
FEE4B0,conference-participant,100,50,10/30/2019
FF227B,earnings,100,50,10/30/2019
FF5413,earnings-positive,100,69,10/30/2019
FF5413,earnings-positive,100,69,10/30/2019
FFCD0E,conference-call,100,50,10/30/2019
FFE543,facility-open,100,65,10/30/2019
0142B5,earnings-per-share-positive,100,69,10/31/2019
0157B1,facility-open,100,65,10/31/2019
033B58,conference-participant,100,50,10/31/2019
03B431,earnings,100,50,10/31/2019
03B431,earnings,100,50,10/31/2019
0490C6,earnings,100,50,10/31/2019
55018,dividend,100,50,10/31/2019
68396,earnings,100,50,10/31/2019
070B45,conference-participant,100,50,10/31/2019
099A92,partnership,100,61,10/31/2019
099C88,business-contract,100,69,10/31/2019
0A748B,earnings,100,50,10/31/2019
0A748B,earnings,100,50,10/31/2019
0BC853,earnings,100,50,10/31/2019
0ED415,earnings,100,50,10/31/2019
0ED415,earnings,100,50,10/31/2019
0ED415,earnings,100,50,10/31/2019
0ED415,earnings,100,50,10/31/2019
0F04E5,conference-participant,100,50,10/31/2019
105D00,dividend,100,50,10/31/2019
106394,earnings,100,50,10/31/2019
12731D,conference-call,100,50,10/31/2019
12731D,conference-call,100,50,10/31/2019
12DE76,partnership,100,61,10/31/2019
14ED2B,dividend-up,100,62,10/31/2019
152E1D,conference-participant,100,50,10/31/2019
15901B,earnings,100,50,10/31/2019
15901B,earnings,100,50,10/31/2019
15B10D,earnings,100,50,10/31/2019
1.79E+10,earnings,100,50,10/31/2019
1.79E+10,executive-appointment,100,54,10/31/2019
1834C0,dividend,100,50,10/31/2019
184866,earnings,100,50,10/31/2019
1866B2,dividend,100,50,10/31/2019
1880C5,conference-call,100,50,10/31/2019
18D9FA,conference-call,100,50,10/31/2019
197019,executive-appointment,100,54,10/31/2019
1D9E55,earnings,100,50,10/31/2019
1D9E55,earnings,100,50,10/31/2019
1D9E55,earnings,100,50,10/31/2019
1D9E55,earnings,100,50,10/31/2019
1D9E55,earnings,100,50,10/31/2019
1D9E55,earnings,100,50,10/31/2019
1D9E55,partnership,100,61,10/31/2019
1DEBBE,earnings,100,50,10/31/2019
1E1125,conference-organizer,100,57,10/31/2019
1E1125,conference-organizer,100,57,10/31/2019
1E1125,conference-organizer,100,57,10/31/2019
1F9258,earnings,100,50,10/31/2019
1F9D90,executive-appointment,100,54,10/31/2019
2031CE,conference-participant,100,50,10/31/2019
2096DE,earnings,100,50,10/31/2019
219B21,earnings,100,50,10/31/2019
219B21,earnings,100,50,10/31/2019
219B21,earnings,100,50,10/31/2019
219B21,earnings,100,50,10/31/2019
219B21,earnings,100,50,10/31/2019
228D42,executive-appointment,100,54,10/31/2019
2491BC,legal-issues-defendant,100,22,10/31/2019
2491BC,legal-issues-defendant,100,22,10/31/2019
24FA23,earnings,100,50,10/31/2019
250BEE,earnings,100,50,10/31/2019
250BEE,earnings,100,50,10/31/2019
250BEE,earnings,100,50,10/31/2019
250BEE,earnings,100,50,10/31/2019
250BEE,earnings,100,50,10/31/2019
253B2F,earnings,100,50,10/31/2019
253B2F,earnings,100,50,10/31/2019
272472,executive-appointment,100,54,10/31/2019
28AC4E,earnings,100,50,10/31/2019
28DCF3,earnings,100,50,10/31/2019
292388,partnership,100,61,10/31/2019
2B7A40,earnings-per-share-positive,100,69,10/31/2019
2B7A40,earnings-positive,100,69,10/31/2019
2B7A40,earnings-positive,100,69,10/31/2019
2B7A40,earnings-positive,100,69,10/31/2019
2BA977,earnings,100,50,10/31/2019
2C681C,conference-call,100,50,10/31/2019
2C681C,conference-call,100,50,10/31/2019
2C7505,earnings,100,50,10/31/2019
2CC71C,conference-call,100,50,10/31/2019
2CD1E0,business-contract,100,69,10/31/2019
2D2D43,earnings,100,50,10/31/2019
2D485F,dividend,100,50,10/31/2019
2D981A,earnings,100,50,10/31/2019
2E2E6E,buybacks,100,74,10/31/2019
2EB88B,revenues,100,50,10/31/2019
2EB88B,partnership,100,61,10/31/2019
2F5256,conference-participant,100,50,10/31/2019
2F5256,award,100,58,10/31/2019
301493,earnings,100,50,10/31/2019
301493,earnings,100,50,10/31/2019
314D88,earnings,100,50,10/31/2019
3159AA,conference-call,100,50,10/31/2019
332F87,earnings-up,100,78,10/31/2019
332F87,earnings-positive,100,69,10/31/2019
332F87,earnings-positive,100,69,10/31/2019
332F87,earnings-positive,100,69,10/31/2019
332F87,earnings-positive,100,69,10/31/2019
332F87,earnings-positive,100,69,10/31/2019
3461CF,product-release,100,64,10/31/2019
35557B,earnings,100,50,10/31/2019
35F4B5,earnings-up,100,68,10/31/2019
35F4B5,acquisition-completed-acquirer,100,49,10/31/2019
366A08,earnings,100,50,10/31/2019
366A08,earnings,100,50,10/31/2019
366A08,earnings,100,50,10/31/2019
366A08,earnings,100,50,10/31/2019
366A08,earnings,100,50,10/31/2019
366A08,earnings,100,50,10/31/2019
366A08,earnings,100,50,10/31/2019
37020C,conference-participant,100,50,10/31/2019
372037,dividend,100,50,10/31/2019
372037,earnings,100,50,10/31/2019
372037,earnings,100,50,10/31/2019
383ADA,earnings,100,50,10/31/2019
384CD3,conference-participant,100,50,10/31/2019
387375,earnings,100,50,10/31/2019
389CFB,earnings,100,50,10/31/2019
3AF7FD,conference-participant,100,50,10/31/2019
3DC887,earnings,100,50,10/31/2019
3DD5E2,executive-appointment,100,54,10/31/2019
3DDE54,earnings,100,50,10/31/2019
3DDE54,earnings,100,50,10/31/2019
3DDE54,earnings,100,50,10/31/2019
3DDE54,earnings,100,50,10/31/2019
3DDE54,earnings,100,50,10/31/2019
3DDE54,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3ED92D,earnings,100,50,10/31/2019
3F6A9C,earnings,100,50,10/31/2019
41B53E,earnings,100,50,10/31/2019
41B53E,earnings,100,50,10/31/2019
41B53E,earnings,100,50,10/31/2019
4290EF,dividend,100,50,10/31/2019
43E8F5,earnings,100,50,10/31/2019
442587,earnings,100,50,10/31/2019
442587,earnings,100,50,10/31/2019
44740A,executive-appointment,100,54,10/31/2019
44A4FC,partnership,100,61,10/31/2019
450ECB,partnership,100,61,10/31/2019
451D61,earnings,100,50,10/31/2019
4806CE,earnings,100,50,10/31/2019
4885C8,earnings,100,50,10/31/2019
499C75,earnings,100,50,10/31/2019
49F4D0,earnings,100,50,10/31/2019
4B49CF,conference-participant,100,50,10/31/2019
4C5CC9,earnings-guidance-up,100,83,10/31/2019
4C5CC9,earnings-guidance-up,100,83,10/31/2019
4C5CC9,earnings-guidance-up,100,83,10/31/2019
4C5CC9,earnings-guidance-up,100,83,10/31/2019
4C6C63,earnings,100,50,10/31/2019
4C6C63,earnings,100,50,10/31/2019
4C6C63,earnings,100,50,10/31/2019
4C6C63,earnings,100,50,10/31/2019
4C6C63,earnings,100,50,10/31/2019
4C6C63,earnings,100,50,10/31/2019
4C6C63,earnings,100,50,10/31/2019
4C6C63,earnings,100,50,10/31/2019
4C6C63,business-contract,100,69,10/31/2019
4D8124,earnings,100,50,10/31/2019
4D8124,earnings,100,50,10/31/2019
4E2D94,earnings,100,50,10/31/2019
4E2D94,dividend,100,50,10/31/2019
4EEE7E,earnings,100,50,10/31/2019
4F783B,dividend,100,50,10/31/2019
524CE4,earnings,100,50,10/31/2019
525A1C,earnings,100,50,10/31/2019
52BF94,earnings,100,50,10/31/2019
52BF94,earnings,100,50,10/31/2019
52BF94,earnings,100,50,10/31/2019
52BF94,earnings,100,50,10/31/2019
54512F,earnings,100,50,10/31/2019
54512F,partnership,100,61,10/31/2019
54512F,partnership,100,61,10/31/2019
54A713,earnings,100,50,10/31/2019
54DF47,acquisition-completed-acquirer,100,49,10/31/2019
56FB7C,dividend-up,100,81,10/31/2019
5704AC,operating-earnings,100,50,10/31/2019
57CAAB,business-contract,100,69,10/31/2019
57CAAB,business-contract,100,69,10/31/2019
586BD7,conference-call,100,50,10/31/2019
58CA9A,regulatory-stress-test,100,50,10/31/2019
5C2A47,executive-appointment,100,54,10/31/2019
5D1329,earnings,100,50,10/31/2019
5D1956,conference-participant,100,50,10/31/2019
5D43A7,earnings,100,50,10/31/2019
5D43A7,earnings,100,50,10/31/2019
5D43A7,earnings,100,50,10/31/2019
5D43A7,earnings,100,50,10/31/2019
5D43A7,earnings,100,50,10/31/2019
5DE5A5,dividend,100,50,10/31/2019
5EF130,conference-call,100,50,10/31/2019
5F2FF7,conference-participant,100,50,10/31/2019
5FDBD0,merger-completed,100,66,10/31/2019
6284B5,earnings,100,50,10/31/2019
6284B5,earnings,100,50,10/31/2019
6284B5,earnings,100,50,10/31/2019
6284B5,earnings,100,50,10/31/2019
62B1C6,dividend,100,50,10/31/2019
62B1C6,earnings,100,50,10/31/2019
62B1C6,dividend,100,50,10/31/2019
633054,partnership,100,61,10/31/2019
63F892,earnings,100,50,10/31/2019
64854A,earnings,100,50,10/31/2019
67303E,earnings,100,50,10/31/2019
6810DE,earnings,100,50,10/31/2019
68E3E0,earnings,100,50,10/31/2019
68E3E0,earnings,100,50,10/31/2019
68E3E0,earnings,100,50,10/31/2019
68E3E0,earnings,100,50,10/31/2019
68E3E0,earnings,100,50,10/31/2019
68E3E0,earnings,100,50,10/31/2019
68E6E9,earnings,100,50,10/31/2019
69FDFC,partnership,100,61,10/31/2019
6A3C35,earnings,100,50,10/31/2019
6A3C35,earnings,100,50,10/31/2019
6A3C35,earnings,100,50,10/31/2019
6A3C35,earnings,100,50,10/31/2019
6A3C35,earnings,100,50,10/31/2019
6A3C35,earnings,100,50,10/31/2019
6B5379,earnings,100,50,10/31/2019
6B5379,earnings,100,50,10/31/2019
6B5379,earnings,100,50,10/31/2019
6CDFC6,executive-appointment,100,54,10/31/2019
6D4636,award,100,58,10/31/2019
6EB9DA,conference-participant,100,50,10/31/2019
6F0A63,earnings,100,50,10/31/2019
6F92A9,earnings,100,50,10/31/2019
7122EB,clinical-trials,100,56,10/31/2019
71553E,conference-participant,100,50,10/31/2019
719477,earnings,100,50,10/31/2019
719477,earnings,100,50,10/31/2019
719477,earnings,100,50,10/31/2019
71E2EF,unit-acquisition-acquiree,100,76,10/31/2019
72C2CE,partnership,100,61,10/31/2019
72C2CE,partnership,100,61,10/31/2019
73A71F,legal-issues-defendant,100,22,10/31/2019
742AAB,conference-call,100,50,10/31/2019
746373,earnings,100,50,10/31/2019
746373,earnings,100,50,10/31/2019
746373,dividend,100,50,10/31/2019
747219,legal-issues-defendant,100,22,10/31/2019
747219,legal-issues-defendant,100,22,10/31/2019
76B926,conference-participant,100,50,10/31/2019
76F067,partnership,100,61,10/31/2019
76F067,partnership,100,61,10/31/2019
76F067,partnership,100,61,10/31/2019
7823A3,legal-issues-defendant,100,22,10/31/2019
787D14,conference-call,100,50,10/31/2019
789ADD,earnings,100,50,10/31/2019
789ADD,earnings,100,50,10/31/2019
789ADD,earnings,100,50,10/31/2019
789ADD,earnings,100,50,10/31/2019
7B8CB5,earnings,100,50,10/31/2019
7BEA98,earnings,100,50,10/31/2019
7C62A3,earnings,100,50,10/31/2019
7CD98F,earnings,100,50,10/31/2019
7D5384,earnings,100,50,10/31/2019
7D5384,earnings,100,50,10/31/2019
7D5384,earnings,100,50,10/31/2019
7D5384,earnings,100,50,10/31/2019
7D5384,earnings,100,50,10/31/2019
7D7716,earnings,100,50,10/31/2019
7D7716,earnings,100,50,10/31/2019
7D7716,earnings,100,50,10/31/2019
7D7716,earnings,100,50,10/31/2019
7D7716,earnings,100,50,10/31/2019
7D7716,earnings,100,50,10/31/2019
7DD584,conference-call,100,50,10/31/2019
7F3A5F,earnings,100,50,10/31/2019
810FAD,conference-participant,100,50,10/31/2019
81EAD4,earnings,100,50,10/31/2019
81EAD4,earnings,100,50,10/31/2019
81EAD4,earnings,100,50,10/31/2019
83E0AC,conference-call,100,50,10/31/2019
85CDC9,partnership,100,61,10/31/2019
85DA04,partnership,100,61,10/31/2019
8.79E+06,earnings,100,50,10/31/2019
87B81A,revenues,100,50,10/31/2019
87B81A,revenues,100,50,10/31/2019
87B81A,revenues,100,50,10/31/2019
87B81A,revenues,100,50,10/31/2019
87B81A,dividend,100,50,10/31/2019
8B1F37,earnings,100,50,10/31/2019
8B9B3B,earnings,100,50,10/31/2019
8BAA15,earnings,100,50,10/31/2019
8BAA15,earnings,100,50,10/31/2019
8DAAB9,partnership,100,61,10/31/2019
8DBBE6,earnings,100,50,10/31/2019
8E0E32,earnings,100,50,10/31/2019
8E82A6,joint-venture,100,62,10/31/2019
9196A2,conference-organizer,100,57,10/31/2019
92005C,clinical-trials-start,100,64,10/31/2019
940C3D,dividend,100,50,10/31/2019
945DE6,earnings,100,50,10/31/2019
945DE6,earnings,100,50,10/31/2019
945DE6,earnings,100,50,10/31/2019
945DE6,earnings,100,50,10/31/2019
94637C,earnings,100,50,10/31/2019
947B0B,earnings,100,50,10/31/2019
949625,earnings,100,50,10/31/2019
94983E,earnings,100,50,10/31/2019
94C0B5,dividend,100,50,10/31/2019
967D92,earnings,100,50,10/31/2019
96B4FF,conference-organizer,100,57,10/31/2019
96BFF4,earnings,100,50,10/31/2019
971334,earnings,100,50,10/31/2019
971334,earnings,100,50,10/31/2019
971334,earnings,100,50,10/31/2019
971334,earnings,100,50,10/31/2019
977A1E,dividend,100,50,10/31/2019
980C14,earnings,100,50,10/31/2019
9810C0,earnings,100,50,10/31/2019
98D33E,dividend,100,50,10/31/2019
9934AD,executive-appointment,100,54,10/31/2019
9.97E+09,earnings,100,50,10/31/2019
9C25FF,earnings,100,50,10/31/2019
9CDA4F,earnings,100,50,10/31/2019
9D30A8,conference-participant,100,50,10/31/2019
9D5FA4,earnings,100,50,10/31/2019
9E3224,earnings,100,50,10/31/2019
9E4A5F,earnings,100,50,10/31/2019
9E98F2,earnings,100,50,10/31/2019
9E98F2,earnings,100,50,10/31/2019
9E98F2,earnings,100,50,10/31/2019
9E98F2,legal-issues-defendant,100,22,10/31/2019
9F048E,earnings,100,50,10/31/2019
9F048E,earnings,100,50,10/31/2019
9F048E,earnings,100,50,10/31/2019
9F048E,earnings,100,50,10/31/2019
9F048E,earnings,100,50,10/31/2019
9F5CBB,dividend,100,50,10/31/2019
9F71E5,dividend,100,50,10/31/2019
9FD2D9,earnings,100,50,10/31/2019
9FD2D9,earnings,100,50,10/31/2019
9FD2D9,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A16DEA,earnings,100,50,10/31/2019
A350C1,dividend,100,50,10/31/2019
A3AAA5,earnings,100,50,10/31/2019
A47F2E,conference-participant,100,50,10/31/2019
A5151E,buybacks,100,74,10/31/2019
A5151E,earnings,100,50,10/31/2019
A52533,earnings,100,50,10/31/2019
A6D095,executive-appointment,100,54,10/31/2019
A6FE1C,unit-acquisition-acquirer,100,49,10/31/2019
A7102F,buybacks,100,74,10/31/2019
A7F0A5,conference-call,100,50,10/31/2019
A806FA,earnings,100,50,10/31/2019
A806FA,earnings,100,50,10/31/2019
A806FA,earnings,100,50,10/31/2019
A806FA,earnings,100,50,10/31/2019
A80FE0,earnings,100,50,10/31/2019
A8AC4C,conference-participant,100,50,10/31/2019
A8FDE8,earnings,100,50,10/31/2019
A8FDE8,earnings,100,50,10/31/2019
A8FDE8,dividend,100,50,10/31/2019
A94637,revenues,100,50,10/31/2019
A94637,revenues,100,50,10/31/2019
ABEE43,conference-participant,100,50,10/31/2019
AC3584,earnings,100,50,10/31/2019
AC7AAE,earnings,100,50,10/31/2019
AC7C4F,business-contract,100,69,10/31/2019
AEFC90,clinical-trials,100,56,10/31/2019
B04426,conference-call,100,50,10/31/2019
B05118,earnings,100,50,10/31/2019
B0B969,earnings,100,50,10/31/2019
B2206F,conference-participant,100,50,10/31/2019
B2256A,earnings,100,50,10/31/2019
B303A6,earnings,100,50,10/31/2019
B303A6,earnings,100,50,10/31/2019
B303A6,earnings,100,50,10/31/2019
B303A6,earnings,100,50,10/31/2019
B381D8,earnings,100,50,10/31/2019
B3ED62,earnings,100,50,10/31/2019
B560AF,earnings,100,50,10/31/2019
B560AF,earnings,100,50,10/31/2019
B560AF,earnings,100,50,10/31/2019
B614F8,analyst-ratings-change-neutral,100,78,10/31/2019
B7EB38,earnings,100,50,10/31/2019
B7EB38,earnings,100,50,10/31/2019
B83D67,earnings,100,50,10/31/2019
BB07E4,dividend,100,50,10/31/2019
BB127B,partnership,100,61,10/31/2019
BB58FF,conference-participant,100,50,10/31/2019
BDF2BD,earnings-up,100,68,10/31/2019
BDF2BD,earnings,100,50,10/31/2019
BDF2BD,earnings,100,50,10/31/2019
BDF2BD,earnings,100,50,10/31/2019
BDF2BD,earnings,100,50,10/31/2019
BDF2BD,earnings,100,50,10/31/2019
BE379D,earnings,100,50,10/31/2019
BE7BA4,earnings,100,50,10/31/2019
C0030A,earnings,100,50,10/31/2019
C0030A,earnings,100,50,10/31/2019
C0030A,earnings,100,50,10/31/2019
C0030A,earnings,100,50,10/31/2019
C0030A,earnings,100,50,10/31/2019
C01737,earnings,100,50,10/31/2019
C03C8B,unit-acquisition-completed-acquirer,100,49,10/31/2019
C0F70B,conference-participant,100,50,10/31/2019
C11C46,executive-appointment,100,54,10/31/2019
C15F8F,conference-participant,100,50,10/31/2019
C16A8F,earnings,100,50,10/31/2019
C16A8F,earnings,100,50,10/31/2019
C16A8F,earnings,100,50,10/31/2019
C16A8F,earnings,100,50,10/31/2019
C22BE8,acquisition-acquirer,100,49,10/31/2019
C2609A,executive-appointment,100,54,10/31/2019
C2609A,dividend,100,50,10/31/2019
C356AC,dividend,100,50,10/31/2019
C356AC,earnings,100,50,10/31/2019
C356AC,earnings,100,50,10/31/2019
C356AC,earnings,100,50,10/31/2019
C356AC,earnings,100,50,10/31/2019
C356AC,earnings,100,50,10/31/2019
C3BAE7,earnings,100,50,10/31/2019
C3BAE7,earnings,100,50,10/31/2019
C3BAE7,earnings,100,50,10/31/2019
C3BAE7,earnings,100,50,10/31/2019
C3BAE7,earnings,100,50,10/31/2019
C3BAE7,earnings,100,50,10/31/2019
C4F9C6,earnings,100,50,10/31/2019
C54140,earnings,100,50,10/31/2019
C66A8C,earnings,100,50,10/31/2019
C66A8C,earnings,100,50,10/31/2019
C66A8C,earnings,100,50,10/31/2019
C66A8C,earnings,100,50,10/31/2019
C66A8C,earnings,100,50,10/31/2019
C6C702,earnings,100,50,10/31/2019
C81E00,regulatory-product-approval-granted,100,81,10/31/2019
C8A248,earnings,100,50,10/31/2019
C8A248,earnings,100,50,10/31/2019
C8A248,earnings,100,50,10/31/2019
C8A248,earnings,100,50,10/31/2019
C8A248,earnings,100,50,10/31/2019
C8A248,earnings,100,50,10/31/2019
C8A248,earnings,100,50,10/31/2019
C98CDB,earnings,100,50,10/31/2019
C99CC8,award,100,58,10/31/2019
C9A96E,earnings,100,50,10/31/2019
CAD7D9,executive-appointment,100,54,10/31/2019
CB22CD,dividend,100,50,10/31/2019
CBBFBF,unit-acquisition-acquirer,100,49,10/31/2019
CBBFBF,unit-acquisition-acquirer,100,49,10/31/2019
CBBFBF,unit-acquisition-acquirer,100,49,10/31/2019
CBBFBF,unit-acquisition-acquirer,100,49,10/31/2019
CBBFBF,unit-acquisition-acquirer,100,49,10/31/2019
CBBFBF,unit-acquisition-acquirer,100,49,10/31/2019
CBBFBF,earnings,100,50,10/31/2019
CBBFBF,earnings,100,50,10/31/2019
CBBFBF,earnings,100,50,10/31/2019
CBBFBF,earnings,100,50,10/31/2019
CBBFBF,earnings,100,50,10/31/2019
CC0C78,clinical-trials,100,56,10/31/2019
CDD75E,executive-appointment,100,54,10/31/2019
CE5C6E,earnings,100,50,10/31/2019
CEC08B,earnings,100,50,10/31/2019
CEC08B,earnings,100,50,10/31/2019
CEC08B,earnings,100,50,10/31/2019
CEC08B,earnings,100,50,10/31/2019
CEC08B,earnings,100,50,10/31/2019
CFD4B6,earnings-up,100,68,10/31/2019
CFD4B6,earnings,100,50,10/31/2019
CFD4B6,earnings,100,50,10/31/2019
D03C7A,earnings,100,50,10/31/2019
D09938,earnings,100,50,10/31/2019
D1173F,earnings,100,50,10/31/2019
D1173F,earnings,100,50,10/31/2019
D1173F,earnings,100,50,10/31/2019
D1173F,earnings,100,50,10/31/2019
D1173F,earnings,100,50,10/31/2019
D1AE3B,executive-appointment,100,54,10/31/2019
D1AE3B,executive-appointment,100,54,10/31/2019
D1C0B9,revenues,100,50,10/31/2019
D1C0B9,earnings,100,50,10/31/2019
D1C0B9,earnings,100,50,10/31/2019
D1C0B9,earnings,100,50,10/31/2019
D56E4C,earnings,100,50,10/31/2019
D56E4C,earnings,100,50,10/31/2019
D650A7,dividend,100,50,10/31/2019
D650A7,revenue-up,100,69,10/31/2019
D650A7,revenue-up,100,69,10/31/2019
D650A7,revenue-up,100,69,10/31/2019
D650A7,revenue-up,100,69,10/31/2019
D65A13,revenues,100,50,10/31/2019
D65A13,revenues,100,50,10/31/2019
D65A13,revenues,100,50,10/31/2019
D6853F,business-contract,100,69,10/31/2019
D6853F,earnings,100,50,10/31/2019
D6853F,earnings,100,50,10/31/2019
D6853F,earnings,100,50,10/31/2019
D75910,credit-extension-recipient,100,69,10/31/2019
D77F7E,executive-appointment,100,54,10/31/2019
D8ECA1,legal-issues-defendant,100,22,10/31/2019
DB7EC3,earnings,100,50,10/31/2019
DB7EC3,earnings,100,50,10/31/2019
DBB28E,partnership,100,61,10/31/2019
DC0D18,earnings,100,50,10/31/2019
DC0D18,earnings,100,50,10/31/2019
DC0D18,earnings,100,50,10/31/2019
DC0D18,earnings,100,50,10/31/2019
DC0D18,earnings,100,50,10/31/2019
DC437D,dividend,100,50,10/31/2019
DC5299,operating-earnings,100,50,10/31/2019
DD0F15,earnings,100,50,10/31/2019
DDCB34,dividend-up,100,65,10/31/2019
DDCB34,earnings,100,50,10/31/2019
DE20DF,operating-earnings,100,50,10/31/2019
DF11D9,dividend,100,50,10/31/2019
DF18E6,conference-call,100,50,10/31/2019
DF1F7A,earnings,100,50,10/31/2019
DF204B,facility-upgrade,100,65,10/31/2019
DF5F14,conference-call,100,50,10/31/2019
E0207A,earnings,100,50,10/31/2019
E0207A,earnings,100,50,10/31/2019
E0207A,earnings,100,50,10/31/2019
E0207A,earnings,100,50,10/31/2019
E09E2B,conference-call,100,50,10/31/2019
E0D3BA,earnings,100,50,10/31/2019
E0E4B7,ipo-pricing,100,50,10/31/2019
E114F4,award,100,58,10/31/2019
E2CFD2,partnership,100,61,10/31/2019
E2F66E,earnings-up,100,68,10/31/2019
E35610,earnings,100,50,10/31/2019
E35610,earnings,100,50,10/31/2019
E35610,earnings,100,50,10/31/2019
E5A3B6,ipo-pricing,100,50,10/31/2019
E61888,conference-call,100,50,10/31/2019
E68C3D,earnings,100,50,10/31/2019
E829E8,unit-acquisition-acquirer,100,49,10/31/2019
E8846E,donation,100,54,10/31/2019
E93A40,executive-appointment,100,54,10/31/2019
EA79C7,earnings,100,50,10/31/2019
ECA300,executive-appointment,100,54,10/31/2019
ED1A74,business-contract,100,69,10/31/2019
ED4560,earnings,100,50,10/31/2019
EE74E1,award,100,58,10/31/2019
EE967B,conference-participant,100,50,10/31/2019
EEA734,conference-participant,100,50,10/31/2019
EEEA9F,conference-participant,100,50,10/31/2019
EF5BED,executive-appointment,100,54,10/31/2019
F0027C,earnings,100,50,10/31/2019
F0B877,earnings,100,50,10/31/2019
F0B877,earnings,100,50,10/31/2019
F11638,earnings,100,50,10/31/2019
F3016C,earnings,100,50,10/31/2019
F3016C,earnings,100,50,10/31/2019
F3016C,earnings,100,50,10/31/2019
F3016C,earnings,100,50,10/31/2019
F46EC9,earnings-up,100,68,10/31/2019
F46EC9,earnings-up,100,68,10/31/2019
F46EC9,earnings-up,100,68,10/31/2019
F46EC9,earnings-up,100,68,10/31/2019
F46EC9,earnings-up,100,68,10/31/2019
F4F46F,earnings,100,50,10/31/2019
F57F6F,earnings,100,50,10/31/2019
F5D410,conference-participant,100,50,10/31/2019
F6581D,private-placement,100,56,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F6FA6A,earnings,100,50,10/31/2019
F85CC0,earnings,100,50,10/31/2019
F85CC0,earnings,100,50,10/31/2019
F8C5D7,operating-earnings,100,50,10/31/2019
F9CAF8,earnings-per-share-up,100,68,10/31/2019
F9CAF8,earnings-per-share-up,100,68,10/31/2019
F9CAF8,earnings-per-share-up,100,68,10/31/2019
FC1B7B,conference-participant,100,50,10/31/2019
FD6926,earnings,100,50,10/31/2019
FD6926,earnings,100,50,10/31/2019
FD6926,earnings,100,50,10/31/2019
FD6926,earnings,100,50,10/31/2019
FD6926,earnings,100,50,10/31/2019
FD6926,dividend,100,50,10/31/2019
FDF799,earnings,100,50,10/31/2019
FDF799,earnings,100,50,10/31/2019
FDF799,earnings,100,50,10/31/2019
FEE4B0,earnings-up,100,68,10/31/2019
FEE4B0,earnings-up,100,68,10/31/2019
FEE4B0,earnings-up,100,68,10/31/2019
FEE4B0,earnings-up,100,68,10/31/2019
FEE4B0,earnings-up,100,68,10/31/2019
13528,conference-call,100,50,11/1/2019
01D03F,product-release,100,64,11/1/2019
0325B7,conference-call,100,50,11/1/2019
43862,earnings,100,50,11/1/2019
51332,credit-rating-affirmation,100,51,11/1/2019
0624BE,earnings,100,50,11/1/2019
71860,partnership,100,61,11/1/2019
0A7650,conference-participant,100,50,11/1/2019
0BC29E,earnings,100,50,11/1/2019
0BC29E,earnings,100,50,11/1/2019
0BC29E,earnings,100,50,11/1/2019
0BC29E,earnings,100,50,11/1/2019
0BC29E,earnings,100,50,11/1/2019
0BC29E,earnings,100,50,11/1/2019
0BC29E,earnings,100,50,11/1/2019
0BC29E,earnings,100,50,11/1/2019
0BF528,conference-call,100,50,11/1/2019
0DBB81,earnings,100,50,11/1/2019
0E5619,conference-call,100,50,11/1/2019
147098,earnings,100,50,11/1/2019
16C7F0,merger-completed,100,66,11/1/2019
1866B2,earnings,100,50,11/1/2019
19C105,earnings,100,50,11/1/2019
19C105,earnings,100,50,11/1/2019
19C105,earnings,100,50,11/1/2019
19C105,dividend,100,50,11/1/2019
1A6A94,earnings,100,50,11/1/2019
1B16C1,earnings,100,50,11/1/2019
1F43A1,earnings,100,50,11/1/2019
1FE7F0,earnings,100,50,11/1/2019
1FE7F0,earnings,100,50,11/1/2019
1FE7F0,earnings,100,50,11/1/2019
1FE7F0,earnings,100,50,11/1/2019
1FE7F0,earnings,100,50,11/1/2019
1FE7F0,earnings,100,50,11/1/2019
23207A,conference-call,100,50,11/1/2019
239106,earnings,100,50,11/1/2019
239106,earnings,100,50,11/1/2019
239106,earnings,100,50,11/1/2019
2491BC,legal-issues-defendant,100,22,11/1/2019
24A89A,legal-issues-defendant,100,22,11/1/2019
24A89A,legal-issues-defendant,100,22,11/1/2019
251988,executive-appointment,100,54,11/1/2019
272704,acquisition-completed-acquirer,100,49,11/1/2019
275300,conference-participant,100,50,11/1/2019
27A791,executive-appointment,100,54,11/1/2019
27BFA1,dividend,100,50,11/1/2019
28DCF3,acquisition-completed-acquirer,100,49,11/1/2019
292388,executive-appointment,100,54,11/1/2019
2AE625,earnings,100,50,11/1/2019
2C19A4,merger-completed,100,66,11/1/2019
2C19A4,merger-completed,100,66,11/1/2019
2C19A4,merger-completed,100,66,11/1/2019
2C3348,earnings,100,50,11/1/2019
2DC88B,earnings,100,50,11/1/2019
2E902B,conference-participant,100,50,11/1/2019
2EB04E,partnership,100,61,11/1/2019
2F6782,conference-participant,100,50,11/1/2019
2F98A5,earnings,100,50,11/1/2019
35F4B5,conference-participant,100,50,11/1/2019
37E18B,conference-call,100,50,11/1/2019
3B318A,executive-appointment,100,54,11/1/2019
3B8484,earnings-up,100,68,11/1/2019
3DCECC,acquisition-completed-acquirer,100,49,11/1/2019
41C528,conference-call,100,50,11/1/2019
423279,dividend,100,50,11/1/2019
4398A2,public-offering,100,43,11/1/2019
449A26,acquisition-completed-acquirer,100,49,11/1/2019
453282,conference-participant,100,50,11/1/2019
45BC35,conference-participant,100,50,11/1/2019
4.60E+06,earnings,100,50,11/1/2019
4A6F00,acquisition-acquirer,100,49,11/1/2019
4B3DC9,conference-participant,100,50,11/1/2019
4B5054,earnings,100,50,11/1/2019
4C31F3,acquisition-completed-acquirer,100,49,11/1/2019
4C31F3,conference-participant,100,50,11/1/2019
4F9487,acquisition-completed-acquirer,100,49,11/1/2019
52015A,acquisition-completed-acquirer,100,49,11/1/2019
5225A4,note-sale,100,52,11/1/2019
52B567,earnings,100,50,11/1/2019
53C421,conference-call,100,50,11/1/2019
57634F,earnings,100,50,11/1/2019
58CA9A,executive-appointment,100,54,11/1/2019
5968F9,earnings,100,50,11/1/2019
5B97B2,unit-acquisition-completed-acquirer,100,49,11/1/2019
5CEE02,acquisition-completed-acquiree,100,76,11/1/2019
62CDDE,conference-participant,100,50,11/1/2019
62CDDE,executive-appointment,100,54,11/1/2019
649CBD,conference-call,100,50,11/1/2019
665618,conference-participant,100,50,11/1/2019
665D7D,earnings,100,50,11/1/2019
66749D,acquisition-completed-acquirer,100,49,11/1/2019
6B236C,dividend,100,50,11/1/2019
6D3B7B,dividend,100,50,11/1/2019
705636,conference-call,100,50,11/1/2019
705636,dividend,100,50,11/1/2019
70FCEF,acquisition-completed-acquirer,100,49,11/1/2019
726EEA,earnings-up,100,68,11/1/2019
726EEA,earnings-up,100,68,11/1/2019
726EEA,earnings-up,100,68,11/1/2019
726EEA,earnings-up,100,68,11/1/2019
726EEA,earnings-up,100,68,11/1/2019
747219,legal-issues-defendant,100,22,11/1/2019
75768D,executive-appointment,100,54,11/1/2019
76BD96,dividend-up,100,81,11/1/2019
7823A3,legal-issues-defendant,100,22,11/1/2019
7823A3,legal-issues-defendant,100,22,11/1/2019
7A3633,unit-acquisition-acquiree,100,76,11/1/2019
7AC86E,executive-appointment,100,54,11/1/2019
7ACBA4,earnings,100,50,11/1/2019
7B0BA6,facility-open,100,65,11/1/2019
7D35D8,legal-issues-defendant,100,22,11/1/2019
7F2922,earnings,100,50,11/1/2019
817ED9,product-release,100,64,11/1/2019
82FD6D,earnings,100,50,11/1/2019
83598E,conference-participant,100,50,11/1/2019
8D4486,partnership,100,61,11/1/2019
902255,dividend,100,50,11/1/2019
9196A2,conference-organizer,100,57,11/1/2019
958938,executive-appointment,100,54,11/1/2019
95F59E,earnings,100,50,11/1/2019
95F59E,earnings,100,50,11/1/2019
95F59E,earnings,100,50,11/1/2019
95F59E,earnings,100,50,11/1/2019
965360,executive-appointment,100,54,11/1/2019
9673BD,dividend,100,50,11/1/2019
977A1E,earnings,100,50,11/1/2019
977A1E,earnings,100,50,11/1/2019
977A1E,earnings,100,50,11/1/2019
990AD0,acquisition-completed-acquiree,100,76,11/1/2019
9934AD,earnings,100,50,11/1/2019
9B4066,facility-sale,100,52,11/1/2019
9E98F2,legal-issues-defendant,100,22,11/1/2019
9EA947,conference-participant,100,50,11/1/2019
9F5997,conference-participant,100,50,11/1/2019
A204A7,earnings,100,50,11/1/2019
A29A46,conference-call,100,50,11/1/2019
A2CA3F,dividend,100,50,11/1/2019
A4BCDE,earnings,100,50,11/1/2019
A5195E,clinical-trials-start,100,64,11/1/2019
A6828A,acquisition-completed-acquiree,100,76,11/1/2019
AD23DE,executive-appointment,100,54,11/1/2019
ADD9DC,facility-open,100,65,11/1/2019
ADFB3A,executive-appointment,100,54,11/1/2019
AE4125,earnings,100,50,11/1/2019
AE4125,earnings,100,50,11/1/2019
AE79CD,executive-appointment,100,54,11/1/2019
AE7D16,earnings,100,50,11/1/2019
B303A6,dividend,100,50,11/1/2019
B4F5F4,conference-call,100,50,11/1/2019
B642E8,earnings,100,50,11/1/2019
B642E8,earnings,100,50,11/1/2019
B642E8,earnings,100,50,11/1/2019
B642E8,earnings,100,50,11/1/2019
B642E8,earnings,100,50,11/1/2019
B642E8,earnings,100,50,11/1/2019
B642E8,earnings,100,50,11/1/2019
B7BDA3,earnings,100,50,11/1/2019
B98EFA,patient-enrollment-start,100,58,11/1/2019
BBC05B,conference-participant,100,50,11/1/2019
C0200F,executive-appointment,100,54,11/1/2019
C1CBA4,dividend,100,50,11/1/2019
C230FE,executive-appointment,100,54,11/1/2019
C3BCD5,earnings,100,50,11/1/2019
C3BCD5,earnings,100,50,11/1/2019
CBA33B,partnership,100,61,11/1/2019
CBCC6A,executive-appointment,100,54,11/1/2019
CEC5B9,conference-call,100,50,11/1/2019
CF351E,earnings,100,50,11/1/2019
CF351E,earnings,100,50,11/1/2019
CF351E,earnings,100,50,11/1/2019
CFD4B6,conference-participant,100,50,11/1/2019
CFF57D,conference-participant,100,50,11/1/2019
D11C1C,conference-call,100,50,11/1/2019
D437C3,board-meeting,100,51,11/1/2019
D437C3,acquisition-completed-acquirer,100,49,11/1/2019
D54E62,earnings-positive,100,69,11/1/2019
D54E62,earnings-positive,100,69,11/1/2019
D54E62,earnings-positive,100,69,11/1/2019
D54E62,earnings-positive,100,69,11/1/2019
D598E7,earnings,100,50,11/1/2019
D6144F,conference-call,100,50,11/1/2019
D8DA3D,legal-issues-defendant,100,22,11/1/2019
DB23C8,earnings,100,50,11/1/2019
DB23C8,earnings,100,50,11/1/2019
DB23C8,earnings,100,50,11/1/2019
DE5611,conference-call,100,50,11/1/2019
DF42A0,conference-call,100,50,11/1/2019
E13782,earnings,100,50,11/1/2019
E3A829,business-contract,100,69,11/1/2019
E70531,earnings,100,50,11/1/2019
E70531,earnings,100,50,11/1/2019
E70531,earnings,100,50,11/1/2019
E70531,earnings,100,50,11/1/2019
E70531,earnings,100,50,11/1/2019
E99180,acquisition-completed-acquirer,100,49,11/1/2019
EB6965,earnings,100,50,11/1/2019
EB6965,earnings,100,50,11/1/2019
EB6965,earnings,100,50,11/1/2019
EB6965,earnings,100,50,11/1/2019
EB6965,earnings,100,50,11/1/2019
EB6965,earnings,100,50,11/1/2019
EBC84C,dividend,100,50,11/1/2019
ED2EFD,earnings,100,50,11/1/2019
EE04F0,earnings,100,50,11/1/2019
EE04F0,earnings,100,50,11/1/2019
EE04F0,earnings,100,50,11/1/2019
EE04F0,earnings,100,50,11/1/2019
EEBCEF,dividend,100,50,11/1/2019
EF7163,earnings,100,50,11/1/2019
F1529C,earnings,100,50,11/1/2019
F1529C,earnings,100,50,11/1/2019
F1529C,executive-resignation,100,44,11/1/2019
F1529C,executive-resignation,100,44,11/1/2019
F18844,executive-appointment,100,54,11/1/2019
F1C04C,dividend,100,50,11/1/2019
F3816D,earnings,100,50,11/1/2019
F48947,earnings,100,50,11/1/2019
F51DB0,earnings,100,50,11/1/2019
F80FF9,conference-call,100,50,11/1/2019
FBDA0F,acquisition-completed-acquirer,100,49,11/1/2019
FCA54E,earnings,100,50,11/1/2019
FD0CA4,executive-appointment,100,54,11/1/2019
168A5D,hirings,100,65,11/2/2019
747219,legal-issues-defendant,100,22,11/2/2019
747219,legal-issues-defendant,100,22,11/2/2019
CFF15D,patent-infringement-defendant,100,26,11/2/2019
D8442A,revenue-up,100,69,11/2/2019
0C136E,acquisition-acquirer,100,49,11/3/2019
2491BC,legal-issues-defendant,100,22,11/3/2019
9.54E+32,executive-appointment,100,54,11/3/2019
C5D2AE,acquisition-acquirer,100,49,11/3/2019
002A99,earnings,100,50,11/4/2019
00326E,executive-appointment,100,54,11/4/2019
003B70,operating-earnings,100,50,11/4/2019
018C11,conference-participant,100,50,11/4/2019
20751,executive-appointment,100,54,11/4/2019
02870F,earnings,100,50,11/4/2019
02870F,earnings,100,50,11/4/2019
02870F,earnings,100,50,11/4/2019
02870F,earnings,100,50,11/4/2019
033B58,earnings,100,50,11/4/2019
034B61,conference-participant,100,50,11/4/2019
03542C,earnings,100,50,11/4/2019
03FAA6,earnings,100,50,11/4/2019
03FAA6,earnings,100,50,11/4/2019
03FAA6,earnings,100,50,11/4/2019
03FAA6,earnings,100,50,11/4/2019
03FAA6,earnings,100,50,11/4/2019
03FAA6,earnings,100,50,11/4/2019
040DBB,earnings,100,50,11/4/2019
04996E,earnings,100,50,11/4/2019
04996E,earnings,100,50,11/4/2019
04EB2F,earnings,100,50,11/4/2019
05AF14,conference-participant,100,50,11/4/2019
06EE79,earnings,100,50,11/4/2019
099C88,conference-participant,100,50,11/4/2019
09DE1F,unit-acquisition-completed-acquirer,100,49,11/4/2019
0A9D0A,dividend,100,50,11/4/2019
0B7375,earnings,100,50,11/4/2019
0DBB81,clinical-trials,100,56,11/4/2019
0E439E,note-sale,100,52,11/4/2019
0E5223,operating-earnings,100,50,11/4/2019
0FE3A6,conference-call,100,50,11/4/2019
1080C0,executive-appointment,100,54,11/4/2019
1151F4,public-offering,100,43,11/4/2019
1201B5,legal-issues-defendant,100,22,11/4/2019
12731D,earnings,100,50,11/4/2019
12731D,earnings,100,50,11/4/2019
12731D,earnings,100,50,11/4/2019
12731D,earnings,100,50,11/4/2019
12731D,earnings,100,50,11/4/2019
12731D,earnings,100,50,11/4/2019
13A782,earnings,100,50,11/4/2019
1490F3,business-contract,100,69,11/4/2019
168A5D,executive-appointment,100,54,11/4/2019
1921DD,business-contract,100,69,11/4/2019
196D18,private-placement,100,56,11/4/2019
1AB023,earnings,100,50,11/4/2019
1AB023,earnings,100,50,11/4/2019
1AB023,earnings,100,50,11/4/2019
1CD09C,conference-participant,100,50,11/4/2019
1E1125,conference-organizer,100,57,11/4/2019
1E1125,conference-organizer,100,57,11/4/2019
1E1125,conference-organizer,100,57,11/4/2019
21D903,conference-participant,100,50,11/4/2019
228D42,partnership,100,61,11/4/2019
228D42,partnership,100,61,11/4/2019
228D42,partnership,100,61,11/4/2019
241AF7,earnings,100,50,11/4/2019
241AF7,earnings,100,50,11/4/2019
2491BC,legal-issues-defendant,100,22,11/4/2019
2491BC,legal-issues-defendant,100,22,11/4/2019
24A89A,legal-issues-defendant,100,22,11/4/2019
24A89A,legal-issues-defendant,100,22,11/4/2019
24C48B,acquisition-completed-acquirer,100,49,11/4/2019
25AB8E,earnings,100,50,11/4/2019
273BA3,acquisition-acquirer,100,49,11/4/2019
278C18,earnings,100,50,11/4/2019
2920D5,dividend,100,50,11/4/2019
2920D5,earnings,100,50,11/4/2019
2D485F,earnings,100,50,11/4/2019
2D485F,earnings,100,50,11/4/2019
2D485F,earnings,100,50,11/4/2019
2D485F,earnings,100,50,11/4/2019
2EBA55,dividend,100,50,11/4/2019
2F9304,earnings,100,50,11/4/2019
31DB20,asset-sale,100,62,11/4/2019
31DB20,earnings,100,50,11/4/2019
3224CC,conference-participant,100,50,11/4/2019
34B411,fundraising,100,64,11/4/2019
36529A,earnings,100,50,11/4/2019
367434,executive-appointment,100,54,11/4/2019
367E1C,earnings,100,50,11/4/2019
385DD4,earnings,100,50,11/4/2019
387541,conference-participant,100,50,11/4/2019
38C46F,dividend,100,50,11/4/2019
3AAEAE,operating-earnings,100,50,11/4/2019
3AF7FD,earnings,100,50,11/4/2019
3AF7FD,dividend,100,50,11/4/2019
3D6933,pretax-earnings-up,100,68,11/4/2019
3D6933,pretax-earnings-up,100,68,11/4/2019
3D7971,earnings,100,50,11/4/2019
3D7971,earnings,100,50,11/4/2019
3D7971,earnings,100,50,11/4/2019
3D7971,earnings,100,50,11/4/2019
3D7971,earnings,100,50,11/4/2019
3D7971,earnings,100,50,11/4/2019
3DD5E2,operating-earnings,100,50,11/4/2019
3ED92D,note-sale,100,52,11/4/2019
407878,conference-call,100,50,11/4/2019
40F7DE,partnership,100,61,11/4/2019
41EC04,earnings,100,50,11/4/2019
41EC04,earnings,100,50,11/4/2019
41EC04,earnings,100,50,11/4/2019
41EC04,legal-issues-defendant,100,22,11/4/2019
41EC04,legal-issues-defendant,100,22,11/4/2019
4290EF,earnings,100,50,11/4/2019
435ACE,conference-participant,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
43A74A,earnings,100,50,11/4/2019
450ECB,partnership,100,61,11/4/2019
450ECB,partnership,100,61,11/4/2019
450ECB,earnings,100,50,11/4/2019
450ECB,earnings,100,50,11/4/2019
46A16E,earnings,100,50,11/4/2019
485445,earnings,100,50,11/4/2019
485445,earnings,100,50,11/4/2019
485445,earnings,100,50,11/4/2019
485445,earnings,100,50,11/4/2019
485445,earnings,100,50,11/4/2019
485445,earnings,100,50,11/4/2019
485445,earnings,100,50,11/4/2019
49A344,executive-appointment,100,54,11/4/2019
49F4D0,note-sale,100,52,11/4/2019
4B7006,acquisition-interest-acquirer,100,46,11/4/2019
4BAF2E,partnership,100,61,11/4/2019
4C31F3,earnings,100,50,11/4/2019
4C31F3,earnings,100,50,11/4/2019
4C3FE9,earnings,100,50,11/4/2019
4F71DC,executive-appointment,100,54,11/4/2019
50070E,conference-call,100,50,11/4/2019
52B567,business-contract,100,69,11/4/2019
5.43E+08,legal-issues-defendant,100,22,11/4/2019
546A27,earnings,100,50,11/4/2019
5.47E+28,operating-earnings,100,50,11/4/2019
57356F,conference-participant,100,50,11/4/2019
57EF50,earnings,100,50,11/4/2019
57EF50,earnings,100,50,11/4/2019
57EF50,earnings,100,50,11/4/2019
57EF50,earnings,100,50,11/4/2019
583A75,partnership,100,61,11/4/2019
586FFD,revenues,100,50,11/4/2019
586FFD,revenues,100,50,11/4/2019
5B3415,earnings,100,50,11/4/2019
5B3415,earnings,100,50,11/4/2019
5B6C11,dividend,100,50,11/4/2019
5C8D61,sanctions-target,100,19,11/4/2019
5D02B7,note-sale,100,52,11/4/2019
5D41E4,partnership,100,61,11/4/2019
5EAA43,partnership,100,61,11/4/2019
5F2FF7,operating-earnings,100,50,11/4/2019
60DD84,acquisition-completed-acquirer,100,49,11/4/2019
61A586,earnings,100,50,11/4/2019
62CDDE,earnings,100,50,11/4/2019
62F41C,earnings,100,50,11/4/2019
62F41C,capital-increase,100,43,11/4/2019
62F41C,dividend,100,50,11/4/2019
62F41C,earnings,100,50,11/4/2019
64E615,conference-participant,100,50,11/4/2019
64FF65,earnings,100,50,11/4/2019
65CF8E,earnings,100,50,11/4/2019
65CF8E,earnings,100,50,11/4/2019
65CF8E,earnings,100,50,11/4/2019
65CF8E,earnings,100,50,11/4/2019
65CF8E,earnings,100,50,11/4/2019
69CE71,partnership,100,61,11/4/2019
6A171E,executive-appointment,100,54,11/4/2019
6A171E,earnings,100,50,11/4/2019
6D0CAB,earnings-per-share-positive,100,69,11/4/2019
6D0CAB,earnings-per-share,100,50,11/4/2019
6D0CAB,earnings-per-share,100,50,11/4/2019
6D0CAB,earnings-per-share,100,50,11/4/2019
6D0CAB,earnings-per-share,100,50,11/4/2019
6D0CAB,earnings-per-share,100,50,11/4/2019
6D0CAB,earnings-per-share,100,50,11/4/2019
6D0CAB,earnings-per-share,100,50,11/4/2019
6-Dec-05,earnings,100,50,11/4/2019
717DB4,earnings,100,50,11/4/2019
717DB4,earnings,100,50,11/4/2019
717DB4,earnings,100,50,11/4/2019
717DB4,earnings,100,50,11/4/2019
717DB4,earnings,100,50,11/4/2019
732A9B,earnings,100,50,11/4/2019
73A213,earnings,100,50,11/4/2019
73A213,earnings,100,50,11/4/2019
73A71F,earnings,100,50,11/4/2019
7.44E+09,earnings,100,50,11/4/2019
747219,legal-issues-defendant,100,22,11/4/2019
7.49E+07,earnings,100,50,11/4/2019
763724,executive-resignation,100,44,11/4/2019
766047,earnings,100,50,11/4/2019
76F067,partnership,100,61,11/4/2019
7712CB,dividend,100,50,11/4/2019
7712CB,earnings,100,50,11/4/2019
7712CB,earnings,100,50,11/4/2019
7712CB,earnings,100,50,11/4/2019
7712CB,earnings,100,50,11/4/2019
7712CB,earnings,100,50,11/4/2019
7712CB,earnings,100,50,11/4/2019
7712CB,earnings,100,50,11/4/2019
7712CB,dividend,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
771985,earnings,100,50,11/4/2019
79167B,buybacks,100,74,11/4/2019
79167B,earnings,100,50,11/4/2019
79167B,earnings,100,50,11/4/2019
79167B,earnings,100,50,11/4/2019
79167B,earnings,100,50,11/4/2019
791EC1,earnings,100,50,11/4/2019
797C20,earnings-per-share-up,100,57,11/4/2019
7A2A49,earnings,100,50,11/4/2019
7A51FE,earnings,100,50,11/4/2019
7B1E50,earnings,100,50,11/4/2019
7B8CB5,dividend,100,50,11/4/2019
7BC92D,earnings,100,50,11/4/2019
7C790D,earnings,100,50,11/4/2019
7EA323,revenue-up,100,69,11/4/2019
7F2922,conference-participant,100,50,11/4/2019
7F3669,earnings,100,50,11/4/2019
7F9BE2,earnings,100,50,11/4/2019
7FDE1C,conference-call,100,50,11/4/2019
805CD8,conference-call,100,50,11/4/2019
83066C,earnings,100,50,11/4/2019
83066C,earnings,100,50,11/4/2019
85DA04,earnings,100,50,11/4/2019
85DA04,earnings,100,50,11/4/2019
85DA04,earnings,100,50,11/4/2019
85DA04,earnings,100,50,11/4/2019
877734,conference-participant,100,50,11/4/2019
88193E,conference-participant,100,50,11/4/2019
885758,legal-issues-defendant,100,22,11/4/2019
890FF4,earnings,100,50,11/4/2019
890FF4,earnings,100,50,11/4/2019
890FF4,earnings,100,50,11/4/2019
890FF4,earnings,100,50,11/4/2019
890FF4,earnings,100,50,11/4/2019
890FF4,earnings,100,50,11/4/2019
890FF4,earnings,100,50,11/4/2019
893904,earnings,100,50,11/4/2019
89F693,unit-acquisition-completed-acquiree,100,67,11/4/2019
89F693,asset-sale,100,62,11/4/2019
8AC740,earnings,100,50,11/4/2019
8C5519,conference-organizer,100,57,11/4/2019
8DA42F,earnings,100,50,11/4/2019
8DA42F,earnings,100,50,11/4/2019
8DA42F,earnings,100,50,11/4/2019
8DCF18,clinical-trials-negative,100,18,11/4/2019
8E3F58,earnings,100,50,11/4/2019
905356,conference-call,100,50,11/4/2019
9087B9,conference-participant,100,50,11/4/2019
90D6A5,earnings,100,50,11/4/2019
90D6A5,earnings,100,50,11/4/2019
90D6A5,earnings,100,50,11/4/2019
90D6A5,earnings,100,50,11/4/2019
911AB8,unit-acquisition-acquirer,100,49,11/4/2019
913437,earnings,100,50,11/4/2019
915E7B,earnings,100,50,11/4/2019
91E5EE,earnings,100,50,11/4/2019
92D757,ownership-decrease-owner,100,46,11/4/2019
934029,conference-participant,100,50,11/4/2019
9368BE,earnings,100,50,11/4/2019
94637C,fundraising,100,64,11/4/2019
9548BB,dividend,100,50,11/4/2019
9.54E+32,legal-issues-defendant,100,22,11/4/2019
957A07,earnings,100,50,11/4/2019
96A6CD,conference-participant,100,50,11/4/2019
972356,partnership,100,61,11/4/2019
97AAF6,earnings,100,50,11/4/2019
97AAF6,earnings,100,50,11/4/2019
97AAF6,earnings,100,50,11/4/2019
97AAF6,earnings,100,50,11/4/2019
97AAF6,earnings,100,50,11/4/2019
97B027,earnings,100,50,11/4/2019
97B027,earnings,100,50,11/4/2019
97B027,earnings,100,50,11/4/2019
97FE80,legal-issues-defendant,100,22,11/4/2019
98CEBB,earnings,100,50,11/4/2019
98D33E,earnings,100,50,11/4/2019
990AD0,conference-organizer,100,57,11/4/2019
9978F1,earnings,100,50,11/4/2019
99ACAD,earnings,100,50,11/4/2019
99ACAD,earnings,100,50,11/4/2019
99ACAD,earnings,100,50,11/4/2019
99ACAD,earnings,100,50,11/4/2019
99ACAD,earnings,100,50,11/4/2019
99DC8D,dividend,100,50,11/4/2019
9C5BA5,earnings,100,50,11/4/2019
9D2790,earnings,100,50,11/4/2019
9D2790,earnings,100,50,11/4/2019
9D2790,earnings,100,50,11/4/2019
9D2790,earnings,100,50,11/4/2019
9D2790,earnings,100,50,11/4/2019
9D30A8,partnership,100,61,11/4/2019
9D65C1,earnings,100,50,11/4/2019
9E575E,patient-enrollment-complete,100,64,11/4/2019
9E575E,patient-enrollment-complete,100,64,11/4/2019
9E575E,earnings,100,50,11/4/2019
9EA947,dividend,100,50,11/4/2019
9EBAFA,acquisition-completed-acquirer,100,49,11/4/2019
9FB4B7,earnings,100,50,11/4/2019
A1E3B3,acquisition-completed-acquirer,100,49,11/4/2019
A1E3B3,earnings,100,50,11/4/2019
A1EAC8,conference-call,100,50,11/4/2019
A247F5,earnings-per-share-positive,100,69,11/4/2019
A247F5,earnings-per-share-positive,100,69,11/4/2019
A247F5,earnings-per-share-positive,100,69,11/4/2019
A28675,earnings,100,50,11/4/2019
A350C1,operating-earnings,100,50,11/4/2019
A350C1,operating-earnings,100,50,11/4/2019
A350C1,operating-earnings,100,50,11/4/2019
A350C1,operating-earnings,100,50,11/4/2019
A350C1,operating-earnings,100,50,11/4/2019
A350C1,operating-earnings,100,50,11/4/2019
A350C1,operating-earnings,100,50,11/4/2019
A52B6B,earnings,100,50,11/4/2019
A6213D,earnings,100,50,11/4/2019
A6FE1C,unit-acquisition-acquirer,100,49,11/4/2019
A72FD9,conference-participant,100,50,11/4/2019
AA3AB8,earnings,100,50,11/4/2019
AA98ED,public-offering,100,43,11/4/2019
AB4A7E,executive-appointment,100,54,11/4/2019
AE4EEB,credit-extension-recipient,100,69,11/4/2019
AFD1CA,facility-open,100,65,11/4/2019
B01111,earnings,100,50,11/4/2019
B01215,conference-call,100,50,11/4/2019
B66928,business-contract,100,69,11/4/2019
B7FA9B,earnings,100,50,11/4/2019
B80AD1,earnings,100,50,11/4/2019
B9764A,partnership,100,61,11/4/2019
B98EFA,patient-enrollment-start,100,58,11/4/2019
B9CD50,earnings,100,50,11/4/2019
BB127B,conference-call,100,50,11/4/2019
BB5271,acquisition-completed-acquirer,100,49,11/4/2019
BB58FF,earnings,100,50,11/4/2019
BE14CF,trading-halt,100,43,11/4/2019
BE5935,executive-appointment,100,54,11/4/2019
BFE02C,partnership,100,61,11/4/2019
C11C46,earnings,100,50,11/4/2019
C15F8F,earnings,100,50,11/4/2019
C3DE7D,earnings,100,50,11/4/2019
C3DE7D,executive-appointment,100,54,11/4/2019
C66A8C,public-offering,100,43,11/4/2019
C7AE14,dividend,100,50,11/4/2019
C81E00,acquisition-acquirer,100,49,11/4/2019
C81E00,acquisition-acquirer,100,49,11/4/2019
C81E00,acquisition-acquirer,100,49,11/4/2019
C83B88,partnership,100,61,11/4/2019
CA212F,earnings,100,50,11/4/2019
CBFFDD,note-sale,100,52,11/4/2019
CBFFDD,earnings,100,50,11/4/2019
CC0C78,earnings,100,50,11/4/2019
CC339B,product-release,100,64,11/4/2019
CC8F6E,earnings,100,50,11/4/2019
CCB623,regulatory-product-approval-granted,100,81,11/4/2019
CD06A2,business-combination,100,54,11/4/2019
CD06A2,business-combination,100,54,11/4/2019
CDAA0E,product-release,100,64,11/4/2019
CDE51C,partnership,100,61,11/4/2019
CF3FF9,patient-enrollment-complete,100,64,11/4/2019
CFD4B6,dividend,100,50,11/4/2019
CFF57D,market-entry,100,57,11/4/2019
D1C26F,executive-appointment,100,54,11/4/2019
D25249,earnings,100,50,11/4/2019
D518D8,revenues,100,50,11/4/2019
D518D8,revenues,100,50,11/4/2019
D518D8,revenues,100,50,11/4/2019
D518D8,revenues,100,50,11/4/2019
D518D8,revenues,100,50,11/4/2019
D518D8,revenues,100,50,11/4/2019
D60BB2,earnings,100,50,11/4/2019
D650A7,executive-appointment,100,54,11/4/2019
D70365,earnings,100,50,11/4/2019
D854DD,conference-call,100,50,11/4/2019
D8DA3D,legal-issues-defendant,100,22,11/4/2019
D8DA3D,legal-issues-defendant,100,22,11/4/2019
D8DA3D,legal-issues-defendant,100,22,11/4/2019
D90F43,earnings,100,50,11/4/2019
D90F43,earnings,100,50,11/4/2019
D90F43,earnings,100,50,11/4/2019
D90F43,earnings,100,50,11/4/2019
D90F43,earnings,100,50,11/4/2019
D90F43,earnings,100,50,11/4/2019
D90F43,earnings,100,50,11/4/2019
D9E036,earnings-up,100,68,11/4/2019
D9E036,earnings,100,50,11/4/2019
DB5CA5,dividend,100,50,11/4/2019
DBFB51,earnings,100,50,11/4/2019
DDB002,executive-appointment,100,54,11/4/2019
DFADDB,earnings,100,50,11/4/2019
E0647D,earnings,100,50,11/4/2019
E0647D,earnings,100,50,11/4/2019
E0647D,earnings,100,50,11/4/2019
E0647D,earnings,100,50,11/4/2019
E0647D,earnings,100,50,11/4/2019
E074A0,earnings,100,50,11/4/2019
E30B34,award,100,58,11/4/2019
E41190,executive-appointment,100,54,11/4/2019
E610CD,earnings,100,50,11/4/2019
E610CD,earnings,100,50,11/4/2019
E610CD,earnings,100,50,11/4/2019
E67C2C,earnings,100,50,11/4/2019
E6A53A,earnings,100,50,11/4/2019
E6A53A,earnings,100,50,11/4/2019
E71AE6,conference-call,100,50,11/4/2019
E7BF32,earnings,100,50,11/4/2019
E7BF32,earnings,100,50,11/4/2019
E9C7C0,product-release,100,64,11/4/2019
EA62FC,earnings,100,50,11/4/2019
EB7D6C,merger-completed,100,66,11/4/2019
ED4560,index-listing,100,76,11/4/2019
ED79D9,conference-call,100,50,11/4/2019
EE967B,executive-appointment,100,54,11/4/2019
F05B1B,business-contract,100,69,11/4/2019
F11638,partnership,100,61,11/4/2019
F1EB39,conference-participant,100,50,11/4/2019
F30508,conference-participant,100,50,11/4/2019
F32F88,dividend,100,50,11/4/2019
F44EA2,earnings,100,50,11/4/2019
F47871,earnings,100,50,11/4/2019
F4CDA3,unit-acquisition-acquirer,100,49,11/4/2019
F4CDA3,unit-acquisition-acquirer,100,49,11/4/2019
F4F46F,product-release,100,64,11/4/2019
F6581D,unit-acquisition-completed-acquirer,100,49,11/4/2019
F6581D,private-placement,100,56,11/4/2019
F6A987,earnings,100,50,11/4/2019
F6E1B5,earnings,100,50,11/4/2019
F73DD1,earnings,100,50,11/4/2019
F748C7,partnership,100,61,11/4/2019
F769E9,conference-call,100,50,11/4/2019
FA840E,campaign-ad-release,100,59,11/4/2019
FC4550,dividend,100,50,11/4/2019
FD0CA4,conference-participant,100,50,11/4/2019
FD6926,conference-participant,100,50,11/4/2019
FDD3FC,earnings,100,50,11/4/2019
FEC475,earnings,100,50,11/4/2019
0157B1,product-release,100,64,11/5/2019
0157B1,product-release,100,64,11/5/2019
018C11,facility-open,100,65,11/5/2019
0325B7,earnings,100,50,11/5/2019
03542C,earnings,100,50,11/5/2019
03FB17,earnings,100,50,11/5/2019
04996E,conference-participant,100,50,11/5/2019
054E7E,earnings,100,50,11/5/2019
06C826,conference-call,100,50,11/5/2019
070B45,acquisition-completed-acquirer,100,49,11/5/2019
070B45,acquisition-completed-acquirer,100,49,11/5/2019
71860,business-contract,100,69,11/5/2019
07EC43,conference-participant,100,50,11/5/2019
84625,earnings,100,50,11/5/2019
84625,earnings,100,50,11/5/2019
09062E,earnings,100,50,11/5/2019
095A04,partnership,100,61,11/5/2019
095A04,earnings,100,50,11/5/2019
09DE1F,partnership,100,61,11/5/2019
0AD2E3,earnings-up,100,68,11/5/2019
0AD2E3,earnings-up,100,68,11/5/2019
0BF198,conference-participant,100,50,11/5/2019
0C2A0D,note-sale,100,52,11/5/2019
0C2A0D,note-sale,100,52,11/5/2019
0EF1AF,conference-participant,100,50,11/5/2019
0FABBD,earnings-guidance-up,100,83,11/5/2019
0FABBD,earnings,100,50,11/5/2019
0FABBD,earnings,100,50,11/5/2019
0FABBD,earnings,100,50,11/5/2019
0FABBD,earnings,100,50,11/5/2019
1080C0,earnings,100,50,11/5/2019
11074E,conference-participant,100,50,11/5/2019
1272B3,earnings,100,50,11/5/2019
14833D,earnings,100,50,11/5/2019
14BA06,earnings,100,50,11/5/2019
152E1D,operating-earnings,100,50,11/5/2019
152E1D,operating-earnings,100,50,11/5/2019
152E1D,operating-earnings,100,50,11/5/2019
152E1D,operating-earnings,100,50,11/5/2019
152E1D,operating-earnings,100,50,11/5/2019
152E1D,operating-earnings,100,50,11/5/2019
157D9F,earnings,100,50,11/5/2019
157D9F,earnings,100,50,11/5/2019
157D9F,earnings,100,50,11/5/2019
157D9F,earnings,100,50,11/5/2019
157D9F,earnings,100,50,11/5/2019
16FC89,earnings,100,50,11/5/2019
17EDA5,partnership,100,61,11/5/2019
184866,conference-participant,100,50,11/5/2019
196D18,clinical-trials,100,56,11/5/2019
1A5D5D,legal-issues-defendant,100,22,11/5/2019
1AB023,earnings,100,50,11/5/2019
1AB023,earnings,100,50,11/5/2019
1AB023,earnings,100,50,11/5/2019
1CB9D3,earnings,100,50,11/5/2019
1CDD1C,earnings,100,50,11/5/2019
1E04A5,trading-halt,100,43,11/5/2019
1E04A5,earnings,100,50,11/5/2019
1E1125,conference-organizer,100,57,11/5/2019
1E1125,conference-organizer,100,57,11/5/2019
1E1125,conference-organizer,100,57,11/5/2019
1E1125,conference-organizer,100,57,11/5/2019
1E1125,conference-organizer,100,57,11/5/2019
1E1125,conference-organizer,100,57,11/5/2019
1E4FB9,earnings,100,50,11/5/2019
2082EA,clinical-trials-positive,100,87,11/5/2019
21245F,revenue-up,100,68,11/5/2019
21245F,revenue-up,100,68,11/5/2019
21245F,revenue-up,100,68,11/5/2019
21F9CA,revenues,100,50,11/5/2019
228D42,partnership,100,61,11/5/2019
228D42,partnership,100,61,11/5/2019
228D42,partnership,100,61,11/5/2019
228D42,product-release,100,64,11/5/2019
238302,earnings,100,50,11/5/2019
24A89A,legal-issues-defendant,100,22,11/5/2019
24FA23,earnings,100,50,11/5/2019
251988,settlement,100,56,11/5/2019
2720AB,acquisition-completed-acquirer,100,49,11/5/2019
28B730,earnings,100,50,11/5/2019
2920D5,conference-participant,100,50,11/5/2019
297DA8,earnings,100,50,11/5/2019
2.90E+62,conference-participant,100,50,11/5/2019
2AA6A8,conference-call,100,50,11/5/2019
2ABF77,conference-call,100,50,11/5/2019
2BAE5F,earnings,100,50,11/5/2019
2BAE5F,earnings,100,50,11/5/2019
2BAE5F,earnings,100,50,11/5/2019
2C3348,earnings,100,50,11/5/2019
2CC71C,earnings,100,50,11/5/2019
2DC88B,conference-participant,100,50,11/5/2019
2E89AE,product-release,100,64,11/5/2019
2EBA55,earnings,100,50,11/5/2019
2F6782,earnings,100,50,11/5/2019
306623,earnings,100,50,11/5/2019
31F25C,legal-issues-defendant,100,22,11/5/2019
32F943,conference-participant,100,50,11/5/2019
337024,earnings,100,50,11/5/2019
337024,earnings,100,50,11/5/2019
337024,earnings,100,50,11/5/2019
34E9F9,earnings,100,50,11/5/2019
34E9F9,earnings,100,50,11/5/2019
34E9F9,earnings,100,50,11/5/2019
34E9F9,earnings,100,50,11/5/2019
34E9F9,earnings,100,50,11/5/2019
367434,clinical-trials-start,100,64,11/5/2019
367E1C,conference-participant,100,50,11/5/2019
36A1CB,earnings,100,50,11/5/2019
36A1CB,earnings,100,50,11/5/2019
37B120,conference-participant,100,50,11/5/2019
3A1C46,earnings,100,50,11/5/2019
3B9886,partnership,100,61,11/5/2019
3C6CCC,earnings,100,50,11/5/2019
3C6CCC,earnings,100,50,11/5/2019
3C6CCC,earnings,100,50,11/5/2019
3C6CCC,earnings,100,50,11/5/2019
3C6CCC,earnings,100,50,11/5/2019
3C6CCC,executive-appointment,100,54,11/5/2019
3C75D6,earnings-up,100,68,11/5/2019
3C75D6,earnings,100,50,11/5/2019
3C75D6,earnings,100,50,11/5/2019
3D7971,unit-acquisition-acquirer,100,49,11/5/2019
3ED92D,note-sale,100,52,11/5/2019
3F1C69,earnings,100,50,11/5/2019
3F4668,revenue-up,100,57,11/5/2019
3F4668,revenue-up,100,69,11/5/2019
3F4668,revenue-up,100,69,11/5/2019
3F4668,revenue-up,100,69,11/5/2019
3F4668,revenue-up,100,69,11/5/2019
3F96D5,earnings,100,50,11/5/2019
4.03E+05,earnings,100,50,11/5/2019
4.03E+05,executive-appointment,100,54,11/5/2019
4.03E+05,dividend,100,50,11/5/2019
40B903,earnings,100,50,11/5/2019
416C55,award,100,58,11/5/2019
417BF9,fundraising,100,64,11/5/2019
41EC04,legal-issues-defendant,100,22,11/5/2019
41EC04,legal-issues-defendant,100,22,11/5/2019
427F32,earnings,100,50,11/5/2019
42DC93,conference-participant,100,50,11/5/2019
435ACE,earnings,100,50,11/5/2019
43A060,earnings,100,50,11/5/2019
43A060,earnings,100,50,11/5/2019
43A060,earnings,100,50,11/5/2019
43A060,earnings,100,50,11/5/2019
43A74A,executive-appointment,100,54,11/5/2019
442769,conference-participant,100,50,11/5/2019
44740A,earnings,100,50,11/5/2019
44A4FC,earnings,100,50,11/5/2019
44ED36,earnings,100,50,11/5/2019
467F2C,conference-participant,100,50,11/5/2019
4885C8,business-contract,100,69,11/5/2019
4.91E+58,revenue-up,100,69,11/5/2019
4.91E+58,revenue-up,100,69,11/5/2019
4.91E+58,revenue-up,100,69,11/5/2019
4.91E+58,revenue-up,100,69,11/5/2019
4.91E+58,revenue-up,100,69,11/5/2019
4.91E+58,revenue-up,100,69,11/5/2019
4.91E+58,revenue-up,100,69,11/5/2019
494EB9,dividend,100,50,11/5/2019
4A2457,earnings,100,50,11/5/2019
4A7C1F,revenue-up,100,69,11/5/2019
4A7C1F,earnings,100,50,11/5/2019
4AC91D,earnings,100,50,11/5/2019
4AE584,executive-appointment,100,54,11/5/2019
4BDCA7,earnings,100,50,11/5/2019
4BEB48,earnings,100,50,11/5/2019
4BEB48,earnings,100,50,11/5/2019
4BEB48,earnings,100,50,11/5/2019
4BEB48,earnings,100,50,11/5/2019
4C3FE9,clinical-trials,100,56,11/5/2019
4C6C63,partnership,100,61,11/5/2019
4C6C63,executive-appointment,100,54,11/5/2019
4DD09F,earnings-up,100,68,11/5/2019
4E3D15,operating-earnings,100,50,11/5/2019
4F783B,earnings,100,50,11/5/2019
4F783B,earnings,100,50,11/5/2019
4F783B,earnings,100,50,11/5/2019
4F783B,earnings,100,50,11/5/2019
4F783B,earnings,100,50,11/5/2019
51888A,buybacks,100,74,11/5/2019
5403F8,earnings,100,50,11/5/2019
545272,earnings,100,50,11/5/2019
5487B1,earnings,100,50,11/5/2019
5487B1,earnings,100,50,11/5/2019
5487B1,earnings,100,50,11/5/2019
5487B1,earnings,100,50,11/5/2019
5487B1,earnings,100,50,11/5/2019
550D01,earnings,100,50,11/5/2019
55C9B5,conference-participant,100,50,11/5/2019
55CD6F,operating-earnings,100,50,11/5/2019
56277A,earnings,100,50,11/5/2019
56FB7C,earnings,100,50,11/5/2019
5876DC,earnings,100,50,11/5/2019
587D25,acquisition-completed-acquirer,100,49,11/5/2019
589803,earnings,100,50,11/5/2019
58C2D4,earnings,100,50,11/5/2019
58CA9A,conference-organizer,100,57,11/5/2019
59A832,earnings,100,50,11/5/2019
5A9A82,earnings,100,50,11/5/2019
5B15E1,earnings,100,50,11/5/2019
5D41E4,earnings,100,50,11/5/2019
5D63F1,earnings,100,50,11/5/2019
5D63F1,executive-appointment,100,54,11/5/2019
5EF130,earnings,100,50,11/5/2019
5EF130,earnings,100,50,11/5/2019
5FE4B6,conference-participant,100,50,11/5/2019
60DD84,fundraising,100,64,11/5/2019
60EA12,dividend,100,50,11/5/2019
60EA12,earnings,100,50,11/5/2019
619882,conference-organizer,100,57,11/5/2019
619882,conference-organizer,100,57,11/5/2019
619882,conference-organizer,100,57,11/5/2019
619882,conference-organizer,100,57,11/5/2019
622DBE,earnings,100,50,11/5/2019
622DBE,legal-issues-defendant,100,22,11/5/2019
62EFEE,earnings,100,50,11/5/2019
62EFEE,dividend,100,50,11/5/2019
62EFEE,buybacks,100,74,11/5/2019
633043,earnings,100,50,11/5/2019
64E615,earnings,100,50,11/5/2019
64E615,earnings,100,50,11/5/2019
64E615,earnings,100,50,11/5/2019
64E615,earnings,100,50,11/5/2019
6.52E+64,legal-issues-defendant,100,22,11/5/2019
6559D8,earnings,100,50,11/5/2019
66CB62,operating-earnings,100,50,11/5/2019
693ECD,earnings,100,50,11/5/2019
6B67BD,earnings,100,50,11/5/2019
6BDA0C,dividend,100,50,11/5/2019
6BF593,earnings,100,50,11/5/2019
6BF593,earnings,100,50,11/5/2019
6D156D,earnings,100,50,11/5/2019
713810,business-contract,100,69,11/5/2019
73A71F,legal-issues-defendant,100,22,11/5/2019
73F70F,conference-call,100,50,11/5/2019
741937,executive-appointment,100,54,11/5/2019
7.45E+28,earnings,100,50,11/5/2019
747219,legal-issues-defendant,100,22,11/5/2019
76959C,earnings,100,50,11/5/2019
76BD96,note-sale,100,52,11/5/2019
76D79A,earnings,100,50,11/5/2019
76DD0C,earnings,100,50,11/5/2019
7734AC,dividend-up,100,81,11/5/2019
7823A3,legal-issues-defendant,100,22,11/5/2019
790D0D,dividend,100,50,11/5/2019
7ACD98,earnings,100,50,11/5/2019
7ACFD4,legal-issues-defendant,100,22,11/5/2019
7ADE57,partnership,100,61,11/5/2019
7B0BA6,earnings,100,50,11/5/2019
7B0BA6,earnings,100,50,11/5/2019
7B0BA6,earnings,100,50,11/5/2019
7B0BA6,earnings,100,50,11/5/2019
7B0BA6,earnings,100,50,11/5/2019
7B0BA6,earnings,100,50,11/5/2019
7B6EB1,earnings,100,50,11/5/2019
7BFF81,business-contract,100,69,11/5/2019
7BFF81,unit-acquisition-acquirer,100,49,11/5/2019
7C4F43,earnings,100,50,11/5/2019
80D744,dividend,100,50,11/5/2019
81A88D,unit-acquisition-acquirer,100,49,11/5/2019
82C202,earnings,100,50,11/5/2019
82F088,earnings,100,50,11/5/2019
82F088,partnership,100,61,11/5/2019
8303CD,executive-appointment,100,54,11/5/2019
83598E,earnings,100,50,11/5/2019
83A065,earnings,100,50,11/5/2019
83B1C8,earnings,100,50,11/5/2019
845533,earnings,100,50,11/5/2019
85DE00,conference-participant,100,50,11/5/2019
862941,earnings,100,50,11/5/2019
8665BA,investment-investor,100,55,11/5/2019
8665BA,investment-investor,100,55,11/5/2019
873DB9,earnings,100,50,11/5/2019
873DB9,earnings,100,50,11/5/2019
873DB9,earnings,100,50,11/5/2019
873DB9,earnings,100,50,11/5/2019
873DB9,earnings,100,50,11/5/2019
873DB9,earnings,100,50,11/5/2019
873DB9,earnings,100,50,11/5/2019
877734,earnings,100,50,11/5/2019
877734,earnings,100,50,11/5/2019
877734,earnings,100,50,11/5/2019
877734,earnings,100,50,11/5/2019
885758,legal-issues-defendant,100,22,11/5/2019
895D56,conference-participant,100,50,11/5/2019
89FBB1,earnings,100,50,11/5/2019
89FBB1,earnings,100,50,11/5/2019
89FBB1,earnings,100,50,11/5/2019
8AB37F,earnings,100,50,11/5/2019
8AB37F,earnings,100,50,11/5/2019
8AB37F,earnings,100,50,11/5/2019
8AB85C,earnings,100,50,11/5/2019
8BAA15,executive-appointment,100,54,11/5/2019
8BFE9A,conference-participant,100,50,11/5/2019
8CF6DD,dividend,100,50,11/5/2019
8CF6DD,executive-appointment,100,54,11/5/2019
8FCA78,dividend,100,50,11/5/2019
902255,earnings,100,50,11/5/2019
902255,earnings,100,50,11/5/2019
902255,earnings,100,50,11/5/2019
9087B9,earnings,100,50,11/5/2019
9087B9,dividend-up,100,81,11/5/2019
911AB8,earnings,100,50,11/5/2019
9196A2,conference-organizer,100,57,11/5/2019
9196A2,conference-organizer,100,57,11/5/2019
92D757,earnings,100,50,11/5/2019
9.31E+77,earnings,100,50,11/5/2019
934029,business-contract,100,69,11/5/2019
938D89,earnings,100,50,11/5/2019
93965C,earnings,100,50,11/5/2019
93965C,earnings,100,50,11/5/2019
944B2E,earnings,100,50,11/5/2019
944B2E,earnings,100,50,11/5/2019
944B2E,earnings,100,50,11/5/2019
944B2E,earnings,100,50,11/5/2019
944B2E,earnings,100,50,11/5/2019
944B2E,earnings,100,50,11/5/2019
9507FF,conference-participant,100,50,11/5/2019
9546A5,conference-call,100,50,11/5/2019
9.65E+07,conference-call,100,50,11/5/2019
968966,earnings,100,50,11/5/2019
96A6CD,earnings,100,50,11/5/2019
97AF94,earnings,100,50,11/5/2019
990AD0,conference-organizer,100,57,11/5/2019
9.97E+09,acquisition-acquirer,100,49,11/5/2019
9.97E+09,public-offering,100,43,11/5/2019
9.97E+09,business-contract,100,69,11/5/2019
9.97E+09,public-offering,100,43,11/5/2019
9B730A,earnings,100,50,11/5/2019
9C3D3C,earnings,100,50,11/5/2019
9C5174,revenues,100,50,11/5/2019
9C5174,revenues,100,50,11/5/2019
9CA432,earnings,100,50,11/5/2019
9D4EC7,dividend,100,50,11/5/2019
9D4EC7,executive-appointment,100,54,11/5/2019
9D5D35,conference-participant,100,50,11/5/2019
9E0811,earnings-up,100,68,11/5/2019
9E98F2,legal-issues-defendant,100,22,11/5/2019
A05C43,earnings,100,50,11/5/2019
A05C43,earnings,100,50,11/5/2019
A05C43,earnings,100,50,11/5/2019
A05C43,earnings,100,50,11/5/2019
A072C4,earnings,100,50,11/5/2019
A1EAC8,dividend-up,100,81,11/5/2019
A26EF7,assets,100,50,11/5/2019
A26EF7,assets,100,50,11/5/2019
A26EF7,assets,100,50,11/5/2019
A29DBD,conference-call,100,50,11/5/2019
A38F30,earnings,100,50,11/5/2019
A4B899,earnings,100,50,11/5/2019
A4CD53,earnings,100,50,11/5/2019
A4CD53,earnings,100,50,11/5/2019
A4CD53,earnings,100,50,11/5/2019
A5195E,partnership,100,61,11/5/2019
A5DD24,acquisition-completed-acquirer,100,49,11/5/2019
A60354,earnings,100,50,11/5/2019
A60354,earnings,100,50,11/5/2019
A60354,earnings,100,50,11/5/2019
A62FD6,public-offering,100,43,11/5/2019
A62FD6,public-offering,100,43,11/5/2019
A631A3,partnership,100,61,11/5/2019
A631A3,partnership,100,61,11/5/2019
A631A3,partnership,100,61,11/5/2019
A631A3,product-release,100,64,11/5/2019
A631A3,product-release,100,64,11/5/2019
A631A3,partnership,100,61,11/5/2019
A631A3,partnership,100,61,11/5/2019
A6D095,clinical-trials-positive,100,87,11/5/2019
A6FC89,conference-call,100,50,11/5/2019
A7102F,earnings-up,100,68,11/5/2019
A7102F,earnings,100,50,11/5/2019
A7102F,earnings,100,50,11/5/2019
A7102F,earnings,100,50,11/5/2019
A7102F,earnings,100,50,11/5/2019
A7102F,earnings,100,50,11/5/2019
A74F6F,revenues,100,50,11/5/2019
A74F6F,revenues,100,50,11/5/2019
A7F0A5,earnings,100,50,11/5/2019
A868C9,revenue-up,100,69,11/5/2019
A868C9,revenues,100,50,11/5/2019
A868C9,revenues,100,50,11/5/2019
A868C9,revenues,100,50,11/5/2019
A94718,earnings,100,50,11/5/2019
AAEE21,note-sale,100,52,11/5/2019
AC3584,partnership,100,61,11/5/2019
AC775C,earnings,100,50,11/5/2019
AC775C,earnings,100,50,11/5/2019
AC775C,earnings,100,50,11/5/2019
ACC7D3,earnings,100,50,11/5/2019
ACDF88,conference-call,100,50,11/5/2019
AE7D16,business-contract,100,69,11/5/2019
AFDF2E,legal-issues-defendant,100,22,11/5/2019
AFDF2E,legal-issues-defendant,100,22,11/5/2019
AFDF2E,legal-issues-defendant,100,22,11/5/2019
B0D41A,earnings,100,50,11/5/2019
B1DF3C,earnings,100,50,11/5/2019
B290A2,earnings,100,50,11/5/2019
B2D799,earnings,100,50,11/5/2019
B3A166,conference-call,100,50,11/5/2019
B54A74,executive-appointment,100,54,11/5/2019
B54A74,earnings,100,50,11/5/2019
B5BA39,conference-participant,100,50,11/5/2019
B7BBFF,earnings,100,50,11/5/2019
B83D67,conference-participant,100,50,11/5/2019
B8A51F,earnings,100,50,11/5/2019
B9764A,earnings,100,50,11/5/2019
B98EFA,earnings,100,50,11/5/2019
B9BDE8,earnings,100,50,11/5/2019
BB0587,earnings,100,50,11/5/2019
BB0787,earnings,100,50,11/5/2019
BCC13E,revenues,100,50,11/5/2019
BCC13E,revenues,100,50,11/5/2019
BCE9DA,earnings,100,50,11/5/2019
BCE9DA,earnings,100,50,11/5/2019
BDA775,earnings,100,50,11/5/2019
BDCC11,legal-issues-defendant,100,22,11/5/2019
BDEC1E,earnings,100,50,11/5/2019
BDF2BD,conference-participant,100,50,11/5/2019
BF79F5,product-release,100,64,11/5/2019
BFEA04,earnings,100,50,11/5/2019
BFEA04,earnings,100,50,11/5/2019
BFEA04,earnings,100,50,11/5/2019
BFEA04,earnings,100,50,11/5/2019
C07E05,earnings,100,50,11/5/2019
C2609A,earnings,100,50,11/5/2019
C27E19,dividend-up,100,81,11/5/2019
C2DD02,conference-call,100,50,11/5/2019
C3BCD5,dividend,100,50,11/5/2019
C3F99F,earnings,100,50,11/5/2019
C4452A,facility-relocation,100,50,11/5/2019
C4706C,conference-call,100,50,11/5/2019
C4A432,conference-call,100,50,11/5/2019
C4A912,earnings,100,50,11/5/2019
C4A912,earnings,100,50,11/5/2019
C4A912,earnings,100,50,11/5/2019
C4A912,earnings,100,50,11/5/2019
C564E4,earnings,100,50,11/5/2019
C584BE,earnings,100,50,11/5/2019
C58D71,earnings,100,50,11/5/2019
C58D71,earnings,100,50,11/5/2019
C5D2AE,conference-participant,100,50,11/5/2019
CB6A9C,earnings,100,50,11/5/2019
CB6A9C,earnings,100,50,11/5/2019
CB6A9C,earnings,100,50,11/5/2019
CB6A9C,earnings,100,50,11/5/2019
CB6A9C,earnings,100,50,11/5/2019
CB6A9C,earnings,100,50,11/5/2019
CBFFDD,legal-issues-defendant,100,22,11/5/2019
CBFFDD,legal-issues-defendant,100,22,11/5/2019
CC176E,earnings,100,50,11/5/2019
CD2A4D,earnings,100,50,11/5/2019
CDAB24,earnings,100,50,11/5/2019
CDC217,clinical-trials-complete,100,56,11/5/2019
CDFCC9,dividend,100,50,11/5/2019
CDFCC9,earnings,100,50,11/5/2019
CDFCC9,earnings,100,50,11/5/2019
CDFCC9,earnings,100,50,11/5/2019
CDFCC9,earnings,100,50,11/5/2019
CDFCC9,earnings,100,50,11/5/2019
CE5C6E,conference-participant,100,50,11/5/2019
CE96E7,partnership,100,61,11/5/2019
CED4D0,earnings,100,50,11/5/2019
CF3FF9,earnings,100,50,11/5/2019
CFF97C,dividend,100,50,11/5/2019
D1588D,conference-participant,100,50,11/5/2019
D29B44,conference-participant,100,50,11/5/2019
D29F43,dividend,100,50,11/5/2019
D33270,executive-appointment,100,54,11/5/2019
D33D8C,executive-resignation,100,44,11/5/2019
D3CEDF,earnings,100,50,11/5/2019
D3CEDF,earnings,100,50,11/5/2019
D3CEDF,earnings,100,50,11/5/2019
D3CEDF,earnings,100,50,11/5/2019
D3CEDF,earnings,100,50,11/5/2019
D3CEDF,earnings,100,50,11/5/2019
D3DE34,earnings,100,50,11/5/2019
D3DE34,earnings,100,50,11/5/2019
D3DE34,earnings,100,50,11/5/2019
D3DE34,earnings,100,50,11/5/2019
D3DE34,earnings,100,50,11/5/2019
D3DE34,earnings,100,50,11/5/2019
D3FD6D,revenues,100,50,11/5/2019
D3FD6D,revenues,100,50,11/5/2019
D3FD6D,revenues,100,50,11/5/2019
D518D8,dividend-up,100,64,11/5/2019
D64EDF,earnings-up,100,68,11/5/2019
D64EDF,earnings,100,50,11/5/2019
D64EDF,earnings,100,50,11/5/2019
D64EDF,earnings,100,50,11/5/2019
D64EDF,earnings,100,50,11/5/2019
D77F7E,earnings,100,50,11/5/2019
D8DA3D,legal-issues-defendant,100,22,11/5/2019
D8ECA1,earnings,100,50,11/5/2019
D8ECA1,legal-issues-defendant,100,22,11/5/2019
D90F43,partnership,100,61,11/5/2019
DA0CB8,earnings,100,50,11/5/2019
DB88A1,product-release,100,64,11/5/2019
DC1405,earnings,100,50,11/5/2019
DD682D,earnings,100,50,11/5/2019
DDEA6A,operating-earnings,100,50,11/5/2019
DF204B,revenues,100,50,11/5/2019
E074A0,conference-participant,100,50,11/5/2019
E0E4B7,ipo-completed,100,76,11/5/2019
E15736,earnings,100,50,11/5/2019
E15736,earnings,100,50,11/5/2019
E28D9C,joint-venture,100,62,11/5/2019
E4CE73,conference-call,100,50,11/5/2019
E5752F,earnings,100,50,11/5/2019
E68733,earnings,100,50,11/5/2019
E68733,earnings,100,50,11/5/2019
E74FED,earnings,100,50,11/5/2019
E802CE,executive-appointment,100,54,11/5/2019
E82A2D,earnings,100,50,11/5/2019
E866D2,executive-appointment,100,54,11/5/2019
E9C7C0,partnership,100,61,11/5/2019
EAA0A7,earnings,100,50,11/5/2019
EAA0A7,earnings,100,50,11/5/2019
EAA0A7,earnings,100,50,11/5/2019
EAA0A7,earnings,100,50,11/5/2019
EC1AF3,earnings,100,50,11/5/2019
ED79D9,conference-call,100,50,11/5/2019
EE04F0,executive-appointment,100,54,11/5/2019
EEBCEF,earnings,100,50,11/5/2019
EFD406,earnings,100,50,11/5/2019
EFD406,earnings,100,50,11/5/2019
EFD406,earnings,100,50,11/5/2019
EFD406,earnings,100,50,11/5/2019
EFD406,earnings,100,50,11/5/2019
EFD406,earnings,100,50,11/5/2019
EFD406,earnings,100,50,11/5/2019
F02170,earnings,100,50,11/5/2019
F3FCC3,dividend,100,50,11/5/2019
F5C8AB,earnings-per-share-positive,100,69,11/5/2019
F5C8AB,earnings-per-share-positive,100,69,11/5/2019
F5C8AB,earnings-per-share,100,50,11/5/2019
F5C8AB,dividend,100,50,11/5/2019
F6FF0D,earnings,100,50,11/5/2019
F6FF0D,earnings,100,50,11/5/2019
F6FF0D,earnings,100,50,11/5/2019
F8084B,earnings-positive,100,69,11/5/2019
F90EE5,earnings,100,50,11/5/2019
FAB97A,earnings,100,50,11/5/2019
FB7724,earnings,100,50,11/5/2019
FC01C0,conference-participant,100,50,11/5/2019
FC1A6E,partnership,100,61,11/5/2019
FC1A6E,revenues,100,50,11/5/2019
FC1F9D,executive-appointment,100,54,11/5/2019
FD554E,earnings,100,50,11/5/2019
FD554E,dividend,100,50,11/5/2019
FDF28E,earnings,100,50,11/5/2019
FFCD0E,earnings,100,50,11/5/2019
00067A,earnings,100,50,11/6/2019
00FC70,conference-call,100,50,11/6/2019
0157B1,product-release,100,64,11/6/2019
01B8D6,earnings,100,50,11/6/2019
01D03F,partnership,100,61,11/6/2019
20751,earnings,100,50,11/6/2019
053EFF,dividend,100,50,11/6/2019
0560D8,conference-participant,100,50,11/6/2019
05D148,earnings,100,50,11/6/2019
061A3B,earnings,100,50,11/6/2019
061A3B,earnings,100,50,11/6/2019
061A3B,earnings,100,50,11/6/2019
06C826,earnings,100,50,11/6/2019
06C826,earnings,100,50,11/6/2019
078D52,revenues,100,50,11/6/2019
078D52,revenues,100,50,11/6/2019
84625,dividend,100,50,11/6/2019
95294,executive-appointment,100,54,11/6/2019
98977,earnings,100,50,11/6/2019
0A0D9E,earnings,100,50,11/6/2019
0A0D9E,earnings,100,50,11/6/2019
0A0D9E,earnings,100,50,11/6/2019
0A9D0A,earnings,100,50,11/6/2019
0BC29E,partnership,100,61,11/6/2019
0C355F,facility-open,100,65,11/6/2019
0C6293,earnings,100,50,11/6/2019
0C6293,earnings,100,50,11/6/2019
0C6293,earnings,100,50,11/6/2019
0CADBC,earnings,100,50,11/6/2019
0CCCB7,dividend,100,50,11/6/2019
0CE204,earnings,100,50,11/6/2019
0CE7F6,earnings,100,50,11/6/2019
0DE3D5,earnings,100,50,11/6/2019
0E439E,dividend,100,50,11/6/2019
0FE3A6,earnings,100,50,11/6/2019
1279ED,earnings,100,50,11/6/2019
12A3A3,partnership,100,61,11/6/2019
136B26,conference-participant,100,50,11/6/2019
13D576,earnings,100,50,11/6/2019
14BA06,partnership,100,61,11/6/2019
152AB9,earnings,100,50,11/6/2019
152AB9,earnings,100,50,11/6/2019
154272,earnings,100,50,11/6/2019
157CC1,earnings,100,50,11/6/2019
165B86,earnings,100,50,11/6/2019
165B86,earnings,100,50,11/6/2019
165B86,earnings,100,50,11/6/2019
165B86,earnings,100,50,11/6/2019
168A5D,partnership,100,61,11/6/2019
1.79E+10,business-contract,100,69,11/6/2019
1834C0,earnings,100,50,11/6/2019
184866,public-offering,100,43,11/6/2019
190B91,earnings,100,50,11/6/2019
190B91,earnings,100,50,11/6/2019
190B91,earnings,100,50,11/6/2019
190B91,earnings,100,50,11/6/2019
190B91,earnings,100,50,11/6/2019
190B91,earnings,100,50,11/6/2019
190B91,earnings,100,50,11/6/2019
197019,executive-appointment,100,54,11/6/2019
1AC649,earnings,100,50,11/6/2019
1C2593,conference-call,100,50,11/6/2019
1C599A,earnings,100,50,11/6/2019
1CD09C,earnings,100,50,11/6/2019
1DB6A6,dividend,100,50,11/6/2019
1E1125,conference-organizer,100,57,11/6/2019
1E1125,conference-organizer,100,57,11/6/2019
1E1125,conference-organizer,100,57,11/6/2019
1E1125,conference-organizer,100,57,11/6/2019
1EBF8D,partnership,100,61,11/6/2019
1EBF8D,partnership,100,61,11/6/2019
1F19C8,earnings,100,50,11/6/2019
1F464F,revenue-up,100,81,11/6/2019
1FAF22,conference-participant,100,50,11/6/2019
2003A5,earnings,100,50,11/6/2019
200D8B,earnings,100,50,11/6/2019
202E5A,earnings,100,50,11/6/2019
2082EA,earnings,100,50,11/6/2019
2158DF,earnings-up,100,68,11/6/2019
2158DF,earnings-up,100,68,11/6/2019
2158DF,earnings-up,100,68,11/6/2019
2158DF,earnings-up,100,68,11/6/2019
2158DF,earnings-up,100,68,11/6/2019
221445,buybacks,100,74,11/6/2019
221783,conference-participant,100,50,11/6/2019
2491BC,legal-issues-defendant,100,22,11/6/2019
24A89A,legal-issues-defendant,100,22,11/6/2019
24C48B,earnings,100,50,11/6/2019
2571FA,earnings,100,50,11/6/2019
2571FA,earnings,100,50,11/6/2019
2571FA,earnings,100,50,11/6/2019
2571FA,earnings,100,50,11/6/2019
263216,earnings,100,50,11/6/2019
263216,earnings,100,50,11/6/2019
263216,earnings,100,50,11/6/2019
263216,earnings,100,50,11/6/2019
263216,earnings,100,50,11/6/2019
263216,earnings,100,50,11/6/2019
26DC29,legal-issues-defendant,100,22,11/6/2019
27B191,earnings,100,50,11/6/2019
27B191,earnings,100,50,11/6/2019
27B191,dividend,100,50,11/6/2019
28F905,earnings,100,50,11/6/2019
28F905,earnings,100,50,11/6/2019
28F905,earnings,100,50,11/6/2019
28F905,earnings,100,50,11/6/2019
295F9F,earnings,100,50,11/6/2019
2A1009,earnings,100,50,11/6/2019
2A1009,earnings,100,50,11/6/2019
2A1009,earnings,100,50,11/6/2019
2A1009,earnings,100,50,11/6/2019
2A1009,earnings,100,50,11/6/2019
2B8179,clinical-trials-start,100,64,11/6/2019
2B8179,earnings,100,50,11/6/2019
2E89AE,earnings,100,50,11/6/2019
2E89AE,earnings,100,50,11/6/2019
2F7A7E,earnings,100,50,11/6/2019
2F960F,earnings,100,50,11/6/2019
315EB0,note-sale,100,52,11/6/2019
315EB0,note-sale,100,52,11/6/2019
31643A,earnings,100,50,11/6/2019
343996,earnings,100,50,11/6/2019
343996,earnings,100,50,11/6/2019
3461CF,credit-rating-downgrade-rater,20,50,11/6/2019
3461CF,conference-participant,100,50,11/6/2019
34A959,legal-issues-defendant,100,22,11/6/2019
34A959,revenues,100,50,11/6/2019
355B19,earnings,100,50,11/6/2019
35AE32,earnings,100,50,11/6/2019
35AE32,earnings,100,50,11/6/2019
35AE32,earnings,100,50,11/6/2019
35AE32,earnings,100,50,11/6/2019
3.50E+27,earnings,100,50,11/6/2019
3.73E+87,partnership,100,61,11/6/2019
3.73E+87,partnership,100,61,11/6/2019
3798B9,earnings,100,50,11/6/2019
37B120,earnings,100,50,11/6/2019
39692D,earnings,100,50,11/6/2019
3A113F,conference-participant,100,50,11/6/2019
3A3447,facility-open,100,65,11/6/2019
3A3447,earnings,100,50,11/6/2019
3B2311,earnings,100,50,11/6/2019
3DCECC,earnings,100,50,11/6/2019
414FFF,conference-call,100,50,11/6/2019
417BF9,conference-call,100,50,11/6/2019
41A93D,earnings,100,50,11/6/2019
41C36B,earnings,100,50,11/6/2019
41C528,earnings,100,50,11/6/2019
41C528,earnings,100,50,11/6/2019
41EC04,legal-issues-defendant,100,22,11/6/2019
41EC04,legal-issues-defendant,100,22,11/6/2019
41EC04,legal-issues-defendant,100,22,11/6/2019
41ED98,conference-call,100,50,11/6/2019
429BFB,earnings,100,50,11/6/2019
42AABD,earnings,100,50,11/6/2019
42AABD,antitrust-suit-defendant,100,21,11/6/2019
42AABD,legal-issues-defendant,100,22,11/6/2019
4398A2,earnings,100,50,11/6/2019
43F4A8,earnings,100,50,11/6/2019
448215,earnings,100,50,11/6/2019
451D61,public-offering,100,43,11/6/2019
45444E,earnings,100,50,11/6/2019
45ABCC,revenue-up,100,85,11/6/2019
45ABCC,revenue-up,100,85,11/6/2019
45ABCC,revenue-up,100,85,11/6/2019
4649D5,earnings,100,50,11/6/2019
4649D5,earnings,100,50,11/6/2019
468DD4,earnings,100,50,11/6/2019
48F795,earnings,100,50,11/6/2019
4.91E+58,loan-recipient,100,59,11/6/2019
49A344,business-contract,100,69,11/6/2019
4A6F00,partnership,100,61,11/6/2019
4A6F00,partnership,100,61,11/6/2019
4BDCA7,clinical-trials,100,56,11/6/2019
4BEB48,conference-participant,100,50,11/6/2019
4C350A,earnings,100,50,11/6/2019
4C350A,earnings,100,50,11/6/2019
4E6F5A,earnings,100,50,11/6/2019
4E7C1F,business-contract,100,69,11/6/2019
4EE14A,operating-earnings,100,50,11/6/2019
4EE14A,operating-earnings,100,50,11/6/2019
5065B1,earnings,100,50,11/6/2019
50702E,earnings,100,50,11/6/2019
507AE7,dividend,100,50,11/6/2019
50D1EC,earnings,100,50,11/6/2019
513A86,earnings,100,50,11/6/2019
514067,earnings,100,50,11/6/2019
51D876,earnings,100,50,11/6/2019
51D876,earnings,100,50,11/6/2019
51D876,earnings,100,50,11/6/2019
51D876,earnings,100,50,11/6/2019
51D876,earnings,100,50,11/6/2019
51D876,earnings,100,50,11/6/2019
51D876,earnings,100,50,11/6/2019
5.43E+08,legal-issues-defendant,100,22,11/6/2019
54A713,dividend,100,50,11/6/2019
553949,dividend,100,50,11/6/2019
56765E,earnings,100,50,11/6/2019
57B174,earnings,100,50,11/6/2019
57B174,earnings,100,50,11/6/2019
57B174,earnings,100,50,11/6/2019
57B174,earnings,100,50,11/6/2019
583A75,revenue-volume,100,50,11/6/2019
58EA22,conference-participant,100,50,11/6/2019
5968F9,earnings,100,50,11/6/2019
5A0FF1,earnings,100,50,11/6/2019
5A0FF1,earnings,100,50,11/6/2019
5BC2F4,dividend,100,50,11/6/2019
5BC2F4,partnership,100,61,11/6/2019
5C2A47,earnings,100,50,11/6/2019
5DD486,dividend,100,50,11/6/2019
5F60CE,earnings,100,50,11/6/2019
6166D1,executive-appointment,100,54,11/6/2019
619882,conference-organizer,100,57,11/6/2019
619882,conference-organizer,100,57,11/6/2019
619882,conference-organizer,100,57,11/6/2019
619882,conference-organizer,100,57,11/6/2019
619882,conference-organizer,100,57,11/6/2019
619882,conference-organizer,100,57,11/6/2019
622DBE,legal-issues-defendant,100,22,11/6/2019
649CBD,earnings,100,50,11/6/2019
649CBD,earnings,100,50,11/6/2019
649CBD,earnings,100,50,11/6/2019
6.52E+64,legal-issues-defendant,100,22,11/6/2019
657097,earnings,100,50,11/6/2019
665440,earnings-up,100,68,11/6/2019
665440,earnings,100,50,11/6/2019
665440,earnings,100,50,11/6/2019
665440,earnings,100,50,11/6/2019
665D7D,note-sale,100,52,11/6/2019
676FFD,earnings,100,50,11/6/2019
694749,earnings,100,50,11/6/2019
694749,earnings,100,50,11/6/2019
694749,earnings,100,50,11/6/2019
694749,earnings,100,50,11/6/2019
694749,executive-appointment,100,54,11/6/2019
698FF9,earnings,100,50,11/6/2019
698FF9,earnings,100,50,11/6/2019
69CE71,earnings,100,50,11/6/2019
69CE71,earnings,100,50,11/6/2019
69CE71,earnings,100,50,11/6/2019
69CE71,earnings,100,50,11/6/2019
69CE71,earnings,100,50,11/6/2019
69CE71,earnings,100,50,11/6/2019
69CE71,earnings,100,50,11/6/2019
69CE71,earnings,100,50,11/6/2019
6A961B,unit-acquisition-acquirer,100,49,11/6/2019
6C6D73,executive-appointment,100,54,11/6/2019
6D1ADF,earnings,100,50,11/6/2019
6D2BF6,earnings,100,50,11/6/2019
6.00E+19,earnings,100,50,11/6/2019
6F30F9,earnings,100,50,11/6/2019
6F3936,executive-appointment,100,54,11/6/2019
6F39FC,earnings,100,50,11/6/2019
6F3FA8,earnings,100,50,11/6/2019
6F3FA8,earnings,100,50,11/6/2019
6F3FA8,earnings,100,50,11/6/2019
6F3FA8,earnings,100,50,11/6/2019
6F3FA8,earnings,100,50,11/6/2019
6F92A9,antitrust-suit-plaintiff,100,44,11/6/2019
70CA28,conference-participant,100,50,11/6/2019
71E2EF,earnings,100,50,11/6/2019
7262F2,earnings,100,50,11/6/2019
731675,acquisition-acquirer,100,49,11/6/2019
732A9B,public-offering,100,43,11/6/2019
73A71F,legal-issues-defendant,100,22,11/6/2019
7410C3,earnings,100,50,11/6/2019
747219,legal-issues-defendant,100,22,11/6/2019
747219,dividend,100,50,11/6/2019
756045,earnings,100,50,11/6/2019
762A3E,conference-organizer,100,57,11/6/2019
76BD96,note-sale,100,52,11/6/2019
76BECC,earnings,100,50,11/6/2019
76BECC,earnings,100,50,11/6/2019
76BECC,earnings,100,50,11/6/2019
76BECC,earnings,100,50,11/6/2019
7710F3,legal-issues-defendant,100,22,11/6/2019
7710F3,legal-issues-defendant,100,22,11/6/2019
7823A3,legal-issues-defendant,100,22,11/6/2019
790C34,award,100,58,11/6/2019
791D59,conference-participant,100,50,11/6/2019
7A3633,earnings,100,50,11/6/2019
7ACD98,partnership,100,61,11/6/2019
7ACD98,partnership,100,61,11/6/2019
7ACD98,partnership,100,61,11/6/2019
7ADE57,partnership,100,61,11/6/2019
7ADE57,executive-appointment,100,54,11/6/2019
7ADE57,partnership,100,61,11/6/2019
7AF5B8,earnings,100,50,11/6/2019
7BFF81,partnership,100,61,11/6/2019
7BFF81,revenues,100,50,11/6/2019
7BFF81,revenues,100,50,11/6/2019
7BFF81,revenues,100,50,11/6/2019
7BFF81,buybacks,100,74,11/6/2019
7D35D8,legal-issues-defendant,100,22,11/6/2019
7DD8CC,earnings,100,50,11/6/2019
7FD8B9,earnings,100,50,11/6/2019
824CCA,earnings,100,50,11/6/2019
824CCA,earnings,100,50,11/6/2019
824CCA,earnings,100,50,11/6/2019
82B57E,earnings,100,50,11/6/2019
83E0AC,earnings,100,50,11/6/2019
86BAC7,dividend,100,50,11/6/2019
87486A,dividend,100,50,11/6/2019
877C0C,business-contract,100,69,11/6/2019
877C0C,earnings,100,50,11/6/2019
885758,legal-issues-defendant,100,22,11/6/2019
88611B,earnings,100,50,11/6/2019
893904,public-offering,100,43,11/6/2019
8BFE9A,partnership,100,61,11/6/2019
8D4486,product-release,100,64,11/6/2019
8DAAB9,dividend-up,100,55,11/6/2019
8E4F9A,operating-earnings,100,50,11/6/2019
8E9CD8,earnings-up,100,68,11/6/2019
8E9CD8,earnings,100,50,11/6/2019
8E9CD8,earnings,100,50,11/6/2019
8E9CD8,earnings,100,50,11/6/2019
8E9CD8,earnings,100,50,11/6/2019
902670,earnings,100,50,11/6/2019
902670,earnings,100,50,11/6/2019
902670,earnings,100,50,11/6/2019
902670,earnings,100,50,11/6/2019
911CA9,earnings,100,50,11/6/2019
911CA9,earnings,100,50,11/6/2019
92005C,earnings,100,50,11/6/2019
92B625,earnings,100,50,11/6/2019
92B73F,dividend,100,50,11/6/2019
92D230,conference-call,100,50,11/6/2019
931AE7,earnings,100,50,11/6/2019
93D207,executive-appointment,100,54,11/6/2019
9470CC,earnings,100,50,11/6/2019
950AB7,earnings,100,50,11/6/2019
958938,earnings,100,50,11/6/2019
95C392,earnings,100,50,11/6/2019
95DC1F,partnership,100,61,11/6/2019
966ACE,earnings,100,50,11/6/2019
97644E,acquisition-acquiree,100,76,11/6/2019
97644E,acquisition-acquiree,100,76,11/6/2019
97644E,asset-sale,100,62,11/6/2019
97FE80,legal-issues-defendant,100,22,11/6/2019
9.86E+03,partnership,100,61,11/6/2019
9.86E+03,partnership,100,61,11/6/2019
9.92E+94,conference-organizer,100,57,11/6/2019
994468,dividend,100,50,11/6/2019
9ABD30,earnings,100,50,11/6/2019
9C009A,earnings,100,50,11/6/2019
9C8BC3,partnership,100,61,11/6/2019
9C8BC3,earnings-positive,100,69,11/6/2019
9C8BC3,earnings-positive,100,69,11/6/2019
9C8BC3,earnings-positive,100,69,11/6/2019
9C8BC3,earnings-positive,100,69,11/6/2019
9C8BC3,earnings-positive,100,69,11/6/2019
9E575E,conference-participant,100,50,11/6/2019
9E91C6,earnings,100,50,11/6/2019
9EBAFA,earnings,100,50,11/6/2019
9F5CBB,earnings,100,50,11/6/2019
9FA83B,earnings,100,50,11/6/2019
9FD2D9,conference-participant,100,50,11/6/2019
9FF5F1,acquisition-acquirer,100,49,11/6/2019
9FF5F1,earnings,100,50,11/6/2019
9FF5F1,acquisition-acquirer,100,49,11/6/2019
A16DEA,conference-participant,100,50,11/6/2019
A1BB98,earnings,100,50,11/6/2019
A1BB98,earnings,100,50,11/6/2019
A1BB98,earnings,100,50,11/6/2019
A1BB98,earnings,100,50,11/6/2019
A1BB98,earnings,100,50,11/6/2019
A1BB98,earnings,100,50,11/6/2019
A21649,earnings,100,50,11/6/2019
A43906,earnings,100,50,11/6/2019
A495F7,earnings,100,50,11/6/2019
A5195E,earnings,100,50,11/6/2019
A60318,earnings,100,50,11/6/2019
A631A3,partnership,100,61,11/6/2019
A63387,earnings,100,50,11/6/2019
A7A0C8,earnings,100,50,11/6/2019
A871B0,earnings,100,50,11/6/2019
A94637,dividend,100,50,11/6/2019
AA98ED,public-offering,100,43,11/6/2019
AAC8B6,earnings,100,50,11/6/2019
AAC8B6,earnings,100,50,11/6/2019
AAC8B6,earnings,100,50,11/6/2019
AAC8B6,earnings,100,50,11/6/2019
AAC8B6,earnings,100,50,11/6/2019
AAC8B6,earnings,100,50,11/6/2019
AAC8B6,earnings,100,50,11/6/2019
ABB493,earnings,100,50,11/6/2019
ACF0B4,earnings,100,50,11/6/2019
AD1ACF,executive-appointment,100,54,11/6/2019
AD23DE,executive-appointment,100,54,11/6/2019
AD6141,earnings,100,50,11/6/2019
AD6141,dividend,100,50,11/6/2019
AD6141,buybacks,100,74,11/6/2019
AE3113,earnings,100,50,11/6/2019
AE79CD,earnings,100,50,11/6/2019
AECCA9,conference-call,100,50,11/6/2019
AED6CF,earnings,100,50,11/6/2019
AED6CF,earnings,100,50,11/6/2019
AED6CF,earnings,100,50,11/6/2019
AED6CF,earnings,100,50,11/6/2019
AED6CF,earnings,100,50,11/6/2019
AED6CF,earnings,100,50,11/6/2019
AED6CF,earnings,100,50,11/6/2019
AF93DE,earnings,100,50,11/6/2019
AFD7DD,earnings,100,50,11/6/2019
AFD7DD,earnings,100,50,11/6/2019
AFDF2E,legal-issues-defendant,100,22,11/6/2019
AFDF2E,legal-issues-defendant,100,22,11/6/2019
AFDF2E,legal-issues-defendant,100,22,11/6/2019
B05000,earnings,100,50,11/6/2019
B13B68,earnings,100,50,11/6/2019
B2E6B5,dividend-up,100,81,11/6/2019
B2E6B5,earnings,100,50,11/6/2019
B2E6B5,earnings,100,50,11/6/2019
B2E6B5,earnings,100,50,11/6/2019
B37FB4,conference-participant,100,50,11/6/2019
B48FC9,revenues,100,50,11/6/2019
B53C12,earnings,100,50,11/6/2019
B5734D,business-contract,100,69,11/6/2019
B5734D,business-contract,100,69,11/6/2019
B5734D,business-contract,100,69,11/6/2019
B5734D,loan-recipient,100,59,11/6/2019
B5734D,loan-recipient,100,59,11/6/2019
B66928,earnings,100,50,11/6/2019
B66928,earnings,100,50,11/6/2019
B66928,earnings,100,50,11/6/2019
B66928,earnings,100,50,11/6/2019
B66928,earnings,100,50,11/6/2019
B66928,earnings,100,50,11/6/2019
B7202A,earnings,100,50,11/6/2019
B73395,earnings,100,50,11/6/2019
B73395,earnings,100,50,11/6/2019
B73395,earnings,100,50,11/6/2019
B73395,earnings,100,50,11/6/2019
B73395,earnings,100,50,11/6/2019
B840EF,earnings,100,50,11/6/2019
B8DD94,earnings,100,50,11/6/2019
B8EF97,revenues,100,50,11/6/2019
BAD655,earnings,100,50,11/6/2019
BB02FB,earnings-per-share-positive,100,69,11/6/2019
BB02FB,earnings-per-share,100,50,11/6/2019
BB02FB,earnings-per-share,100,50,11/6/2019
BB02FB,earnings-per-share,100,50,11/6/2019
BB02FB,earnings-per-share,100,50,11/6/2019
BCC13E,executive-appointment,100,54,11/6/2019
BCC55F,earnings,100,50,11/6/2019
BCC55F,earnings,100,50,11/6/2019
BCC55F,earnings,100,50,11/6/2019
BCC55F,earnings,100,50,11/6/2019
BDE867,dividend,100,50,11/6/2019
BF79F5,partnership,100,61,11/6/2019
C1114B,earnings,100,50,11/6/2019
C1114B,earnings,100,50,11/6/2019
C1114B,earnings,100,50,11/6/2019
C1114B,earnings,100,50,11/6/2019
C188F8,earnings,100,50,11/6/2019
C29715,buybacks,100,74,11/6/2019
C3EE99,conference-call,100,50,11/6/2019
C407A0,earnings,100,50,11/6/2019
C425AE,earnings,100,50,11/6/2019
C48574,executive-appointment,100,54,11/6/2019
C4FBDC,earnings-up,100,68,11/6/2019
C4FBDC,earnings,100,50,11/6/2019
C4FBDC,earnings,100,50,11/6/2019
C4FBDC,earnings,100,50,11/6/2019
C4FBDC,earnings,100,50,11/6/2019
C5C137,product-release,100,64,11/6/2019
C5C137,product-release,100,64,11/6/2019
C5E100,earnings,100,50,11/6/2019
C624A1,earnings,100,50,11/6/2019
C624A1,earnings,100,50,11/6/2019
C62AA4,earnings,100,50,11/6/2019
C659EB,conference-participant,100,50,11/6/2019
C66A8C,public-offering,100,43,11/6/2019
C66B44,executive-appointment,100,54,11/6/2019
C66B44,executive-appointment,100,54,11/6/2019
C85A72,conference-participant,100,50,11/6/2019
C951A2,earnings,100,50,11/6/2019
C951A2,earnings,100,50,11/6/2019
C951A2,earnings,100,50,11/6/2019
C951A2,earnings,100,50,11/6/2019
C951A2,earnings,100,50,11/6/2019
C951A2,earnings,100,50,11/6/2019
C9739A,conference-participant,100,50,11/6/2019
C97B2D,note-sale,100,52,11/6/2019
C9E04B,product-release,100,64,11/6/2019
C9E04B,product-release,100,64,11/6/2019
C9E04B,product-release,100,64,11/6/2019
C9E04B,earnings,100,50,11/6/2019
CA212F,dividend,100,50,11/6/2019
CA99D7,earnings,100,50,11/6/2019
CB7AB2,earnings,100,50,11/6/2019
CB89EA,earnings,100,50,11/6/2019
CBDB4D,earnings,100,50,11/6/2019
CC35BE,earnings,100,50,11/6/2019
CC35BE,earnings,100,50,11/6/2019
CC35BE,earnings,100,50,11/6/2019
CC35BE,earnings,100,50,11/6/2019
CC35BE,earnings,100,50,11/6/2019
CD4DA8,conference-organizer,100,57,11/6/2019
CDAF5B,executive-appointment,100,54,11/6/2019
CDC217,earnings,100,50,11/6/2019
CDE118,dividend,100,50,11/6/2019
CE4E6D,credit-extension-recipient,100,69,11/6/2019
CE4E6D,earnings,100,50,11/6/2019
CE4E6D,earnings,100,50,11/6/2019
CE4E6D,earnings,100,50,11/6/2019
CE4E6D,earnings,100,50,11/6/2019
CFD4B6,facility-open,100,65,11/6/2019
CFF15D,earnings,100,50,11/6/2019
CFF15D,executive-appointment,100,54,11/6/2019
CFF15D,earnings,100,50,11/6/2019
CFF57D,conference-participant,100,50,11/6/2019
D07B07,earnings,100,50,11/6/2019
D0909F,conference-participant,100,50,11/6/2019
D29B44,earnings,100,50,11/6/2019
D57D99,product-release,100,64,11/6/2019
D5A350,dividend-up,100,58,11/6/2019
D64EDF,note-sale,100,52,11/6/2019
D64EDF,note-sale,100,52,11/6/2019
D76AEF,earnings,100,50,11/6/2019
D82EF3,partnership,100,61,11/6/2019
D82EF3,partnership,100,61,11/6/2019
D8DA3D,earnings,100,50,11/6/2019
D8DA3D,earnings,100,50,11/6/2019
D8DA3D,earnings,100,50,11/6/2019
D8DA3D,earnings,100,50,11/6/2019
D8DA3D,earnings,100,50,11/6/2019
D8DA3D,earnings,100,50,11/6/2019
D8DA3D,legal-issues-defendant,100,22,11/6/2019
D8ECA1,legal-issues-defendant,100,22,11/6/2019
D90F43,partnership,100,61,11/6/2019
DA48E4,business-contract,100,69,11/6/2019
DB2E4E,earnings,100,50,11/6/2019
DC1405,conference-participant,100,50,11/6/2019
DD0F15,earnings,100,50,11/6/2019
DE4924,conference-call,100,50,11/6/2019
DF01B1,earnings,100,50,11/6/2019
DF01B1,earnings,100,50,11/6/2019
DF01B1,earnings,100,50,11/6/2019
DF01B1,earnings,100,50,11/6/2019
DF16DE,earnings,100,50,11/6/2019
DF5F14,earnings,100,50,11/6/2019
E00373,partnership,100,61,11/6/2019
E05026,earnings,100,50,11/6/2019
E06265,earnings,100,50,11/6/2019
E16133,earnings,100,50,11/6/2019
E19A99,earnings,100,50,11/6/2019
E20392,conference-participant,100,50,11/6/2019
E20392,earnings,100,50,11/6/2019
E28D9C,earnings,100,50,11/6/2019
E38906,earnings,100,50,11/6/2019
E61888,earnings,100,50,11/6/2019
E866D2,partnership,100,61,11/6/2019
E8C557,earnings,100,50,11/6/2019
E959F3,dividend,100,50,11/6/2019
E9C7C0,earnings,100,50,11/6/2019
E9C7C0,earnings,100,50,11/6/2019
E9C7C0,earnings,100,50,11/6/2019
E9C7C0,earnings,100,50,11/6/2019
E9C7C0,earnings,100,50,11/6/2019
E9C7C0,earnings,100,50,11/6/2019
E9C7C0,earnings,100,50,11/6/2019
EB43F4,earnings,100,50,11/6/2019
EBC84C,conference-participant,100,50,11/6/2019
EC8116,earnings,100,50,11/6/2019
ECF4F8,earnings,100,50,11/6/2019
EEA734,earnings,100,50,11/6/2019
EEB5F9,earnings,100,50,11/6/2019
EF25A5,conference-participant,100,50,11/6/2019
F02D0A,earnings,100,50,11/6/2019
F02D0A,earnings,100,50,11/6/2019
F0B335,earnings,100,50,11/6/2019
F18844,earnings,100,50,11/6/2019
F18844,dividend,100,50,11/6/2019
F2E253,earnings,100,50,11/6/2019
F2E253,earnings,100,50,11/6/2019
F2E253,earnings,100,50,11/6/2019
F2E253,earnings,100,50,11/6/2019
F2E253,earnings,100,50,11/6/2019
F2E253,earnings,100,50,11/6/2019
F3FCC3,earnings-up,100,68,11/6/2019
F46EC9,conference-participant,100,50,11/6/2019
F4E992,conference-call,100,50,11/6/2019
F5349B,earnings,100,50,11/6/2019
F5349B,dividend,100,50,11/6/2019
F569FD,earnings,100,50,11/6/2019
F58C23,conference-call,100,50,11/6/2019
F6DE54,product-release,100,64,11/6/2019
F73DD1,dividend,100,50,11/6/2019
F73DD1,earnings,100,50,11/6/2019
F73DD1,earnings,100,50,11/6/2019
F73DD1,earnings,100,50,11/6/2019
F73DD1,earnings,100,50,11/6/2019
F73DD1,earnings,100,50,11/6/2019
F73DD1,earnings,100,50,11/6/2019
F73DD1,earnings,100,50,11/6/2019
F7ADEB,earnings,100,50,11/6/2019
F93C8A,earnings,100,50,11/6/2019
FAAFA2,executive-appointment,100,54,11/6/2019
FBD92D,executive-resignation,100,44,11/6/2019
FC01C0,earnings,100,50,11/6/2019
FC9869,earnings,100,50,11/6/2019
FCA54E,earnings,100,50,11/6/2019
FD2565,earnings,100,50,11/6/2019
FD9A97,conference-participant,100,50,11/6/2019
FF227B,earnings,100,50,11/6/2019
00067A,partnership,100,61,11/7/2019
001F1B,revenues,100,50,11/7/2019
00D6B5,earnings,100,50,11/7/2019
02ACBD,earnings,100,50,11/7/2019
48590,earnings,100,50,11/7/2019
0490C6,partnership,100,61,11/7/2019
0560D8,earnings,100,50,11/7/2019
68396,earnings,100,50,11/7/2019
75172,earnings,100,50,11/7/2019
75172,executive-appointment,100,54,11/7/2019
0919B1,earnings,100,50,11/7/2019
0A59F8,earnings,100,50,11/7/2019
0A59F8,earnings,100,50,11/7/2019
0A59F8,earnings,100,50,11/7/2019
0A59F8,earnings,100,50,11/7/2019
0A59F8,earnings,100,50,11/7/2019
0A59F8,earnings,100,50,11/7/2019
0A77DB,revenue-up,100,69,11/7/2019
0A9D0A,partnership,100,61,11/7/2019
0A9D0A,partnership,100,61,11/7/2019
0B13E8,earnings,100,50,11/7/2019
0B4D10,dividend,100,50,11/7/2019
0B57D7,dividend,100,50,11/7/2019
0CCCB7,earnings,100,50,11/7/2019
0E499E,earnings,100,50,11/7/2019
0E5619,earnings,100,50,11/7/2019
0F2BC9,revenue-up,100,69,11/7/2019
0F2BC9,revenue-up,100,69,11/7/2019
0F2BC9,revenue-up,100,69,11/7/2019
0FDE97,unit-acquisition-acquiree,100,76,11/7/2019
102F04,earnings,100,50,11/7/2019
102F04,executive-appointment,100,54,11/7/2019
1096C6,earnings,100,50,11/7/2019
11A49E,executive-appointment,100,54,11/7/2019
11A49E,earnings,100,50,11/7/2019
1201B5,earnings,100,50,11/7/2019
12DE76,partnership,100,61,11/7/2019
12E454,partnership,100,61,11/7/2019
133644,earnings,100,50,11/7/2019
136B26,earnings,100,50,11/7/2019
138DDE,earnings,100,50,11/7/2019
13C3E0,partnership,100,61,11/7/2019
15789A,conference-participant,100,50,11/7/2019
15B10D,earnings,100,50,11/7/2019
15B10D,earnings,100,50,11/7/2019
15B10D,earnings,100,50,11/7/2019
182B8C,earnings,100,50,11/7/2019
184988,earnings,100,50,11/7/2019
18D9FA,business-contract,100,69,11/7/2019
1A5957,earnings,100,50,11/7/2019
1A5957,earnings,100,50,11/7/2019
1A5957,earnings,100,50,11/7/2019
1A5957,earnings,100,50,11/7/2019
1BC12C,unit-acquisition-acquirer,100,49,11/7/2019
1D9E55,conference-participant,100,50,11/7/2019
1E04A5,trading-resumed,100,58,11/7/2019
1E1125,conference-organizer,100,57,11/7/2019
1E1125,conference-organizer,100,57,11/7/2019
1E5786,executive-appointment,100,54,11/7/2019
1F352C,earnings,100,50,11/7/2019
1FC422,earnings,100,50,11/7/2019
20403D,earnings,100,50,11/7/2019
205AD5,legal-issues-defendant,100,22,11/7/2019
21268E,earnings,100,50,11/7/2019
221783,earnings,100,50,11/7/2019
221783,earnings,100,50,11/7/2019
221783,earnings,100,50,11/7/2019
221783,earnings,100,50,11/7/2019
221783,earnings,100,50,11/7/2019
2262BD,earnings,100,50,11/7/2019
228D42,partnership,100,61,11/7/2019
228D42,partnership,100,61,11/7/2019
228D42,partnership,100,61,11/7/2019
228D42,partnership,100,61,11/7/2019
232053,earnings,100,50,11/7/2019
23207A,earnings,100,50,11/7/2019
23207A,earnings,100,50,11/7/2019
2.45E+15,executive-appointment,100,54,11/7/2019
2.45E+15,dividend,100,50,11/7/2019
2491BC,legal-issues-defendant,100,22,11/7/2019
24A89A,legal-issues-defendant,100,22,11/7/2019
25102A,product-release,100,64,11/7/2019
25102A,product-release,100,64,11/7/2019
25102A,product-release,100,64,11/7/2019
26DC29,legal-issues-defendant,100,22,11/7/2019
26F99F,earnings,100,50,11/7/2019
27C10F,earnings,100,50,11/7/2019
27C10F,earnings,100,50,11/7/2019
27C10F,earnings,100,50,11/7/2019
27C10F,earnings,100,50,11/7/2019
28AC4E,legal-issues-defendant,100,22,11/7/2019
28F905,earnings,100,50,11/7/2019
28F905,earnings,100,50,11/7/2019
28F905,earnings,100,50,11/7/2019
28F905,earnings,100,50,11/7/2019
28F905,earnings,100,50,11/7/2019
28F905,earnings,100,50,11/7/2019
28F905,earnings,100,50,11/7/2019
28F905,earnings,100,50,11/7/2019
2A4131,earnings,100,50,11/7/2019
2B5483,earnings,100,50,11/7/2019
2B7A40,dividend,100,50,11/7/2019
2B7A40,conference-participant,100,50,11/7/2019
2BBE62,earnings,100,50,11/7/2019
2BBE62,earnings,100,50,11/7/2019
2BBE62,earnings,100,50,11/7/2019
2BBE62,earnings,100,50,11/7/2019
2C35B5,earnings,100,50,11/7/2019
2C681C,earnings,100,50,11/7/2019
2C681C,earnings,100,50,11/7/2019
2D643C,conference-participant,100,50,11/7/2019
2E1322,earnings,100,50,11/7/2019
2E1322,earnings,100,50,11/7/2019
2E61CC,partnership,100,61,11/7/2019
2EC172,earnings,100,50,11/7/2019
2EC172,earnings,100,50,11/7/2019
2EC172,earnings,100,50,11/7/2019
2EC172,earnings,100,50,11/7/2019
2EC172,earnings,100,50,11/7/2019
2EC172,earnings,100,50,11/7/2019
30DE64,earnings,100,50,11/7/2019
315EB0,facility-open,100,65,11/7/2019
32F943,earnings,100,50,11/7/2019
342218,earnings,100,50,11/7/2019
342218,earnings,100,50,11/7/2019
34A959,legal-issues-defendant,100,22,11/7/2019
3587B4,earnings,100,50,11/7/2019
3587B4,earnings,100,50,11/7/2019
3587B4,earnings,100,50,11/7/2019
3587B4,earnings,100,50,11/7/2019
367434,earnings,100,50,11/7/2019
36A1CB,dividend,100,50,11/7/2019
370C50,partnership,100,61,11/7/2019
371B0A,earnings-up,100,68,11/7/2019
37426C,conference-call,100,50,11/7/2019
37B618,earnings,100,50,11/7/2019
37E18B,operating-earnings,100,50,11/7/2019
382EAE,operating-earnings,100,50,11/7/2019
382EAE,buybacks,100,74,11/7/2019
385DD4,dividend,100,50,11/7/2019
396D7C,earnings,100,50,11/7/2019
3C3B6B,earnings,100,50,11/7/2019
3DB18B,earnings,100,50,11/7/2019
3E39A5,revenues,100,50,11/7/2019
3ED92D,note-sale,100,52,11/7/2019
3EE65E,earnings,100,50,11/7/2019
40F7DE,conference-call,100,50,11/7/2019
4135F7,earnings-up,100,68,11/7/2019
416291,earnings,100,50,11/7/2019
41EC04,legal-issues-defendant,100,22,11/7/2019
41EC04,legal-issues-defendant,100,22,11/7/2019
41EC04,legal-issues-defendant,100,22,11/7/2019
42312F,earnings,100,50,11/7/2019
42AABD,legal-issues-defendant,100,22,11/7/2019
448BF3,earnings,100,50,11/7/2019
449447,revenue-up,100,70,11/7/2019
46017C,earnings,100,50,11/7/2019
49CC59,earnings,100,50,11/7/2019
4BBA23,earnings,100,50,11/7/2019
4BF3D6,earnings,100,50,11/7/2019
4C92B9,earnings,100,50,11/7/2019
4D229C,earnings,100,50,11/7/2019
4D72C8,earnings,100,50,11/7/2019
4D72C8,earnings,100,50,11/7/2019
4DD203,earnings,100,50,11/7/2019
4E3D15,executive-appointment,100,54,11/7/2019
4F71DC,partnership,100,61,11/7/2019
4F9926,executive-appointment,100,54,11/7/2019
4FCC78,earnings,100,50,11/7/2019
50070E,earnings,100,50,11/7/2019
513A86,conference-participant,100,50,11/7/2019
52FB2F,earnings,100,50,11/7/2019
52FB2F,earnings,100,50,11/7/2019
52FB2F,earnings,100,50,11/7/2019
52FB2F,earnings,100,50,11/7/2019
52FB2F,earnings,100,50,11/7/2019
539F49,conference-participant,100,50,11/7/2019
5.43E+08,legal-issues-defendant,100,22,11/7/2019
5.43E+08,conference-participant,100,50,11/7/2019
54512F,earnings,100,50,11/7/2019
54DF47,earnings,100,50,11/7/2019
55ACCB,earnings,100,50,11/7/2019
55ACCB,earnings,100,50,11/7/2019
55ACCB,earnings,100,50,11/7/2019
55ACCB,earnings,100,50,11/7/2019
55C9B5,partnership,100,61,11/7/2019
55C9B5,partnership,100,61,11/7/2019
55C9B5,partnership,100,61,11/7/2019
55D0F3,earnings,100,50,11/7/2019
562853,dividend,100,50,11/7/2019
567F3D,dividend,100,50,11/7/2019
56EFC7,dividend,100,50,11/7/2019
56EFC7,executive-appointment,100,54,11/7/2019
57356F,note-sale,100,52,11/7/2019
57A854,conference-participant,100,50,11/7/2019
57CAAB,fast-track-designation,100,81,11/7/2019
57CAAB,conference-participant,100,50,11/7/2019
583223,earnings,100,50,11/7/2019
586BD7,earnings,100,50,11/7/2019
58B46F,earnings-per-share-positive,100,69,11/7/2019
59872F,conference-call,100,50,11/7/2019
5AA3B1,earnings,100,50,11/7/2019
5AA3B1,earnings,100,50,11/7/2019
5AA3B1,earnings,100,50,11/7/2019
5AA3B1,earnings,100,50,11/7/2019
5B3FA2,earnings,100,50,11/7/2019
5C2A47,earnings,100,50,11/7/2019
5DE5A5,conference-participant,100,50,11/7/2019
5E1DF3,earnings,100,50,11/7/2019
5EAA43,earnings,100,50,11/7/2019
5F3D91,clinical-trials-start,100,64,11/7/2019
5F60CE,earnings-positive,100,69,11/7/2019
5FE4B6,dividend,100,50,11/7/2019
60FE03,earnings,100,50,11/7/2019
619882,conference-organizer,100,57,11/7/2019
619882,conference-organizer,100,57,11/7/2019
619882,conference-organizer,100,57,11/7/2019
619882,conference-organizer,100,57,11/7/2019
622DBE,legal-issues-defendant,100,22,11/7/2019
636639,dividend,100,50,11/7/2019
64636E,earnings,100,50,11/7/2019
6.52E+64,earnings,100,50,11/7/2019
6.52E+64,earnings,100,50,11/7/2019
6.52E+64,legal-issues-defendant,100,22,11/7/2019
6634D9,earnings,100,50,11/7/2019
68586A,earnings,100,50,11/7/2019
69C99E,earnings,100,50,11/7/2019
6A01DF,earnings,100,50,11/7/2019
6B0784,earnings,100,50,11/7/2019
6B6375,earnings,100,50,11/7/2019
6BC6F9,earnings,100,50,11/7/2019
6BD606,earnings-positive,100,69,11/7/2019
6BD606,earnings-positive,100,69,11/7/2019
6BDA0C,earnings,100,50,11/7/2019
6BDA0C,earnings,100,50,11/7/2019
6BDA0C,earnings,100,50,11/7/2019
6BDA0C,earnings,100,50,11/7/2019
6D3F35,business-contract,100,69,11/7/2019
6D3F35,business-contract,100,69,11/7/2019
6D3F35,earnings,100,50,11/7/2019
6D3F35,earnings,100,50,11/7/2019
6D3F35,earnings,100,50,11/7/2019
6D3F35,earnings,100,50,11/7/2019
6D3F35,earnings,100,50,11/7/2019
6D9ECA,earnings,100,50,11/7/2019
6DDA15,earnings,100,50,11/7/2019
6DDA15,earnings,100,50,11/7/2019
6DDA15,earnings,100,50,11/7/2019
6DDA15,earnings,100,50,11/7/2019
6DDA15,earnings,100,50,11/7/2019
6DDA15,earnings,100,50,11/7/2019
6-Dec-05,product-release,100,64,11/7/2019
6-Dec-05,earnings,100,50,11/7/2019
6E8864,operating-earnings,100,50,11/7/2019
6EA292,earnings,100,50,11/7/2019
6F39FC,dividend,100,50,11/7/2019
705636,earnings-up,100,61,11/7/2019
71553E,acquisition-acquirer,100,49,11/7/2019
71553E,acquisition-acquirer,100,49,11/7/2019
71553E,earnings,100,50,11/7/2019
719477,conference-call,100,50,11/7/2019
71B0CF,earnings,100,50,11/7/2019
7255D2,earnings,100,50,11/7/2019
72FCA3,executive-appointment,100,54,11/7/2019
732A9B,public-offering,100,43,11/7/2019
73A71F,legal-issues-defendant,100,22,11/7/2019
741937,executive-appointment,100,54,11/7/2019
742AAB,earnings-guidance,100,50,11/7/2019
747219,legal-issues-defendant,100,22,11/7/2019
747219,earnings,100,50,11/7/2019
756045,executive-appointment,100,54,11/7/2019
762B8D,earnings,100,50,11/7/2019
769F40,earnings,100,50,11/7/2019
76F067,conference-participant,100,50,11/7/2019
7710F3,legal-issues-defendant,100,22,11/7/2019
7712CB,executive-appointment,100,54,11/7/2019
7712CB,executive-appointment,100,54,11/7/2019
7740DE,same-store-sales-up,100,53,11/7/2019
7771D7,earnings-positive,100,69,11/7/2019
7771D7,earnings,100,50,11/7/2019
7771D7,earnings,100,50,11/7/2019
7823A3,legal-issues-defendant,100,22,11/7/2019
7823A3,legal-issues-defendant,100,22,11/7/2019
787D14,earnings,100,50,11/7/2019
79167B,executive-death,100,31,11/7/2019
791EC1,dividend,100,50,11/7/2019
793C11,executive-appointment,100,54,11/7/2019
793C11,earnings,100,50,11/7/2019
7ACD98,facility-open,100,65,11/7/2019
7B1156,earnings,100,50,11/7/2019
7B9212,revenues,100,50,11/7/2019
7BEA98,earnings,100,50,11/7/2019
7D35D8,legal-issues-defendant,100,22,11/7/2019
7D35D8,legal-issues-defendant,100,22,11/7/2019
7D85A9,earnings,100,50,11/7/2019
7E1542,ipo-pricing,100,50,11/7/2019
7E2DE6,acquisition-completed-acquirer,100,49,11/7/2019
7F3665,earnings,100,50,11/7/2019
7FDE1C,earnings,100,50,11/7/2019
7FDE1C,rights-issue,100,43,11/7/2019
803FED,earnings,100,50,11/7/2019
81222C,earnings,100,50,11/7/2019
817ED9,executive-resignation,100,44,11/7/2019
817ED9,executive-resignation,100,44,11/7/2019
817ED9,executive-resignation,100,44,11/7/2019
818A2F,earnings,100,50,11/7/2019
818A2F,earnings,100,50,11/7/2019
82C202,conference-participant,100,50,11/7/2019
834152,earnings,100,50,11/7/2019
834152,partnership,100,61,11/7/2019
834152,earnings,100,50,11/7/2019
83E0AC,conference-call,100,50,11/7/2019
848C0B,earnings,100,50,11/7/2019
858942,earnings,100,50,11/7/2019
858942,executive-appointment,100,54,11/7/2019
85DE00,conference-participant,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
86AA9C,earnings,100,50,11/7/2019
87486A,earnings,100,50,11/7/2019
87486A,earnings,100,50,11/7/2019
87486A,earnings,100,50,11/7/2019
87486A,earnings,100,50,11/7/2019
881190,dividend,100,50,11/7/2019
885758,earnings,100,50,11/7/2019
88923D,earnings,100,50,11/7/2019
88923D,earnings,100,50,11/7/2019
88923D,earnings,100,50,11/7/2019
88923D,earnings,100,50,11/7/2019
88923D,earnings,100,50,11/7/2019
88923D,earnings,100,50,11/7/2019
893904,public-offering,100,43,11/7/2019
895D56,operating-earnings,100,50,11/7/2019
8B3B0E,conference-participant,100,50,11/7/2019
8B9B3B,earnings,100,50,11/7/2019
8BFE9A,earnings,100,50,11/7/2019
8C6C1B,conference-call,100,50,11/7/2019
8D5145,dividend,100,50,11/7/2019
8E10BF,conference-call,100,50,11/7/2019
8E8E6E,partnership,100,61,11/7/2019
8F3BCC,earnings-per-share-positive,100,69,11/7/2019
9043FE,facility-open,100,65,11/7/2019
9043FE,facility-open,100,65,11/7/2019
922F0C,executive-appointment,100,54,11/7/2019
922F0C,dividend,100,50,11/7/2019
92D757,earnings,100,50,11/7/2019
92D757,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.36E+10,earnings,100,50,11/7/2019
9.39E+69,earnings,100,50,11/7/2019
93AD2E,executive-appointment,100,54,11/7/2019
93AD2E,earnings,100,50,11/7/2019
943239,earnings,100,50,11/7/2019
943239,earnings,100,50,11/7/2019
943239,earnings,100,50,11/7/2019
947B0B,earnings,100,50,11/7/2019
94A326,ipo-pricing,100,50,11/7/2019
9592FB,earnings,100,50,11/7/2019
95A92E,earnings,100,50,11/7/2019
9.65E+07,earnings,100,50,11/7/2019
9.65E+07,earnings,100,50,11/7/2019
9.65E+07,earnings,100,50,11/7/2019
966DBE,earnings,100,50,11/7/2019
966DBE,earnings,100,50,11/7/2019
966DBE,earnings,100,50,11/7/2019
966DBE,earnings,100,50,11/7/2019
966DBE,earnings,100,50,11/7/2019
9673BD,earnings-up,100,68,11/7/2019
9673BD,earnings,100,50,11/7/2019
9673BD,earnings,100,50,11/7/2019
96BFF4,revenues,100,50,11/7/2019
96BFF4,revenues,100,50,11/7/2019
96BFF4,revenues,100,50,11/7/2019
9.74E+08,award,100,58,11/7/2019
97FE80,earnings,100,50,11/7/2019
9.86E+03,earnings,100,50,11/7/2019
99028D,earnings,100,50,11/7/2019
9A2760,earnings-up,100,68,11/7/2019
9A2760,earnings,100,50,11/7/2019
9A2760,earnings,100,50,11/7/2019
9A2760,earnings,100,50,11/7/2019
9A2760,earnings,100,50,11/7/2019
9B0C9C,earnings,100,50,11/7/2019
9BB35A,earnings,100,50,11/7/2019
9BB35A,earnings,100,50,11/7/2019
9BB35A,earnings,100,50,11/7/2019
9BB35A,earnings,100,50,11/7/2019
9BB35A,earnings,100,50,11/7/2019
9BB35A,earnings,100,50,11/7/2019
9BB35A,earnings,100,50,11/7/2019
9BF177,partnership,100,61,11/7/2019
9C5174,conference-participant,100,50,11/7/2019
9CDA4F,earnings,100,50,11/7/2019
9CE4C7,dividend,100,50,11/7/2019
9D307D,earnings,100,50,11/7/2019
9D6A24,dividend-up,100,52,11/7/2019
9D6A24,earnings,100,50,11/7/2019
9DDE1B,dividend,100,50,11/7/2019
9E5C2C,earnings,100,50,11/7/2019
9E98F2,legal-issues-defendant,100,22,11/7/2019
9EA947,award,100,58,11/7/2019
A01664,earnings,100,50,11/7/2019
A0F146,earnings,100,50,11/7/2019
A15C71,earnings,100,50,11/7/2019
A1EAC8,earnings,100,50,11/7/2019
A3800A,earnings,100,50,11/7/2019
A3F598,earnings,100,50,11/7/2019
A3F598,earnings,100,50,11/7/2019
A3F598,earnings,100,50,11/7/2019
A3F598,earnings,100,50,11/7/2019
A403CF,earnings,100,50,11/7/2019
A403CF,dividend,100,50,11/7/2019
A790A5,conference-call,100,50,11/7/2019
AB4A7E,earnings-up,100,68,11/7/2019
AB4A7E,earnings-up,100,68,11/7/2019
AB4A7E,earnings-up,100,68,11/7/2019
AB4A7E,earnings-up,100,68,11/7/2019
AC3584,revenue-up,100,87,11/7/2019
AC3584,revenue-up,100,87,11/7/2019
AC3584,revenue-up,100,87,11/7/2019
AC642C,earnings,100,50,11/7/2019
AC642C,earnings,100,50,11/7/2019
AC7AAE,earnings,100,50,11/7/2019
AD23DE,partnership,100,61,11/7/2019
AD23DE,dividend,100,50,11/7/2019
AD3C93,acquisition-completed-acquirer,100,49,11/7/2019
AD6141,asset-sale,100,62,11/7/2019
ADF092,earnings,100,50,11/7/2019
ADF092,earnings,100,50,11/7/2019
AEBB80,earnings,100,50,11/7/2019
AEEB76,conference-participant,100,50,11/7/2019
AFD1CA,conference-participant,100,50,11/7/2019
AFDF2E,legal-issues-defendant,100,22,11/7/2019
B01215,earnings,100,50,11/7/2019
B04426,earnings,100,50,11/7/2019
B1A85D,earnings,100,50,11/7/2019
B1B10C,executive-appointment,100,54,11/7/2019
B1FC3B,award,100,58,11/7/2019
B381D8,earnings,100,50,11/7/2019
B48D6A,earnings,100,50,11/7/2019
B5BA39,unit-acquisition-acquiree,100,76,11/7/2019
B5BA39,earnings,100,50,11/7/2019
B5BA39,unit-acquisition-acquiree,100,76,11/7/2019
B5BA39,unit-acquisition-acquiree,100,76,11/7/2019
B80AD1,earnings,100,50,11/7/2019
B9CD50,award,100,58,11/7/2019
B9CD50,conference-participant,100,50,11/7/2019
BB127B,award,100,58,11/7/2019
BBF349,earnings,100,50,11/7/2019
BBF349,earnings,100,50,11/7/2019
BBF349,earnings,100,50,11/7/2019
BD9668,product-release,100,64,11/7/2019
BD9668,dividend-up,100,81,11/7/2019
BDCC11,earnings,100,50,11/7/2019
BDE867,executive-appointment,100,54,11/7/2019
BE379D,conference-call,100,50,11/7/2019
BE5935,earnings,100,50,11/7/2019
C01737,earnings,100,50,11/7/2019
C0200F,dividend,100,50,11/7/2019
C037A8,earnings,100,50,11/7/2019
C03C8B,earnings,100,50,11/7/2019
C03C8B,earnings,100,50,11/7/2019
C03C8B,earnings,100,50,11/7/2019
C03C8B,earnings,100,50,11/7/2019
C03C8B,earnings,100,50,11/7/2019
C03C8B,earnings,100,50,11/7/2019
C2F597,earnings,100,50,11/7/2019
C4F9C6,earnings,100,50,11/7/2019
C5C0E9,earnings,100,50,11/7/2019
C5C137,earnings,100,50,11/7/2019
C83B88,facility-open,100,65,11/7/2019
C8A059,earnings,100,50,11/7/2019
C9E4EC,earnings,100,50,11/7/2019
CC8F6E,conference-participant,100,50,11/7/2019
CCB623,acquisition-acquirer,100,49,11/7/2019
CCB623,earnings,100,50,11/7/2019
CD051C,earnings,100,50,11/7/2019
CDAA0E,earnings,100,50,11/7/2019
CDAF5B,dividend,100,50,11/7/2019
CE5C6E,earnings,100,50,11/7/2019
CE5C6E,earnings,100,50,11/7/2019
CF6A5A,dividend,100,50,11/7/2019
D09938,earnings,100,50,11/7/2019
D11C1C,operating-earnings,100,50,11/7/2019
D17C1B,partnership,100,61,11/7/2019
D1C26F,earnings,100,50,11/7/2019
D296C6,earnings,100,50,11/7/2019
D3FA2C,earnings,100,50,11/7/2019
D5938F,earnings,100,50,11/7/2019
D598E7,business-contract,100,69,11/7/2019
D6144F,earnings,100,50,11/7/2019
D63B0F,earnings,100,50,11/7/2019
D63B0F,earnings,100,50,11/7/2019
D63B0F,earnings,100,50,11/7/2019
D63B0F,dividend,100,50,11/7/2019
D6534D,dividend,100,50,11/7/2019
D697DE,earnings,100,50,11/7/2019
D69D42,earnings,100,50,11/7/2019
D6EAA3,earnings,100,50,11/7/2019
D6EAA3,earnings,100,50,11/7/2019
D6EAA3,earnings,100,50,11/7/2019
D6EAA3,earnings,100,50,11/7/2019
D6EAA3,earnings,100,50,11/7/2019
D6EAA3,earnings,100,50,11/7/2019
D78CCD,earnings,100,50,11/7/2019
D82EF3,partnership,100,61,11/7/2019
D8C09D,earnings,100,50,11/7/2019
D8ECA1,legal-issues-defendant,100,22,11/7/2019
D90441,earnings,100,50,11/7/2019
D90441,earnings,100,50,11/7/2019
D90441,earnings,100,50,11/7/2019
DA48E4,earnings-per-share,100,50,11/7/2019
DA48E4,earnings-per-share,100,50,11/7/2019
DA48E4,earnings-per-share,100,50,11/7/2019
DA48E4,earnings-per-share,100,50,11/7/2019
DA48E4,earnings-per-share,100,50,11/7/2019
DA48E4,earnings-per-share,100,50,11/7/2019
DA9443,earnings,100,50,11/7/2019
DC2B00,conference-call,100,50,11/7/2019
DD1BA1,earnings,100,50,11/7/2019
DD1BA1,earnings,100,50,11/7/2019
DD1BA1,earnings,100,50,11/7/2019
DD1BA1,earnings,100,50,11/7/2019
DD1BA1,earnings,100,50,11/7/2019
DD1BA1,earnings,100,50,11/7/2019
DD682D,executive-appointment,100,54,11/7/2019
DF11D9,executive-appointment,100,54,11/7/2019
DF18E6,earnings,100,50,11/7/2019
DF8855,earnings-up,100,68,11/7/2019
DF8855,earnings-up,100,68,11/7/2019
DF8855,earnings-up,100,68,11/7/2019
DF8855,earnings-up,100,68,11/7/2019
DF8855,earnings-up,100,68,11/7/2019
DFADDB,earnings,100,50,11/7/2019
E06265,dividend,100,50,11/7/2019
E114F4,earnings,100,50,11/7/2019
E114F4,earnings,100,50,11/7/2019
E114F4,earnings,100,50,11/7/2019
E1BD05,earnings,100,50,11/7/2019
E1BD05,earnings,100,50,11/7/2019
E1C16B,public-offering,100,43,11/7/2019
E21871,dividend,100,50,11/7/2019
E2CB7B,unit-acquisition-acquirer,100,49,11/7/2019
E2CB7B,earnings,100,50,11/7/2019
E41190,earnings,100,50,11/7/2019
E41190,earnings,100,50,11/7/2019
E41190,earnings,100,50,11/7/2019
E41190,earnings,100,50,11/7/2019
E68E62,earnings,100,50,11/7/2019
E71AE6,earnings,100,50,11/7/2019
E72599,earnings,100,50,11/7/2019
E754F0,earnings,100,50,11/7/2019
E8846E,executive-appointment,100,54,11/7/2019
E96E0B,earnings,100,50,11/7/2019
EA62FC,conference-participant,100,50,11/7/2019
EAEBF3,earnings,100,50,11/7/2019
ED3CA8,earnings,100,50,11/7/2019
ED9576,dividend,100,50,11/7/2019
ED9C04,earnings,100,50,11/7/2019
ED9C04,earnings,100,50,11/7/2019
ED9C04,earnings,100,50,11/7/2019
ED9C04,earnings,100,50,11/7/2019
ED9C04,earnings,100,50,11/7/2019
EF1AD9,product-release,100,64,11/7/2019
EF25A5,earnings,100,50,11/7/2019
EF25A5,earnings,100,50,11/7/2019
EF25A5,earnings,100,50,11/7/2019
EF25A5,earnings,100,50,11/7/2019
EF25A5,executive-resignation,100,44,11/7/2019
EF5914,earnings,100,50,11/7/2019
EFA7B2,merger-completed,100,66,11/7/2019
F0027C,earnings,100,50,11/7/2019
F00285,earnings,100,50,11/7/2019
F0B335,conference-participant,100,50,11/7/2019
F4E882,legal-issues-defendant,100,22,11/7/2019
F5D410,board-meeting,100,51,11/7/2019
F6581D,earnings,100,50,11/7/2019
F6E248,acquisition-acquirer,100,49,11/7/2019
F6E248,acquisition-acquirer,100,49,11/7/2019
F6E248,partnership,100,61,11/7/2019
F748C7,partnership,100,61,11/7/2019
F769E9,earnings,100,50,11/7/2019
F7935D,earnings,100,50,11/7/2019
F80FF9,earnings,100,50,11/7/2019
F80FF9,partnership,100,61,11/7/2019
F83279,earnings,100,50,11/7/2019
F83279,earnings,100,50,11/7/2019
F88147,earnings,100,50,11/7/2019
F8BA6C,conference-participant,100,50,11/7/2019
F9AA02,earnings,100,50,11/7/2019
FA840E,earnings,100,50,11/7/2019
FAE021,dividend,100,50,11/7/2019
FB728F,earnings,100,50,11/7/2019
FB7724,legal-issues-defendant,100,22,11/7/2019
FBD92D,earnings,100,50,11/7/2019
FBD92D,earnings,100,50,11/7/2019
FBD92D,earnings,100,50,11/7/2019
FC1F9D,dividend,100,50,11/7/2019
FD2565,conference-participant,100,50,11/7/2019
FD39EB,earnings,100,50,11/7/2019
FD4588,earnings,100,50,11/7/2019
FD4588,earnings,100,50,11/7/2019
FD4588,earnings,100,50,11/7/2019
FD4588,earnings,100,50,11/7/2019
FE609F,conference-call,100,50,11/7/2019
06CB5B,earnings,100,50,11/8/2019
95294,acquisition-acquirer,100,49,11/8/2019
0E64D4,earnings,100,50,11/8/2019
0E64D4,earnings,100,50,11/8/2019
0E64D4,earnings,100,50,11/8/2019
0E64D4,earnings,100,50,11/8/2019
0F65C9,conference-participant,100,50,11/8/2019
0FC848,earnings,100,50,11/8/2019
152FA5,earnings,100,50,11/8/2019
16B882,earnings,100,50,11/8/2019
184866,public-offering,100,43,11/8/2019
184866,public-offering,100,43,11/8/2019
184988,clinical-trials,100,56,11/8/2019
18D9FA,earnings,100,50,11/8/2019
18D9FA,earnings,100,50,11/8/2019
197612,conference-participant,100,50,11/8/2019
19CAC7,dividend,100,50,11/8/2019
1A5D5D,legal-issues-defendant,100,22,11/8/2019
1CD4B5,conference-participant,100,50,11/8/2019
1E1125,conference-organizer,100,57,11/8/2019
1E1125,conference-organizer,100,57,11/8/2019
1FCC00,fundraising,100,64,11/8/2019
1FE3CB,note-sale,100,52,11/8/2019
21153F,buybacks,100,74,11/8/2019
21153F,buybacks,100,74,11/8/2019
225CA2,business-contract,100,69,11/8/2019
2491BC,legal-issues-defendant,100,22,11/8/2019
251988,executive-appointment,100,54,11/8/2019
26DC29,legal-issues-defendant,100,22,11/8/2019
28F905,legal-issues-defendant,100,22,11/8/2019
292A70,acquisition-completed-acquirer,100,49,11/8/2019
2B0AF4,dividend-suspended,100,13,11/8/2019
2BA977,legal-issues-defendant,100,22,11/8/2019
2CB4C9,partnership,100,61,11/8/2019
2DDB22,earnings,100,50,11/8/2019
306623,conference-participant,100,50,11/8/2019
3461CF,credit-rating-confirmation-rater,20,50,11/8/2019
3461CF,unit-acquisition-completed-acquiree,100,67,11/8/2019
34A959,legal-issues-defendant,100,22,11/8/2019
35F4B5,dividend,100,50,11/8/2019
36C09B,conference-call,100,50,11/8/2019
371B0A,conference-participant,100,50,11/8/2019
3B9886,conference-call,100,50,11/8/2019
3D7971,award,100,58,11/8/2019
3DED49,conference-call,100,50,11/8/2019
3E39A5,conference-participant,100,50,11/8/2019
3FBC9B,executive-appointment,100,54,11/8/2019
41EC04,legal-issues-defendant,100,22,11/8/2019
41EC04,fraud-defendant,100,20,11/8/2019
41EC04,legal-issues-defendant,100,22,11/8/2019
42AABD,legal-issues-defendant,100,22,11/8/2019
42AABD,legal-issues-defendant,100,22,11/8/2019
42AABD,legal-issues-defendant,100,22,11/8/2019
43A74A,conference-participant,100,50,11/8/2019
4A2457,business-contract,100,69,11/8/2019
4D8124,executive-appointment,100,54,11/8/2019
4E3D15,dividend,100,50,11/8/2019
4E4E75,settlement,100,56,11/8/2019
4EE167,conference-participant,100,50,11/8/2019
50070E,conference-organizer,100,57,11/8/2019
52B567,earnings,100,50,11/8/2019
52B567,earnings,100,50,11/8/2019
52B567,earnings,100,50,11/8/2019
52B567,earnings,100,50,11/8/2019
5.43E+08,legal-issues-defendant,100,22,11/8/2019
54F1D2,earnings,100,50,11/8/2019
55C9B5,partnership,100,61,11/8/2019
55C9B5,partnership,100,61,11/8/2019
56277A,conference-participant,100,50,11/8/2019
5876DC,buybacks,100,74,11/8/2019
58CA9A,conference-participant,100,50,11/8/2019
5A0FF1,conference-participant,100,50,11/8/2019
5B35C7,earnings,100,50,11/8/2019
5B35C7,earnings,100,50,11/8/2019
5D41E4,conference-participant,100,50,11/8/2019
61E975,conference-participant,100,50,11/8/2019
622DBE,legal-issues-defendant,100,22,11/8/2019
6.52E+64,legal-issues-defendant,100,22,11/8/2019
665D7D,regulatory-product-application,100,69,11/8/2019
665D7D,clinical-trials-filed,100,60,11/8/2019
66667F,revenue-up,100,79,11/8/2019
67B052,clinical-trials,100,56,11/8/2019
6925EB,clinical-trials,100,56,11/8/2019
6925EB,earnings,100,50,11/8/2019
69FDFC,partnership,100,61,11/8/2019
6A6BDC,dividend,100,50,11/8/2019
6D0CAB,dividend,100,50,11/8/2019
713810,conference-participant,100,50,11/8/2019
723548,earnings,100,50,11/8/2019
726DDF,earnings,100,50,11/8/2019
72FCA3,facility-open,100,65,11/8/2019
73A71F,legal-issues-defendant,100,22,11/8/2019
741937,earnings,100,50,11/8/2019
741937,earnings,100,50,11/8/2019
741937,earnings,100,50,11/8/2019
747219,legal-issues-defendant,100,22,11/8/2019
769F40,executive-appointment,100,54,11/8/2019
76E80F,dividend,100,50,11/8/2019
7710F3,legal-issues-defendant,100,22,11/8/2019
7823A3,legal-issues-defendant,100,22,11/8/2019
7823A3,conference-participant,100,50,11/8/2019
789A7D,earnings,100,50,11/8/2019
7ACFD4,legal-issues-defendant,100,22,11/8/2019
7B0BA6,conference-participant,100,50,11/8/2019
7B1E50,earnings-guidance,100,50,11/8/2019
7B1E50,earnings-guidance,100,50,11/8/2019
7BAAE7,dividend,100,50,11/8/2019
7D35D8,legal-issues-defendant,100,22,11/8/2019
7F3FBC,ipo,100,71,11/8/2019
82C202,clinical-trials-positive,100,87,11/8/2019
82C202,clinical-trials-positive,100,87,11/8/2019
8.40E+120,clinical-trials,100,56,11/8/2019
855DF7,earnings,100,50,11/8/2019
863350,executive-appointment,100,54,11/8/2019
8665BA,dividend,100,50,11/8/2019
883D82,earnings,100,50,11/8/2019
890FF4,conference-participant,100,50,11/8/2019
8BFAA4,earnings,100,50,11/8/2019
8BFAA4,earnings,100,50,11/8/2019
8BFAA4,earnings,100,50,11/8/2019
8BFAA4,earnings,100,50,11/8/2019
8DE56F,earnings,100,50,11/8/2019
8DE56F,earnings,100,50,11/8/2019
8FCA78,executive-appointment,100,54,11/8/2019
92D230,earnings,100,50,11/8/2019
92D230,earnings,100,50,11/8/2019
92D230,earnings,100,50,11/8/2019
92D230,earnings,100,50,11/8/2019
92D230,earnings,100,50,11/8/2019
92D230,earnings,100,50,11/8/2019
92D230,earnings,100,50,11/8/2019
968966,dividend,100,50,11/8/2019
96B4FF,clinical-trials,100,56,11/8/2019
980C14,dividend,100,50,11/8/2019
9C3D3C,conference-participant,100,50,11/8/2019
9E98F2,legal-issues-defendant,100,22,11/8/2019
A47A7D,business-contract,100,69,11/8/2019
A6828A,clinical-trials-filed,100,60,11/8/2019
A6828A,clinical-trials,100,56,11/8/2019
A8E72A,earnings,100,50,11/8/2019
AA98ED,public-offering,100,43,11/8/2019
ACD9A4,dividend,100,50,11/8/2019
ADFB3A,earnings,100,50,11/8/2019
AE0CCE,ipo-pricing,100,50,11/8/2019
AFF7B4,board-meeting,100,51,11/8/2019
B08C51,earnings,100,50,11/8/2019
B106FA,earnings,100,50,11/8/2019
B1DF3C,conference-participant,100,50,11/8/2019
B303A6,legal-issues-defendant,100,22,11/8/2019
B4F5F4,earnings,100,50,11/8/2019
B7202A,conference-participant,100,50,11/8/2019
B8F71F,dividend,100,50,11/8/2019
B8F71F,executive-appointment,100,54,11/8/2019
BD44C9,earnings,100,50,11/8/2019
BDE867,earnings,100,50,11/8/2019
BDE867,earnings,100,50,11/8/2019
BDE867,earnings,100,50,11/8/2019
BDE867,earnings,100,50,11/8/2019
C062D4,conference-participant,100,50,11/8/2019
C36189,earnings,100,50,11/8/2019
C564E4,conference-participant,100,50,11/8/2019
C584BE,earnings,100,50,11/8/2019
C8923A,conference-participant,100,50,11/8/2019
CB88B3,conference-participant,100,50,11/8/2019
CC176E,executive-appointment,100,54,11/8/2019
CD4DA8,conference-organizer,100,57,11/8/2019
CE2791,earnings,100,50,11/8/2019
D45285,earnings,100,50,11/8/2019
D45285,earnings,100,50,11/8/2019
D854F3,dividend,100,50,11/8/2019
D8DA3D,legal-issues-defendant,100,22,11/8/2019
D8ECA1,legal-issues-defendant,100,22,11/8/2019
D9FC89,credit-extension-recipient,100,69,11/8/2019
DB5CA5,earnings,100,50,11/8/2019
DBB28E,conference-call,100,50,11/8/2019
DF1F7A,dividend,100,50,11/8/2019
E11C41,earnings,100,50,11/8/2019
E6C8DC,business-combination,100,54,11/8/2019
E6D89E,partnership,100,61,11/8/2019
E94704,dividend-up,100,64,11/8/2019
EF5BED,earnings,100,50,11/8/2019
F3816D,earnings,100,50,11/8/2019
F569FD,conference-call,100,50,11/8/2019
F6DE54,conference-participant,100,50,11/8/2019
F9AA02,earnings,100,50,11/8/2019
F9CAF8,dividend,100,50,11/8/2019
FA840E,conference-participant,100,50,11/8/2019
FC1A6E,conference-participant,100,50,11/8/2019
FCA54E,public-offering,100,43,11/8/2019
FD0CA4,conference-participant,100,50,11/8/2019
FF227B,clinical-trials,100,56,11/8/2019
FF4BA4,dividend,100,50,11/8/2019
1A5D5D,legal-issues-defendant,100,22,11/9/2019
1A5D5D,legal-issues-defendant,100,22,11/9/2019
202E5A,clinical-trials,100,56,11/9/2019
28F905,legal-issues-defendant,100,22,11/9/2019
2C7505,clinical-trials-start,100,64,11/9/2019
2C7505,clinical-trials-start,100,64,11/9/2019
7A0EC4,partnership,100,61,11/9/2019
9978F1,clinical-trials,100,56,11/9/2019
AFDF2E,legal-issues-defendant,100,22,11/9/2019
D36B23,clinical-trials,100,56,11/9/2019
D8DA3D,legal-issues-defendant,100,22,11/9/2019
F72E4B,earnings,100,50,11/9/2019
F72E4B,earnings,100,50,11/9/2019
24A89A,legal-issues-defendant,100,22,11/10/2019
649CBD,clinical-trials,100,56,11/10/2019
8.10E+32,award,100,58,11/10/2019
002A99,earnings,100,50,11/11/2019
95294,earnings,100,50,11/11/2019
0A6824,dividend,100,50,11/11/2019
0A6824,executive-appointment,100,54,11/11/2019
0B400D,earnings,100,50,11/11/2019
0C2A0D,partnership,100,61,11/11/2019
0C6861,earnings,100,50,11/11/2019
0EF1AF,conference-call,100,50,11/11/2019
0F2BC9,unit-acquisition-acquirer,100,49,11/11/2019
0F65C9,acquisition-acquirer,100,49,11/11/2019
0FC848,earnings,100,50,11/11/2019
10100E,earnings,100,50,11/11/2019
1201B5,executive-appointment,100,54,11/11/2019
139303,conference-organizer,100,57,11/11/2019
15789A,earnings,100,50,11/11/2019
182BE7,earnings,100,50,11/11/2019
196D18,earnings,100,50,11/11/2019
1A5D5D,legal-issues-defendant,100,22,11/11/2019
1A5D5D,legal-issues-defendant,100,22,11/11/2019
1A5D5D,legal-issues-defendant,100,22,11/11/2019
1A5D5D,legal-issues-defendant,100,22,11/11/2019
1AE9D5,revenue-up,100,71,11/11/2019
1AE9D5,revenue-up,100,69,11/11/2019
1CF3A8,conference-call,100,50,11/11/2019
1E1125,conference-organizer,100,57,11/11/2019
1FE7F0,conference-participant,100,50,11/11/2019
205AD5,executive-appointment,100,54,11/11/2019
214051,executive-appointment,100,54,11/11/2019
2158DF,conference-participant,100,50,11/11/2019
21D903,earnings,100,50,11/11/2019
21D903,earnings,100,50,11/11/2019
221783,executive-appointment,100,54,11/11/2019
228D42,product-release,100,64,11/11/2019
241AF7,award,100,58,11/11/2019
2491BC,legal-issues-defendant,100,22,11/11/2019
24A89A,legal-issues-defendant,100,22,11/11/2019
25102A,conference-participant,100,50,11/11/2019
27C10F,award,100,58,11/11/2019
28F905,legal-issues-defendant,100,22,11/11/2019
2B49F4,dividend,100,50,11/11/2019
2B5483,conference-participant,100,50,11/11/2019
2D981A,merger,100,66,11/11/2019
2D981A,merger,100,66,11/11/2019
2D981A,merger,100,66,11/11/2019
2D981A,merger,100,66,11/11/2019
2D981A,merger,100,66,11/11/2019
2D981A,merger,100,66,11/11/2019
306623,executive-appointment,100,54,11/11/2019
31803E,conference-participant,100,50,11/11/2019
32C8CD,earnings,100,50,11/11/2019
396D7C,conference-participant,100,50,11/11/2019
3AAEAE,clinical-trials-start,100,64,11/11/2019
41C36B,clinical-trials,100,56,11/11/2019
41EC04,legal-issues-defendant,100,22,11/11/2019
422A82,earnings,100,50,11/11/2019
422A82,earnings,100,50,11/11/2019
422A82,earnings,100,50,11/11/2019
442587,acquisition-interest-acquirer,100,46,11/11/2019
485445,business-contract,100,69,11/11/2019
485445,business-contract,100,69,11/11/2019
4A6F00,partnership,100,61,11/11/2019
4A6F00,partnership,100,61,11/11/2019
4AE584,revenue-up,100,69,11/11/2019
4AE584,revenue-up,100,69,11/11/2019
4AE584,revenue-up,100,69,11/11/2019
4EEB00,conference-call,100,50,11/11/2019
52FB2F,settlement,100,56,11/11/2019
5.43E+08,legal-issues-defendant,100,22,11/11/2019
56277A,conference-participant,100,50,11/11/2019
58CA9A,partnership,100,61,11/11/2019
5CEE02,earnings,100,50,11/11/2019
619882,conference-organizer,100,57,11/11/2019
633054,partnership,100,61,11/11/2019
6391C2,ipo-pricing,100,50,11/11/2019
6FCEF9,earnings,100,50,11/11/2019
747219,legal-issues-defendant,100,22,11/11/2019
747219,legal-issues-defendant,100,22,11/11/2019
748EB6,earnings,100,50,11/11/2019
762A3E,conference-organizer,100,57,11/11/2019
762A3E,conference-organizer,100,57,11/11/2019
7710F3,legal-issues-defendant,100,22,11/11/2019
7823A3,legal-issues-defendant,100,22,11/11/2019
7E1D5D,unit-acquisition-acquirer,100,49,11/11/2019
8B8656,partnership,100,61,11/11/2019
911AB8,earnings-guidance,100,50,11/11/2019
9.31E+77,clinical-trials-filed,100,60,11/11/2019
9592FB,conference-participant,100,50,11/11/2019
96B4FF,earnings,100,50,11/11/2019
97FE80,legal-issues-defendant,100,22,11/11/2019
9.86E+03,conference-participant,100,50,11/11/2019
990AD0,conference-organizer,100,57,11/11/2019
994468,unit-acquisition-acquirer,100,49,11/11/2019
994468,unit-acquisition-acquirer,100,49,11/11/2019
9C5BA5,conference-participant,100,50,11/11/2019
9E98F2,legal-issues-defendant,100,22,11/11/2019
9F71E5,partnership,100,61,11/11/2019
9F71E5,partnership,100,61,11/11/2019
9F71E5,partnership,100,61,11/11/2019
A29A46,earnings,100,50,11/11/2019
A790A5,partnership,100,61,11/11/2019
A79F7D,earnings,100,50,11/11/2019
AD22F2,conference-call,100,50,11/11/2019
AFDF2E,legal-issues-defendant,100,22,11/11/2019
B09B1F,conference-participant,100,50,11/11/2019
B0FE08,earnings,100,50,11/11/2019
B0FE08,earnings,100,50,11/11/2019
B0FE08,earnings,100,50,11/11/2019
B0FE08,earnings,100,50,11/11/2019
B13B68,conference-participant,100,50,11/11/2019
B2206F,award,100,58,11/11/2019
B3A166,earnings,100,50,11/11/2019
B4C673,dividend,100,50,11/11/2019
B803B1,earnings,100,50,11/11/2019
BFD0A7,earnings,100,50,11/11/2019
BFD0A7,earnings,100,50,11/11/2019
BFD0A7,earnings,100,50,11/11/2019
C3BAE7,note-sale,100,52,11/11/2019
C8FAC7,partnership,100,61,11/11/2019
C93C44,business-contract,100,69,11/11/2019
CAC8D0,donation,100,54,11/11/2019
CDD75E,earnings,100,50,11/11/2019
CE4FD9,acquisition-acquirer,100,49,11/11/2019
CFF97C,credit-rating-upgrade-rater,20,50,11/11/2019
CFF97C,credit-rating-upgrade-rater,20,50,11/11/2019
CFF97C,credit-rating-upgrade-rater,20,50,11/11/2019
D8ECA1,legal-issues-defendant,100,22,11/11/2019
D8ECA1,legal-issues-defendant,100,22,11/11/2019
DAFED3,conference-participant,100,50,11/11/2019
E0207A,executive-appointment,100,54,11/11/2019
E22FDE,business-contract,100,69,11/11/2019
E68733,executive-appointment,100,54,11/11/2019
E82A2D,trading-listing,100,61,11/11/2019
F1CD47,conference-participant,100,50,11/11/2019
F4CDA3,conference-participant,100,50,11/11/2019
F4D241,earnings,100,50,11/11/2019
FEC475,dividend,100,50,11/11/2019
FEE4B0,public-offering,100,43,11/11/2019
00067A,partnership,100,61,11/12/2019
9397,credit-extension-recipient,100,69,11/12/2019
0157B1,partnership,100,61,11/12/2019
02FC1A,earnings,100,50,11/12/2019
02FC1A,earnings,100,50,11/12/2019
033B58,earnings,100,50,11/12/2019
03596A,earnings,100,50,11/12/2019
03B8CF,dividend,100,50,11/12/2019
03FAA6,award,100,58,11/12/2019
03FAA6,award,100,58,11/12/2019
0490C6,earnings,100,50,11/12/2019
0490C6,earnings,100,50,11/12/2019
0490C6,earnings,100,50,11/12/2019
0490C6,earnings,100,50,11/12/2019
05D148,clinical-trials,100,56,11/12/2019
0968A5,conference-call,100,50,11/12/2019
09DE1F,earnings,100,50,11/12/2019
0BD199,earnings,100,50,11/12/2019
0CCCB7,executive-appointment,100,54,11/12/2019
0CCCB7,executive-appointment,100,54,11/12/2019
0D03C8,earnings,100,50,11/12/2019
0F0693,fundraising,100,64,11/12/2019
1080C0,conference-participant,100,50,11/12/2019
12E454,partnership,100,61,11/12/2019
133644,conference-participant,100,50,11/12/2019
139303,conference-organizer,100,57,11/12/2019
14391F,earnings,100,50,11/12/2019
14391F,earnings,100,50,11/12/2019
14391F,earnings,100,50,11/12/2019
14391F,earnings,100,50,11/12/2019
14391F,earnings,100,50,11/12/2019
14391F,earnings,100,50,11/12/2019
143C52,conference-call,100,50,11/12/2019
147098,dividend,100,50,11/12/2019
15A388,earnings-positive,100,69,11/12/2019
15A388,earnings-positive,100,69,11/12/2019
15A388,earnings-positive,100,69,11/12/2019
15A388,earnings-positive,100,69,11/12/2019
15A388,earnings-positive,100,69,11/12/2019
15A388,executive-appointment,100,54,11/12/2019
168A5D,partnership,100,61,11/12/2019
17EDA5,partnership,100,61,11/12/2019
1880C5,earnings,100,50,11/12/2019
18D9FA,executive-appointment,100,54,11/12/2019
19BF16,earnings,100,50,11/12/2019
19BF16,earnings,100,50,11/12/2019
19BF16,earnings,100,50,11/12/2019
19BF16,earnings,100,50,11/12/2019
1A5D5D,legal-issues-defendant,100,22,11/12/2019
1A5D5D,legal-issues-defendant,100,22,11/12/2019
1AE482,revenue-up,100,55,11/12/2019
1AE482,revenue-up,100,55,11/12/2019
1AE482,revenue-up,100,55,11/12/2019
1CD4B5,earnings,100,50,11/12/2019
1D3A00,conference-call,100,50,11/12/2019
1D943E,earnings,100,50,11/12/2019
1F352C,earnings,100,50,11/12/2019
2082EA,conference-participant,100,50,11/12/2019
239106,conference-participant,100,50,11/12/2019
2491BC,legal-issues-defendant,100,22,11/12/2019
24A89A,earnings,100,50,11/12/2019
24A89A,earnings,100,50,11/12/2019
24A89A,legal-issues-defendant,100,22,11/12/2019
24FA23,conference-participant,100,50,11/12/2019
25102A,unit-acquisition-acquiree,100,76,11/12/2019
251988,partnership,100,61,11/12/2019
251988,partnership,100,61,11/12/2019
251988,partnership,100,61,11/12/2019
25D3CE,earnings,100,50,11/12/2019
267718,clinical-trials,100,56,11/12/2019
267718,clinical-trials,100,56,11/12/2019
267718,clinical-trials,100,56,11/12/2019
26E3BA,earnings,100,50,11/12/2019
284289,conference-participant,100,50,11/12/2019
28AF37,executive-appointment,100,54,11/12/2019
28AF37,earnings,100,50,11/12/2019
28AF37,earnings,100,50,11/12/2019
28AF37,earnings,100,50,11/12/2019
28AF37,earnings,100,50,11/12/2019
28F905,legal-issues-defendant,100,22,11/12/2019
28F905,legal-issues-defendant,100,22,11/12/2019
28F905,legal-issues-defendant,100,22,11/12/2019
2A6DBE,earnings,100,50,11/12/2019
2AA6A8,partnership,100,61,11/12/2019
2AA6A8,earnings,100,50,11/12/2019
2B0AF4,executive-appointment,100,54,11/12/2019
2CA60F,earnings,100,50,11/12/2019
2CA60F,earnings,100,50,11/12/2019
2CA60F,earnings,100,50,11/12/2019
2E902B,conference-participant,100,50,11/12/2019
2F9304,partnership,100,61,11/12/2019
31803E,earnings,100,50,11/12/2019
31F25C,legal-issues-defendant,100,22,11/12/2019
33AD83,conference-call,100,50,11/12/2019
3461CF,partnership,100,61,11/12/2019
34B97A,executive-appointment,100,54,11/12/2019
36C09B,earnings,100,50,11/12/2019
3.73E+87,partnership,100,61,11/12/2019
385DD4,business-contract,100,69,11/12/2019
385DD4,business-contract,100,69,11/12/2019
385DD4,business-contract,100,69,11/12/2019
3A3447,facility-open,100,65,11/12/2019
3A4BDB,executive-appointment,100,54,11/12/2019
3AAEAE,clinical-trials-start,100,64,11/12/2019
3B2311,conference-participant,100,50,11/12/2019
3B50FE,conference-call,100,50,11/12/2019
3C7F5F,earnings,100,50,11/12/2019
3C7F5F,earnings,100,50,11/12/2019
3C8A04,dividend,100,50,11/12/2019
3E70FC,earnings,100,50,11/12/2019
3F1C69,conference-participant,100,50,11/12/2019
407878,earnings,100,50,11/12/2019
40F7DE,earnings,100,50,11/12/2019
416C55,earnings,100,50,11/12/2019
41EC04,legal-issues-defendant,100,22,11/12/2019
41ED98,earnings,100,50,11/12/2019
41ED98,unit-acquisition-acquiree,100,76,11/12/2019
42EFC7,earnings,100,50,11/12/2019
43A74A,executive-appointment,100,54,11/12/2019
442587,facility-open,100,65,11/12/2019
450ECB,conference-call,100,50,11/12/2019
458D2C,product-release,100,64,11/12/2019
458D2C,revenue-volume,100,50,11/12/2019
4.60E+06,earnings,100,50,11/12/2019
47BA98,acquisition-completed-acquirer,100,49,11/12/2019
49A344,executive-appointment,100,54,11/12/2019
4A3438,earnings,100,50,11/12/2019
4A3438,earnings,100,50,11/12/2019
4A3438,earnings,100,50,11/12/2019
4C350A,conference-call,100,50,11/12/2019
4C3FE9,earnings,100,50,11/12/2019
4CDA2B,earnings,100,50,11/12/2019
4D371E,executive-appointment,100,54,11/12/2019
4EEB00,operating-earnings,100,50,11/12/2019
4FB770,dividend,100,50,11/12/2019
50D1EC,conference-participant,100,50,11/12/2019
510EA1,earnings,100,50,11/12/2019
523039,earnings,100,50,11/12/2019
52B567,conference-participant,100,50,11/12/2019
532D47,note-sale,100,52,11/12/2019
539F49,earnings,100,50,11/12/2019
5.43E+08,legal-issues-defendant,100,22,11/12/2019
546A27,earnings,100,50,11/12/2019
55438C,executive-appointment,100,54,11/12/2019
5546DA,executive-appointment,100,54,11/12/2019
556F08,earnings,100,50,11/12/2019
57A854,earnings-up,100,68,11/12/2019
57A854,earnings,100,50,11/12/2019
57A854,earnings,100,50,11/12/2019
57DDB9,business-contract,100,69,11/12/2019
587D25,earnings,100,50,11/12/2019
58CA9A,partnership,100,61,11/12/2019
58EA22,earnings,100,50,11/12/2019
5A423F,conference-participant,100,50,11/12/2019
5B226B,revenue-up,100,64,11/12/2019
5B226B,revenue-up,100,64,11/12/2019
5B226B,revenue-up,100,64,11/12/2019
5B7739,earnings,100,50,11/12/2019
5D02B7,conference-call,100,50,11/12/2019
5DD486,executive-resignation,100,44,11/12/2019
5F1B7B,earnings,100,50,11/12/2019
5F3D91,earnings,100,50,11/12/2019
5F3D91,earnings,100,50,11/12/2019
5F3D91,earnings,100,50,11/12/2019
6.18E+08,facility-open,100,65,11/12/2019
61BCA7,executive-appointment,100,54,11/12/2019
622DBE,legal-issues-defendant,100,22,11/12/2019
622DBE,legal-issues-defendant,100,22,11/12/2019
629F0F,earnings,100,50,11/12/2019
657097,unit-acquisition-acquirer,100,49,11/12/2019
65D0AA,conference-participant,100,50,11/12/2019
665440,conference-participant,100,50,11/12/2019
66749D,dividend,100,50,11/12/2019
66ECFD,dividend-up,100,81,11/12/2019
66ECFD,acquisition-acquirer,100,49,11/12/2019
67303E,partnership,100,61,11/12/2019
673C9A,earnings,100,50,11/12/2019
68AB62,earnings,100,50,11/12/2019
69494C,conference-call,100,50,11/12/2019
698FF9,public-offering,100,43,11/12/2019
6B67BD,earnings,100,50,11/12/2019
6F3936,conference-call,100,50,11/12/2019
71694D,earnings,100,50,11/12/2019
728737,dividend,100,50,11/12/2019
72CB93,conference-participant,100,50,11/12/2019
73A71F,legal-issues-defendant,100,22,11/12/2019
73F70F,dividend,100,50,11/12/2019
747219,conference-participant,100,50,11/12/2019
747219,legal-issues-defendant,100,22,11/12/2019
756045,executive-appointment,100,54,11/12/2019
763DBE,earnings,100,50,11/12/2019
76B926,dividend,100,50,11/12/2019
76DD0C,executive-appointment,100,54,11/12/2019
7710F3,legal-issues-defendant,100,22,11/12/2019
7710F3,earnings,100,50,11/12/2019
7710F3,earnings,100,50,11/12/2019
7823A3,partnership,100,61,11/12/2019
7823A3,legal-issues-defendant,100,22,11/12/2019
787D14,executive-appointment,100,54,11/12/2019
78F776,earnings,100,50,11/12/2019
7ACFD4,earnings,100,50,11/12/2019
7ACFD4,earnings,100,50,11/12/2019
7ACFD4,earnings,100,50,11/12/2019
7ACFD4,earnings,100,50,11/12/2019
7ACFD4,earnings,100,50,11/12/2019
7BC92D,earnings,100,50,11/12/2019
7BEA98,conference-participant,100,50,11/12/2019
7C4F43,earnings,100,50,11/12/2019
7E1542,ipo-completed,100,76,11/12/2019
7FEEE1,earnings,100,50,11/12/2019
805CD8,clinical-trials-start,100,64,11/12/2019
805CD8,earnings,100,50,11/12/2019
810FAD,partnership,100,61,11/12/2019
819492,earnings,100,50,11/12/2019
8195B7,earnings,100,50,11/12/2019
81EAD4,partnership,100,61,11/12/2019
82E58A,dividend,100,50,11/12/2019
85CDC9,regulatory-product-approval-granted,100,81,11/12/2019
85CDC9,conference-participant,100,50,11/12/2019
8.79E+06,earnings,100,50,11/12/2019
89E771,earnings,100,50,11/12/2019
89F693,debt-extension-recipient,100,73,11/12/2019
8A8E41,conference-participant,100,50,11/12/2019
8AB85C,clinical-trials-start,100,64,11/12/2019
8AB85C,earnings,100,50,11/12/2019
8B4A45,facility-open,100,65,11/12/2019
8B9B3B,conference-participant,100,50,11/12/2019
8BAA15,business-contract,100,69,11/12/2019
8BAA15,business-contract,100,69,11/12/2019
8BAA15,business-contract,100,69,11/12/2019
8D0EEA,earnings,100,50,11/12/2019
8D4486,executive-appointment,100,54,11/12/2019
8D4486,executive-appointment,100,54,11/12/2019
8D4486,partnership,100,61,11/12/2019
8D5145,executive-appointment,100,54,11/12/2019
8DCF18,earnings,100,50,11/12/2019
8DCF18,earnings,100,50,11/12/2019
8DCF18,note-sale,100,52,11/12/2019
9196A2,conference-organizer,100,57,11/12/2019
925759,conference-participant,100,50,11/12/2019
92D757,product-release,100,64,11/12/2019
92D757,conference-participant,100,50,11/12/2019
9.31E+77,conference-participant,100,50,11/12/2019
938D89,earnings,100,50,11/12/2019
93F143,dividend,100,50,11/12/2019
95C575,dividend,100,50,11/12/2019
968B00,dividend,100,50,11/12/2019
96B4FF,public-offering,100,43,11/12/2019
97644E,earnings,100,50,11/12/2019
97644E,earnings,100,50,11/12/2019
97644E,earnings,100,50,11/12/2019
97644E,earnings,100,50,11/12/2019
97644E,earnings,100,50,11/12/2019
990AD0,conference-organizer,100,57,11/12/2019
99ACAD,note-sale,100,52,11/12/2019
9BB35A,public-offering,100,43,11/12/2019
9BF177,executive-appointment,100,54,11/12/2019
9C3D3C,earnings,100,50,11/12/2019
9C3D3C,earnings,100,50,11/12/2019
9C3D3C,earnings,100,50,11/12/2019
9C3D3C,earnings,100,50,11/12/2019
9D30A8,product-release,100,64,11/12/2019
9D30A8,product-release,100,64,11/12/2019
9D65C1,conference-participant,100,50,11/12/2019
9E575E,conference-participant,100,50,11/12/2019
9FB4B7,clinical-trials-positive,100,87,11/12/2019
A017F4,earnings,100,50,11/12/2019
A28675,earnings,100,50,11/12/2019
A29DBD,earnings,100,50,11/12/2019
A2C979,earnings,100,50,11/12/2019
A350C1,executive-appointment,100,54,11/12/2019
A3AAA5,dividend,100,50,11/12/2019
A48593,earnings,100,50,11/12/2019
A5195E,public-offering,100,43,11/12/2019
A631A3,earnings,100,50,11/12/2019
A6FE1C,unit-acquisition-acquirer,100,49,11/12/2019
A8E72A,earnings,100,50,11/12/2019
AD1ACF,earnings,100,50,11/12/2019
AEEB76,earnings,100,50,11/12/2019
AEEB76,earnings,100,50,11/12/2019
AFDF2E,legal-issues-defendant,100,22,11/12/2019
AFF7B4,fundraising,100,64,11/12/2019
B05000,conference-participant,100,50,11/12/2019
B1A85D,note-sale,100,52,11/12/2019
B33E77,earnings,100,50,11/12/2019
B508E5,executive-appointment,100,54,11/12/2019
B508E5,earnings,100,50,11/12/2019
B508E5,earnings,100,50,11/12/2019
B6843B,earnings,100,50,11/12/2019
B6843B,earnings,100,50,11/12/2019
B6843B,earnings,100,50,11/12/2019
B6843B,earnings,100,50,11/12/2019
B6843B,earnings,100,50,11/12/2019
BDD12C,executive-appointment,100,54,11/12/2019
BDEF34,dividend,100,50,11/12/2019
BE645B,earnings,100,50,11/12/2019
BF5959,conference-call,100,50,11/12/2019
C0BA36,earnings,100,50,11/12/2019
C11C46,conference-participant,100,50,11/12/2019
C2DD02,earnings,100,50,11/12/2019
C45C1F,conference-participant,100,50,11/12/2019
C4A432,partnership,100,61,11/12/2019
C93C44,earnings,100,50,11/12/2019
C9732E,earnings,100,50,11/12/2019
C9739A,earnings,100,50,11/12/2019
C97B2D,note-sale,100,52,11/12/2019
CC0C78,revenues,100,50,11/12/2019
CD051C,conference-participant,100,50,11/12/2019
CD2A4D,partnership,100,61,11/12/2019
CDC817,earnings,100,50,11/12/2019
D03C7A,index-listing,100,76,11/12/2019
D0DE27,earnings,100,50,11/12/2019
D13F1C,earnings,100,50,11/12/2019
D13F1C,earnings,100,50,11/12/2019
D13F1C,earnings,100,50,11/12/2019
D13F1C,earnings,100,50,11/12/2019
D13F1C,earnings,100,50,11/12/2019
D1588D,earnings,100,50,11/12/2019
D17C1B,revenue-volume,100,50,11/12/2019
D27FAB,earnings,100,50,11/12/2019
D36B23,earnings,100,50,11/12/2019
D36B23,public-offering,100,43,11/12/2019
D4C0CB,earnings,100,50,11/12/2019
D5938F,conference-participant,100,50,11/12/2019
D5B13D,earnings,100,50,11/12/2019
D63B0F,executive-appointment,100,54,11/12/2019
D75910,conference-call,100,50,11/12/2019
D77F7E,note-sale,100,52,11/12/2019
D8DA3D,legal-issues-defendant,100,22,11/12/2019
D8DA3D,note-sale,100,52,11/12/2019
D8DA3D,note-sale,100,52,11/12/2019
D8DA3D,legal-issues-defendant,100,22,11/12/2019
D8DA3D,legal-issues-defendant,100,22,11/12/2019
D8DA3D,note-sale,100,52,11/12/2019
D8ECA1,earnings,100,50,11/12/2019
D8ECA1,earnings,100,50,11/12/2019
D8ECA1,earnings,100,50,11/12/2019
D8ECA1,earnings,100,50,11/12/2019
D8ECA1,earnings,100,50,11/12/2019
D8ECA1,legal-issues-defendant,100,22,11/12/2019
D95385,earnings,100,50,11/12/2019
DA91AE,dividend,100,50,11/12/2019
DA9443,conference-participant,100,50,11/12/2019
DB88A1,award,100,58,11/12/2019
DBCA3F,market-entry,100,57,11/12/2019
DC0066,earnings,100,50,11/12/2019
DC6EF3,earnings,100,50,11/12/2019
DF01B1,conference-participant,100,50,11/12/2019
DF42A0,dividend,100,50,11/12/2019
DF42A0,earnings,100,50,11/12/2019
DF42A0,earnings,100,50,11/12/2019
DF42A0,earnings,100,50,11/12/2019
DF42A0,earnings,100,50,11/12/2019
E09997,earnings,100,50,11/12/2019
E13782,earnings,100,50,11/12/2019
E15736,acquisition-completed-acquirer,100,49,11/12/2019
E1E093,business-contract,100,69,11/12/2019
E28D9C,conference-participant,100,50,11/12/2019
E2CFD2,note-sale,100,52,11/12/2019
E3656D,earnings,100,50,11/12/2019
E5C910,earnings,100,50,11/12/2019
E69BA5,conference-participant,100,50,11/12/2019
E71AE6,conference-participant,100,50,11/12/2019
E829E8,dividend,100,50,11/12/2019
E99180,note-sale,100,52,11/12/2019
EB1E1A,earnings,100,50,11/12/2019
EB43F4,earnings,100,50,11/12/2019
EB5E78,earnings,100,50,11/12/2019
EB5E78,earnings,100,50,11/12/2019
EB5E78,earnings,100,50,11/12/2019
EB5E78,earnings,100,50,11/12/2019
ED22DC,earnings,100,50,11/12/2019
EF5BED,executive-appointment,100,54,11/12/2019
EF77A3,business-contract,100,69,11/12/2019
F0027C,conference-participant,100,50,11/12/2019
F0EEFB,conference-participant,100,50,11/12/2019
F1C04C,facility-upgrade,100,65,11/12/2019
F209B4,conference-participant,100,50,11/12/2019
F3816D,conference-participant,100,50,11/12/2019
F39E1E,earnings,100,50,11/12/2019
F4E882,revenue-volume-up,100,69,11/12/2019
F4E882,conference-call,100,50,11/12/2019
F58C23,earnings,100,50,11/12/2019
F58C23,earnings,100,50,11/12/2019
F6581D,earnings,100,50,11/12/2019
F6A987,dividend,100,50,11/12/2019
F6DE54,dividend,100,50,11/12/2019
F6E1B5,earnings,100,50,11/12/2019
F93C8A,dividend,100,50,11/12/2019
F9AA02,clinical-trials-start,100,64,11/12/2019
FA840E,public-offering,100,43,11/12/2019
FC80E6,dividend,100,50,11/12/2019
FE609F,earnings,100,50,11/12/2019
FEC475,partnership,100,61,11/12/2019
FEC475,partnership,100,61,11/12/2019
00326E,earnings,100,50,11/13/2019
02FC1A,conference-participant,100,50,11/13/2019
0A6824,earnings,100,50,11/13/2019
0A9D0A,conference-participant,100,50,11/13/2019
0AD2E3,conference-participant,100,50,11/13/2019
0B400D,legal-issues-defendant,100,22,11/13/2019
0B400D,earnings,100,50,11/13/2019
0B400D,earnings,100,50,11/13/2019
0B400D,earnings,100,50,11/13/2019
0BD970,buybacks,100,74,11/13/2019
0C2A0D,conference-participant,100,50,11/13/2019
0DBB81,conference-participant,100,50,11/13/2019
0E499E,conference-participant,100,50,11/13/2019
0EF1AF,earnings,100,50,11/13/2019
0FC848,legal-issues-defendant,100,22,11/13/2019
1065BC,dividend,100,50,11/13/2019
1220D2,conference-participant,100,50,11/13/2019
1272B3,partnership,100,61,11/13/2019
1272B3,executive-appointment,100,54,11/13/2019
12DE76,earnings,100,50,11/13/2019
12DE76,earnings,100,50,11/13/2019
12DE76,earnings,100,50,11/13/2019
12DE76,earnings,100,50,11/13/2019
13C3E0,partnership,100,61,11/13/2019
168A5D,facility-open,100,65,11/13/2019
1866B2,executive-appointment,100,54,11/13/2019
1921DD,partnership,100,61,11/13/2019
19C105,executive-appointment,100,54,11/13/2019
1A3E1B,earnings,100,50,11/13/2019
1A5D5D,legal-issues-defendant,100,22,11/13/2019
1AC649,conference-participant,100,50,11/13/2019
1B5FEA,earnings,100,50,11/13/2019
1B5FEA,earnings,100,50,11/13/2019
1B5FEA,earnings,100,50,11/13/2019
1B6F77,earnings,100,50,11/13/2019
1EBF8D,product-release,100,64,11/13/2019
1F19C8,market-entry,100,57,11/13/2019
1FA886,buybacks,100,74,11/13/2019
2491BC,legal-issues-defendant,100,22,11/13/2019
24CB56,earnings,100,50,11/13/2019
267718,business-contract,100,69,11/13/2019
267718,business-contract,100,69,11/13/2019
26DC29,legal-issues-defendant,100,22,11/13/2019
28F905,legal-issues-defendant,100,22,11/13/2019
2B8179,conference-participant,100,50,11/13/2019
2D76CE,earnings,100,50,11/13/2019
2D76CE,earnings,100,50,11/13/2019
2D76CE,earnings,100,50,11/13/2019
2F7474,dividend,100,50,11/13/2019
3587B4,partnership,100,61,11/13/2019
3AAEAE,conference-participant,100,50,11/13/2019
3CCC90,partnership,100,61,11/13/2019
3DD5E2,conference-participant,100,50,11/13/2019
3F96D5,public-offering,100,43,11/13/2019
41EC04,legal-issues-defendant,100,22,11/13/2019
429BFB,conference-participant,100,50,11/13/2019
4398A2,earnings,100,50,11/13/2019
451D61,public-offering,100,43,11/13/2019
49A344,business-contract,100,69,11/13/2019
4AC91D,partnership,100,61,11/13/2019
4AC91D,product-release,100,64,11/13/2019
4BDCA7,conference-participant,100,50,11/13/2019
4C2F17,earnings,100,50,11/13/2019
4ECD1A,earnings,100,50,11/13/2019
51F541,dividend,100,50,11/13/2019
520632,executive-appointment,100,54,11/13/2019
520632,executive-appointment,100,54,11/13/2019
53EF9E,dividend,100,50,11/13/2019
564F3E,dividend,100,50,11/13/2019
56EFC7,earnings,100,50,11/13/2019
586FFD,dividend-up,100,81,11/13/2019
59DB8C,conference-participant,100,50,11/13/2019
5D63F1,note-sale,100,52,11/13/2019
5F2FF7,partnership,100,61,11/13/2019
619882,partnership,100,61,11/13/2019
620381,earnings,100,50,11/13/2019
622DBE,legal-issues-defendant,100,22,11/13/2019
62A48D,earnings,100,50,11/13/2019
62CDDE,conference-participant,100,50,11/13/2019
6391C2,ipo-completed,100,76,11/13/2019
65CF8E,dividend,100,50,11/13/2019
65CF8E,dividend,100,50,11/13/2019
665D7D,note-sale,100,52,11/13/2019
67B052,conference-participant,100,50,11/13/2019
6830FE,partnership,100,61,11/13/2019
6830FE,partnership,100,61,11/13/2019
68E6E9,dividend-up,100,81,11/13/2019
693ECD,patent-awarded,100,72,11/13/2019
6C4D2F,dividend,100,50,11/13/2019
6F22E7,conference-call,100,50,11/13/2019
722DE3,earnings-up,100,68,11/13/2019
722DE3,earnings,100,50,11/13/2019
72FCA3,facility-open,100,65,11/13/2019
747219,legal-issues-defendant,100,22,11/13/2019
76E80F,conference-call,100,50,11/13/2019
7823A3,legal-issues-defendant,100,22,11/13/2019
7AF907,earnings,100,50,11/13/2019
7D35D8,legal-issues-defendant,100,22,11/13/2019
7E1D5D,earnings,100,50,11/13/2019
82E58A,executive-appointment,100,54,11/13/2019
834152,public-offering,100,43,11/13/2019
8665BA,facility-open,100,65,11/13/2019
885758,legal-issues-defendant,100,22,11/13/2019
89F693,conference-participant,100,50,11/13/2019
8B6E7E,earnings,100,50,11/13/2019
8B6E7E,earnings,100,50,11/13/2019
8B6E7E,earnings,100,50,11/13/2019
8B6E7E,earnings,100,50,11/13/2019
8E3F58,public-offering,100,43,11/13/2019
8FF2EF,earnings,100,50,11/13/2019
913437,earnings,100,50,11/13/2019
9196A2,partnership,100,61,11/13/2019
9196A2,conference-organizer,100,57,11/13/2019
934CC3,earnings,100,50,11/13/2019
934CC3,executive-appointment,100,54,11/13/2019
93D207,executive-appointment,100,54,11/13/2019
949625,note-sale,100,52,11/13/2019
949625,note-sale,100,52,11/13/2019
9546A5,earnings,100,50,11/13/2019
95DC1F,partnership,100,61,11/13/2019
968966,partnership,100,61,11/13/2019
9A02C4,product-release,100,64,11/13/2019
9C25FF,partnership,100,61,11/13/2019
9D5D35,executive-appointment,100,54,11/13/2019
9E298A,dividend-up,100,81,11/13/2019
9F18FA,note-sale,100,52,11/13/2019
9F18FA,note-sale,100,52,11/13/2019
A01200,earnings,100,50,11/13/2019
A01200,earnings,100,50,11/13/2019
A01200,earnings,100,50,11/13/2019
A01200,earnings,100,50,11/13/2019
A1BB98,conference-participant,100,50,11/13/2019
A2A9BA,earnings,100,50,11/13/2019
A4BCDE,conference-participant,100,50,11/13/2019
A4D173,partnership,100,61,11/13/2019
A5DD24,conference-participant,100,50,11/13/2019
A7A0C8,conference-participant,100,50,11/13/2019
AD3C93,executive-appointment,100,54,11/13/2019
AE0CCE,ipo-completed,100,76,11/13/2019
AE0CCE,executive-appointment,100,54,11/13/2019
AE79CD,earnings,100,50,11/13/2019
AFDF2E,legal-issues-defendant,100,22,11/13/2019
B08C51,earnings,100,50,11/13/2019
B1A85D,note-sale,100,52,11/13/2019
B1DF3C,conference-participant,100,50,11/13/2019
B96637,award,100,58,11/13/2019
B9764A,partnership,100,61,11/13/2019
BD682F,dividend,100,50,11/13/2019
BFAEB4,legal-issues-defendant,100,22,11/13/2019
C01737,conference-participant,100,50,11/13/2019
C22BE8,acquisition-completed-acquirer,100,49,11/13/2019
C3F99F,conference-participant,100,50,11/13/2019
C8923A,conference-participant,100,50,11/13/2019
CA212F,business-contract,100,69,11/13/2019
CC8F6E,legal-issues-defendant,100,22,11/13/2019
CDAA0E,conference-participant,100,50,11/13/2019
CE5664,campaign-ad-release,100,59,11/13/2019
CE96E7,conference-participant,100,50,11/13/2019
CF073E,earnings,100,50,11/13/2019
D07B07,conference-participant,100,50,11/13/2019
D437C3,partnership,100,61,11/13/2019
D437C3,partnership,100,61,11/13/2019
D82EF3,product-release,100,64,11/13/2019
D854DD,earnings,100,50,11/13/2019
D88EF3,partnership,100,61,11/13/2019
D8DA3D,legal-issues-defendant,100,22,11/13/2019
DB9F70,earnings,100,50,11/13/2019
DBB28E,partnership,100,61,11/13/2019
DD0099,dividend,100,50,11/13/2019
DDEA6A,conference-participant,100,50,11/13/2019
DE4924,dividend,100,50,11/13/2019
DE4924,earnings,100,50,11/13/2019
E28D9C,executive-appointment,100,54,11/13/2019
E35610,product-release,100,64,11/13/2019
E38906,conference-participant,100,50,11/13/2019
E4CE73,executive-appointment,100,54,11/13/2019
E598FB,conference-participant,100,50,11/13/2019
E69BA5,dividend,100,50,11/13/2019
E8B21D,dividend,100,50,11/13/2019
EAEBF3,note-sale,100,52,11/13/2019
ED22DC,conference-participant,100,50,11/13/2019
EEB5F9,conference-participant,100,50,11/13/2019
F0B2B5,executive-resignation,100,44,11/13/2019
F1C04C,conference-participant,100,50,11/13/2019
F1EB39,government-contract,100,69,11/13/2019
F4E992,earnings,100,50,11/13/2019
F6E248,stake-acquirer,100,48,11/13/2019
F6E248,stake-acquirer,100,48,11/13/2019
F92DBC,partnership,100,61,11/13/2019
FAB97A,conference-participant,100,50,11/13/2019
FC1736,partnership,100,61,11/13/2019
FDD3FC,conference-participant,100,50,11/13/2019
FE609F,earnings,100,50,11/13/2019
FEC475,executive-appointment,100,54,11/13/2019
13528,dividend,100,50,11/14/2019
0157B1,business-contract,100,69,11/14/2019
0157B1,market-entry,100,57,11/14/2019
20751,conference-participant,100,50,11/14/2019
02FC1A,conference-participant,100,50,11/14/2019
03D5F9,merger,100,66,11/14/2019
03D5F9,merger,100,66,11/14/2019
03D5F9,executive-resignation,100,44,11/14/2019
0490C6,index-listing,100,76,11/14/2019
0624BE,dividend,100,50,11/14/2019
06A456,conference-call,100,50,11/14/2019
71860,conference-participant,100,50,11/14/2019
081AB9,conference-participant,100,50,11/14/2019
09062E,conference-participant,100,50,11/14/2019
0AAD90,earnings,100,50,11/14/2019
0B400D,legal-issues-defendant,100,22,11/14/2019
0BF198,executive-appointment,100,54,11/14/2019
0FDE97,product-release,100,64,11/14/2019
1201B5,earnings,100,50,11/14/2019
1201B5,earnings,100,50,11/14/2019
1201B5,earnings,100,50,11/14/2019
135B09,dividend-up,100,81,11/14/2019
139303,conference-organizer,100,57,11/14/2019
14391F,public-offering,100,43,11/14/2019
143C52,regulatory-product-warning,100,23,11/14/2019
1490F3,award,100,58,11/14/2019
157CC1,earnings,100,50,11/14/2019
1.79E+10,dividend,100,50,11/14/2019
17EDA5,executive-appointment,100,54,11/14/2019
196D18,conference-participant,100,50,11/14/2019
1A5D5D,legal-issues-defendant,100,22,11/14/2019
1A5D5D,fraud-defendant,100,20,11/14/2019
1DE526,earnings,100,50,11/14/2019
221445,dividend,100,50,11/14/2019
228D42,partnership,100,61,11/14/2019
228D42,partnership,100,61,11/14/2019
2491BC,partnership,100,61,11/14/2019
2491BC,legal-issues-defendant,100,22,11/14/2019
249B39,dividend,100,50,11/14/2019
24A89A,legal-issues-defendant,100,22,11/14/2019
26DC29,conference-call,100,50,11/14/2019
26DC29,legal-issues-defendant,100,22,11/14/2019
26F99F,earnings,100,50,11/14/2019
28F905,legal-issues-defendant,100,22,11/14/2019
28F905,fraud-defendant,100,20,11/14/2019
29A4CC,merger-regulatory-approval,100,81,11/14/2019
29A4CC,merger-regulatory-approval,100,81,11/14/2019
2CC60C,conference-call,100,50,11/14/2019
2CC71C,conference-participant,100,50,11/14/2019
2DA92D,executive-appointment,100,54,11/14/2019
2EB88B,partnership,100,61,11/14/2019
2EC172,conference-participant,100,50,11/14/2019
2F5256,dividend,100,50,11/14/2019
3159AA,earnings,100,50,11/14/2019
3159AA,dividend,100,50,11/14/2019
3159AA,product-recall,100,29,11/14/2019
31F25C,legal-issues-defendant,100,22,11/14/2019
32F943,partnership,100,61,11/14/2019
3301B7,executive-appointment,100,54,11/14/2019
3461CF,credit-rating-confirmation-rater,20,50,11/14/2019
34A959,legal-issues-defendant,100,22,11/14/2019
34B411,note-sale,100,52,11/14/2019
3587B4,partnership,100,61,11/14/2019
366C3B,partnership,100,61,11/14/2019
371B0A,conference-participant,100,50,11/14/2019
37426C,earnings,100,50,11/14/2019
384CD3,dividend,100,50,11/14/2019
3A3447,dividend-up,100,81,11/14/2019
401072,conference-participant,100,50,11/14/2019
416C55,partnership,100,61,11/14/2019
41785E,dividend,100,50,11/14/2019
417BF9,partnership,100,61,11/14/2019
417BF9,partnership,100,61,11/14/2019
41EC04,legal-issues-defendant,100,22,11/14/2019
41ED98,executive-appointment,100,54,11/14/2019
41ED98,executive-appointment,100,54,11/14/2019
422A82,earnings,100,50,11/14/2019
45ABCC,revenue-volume-up,100,56,11/14/2019
4.91E+58,executive-appointment,100,54,11/14/2019
4.91E+58,executive-appointment,100,54,11/14/2019
4A6F00,product-release,100,64,11/14/2019
4AC91D,dividend,100,50,11/14/2019
4C37C5,executive-appointment,100,54,11/14/2019
4CDA2B,conference-participant,100,50,11/14/2019
4ECD1A,earnings,100,50,11/14/2019
4ECD1A,earnings,100,50,11/14/2019
4ECD1A,earnings,100,50,11/14/2019
519FE0,earnings,100,50,11/14/2019
519FE0,earnings,100,50,11/14/2019
519FE0,earnings,100,50,11/14/2019
519FE0,earnings,100,50,11/14/2019
519FE0,earnings,100,50,11/14/2019
589846,product-release,100,64,11/14/2019
5D02B7,dividend,100,50,11/14/2019
5DD486,product-release,100,64,11/14/2019
5EAA43,dividend,100,50,11/14/2019
601785,acquisition-completed-acquirer,100,49,11/14/2019
6166D1,executive-appointment,100,54,11/14/2019
622DBE,legal-issues-defendant,100,22,11/14/2019
693ECD,earnings,100,50,11/14/2019
693ECD,earnings,100,50,11/14/2019
69494C,earnings,100,50,11/14/2019
698FF9,public-offering,100,43,11/14/2019
6BF593,executive-appointment,100,54,11/14/2019
6CC55E,conference-participant,100,50,11/14/2019
6D2BF6,earnings,100,50,11/14/2019
6EB9DA,donation,100,54,11/14/2019
701531,conference-participant,100,50,11/14/2019
713810,same-store-sales-up,100,53,11/14/2019
73A71F,legal-issues-defendant,100,22,11/14/2019
7.45E+28,regulatory-product-approval-granted,100,81,11/14/2019
7.45E+28,earnings,100,50,11/14/2019
763DBE,executive-resignation,100,44,11/14/2019
769F40,dividend,100,50,11/14/2019
76DD0C,earnings,100,50,11/14/2019
7823A3,legal-issues-defendant,100,22,11/14/2019
791EC1,business-contract,100,69,11/14/2019
7A0EC4,earnings,100,50,11/14/2019
7ACFD4,legal-issues-defendant,100,22,11/14/2019
7ACFD4,legal-issues-defendant,100,22,11/14/2019
7B6C88,earnings,100,50,11/14/2019
7D35D8,legal-issues-defendant,100,22,11/14/2019
7EA323,earnings,100,50,11/14/2019
7F7C87,earnings,100,50,11/14/2019
7FD8B9,conference-participant,100,50,11/14/2019
8.10E+32,conference-organizer,100,57,11/14/2019
810FAD,dividend,100,50,11/14/2019
817ED9,dividend,100,50,11/14/2019
834152,public-offering,100,43,11/14/2019
873DB9,conference-participant,100,50,11/14/2019
8AB85C,conference-participant,100,50,11/14/2019
8BE916,dividend,100,50,11/14/2019
8DCF18,note-sale,100,52,11/14/2019
8E10BF,earnings,100,50,11/14/2019
8E3F58,public-offering,100,43,11/14/2019
8EEA28,earnings,100,50,11/14/2019
9196A2,conference-organizer,100,57,11/14/2019
9196A2,conference-organizer,100,57,11/14/2019
92D757,dividend,100,50,11/14/2019
93F143,acquisition-completed-acquirer,100,49,11/14/2019
94983E,dividend,100,50,11/14/2019
96B4FF,public-offering,100,43,11/14/2019
9.86E+03,product-release,100,64,11/14/2019
990AD0,conference-organizer,100,57,11/14/2019
990AD0,acquisition-completed-acquiree,100,76,11/14/2019
99B61C,executive-appointment,100,54,11/14/2019
9AF3DC,investment-investor,100,55,11/14/2019
9AF3DC,facility-upgrade,100,65,11/14/2019
9BB35A,public-offering,100,43,11/14/2019
9D2790,dividend,100,50,11/14/2019
9FA83B,executive-appointment,100,54,11/14/2019
A01200,conference-participant,100,50,11/14/2019
A1BB98,dividend,100,50,11/14/2019
A2C979,conference-participant,100,50,11/14/2019
A4BCDE,earnings,100,50,11/14/2019
A5195E,public-offering,100,43,11/14/2019
A5195E,conference-participant,100,50,11/14/2019
A60354,dividend,100,50,11/14/2019
A60354,executive-appointment,100,54,11/14/2019
A631A3,partnership,100,61,11/14/2019
A6FC89,executive-appointment,100,54,11/14/2019
A79F7D,earnings,100,50,11/14/2019
A7A0C8,earnings,100,50,11/14/2019
AA98ED,public-offering,100,43,11/14/2019
ADD9DC,market-entry,100,57,11/14/2019
B0D41A,conference-participant,100,50,11/14/2019
B446B8,business-contract,100,69,11/14/2019
B48D6A,partnership,100,61,11/14/2019
B4C673,product-release,100,64,11/14/2019
B83BCE,conference-participant,100,50,11/14/2019
BA0442,earnings,100,50,11/14/2019
BB0587,dividend,100,50,11/14/2019
BB0787,dividend,100,50,11/14/2019
BB127B,partnership,100,61,11/14/2019
BBC05B,conference-participant,100,50,11/14/2019
BF5959,revenue-up,100,67,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C4452A,earnings,100,50,11/14/2019
C45CE7,dividend,100,50,11/14/2019
C58D71,conference-participant,100,50,11/14/2019
C9A96E,conference-participant,100,50,11/14/2019
C9A96E,conference-participant,100,50,11/14/2019
CCB623,conference-participant,100,50,11/14/2019
CE8A7B,earnings,100,50,11/14/2019
CE96E7,dividend,100,50,11/14/2019
CEC08B,business-contract,100,69,11/14/2019
CF3FF9,conference-participant,100,50,11/14/2019
CF6A5A,operating-earnings,100,50,11/14/2019
D437C3,partnership,100,61,11/14/2019
D5B13D,conference-participant,100,50,11/14/2019
D64C6D,dividend-up,100,61,11/14/2019
D64C6D,executive-appointment,100,54,11/14/2019
D721C6,facility-open,100,65,11/14/2019
D76AEF,dividend,100,50,11/14/2019
D8ECA1,legal-issues-defendant,100,22,11/14/2019
D8ECA1,legal-issues-defendant,100,22,11/14/2019
D8F347,dividend,100,50,11/14/2019
D8F347,executive-appointment,100,54,11/14/2019
DAFED3,dividend,100,50,11/14/2019
E09E2B,earnings,100,50,11/14/2019
E09E2B,earnings,100,50,11/14/2019
E09E2B,earnings,100,50,11/14/2019
E2CB7B,conference-participant,100,50,11/14/2019
E49AA3,dividend,100,50,11/14/2019
E4CE73,partnership,100,61,11/14/2019
E5C910,conference-participant,100,50,11/14/2019
E610CD,acquisition-acquirer,100,49,11/14/2019
E6A53A,dividend,100,50,11/14/2019
E6A53A,dividend,100,50,11/14/2019
E7BF32,conference-participant,100,50,11/14/2019
E7BF32,conference-participant,100,50,11/14/2019
E8E899,partnership,100,61,11/14/2019
EE04F0,executive-appointment,100,54,11/14/2019
F05B1B,earnings,100,50,11/14/2019
F05B1B,earnings,100,50,11/14/2019
F1EB39,business-contract,100,69,11/14/2019
F509E2,conference-call,100,50,11/14/2019
F569FD,conference-participant,100,50,11/14/2019
F5C78B,partnership,100,61,11/14/2019
F5D499,earnings,100,50,11/14/2019
F6A392,earnings,100,50,11/14/2019
F82D37,buybacks,100,74,11/14/2019
F82D37,note-sale,100,52,11/14/2019
F88147,earnings,100,50,11/14/2019
F93C8A,public-offering,100,43,11/14/2019
F93C8A,public-offering,100,43,11/14/2019
FA35C6,partnership,100,61,11/14/2019
FA40E2,unit-acquisition-acquiree,100,76,11/14/2019
FC4550,dividend,100,50,11/14/2019
FDC7E6,conference-participant,100,50,11/14/2019
FF4343,dividend,100,50,11/14/2019
002A99,legal-issues-defendant,100,22,11/15/2019
01D03F,acquisition-acquirer,100,49,11/15/2019
036C6F,dividend,100,50,11/15/2019
0E5619,conference-participant,100,50,11/15/2019
12A3A3,dividend,100,50,11/15/2019
139303,buybacks,100,74,11/15/2019
1A5D5D,legal-issues-defendant,100,22,11/15/2019
1B6F77,clinical-trials,100,56,11/15/2019
228D42,partnership,100,61,11/15/2019
2491BC,legal-issues-defendant,100,22,11/15/2019
24C48B,dividend,100,50,11/15/2019
26F99F,conference-participant,100,50,11/15/2019
2.89E+11,dividend,100,50,11/15/2019
28F905,legal-issues-defendant,100,22,11/15/2019
28F905,legal-issues-defendant,100,22,11/15/2019
2B49F4,conference-call,100,50,11/15/2019
2B9DBB,dividend,100,50,11/15/2019
2B9DBB,executive-appointment,100,54,11/15/2019
2C35B5,conference-participant,100,50,11/15/2019
31F25C,legal-issues-defendant,100,22,11/15/2019
34A959,acquisition-acquirer,100,49,11/15/2019
367434,conference-participant,100,50,11/15/2019
3E39A5,award,100,58,11/15/2019
41EC04,legal-issues-defendant,100,22,11/15/2019
41EC04,legal-issues-defendant,100,22,11/15/2019
422CE3,partnership,100,61,11/15/2019
422CE3,partnership,100,61,11/15/2019
51E682,dividend,100,50,11/15/2019
51E682,executive-appointment,100,54,11/15/2019
57356F,note-sale,100,52,11/15/2019
586BD7,conference-participant,100,50,11/15/2019
5BE42C,executive-appointment,100,54,11/15/2019
5D87DF,earnings,100,50,11/15/2019
5E6959,dividend-up,100,61,11/15/2019
619882,dividend,100,50,11/15/2019
622DBE,legal-issues-defendant,100,22,11/15/2019
6844D2,dividend,100,50,11/15/2019
68E6E9,executive-resignation,100,44,11/15/2019
6D156D,legal-issues-defendant,100,22,11/15/2019
735388,dividend,100,50,11/15/2019
73A71F,legal-issues-defendant,100,22,11/15/2019
747219,legal-issues-defendant,100,22,11/15/2019
7823A3,legal-issues-defendant,100,22,11/15/2019
7A51FE,dividend,100,50,11/15/2019
7ACFD4,legal-issues-defendant,100,22,11/15/2019
7B9AFA,conference-participant,100,50,11/15/2019
7D35D8,legal-issues-defendant,100,22,11/15/2019
7E1D5D,acquisition-completed-acquirer,100,49,11/15/2019
8.10E+32,dividend,100,50,11/15/2019
862941,conference-participant,100,50,11/15/2019
88611B,dividend,100,50,11/15/2019
8CF6DD,conference-call,100,50,11/15/2019
8F6995,earnings-up,100,68,11/15/2019
94637C,acquisition-regulatory-approval-acquirer,100,54,11/15/2019
94983E,conference-participant,100,50,11/15/2019
9592FB,product-release,100,64,11/15/2019
97FE80,legal-issues-defendant,100,22,11/15/2019
9FB4B7,conference-participant,100,50,11/15/2019
9FF5F1,conference-participant,100,50,11/15/2019
A21649,dividend,100,50,11/15/2019
A4B899,dividend,100,50,11/15/2019
A5628C,partnership,100,61,11/15/2019
A8FDE8,conference-participant,100,50,11/15/2019
A9ED24,dividend,100,50,11/15/2019
AB7726,dividend-up,100,81,11/15/2019
AB7726,executive-appointment,100,54,11/15/2019
AFDF2E,legal-issues-defendant,100,22,11/15/2019
AFDF2E,legal-issues-defendant,100,22,11/15/2019
B01111,executive-appointment,100,54,11/15/2019
B33E77,conference-participant,100,50,11/15/2019
B37FB4,dividend,100,50,11/15/2019
B762D3,dividend,100,50,11/15/2019
BB127B,product-release,100,64,11/15/2019
BFE02C,dividend,100,50,11/15/2019
CA99D7,dividend,100,50,11/15/2019
CBFFDD,note-sale,100,52,11/15/2019
CC8F6E,legal-issues-defendant,100,22,11/15/2019
CE1002,award,100,58,11/15/2019
D36B23,public-offering,100,43,11/15/2019
D60BB2,dividend,100,50,11/15/2019
D77F7E,note-sale,100,52,11/15/2019
D8442A,revenue-up,100,69,11/15/2019
D8DA3D,legal-issues-defendant,100,22,11/15/2019
D8ECA1,legal-issues-defendant,100,22,11/15/2019
DB23C8,conference-participant,100,50,11/15/2019
DB5CA5,campaign-ad-release,100,59,11/15/2019
DB7EC3,executive-resignation,100,44,11/15/2019
DD0099,acquisition-regulatory-approval-acquirer,100,54,11/15/2019
DDCB34,conference-participant,100,50,11/15/2019
E0D3BA,note-sale,100,52,11/15/2019
E0D3BA,note-sale,100,52,11/15/2019
E3E68E,executive-appointment,100,54,11/15/2019
E3E68E,executive-appointment,100,54,11/15/2019
E8846E,dividend,100,50,11/15/2019
EAEA91,operating-earnings-up,100,68,11/15/2019
F5D410,note-sale,100,52,11/15/2019
F90EE5,executive-appointment,100,54,11/15/2019
FA840E,public-offering,100,43,11/15/2019
FCA54E,public-offering,100,43,11/15/2019
FF5413,dividend,100,50,11/15/2019
1A5D5D,legal-issues-defendant,100,22,11/16/2019
2491BC,legal-issues-defendant,100,22,11/16/2019
28F905,legal-issues-defendant,100,22,11/16/2019
34A959,legal-issues-defendant,100,22,11/16/2019
41EC04,legal-issues-defendant,100,22,11/16/2019
622DBE,legal-issues-defendant,100,22,11/16/2019
7823A3,legal-issues-defendant,100,22,11/16/2019
7ACFD4,legal-issues-defendant,100,22,11/16/2019
D8ECA1,legal-issues-defendant,100,22,11/16/2019
4BF3D6,conference-call,100,50,11/17/2019
0358AF,revenue-up,100,69,11/18/2019
09F623,conference-participant,100,50,11/18/2019
0A59F8,note-sale,100,52,11/18/2019
0BC29E,executive-appointment,100,54,11/18/2019
0C28D1,business-contract,100,69,11/18/2019
0DC050,partnership,100,61,11/18/2019
0F2BC9,business-contract,100,69,11/18/2019
106394,note-sale,100,52,11/18/2019
126F95,dividend,100,50,11/18/2019
139303,conference-organizer,100,57,11/18/2019
139303,conference-organizer,100,57,11/18/2019
14ED2B,acquisition-acquirer,100,49,11/18/2019
17EDA5,product-release,100,64,11/18/2019
17EDA5,partnership,100,61,11/18/2019
17EDA5,partnership,100,61,11/18/2019
1921DD,partnership,100,61,11/18/2019
1A5D5D,legal-issues-defendant,100,22,11/18/2019
1A5D5D,legal-issues-defendant,100,22,11/18/2019
1B9535,executive-appointment,100,54,11/18/2019
2082EA,acquisition-acquirer,100,49,11/18/2019
228D42,partnership,100,61,11/18/2019
2491BC,legal-issues-defendant,100,22,11/18/2019
2491BC,legal-issues-defendant,100,22,11/18/2019
24A89A,legal-issues-defendant,100,22,11/18/2019
26DC29,award,100,58,11/18/2019
273BA3,product-release,100,64,11/18/2019
28F905,legal-issues-defendant,100,22,11/18/2019
2AE625,executive-appointment,100,54,11/18/2019
2E36AD,business-contract,100,69,11/18/2019
3471C0,executive-appointment,100,54,11/18/2019
34A959,legal-issues-defendant,100,22,11/18/2019
36C09B,conference-participant,100,50,11/18/2019
387541,note-sale,100,52,11/18/2019
3A3447,executive-appointment,100,54,11/18/2019
3A6D90,executive-resignation,100,44,11/18/2019
3B318A,conference-call,100,50,11/18/2019
3B8484,acquisition-acquirer,100,49,11/18/2019
3BB616,note-sale,100,52,11/18/2019
3ED92D,note-sale,100,52,11/18/2019
3ED92D,note-sale,100,52,11/18/2019
41EC04,legal-issues-defendant,100,22,11/18/2019
41EC04,legal-issues-defendant,100,22,11/18/2019
47FCF2,public-offering,100,43,11/18/2019
4A6F00,partnership,100,61,11/18/2019
4BF3D6,clinical-trials-complete,100,56,11/18/2019
4BF3D6,public-offering,100,43,11/18/2019
4F9926,stake-acquirer,100,48,11/18/2019
50070E,analyst-ratings-set-positive-rater,20,50,11/18/2019
524CE4,earnings-guidance-up,100,83,11/18/2019
524CE4,earnings-guidance-up,100,83,11/18/2019
548AC0,conference-call,100,50,11/18/2019
57CAAB,partnership,100,61,11/18/2019
57DDB9,executive-appointment,100,54,11/18/2019
57DDB9,executive-appointment,100,54,11/18/2019
57DDB9,executive-appointment,100,54,11/18/2019
59872F,executive-appointment,100,54,11/18/2019
5A9F54,executive-appointment,100,54,11/18/2019
5D16CF,executive-appointment,100,54,11/18/2019
6166D1,acquisition-acquirer,100,49,11/18/2019
622DBE,legal-issues-defendant,100,22,11/18/2019
63F892,partnership,100,61,11/18/2019
63F892,business-contract,100,69,11/18/2019
63F892,business-contract,100,69,11/18/2019
665D7D,debt-extension-recipient,100,73,11/18/2019
6A961B,conference-participant,100,50,11/18/2019
6E705B,business-contract,100,69,11/18/2019
6F39FC,public-offering,100,43,11/18/2019
73A71F,legal-issues-defendant,100,22,11/18/2019
7823A3,legal-issues-defendant,100,22,11/18/2019
7A0EC4,business-contract,100,69,11/18/2019
7A0EC4,business-contract,100,69,11/18/2019
7ACFD4,legal-issues-defendant,100,22,11/18/2019
7BEA98,executive-appointment,100,54,11/18/2019
7D35D8,legal-issues-defendant,100,22,11/18/2019
81222C,executive-appointment,100,54,11/18/2019
8.10E+205,conference-call,100,50,11/18/2019
834152,conference-participant,100,50,11/18/2019
834152,public-offering,100,43,11/18/2019
8.40E+120,clinical-trials,100,56,11/18/2019
859D62,earnings,100,50,11/18/2019
8.79E+06,partnership,100,61,11/18/2019
88D80A,earnings,100,50,11/18/2019
8E8E6E,unit-acquisition-completed-acquiree,100,67,11/18/2019
8EF425,note-sale,100,52,11/18/2019
905356,earnings-per-share-positive,100,69,11/18/2019
905356,earnings,100,50,11/18/2019
9196A2,public-offering,100,43,11/18/2019
971334,dividend,100,50,11/18/2019
97FE80,legal-issues-defendant,100,22,11/18/2019
9B4066,unit-acquisition-acquirer,100,49,11/18/2019
9CA619,dividend,100,50,11/18/2019
9FA83B,public-offering,100,43,11/18/2019
A16DEA,note-sale,100,52,11/18/2019
A495F7,award,100,58,11/18/2019
A52B6B,conference-participant,100,50,11/18/2019
A72FD9,earnings,100,50,11/18/2019
AADE0B,unit-acquisition-acquirer,100,49,11/18/2019
AC7C4F,partnership,100,61,11/18/2019
ACC7D3,conference-participant,100,50,11/18/2019
AD3008,note-sale,100,52,11/18/2019
AD375D,business-contract,100,69,11/18/2019
AD375D,public-offering,100,43,11/18/2019
ADFB3A,executive-appointment,100,54,11/18/2019
AEFC90,clinical-trials,100,56,11/18/2019
AEFC90,clinical-trials,100,56,11/18/2019
AFDF2E,legal-issues-defendant,100,22,11/18/2019
B303A6,index-listing,100,76,11/18/2019
BB88B6,executive-appointment,100,54,11/18/2019
C407A0,patent-infringement-plaintiff,100,47,11/18/2019
C48574,conference-participant,100,50,11/18/2019
C7863D,settlement,100,56,11/18/2019
C7FC95,business-contract,100,69,11/18/2019
C83B88,antitrust-suit-defendant,100,21,11/18/2019
C8FAC7,award,100,58,11/18/2019
C93C44,conference-participant,100,50,11/18/2019
C94CFC,earnings,100,50,11/18/2019
C9739A,executive-appointment,100,54,11/18/2019
CAB222,partnership,100,61,11/18/2019
CC176E,executive-appointment,100,54,11/18/2019
CC6FF5,conference-participant,100,50,11/18/2019
CE8251,business-contract,100,69,11/18/2019
CFF97C,conference-participant,100,50,11/18/2019
D03C7A,dividend,100,50,11/18/2019
D4AC65,executive-appointment,100,54,11/18/2019
D8DA3D,legal-issues-defendant,100,22,11/18/2019
D8ECA1,dividend,100,50,11/18/2019
D8ECA1,legal-issues-defendant,100,22,11/18/2019
D95385,conference-participant,100,50,11/18/2019
DB5CA5,public-offering,100,43,11/18/2019
DB5CA5,public-offering,100,43,11/18/2019
DB7014,unit-acquisition-acquirer,100,49,11/18/2019
DBB28E,product-release,100,64,11/18/2019
DFADDB,business-contract,100,69,11/18/2019
DFADDB,business-contract,100,69,11/18/2019
E09E2B,partnership,100,61,11/18/2019
E09E2B,partnership,100,61,11/18/2019
E261E9,earnings,100,50,11/18/2019
E28D9C,conference-participant,100,50,11/18/2019
E592F0,legal-issues-plaintiff,100,44,11/18/2019
E6A53A,earnings,100,50,11/18/2019
E6A53A,earnings,100,50,11/18/2019
E6A53A,earnings,100,50,11/18/2019
E71AE6,patient-enrollment-complete,100,64,11/18/2019
E71AE6,patient-enrollment-complete,100,64,11/18/2019
E90C84,dividend,100,50,11/18/2019
EAA0A7,conference-participant,100,50,11/18/2019
ECD263,partnership,100,61,11/18/2019
EE1E44,business-combination,100,54,11/18/2019
EF1AD9,executive-appointment,100,54,11/18/2019
F18844,partnership,100,61,11/18/2019
F2BC3D,earnings,100,50,11/18/2019
F4E882,note-sale,100,52,11/18/2019
F4E882,note-sale,100,52,11/18/2019
F5349B,executive-appointment,100,54,11/18/2019
FC1F9D,facility-close,100,47,11/18/2019
FC1F9D,facility-close,100,47,11/18/2019
FEBFE1,trading-listing,100,61,11/18/2019
0157B1,partnership,100,61,11/19/2019
03B431,conference-participant,100,50,11/19/2019
03D5F9,partnership,100,61,11/19/2019
55018,partnership,100,61,11/19/2019
099C88,business-contract,100,69,11/19/2019
0BC29E,market-entry,100,57,11/19/2019
0C6861,note-sale,100,52,11/19/2019
0CE7F6,dividend,100,50,11/19/2019
0EF1AF,executive-appointment,100,54,11/19/2019
0F0440,earnings,100,50,11/19/2019
0F0440,earnings,100,50,11/19/2019
10673F,dividend,100,50,11/19/2019
12F98C,executive-appointment,100,54,11/19/2019
139303,conference-organizer,100,57,11/19/2019
139303,conference-organizer,100,57,11/19/2019
139303,conference-organizer,100,57,11/19/2019
139303,conference-organizer,100,57,11/19/2019
14391F,executive-appointment,100,54,11/19/2019
143C52,executive-resignation,100,44,11/19/2019
14ED2B,note-sale,100,52,11/19/2019
152AB9,business-contract,100,69,11/19/2019
152FA5,conference-participant,100,50,11/19/2019
15B10D,earnings-guidance,100,50,11/19/2019
168A5D,partnership,100,61,11/19/2019
1A3E1B,merger-regulatory-approval,100,81,11/19/2019
1A3E1B,merger-regulatory-approval,100,81,11/19/2019
1A5D5D,legal-issues-defendant,100,22,11/19/2019
1E1125,conference-organizer,100,57,11/19/2019
1E1125,conference-organizer,100,57,11/19/2019
1E1125,conference-organizer,100,57,11/19/2019
1E9A6D,acquisition-regulatory-approval-acquirer,100,54,11/19/2019
1EBF8D,dividend,100,50,11/19/2019
1FAF22,dividend,100,50,11/19/2019
2158DF,partnership,100,61,11/19/2019
223552,earnings,100,50,11/19/2019
228D42,partnership,100,61,11/19/2019
228D42,partnership,100,61,11/19/2019
2491BC,legal-issues-defendant,100,22,11/19/2019
263216,dividend-up,100,81,11/19/2019
28F905,legal-issues-defendant,100,22,11/19/2019
2E0496,executive-appointment,100,54,11/19/2019
2E0496,executive-appointment,100,54,11/19/2019
2EB04E,partnership,100,61,11/19/2019
2F1299,earnings,100,50,11/19/2019
319BE2,buybacks,100,74,11/19/2019
33AD83,product-release,100,64,11/19/2019
33AD83,product-release,100,64,11/19/2019
34B97A,award,100,58,11/19/2019
387541,note-sale,100,52,11/19/2019
3D7971,dividend,100,50,11/19/2019
40B903,earnings,100,50,11/19/2019
40B903,earnings,100,50,11/19/2019
40B903,earnings,100,50,11/19/2019
40B903,earnings,100,50,11/19/2019
416C55,partnership,100,61,11/19/2019
41EC04,legal-issues-defendant,100,22,11/19/2019
44A4FC,executive-appointment,100,54,11/19/2019
450ECB,partnership,100,61,11/19/2019
450ECB,partnership,100,61,11/19/2019
46CF27,unit-acquisition-acquirer,100,49,11/19/2019
46CF27,unit-acquisition-acquirer,100,49,11/19/2019
49BBBC,earnings,100,50,11/19/2019
4C2F17,partnership,100,61,11/19/2019
4C2F17,conference-participant,100,50,11/19/2019
4F9926,partnership,100,61,11/19/2019
50070E,executive-resignation,100,44,11/19/2019
50070E,executive-resignation,100,44,11/19/2019
50070E,executive-resignation,100,44,11/19/2019
50070E,executive-resignation,100,44,11/19/2019
50070E,conference-organizer,100,57,11/19/2019
5480A7,executive-appointment,100,54,11/19/2019
5480A7,dividend-up,100,57,11/19/2019
54F271,earnings,100,50,11/19/2019
550D01,facility-open,100,65,11/19/2019
55438C,business-contract,100,69,11/19/2019
55438C,business-contract,100,69,11/19/2019
56AFF4,dividend,100,50,11/19/2019
5F3D91,executive-appointment,100,54,11/19/2019
60FE03,public-offering,100,43,11/19/2019
616E3B,dividend,100,50,11/19/2019
61B81B,unit-acquisition-completed-acquiree,100,67,11/19/2019
62CDDE,conference-participant,100,50,11/19/2019
69345C,product-release,100,64,11/19/2019
69FDFC,executive-appointment,100,54,11/19/2019
6D9B53,clinical-trials,100,56,11/19/2019
6F39FC,public-offering,100,43,11/19/2019
73C9E2,unit-acquisition-completed-acquirer,100,49,11/19/2019
73C9E2,acquisition-completed-acquirer,100,49,11/19/2019
756BB4,earnings,100,50,11/19/2019
769F40,executive-appointment,100,54,11/19/2019
7823A3,legal-issues-defendant,100,22,11/19/2019
78F776,public-offering,100,43,11/19/2019
791D59,partnership,100,61,11/19/2019
7A0EC4,conference-participant,100,50,11/19/2019
7AB859,acquisition-acquirer,100,49,11/19/2019
7ACFD4,legal-issues-defendant,100,22,11/19/2019
7F3669,conference-participant,100,50,11/19/2019
7F9984,conference-participant,100,50,11/19/2019
82E58A,earnings,100,50,11/19/2019
83A065,public-offering,100,43,11/19/2019
83E0AC,dividend,100,50,11/19/2019
859D62,partnership,100,61,11/19/2019
860AB6,award,100,58,11/19/2019
8665BA,index-listing,100,76,11/19/2019
8D4486,partnership,100,61,11/19/2019
8E8E6E,executive-appointment,100,54,11/19/2019
8EDACA,conference-call,100,50,11/19/2019
925759,business-contract,100,69,11/19/2019
954004,conference-call,100,50,11/19/2019
95DC1F,partnership,100,61,11/19/2019
967D92,dividend,100,50,11/19/2019
9.86E+03,partnership,100,61,11/19/2019
990AD0,conference-organizer,100,57,11/19/2019
990AD0,conference-organizer,100,57,11/19/2019
9D2790,executive-appointment,100,54,11/19/2019
9D307D,partnership,100,61,11/19/2019
9D307D,partnership,100,61,11/19/2019
9F18FA,earnings,100,50,11/19/2019
9F18FA,earnings,100,50,11/19/2019
A26EF7,rights-issue,100,43,11/19/2019
A28C54,business-contract,100,69,11/19/2019
A398F8,conference-participant,100,50,11/19/2019
A60318,executive-appointment,100,54,11/19/2019
A631A3,conference-participant,100,50,11/19/2019
A631A3,conference-participant,100,50,11/19/2019
A63387,executive-appointment,100,54,11/19/2019
A761FE,conference-call,100,50,11/19/2019
A868C9,business-contract,100,69,11/19/2019
ACDF88,earnings,100,50,11/19/2019
ACDF88,earnings,100,50,11/19/2019
ACDF88,earnings,100,50,11/19/2019
AD23DE,business-contract,100,69,11/19/2019
AFDF2E,legal-issues-defendant,100,22,11/19/2019
B508E5,business-contract,100,69,11/19/2019
B560AF,dividend,100,50,11/19/2019
BB127B,partnership,100,61,11/19/2019
BCC55F,partnership,100,61,11/19/2019
BCC55F,partnership,100,61,11/19/2019
BCE9DA,executive-appointment,100,54,11/19/2019
BCE9DA,executive-appointment,100,54,11/19/2019
BFAEB4,legal-issues-defendant,100,22,11/19/2019
C3BAE7,conference-participant,100,50,11/19/2019
C4706C,earnings,100,50,11/19/2019
C4A241,conference-participant,100,50,11/19/2019
C4C77F,conference-call,100,50,11/19/2019
C83B88,product-release,100,64,11/19/2019
CAB222,conference-participant,100,50,11/19/2019
CB89EA,executive-appointment,100,54,11/19/2019
CBFFDD,legal-issues-defendant,100,22,11/19/2019
CD4DA8,conference-organizer,100,57,11/19/2019
CD4DA8,conference-organizer,100,57,11/19/2019
CE5664,executive-appointment,100,54,11/19/2019
CE5664,dividend,100,50,11/19/2019
CE96E7,partnership,100,61,11/19/2019
CEC08B,merger-completed,100,66,11/19/2019
CFF97C,revenue-up,100,69,11/19/2019
CFF97C,note-sale,100,52,11/19/2019
D1173F,note-sale,100,52,11/19/2019
D1173F,note-sale,100,52,11/19/2019
D1AE3B,dividend,100,50,11/19/2019
D33D8C,business-contract,100,69,11/19/2019
D36B23,public-offering,100,43,11/19/2019
D4AC65,partnership,100,61,11/19/2019
D8ECA1,legal-issues-defendant,100,22,11/19/2019
DB5CA5,public-offering,100,43,11/19/2019
DB9829,earnings,100,50,11/19/2019
DBB28E,partnership,100,61,11/19/2019
DDEA6A,partnership,100,61,11/19/2019
DDEA6A,business-contract,100,69,11/19/2019
DDEA6A,business-contract,100,69,11/19/2019
DF6FDD,executive-appointment,100,54,11/19/2019
E12A6E,executive-appointment,100,54,11/19/2019
E1E093,partnership,100,61,11/19/2019
E20BFE,revenues,100,50,11/19/2019
E20BFE,revenues,100,50,11/19/2019
E2CFD2,conference-participant,100,50,11/19/2019
E30B34,executive-appointment,100,54,11/19/2019
E30B34,dividend,100,50,11/19/2019
E30B34,dividend,100,50,11/19/2019
E4CE73,conference-participant,100,50,11/19/2019
E68733,earnings,100,50,11/19/2019
E68733,earnings,100,50,11/19/2019
E68733,earnings,100,50,11/19/2019
E74B55,product-release,100,64,11/19/2019
E74B55,product-release,100,64,11/19/2019
E8846E,conference-organizer,100,57,11/19/2019
E8846E,conference-organizer,100,57,11/19/2019
E959F3,conference-participant,100,50,11/19/2019
EAEBF3,conference-participant,100,50,11/19/2019
ED2EFD,public-offering,100,43,11/19/2019
ED79D9,product-release,100,64,11/19/2019
EF25A5,product-release,100,64,11/19/2019
EF45B6,earnings,100,50,11/19/2019
F02170,executive-appointment,100,54,11/19/2019
F1EB39,conference-call,100,50,11/19/2019
F294DD,dividend-up,100,81,11/19/2019
F30508,conference-call,100,50,11/19/2019
F39E1E,legal-issues-defendant,100,22,11/19/2019
F48947,conference-participant,100,50,11/19/2019
F4E882,legal-issues-defendant,100,22,11/19/2019
F4F46F,conference-participant,100,50,11/19/2019
F5349B,note-sale,100,52,11/19/2019
F5349B,note-sale,100,52,11/19/2019
F6DCE4,conference-call,100,50,11/19/2019
FCA54E,public-offering,100,43,11/19/2019
FDF799,conference-participant,100,50,11/19/2019
FFCD0E,business-contract,100,69,11/19/2019
0157B1,partnership,100,61,11/20/2019
099C88,business-contract,100,69,11/20/2019
0A7650,dividend,100,50,11/20/2019
12DE76,partnership,100,61,11/20/2019
139303,conference-organizer,100,57,11/20/2019
139303,conference-organizer,100,57,11/20/2019
139303,conference-organizer,100,57,11/20/2019
139303,conference-organizer,100,57,11/20/2019
139303,conference-organizer,100,57,11/20/2019
139303,conference-organizer,100,57,11/20/2019
13C3E0,partnership,100,61,11/20/2019
1490F3,dividend,100,50,11/20/2019
190B91,partnership,100,61,11/20/2019
197612,dividend,100,50,11/20/2019
1A5D5D,legal-issues-defendant,100,22,11/20/2019
1A5D5D,legal-issues-defendant,100,22,11/20/2019
1BC12C,legal-issues-plaintiff,100,44,11/20/2019
1E1125,conference-organizer,100,57,11/20/2019
1E1125,conference-organizer,100,57,11/20/2019
1E9A6D,campaign-ad-release,100,59,11/20/2019
1EBF8D,partnership,100,61,11/20/2019
1FA886,buybacks,100,74,11/20/2019
2031CE,dividend-up,100,81,11/20/2019
2093B1,dividend,100,50,11/20/2019
21022F,market-entry,100,57,11/20/2019
21022F,market-entry,100,57,11/20/2019
2158DF,partnership,100,61,11/20/2019
227F04,conference-participant,100,50,11/20/2019
24A89A,legal-issues-defendant,100,22,11/20/2019
24C48B,acquisition-acquirer,100,49,11/20/2019
24CB56,conference-participant,100,50,11/20/2019
26DC29,product-release,100,64,11/20/2019
26DC29,legal-issues-defendant,100,22,11/20/2019
274B8A,conference-call,100,50,11/20/2019
284289,dividend-up,100,81,11/20/2019
28F905,legal-issues-defendant,100,22,11/20/2019
28F905,legal-issues-defendant,100,22,11/20/2019
29A4CC,dividend,100,50,11/20/2019
2F1299,executive-appointment,100,54,11/20/2019
2FEA66,dividend,100,50,11/20/2019
339F20,dividend-up,100,81,11/20/2019
34A959,legal-issues-defendant,100,22,11/20/2019
34A959,legal-issues-defendant,100,22,11/20/2019
3B2311,conference-participant,100,50,11/20/2019
3ED92D,note-sale,100,52,11/20/2019
3F96D5,partnership,100,61,11/20/2019
3F96D5,conference-participant,100,50,11/20/2019
40F7DE,award,100,58,11/20/2019
416C55,partnership,100,61,11/20/2019
416C55,partnership,100,61,11/20/2019
42DC93,business-contract,100,69,11/20/2019
444CC8,earnings-up,100,68,11/20/2019
444CC8,acquisition-acquirer,100,49,11/20/2019
46017C,conference-participant,100,50,11/20/2019
49A344,award,100,58,11/20/2019
49F4D0,dividend,100,50,11/20/2019
4A6F00,partnership,100,61,11/20/2019
4A6F00,partnership,100,61,11/20/2019
4A6F00,product-release,100,64,11/20/2019
4A6F00,business-contract,100,69,11/20/2019
50070E,conference-organizer,100,57,11/20/2019
504FE2,award,100,58,11/20/2019
55438C,business-contract,100,69,11/20/2019
587EDF,earnings,100,50,11/20/2019
589846,conference-call,100,50,11/20/2019
59DB8C,executive-appointment,100,54,11/20/2019
59DB8C,earnings,100,50,11/20/2019
5B226B,dividend,100,50,11/20/2019
5C8D61,conference-participant,100,50,11/20/2019
5D87DF,dividend-up,100,81,11/20/2019
5E6959,partnership,100,61,11/20/2019
5F9CE3,dividend,100,50,11/20/2019
60FE03,public-offering,100,43,11/20/2019
622DBE,legal-issues-defendant,100,22,11/20/2019
622DBE,legal-issues-defendant,100,22,11/20/2019
662682,unit-acquisition-acquirer,100,49,11/20/2019
662682,unit-acquisition-acquirer,100,49,11/20/2019
665D7D,partnership,100,61,11/20/2019
665D7D,partnership,100,61,11/20/2019
665D7D,partnership,100,61,11/20/2019
665D7D,partnership,100,61,11/20/2019
69FDFC,earnings,100,50,11/20/2019
6AACDD,clinical-trials,100,56,11/20/2019
6B236C,public-offering,100,43,11/20/2019
6BF593,executive-appointment,100,54,11/20/2019
6D9B53,public-offering,100,43,11/20/2019
6DBBBC,unit-acquisition-acquiree,100,76,11/20/2019
6DBBBC,unit-acquisition-acquiree,100,76,11/20/2019
6.00E+19,business-contract,100,69,11/20/2019
6F22E7,earnings,100,50,11/20/2019
719477,dividend,100,50,11/20/2019
723548,public-offering,100,43,11/20/2019
7239BB,conference-call,100,50,11/20/2019
726DDF,legal-issues-defendant,100,22,11/20/2019
7448A3,dividend,100,50,11/20/2019
747219,legal-issues-defendant,100,22,11/20/2019
748EB6,conference-participant,100,50,11/20/2019
763DBE,conference-participant,100,50,11/20/2019
76E80F,revenues,100,50,11/20/2019
76E80F,revenues,100,50,11/20/2019
76E80F,revenues,100,50,11/20/2019
76E80F,revenues,100,50,11/20/2019
78A1BB,dividend-up,100,81,11/20/2019
7ACFD4,legal-issues-defendant,100,22,11/20/2019
7C62A3,award,100,58,11/20/2019
7CD98F,dividend,100,50,11/20/2019
82F088,conference-participant,100,50,11/20/2019
83A065,public-offering,100,43,11/20/2019
85AD00,executive-appointment,100,54,11/20/2019
85AD00,dividend,100,50,11/20/2019
863350,earnings,100,50,11/20/2019
8A0368,conference-participant,100,50,11/20/2019
8B4A45,earnings,100,50,11/20/2019
8C6C1B,dividend,100,50,11/20/2019
8D4486,product-release,100,64,11/20/2019
8E0E32,earnings,100,50,11/20/2019
9196A2,partnership,100,61,11/20/2019
934CC3,partnership,100,61,11/20/2019
93C130,dividend,100,50,11/20/2019
93D207,conference-participant,100,50,11/20/2019
940C3D,partnership,100,61,11/20/2019
94637C,acquisition-completed-acquirer,100,49,11/20/2019
94637C,acquisition-completed-acquirer,100,49,11/20/2019
97FE80,legal-issues-defendant,100,22,11/20/2019
9F62D1,dividend,100,50,11/20/2019
9F6B1A,award,100,58,11/20/2019
9F6B1A,award,100,58,11/20/2019
9F6B1A,partnership,100,61,11/20/2019
A37D68,earnings,100,50,11/20/2019
A47A7D,facility-open,100,65,11/20/2019
A63387,earnings,100,50,11/20/2019
A63387,earnings,100,50,11/20/2019
A63387,earnings,100,50,11/20/2019
A63387,earnings,100,50,11/20/2019
A63387,earnings,100,50,11/20/2019
A63387,earnings,100,50,11/20/2019
A7102F,conference-participant,100,50,11/20/2019
A790A5,earnings,100,50,11/20/2019
A94A7B,conference-participant,100,50,11/20/2019
AAEE21,earnings-guidance-up,100,83,11/20/2019
AD23DE,business-contract,100,69,11/20/2019
AD3008,note-sale,100,52,11/20/2019
AE4EEB,executive-appointment,100,54,11/20/2019
AEEB76,conference-participant,100,50,11/20/2019
AFD1CA,facility-open,100,65,11/20/2019
AFDF2E,legal-issues-defendant,100,22,11/20/2019
B508E5,conference-participant,100,50,11/20/2019
B560AF,executive-appointment,100,54,11/20/2019
B934BF,dividend-up,100,81,11/20/2019
BB0587,note-sale,100,52,11/20/2019
C83B88,product-release,100,64,11/20/2019
C9D866,note-sale,100,52,11/20/2019
C9D866,public-offering,100,43,11/20/2019
C9F39B,executive-appointment,100,54,11/20/2019
CC8F6E,legal-issues-defendant,100,22,11/20/2019
CCBBAD,buybacks,100,74,11/20/2019
CD4DA8,conference-organizer,100,57,11/20/2019
CE96E7,acquisition-completed-acquiree,100,76,11/20/2019
CFF15D,partnership,100,61,11/20/2019
CFF97C,note-sale,100,52,11/20/2019
D0DE27,dividend,100,50,11/20/2019
D17C1B,executive-appointment,100,54,11/20/2019
D2C0B6,earnings,100,50,11/20/2019
D33270,award,100,58,11/20/2019
D393DF,acquisition-acquirer,100,49,11/20/2019
D393DF,acquisition-acquirer,100,49,11/20/2019
D56D6D,earnings,100,50,11/20/2019
D57D99,executive-appointment,100,54,11/20/2019
D598E7,partnership,100,61,11/20/2019
D5AF19,dividend,100,50,11/20/2019
D721C6,dividend,100,50,11/20/2019
D8442A,market-entry,100,57,11/20/2019
D854DD,merger-regulatory-approval,100,81,11/20/2019
D8DBA3,dividend-up,100,81,11/20/2019
DC1405,conference-participant,100,50,11/20/2019
DF18E6,conference-participant,100,50,11/20/2019
DF6FDD,dividend,100,50,11/20/2019
E13782,public-offering,100,43,11/20/2019
E15736,note-sale,100,52,11/20/2019
E2CFD2,note-sale,100,52,11/20/2019
E5752F,earnings,100,50,11/20/2019
E67C2C,conference-participant,100,50,11/20/2019
E845D9,earnings,100,50,11/20/2019
E845D9,earnings,100,50,11/20/2019
E866D2,dividend,100,50,11/20/2019
E8846E,conference-participant,100,50,11/20/2019
E9C7C0,partnership,100,61,11/20/2019
EB2F14,dividend,100,50,11/20/2019
ED2EFD,public-offering,100,43,11/20/2019
ED79D9,dividend-up,100,81,11/20/2019
F0B2B5,executive-appointment,100,54,11/20/2019
F0B2B5,executive-appointment,100,54,11/20/2019
F0B2B5,executive-appointment,100,54,11/20/2019
F0B2B5,executive-appointment,100,54,11/20/2019
F0B2B5,executive-appointment,100,54,11/20/2019
F0B2B5,executive-appointment,100,54,11/20/2019
F6DCE4,earnings,100,50,11/20/2019
F6DCE4,earnings,100,50,11/20/2019
F6DCE4,earnings,100,50,11/20/2019
F7902B,conference-participant,100,50,11/20/2019
FAB97A,note-sale,100,52,11/20/2019
FAB97A,note-sale,100,52,11/20/2019
FC1B7B,dividend,100,50,11/20/2019
FF6644,business-contract,100,69,11/20/2019
FFCD0E,earnings-guidance,100,50,11/20/2019
003B70,executive-appointment,100,54,11/21/2019
00E601,dividend,100,50,11/21/2019
00FC70,earnings,100,50,11/21/2019
0157B1,partnership,100,61,11/21/2019
0157B1,partnership,100,61,11/21/2019
0157B1,partnership,100,61,11/21/2019
02870F,dividend,100,50,11/21/2019
03FB17,dividend,100,50,11/21/2019
048B70,conference-call,100,50,11/21/2019
04EB2F,conference-participant,100,50,11/21/2019
0BC29E,partnership,100,61,11/21/2019
0BC29E,partnership,100,61,11/21/2019
0C8D82,executive-appointment,100,54,11/21/2019
0D03C8,conference-participant,100,50,11/21/2019
0E2992,dividend,100,50,11/21/2019
0F0693,conference-participant,100,50,11/21/2019
106394,note-sale,100,52,11/21/2019
12A3A3,conference-call,100,50,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
139303,conference-organizer,100,57,11/21/2019
152AB9,conference-participant,100,50,11/21/2019
168A5D,acquisition-acquirer,100,49,11/21/2019
19BF16,partnership,100,61,11/21/2019
1C2593,earnings,100,50,11/21/2019
1CF3A8,earnings,100,50,11/21/2019
1E1125,conference-organizer,100,57,11/21/2019
1E8A99,dividend-up,100,81,11/21/2019
1F716B,donation,100,54,11/21/2019
205AD5,conference-organizer,100,57,11/21/2019
2082EA,regulatory-product-approval-granted,100,81,11/21/2019
228D42,partnership,100,61,11/21/2019
2491BC,legal-issues-defendant,100,22,11/21/2019
2491BC,legal-issues-defendant,100,22,11/21/2019
24CB56,dividend,100,50,11/21/2019
26DC29,legal-issues-defendant,100,22,11/21/2019
26DC29,product-release,100,64,11/21/2019
279916,earnings,100,50,11/21/2019
2ABF77,earnings,100,50,11/21/2019
2ABF77,earnings,100,50,11/21/2019
2BA977,legal-issues-defendant,100,22,11/21/2019
2CB4C9,award,100,58,11/21/2019
2E0496,product-release,100,64,11/21/2019
2E0496,product-release,100,64,11/21/2019
2F9304,earnings,100,50,11/21/2019
33AD83,partnership,100,61,11/21/2019
33AD83,conference-participant,100,50,11/21/2019
34A959,legal-issues-defendant,100,22,11/21/2019
353DBB,acquisition-acquiree,100,76,11/21/2019
39692D,conference-participant,100,50,11/21/2019
3A94DF,dividend,100,50,11/21/2019
3DE4D1,executive-appointment,100,54,11/21/2019
3DE4D1,dividend,100,50,11/21/2019
3EE65E,earnings,100,50,11/21/2019
3EE65E,conference-participant,100,50,11/21/2019
4.00E+163,earnings,100,50,11/21/2019
40F7DE,executive-appointment,100,54,11/21/2019
417BF9,earnings,100,50,11/21/2019
422CE3,dividend,100,50,11/21/2019
422CE3,earnings,100,50,11/21/2019
422CE3,earnings,100,50,11/21/2019
422CE3,earnings,100,50,11/21/2019
422CE3,earnings,100,50,11/21/2019
43E8F5,conference-participant,100,50,11/21/2019
44209A,executive-appointment,100,54,11/21/2019
47FCF2,public-offering,100,43,11/21/2019
4A6F00,partnership,100,61,11/21/2019
4BF3D6,public-offering,100,43,11/21/2019
4C2F17,conference-participant,100,50,11/21/2019
4ECD1A,dividend,100,50,11/21/2019
4F0A80,dividend,100,50,11/21/2019
4F71DC,conference-call,100,50,11/21/2019
507AE7,award,100,58,11/21/2019
514067,conference-participant,100,50,11/21/2019
53C421,earnings,100,50,11/21/2019
543900,dividend,100,50,11/21/2019
58CA9A,award,100,58,11/21/2019
58CA9A,award,100,58,11/21/2019
5B3FA2,conference-participant,100,50,11/21/2019
5B6C11,partnership,100,61,11/21/2019
5B6C11,executive-appointment,100,54,11/21/2019
5B6C11,partnership,100,61,11/21/2019
5EAA43,business-contract,100,69,11/21/2019
6166D1,investment-investor,100,55,11/21/2019
61BCA7,award,100,58,11/21/2019
61BCA7,executive-appointment,100,54,11/21/2019
622DBE,legal-issues-defendant,100,22,11/21/2019
63F892,business-contract,100,69,11/21/2019
665D7D,partnership,100,61,11/21/2019
665D7D,business-contract,100,69,11/21/2019
665D7D,business-contract,100,69,11/21/2019
6830FE,earnings,100,50,11/21/2019
69CE71,partnership,100,61,11/21/2019
6B236C,public-offering,100,43,11/21/2019
6C6D73,patient-enrollment-start,100,58,11/21/2019
6C987C,dividend,100,50,11/21/2019
6E8349,dividend,100,50,11/21/2019
6F3FA8,dividend,100,50,11/21/2019
6FCEF9,earnings,100,50,11/21/2019
704B78,conference-participant,100,50,11/21/2019
717DB4,conference-participant,100,50,11/21/2019
731675,product-release,100,64,11/21/2019
732A9B,executive-appointment,100,54,11/21/2019
73A71F,legal-issues-defendant,100,22,11/21/2019
73A71F,legal-issues-defendant,100,22,11/21/2019
73F70F,earnings,100,50,11/21/2019
73F7F9,conference-call,100,50,11/21/2019
747219,legal-issues-defendant,100,22,11/21/2019
756BB4,executive-appointment,100,54,11/21/2019
76F067,acquisition-completed-acquirer,100,49,11/21/2019
76F067,acquisition-completed-acquirer,100,49,11/21/2019
76F067,acquisition-completed-acquirer,100,49,11/21/2019
7740DE,earnings-per-share-positive,100,69,11/21/2019
7823A3,legal-issues-defendant,100,22,11/21/2019
78F9ED,dividend,100,50,11/21/2019
7ACFD4,legal-issues-defendant,100,22,11/21/2019
7B0BA6,note-sale,100,52,11/21/2019
7F3FBC,ipo-pricing,100,50,11/21/2019
817ED9,earnings,100,50,11/21/2019
817ED9,earnings,100,50,11/21/2019
817ED9,earnings,100,50,11/21/2019
817ED9,earnings,100,50,11/21/2019
838ADD,conference-participant,100,50,11/21/2019
859D62,dividend-up,100,55,11/21/2019
8614A2,earnings,100,50,11/21/2019
88193E,regulatory-product-approval-granted,100,81,11/21/2019
8C6C1B,earnings,100,50,11/21/2019
8C6C1B,earnings,100,50,11/21/2019
8F6995,conference-call,100,50,11/21/2019
901327,dividend,100,50,11/21/2019
92B625,executive-appointment,100,54,11/21/2019
95DC1F,conference-call,100,50,11/21/2019
95F59E,unit-acquisition-acquirer,100,49,11/21/2019
97AAF6,award,100,58,11/21/2019
97FE80,legal-issues-defendant,100,22,11/21/2019
990AD0,conference-organizer,100,57,11/21/2019
9.97E+09,dividend,100,50,11/21/2019
99DC8D,conference-call,100,50,11/21/2019
9E298A,earnings,100,50,11/21/2019
9F37C5,dividend,100,50,11/21/2019
9FA83B,public-offering,100,43,11/21/2019
9FA83B,conference-participant,100,50,11/21/2019
A3F598,settlement,100,56,11/21/2019
A6FE1C,unit-acquisition-acquirer,100,49,11/21/2019
A7102F,product-release,100,64,11/21/2019
ACDF88,dividend,100,50,11/21/2019
AEBB80,shareholder-rights-plan,100,43,11/21/2019
AF93DE,credit-extension-recipient,100,69,11/21/2019
B076A1,dividend,100,50,11/21/2019
B1FC3B,acquisition-acquirer,100,49,11/21/2019
B2206F,conference-participant,100,50,11/21/2019
B48FC9,conference-participant,100,50,11/21/2019
B66928,product-release,100,64,11/21/2019
BC5680,legal-issues-defendant,100,22,11/21/2019
BC5680,legal-issues-defendant,100,22,11/21/2019
BC5680,legal-issues-defendant,100,22,11/21/2019
BC5680,legal-issues-defendant,100,22,11/21/2019
BC5680,legal-issues-defendant,100,22,11/21/2019
BCC55F,executive-appointment,100,54,11/21/2019
BD15E8,dividend,100,50,11/21/2019
BD8517,executive-appointment,100,54,11/21/2019
BDE867,conference-participant,100,50,11/21/2019
BF5959,business-contract,100,69,11/21/2019
C0F70B,conference-participant,100,50,11/21/2019
C2609A,facility-open,100,65,11/21/2019
C3DE7D,executive-appointment,100,54,11/21/2019
C3DE7D,earnings,100,50,11/21/2019
C3EE99,revenue-up,100,69,11/21/2019
C4A432,donation,100,54,11/21/2019
C5C0E9,conference-participant,100,50,11/21/2019
C5C137,earnings,100,50,11/21/2019
C5C137,earnings,100,50,11/21/2019
C5C137,earnings,100,50,11/21/2019
C5C137,earnings,100,50,11/21/2019
C6C702,award,100,58,11/21/2019
C6C702,award,100,58,11/21/2019
C83B88,award,100,58,11/21/2019
C9B932,note-sale,100,52,11/21/2019
C9B932,note-sale,100,52,11/21/2019
CA3CB9,earnings,100,50,11/21/2019
CC8F6E,legal-issues-defendant,100,22,11/21/2019
CC8F6E,legal-issues-defendant,100,22,11/21/2019
CD4DA8,conference-organizer,100,57,11/21/2019
CD4DA8,conference-organizer,100,57,11/21/2019
CDD75E,conference-participant,100,50,11/21/2019
CEC5B9,earnings,100,50,11/21/2019
CEC5B9,earnings,100,50,11/21/2019
CEC5B9,earnings,100,50,11/21/2019
CEC5B9,earnings,100,50,11/21/2019
CEDFD5,patient-enrollment-complete,100,64,11/21/2019
CEDFD5,patient-enrollment-complete,100,64,11/21/2019
CF7292,conference-call,100,50,11/21/2019
CFF57D,conference-call,100,50,11/21/2019
CFF97C,unit-acquisition-acquirer,100,49,11/21/2019
CFF97C,credit-rating-affirmation-rater,20,50,11/21/2019
D78BF1,dividend,100,50,11/21/2019
D854DD,acquisition-completed-acquirer,100,49,11/21/2019
D8DA3D,legal-issues-defendant,100,22,11/21/2019
D8ECA1,legal-issues-defendant,100,22,11/21/2019
DB5CA5,public-offering,100,43,11/21/2019
DD1BA1,conference-organizer,100,57,11/21/2019
DF16DE,partnership,100,61,11/21/2019
DF16DE,business-contract,100,69,11/21/2019
DF16DE,business-contract,100,69,11/21/2019
DF204B,facility-open,100,65,11/21/2019
DF204B,dividend,100,50,11/21/2019
DF5F14,note-sale,100,52,11/21/2019
E13782,public-offering,100,43,11/21/2019
E19A99,acquisition-completed-acquirer,100,49,11/21/2019
E1E36F,conference-participant,100,50,11/21/2019
E261E9,executive-appointment,100,54,11/21/2019
E5752F,earnings-up,100,68,11/21/2019
E68733,regulatory-product-approval-granted,100,81,11/21/2019
E68733,regulatory-product-approval-granted,100,81,11/21/2019
E8846E,conference-organizer,100,57,11/21/2019
EB6965,award,100,58,11/21/2019
ECDEB2,dividend,100,50,11/21/2019
ED1A74,clinical-trials,100,56,11/21/2019
ED9C04,conference-participant,100,50,11/21/2019
F0A9DE,dividend,100,50,11/21/2019
F11638,revenue-up,100,65,11/21/2019
F11638,revenue-up,100,65,11/21/2019
F11638,revenue-up,100,65,11/21/2019
F11638,revenue-up,100,65,11/21/2019
F11638,revenue-up,100,65,11/21/2019
F1CD47,dividend,100,50,11/21/2019
F1EB39,settlement,100,56,11/21/2019
F3816D,executive-appointment,100,54,11/21/2019
F5D410,note-sale,100,52,11/21/2019
F5D410,public-offering,100,43,11/21/2019
F748C7,earnings,100,50,11/21/2019
F82D37,executive-appointment,100,54,11/21/2019
F8BA6C,conference-participant,100,50,11/21/2019
F92DBC,expenses-down,100,61,11/21/2019
FC1F9D,donation,100,54,11/21/2019
FD6926,conference-participant,100,50,11/21/2019
FDE409,unit-acquisition-acquiree,100,76,11/21/2019
FDE409,earnings,100,50,11/21/2019
FDF1C0,dividend,100,50,11/21/2019
03596A,business-contract,100,69,11/22/2019
03596A,business-contract,100,69,11/22/2019
03B8CF,partnership,100,61,11/22/2019
083F72,earnings,100,50,11/22/2019
0CE7F6,earnings,100,50,11/22/2019
139303,conference-organizer,100,57,11/22/2019
18D9FA,fundraising,100,64,11/22/2019
1921DD,partnership,100,61,11/22/2019
1D943E,conference-participant,100,50,11/22/2019
20BEEA,dividend,100,50,11/22/2019
21022F,executive-appointment,100,54,11/22/2019
22C58E,conference-participant,100,50,11/22/2019
2491BC,legal-issues-defendant,100,22,11/22/2019
2491BC,legal-issues-defendant,100,22,11/22/2019
24A89A,legal-issues-defendant,100,22,11/22/2019
26DC29,conference-participant,100,50,11/22/2019
28F905,legal-issues-defendant,100,22,11/22/2019
29A4CC,merger-completed,100,66,11/22/2019
2A1009,clinical-trials-positive,100,87,11/22/2019
2DB344,dividend,100,50,11/22/2019
2F7474,dividend,100,50,11/22/2019
2F98A5,earnings,100,50,11/22/2019
39FB23,product-release,100,64,11/22/2019
3B9886,earnings,100,50,11/22/2019
3B9886,earnings,100,50,11/22/2019
3B9886,earnings,100,50,11/22/2019
3B9886,earnings,100,50,11/22/2019
41D61C,dividend,100,50,11/22/2019
41EC04,legal-issues-defendant,100,22,11/22/2019
41EC04,legal-issues-defendant,100,22,11/22/2019
4A2457,award,100,58,11/22/2019
4C37C5,partnership,100,61,11/22/2019
4E4E75,conference-call,100,50,11/22/2019
4E7C1F,earnings,100,50,11/22/2019
4E7C1F,earnings,100,50,11/22/2019
50070E,conference-organizer,100,57,11/22/2019
5088A5,dividend,100,50,11/22/2019
524CE4,conference-participant,100,50,11/22/2019
55438C,executive-resignation,100,44,11/22/2019
5B35C7,dividend,100,50,11/22/2019
622DBE,legal-issues-defendant,100,22,11/22/2019
698FF9,dividend,100,50,11/22/2019
6D2BF6,conference-participant,100,50,11/22/2019
6DC1D7,dividend,100,50,11/22/2019
73A71F,legal-issues-defendant,100,22,11/22/2019
75F665,dividend,100,50,11/22/2019
7740DE,dividend,100,50,11/22/2019
7823A3,legal-issues-defendant,100,22,11/22/2019
78F776,public-offering,100,43,11/22/2019
7ACFD4,legal-issues-defendant,100,22,11/22/2019
7B0BA6,note-sale,100,52,11/22/2019
7B9212,earnings,100,50,11/22/2019
7B9212,earnings,100,50,11/22/2019
7D35D8,legal-issues-defendant,100,22,11/22/2019
7F2922,facility-open,100,65,11/22/2019
7FDE1C,rights-issue,100,43,11/22/2019
873DB9,conference-participant,100,50,11/22/2019
88350F,executive-appointment,100,54,11/22/2019
8B2C4A,legal-issues-defendant,100,22,11/22/2019
8DA42F,legal-issues-defendant,100,22,11/22/2019
9981C6,earnings,100,50,11/22/2019
9BBFA5,conference-call,100,50,11/22/2019
A16DEA,partnership,100,61,11/22/2019
A60354,acquisition-acquirer,100,49,11/22/2019
A7102F,legal-issues-defendant,100,22,11/22/2019
AEEB76,business-contract,100,69,11/22/2019
B0FE08,dividend,100,50,11/22/2019
B66928,executive-resignation,100,44,11/22/2019
BB0587,note-sale,100,52,11/22/2019
BC5680,fraud-defendant,100,20,11/22/2019
BC5680,legal-issues-defendant,100,22,11/22/2019
BDA775,unit-acquisition-acquiree,100,76,11/22/2019
C15F8F,earnings,100,50,11/22/2019
CBFFDD,conference-participant,100,50,11/22/2019
CD4DA8,conference-organizer,100,57,11/22/2019
D8ECA1,legal-issues-defendant,100,22,11/22/2019
D8ECA1,legal-issues-defendant,100,22,11/22/2019
DE5611,dividend,100,50,11/22/2019
E1C16B,conference-participant,100,50,11/22/2019
E259C7,dividend,100,50,11/22/2019
E2CFD2,note-sale,100,52,11/22/2019
E30B34,award,100,58,11/22/2019
E5752F,partnership,100,61,11/22/2019
E5F0A8,executive-appointment,100,54,11/22/2019
ECA300,conference-call,100,50,11/22/2019
ECF4F8,executive-appointment,100,54,11/22/2019
ED2EFD,public-offering,100,43,11/22/2019
FC01C0,conference-participant,100,50,11/22/2019
1A5D5D,legal-issues-defendant,100,22,11/23/2019
2491BC,legal-issues-defendant,100,22,11/23/2019
41EC04,legal-issues-defendant,100,22,11/23/2019
448BF3,clinical-trials,100,56,11/23/2019
622DBE,legal-issues-defendant,100,22,11/23/2019
D8ECA1,legal-issues-defendant,100,22,11/23/2019
2491BC,legal-issues-defendant,100,22,11/24/2019
73A71F,legal-issues-defendant,100,22,11/24/2019
7823A3,legal-issues-defendant,100,22,11/24/2019
7ACFD4,legal-issues-defendant,100,22,11/24/2019
7ACFD4,legal-issues-defendant,100,22,11/24/2019
97FE80,legal-issues-defendant,100,22,11/24/2019
A9ED24,unit-acquisition-acquiree,100,76,11/24/2019
AFDF2E,legal-issues-defendant,100,22,11/24/2019
CC8F6E,legal-issues-defendant,100,22,11/24/2019
D8DA3D,legal-issues-defendant,100,22,11/24/2019
D8ECA1,legal-issues-defendant,100,22,11/24/2019
00067A,partnership,100,61,11/25/2019
0157B1,partnership,100,61,11/25/2019
033B58,conference-participant,100,50,11/25/2019
048B70,earnings-up,100,68,11/25/2019
048B70,earnings-up,100,68,11/25/2019
048B70,earnings-up,100,68,11/25/2019
048B70,earnings-up,100,68,11/25/2019
048B70,earnings-up,100,68,11/25/2019
054B55,dividend,100,50,11/25/2019
099C88,business-contract,100,69,11/25/2019
0BC29E,dividend,100,50,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
139303,conference-organizer,100,57,11/25/2019
1921DD,executive-appointment,100,54,11/25/2019
1A2D9F,facility-open,100,65,11/25/2019
1A5D5D,legal-issues-defendant,100,22,11/25/2019
1A5D5D,legal-issues-defendant,100,22,11/25/2019
1E1125,conference-organizer,100,57,11/25/2019
1E1125,conference-organizer,100,57,11/25/2019
1E1125,conference-organizer,100,57,11/25/2019
1FA886,product-release,100,64,11/25/2019
2491BC,legal-issues-defendant,100,22,11/25/2019
26008A,conference-call,100,50,11/25/2019
28F905,legal-issues-defendant,100,22,11/25/2019
297DA8,partnership,100,61,11/25/2019
2EBC0B,dividend,100,50,11/25/2019
3.14E+47,dividend,100,50,11/25/2019
3.50E+27,executive-appointment,100,54,11/25/2019
3.50E+27,executive-resignation,100,44,11/25/2019
3.50E+27,dividend,100,50,11/25/2019
367434,public-offering,100,43,11/25/2019
3A113F,conference-participant,100,50,11/25/2019
3A6D90,executive-appointment,100,54,11/25/2019
3C11C4,earnings,100,50,11/25/2019
3C3B6B,executive-appointment,100,54,11/25/2019
3CCC90,market-entry,100,57,11/25/2019
3DD5E2,conference-participant,100,50,11/25/2019
3F6A9C,executive-appointment,100,54,11/25/2019
414FFF,earnings-above-expectations,100,88,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
414FFF,earnings,100,50,11/25/2019
41EC04,legal-issues-defendant,100,22,11/25/2019
42978B,conference-call,100,50,11/25/2019
451D61,executive-appointment,100,54,11/25/2019
460C93,executive-appointment,100,54,11/25/2019
4806CE,product-release,100,64,11/25/2019
4BEB48,conference-participant,100,50,11/25/2019
4C37C5,product-release,100,64,11/25/2019
4C37C5,product-release,100,64,11/25/2019
4E6F5A,partnership,100,61,11/25/2019
4E7C1F,conference-participant,100,50,11/25/2019
4EE167,conference-participant,100,50,11/25/2019
4EEB00,conference-participant,100,50,11/25/2019
50070E,conference-organizer,100,57,11/25/2019
50702E,business-contract,100,69,11/25/2019
50702E,business-contract,100,69,11/25/2019
510EA1,executive-appointment,100,54,11/25/2019
57A854,executive-appointment,100,54,11/25/2019
59872F,earnings,100,50,11/25/2019
59A832,dividend,100,50,11/25/2019
5B3FA2,conference-participant,100,50,11/25/2019
5F6D73,executive-appointment,100,54,11/25/2019
619882,business-contract,100,69,11/25/2019
622DBE,legal-issues-defendant,100,22,11/25/2019
6284B5,executive-appointment,100,54,11/25/2019
62B1C6,executive-resignation,100,44,11/25/2019
62B1C6,executive-resignation,100,44,11/25/2019
64E346,conference-participant,100,50,11/25/2019
66A667,acquisition-acquirer,100,49,11/25/2019
66A667,acquisition-acquirer,100,49,11/25/2019
68BA15,earnings,100,50,11/25/2019
6DBBBC,partnership,100,61,11/25/2019
6DBBBC,partnership,100,61,11/25/2019
6DBBBC,partnership,100,61,11/25/2019
6DBBBC,partnership,100,61,11/25/2019
6E705B,partnership,100,61,11/25/2019
71694D,conference-participant,100,50,11/25/2019
73A71F,legal-issues-defendant,100,22,11/25/2019
7.45E+28,conference-participant,100,50,11/25/2019
75F982,business-contract,100,69,11/25/2019
75F982,business-contract,100,69,11/25/2019
75F982,business-contract,100,69,11/25/2019
766047,product-release,100,64,11/25/2019
76D79A,unit-acquisition-acquirer,100,49,11/25/2019
7823A3,legal-issues-defendant,100,22,11/25/2019
790D0D,earnings,100,50,11/25/2019
7ACFD4,legal-issues-defendant,100,22,11/25/2019
7D35D8,legal-issues-defendant,100,22,11/25/2019
7F3665,executive-appointment,100,54,11/25/2019
7F9E16,business-contract,100,69,11/25/2019
805CD8,executive-appointment,100,54,11/25/2019
83B1C8,regulatory-product-approval-granted,100,81,11/25/2019
83B1C8,regulatory-product-approval-granted,100,81,11/25/2019
85DE00,conference-participant,100,50,11/25/2019
873DB9,dividend,100,50,11/25/2019
88193E,conference-participant,100,50,11/25/2019
8BFAA4,executive-appointment,100,54,11/25/2019
8DA42F,legal-issues-defendant,100,22,11/25/2019
8DA42F,legal-issues-defendant,100,22,11/25/2019
8E3F58,conference-participant,100,50,11/25/2019
8F6995,dividend-up,100,56,11/25/2019
91E5EE,conference-participant,100,50,11/25/2019
925759,clinical-trials-start,100,64,11/25/2019
9470CC,award,100,58,11/25/2019
990AD0,conference-organizer,100,57,11/25/2019
990AD0,conference-organizer,100,57,11/25/2019
9CA619,conference-call,100,50,11/25/2019
9E4A5F,conference-participant,100,50,11/25/2019
9E575E,regulatory-product-application,100,69,11/25/2019
9E98F2,legal-issues-defendant,100,22,11/25/2019
A350C1,conference-participant,100,50,11/25/2019
A52B6B,acquisition-interest-acquirer,100,46,11/25/2019
A52B6B,earnings,100,50,11/25/2019
A60354,acquisition-acquirer,100,49,11/25/2019
A6FB29,earnings,100,50,11/25/2019
ABB493,conference-participant,100,50,11/25/2019
AC642C,conference-participant,100,50,11/25/2019
AC642C,conference-participant,100,50,11/25/2019
AD22F2,earnings,100,50,11/25/2019
AD22F2,earnings,100,50,11/25/2019
AD22F2,earnings,100,50,11/25/2019
AD22F2,earnings,100,50,11/25/2019
AD22F2,earnings,100,50,11/25/2019
AD3C93,conference-call,100,50,11/25/2019
ADD9DC,earnings,100,50,11/25/2019
AE7D16,stake-acquiree,100,62,11/25/2019
AEFC90,earnings,100,50,11/25/2019
B33E77,conference-participant,100,50,11/25/2019
B3CB74,conference-organizer,100,57,11/25/2019
B4C673,facility-open,100,65,11/25/2019
B5734D,executive-appointment,100,54,11/25/2019
B8A51F,regulatory-product-approval-granted,100,81,11/25/2019
BC5680,legal-issues-defendant,100,22,11/25/2019
C11C46,conference-participant,100,50,11/25/2019
C4A432,executive-appointment,100,54,11/25/2019
C4A432,dividend-up,100,81,11/25/2019
C5D2AE,acquisition-completed-acquirer,100,49,11/25/2019
C81E00,note-sale,100,52,11/25/2019
C81E00,note-sale,100,52,11/25/2019
CCB623,acquisition-completed-acquirer,100,49,11/25/2019
CD4DA8,conference-organizer,100,57,11/25/2019
CD4DA8,conference-organizer,100,57,11/25/2019
CD4DA8,conference-organizer,100,57,11/25/2019
CD4DA8,conference-organizer,100,57,11/25/2019
CD4DA8,conference-organizer,100,57,11/25/2019
CD4DA8,conference-organizer,100,57,11/25/2019
CD4DA8,conference-organizer,100,57,11/25/2019
CD4DA8,conference-organizer,100,57,11/25/2019
CDC817,conference-participant,100,50,11/25/2019
CF3FF9,clinical-trials-suspended,100,24,11/25/2019
D1588D,clinical-trials,100,56,11/25/2019
D1C26F,partnership,100,61,11/25/2019
D33D8C,acquisition-acquirer,100,49,11/25/2019
D6853F,conference-participant,100,50,11/25/2019
D854DD,executive-appointment,100,54,11/25/2019
D8DA3D,legal-issues-defendant,100,22,11/25/2019
D8ECA1,legal-issues-defendant,100,22,11/25/2019
DA91AE,earnings,100,50,11/25/2019
DA91AE,acquisition-acquirer,100,49,11/25/2019
DB88A1,earnings,100,50,11/25/2019
DBB28E,earnings,100,50,11/25/2019
DF5F14,public-offering,100,43,11/25/2019
E0E4B7,conference-participant,100,50,11/25/2019
E598FB,earnings,100,50,11/25/2019
E8846E,conference-organizer,100,57,11/25/2019
E96E0B,executive-appointment,100,54,11/25/2019
ED79D9,earnings,100,50,11/25/2019
F0B2B5,executive-appointment,100,54,11/25/2019
F209B4,conference-participant,100,50,11/25/2019
F8BA6C,trading-listing,100,61,11/25/2019
FC8733,conference-participant,100,50,11/25/2019
01478A,dividend,100,50,11/26/2019
018C11,facility-open,100,65,11/26/2019
02FC1A,conference-participant,100,50,11/26/2019
04EB2F,conference-participant,100,50,11/26/2019
0624BE,earnings,100,50,11/26/2019
68396,dividend,100,50,11/26/2019
091B6C,conference-participant,100,50,11/26/2019
091B6C,conference-participant,100,50,11/26/2019
0968A5,earnings,100,50,11/26/2019
0986B5,dividend,100,50,11/26/2019
0B7375,conference-participant,100,50,11/26/2019
0BF198,conference-participant,100,50,11/26/2019
0C2A0D,conference-participant,100,50,11/26/2019
0CE204,conference-participant,100,50,11/26/2019
0E499E,conference-participant,100,50,11/26/2019
0FABBD,conference-participant,100,50,11/26/2019
106394,note-sale,100,52,11/26/2019
1080C0,conference-participant,100,50,11/26/2019
108BD2,executive-appointment,100,54,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
139303,conference-organizer,100,57,11/26/2019
143C52,earnings,100,50,11/26/2019
152FA5,conference-participant,100,50,11/26/2019
165B86,conference-participant,100,50,11/26/2019
1748F6,earnings,100,50,11/26/2019
1880C5,conference-participant,100,50,11/26/2019
190BE6,earnings,100,50,11/26/2019
1A5D5D,legal-issues-defendant,100,22,11/26/2019
1AE9D5,conference-participant,100,50,11/26/2019
1BDB2A,conference-participant,100,50,11/26/2019
1D3A00,dividend,100,50,11/26/2019
1D3A00,earnings,100,50,11/26/2019
1D3A00,earnings,100,50,11/26/2019
1D3A00,earnings,100,50,11/26/2019
1D3A00,earnings,100,50,11/26/2019
1E1125,conference-organizer,100,57,11/26/2019
1E1125,conference-organizer,100,57,11/26/2019
1E1125,conference-organizer,100,57,11/26/2019
1FAF22,legal-issues-defendant,100,22,11/26/2019
1FAF22,legal-issues-defendant,100,22,11/26/2019
1FAF22,legal-issues-defendant,100,22,11/26/2019
1FCC00,conference-call,100,50,11/26/2019
2082EA,conference-participant,100,50,11/26/2019
2158DF,conference-participant,100,50,11/26/2019
221AD7,executive-appointment,100,54,11/26/2019
228D42,partnership,100,61,11/26/2019
228D42,partnership,100,61,11/26/2019
2491BC,legal-issues-defendant,100,22,11/26/2019
2C3348,conference-participant,100,50,11/26/2019
2CA60F,conference-participant,100,50,11/26/2019
2DA92D,dividend,100,50,11/26/2019
2E0445,conference-participant,100,50,11/26/2019
2E1322,conference-participant,100,50,11/26/2019
2F6782,conference-participant,100,50,11/26/2019
2F9304,conference-participant,100,50,11/26/2019
33AD83,earnings,100,50,11/26/2019
33E9D5,earnings,100,50,11/26/2019
36529A,conference-participant,100,50,11/26/2019
367434,public-offering,100,43,11/26/2019
367E1C,conference-participant,100,50,11/26/2019
387541,note-sale,100,52,11/26/2019
3B50FE,earnings,100,50,11/26/2019
3CBA2A,acquisition-acquiree,100,76,11/26/2019
3F4497,buybacks,100,74,11/26/2019
41EC04,legal-issues-defendant,100,22,11/26/2019
42EFC7,conference-participant,100,50,11/26/2019
44ED36,executive-appointment,100,54,11/26/2019
44ED36,executive-appointment,100,54,11/26/2019
45BC35,conference-participant,100,50,11/26/2019
4A6F00,layoffs,100,43,11/26/2019
4AC91D,executive-appointment,100,54,11/26/2019
4AC91D,earnings,100,50,11/26/2019
4BF3D6,conference-participant,100,50,11/26/2019
4E6F5A,conference-participant,100,50,11/26/2019
50070E,conference-organizer,100,57,11/26/2019
50070E,conference-organizer,100,57,11/26/2019
50070E,conference-organizer,100,57,11/26/2019
523039,conference-participant,100,50,11/26/2019
54F271,earnings,100,50,11/26/2019
586BD7,conference-participant,100,50,11/26/2019
5D1329,conference-participant,100,50,11/26/2019
5E7E82,earnings-above-expectations,100,88,11/26/2019
5F3D91,conference-participant,100,50,11/26/2019
61B81B,conference-participant,100,50,11/26/2019
620381,conference-participant,100,50,11/26/2019
622DBE,legal-issues-defendant,100,22,11/26/2019
6284B5,conference-participant,100,50,11/26/2019
64E346,earnings,100,50,11/26/2019
6B6375,conference-participant,100,50,11/26/2019
6C6D73,business-contract,100,69,11/26/2019
6CD55A,dividend,100,50,11/26/2019
6D4636,award,100,58,11/26/2019
6F3936,earnings,100,50,11/26/2019
6F3936,earnings,100,50,11/26/2019
6F3936,earnings,100,50,11/26/2019
6F3936,earnings,100,50,11/26/2019
6F3936,earnings,100,50,11/26/2019
6F3936,earnings,100,50,11/26/2019
6F3936,earnings,100,50,11/26/2019
71694D,conference-participant,100,50,11/26/2019
729368,conference-organizer,100,57,11/26/2019
73A71F,legal-issues-defendant,100,22,11/26/2019
73A71F,legal-issues-defendant,100,22,11/26/2019
7823A3,legal-issues-defendant,100,22,11/26/2019
789ADD,conference-participant,100,50,11/26/2019
7A5097,earnings,100,50,11/26/2019
7ACFD4,legal-issues-defendant,100,22,11/26/2019
7C4F43,conference-participant,100,50,11/26/2019
7D35D8,legal-issues-defendant,100,22,11/26/2019
7FEEE1,conference-participant,100,50,11/26/2019
805CD8,conference-participant,100,50,11/26/2019
848C0B,dividend-up,100,81,11/26/2019
877C0C,conference-participant,100,50,11/26/2019
8DA42F,legal-issues-defendant,100,22,11/26/2019
8E10BF,conference-participant,100,50,11/26/2019
8EDACA,earnings-guidance,100,50,11/26/2019
8EDACA,conference-participant,100,50,11/26/2019
8F6995,executive-resignation,100,44,11/26/2019
902255,dividend-up,100,54,11/26/2019
9196A2,conference-organizer,100,57,11/26/2019
9196A2,conference-organizer,100,57,11/26/2019
9196A2,conference-organizer,100,57,11/26/2019
931AE7,conference-participant,100,50,11/26/2019
958938,executive-appointment,100,54,11/26/2019
95C392,award,100,58,11/26/2019
96B4FF,conference-participant,100,50,11/26/2019
972356,product-release,100,64,11/26/2019
97FE80,legal-issues-defendant,100,22,11/26/2019
97FE80,legal-issues-defendant,100,22,11/26/2019
98A286,earnings,100,50,11/26/2019
990AD0,conference-organizer,100,57,11/26/2019
990AD0,conference-organizer,100,57,11/26/2019
9B730A,conference-participant,100,50,11/26/2019
9D56F2,dividend-up,100,81,11/26/2019
9F6B1A,executive-appointment,100,54,11/26/2019
9FA83B,executive-appointment,100,54,11/26/2019
A15C71,executive-appointment,100,54,11/26/2019
A1E3B3,earnings,100,50,11/26/2019
A1E3B3,earnings,100,50,11/26/2019
A1E3B3,earnings,100,50,11/26/2019
A1E3B3,earnings,100,50,11/26/2019
A5E715,dividend,100,50,11/26/2019
A631A3,earnings,100,50,11/26/2019
A631A3,revenues,100,50,11/26/2019
A6FE1C,acquisition-acquirer,100,49,11/26/2019
A72AB6,earnings-above-expectations,100,88,11/26/2019
A761FE,earnings,100,50,11/26/2019
A761FE,earnings,100,50,11/26/2019
A8FDE8,conference-participant,100,50,11/26/2019
AAC8B6,dividend-up,100,81,11/26/2019
AAC8B6,dividend-up,100,81,11/26/2019
AB4A7E,conference-participant,100,50,11/26/2019
ACDF88,partnership,100,61,11/26/2019
AD375D,index-listing,100,76,11/26/2019
ADFB3A,conference-participant,100,50,11/26/2019
AEF2C3,conference-participant,100,50,11/26/2019
AEFC90,conference-participant,100,50,11/26/2019
B01111,earnings,100,50,11/26/2019
B1A85D,note-sale,100,52,11/26/2019
B1FC3B,business-contract,100,69,11/26/2019
B290A2,conference-participant,100,50,11/26/2019
B3CB74,conference-organizer,100,57,11/26/2019
B3CB74,conference-organizer,100,57,11/26/2019
B446B8,investment-investor,100,55,11/26/2019
B4B281,earnings,100,50,11/26/2019
B4B281,earnings,100,50,11/26/2019
B4B281,earnings,100,50,11/26/2019
B7202A,conference-participant,100,50,11/26/2019
B803B1,note-sale,100,52,11/26/2019
B9CD50,conference-participant,100,50,11/26/2019
BB88B6,conference-participant,100,50,11/26/2019
BBC05B,business-contract,100,69,11/26/2019
BDF85E,earnings,100,50,11/26/2019
C0BA36,conference-participant,100,50,11/26/2019
C15F8F,conference-participant,100,50,11/26/2019
C22BE8,earnings,100,50,11/26/2019
C45C1F,conference-participant,100,50,11/26/2019
C4A432,earnings,100,50,11/26/2019
C564E4,conference-participant,100,50,11/26/2019
C58D71,conference-participant,100,50,11/26/2019
C5C137,fundraising,100,64,11/26/2019
C83B88,conference-participant,100,50,11/26/2019
CC6F6E,earnings,100,50,11/26/2019
CC6F6E,earnings,100,50,11/26/2019
CC6F6E,earnings,100,50,11/26/2019
CC6F6E,earnings,100,50,11/26/2019
CC8F6E,legal-issues-defendant,100,22,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CD4DA8,conference-organizer,100,57,11/26/2019
CE5C6E,conference-participant,100,50,11/26/2019
D15833,dividend,100,50,11/26/2019
D1588D,conference-participant,100,50,11/26/2019
D1CFC8,conference-call,100,50,11/26/2019
D36B23,conference-participant,100,50,11/26/2019
D4C0CB,conference-participant,100,50,11/26/2019
D56D6D,executive-appointment,100,54,11/26/2019
D58A11,conference-participant,100,50,11/26/2019
D5AF19,conference-participant,100,50,11/26/2019
D5B13D,conference-participant,100,50,11/26/2019
D6EAA3,conference-participant,100,50,11/26/2019
D8DA3D,legal-issues-defendant,100,22,11/26/2019
D8ECA1,legal-issues-defendant,100,22,11/26/2019
DA48E4,dividend,100,50,11/26/2019
DB23C8,conference-participant,100,50,11/26/2019
DB23C8,conference-participant,100,50,11/26/2019
DB9F70,conference-participant,100,50,11/26/2019
DC0066,conference-participant,100,50,11/26/2019
DF16DE,conference-participant,100,50,11/26/2019
E13782,conference-participant,100,50,11/26/2019
E20392,conference-participant,100,50,11/26/2019
E28D9C,executive-appointment,100,54,11/26/2019
E38906,clinical-trials-filed,100,60,11/26/2019
E4CE73,earnings,100,50,11/26/2019
E598FB,conference-participant,100,50,11/26/2019
E68C3D,earnings,100,50,11/26/2019
E68C3D,executive-appointment,100,54,11/26/2019
E69BA5,conference-participant,100,50,11/26/2019
E70531,executive-appointment,100,54,11/26/2019
E8846E,conference-organizer,100,57,11/26/2019
E8846E,conference-organizer,100,57,11/26/2019
E8846E,conference-participant,100,50,11/26/2019
E8846E,conference-organizer,100,57,11/26/2019
E8846E,conference-organizer,100,57,11/26/2019
ED79D9,award,100,58,11/26/2019
F02170,revenue-up,100,64,11/26/2019
F02170,revenues,100,50,11/26/2019
F02170,revenues,100,50,11/26/2019
F02170,revenues,100,50,11/26/2019
F02170,revenues,100,50,11/26/2019
F3FCC3,conference-participant,100,50,11/26/2019
F43A11,product-release,100,64,11/26/2019
F8BA6C,business-contract,100,69,11/26/2019
F9AA02,public-offering,100,43,11/26/2019
F9CAF8,unit-acquisition-acquirer,100,49,11/26/2019
FD554E,conference-participant,100,50,11/26/2019
FD9A97,conference-participant,100,50,11/26/2019
FFE543,credit-extension-recipient,100,69,11/26/2019
55018,legal-issues-defendant,100,22,11/27/2019
0E5619,conference-participant,100,50,11/27/2019
1220D2,conference-participant,100,50,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
139303,conference-organizer,100,57,11/27/2019
154272,regulatory-product-approval-granted,100,81,11/27/2019
159739,dividend,100,50,11/27/2019
159739,dividend,100,50,11/27/2019
159739,conference-call,100,50,11/27/2019
159739,conference-call,100,50,11/27/2019
184866,conference-participant,100,50,11/27/2019
1E1125,conference-organizer,100,57,11/27/2019
1E1125,conference-organizer,100,57,11/27/2019
1E1125,conference-organizer,100,57,11/27/2019
1E1125,conference-organizer,100,57,11/27/2019
1E1125,conference-organizer,100,57,11/27/2019
1FA886,buybacks,100,74,11/27/2019
1FAF22,legal-issues-defendant,100,22,11/27/2019
2491BC,legal-issues-defendant,100,22,11/27/2019
24A89A,legal-issues-defendant,100,22,11/27/2019
26DC29,legal-issues-defendant,100,22,11/27/2019
28F905,legal-issues-defendant,100,22,11/27/2019
28F905,legal-issues-defendant,100,22,11/27/2019
2A02DC,conference-participant,100,50,11/27/2019
2BA977,legal-issues-defendant,100,22,11/27/2019
2D981A,conference-participant,100,50,11/27/2019
3BBD10,conference-participant,100,50,11/27/2019
3C75D6,executive-appointment,100,54,11/27/2019
41EC04,legal-issues-defendant,100,22,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
431B74,earnings-positive,100,69,11/27/2019
4D371E,conference-participant,100,50,11/27/2019
4E7C1F,executive-appointment,100,54,11/27/2019
50070E,conference-organizer,100,57,11/27/2019
50070E,conference-organizer,100,57,11/27/2019
50070E,conference-organizer,100,57,11/27/2019
504FE2,conference-participant,100,50,11/27/2019
51888A,asset-sale,100,62,11/27/2019
53A226,dividend,100,50,11/27/2019
57A854,conference-participant,100,50,11/27/2019
59872F,conference-participant,100,50,11/27/2019
5E7E82,dividend,100,50,11/27/2019
622DBE,legal-issues-defendant,100,22,11/27/2019
6F0A63,dividend-up,100,53,11/27/2019
6F22E7,conference-participant,100,50,11/27/2019
732A9B,conference-participant,100,50,11/27/2019
73A71F,legal-issues-defendant,100,22,11/27/2019
747219,legal-issues-defendant,100,22,11/27/2019
7ACFD4,legal-issues-defendant,100,22,11/27/2019
7ADE57,conference-call,100,50,11/27/2019
7B1156,conference-participant,100,50,11/27/2019
7B8CB5,note-sale,100,52,11/27/2019
7D35D8,legal-issues-defendant,100,22,11/27/2019
7F3FBC,ipo-completed,100,76,11/27/2019
86A1B9,product-release,100,64,11/27/2019
89E771,earnings,100,50,11/27/2019
8B1E11,index-listing,100,76,11/27/2019
8B9B3B,conference-participant,100,50,11/27/2019
8DA42F,legal-issues-defendant,100,22,11/27/2019
911AB8,business-contract,100,69,11/27/2019
911AB8,business-contract,100,69,11/27/2019
97693A,conference-call,100,50,11/27/2019
990AD0,conference-organizer,100,57,11/27/2019
9E5C2C,note-sale,100,52,11/27/2019
9E98F2,legal-issues-defendant,100,22,11/27/2019
A631A3,conference-participant,100,50,11/27/2019
A631A3,conference-participant,100,50,11/27/2019
A6ABE9,earnings-guidance,100,50,11/27/2019
A790A5,award,100,58,11/27/2019
AFDF2E,legal-issues-defendant,100,22,11/27/2019
AFDF2E,legal-issues-defendant,100,22,11/27/2019
B0D41A,conference-participant,100,50,11/27/2019
B3CB74,conference-organizer,100,57,11/27/2019
BC3AD2,dividend,100,50,11/27/2019
BCC55F,executive-appointment,100,54,11/27/2019
C7859D,conference-participant,100,50,11/27/2019
CD4DA8,conference-organizer,100,57,11/27/2019
CD4DA8,conference-organizer,100,57,11/27/2019
CD4DA8,conference-organizer,100,57,11/27/2019
CD4DA8,conference-organizer,100,57,11/27/2019
CD4DA8,conference-organizer,100,57,11/27/2019
CF351E,earnings-guidance,100,50,11/27/2019
CF7292,executive-appointment,100,54,11/27/2019
D65A13,conference-participant,100,50,11/27/2019
D8DA3D,legal-issues-defendant,100,22,11/27/2019
DCD97F,business-contract,100,69,11/27/2019
DDEA6A,conference-participant,100,50,11/27/2019
DE4924,conference-participant,100,50,11/27/2019
E0207A,conference-participant,100,50,11/27/2019
E124EB,conference-participant,100,50,11/27/2019
E68C3D,conference-participant,100,50,11/27/2019
E8846E,conference-organizer,100,57,11/27/2019
E8846E,executive-appointment,100,54,11/27/2019
EB7D6C,trading-listing,100,61,11/27/2019
ECF709,earnings,100,50,11/27/2019
F02170,conference-participant,100,50,11/27/2019
F48947,executive-appointment,100,54,11/27/2019
F5349B,note-sale,100,52,11/27/2019
F569FD,conference-participant,100,50,11/27/2019
F5D499,executive-appointment,100,54,11/27/2019
F66B58,conference-call,100,50,11/27/2019
F6E248,donation,100,54,11/27/2019
F9AA02,public-offering,100,43,11/27/2019
FEC475,legal-issues-defendant,100,22,11/27/2019
01D03F,regulatory-product-approval-granted,100,81,11/28/2019
2491BC,legal-issues-defendant,100,22,11/28/2019
2BA977,legal-issues-defendant,100,22,11/28/2019
41EC04,legal-issues-defendant,100,22,11/28/2019
622DBE,legal-issues-defendant,100,22,11/28/2019
62F41C,product-release,100,64,11/28/2019
73A71F,legal-issues-defendant,100,22,11/28/2019
7823A3,legal-issues-defendant,100,22,11/28/2019
7ACFD4,legal-issues-defendant,100,22,11/28/2019
C0030A,revenue-up,100,69,11/28/2019
D8442A,revenue-up,100,69,11/28/2019
D8442A,revenues,100,50,11/28/2019
D8442A,revenues,100,50,11/28/2019
07C907,dividend,100,50,11/29/2019
0F0440,product-release,100,64,11/29/2019
0F0440,product-release,100,64,11/29/2019
139303,conference-organizer,100,57,11/29/2019
139303,conference-organizer,100,57,11/29/2019
139303,conference-organizer,100,57,11/29/2019
1A5D5D,legal-issues-defendant,100,22,11/29/2019
1E1125,conference-organizer,100,57,11/29/2019
2491BC,legal-issues-defendant,100,22,11/29/2019
2BA977,legal-issues-defendant,100,22,11/29/2019
33AD83,revenue-up,100,69,11/29/2019
35AE32,conference-participant,100,50,11/29/2019
41EC04,legal-issues-defendant,100,22,11/29/2019
54DF47,dividend,100,50,11/29/2019
567F3D,conference-participant,100,50,11/29/2019
61BCA7,acquisition-completed-acquirer,100,49,11/29/2019
622DBE,legal-issues-defendant,100,22,11/29/2019
73A71F,legal-issues-defendant,100,22,11/29/2019
747219,legal-issues-defendant,100,22,11/29/2019
7823A3,legal-issues-defendant,100,22,11/29/2019
7ACFD4,legal-issues-defendant,100,22,11/29/2019
804708,dividend,100,50,11/29/2019
8D0EEA,conference-participant,100,50,11/29/2019
92B625,conference-participant,100,50,11/29/2019
9BF177,earnings,100,50,11/29/2019
C01737,conference-participant,100,50,11/29/2019
D8442A,revenues,100,50,11/29/2019
D8442A,revenue-up,100,69,11/29/2019
D8DA3D,legal-issues-defendant,100,22,11/29/2019
FEC475,legal-issues-defendant,100,22,11/29/2019
FEC475,legal-issues-defendant,100,22,11/29/2019
2491BC,legal-issues-defendant,100,22,11/30/2019
2BA977,legal-issues-defendant,100,22,11/30/2019
41EC04,legal-issues-defendant,100,22,11/30/2019
622DBE,legal-issues-defendant,100,22,11/30/2019
73A71F,legal-issues-defendant,100,22,11/30/2019
8DA42F,legal-issues-defendant,100,22,11/30/2019
9E98F2,legal-issues-defendant,100,22,11/30/2019
55018,legal-issues-defendant,100,22,12/1/2019
1A5D5D,legal-issues-defendant,100,22,12/1/2019
1FAF22,legal-issues-defendant,100,22,12/1/2019
2491BC,legal-issues-defendant,100,22,12/1/2019
2BA977,legal-issues-defendant,100,22,12/1/2019
41EC04,legal-issues-defendant,100,22,12/1/2019
4A6F00,revenue-up,100,69,12/1/2019
622DBE,legal-issues-defendant,100,22,12/1/2019
BC5680,legal-issues-defendant,100,22,12/1/2019
E09E2B,partnership,100,61,12/1/2019
FEC475,legal-issues-defendant,100,22,12/1/2019
13528,unit-acquisition-acquirer,100,49,12/2/2019
0157B1,partnership,100,61,12/2/2019
0157B1,product-release,100,64,12/2/2019
0157B1,product-release,100,64,12/2/2019
02870F,executive-appointment,100,54,12/2/2019
04996E,award,100,58,12/2/2019
55018,legal-issues-defendant,100,22,12/2/2019
0A9D0A,acquisition-completed-acquirer,100,49,12/2/2019
0CCCB7,award,100,58,12/2/2019
1201B5,product-release,100,64,12/2/2019
1220D2,conference-participant,100,50,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
139303,conference-organizer,100,57,12/2/2019
15789A,asset-sale,100,62,12/2/2019
157CC1,product-release,100,64,12/2/2019
1782D5,dividend,100,50,12/2/2019
17EDA5,unit-acquisition-completed-acquiree,100,67,12/2/2019
1921DD,partnership,100,61,12/2/2019
1E1125,conference-organizer,100,57,12/2/2019
1E1125,conference-organizer,100,57,12/2/2019
1E1125,conference-organizer,100,57,12/2/2019
1E1125,conference-organizer,100,57,12/2/2019
1EBF8D,conference-participant,100,50,12/2/2019
1F3CFB,conference-participant,100,50,12/2/2019
1F716B,business-contract,100,69,12/2/2019
1FA886,business-contract,100,69,12/2/2019
1FAF22,acquisition-acquirer,100,49,12/2/2019
228D42,executive-appointment,100,54,12/2/2019
2491BC,legal-issues-defendant,100,22,12/2/2019
2491BC,note-sale,100,52,12/2/2019
25D3CE,conference-participant,100,50,12/2/2019
28F905,executive-appointment,100,54,12/2/2019
28F905,legal-issues-defendant,100,22,12/2/2019
2BA977,legal-issues-defendant,100,22,12/2/2019
2E902B,conference-participant,100,50,12/2/2019
2EB88B,business-contract,100,69,12/2/2019
314D88,conference-participant,100,50,12/2/2019
3.20E+263,conference-participant,100,50,12/2/2019
33AD83,executive-appointment,100,54,12/2/2019
367E1C,business-contract,100,69,12/2/2019
367E1C,business-contract,100,69,12/2/2019
37727A,joint-venture,100,62,12/2/2019
384CD3,buybacks,100,74,12/2/2019
385DD4,conference-participant,100,50,12/2/2019
41A93D,conference-participant,100,50,12/2/2019
41EC04,legal-issues-defendant,100,22,12/2/2019
451D61,executive-appointment,100,54,12/2/2019
467F2C,buybacks,100,74,12/2/2019
468DD4,acquisition-acquirer,100,49,12/2/2019
4.60E+06,executive-appointment,100,54,12/2/2019
4A3438,acquisition-completed-acquirer,100,49,12/2/2019
4C7DB5,dividend,100,50,12/2/2019
4E6F5A,conference-call,100,50,12/2/2019
50070E,conference-organizer,100,57,12/2/2019
50070E,conference-organizer,100,57,12/2/2019
5.43E+08,conference-participant,100,50,12/2/2019
55CD6F,dividend,100,50,12/2/2019
5675EB,acquisition-completed-acquirer,100,49,12/2/2019
5A9F54,note-sale,100,52,12/2/2019
5A9F54,note-sale,100,52,12/2/2019
5BE42C,unit-acquisition-completed-acquirer,100,49,12/2/2019
5C7601,executive-resignation,100,44,12/2/2019
5D41E4,executive-appointment,100,54,12/2/2019
5EAA43,business-contract,100,69,12/2/2019
622DBE,legal-issues-defendant,100,22,12/2/2019
6284B5,executive-appointment,100,54,12/2/2019
66E04A,facility-open,100,65,12/2/2019
69CE71,business-contract,100,69,12/2/2019
69CE71,business-contract,100,69,12/2/2019
69FDFC,executive-appointment,100,54,12/2/2019
6B236C,executive-appointment,100,54,12/2/2019
6CF43C,executive-appointment,100,54,12/2/2019
6DBBBC,investment-investor,100,55,12/2/2019
6F0096,dividend,100,50,12/2/2019
70FCEF,earnings,100,50,12/2/2019
713810,conference-participant,100,50,12/2/2019
722D55,conference-participant,100,50,12/2/2019
7255D2,public-offering,100,43,12/2/2019
73A213,conference-participant,100,50,12/2/2019
73A71F,legal-issues-defendant,100,22,12/2/2019
769F40,executive-appointment,100,54,12/2/2019
76D79A,dividend,100,50,12/2/2019
7710F3,partnership,100,61,12/2/2019
7710F3,public-offering,100,43,12/2/2019
7823A3,legal-issues-defendant,100,22,12/2/2019
7A5097,executive-appointment,100,54,12/2/2019
7ACD98,public-offering,100,43,12/2/2019
8.10E+32,joint-venture,100,62,12/2/2019
8.10E+205,earnings,100,50,12/2/2019
82C202,business-contract,100,69,12/2/2019
83598E,acquisition-acquirer,100,49,12/2/2019
83B1C8,executive-appointment,100,54,12/2/2019
8BE916,asset-sale,100,62,12/2/2019
8EF425,dividend,100,50,12/2/2019
8FCA78,conference-participant,100,50,12/2/2019
9087B9,unit-acquisition-completed-acquirer,100,49,12/2/2019
9087B9,unit-acquisition-completed-acquirer,100,49,12/2/2019
911AB8,buybacks,100,74,12/2/2019
91E5EE,private-placement,100,56,12/2/2019
934029,clinical-trials,100,56,12/2/2019
934029,clinical-trials,100,56,12/2/2019
94637C,fundraising,100,64,12/2/2019
954004,executive-appointment,100,54,12/2/2019
968966,unit-acquisition-completed-acquiree,100,67,12/2/2019
9.74E+08,patent-awarded,100,72,12/2/2019
997348,dividend,100,50,12/2/2019
9E575E,executive-appointment,100,54,12/2/2019
A1EAC8,business-contract,100,69,12/2/2019
A26EF7,rights-issue,100,43,12/2/2019
A63387,product-release,100,64,12/2/2019
A79D88,conference-participant,100,50,12/2/2019
A7A0C8,conference-participant,100,50,12/2/2019
A80FE0,conference-participant,100,50,12/2/2019
A8E72A,conference-participant,100,50,12/2/2019
A8E72A,public-offering,100,43,12/2/2019
AC7C4F,business-contract,100,69,12/2/2019
AD6141,executive-appointment,100,54,12/2/2019
AEFC90,public-offering,100,43,12/2/2019
B05118,conference-participant,100,50,12/2/2019
B1FC3B,earnings,100,50,12/2/2019
B3CB74,conference-organizer,100,57,12/2/2019
B3CB74,conference-organizer,100,57,12/2/2019
B3CB74,conference-organizer,100,57,12/2/2019
B98EFA,conference-participant,100,50,12/2/2019
BB127B,conference-participant,100,50,12/2/2019
BC5680,legal-issues-defendant,100,22,12/2/2019
BE5935,executive-appointment,100,54,12/2/2019
BE645B,conference-participant,100,50,12/2/2019
BEA527,conference-participant,100,50,12/2/2019
BFCACF,executive-appointment,100,54,12/2/2019
C0BA36,award,100,58,12/2/2019
C22BE8,dividend,100,50,12/2/2019
C48574,executive-appointment,100,54,12/2/2019
C4F567,partnership,100,61,12/2/2019
C5D2AE,award,100,58,12/2/2019
C9C62A,earnings,100,50,12/2/2019
CBB77B,earnings,100,50,12/2/2019
CC6FF5,partnership,100,61,12/2/2019
CC6FF5,acquisition-acquirer,100,49,12/2/2019
CD4DA8,conference-organizer,100,57,12/2/2019
CD4DA8,conference-organizer,100,57,12/2/2019
CD4DA8,conference-organizer,100,57,12/2/2019
CD4DA8,conference-organizer,100,57,12/2/2019
CD4DA8,conference-organizer,100,57,12/2/2019
CDC817,conference-participant,100,50,12/2/2019
CFF97C,conference-participant,100,50,12/2/2019
D1C26F,conference-participant,100,50,12/2/2019
D4463B,unit-acquisition-completed-acquiree,100,67,12/2/2019
D8442A,revenue-up,100,69,12/2/2019
DA0A9E,executive-appointment,100,54,12/2/2019
DC5299,dividend,100,50,12/2/2019
DD0099,merger-completed,100,66,12/2/2019
DD1BA1,conference-organizer,100,57,12/2/2019
DD1BA1,executive-appointment,100,54,12/2/2019
DE4924,acquisition-acquirer,100,49,12/2/2019
DF5F14,index-listing,100,76,12/2/2019
E0207A,acquisition-completed-acquirer,100,49,12/2/2019
E09E2B,partnership,100,61,12/2/2019
E09E2B,partnership,100,61,12/2/2019
E38906,clinical-trials-positive,100,87,12/2/2019
E598FB,clinical-trials-start,100,64,12/2/2019
E68C3D,business-contract,100,69,12/2/2019
E8846E,conference-organizer,100,57,12/2/2019
E8846E,executive-appointment,100,54,12/2/2019
EAA0A7,conference-participant,100,50,12/2/2019
EC99D0,executive-appointment,100,54,12/2/2019
ECDEB2,buybacks,100,74,12/2/2019
ECE814,ipo,100,71,12/2/2019
EF45B6,dividend,100,50,12/2/2019
EF5BED,executive-appointment,100,54,12/2/2019
F0027C,clinical-trials-start,100,64,12/2/2019
F209B4,award,100,58,12/2/2019
F2BC3D,earnings,100,50,12/2/2019
F30508,conference-participant,100,50,12/2/2019
F4F46F,award,100,58,12/2/2019
F58C23,executive-resignation,100,44,12/2/2019
F5D410,business-contract,100,69,12/2/2019
F5D410,business-contract,100,69,12/2/2019
F9AA02,conference-participant,100,50,12/2/2019
FA36A4,index-listing,100,76,12/2/2019
FBD92D,conference-participant,100,50,12/2/2019
FC01C0,legal-issues-defendant,100,22,12/2/2019
FEC475,legal-issues-defendant,100,22,12/2/2019
FF6644,legal-issues-defendant,100,22,12/2/2019
003B70,business-contract,100,69,12/3/2019
00698D,conference-call,100,50,12/3/2019
0157B1,partnership,100,61,12/3/2019
0157B1,product-release,100,64,12/3/2019
0157B1,product-release,100,64,12/3/2019
0157B1,partnership,100,61,12/3/2019
0157B1,partnership,100,61,12/3/2019
0157B1,business-contract,100,69,12/3/2019
01D03F,regulatory-product-approval-granted,100,81,12/3/2019
01D03F,regulatory-product-approval-granted,100,81,12/3/2019
03FAA6,note-sale,100,52,12/3/2019
054B55,settlement,100,56,12/3/2019
0A59F8,partnership,100,61,12/3/2019
10100E,conference-participant,100,50,12/3/2019
1201B5,conference-participant,100,50,12/3/2019
1348C9,dividend,100,50,12/3/2019
139303,conference-organizer,100,57,12/3/2019
139303,conference-organizer,100,57,12/3/2019
139303,conference-organizer,100,57,12/3/2019
139303,conference-organizer,100,57,12/3/2019
139303,conference-organizer,100,57,12/3/2019
14391F,public-offering,100,43,12/3/2019
190B91,partnership,100,61,12/3/2019
1A5D5D,legal-issues-defendant,100,22,12/3/2019
1D943E,conference-organizer,100,57,12/3/2019
1E1125,conference-organizer,100,57,12/3/2019
1FA886,acquisition-completed-acquiree,100,76,12/3/2019
1FAF22,legal-issues-defendant,100,22,12/3/2019
205AD5,executive-appointment,100,54,12/3/2019
20BEEA,credit-extension-recipient,100,69,12/3/2019
2491BC,legal-issues-defendant,100,22,12/3/2019
24A89A,legal-issues-defendant,100,22,12/3/2019
26DC29,legal-issues-defendant,100,22,12/3/2019
28AF37,conference-participant,100,50,12/3/2019
2B8179,clinical-trials,100,56,12/3/2019
2EB88B,reorganization,100,53,12/3/2019
3461CF,award,100,58,12/3/2019
3461CF,conference-participant,100,50,12/3/2019
3471C0,executive-appointment,100,54,12/3/2019
384CD3,conference-participant,100,50,12/3/2019
38C46F,dividend,100,50,12/3/2019
3B37F7,executive-appointment,100,54,12/3/2019
3BB616,note-sale,100,52,12/3/2019
3F1C69,clinical-trials-positive,100,87,12/3/2019
3F1C69,conference-participant,100,50,12/3/2019
4017AD,executive-appointment,100,54,12/3/2019
40B903,dividend,100,50,12/3/2019
41EC04,legal-issues-defendant,100,22,12/3/2019
41EC04,legal-issues-defendant,100,22,12/3/2019
42AABD,executive-appointment,100,54,12/3/2019
44A4FC,partnership,100,61,12/3/2019
4A3438,conference-participant,100,50,12/3/2019
4B3676,conference-participant,100,50,12/3/2019
4B3676,conference-participant,100,50,12/3/2019
4B7006,earnings,100,50,12/3/2019
4C7DB5,acquisition-acquirer,100,49,12/3/2019
4C7DB5,acquisition-acquirer,100,49,12/3/2019
4C7DB5,acquisition-acquirer,100,49,12/3/2019
4E913D,partnership,100,61,12/3/2019
50070E,conference-organizer,100,57,12/3/2019
50070E,conference-organizer,100,57,12/3/2019
50070E,conference-organizer,100,57,12/3/2019
50070E,conference-organizer,100,57,12/3/2019
50070E,conference-organizer,100,57,12/3/2019
550D01,partnership,100,61,12/3/2019
55C9B5,dividend,100,50,12/3/2019
583223,acquisition-completed-acquirer,100,49,12/3/2019
5D16CF,dividend,100,50,12/3/2019
5EAA43,executive-appointment,100,54,12/3/2019
5F2FF7,operating-earnings,100,50,12/3/2019
61BCA7,partnership,100,61,12/3/2019
649CBD,executive-appointment,100,54,12/3/2019
665440,executive-appointment,100,54,12/3/2019
665618,acquisition-completed-acquirer,100,49,12/3/2019
665D7D,partnership,100,61,12/3/2019
66A667,partnership,100,61,12/3/2019
66A667,partnership,100,61,12/3/2019
69C99E,clinical-trials-positive,100,87,12/3/2019
69FDFC,award,100,58,12/3/2019
6BC6F9,executive-appointment,100,54,12/3/2019
6CB7F9,buybacks,100,74,12/3/2019
722DE3,business-contract,100,69,12/3/2019
7255D2,business-contract,100,69,12/3/2019
73A71F,legal-issues-defendant,100,22,12/3/2019
7.45E+28,executive-appointment,100,54,12/3/2019
747219,legal-issues-defendant,100,22,12/3/2019
75768D,conference-call,100,50,12/3/2019
7823A3,legal-issues-defendant,100,22,12/3/2019
789A7D,executive-appointment,100,54,12/3/2019
791D59,partnership,100,61,12/3/2019
7B8CB5,conference-participant,100,50,12/3/2019
7B9212,dividend,100,50,12/3/2019
7BFF81,partnership,100,61,12/3/2019
7BFF81,conference-participant,100,50,12/3/2019
7D35D8,legal-issues-defendant,100,22,12/3/2019
81222C,conference-participant,100,50,12/3/2019
826FD6,earnings,100,50,12/3/2019
834152,clinical-trials,100,56,12/3/2019
85DA04,executive-appointment,100,54,12/3/2019
880C0C,dividend-up,100,81,12/3/2019
890FF4,executive-appointment,100,54,12/3/2019
8A8E41,partnership,100,61,12/3/2019
8B8656,donation,100,54,12/3/2019
8CF6DD,conference-participant,100,50,12/3/2019
8D4AE6,dividend,100,50,12/3/2019
903AB4,dividend-up,100,81,12/3/2019
9043FE,debt-extension-recipient,100,73,12/3/2019
9043FE,debt-extension-recipient,100,73,12/3/2019
9196A2,conference-organizer,100,57,12/3/2019
93D207,partnership,100,61,12/3/2019
950AB7,index-listing,100,76,12/3/2019
954004,earnings,100,50,12/3/2019
954004,executive-appointment,100,54,12/3/2019
954A47,executive-resignation,100,44,12/3/2019
98CEBB,business-contract,100,69,12/3/2019
990AD0,conference-organizer,100,57,12/3/2019
990AD0,conference-organizer,100,57,12/3/2019
994468,unit-acquisition-completed-acquirer,100,49,12/3/2019
9E575E,public-offering,100,43,12/3/2019
9E98F2,legal-issues-defendant,100,22,12/3/2019
9E98F2,legal-issues-defendant,100,22,12/3/2019
A017F4,executive-appointment,100,54,12/3/2019
A247F5,note-sale,100,52,12/3/2019
A247F5,note-sale,100,52,12/3/2019
A6828A,partnership,100,61,12/3/2019
A868C9,executive-appointment,100,54,12/3/2019
A8E2FE,public-offering,100,43,12/3/2019
AD3C93,conference-participant,100,50,12/3/2019
AE3113,executive-appointment,100,54,12/3/2019
AEBB80,dividend-up,100,81,12/3/2019
AECCA9,dividend,100,50,12/3/2019
AED61E,earnings-up,100,68,12/3/2019
AED61E,earnings,100,50,12/3/2019
AED61E,earnings,100,50,12/3/2019
AED61E,earnings,100,50,12/3/2019
AFDF2E,legal-issues-defendant,100,22,12/3/2019
AFDF2E,earnings-revision,100,29,12/3/2019
AFDF2E,legal-issues-defendant,100,22,12/3/2019
AFF43F,buybacks,100,74,12/3/2019
B3CB74,conference-organizer,100,57,12/3/2019
B3CB74,conference-organizer,100,57,12/3/2019
B5766D,executive-appointment,100,54,12/3/2019
B614F8,regulatory-product-approval-granted,100,81,12/3/2019
BB02FB,partnership,100,61,12/3/2019
BB127B,earnings-up,100,68,12/3/2019
BCC55F,award,100,58,12/3/2019
BDCC11,legal-issues-defendant,100,22,12/3/2019
BF5959,conference-participant,100,50,12/3/2019
BFD0A7,conference-participant,100,50,12/3/2019
C0030A,award,100,58,12/3/2019
C037A8,executive-appointment,100,54,12/3/2019
C2F597,conference-participant,100,50,12/3/2019
C36189,conference-participant,100,50,12/3/2019
C3DE7D,business-contract,100,69,12/3/2019
C4452A,dividend,100,50,12/3/2019
C54140,conference-participant,100,50,12/3/2019
C5C137,note-sale,100,52,12/3/2019
C5C137,note-sale,100,52,12/3/2019
C5C137,note-sale,100,52,12/3/2019
C74887,earnings,100,50,12/3/2019
C83B88,product-release,100,64,12/3/2019
C83B88,product-release,100,64,12/3/2019
C941DC,acquisition-acquirer,100,49,12/3/2019
C99CC8,business-contract,100,69,12/3/2019
C9E107,conference-participant,100,50,12/3/2019
CA1620,conference-participant,100,50,12/3/2019
CAC8D0,earnings,100,50,12/3/2019
CD4DA8,conference-participant,100,50,12/3/2019
CDAF5B,dividend,100,50,12/3/2019
CDFCC9,conference-participant,100,50,12/3/2019
CDFCC9,earnings-guidance,100,50,12/3/2019
CEDFD5,clinical-trials-positive,100,87,12/3/2019
CEDFD5,clinical-trials-positive,100,87,12/3/2019
D0DFE5,market-entry,100,57,12/3/2019
D296C6,dividend,100,50,12/3/2019
D33270,business-contract,100,69,12/3/2019
D60BB2,partnership,100,61,12/3/2019
D64C6D,conference-call,100,50,12/3/2019
D7AC6E,board-meeting,100,51,12/3/2019
D88EF3,note-sale,100,52,12/3/2019
D88EF3,note-sale,100,52,12/3/2019
D8DA3D,legal-issues-defendant,100,22,12/3/2019
DB9829,dividend,100,50,12/3/2019
DBB28E,business-contract,100,69,12/3/2019
DC486E,dividend,100,50,12/3/2019
DC486E,dividend,100,50,12/3/2019
DD0F15,executive-appointment,100,54,12/3/2019
DE5611,earnings,100,50,12/3/2019
E0E4B7,earnings,100,50,12/3/2019
E1C16B,dividend,100,50,12/3/2019
E5A3B6,partnership,100,61,12/3/2019
E5C910,regulatory-product-approval-granted,100,81,12/3/2019
E610CD,conference-participant,100,50,12/3/2019
E6D89E,partnership,100,61,12/3/2019
EB5E78,conference-participant,100,50,12/3/2019
EC99D0,partnership,100,61,12/3/2019
EC99D0,partnership,100,61,12/3/2019
ECF709,board-meeting,100,51,12/3/2019
ED4560,conference-participant,100,50,12/3/2019
EF5BED,conference-participant,100,50,12/3/2019
F1EB39,earnings,100,50,12/3/2019
F43A11,conference-call,100,50,12/3/2019
F4CDA3,unit-acquisition-acquirer,100,49,12/3/2019
F4CDA3,unit-acquisition-acquirer,100,49,12/3/2019
F5D410,debt-extension-recipient,100,73,12/3/2019
F6DE54,product-price-raise,100,57,12/3/2019
FA35C6,conference-participant,100,50,12/3/2019
FA40E2,earnings,100,50,12/3/2019
FBDA0F,unit-acquisition-acquirer,100,49,12/3/2019
FC01C0,legal-issues-defendant,100,22,12/3/2019
FEC475,legal-issues-defendant,100,22,12/3/2019
FEC475,legal-issues-defendant,100,22,12/3/2019
00067A,partnership,100,61,12/4/2019
00067A,partnership,100,61,12/4/2019
00067A,partnership,100,61,12/4/2019
0157B1,partnership,100,61,12/4/2019
0157B1,partnership,100,61,12/4/2019
0157B1,partnership,100,61,12/4/2019
01D03F,regulatory-product-approval-granted,100,81,12/4/2019
01D03F,regulatory-product-approval-granted,100,81,12/4/2019
0A0D9E,conference-participant,100,50,12/4/2019
0BD4E8,dividend,100,50,12/4/2019
10100E,executive-appointment,100,54,12/4/2019
12DE76,partnership,100,61,12/4/2019
12E454,business-contract,100,69,12/4/2019
14BA06,dividend,100,50,12/4/2019
14BA33,dividend,100,50,12/4/2019
15901B,conference-participant,100,50,12/4/2019
1A5D5D,legal-issues-defendant,100,22,12/4/2019
1D1B07,earnings,100,50,12/4/2019
1D1B07,earnings,100,50,12/4/2019
1DF15D,dividend,100,50,12/4/2019
1E83DE,earnings,100,50,12/4/2019
1FA886,buybacks,100,74,12/4/2019
1FAF22,conference-participant,100,50,12/4/2019
227D48,dividend,100,50,12/4/2019
228D42,dividend,100,50,12/4/2019
2491BC,legal-issues-defendant,100,22,12/4/2019
24C48B,note-sale,100,52,12/4/2019
25102A,conference-participant,100,50,12/4/2019
25A6CC,legal-issues-defendant,100,22,12/4/2019
25A6CC,legal-issues-defendant,100,22,12/4/2019
25A6CC,legal-issues-defendant,100,22,12/4/2019
25A6CC,legal-issues-defendant,100,22,12/4/2019
25A6CC,legal-issues-defendant,100,22,12/4/2019
25A6CC,fraud-defendant,100,20,12/4/2019
26CC63,earnings,100,50,12/4/2019
26DC29,legal-issues-defendant,100,22,12/4/2019
292388,conference-participant,100,50,12/4/2019
2E0496,acquisition-acquirer,100,49,12/4/2019
2E0496,acquisition-acquirer,100,49,12/4/2019
3159AA,facility-open,100,65,12/4/2019
33AD83,executive-appointment,100,54,12/4/2019
34A959,acquisition-regulatory-approval-acquirer,100,54,12/4/2019
3B20AB,product-release,100,64,12/4/2019
3C6CCC,public-offering,100,43,12/4/2019
3F4668,executive-appointment,100,54,12/4/2019
41EC04,legal-issues-defendant,100,22,12/4/2019
431B74,dividend,100,50,12/4/2019
431B74,dividend,100,50,12/4/2019
46A16E,executive-appointment,100,54,12/4/2019
4E6F5A,public-offering,100,43,12/4/2019
50070E,conference-organizer,100,57,12/4/2019
50070E,conference-organizer,100,57,12/4/2019
50070E,conference-organizer,100,57,12/4/2019
50070E,conference-organizer,100,57,12/4/2019
543900,earnings,100,50,12/4/2019
543900,earnings,100,50,12/4/2019
543900,earnings,100,50,12/4/2019
543900,earnings,100,50,12/4/2019
543900,earnings,100,50,12/4/2019
543900,earnings,100,50,12/4/2019
543900,earnings,100,50,12/4/2019
5.47E+28,clinical-trials,100,56,12/4/2019
56765E,note-sale,100,52,12/4/2019
56765E,note-sale,100,52,12/4/2019
56EFC7,earnings,100,50,12/4/2019
589846,earnings,100,50,12/4/2019
59B229,executive-appointment,100,54,12/4/2019
5A423F,executive-appointment,100,54,12/4/2019
5A64D5,facility-open,100,65,12/4/2019
5D41E4,conference-participant,100,50,12/4/2019
619882,conference-organizer,100,57,12/4/2019
633054,product-release,100,64,12/4/2019
6CBF41,earnings,100,50,12/4/2019
6CBF41,earnings,100,50,12/4/2019
6D2BF6,conference-participant,100,50,12/4/2019
6D3F35,conference-participant,100,50,12/4/2019
6F6559,earnings,100,50,12/4/2019
7239BB,earnings,100,50,12/4/2019
73A71F,legal-issues-defendant,100,22,12/4/2019
747219,legal-issues-defendant,100,22,12/4/2019
75F982,dividend,100,50,12/4/2019
7710F3,public-offering,100,43,12/4/2019
7823A3,legal-issues-defendant,100,22,12/4/2019
791D59,partnership,100,61,12/4/2019
7ADE57,earnings,100,50,12/4/2019
7ADE57,earnings,100,50,12/4/2019
7ADE57,earnings,100,50,12/4/2019
7ADE57,earnings,100,50,12/4/2019
7ADE57,earnings,100,50,12/4/2019
7D35D8,legal-issues-defendant,100,22,12/4/2019
7D35D8,legal-issues-defendant,100,22,12/4/2019
7E1542,earnings,100,50,12/4/2019
7E1D5D,earnings,100,50,12/4/2019
7E1D5D,earnings,100,50,12/4/2019
7E1D5D,earnings,100,50,12/4/2019
7E1D5D,earnings,100,50,12/4/2019
7FC386,dividend-up,100,81,12/4/2019
82E58A,public-offering,100,43,12/4/2019
863350,earnings,100,50,12/4/2019
8665BA,facility-open,100,65,12/4/2019
8B2C4A,note-sale,100,52,12/4/2019
8BAA15,patent-infringement-plaintiff,100,47,12/4/2019
8EDACA,note-sale,100,52,12/4/2019
92D757,conference-participant,100,50,12/4/2019
934CC3,facility-upgrade,100,65,12/4/2019
9470CC,conference-participant,100,50,12/4/2019
9.82E+06,earnings,100,50,12/4/2019
98A286,earnings-per-share,100,50,12/4/2019
990AD0,fundraising,100,64,12/4/2019
99DC8D,earnings,100,50,12/4/2019
9A602D,dividend-up,100,52,12/4/2019
9CDA4F,conference-participant,100,50,12/4/2019
9E575E,public-offering,100,43,12/4/2019
9E98F2,legal-issues-defendant,100,22,12/4/2019
9F71E5,conference-participant,100,50,12/4/2019
A16DEA,dividend,100,50,12/4/2019
A16DEA,executive-appointment,100,54,12/4/2019
A1E3B3,conference-participant,100,50,12/4/2019
A247F5,conference-participant,100,50,12/4/2019
A2A9BA,unit-acquisition-completed-acquirer,100,49,12/4/2019
A631A3,conference-organizer,100,57,12/4/2019
A631A3,award,100,58,12/4/2019
A6FB29,earnings-up,100,68,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings,100,50,12/4/2019
A6FB29,earnings-up,100,68,12/4/2019
A7102F,partnership,100,61,12/4/2019
A72FD9,earnings,100,50,12/4/2019
A8E2FE,public-offering,100,43,12/4/2019
AA3AB8,earnings,100,50,12/4/2019
AAEE21,executive-appointment,100,54,12/4/2019
AD6141,conference-participant,100,50,12/4/2019
AECCA9,earnings,100,50,12/4/2019
AEFC90,public-offering,100,43,12/4/2019
AFDF2E,legal-issues-defendant,100,22,12/4/2019
B1A85D,partnership,100,61,12/4/2019
B1FC3B,dividend,100,50,12/4/2019
B303A6,executive-appointment,100,54,12/4/2019
B3CB74,conference-organizer,100,57,12/4/2019
B3CB74,conference-organizer,100,57,12/4/2019
B8EF97,earnings,100,50,12/4/2019
BC5680,product-release,100,64,12/4/2019
BCC55F,conference-participant,100,50,12/4/2019
BE5935,executive-resignation,100,44,12/4/2019
BE5935,conference-participant,100,50,12/4/2019
C188F8,clinical-trials-positive,100,87,12/4/2019
C7859D,dividend,100,50,12/4/2019
C81E00,dividend-up,100,61,12/4/2019
C81E00,dividend-up,100,61,12/4/2019
C83B88,board-meeting,100,51,12/4/2019
C9D866,conference-participant,100,50,12/4/2019
CBB77B,dividend,100,50,12/4/2019
CD4DA8,executive-appointment,100,54,12/4/2019
D0909F,dividend,100,50,12/4/2019
D17C1B,executive-appointment,100,54,12/4/2019
D29B44,executive-appointment,100,54,12/4/2019
D8DA3D,legal-issues-defendant,100,22,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DB88A1,earnings,100,50,12/4/2019
DCD97F,dividend,100,50,12/4/2019
DD1BA1,conference-participant,100,50,12/4/2019
DF532D,conference-participant,100,50,12/4/2019
DF5F14,public-offering,100,43,12/4/2019
E35610,revenue-up,100,75,12/4/2019
E5A3B6,executive-appointment,100,54,12/4/2019
E68733,product-release,100,64,12/4/2019
E754F0,executive-appointment,100,54,12/4/2019
EB43F4,public-offering,100,43,12/4/2019
F1529C,conference-participant,100,50,12/4/2019
F3EDB4,earnings,100,50,12/4/2019
F83279,dividend,100,50,12/4/2019
F8BA6C,conference-participant,100,50,12/4/2019
FC4550,dividend,100,50,12/4/2019
FDD3FC,executive-appointment,100,54,12/4/2019
FE7A63,dividend,100,50,12/4/2019
FEC475,legal-issues-defendant,100,22,12/4/2019
FEC475,legal-issues-defendant,100,22,12/4/2019
FF4343,note-sale,100,52,12/4/2019
FF4343,note-sale,100,52,12/4/2019
0157B1,partnership,100,61,12/5/2019
0157B1,partnership,100,61,12/5/2019
0157B1,partnership,100,61,12/5/2019
03FAA6,note-sale,100,52,12/5/2019
55018,conference-organizer,100,57,12/5/2019
06A456,earnings,100,50,12/5/2019
06A456,earnings,100,50,12/5/2019
06A456,earnings,100,50,12/5/2019
0B73A7,executive-appointment,100,54,12/5/2019
0B73A7,executive-appointment,100,54,12/5/2019
0BF528,earnings,100,50,12/5/2019
0DBB81,patient-enrollment-complete,100,64,12/5/2019
1096C6,business-contract,100,69,12/5/2019
14BA33,dividend,100,50,12/5/2019
168A5D,partnership,100,61,12/5/2019
16F4D8,conference-participant,100,50,12/5/2019
19C105,note-sale,100,52,12/5/2019
1AD9CC,earnings,100,50,12/5/2019
1BC12C,partnership,100,61,12/5/2019
221783,public-offering,100,43,12/5/2019
2491BC,legal-issues-defendant,100,22,12/5/2019
25A6CC,legal-issues-defendant,100,22,12/5/2019
25A6CC,legal-issues-defendant,100,22,12/5/2019
25A6CC,legal-issues-defendant,100,22,12/5/2019
25A6CC,legal-issues-defendant,100,22,12/5/2019
26DC29,earnings,100,50,12/5/2019
279916,earnings,100,50,12/5/2019
27A791,executive-appointment,100,54,12/5/2019
27B191,note-sale,100,52,12/5/2019
2E2E6E,dividend-up,100,64,12/5/2019
2F98A5,product-recall,100,29,12/5/2019
2FF046,earnings,100,50,12/5/2019
2FF046,earnings,100,50,12/5/2019
2FF046,earnings,100,50,12/5/2019
2FF046,earnings,100,50,12/5/2019
343996,dividend-guidance-up,100,57,12/5/2019
343996,executive-appointment,100,54,12/5/2019
3.73E+87,patent-infringement-defendant,100,26,12/5/2019
37E18B,conference-participant,100,50,12/5/2019
3A3447,product-release,100,64,12/5/2019
3C6CCC,public-offering,100,43,12/5/2019
3DDE54,executive-appointment,100,54,12/5/2019
41EC04,legal-issues-defendant,100,22,12/5/2019
4398A2,business-contract,100,69,12/5/2019
47752F,dividend,100,50,12/5/2019
4E4E75,operating-earnings,100,50,12/5/2019
4E6F5A,public-offering,100,43,12/5/2019
50070E,conference-organizer,100,57,12/5/2019
56EA2B,dividend,100,50,12/5/2019
583A75,revenue-volume,100,50,12/5/2019
586BD7,clinical-trials-positive,100,87,12/5/2019
587EDF,earnings,100,50,12/5/2019
589803,clinical-trials-positive,100,87,12/5/2019
589803,clinical-trials-positive,100,87,12/5/2019
609208,conference-call,100,50,12/5/2019
619882,conference-organizer,100,57,12/5/2019
619882,business-contract,100,69,12/5/2019
619882,business-contract,100,69,12/5/2019
61B81B,unit-acquisition-acquiree,100,76,12/5/2019
62EFEE,executive-appointment,100,54,12/5/2019
636BBF,earnings,100,50,12/5/2019
66E04A,partnership,100,61,12/5/2019
67B052,executive-appointment,100,54,12/5/2019
6830FE,earnings,100,50,12/5/2019
68586A,conference-participant,100,50,12/5/2019
6CC55E,conference-participant,100,50,12/5/2019
6EA292,dividend,100,50,12/5/2019
70FCEF,earnings,100,50,12/5/2019
71694D,conference-participant,100,50,12/5/2019
722DE3,legal-issues-defendant,100,22,12/5/2019
73A213,conference-participant,100,50,12/5/2019
73A71F,legal-issues-defendant,100,22,12/5/2019
73F7F9,earnings,100,50,12/5/2019
747219,legal-issues-defendant,100,22,12/5/2019
756BB4,earnings,100,50,12/5/2019
756BB4,executive-appointment,100,54,12/5/2019
7740DE,same-store-sales-up,100,52,12/5/2019
7.83E+79,public-offering,100,43,12/5/2019
7.83E+79,merger,100,66,12/5/2019
7A0EC4,earnings,100,50,12/5/2019
7A10FF,dividend,100,50,12/5/2019
7B9212,revenues,100,50,12/5/2019
7C75FD,note-sale,100,52,12/5/2019
7C75FD,note-sale,100,52,12/5/2019
7D5FD6,dividend-up,100,59,12/5/2019
805CD8,public-offering,100,43,12/5/2019
82E58A,public-offering,100,43,12/5/2019
838ADD,conference-participant,100,50,12/5/2019
859D62,earnings,100,50,12/5/2019
859D62,earnings,100,50,12/5/2019
859D62,earnings,100,50,12/5/2019
859D62,earnings,100,50,12/5/2019
859D62,earnings,100,50,12/5/2019
859D62,earnings,100,50,12/5/2019
895D56,market-entry,100,57,12/5/2019
89E771,dividend,100,50,12/5/2019
8A8E41,dividend,100,50,12/5/2019
8A8E41,executive-appointment,100,54,12/5/2019
8AB85C,clinical-trials-start,100,64,12/5/2019
8BFAA4,private-placement,100,56,12/5/2019
8D4486,award,100,58,12/5/2019
8E4250,earnings,100,50,12/5/2019
8F8F2F,dividend,100,50,12/5/2019
8FCA78,acquisition-acquirer,100,49,12/5/2019
9087B9,buybacks,100,74,12/5/2019
90B678,earnings-positive,100,69,12/5/2019
92D757,partnership,100,61,12/5/2019
93D207,product-release,100,64,12/5/2019
942633,dividend,100,50,12/5/2019
94563D,product-release,100,64,12/5/2019
94637C,dividend-up,100,81,12/5/2019
95DC1F,earnings,100,50,12/5/2019
95DC1F,earnings,100,50,12/5/2019
95DC1F,earnings,100,50,12/5/2019
95DC1F,earnings,100,50,12/5/2019
95DC1F,earnings,100,50,12/5/2019
95DC1F,earnings,100,50,12/5/2019
977A1E,product-release,100,64,12/5/2019
98CEBB,partnership,100,61,12/5/2019
990AD0,conference-organizer,100,57,12/5/2019
9934AD,executive-appointment,100,54,12/5/2019
9E575E,clinical-trials,100,56,12/5/2019
9E98F2,legal-issues-defendant,100,22,12/5/2019
A1BB98,executive-appointment,100,54,12/5/2019
A2C979,executive-appointment,100,54,12/5/2019
A37D68,earnings,100,50,12/5/2019
A4BCDE,dividend,100,50,12/5/2019
A6828A,partnership,100,61,12/5/2019
A6828A,partnership,100,61,12/5/2019
A6828A,executive-appointment,100,54,12/5/2019
A6FB29,earnings-up,100,68,12/5/2019
A6FC89,earnings,100,50,12/5/2019
A6FC89,earnings,100,50,12/5/2019
A6FC89,earnings,100,50,12/5/2019
A6FC89,earnings,100,50,12/5/2019
A6FC89,earnings,100,50,12/5/2019
A6FE1C,unit-acquisition-acquirer,100,49,12/5/2019
AA7FE0,conference-call,100,50,12/5/2019
AA98ED,dividend,100,50,12/5/2019
ADD9DC,earnings,100,50,12/5/2019
AFDF2E,earnings,100,50,12/5/2019
AFDF2E,earnings,100,50,12/5/2019
B08C51,conference-participant,100,50,12/5/2019
B1A85D,product-release,100,64,12/5/2019
B1DF3C,conference-participant,100,50,12/5/2019
B3CB74,conference-organizer,100,57,12/5/2019
B3ED62,award,100,58,12/5/2019
BE14CF,conference-participant,100,50,12/5/2019
C06EB6,conference-call,100,50,12/5/2019
C4FBDC,dividend-up,100,66,12/5/2019
C659EB,dividend-up,100,81,12/5/2019
C6C702,conference-participant,100,50,12/5/2019
C9881C,conference-call,100,50,12/5/2019
CA1620,dividend,100,50,12/5/2019
CD06A2,conference-participant,100,50,12/5/2019
CF7292,earnings,100,50,12/5/2019
CFF57D,earnings,100,50,12/5/2019
CFF57D,earnings,100,50,12/5/2019
CFF57D,earnings,100,50,12/5/2019
CFF57D,earnings,100,50,12/5/2019
D3F64D,dividend,100,50,12/5/2019
D4070C,dividend-up,100,81,12/5/2019
D4070C,dividend-up,100,81,12/5/2019
D854DD,dividend,100,50,12/5/2019
D8DA3D,legal-issues-defendant,100,22,12/5/2019
DA0A9E,conference-call,100,50,12/5/2019
DA0CB8,dividend-up,100,58,12/5/2019
DC2B00,earnings,100,50,12/5/2019
DF5F14,public-offering,100,43,12/5/2019
E09556,conference-call,100,50,12/5/2019
E30B34,conference-participant,100,50,12/5/2019
E30B34,conference-participant,100,50,12/5/2019
E49AA3,conference-participant,100,50,12/5/2019
E68C3D,patent-infringement-plaintiff,100,47,12/5/2019
EB43F4,public-offering,100,43,12/5/2019
ED2EFD,conference-participant,100,50,12/5/2019
F05B1B,acquisition-acquirer,100,49,12/5/2019
F05B1B,acquisition-acquirer,100,49,12/5/2019
F05B1B,acquisition-acquirer,100,49,12/5/2019
F05B1B,acquisition-acquirer,100,49,12/5/2019
F0B877,unit-acquisition-acquirer,100,49,12/5/2019
F2E253,legal-issues-plaintiff,100,44,12/5/2019
F4E992,partnership,100,61,12/5/2019
F66B58,dividend,100,50,12/5/2019
F7935D,private-placement,100,56,12/5/2019
FC01C0,legal-issues-defendant,100,22,12/5/2019
FC1F9D,executive-appointment,100,54,12/5/2019
FD2565,partnership,100,61,12/5/2019
FDE409,earnings,100,50,12/5/2019
FEBFE1,conference-participant,100,50,12/5/2019
001F1B,revenues,100,50,12/6/2019
0157B1,partnership,100,61,12/6/2019
0358AF,dividend,100,50,12/6/2019
036C6F,conference-participant,100,50,12/6/2019
0C136E,executive-appointment,100,54,12/6/2019
0C136E,dividend,100,50,12/6/2019
0CCCB7,executive-appointment,100,54,12/6/2019
106394,unit-acquisition-acquirer,100,49,12/6/2019
11B8A4,acquisition-acquirer,100,49,12/6/2019
1921DD,dividend,100,50,12/6/2019
1921DD,dividend,100,50,12/6/2019
1921DD,dividend,100,50,12/6/2019
19C105,note-sale,100,52,12/6/2019
1AB023,unit-acquisition-completed-acquirer,100,49,12/6/2019
1AB023,acquisition-completed-acquirer,100,49,12/6/2019
1AB023,unit-acquisition-completed-acquirer,100,49,12/6/2019
1AB023,acquisition-completed-acquirer,100,49,12/6/2019
1AB023,unit-acquisition-completed-acquirer,100,49,12/6/2019
1AB023,acquisition-completed-acquirer,100,49,12/6/2019
1CD708,dividend-up,100,81,12/6/2019
1FA886,partnership,100,61,12/6/2019
1FCC00,dividend,100,50,12/6/2019
1FCC00,same-store-sales-meet-expectations,100,56,12/6/2019
1FCC00,same-store-sales,100,50,12/6/2019
1FCC00,same-store-sales,100,50,12/6/2019
2.45E+15,reorganization-approval,100,74,12/6/2019
2491BC,note-sale,100,52,12/6/2019
2491BC,legal-issues-defendant,100,22,12/6/2019
26DC29,earnings,100,50,12/6/2019
292A70,earnings,100,50,12/6/2019
2EBA55,dividend,100,50,12/6/2019
3461CF,credit-rating-set-rater,20,50,12/6/2019
34A959,business-contract,100,69,12/6/2019
34B97A,business-contract,100,69,12/6/2019
3F1C69,clinical-trials,100,56,12/6/2019
42978B,revenues,100,50,12/6/2019
42978B,revenues,100,50,12/6/2019
42978B,revenues,100,50,12/6/2019
42978B,revenues,100,50,12/6/2019
4A2457,business-contract,100,69,12/6/2019
4CDA2B,clinical-trials,100,56,12/6/2019
4D8313,dividend-up,100,59,12/6/2019
50070E,conference-organizer,100,57,12/6/2019
53F491,buybacks,100,74,12/6/2019
553949,unit-acquisition-completed-acquirer,100,49,12/6/2019
553949,unit-acquisition-acquirer,100,49,12/6/2019
5DD48B,award,100,58,12/6/2019
6DBBBC,dividend,100,50,12/6/2019
6F39FC,dividend,100,50,12/6/2019
6F5DD2,conference-participant,100,50,12/6/2019
7255D2,public-offering,100,43,12/6/2019
73A213,conference-participant,100,50,12/6/2019
73A71F,legal-issues-defendant,100,22,12/6/2019
7823A3,legal-issues-defendant,100,22,12/6/2019
7.83E+79,public-offering,100,43,12/6/2019
7999F3,dividend,100,50,12/6/2019
7ACD98,public-offering,100,43,12/6/2019
7B4B91,dividend,100,50,12/6/2019
7B8CB5,note-sale,100,52,12/6/2019
7B8CB5,note-sale,100,52,12/6/2019
7D35D8,legal-issues-defendant,100,22,12/6/2019
7F3FBC,dividend,100,50,12/6/2019
805CD8,public-offering,100,43,12/6/2019
8A8E41,partnership,100,61,12/6/2019
8B2C4A,note-sale,100,52,12/6/2019
8C5519,dividend,100,50,12/6/2019
90D6A5,dividend,100,50,12/6/2019
91E5EE,dividend,100,50,12/6/2019
950CDB,earnings,100,50,12/6/2019
9981C6,dividend,100,50,12/6/2019
9981C6,revenue-up,100,69,12/6/2019
9981C6,revenue-up,100,69,12/6/2019
9B71A7,earnings,100,50,12/6/2019
9CA432,dividend,100,50,12/6/2019
9E98F2,legal-issues-defendant,100,22,12/6/2019
A6FC89,conference-participant,100,50,12/6/2019
A6FE1C,acquisition-acquirer,100,49,12/6/2019
A8E72A,public-offering,100,43,12/6/2019
A96867,dividend,100,50,12/6/2019
AAC8B6,unit-acquisition-acquiree,100,76,12/6/2019
AAC8B6,unit-acquisition-acquiree,100,76,12/6/2019
AE0CCE,business-contract,100,69,12/6/2019
AEFC90,public-offering,100,43,12/6/2019
B1FC3B,conference-participant,100,50,12/6/2019
C9C62A,earnings,100,50,12/6/2019
CEC5B9,buybacks,100,74,12/6/2019
CF351E,dividend-up,100,81,12/6/2019
D88EF3,conference-call,100,50,12/6/2019
E68733,dividend,100,50,12/6/2019
E68733,dividend,100,50,12/6/2019
E6EDED,dividend,100,50,12/6/2019
EA79C7,legal-issues-defendant,100,22,12/6/2019
EB7FBF,conference-call,100,50,12/6/2019
ECA300,earnings,100,50,12/6/2019
EE6F1C,business-contract,100,69,12/6/2019
EE967B,partnership,100,61,12/6/2019
FEC475,legal-issues-defendant,100,22,12/6/2019
FEC475,legal-issues-defendant,100,22,12/6/2019
24A89A,legal-issues-defendant,100,22,12/7/2019
25A6CC,legal-issues-defendant,100,22,12/7/2019
25A6CC,legal-issues-defendant,100,22,12/7/2019
267718,clinical-trials,100,56,12/7/2019
26DC29,legal-issues-defendant,100,22,12/7/2019
6.52E+64,settlement,100,56,12/7/2019
747219,legal-issues-defendant,100,22,12/7/2019
7823A3,legal-issues-defendant,100,22,12/7/2019
966ACE,clinical-trials,100,56,12/7/2019
A6828A,acquisition-acquirer,100,49,12/7/2019
B0D41A,clinical-trials,100,56,12/7/2019
B0D41A,clinical-trials,100,56,12/7/2019
BAD655,clinical-trials,100,56,12/7/2019
D1588D,clinical-trials,100,56,12/7/2019
D1588D,clinical-trials,100,56,12/7/2019
448BF3,clinical-trials,100,56,12/8/2019
8DA42F,legal-issues-defendant,100,22,12/8/2019
B0D41A,clinical-trials,100,56,12/8/2019
B0D41A,clinical-trials,100,56,12/8/2019
BC5680,legal-issues-defendant,100,22,12/8/2019
D1588D,clinical-trials,100,56,12/8/2019
D1588D,clinical-trials,100,56,12/8/2019
E68E62,clinical-trials,100,56,12/8/2019
ED1A74,clinical-trials,100,56,12/8/2019
F30508,clinical-trials,100,56,12/8/2019
F30508,clinical-trials,100,56,12/8/2019
FEC475,legal-issues-defendant,100,22,12/8/2019
FEC475,legal-issues-defendant,100,22,12/8/2019
03542C,dividend,100,50,12/9/2019
43862,clinical-trials,100,56,12/9/2019
048B70,executive-appointment,100,54,12/9/2019
61366,executive-appointment,100,54,12/9/2019
0AAD90,clinical-trials,100,56,12/9/2019
0AAD90,clinical-trials,100,56,12/9/2019
0B13E8,executive-appointment,100,54,12/9/2019
0B4D10,executive-appointment,100,54,12/9/2019
0CC62B,conference-participant,100,50,12/9/2019
0CCCB7,commodity-buy,100,55,12/9/2019
10AE08,facility-open,100,65,12/9/2019
12DE76,partnership,100,61,12/9/2019
12DE76,dividend,100,50,12/9/2019
135B09,earnings-guidance-up,100,83,12/9/2019
159AE4,conference-call,100,50,12/9/2019
1A3E1B,merger-completed,100,66,12/9/2019
1AB023,conference-participant,100,50,12/9/2019
1AB023,conference-participant,100,50,12/9/2019
1AB023,conference-participant,100,50,12/9/2019
1D1B07,executive-appointment,100,54,12/9/2019
1D1B07,executive-appointment,100,54,12/9/2019
1E04A5,award,100,58,12/9/2019
1EBF8D,acquisition-acquirer,100,49,12/9/2019
1EBF8D,acquisition-acquirer,100,49,12/9/2019
2082EA,executive-appointment,100,54,12/9/2019
241AF7,dividend,100,50,12/9/2019
2491BC,legal-issues-defendant,100,22,12/9/2019
2491BC,legal-issues-defendant,100,22,12/9/2019
2491BC,legal-issues-defendant,100,22,12/9/2019
24A89A,clinical-trials-start,100,64,12/9/2019
24A89A,clinical-trials-start,100,64,12/9/2019
24C48B,note-sale,100,52,12/9/2019
25102A,conference-call,100,50,12/9/2019
25A6CC,legal-issues-defendant,100,22,12/9/2019
26DC29,legal-issues-defendant,100,22,12/9/2019
297DA8,product-release,100,64,12/9/2019
2F7A7E,dividend,100,50,12/9/2019
30AB63,earnings-guidance,100,50,12/9/2019
31643A,dividend,100,50,12/9/2019
36C09B,clinical-trials,100,56,12/9/2019
36C09B,clinical-trials,100,56,12/9/2019
385DD4,acquisition-completed-acquirer,100,49,12/9/2019
385DD4,acquisition-completed-acquirer,100,49,12/9/2019
39FB23,executive-appointment,100,54,12/9/2019
3B318A,earnings,100,50,12/9/2019
3B8484,acquisition-acquirer,100,49,12/9/2019
41EC04,legal-issues-defendant,100,22,12/9/2019
43E8F5,partnership,100,61,12/9/2019
43E8F5,partnership,100,61,12/9/2019
448215,dividend-up,100,81,12/9/2019
47752F,executive-resignation,100,44,12/9/2019
4A5C8D,executive-appointment,100,54,12/9/2019
4B7006,acquisition-completed-acquirer,100,49,12/9/2019
4BDCA7,clinical-trials,100,56,12/9/2019
4D971D,executive-appointment,100,54,12/9/2019
4F71DC,earnings,100,50,12/9/2019
5065B1,dividend,100,50,12/9/2019
50702E,public-offering,100,43,12/9/2019
51888A,buybacks,100,74,12/9/2019
51888A,acquisition-acquirer,100,49,12/9/2019
519FE0,executive-appointment,100,54,12/9/2019
53E575,acquisition-completed-acquirer,100,49,12/9/2019
56765E,acquisition-completed-acquirer,100,49,12/9/2019
56765E,acquisition-completed-acquirer,100,49,12/9/2019
56AFF4,business-combination,100,54,12/9/2019
56EA2B,conference-call,100,50,12/9/2019
57634F,note-sale,100,52,12/9/2019
57634F,note-sale,100,52,12/9/2019
5BC2F4,executive-appointment,100,54,12/9/2019
5F9CE3,note-sale,100,52,12/9/2019
605F40,facility-open,100,65,12/9/2019
609208,executive-appointment,100,54,12/9/2019
619882,conference-organizer,100,57,12/9/2019
619882,conference-organizer,100,57,12/9/2019
61A586,campaign-ad-release,100,59,12/9/2019
633043,note-sale,100,52,12/9/2019
6.52E+64,settlement,100,56,12/9/2019
65D0AA,executive-appointment,100,54,12/9/2019
665D7D,partnership,100,61,12/9/2019
665D7D,partnership,100,61,12/9/2019
6830FE,executive-appointment,100,54,12/9/2019
6B236C,unit-acquisition-acquiree,100,76,12/9/2019
6B6375,clinical-trials,100,56,12/9/2019
6D9ECA,executive-appointment,100,54,12/9/2019
7032D0,dividend,100,50,12/9/2019
70FCEF,note-sale,100,52,12/9/2019
73A213,conference-participant,100,50,12/9/2019
76BD96,public-offering,100,43,12/9/2019
7771D7,buybacks,100,74,12/9/2019
7823A3,legal-issues-defendant,100,22,12/9/2019
7999F3,donation,100,54,12/9/2019
7ACD98,executive-appointment,100,54,12/9/2019
7D35D8,legal-issues-defendant,100,22,12/9/2019
7D7716,executive-resignation,100,44,12/9/2019
7F3669,unit-acquisition-completed-acquirer,100,49,12/9/2019
7F3669,unit-acquisition-completed-acquirer,100,49,12/9/2019
82B57E,executive-appointment,100,54,12/9/2019
8303CD,award,100,58,12/9/2019
8AB37F,revenue-up,100,87,12/9/2019
8AB85C,clinical-trials,100,56,12/9/2019
8BAA15,executive-appointment,100,54,12/9/2019
8D0EEA,public-offering,100,43,12/9/2019
8E93A4,business-combination,100,54,12/9/2019
92D757,business-contract,100,69,12/9/2019
93633B,dividend,100,50,12/9/2019
94563D,partnership,100,61,12/9/2019
94637C,clinical-trials,100,56,12/9/2019
9.54E+32,executive-appointment,100,54,12/9/2019
958938,clinical-trials,100,56,12/9/2019
96B4FF,executive-appointment,100,54,12/9/2019
97693A,executive-resignation,100,44,12/9/2019
9C8BC3,dividend-up,100,55,12/9/2019
9CA432,public-offering,100,43,12/9/2019
9D56F2,partnership,100,61,12/9/2019
A01983,dividend,100,50,12/9/2019
A666C8,executive-appointment,100,54,12/9/2019
A6828A,partnership,100,61,12/9/2019
A8E2FE,public-offering,100,43,12/9/2019
AAC8B6,asset-sale,100,62,12/9/2019
AAC8B6,asset-sale,100,62,12/9/2019
AEF2C3,acquisition-acquirer,100,49,12/9/2019
B01111,donation,100,54,12/9/2019
B106FA,conference-participant,100,50,12/9/2019
B2256A,acquisition-acquirer,100,49,12/9/2019
B3CB74,conference-organizer,100,57,12/9/2019
B642E8,dividend,100,50,12/9/2019
B72BE9,dividend-up,100,81,12/9/2019
B9CD50,note-sale,100,52,12/9/2019
BDF2BD,executive-appointment,100,54,12/9/2019
C0BA36,conference-participant,100,50,12/9/2019
C4F9C6,conference-organizer,100,57,12/9/2019
C598D7,acquisition-acquirer,100,49,12/9/2019
C74887,clinical-trials,100,56,12/9/2019
CA1620,partnership,100,61,12/9/2019
CA1620,partnership,100,61,12/9/2019
CBB77B,earnings,100,50,12/9/2019
CBB77B,earnings,100,50,12/9/2019
CC339B,dividend,100,50,12/9/2019
CDC817,executive-appointment,100,54,12/9/2019
CF211D,earnings,100,50,12/9/2019
D25249,dividend,100,50,12/9/2019
D2E553,revenue-up,100,71,12/9/2019
D2E553,revenue-up,100,71,12/9/2019
D6489C,executive-appointment,100,54,12/9/2019
D75910,earnings,100,50,12/9/2019
D75910,earnings,100,50,12/9/2019
D75910,earnings,100,50,12/9/2019
D75910,earnings,100,50,12/9/2019
D75910,earnings,100,50,12/9/2019
D88EF3,conference-participant,100,50,12/9/2019
DB88A1,award,100,58,12/9/2019
DCD97F,executive-appointment,100,54,12/9/2019
E28D9C,partnership,100,61,12/9/2019
E3656D,earnings,100,50,12/9/2019
E68E62,clinical-trials,100,56,12/9/2019
E72599,public-offering,100,43,12/9/2019
E754F0,executive-appointment,100,54,12/9/2019
EA62FC,executive-appointment,100,54,12/9/2019
EEB5F9,clinical-trials,100,56,12/9/2019
EEB5F9,public-offering,100,43,12/9/2019
EF5BED,partnership,100,61,12/9/2019
F1EB39,conference-participant,100,50,12/9/2019
F793FA,facility-open,100,65,12/9/2019
FAB97A,award,100,58,12/9/2019
FADF1A,earnings,100,50,12/9/2019
FC1736,earnings,100,50,12/9/2019
FEBFE1,earnings,100,50,12/9/2019
FF4343,note-sale,100,52,12/9/2019
00326E,award,100,58,12/10/2019
13528,partnership,100,61,12/10/2019
13528,award,100,58,12/10/2019
0157B1,partnership,100,61,12/10/2019
018C11,facility-open,100,65,12/10/2019
04CCCD,revenue-up,100,69,12/10/2019
0BA2EF,earnings,100,50,12/10/2019
0BA2EF,earnings,100,50,12/10/2019
0E3436,earnings,100,50,12/10/2019
0E3436,earnings,100,50,12/10/2019
0F04E5,legal-issues-defendant,100,22,12/10/2019
131443,buybacks,100,74,12/10/2019
14833D,partnership,100,61,12/10/2019
14BA06,business-contract,100,69,12/10/2019
1921DD,business-contract,100,69,12/10/2019
1CDD1C,donation,100,54,12/10/2019
1EBF8D,partnership,100,61,12/10/2019
1F08A6,dividend,100,50,12/10/2019
20403D,dividend,100,50,12/10/2019
228D42,partnership,100,61,12/10/2019
25A6CC,legal-issues-defendant,100,22,12/10/2019
25DD05,dividend,100,50,12/10/2019
25DD05,dividend,100,50,12/10/2019
26DC29,legal-issues-defendant,100,22,12/10/2019
292388,earnings,100,50,12/10/2019
292A70,product-release,100,64,12/10/2019
2BAE5F,dividend,100,50,12/10/2019
2D2D43,earnings,100,50,12/10/2019
2E61CC,award,100,58,12/10/2019
30DE64,clinical-trials-positive,100,87,12/10/2019
326EDD,dividend,100,50,12/10/2019
32DCB3,executive-appointment,100,54,12/10/2019
36E479,earnings,100,50,12/10/2019
37B618,dividend,100,50,12/10/2019
3A6D90,executive-appointment,100,54,12/10/2019
3F96D5,business-contract,100,69,12/10/2019
41C36B,public-offering,100,43,12/10/2019
442587,partnership,100,61,12/10/2019
44A4FC,partnership,100,61,12/10/2019
453282,buybacks,100,74,12/10/2019
49F4D0,public-offering,100,43,12/10/2019
4A6F00,product-release,100,64,12/10/2019
4A6F00,product-release,100,64,12/10/2019
4DAF5F,partnership,100,61,12/10/2019
4E913D,partnership,100,61,12/10/2019
4F71DC,public-offering,100,43,12/10/2019
50070E,partnership,100,61,12/10/2019
50702E,public-offering,100,43,12/10/2019
52D936,executive-appointment,100,54,12/10/2019
5487B1,dividend,100,50,12/10/2019
548AC0,earnings,100,50,12/10/2019
54F1D2,award,100,58,12/10/2019
553949,partnership,100,61,12/10/2019
553949,facility-open,100,65,12/10/2019
55C289,dividend,100,50,12/10/2019
55C9B5,partnership,100,61,12/10/2019
58CA9A,acquisition-interest-acquirer,100,46,12/10/2019
5B6C11,dividend,100,50,12/10/2019
5D63F1,index-listing,100,76,12/10/2019
6166D1,executive-appointment,100,54,12/10/2019
619882,conference-organizer,100,57,12/10/2019
619882,dividend,100,50,12/10/2019
627186,earnings,100,50,12/10/2019
641F17,earnings,100,50,12/10/2019
657097,dividend,100,50,12/10/2019
66A667,earnings,100,50,12/10/2019
66A667,earnings,100,50,12/10/2019
6830FE,legal-issues-defendant,100,22,12/10/2019
6DBBBC,executive-resignation,100,44,12/10/2019
6DBBBC,capex,100,50,12/10/2019
6DBBBC,capex,100,50,12/10/2019
726DDF,unit-acquisition-completed-acquiree,100,67,12/10/2019
728737,dividend,100,50,12/10/2019
728737,dividend,100,50,12/10/2019
742AAB,partnership,100,61,12/10/2019
76BD96,public-offering,100,43,12/10/2019
775439,earnings,100,50,12/10/2019
7F3A5F,partnership,100,61,12/10/2019
817ED9,partnership,100,61,12/10/2019
8303CD,product-release,100,64,12/10/2019
83A065,dividend,100,50,12/10/2019
877C0C,stake-acquirer,100,48,12/10/2019
877C0C,stake-acquirer,100,48,12/10/2019
8A8E41,partnership,100,61,12/10/2019
8B1F37,dividend,100,50,12/10/2019
8BFE9A,public-offering,100,43,12/10/2019
8D0EEA,public-offering,100,43,12/10/2019
8D4486,award,100,58,12/10/2019
8EF425,dividend-up,100,81,12/10/2019
915E7B,dividend,100,50,12/10/2019
94637C,clinical-trials-start,100,64,12/10/2019
94A326,earnings,100,50,12/10/2019
9.54E+32,executive-appointment,100,54,12/10/2019
9592FB,public-offering,100,43,12/10/2019
966ACE,public-offering,100,43,12/10/2019
967D92,dividend,100,50,12/10/2019
96A6CD,clinical-trials,100,56,12/10/2019
972356,partnership,100,61,12/10/2019
9.74E+08,partnership,100,61,12/10/2019
97644E,conference-participant,100,50,12/10/2019
980C14,dividend,100,50,12/10/2019
9.92E+94,dividend,100,50,12/10/2019
9B5968,partnership,100,61,12/10/2019
9CA432,public-offering,100,43,12/10/2019
9D30A8,product-release,100,64,12/10/2019
9D30A8,product-release,100,64,12/10/2019
9D65C1,note-sale,100,52,12/10/2019
A0F146,business-contract,100,69,12/10/2019
A16DEA,product-release,100,64,12/10/2019
A37D68,conference-participant,100,50,12/10/2019
A43906,dividend,100,50,12/10/2019
A48593,executive-appointment,100,54,12/10/2019
A6828A,conference-call,100,50,12/10/2019
A6FE1C,acquisition-acquirer,100,49,12/10/2019
A868C9,executive-appointment,100,54,12/10/2019
ACF77B,dividend,100,50,12/10/2019
AF210D,note-sale,100,52,12/10/2019
B13B68,partnership,100,61,12/10/2019
B1FC3B,business-contract,100,69,12/10/2019
B6082A,dividend,100,50,12/10/2019
B8A51F,public-offering,100,43,12/10/2019
B8F71F,note-sale,100,52,12/10/2019
BDF85E,revenue-up,100,56,12/10/2019
BDF85E,revenue-up,100,56,12/10/2019
BFAEB4,conference-call,100,50,12/10/2019
BFE02C,executive-appointment,100,54,12/10/2019
C48574,revenue-up,100,69,12/10/2019
C48574,revenue-up,100,69,12/10/2019
C48574,revenue-up,100,69,12/10/2019
C48574,revenue-up,100,69,12/10/2019
C4F9C6,executive-resignation,100,44,12/10/2019
C8257F,dividend,100,50,12/10/2019
C8FAC7,partnership,100,61,12/10/2019
CE4E6D,product-release,100,64,12/10/2019
D1173F,business-contract,100,69,12/10/2019
D1C26F,executive-appointment,100,54,12/10/2019
D2B9E5,partnership,100,61,12/10/2019
D4070C,executive-resignation,100,44,12/10/2019
D4070C,executive-resignation,100,44,12/10/2019
D42DBA,earnings,100,50,12/10/2019
D437C3,partnership,100,61,12/10/2019
D56D6D,dividend,100,50,12/10/2019
D5A350,acquisition-acquirer,100,49,12/10/2019
D7AC6E,dividend-up,100,81,12/10/2019
D8442A,revenue-up,100,69,12/10/2019
D9FC89,partnership,100,61,12/10/2019
D9FC89,partnership,100,61,12/10/2019
DC0998,executive-appointment,100,54,12/10/2019
DDEA6A,executive-appointment,100,54,12/10/2019
E09556,earnings,100,50,12/10/2019
E09556,earnings,100,50,12/10/2019
E09556,earnings,100,50,12/10/2019
E124EB,dividend,100,50,12/10/2019
E21871,conference-participant,100,50,12/10/2019
E30B34,award,100,58,12/10/2019
E5A3B6,executive-appointment,100,54,12/10/2019
E68E62,public-offering,100,43,12/10/2019
E8846E,conference-organizer,100,57,12/10/2019
ECF709,same-store-sales-up,100,53,12/10/2019
ECF709,same-store-sales-up,100,62,12/10/2019
ECF709,same-store-sales-up,100,62,12/10/2019
EF77A3,earnings,100,50,12/10/2019
F1529C,acquisition-acquirer,100,49,12/10/2019
F1529C,acquisition-acquirer,100,49,12/10/2019
F1529C,acquisition-acquirer,100,49,12/10/2019
F1529C,acquisition-acquirer,100,49,12/10/2019
F1C04C,award,100,58,12/10/2019
F43A11,earnings,100,50,12/10/2019
FA40E2,dividend,100,50,12/10/2019
00067A,product-release,100,64,12/11/2019
0919B1,dividend,100,50,12/11/2019
0A0CF0,dividend,100,50,12/11/2019
0BA2EF,dividend,100,50,12/11/2019
0FC848,executive-appointment,100,54,12/11/2019
105D00,executive-appointment,100,54,12/11/2019
1151F4,dividend,100,50,12/11/2019
11A49E,public-offering,100,43,12/11/2019
1748F6,earnings,100,50,12/11/2019
1834C0,conference-participant,100,50,12/11/2019
1921DD,business-contract,100,69,12/11/2019
1921DD,business-contract,100,69,12/11/2019
1FA886,buybacks,100,74,12/11/2019
20BEEA,note-sale,100,52,12/11/2019
2491BC,legal-issues-defendant,100,22,12/11/2019
24A89A,legal-issues-defendant,100,22,12/11/2019
24D81E,hirings,100,65,12/11/2019
25A6CC,legal-issues-defendant,100,22,12/11/2019
2667B6,executive-appointment,100,54,12/11/2019
2667B6,executive-appointment,100,54,12/11/2019
2667B6,executive-appointment,100,54,12/11/2019
2667B6,executive-appointment,100,54,12/11/2019
26DC29,legal-issues-defendant,100,22,12/11/2019
275300,dividend,100,50,12/11/2019
27B191,note-sale,100,52,12/11/2019
292388,product-release,100,64,12/11/2019
2BA977,dividend,100,50,12/11/2019
2CC60C,revenues,100,50,12/11/2019
2DC88B,partnership,100,61,12/11/2019
2F960F,public-offering,100,43,12/11/2019
337024,buybacks,100,74,12/11/2019
3587B4,executive-appointment,100,54,12/11/2019
37B618,asset-sale,100,62,12/11/2019
397A8F,earnings,100,50,12/11/2019
3DB18B,executive-appointment,100,54,12/11/2019
3DDE54,earnings,100,50,12/11/2019
41C36B,public-offering,100,43,12/11/2019
41EC04,legal-issues-defendant,100,22,12/11/2019
43A060,partnership,100,61,12/11/2019
458D2C,revenue-volume,100,50,12/11/2019
485445,dividend,100,50,12/11/2019
49F4D0,public-offering,100,43,12/11/2019
4CDA2B,executive-appointment,100,54,12/11/2019
4EE14A,unit-acquisition-acquirer,100,49,12/11/2019
4EE14A,unit-acquisition-acquirer,100,49,12/11/2019
4EE14A,unit-acquisition-acquirer,100,49,12/11/2019
4F9926,partnership,100,61,12/11/2019
4FB770,award,100,58,12/11/2019
57356F,conference-call,100,50,12/11/2019
59B229,earnings-guidance,100,50,12/11/2019
59B229,earnings-guidance,100,50,12/11/2019
59DB8C,earnings,100,50,12/11/2019
5D41E4,conference-participant,100,50,12/11/2019
619882,conference-organizer,100,57,12/11/2019
62CDDE,buybacks,100,74,12/11/2019
6830FE,legal-issues-defendant,100,22,12/11/2019
69FDFC,award,100,58,12/11/2019
6B494E,facility-upgrade,100,65,12/11/2019
6-Dec-05,conference-participant,100,50,12/11/2019
70CA28,public-offering,100,43,12/11/2019
743C70,earnings,100,50,12/11/2019
747219,conference-participant,100,50,12/11/2019
747219,legal-issues-defendant,100,22,12/11/2019
7.49E+07,clinical-trials-filed,100,60,12/11/2019
762A3E,partnership,100,61,12/11/2019
762A3E,partnership,100,61,12/11/2019
767F86,dividend,100,50,12/11/2019
76F067,dividend-up,100,60,12/11/2019
7823A3,legal-issues-defendant,100,22,12/11/2019
7F9984,award,100,58,12/11/2019
8303CD,partnership,100,61,12/11/2019
8B8656,earnings,100,50,12/11/2019
8BAA15,executive-appointment,100,54,12/11/2019
8D9993,executive-resignation,100,44,12/11/2019
8FF2EF,earnings,100,50,12/11/2019
90D6A5,dividend,100,50,12/11/2019
950CDB,dividend,100,50,12/11/2019
9.54E+32,executive-appointment,100,54,12/11/2019
95DC1F,partnership,100,61,12/11/2019
97693A,earnings,100,50,12/11/2019
977A1E,partnership,100,61,12/11/2019
977A1E,partnership,100,61,12/11/2019
9810C0,dividend,100,50,12/11/2019
990AD0,ownership-decrease-held,100,49,12/11/2019
990AD0,ownership-decrease-held,100,49,12/11/2019
9CDA4F,conference-participant,100,50,12/11/2019
9E98F2,legal-issues-defendant,100,22,12/11/2019
9FD2D9,executive-appointment,100,54,12/11/2019
A1EAC8,executive-appointment,100,54,12/11/2019
A3AAA5,dividend,100,50,12/11/2019
A5151E,executive-appointment,100,54,12/11/2019
A5195E,regulatory-product-application,100,69,12/11/2019
AD9F1D,buybacks,100,74,12/11/2019
AEFC90,clinical-trials-filed,100,60,12/11/2019
AFDF2E,legal-issues-defendant,100,22,12/11/2019
B37FB4,earnings,100,50,12/11/2019
B9CD50,note-sale,100,52,12/11/2019
BF5959,partnership,100,61,12/11/2019
C03C8B,dividend,100,50,12/11/2019
C16A8F,facility-close,100,47,12/11/2019
C50B26,earnings,100,50,12/11/2019
C83B88,partnership,100,61,12/11/2019
CFF97C,credit-rating-outlook-positive-rater,20,50,12/11/2019
D17C1B,revenue-volume,100,50,12/11/2019
D2C0B6,earnings,100,50,12/11/2019
D33D8C,dividend,100,50,12/11/2019
D48275,conference-call,100,50,12/11/2019
D56D6D,earnings,100,50,12/11/2019
D75910,dividend,100,50,12/11/2019
DF5F14,dividend,100,50,12/11/2019
E5A3B6,earnings,100,50,12/11/2019
E68E62,public-offering,100,43,12/11/2019
E72599,public-offering,100,43,12/11/2019
E802CE,acquisition-acquirer,100,49,12/11/2019
EE967B,dividend,100,50,12/11/2019
EEB5F9,public-offering,100,43,12/11/2019
F0A9DE,partnership,100,61,12/11/2019
F18844,executive-appointment,100,54,12/11/2019
F48947,conference-participant,100,50,12/11/2019
F509E2,earnings,100,50,12/11/2019
F5D059,conference-call,100,50,12/11/2019
F66B58,earnings,100,50,12/11/2019
F66B58,executive-appointment,100,54,12/11/2019
F6E248,partnership,100,61,12/11/2019
F6E248,partnership,100,61,12/11/2019
F6E248,regulatory-product-application,100,69,12/11/2019
FA35C6,executive-appointment,100,54,12/11/2019
FA35C6,earnings-guidance-up,100,83,12/11/2019
FEC475,legal-issues-defendant,100,22,12/11/2019
00326D,dividend,100,50,12/12/2019
01D03F,business-contract,100,69,12/12/2019
054E7E,executive-appointment,100,54,12/12/2019
091B6C,partnership,100,61,12/12/2019
091B6C,partnership,100,61,12/12/2019
091B6C,partnership,100,61,12/12/2019
09DE1F,earnings,100,50,12/12/2019
0B4D10,dividend,100,50,12/12/2019
0BF528,conference-participant,100,50,12/12/2019
0C2A0D,buybacks,100,74,12/12/2019
106394,dividend,100,50,12/12/2019
10943B,acquisition-acquirer,100,49,12/12/2019
15901B,stake-acquiree,100,62,12/12/2019
16FC89,dividend,100,50,12/12/2019
1921DD,acquisition-completed-acquiree,100,76,12/12/2019
1D1B07,business-contract,100,69,12/12/2019
1EBF8D,partnership,100,61,12/12/2019
1EBF8D,partnership,100,61,12/12/2019
1EBF8D,partnership,100,61,12/12/2019
1F08A6,executive-appointment,100,54,12/12/2019
228D42,partnership,100,61,12/12/2019
2491BC,legal-issues-defendant,100,22,12/12/2019
24A89A,legal-issues-defendant,100,22,12/12/2019
253B2F,dividend-up,100,72,12/12/2019
25A6CC,legal-issues-defendant,100,22,12/12/2019
26DC29,legal-issues-defendant,100,22,12/12/2019
282C18,dividend,100,50,12/12/2019
297DA8,executive-appointment,100,54,12/12/2019
2BF36E,dividend,100,50,12/12/2019
2F6782,asset-sale,100,62,12/12/2019
306623,ownership-decrease-owner,100,46,12/12/2019
33E9D5,earnings,100,50,12/12/2019
34B411,buybacks,100,74,12/12/2019
37727A,dividend,100,50,12/12/2019
3BE00F,dividend,100,50,12/12/2019
3CCC90,partnership,100,61,12/12/2019
3E15F6,dividend-up,100,53,12/12/2019
415188,executive-appointment,100,54,12/12/2019
44A4FC,product-release,100,64,12/12/2019
492117,acquisition-acquirer,100,49,12/12/2019
494EB9,legal-issues-defendant,100,22,12/12/2019
4A5C8D,joint-venture,100,62,12/12/2019
4A5C8D,business-contract,100,69,12/12/2019
4C37C5,dividend,100,50,12/12/2019
4F9926,business-contract,100,69,12/12/2019
504FE2,business-contract,100,69,12/12/2019
50702E,public-offering,100,43,12/12/2019
553949,executive-appointment,100,54,12/12/2019
5675EB,note-sale,100,52,12/12/2019
59F0B0,credit-extension-recipient,100,69,12/12/2019
5AA3B1,conference-participant,100,50,12/12/2019
5CC29D,conference-call,100,50,12/12/2019
5DD486,dividend,100,50,12/12/2019
619882,conference-organizer,100,57,12/12/2019
61B81B,conference-call,100,50,12/12/2019
6.52E+64,legal-issues-defendant,100,22,12/12/2019
6830FE,partnership,100,61,12/12/2019
6ABCB8,dividend,100,50,12/12/2019
6BF593,executive-appointment,100,54,12/12/2019
6.00E+19,product-release,100,64,12/12/2019
70CA28,public-offering,100,43,12/12/2019
70FCEF,note-sale,100,52,12/12/2019
72FCA3,partnership,100,61,12/12/2019
72FCA3,earnings,100,50,12/12/2019
7410C3,earnings-guidance-up,100,83,12/12/2019
7410C3,earnings-guidance-up,100,83,12/12/2019
747219,legal-issues-defendant,100,22,12/12/2019
747219,legal-issues-defendant,100,22,12/12/2019
766047,executive-appointment,100,54,12/12/2019
7823A3,legal-issues-defendant,100,22,12/12/2019
7ACBA4,dividend,100,50,12/12/2019
7D35D8,legal-issues-defendant,100,22,12/12/2019
8.10E+205,public-offering,100,43,12/12/2019
8377DB,earnings,100,50,12/12/2019
89B2E7,dividend,100,50,12/12/2019
8AB85C,conference-participant,100,50,12/12/2019
8B3B0E,dividend,100,50,12/12/2019
925759,note-sale,100,52,12/12/2019
9.36E+10,fundraising,100,64,12/12/2019
94983E,fundraising,100,64,12/12/2019
95DC1F,executive-appointment,100,54,12/12/2019
966ACE,executive-appointment,100,54,12/12/2019
96F126,partnership,100,61,12/12/2019
986AF6,earnings-guidance,100,50,12/12/2019
9CA432,public-offering,100,43,12/12/2019
9D65C1,note-sale,100,52,12/12/2019
9E98F2,legal-issues-defendant,100,22,12/12/2019
A21649,dividend,100,50,12/12/2019
A63820,earnings,100,50,12/12/2019
A868C9,business-contract,100,69,12/12/2019
AC7C4F,executive-appointment,100,54,12/12/2019
AFDF2E,legal-issues-defendant,100,22,12/12/2019
B8EF97,operating-earnings,100,50,12/12/2019
BB0787,executive-resignation,100,44,12/12/2019
BB127B,executive-appointment,100,54,12/12/2019
BD682F,dividend,100,50,12/12/2019
BDE867,executive-appointment,100,54,12/12/2019
BFAEB4,legal-issues-defendant,100,22,12/12/2019
C05839,dividend,100,50,12/12/2019
C06EB6,revenue-up,100,69,12/12/2019
C06EB6,revenues,100,50,12/12/2019
C06EB6,revenues,100,50,12/12/2019
C188F8,product-release,100,64,12/12/2019
C2DD02,dividend,100,50,12/12/2019
C48574,public-offering,100,43,12/12/2019
C5C137,executive-appointment,100,54,12/12/2019
C62AA4,dividend,100,50,12/12/2019
C83B88,executive-appointment,100,54,12/12/2019
C83B88,partnership,100,61,12/12/2019
C83B88,conference-call,100,50,12/12/2019
CAD7D9,conference-call,100,50,12/12/2019
CE8251,conference-call,100,50,12/12/2019
CE8251,conference-call,100,50,12/12/2019
D2E553,dividend,100,50,12/12/2019
D3DE34,executive-appointment,100,54,12/12/2019
D3DE34,executive-appointment,100,54,12/12/2019
D56D6D,executive-resignation,100,44,12/12/2019
D75910,partnership,100,61,12/12/2019
D75910,partnership,100,61,12/12/2019
D8DA3D,legal-issues-defendant,100,22,12/12/2019
E8B315,dividend,100,50,12/12/2019
EB36DE,ownership-decrease-owner,100,46,12/12/2019
EB36DE,asset-sale,100,62,12/12/2019
EBD89A,business-contract,100,69,12/12/2019
F0EEFB,unit-acquisition-acquirer,100,49,12/12/2019
F5D410,earnings-guidance,100,50,12/12/2019
F5D410,earnings-guidance,100,50,12/12/2019
F6DA75,earnings,100,50,12/12/2019
FACF19,joint-venture,100,62,12/12/2019
FC1B7B,conference-call,100,50,12/12/2019
FE7A63,executive-appointment,100,54,12/12/2019
FE89E0,conference-call,100,50,12/12/2019
01D03F,clinical-trials-positive,100,87,12/13/2019
01D03F,clinical-trials,100,56,12/13/2019
01D03F,clinical-trials,100,56,12/13/2019
01D03F,clinical-trials,100,56,12/13/2019
01D03F,clinical-trials,100,56,12/13/2019
070B45,index-listing,100,76,12/13/2019
16C544,dividend,100,50,12/13/2019
1F716B,buybacks,100,74,12/13/2019
2491BC,legal-issues-defendant,100,22,12/13/2019
24A89A,legal-issues-defendant,100,22,12/13/2019
25A6CC,legal-issues-defendant,100,22,12/13/2019
26DC29,legal-issues-defendant,100,22,12/13/2019
29B702,dividend,100,50,12/13/2019
2E902B,dividend,100,50,12/13/2019
2EB88B,executive-resignation,100,44,12/13/2019
2F960F,dividend,100,50,12/13/2019
328250,merger-completed,100,66,12/13/2019
3461CF,award,100,58,12/13/2019
3B318A,executive-appointment,100,54,12/13/2019
4017AD,dividend,100,50,12/13/2019
4F71DC,public-offering,100,43,12/13/2019
520632,dividend-up,100,62,12/13/2019
54DF47,dividend,100,50,12/13/2019
5A9F54,credit-extension-recipient,100,69,12/13/2019
5D63F1,dividend-up,100,81,12/13/2019
5DD486,conference-call,100,50,12/13/2019
619882,dividend,100,50,12/13/2019
6.52E+64,reorganization,100,53,12/13/2019
6.52E+64,reorganization,100,53,12/13/2019
69345C,partnership,100,61,12/13/2019
69345C,partnership,100,61,12/13/2019
6BF593,dividend,100,50,12/13/2019
6FCEF9,buybacks,100,74,12/13/2019
763724,executive-appointment,100,54,12/13/2019
763DBE,settlement,100,56,12/13/2019
7D35D8,legal-issues-defendant,100,22,12/13/2019
7E2DE6,earnings,100,50,12/13/2019
7FDE1C,rights-issue,100,43,12/13/2019
8.10E+205,public-offering,100,43,12/13/2019
826FD6,dividend,100,50,12/13/2019
85CDC9,clinical-trials-positive,100,87,12/13/2019
8AC740,dividend,100,50,12/13/2019
954A47,dividend,100,50,12/13/2019
966ACE,public-offering,100,43,12/13/2019
9.74E+08,dividend,100,50,12/13/2019
977A1E,dividend-up,100,81,12/13/2019
986AF6,dividend-up,100,81,12/13/2019
9C25FF,legal-issues-defendant,100,22,12/13/2019
9E98F2,legal-issues-defendant,100,22,12/13/2019
AEFC90,executive-appointment,100,54,12/13/2019
B8A51F,public-offering,100,43,12/13/2019
BCE9DA,dividend,100,50,12/13/2019
BCE9DA,dividend,100,50,12/13/2019
BF79F5,dividend,100,50,12/13/2019
BFAEB4,legal-issues-defendant,100,22,12/13/2019
BFAEB4,legal-issues-defendant,100,22,12/13/2019
C062D4,product-release,100,64,12/13/2019
C2E120,dividend,100,50,12/13/2019
C2F597,executive-appointment,100,54,12/13/2019
C97B2D,regulatory-product-approval-granted,100,81,12/13/2019
C9F39B,dividend,100,50,12/13/2019
CEDFD5,clinical-trials,100,56,12/13/2019
CEDFD5,clinical-trials,100,56,12/13/2019
D296C6,dividend,100,50,12/13/2019
D3FA2C,dividend,100,50,12/13/2019
D69D42,dividend,100,50,12/13/2019
D96202,conference-call,100,50,12/13/2019
DD7A96,dividend,100,50,12/13/2019
E68E62,public-offering,100,43,12/13/2019
E8D221,earnings,100,50,12/13/2019
EA4E68,dividend-up,100,81,12/13/2019
EBD89A,executive-appointment,100,54,12/13/2019
ECD263,earnings,100,50,12/13/2019
ECE814,ipo-pricing,100,50,12/13/2019
EEB5F9,public-offering,100,43,12/13/2019
EF7163,dividend,100,50,12/13/2019
F30508,settlement,100,56,12/13/2019
F93C8A,executive-appointment,100,54,12/13/2019
FC9A88,note-sale,100,52,12/13/2019
FDE409,executive-appointment,100,54,12/13/2019
2491BC,legal-issues-defendant,100,22,12/14/2019
26DC29,legal-issues-defendant,100,22,12/14/2019
9E98F2,legal-issues-defendant,100,22,12/14/2019
D721C6,facility-open,100,65,12/14/2019
D8DA3D,legal-issues-defendant,100,22,12/14/2019
485445,merger,100,66,12/15/2019
485445,merger,100,66,12/15/2019
485445,merger,100,66,12/15/2019
BC5680,legal-issues-defendant,100,22,12/15/2019
BFAEB4,legal-issues-defendant,100,22,12/15/2019
C8A248,merger,100,66,12/15/2019
C8A248,merger,100,66,12/15/2019
C8A248,merger,100,66,12/15/2019
0157B1,partnership,100,61,12/16/2019
0157B1,partnership,100,61,12/16/2019
01D03F,acquisition-interest-acquirer,100,46,12/16/2019
036C6F,earnings,100,50,12/16/2019
03CF95,partnership,100,61,12/16/2019
03D5F9,partnership,100,61,12/16/2019
03FB17,partnership,100,61,12/16/2019
040DBB,dividend,100,50,12/16/2019
040DBB,executive-resignation,100,44,12/16/2019
054B55,acquisition-completed-acquirer,100,49,12/16/2019
55018,conference-call,100,50,12/16/2019
099C88,business-contract,100,69,12/16/2019
0C355F,executive-appointment,100,54,12/16/2019
1080C0,fast-track-designation,100,81,12/16/2019
11A49E,public-offering,100,43,12/16/2019
138DDE,dividend,100,50,12/16/2019
17EDA5,acquisition-acquirer,100,49,12/16/2019
1B6F77,trading-listing,100,61,12/16/2019
1E1125,reverse-stock-splits,100,51,12/16/2019
1F716B,conference-call,100,50,12/16/2019
20BEEA,earnings-guidance,100,50,12/16/2019
2158DF,index-listing,100,76,12/16/2019
25A6CC,legal-issues-defendant,100,22,12/16/2019
26008A,earnings-up,100,68,12/16/2019
26008A,earnings-up,100,68,12/16/2019
26008A,earnings-up,100,68,12/16/2019
26008A,earnings-up,100,68,12/16/2019
267718,dividend,100,50,12/16/2019
26DC29,legal-issues-defendant,100,22,12/16/2019
26DC29,legal-issues-defendant,100,22,12/16/2019
2920D5,earnings,100,50,12/16/2019
2CC71C,executive-appointment,100,54,12/16/2019
2D2D43,executive-appointment,100,54,12/16/2019
2E6514,executive-appointment,100,54,12/16/2019
306623,partnership,100,61,12/16/2019
30CBF9,partnership,100,61,12/16/2019
34B411,merger-regulatory-approval,100,81,12/16/2019
36E479,earnings,100,50,12/16/2019
3A113F,conference-participant,100,50,12/16/2019
3B9886,executive-appointment,100,54,12/16/2019
3C8A04,conference-call,100,50,12/16/2019
3CCC90,conference-call,100,50,12/16/2019
3D7971,executive-appointment,100,54,12/16/2019
43A060,partnership,100,61,12/16/2019
494EB9,legal-issues-defendant,100,22,12/16/2019
4A6F00,product-release,100,64,12/16/2019
4A6F00,partnership,100,61,12/16/2019
4A6F00,partnership,100,61,12/16/2019
4A6F00,partnership,100,61,12/16/2019
4A6F00,partnership,100,61,12/16/2019
4A6F00,partnership,100,61,12/16/2019
4C37C5,conference-call,100,50,12/16/2019
4F783B,dividend,100,50,12/16/2019
50070E,investment-investor,100,55,12/16/2019
50070E,investment-investor,100,55,12/16/2019
50070E,regulatory-investigation,100,22,12/16/2019
520632,executive-appointment,100,54,12/16/2019
548AC0,executive-appointment,100,54,12/16/2019
55438C,dividend,100,50,12/16/2019
56277A,dividend,100,50,12/16/2019
5675EB,dividend,100,50,12/16/2019
5675EB,note-sale,100,52,12/16/2019
56AFF4,legal-issues-defendant,100,22,12/16/2019
5704AC,dividend,100,50,12/16/2019
58CA9A,partnership,100,61,12/16/2019
5A423F,conference-participant,100,50,12/16/2019
5FDBD0,executive-appointment,100,54,12/16/2019
6166D1,conference-call,100,50,12/16/2019
616E3B,dividend-guidance-up,100,83,12/16/2019
619882,conference-organizer,100,57,12/16/2019
619882,conference-organizer,100,57,12/16/2019
619882,conference-organizer,100,57,12/16/2019
63F892,partnership,100,61,12/16/2019
65D0AA,executive-appointment,100,54,12/16/2019
665440,partnership,100,61,12/16/2019
69345C,executive-appointment,100,54,12/16/2019
694749,executive-appointment,100,54,12/16/2019
6B0784,executive-resignation,100,44,12/16/2019
6B0784,executive-resignation,100,44,12/16/2019
6CF43C,dividend,100,50,12/16/2019
6D9ECA,executive-appointment,100,54,12/16/2019
6.00E+19,executive-appointment,100,54,12/16/2019
6F5DD2,earnings,100,50,12/16/2019
6F5DD2,earnings,100,50,12/16/2019
763DBE,orphan-drug-designation,100,76,12/16/2019
7C4168,executive-appointment,100,54,12/16/2019
7DC1C4,conference-participant,100,50,12/16/2019
877C0C,executive-appointment,100,54,12/16/2019
89B2E7,dividend,100,50,12/16/2019
8BFE9A,public-offering,100,43,12/16/2019
911AB8,stake-acquiree,100,62,12/16/2019
911AB8,stake-acquiree,100,62,12/16/2019
9196A2,dividend,100,50,12/16/2019
92D9C9,dividend,100,50,12/16/2019
954A47,dividend,100,50,12/16/2019
9B4066,unit-acquisition-acquirer,100,49,12/16/2019
9B5968,executive-appointment,100,54,12/16/2019
9BB35A,award,100,58,12/16/2019
9E98F2,legal-issues-defendant,100,22,12/16/2019
9E98F2,legal-issues-defendant,100,22,12/16/2019
A29A46,business-contract,100,69,12/16/2019
A29A46,business-contract,100,69,12/16/2019
A52B6B,partnership,100,61,12/16/2019
A6828A,regulatory-product-approval-granted,100,81,12/16/2019
A70BF5,earnings,100,50,12/16/2019
A75D43,acquisition-completed-acquirer,100,49,12/16/2019
A9ED24,dividend,100,50,12/16/2019
AA1EAA,dividend,100,50,12/16/2019
AA5C8E,business-contract,100,69,12/16/2019
ABEE43,facility-open,100,65,12/16/2019
AEEB76,trading-listing,100,61,12/16/2019
B13B68,acquisition-acquirer,100,49,12/16/2019
B13B68,acquisition-acquirer,100,49,12/16/2019
B1A85D,business-contract,100,69,12/16/2019
B446B8,partnership,100,61,12/16/2019
BB127B,partnership,100,61,12/16/2019
BE14CF,executive-appointment,100,54,12/16/2019
BFAEB4,legal-issues-defendant,100,22,12/16/2019
C50B26,acquisition-acquirer,100,49,12/16/2019
C50B26,acquisition-acquirer,100,49,12/16/2019
C50B26,acquisition-acquirer,100,49,12/16/2019
C50B26,acquisition-acquirer,100,49,12/16/2019
C83B88,executive-resignation,100,44,12/16/2019
C9739A,orphan-drug-designation,100,76,12/16/2019
CDE51C,partnership,100,61,12/16/2019
CF6A5A,operating-earnings,100,50,12/16/2019
D0909F,acquisition-completed-acquiree,100,76,12/16/2019
D11C1C,dividend,100,50,12/16/2019
D139BC,dividend,100,50,12/16/2019
D17C1B,product-resumed,100,52,12/16/2019
D5938F,public-offering,100,43,12/16/2019
D77F7E,executive-appointment,100,54,12/16/2019
DAFED3,conference-participant,100,50,12/16/2019
DB23C8,asset-sale,100,62,12/16/2019
E26FC3,executive-appointment,100,54,12/16/2019
E28D9C,partnership,100,61,12/16/2019
E3A829,legal-issues-defendant,100,22,12/16/2019
E68733,partnership,100,61,12/16/2019
E68733,partnership,100,61,12/16/2019
E8846E,settlement,100,56,12/16/2019
EAA0A7,partnership,100,61,12/16/2019
EBD89A,business-contract,100,69,12/16/2019
ED22DC,patient-enrollment-complete,100,64,12/16/2019
ED7F13,dividend,100,50,12/16/2019
EE6F1C,executive-appointment,100,54,12/16/2019
EF1AD9,note-sale,100,52,12/16/2019
EF5BED,business-contract,100,69,12/16/2019
F0B877,buybacks,100,74,12/16/2019
F1529C,conference-call,100,50,12/16/2019
F30508,dividend-up,100,65,12/16/2019
F6E248,clinical-trials,100,56,12/16/2019
F7935D,partnership,100,61,12/16/2019
F7FCA4,note-sale,100,52,12/16/2019
F7FCA4,note-sale,100,52,12/16/2019
F80389,dividend,100,50,12/16/2019
FC1736,revenues,100,50,12/16/2019
FC1736,revenues,100,50,12/16/2019
FC1736,revenues,100,50,12/16/2019
FD2565,executive-appointment,100,54,12/16/2019
FDD3FC,clinical-trials-filed,100,60,12/16/2019
0157B1,executive-appointment,100,54,12/17/2019
01D03F,acquisition-acquirer,100,49,12/17/2019
01D03F,acquisition-completed-acquirer,100,49,12/17/2019
03CF95,partnership,100,61,12/17/2019
04EB2F,partnership,100,61,12/17/2019
05AF14,earnings,100,50,12/17/2019
05AF14,dividend,100,50,12/17/2019
05D148,clinical-trials-positive,100,87,12/17/2019
0E499E,clinical-trials-positive,100,87,12/17/2019
0F91FC,partnership,100,61,12/17/2019
0F91FC,partnership,100,61,12/17/2019
108A2B,dividend,100,50,12/17/2019
129DC8,conference-participant,100,50,12/17/2019
12E454,partnership,100,61,12/17/2019
12E454,partnership,100,61,12/17/2019
12E454,partnership,100,61,12/17/2019
15B10D,partnership,100,61,12/17/2019
168A5D,partnership,100,61,12/17/2019
1AB808,partnership,100,61,12/17/2019
1AF7E2,revenue-guidance,100,50,12/17/2019
1AF7E2,dividend,100,50,12/17/2019
1EBF8D,acquisition-acquirer,100,49,12/17/2019
1EBF8D,acquisition-completed-acquirer,100,49,12/17/2019
21245F,executive-appointment,100,54,12/17/2019
228D42,partnership,100,61,12/17/2019
2491BC,legal-issues-defendant,100,22,12/17/2019
2491BC,legal-issues-defendant,100,22,12/17/2019
24A89A,legal-issues-defendant,100,22,12/17/2019
25A6CC,legal-issues-defendant,100,22,12/17/2019
292388,earnings,100,50,12/17/2019
2B0AF4,executive-appointment,100,54,12/17/2019
2C7505,clinical-trials-positive,100,87,12/17/2019
2CC60C,dividend,100,50,12/17/2019
2FDEE3,dividend,100,50,12/17/2019
30DFD3,buybacks,100,74,12/17/2019
3.14E+47,dividend,100,50,12/17/2019
3.73E+87,partnership,100,61,12/17/2019
3AAEAE,conference-participant,100,50,12/17/2019
3BB616,dividend,100,50,12/17/2019
3BCF24,dividend-up,100,60,12/17/2019
4017AD,executive-appointment,100,54,12/17/2019
41EC04,legal-issues-defendant,100,22,12/17/2019
420168,dividend-up,100,81,12/17/2019
43A060,business-contract,100,69,12/17/2019
44A4FC,conference-organizer,100,57,12/17/2019
4A6F00,legal-verdict-disfavored,100,22,12/17/2019
4C37C5,executive-appointment,100,54,12/17/2019
4C6C63,partnership,100,61,12/17/2019
4D203E,market-entry,100,57,12/17/2019
4E4E75,dividend,100,50,12/17/2019
4F71DC,public-offering,100,43,12/17/2019
539F49,business-contract,100,69,12/17/2019
545272,dividend,100,50,12/17/2019
5B97B2,dividend,100,50,12/17/2019
5D0337,index-listing,100,76,12/17/2019
5F2FF7,business-contract,100,69,12/17/2019
6166D1,dividend,100,50,12/17/2019
619882,conference-organizer,100,57,12/17/2019
619882,conference-organizer,100,57,12/17/2019
619882,conference-organizer,100,57,12/17/2019
619882,conference-organizer,100,57,12/17/2019
619882,conference-organizer,100,57,12/17/2019
6.52E+64,legal-issues-defendant,100,22,12/17/2019
6.52E+64,business-contract,100,69,12/17/2019
6.52E+64,legal-issues-defendant,100,22,12/17/2019
6844D2,earnings,100,50,12/17/2019
6844D2,earnings,100,50,12/17/2019
6844D2,earnings,100,50,12/17/2019
69C99E,index-listing,100,76,12/17/2019
6CDFC6,executive-appointment,100,54,12/17/2019
6D3B7B,dividend,100,50,12/17/2019
6E7060,dividend,100,50,12/17/2019
70CA28,public-offering,100,43,12/17/2019
73C521,earnings,100,50,12/17/2019
747219,legal-issues-defendant,100,22,12/17/2019
747219,legal-issues-defendant,100,22,12/17/2019
7.40E+289,dividend,100,50,12/17/2019
7823A3,legal-issues-defendant,100,22,12/17/2019
7823A3,legal-issues-defendant,100,22,12/17/2019
7A10FF,executive-appointment,100,54,12/17/2019
7A5097,dividend,100,50,12/17/2019
7BFF81,executive-appointment,100,54,12/17/2019
7E1D5D,product-release,100,64,12/17/2019
804708,executive-appointment,100,54,12/17/2019
810FAD,business-contract,100,69,12/17/2019
82F088,conference-participant,100,50,12/17/2019
8377DB,dividend,100,50,12/17/2019
85AD00,dividend,100,50,12/17/2019
8AC65D,executive-appointment,100,54,12/17/2019
8C5519,earnings,100,50,12/17/2019
8D0EEA,public-offering,100,43,12/17/2019
92B047,executive-appointment,100,54,12/17/2019
9592FB,public-offering,100,43,12/17/2019
990AD0,dividend,100,50,12/17/2019
9D65C1,product-release,100,64,12/17/2019
9D6A24,conference-call,100,50,12/17/2019
9E3224,dividend,100,50,12/17/2019
A1BB98,executive-appointment,100,54,12/17/2019
A1EAC8,product-release,100,64,12/17/2019
A3800A,conference-participant,100,50,12/17/2019
A398F8,executive-appointment,100,54,12/17/2019
A63387,executive-appointment,100,54,12/17/2019
A6828A,business-contract,100,69,12/17/2019
AA247D,credit-extension-recipient,100,69,12/17/2019
AC7C4F,earnings,100,50,12/17/2019
AD3008,conference-participant,100,50,12/17/2019
AFDF2E,legal-issues-defendant,100,22,12/17/2019
B0998E,dividend,100,50,12/17/2019
B303A6,legal-issues-defendant,100,22,12/17/2019
B303A6,legal-issues-defendant,100,22,12/17/2019
B303A6,legal-issues-defendant,100,22,12/17/2019
B303A6,legal-issues-defendant,100,22,12/17/2019
B303A6,legal-issues-defendant,100,22,12/17/2019
B4C673,business-contract,100,69,12/17/2019
B5DE80,conference-call,100,50,12/17/2019
B8F71F,earnings,100,50,12/17/2019
BCC55F,partnership,100,61,12/17/2019
BFAEB4,earnings,100,50,12/17/2019
C0030A,business-contract,100,69,12/17/2019
C3BAE7,conference-participant,100,50,12/17/2019
C3F99F,executive-appointment,100,54,12/17/2019
C4F9C6,patient-enrollment-start,100,58,12/17/2019
C5C137,note-sale,100,52,12/17/2019
C5C137,note-sale,100,52,12/17/2019
C65004,conference-participant,100,50,12/17/2019
C7FC95,partnership,100,61,12/17/2019
C83B88,business-contract,100,69,12/17/2019
C8FAC7,partnership,100,61,12/17/2019
CE4FD9,note-sale,100,52,12/17/2019
CFF15D,partnership,100,61,12/17/2019
D07B07,index-listing,100,76,12/17/2019
D1AE3B,conference-call,100,50,12/17/2019
D1CFC8,earnings,100,50,12/17/2019
D33270,executive-appointment,100,54,12/17/2019
D437C3,product-release,100,64,12/17/2019
D437C3,product-release,100,64,12/17/2019
D437C3,product-release,100,64,12/17/2019
D5938F,public-offering,100,43,12/17/2019
D598E7,conference-call,100,50,12/17/2019
D69D42,executive-appointment,100,54,12/17/2019
D8442A,legal-issues-defendant,100,22,12/17/2019
D8DA3D,legal-issues-defendant,100,22,12/17/2019
DB9F70,public-offering,100,43,12/17/2019
DFADDB,orphan-drug-designation,100,76,12/17/2019
DFADDB,orphan-drug-designation,100,76,12/17/2019
E05DC8,acquisition-acquirer,100,49,12/17/2019
E0E4B7,conference-participant,100,50,12/17/2019
E11C41,dividend,100,50,12/17/2019
E68733,acquisition-acquirer,100,49,12/17/2019
E6D89E,acquisition-interest-acquirer,100,46,12/17/2019
F04E05,buybacks,100,74,12/17/2019
F15E41,acquisition-regulatory-approval-acquirer,100,54,12/17/2019
F15E41,acquisition-regulatory-approval-acquirer,100,54,12/17/2019
F2BC3D,acquisition-acquirer,100,49,12/17/2019
F2BC3D,acquisition-acquirer,100,49,12/17/2019
F30508,earnings-guidance,100,50,12/17/2019
F30508,earnings-guidance,100,50,12/17/2019
F4CDA3,dividend-up,100,81,12/17/2019
FC1A6E,executive-appointment,100,54,12/17/2019
FE7A63,earnings,100,50,12/17/2019
FEC475,legal-issues-defendant,100,22,12/17/2019
01D03F,partnership,100,61,12/18/2019
0325B7,business-contract,100,69,12/18/2019
03F5A4,dividend,100,50,12/18/2019
054E7E,partnership,100,61,12/18/2019
08A40F,partnership,100,61,12/18/2019
0A0CF0,executive-appointment,100,54,12/18/2019
0A9D0A,conference-participant,100,50,12/18/2019
0AB700,dividend,100,50,12/18/2019
0BC29E,executive-appointment,100,54,12/18/2019
1201B5,legal-issues-defendant,100,22,12/18/2019
1490F3,business-contract,100,69,12/18/2019
14ED2B,acquisition-completed-acquirer,100,49,12/18/2019
152AB9,conference-participant,100,50,12/18/2019
165B86,product-release,100,64,12/18/2019
184866,orphan-drug-designation,100,76,12/18/2019
184866,orphan-drug-designation,100,76,12/18/2019
188394,executive-appointment,100,54,12/18/2019
1AB808,executive-resignation,100,44,12/18/2019
1B4F31,stake-acquiree,100,62,12/18/2019
1DF15D,dividend,100,50,12/18/2019
1E04A5,product-release,100,64,12/18/2019
1E83DE,earnings,100,50,12/18/2019
1F43A1,dividend,100,50,12/18/2019
1FA886,buybacks,100,74,12/18/2019
238302,dividend,100,50,12/18/2019
2491BC,legal-issues-defendant,100,22,12/18/2019
26CC63,partnership,100,61,12/18/2019
28DCF3,merger,100,66,12/18/2019
292A70,dividend,100,50,12/18/2019
2E902B,earnings-guidance,100,50,12/18/2019
33FD66,earnings,100,50,12/18/2019
3461CF,analyst-ratings-change-negative-rater,20,50,12/18/2019
39FB23,executive-appointment,100,54,12/18/2019
3B2311,acquisition-completed-acquirer,100,49,12/18/2019
3B2311,unit-acquisition-acquirer,100,49,12/18/2019
3CCC90,business-contract,100,69,12/18/2019
3F4497,dividend,100,50,12/18/2019
49BBBC,earnings,100,50,12/18/2019
4A5C8D,earnings-guidance-meet-expectations,100,59,12/18/2019
4A6F00,acquisition-acquiree,100,76,12/18/2019
4AE584,unit-acquisition-acquirer,100,49,12/18/2019
4BDCA7,executive-appointment,100,54,12/18/2019
4EEE7E,award,100,58,12/18/2019
4F9487,dividend,100,50,12/18/2019
50702E,campaign-ad-retired,100,48,12/18/2019
57634F,note-sale,100,52,12/18/2019
59F0B0,conference-call,100,50,12/18/2019
5A53BF,regulatory-investigation,100,22,12/18/2019
5A53BF,regulatory-product-application,100,69,12/18/2019
609208,earnings,100,50,12/18/2019
619882,conference-organizer,100,57,12/18/2019
619882,conference-organizer,100,57,12/18/2019
619882,conference-organizer,100,57,12/18/2019
619882,conference-organizer,100,57,12/18/2019
619882,conference-organizer,100,57,12/18/2019
619882,conference-organizer,100,57,12/18/2019
619882,conference-organizer,100,57,12/18/2019
6391C2,earnings,100,50,12/18/2019
63E8D5,dividend,100,50,12/18/2019
6.52E+64,legal-issues-defendant,100,22,12/18/2019
665D7D,regulatory-product-approval-granted,100,81,12/18/2019
69C99E,public-offering,100,43,12/18/2019
69FDFC,business-contract,100,69,12/18/2019
6DDA15,executive-resignation,100,44,12/18/2019
6F6559,earnings,100,50,12/18/2019
6F6559,earnings,100,50,12/18/2019
6F6559,earnings,100,50,12/18/2019
6F6559,earnings,100,50,12/18/2019
747219,legal-issues-defendant,100,22,12/18/2019
748EB6,index-listing,100,76,12/18/2019
75F665,conference-call,100,50,12/18/2019
76DD0C,executive-appointment,100,54,12/18/2019
775439,dividend,100,50,12/18/2019
7823A3,legal-issues-defendant,100,22,12/18/2019
7C4F43,partnership,100,61,12/18/2019
7FDE1C,business-contract,100,69,12/18/2019
82B57E,executive-appointment,100,54,12/18/2019
860AB6,dividend,100,50,12/18/2019
86A1B9,acquisition-acquiree,100,76,12/18/2019
8F3231,conference-call,100,50,12/18/2019
8F3231,buybacks,100,74,12/18/2019
911ACB,dividend,100,50,12/18/2019
91C82E,conference-call,100,50,12/18/2019
91E5EE,private-placement,100,56,12/18/2019
925759,executive-appointment,100,54,12/18/2019
934029,conference-call,100,50,12/18/2019
940C3D,earnings,100,50,12/18/2019
94563D,conference-participant,100,50,12/18/2019
94637C,clinical-trials-filed,100,60,12/18/2019
95DE39,note-sale,100,52,12/18/2019
967D92,expenses-charge,100,28,12/18/2019
967D92,acquisition-acquirer,100,49,12/18/2019
9B730A,clinical-trials,100,56,12/18/2019
9BF177,earnings,100,50,12/18/2019
9C25FF,legal-issues-defendant,100,22,12/18/2019
9CA619,earnings,100,50,12/18/2019
9F62D1,acquisition-acquirer,100,49,12/18/2019
A5A4F5,executive-appointment,100,54,12/18/2019
A60318,earnings,100,50,12/18/2019
A63387,product-release,100,64,12/18/2019
A7102F,conference-participant,100,50,12/18/2019
AC1952,executive-appointment,100,54,12/18/2019
AE0CCE,earnings,100,50,12/18/2019
AE7D16,partnership,100,61,12/18/2019
AFDF2E,legal-issues-defendant,100,22,12/18/2019
B08954,buybacks,100,74,12/18/2019
B303A6,legal-issues-defendant,100,22,12/18/2019
B303A6,legal-issues-defendant,100,22,12/18/2019
B303A6,legal-issues-defendant,100,22,12/18/2019
B48D6A,public-offering,100,43,12/18/2019
BA218A,dividend,100,50,12/18/2019
BB5142,executive-resignation,100,44,12/18/2019
BD8517,business-contract,100,69,12/18/2019
C03C8B,conference-participant,100,50,12/18/2019
C2609A,acquisition-acquiree,100,76,12/18/2019
C9732E,legal-issues-defendant,100,22,12/18/2019
CB22CD,executive-appointment,100,54,12/18/2019
CC0C78,business-contract,100,69,12/18/2019
CF073E,executive-appointment,100,54,12/18/2019
CF351E,earnings-guidance,100,50,12/18/2019
CFF97C,analyst-ratings-change-negative-rater,20,50,12/18/2019
D1173F,executive-appointment,100,54,12/18/2019
D2B9E5,acquisition-acquiree,100,76,12/18/2019
D33270,government-contract,100,69,12/18/2019
D33270,government-contract,100,69,12/18/2019
D3FD6D,dividend,100,50,12/18/2019
D4463B,dividend,100,50,12/18/2019
D54E62,acquisition-acquirer,100,49,12/18/2019
D622D5,dividend-up,100,81,12/18/2019
D622D5,executive-resignation,100,44,12/18/2019
D622D5,earnings,100,50,12/18/2019
D8DBA3,merger,100,66,12/18/2019
D8DBA3,merger,100,66,12/18/2019
DAFED3,executive-appointment,100,54,12/18/2019
DB9829,earnings,100,50,12/18/2019
DB9829,earnings,100,50,12/18/2019
DB9829,earnings,100,50,12/18/2019
DB9829,earnings,100,50,12/18/2019
DB9829,earnings,100,50,12/18/2019
DBEF02,buybacks,100,74,12/18/2019
DF18E6,conference-participant,100,50,12/18/2019
E09E2B,partnership,100,61,12/18/2019
E09E2B,partnership,100,61,12/18/2019
E124EB,legal-issues-defendant,100,22,12/18/2019
E6A53A,product-release,100,64,12/18/2019
E6A53A,product-release,100,64,12/18/2019
E7BF32,clinical-trials,100,56,12/18/2019
E7BF32,clinical-trials,100,56,12/18/2019
E99180,dividend,100,50,12/18/2019
EB43F4,partnership,100,61,12/18/2019
EC99D0,conference-call,100,50,12/18/2019
EE6F1C,earnings,100,50,12/18/2019
EFD406,executive-appointment,100,54,12/18/2019
F3D2EB,dividend,100,50,12/18/2019
F3EDB4,dividend,100,50,12/18/2019
F5349B,executive-appointment,100,54,12/18/2019
F5D059,acquisition-acquirer,100,49,12/18/2019
F5D499,acquisition-acquirer,100,49,12/18/2019
FC1F9D,executive-appointment,100,54,12/18/2019
FE7A63,executive-appointment,100,54,12/18/2019
00698D,earnings,100,50,12/19/2019
13528,partnership,100,61,12/19/2019
0157B1,hirings,100,65,12/19/2019
01B8D6,conference-participant,100,50,12/19/2019
01D03F,regulatory-product-approval-granted,100,81,12/19/2019
034B61,partnership,100,61,12/19/2019
03CF95,acquisition-completed-acquirer,100,49,12/19/2019
05AF14,executive-appointment,100,54,12/19/2019
06EF42,earnings,100,50,12/19/2019
07C907,executive-appointment,100,54,12/19/2019
099C88,government-contract,100,69,12/19/2019
0A0CF0,earnings,100,50,12/19/2019
0CC62B,business-combination,100,54,12/19/2019
0CC62B,business-combination,100,54,12/19/2019
0CC62B,business-combination,100,54,12/19/2019
0CC62B,business-combination,100,54,12/19/2019
0CC62B,business-combination,100,54,12/19/2019
0CC62B,business-combination,100,54,12/19/2019
0CE204,business-combination,100,54,12/19/2019
0CE204,business-combination,100,54,12/19/2019
0CE204,business-combination,100,54,12/19/2019
0F04E5,executive-appointment,100,54,12/19/2019
1220D2,business-contract,100,69,12/19/2019
1220D2,business-contract,100,69,12/19/2019
16B183,dividend,100,50,12/19/2019
188394,dividend-up,100,60,12/19/2019
18D9FA,executive-appointment,100,54,12/19/2019
19BF16,conference-participant,100,50,12/19/2019
1A9DE1,dividend,100,50,12/19/2019
1C2593,executive-appointment,100,54,12/19/2019
1CD4B5,index-listing,100,76,12/19/2019
1FAF22,legal-issues-defendant,100,22,12/19/2019
200D8B,business-contract,100,69,12/19/2019
205AD5,conference-call,100,50,12/19/2019
2093B1,buybacks,100,74,12/19/2019
21153F,business-contract,100,69,12/19/2019
21153F,business-contract,100,69,12/19/2019
21153F,business-contract,100,69,12/19/2019
228D42,product-release,100,64,12/19/2019
228D42,partnership,100,61,12/19/2019
228D42,partnership,100,61,12/19/2019
228D42,partnership,100,61,12/19/2019
22C58E,product-release,100,64,12/19/2019
2491BC,legal-issues-defendant,100,22,12/19/2019
24A89A,legal-issues-defendant,100,22,12/19/2019
24A89A,public-offering,100,43,12/19/2019
24A89A,public-offering,100,43,12/19/2019
25A6CC,legal-issues-defendant,100,22,12/19/2019
26DC29,conference-participant,100,50,12/19/2019
292A70,executive-appointment,100,54,12/19/2019
2A17B1,merger,100,66,12/19/2019
2A17B1,merger-completed,100,66,12/19/2019
2C3348,conference-participant,100,50,12/19/2019
2E89AE,conference-participant,100,50,12/19/2019
342218,dividend,100,50,12/19/2019
3461CF,credit-rating-upgrade-rater,20,50,12/19/2019
349DA4,business-contract,100,69,12/19/2019
3587B4,acquisition-acquiree,100,76,12/19/2019
37426C,patent-awarded,100,72,12/19/2019
39FB23,earnings,100,50,12/19/2019
3C7F5F,dividend,100,50,12/19/2019
448BF3,conference-participant,100,50,12/19/2019
449A26,conference-call,100,50,12/19/2019
47FCF2,award,100,58,12/19/2019
4A2457,business-contract,100,69,12/19/2019
4A6F00,partnership,100,61,12/19/2019
4B3555,dividend,100,50,12/19/2019
4B3676,business-contract,100,69,12/19/2019
4B3676,business-contract,100,69,12/19/2019
5065B1,asset-sale,100,62,12/19/2019
5.43E+08,clinical-trials-filed,100,60,12/19/2019
55438C,earnings,100,50,12/19/2019
55438C,conference-call,100,50,12/19/2019
56277A,conference-call,100,50,12/19/2019
57A854,index-listing,100,76,12/19/2019
5BC2F4,dividend,100,50,12/19/2019
5C7601,earnings,100,50,12/19/2019
5CC29D,dividend-up,100,81,12/19/2019
5DD48B,product-release,100,64,12/19/2019
5FDBD0,partnership,100,61,12/19/2019
615B6D,merger-completed,100,66,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
619882,conference-organizer,100,57,12/19/2019
622DBE,business-contract,100,69,12/19/2019
622DBE,business-contract,100,69,12/19/2019
6284B5,executive-appointment,100,54,12/19/2019
633043,buybacks,100,74,12/19/2019
633043,dividend,100,50,12/19/2019
66ECFD,earnings,100,50,12/19/2019
69C99E,public-offering,100,43,12/19/2019
6A171E,executive-resignation,100,44,12/19/2019
6CC55E,executive-appointment,100,54,12/19/2019
6D9ECA,conference-participant,100,50,12/19/2019
6DDA15,legal-issues-defendant,100,22,12/19/2019
729368,executive-appointment,100,54,12/19/2019
747219,legal-issues-defendant,100,22,12/19/2019
7.40E+289,executive-resignation,100,44,12/19/2019
75768D,earnings,100,50,12/19/2019
765913,executive-appointment,100,54,12/19/2019
76E80F,partnership,100,61,12/19/2019
76F067,clinical-trials-filed,100,60,12/19/2019
7823A3,legal-issues-defendant,100,22,12/19/2019
78A1BB,merger-completed,100,66,12/19/2019
791EC1,business-contract,100,69,12/19/2019
7A975D,earnings,100,50,12/19/2019
7ADE57,dividend,100,50,12/19/2019
7C75FD,note-sale,100,52,12/19/2019
7D5FD6,earnings,100,50,12/19/2019
805CD8,conference-participant,100,50,12/19/2019
84AB66,note-sale,100,52,12/19/2019
850779,earnings,100,50,12/19/2019
868808,dividend,100,50,12/19/2019
86A1B9,unit-acquisition-acquiree,100,76,12/19/2019
86A1B9,partnership,100,61,12/19/2019
8BAA15,government-contract,100,69,12/19/2019
8BFAA4,debt-extension-recipient,100,73,12/19/2019
8F3BCC,earnings,100,50,12/19/2019
9196A2,fundraising,100,64,12/19/2019
92D757,conference-participant,100,50,12/19/2019
93AD2E,acquisition-interest-acquiree,100,82,12/19/2019
93AD2E,acquisition-interest-acquiree,100,82,12/19/2019
944B2E,business-contract,100,69,12/19/2019
945DE6,dividend,100,50,12/19/2019
94637C,earnings,100,50,12/19/2019
94637C,partnership,100,61,12/19/2019
9507FF,conference-participant,100,50,12/19/2019
9A602D,business-combination,100,54,12/19/2019
9A602D,business-combination,100,54,12/19/2019
9A602D,business-combination,100,54,12/19/2019
9A602D,business-combination,100,54,12/19/2019
9A602D,business-combination,100,54,12/19/2019
9A602D,business-combination,100,54,12/19/2019
9BBFA5,earnings,100,50,12/19/2019
9C5BA5,supply-decrease,100,28,12/19/2019
9C5BA5,dividend,100,50,12/19/2019
9D56F2,conference-call,100,50,12/19/2019
9EA947,business-contract,100,69,12/19/2019
A21649,executive-appointment,100,54,12/19/2019
A4CD53,conference-participant,100,50,12/19/2019
A5628C,executive-appointment,100,54,12/19/2019
A60354,acquisition-completed-acquirer,100,49,12/19/2019
A6828A,business-contract,100,69,12/19/2019
A6828A,conference-participant,100,50,12/19/2019
A7A0BD,business-contract,100,69,12/19/2019
A80FE0,conference-participant,100,50,12/19/2019
A8E72A,executive-appointment,100,54,12/19/2019
AE4EEB,dividend,100,50,12/19/2019
AFDF2E,legal-issues-defendant,100,22,12/19/2019
B1B10C,acquisition-acquirer,100,49,12/19/2019
B1B10C,acquisition-acquirer,100,49,12/19/2019
B1B10C,earnings-guidance-up,100,83,12/19/2019
B1B10C,earnings-guidance-up,100,83,12/19/2019
B303A6,legal-issues-defendant,100,22,12/19/2019
B303A6,legal-issues-defendant,100,22,12/19/2019
B303A6,legal-issues-defendant,100,22,12/19/2019
BBF349,asset-sale,100,62,12/19/2019
BCC55F,trading-listing,100,61,12/19/2019
BDE867,executive-appointment,100,54,12/19/2019
BDF85E,dividend,100,50,12/19/2019
BE14CF,executive-appointment,100,54,12/19/2019
BE7BA4,executive-appointment,100,54,12/19/2019
C062D4,conference-participant,100,50,12/19/2019
C564E4,conference-participant,100,50,12/19/2019
C58D71,index-listing,100,76,12/19/2019
C65004,business-contract,100,69,12/19/2019
C9E107,executive-appointment,100,54,12/19/2019
CAC8D0,earnings,100,50,12/19/2019
CEC5B9,acquisition-interest-acquirer,100,46,12/19/2019
CEC5B9,acquisition-interest-acquirer,100,46,12/19/2019
D064D5,earnings,100,50,12/19/2019
D1AE3B,executive-appointment,100,54,12/19/2019
D21D8A,dividend,100,50,12/19/2019
D3FA2C,credit-extension-recipient,100,69,12/19/2019
D5938F,public-offering,100,43,12/19/2019
D6144F,unit-acquisition-completed-acquirer,100,49,12/19/2019
D64C6D,earnings,100,50,12/19/2019
D7AC6E,conference-call,100,50,12/19/2019
D854F3,conference-call,100,50,12/19/2019
D8DA3D,legal-issues-defendant,100,22,12/19/2019
DC0066,executive-appointment,100,54,12/19/2019
DC486E,earnings,100,50,12/19/2019
DC486E,earnings,100,50,12/19/2019
DFADDB,business-contract,100,69,12/19/2019
E1BD05,buybacks,100,74,12/19/2019
E1E093,business-contract,100,69,12/19/2019
E26FC3,executive-appointment,100,54,12/19/2019
E84500,dividend,100,50,12/19/2019
E8E899,earnings,100,50,12/19/2019
EB2F14,buybacks,100,74,12/19/2019
ECDEB2,dividend,100,50,12/19/2019
ED79D9,conference-participant,100,50,12/19/2019
ED9576,earnings-guidance,100,50,12/19/2019
EF77A3,executive-resignation,100,44,12/19/2019
EF77A3,earnings,100,50,12/19/2019
F30508,campaign-ad-release,100,59,12/19/2019
F3816D,private-placement,100,56,12/19/2019
F3816D,patient-enrollment-complete,100,64,12/19/2019
F3EDB4,earnings,100,50,12/19/2019
F5D410,debt-extension-recipient,100,73,12/19/2019
F6E248,regulatory-product-application,100,69,12/19/2019
F6E248,regulatory-product-application,100,69,12/19/2019
F6E248,regulatory-product-application,100,69,12/19/2019
FA35C6,executive-appointment,100,54,12/19/2019
FA40E2,earnings-positive,100,69,12/19/2019
FA40E2,earnings,100,50,12/19/2019
FA40E2,earnings,100,50,12/19/2019
FA40E2,earnings,100,50,12/19/2019
FA40E2,earnings,100,50,12/19/2019
FA40E2,earnings,100,50,12/19/2019
FA40E2,earnings,100,50,12/19/2019
FA40E2,earnings,100,50,12/19/2019
0358AF,earnings,100,50,12/20/2019
09062E,conference-participant,100,50,12/20/2019
0E2992,conference-call,100,50,12/20/2019
0F2BC9,acquisition-completed-acquirer,100,49,12/20/2019
10AE08,equity-shelf-registration,100,43,12/20/2019
152E1D,executive-appointment,100,54,12/20/2019
1FAF22,legal-issues-defendant,100,22,12/20/2019
21245F,product-release,100,64,12/20/2019
2491BC,legal-issues-defendant,100,22,12/20/2019
24A89A,public-offering,100,43,12/20/2019
24A89A,public-offering,100,43,12/20/2019
24A89A,legal-issues-defendant,100,22,12/20/2019
25A6CC,legal-issues-defendant,100,22,12/20/2019
28F905,legal-issues-defendant,100,22,12/20/2019
292A70,earnings,100,50,12/20/2019
339F20,dividend-up,100,57,12/20/2019
3C7F5F,stake-acquirer,100,48,12/20/2019
3FACA7,earnings,100,50,12/20/2019
41EC04,legal-issues-defendant,100,22,12/20/2019
49F4D0,dividend,100,50,12/20/2019
4A7C1F,executive-appointment,100,54,12/20/2019
4B3676,acquisition-acquirer,100,49,12/20/2019
4B3676,acquisition-acquirer,100,49,12/20/2019
4BDCA7,executive-appointment,100,54,12/20/2019
4C92B9,executive-appointment,100,54,12/20/2019
4CDA2B,index-listing,100,76,12/20/2019
4D371E,earnings,100,50,12/20/2019
53E575,conference-participant,100,50,12/20/2019
55438C,supply-decrease,100,4,12/20/2019
55438C,business-contract-terminated,100,31,12/20/2019
619882,conference-organizer,100,57,12/20/2019
619882,conference-organizer,100,57,12/20/2019
619882,conference-organizer,100,57,12/20/2019
619882,conference-organizer,100,57,12/20/2019
61A586,executive-appointment,100,54,12/20/2019
6.52E+64,legal-issues-defendant,100,22,12/20/2019
665D7D,debt-extension-recipient,100,73,12/20/2019
6A171E,conference-participant,100,50,12/20/2019
6DBBBC,acquisition-acquirer,100,49,12/20/2019
6DDA15,legal-issues-defendant,100,22,12/20/2019
6DDA15,legal-issues-defendant,100,22,12/20/2019
6DDA15,legal-issues-defendant,100,22,12/20/2019
6DDA15,legal-issues-defendant,100,22,12/20/2019
6F30F9,earnings,100,50,12/20/2019
723548,dividend,100,50,12/20/2019
73C521,executive-resignation,100,44,12/20/2019
747219,legal-issues-defendant,100,22,12/20/2019
7823A3,legal-issues-defendant,100,22,12/20/2019
7BEA98,private-placement,100,56,12/20/2019
7C4F43,executive-appointment,100,54,12/20/2019
7FDE1C,product-release,100,64,12/20/2019
8817D5,conference-call,100,50,12/20/2019
88D80A,dividend,100,50,12/20/2019
8F6995,executive-appointment,100,54,12/20/2019
9043FE,executive-appointment,100,54,12/20/2019
9043FE,executive-appointment,100,54,12/20/2019
915E7B,dividend,100,50,12/20/2019
93F143,partnership,100,61,12/20/2019
94637C,regulatory-product-approval-granted,100,81,12/20/2019
95F59E,conference-participant,100,50,12/20/2019
9B4066,unit-acquisition-acquirer,100,49,12/20/2019
9C5174,conference-participant,100,50,12/20/2019
9FA83B,acquisition-regulatory-approval-acquirer,100,54,12/20/2019
A02FB1,executive-appointment,100,54,12/20/2019
A16DEA,executive-appointment,100,54,12/20/2019
A1EAC8,business-contract,100,69,12/20/2019
A26EF7,rights-issue,100,43,12/20/2019
A6828A,acquisition-acquirer,100,49,12/20/2019
A6FE1C,unit-acquisition-acquirer,100,49,12/20/2019
AA7FE0,earnings,100,50,12/20/2019
AA7FE0,earnings,100,50,12/20/2019
AA7FE0,earnings,100,50,12/20/2019
AA7FE0,earnings,100,50,12/20/2019
AA7FE0,earnings,100,50,12/20/2019
AEFC90,clinical-trials-start,100,64,12/20/2019
B303A6,legal-issues-defendant,100,22,12/20/2019
B303A6,legal-issues-defendant,100,22,12/20/2019
B4C673,unit-acquisition-acquiree,100,76,12/20/2019
B76C82,capital-increase-completed,100,61,12/20/2019
B9BDE8,conference-participant,100,50,12/20/2019
BE86A1,dividend,100,50,12/20/2019
C2F597,merger,100,66,12/20/2019
C83B88,partnership,100,61,12/20/2019
C9732E,legal-issues-defendant,100,22,12/20/2019
CBBFBF,supply-decrease,100,28,12/20/2019
CBBFBF,business-contract-terminated,100,31,12/20/2019
DB9F70,public-offering,100,43,12/20/2019
E6EDED,conference-call,100,50,12/20/2019
E959F3,conference-call,100,50,12/20/2019
E99180,acquisition-acquirer,100,49,12/20/2019
EB2F14,executive-appointment,100,54,12/20/2019
EB61C4,executive-appointment,100,54,12/20/2019
EC8116,dividend,100,50,12/20/2019
F6581D,capital-increase,100,43,12/20/2019
F6E248,regulatory-product-approval-granted,100,81,12/20/2019
F748C7,dividend,100,50,12/20/2019
F7FCA4,note-sale,100,52,12/20/2019
F82D37,conference-call,100,50,12/20/2019
F9AA02,clinical-trials-start,100,64,12/20/2019
FEC475,legal-issues-defendant,100,22,12/20/2019
2491BC,legal-issues-defendant,100,22,12/21/2019
25A6CC,legal-issues-defendant,100,22,12/21/2019
6.52E+64,legal-issues-defendant,100,22,12/21/2019
6DDA15,legal-issues-defendant,100,22,12/21/2019
747219,legal-issues-defendant,100,22,12/21/2019
7823A3,legal-issues-defendant,100,22,12/21/2019
7D35D8,legal-issues-defendant,100,22,12/21/2019
D8DA3D,legal-issues-defendant,100,22,12/21/2019
E70531,supply-increase,100,74,12/21/2019
002A99,regulatory-product-application,100,69,12/23/2019
00698D,executive-resignation,100,44,12/23/2019
01478A,executive-appointment,100,54,12/23/2019
0157B1,product-release,100,64,12/23/2019
01D03F,business-contract,100,69,12/23/2019
03542C,unit-acquisition-acquirer,100,49,12/23/2019
0CC01F,earnings,100,50,12/23/2019
0DC050,unit-acquisition-acquirer,100,49,12/23/2019
16B183,joint-venture,100,62,12/23/2019
232053,credit-extension-recipient,100,69,12/23/2019
2491BC,legal-issues-defendant,100,22,12/23/2019
2491BC,legal-issues-defendant,100,22,12/23/2019
25A6CC,legal-issues-defendant,100,22,12/23/2019
25D3CE,business-contract,100,69,12/23/2019
267718,business-contract,100,69,12/23/2019
2A02DC,conference-participant,100,50,12/23/2019
2E1322,acquisition-acquiree,100,76,12/23/2019
2E1322,acquisition-acquiree,100,76,12/23/2019
2E1322,acquisition-acquiree,100,76,12/23/2019
2E1322,acquisition-acquiree,100,76,12/23/2019
2EBA55,dividend,100,50,12/23/2019
2EC172,acquisition-acquirer,100,49,12/23/2019
2F24A5,earnings,100,50,12/23/2019
31803E,conference-participant,100,50,12/23/2019
32F943,business-contract,100,69,12/23/2019
32F943,partnership,100,61,12/23/2019
349DA4,regulatory-product-approval-granted,100,81,12/23/2019
34B411,business-contract,100,69,12/23/2019
34E9F9,government-contract,100,69,12/23/2019
385DD4,facility-open,100,65,12/23/2019
3A3447,facility-open,100,65,12/23/2019
3B8484,executive-appointment,100,54,12/23/2019
41EC04,legal-issues-defendant,100,22,12/23/2019
41ED98,board-meeting,100,51,12/23/2019
451D61,conference-participant,100,50,12/23/2019
46017C,conference-participant,100,50,12/23/2019
510EA6,earnings,100,50,12/23/2019
510EA6,earnings,100,50,12/23/2019
543900,unit-acquisition-completed-acquiree,100,67,12/23/2019
55C9B5,acquisition-acquirer,100,49,12/23/2019
5BC2F4,executive-appointment,100,54,12/23/2019
5D16CF,acquisition-completed-acquirer,100,49,12/23/2019
5DD48B,executive-appointment,100,54,12/23/2019
619882,conference-organizer,100,57,12/23/2019
619882,conference-organizer,100,57,12/23/2019
619882,conference-organizer,100,57,12/23/2019
619882,conference-organizer,100,57,12/23/2019
619882,conference-organizer,100,57,12/23/2019
619882,conference-organizer,100,57,12/23/2019
619882,conference-organizer,100,57,12/23/2019
6.52E+64,legal-issues-defendant,100,22,12/23/2019
657097,unit-acquisition-acquirer,100,49,12/23/2019
69494C,executive-resignation,100,44,12/23/2019
69C99E,public-offering,100,43,12/23/2019
6ACFBF,acquisition-acquirer,100,49,12/23/2019
6ACFBF,acquisition-acquirer,100,49,12/23/2019
6DDA15,legal-issues-defendant,100,22,12/23/2019
6DDA15,legal-issues-defendant,100,22,12/23/2019
6DDA15,legal-issues-defendant,100,22,12/23/2019
6F5DD2,public-offering,100,43,12/23/2019
713810,product-release,100,64,12/23/2019
741937,executive-appointment,100,54,12/23/2019
7448A3,conference-participant,100,50,12/23/2019
747219,legal-issues-defendant,100,22,12/23/2019
747219,legal-issues-defendant,100,22,12/23/2019
763DBE,conference-participant,100,50,12/23/2019
76DD0C,executive-appointment,100,54,12/23/2019
7823A3,legal-issues-defendant,100,22,12/23/2019
7823A3,legal-issues-defendant,100,22,12/23/2019
791EC1,unit-acquisition-acquirer,100,49,12/23/2019
7EA323,executive-appointment,100,54,12/23/2019
7FD8B9,partnership,100,61,12/23/2019
830BDB,regulatory-product-application,100,69,12/23/2019
88D80A,acquisition-completed-acquirer,100,49,12/23/2019
934029,clinical-trials-filed,100,60,12/23/2019
94637C,regulatory-product-approval-granted,100,81,12/23/2019
95F59E,unit-acquisition-completed-acquirer,100,49,12/23/2019
9F37C5,dividend,100,50,12/23/2019
9F71E5,executive-appointment,100,54,12/23/2019
A072C4,business-contract,100,69,12/23/2019
A52B6B,acquisition-completed-acquirer,100,49,12/23/2019
A8CBDA,conference-call,100,50,12/23/2019
AD375D,dividend,100,50,12/23/2019
AFF43F,earnings,100,50,12/23/2019
B303A6,legal-issues-defendant,100,22,12/23/2019
B303A6,legal-issues-defendant,100,22,12/23/2019
B840EF,partnership,100,61,12/23/2019
B9CD50,note-sale,100,52,12/23/2019
BDEC1E,regulatory-product-approval-granted,100,81,12/23/2019
BEA527,partnership,100,61,12/23/2019
BEA527,partnership,100,61,12/23/2019
C0030A,executive-appointment,100,54,12/23/2019
C22BE8,executive-appointment,100,54,12/23/2019
C7859D,conference-call,100,50,12/23/2019
D0909F,resource-discovery,100,88,12/23/2019
D1588D,index-listing,100,76,12/23/2019
D518D8,partnership,100,61,12/23/2019
D8DA3D,legal-issues-defendant,100,22,12/23/2019
D93A25,conference-call,100,50,12/23/2019
DAFED3,conference-call,100,50,12/23/2019
E2F130,conference-call,100,50,12/23/2019
E598FB,clinical-trials-start,100,64,12/23/2019
E8846E,earnings,100,50,12/23/2019
EAEA91,dividend,100,50,12/23/2019
EBD89A,business-contract,100,69,12/23/2019
ED4560,conference-participant,100,50,12/23/2019
F47871,regulatory-product-application,100,69,12/23/2019
F47871,clinical-trials-filed,100,60,12/23/2019
F5D499,executive-appointment,100,54,12/23/2019
F6E248,conference-participant,100,50,12/23/2019
0BC853,acquisition-interest-acquirer,100,46,12/24/2019
1201B5,acquisition-interest-acquirer,100,46,12/24/2019
1FAF22,legal-issues-defendant,100,22,12/24/2019
2491BC,legal-issues-defendant,100,22,12/24/2019
24A89A,public-offering,100,43,12/24/2019
24A89A,public-offering,100,43,12/24/2019
24A89A,legal-issues-defendant,100,22,12/24/2019
25A6CC,legal-issues-defendant,100,22,12/24/2019
272704,earnings,100,50,12/24/2019
275300,conference-participant,100,50,12/24/2019
4A6F00,partnership,100,61,12/24/2019
58CA9A,acquisition-interest-acquirer,100,46,12/24/2019
6.52E+64,legal-issues-defendant,100,22,12/24/2019
6DDA15,legal-issues-defendant,100,22,12/24/2019
6F5DD2,public-offering,100,43,12/24/2019
747219,legal-issues-defendant,100,22,12/24/2019
7B8CB5,analyst-ratings-change-positive,100,78,12/24/2019
8DE74B,partnership,100,61,12/24/2019
AE79CD,private-placement,100,56,12/24/2019
AFDF2E,legal-issues-defendant,100,22,12/24/2019
B303A6,legal-issues-defendant,100,22,12/24/2019
B6CD92,dividend-up,100,81,12/24/2019
CFF97C,analyst-ratings-change-positive-rater,20,50,12/24/2019
D90F43,executive-resignation,100,44,12/24/2019
E68C3D,business-contract,100,69,12/24/2019
E68C3D,business-contract,100,69,12/24/2019
F4E882,legal-issues-defendant,100,22,12/24/2019
F4E882,legal-issues-defendant,100,22,12/24/2019
F6E248,business-contract,100,69,12/24/2019
0BC853,acquisition-interest-acquirer,100,46,12/26/2019
1A5D5D,legal-issues-defendant,100,22,12/26/2019
1FAF22,legal-issues-defendant,100,22,12/26/2019
202E5A,executive-resignation,100,44,12/26/2019
2491BC,legal-issues-defendant,100,22,12/26/2019
250BEE,stake-acquirer,100,48,12/26/2019
250BEE,stake-acquirer,100,48,12/26/2019
250BEE,stake-acquirer,100,48,12/26/2019
25A6CC,legal-issues-defendant,100,22,12/26/2019
3A3447,facility-open,100,65,12/26/2019
41EC04,legal-issues-defendant,100,22,12/26/2019
619882,conference-organizer,100,57,12/26/2019
6DBBBC,business-contract,100,69,12/26/2019
6DDA15,legal-issues-defendant,100,22,12/26/2019
747219,legal-issues-defendant,100,22,12/26/2019
834152,partnership,100,61,12/26/2019
877C0C,conference-participant,100,50,12/26/2019
A6FE1C,acquisition-acquirer,100,49,12/26/2019
AFDF2E,earnings-revision,100,29,12/26/2019
B303A6,legal-issues-defendant,100,22,12/26/2019
C4F9C6,regulatory-product-approval-granted,100,81,12/26/2019
D15833,dividend,100,50,12/26/2019
D8DA3D,legal-issues-defendant,100,22,12/26/2019
E9FF33,earnings,100,50,12/26/2019
F4E882,legal-issues-defendant,100,22,12/26/2019
FEC475,legal-issues-defendant,100,22,12/26/2019
FF4BA4,earnings,100,50,12/26/2019
10C19B,earnings,100,50,12/27/2019
1FAF22,legal-issues-defendant,100,22,12/27/2019
2491BC,legal-issues-defendant,100,22,12/27/2019
25A6CC,legal-issues-defendant,100,22,12/27/2019
3A3447,facility-open,100,65,12/27/2019
453282,earnings,100,50,12/27/2019
52D936,acquisition-completed-acquirer,100,49,12/27/2019
55C9B5,conference-call,100,50,12/27/2019
619882,conference-organizer,100,57,12/27/2019
6DDA15,legal-issues-defendant,100,22,12/27/2019
6DDA15,legal-issues-defendant,100,22,12/27/2019
6F0A63,executive-appointment,100,54,12/27/2019
747219,legal-issues-defendant,100,22,12/27/2019
747219,legal-issues-defendant,100,22,12/27/2019
747219,legal-issues-defendant,100,22,12/27/2019
A6FE1C,unit-acquisition-acquirer,100,49,12/27/2019
A6FE1C,unit-acquisition-acquirer,100,49,12/27/2019
AFDF2E,legal-issues-defendant,100,22,12/27/2019
AFDF2E,legal-issues-defendant,100,22,12/27/2019
B303A6,legal-issues-defendant,100,22,12/27/2019
B381D8,legal-issues-defendant,100,22,12/27/2019
CAD7D9,executive-resignation,100,44,12/27/2019
D8DA3D,legal-issues-defendant,100,22,12/27/2019
F4E882,legal-issues-defendant,100,22,12/27/2019
F4E882,legal-issues-defendant,100,22,12/27/2019
F85CC0,dividend,100,50,12/27/2019
F85CC0,dividend,100,50,12/27/2019
1A5D5D,legal-issues-defendant,100,22,12/28/2019
2491BC,legal-issues-defendant,100,22,12/28/2019
24A89A,legal-issues-defendant,100,22,12/28/2019
25A6CC,legal-issues-defendant,100,22,12/28/2019
41EC04,legal-issues-defendant,100,22,12/28/2019
41EC04,legal-issues-defendant,100,22,12/28/2019
747219,legal-issues-defendant,100,22,12/28/2019
AFDF2E,legal-issues-defendant,100,22,12/28/2019
B303A6,legal-issues-defendant,100,22,12/28/2019
D8DA3D,legal-issues-defendant,100,22,12/28/2019
F4E882,legal-issues-defendant,100,22,12/28/2019
F4E882,legal-issues-defendant,100,22,12/28/2019
FEC475,legal-issues-defendant,100,22,12/28/2019
FEC475,legal-issues-defendant,100,22,12/28/2019
6DDA15,legal-issues-defendant,100,22,12/29/2019
00326E,index-listing,100,76,12/30/2019
033B58,clinical-trials-start,100,64,12/30/2019
04CCCD,dividend,100,50,12/30/2019
0C6861,dividend,100,50,12/30/2019
0F65C9,index-listing,100,76,12/30/2019
10C19B,executive-appointment,100,54,12/30/2019
1A5D5D,legal-issues-defendant,100,22,12/30/2019
1FA886,business-contract,100,69,12/30/2019
1FAF22,legal-issues-defendant,100,22,12/30/2019
202E5A,conference-participant,100,50,12/30/2019
2491BC,legal-issues-defendant,100,22,12/30/2019
2491BC,legal-issues-defendant,100,22,12/30/2019
251988,earnings,100,50,12/30/2019
25A6CC,legal-issues-defendant,100,22,12/30/2019
2ABF77,conference-participant,100,50,12/30/2019
2EBA55,buybacks,100,74,12/30/2019
2F7474,dividend,100,50,12/30/2019
367434,clinical-trials-start,100,64,12/30/2019
3A3447,facility-open,100,65,12/30/2019
3C6CCC,unit-acquisition-acquirer,100,49,12/30/2019
3D9999,earnings,100,50,12/30/2019
41EC04,legal-issues-defendant,100,22,12/30/2019
429BFB,conference-participant,100,50,12/30/2019
4E7C1F,conference-participant,100,50,12/30/2019
4EC4C1,conference-call,100,50,12/30/2019
546A9C,conference-call,100,50,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
619882,conference-organizer,100,57,12/30/2019
622DBE,legal-issues-defendant,100,22,12/30/2019
6D156D,conference-participant,100,50,12/30/2019
6DDA15,legal-issues-defendant,100,22,12/30/2019
747219,legal-issues-defendant,100,22,12/30/2019
747219,legal-issues-defendant,100,22,12/30/2019
7771D7,earnings,100,50,12/30/2019
85AD00,conference-call,100,50,12/30/2019
8E10BF,clinical-trials-start,100,64,12/30/2019
8FE7A5,conference-participant,100,50,12/30/2019
94983E,conference-participant,100,50,12/30/2019
96F126,product-release,100,64,12/30/2019
9F5CBB,dividend,100,50,12/30/2019
9FA83B,acquisition-completed-acquirer,100,49,12/30/2019
A5DD24,executive-appointment,100,54,12/30/2019
A631A3,acquisition-completed-acquirer,100,49,12/30/2019
A6828A,acquisition-completed-acquirer,100,49,12/30/2019
A6FE1C,unit-acquisition-acquirer,100,49,12/30/2019
A7A0C8,business-contract,100,69,12/30/2019
AA3AB8,conference-participant,100,50,12/30/2019
AA98ED,acquisition-completed-acquirer,100,49,12/30/2019
AFDF2E,legal-issues-defendant,100,22,12/30/2019
AFDF2E,legal-issues-defendant,100,22,12/30/2019
B303A6,legal-issues-defendant,100,22,12/30/2019
B508E5,conference-participant,100,50,12/30/2019
B5766D,conference-call,100,50,12/30/2019
BC5680,legal-issues-defendant,100,22,12/30/2019
C0BA36,conference-participant,100,50,12/30/2019
C9F39B,conference-call,100,50,12/30/2019
CC8F6E,regulatory-product-approval-granted,100,81,12/30/2019
D65A13,conference-participant,100,50,12/30/2019
D78BF1,earnings,100,50,12/30/2019
D854F3,conference-participant,100,50,12/30/2019
D8DA3D,legal-issues-defendant,100,22,12/30/2019
E0339F,earnings,100,50,12/30/2019
F4E882,legal-issues-defendant,100,22,12/30/2019
F4E882,legal-issues-defendant,100,22,12/30/2019
F92DBC,asset-sale,100,62,12/30/2019
FB728F,name-change,100,49,12/30/2019
FEC475,legal-issues-defendant,100,22,12/30/2019
157D9F,conference-call,100,50,12/31/2019
16C7F0,conference-call,100,50,12/31/2019
1A5D5D,legal-issues-defendant,100,22,12/31/2019
1F352C,conference-call,100,50,12/31/2019
1FAF22,legal-issues-defendant,100,22,12/31/2019
24A89A,legal-issues-defendant,100,22,12/31/2019
25A6CC,legal-issues-defendant,100,22,12/31/2019
2E1322,legal-issues-defendant,100,22,12/31/2019
31553A,earnings,100,50,12/31/2019
3A3447,facility-open,100,65,12/31/2019
41EC04,legal-issues-defendant,100,22,12/31/2019
46CF27,earnings,100,50,12/31/2019
4A2457,government-contract,100,69,12/31/2019
58CA9A,earnings,100,50,12/31/2019
619882,conference-organizer,100,57,12/31/2019
619882,conference-organizer,100,57,12/31/2019
619882,conference-organizer,100,57,12/31/2019
619882,conference-organizer,100,57,12/31/2019
6284B5,facility-upgrade,100,65,12/31/2019
657097,executive-appointment,100,54,12/31/2019
69CE71,conference-participant,100,50,12/31/2019
6DDA15,legal-issues-defendant,100,22,12/31/2019
729368,conference-participant,100,50,12/31/2019
765913,earnings,100,50,12/31/2019
8BFAA4,executive-appointment,100,54,12/31/2019
8DCBBB,conference-call,100,50,12/31/2019
A60318,facility-open,100,65,12/31/2019
A6FE1C,unit-acquisition-acquirer,100,49,12/31/2019
AFDF2E,legal-issues-defendant,100,22,12/31/2019
B303A6,legal-issues-defendant,100,22,12/31/2019
B48FC9,conference-participant,100,50,12/31/2019
B803B1,dividend,100,50,12/31/2019
BC5680,legal-issues-defendant,100,22,12/31/2019
C598D7,conference-call,100,50,12/31/2019
D8DA3D,legal-issues-defendant,100,22,12/31/2019
E09556,executive-appointment,100,54,12/31/2019
E96E0B,conference-participant,100,50,12/31/2019
F4E882,fraud-defendant,100,20,12/31/2019
F4E882,legal-issues-defendant,100,22,12/31/2019
FB7724,conference-participant,100,50,12/31/2019
FC4550,conference-call,100,50,12/31/2019
FEC475,legal-issues-defendant,100,22,12/31/2019
